data_1ycm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ycm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.409 0 CA-C-O 120.604 0.24 . . . . 6.79 111.342 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 41.6 m80 56.34 -72.33 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.059 1.743 . . . . 4.5199999999999996 110.956 -159.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -104.85 101.3 10.9 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.915 0.886 . . . . 4.6299999999999999 112.315 -169.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 25.8 mm -81.77 91.77 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 108.478 -0.934 . . . . 3.29 108.478 170.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.644 ' HG1' ' H ' ' A' ' 158' ' ' ASP . 25.1 p -79.93 125.21 29.45 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.137 -0.69 . . . . 1.6100000000000001 109.137 171.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -130.75 158.47 40.03 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.383 0.673 . . . . 5.1299999999999999 111.031 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -144.47 145.04 31.66 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.521 -0.918 . . . . 6.0300000000000002 108.521 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.99 147.24 5.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 108.143 -1.058 . . . . 1.46 108.143 174.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -84.71 -44.32 13.49 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.455 -0.572 . . . . 4.4299999999999997 109.455 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -153.25 171.58 18.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.912 -0.773 . . . . 2.25 108.912 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -128.13 129.95 47.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.876 1.27 . . . . 3.1299999999999999 108.15 -163.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.478 ' HG1' ' CG ' ' A' ' 124' ' ' ASP . 6.5 t -63.47 114.18 12.19 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 118.539 0.609 . . . . 2.6699999999999999 109.739 -175.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -68.41 -17.98 43.96 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.488 2.792 . . . . 1.9399999999999999 111.125 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.478 ' CG ' ' HG1' ' A' ' 122' ' ' THR . 0.1 OUTLIER -42.22 -34.25 0.74 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.632 2.773 . . . . 2.27 111.61 174.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.51 -179.64 5.57 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.056 1.342 . . . . 2.77 109.418 175.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -71.32 132.38 44.8 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 109.22 -0.659 . . . . 3.0899999999999999 109.22 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 53.5 ttt-85 -47.79 -40.41 20.82 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.507 0.558 . . . . 2.7999999999999998 112.507 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -50.38 -55.33 16.15 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.812 -0.81 . . . . 2.8399999999999999 108.812 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -55.11 -45.03 75.49 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.937 1.695 . . . . 2.2599999999999998 111.908 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.63 -57.83 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 O-C-N 121.418 -0.802 . . . . 1.8700000000000001 109.694 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.496 ' HB3' ' HZ2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -68.03 -27.53 66.61 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 117.919 -1.513 . . . . 1.78 109.184 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -59.72 -47.91 83.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.206 0.912 . . . . 3.2000000000000002 110.383 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.82 -52.56 64.95 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.081 0.552 . . . . 0.48999999999999999 110.508 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.05 -37.6 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.289 -0.634 . . . . 2.46 109.289 -175.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -55.34 -60.83 2.85 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.502 1.121 . . . . 4.7400000000000002 108.021 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -58.0 -45.86 86.16 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.246 1.018 . . . . 2.3599999999999999 109.445 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.53 -52.66 36.66 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.968 0.907 . . . . 0.68999999999999995 111.429 175.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.461 ' HB3' ' CD2' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -53.67 -55.48 25.69 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 110.091 -0.337 . . . . 5.71 110.091 170.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.55 -44.61 46.71 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.314 1.046 . . . . 3.4900000000000002 110.497 -171.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.2 t -47.58 -54.06 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.109 0.964 . . . . 1.54 110.098 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.433 ' CZ3' HG23 ' A' ' 258' ' ' ILE . 83.8 m95 -72.08 -41.07 67.78 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.283 -0.636 . . . . 0.82999999999999996 109.283 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.02 -22.76 51.36 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.919 0.888 . . . . 2.0 111.271 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -75.37 -43.63 49.32 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.088 0.955 . . . . 2.0 110.942 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 65.8 t -84.87 -49.39 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.685 1.194 . . . . 3.02 110.825 -173.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 81.6 p -77.24 158.0 80.09 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 107.976 -1.12 . . . . 1.3600000000000001 107.976 174.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.08 -1.03 10.72 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.75 1.633 . . . . 0.83999999999999997 112.601 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.4 mt -62.24 139.76 58.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.021 0.828 . . . . 2.6800000000000002 110.263 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.38 97.13 6.14 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.049 -1.093 . . . . 8.5399999999999991 108.049 177.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.461 ' CD2' ' HB3' ' A' ' 138' ' ' PHE . 0.4 OUTLIER -64.56 153.82 38.03 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.373 0.508 . . . . 8.4499999999999993 112.373 175.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.57 113.77 3.42 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 123.948 0.899 . . . . 1.48 110.103 176.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.496 ' HZ2' ' HB3' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -82.47 139.6 33.86 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.526 -0.916 . . . . 2.8100000000000001 108.526 173.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.1 pp -139.34 114.28 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.309 -0.997 . . . . 1.5800000000000001 108.309 172.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -80.15 -15.74 56.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.452 -0.34 . . . . 2.6600000000000001 110.753 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 72.2 p -124.37 89.2 3.03 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 124.585 1.154 . . . . 3.4500000000000002 110.798 -170.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 145.83 -143.38 11.61 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.41 -1.876 . . . . 2.0499999999999998 108.41 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 33.6 mtt -127.43 131.18 50.28 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.857 2.063 . . . . 5.5999999999999996 107.751 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -109.94 167.22 10.33 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.589 1.556 . . . . 0.88 109.274 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.644 ' H ' ' HG1' ' A' ' 115' ' ' THR . 26.2 t70 -79.94 -50.59 10.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.761 -0.829 . . . . 2.3399999999999999 108.761 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 12.3 pt -106.75 169.08 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.454 0.645 . . . . 1.1699999999999999 109.742 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.64 135.74 35.2 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.929 1.292 . . . . 2.8900000000000001 109.848 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.8 t -100.75 102.56 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.051 0.94 . . . . 1.1599999999999999 109.476 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.3 t -89.17 88.7 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 126.023 1.729 . . . . 2.1600000000000001 111.341 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -81.78 105.43 12.91 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 107.115 -1.439 . . . . 7.0599999999999996 107.115 170.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -123.95 151.76 43.24 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 118.415 0.552 . . . . 1.03 109.737 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.56 99.88 6.53 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.847 1.259 . . . . 4.8300000000000001 109.699 -167.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 54.13 43.29 73.66 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.426 1.012 . . . . 3.7000000000000002 111.439 172.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -157.27 176.39 12.76 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.467 0.707 . . . . 5.5800000000000001 109.895 -170.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.287 0 C-N-CA 127.522 2.329 . . . . 4.75 110.439 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.237 0 CA-C-O 119.254 -0.403 . . . . 3.2799999999999998 110.838 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -160.52 166.69 28.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.13 1.772 . . . . 7.7999999999999998 106.34 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.8 p30 -153.76 168.91 24.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.295 -1.372 . . . . 3.6899999999999999 107.295 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -66.79 -148.18 0.09 OUTLIER Glycine 0 CA--C 1.533 1.162 0 CA-C-O 122.867 1.26 . . . . 1.8500000000000001 114.264 -170.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.13 78.78 0.51 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.488 1.515 . . . . 4.5999999999999996 110.065 -171.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 135.7 -159.23 24.12 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 108.711 -1.756 . . . . 2.3399999999999999 108.711 -174.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 64.57 -125.03 30.43 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.892 -1.283 . . . . 2.1499999999999999 109.892 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . 0.276 21.0 mm -77.21 132.32 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 108.67 -0.863 . . . . 2.46 108.67 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 9.1 mp -85.27 -63.1 1.38 Allowed 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.373 2.269 . . . . 1.5 109.303 168.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -168.75 152.4 5.48 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 114.385 1.254 . . . . 0.67000000000000004 114.385 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -151.2 138.82 19.65 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.157 0.983 . . . . 1.48 112.772 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . 0.26 . . -163.51 162.21 24.47 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.479 1.911 . . . . 0.81999999999999995 106.087 -157.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -149.28 140.74 23.32 Favored 'General case' 0 C--O 1.227 -0.089 0 N-CA-C 109.282 -0.636 . . . . 4.6500000000000004 109.282 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.94 -87.34 1.77 Allowed Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.189 -1.164 . . . . 0.62 110.189 173.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -69.92 89.38 0.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.72 2.947 . . . . 1.5700000000000001 110.855 -173.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -165.37 172.12 40.85 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 108.047 -2.021 . . . . 1.3899999999999999 108.047 171.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.2 p -84.06 172.81 11.65 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.147 0.979 . . . . 2.8100000000000001 109.782 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.93 -103.54 0.14 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.033 0.825 . . . . 1.52 112.409 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.425 HD13 ' HE2' ' A' ' 196' ' ' HIS . 4.9 tp -59.43 -40.2 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-O 118.371 -0.823 . . . . 1.6499999999999999 109.282 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -36.1 132.13 0.79 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.632 1.11 . . . . 1.3100000000000001 113.0 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.82 -43.28 1.77 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.944 1.735 . . . . 0.89000000000000001 110.915 -164.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.62 159.97 15.62 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.635 0.774 . . . . 1.46 109.482 -162.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -138.75 125.24 20.57 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 117.96 -1.019 . . . . 0.98999999999999999 113.392 -168.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.425 ' HE2' HD13 ' A' ' 191' ' ' ILE . 1.9 m170 -111.83 139.58 47.19 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 119.423 1.01 . . . . 2.98 109.234 -168.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -135.99 148.41 48.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.177 0.899 . . . . 4.1299999999999999 110.741 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -73.33 82.2 1.39 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.411 -1.268 . . . . 2.3799999999999999 110.462 -176.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -61.05 -27.1 68.1 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 121.205 -0.934 . . . . 3.7400000000000002 110.833 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.76 -43.4 12.99 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.263 1.425 . . . . 2.6600000000000001 109.793 172.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -70.89 157.11 38.72 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 123.827 1.775 . . . . 2.0299999999999998 112.581 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -102.4 87.71 3.09 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 112.727 -2.033 . . . . 7.4299999999999997 106.698 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -75.06 154.34 37.97 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 113.762 -1.563 . . . . 1.52 107.595 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.3 p -136.3 137.64 40.89 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.387 0.613 . . . . 2.3199999999999998 109.5 -171.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.9 -47.04 88.24 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.333 -1.479 . . . . 2.29 110.33 173.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -65.61 151.63 46.03 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.588 -0.733 . . . . 2.3700000000000001 110.37 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.7 m -60.27 -38.33 83.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.75 1.22 . . . . 4.79 110.555 -171.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -55.62 120.82 20.43 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-O 118.829 -0.984 . . . . 3.1099999999999999 111.98 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 109.17 -125.71 7.81 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.94 -1.664 . . . . 2.3900000000000001 108.94 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 m -117.07 117.15 28.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.372 -1.714 . . . . 1.1499999999999999 106.372 164.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -77.24 122.11 24.61 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.523 -0.871 . . . . 1.3200000000000001 110.742 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 20.3 tp -56.31 -53.65 54.81 Favored 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 109.6 -0.518 . . . . 2.8500000000000001 109.6 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -48.54 -46.05 38.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.055 0.455 . . . . 2.48 110.135 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.8 tt -57.37 -65.26 0.66 Allowed 'General case' 0 C--O 1.23 0.07 0 C-N-CA 123.85 0.86 . . . . 1.53 110.223 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.29 0.8 OUTLIER -56.49 -40.09 74.34 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.445 0.641 . . . . 2.0 110.214 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.62 -46.75 77.35 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 117.358 -1.306 . . . . 0.51000000000000001 110.36 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 66.4 t -48.79 -45.65 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 120.422 1.464 . . . . 1.26 110.803 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.532 ' CE1' ' O ' ' A' ' 236' ' ' MET . 60.1 t60 -64.15 -50.33 68.61 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.933 0.893 . . . . 3.5699999999999998 112.447 176.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -64.85 -42.92 94.51 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.695 -1.253 . . . . 3.0699999999999998 112.494 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.1 mp -55.51 -43.12 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 107.795 -1.187 . . . . 1.4299999999999999 107.795 172.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.99 -52.0 27.85 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 112.246 -0.341 . . . . 0.77000000000000002 112.246 169.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.51 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 20.0 m-70 -49.48 -52.34 29.94 Favored 'General case' 0 C--N 1.341 0.197 0 O-C-N 122.06 -0.67 . . . . 2.52 110.658 173.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 89.2 p -62.84 -45.85 90.68 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.518 0.562 . . . . 2.46 112.518 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 91.0 mt -56.8 -41.62 78.06 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.647 -0.501 . . . . 3.0 109.647 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 118.43 29.11 1.99 Allowed Glycine 0 C--N 1.337 0.626 0 C-N-CA 124.978 1.275 . . . . 1.2 111.491 171.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.0 143.57 43.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.935 -1.506 . . . . 5.1100000000000003 106.935 -173.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -72.9 143.8 34.06 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.072 -1.211 . . . . 3.1800000000000002 110.072 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -50.92 118.24 3.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.723 0.762 . . . . 1.6799999999999999 110.088 172.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 64.9 m -78.72 173.15 12.76 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.615 -0.513 . . . . 1.3300000000000001 109.615 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.11 30.23 2.47 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.68 0.792 . . . . 3.0 110.742 -170.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -132.06 133.18 23.63 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 106.898 -1.519 . . . . 1.8799999999999999 106.898 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.94 -14.4 44.95 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.449 2.099 . . . . 1.1200000000000001 114.162 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -81.13 -27.79 35.37 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.121 0.968 . . . . 1.6899999999999999 111.279 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.22 152.64 45.17 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.849 -0.797 . . . . 0.68999999999999995 108.849 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 66.8 t -99.11 -25.88 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.296 -0.865 . . . . 0.64000000000000001 109.536 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.532 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 10.8 tpt -65.59 -18.73 65.54 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.157 -0.964 . . . . 3.5499999999999998 113.073 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.471 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.1 157.34 0.66 Allowed Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.719 1.608 . . . . 4.2400000000000002 113.457 -175.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.93 -20.63 16.86 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.712 1.608 . . . . 1.22 111.453 174.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.371 0.2 OUTLIER -77.38 178.03 7.49 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.512 1.125 . . . . 2.0899999999999999 109.1 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -126.66 147.64 49.91 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.418 -1.327 . . . . 3.79 107.418 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -150.54 146.47 26.6 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.047 -1.464 . . . . 3.98 107.047 170.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -72.47 83.41 1.1 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.24 1.016 . . . . 5.25 108.61 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.7 m -76.71 136.75 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 109.413 -0.588 . . . . 1.8300000000000001 109.413 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -87.09 117.97 26.18 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.1 -0.5 . . . . 3.0899999999999999 110.063 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 20.9 mt -60.49 -20.44 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 119.223 -0.417 . . . . 3.3799999999999999 110.222 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -52.35 -36.02 52.57 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.333 0.969 . . . . 3.5099999999999998 111.83 171.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.0 m -81.54 -47.69 12.77 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 122.756 0.423 . . . . 2.5299999999999998 110.31 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 62.1 t80 45.61 73.33 0.17 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.315 1.446 . . . . 5.4500000000000002 111.868 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.89 168.77 23.98 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 121.278 -0.889 . . . . 6.2300000000000004 110.222 177.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.4 ' HG ' ' CZ3' ' A' ' 141' ' ' TRP . 1.3 mm? -108.86 149.03 29.71 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.762 1.625 . . . . 0.83999999999999997 108.066 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.9 m -77.44 158.38 30.04 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 121.17 -0.212 . . . . 1.3799999999999999 111.415 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -58.28 -47.87 82.26 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.728 0.411 . . . . 0.87 110.549 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -55.46 -40.21 71.34 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.039 0.935 . . . . 3.6400000000000001 110.035 176.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.42 -52.1 59.79 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.789 0.835 . . . . 2.0099999999999998 109.815 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.9 mt -56.11 -42.86 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 127.063 2.145 . . . . 0.85999999999999999 112.271 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -61.71 -42.45 98.96 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.177 -1.577 . . . . 9.2599999999999998 110.383 172.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -54.34 -53.14 39.83 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.285 -1.126 . . . . 0.92000000000000004 110.285 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.433 HG23 ' CZ3' ' A' ' 141' ' ' TRP . 1.8 pp -63.96 -43.04 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 O-C-N 122.104 -0.645 . . . . 3.1200000000000001 110.724 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -65.81 -20.14 66.14 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.843 0.747 . . . . 2.77 112.368 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 t -52.11 -33.39 39.55 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.633 0.651 . . . . 2.8700000000000001 110.789 168.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 14.8 mt . . . . . 0 N--CA 1.452 -0.372 0 O-C-N 121.594 -0.691 . . . . 3.54 110.196 175.235 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.231 0 N-CA-C 110.056 -0.35 . . . . 6.1100000000000003 110.056 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 2.1 m170 63.16 -63.17 0.12 Allowed 'General case' 0 C--N 1.342 0.244 0 C-N-CA 126.462 1.905 . . . . 4.8600000000000003 113.197 -172.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -79.04 104.11 9.45 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.321 -0.992 . . . . 3.8100000000000001 108.321 -176.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 9.2 mm -113.36 142.57 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.09 -1.448 . . . . 2.4500000000000002 107.09 173.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.51 ' HG1' ' H ' ' A' ' 158' ' ' ASP . 10.6 p -135.61 140.67 44.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.66 -0.867 . . . . 1.5600000000000001 108.66 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -126.73 160.48 30.7 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.645 0.778 . . . . 5.0899999999999999 111.453 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.52 145.8 31.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.252 1.021 . . . . 5.21 108.994 174.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -94.47 159.82 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.105 -1.443 . . . . 1.0900000000000001 107.105 173.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.465 ' ND2' ' H ' ' A' ' 163' ' ' PHE . 1.3 p30 -101.84 -38.95 7.61 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.815 0.846 . . . . 3.6899999999999999 110.385 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -150.78 173.56 14.07 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.077 1.351 . . . . 2.3999999999999999 107.868 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.442 ' HH ' ' ND2' ' A' ' 153' ' ' ASN . 73.7 m-85 -113.5 129.54 56.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.058 0.943 . . . . 3.0800000000000001 109.641 -175.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -41.08 135.48 1.71 Allowed Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.536 1.534 . . . . 3.75 109.64 165.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -84.97 -23.15 2.59 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.44 2.76 . . . . 2.7400000000000002 110.323 167.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.26 -43.95 33.05 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.74 1.616 . . . . 3.1699999999999999 111.085 -174.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 7.8 mtm -127.18 173.38 9.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.431 1.492 . . . . 2.8599999999999999 109.435 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -71.64 152.76 42.59 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.292 0.637 . . . . 3.2999999999999998 110.498 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -44.97 -52.58 8.64 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.915 0.886 . . . . 3.4100000000000001 112.067 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -64.67 -5.28 5.37 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.492 -0.766 . . . . 2.8599999999999999 113.061 -177.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -103.63 -41.74 5.86 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.551 1.54 . . . . 2.4199999999999999 110.56 168.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.5 m -57.62 -52.69 54.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 O-C-N 121.123 -0.986 . . . . 4.1900000000000004 110.021 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.36 -24.74 64.83 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 118.41 -1.316 . . . . 1.6799999999999999 108.449 178.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -63.38 -49.94 71.86 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 120.298 1.408 . . . . 3.3399999999999999 110.402 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.28 -55.12 27.11 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 123.421 0.688 . . . . 0.42999999999999999 109.828 175.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.88 -41.75 92.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 120.495 -0.482 . . . . 3.6000000000000001 110.09 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.6 ttt-85 -57.51 -54.16 49.97 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.906 1.282 . . . . 5.3899999999999997 108.146 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.9 mmmp? -60.27 -46.62 89.17 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.886 0.875 . . . . 2.75 109.291 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.72 -53.43 31.47 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.421 0.689 . . . . 0.46999999999999997 111.238 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -53.84 -50.8 65.4 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.197 0.599 . . . . 5.71 109.969 171.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.57 -38.25 74.52 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 119.166 -0.445 . . . . 2.3599999999999999 111.313 -173.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 98.4 t -51.04 -58.8 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.332 1.053 . . . . 1.6200000000000001 109.127 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.415 ' CZ3' ' HG ' ' A' ' 250' ' ' LEU . 45.7 m95 -72.8 -34.68 67.05 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.299 -0.63 . . . . 1.1499999999999999 109.299 -174.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 t -64.2 -27.24 68.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.129 0.572 . . . . 1.95 111.652 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -70.31 -46.36 64.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 121.573 -0.705 . . . . 1.3 109.56 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.9 t -77.39 -56.46 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.217 0.607 . . . . 3.1499999999999999 110.792 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 72.3 p -80.27 157.07 73.52 Favored Pre-proline 0 CA--C 1.53 0.193 0 N-CA-C 108.564 -0.902 . . . . 1.21 108.564 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.07 3.01 7.01 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.844 1.696 . . . . 1.1000000000000001 112.869 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.8 mt -73.71 100.55 3.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.101 0.864 . . . . 2.6600000000000001 109.928 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -84.61 96.67 9.26 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.096 0.959 . . . . 4.4100000000000001 109.132 -169.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -79.25 154.79 28.92 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.313 1.045 . . . . 6.8300000000000001 112.831 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -155.42 138.98 15.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.681 1.192 . . . . 1.6599999999999999 108.505 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.38 142.1 28.0 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 108.476 -0.935 . . . . 2.8599999999999999 108.476 173.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.2 pt -130.52 115.87 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.397 -1.334 . . . . 1.7 107.397 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.442 ' ND2' ' HH ' ' A' ' 121' ' ' TYR . 6.1 m120 -80.73 -0.31 37.88 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.421 -0.585 . . . . 2.8199999999999998 109.421 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 39.3 m -153.18 113.72 4.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.599 1.16 . . . . 2.79 108.433 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 138.81 -152.42 22.15 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 107.969 -2.053 . . . . 1.8600000000000001 107.969 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -127.89 125.13 39.07 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.453 1.901 . . . . 5.96 107.04 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.69 166.02 11.11 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.429 1.091 . . . . 0.81999999999999995 109.557 -173.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.51 ' H ' ' HG1' ' A' ' 115' ' ' THR . 23.1 t0 -77.97 -41.83 34.85 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.377 -0.971 . . . . 1.8799999999999999 108.377 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.523 ' CD1' ' HG ' ' A' ' 223' ' ' SER . 33.1 pt -124.48 159.93 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.924 0.89 . . . . 1.3300000000000001 111.262 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.6 tt -126.97 128.29 46.16 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.321 1.449 . . . . 2.3700000000000001 109.947 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.8 t -92.93 98.05 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 125.769 1.627 . . . . 0.95999999999999996 108.097 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.9 t -80.14 136.02 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.719 -1.215 . . . . 1.95 107.719 170.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.465 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 7.3 m-85 -122.63 112.99 18.64 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 103.577 -2.749 . . . . 6.9100000000000001 103.577 166.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -147.65 159.76 43.42 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.4 -0.963 . . . . 1.3700000000000001 108.4 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.79 131.39 47.79 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.027 -1.101 . . . . 5.3300000000000001 108.027 -172.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 73.77 -113.18 4.1 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 111.062 -0.815 . . . . 1.71 111.062 -176.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -129.32 83.67 2.16 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.251 1.025 . . . . 2.29 110.527 -168.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 7.7 p80 . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 120.877 0.37 . . . . 3.8399999999999999 111.97 -179.602 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.103 0 N-CA-C 114.703 1.372 . . . . 2.9900000000000002 114.703 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -123.72 164.93 18.15 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.103 0.961 . . . . 7.3399999999999999 109.683 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -168.98 25.36 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.664 -0.698 . . . . 2.3599999999999999 111.101 -158.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.17 -159.01 41.2 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.25 -1.14 . . . . 1.79 110.25 -171.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.56 104.67 1.32 Allowed 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 122.217 -0.578 . . . . 6.4199999999999999 110.304 175.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 156.44 -179.01 32.63 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 108.678 -1.769 . . . . 2.3399999999999999 108.678 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 45.28 -117.94 2.61 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 126.312 1.911 . . . . 1.9399999999999999 111.123 171.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.3 mm -87.24 132.38 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 108.501 -0.926 . . . . 2.5099999999999998 108.501 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.43 -42.77 18.13 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.708 1.603 . . . . 1.6599999999999999 109.537 170.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.77 158.62 23.08 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.495 -0.753 . . . . 0.82999999999999996 110.423 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -138.44 114.63 10.22 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.647 1.179 . . . . 1.5 113.572 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.21 163.76 27.86 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.919 2.088 . . . . 0.67000000000000004 108.657 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -142.24 153.4 43.93 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.878 -1.527 . . . . 4.29 106.878 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -103.09 -90.35 2.15 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.296 -1.122 . . . . 0.68999999999999995 110.296 172.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.04 82.74 0.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.93 3.086 . . . . 1.5800000000000001 110.965 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -157.96 159.81 30.26 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 108.933 -1.667 . . . . 1.29 108.933 170.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.465 ' H ' ' HG ' ' A' ' 189' ' ' SER . 2.8 p -78.85 171.34 15.32 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.862 0.865 . . . . 2.6899999999999999 110.101 177.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 54.28 -106.53 0.5 Allowed Glycine 0 C--O 1.244 0.721 0 C-N-CA 123.635 0.636 . . . . 1.6100000000000001 111.626 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.4 tp -59.02 -43.22 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 118.501 -0.761 . . . . 1.75 109.14 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -43.3 135.05 4.96 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.492 1.044 . . . . 1.22 112.74 -177.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 107.0 -43.08 1.76 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.485 1.993 . . . . 0.75 110.751 -165.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.87 171.73 10.61 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.502 1.121 . . . . 1.51 110.957 -165.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.31 121.03 8.07 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.66 0.985 . . . . 0.81000000000000005 113.66 -168.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -114.92 113.8 24.63 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 118.923 -0.56 . . . . 3.3900000000000001 112.073 -172.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -100.34 145.67 27.88 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.203 0.91 . . . . 4.1900000000000004 112.412 -177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -73.21 82.66 1.34 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.851 0.834 . . . . 2.79 110.018 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -54.45 -28.96 47.87 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.293 -0.88 . . . . 3.4500000000000002 111.352 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.82 -36.73 65.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.79 -0.448 . . . . 3.1299999999999999 109.79 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.79 146.01 50.02 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 122.374 1.083 . . . . 2.4900000000000002 109.154 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -92.15 92.25 8.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.357 -1.349 . . . . 3.6899999999999999 107.357 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -78.01 131.46 37.38 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.443 -1.317 . . . . 1.51 107.443 -178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 41.0 p -116.87 136.09 53.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.428 0.691 . . . . 1.8799999999999999 109.605 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.1 t -51.13 -49.39 60.89 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.622 1.169 . . . . 2.27 109.717 169.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.39 -179.36 5.69 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.149 0.98 . . . . 2.4199999999999999 111.541 173.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.2 m -56.75 -56.56 19.89 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.791 1.236 . . . . 4.2300000000000004 111.461 -173.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 42.97 -105.9 0.07 OUTLIER Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.017 1.294 . . . . 2.71 114.774 169.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -117.93 -63.3 0.31 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.252 0.93 . . . . 1.8700000000000001 111.348 -172.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.37 164.55 27.18 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.193 -2.151 . . . . 1.6899999999999999 105.193 165.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -116.9 133.24 56.26 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 119.248 0.931 . . . . 1.48 110.967 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 31.4 tp -62.78 -53.58 52.21 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.127 -0.488 . . . . 3.0 109.985 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -50.87 -42.68 59.14 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.205 0.526 . . . . 2.23 109.852 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.02 -63.61 1.24 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.319 0.648 . . . . 1.6200000000000001 109.656 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.315 2.0 m -57.14 -38.43 73.49 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.035 0.445 . . . . 1.9299999999999999 110.651 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.76 -56.65 14.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 118.106 -0.95 . . . . 0.41999999999999998 111.142 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 90.1 t -51.27 -39.42 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 120.538 1.517 . . . . 1.1899999999999999 111.291 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.917 ' NE2' ' CE1' ' A' ' 222' ' ' HIS . 0.5 OUTLIER -64.63 -51.4 62.82 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.128 0.971 . . . . 3.9100000000000001 112.195 174.038 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.46 -45.74 71.64 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.069 -1.019 . . . . 2.6899999999999999 111.965 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.45 -43.99 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 106.616 -1.624 . . . . 1.46 106.616 170.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.2 -53.38 23.73 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 123.695 0.664 . . . . 0.56999999999999995 113.105 170.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.917 ' CE1' ' NE2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -51.25 -42.12 60.82 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 121.848 -0.795 . . . . 2.7599999999999998 110.999 174.163 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.523 ' HG ' ' CD1' ' A' ' 159' ' ' ILE . 8.4 t -51.24 -43.45 61.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 123.602 0.564 . . . . 2.5499999999999998 112.07 -178.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 -60.09 3.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.648 -0.821 . . . . 3.8700000000000001 109.9 174.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 135.98 92.26 0.35 Allowed Glycine 0 C--N 1.338 0.676 0 N-CA-C 111.805 -0.518 . . . . 1.46 111.805 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.689 HD23 ' CE1' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -99.39 177.61 5.13 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.584 0.587 . . . . 7.2000000000000002 112.584 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -120.73 20.7 8.67 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.724 1.154 . . . . 3.0800000000000001 112.74 172.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 30.8 m80 56.14 95.69 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.14 1.776 . . . . 2.2200000000000002 113.08 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.1 m -73.96 171.59 13.17 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.873 0.469 . . . . 1.6000000000000001 110.592 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.7 t -137.25 47.06 2.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.186 0.994 . . . . 3.75 109.101 -169.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -148.9 123.62 4.86 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 107.18 -1.415 . . . . 2.1400000000000001 107.18 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.19 -3.47 13.86 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.191 1.927 . . . . 1.8 114.011 -170.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -82.31 -24.36 34.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.493 1.042 . . . . 1.98 109.943 169.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -82.07 152.6 26.52 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.458 0.703 . . . . 0.81000000000000005 109.632 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 24.0 t -104.52 -21.24 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.246 1.018 . . . . 0.71999999999999997 111.334 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.44 -18.39 17.92 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.479 -0.763 . . . . 3.6899999999999999 112.99 168.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.75 157.31 7.91 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 120.915 -1.116 . . . . 4.4400000000000004 113.353 -176.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.53 -16.98 11.58 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.371 2.047 . . . . 0.98999999999999999 111.791 173.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.355 0.2 OUTLIER -78.49 172.9 12.98 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.963 1.305 . . . . 1.8899999999999999 109.697 -178.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -119.68 142.6 48.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.286 1.435 . . . . 3.4900000000000002 107.265 173.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -156.08 125.73 6.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.422 -1.325 . . . . 4.6500000000000004 107.422 170.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -45.52 142.13 2.42 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.063 1.345 . . . . 3.6099999999999999 112.087 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.0 139.38 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.115 0.966 . . . . 2.5 109.363 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -41.11 96.8 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.111 0.964 . . . . 3.9100000000000001 111.431 171.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 6.1 mt 66.29 18.78 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.623 1.569 . . . . 3.4900000000000002 110.142 -160.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -71.05 -64.09 0.97 Allowed 'General case' 0 C--N 1.343 0.304 0 O-C-N 120.937 -1.102 . . . . 3.6200000000000001 109.865 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 7.4 m -71.94 -39.73 69.22 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.496 -0.775 . . . . 2.0800000000000001 109.558 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 53.05 71.91 0.46 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.336 1.065 . . . . 5.8600000000000003 109.411 176.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -151.36 165.0 35.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.433 -0.951 . . . . 4.25 108.433 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.415 ' HG ' ' CZ3' ' A' ' 141' ' ' TRP . 1.9 mm? -95.42 174.19 7.14 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.419 1.488 . . . . 0.89000000000000001 108.591 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.5 m -91.15 150.73 21.26 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 120.95 -1.094 . . . . 1.5800000000000001 112.217 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.78 -43.37 65.8 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.51 -0.552 . . . . 0.82999999999999996 109.51 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.59 -51.6 68.83 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.954 0.883 . . . . 2.2799999999999998 110.383 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -57.6 -47.28 82.6 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.572 -1.194 . . . . 2.0699999999999998 110.188 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 52.6 mt -52.03 -36.79 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.371 1.868 . . . . 0.81999999999999995 111.329 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 36.7 mtt85 -70.43 -49.06 52.7 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 120.945 -1.097 . . . . 5.9100000000000001 110.177 172.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -45.09 -56.86 5.8 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.708 0.67 . . . . 1.04 111.649 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.87 -46.95 92.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.134 0.974 . . . . 2.9700000000000002 110.434 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -59.69 -26.6 65.72 Favored 'General case' 0 C--N 1.343 0.303 0 O-C-N 120.641 -1.287 . . . . 2.7999999999999998 111.647 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.0 t -49.33 -26.46 3.13 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.652 0.612 . . . . 2.6099999999999999 112.652 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 16.5 mt . . . . . 0 CA--C 1.528 0.099 0 C-N-CA 123.441 0.697 . . . . 3.4500000000000002 111.867 175.875 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.554 0 CA-C-O 121.601 0.715 . . . . 13.02 110.251 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -104.14 19.64 19.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.369 1.468 . . . . 5.8499999999999996 111.084 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -85.45 78.47 9.7 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 109.371 -0.603 . . . . 4.2699999999999996 109.371 -172.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.3 mm -88.03 82.16 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 122.728 1.252 . . . . 2.4399999999999999 108.327 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 p -77.77 126.68 31.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.91 -1.515 . . . . 1.6699999999999999 106.91 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.42 ' CE1' ' CD2' ' A' ' 138' ' ' PHE . 41.7 p90 -128.19 167.14 17.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.855 0.862 . . . . 4.4000000000000004 110.67 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -156.24 177.2 11.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.09 0.471 . . . . 5.4000000000000004 111.076 168.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.29 168.36 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.953 1.301 . . . . 1.4199999999999999 108.199 174.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -95.14 -51.89 4.44 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.736 0.814 . . . . 4.2400000000000002 109.587 169.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.83 153.8 30.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.912 0.485 . . . . 3.9900000000000002 111.638 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -78.31 108.0 11.33 Favored 'General case' 0 CA--C 1.53 0.212 0 N-CA-C 108.369 -0.975 . . . . 3.7599999999999998 108.369 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.9 t -60.17 146.82 82.46 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 118.655 0.662 . . . . 2.7799999999999998 110.575 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.39 -15.97 24.79 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.444 2.763 . . . . 1.9299999999999999 111.356 170.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -47.29 -42.62 21.33 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.829 0.852 . . . . 2.5 111.452 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 5.3 mtm -130.3 175.58 8.82 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.635 1.174 . . . . 2.3700000000000001 108.206 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -75.97 144.8 40.77 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.751 -0.463 . . . . 2.98 109.751 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -45.76 -53.87 8.83 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.486 0.715 . . . . 3.1400000000000001 112.451 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -48.54 -38.94 21.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.402 0.681 . . . . 4.1200000000000001 109.272 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -82.4 -43.09 17.78 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.328 1.851 . . . . 2.04 113.183 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.3 t -50.15 -55.05 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 O-C-N 120.789 -1.194 . . . . 1.8 109.051 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.412 ' OD2' ' NZ ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -71.98 -19.73 61.83 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 119.161 -1.016 . . . . 1.79 109.991 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.426 ' HH ' ' HZ1' ' A' ' 136' ' ' LYS . 27.0 t80 -64.34 -52.62 57.46 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 119.734 1.152 . . . . 3.2400000000000002 109.133 176.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.9 -53.1 44.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 122.998 0.519 . . . . 0.41999999999999998 110.33 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.2 -46.73 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 109.769 -0.456 . . . . 3.5899999999999999 109.769 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -50.77 -55.37 17.05 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 124.365 1.066 . . . . 4.9199999999999999 108.428 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.426 ' HZ1' ' HH ' ' A' ' 132' ' ' TYR . 4.0 mmmt -63.03 -48.89 76.82 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.624 1.169 . . . . 2.5099999999999998 109.292 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -45.89 -55.74 6.32 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.145 0.578 . . . . 0.60999999999999999 111.681 175.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.42 ' CD2' ' CE1' ' A' ' 116' ' ' TYR . 52.8 m-85 -57.54 -48.99 77.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.256 -0.429 . . . . 5.7699999999999996 110.657 173.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.7 -32.87 65.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 113.069 0.766 . . . . 2.75 113.069 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.4 t -63.58 -57.04 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 119.425 1.011 . . . . 1.04 108.518 176.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.546 ' CZ3' HG23 ' A' ' 258' ' ' ILE . 16.9 m95 -68.46 -36.72 79.38 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.039 -0.726 . . . . 1.01 109.039 -172.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.6 t -67.6 -13.09 61.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 118.882 -0.58 . . . . 1.97 112.291 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.17 -54.94 4.47 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 107.946 -1.131 . . . . 1.23 107.946 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.6 m -74.1 -40.88 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 116.105 -0.498 . . . . 2.4100000000000001 111.785 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.1 p -87.06 142.68 34.02 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 107.671 -1.233 . . . . 1.3 107.671 176.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.53 4.95 3.09 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.835 2.356 . . . . 0.75 113.546 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.4 130.43 42.86 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.84 1.256 . . . . 3.5299999999999998 107.818 175.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -97.25 108.34 21.04 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.335 -0.987 . . . . 5.3300000000000001 108.335 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -87.11 142.1 28.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.039 -0.528 . . . . 7.0199999999999996 111.073 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -142.91 117.79 9.95 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.698 0.799 . . . . 1.5900000000000001 110.136 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.412 ' NZ ' ' OD2' ' A' ' 131' ' ' ASP . 20.6 ttpt -78.5 142.75 37.2 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.089 -1.078 . . . . 3.3700000000000001 108.089 172.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.9 pt -134.56 144.04 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 105.519 -2.03 . . . . 1.6200000000000001 105.519 166.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.07 -61.83 1.64 Allowed 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 107.029 -1.471 . . . . 3.4399999999999999 107.029 168.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.4 m -86.67 101.09 12.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.493 0.717 . . . . 2.8900000000000001 110.129 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 153.88 153.4 6.4 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 107.323 -2.311 . . . . 2.3500000000000001 107.323 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.5 ttt -79.37 143.28 35.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.302 -1.37 . . . . 8.2400000000000002 107.302 168.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -127.65 165.44 19.98 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.682 1.193 . . . . 1.45 108.404 -173.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -69.21 -58.21 4.35 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.863 0.839 . . . . 1.9399999999999999 109.359 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.2 pt -105.75 134.49 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.14 -1.059 . . . . 2.1499999999999999 108.14 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . 0.358 0.0 OUTLIER -128.76 132.44 47.91 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.411 -0.806 . . . . 3.6099999999999999 109.424 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.9 t -82.67 106.1 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.677 -0.86 . . . . 1.1000000000000001 108.677 -175.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . 0.417 7.8 t -95.22 94.87 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.411 1.084 . . . . 2.1800000000000002 112.831 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -79.51 115.47 19.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.555 -2.017 . . . . 6.5899999999999999 105.555 167.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -139.57 164.73 29.13 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.294 -1.743 . . . . 1.3100000000000001 106.294 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -132.02 142.6 49.62 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.865 -0.791 . . . . 6.1799999999999997 108.865 -170.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 73.47 -86.1 0.62 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.415 1.007 . . . . 1.97 111.243 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -150.34 145.15 25.95 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 121.581 -0.952 . . . . 2.5 108.661 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.4 p80 . . . . . 0 CA--C 1.533 0.303 0 CA-C-O 121.648 0.737 . . . . 3.5800000000000001 111.05 -178.952 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.093 0 N-CA-C 111.772 0.286 . . . . 2.96 111.772 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -118.25 172.35 7.5 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 107.82 -1.178 . . . . 7.3499999999999996 107.82 -172.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -178.56 28.12 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.814 0.301 . . . . 2.71 111.814 -161.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 60.07 -155.16 31.45 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 119.015 -1.564 . . . . 2.0499999999999998 110.261 -160.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -79.52 106.81 11.82 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.322 0.649 . . . . 5.4500000000000002 110.738 -175.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 148.33 -168.65 29.02 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 108.45 -1.86 . . . . 2.77 108.45 -168.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.68 -112.23 2.64 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 125.83 1.681 . . . . 2.6000000000000001 109.911 172.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . 0.571 4.0 mm -109.07 149.27 12.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.565 -0.902 . . . . 2.2599999999999998 108.565 173.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . 0.276 4.4 mp -81.68 -59.02 2.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.74 2.016 . . . . 1.6899999999999999 108.402 170.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.87 153.92 17.2 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 122.251 1.024 . . . . 0.64000000000000001 113.291 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -143.88 132.44 22.3 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 114.522 1.304 . . . . 1.1699999999999999 114.522 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -160.49 162.27 33.05 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.655 1.982 . . . . 0.64000000000000001 106.144 -164.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -157.97 156.21 30.8 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 107.631 -1.248 . . . . 4.6200000000000001 107.631 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.33 -88.93 1.75 Allowed Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.186 -0.786 . . . . 0.68999999999999995 111.206 173.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.22 82.82 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.828 3.019 . . . . 1.49 111.547 -171.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -159.03 161.67 32.12 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.051 -1.62 . . . . 1.3 109.051 170.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.9 m -78.51 167.2 21.63 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.077 0.465 . . . . 3.0699999999999998 110.461 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 55.07 -106.32 0.52 Allowed Glycine 0 CA--C 1.529 0.906 0 C-N-CA 123.826 0.727 . . . . 1.6200000000000001 112.059 174.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.8 tp -63.54 -27.58 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.158 0.983 . . . . 1.6899999999999999 110.705 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.19 148.61 19.26 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 110.452 -1.059 . . . . 1.1100000000000001 110.452 172.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 87.92 -45.16 3.29 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.932 1.253 . . . . 0.64000000000000001 110.733 -163.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -84.08 171.74 12.62 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 121.681 -0.894 . . . . 1.25 109.843 -161.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -142.93 120.49 11.75 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 119.236 -0.411 . . . . 0.77000000000000002 112.058 -175.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.453 ' N ' ' CD2' ' A' ' 196' ' ' HIS . 14.5 m80 -109.34 133.83 52.57 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 118.413 -0.803 . . . . 3.2799999999999998 109.591 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -120.75 148.69 43.63 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.301 0.5 . . . . 4.4199999999999999 109.829 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -67.24 89.73 0.2 Allowed 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 124.658 1.224 . . . . 2.7000000000000002 109.533 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -66.64 -26.9 67.28 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.18 -0.95 . . . . 2.9500000000000002 109.499 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.39 -42.41 21.84 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.948 0.899 . . . . 3.3500000000000001 109.404 171.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -73.57 170.37 15.33 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.582 1.182 . . . . 2.6200000000000001 112.272 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -117.62 91.19 3.5 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.779 -1.563 . . . . 4.4900000000000002 106.779 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -75.81 158.33 32.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.634 -0.712 . . . . 1.4299999999999999 109.438 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 75.3 p -138.57 144.43 39.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.608 -0.515 . . . . 1.99 109.608 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 13.7 t -61.23 -43.52 98.74 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 125.913 1.685 . . . . 2.0899999999999999 113.871 169.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.88 174.68 10.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.9 -0.778 . . . . 2.3900000000000001 108.9 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.7 m -43.63 -57.33 3.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.214 1.806 . . . . 4.2199999999999998 109.997 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 51.09 -88.38 0.01 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.375 1.464 . . . . 2.6499999999999999 113.338 167.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -147.07 -69.51 0.01 OUTLIER Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.912 -1.675 . . . . 2.0699999999999998 108.912 168.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.4 m -105.85 97.42 7.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.5 -1.667 . . . . 1.5700000000000001 106.5 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.16 109.31 3.49 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.343 -1.354 . . . . 3.1099999999999999 107.343 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 29.2 tp -47.62 -54.54 11.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.327 1.421 . . . . 2.71 111.853 -166.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -40.34 -43.69 1.8 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.956 1.302 . . . . 3.5499999999999998 111.202 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -64.05 1.08 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.281 0.632 . . . . 2.54 111.259 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.291 1.2 m -56.94 -40.84 77.13 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.995 -0.372 . . . . 1.8899999999999999 109.995 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.6 -49.88 64.17 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.58 -0.724 . . . . 0.56999999999999995 111.312 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 61.4 t -54.83 -41.49 57.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 119.567 1.076 . . . . 1.3300000000000001 110.973 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.473 ' CE1' ' O ' ' A' ' 236' ' ' MET 0.449 2.7 t-160 -63.53 -49.47 73.38 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.234 0.614 . . . . 3.2999999999999998 111.535 176.46 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.09 -48.11 72.01 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.897 -1.127 . . . . 3.6499999999999999 111.531 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.36 -39.55 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 107.561 -1.274 . . . . 1.8600000000000001 107.561 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.49 -55.78 6.72 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.552 1.073 . . . . 0.64000000000000001 111.673 165.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.438 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 1.9 m-70 -51.89 -47.73 64.42 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.715 -0.873 . . . . 2.0899999999999999 110.698 174.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 67.9 m -54.17 -38.34 65.47 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.293 0.849 . . . . 3.1000000000000001 113.293 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 8.4 mp -56.6 -40.73 75.81 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 119.431 1.014 . . . . 4.2000000000000002 110.266 172.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 117.44 28.89 2.23 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 125.045 1.307 . . . . 1.6599999999999999 111.602 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.95 137.89 36.96 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.074 -0.713 . . . . 4.3600000000000003 109.074 -170.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.77 140.23 21.5 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.655 -0.978 . . . . 2.7599999999999998 110.655 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -47.87 116.23 1.43 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.635 0.774 . . . . 1.8700000000000001 111.307 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 31.7 m -78.56 -177.35 5.28 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.385 0.674 . . . . 1.3999999999999999 109.195 172.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 23.4 m -148.79 39.54 0.87 Allowed 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.328 -0.857 . . . . 3.1200000000000001 109.387 -172.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.13 131.64 15.51 Favored Pre-proline 0 N--CA 1.447 -0.614 0 N-CA-C 106.599 -1.63 . . . . 1.55 106.599 -174.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.52 -9.55 14.8 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.096 1.864 . . . . 1.23 114.367 -172.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -82.07 -26.31 33.78 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.304 0.956 . . . . 1.6599999999999999 109.771 170.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -70.43 148.28 48.51 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.325 -0.62 . . . . 0.76000000000000001 109.325 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 90.2 t -93.92 -23.9 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 123.574 0.749 . . . . 0.93000000000000005 109.383 177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.473 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -49.54 -38.52 31.11 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.859 0.689 . . . . 2.8700000000000001 112.859 175.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.431 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -46.95 149.1 1.65 Allowed Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 126.219 1.808 . . . . 4.4199999999999999 112.802 -165.049 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.68 -16.89 29.97 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.541 1.494 . . . . 0.94999999999999996 111.971 176.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.373 0.2 OUTLIER -78.85 -179.54 6.63 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.132 1.373 . . . . 1.97 110.148 176.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -127.39 153.88 45.69 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.594 -1.632 . . . . 3.48 106.594 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -148.56 117.45 6.72 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.615 -1.254 . . . . 2.6699999999999999 107.615 168.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -63.68 122.47 16.46 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.63 -0.878 . . . . 3.5600000000000001 108.63 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.3 m -145.96 154.55 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 O-C-N 123.771 0.669 . . . . 4.25 110.035 169.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -50.56 110.67 0.44 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.58 1.952 . . . . 3.7200000000000002 111.539 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.8 pp -57.55 -19.8 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.091 0.956 . . . . 4.4000000000000004 112.752 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -70.09 -49.7 48.27 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.433 0.693 . . . . 4.2400000000000002 110.899 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 91.7 m -83.88 -30.02 26.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.115 0.566 . . . . 2.48 109.974 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -34.56 116.71 0.33 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.446 1.498 . . . . 9.8300000000000001 111.581 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.27 175.82 10.76 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.714 1.206 . . . . 3.6000000000000001 108.698 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.436 ' HG ' ' CZ3' ' A' ' 141' ' ' TRP . 1.1 mm? -83.3 141.78 31.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.44 -0.948 . . . . 1.1200000000000001 108.44 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.4 m -77.87 155.38 31.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 110.09 -0.337 . . . . 1.48 110.09 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.28 -45.28 62.07 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.005 0.431 . . . . 0.93000000000000005 110.138 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -51.1 -54.11 28.03 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.884 0.874 . . . . 2.1899999999999999 110.191 173.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -59.27 -51.76 68.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.087 -0.961 . . . . 2.1499999999999999 109.92 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.5 mt -49.07 -52.43 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.775 1.63 . . . . 1.23 110.263 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -59.44 -40.51 87.02 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.391 -1.443 . . . . 7.6699999999999999 110.568 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -49.04 -55.05 12.44 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 111.963 -0.455 . . . . 0.91000000000000003 111.963 167.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.546 HG23 ' CZ3' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -60.85 -40.67 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 118.508 1.154 . . . . 3.21 110.282 -173.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -64.74 -17.96 64.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.498 -0.881 . . . . 2.7200000000000002 111.245 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.0 t -63.02 -17.43 62.21 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.473 0.709 . . . . 2.9199999999999999 112.446 171.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 66.7 mt . . . . . 0 CA--C 1.536 0.438 0 C-N-CA 124.657 1.183 . . . . 3.0899999999999999 111.501 172.88 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 110.072 -0.344 . . . . 9.9700000000000006 110.072 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 57.9 -78.34 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.142 1.377 . . . . 5.2699999999999996 111.283 -170.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -124.63 109.15 12.81 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.102 1.361 . . . . 5.4500000000000002 109.572 -177.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.7 138.18 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.069 0 N-CA-C 106.641 -1.614 . . . . 3.4900000000000002 106.641 170.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.581 ' HG1' ' H ' ' A' ' 158' ' ' ASP . 10.1 p -125.1 139.47 53.75 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.739 -1.208 . . . . 1.55 107.739 177.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -123.04 161.59 24.02 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.696 0.798 . . . . 4.8399999999999999 110.342 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.95 147.82 32.11 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.752 -0.833 . . . . 6.4400000000000004 108.752 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -104.95 149.26 8.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 C-N-CA 123.559 0.744 . . . . 1.05 109.312 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.527 ' H ' HD21 ' A' ' 119' ' ' ASN . 1.4 p30 -104.85 -47.6 3.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.158 1.783 . . . . 3.27 109.648 -172.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -139.18 164.63 29.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.98 -1.119 . . . . 3.2200000000000002 107.98 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -128.16 118.67 23.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.846 -1.539 . . . . 3.2999999999999998 106.846 -174.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.401 ' HG1' ' CG ' ' A' ' 124' ' ' ASP . 8.9 t -66.78 122.98 84.74 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.77 0.828 . . . . 2.8900000000000001 109.384 -173.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -68.84 -17.76 41.73 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.791 2.994 . . . . 2.0099999999999998 111.562 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.401 ' CG ' ' HG1' ' A' ' 122' ' ' THR . 2.4 m-20 -34.3 -42.42 0.13 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.451 2.301 . . . . 2.5699999999999998 112.462 171.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 19.4 mtm -132.69 177.73 7.4 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.261 1.425 . . . . 2.4399999999999999 109.046 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -64.05 142.32 58.45 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 108.824 -0.806 . . . . 3.9500000000000002 108.824 172.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 43.9 ttt-85 -47.68 -51.15 22.78 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.506 -0.746 . . . . 2.8700000000000001 110.491 172.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.33 6.28 3.01 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.453 0.538 . . . . 5.2400000000000002 112.453 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -102.08 -41.92 6.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.15 1.78 . . . . 1.76 109.632 162.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 62.4 t -54.02 -54.79 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 O-C-N 120.508 -1.37 . . . . 1.74 109.719 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -26.43 68.13 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 118.647 -1.221 . . . . 1.76 109.469 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -65.0 -44.71 88.35 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 118.832 0.742 . . . . 3.6600000000000001 111.004 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.91 -52.27 65.76 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.76 0.824 . . . . 0.46000000000000002 110.481 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.51 -37.24 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 109.291 -0.633 . . . . 2.6200000000000001 109.291 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -52.27 -61.37 2.31 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 107.851 -1.166 . . . . 4.2400000000000002 107.851 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -52.34 -53.62 42.18 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.209 1.004 . . . . 2.7200000000000002 110.546 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.21 -49.52 63.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.792 0.837 . . . . 0.68999999999999995 111.834 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.405 ' CD1' ' HB2' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -63.59 -47.23 82.3 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.52 -0.918 . . . . 7.3600000000000003 108.52 176.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.18 -38.95 63.28 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.695 0.398 . . . . 2.6400000000000001 110.599 -171.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 82.3 t -49.79 -58.51 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.34 1.056 . . . . 1.02 109.249 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.406 ' CZ3' ' HG ' ' A' ' 250' ' ' LEU . 17.3 m95 -68.63 -37.23 79.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 119.836 -0.746 . . . . 1.1100000000000001 109.087 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -20.2 65.48 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.374 0.509 . . . . 2.46 112.374 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -78.98 -49.39 12.83 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.527 -0.916 . . . . 1.6899999999999999 108.527 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 26.5 t -75.46 -54.91 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 122.775 0.43 . . . . 3.04 110.877 -174.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.6 p -76.93 157.33 81.74 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 107.758 -1.201 . . . . 1.25 107.758 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.88 15.07 0.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.744 1.629 . . . . 0.91000000000000003 113.594 174.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.04 145.94 55.02 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 122.257 2.299 . . . . 3.7000000000000002 109.641 175.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -110.63 86.93 2.41 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.939 -1.504 . . . . 5.6299999999999999 106.939 160.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.405 ' HB2' ' CD1' ' A' ' 138' ' ' PHE . 3.9 m-85 -71.02 154.43 41.8 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.189 -0.671 . . . . 7.3499999999999996 109.189 163.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.6 t -155.34 144.93 21.23 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.271 1.028 . . . . 1.4399999999999999 108.51 170.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -92.29 138.6 31.39 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 119.493 1.042 . . . . 3.5699999999999998 108.471 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.8 pp -138.29 124.46 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.243 -1.392 . . . . 1.6799999999999999 107.243 167.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -88.03 -7.64 56.73 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 122.384 0.274 . . . . 3.4199999999999999 111.26 172.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 62.2 p -130.11 96.79 4.27 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.024 0.929 . . . . 3.23 109.927 -170.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 140.03 -150.74 21.7 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 106.601 -2.6 . . . . 2.1400000000000001 106.601 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 43.4 ttm -122.54 137.18 54.97 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.452 -1.684 . . . . 4.8799999999999999 106.452 173.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -111.85 170.16 8.33 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.738 1.215 . . . . 0.83999999999999997 109.664 -177.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.581 ' H ' ' HG1' ' A' ' 115' ' ' THR . 11.3 t70 -84.16 -55.7 4.05 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.646 0.778 . . . . 2.0800000000000001 109.361 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.9 pt -101.91 164.26 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.143 -0.688 . . . . 1.23 109.143 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.05 132.31 38.08 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.988 -0.745 . . . . 2.52 108.988 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 10.7 t -78.48 143.03 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.967 -1.123 . . . . 1.55 107.967 168.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 66.6 t -108.24 128.78 63.46 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 C-N-CA 124.546 1.138 . . . . 2.02 108.021 165.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.432 ' N ' HD22 ' A' ' 119' ' ' ASN . 5.7 m-85 -124.31 99.8 6.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 103.903 -2.628 . . . . 6.1699999999999999 103.903 170.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.51 160.13 33.31 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.991 -1.485 . . . . 1.1399999999999999 106.991 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -121.72 128.25 51.6 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.406 -1.331 . . . . 5.1200000000000001 107.406 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 65.79 -161.7 43.04 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-O 121.629 0.572 . . . . 2.23 112.37 -171.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.17 110.06 11.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.269 0.628 . . . . 2.6099999999999999 109.654 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 . . . . . 0 C--O 1.227 -0.08 0 C-N-CA 125.615 1.566 . . . . 4.7300000000000004 110.14 -177.849 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.202 0 N-CA-C 112.791 0.663 . . . . 3.5 112.791 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -104.63 149.57 25.43 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.467 1.107 . . . . 7.3600000000000003 109.551 -166.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -171.8 10.16 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.323 0.86 . . . . 3.4300000000000002 113.323 -155.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 65.82 -149.96 51.68 Favored Glycine 0 CA--C 1.537 1.428 0 N-CA-C 109.895 -1.282 . . . . 2.6099999999999999 109.895 -162.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -80.3 63.94 4.95 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.66 1.23 . . . . 4.8200000000000003 114.042 -162.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -164.13 -143.77 3.82 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 106.992 -2.443 . . . . 2.23 106.992 160.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.69 -127.31 40.08 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.27 -1.532 . . . . 2.52 109.27 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . 0.267 1.0 OUTLIER -100.39 148.77 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 106.214 -1.773 . . . . 2.9399999999999999 106.214 173.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.22 -46.1 12.21 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.851 0.861 . . . . 3.0099999999999998 109.644 164.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -163.48 165.69 23.48 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.238 -0.914 . . . . 0.65000000000000002 111.246 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.56 141.71 26.09 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.697 0.799 . . . . 1.73 112.398 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -161.79 158.04 25.09 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.97 0.908 . . . . 0.69999999999999996 109.853 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -147.87 139.35 23.72 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.617 1.167 . . . . 4.2800000000000002 108.129 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -85.77 -78.71 1.18 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.365 -1.094 . . . . 0.59999999999999998 110.365 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.78 104.08 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.355 2.703 . . . . 1.55 110.514 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -178.53 172.48 44.85 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 108.242 -1.943 . . . . 1.26 108.242 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 63.9 m -84.05 165.35 18.63 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.025 -0.731 . . . . 2.6000000000000001 109.025 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 53.31 -95.23 0.02 OUTLIER Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.202 0.906 . . . . 2.0600000000000001 112.535 172.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.5 tp -63.35 -16.49 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 125.129 1.372 . . . . 1.8899999999999999 111.504 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -44.37 129.58 7.18 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 110.792 -0.923 . . . . 1.6499999999999999 110.792 166.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 86.07 -31.09 4.13 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.34 1.448 . . . . 1.22 112.891 -175.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -83.34 147.51 27.88 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.484 1.142 . . . . 1.27 109.739 -166.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.78 124.04 38.78 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 118.762 -0.637 . . . . 0.80000000000000004 112.454 -172.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . 0.341 0.0 OUTLIER -112.4 109.06 18.45 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.079 0.551 . . . . 3.1699999999999999 112.19 -165.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -96.2 138.22 34.12 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.661 0.664 . . . . 3.9300000000000002 110.449 -177.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -62.24 92.51 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.171 -0.677 . . . . 3.2799999999999998 109.171 170.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -64.83 -37.54 87.95 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 120.51 -1.369 . . . . 2.6600000000000001 109.576 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -50.46 -27.94 7.42 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.593 0.757 . . . . 2.7400000000000002 110.907 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -66.27 155.15 37.99 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.859 1.264 . . . . 2.8100000000000001 110.179 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -95.78 93.62 7.19 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.583 -1.636 . . . . 5.0999999999999996 106.583 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -78.76 155.75 29.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.695 -0.854 . . . . 1.51 108.695 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.92 136.82 24.46 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.304 0.641 . . . . 4.1699999999999999 111.285 -176.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.2 t -58.03 -45.35 87.08 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.188 0.995 . . . . 1.8999999999999999 111.495 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -74.77 -154.85 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.646 1.179 . . . . 4.7000000000000002 110.761 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.461 ' H ' ' HG ' ' A' ' 207' ' ' SER . 7.4 p -79.16 -68.27 0.67 Allowed 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.938 -1.101 . . . . 3.9700000000000002 110.455 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 38.63 -106.03 0.05 OUTLIER Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.465 1.983 . . . . 2.73 113.495 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.55 -72.28 1.13 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.216 0.912 . . . . 2.2200000000000002 110.839 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 4.3 m -136.45 153.92 50.92 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 106.686 -1.598 . . . . 1.76 106.686 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -107.77 124.75 50.5 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 123.651 0.594 . . . . 1.53 111.968 173.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.17 -53.65 55.86 Favored 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.241 -0.652 . . . . 2.46 109.241 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -49.07 -46.99 45.31 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.667 0.746 . . . . 2.3999999999999999 110.232 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.6 tt -61.5 -61.58 2.43 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.921 0.888 . . . . 1.6799999999999999 110.0 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.279 0.6 OUTLIER -55.99 -37.94 69.79 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.383 -0.198 . . . . 1.8400000000000001 110.904 179.472 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.34 -54.92 29.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 124.591 1.156 . . . . 0.64000000000000001 110.687 175.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.8 t -48.08 -43.45 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 120.12 1.327 . . . . 1.2 110.903 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.487 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 42.6 t-80 -56.62 -56.54 20.12 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.396 1.078 . . . . 3.25 113.845 171.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -82.1 -43.32 17.98 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.134 -0.979 . . . . 3.6899999999999999 112.679 -170.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.26 -33.95 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.056 -0.72 . . . . 1.95 109.056 164.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.5 -53.68 43.07 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 110.763 -0.935 . . . . 0.76000000000000001 110.763 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.487 ' NE2' ' NE2' ' A' ' 218' ' ' HIS 0.281 62.5 m170 -53.44 -41.19 65.83 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.456 -1.026 . . . . 3.96 111.944 173.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 34.7 t -47.82 -52.97 16.97 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.131 0.972 . . . . 2.6600000000000001 112.346 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.12 -10.85 60.44 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.614 -0.679 . . . . 4.3200000000000003 112.786 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 104.51 43.31 1.73 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 124.289 0.947 . . . . 1.1899999999999999 111.792 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 7.9 mt -77.35 115.37 17.06 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 117.373 0.586 . . . . 4.2800000000000002 111.546 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -66.43 154.96 51.8 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 109.507 -1.437 . . . . 3.1099999999999999 109.507 162.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -68.61 121.54 16.63 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.746 0.773 . . . . 2.7000000000000002 112.716 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.9 m -79.93 118.1 21.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.772 -1.566 . . . . 2.3100000000000001 106.772 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.7 p -76.12 63.29 1.81 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.24 0.927 . . . . 4.3700000000000001 110.502 -175.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -155.78 131.36 5.48 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.85 1.26 . . . . 1.6699999999999999 108.34 -173.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.92 -14.65 9.78 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.776 1.651 . . . . 1.8799999999999999 114.124 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -42.09 59.76 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 119.57 1.077 . . . . 3.2999999999999998 108.971 172.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -57.73 116.41 3.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.744 1.217 . . . . 1.79 110.451 176.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.0 t -62.2 -17.9 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.383 -0.826 . . . . 0.89000000000000001 110.896 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.449 ' HE3' ' CD2' ' A' ' 222' ' ' HIS . 0.0 OUTLIER -51.89 -42.41 62.67 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.331 -0.856 . . . . 3.0600000000000001 113.135 169.029 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -61.03 147.31 86.35 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 109.027 -0.731 . . . . 9.1699999999999999 109.027 -165.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.88 -14.01 32.24 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.375 1.384 . . . . 1.1599999999999999 112.566 -172.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.354 0.2 OUTLIER -76.94 128.01 33.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.751 0.705 . . . . 2.3199999999999998 109.121 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -75.82 129.91 37.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.794 -1.187 . . . . 4.6799999999999997 107.794 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -135.67 139.36 43.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.708 -1.59 . . . . 3.46 106.708 174.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -57.77 120.96 9.34 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.542 -0.91 . . . . 3.5600000000000001 108.542 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.1 m -101.09 130.72 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.854 -0.425 . . . . 2.3799999999999999 109.854 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.66 86.71 0.66 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.491 -0.559 . . . . 4.8300000000000001 109.491 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.6 mt -51.48 -31.3 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.404 0.682 . . . . 3.79 109.449 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -42.05 -49.46 4.72 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.362 1.065 . . . . 3.71 112.404 169.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 35.0 m -84.84 -41.63 15.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.56 0.744 . . . . 1.77 110.24 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 71.1 t80 60.96 75.5 0.41 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.287 1.035 . . . . 5.3099999999999996 109.545 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.06 169.19 25.11 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.135 0.574 . . . . 5.5999999999999996 110.688 -177.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.406 ' HG ' ' CZ3' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -113.76 176.87 4.84 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.505 1.522 . . . . 1.45 107.859 175.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 68.2 m -77.96 145.41 36.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 122.742 0.417 . . . . 1.29 110.7 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.36 -43.19 54.18 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.173 0.589 . . . . 1.54 110.402 171.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -53.43 -55.49 24.69 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.627 0.727 . . . . 2.8700000000000001 110.183 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -59.09 -47.69 84.32 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.078 -0.965 . . . . 2.25 109.02 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 59.3 mt -51.06 -32.31 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.647 1.979 . . . . 1.9399999999999999 112.524 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -73.42 -57.16 4.2 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 121.293 -0.879 . . . . 6.9000000000000004 110.026 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -47.24 -53.85 10.88 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 121.19 0.328 . . . . 1.9199999999999999 112.291 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 2.0 pp -55.88 -32.65 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.946 1.698 . . . . 3.23 111.056 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -78.3 -45.11 23.53 Favored 'General case' 0 C--N 1.339 0.126 0 O-C-N 121.708 -0.62 . . . . 3.2200000000000002 109.811 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 15.1 m -51.99 -31.04 27.72 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.58 0.585 . . . . 4.5 112.58 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 N--CA 1.465 0.324 0 N-CA-C 114.222 1.193 . . . . 4.5599999999999996 114.222 172.78 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.3 tttt . . . . . 0 CA--C 1.532 0.283 0 CA-C-O 119.499 -0.286 . . . . 7.2400000000000002 110.561 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 15.0 m170 67.02 -54.33 0.45 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.467 1.907 . . . . 4.2800000000000002 112.889 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -107.0 114.52 28.65 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.324 1.45 . . . . 5.0700000000000003 110.139 -176.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.7 mp -141.6 80.44 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.667 1.187 . . . . 3.52 108.396 -173.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.22 141.39 37.19 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.964 -1.124 . . . . 1.73 107.964 174.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -127.31 159.79 33.31 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.145 0.978 . . . . 4.3499999999999996 108.705 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -154.94 173.21 16.86 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.727 0.694 . . . . 5.04 110.419 172.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.78 159.39 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.226 1.01 . . . . 1.0700000000000001 109.834 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -100.29 -42.98 6.43 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.01 0.924 . . . . 3.6200000000000001 109.994 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -149.41 170.46 18.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.751 0.82 . . . . 2.52 109.831 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -117.9 101.76 8.54 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.368 1.467 . . . . 3.7200000000000002 107.959 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.4 t -58.55 125.89 77.69 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.96 0.904 . . . . 2.73 109.173 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.17 -17.26 45.29 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.717 2.945 . . . . 1.95 111.411 -172.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -35.06 -43.75 0.21 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.002 1.721 . . . . 2.2000000000000002 111.827 170.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -130.88 174.59 9.83 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 124.994 1.317 . . . . 2.5 110.037 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -73.13 140.2 46.93 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.65 0.78 . . . . 3.0099999999999998 109.487 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -46.61 -51.41 15.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.035 0.445 . . . . 3.3999999999999999 111.892 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.5 -8.11 8.63 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.742 0.817 . . . . 3.46 112.723 -176.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -100.66 -48.45 4.51 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.695 1.598 . . . . 1.9299999999999999 109.314 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.93 -56.59 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 125.274 1.43 . . . . 1.77 109.374 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -24.53 64.48 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 118.334 -0.841 . . . . 1.8200000000000001 109.349 -177.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -65.84 -50.25 65.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.627 0.648 . . . . 4.6699999999999999 110.071 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -49.67 -54.85 16.23 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.919 0.888 . . . . 0.63 110.091 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -71.38 -30.99 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.028 -0.533 . . . . 2.73 110.233 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -55.04 -54.6 40.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.765 1.269 . . . . 4.5300000000000002 108.157 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -68.82 -39.28 80.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.588 1.555 . . . . 2.3900000000000001 110.282 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -46.44 -57.11 4.97 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 122.576 0.35 . . . . 0.85999999999999999 110.63 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -60.43 -48.55 81.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 119.661 -0.816 . . . . 5.54 111.15 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -45.34 -48.92 13.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.416 0.687 . . . . 4.9100000000000001 111.093 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 94.8 t -58.36 -51.0 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 122.717 0.407 . . . . 1.72 109.941 -173.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -68.68 -33.67 74.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.679 -0.86 . . . . 0.98999999999999999 108.679 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.14 -19.53 61.63 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.251 0.478 . . . . 2.0299999999999998 111.911 174.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -81.27 -42.87 20.01 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.024 0.829 . . . . 2.6499999999999999 108.985 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.7 m -79.87 -54.37 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 112.17 0.433 . . . . 2.1099999999999999 112.17 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 54.4 p -81.83 147.14 57.76 Favored Pre-proline 0 N--CA 1.45 -0.442 0 N-CA-C 108.382 -0.969 . . . . 1.1599999999999999 108.382 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.73 5.01 4.1 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.813 2.342 . . . . 0.90000000000000002 113.008 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.4 125.9 27.93 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.371 1.468 . . . . 3.96 108.589 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -98.17 93.53 6.3 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 109.277 -0.638 . . . . 5.0599999999999996 109.277 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -78.57 149.45 33.01 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.469 -0.332 . . . . 7.2400000000000002 110.797 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.4 t -151.4 137.31 18.12 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.714 -0.476 . . . . 1.6299999999999999 109.714 172.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -90.45 160.09 16.2 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.266 -1.013 . . . . 3.9100000000000001 108.266 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -152.12 152.21 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 104.747 -2.316 . . . . 1.9199999999999999 104.747 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.03 -39.43 21.26 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.262 -0.644 . . . . 3.9500000000000002 109.262 172.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.5 m -75.71 146.23 40.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.283 -0.636 . . . . 4.1799999999999997 109.283 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -78.87 59.29 4.23 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.387 -0.674 . . . . 5.8499999999999996 112.699 -173.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.2 mtt -116.37 72.89 0.83 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.152 0.981 . . . . 7.7599999999999998 109.594 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -141.53 162.68 34.9 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.49 0.716 . . . . 0.94999999999999996 111.702 -173.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -70.97 -46.54 62.17 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.073 -1.084 . . . . 2.0299999999999998 108.073 170.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.9 pt -124.23 146.16 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.017 -0.992 . . . . 2.1099999999999999 108.601 -171.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . 0.308 0.0 OUTLIER -129.93 139.22 51.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.097 -0.705 . . . . 3.54 109.097 176.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.6 t -79.93 112.08 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 118.579 -0.724 . . . . 0.81000000000000005 109.113 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . 0.479 7.4 p -109.0 97.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 N-CA-C 113.47 0.915 . . . . 3.9700000000000002 113.47 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -79.82 130.04 34.98 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.326 1.85 . . . . 6.3300000000000001 107.077 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -141.6 162.11 36.28 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.409 0.549 . . . . 1.0800000000000001 111.029 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -119.01 126.75 52.46 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.897 1.279 . . . . 6.2999999999999998 108.209 -172.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 46.62 -130.35 11.83 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 123.59 0.614 . . . . 1.73 112.208 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.96 138.2 38.72 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.266 0.627 . . . . 2.4700000000000002 109.511 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 114.124 1.157 . . . . 3.29 114.124 -175.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 118.824 -0.608 . . . . 2.8199999999999998 111.734 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -89.83 156.52 18.43 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 107.366 -1.346 . . . . 9.1199999999999992 107.366 167.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -158.14 11.55 0.18 Allowed 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 126.82 2.048 . . . . 3.1899999999999999 111.105 -157.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 105.29 165.22 23.78 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.351 -1.1 . . . . 2.6499999999999999 110.351 -165.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -58.11 118.0 4.97 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.526 -0.916 . . . . 4.6900000000000004 108.526 166.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.91 -160.81 13.74 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 109.95 -1.26 . . . . 2.0499999999999998 109.95 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.92 -102.94 0.2 Allowed Glycine 0 C--N 1.339 0.715 0 N-CA-C 109.167 -1.573 . . . . 1.8500000000000001 109.167 -171.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . 0.314 12.8 mm -90.73 130.04 40.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.111 -1.07 . . . . 2.6299999999999999 108.111 171.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.8 mp -82.48 -61.18 1.96 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.806 -0.812 . . . . 1.51 108.806 166.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -158.8 149.65 20.15 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 113.332 0.864 . . . . 0.93999999999999995 113.332 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -131.97 117.05 17.91 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.563 1.945 . . . . 1.1899999999999999 114.678 -170.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -144.19 160.54 40.78 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 128.245 2.618 . . . . 0.59999999999999998 106.388 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.93 149.84 28.65 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.691 -1.596 . . . . 4.9100000000000001 106.691 -177.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -102.15 -86.99 1.97 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-O 119.455 -0.636 . . . . 0.70999999999999996 111.768 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.57 86.83 0.43 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.501 2.801 . . . . 1.5900000000000001 110.543 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -163.71 157.85 30.17 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 108.419 -1.872 . . . . 1.26 108.419 170.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.0 m -80.37 173.87 12.17 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.224 0.535 . . . . 3.2000000000000002 110.45 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 56.53 -112.47 3.41 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.575 0.607 . . . . 1.3200000000000001 111.648 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.1 tp -59.79 -40.05 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 O-C-N 122.131 -0.629 . . . . 1.5600000000000001 109.365 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -39.24 136.06 1.37 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.393 0.997 . . . . 1.1100000000000001 112.288 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.51 -47.58 1.17 Allowed Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.179 1.371 . . . . 0.69999999999999996 111.186 -164.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -84.94 154.12 22.38 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.748 0.774 . . . . 1.3 109.226 -159.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.41 116.71 20.17 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.528 0.936 . . . . 0.71999999999999997 113.528 -166.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -114.86 135.14 54.53 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 118.289 0.495 . . . . 2.8700000000000001 111.629 -163.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -125.36 146.51 49.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.249 -0.649 . . . . 4.0300000000000002 109.249 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -66.52 96.76 0.39 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.073 -0.967 . . . . 2.8199999999999998 109.806 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.44 -42.76 98.66 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 120.558 -1.339 . . . . 3.1800000000000002 111.639 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -53.85 -35.49 61.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.658 1.183 . . . . 2.8599999999999999 110.14 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -67.4 133.94 50.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.721 -1.585 . . . . 2.1099999999999999 106.721 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -93.39 94.25 8.61 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.131 -2.174 . . . . 3.77 105.131 -173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 23.7 m95 -75.79 152.87 37.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.277 -1.749 . . . . 1.3700000000000001 106.277 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 p -128.05 124.5 37.24 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.231 -1.396 . . . . 2.0800000000000001 107.231 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -49.9 75.91 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 120.51 1.504 . . . . 2.5099999999999998 108.028 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.74 177.93 2.33 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.725 0.41 . . . . 2.6299999999999999 110.536 176.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.1 t -48.53 -55.31 11.41 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.726 1.211 . . . . 4.2599999999999998 110.723 -171.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 40.78 -106.64 0.07 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.147 1.356 . . . . 2.9300000000000002 114.611 165.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -121.37 -67.84 0.26 Allowed Glycine 0 CA--C 1.525 0.709 0 C-N-CA 124.293 0.949 . . . . 1.8799999999999999 110.93 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.4 m -131.95 140.69 49.08 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.33 -1.73 . . . . 1.49 106.33 174.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -95.3 129.82 42.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 123.733 0.646 . . . . 1.5600000000000001 111.251 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -47.59 85.18 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.529 -0.759 . . . . 2.3100000000000001 110.137 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -55.51 -38.23 68.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.621 0.768 . . . . 4.0300000000000002 111.475 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.68 -63.4 1.23 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.791 0.836 . . . . 2.5099999999999998 109.706 176.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.303 0.2 OUTLIER -56.4 -38.75 71.95 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.251 -0.432 . . . . 2.21 110.19 -178.148 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.99 -58.5 7.06 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 117.857 -1.068 . . . . 0.71999999999999997 110.641 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -44.01 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 120.275 1.398 . . . . 3.27 111.316 -174.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.751 ' NE2' ' NE2' ' A' ' 222' ' ' HIS 0.48 3.2 t-160 -49.76 -60.9 2.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.555 1.142 . . . . 3.1899999999999999 111.686 169.362 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -58.39 -41.72 85.5 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 120.835 -1.166 . . . . 2.8700000000000001 111.946 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.4 mp -68.68 -39.18 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 109.046 -0.724 . . . . 1.49 109.046 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -52.97 -44.9 62.15 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 111.402 -0.679 . . . . 0.77000000000000002 111.402 167.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.751 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 3.0 m-70 -53.93 -48.68 69.97 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 117.783 0.791 . . . . 2.04 109.302 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.5 p -61.2 -18.5 58.55 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.59 0.959 . . . . 2.52 113.59 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.6 mt -79.1 -58.98 2.96 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 106.966 -1.494 . . . . 2.7999999999999998 106.966 171.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 149.86 79.66 0.03 OUTLIER Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.615 -0.721 . . . . 1.21 111.859 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 8.7 mt -133.38 102.69 5.63 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.697 -1.223 . . . . 4.0499999999999998 107.697 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -77.81 46.94 2.71 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.14 -0.811 . . . . 3.4199999999999999 112.777 -176.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 63.7 m80 71.38 120.08 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.09 2.156 . . . . 1.9399999999999999 113.0 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 68.4 m -77.55 -179.83 6.08 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.933 -0.395 . . . . 1.28 109.933 173.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.3 t -142.14 29.91 1.63 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.954 0.901 . . . . 3.23 110.005 -171.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.03 143.35 45.23 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.69 1.596 . . . . 2.1600000000000001 107.002 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -86.2 -12.61 5.74 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.158 1.905 . . . . 1.2 114.493 -172.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -81.2 -40.36 23.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.162 -1.051 . . . . 1.6799999999999999 108.162 170.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.401 ' N ' ' HG ' ' A' ' 251' ' ' SER . . . -54.0 145.78 15.93 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.784 0.834 . . . . 0.73999999999999999 110.502 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.5 -17.26 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.2 1.0 . . . . 0.75 109.826 -176.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 50.9 mmm -77.5 -12.42 59.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.074 1.139 . . . . 2.71 114.074 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.423 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.9 155.49 1.05 Allowed Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.425 1.09 . . . . 4.3499999999999996 113.275 177.011 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.34 -21.69 19.63 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.774 1.65 . . . . 1.0700000000000001 111.428 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.319 0.6 OUTLIER -76.8 173.19 11.97 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.824 1.25 . . . . 2.48 109.362 176.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -116.78 148.75 40.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.285 -1.376 . . . . 3.2599999999999998 107.285 171.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -141.45 122.07 14.24 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.301 -1.74 . . . . 2.6200000000000001 106.301 166.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -61.22 144.4 53.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.054 -0.721 . . . . 3.8799999999999999 109.054 168.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 25.9 m -133.97 159.36 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.023 0.929 . . . . 2.4199999999999999 108.723 167.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.81 -10.66 39.74 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 127.05 2.14 . . . . 4.04 113.107 -174.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . 0.257 24.0 mm 71.78 -23.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 127.081 2.152 . . . . 3.9100000000000001 112.104 -176.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -47.04 -67.04 0.32 Allowed 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 113.81 1.041 . . . . 3.9100000000000001 113.81 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 22.6 m -81.61 -50.15 9.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.528 -0.545 . . . . 1.96 109.528 -173.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 38.5 t80 39.43 82.9 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.435 1.894 . . . . 8.1600000000000001 112.885 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.09 162.18 32.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.829 0.851 . . . . 4.3600000000000003 109.387 -176.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -83.03 146.79 28.54 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.808 -1.182 . . . . 1.1000000000000001 107.808 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' SER . . . . . 0.401 ' HG ' ' N ' ' A' ' 234' ' ' ALA . 5.9 m -76.79 157.28 31.69 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.022 0.529 . . . . 2.04 110.634 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.2 67.21 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 110.045 -0.354 . . . . 1.1599999999999999 110.045 172.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -51.09 -56.78 10.94 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.904 0.859 . . . . 3.0600000000000001 110.262 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -58.53 -42.15 87.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.068 -0.969 . . . . 2.1299999999999999 111.589 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 41.7 mt -57.49 -44.73 85.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.181 1.393 . . . . 1.02 109.604 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -63.15 -45.12 93.36 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.417 -0.802 . . . . 5.1299999999999999 110.622 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -46.09 -62.88 3.2 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.727 -0.549 . . . . 1.01 111.727 173.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 2.8 pp -60.21 -42.44 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 O-C-N 121.803 -0.822 . . . . 3.1200000000000001 111.939 -176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -63.28 -21.53 66.3 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.195 -0.602 . . . . 3.1499999999999999 112.054 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.6 t -53.21 -25.56 14.46 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.99 -0.444 . . . . 2.4900000000000002 111.743 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 56.1 mt . . . . . 0 CA--C 1.531 0.222 0 C-N-CA 124.212 1.005 . . . . 3.3300000000000001 111.814 176.237 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 112.272 0.471 . . . . 6.8399999999999999 112.272 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.6 -69.61 0.09 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.766 1.226 . . . . 5.0800000000000001 112.32 -173.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.9 95.15 4.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 119.024 0.829 . . . . 3.77 111.339 -169.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.0 mm -94.03 80.68 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 108.207 -1.035 . . . . 2.6299999999999999 108.207 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.8 p -77.61 129.66 35.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.18 -1.044 . . . . 1.54 108.18 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.401 ' CE2' HD12 ' A' ' 134' ' ' ILE . 39.4 p90 -129.01 163.0 26.31 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.16 0.584 . . . . 5.0 110.59 -178.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.847 HH21 ' HH ' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -148.08 151.8 36.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.618 -0.882 . . . . 7.3200000000000003 108.618 174.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -100.47 144.21 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.142 -1.059 . . . . 1.27 108.142 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -83.99 -58.32 2.83 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.611 -1.255 . . . . 4.4900000000000002 107.611 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -123.8 160.18 27.92 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.782 1.233 . . . . 2.29 109.213 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.847 ' HH ' HH21 ' A' ' 117' ' ' ARG . 71.4 m-85 -111.94 127.32 55.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.237 1.415 . . . . 3.1699999999999999 107.262 -175.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.39 131.03 34.1 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 118.356 0.525 . . . . 3.5099999999999998 110.044 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -87.66 -17.24 2.78 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.848 3.032 . . . . 2.0299999999999998 110.794 171.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -44.55 -48.16 10.24 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 125.442 1.497 . . . . 2.0600000000000001 110.863 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 6.8 ptp -124.33 176.49 6.42 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.097 0.959 . . . . 3.4399999999999999 109.135 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -65.7 134.26 52.82 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.363 -0.236 . . . . 3.0800000000000001 110.363 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -52.58 -47.78 66.65 Favored 'General case' 0 CA--C 1.524 -0.043 0 O-C-N 122.028 -0.42 . . . . 4.4400000000000004 111.651 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -51.01 -25.92 5.4 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.685 -0.674 . . . . 3.2200000000000002 111.529 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -93.02 -35.32 13.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.992 1.317 . . . . 1.98 112.004 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -52.45 -56.58 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 120.469 -1.395 . . . . 1.74 108.875 171.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.83 -25.46 65.57 Favored 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 117.729 -1.588 . . . . 1.74 108.632 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -63.71 -45.43 90.0 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.856 1.207 . . . . 3.1499999999999999 111.216 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.75 -53.01 60.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 122.771 0.428 . . . . 0.56000000000000005 110.187 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.401 HD12 ' CE2' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -70.3 -37.26 70.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.834 -0.432 . . . . 2.8799999999999999 109.834 -176.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -54.07 -59.98 3.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.337 1.455 . . . . 3.7599999999999998 107.848 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -63.16 -43.88 97.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.408 -0.814 . . . . 3.4399999999999999 109.764 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.32 -52.2 47.48 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.372 0.669 . . . . 0.44 111.909 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.04 -46.39 88.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.098 -1.041 . . . . 8.0700000000000003 109.018 174.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.29 -29.03 63.55 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 118.746 -0.645 . . . . 2.5 111.579 -172.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 99.0 t -59.83 -63.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 118.984 0.811 . . . . 1.1299999999999999 109.494 171.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.439 ' CZ3' HG23 ' A' ' 258' ' ' ILE . 46.8 m95 -66.04 -41.15 91.26 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.873 -0.788 . . . . 0.96999999999999997 108.873 -170.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 t -69.08 -4.91 19.03 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 124.312 1.045 . . . . 1.8700000000000001 112.054 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -89.66 -55.98 3.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.05 -0.722 . . . . 1.1000000000000001 109.05 167.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.97 -51.44 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 112.8 0.667 . . . . 2.1600000000000001 112.8 -174.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 42.3 p -79.76 151.96 74.43 Favored Pre-proline 0 N--CA 1.443 -0.812 0 N-CA-C 107.427 -1.323 . . . . 1.8500000000000001 107.427 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.35 12.76 1.48 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.373 2.049 . . . . 0.84999999999999998 112.248 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.61 149.45 50.05 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.221 -0.924 . . . . 3.6600000000000001 109.079 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -120.79 87.46 2.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.661 -1.607 . . . . 5.8499999999999996 106.661 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -72.37 149.07 44.68 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.11 -0.496 . . . . 7.1200000000000001 109.77 172.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.3 t -155.73 129.34 8.43 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 119.172 -0.442 . . . . 1.49 110.01 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.68 149.87 27.1 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.224 -1.028 . . . . 3.1600000000000001 108.224 171.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.0 pt -134.67 119.88 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.627 -1.62 . . . . 1.7 106.627 171.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -76.87 -22.3 53.68 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.505 -0.554 . . . . 3.6499999999999999 109.505 173.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -136.8 113.27 10.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.25 1.42 . . . . 3.0600000000000001 108.858 -176.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 149.5 -144.67 12.33 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 108.739 -1.744 . . . . 2.46 108.739 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 28.2 mtt -135.19 131.87 37.26 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 126.384 1.874 . . . . 4.8799999999999999 107.511 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.77 162.92 14.3 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.552 1.541 . . . . 0.88 110.102 -175.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -86.89 -48.59 8.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.08 0.952 . . . . 1.8799999999999999 109.68 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.2 pt -107.07 166.5 3.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.246 -0.65 . . . . 1.1299999999999999 109.246 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.45 141.11 43.53 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.081 0.552 . . . . 3.0899999999999999 111.269 174.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 73.3 t -90.8 122.77 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.41 -0.959 . . . . 1.0700000000000001 108.41 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.1 t -97.64 115.35 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.745 -0.835 . . . . 2.1099999999999999 108.745 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -107.54 113.37 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.953 -2.239 . . . . 6.4699999999999998 104.953 163.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.13 148.84 50.6 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.77 -1.196 . . . . 1.26 107.77 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.96 105.96 15.99 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.996 0.81 . . . . 6.6500000000000004 109.639 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.19 -134.51 13.6 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.609 -0.997 . . . . 1.8700000000000001 110.609 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.32 137.64 39.99 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 122.043 -0.68 . . . . 2.2999999999999998 109.697 -171.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.25 0 CA-C-O 121.385 0.612 . . . . 3.2999999999999998 110.964 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 113.503 0.927 . . . . 2.7799999999999998 113.503 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -128.67 165.68 20.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.084 1.354 . . . . 7.2999999999999998 109.036 -168.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -169.08 15.65 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.429 0.9 . . . . 2.6699999999999999 113.429 -153.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 73.12 -160.65 54.07 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 109.812 -1.315 . . . . 1.74 109.812 -164.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -81.5 55.16 2.54 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.297 -0.531 . . . . 6.7999999999999998 112.427 -170.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -142.51 -158.77 7.67 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 107.998 -2.041 . . . . 2.7200000000000002 107.998 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.56 -138.07 41.48 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.172 -1.171 . . . . 2.3500000000000001 110.172 172.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.3 tp -78.84 151.69 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 109.07 -0.715 . . . . 3.5299999999999998 109.07 173.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.9 tp -84.32 -39.13 19.53 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.523 1.529 . . . . 1.72 111.146 171.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -167.51 164.07 14.81 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.712 0.805 . . . . 0.80000000000000004 109.694 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -145.71 124.66 12.75 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.336 1.235 . . . . 1.3100000000000001 114.336 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -139.52 161.28 37.88 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.065 2.146 . . . . 0.70999999999999996 108.455 -173.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -148.77 141.84 24.9 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.443 -0.947 . . . . 3.8100000000000001 108.443 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -92.08 -83.14 1.48 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.586 -1.006 . . . . 0.65000000000000002 110.586 171.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.2 98.69 0.84 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.104 2.536 . . . . 1.5900000000000001 111.07 -170.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -174.23 173.44 45.99 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.168 -1.973 . . . . 1.21 108.168 172.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 72.1 m -89.53 173.24 8.44 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.977 0.511 . . . . 3.8900000000000001 109.679 169.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 54.66 -101.96 0.12 Allowed Glycine 0 C--O 1.243 0.686 0 C-N-CA 124.069 0.842 . . . . 1.8100000000000001 111.424 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.535 ' CG1' ' HE2' ' A' ' 196' ' ' HIS . 7.1 tp -59.35 -41.14 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-O 117.912 -1.042 . . . . 1.8 109.036 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -33.96 129.48 0.47 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.633 1.111 . . . . 1.22 113.11 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 97.16 -34.94 4.73 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.268 1.413 . . . . 0.92000000000000004 112.125 -167.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -86.47 159.37 19.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.736 1.268 . . . . 1.23 110.72 -165.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -133.66 121.59 22.21 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.385 0.883 . . . . 0.90000000000000002 113.385 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.535 ' HE2' ' CG1' ' A' ' 191' ' ' ILE . 2.2 m170 -109.15 112.25 24.31 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-O 117.473 -1.251 . . . . 2.9100000000000001 111.957 -167.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -106.77 145.0 32.6 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 121.336 1.88 . . . . 4.4699999999999998 111.213 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.36 83.34 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.226 1.011 . . . . 3.0499999999999998 110.227 177.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.81 -24.64 67.84 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 120.376 -1.452 . . . . 2.73 109.901 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.44 -35.42 28.6 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.104 -0.997 . . . . 4.3099999999999996 111.192 169.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -74.22 161.75 29.62 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.668 1.223 . . . . 2.6400000000000001 110.985 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -102.46 95.93 6.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.243 -1.392 . . . . 4.0599999999999996 107.243 176.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -78.27 140.23 38.87 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.549 -0.908 . . . . 1.51 108.549 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.6 p -122.61 105.85 10.47 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 107.599 -1.26 . . . . 1.98 107.599 -172.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.2 t -48.47 -33.24 9.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.384 1.474 . . . . 2.2599999999999998 114.329 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -71.07 178.27 3.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.634 0.73 . . . . 3.0299999999999998 111.455 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.1 m -66.31 -47.4 73.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 121.116 -0.99 . . . . 5.0499999999999998 109.665 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -62.82 132.41 43.62 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.107 -0.951 . . . . 3.2599999999999998 111.241 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 101.46 -119.52 6.53 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.257 -1.137 . . . . 2.6299999999999999 110.257 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.8 m -124.77 106.77 10.31 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.915 -1.143 . . . . 1.4099999999999999 107.915 167.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.93 108.73 2.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.369 -0.604 . . . . 2.0699999999999998 109.369 174.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 37.9 tp -50.78 -43.5 58.52 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.556 0.617 . . . . 2.6899999999999999 111.115 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -44.06 -46.0 8.29 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.952 0.501 . . . . 2.27 111.125 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.5 mp -59.51 -63.45 1.3 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.516 0.674 . . . . 3.3900000000000001 110.061 -173.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.349 1.3 m -60.32 -37.14 79.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.729 -0.669 . . . . 1.8700000000000001 109.691 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.85 -53.84 50.12 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 117.955 -1.022 . . . . 0.40000000000000002 110.549 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 62.7 t -50.66 -49.94 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.968 1.258 . . . . 1.1799999999999999 109.538 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.588 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 82.7 t60 -56.82 -45.09 82.5 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.236 -0.915 . . . . 3.7799999999999998 113.313 177.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -83.23 -48.18 10.75 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.085 -1.009 . . . . 3.04 112.448 -170.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.37 -33.77 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.364 -1.347 . . . . 1.6499999999999999 107.364 164.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.15 -61.44 5.79 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.95 -0.86 . . . . 0.77000000000000002 110.95 168.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.588 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 17.5 m-70 -47.36 -56.48 6.79 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.495 -1.003 . . . . 2.0800000000000001 110.743 174.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.0 m -46.36 -40.15 11.48 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 113.226 0.825 . . . . 3.0899999999999999 113.226 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.72 -33.88 76.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 118.924 0.784 . . . . 4.54 110.127 -174.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 130.61 46.18 0.15 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.933 1.73 . . . . 1.3200000000000001 112.603 172.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.8 mt -119.45 147.72 44.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.586 1.193 . . . . 4.46 113.198 -172.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -88.13 166.42 35.18 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.879 1.228 . . . . 2.8900000000000001 110.721 173.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -70.35 121.85 18.46 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.562 0.745 . . . . 2.04 110.536 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 66.5 m -77.01 -179.39 5.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.261 0.625 . . . . 1.6100000000000001 110.903 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 17.6 m -135.53 39.1 2.86 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.038 1.335 . . . . 2.77 110.35 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -135.77 136.33 23.32 Favored Pre-proline 0 N--CA 1.452 -0.325 0 N-CA-C 107.524 -1.287 . . . . 1.99 107.524 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.3 -13.38 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.315 2.01 . . . . 1.1200000000000001 114.325 -175.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -41.69 21.97 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.946 0.898 . . . . 2.9900000000000002 109.068 173.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.29 139.88 34.92 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.333 1.053 . . . . 0.79000000000000004 111.041 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 76.6 t -86.48 -15.18 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.943 0.878 . . . . 0.72999999999999998 110.978 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 3.7 tpt -80.25 -21.71 42.48 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.166 -0.959 . . . . 2.1299999999999999 112.916 -171.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -49.83 165.02 0.32 Allowed Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 128.091 2.556 . . . . 4.4100000000000001 114.59 175.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -78.29 -21.11 10.69 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.536 1.491 . . . . 1.02 112.103 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.365 0.2 OUTLIER -78.64 -178.58 5.97 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.375 1.47 . . . . 1.98 110.686 -176.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -111.05 153.91 24.96 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.491 1.517 . . . . 4.3499999999999996 108.926 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.0 tptt -149.53 133.13 16.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 106.858 -1.534 . . . . 3.7999999999999998 106.858 169.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -70.19 111.69 6.0 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.416 -0.957 . . . . 4.1399999999999997 108.416 170.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 20.6 m -121.65 118.17 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.737 0.815 . . . . 1.97 109.015 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.73 114.0 4.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.557 -0.714 . . . . 3.3599999999999999 110.31 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.1 pp -52.09 -29.72 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 C-N-CA 124.642 1.177 . . . . 4.75 111.231 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -52.8 -40.94 63.69 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.854 0.861 . . . . 4.4000000000000004 110.884 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 35.9 m -73.48 -36.39 65.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 119.108 -0.472 . . . . 2.1000000000000001 110.515 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 44.4 t80 52.47 72.65 0.39 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.007 0.923 . . . . 6.1699999999999999 110.084 172.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.41 167.12 30.55 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.099 -1.001 . . . . 3.5899999999999999 110.965 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.08 -170.46 1.72 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.542 1.937 . . . . 1.48 109.463 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 13.9 m -109.85 149.12 30.32 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.574 1.15 . . . . 1.46 111.295 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.4 -48.84 65.43 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.984 -0.448 . . . . 0.94999999999999996 111.573 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -64.11 -22.88 67.11 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.902 0.334 . . . . 2.9700000000000002 111.902 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -77.78 -47.83 18.02 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.967 -0.458 . . . . 3.4100000000000001 110.805 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 67.8 mt -54.48 -40.65 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.151 1.38 . . . . 0.93000000000000005 110.974 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -56.8 -47.79 79.4 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.311 -1.493 . . . . 7.71 111.214 170.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -57.48 -48.92 77.45 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.625 1.107 . . . . 1.04 110.545 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.439 HG23 ' CZ3' ' A' ' 141' ' ' TRP 0.26 1.6 pp -64.08 -44.03 97.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 O-C-N 121.491 -1.005 . . . . 3.3300000000000001 109.686 -176.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -64.03 -30.23 71.32 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.465 -1.397 . . . . 2.6499999999999999 111.787 176.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.6 t -50.76 -14.82 0.22 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.535 1.309 . . . . 2.52 114.535 169.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 19.2 mt . . . . . 0 C--N 1.345 0.396 0 CA-C-N 120.388 1.449 . . . . 3.3100000000000001 112.713 165.392 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.7 mttt . . . . . 0 C--O 1.225 -0.217 0 CA-C-O 122.494 1.14 . . . . 6.5 111.582 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -73.7 -46.77 44.24 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.172 -0.955 . . . . 3.9100000000000001 108.572 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -126.82 118.41 24.57 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.287 0.635 . . . . 4.7800000000000002 112.452 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.15 92.71 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 107.251 -1.389 . . . . 3.2200000000000002 107.251 172.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.647 ' HG1' ' H ' ' A' ' 158' ' ' ASP . 71.6 p -81.39 136.97 35.73 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.338 -0.986 . . . . 1.5800000000000001 108.338 173.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -142.51 164.87 28.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.336 0.516 . . . . 4.8700000000000001 112.294 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -147.1 142.87 27.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.129 0.971 . . . . 5.5499999999999998 108.435 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.92 164.3 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.555 0.742 . . . . 1.1599999999999999 109.327 172.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.552 ' H ' HD21 ' A' ' 119' ' ' ASN . 0.1 OUTLIER -109.33 -56.33 2.31 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 126.148 1.779 . . . . 3.75 108.441 179.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -139.77 120.98 14.83 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.776 -0.824 . . . . 3.3300000000000001 108.776 -167.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -81.26 113.08 19.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.349 -0.982 . . . . 3.8500000000000001 108.349 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -52.27 128.78 40.98 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 123.025 0.53 . . . . 2.8300000000000001 110.314 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.68 -15.88 11.95 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.69 2.927 . . . . 1.8700000000000001 110.553 173.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -46.2 -39.17 9.36 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.366 1.066 . . . . 2.04 110.479 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 42.4 mtm -124.95 -176.72 3.63 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.316 1.447 . . . . 2.3799999999999999 109.954 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -73.87 144.01 45.61 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.432 -0.581 . . . . 3.0499999999999998 109.432 170.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 64.2 ttt-85 -51.04 -45.55 61.36 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.413 -0.804 . . . . 3.5299999999999998 110.722 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -61.81 -13.0 19.94 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.508 0.723 . . . . 3.4100000000000001 112.028 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -94.52 -45.38 7.44 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.344 1.458 . . . . 1.8999999999999999 109.568 172.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 52.4 t -55.8 -59.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.792 1.237 . . . . 1.75 109.831 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -24.14 65.67 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 117.602 -1.639 . . . . 1.78 108.987 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.529 ' HH ' ' HZ2' ' A' ' 136' ' ' LYS . 23.0 t80 -64.55 -46.61 82.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.798 0.727 . . . . 3.1200000000000001 111.208 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.09 -53.34 58.23 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.465 0.706 . . . . 0.40000000000000002 109.846 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.65 -36.84 72.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 109.516 -0.549 . . . . 2.8799999999999999 109.516 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -57.27 12.45 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 122.173 0.987 . . . . 5.6600000000000001 108.511 178.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.529 ' HZ2' ' HH ' ' A' ' 132' ' ' TYR . 6.2 mmmm -62.03 -43.96 97.72 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.225 -0.657 . . . . 2.3500000000000001 109.225 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -48.39 -53.99 15.64 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.437 0.695 . . . . 0.46000000000000002 112.758 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 149' ' ' PHE . 0.3 OUTLIER -62.25 -47.02 86.23 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 119.304 -0.958 . . . . 8.2100000000000009 109.103 176.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.31 -37.05 71.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 122.511 0.324 . . . . 2.48 110.704 -169.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.0 t -54.63 -52.22 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 109.139 -0.689 . . . . 1.21 109.139 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.445 ' CZ2' ' SD ' ' A' ' 236' ' ' MET . 64.4 m95 -69.69 -35.29 74.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.501 -0.749 . . . . 1.02 109.463 -177.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.6 t -64.2 -16.46 62.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.375 0.67 . . . . 2.4100000000000001 112.16 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -83.38 -51.05 7.73 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.116 -1.068 . . . . 1.2 108.116 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.5 m -74.54 -44.46 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 112.393 0.516 . . . . 2.48 112.393 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 56.4 p -84.84 150.63 56.34 Favored Pre-proline 0 N--CA 1.445 -0.714 0 N-CA-C 108.902 -0.777 . . . . 1.25 108.902 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.52 10.46 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.61 2.207 . . . . 0.89000000000000001 112.636 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 43.8 mt -67.72 133.95 50.19 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.263 1.425 . . . . 3.0 110.309 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.56 82.68 1.69 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.832 -1.173 . . . . 5.9500000000000002 107.832 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.458 ' HB2' ' CD1' ' A' ' 138' ' ' PHE . 77.4 m-85 -67.66 159.17 30.55 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.051 -0.522 . . . . 6.46 111.131 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.3 t -155.79 125.87 6.59 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.83 0.741 . . . . 1.6399999999999999 110.629 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -78.78 137.26 37.65 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 107.256 -1.387 . . . . 2.9300000000000002 107.256 167.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.2 pt -135.08 105.58 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.467 -0.938 . . . . 2.2599999999999998 108.467 170.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -77.41 -15.45 59.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.486 -0.325 . . . . 3.1299999999999999 110.169 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.3 m -127.32 102.02 6.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.308 1.043 . . . . 2.7200000000000002 109.249 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.0 -155.26 26.36 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 108.81 -1.716 . . . . 1.8700000000000001 108.81 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 31.4 mtp -117.71 130.16 56.16 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.129 2.572 . . . . 4.8300000000000001 105.88 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -119.14 161.19 20.73 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.291 1.036 . . . . 0.81999999999999995 109.91 -173.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.647 ' H ' ' HG1' ' A' ' 115' ' ' THR . 9.3 t70 -68.82 -54.61 14.83 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.972 -0.751 . . . . 1.8700000000000001 108.972 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.3 pt -114.3 135.96 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.527 0.731 . . . . 1.4299999999999999 109.271 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.72 131.56 52.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.224 -1.028 . . . . 2.9700000000000002 108.224 172.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.32 124.54 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 106.937 -1.505 . . . . 0.82999999999999996 106.937 169.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.9 t -98.51 137.84 24.85 Favored 'Isoleucine or valine' 0 C--N 1.346 0.422 0 C-N-CA 125.049 1.339 . . . . 1.8 108.92 171.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -130.26 107.56 9.37 Favored 'General case' 0 C--N 1.335 -0.054 0 N-CA-C 106.569 -1.641 . . . . 6.6399999999999997 106.569 171.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -123.26 154.42 38.84 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.51 0.672 . . . . 0.89000000000000001 112.35 -173.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -92.17 70.01 5.28 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.792 0.837 . . . . 7.1600000000000001 109.66 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 95.13 -150.33 19.65 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.66 -0.976 . . . . 2.6000000000000001 110.66 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.55 81.3 3.23 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.96 -0.729 . . . . 3.3300000000000001 112.107 -162.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.541 0.623 0 C-N-CA 124.876 1.27 . . . . 3.4399999999999999 112.561 173.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.146 0 CA-C-O 119.658 -0.21 . . . . 5.1200000000000001 111.333 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -110.09 166.54 10.87 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 122.933 0.493 . . . . 7.5999999999999996 110.085 166.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -172.92 164.94 5.1 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 127.389 2.276 . . . . 3.8900000000000001 106.539 -170.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -72.39 -143.35 0.47 Allowed Glycine 0 CA--C 1.525 0.68 0 O-C-N 123.969 0.793 . . . . 2.2400000000000002 111.344 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -61.73 108.15 0.95 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.392 0.677 . . . . 6.3300000000000001 110.795 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.24 -145.68 18.11 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.679 -1.368 . . . . 1.9299999999999999 109.679 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 45.44 -126.93 8.02 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 126.136 1.827 . . . . 1.8600000000000001 111.706 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.3 mm -79.99 144.0 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-O 122.218 1.008 . . . . 2.5499999999999998 108.702 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.0 mp -84.23 -62.04 1.66 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.576 1.95 . . . . 1.3799999999999999 109.445 170.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -159.56 158.4 31.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 120.637 -1.29 . . . . 0.53000000000000003 110.151 -172.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -144.06 135.52 25.83 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 114.247 1.202 . . . . 1.5900000000000001 114.247 172.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -149.43 164.04 36.09 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.264 2.226 . . . . 0.55000000000000004 107.8 -169.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -150.05 143.49 25.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.09 -0.707 . . . . 4.1500000000000004 109.09 -173.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -87.11 -130.18 2.94 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.789 -1.006 . . . . 0.69999999999999996 110.665 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.09 105.21 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.54 2.16 . . . . 3.0699999999999998 110.56 -173.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -167.36 168.05 40.26 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 107.56 -2.216 . . . . 1.47 107.56 176.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.5 m -78.16 167.65 21.08 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.42 0.629 . . . . 2.7799999999999998 111.659 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 53.59 -111.78 2.05 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.173 0.892 . . . . 1.3400000000000001 112.165 173.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.5 tp -60.55 -37.26 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 118.239 -0.886 . . . . 1.49 109.61 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -32.58 131.42 0.25 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.176 1.37 . . . . 1.1399999999999999 113.199 173.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.08 -48.89 1.18 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.58 1.562 . . . . 0.75 111.171 -165.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.45 153.13 23.55 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.537 -0.912 . . . . 1.3 108.537 -161.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.39 120.57 30.16 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 118.001 -0.999 . . . . 0.69999999999999996 112.274 -172.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.47 129.51 56.53 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-N 119.213 0.915 . . . . 3.1099999999999999 110.123 -166.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.407 ' CE2' ' HG3' ' A' ' 219' ' ' GLU . 25.2 m-85 -121.63 150.72 41.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 118.736 0.698 . . . . 4.0700000000000003 110.252 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -79.55 77.73 6.12 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 122.082 0.944 . . . . 3.6000000000000001 111.962 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -48.06 -33.43 8.07 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 119.971 -1.706 . . . . 2.75 111.506 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -36.32 -47.8 0.61 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.773 1.229 . . . . 2.6499999999999999 112.004 171.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -73.81 170.18 15.86 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.09 1.356 . . . . 2.2599999999999998 111.0 -175.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -107.41 94.03 4.87 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.885 -1.524 . . . . 3.5800000000000001 106.885 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -82.83 151.46 26.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.587 -0.733 . . . . 1.8500000000000001 109.652 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.99 161.99 29.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.725 0.774 . . . . 2.8100000000000001 110.836 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.39 -41.02 70.18 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.401 2.28 . . . . 2.1800000000000002 111.684 169.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -80.37 157.79 26.22 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.533 -0.758 . . . . 2.77 110.358 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.8 m -70.58 -33.67 71.34 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.175 1.39 . . . . 5.4400000000000004 111.622 -170.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.69 116.3 8.43 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-O 118.402 -1.221 . . . . 2.9900000000000002 110.244 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 109.18 -121.02 6.0 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 107.812 -2.115 . . . . 2.8100000000000001 107.812 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.4 m -124.72 138.66 54.28 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.681 -1.229 . . . . 1.23 107.681 159.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.27 116.44 29.01 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.83 -0.623 . . . . 2.1800000000000002 109.864 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.74 -56.43 10.28 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.268 0.627 . . . . 2.2200000000000002 109.706 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -43.15 -50.87 6.19 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.515 1.526 . . . . 2.3799999999999999 111.892 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.0 tt -62.37 -58.12 8.84 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.61 -0.515 . . . . 1.8200000000000001 109.61 -172.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.291 6.1 m -58.16 -41.47 83.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.948 -0.301 . . . . 1.8899999999999999 110.649 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.79 -49.64 57.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.619 -0.705 . . . . 0.41999999999999998 111.009 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 58.3 t -57.28 -44.76 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 119.533 1.06 . . . . 1.3200000000000001 111.098 -177.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.754 ' NE2' ' CE1' ' A' ' 222' ' ' HIS . 1.0 OUTLIER -57.1 -50.22 73.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.522 1.129 . . . . 3.7200000000000002 111.948 172.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.568 ' HG2' ' HD1' ' A' ' 218' ' ' HIS . 15.0 mm-40 -71.16 -46.93 60.48 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.457 -0.777 . . . . 2.6299999999999999 112.385 -174.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.11 -39.29 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 107.48 -1.304 . . . . 1.46 107.48 170.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.05 -56.92 5.73 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 123.659 0.647 . . . . 0.60999999999999999 112.919 164.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.754 ' CE1' ' NE2' ' A' ' 218' ' ' HIS 0.266 0.3 OUTLIER -49.94 -46.62 52.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.781 0.79 . . . . 2.8199999999999998 110.904 178.258 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.2 t -51.94 -38.05 54.99 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 123.491 0.494 . . . . 3.1099999999999999 112.275 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 mt -70.91 -59.35 2.84 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 107.528 -1.286 . . . . 3.0 107.528 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 139.44 104.11 0.59 Allowed Glycine 0 C--N 1.337 0.611 0 N-CA-C 110.016 -1.234 . . . . 1.7 110.016 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.526 HD23 ' CE1' ' A' ' 222' ' ' HIS . 3.1 pp -130.73 145.42 51.94 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.52 0.728 . . . . 6.7999999999999998 111.847 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -101.06 28.34 16.48 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.65 1.119 . . . . 3.1400000000000001 112.456 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.475 ' H ' ' CD1' ' A' ' 226' ' ' LEU . 32.7 m80 57.39 102.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.393 2.677 . . . . 2.0899999999999999 112.698 -176.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 7.1 m -72.29 170.12 14.79 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.229 -0.656 . . . . 1.1200000000000001 109.229 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.2 m -140.72 44.33 1.83 Allowed 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.472 -0.768 . . . . 3.1699999999999999 110.268 -171.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -143.18 132.08 11.52 Favored Pre-proline 0 N--CA 1.447 -0.614 0 N-CA-C 106.977 -1.49 . . . . 1.75 106.977 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.56 -14.82 27.62 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.972 1.781 . . . . 1.8100000000000001 114.153 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -72.13 -23.61 61.33 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.475 1.034 . . . . 2.0800000000000001 110.269 171.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.31 158.03 31.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.357 0.599 . . . . 1.1699999999999999 110.607 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 45.2 t -110.99 -25.98 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.302 1.441 . . . . 0.79000000000000004 111.074 173.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.445 ' SD ' ' CZ2' ' A' ' 141' ' ' TRP . 52.6 mmm -65.92 -11.86 50.35 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.158 -0.964 . . . . 3.9700000000000002 111.759 173.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.57 159.35 3.45 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.788 1.635 . . . . 4.9199999999999999 113.959 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.25 -17.86 7.59 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.92 2.413 . . . . 1.0600000000000001 111.524 170.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.3 0.2 OUTLIER -77.21 176.06 9.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.737 1.215 . . . . 3.1000000000000001 108.776 179.063 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -143.19 141.27 31.08 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 104.568 -2.382 . . . . 3.8900000000000001 104.568 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -156.24 145.21 20.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 104.873 -2.269 . . . . 5.29 104.873 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -49.04 109.59 0.27 Allowed 'General case' 0 C--N 1.339 0.118 0 N-CA-C 108.157 -1.053 . . . . 3.9700000000000002 108.157 168.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.91 149.06 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 123.908 0.883 . . . . 1.99 108.891 171.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -60.0 78.5 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.496 2.318 . . . . 5.9699999999999998 111.236 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 39.0 mm -44.95 -35.12 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.864 1.266 . . . . 4.8799999999999999 110.794 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -55.06 -64.76 0.74 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.179 0.807 . . . . 5.0499999999999998 113.179 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 92.7 m -82.22 -51.18 8.19 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.676 -0.861 . . . . 2.5600000000000001 108.676 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 29.2 t80 38.8 72.9 0.12 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.645 1.978 . . . . 8.6400000000000006 113.083 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.75 159.29 15.9 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.266 -0.879 . . . . 6.2400000000000002 109.532 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -85.91 143.88 27.97 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.543 -0.91 . . . . 1.1899999999999999 108.543 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.0 m -76.63 156.14 32.93 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 110.572 -0.158 . . . . 1.47 110.572 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.87 80.88 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.783 -0.451 . . . . 0.97999999999999998 109.783 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.15 -57.68 6.27 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 122.261 1.029 . . . . 2.6000000000000001 109.699 174.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -59.11 -39.61 82.81 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.563 -1.199 . . . . 2.2200000000000002 112.266 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 35.5 mt -55.47 -35.14 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 119.114 0.87 . . . . 1.1299999999999999 110.047 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -66.51 -53.31 36.43 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.468 -0.77 . . . . 5.0 110.014 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -50.77 -54.78 20.43 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 123.077 0.37 . . . . 1.3600000000000001 112.532 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.48 -43.35 94.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 121.851 -0.793 . . . . 2.96 110.462 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.03 -17.17 64.79 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.66 1.118 . . . . 3.29 112.243 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.1 t -66.12 -11.66 50.5 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.246 -1.359 . . . . 3.48 113.407 167.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . 0.293 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.084 0 CA-C-N 120.66 1.573 . . . . 5.4000000000000004 110.162 172.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.0 mptt . . . . . 0 CA--C 1.534 0.35 0 N-CA-C 108.477 -0.935 . . . . 6.4100000000000001 108.477 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 67.38 -61.14 0.36 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.16 1.784 . . . . 4.6299999999999999 110.283 -168.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -113.25 130.16 56.32 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 125.848 1.659 . . . . 3.9700000000000002 109.72 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.8 mt -138.45 105.51 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 123.54 0.525 . . . . 3.9100000000000001 110.499 173.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 p -101.57 145.82 28.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.474 1.109 . . . . 2.3900000000000001 110.914 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.465 ' HH ' ' HB2' ' A' ' 149' ' ' PHE . 6.8 m-85 -127.1 150.11 49.63 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.305 0.642 . . . . 6.2800000000000002 110.58 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -138.59 142.13 39.18 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.122 0.569 . . . . 5.5999999999999996 109.822 174.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.7 mt -99.8 151.71 4.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.936 -1.135 . . . . 1.24 107.936 174.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -91.92 -56.5 3.06 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.001 -1.111 . . . . 4.0800000000000001 108.001 177.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -144.01 157.86 44.07 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 124.959 1.304 . . . . 2.79 108.78 -171.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -112.75 143.86 43.25 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.659 1.184 . . . . 3.73 108.985 -169.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.31 127.21 86.75 Favored Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 108.528 -0.916 . . . . 3.5699999999999998 108.528 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.26 -18.13 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.13 2.553 . . . . 2.0499999999999998 112.033 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.98 -46.79 64.99 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 118.983 0.811 . . . . 2.23 109.609 174.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 50.8 mtm -105.96 174.26 5.96 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.836 -1.075 . . . . 2.3900000000000001 109.009 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -80.76 135.11 35.93 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.228 -1.027 . . . . 2.9199999999999999 108.228 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -45.76 -52.24 11.4 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 118.673 0.669 . . . . 3.8399999999999999 111.97 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -51.68 -46.87 63.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.482 -0.487 . . . . 4.0 109.731 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.43 -39.96 92.74 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.465 1.506 . . . . 1.8899999999999999 111.541 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.8 t -56.04 -56.5 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.205 -1.035 . . . . 1.78 108.205 175.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.8 -22.88 61.51 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.026 -1.07 . . . . 1.73 110.312 -176.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -67.9 -49.33 62.56 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.24 1.016 . . . . 3.6200000000000001 109.194 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.44 -54.74 36.69 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 123.71 0.804 . . . . 0.44 109.213 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -68.0 -34.71 68.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 120.212 -0.595 . . . . 3.5099999999999998 110.356 -176.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -56.45 -60.47 3.48 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 108.191 -1.04 . . . . 4.5800000000000001 108.191 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -62.65 -42.9 99.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.592 1.557 . . . . 2.3999999999999999 108.78 -172.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.38 -54.16 18.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.728 0.811 . . . . 0.52000000000000002 110.328 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.47 ' CE1' HG21 ' A' ' 220' ' ' ILE . 4.0 m-85 -58.84 -51.91 68.01 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 118.886 -0.578 . . . . 5.71 110.999 171.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.42 -33.5 21.06 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.745 0.646 . . . . 2.7999999999999998 112.745 -174.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 77.8 t -69.21 -47.32 74.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.583 0.753 . . . . 1.46 110.468 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.455 ' CZ3' ' CG2' ' A' ' 258' ' ' ILE . 7.1 m95 -69.78 -32.4 70.86 Favored 'General case' 0 N--CA 1.456 -0.155 0 O-C-N 120.631 -1.293 . . . . 1.0700000000000001 110.638 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.47 -11.08 60.34 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.1 1.36 . . . . 1.8799999999999999 110.778 176.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.63 -45.37 17.38 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 107.809 -1.182 . . . . 1.3999999999999999 107.809 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.0 m -84.07 -45.64 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 112.473 0.546 . . . . 2.4700000000000002 112.473 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 19.9 p -78.86 150.8 75.84 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 107.768 -1.197 . . . . 1.1699999999999999 107.768 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -72.96 1.91 6.02 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 121.971 1.781 . . . . 1.1899999999999999 112.678 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.1 mt -69.6 142.14 53.59 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.384 1.474 . . . . 3.1299999999999999 109.274 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 103.0 12.62 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.749 -0.834 . . . . 4.9199999999999999 108.749 174.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.465 ' HB2' ' HH ' ' A' ' 116' ' ' TYR . 0.8 OUTLIER -67.96 146.3 53.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.551 0.74 . . . . 8.5399999999999991 110.917 176.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.7 t -152.44 95.15 2.0 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.638 0.653 . . . . 1.3500000000000001 111.964 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.92 133.81 39.13 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 120.583 -1.323 . . . . 4.0700000000000003 108.41 171.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.4 pp -130.56 174.38 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.392 -1.707 . . . . 2.21 106.392 171.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -134.14 21.24 3.76 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 121.613 -0.679 . . . . 3.4700000000000002 109.525 172.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 85.5 m -157.03 117.16 3.51 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.071 -1.455 . . . . 3.0099999999999998 107.071 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 121.34 -144.63 16.72 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 108.209 -1.956 . . . . 2.3999999999999999 108.209 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 33.0 mtt -110.11 139.11 45.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.982 1.313 . . . . 4.96 109.43 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -127.23 159.74 33.39 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.241 1.416 . . . . 1.0800000000000001 109.809 173.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.42 -54.45 6.71 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.054 -1.462 . . . . 2.5299999999999998 107.054 168.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.58 151.58 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 122.397 1.094 . . . . 2.1000000000000001 111.253 -168.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.7 mt -126.08 125.01 41.87 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 112.398 -2.183 . . . . 3.0600000000000001 107.876 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 38.0 t -91.87 105.43 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.934 -1.136 . . . . 0.95999999999999996 107.934 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 62.2 t -110.8 102.88 14.61 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 C-N-CA 123.916 0.887 . . . . 2.1699999999999999 109.237 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -80.61 155.98 26.62 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.955 -1.128 . . . . 8.0500000000000007 107.955 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -158.16 -173.49 4.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.176 0.444 . . . . 1.25 110.199 167.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -129.5 145.89 51.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.296 1.039 . . . . 4.9400000000000004 108.876 170.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.4 -126.24 19.15 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.354 0.978 . . . . 1.97 111.987 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.38 132.92 37.57 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.301 1.04 . . . . 2.6800000000000002 109.677 -173.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' A' ' 168' ' ' HIS 0.255 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.571 0 CA-C-O 123.277 1.513 . . . . 3.8599999999999999 111.193 179.266 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.401 0 CA-C-O 118.173 -0.917 . . . . 2.7799999999999998 111.234 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.407 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 39.5 t80 -92.08 156.03 17.66 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 122.434 1.111 . . . . 9.1899999999999995 110.318 175.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 35.9 p30 -166.02 30.48 0.05 OUTLIER 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.774 -1.557 . . . . 3.52 110.127 -152.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 84.63 172.06 48.72 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.435 -0.666 . . . . 2.98 111.435 -172.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.94 124.99 18.45 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.631 -0.507 . . . . 4.4800000000000004 109.631 167.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 97.08 -154.67 20.55 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.283 -1.127 . . . . 2.4900000000000002 110.283 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 57.61 -122.94 31.11 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 109.451 -1.459 . . . . 2.1499999999999999 109.451 -173.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.6 mm -75.93 128.79 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 105.961 -1.866 . . . . 2.3999999999999999 105.961 168.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.3 mp -81.08 -50.67 9.36 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.008 -0.738 . . . . 1.74 109.008 172.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -161.71 163.61 29.59 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.369 0.268 . . . . 0.55000000000000004 110.328 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -142.82 112.41 6.83 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.321 1.448 . . . . 1.28 113.691 -169.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -146.75 162.0 39.46 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 127.443 2.297 . . . . 0.92000000000000004 107.166 -175.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.86 151.83 16.78 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.801 -0.814 . . . . 7.3399999999999999 108.801 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -102.5 -84.42 1.8 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.61 1.1 . . . . 0.98999999999999999 110.486 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.62 94.46 0.61 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.806 3.004 . . . . 1.5800000000000001 110.625 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -163.91 154.75 25.79 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 108.412 -1.875 . . . . 1.29 108.412 170.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.7 m -78.44 170.28 16.9 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.418 -0.586 . . . . 2.9900000000000002 109.418 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 72.19 -118.81 6.99 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.517 -1.433 . . . . 1.99 109.517 -175.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . 0.266 3.5 tp -84.92 21.71 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 124.304 1.041 . . . . 4.0599999999999996 112.723 -168.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -55.46 143.32 35.23 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 120.891 -1.131 . . . . 2.48 114.231 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 94.04 -32.67 5.73 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.572 1.082 . . . . 1.1200000000000001 111.111 -173.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.28 158.97 18.31 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.666 0.733 . . . . 1.6000000000000001 109.423 -158.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -142.71 127.15 17.79 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.114 0.783 . . . . 0.87 113.114 -157.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -117.8 131.51 56.56 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 117.94 -1.029 . . . . 3.1000000000000001 110.673 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -113.54 152.17 30.6 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.561 0.696 . . . . 8.0099999999999998 111.556 167.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.19 85.08 0.75 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.773 -1.103 . . . . 2.79 108.529 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -60.91 -31.74 71.23 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.4 -1.438 . . . . 2.5299999999999998 111.029 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -47.62 -42.3 23.86 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.304 0.573 . . . . 2.73 110.517 172.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.36 135.34 51.66 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.486 -1.301 . . . . 2.1299999999999999 107.486 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -88.27 94.85 9.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.195 -1.78 . . . . 3.6000000000000001 106.195 -174.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -76.12 138.05 40.5 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.663 -1.606 . . . . 1.49 106.663 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 35.9 p -118.01 124.08 47.27 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.024 -1.843 . . . . 2.1400000000000001 106.024 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.1 t -51.91 -46.5 64.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 121.657 2.026 . . . . 2.4700000000000002 110.452 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.92 132.67 47.19 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.229 -0.896 . . . . 2.9300000000000002 109.768 167.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 11.1 p -39.82 -57.08 1.64 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.693 1.597 . . . . 4.6900000000000004 110.744 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 18.95 -88.9 0.01 OUTLIER Glycine 0 CA--C 1.524 0.622 0 C-N-CA 128.564 2.983 . . . . 2.5600000000000001 115.406 163.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -81.97 -80.22 0.93 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.811 -1.716 . . . . 1.8200000000000001 108.811 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.3 m -150.95 111.2 4.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.048 -1.093 . . . . 1.28 108.048 170.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -61.33 117.81 6.12 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.35 0.66 . . . . 1.52 110.822 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 46.0 tp -53.69 -48.25 69.71 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 119.298 -0.382 . . . . 2.8399999999999999 110.089 178.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -49.68 -42.91 46.75 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.993 0.517 . . . . 2.4199999999999999 111.152 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.34 -59.44 5.41 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.041 0.937 . . . . 1.71 110.32 -176.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.265 0.2 OUTLIER -61.77 -38.71 89.04 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.647 -0.252 . . . . 2.1400000000000001 111.073 177.458 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.42 -56.67 16.36 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 117.954 -1.022 . . . . 0.46000000000000002 109.343 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 93.0 t -47.54 -42.6 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 119.996 1.271 . . . . 1.22 110.986 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.777 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 0.2 OUTLIER -59.92 -51.06 71.29 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.119 0.567 . . . . 3.9700000000000002 111.263 175.365 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -64.53 -54.71 28.01 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 121.043 -1.036 . . . . 4.1500000000000004 110.845 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.47 HG21 ' CE1' ' A' ' 138' ' ' PHE . 1.7 mp -49.34 -46.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 127.041 2.137 . . . . 1.6000000000000001 109.247 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -58.5 -44.84 95.17 Favored Glycine 0 CA--C 1.534 1.261 0 O-C-N 121.482 -0.761 . . . . 0.76000000000000001 111.506 172.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.777 ' NE2' ' NE2' ' A' ' 218' ' ' HIS 0.264 6.7 m-70 -51.94 -49.06 63.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.237 1.518 . . . . 2.0099999999999998 110.855 171.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.3 m -55.42 -44.9 76.7 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.48 1.112 . . . . 3.1200000000000001 111.482 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 93.3 mt -59.28 -52.55 65.17 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.565 -0.531 . . . . 3.3399999999999999 109.565 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 139.37 92.27 0.23 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.679 1.133 . . . . 1.23 111.585 170.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.6 mt -145.96 112.46 5.89 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.242 1.021 . . . . 4.21 111.57 -171.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -79.0 43.38 2.44 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.68 1.133 . . . . 2.6699999999999999 113.664 -174.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 71.6 m80 60.73 175.28 0.1 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.689 1.596 . . . . 1.9299999999999999 113.79 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 69.7 m -139.84 -178.73 5.56 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.903 2.081 . . . . 1.46 108.07 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 27.7 t -143.33 31.74 1.35 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.905 0.882 . . . . 3.3900000000000001 111.128 -173.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -127.92 137.3 30.5 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 106.932 -1.507 . . . . 1.6499999999999999 106.932 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.97 -11.72 14.91 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.39 2.06 . . . . 1.29 114.77 -173.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -81.96 -29.12 32.34 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.916 0.886 . . . . 1.78 109.274 168.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.95 151.87 45.99 Favored 'General case' 0 CA--C 1.519 -0.229 0 O-C-N 121.883 -0.511 . . . . 0.69999999999999996 109.774 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 88.4 t -98.27 -24.29 4.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.508 0.723 . . . . 0.98999999999999999 109.993 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.84 -15.09 58.01 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 114.029 1.122 . . . . 2.46 114.029 177.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -49.65 154.77 1.58 Allowed Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 113.032 0.752 . . . . 4.6100000000000003 113.032 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.27 -23.05 21.32 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.473 1.449 . . . . 1.3200000000000001 111.638 172.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.291 0.6 OUTLIER -79.31 -178.6 6.31 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.497 1.519 . . . . 2.6499999999999999 111.084 -179.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -116.64 155.61 28.49 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.894 1.678 . . . . 3.7000000000000002 107.026 171.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.77 125.65 7.76 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.113 -1.069 . . . . 2.8300000000000001 108.113 165.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -63.37 125.69 24.98 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.066 0.946 . . . . 4.4699999999999998 109.733 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 16.3 m -141.24 148.27 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 108.276 -1.009 . . . . 2.73 108.276 167.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.67 127.96 33.98 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.993 1.317 . . . . 3.6299999999999999 110.239 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.7 pp -58.35 -28.52 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 122.604 0.361 . . . . 4.8099999999999996 111.917 -173.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -76.6 -43.12 39.85 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 123.625 0.77 . . . . 5.4699999999999998 111.942 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 91.1 m -80.55 -27.18 37.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.32 0.648 . . . . 2.9300000000000002 109.628 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -26.13 113.72 0.05 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.869 2.068 . . . . 9.0 112.403 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.35 158.18 44.78 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.129 1.371 . . . . 4.71 109.078 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.406 ' HG ' ' CZ3' ' A' ' 141' ' ' TRP . 1.8 mm? -83.44 146.28 28.51 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.853 -1.166 . . . . 1.1499999999999999 107.853 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.0 m -79.48 152.61 30.14 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 119.705 -0.188 . . . . 1.21 111.304 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.17 -42.46 63.45 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.635 0.374 . . . . 0.82999999999999996 110.857 172.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -50.0 -57.81 6.79 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 122.287 1.041 . . . . 2.7000000000000002 109.681 172.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.93 -41.34 87.11 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.23 -1.35 . . . . 2.3799999999999999 110.495 -176.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 80.0 mt -54.97 -40.12 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.351 1.46 . . . . 1.1699999999999999 111.389 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -67.9 -44.64 76.5 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 120.694 -1.253 . . . . 4.9800000000000004 110.22 174.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -46.65 -55.88 7.79 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.823 -0.911 . . . . 1.05 110.823 174.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.455 ' CG2' ' CZ3' ' A' ' 141' ' ' TRP . 2.0 pp -64.62 -43.93 96.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 O-C-N 121.826 -0.808 . . . . 3.2999999999999998 111.163 -175.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -64.63 -18.41 64.9 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.628 0.649 . . . . 3.4700000000000002 112.057 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.3 t -51.56 -33.11 30.97 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.738 0.699 . . . . 3.1299999999999999 111.312 169.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 16.2 mt . . . . . 0 C--N 1.346 0.438 0 CA-C-N 119.218 0.917 . . . . 3.48 112.802 172.108 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.5 mptt . . . . . 0 CA--C 1.528 0.12 0 N-CA-C 109.91 -0.404 . . . . 6.54 109.91 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 61.56 -63.07 0.09 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.908 1.283 . . . . 5.0 111.172 -159.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -77.8 99.68 6.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.41 0.55 . . . . 4.3399999999999999 111.22 -170.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.8 mm -117.08 108.02 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.726 -0.842 . . . . 2.7000000000000002 108.726 174.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 40.3 p -120.03 125.05 47.39 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 117.792 -1.099 . . . . 1.53 109.3 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.57 159.23 24.75 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.626 1.17 . . . . 4.0199999999999996 112.24 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -133.91 149.43 51.29 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.071 0.948 . . . . 6.3099999999999996 109.362 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.8 mt -107.03 137.68 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.466 1.506 . . . . 1.6299999999999999 107.271 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -98.22 -45.26 6.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.989 0.359 . . . . 3.0800000000000001 110.423 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -143.32 161.99 36.87 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.794 -0.817 . . . . 2.2200000000000002 108.794 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -127.41 134.15 49.92 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.47 -1.678 . . . . 4.3200000000000003 106.47 -165.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.525 ' HG1' ' CG ' ' A' ' 124' ' ' ASP . 7.7 t -70.39 115.53 35.78 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 118.797 0.726 . . . . 3.0 109.754 -173.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.99 -17.05 51.06 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 124.006 3.137 . . . . 1.9199999999999999 111.719 -173.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.525 ' CG ' ' HG1' ' A' ' 122' ' ' THR . 0.4 OUTLIER -33.15 -41.14 0.07 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.416 2.686 . . . . 2.1200000000000001 112.074 170.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -133.94 -179.88 5.82 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.1 0.96 . . . . 2.8199999999999998 109.581 171.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -66.09 131.83 47.09 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.451 -0.944 . . . . 3.2599999999999998 108.451 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -44.4 -45.06 8.77 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.063 0.394 . . . . 3.73 112.063 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -46.86 -47.61 21.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.553 0.692 . . . . 3.5699999999999998 109.437 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.34 -39.05 78.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.434 -0.803 . . . . 2.0600000000000001 111.709 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 80.7 t -58.08 -54.28 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 O-C-N 121.6 -0.687 . . . . 1.8100000000000001 109.264 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.14 -25.76 67.12 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 118.02 -1.472 . . . . 1.6899999999999999 109.294 177.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -66.13 -44.91 82.88 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 120.271 1.396 . . . . 3.1099999999999999 110.207 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.75 -52.87 61.16 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.77 0.828 . . . . 0.40000000000000002 110.048 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.67 -34.65 66.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 120.488 -0.485 . . . . 3.0899999999999999 109.742 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.87 -57.01 14.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.604 1.192 . . . . 5.0 108.154 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 mmmm -58.27 -49.01 78.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.997 -1.001 . . . . 2.4399999999999999 108.765 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -44.69 -54.66 5.99 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.106 0.963 . . . . 0.56000000000000005 112.52 175.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -62.38 -46.21 89.66 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 118.989 -1.084 . . . . 8.1600000000000001 110.774 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.36 -42.31 73.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 123.316 0.385 . . . . 3.8900000000000001 110.131 -173.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.01 -52.06 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 120.812 0.339 . . . . 2.0699999999999998 110.088 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.489 ' CZ3' ' HG ' ' A' ' 250' ' ' LEU . 67.3 m95 -71.9 -44.3 63.94 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.906 -0.775 . . . . 0.89000000000000001 108.906 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.4 t -57.29 -26.78 61.4 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.985 0.514 . . . . 2.1200000000000001 111.198 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -39.44 89.7 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 122.743 0.417 . . . . 2.1499999999999999 110.881 175.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 81.1 t -82.88 -55.44 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.932 1.293 . . . . 3.3900000000000001 109.61 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 43.6 p -84.92 150.55 55.91 Favored Pre-proline 0 N--CA 1.447 -0.577 0 C-N-CA 123.166 0.586 . . . . 1.8200000000000001 109.93 -172.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.96 8.13 1.79 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 121.509 1.472 . . . . 0.94999999999999996 112.949 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.69 111.95 12.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.326 1.05 . . . . 3.73 108.471 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.62 86.16 3.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.418 -1.327 . . . . 4.7599999999999998 107.418 175.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -67.57 128.96 38.38 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.082 -0.963 . . . . 7.0099999999999998 109.423 170.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.97 134.65 38.82 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 123.964 0.906 . . . . 1.9199999999999999 110.162 172.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -92.84 127.22 38.27 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 107.605 -1.257 . . . . 3.1499999999999999 107.605 173.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.7 pt -130.81 101.19 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.924 -1.139 . . . . 2.3799999999999999 107.924 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -91.75 27.04 2.17 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.673 -0.642 . . . . 3.3599999999999999 111.1 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.94 78.86 1.41 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.89 1.276 . . . . 3.4700000000000002 110.096 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 150.32 -132.29 3.9 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 108.697 -1.761 . . . . 2.0499999999999998 108.697 171.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.1 mtt -128.55 144.86 51.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.851 1.66 . . . . 5.7599999999999998 107.678 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.52 172.66 10.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.85 1.66 . . . . 0.81999999999999995 109.534 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.73 -57.38 3.7 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.089 0.956 . . . . 1.9199999999999999 108.982 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.3 pt -105.17 152.6 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.154 -0.93 . . . . 1.47 108.877 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 tt -131.11 130.34 43.02 Favored 'General case' 0 CA--C 1.523 -0.075 0 N-CA-C 113.31 0.856 . . . . 2.8999999999999999 113.31 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.23 102.68 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.827 -0.805 . . . . 1.01 108.827 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.2 t -93.57 131.29 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.814 2.046 . . . . 1.8899999999999999 108.813 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -129.12 112.92 14.47 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 105.641 -1.985 . . . . 6.4400000000000004 105.641 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -133.97 161.65 34.22 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 123.658 0.783 . . . . 1.0800000000000001 110.978 -165.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.4 121.06 32.76 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.446 1.098 . . . . 7.5700000000000003 110.629 -170.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 65.09 -70.49 0.08 OUTLIER Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.543 -1.143 . . . . 1.8400000000000001 112.216 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.28 163.98 13.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.148 1.474 . . . . 2.8199999999999998 110.62 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 4.0 p80 . . . . . 0 CA--C 1.531 0.231 0 C-N-CA 123.511 0.724 . . . . 3.9500000000000002 109.887 164.162 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 114.219 1.192 . . . . 3.1000000000000001 114.219 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 2.8 t80 -121.96 161.41 22.93 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.858 1.208 . . . . 8.9399999999999995 107.771 165.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.43 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 40.7 p-10 -164.32 24.46 0.07 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 113.519 -1.673 . . . . 2.73 110.002 -148.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 86.08 171.34 47.85 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 122.157 0.865 . . . . 1.8799999999999999 111.79 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -72.21 100.86 2.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.658 -0.771 . . . . 5.6399999999999997 109.34 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 131.13 -161.84 23.56 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.64 -1.784 . . . . 1.6200000000000001 108.64 -167.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.68 -121.94 24.97 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.547 -1.421 . . . . 1.45 109.547 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . 0.396 1.8 tp -78.47 140.06 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.361 -1.348 . . . . 3.1699999999999999 107.361 175.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.41 -55.67 4.36 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.769 -0.826 . . . . 2.04 108.769 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -169.99 179.87 3.44 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.948 0.899 . . . . 0.94999999999999996 110.09 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.54 143.41 51.18 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 125.955 1.702 . . . . 2.4399999999999999 111.896 -176.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -161.71 159.17 26.97 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.207 -1.405 . . . . 0.88 107.207 164.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.5 143.82 15.06 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.75 -1.574 . . . . 5.7599999999999998 106.75 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.08 -86.6 1.71 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.025 -1.23 . . . . 0.66000000000000003 110.025 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.64 99.38 0.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.254 2.636 . . . . 1.51 110.915 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -175.39 165.11 35.85 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.064 -1.615 . . . . 1.2 109.064 172.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.68 168.7 16.04 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.164 0.586 . . . . 3.3700000000000001 109.868 172.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 55.48 -105.79 0.47 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.01 0.814 . . . . 1.6399999999999999 111.827 173.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.7 tp -64.2 -23.28 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.44 0.696 . . . . 1.8700000000000001 111.002 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -49.4 143.34 9.74 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.854 -0.898 . . . . 1.1200000000000001 110.854 170.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 84.2 -36.07 2.93 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.253 0.93 . . . . 0.72999999999999998 112.358 -169.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -76.73 178.4 6.81 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.068 1.434 . . . . 1.27 110.681 -166.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -153.02 133.81 13.89 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.266 -2.494 . . . . 1.1200000000000001 104.266 -165.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.457 ' CD2' ' C ' ' A' ' 196' ' ' HIS 0.315 14.3 t-80 -155.07 85.16 1.08 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 117.199 -1.8 . . . . 6.9400000000000004 112.489 -133.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -103.67 147.16 27.57 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.244 1.018 . . . . 3.98 112.16 -158.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.87 81.03 0.46 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.022 1.329 . . . . 2.79 109.58 173.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -53.72 -50.04 66.78 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.068 -1.645 . . . . 3.0299999999999998 111.329 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -51.0 -26.15 5.66 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.293 0.637 . . . . 3.3999999999999999 111.674 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -68.43 153.06 44.49 Favored 'General case' 0 C--O 1.243 0.754 0 O-C-N 120.607 -1.308 . . . . 2.2400000000000002 109.445 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -97.33 90.14 4.99 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.627 -1.99 . . . . 4.0199999999999996 105.627 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -77.57 161.79 27.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.12 -1.067 . . . . 1.77 108.12 -177.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 56.7 p -132.75 141.88 48.75 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 122.088 0.946 . . . . 2.1400000000000001 111.19 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.7 t -60.66 -40.32 91.63 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.607 1.563 . . . . 2.29 111.789 163.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -79.55 -177.08 5.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.607 1.163 . . . . 3.0899999999999999 111.496 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 41.6 t -72.89 -50.95 20.65 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.831 0.852 . . . . 5.1299999999999999 110.77 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -55.07 112.71 3.06 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.853 0.74 . . . . 3.1600000000000001 112.724 -167.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 108.4 -121.28 6.23 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 107.634 -2.186 . . . . 3.1200000000000001 107.634 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.7 m -119.35 130.56 55.42 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.666 -1.605 . . . . 1.79 106.666 168.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -89.48 118.9 29.47 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 109.211 -0.663 . . . . 1.3500000000000001 109.211 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.98 -53.96 23.12 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 122.988 0.515 . . . . 2.3599999999999999 109.808 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -54.98 -45.01 74.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.18 0.592 . . . . 3.3300000000000001 110.67 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.7 tt -62.29 -58.83 6.26 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.745 -0.597 . . . . 1.5800000000000001 109.854 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.315 2.2 m -59.2 -33.13 70.6 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.522 -0.471 . . . . 1.8300000000000001 110.922 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.0 -45.77 86.31 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.281 -0.887 . . . . 0.56000000000000005 110.898 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 89.0 t -55.05 -48.47 75.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 120.044 1.293 . . . . 1.1899999999999999 110.263 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.681 ' CE1' ' O ' ' A' ' 237' ' ' PHE . 0.3 OUTLIER -52.32 -53.06 49.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.478 1.511 . . . . 3.6299999999999999 111.532 172.09 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -68.44 -53.14 25.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 119.159 0.89 . . . . 3.7200000000000002 113.362 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.01 -41.61 68.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 108.604 -0.887 . . . . 1.4199999999999999 108.604 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.77 -48.44 78.01 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 111.289 -0.724 . . . . 0.68999999999999995 111.289 173.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -57.65 -45.72 85.12 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.295 -1.121 . . . . 3.77 111.209 175.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.7 t -54.98 -56.71 16.71 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.479 1.112 . . . . 2.6600000000000001 110.94 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.6 pp -62.39 -34.69 77.22 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.323 -0.551 . . . . 3.79 111.779 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 146.35 107.79 0.53 Allowed Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.18 -1.168 . . . . 2.6699999999999999 110.18 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.423 ' H ' HD21 ' A' ' 226' ' ' LEU . 0.9 OUTLIER -75.69 160.89 29.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 122.984 0.514 . . . . 8.8000000000000007 111.923 176.587 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.22 42.69 0.84 Allowed Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.572 -1.411 . . . . 3.9399999999999999 109.572 167.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -0.88 93.22 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.189 2.596 . . . . 2.2999999999999998 116.139 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.8 m -74.89 171.03 14.76 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.351 0.66 . . . . 1.75 110.495 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 9.5 p -124.66 5.62 8.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.321 1.849 . . . . 4.2000000000000002 111.216 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -96.75 128.0 37.42 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 125.134 1.374 . . . . 1.96 108.532 -172.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -62.55 -14.21 38.22 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.992 2.462 . . . . 1.95 113.614 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -80.11 -34.16 38.09 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.952 0.901 . . . . 2.5800000000000001 110.279 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.68 136.41 39.11 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.68 -0.859 . . . . 0.79000000000000004 108.68 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 45.8 t -85.55 -21.24 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 122.414 0.285 . . . . 0.64000000000000001 110.345 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -21.79 59.77 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 113.945 1.091 . . . . 2.1400000000000001 113.945 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.681 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -49.48 173.15 0.08 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.56 2.344 . . . . 4.5700000000000003 114.533 -173.087 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -90.24 -22.1 0.82 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.759 1.639 . . . . 1.51 111.685 166.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.293 0.7 OUTLIER -86.94 100.73 12.8 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.78 1.232 . . . . 3.04 110.696 -170.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . 0.329 31.5 t80 -73.63 133.24 43.42 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.036 0.834 . . . . 3.6299999999999999 108.992 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.56 145.99 21.92 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.82 -1.548 . . . . 3.0800000000000001 106.82 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -53.37 127.36 24.54 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.981 0.912 . . . . 3.9100000000000001 111.726 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 31.7 m -98.86 146.55 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.708 0.633 . . . . 2.27 112.708 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -74.54 77.92 1.96 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.878 0.847 . . . . 5.21 111.002 175.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 17.8 mm -54.2 -22.46 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.875 -0.602 . . . . 4.9900000000000002 111.498 168.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -43.57 -48.69 7.57 Favored 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 123.192 0.597 . . . . 4.2300000000000004 112.115 167.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.5 m -84.71 -41.78 15.9 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.134 0.574 . . . . 2.29 110.387 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 60.0 t80 58.5 76.24 0.35 Allowed 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.614 0.766 . . . . 5.2699999999999996 109.778 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.84 174.82 14.41 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 121.58 -0.7 . . . . 4.6299999999999999 109.715 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.489 ' HG ' ' CZ3' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -116.98 163.1 16.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.028 1.331 . . . . 0.84999999999999998 108.459 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 63.5 m -81.09 147.39 30.13 Favored 'General case' 0 C--O 1.225 -0.213 0 O-C-N 122.154 -0.341 . . . . 1.6399999999999999 111.816 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.86 -40.24 60.24 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 122.986 0.514 . . . . 1.24 110.833 169.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -51.44 -58.46 6.2 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.095 0.95 . . . . 2.6099999999999999 109.781 171.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -58.02 -45.07 87.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.96 1.304 . . . . 2.0899999999999999 110.482 -173.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 63.3 mt -46.76 -38.79 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.319 1.448 . . . . 1.73 111.222 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -68.3 -46.55 70.01 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.896 0.771 . . . . 5.6100000000000003 111.205 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -57.14 -55.36 30.73 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 118.788 0.722 . . . . 1.47 111.504 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 2.2 pp -61.15 -39.66 83.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 122.938 0.495 . . . . 3.6699999999999999 111.426 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -70.0 -22.54 63.11 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.042 0.837 . . . . 4.0 112.282 172.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.9 t -64.73 -10.75 29.7 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.303 -1.332 . . . . 3.0099999999999998 113.66 176.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . 0.36 0.0 OUTLIER . . . . . 0 CA--C 1.551 0.983 0 C-N-CA 125.682 1.593 . . . . 5.0800000000000001 114.125 -176.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 110.355 -0.239 . . . . 6.21 110.355 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 65.52 -71.39 0.08 Allowed 'General case' 0 C--N 1.341 0.225 0 C-N-CA 125.916 1.686 . . . . 4.3700000000000001 110.189 -173.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -103.96 122.46 45.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.846 0.859 . . . . 6.6600000000000001 110.065 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.464 ' HB ' ' CD1' ' A' ' 149' ' ' PHE . 1.5 mm -106.69 88.72 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.016 -1.105 . . . . 2.48 108.016 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 p -78.21 131.86 37.33 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.846 -1.159 . . . . 1.6200000000000001 108.897 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -125.73 164.46 20.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.144 0.978 . . . . 4.6299999999999999 110.614 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.21 149.61 28.15 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.636 -0.875 . . . . 7.1500000000000004 108.636 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.5 mt -89.28 150.5 3.7 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 N-CA-C 108.311 -0.996 . . . . 1.25 108.311 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.493 ' H ' HD21 ' A' ' 119' ' ' ASN . 0.8 OUTLIER -81.45 -55.31 4.78 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.604 -0.887 . . . . 3.3300000000000001 108.604 175.686 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -151.25 176.27 11.38 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.782 0.833 . . . . 2.3300000000000001 109.31 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -106.41 146.93 29.89 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.294 1.038 . . . . 3.3199999999999998 109.859 -174.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.2 t -93.25 141.19 23.68 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 124.413 1.085 . . . . 2.52 108.353 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.79 -22.12 9.19 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.044 2.496 . . . . 1.95 111.308 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -29.85 -51.57 0.13 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.976 2.11 . . . . 2.21 113.013 172.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 11.3 mtm -131.29 170.51 14.52 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.934 1.294 . . . . 2.2400000000000002 108.195 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -69.91 149.5 47.74 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.086 0.554 . . . . 4.0999999999999996 109.578 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 29.0 ttt-85 -49.04 -44.95 42.09 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.265 0.626 . . . . 3.7200000000000002 111.496 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.55 3.47 3.05 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.737 1.014 . . . . 2.9900000000000002 113.737 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -112.12 -42.05 3.82 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 125.696 1.598 . . . . 1.96 109.635 164.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.8 t -51.74 -57.58 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.113 0.965 . . . . 1.79 109.538 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.402 ' OD2' ' NZ ' ' A' ' 151' ' ' LYS . 0.1 OUTLIER -73.23 -21.68 60.58 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 118.986 -1.086 . . . . 1.6799999999999999 109.414 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -65.57 -47.5 75.59 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.191 0.905 . . . . 3.1600000000000001 109.844 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.15 -52.65 63.58 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.533 1.133 . . . . 0.52000000000000002 109.191 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.39 -40.97 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 120.853 -0.339 . . . . 2.48 111.191 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -49.74 -58.82 4.58 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.518 -1.289 . . . . 5.2199999999999998 107.518 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -59.12 -49.81 76.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.334 1.454 . . . . 3.3300000000000001 110.5 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.72 -49.95 45.91 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.529 0.732 . . . . 0.81000000000000005 111.329 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.486 ' CD1' ' CD1' ' A' ' 149' ' ' PHE . 31.2 m-85 -58.55 -54.04 51.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.309 0.576 . . . . 5.9800000000000004 109.91 173.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -39.88 67.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.486 -0.779 . . . . 2.3900000000000001 111.156 -172.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 68.5 t -48.71 -64.24 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.772 1.229 . . . . 1.5600000000000001 109.852 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -68.55 -35.28 77.2 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.693 -0.854 . . . . 1.3999999999999999 108.693 -174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.1 -16.78 63.86 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 123.708 0.63 . . . . 2.1600000000000001 112.199 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -82.42 -47.88 11.75 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 108.384 -0.969 . . . . 1.6100000000000001 108.384 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.8 m -74.39 -43.88 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 112.635 0.606 . . . . 2.3599999999999999 112.635 -177.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 51.4 p -89.34 158.01 46.77 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 109.424 -0.584 . . . . 1.48 109.424 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.87 -0.95 9.18 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.431 2.088 . . . . 0.89000000000000001 113.334 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.3 mt -59.91 141.31 55.71 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.259 1.424 . . . . 3.27 109.466 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -118.75 90.54 3.35 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.201 -1.037 . . . . 5.0599999999999996 108.201 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.486 ' CD1' ' CD1' ' A' ' 138' ' ' PHE . 30.9 m-85 -70.03 143.73 52.44 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.03 -0.532 . . . . 7.2199999999999998 109.969 173.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -151.88 130.74 12.48 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.553 0.615 . . . . 1.3600000000000001 110.619 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.402 ' NZ ' ' OD2' ' A' ' 131' ' ' ASP . 4.0 ttmt -86.54 138.67 31.53 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.064 -0.717 . . . . 3.1099999999999999 109.064 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.8 pp -140.72 98.53 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 118.224 0.466 . . . . 2.04 110.515 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -80.2 26.73 0.35 Allowed 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.291 -1.506 . . . . 3.1400000000000001 110.708 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 45.5 p -154.07 78.08 1.1 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.157 0.983 . . . . 3.8999999999999999 108.565 -171.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 145.87 -122.84 1.74 Allowed Glycine 0 C--N 1.335 0.513 0 N-CA-C 108.189 -1.965 . . . . 2.3300000000000001 108.189 174.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -149.71 135.07 18.25 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.573 -1.269 . . . . 6.5899999999999999 107.573 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -112.43 163.01 14.95 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.36 1.464 . . . . 0.80000000000000004 110.141 -175.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -79.16 -44.72 21.37 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.991 0.9 . . . . 2.02 108.856 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.513 HD11 ' HG ' ' A' ' 223' ' ' SER . 5.7 pt -112.91 166.44 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.832 0.825 . . . . 1.3799999999999999 112.04 177.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.76 136.57 35.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.68 1.592 . . . . 2.9900000000000002 109.272 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.2 t -79.49 138.76 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 107.375 -1.342 . . . . 1.25 107.375 166.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 73.7 t -108.25 139.42 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 106.923 -1.51 . . . . 1.8999999999999999 106.923 164.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.91 137.9 51.9 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.656 -1.979 . . . . 7.8099999999999996 105.656 172.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -158.41 157.7 32.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.55 0.614 . . . . 1.4199999999999999 109.478 165.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -104.15 119.39 38.84 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.983 -1.118 . . . . 5.6200000000000001 107.983 168.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 71.77 -170.99 48.27 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.74 -0.544 . . . . 2.0699999999999998 111.74 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.66 78.35 3.31 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 122.011 -0.699 . . . . 3.71 110.92 -164.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.5 p80 . . . . . 0 N--CA 1.454 -0.239 0 C-N-CA 124.247 1.019 . . . . 3.7000000000000002 113.36 -175.258 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 107.93 -1.137 . . . . 5.0700000000000003 107.93 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -105.03 171.55 7.26 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 124.814 1.246 . . . . 7.2599999999999998 108.302 164.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -161.72 162.27 29.65 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.314 1.446 . . . . 3.3300000000000001 108.684 -172.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -65.82 -156.04 0.31 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.146 0.879 . . . . 2.0899999999999999 112.726 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -56.15 106.91 0.31 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.592 0.757 . . . . 4.9500000000000002 111.5 -171.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.59 -146.9 18.6 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.183 -1.567 . . . . 2.0600000000000001 109.183 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.53 -126.32 24.21 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 125.342 1.448 . . . . 1.78 110.913 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.2 mm -76.99 130.66 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 122.488 1.137 . . . . 2.29 108.023 173.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.1 mp -84.37 -46.27 11.9 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.725 2.01 . . . . 1.8300000000000001 110.11 170.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -168.37 172.55 8.31 Favored 'General case' 0 C--N 1.338 0.107 0 O-C-N 121.042 -1.036 . . . . 0.90000000000000002 111.402 -176.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -158.33 139.59 13.33 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.092 0.957 . . . . 1.3799999999999999 111.469 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -162.59 174.38 12.69 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.763 -1.199 . . . . 0.77000000000000002 107.763 -174.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.59 151.43 18.69 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.26 -1.015 . . . . 7.8399999999999999 108.26 -173.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -102.31 -79.34 1.38 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.201 -1.56 . . . . 0.93000000000000005 109.201 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.24 177.6 6.41 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.986 2.457 . . . . 2.27 110.51 176.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 97.2 132.11 7.29 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 109.796 -1.322 . . . . 2.4700000000000002 109.796 -175.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.3 p -77.92 150.78 34.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.538 0.735 . . . . 3.0299999999999998 109.472 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.46 -132.2 10.61 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 108.04 -2.024 . . . . 1.8500000000000001 108.04 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . 0.254 10.7 tp -62.94 -43.21 98.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 117.955 -1.022 . . . . 3.9900000000000002 110.662 -171.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 31.15 130.36 0.0 OUTLIER Glycine 0 CA--C 1.544 1.879 0 C-N-CA 130.299 3.809 . . . . 1.98 119.063 164.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 84.83 -21.73 10.74 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.093 -1.828 . . . . 1.0 111.845 -175.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -84.7 148.85 26.17 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 124.638 1.175 . . . . 1.6100000000000001 110.437 -169.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.42 124.56 36.57 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.5 0.556 . . . . 0.68999999999999995 112.5 -162.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -114.25 108.34 16.81 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 117.208 -1.377 . . . . 2.96 110.199 -168.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.11 147.12 23.77 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 121.761 2.073 . . . . 3.7599999999999998 110.119 172.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -70.16 99.45 1.5 Allowed 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 123.585 0.553 . . . . 2.7400000000000002 109.891 176.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -14.59 61.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.217 -0.897 . . . . 3.0800000000000001 110.896 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -57.66 -32.05 66.93 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 121.045 1.748 . . . . 2.6200000000000001 109.498 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.61 170.12 15.86 Favored 'General case' 0 C--O 1.246 0.891 0 C-N-CA 125.044 1.337 . . . . 2.77 110.292 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -117.13 100.9 8.03 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.01 -1.107 . . . . 5.7300000000000004 108.01 169.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -78.33 146.23 34.84 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.637 -1.165 . . . . 1.77 109.305 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.3 p -120.47 138.58 53.74 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.732 0.813 . . . . 2.23 109.667 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -50.09 -49.48 51.44 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.745 1.218 . . . . 2.1499999999999999 110.059 169.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -82.26 -178.47 7.05 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.034 1.334 . . . . 2.73 111.654 175.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.658 ' HG ' ' HH ' ' A' ' 242' ' ' TYR . 1.1 m -54.08 -58.12 8.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.343 1.457 . . . . 4.1699999999999999 110.943 -172.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 43.02 -100.49 0.02 OUTLIER Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.312 1.434 . . . . 2.5899999999999999 114.409 169.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -116.71 -70.67 0.44 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.536 -1.026 . . . . 1.73 110.536 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.72 177.65 7.47 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.702 -1.962 . . . . 1.8100000000000001 105.702 169.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -132.92 130.97 40.33 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.924 0.784 . . . . 1.6299999999999999 111.658 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -62.4 -48.97 77.37 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 108.358 -0.979 . . . . 2.6499999999999999 108.358 -174.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -50.63 -50.37 54.53 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.665 -0.495 . . . . 2.3300000000000001 109.665 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 7.0 tt -58.65 -58.98 6.19 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.637 1.175 . . . . 1.9099999999999999 109.366 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.317 6.7 m -58.86 -37.52 76.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.574 0.702 . . . . 1.6799999999999999 110.784 176.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.39 -43.76 96.34 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 121.367 -0.833 . . . . 0.90000000000000002 110.877 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 44.1 t -52.84 -44.81 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.948 1.249 . . . . 2.1499999999999999 109.93 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.546 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 6.4 t-160 -52.24 -58.55 6.28 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.956 1.303 . . . . 3.2799999999999998 112.667 169.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -69.17 -33.89 74.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.93 1.085 . . . . 3.1299999999999999 113.93 -174.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.404 HG13 ' CE1' ' A' ' 138' ' ' PHE . 0.4 OUTLIER -71.55 -37.85 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 107.282 -1.377 . . . . 1.8500000000000001 107.282 175.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -52.01 -48.44 52.04 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 110.673 -0.971 . . . . 0.81000000000000005 110.673 167.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.546 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 18.1 m170 -58.79 -44.75 90.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.908 -0.76 . . . . 4.6100000000000003 111.265 174.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.513 ' HG ' HD11 ' A' ' 159' ' ' ILE . 47.6 t -54.0 -55.43 27.33 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.021 0.528 . . . . 2.3900000000000001 111.823 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.2 pp -60.88 -33.72 73.52 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 118.697 -0.668 . . . . 4.3600000000000003 112.415 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 114.57 102.99 2.48 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.105 -1.198 . . . . 1.5 110.105 172.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -108.3 167.17 10.21 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.088 1.144 . . . . 7.3899999999999997 114.088 -175.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -113.2 11.94 24.19 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.411 1.005 . . . . 3.3799999999999999 113.348 167.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 4.5 m80 64.53 98.87 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.904 1.682 . . . . 2.4100000000000001 114.535 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.6 m -75.08 161.9 29.01 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.038 0.447 . . . . 1.6599999999999999 110.44 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.1 p -122.11 11.46 10.2 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.406 1.482 . . . . 3.4100000000000001 111.541 -165.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -119.25 138.57 26.48 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 125.463 1.505 . . . . 1.75 108.664 -169.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -80.81 -12.59 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.946 1.764 . . . . 1.46 114.992 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -75.23 -24.06 57.66 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 120.247 1.385 . . . . 1.77 110.128 172.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -71.77 167.85 19.05 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.941 1.296 . . . . 0.94999999999999996 111.878 176.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.07 -26.14 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 125.668 1.587 . . . . 0.95999999999999996 111.93 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -26.81 68.97 Favored 'General case' 0 C--O 1.245 0.818 0 O-C-N 120.54 -1.35 . . . . 3.02 112.235 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -48.22 177.1 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 130.249 3.419 . . . . 4.7699999999999996 114.094 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -90.09 -18.4 1.41 Allowed 'Trans proline' 0 CA--C 1.537 0.634 0 CA-C-N 122.319 1.864 . . . . 1.54 112.13 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.36 0.2 OUTLIER -81.22 -176.77 6.15 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.086 1.354 . . . . 2.25 110.764 -172.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -113.95 150.07 34.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.341 1.456 . . . . 3.5600000000000001 108.059 171.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.97 137.28 13.89 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.103 -1.073 . . . . 3.5499999999999998 108.103 169.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.658 ' HH ' ' HG ' ' A' ' 207' ' ' SER . 68.9 t80 -65.17 121.25 14.32 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.72 0.808 . . . . 3.9100000000000001 110.562 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.33 135.81 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.165 0.986 . . . . 1.8400000000000001 108.792 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.82 117.38 21.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.844 -0.799 . . . . 5.1299999999999999 108.844 176.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.1 pp -53.03 -33.62 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 C-N-CA 122.922 0.489 . . . . 4.5 110.348 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -52.53 -36.06 54.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.092 0.957 . . . . 4.5800000000000001 112.045 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 25.1 m -74.01 -48.29 31.19 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 119.17 -0.443 . . . . 2.8500000000000001 109.959 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 53.35 87.65 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.271 1.028 . . . . 5.7699999999999996 110.445 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.02 163.21 37.96 Favored 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 121.466 -0.771 . . . . 4.5499999999999998 110.773 175.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.27 154.48 30.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.601 1.56 . . . . 0.84999999999999998 107.836 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.2 m -79.18 152.66 30.56 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 118.012 0.369 . . . . 1.72 111.1 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -58.77 -41.78 87.42 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.762 -0.586 . . . . 1.0800000000000001 111.417 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -51.53 -51.5 54.78 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.903 0.858 . . . . 2.3300000000000001 108.941 171.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.59 -47.07 85.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.8 -1.091 . . . . 2.25 111.442 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 69.2 mt -44.61 -37.6 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.676 1.19 . . . . 1.3400000000000001 111.26 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -65.29 -63.2 1.16 Allowed 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.529 -0.732 . . . . 5.2800000000000002 110.989 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -55.83 -46.66 82.72 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.723 -0.551 . . . . 0.98999999999999999 111.723 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 2.0 pp -70.0 -28.75 37.53 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 C-N-CA 124.76 1.224 . . . . 3.5899999999999999 110.503 -173.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -84.62 -24.19 29.21 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.645 1.111 . . . . 3.3700000000000001 112.024 171.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 46.1 m -58.32 -33.1 69.13 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.85 0.75 . . . . 3.1099999999999999 111.699 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 30.5 mt . . . . . 0 N--CA 1.449 -0.525 0 C-N-CA 126.336 1.854 . . . . 4.6900000000000004 112.498 177.703 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.558 0 CA-C-O 119.484 -0.293 . . . . 7.0800000000000001 110.974 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 66.08 -71.3 0.09 Allowed 'General case' 0 C--O 1.231 0.118 0 C-N-CA 127.01 2.124 . . . . 5.0899999999999999 110.48 -177.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -116.5 118.19 31.99 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.443 1.497 . . . . 3.96 107.546 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 24.0 mm -115.36 154.06 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.509 -1.293 . . . . 3.3999999999999999 107.509 160.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.92 133.31 13.63 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 104.509 -2.404 . . . . 3.2999999999999998 104.509 -171.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -128.79 169.18 14.85 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 123.806 0.842 . . . . 5.4199999999999999 111.383 -174.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -153.55 155.59 36.45 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.487 -0.931 . . . . 5.3600000000000003 108.487 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -95.32 162.12 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.719 -1.586 . . . . 1.51 106.719 172.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -86.08 -48.86 8.25 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.032 -1.099 . . . . 4.1600000000000001 108.032 172.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -157.25 167.47 30.25 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.359 1.064 . . . . 2.6899999999999999 109.189 -170.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.592 ' HH ' HD22 ' A' ' 153' ' ' ASN . 51.1 m-85 -112.24 173.03 6.56 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.454 1.502 . . . . 2.9199999999999999 108.927 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.7 t -129.58 135.22 27.2 Favored Pre-proline 0 N--CA 1.445 -0.683 0 N-CA-C 105.83 -1.915 . . . . 2.6699999999999999 105.83 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.48 -19.06 17.23 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.251 2.634 . . . . 2.5299999999999998 112.085 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -37.58 -41.84 0.5 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.406 2.682 . . . . 2.5699999999999998 112.604 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.5 ptp -136.39 173.56 11.58 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.991 0.917 . . . . 3.48 108.88 173.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -70.02 142.0 52.81 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.915 -0.402 . . . . 3.1699999999999999 109.915 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -52.77 -47.7 67.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.118 -0.467 . . . . 3.5800000000000001 111.885 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -45.23 -49.6 12.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.045 -0.724 . . . . 3.8900000000000001 109.045 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.74 -40.71 92.41 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.19 0.996 . . . . 2.0099999999999998 113.364 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.4 t -53.67 -54.63 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.318 -0.993 . . . . 1.74 108.318 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -37.22 83.73 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 119.121 -1.032 . . . . 1.72 108.837 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -55.6 -45.35 77.45 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 119.598 1.09 . . . . 3.5800000000000001 111.753 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.18 -52.16 59.72 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 120.894 0.378 . . . . 0.48999999999999999 110.415 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -72.88 -31.82 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.917 -0.583 . . . . 2.52 110.549 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -57.24 13.1 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.769 -1.567 . . . . 3.8199999999999998 106.769 177.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -66.96 -44.53 80.31 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.427 -1.261 . . . . 2.1899999999999999 109.11 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.24 -53.82 25.49 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 112.483 0.549 . . . . 0.45000000000000001 112.483 173.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.72 -48.37 81.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 119.019 -1.073 . . . . 7.9400000000000004 108.127 177.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.47 -29.7 62.02 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.638 -0.696 . . . . 2.8599999999999999 112.082 -173.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 99.4 t -60.75 -66.8 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 119.02 0.827 . . . . 1.26 109.33 174.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -69.49 -43.09 73.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.465 -0.939 . . . . 1.04 108.465 -169.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.1 t -58.3 -19.01 31.3 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.777 1.231 . . . . 1.8100000000000001 111.865 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -79.29 -44.42 21.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 118.206 0.457 . . . . 1.76 109.929 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.0 m -76.36 -39.92 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 111.907 0.336 . . . . 2.3700000000000001 111.907 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.6 p -83.46 152.69 64.47 Favored Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 107.876 -1.157 . . . . 1.5700000000000001 107.876 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.33 11.39 1.55 Allowed 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.117 2.545 . . . . 1.6899999999999999 113.857 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.86 127.56 56.22 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.238 1.415 . . . . 3.79 110.251 -173.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.29 117.58 33.0 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.034 0.533 . . . . 4.4199999999999999 110.096 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -81.01 160.51 24.55 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.329 1.052 . . . . 7.46 110.772 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.8 t -156.7 144.86 19.55 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.466 1.506 . . . . 2.0299999999999998 107.384 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -89.91 149.37 22.64 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 120.491 1.496 . . . . 2.9100000000000001 108.899 173.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.9 pt -127.01 147.78 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 105.742 -1.948 . . . . 1.8500000000000001 105.742 164.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.592 HD22 ' HH ' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -102.44 -5.41 24.11 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.898 0.479 . . . . 3.4700000000000002 110.515 172.471 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 99.4 m -155.4 117.53 4.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.405 -1.332 . . . . 3.1899999999999999 107.405 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 140.76 177.4 16.11 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 107.711 -2.156 . . . . 1.8899999999999999 107.711 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.3 mmt -87.83 141.33 28.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.164 -1.05 . . . . 7.1900000000000004 108.164 164.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -123.42 168.89 11.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.19 -1.411 . . . . 0.90000000000000002 107.19 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -76.46 -45.21 32.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.833 -0.803 . . . . 1.6499999999999999 108.833 -175.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.2 pt -113.94 176.69 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 124.617 1.167 . . . . 1.21 109.91 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.11 135.38 30.87 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.178 1.391 . . . . 2.8599999999999999 109.072 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 36.5 t -93.32 108.68 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.227 -1.398 . . . . 0.85999999999999999 107.227 168.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.07 107.24 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.747 1.219 . . . . 3.7400000000000002 109.964 -175.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -88.4 171.68 9.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.284 -1.006 . . . . 7.21 108.284 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.62 -169.59 3.16 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.279 -1.378 . . . . 1.7 107.279 167.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 35.0 mtm180 -139.51 125.81 20.17 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.719 -0.845 . . . . 6.5999999999999996 108.719 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.61 -67.88 3.07 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 125.366 1.46 . . . . 2.6299999999999999 110.599 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -155.95 159.7 39.46 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.553 0.741 . . . . 2.4900000000000002 109.075 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 106.872 -1.529 . . . . 3.3599999999999999 106.872 168.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 108.086 -1.079 . . . . 4.4199999999999999 108.086 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -105.41 172.49 6.76 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.797 1.239 . . . . 7.54 108.11 163.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -162.98 153.8 16.83 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.122 0.969 . . . . 3.8399999999999999 109.175 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -70.84 -149.61 0.59 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.59 0.614 . . . . 1.75 113.203 -174.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -54.31 109.41 0.48 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.708 1.203 . . . . 4.5599999999999996 110.083 -176.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 99.49 -144.38 17.02 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.723 -1.351 . . . . 1.8799999999999999 109.723 -171.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 48.26 -132.32 19.8 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.418 -1.473 . . . . 1.6100000000000001 109.418 -170.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 tp -77.72 148.51 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 118.038 0.919 . . . . 3.9500000000000002 108.855 175.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . 0.5 5.4 mp -84.75 -44.98 12.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.297 1.439 . . . . 1.8300000000000001 110.577 173.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -165.63 168.28 16.45 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 122.189 -0.319 . . . . 0.87 111.011 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -146.99 120.64 9.16 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 124.277 1.031 . . . . 1.29 113.782 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -139.07 160.96 38.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 120.656 -1.278 . . . . 0.75 107.62 -176.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -141.65 149.6 40.85 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.351 -1.352 . . . . 4.4500000000000002 107.351 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -100.84 -87.63 1.98 Allowed Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.622 -0.991 . . . . 0.81999999999999995 110.622 173.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.17 84.71 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.523 2.815 . . . . 1.53 111.53 -169.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -159.24 165.21 34.24 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.234 -1.546 . . . . 1.3700000000000001 109.234 170.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.0 p -79.39 172.79 13.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.752 0.821 . . . . 3.2799999999999998 109.536 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.21 -105.7 0.27 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 123.865 0.745 . . . . 1.6499999999999999 111.838 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.4 tp -59.65 -40.58 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 118.717 -0.659 . . . . 1.6299999999999999 110.006 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -41.49 135.46 2.97 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 118.976 0.807 . . . . 1.1399999999999999 112.429 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 98.87 -36.98 3.69 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.873 1.702 . . . . 0.65000000000000002 111.646 -166.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -84.02 160.42 21.0 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.946 0.873 . . . . 1.24 110.34 -163.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -134.05 130.71 37.91 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.605 0.762 . . . . 0.68000000000000005 111.871 -169.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -119.96 99.52 6.67 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 117.925 -1.036 . . . . 2.7000000000000002 110.793 -161.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -84.73 139.11 32.22 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 121.165 1.802 . . . . 4.2199999999999998 111.468 176.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.87 61.88 0.42 Allowed 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 123.687 0.617 . . . . 3.3700000000000001 110.329 171.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.21 -6.37 13.42 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 120.607 -1.308 . . . . 5.2300000000000004 111.997 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -27.15 -65.02 0.08 Allowed 'General case' 0 C--N 1.341 0.205 0 C-N-CA 127.851 2.46 . . . . 5.2000000000000002 110.055 158.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . 0.256 2.2 pt-20 -78.72 175.5 10.38 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.308 -0.86 . . . . 3.5800000000000001 110.562 -169.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -98.42 103.11 15.03 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 106.223 -1.769 . . . . 4.7999999999999998 106.223 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -78.3 134.52 37.5 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.918 -1.512 . . . . 1.96 106.918 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.1 p -132.35 75.8 1.66 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.412 -1.329 . . . . 3.2000000000000002 107.412 -171.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.04 -49.31 70.63 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 123.864 0.866 . . . . 4.1200000000000001 108.817 -174.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -55.48 -32.76 63.1 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.906 0.706 . . . . 4.54 112.906 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.8 t -81.47 -42.43 20.32 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.216 0.606 . . . . 7.6500000000000004 110.495 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 106.02 16.57 14.83 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.92 1.247 . . . . 4.3899999999999997 112.952 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.71 -84.62 0.18 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.475 -1.05 . . . . 2.1699999999999999 110.475 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 61.9 m -107.79 119.85 40.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.007 -2.59 . . . . 1.5700000000000001 104.007 157.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -94.84 115.26 27.26 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 124.333 1.021 . . . . 1.4399999999999999 108.293 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.67 -48.66 49.37 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.453 0.701 . . . . 2.25 110.409 -177.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -47.92 -49.77 29.07 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.205 0.602 . . . . 2.3700000000000001 110.955 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.1 tt -56.7 -60.24 3.84 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.144 0.978 . . . . 1.5800000000000001 109.676 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.266 93.4 m -57.52 -41.98 81.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.572 -0.74 . . . . 2.02 110.692 177.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.08 -39.62 86.71 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 118.268 -0.872 . . . . 0.54000000000000004 112.1 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.8 t -56.07 -57.65 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 119.842 1.201 . . . . 1.1599999999999999 108.658 175.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.61 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 0.4 OUTLIER -43.84 -53.57 5.92 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.729 0.812 . . . . 3.9900000000000002 112.492 172.133 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -69.07 -34.66 75.5 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.264 -0.898 . . . . 2.52 113.207 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 4.4 mm -60.6 -47.12 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 106.955 -1.498 . . . . 3.9100000000000001 106.955 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.58 -51.18 33.74 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 111.667 -0.573 . . . . 0.81000000000000005 111.667 173.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.61 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 4.3 m-70 -54.36 -49.16 70.45 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 121.483 -1.01 . . . . 1.9099999999999999 111.42 176.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 14.5 t -51.57 -48.04 63.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 123.401 0.438 . . . . 2.4500000000000002 111.341 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.22 -36.65 84.37 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.163 -0.615 . . . . 2.77 110.185 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 116.05 55.68 0.34 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 109.934 -1.266 . . . . 1.3100000000000001 109.934 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -103.32 125.3 49.88 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.075 0.55 . . . . 4.9900000000000002 110.475 173.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.61 139.81 47.09 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.461 -1.056 . . . . 2.6600000000000001 110.461 171.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.402 ' CD2' ' CE1' ' A' ' 222' ' ' HIS . 17.7 m80 -43.69 114.17 0.61 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.537 1.535 . . . . 1.98 111.647 173.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 55.8 m -73.93 165.97 24.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.431 0.56 . . . . 1.25 109.78 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 12.4 m -128.33 39.99 3.74 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.437 1.495 . . . . 3.1699999999999999 110.12 -167.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -141.4 142.35 26.27 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 106.863 -1.532 . . . . 1.75 106.863 -174.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -88.98 -14.19 2.87 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.176 1.917 . . . . 1.1599999999999999 114.793 -174.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -82.1 -32.05 30.41 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.065 0.946 . . . . 2.1200000000000001 109.093 172.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.73 152.62 6.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.516 0.727 . . . . 0.92000000000000004 111.014 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 57.7 t -110.5 -20.38 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.254 -1.339 . . . . 0.93999999999999995 110.261 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -31.61 71.59 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.462 1.028 . . . . 2.77 111.181 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -48.07 159.3 0.49 Allowed Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 127.178 2.191 . . . . 4.6500000000000004 114.013 -174.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -71.81 -23.09 22.83 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.415 1.41 . . . . 1.6000000000000001 111.884 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.355 0.2 OUTLIER -78.24 173.29 12.43 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.076 1.35 . . . . 2.3700000000000001 110.219 -171.221 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -112.17 140.76 46.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.414 -1.328 . . . . 3.7000000000000002 107.414 172.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.6 125.59 12.82 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.461 -2.051 . . . . 2.9100000000000001 105.461 172.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -53.22 130.86 35.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.166 0.986 . . . . 4.3799999999999999 110.529 -176.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.53 137.22 52.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 C-N-CA 123.599 0.76 . . . . 2.3799999999999999 110.365 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.85 -42.43 97.58 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.539 1.135 . . . . 3.4199999999999999 111.7 171.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 6.7 mt 69.32 8.57 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 126.118 1.767 . . . . 3.3999999999999999 110.851 -159.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -64.22 -53.96 41.02 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 120.597 -1.315 . . . . 4.2000000000000002 111.253 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 12.1 m -81.82 -41.37 21.18 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.964 0.906 . . . . 2.3700000000000001 109.872 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 57.3 t80 57.43 72.81 0.49 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 122.09 0.948 . . . . 5.5599999999999996 109.953 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.21 162.04 37.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.955 -0.757 . . . . 3.2999999999999998 108.955 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -95.95 158.21 15.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.637 1.575 . . . . 0.88 108.281 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 2.9 m -76.13 158.71 31.45 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 122.059 -0.401 . . . . 1.4099999999999999 110.695 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.73 -43.74 85.52 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.568 -0.16 . . . . 1.3400000000000001 110.568 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -53.25 -55.92 20.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.564 0.697 . . . . 2.6499999999999999 109.492 173.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.36 -42.32 81.81 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.396 -0.82 . . . . 2.25 110.919 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.467 ' HA ' ' CG2' ' A' ' 258' ' ' ILE . 38.9 mt -55.96 -22.33 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 126.871 2.068 . . . . 1.5600000000000001 111.498 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 -77.14 -55.47 5.41 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.817 -1.177 . . . . 6.2000000000000002 110.273 168.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -50.7 -55.48 17.35 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.534 -1.027 . . . . 0.88 110.534 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.467 ' CG2' ' HA ' ' A' ' 255' ' ' ILE . 0.0 OUTLIER -41.85 -56.26 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 C-N-CA 125.347 1.459 . . . . 3.7400000000000002 111.527 175.597 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -72.98 -21.61 60.82 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.997 0.817 . . . . 2.4700000000000002 110.791 -173.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.9 t -67.15 -25.49 66.19 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 118.695 -0.669 . . . . 2.7400000000000002 111.553 168.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.539 0.522 0 C-N-CA 126.934 2.094 . . . . 5.6299999999999999 112.518 -174.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 109.191 -0.67 . . . . 7.6200000000000001 109.191 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.11 -66.96 0.09 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.218 1.807 . . . . 4.8399999999999999 112.25 -175.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -79.85 107.85 12.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.159 1.384 . . . . 3.5600000000000001 107.841 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.66 136.89 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 106.564 -1.643 . . . . 3.2200000000000002 106.564 168.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.3 t -142.9 142.95 31.86 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 120.702 0.287 . . . . 3.1899999999999999 110.713 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -130.17 163.84 25.78 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.507 1.123 . . . . 5.4900000000000002 111.488 -170.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -145.22 142.28 29.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.934 -0.765 . . . . 4.9100000000000001 108.934 173.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -83.33 152.91 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 108.499 -0.926 . . . . 1.3200000000000001 108.499 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -88.22 -45.41 10.11 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.391 -0.596 . . . . 4.25 109.391 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -155.35 170.22 22.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.222 -1.029 . . . . 2.3999999999999999 108.222 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.07 127.28 53.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.141 0.976 . . . . 2.9700000000000002 108.916 -165.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.3 t -64.4 124.01 84.49 Favored Pre-proline 0 N--CA 1.442 -0.86 0 C-N-CA 123.941 0.897 . . . . 3.5899999999999999 109.419 -176.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -69.89 -19.07 35.96 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.499 2.8 . . . . 2.2799999999999998 110.138 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -36.59 -40.34 0.25 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.715 2.006 . . . . 2.7799999999999998 111.808 169.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 16.2 mtm -135.76 177.29 7.95 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.255 1.422 . . . . 2.73 109.506 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -76.53 141.98 41.02 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.548 -0.72 . . . . 3.5899999999999999 109.262 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 54.6 ttt-85 -41.54 -48.93 4.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.707 0.685 . . . . 2.7999999999999998 112.285 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -49.39 -47.06 47.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.707 -0.479 . . . . 3.3700000000000001 109.707 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -69.46 -40.71 76.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.408 1.483 . . . . 1.8500000000000001 111.101 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 56.8 t -54.06 -53.82 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 120.811 -1.181 . . . . 1.8300000000000001 109.555 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -25.69 65.29 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 118.77 -1.172 . . . . 1.98 110.01 178.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -63.12 -47.83 81.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.891 0.769 . . . . 3.1000000000000001 109.798 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.91 -53.46 56.57 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.352 0.661 . . . . 0.45000000000000001 110.498 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.82 -41.35 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 109.284 -0.636 . . . . 3.0099999999999998 109.284 -178.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -50.41 -58.59 5.37 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.371 -0.974 . . . . 4.2199999999999998 108.371 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -60.3 -52.0 67.14 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.522 1.129 . . . . 2.3399999999999999 109.249 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -46.48 -49.17 18.77 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 123.944 0.898 . . . . 0.65000000000000002 112.289 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.435 ' HB3' ' CD2' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -66.02 -45.99 79.53 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.996 -0.742 . . . . 6.2300000000000004 108.996 178.086 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.03 -42.25 37.61 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.759 0.824 . . . . 3.8300000000000001 110.829 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.0 t -48.46 -61.51 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.059 0.944 . . . . 1.1599999999999999 110.134 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -73.09 -32.5 65.02 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.423 -0.798 . . . . 1.27 109.736 -175.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 t -61.03 -17.87 54.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.932 0.493 . . . . 2.0699999999999998 111.332 175.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.02 -45.98 15.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.839 -0.8 . . . . 2.3199999999999998 108.839 -177.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.6 m -78.85 -46.28 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.412 0.685 . . . . 2.1800000000000002 111.971 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 43.2 p -82.79 159.14 64.05 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.407 -0.59 . . . . 1.3500000000000001 109.407 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.92 -1.8 11.84 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.764 1.643 . . . . 0.81000000000000005 112.581 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.9 mp -65.34 127.37 31.47 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.59 -0.893 . . . . 3.5099999999999998 108.59 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.44 96.19 6.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.921 -1.14 . . . . 5.1699999999999999 107.921 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.435 ' CD2' ' HB3' ' A' ' 138' ' ' PHE . 1.4 p90 -69.12 155.48 40.31 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.347 -0.388 . . . . 8.2100000000000009 111.534 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.9 t -158.85 140.19 13.19 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.016 0.826 . . . . 2.1099999999999999 111.079 163.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.01 149.83 22.37 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.025 -1.102 . . . . 2.8999999999999999 108.025 171.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.9 pp -129.75 156.9 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 106.018 -1.845 . . . . 2.6200000000000001 106.018 173.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -111.7 -16.62 13.18 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.242 0.339 . . . . 3.6299999999999999 110.577 172.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.9 m -107.19 78.04 1.19 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.603 0.761 . . . . 3.1099999999999999 109.753 -174.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 15.06 63.59 0.01 OUTLIER Glycine 0 CA--C 1.537 1.447 0 C-N-CA 128.144 2.783 . . . . 4.2000000000000002 118.286 171.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 31.7 mtt -147.8 75.69 1.36 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.092 1.357 . . . . 8.9800000000000004 107.786 166.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -124.06 155.08 38.98 Favored 'General case' 0 N--CA 1.461 0.08 0 C-N-CA 123.614 0.766 . . . . 1.1100000000000001 109.598 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.23 -49.46 7.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.042 0.937 . . . . 2.1899999999999999 108.691 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.9 pt -110.25 161.52 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.464 0.705 . . . . 1.1899999999999999 110.511 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.14 140.02 52.91 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.434 0.693 . . . . 3.1499999999999999 110.324 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.87 100.13 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.702 0.801 . . . . 1.1799999999999999 109.215 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.33 93.19 4.23 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 C-N-CA 125.007 1.323 . . . . 1.95 111.05 -171.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -80.94 116.22 20.8 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.536 -1.653 . . . . 6.7599999999999998 106.536 172.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -140.3 155.49 46.81 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 119.135 0.879 . . . . 1.03 109.431 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -124.38 128.51 49.18 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.821 0.849 . . . . 4.96 109.207 -164.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 48.63 -126.75 17.37 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.561 1.077 . . . . 1.8400000000000001 111.948 -164.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.15 137.82 38.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.103 0.561 . . . . 2.2599999999999998 109.722 -175.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.24 0 N-CA-C 112.839 0.681 . . . . 3.5800000000000001 112.839 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.354 0 CA-C-O 118.516 -0.754 . . . . 3.02 111.089 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 200' ' ' ASP . 48.5 t80 -90.8 151.18 21.29 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.864 0.84 . . . . 9.2599999999999998 109.379 173.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -152.18 4.5 0.39 Allowed 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 126.421 1.888 . . . . 2.9500000000000002 111.779 -162.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.5 -173.02 24.55 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 122.067 0.815 . . . . 2.1400000000000001 112.301 -162.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 68.83 0.36 Allowed 'General case' 0 C--N 1.341 0.222 0 C-N-CA 127.32 2.248 . . . . 5.5899999999999999 110.471 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.35 -157.88 27.87 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 109.329 -1.508 . . . . 1.98 109.329 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 51.14 -125.28 24.22 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 127.097 2.284 . . . . 1.76 110.263 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 4.5 mm -78.82 138.66 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.26 -1.385 . . . . 2.6200000000000001 107.26 174.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . 0.412 2.6 mp -84.46 -53.82 5.17 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.965 1.306 . . . . 1.6200000000000001 109.527 165.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.06 162.26 28.66 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 122.104 -0.373 . . . . 0.66000000000000003 110.132 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -144.37 121.31 11.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.995 1.318 . . . . 1.1399999999999999 114.495 -173.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -143.27 166.64 24.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 127.492 2.317 . . . . 0.91000000000000003 109.271 -171.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -151.78 143.25 23.48 Favored 'General case' 0 C--O 1.227 -0.09 0 N-CA-C 108.739 -0.838 . . . . 4.9500000000000002 108.739 175.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -91.06 -88.62 1.39 Allowed Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.347 -1.101 . . . . 0.60999999999999999 110.347 174.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.69 94.45 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.023 2.482 . . . . 1.4299999999999999 111.028 -174.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -170.2 161.66 34.8 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.069 -1.613 . . . . 1.4099999999999999 109.069 171.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 14.4 m -79.27 168.51 19.45 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.076 0.55 . . . . 2.7999999999999998 110.642 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 54.84 -106.04 0.46 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.813 0.721 . . . . 2.04 111.596 173.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.0 tp -59.69 -40.48 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 118.831 -0.604 . . . . 1.8200000000000001 109.465 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -44.79 141.4 3.78 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.123 -0.986 . . . . 1.3600000000000001 112.489 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 95.23 -37.97 3.26 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.504 1.526 . . . . 0.80000000000000004 111.25 -162.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -86.9 164.06 16.8 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.903 0.851 . . . . 1.1699999999999999 110.33 -166.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -139.6 121.06 15.08 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.85999999999999999 111.91 -172.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -110.54 132.13 54.45 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 118.203 -0.903 . . . . 2.98 109.328 -169.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -123.44 146.5 47.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.885 1.221 . . . . 3.96 110.541 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -66.02 90.51 0.14 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.803 -0.814 . . . . 2.7400000000000002 108.803 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -57.31 -47.37 81.69 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 119.757 -1.839 . . . . 3.1299999999999999 110.61 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 174' ' ' PHE . 1.9 t70 -51.4 -27.55 10.36 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.552 0.741 . . . . 2.8700000000000001 111.285 -178.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -67.17 136.89 55.77 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.074 -1.454 . . . . 2.7599999999999998 107.074 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.61 88.96 6.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.095 -1.076 . . . . 4.2800000000000002 108.095 -172.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 32.8 m95 -79.23 134.49 36.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.513 -1.292 . . . . 1.54 107.513 -174.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.6 p -122.55 137.67 54.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.646 -0.872 . . . . 2.0299999999999998 108.646 -176.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.5 t -50.47 -41.73 53.52 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 124.146 0.978 . . . . 1.9299999999999999 111.654 172.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -86.36 -154.39 0.22 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.323 0.649 . . . . 3.52 111.706 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.4 m -66.37 -62.29 1.55 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.579 0.752 . . . . 3.7999999999999998 110.474 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 39.97 -116.24 0.69 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.25 1.405 . . . . 2.75 113.787 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.03 -54.75 0.66 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.714 1.15 . . . . 2.1600000000000001 110.281 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.58 179.34 6.62 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.869 -1.53 . . . . 1.9199999999999999 106.869 172.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -136.89 127.63 27.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 122.942 0.497 . . . . 2.0099999999999998 111.36 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 25.2 tp -59.14 -51.54 69.59 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 123.838 0.711 . . . . 3.0899999999999999 110.314 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -50.41 -45.48 55.68 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.352 0.596 . . . . 2.2599999999999998 109.654 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.7 tt -63.55 -59.1 5.07 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.588 -0.695 . . . . 1.6200000000000001 110.299 -174.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.256 1.8 m -57.33 -38.94 74.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.351 -0.386 . . . . 1.9299999999999999 110.541 178.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.32 -60.39 3.36 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 117.093 -1.432 . . . . 0.64000000000000001 109.856 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 85.2 t -45.48 -50.64 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 121.234 1.834 . . . . 1.1599999999999999 110.672 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.646 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 26.1 t60 -57.43 -58.29 8.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.727 0.811 . . . . 3.4500000000000002 112.523 175.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.26 -42.41 79.65 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.644 -1.285 . . . . 2.96 111.911 -173.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -53.16 -41.1 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 123.972 0.909 . . . . 1.79 109.907 167.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.72 -51.45 38.82 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 123.845 0.736 . . . . 0.62 111.262 170.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.646 ' NE2' ' NE2' ' A' ' 218' ' ' HIS 0.3 20.9 m-70 -53.91 -51.52 63.48 Favored 'General case' 0 C--O 1.226 -0.177 0 O-C-N 121.638 -0.919 . . . . 2.1299999999999999 109.902 172.782 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.5 m -52.87 -51.04 62.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.529 0.566 . . . . 2.6899999999999999 112.529 -177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.49 -28.94 70.0 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 119.137 -0.458 . . . . 3.9399999999999999 111.595 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 114.9 82.65 1.06 Allowed Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.474 -1.05 . . . . 1.3799999999999999 110.474 172.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 10.7 mt -134.55 142.95 47.13 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 117.622 0.711 . . . . 4.2000000000000002 110.401 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -77.5 164.3 52.16 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.127 -1.189 . . . . 2.9399999999999999 110.127 169.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -71.77 116.9 12.69 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.833 0.853 . . . . 2.1600000000000001 110.158 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.5 m -76.7 175.16 9.63 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.036 0.534 . . . . 1.72 110.896 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 30.4 m -136.84 40.97 2.53 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.637 1.175 . . . . 3.0299999999999998 110.762 -170.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -140.73 141.77 26.03 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.725 -1.583 . . . . 2.2799999999999998 106.725 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -85.51 -12.48 6.53 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.151 1.901 . . . . 1.3200000000000001 114.955 -174.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -80.66 -30.28 36.55 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.365 0.984 . . . . 1.75 109.552 173.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -59.27 153.82 17.8 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.963 0.905 . . . . 1.0700000000000001 110.258 170.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 50.0 t -105.49 -18.77 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.389 -1.278 . . . . 0.71999999999999997 109.873 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 7.5 tpt -76.69 -17.74 58.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.182 -0.949 . . . . 2.52 113.506 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.4 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -49.56 157.78 0.91 Allowed Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.542 1.537 . . . . 4.1399999999999997 113.32 174.086 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.92 -19.21 18.26 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.874 1.716 . . . . 0.87 111.587 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.371 0.2 OUTLIER -77.32 177.0 8.29 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.293 1.437 . . . . 2.0899999999999999 109.834 -179.132 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -120.92 142.47 49.69 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.113 -1.44 . . . . 3.4100000000000001 107.113 174.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -148.44 123.37 10.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 104.899 -2.26 . . . . 3.46 104.899 172.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -52.44 115.83 1.96 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.417 0.553 . . . . 3.9300000000000002 109.552 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.4 m -108.99 126.25 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.764 -1.198 . . . . 1.77 107.764 171.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.43 108.36 3.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.966 -0.753 . . . . 3.8799999999999999 108.966 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.4 pp -50.57 -32.1 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.054 0 C-N-CA 125.361 1.464 . . . . 4.5700000000000003 111.182 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -50.97 -38.97 54.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.343 0.657 . . . . 3.96 111.721 175.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.9 m -68.22 -46.71 69.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.201 0.6 . . . . 2.5 109.935 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 9.1 t80 52.61 82.89 0.07 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.036 1.334 . . . . 6.29 110.975 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.41 167.59 27.0 Favored 'General case' 0 CA--C 1.521 -0.15 0 O-C-N 120.525 -1.359 . . . . 4.6399999999999997 111.712 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -111.01 156.09 21.78 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.898 1.679 . . . . 0.98999999999999999 107.554 173.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.5 m -78.33 154.24 31.0 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.228 -0.286 . . . . 1.26 110.228 175.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -53.31 -45.61 69.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.622 0.369 . . . . 1.02 110.033 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -51.92 -57.18 10.18 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 122.071 0.939 . . . . 2.5299999999999998 110.057 174.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -58.26 -40.43 81.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.631 -1.168 . . . . 2.2999999999999998 111.379 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 45.8 mt -57.69 -47.31 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.656 0.782 . . . . 0.89000000000000001 110.051 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 32.5 mtt180 -59.92 -43.52 94.86 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 120.683 -1.26 . . . . 5.6600000000000001 110.144 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -48.26 -46.29 27.97 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.024 -0.831 . . . . 1.0 111.024 170.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.73 -47.88 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 O-C-N 121.776 -0.838 . . . . 4.5499999999999998 110.905 -176.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -63.03 -27.28 69.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.362 -0.935 . . . . 3.9700000000000002 110.582 -175.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 11.9 m -51.41 -19.66 1.46 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.987 1.106 . . . . 3.5499999999999998 113.987 171.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 18.5 mt . . . . . 0 C--N 1.349 0.568 0 CA-C-N 120.601 1.546 . . . . 3.2200000000000002 113.439 164.836 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 110.021 -0.363 . . . . 5.9400000000000004 110.021 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 27.6 m170 61.0 -69.48 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.921 1.289 . . . . 5.0499999999999998 111.353 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -79.91 91.29 5.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 119.046 0.839 . . . . 3.48 110.545 -176.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.0 mp -91.8 88.2 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 107.278 -1.378 . . . . 3.6499999999999999 107.278 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.549 ' HG1' ' H ' ' A' ' 158' ' ' ASP . 31.2 p -81.39 120.09 24.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.262 -1.384 . . . . 1.6399999999999999 107.262 177.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -128.69 171.7 11.94 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 119.219 0.918 . . . . 4.6500000000000004 110.688 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -157.37 176.65 12.39 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.636 -0.665 . . . . 4.8499999999999996 109.829 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.8 mm -109.4 162.96 6.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.184 1.393 . . . . 2.71 108.332 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -102.57 -62.87 1.22 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.342 0.657 . . . . 4.3899999999999997 109.975 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -144.02 159.72 42.11 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.961 1.305 . . . . 2.02 107.595 176.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -111.67 127.31 55.73 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.218 -1.401 . . . . 3.7400000000000002 107.218 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.76 130.53 94.83 Favored Pre-proline 0 N--CA 1.444 -0.732 0 C-N-CA 124.05 0.94 . . . . 5.5 109.842 -177.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -70.04 -27.06 25.61 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.771 2.314 . . . . 2.8500000000000001 109.995 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.8 -28.71 69.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.527 1.131 . . . . 4.7599999999999998 111.368 171.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 35.9 mmt -102.23 179.88 4.18 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.116 0.871 . . . . 5.6200000000000001 109.457 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -105.23 113.72 27.48 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 108.11 -1.07 . . . . 3.48 108.11 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.48 -59.98 2.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.534 1.061 . . . . 3.3300000000000001 112.931 -176.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -49.26 -43.6 43.03 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 108.851 -0.796 . . . . 2.7799999999999998 108.851 -174.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -66.61 -42.96 86.04 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.9 1.28 . . . . 1.6699999999999999 112.571 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.2 t -58.48 -54.2 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 O-C-N 120.842 -1.161 . . . . 2.0299999999999998 108.798 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.428 ' OD2' ' NZ ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -62.92 -45.78 90.89 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.281 -1.007 . . . . 2.1400000000000001 108.281 178.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -53.3 -44.67 68.53 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.018 0.927 . . . . 4.6200000000000001 110.963 -176.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.25 -49.22 69.99 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 122.697 0.399 . . . . 0.67000000000000004 110.608 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.07 -31.17 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 120.874 0.369 . . . . 2.6800000000000002 110.315 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -62.23 -53.6 52.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.724 1.609 . . . . 4.0199999999999996 107.009 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -70.0 -44.8 68.62 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.886 1.674 . . . . 2.1499999999999999 109.863 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -47.34 -52.25 17.04 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.836 0.35 . . . . 0.60999999999999999 111.09 170.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.479 ' HB3' ' CD2' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -57.66 -56.46 21.64 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.951 -0.759 . . . . 5.79 108.951 177.692 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.78 -49.43 38.65 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.926 1.29 . . . . 4.46 110.98 -173.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.0 t -51.14 -50.66 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.425 1.09 . . . . 1.49 109.773 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -73.77 -32.33 63.74 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.693 -0.63 . . . . 1.5600000000000001 110.369 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.32 -7.29 41.5 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.206 1.402 . . . . 1.9099999999999999 111.283 175.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.61 -51.02 5.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.373 -0.973 . . . . 1.73 108.373 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.8 m -68.99 -41.4 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 111.969 0.359 . . . . 2.3100000000000001 111.969 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.454 ' HG1' ' H ' ' A' ' 147' ' ' LEU . 30.2 p -87.2 160.27 49.13 Favored Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 108.9 -0.778 . . . . 2.0299999999999998 108.9 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -73.51 2.86 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 121.889 1.726 . . . . 0.93999999999999995 112.325 170.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.454 ' H ' ' HG1' ' A' ' 145' ' ' THR . 35.0 mt -68.54 154.92 40.95 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.254 -0.904 . . . . 3.1200000000000001 110.817 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 99.23 5.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.836 1.654 . . . . 6.3300000000000001 109.611 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.479 ' CD2' ' HB3' ' A' ' 138' ' ' PHE . 1.7 p90 -63.51 152.5 38.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.741 -0.663 . . . . 8.7300000000000004 112.007 170.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.6 t -155.11 117.68 4.28 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.698 -0.668 . . . . 1.6499999999999999 111.06 173.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.428 ' NZ ' ' OD2' ' A' ' 131' ' ' ASP . 6.0 ttmt -81.59 131.02 35.26 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 119.514 1.052 . . . . 3.2999999999999998 109.563 175.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.24 88.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 122.001 0.905 . . . . 2.1400000000000001 109.411 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -87.13 33.27 0.67 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.599 0.76 . . . . 3.1499999999999999 110.424 176.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.1 p -149.62 77.97 1.35 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.094 1.358 . . . . 3.2200000000000002 108.982 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 147.71 -120.39 1.22 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.571 -1.411 . . . . 2.04 109.571 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 27.5 mtp -139.53 136.03 34.07 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 127.147 2.179 . . . . 4.8300000000000001 106.352 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.83 165.86 18.54 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.696 1.198 . . . . 0.71999999999999997 109.598 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.549 ' H ' ' HG1' ' A' ' 115' ' ' THR . 31.6 t0 -73.59 -53.0 11.52 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.159 0.984 . . . . 2.2400000000000002 108.4 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.2 pt -119.69 147.76 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.669 -0.696 . . . . 1.23 111.224 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.4 tt -122.95 133.13 54.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.014 1.326 . . . . 3.1099999999999999 109.142 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.7 t -81.19 101.02 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.571 1.148 . . . . 1.03 108.535 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.8 t -78.9 111.75 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.784 -0.821 . . . . 1.8400000000000001 108.784 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -99.0 118.32 35.51 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.203 -1.777 . . . . 6.2300000000000004 106.203 166.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -143.78 161.42 38.66 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.972 -1.121 . . . . 1.1100000000000001 107.972 -176.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -122.99 142.39 50.89 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.335 -1.358 . . . . 4.79 107.335 172.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.434 ' HA2' ' CD1' ' A' ' 174' ' ' PHE . . . 83.98 174.73 50.54 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.982 -0.447 . . . . 2.0 111.982 170.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.14 77.75 3.68 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.915 -0.756 . . . . 3.3399999999999999 109.9 -170.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 123.696 0.798 . . . . 3.6699999999999999 112.269 -175.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.255 0 N-CA-C 110.145 -0.317 . . . . 3.3399999999999999 110.145 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.512 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -83.95 170.72 13.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.677 -1.231 . . . . 9.3100000000000005 107.677 178.147 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.512 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 9.2 p30 175.39 33.14 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.906 1.282 . . . . 2.3500000000000001 112.879 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 53.15 -156.84 4.94 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 120.984 -1.073 . . . . 1.73 111.543 -172.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -76.3 62.14 1.75 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.833 0.853 . . . . 5.0599999999999996 112.567 -175.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -162.17 -154.8 7.69 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 107.839 -2.104 . . . . 2.1899999999999999 107.839 168.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 35.81 -113.6 0.15 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 127.966 2.698 . . . . 1.6499999999999999 112.219 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.1 mm -79.58 139.47 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 118.126 0.963 . . . . 2.5499999999999998 109.001 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.5 mp -80.52 -59.9 2.52 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.983 -1.117 . . . . 1.51 107.983 170.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -163.51 159.77 22.41 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.761 -0.459 . . . . 1.0600000000000001 109.761 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -146.55 117.15 7.54 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.264 1.426 . . . . 1.3799999999999999 113.666 -166.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -136.37 159.47 41.67 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.004 1.722 . . . . 0.93999999999999995 109.208 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -148.65 144.03 26.9 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.953 -1.499 . . . . 3.7999999999999998 106.953 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -93.01 -89.99 1.55 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.166 0.888 . . . . 0.88 110.916 173.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.28 97.91 0.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.799 2.333 . . . . 1.5600000000000001 110.962 -175.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -169.01 161.68 35.38 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 108.24 -1.944 . . . . 1.49 108.24 171.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.4 t -80.96 178.38 8.45 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.509 0.654 . . . . 3.9500000000000002 110.466 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 46.24 -109.8 0.41 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.643 1.116 . . . . 1.51 111.314 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.7 tp -59.87 -42.25 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 118.169 -0.92 . . . . 1.76 109.826 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -38.6 128.97 1.85 Allowed Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.805 1.193 . . . . 1.29 112.664 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 108.86 -50.83 0.75 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.366 1.936 . . . . 0.84999999999999998 109.686 -162.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.24 148.02 28.62 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.398 1.079 . . . . 2.6099999999999999 110.481 -166.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -117.95 121.43 40.67 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.498 1.119 . . . . 0.67000000000000004 111.248 -170.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -111.54 122.7 48.53 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 118.512 0.597 . . . . 2.9700000000000002 111.381 -168.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -111.06 136.16 50.5 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.973 -1.121 . . . . 3.8599999999999999 107.973 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -67.0 93.55 0.28 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.476 -1.675 . . . . 2.8500000000000001 106.476 172.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -39.12 82.86 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.688 1.131 . . . . 3.4100000000000001 109.193 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -34.66 -48.87 0.39 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 127.092 2.157 . . . . 2.9700000000000002 110.543 -167.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -61.13 179.7 0.18 Allowed 'General case' 0 C--O 1.24 0.597 0 C-N-CA 126.167 1.787 . . . . 4.6699999999999999 112.283 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -115.52 87.14 2.6 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 105.538 -2.023 . . . . 3.7999999999999998 105.538 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -75.67 163.32 27.43 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.93 -1.032 . . . . 1.3899999999999999 108.276 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.8 p -129.22 144.15 51.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.38 -0.971 . . . . 2.0699999999999998 108.38 174.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . 0.258 6.3 t -61.31 -40.47 94.29 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 126.113 1.765 . . . . 2.3300000000000001 112.414 165.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -96.37 -172.44 2.53 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.406 1.082 . . . . 3.4500000000000002 108.365 177.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.405 ' H ' ' HG ' ' A' ' 207' ' ' SER . 5.3 m -47.53 -65.7 0.52 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.785 2.034 . . . . 4.3200000000000003 110.594 -173.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 45.77 -104.49 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 125.896 1.712 . . . . 2.8900000000000001 114.364 165.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -112.38 -81.48 1.12 Allowed Glycine 0 C--N 1.335 0.495 0 N-CA-C 109.677 -1.369 . . . . 2.3599999999999999 109.677 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.3 m -115.79 123.3 47.88 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.654 -1.98 . . . . 1.6599999999999999 105.654 167.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.79 111.97 10.53 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.839 -0.8 . . . . 2.73 108.839 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.01 -54.41 24.78 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.057 0.844 . . . . 2.3900000000000001 110.585 -175.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -44.77 -43.86 8.88 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.77 1.228 . . . . 3.1699999999999999 111.352 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.93 -64.74 0.84 Allowed 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.929 -0.482 . . . . 1.53 109.942 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.324 3.4 m -53.89 -43.37 69.59 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.377 0.608 . . . . 1.8 110.701 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.45 -42.73 54.61 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.918 -0.583 . . . . 0.47999999999999998 111.793 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 83.9 t -62.65 -42.78 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 119.699 1.136 . . . . 1.1899999999999999 111.339 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.513 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 5.8 t60 -55.33 -47.33 75.83 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.977 0.911 . . . . 3.6600000000000001 109.456 174.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -76.13 -32.75 59.29 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 114.257 1.206 . . . . 3.4900000000000002 114.257 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 4.7 mm -58.0 -50.85 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 106.886 -1.524 . . . . 3.5899999999999999 106.886 171.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.76 -45.46 48.68 Favored Glycine 0 CA--C 1.537 1.436 0 N-CA-C 111.931 -0.468 . . . . 0.98999999999999999 111.931 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.513 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 3.8 m-70 -55.08 -50.56 68.87 Favored 'General case' 0 C--O 1.226 -0.18 0 O-C-N 121.569 -0.959 . . . . 2.04 110.335 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 1.5 t -52.21 -49.63 63.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.482 0.713 . . . . 2.9199999999999999 111.377 176.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 10.2 mt -60.1 -45.65 92.24 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.374 0.534 . . . . 3.0 109.721 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 134.48 38.99 0.19 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 123.812 0.72 . . . . 1.3100000000000001 112.608 168.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.06 116.73 24.45 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.132 0.966 . . . . 4.3700000000000001 110.156 174.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.42 52.51 4.36 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.301 -0.722 . . . . 2.8500000000000001 113.151 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 72.5 m80 66.28 161.85 0.15 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.28 1.432 . . . . 1.9099999999999999 113.022 -175.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 74.1 m -131.73 -178.51 4.91 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.872 1.669 . . . . 1.3600000000000001 109.431 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 7.4 p -146.79 16.03 1.24 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.991 1.316 . . . . 3.3100000000000001 111.006 -165.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -115.79 138.52 24.01 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 106.878 -1.527 . . . . 2.5099999999999998 106.878 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.92 -17.49 10.78 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.923 1.749 . . . . 2.0099999999999998 114.182 -172.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.6 mtmt -83.65 -28.35 28.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.94 0.791 . . . . 1.9099999999999999 109.852 173.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.21 147.69 39.05 Favored 'General case' 0 C--O 1.225 -0.19 0 O-C-N 121.902 -0.499 . . . . 0.76000000000000001 110.792 173.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 71.2 t -92.97 -23.5 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.724 1.21 . . . . 0.65000000000000002 109.72 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 16.9 tpp -70.05 -14.68 62.79 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.471 1.108 . . . . 2.7000000000000002 113.411 177.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.406 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -51.33 147.02 10.83 Favored Pre-proline 0 CA--C 1.539 0.545 0 O-C-N 121.378 -0.826 . . . . 4.2000000000000002 112.944 177.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.92 -16.2 29.33 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.317 2.011 . . . . 1.3 111.631 174.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.301 0.1 OUTLIER -76.35 169.13 18.8 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.2 -1.037 . . . . 2.8199999999999998 108.2 171.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -128.01 146.98 50.49 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 104.808 -2.293 . . . . 3.2599999999999998 104.808 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.23 144.18 20.78 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.476 -1.305 . . . . 2.8199999999999998 107.476 171.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -62.9 144.35 56.79 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.977 0.911 . . . . 3.52 111.051 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.85 154.35 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.555 0.742 . . . . 2.1099999999999999 110.672 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.18 -16.23 59.45 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.993 1.717 . . . . 3.5 114.334 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . 0.25 14.0 mm 72.21 -41.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 128.019 2.527 . . . . 4.2800000000000002 111.085 -176.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -78.99 -51.81 9.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.878 0.871 . . . . 3.4199999999999999 111.197 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 47.5 m -78.46 -18.07 55.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.482 1.113 . . . . 2.8399999999999999 110.652 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -39.3 110.82 0.15 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.531 1.532 . . . . 9.2799999999999994 112.11 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.02 163.88 31.59 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.448 1.099 . . . . 3.98 109.906 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.08 137.42 36.0 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.831 -1.174 . . . . 1.1000000000000001 107.831 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.7 m -77.41 160.66 28.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.651 0.262 . . . . 1.4299999999999999 110.816 -175.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.76 -48.35 78.04 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 110.059 -0.348 . . . . 0.93000000000000005 110.059 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -48.31 -51.88 24.04 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.765 0.793 . . . . 2.6000000000000001 109.96 172.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.97 -47.52 80.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.079 -1.419 . . . . 2.2000000000000002 109.09 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.5 mt -59.86 -47.46 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.816 1.646 . . . . 1.01 111.226 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -60.08 -44.27 94.89 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.346 -1.471 . . . . 5.2400000000000002 109.858 175.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -49.62 -42.59 36.02 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.937 -0.865 . . . . 0.83999999999999997 110.937 170.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.58 -47.04 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 117.826 0.813 . . . . 4.6100000000000003 110.561 -177.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -68.16 -15.95 63.79 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 119.701 -0.8 . . . . 2.6299999999999999 110.849 -178.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.14 -17.69 3.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.755 0.822 . . . . 2.79 112.873 165.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 56.7 mt . . . . . 0 CA--C 1.54 0.569 0 CA-C-N 120.076 1.307 . . . . 2.9199999999999999 111.753 161.877 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.1 mptt . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 120.483 0.183 . . . . 6.9000000000000004 111.297 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 60.34 -80.27 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.586 1.555 . . . . 4.4199999999999999 109.407 -165.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -114.81 111.84 21.85 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.461 1.105 . . . . 4.5599999999999996 111.499 -168.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.415 HG22 ' CE1' ' A' ' 116' ' ' TYR . 18.0 mm -128.52 103.87 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.926 0.87 . . . . 3.4500000000000002 112.157 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -86.91 140.98 29.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.25 2.22 . . . . 2.27 109.49 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.438 ' CD2' ' CE2' ' A' ' 138' ' ' PHE . 10.3 m-85 -124.47 167.78 13.96 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.579 1.151 . . . . 7.1100000000000003 110.84 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -149.52 149.55 30.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.802 1.241 . . . . 8.3200000000000003 109.608 176.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.4 mt -102.68 155.69 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.656 -1.239 . . . . 1.1399999999999999 107.656 173.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -97.57 -44.56 6.75 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.11 0.564 . . . . 3.3900000000000001 110.156 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -149.03 164.85 33.42 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.865 0.466 . . . . 2.25 110.149 174.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -111.15 127.97 55.75 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.149 1.38 . . . . 2.8399999999999999 107.574 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.1 t -60.46 136.84 92.2 Favored Pre-proline 0 N--CA 1.442 -0.829 0 C-N-CA 122.931 0.492 . . . . 2.54 109.742 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.22 -18.64 14.08 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.16 2.573 . . . . 1.9399999999999999 111.009 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -40.41 -46.58 2.42 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.622 1.569 . . . . 2.0 111.452 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -128.24 176.33 7.76 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.544 1.538 . . . . 2.7799999999999998 109.253 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -73.86 143.42 45.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.285 0.634 . . . . 3.04 110.452 174.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.3 ttt-85 -47.19 -45.0 22.71 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.475 0.71 . . . . 3.7799999999999998 111.512 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.63 -10.04 11.01 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.023 0.929 . . . . 4.2000000000000002 112.997 -177.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -100.03 -45.11 5.78 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.387 1.475 . . . . 2.1699999999999999 110.434 168.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 73.9 t -53.41 -54.94 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 123.991 0.916 . . . . 1.79 109.511 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.439 ' HB3' ' HZ3' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -71.75 -25.53 62.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 117.447 -1.701 . . . . 1.9399999999999999 109.81 178.429 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -59.11 -48.17 82.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.422 1.01 . . . . 3.6499999999999999 109.042 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.27 -52.7 51.25 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 116.21 -0.45 . . . . 0.46000000000000002 111.486 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -36.57 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.663 0.744 . . . . 2.6099999999999999 110.131 -173.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.7 ttm-85 -55.57 -54.87 38.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.479 1.112 . . . . 4.9000000000000004 108.276 173.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -66.34 -41.11 90.06 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.431 0.692 . . . . 2.0800000000000001 109.658 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -47.12 -54.46 10.47 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 118.551 0.614 . . . . 0.54000000000000004 110.686 169.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.438 ' CE2' ' CD2' ' A' ' 116' ' ' TYR . 34.5 m-85 -59.81 -42.67 93.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.476 -0.49 . . . . 5.5499999999999998 111.588 176.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -50.28 -39.85 46.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.393 0.677 . . . . 4.5 110.515 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.6 t -61.0 -56.24 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.131 -0.692 . . . . 1.6100000000000001 109.131 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 26.8 m95 -75.24 -35.21 61.44 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 122.054 -0.404 . . . . 1.1000000000000001 110.585 -173.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 89.0 p -70.7 -15.53 62.71 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.359 0.503 . . . . 2.8799999999999999 112.359 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.13 -48.39 11.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.549 -1.278 . . . . 1.5700000000000001 107.549 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 26.7 m -75.64 -40.42 40.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 113.191 0.811 . . . . 2.3900000000000001 113.191 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 31.7 p -100.06 140.71 21.71 Favored Pre-proline 0 N--CA 1.447 -0.624 0 N-CA-C 108.466 -0.939 . . . . 1.49 108.466 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.33 12.03 0.89 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.241 2.627 . . . . 1.1899999999999999 113.637 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.2 mt -70.09 115.52 9.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.58 1.152 . . . . 3.1200000000000001 108.845 -175.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -82.53 89.79 6.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 122.445 1.117 . . . . 5.7000000000000002 108.282 -172.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.18 146.1 48.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.738 -2.028 . . . . 7.8899999999999997 109.299 170.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.6 t -151.19 147.31 26.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.881 -1.526 . . . . 1.6899999999999999 106.881 165.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.439 ' HZ3' ' HB3' ' A' ' 131' ' ' ASP . 2.5 tmmt? -125.64 129.75 50.24 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 107.363 -1.347 . . . . 3.0099999999999998 107.363 175.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.6 pp -133.75 170.69 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 105.952 -1.87 . . . . 2.4500000000000002 105.952 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -142.63 27.37 1.69 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.798 0.726 . . . . 4.3899999999999997 109.094 169.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 58.2 p -150.72 78.46 1.31 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.401 1.08 . . . . 3.48 108.531 -172.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.15 -128.08 2.76 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 108.028 -2.029 . . . . 2.0299999999999998 108.028 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.0 mtt -126.43 148.81 49.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.407 1.083 . . . . 4.9100000000000001 109.552 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -141.42 160.65 39.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.137 1.375 . . . . 0.93999999999999995 109.299 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -80.86 -58.91 2.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.636 1.974 . . . . 1.98 107.786 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -91.02 179.04 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 122.035 0.921 . . . . 1.8899999999999999 111.243 176.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 tt -138.75 127.61 23.66 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.495 2.318 . . . . 2.6600000000000001 109.094 167.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 20.6 t -86.26 105.73 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.702 -1.221 . . . . 0.76000000000000001 107.702 170.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.3 t -81.56 140.31 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 107.43 -1.322 . . . . 1.8899999999999999 107.43 170.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.29 90.32 2.41 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.568 -2.012 . . . . 6.0599999999999996 105.568 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.42 158.83 39.76 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.068 0.547 . . . . 1.0 109.988 -165.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 14.0 ptt-85 -124.0 115.57 21.43 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.837 0.855 . . . . 5.7800000000000002 109.935 -162.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 60.48 -97.65 0.12 Allowed Glycine 0 CA--C 1.535 1.328 0 C-N-CA 123.335 0.493 . . . . 1.6000000000000001 112.292 -175.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.39 135.8 35.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.785 0.834 . . . . 3.1899999999999999 109.06 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 . . . . . 0 C--O 1.226 -0.148 0 N-CA-C 111.621 0.23 . . . . 5.0599999999999996 111.621 176.254 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 121.342 0.591 . . . . 3.9199999999999999 111.113 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -109.24 -179.28 3.79 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 106.917 -1.512 . . . . 7.4900000000000002 106.917 159.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -143.74 -168.16 2.77 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.539 1.936 . . . . 3.9900000000000002 106.149 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -90.34 -141.64 9.18 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.952 -0.859 . . . . 2.02 110.952 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.449 ' NZ ' ' OD1' ' A' ' 200' ' ' ASP . 0.1 OUTLIER -58.63 114.85 2.69 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.935 -0.765 . . . . 8.6500000000000004 108.935 169.578 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.92 -155.94 16.21 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.083 -1.207 . . . . 2.1499999999999999 110.083 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.28 -119.44 11.95 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 109.946 -1.262 . . . . 2.02 109.946 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . 0.339 2.2 mt -90.58 137.27 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 107.129 -1.434 . . . . 3.46 107.129 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -85.68 -56.85 3.3 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.12 1.368 . . . . 3.1099999999999999 109.856 166.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -156.07 162.17 40.31 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 121.129 -0.982 . . . . 0.91000000000000003 112.322 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -145.15 116.07 7.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.36 1.464 . . . . 1.23 114.265 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.77 159.04 40.9 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.951 2.1 . . . . 0.93999999999999995 108.308 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -144.42 148.21 34.33 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.965 -1.494 . . . . 4.5599999999999996 106.965 172.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -98.81 -82.34 1.66 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.851 -0.9 . . . . 1.1299999999999999 110.851 170.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.97 92.71 0.71 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.396 2.73 . . . . 2.46 110.551 -172.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -175.39 157.38 23.94 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 108.661 -1.776 . . . . 2.3199999999999998 108.661 171.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.3 m -77.54 157.62 30.27 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.11 -0.7 . . . . 3.7000000000000002 109.11 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.89 -110.69 3.11 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.931 -0.868 . . . . 2.5600000000000001 110.931 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.434 HG12 ' CE1' ' A' ' 196' ' ' HIS . 5.1 tp -63.03 -42.28 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 O-C-N 121.468 -1.019 . . . . 2.4900000000000002 109.632 -170.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -30.75 129.56 0.16 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 126.252 1.882 . . . . 2.1200000000000001 113.814 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 103.78 -52.75 0.75 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.465 1.983 . . . . 0.92000000000000004 109.757 -164.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -84.09 160.61 20.89 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.054 0.942 . . . . 1.98 111.314 -167.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -138.91 124.52 19.53 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 118.136 -0.935 . . . . 0.73999999999999999 111.56 -172.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.434 ' CE1' HG12 ' A' ' 191' ' ' ILE . 1.0 OUTLIER -112.38 127.21 55.95 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-O 117.721 -1.133 . . . . 2.7599999999999998 109.244 -173.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -114.2 151.44 32.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.202 1.365 . . . . 4.1799999999999997 110.947 174.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -73.83 101.34 3.71 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.417 -0.811 . . . . 3.4300000000000002 109.964 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.36 -29.67 70.93 Favored 'General case' 0 C--O 1.24 0.596 0 O-C-N 121.485 -0.76 . . . . 2.5 111.147 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.449 ' OD1' ' NZ ' ' A' ' 177' ' ' LYS . 12.3 t70 -59.44 -31.9 69.72 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.393 0.997 . . . . 3.1099999999999999 109.344 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -68.03 150.51 48.35 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 122.107 0.956 . . . . 2.8300000000000001 108.884 -176.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -102.3 93.03 4.98 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 105.695 -1.965 . . . . 4.9000000000000004 105.695 174.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -77.85 138.79 39.13 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 108.536 -0.912 . . . . 1.5 108.536 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.714 ' HG1' ' HD1' ' A' ' 206' ' ' HIS . 0.1 OUTLIER -158.7 108.79 2.02 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 120.975 1.716 . . . . 3.3399999999999999 111.023 -178.127 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.33 -51.38 54.88 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 118.4 0.545 . . . . 4.3799999999999999 111.0 162.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.714 ' HD1' ' HG1' ' A' ' 204' ' ' THR . 3.8 p-80 -65.54 -38.3 89.22 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.7 -0.682 . . . . 4.9199999999999999 111.875 -161.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 21.3 t -80.52 -43.25 21.05 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.345 0.658 . . . . 7.4199999999999999 109.773 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 114.6 -31.69 6.24 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.314 -0.715 . . . . 3.7000000000000002 112.131 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -21.91 -85.0 0.01 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 128.164 2.792 . . . . 1.8799999999999999 114.545 -171.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 26.1 m -122.49 123.37 41.1 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 104.563 -2.384 . . . . 1.29 104.563 156.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -84.97 125.33 32.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.101 0.864 . . . . 1.3600000000000001 109.236 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 43.6 tp -53.94 -51.83 62.54 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 118.044 0.384 . . . . 2.71 110.397 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -50.23 -46.76 55.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.108 0.563 . . . . 3.29 110.488 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.12 -63.39 1.2 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.373 1.069 . . . . 1.5800000000000001 110.866 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.37 0.9 OUTLIER -59.13 -39.86 83.65 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.918 0.39 . . . . 1.99 110.453 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.41 62.31 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 116.822 -1.561 . . . . 0.52000000000000002 109.409 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 8.4 t -44.45 -55.25 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 121.117 1.78 . . . . 2.2200000000000002 111.473 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.642 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 0.4 OUTLIER -51.71 -46.77 64.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.302 0.641 . . . . 3.52 111.802 178.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.443 ' HG2' ' HD1' ' A' ' 218' ' ' HIS . 9.0 mm-40 -79.51 -47.23 15.93 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.283 -0.885 . . . . 2.77 112.58 -173.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.3 mp -56.53 -41.61 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.035 1.734 . . . . 1.95 107.871 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.36 -47.33 83.54 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.284 -0.726 . . . . 0.96999999999999997 111.284 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.642 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 7.1 m-70 -52.59 -52.31 55.81 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.433 -1.04 . . . . 2.2799999999999998 110.389 174.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.0 m -51.06 -47.64 61.73 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.923 0.783 . . . . 2.9900000000000002 112.476 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -18.87 15.18 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.204 1.002 . . . . 4.1399999999999997 112.276 176.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 120.4 6.7 9.54 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 125.659 1.599 . . . . 1.8300000000000001 111.243 173.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 49.7 mt -88.89 109.36 20.15 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 117.842 0.821 . . . . 5.8099999999999996 110.498 -159.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -60.63 158.47 28.07 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.503 1.049 . . . . 3.4700000000000002 112.49 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.429 ' CD2' ' CE1' ' A' ' 222' ' ' HIS . 27.1 m80 -62.77 121.64 13.93 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.54 0.736 . . . . 1.8 111.5 -177.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.416 ' HG ' ' HB3' ' A' ' 236' ' ' MET . 64.8 m -77.94 178.39 7.5 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.442 0.639 . . . . 1.5800000000000001 110.678 171.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 p -125.22 6.49 7.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.905 2.082 . . . . 4.1600000000000001 111.927 -164.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -118.38 136.68 24.11 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.264 1.426 . . . . 2.5299999999999998 108.045 -171.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.63 -13.49 14.7 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.679 2.253 . . . . 2.0600000000000001 114.439 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -80.5 -37.7 31.2 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.605 1.162 . . . . 1.8400000000000001 108.892 173.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.02 149.0 24.33 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.424 0.69 . . . . 0.95999999999999996 110.891 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.7 t -93.34 -17.82 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.234 -0.894 . . . . 0.83999999999999997 110.504 177.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.416 ' HB3' ' HG ' ' A' ' 229' ' ' SER . 0.5 OUTLIER -73.73 -20.94 60.37 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 113.139 0.792 . . . . 2.3399999999999999 113.139 -174.419 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -52.92 167.97 0.37 Allowed Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.932 1.693 . . . . 4.1699999999999999 113.644 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -83.98 -14.44 7.39 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 121.942 1.761 . . . . 1.6599999999999999 112.332 173.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.294 0.0 OUTLIER -79.35 176.74 9.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.913 1.285 . . . . 2.5800000000000001 109.781 178.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -121.39 140.94 51.48 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.04 1.736 . . . . 3.6000000000000001 106.503 176.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -151.31 132.51 14.46 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 105.095 -2.187 . . . . 3.4399999999999999 105.095 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -61.21 123.1 16.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.149 0.432 . . . . 3.8700000000000001 110.428 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.2 m -100.85 134.05 42.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 122.818 0.447 . . . . 2.3500000000000001 109.997 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -81.96 90.56 6.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 122.224 1.012 . . . . 3.3900000000000001 109.807 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 92.9 mt -54.06 -24.77 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.191 0.996 . . . . 3.9199999999999999 110.757 178.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -46.74 -45.41 19.65 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.4 0.546 . . . . 3.7999999999999998 111.868 170.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 25.6 m -84.04 -42.32 16.28 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.404 0.682 . . . . 2.0099999999999998 109.895 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 69.8 t80 58.28 68.59 0.81 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.792 0.806 . . . . 5.21 110.223 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -160.49 165.22 31.33 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.009 -0.737 . . . . 4.4199999999999999 109.009 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.17 -175.15 2.68 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.087 1.355 . . . . 2.4700000000000002 110.145 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 39.1 m -81.93 141.68 33.11 Favored 'General case' 0 C--O 1.222 -0.377 0 O-C-N 120.872 -1.143 . . . . 1.4299999999999999 112.029 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.46 -39.61 57.79 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.231 0.539 . . . . 1.0600000000000001 111.026 169.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -66.74 -21.7 66.06 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.929 0.714 . . . . 3.75 112.929 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.36 -51.81 7.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.903 0.881 . . . . 3.3700000000000001 109.57 169.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 56.1 mt -47.58 -43.61 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.13 1.772 . . . . 1.29 111.77 -175.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -52.91 -53.53 47.96 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.823 0.344 . . . . 5.4500000000000002 111.32 172.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.03 -54.37 30.89 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.089 -1.605 . . . . 1.96 109.089 -171.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 2.8 pp -55.37 -35.9 38.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 123.667 0.787 . . . . 3.3700000000000001 112.348 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -73.04 -49.13 30.51 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 118.443 -0.789 . . . . 3.54 111.359 172.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 24.3 m -51.01 -37.15 43.39 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.736 1.153 . . . . 4.9400000000000004 112.321 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 CA--C 1.534 0.353 0 C-N-CA 124.277 1.031 . . . . 6.2699999999999996 111.489 176.64 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 112.064 0.394 . . . . 6.7599999999999998 112.064 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 56.27 -66.5 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.426 1.49 . . . . 4.6699999999999999 110.645 -154.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -120.25 114.34 21.76 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.127 0.971 . . . . 5.04 112.377 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.9 mm -95.03 88.28 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 122.403 1.097 . . . . 3.3900000000000001 109.024 168.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.97 123.87 29.85 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.26 -1.385 . . . . 2.6000000000000001 107.26 176.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -127.08 163.28 24.13 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.531 1.059 . . . . 4.9100000000000001 112.458 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -142.2 144.11 33.24 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.487 1.115 . . . . 6.5300000000000002 109.233 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -92.99 151.79 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 109.5 -0.556 . . . . 1.21 109.5 176.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -86.46 -50.58 6.77 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.813 -0.81 . . . . 4.1100000000000003 108.813 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -133.02 176.69 8.28 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 123.84 0.712 . . . . 3.29 111.777 174.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -138.94 160.93 38.57 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.431 1.893 . . . . 3.2999999999999998 107.136 -177.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 90.6 m 46.99 56.26 17.09 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 123.505 0.722 . . . . 9.0500000000000007 111.858 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.12 -39.96 1.46 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.121 1.881 . . . . 6.8600000000000003 109.326 171.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.99 3.88 0.72 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.543 0.737 . . . . 2.0800000000000001 112.75 -175.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 7.3 mtm -150.24 168.4 24.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.937 1.244 . . . . 2.23 110.843 -169.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -69.85 140.56 53.24 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.691 -0.485 . . . . 3.3399999999999999 109.691 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -56.9 -40.0 75.46 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.267 -0.896 . . . . 2.75 112.138 -174.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.4 -3.06 5.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.892 -0.575 . . . . 3.48 112.289 -178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -96.69 -50.36 4.73 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.866 1.266 . . . . 2.6800000000000002 110.357 161.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.1 m -58.43 -49.42 82.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 O-C-N 121.105 -0.997 . . . . 4.1699999999999999 110.439 -169.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -71.79 -24.46 61.74 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 118.745 -1.182 . . . . 2.25 109.172 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -66.31 -48.93 68.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.659 1.118 . . . . 4.2599999999999998 109.682 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.68 -49.5 76.3 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 123.774 0.829 . . . . 0.63 110.143 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.9 tp -70.88 -38.06 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.951 0.405 . . . . 2.9900000000000002 110.469 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -54.87 41.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.725 -1.213 . . . . 4.3899999999999997 107.725 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -59.24 -51.5 69.72 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.043 -0.981 . . . . 2.54 110.115 176.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -46.08 -50.36 15.37 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 118.686 0.676 . . . . 0.71999999999999997 112.307 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.31 -51.6 62.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 118.839 -1.144 . . . . 8.2699999999999996 109.196 175.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.16 -27.23 65.46 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.641 0.776 . . . . 2.7599999999999998 112.0 -170.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.66 -54.76 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.561 1.144 . . . . 1.3100000000000001 109.293 171.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.424 ' CZ3' ' HG ' ' A' ' 250' ' ' LEU . 59.3 m95 -73.6 -33.84 64.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 121.593 -0.692 . . . . 0.87 109.325 -174.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 74.0 m -65.62 -17.35 64.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 118.736 0.698 . . . . 1.97 112.571 173.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -75.71 -46.62 30.1 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.033 0.833 . . . . 1.1499999999999999 109.068 174.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 57.3 t -74.38 -54.3 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.598 0.759 . . . . 3.2799999999999998 110.455 -176.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.409 ' HG1' ' H ' ' A' ' 147' ' ' LEU . 24.4 p -90.08 158.61 43.95 Favored Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 124.945 1.298 . . . . 1.6699999999999999 109.823 -174.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -74.31 2.64 6.01 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.088 1.859 . . . . 0.91000000000000003 112.848 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.409 ' H ' ' HG1' ' A' ' 145' ' ' THR . 45.9 mt -63.62 114.99 4.3 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.367 0.985 . . . . 3.27 110.396 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.5 76.06 2.53 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.348 -1.353 . . . . 5.5599999999999996 107.348 -170.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -63.48 161.2 14.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.479 -0.782 . . . . 6.5599999999999996 112.364 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.8 t -152.09 138.94 18.93 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.833 -1.543 . . . . 1.6200000000000001 106.833 168.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -77.82 147.48 35.19 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.71 -1.959 . . . . 3.75 105.71 156.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.2 pt -132.51 120.83 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 105.556 -2.016 . . . . 1.9299999999999999 105.556 156.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -75.12 -18.11 60.3 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.599 -0.688 . . . . 3.5899999999999999 110.879 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.83 111.97 8.5 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 125.549 1.54 . . . . 3.1400000000000001 109.299 -161.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 137.63 -137.15 8.68 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 108.415 -1.874 . . . . 1.9399999999999999 108.415 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.6 mmt -131.42 135.83 47.49 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.601 1.56 . . . . 7.75 107.223 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -124.98 165.98 17.16 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.867 1.267 . . . . 1.03 110.154 -172.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -76.86 -57.42 3.86 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 122.036 0.922 . . . . 2.1499999999999999 109.104 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.0 pt -109.26 155.41 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.699 -1.593 . . . . 1.23 106.699 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . 0.36 0.0 OUTLIER -139.64 140.74 37.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 121.251 -0.906 . . . . 3.3700000000000001 109.815 175.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 33.2 t -83.82 99.39 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 106.985 -1.487 . . . . 1.3 106.985 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.3 p -102.41 124.76 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 107.173 -1.417 . . . . 3.9300000000000002 107.173 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -86.36 150.08 24.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.118 -1.438 . . . . 9.0800000000000001 107.118 167.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.73 156.55 31.84 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.783 -1.562 . . . . 1.1000000000000001 106.783 161.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -119.44 140.78 49.87 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.625 -1.62 . . . . 6.2699999999999996 106.625 164.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 22.25 53.71 0.02 OUTLIER Glycine 0 CA--C 1.531 1.079 0 C-N-CA 128.137 2.779 . . . . 3.46 115.937 -173.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -156.63 138.67 14.49 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.212 -1.033 . . . . 4.79 108.212 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.398 0 C-N-CA 127.315 2.246 . . . . 6.5099999999999998 108.415 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.375 0 N-CA-C 109.649 -0.5 . . . . 3.1299999999999999 109.649 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.412 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -166.98 -171.98 1.94 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.249 -1.389 . . . . 9.7799999999999994 107.249 176.045 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.412 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 4.0 p30 -171.57 44.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 O-C-N 124.629 1.205 . . . . 2.6099999999999999 109.854 171.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 52.64 -156.54 4.53 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.652 -0.979 . . . . 1.8500000000000001 110.652 -167.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -64.78 140.67 58.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.82 -0.811 . . . . 6.5199999999999996 111.462 170.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 93.05 -164.33 27.3 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 125.462 1.506 . . . . 1.5700000000000001 110.344 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.11 -118.15 9.6 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.834 1.683 . . . . 1.53 111.729 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.27 123.26 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 106.0 -1.852 . . . . 2.7599999999999998 106.0 175.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . 0.669 7.3 mp -76.91 -63.95 1.24 Allowed 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.266 -1.383 . . . . 1.8899999999999999 107.266 168.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -159.16 155.98 28.17 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 113.757 1.021 . . . . 0.80000000000000004 113.757 -168.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . 0.351 0.0 OUTLIER -103.32 142.44 34.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.544 1.938 . . . . 2.8999999999999999 110.351 176.005 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -164.43 165.79 21.16 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.628 -1.99 . . . . 0.87 105.628 154.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -151.44 152.36 32.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 104.719 -2.326 . . . . 4.3600000000000003 104.719 173.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -91.88 -78.97 1.4 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 109.964 -1.255 . . . . 0.77000000000000002 109.964 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -69.85 176.71 6.47 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.385 2.057 . . . . 2.1200000000000001 110.089 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 90.12 144.03 11.19 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.86 -1.296 . . . . 2.1000000000000001 109.86 -172.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.3 p -82.55 -178.73 7.18 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.518 1.127 . . . . 2.9700000000000002 110.479 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 61.36 -115.37 7.81 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.802 -0.919 . . . . 1.4399999999999999 110.802 173.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.9 tp -60.21 -40.55 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.419 -0.586 . . . . 1.6799999999999999 109.419 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -39.35 136.41 1.37 Allowed Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.469 1.033 . . . . 1.1499999999999999 112.295 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 96.6 -42.17 2.26 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.452 1.025 . . . . 0.78000000000000003 112.448 -165.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -74.57 171.64 13.47 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.953 1.376 . . . . 1.3999999999999999 111.749 -159.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -132.55 112.81 12.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.994 -1.484 . . . . 2.02 106.994 -163.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -132.48 101.94 5.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.644 -0.502 . . . . 7.54 109.644 -156.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -104.96 133.53 49.6 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.438 1.017 . . . . 3.6499999999999999 109.695 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -57.0 105.67 0.24 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.549 -0.908 . . . . 2.75 108.549 171.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -59.39 -33.54 71.33 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.9 0.88 . . . . 3.1299999999999999 110.925 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.5 -27.15 67.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.51 0.671 . . . . 3.4199999999999999 109.462 -176.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -68.58 133.62 48.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.705 -1.591 . . . . 3.04 106.705 171.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -98.44 96.01 7.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.957 -1.868 . . . . 9.1699999999999999 105.957 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 43.8 m95 -75.13 159.98 31.0 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.999 -1.111 . . . . 1.6399999999999999 107.999 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 12.8 p -139.76 139.6 36.51 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.097 0.475 . . . . 2.3700000000000001 111.454 -173.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.2 t -64.3 -49.34 72.19 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.938 -1.101 . . . . 1.96 111.293 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -81.41 -167.38 1.45 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.938 0.895 . . . . 4.1799999999999997 109.697 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 20.8 t -56.82 -56.32 23.04 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.869 -0.419 . . . . 4.5800000000000001 109.869 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 50.43 -94.85 0.01 OUTLIER Glycine 0 C--N 1.34 0.764 0 C-N-CA 124.869 1.224 . . . . 2.71 113.056 171.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -140.01 -75.26 0.05 OUTLIER Glycine 0 CA--C 1.523 0.572 0 N-CA-C 108.926 -1.67 . . . . 1.9299999999999999 108.926 170.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 11.5 m -108.25 119.29 39.05 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.447 -1.686 . . . . 1.8899999999999999 106.447 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -78.5 125.91 30.03 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 120.103 -0.639 . . . . 1.5600000000000001 109.641 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.34 -52.67 62.72 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 109.115 -0.698 . . . . 2.1299999999999999 109.115 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -52.93 -42.12 65.12 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.955 0.502 . . . . 3.5600000000000001 110.277 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -60.56 3.6 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.284 -0.885 . . . . 2.1099999999999999 111.184 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.343 2.0 m -54.97 -38.91 68.41 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 110.259 -0.274 . . . . 1.78 110.259 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.36 -53.21 60.81 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 118.704 -0.665 . . . . 0.53000000000000003 110.236 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 97.6 t -53.48 -47.38 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 119.542 1.065 . . . . 1.2 109.864 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.417 ' ND1' ' O ' ' A' ' 237' ' ' PHE 0.455 5.7 t60 -51.52 -51.44 55.17 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.363 1.065 . . . . 2.9500000000000002 113.819 170.637 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.99 -48.6 12.02 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.053 1.297 . . . . 2.9399999999999999 113.809 -173.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.3 -39.92 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 106.66 -1.607 . . . . 1.51 106.66 167.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -47.88 -57.86 7.4 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.451 1.024 . . . . 0.77000000000000002 113.634 166.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.468 ' NE2' ' NE2' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -50.36 -48.99 55.4 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.449 1.125 . . . . 2.3199999999999998 110.041 176.118 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 69.4 p -61.75 -19.92 62.97 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 113.55 0.944 . . . . 2.3900000000000001 113.55 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.4 mt -66.01 -67.93 0.41 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.713 -1.588 . . . . 3.0899999999999999 106.713 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 156.62 66.15 0.01 OUTLIER Glycine 0 C--O 1.228 -0.259 0 N-CA-C 108.721 -1.752 . . . . 1.1699999999999999 108.721 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.69 136.64 53.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.732 1.613 . . . . 6.2699999999999996 107.035 -174.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -109.83 41.81 2.13 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.239 0.923 . . . . 2.9900000000000002 111.902 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.468 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 70.1 m80 68.81 110.66 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.874 2.069 . . . . 1.6599999999999999 113.407 178.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 34.9 m -74.8 160.51 30.6 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.611 -0.885 . . . . 1.6299999999999999 108.611 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 66.7 m -133.24 47.84 2.45 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.883 1.273 . . . . 3.3599999999999999 108.957 -170.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -143.59 141.14 18.35 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.782 1.633 . . . . 1.8200000000000001 106.607 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -91.39 -8.92 3.07 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.197 1.931 . . . . 1.0700000000000001 114.533 -173.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . 0.455 ' CB ' ' HG ' ' A' ' 251' ' ' SER . 14.9 mtmt -82.17 -37.61 25.87 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.134 -0.979 . . . . 1.72 108.372 170.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -53.18 152.07 4.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.585 1.154 . . . . 0.98999999999999999 111.534 172.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 84.0 t -106.68 -25.9 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.352 1.061 . . . . 0.95999999999999996 111.289 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 4.5 mtt -60.91 -27.39 68.14 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.161 -0.962 . . . . 4.3799999999999999 113.43 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.417 ' O ' ' ND1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.34 160.15 0.46 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 127.975 2.51 . . . . 4.6200000000000001 114.455 -171.28 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.54 -21.23 15.08 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.669 1.579 . . . . 1.1000000000000001 111.818 175.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.368 0.2 OUTLIER -78.03 178.13 7.75 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.126 0.97 . . . . 1.9399999999999999 108.976 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -126.25 149.74 48.89 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.915 -1.513 . . . . 3.75 106.915 174.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -153.5 120.28 5.65 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 104.677 -2.342 . . . . 3.9700000000000002 104.677 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -60.76 122.47 14.87 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.256 -0.646 . . . . 3.5699999999999998 109.256 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.9 m -125.22 142.37 42.29 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.051 0 CA-C-O 121.056 0.455 . . . . 2.0099999999999998 110.961 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.09 91.48 0.16 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.384 1.474 . . . . 3.0299999999999998 108.172 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 2.2 pp -51.7 -29.0 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 123.971 0.909 . . . . 4.1500000000000004 111.419 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -50.29 -40.15 47.59 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.853 1.261 . . . . 4.4400000000000004 111.461 174.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 85.7 m -67.7 -45.89 73.82 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.516 0.727 . . . . 1.96 109.982 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 50.38 81.78 0.06 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.249 1.02 . . . . 6.3300000000000001 110.88 177.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.55 158.36 38.32 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.748 -0.834 . . . . 3.9700000000000002 108.748 167.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.424 ' HG ' ' CZ3' ' A' ' 141' ' ' TRP . 1.3 mm? -105.76 160.63 15.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.531 1.532 . . . . 0.89000000000000001 107.379 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' SER . . . . . 0.455 ' HG ' ' CB ' ' A' ' 233' ' ' LYS . 26.3 m -78.21 152.71 32.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.895 -0.503 . . . . 1.6299999999999999 110.77 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -54.83 -45.99 74.55 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.882 0.473 . . . . 0.73999999999999999 110.323 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -50.33 -54.48 21.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.698 0.761 . . . . 2.4399999999999999 109.924 172.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.77 -47.11 86.99 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.899 -1.046 . . . . 2.1800000000000002 110.35 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.9 mt -50.93 -49.22 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 125.576 1.551 . . . . 0.96999999999999997 110.055 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -58.15 -48.87 78.91 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.827 -1.171 . . . . 5.7800000000000002 110.492 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -56.91 -34.77 66.03 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.514 0.578 . . . . 1.3100000000000001 112.824 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.83 -49.34 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.622 -1.251 . . . . 4.71 107.622 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -63.59 -23.18 67.28 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.138 -0.977 . . . . 3.79 111.772 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.4 m -47.61 -18.77 0.15 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.291 1.219 . . . . 2.6000000000000001 114.291 168.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 C--N 1.343 0.324 0 CA-C-N 119.428 1.013 . . . . 3.1800000000000002 113.319 169.299 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.539 0.546 0 N-CA-C 113.141 0.793 . . . . 8.2699999999999996 113.141 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.6 m170 69.72 -61.54 0.44 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 127.704 2.401 . . . . 5.2599999999999998 111.155 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -79.56 108.51 13.15 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.98 1.312 . . . . 5.4100000000000001 108.199 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.4 mm -132.19 136.49 56.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.606 -1.627 . . . . 4.2000000000000002 106.606 171.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.827 ' HG1' ' H ' ' A' ' 158' ' ' ASP . 10.4 p -110.58 141.22 44.08 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.194 0.998 . . . . 1.97 109.116 177.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.457 ' HH ' HD22 ' A' ' 224' ' ' LEU . 5.5 m-85 -126.77 152.15 47.27 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.127 0.971 . . . . 8.0800000000000001 108.768 -172.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -146.94 143.02 28.17 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.357 -0.608 . . . . 5.4000000000000004 109.357 178.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.4 mt -88.36 156.98 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.947 -1.131 . . . . 1.24 107.947 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.15 -46.0 6.01 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.532 0.605 . . . . 3.8799999999999999 109.976 -178.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -136.43 -179.8 5.9 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.491 0.716 . . . . 3.8500000000000001 109.162 173.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -120.98 110.62 16.49 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 105.749 -1.945 . . . . 3.0099999999999998 105.749 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.659 ' HG1' ' H ' ' A' ' 124' ' ' ASP . 0.9 OUTLIER -66.95 141.48 96.72 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-N 119.038 0.836 . . . . 2.8599999999999999 110.282 -173.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -68.36 -14.71 40.82 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.865 3.044 . . . . 1.8899999999999999 111.377 174.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.659 ' H ' ' HG1' ' A' ' 122' ' ' THR . 43.6 m-20 -41.84 -41.32 2.35 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.695 0.798 . . . . 2.4500000000000002 110.72 173.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -134.6 -177.39 4.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.587 1.155 . . . . 2.5499999999999998 109.94 175.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -84.86 156.45 21.29 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.31 0.644 . . . . 3.1099999999999999 109.821 170.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 57.6 ttt-85 -52.47 -50.06 63.41 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.876 0.695 . . . . 3.6699999999999999 112.876 -176.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.22 -2.22 15.25 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.598 -0.715 . . . . 4.9400000000000004 111.84 -176.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -98.71 -45.03 6.18 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.529 1.059 . . . . 1.72 109.95 164.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.43 -47.45 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.546 -0.721 . . . . 3.0600000000000001 109.367 -172.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.25 -26.44 61.11 Favored 'General case' 0 C--O 1.213 -0.846 0 C-N-CA 118.488 -1.285 . . . . 1.8600000000000001 108.709 177.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -61.85 -50.68 71.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 119.918 1.235 . . . . 3.77 109.453 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.22 -53.33 55.0 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.031 0.932 . . . . 0.93999999999999995 109.743 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -69.39 -40.35 79.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.442 0.639 . . . . 2.3500000000000001 111.075 -175.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -58.06 -52.71 64.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.41 1.484 . . . . 5.96 107.783 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -62.94 -51.47 66.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.1 0.96 . . . . 2.54 110.661 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -48.17 -46.03 34.22 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 123.782 0.833 . . . . 1.0800000000000001 110.869 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.403 ' CZ ' HD23 ' A' ' 224' ' ' LEU . 0.7 OUTLIER -66.27 -53.83 32.12 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.324 -0.853 . . . . 6.0199999999999996 110.139 176.068 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -47.38 -40.24 17.1 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.392 1.077 . . . . 3.8799999999999999 111.934 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 84.5 t -48.93 -48.75 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 125.195 1.398 . . . . 1.3400000000000001 109.449 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.512 ' CZ3' ' HG ' ' A' ' 250' ' ' LEU . 59.3 m95 -80.23 -38.35 31.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.381 0.672 . . . . 0.97999999999999998 111.497 178.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.5 m -61.99 -24.92 67.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.983 0.811 . . . . 3.7999999999999998 111.577 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -73.34 -45.16 56.79 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.885 -0.413 . . . . 1.28 109.885 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 93.4 t -77.62 -49.84 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.227 1.011 . . . . 3.2000000000000002 110.165 -171.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 81.2 p -79.43 153.94 76.48 Favored Pre-proline 0 N--CA 1.447 -0.618 0 N-CA-C 109.145 -0.687 . . . . 1.48 109.145 175.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.58 4.28 6.51 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.265 1.977 . . . . 0.84999999999999998 112.55 173.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.6 mt -71.53 125.62 27.54 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.643 1.111 . . . . 2.8100000000000001 109.658 -170.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -89.68 76.81 7.23 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.14 -1.43 . . . . 5.04 107.14 -169.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -61.48 156.13 20.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 118.143 -1.423 . . . . 7.7400000000000002 112.76 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.8 t -154.01 92.97 1.59 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.875 -0.787 . . . . 2.46 108.875 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -79.08 128.12 32.87 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.831 -0.803 . . . . 7.5300000000000002 108.831 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.8 pp -133.89 148.71 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 105.901 -1.888 . . . . 1.9199999999999999 105.901 174.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -115.8 6.07 14.27 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 118.079 0.4 . . . . 3.7999999999999998 111.79 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.9 p -136.4 119.55 16.59 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.828 0.851 . . . . 3.1400000000000001 108.817 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 121.6 -149.09 17.26 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 107.213 -2.355 . . . . 2.1400000000000001 107.213 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -114.77 138.0 51.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.233 1.413 . . . . 5.8499999999999996 107.298 172.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.08 164.27 12.79 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.691 1.196 . . . . 1.02 109.558 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.827 ' H ' ' HG1' ' A' ' 115' ' ' THR . 8.5 t70 -77.13 -46.66 22.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.829 -1.175 . . . . 2.73 107.829 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.426 HG12 ' CD2' ' A' ' 116' ' ' TYR . 0.7 OUTLIER -107.95 172.62 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 121.486 0.66 . . . . 2.2799999999999998 111.554 173.453 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.58 133.67 36.61 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.008 2.123 . . . . 2.5499999999999998 110.22 170.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.9 t -93.45 107.06 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.589 -1.263 . . . . 1.0900000000000001 107.589 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 70.6 t -117.2 81.48 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.682 1.193 . . . . 2.21 109.378 -174.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -77.31 149.03 35.36 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.605 -1.628 . . . . 6.1200000000000001 106.605 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.07 -170.4 3.27 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.266 -1.013 . . . . 1.3799999999999999 108.266 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.06 141.35 47.15 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.587 0.63 . . . . 7.6699999999999999 110.127 -178.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 33.25 -111.23 0.06 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.907 2.194 . . . . 2.3300000000000001 113.72 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.84 112.67 14.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.815 -1.18 . . . . 2.8599999999999999 107.815 174.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 . . . . . 0 C--O 1.227 -0.098 0 C-N-CA 124.411 1.084 . . . . 5.5700000000000003 110.876 -177.035 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 113.001 0.741 . . . . 4.0499999999999998 113.001 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -96.96 174.15 6.92 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.899 0.88 . . . . 7.6299999999999999 109.832 168.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -137.63 166.57 23.6 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.698 1.999 . . . . 3.6200000000000001 107.872 176.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -70.92 -156.96 2.18 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.384 0.516 . . . . 2.8399999999999999 112.891 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -51.91 111.01 0.54 Allowed 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.571 -0.958 . . . . 4.2599999999999998 111.541 177.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.4 -151.79 17.47 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.474 -1.45 . . . . 2.79 109.474 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.33 -126.32 23.34 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 124.937 1.256 . . . . 2.6400000000000001 110.372 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.1 mm -78.21 124.75 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 107.532 -1.284 . . . . 2.27 107.532 172.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.8 mp -83.48 -31.71 26.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.318 -0.855 . . . . 2.23 110.653 167.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -171.15 153.28 3.66 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 114.929 1.455 . . . . 0.92000000000000004 114.929 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -136.3 125.95 25.42 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 126.543 1.937 . . . . 1.3200000000000001 113.626 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -157.32 162.03 39.11 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 128.168 2.587 . . . . 0.68999999999999995 104.935 -172.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -149.0 155.33 40.64 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.284 -2.117 . . . . 4.9199999999999999 105.284 171.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -101.41 -74.65 1.08 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.374 -1.09 . . . . 0.79000000000000004 110.374 172.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -68.52 174.12 8.83 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.067 1.845 . . . . 1.6599999999999999 110.204 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 83.12 164.47 36.05 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.198 -1.161 . . . . 2.8999999999999999 110.198 -170.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.8 p -82.9 179.94 7.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.157 0.983 . . . . 3.3100000000000001 111.302 -175.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.27 -114.17 6.54 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.363 0.506 . . . . 1.9299999999999999 111.915 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . 0.255 2.7 tp -60.57 -40.78 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 117.386 -1.293 . . . . 2.04 109.195 -174.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -20.77 115.73 0.01 OUTLIER Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.332 1.92 . . . . 1.5600000000000001 113.56 169.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 109.99 -49.44 0.85 Allowed Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.993 2.235 . . . . 0.89000000000000001 110.64 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -83.87 164.81 19.23 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.349 1.46 . . . . 2.1000000000000001 111.216 -168.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.11 131.99 18.07 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.945 1.091 . . . . 0.78000000000000003 113.945 -172.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -116.55 120.4 38.59 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-O 118.257 -0.878 . . . . 3.3399999999999999 110.352 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.0 150.57 22.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.975 0.807 . . . . 3.8399999999999999 111.877 169.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -76.25 93.17 3.37 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.047 0.939 . . . . 2.5499999999999998 112.064 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -77.76 -8.43 57.97 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 118.061 -0.971 . . . . 3.2599999999999998 111.632 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -57.36 -47.13 82.42 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 107.751 -1.203 . . . . 3.48 107.751 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . 0.268 9.5 pt-20 -73.49 175.57 6.89 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.922 1.344 . . . . 3.21 111.52 173.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -133.08 85.13 2.19 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.458 -1.682 . . . . 6.6100000000000003 106.458 -171.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.15 163.51 27.77 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.105 -1.407 . . . . 2.9900000000000002 108.286 169.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.2 p -145.82 166.35 26.19 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.406 -0.961 . . . . 3.25 108.406 173.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.7 t -49.8 -39.26 37.73 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 121.214 -0.929 . . . . 2.96 111.013 165.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.69 138.98 40.42 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.313 0.645 . . . . 3.4700000000000002 110.628 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.2 m -63.6 -16.95 62.27 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.485 1.514 . . . . 4.5099999999999998 112.603 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.96 -66.07 2.98 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.157 0.885 . . . . 2.73 115.131 -167.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -80.27 -89.59 0.51 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.409 -0.676 . . . . 2.0499999999999998 111.409 -166.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 18.4 m -131.89 170.71 14.5 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 103.179 -2.897 . . . . 1.8999999999999999 103.179 158.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -130.58 133.52 46.26 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 118.14 0.427 . . . . 2.1299999999999999 111.009 171.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.69 -45.87 88.08 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.216 -0.661 . . . . 2.73 109.216 -175.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.21 -47.33 54.81 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 109.499 -0.556 . . . . 2.7000000000000002 109.499 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.77 -60.45 3.43 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.038 0.935 . . . . 3.7000000000000002 110.289 -178.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 8.5 m -56.22 -41.9 76.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.961 -0.563 . . . . 2.5899999999999999 110.549 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.68 -51.63 68.76 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 117.921 -1.038 . . . . 0.56999999999999995 110.549 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 70.9 t -45.89 -46.64 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 119.669 1.122 . . . . 1.3200000000000001 110.22 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 1.102 ' NE2' ' NE2' ' A' ' 222' ' ' HIS 0.494 0.3 OUTLIER -64.76 -47.28 78.76 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.627 -0.671 . . . . 3.8700000000000001 112.443 178.059 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . 0.403 ' HG2' ' HD1' ' A' ' 218' ' ' HIS 0.285 19.5 mm-40 -70.42 -48.59 55.33 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 120.727 -1.233 . . . . 2.9300000000000002 113.376 -176.268 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -51.66 -42.01 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 107.862 -1.162 . . . . 2.1000000000000001 107.862 171.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -54.86 -55.07 29.58 Favored Glycine 0 CA--C 1.539 1.588 0 N-CA-C 111.595 -0.602 . . . . 0.53000000000000003 111.595 172.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 1.102 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 18.4 m-70 -50.22 -58.19 6.16 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 117.878 0.839 . . . . 2.0499999999999998 110.514 177.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.9 t -47.94 -49.67 29.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.963 2.105 . . . . 2.6200000000000001 110.737 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.457 HD22 ' HH ' ' A' ' 116' ' ' TYR . 0.3 OUTLIER -65.32 -37.12 86.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 122.962 0.505 . . . . 4.5800000000000001 110.061 -178.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 143.93 70.45 0.02 OUTLIER Glycine 0 C--N 1.338 0.67 0 N-CA-C 112.001 -0.44 . . . . 1.1699999999999999 112.001 160.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 11.1 mt -133.94 155.61 49.62 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.182 0.593 . . . . 4.0199999999999996 110.312 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -132.19 48.91 0.94 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.823 1.201 . . . . 3.0 110.122 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 70.04 165.17 0.27 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.778 1.631 . . . . 5.0300000000000002 112.514 -176.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.3 m -132.71 141.28 48.49 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.089 -1.819 . . . . 1.8300000000000001 106.089 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 31.5 t -80.34 47.55 0.93 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.004 0.522 . . . . 2.9100000000000001 111.718 -170.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -154.27 135.56 8.86 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-O 118.472 -0.775 . . . . 2.0099999999999998 109.775 -171.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.89 -16.77 7.37 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.82 2.347 . . . . 1.99 114.403 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -76.44 -36.6 57.85 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.458 -1.401 . . . . 2.7200000000000002 109.033 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.98 124.66 17.47 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.325 0.583 . . . . 1.3200000000000001 109.586 167.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 69.2 t -64.59 -25.22 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.926 -0.768 . . . . 0.96999999999999997 108.926 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 1.2 mmt -49.0 -23.96 1.34 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.099 1.518 . . . . 2.6800000000000002 115.099 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -53.91 139.47 52.69 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 119.366 0.985 . . . . 7.8899999999999997 110.59 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.88 -23.45 62.13 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.274 1.982 . . . . 1.4399999999999999 112.021 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.361 0.2 OUTLIER -94.52 154.43 17.41 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.606 -0.886 . . . . 3.4700000000000002 108.606 178.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -72.86 150.03 43.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.617 -0.883 . . . . 3.54 108.617 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -141.75 139.82 32.93 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.33 -0.989 . . . . 4.0300000000000002 108.33 173.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -76.26 77.7 3.05 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.765 0.826 . . . . 4.9500000000000002 109.509 -176.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 25.5 m -83.79 103.59 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 116.016 -0.538 . . . . 1.8500000000000001 109.957 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.26 115.54 3.59 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.872 0.368 . . . . 3.5299999999999998 110.323 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 8.8 mt -57.45 -24.42 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.268 0.627 . . . . 3.5800000000000001 109.75 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -41.95 -43.54 3.15 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 124.121 0.968 . . . . 3.8199999999999998 112.621 168.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 14.0 m -82.65 -47.74 11.72 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.204 0.602 . . . . 3.29 110.053 -177.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 59.7 t80 52.82 69.4 0.7 Allowed 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.256 1.022 . . . . 5.3099999999999996 110.873 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -157.94 170.12 23.04 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.447 -0.783 . . . . 4.4400000000000004 110.142 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.512 ' HG ' ' CZ3' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -109.89 152.4 25.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.972 1.709 . . . . 1.03 107.47 -179.05 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.0 151.35 33.63 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 121.423 -0.798 . . . . 1.72 111.195 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -47.69 -47.2 29.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.669 0.788 . . . . 1.0600000000000001 110.786 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -57.49 -45.7 84.58 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.444 0.64 . . . . 2.4500000000000002 110.8 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -58.26 -50.61 72.97 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.993 -1.003 . . . . 2.3599999999999999 108.866 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.5 mt -55.29 -33.16 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.078 1.751 . . . . 1.3300000000000001 112.525 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -70.94 -50.79 30.79 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.726 -1.234 . . . . 6.8099999999999996 109.809 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -46.87 -52.52 11.54 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.366 -0.694 . . . . 1.02 111.366 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 1.9 pp -63.08 -45.48 98.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.655 0.782 . . . . 2.8999999999999999 109.711 -176.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -61.47 -30.24 70.47 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 120.815 -1.178 . . . . 2.9199999999999999 110.947 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.88 -17.56 0.59 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.573 0.953 . . . . 2.2799999999999998 113.573 172.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 36.4 mt . . . . . 0 C--N 1.346 0.43 0 CA-C-N 120.026 1.284 . . . . 3.1800000000000002 113.196 164.062 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.442 ' HZ2' HD12 ' A' ' 147' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 106.919 -1.511 . . . . 12.0 106.919 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -139.35 -88.41 0.21 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.087 0.955 . . . . 8.2400000000000002 108.637 173.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -146.12 145.51 30.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.591 1.556 . . . . 4.9199999999999999 107.761 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.86 96.83 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.32 -0.993 . . . . 3.9500000000000002 108.32 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -104.41 140.4 37.97 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.683 1.593 . . . . 1.6200000000000001 108.963 -174.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -122.79 160.81 25.21 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.115 0.966 . . . . 6.3399999999999999 111.821 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -146.46 144.66 29.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.336 1.054 . . . . 9.1199999999999992 110.012 177.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.4 mt -106.0 156.3 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.204 1.402 . . . . 1.49 107.509 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.443 HD22 ' HG ' ' A' ' 160' ' ' LEU . 45.7 m-80 -107.04 -44.15 4.46 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.917 0.887 . . . . 4.04 110.54 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -152.2 172.96 15.57 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.499 1.119 . . . . 2.1800000000000002 107.98 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -127.56 139.57 52.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.136 1.374 . . . . 3.1099999999999999 107.86 -170.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.8 t -66.3 141.7 97.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.277 -0.638 . . . . 2.6200000000000001 109.277 172.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -77.77 -16.31 14.69 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.74 2.96 . . . . 2.21 111.088 173.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -44.19 -44.37 7.75 Favored 'General case' 0 C--N 1.345 0.374 0 C-N-CA 124.875 1.27 . . . . 2.5800000000000001 111.357 -178.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 22.0 mtm -126.28 168.86 13.53 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.919 1.687 . . . . 2.2799999999999998 107.756 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -65.7 143.27 57.65 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 108.979 -0.748 . . . . 3.2000000000000002 108.979 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -47.34 -48.21 25.51 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.01 0.823 . . . . 4.8600000000000003 110.99 174.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -58.44 -18.81 31.4 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.54 -0.743 . . . . 3.1400000000000001 112.205 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -93.59 -42.2 9.33 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.128 1.771 . . . . 2.0600000000000001 110.458 173.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.5 t -53.22 -55.47 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 O-C-N 120.603 -1.31 . . . . 1.78 109.48 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -24.88 65.01 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 117.897 -1.521 . . . . 1.8600000000000001 109.482 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -62.93 -48.89 76.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.399 0.999 . . . . 3.3599999999999999 109.889 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.97 -48.8 80.25 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 122.403 0.281 . . . . 0.53000000000000003 110.677 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -37.24 70.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 121.227 0.537 . . . . 2.6899999999999999 109.933 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -55.42 31.48 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.277 1.031 . . . . 3.75 108.496 176.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -61.58 -46.64 89.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.397 1.079 . . . . 2.6400000000000001 109.394 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -48.43 -55.77 9.98 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.364 0.666 . . . . 0.64000000000000001 110.701 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -55.99 -51.78 66.51 Favored 'General case' 0 N--CA 1.457 -0.104 0 O-C-N 121.806 -0.559 . . . . 5.5899999999999999 110.394 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.9 -35.27 57.92 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.757 0.651 . . . . 2.6800000000000002 112.757 -175.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 91.4 t -56.89 -51.76 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 123.949 0.9 . . . . 1.3400000000000001 109.862 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -77.35 -28.08 52.88 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.794 -0.566 . . . . 1.21 109.793 -175.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.34 -31.83 72.51 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.952 0.901 . . . . 1.6200000000000001 109.744 175.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -66.05 -49.27 68.27 Favored 'General case' 0 C--N 1.341 0.23 0 O-C-N 121.644 -0.66 . . . . 1.27 109.682 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 64.7 t -70.77 -54.4 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 123.07 0.548 . . . . 3.0899999999999999 110.408 -176.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.482 ' CG2' HG13 ' A' ' 258' ' ' ILE . 81.5 p -82.5 137.19 45.04 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 109.603 -0.517 . . . . 1.9199999999999999 109.603 -174.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -68.05 19.79 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.555 2.836 . . . . 1.74 113.88 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.442 HD12 ' HZ2' ' A' ' 111' ' ' LYS . 2.9 mp -81.06 166.08 21.07 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.774 1.63 . . . . 4.29 108.774 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -124.63 86.13 2.51 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.714 -0.847 . . . . 4.54 108.714 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -74.4 142.32 45.02 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.594 1.158 . . . . 7.1699999999999999 113.256 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 t -151.9 101.57 2.76 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.017 1.117 . . . . 1.4299999999999999 114.017 -176.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.39 126.1 30.76 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 120.157 -1.589 . . . . 4.1399999999999997 109.963 172.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.6 pp -125.6 149.35 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.885 -1.524 . . . . 2.1800000000000002 106.885 174.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -101.73 -15.63 16.91 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.825 0.345 . . . . 2.7599999999999998 110.557 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 55.1 m -144.4 132.41 21.55 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.405 -2.072 . . . . 3.21 105.405 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 141.5 -155.27 25.17 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 106.882 -2.487 . . . . 2.1600000000000001 106.882 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.6 mtt -119.99 140.3 51.17 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.533 -2.025 . . . . 5.7599999999999998 105.533 174.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -144.26 153.5 42.1 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.026 -1.102 . . . . 0.98999999999999999 108.026 -176.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.29 -56.69 4.34 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.427 -1.323 . . . . 1.8500000000000001 107.427 -167.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.1 pt -86.16 -174.66 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 114.82 -1.082 . . . . 1.6200000000000001 110.541 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.443 ' HG ' HD22 ' A' ' 119' ' ' ASN . 1.1 tp -145.39 134.65 22.92 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.862 2.065 . . . . 3.4100000000000001 107.689 173.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.7 t -97.04 98.33 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.182 -1.044 . . . . 0.81999999999999995 108.182 172.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 72.7 t -80.25 129.34 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.804 -1.184 . . . . 2.02 107.804 173.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -111.07 126.55 54.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 104.618 -2.364 . . . . 6.3799999999999999 104.618 156.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -144.2 157.94 44.01 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 109.424 -0.584 . . . . 1.3700000000000001 109.424 175.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.26 91.31 2.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.851 1.261 . . . . 4.8399999999999999 109.347 -173.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 115.28 -55.31 0.54 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.759 1.171 . . . . 1.95 111.093 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -152.78 165.73 34.46 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.998 0.919 . . . . 3.02 108.787 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.239 0 N-CA-C 112.642 0.608 . . . . 4.1699999999999999 112.642 173.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.166 0.031 . . . . 3.1499999999999999 111.049 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -112.09 174.84 5.69 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.58 1.552 . . . . 7.4800000000000004 107.646 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -179.38 31.99 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.878 0.871 . . . . 2.3100000000000001 111.536 -174.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 55.01 -155.12 9.11 Favored Glycine 0 CA--C 1.532 1.148 0 O-C-N 120.714 -1.241 . . . . 1.8200000000000001 111.604 -170.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -69.37 98.36 1.07 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.271 1.028 . . . . 4.8099999999999996 110.772 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 152.15 -175.21 30.94 Favored Glycine 0 C--O 1.24 0.512 0 N-CA-C 111.308 -0.717 . . . . 1.97 111.308 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 45.53 -118.6 3.09 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 126.834 2.159 . . . . 1.53 111.131 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.9 mm -80.58 129.61 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.723 -1.214 . . . . 2.0899999999999999 107.723 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.42 -44.88 16.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.209 1.404 . . . . 3.2400000000000002 109.025 165.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -164.26 149.76 10.5 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 113.062 0.764 . . . . 0.67000000000000004 113.062 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -131.68 115.0 15.47 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.758 1.623 . . . . 1.29 112.469 -174.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -147.43 160.19 42.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.55 2.74 . . . . 0.59999999999999998 105.476 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -150.45 160.05 44.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.855 -1.535 . . . . 5.0899999999999999 106.855 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -81.65 -69.07 1.41 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.173 0.892 . . . . 1.55 111.968 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -58.73 132.79 49.98 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.42 2.08 . . . . 3.6600000000000001 109.215 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -75.69 44.7 1.78 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.639 1.114 . . . . 3.8300000000000001 112.876 -171.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.3 m -77.38 78.93 3.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.636 -1.246 . . . . 6.0999999999999996 107.636 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.53 -101.26 0.75 Allowed Glycine 0 C--O 1.244 0.778 0 N-CA-C 110.317 -1.113 . . . . 3.1200000000000001 110.317 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 2.7 tp -64.41 -39.34 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 121.67 -0.9 . . . . 2.5099999999999998 109.465 -174.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -45.19 159.01 0.2 Allowed Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.468 1.032 . . . . 2.4900000000000002 115.459 176.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 85.68 -52.89 4.65 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 109.715 -1.354 . . . . 1.45 109.715 -159.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.01 162.67 27.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.138 1.375 . . . . 1.95 108.418 -172.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -135.14 121.62 20.54 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.528 0.603 . . . . 0.69999999999999996 112.614 -174.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -113.92 113.39 24.78 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-O 118.729 -0.653 . . . . 2.8599999999999999 111.073 -171.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -96.28 144.65 26.26 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.371 0.668 . . . . 4.0300000000000002 110.572 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -68.67 97.44 0.8 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.454 -0.794 . . . . 2.6899999999999999 111.158 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -70.57 -30.15 66.78 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 120.978 -1.077 . . . . 2.6899999999999999 109.834 173.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -46.89 -42.01 16.82 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.261 1.424 . . . . 2.6400000000000001 109.301 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -74.81 172.13 12.73 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 122.347 1.07 . . . . 2.4399999999999999 113.07 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -113.64 96.11 5.69 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.712 -1.218 . . . . 5.1399999999999997 107.712 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -75.03 151.04 38.76 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.931 -1.137 . . . . 1.52 107.931 172.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 82.4 p -129.92 134.19 47.33 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.407 0.683 . . . . 1.99 109.78 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.6 t -51.57 -43.87 62.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 123.961 0.904 . . . . 1.8700000000000001 111.314 172.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.25 -157.88 0.34 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.645 1.178 . . . . 2.4199999999999999 111.63 -178.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.5 m -60.66 -66.59 0.5 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.336 1.055 . . . . 3.9700000000000002 110.801 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 42.66 -103.81 0.04 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.106 1.336 . . . . 2.8599999999999999 114.825 174.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -125.98 -71.93 0.19 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.309 0.957 . . . . 1.75 110.984 -173.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.3 m -119.21 168.14 11.17 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 105.556 -2.016 . . . . 1.75 105.556 167.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -123.56 128.99 50.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.156 0.182 . . . . 1.3899999999999999 111.113 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.33 -48.14 81.12 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 118.699 -0.667 . . . . 3.1200000000000001 109.495 -177.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -50.52 -43.9 56.06 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.89 0.768 . . . . 2.1899999999999999 110.426 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 7.4 tt -63.24 -60.35 3.52 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.765 0.826 . . . . 1.53 109.698 -175.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.338 20.1 m -61.27 -38.01 85.2 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 120.454 -0.498 . . . . 1.6799999999999999 111.128 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.09 -60.69 2.83 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 118.199 -0.905 . . . . 0.40999999999999998 109.48 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.87 -45.3 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 119.12 0.873 . . . . 2.7200000000000002 111.061 -173.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 236' ' ' MET . 13.0 t60 -52.1 -61.79 2.04 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.236 1.015 . . . . 3.6200000000000001 112.762 168.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -57.41 -38.43 74.31 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.443 -1.411 . . . . 2.8599999999999999 112.184 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.97 -36.16 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 108.247 -1.02 . . . . 1.72 108.247 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -55.81 -44.07 87.03 Favored Glycine 0 CA--C 1.538 1.486 0 O-C-N 121.808 -0.558 . . . . 0.64000000000000001 111.747 166.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.512 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 3.2 m-70 -55.35 -50.04 70.68 Favored 'General case' 0 C--N 1.344 0.343 0 O-C-N 122.106 -0.643 . . . . 2.1200000000000001 109.272 175.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.2 t -44.09 -56.32 4.12 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.204 1.002 . . . . 2.5699999999999998 112.4 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.16 -55.49 28.24 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 119.101 0.864 . . . . 4.4500000000000002 108.879 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 155.38 37.07 0.02 OUTLIER Glycine 0 C--N 1.337 0.6 0 C-N-CA 120.906 -0.664 . . . . 1.1299999999999999 114.607 174.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.3 mt -84.64 113.11 21.04 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.65 1.225 . . . . 4.4800000000000004 110.695 175.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -74.56 60.62 2.43 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.928 0.775 . . . . 2.2999999999999998 111.552 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 78.3 m80 60.17 -170.65 0.14 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.099 1.359 . . . . 2.9300000000000002 112.353 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 58.1 m -148.06 -178.38 6.26 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.813 1.645 . . . . 1.3200000000000001 108.865 167.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.9 t -139.19 38.72 2.11 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.884 0.874 . . . . 2.7200000000000002 110.193 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -140.55 143.13 31.51 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.436 -1.69 . . . . 1.6699999999999999 106.436 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -87.6 -13.58 4.05 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.848 1.698 . . . . 1.1499999999999999 114.62 -173.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 18.2 mtmt -80.32 -36.83 33.69 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.948 -1.13 . . . . 1.5700000000000001 107.948 170.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.33 137.27 42.13 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.408 0.623 . . . . 0.71999999999999997 110.682 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 58.0 t -86.73 -17.04 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 114.751 -1.113 . . . . 0.84999999999999998 109.886 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.517 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 7.9 tpt -76.15 -18.27 59.2 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 114.06 1.133 . . . . 2.27 114.06 -172.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.487 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.86 161.05 0.43 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 126.217 1.807 . . . . 4.29 114.389 176.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.32 -14.39 13.19 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.846 1.698 . . . . 0.94999999999999996 112.37 172.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.385 0.2 OUTLIER -78.39 168.1 20.32 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.539 -0.911 . . . . 2.0499999999999998 108.539 176.605 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -112.48 133.96 54.27 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.315 -1.735 . . . . 3.7799999999999998 106.315 172.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -134.92 148.35 50.03 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.997 -1.112 . . . . 4.0 107.997 172.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -71.38 79.56 0.75 Allowed 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.778 1.231 . . . . 5.1900000000000004 109.174 178.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.8 m -76.63 112.76 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.831 -0.803 . . . . 2.0800000000000001 108.831 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -64.77 118.22 8.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.965 -0.561 . . . . 3.0099999999999998 110.501 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 33.0 mm -58.98 -21.79 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.877 0.871 . . . . 4.0899999999999999 111.197 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -55.49 -33.29 63.57 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.373 0.988 . . . . 3.6000000000000001 111.595 172.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.6 m -80.33 -50.75 9.75 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.751 -0.463 . . . . 2.54 109.751 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 54.2 t80 46.48 73.99 0.16 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.412 1.485 . . . . 5.46 112.142 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.76 167.91 25.87 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.558 -0.714 . . . . 3.4500000000000002 109.781 175.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.429 ' CD2' ' N ' ' A' ' 250' ' ' LEU . 0.3 OUTLIER -102.43 141.12 35.78 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 105.693 -1.966 . . . . 1.0700000000000001 105.693 178.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.28 170.99 14.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.789 -0.449 . . . . 2.21 109.789 -172.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.92 -42.59 85.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.154 -0.618 . . . . 0.94999999999999996 110.078 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.09 -45.81 89.9 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 110.3 -0.259 . . . . 2.6400000000000001 110.3 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -56.22 -51.51 67.82 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.259 -1.015 . . . . 2.9700000000000002 108.259 175.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 57.0 mt -59.3 -31.2 45.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 126.805 2.042 . . . . 0.88 112.663 -175.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -70.33 -58.53 3.65 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.039 -1.038 . . . . 6.4199999999999999 110.04 172.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -56.93 -44.2 92.63 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 111.758 -0.537 . . . . 1.1599999999999999 111.758 -175.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.482 HG13 ' CG2' ' A' ' 145' ' ' THR . 10.2 tp -59.42 -34.77 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.08 0.952 . . . . 4.9500000000000002 111.816 -176.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -86.41 -26.08 24.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.852 -0.53 . . . . 2.9700000000000002 110.623 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.7 t -53.32 -18.22 2.35 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 117.851 -1.071 . . . . 2.6000000000000001 113.064 171.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.4 mm? . . . . . 0 N--CA 1.451 -0.403 0 C-N-CA 125.654 1.582 . . . . 3.8100000000000001 113.472 166.445 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 tptt . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 110.526 -0.175 . . . . 6.8499999999999996 110.526 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.0 m80 64.28 -62.23 0.18 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.894 2.078 . . . . 5.54 113.872 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -86.6 101.73 13.5 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.018 1.327 . . . . 4.3399999999999999 110.06 -172.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.7 mm -124.15 109.57 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.539 -0.912 . . . . 2.7200000000000002 108.539 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.536 ' HG1' ' H ' ' A' ' 158' ' ' ASP . 2.5 p -101.92 146.69 27.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.459 1.104 . . . . 1.6000000000000001 109.858 -178.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.43 ' CZ ' ' CE1' ' A' ' 138' ' ' PHE . 1.9 m-85 -130.11 159.78 35.75 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 119.194 -0.432 . . . . 6.5 111.045 -176.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -143.08 146.3 33.67 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.769 0.827 . . . . 6.1399999999999997 109.045 175.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.34 157.54 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.458 -0.942 . . . . 1.46 108.458 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.457 ' H ' HD21 ' A' ' 119' ' ' ASN . 0.1 OUTLIER -91.61 -57.66 2.69 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.502 0.721 . . . . 3.5800000000000001 109.746 171.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -149.79 171.68 16.35 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 110.168 -0.308 . . . . 2.0899999999999999 110.168 175.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -105.68 118.08 35.66 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.974 1.31 . . . . 3.8900000000000001 107.792 -175.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.6 t -71.07 135.7 84.95 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.636 -0.876 . . . . 3.0 108.636 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.03 -19.72 22.7 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.777 2.318 . . . . 2.2999999999999998 112.548 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.64 -43.49 3.85 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.097 1.759 . . . . 2.5899999999999999 112.37 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -128.44 -179.89 5.28 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.371 1.468 . . . . 2.7200000000000002 108.237 175.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -85.26 145.47 27.53 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.358 0.599 . . . . 2.8999999999999999 110.24 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.9 ttt-85 -49.87 -47.58 51.77 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.635 0.774 . . . . 3.75 111.859 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -62.29 -4.88 2.0 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.012 0.925 . . . . 3.0099999999999998 112.909 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -101.42 -46.35 5.03 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.104 1.762 . . . . 2.1400000000000001 110.029 169.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 66.1 t -54.3 -56.37 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 124.569 1.147 . . . . 1.73 109.518 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -26.96 65.83 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 118.182 -1.407 . . . . 1.8 109.678 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -60.09 -50.12 74.95 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 119.613 1.097 . . . . 3.02 110.01 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.65 -54.42 37.94 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 123.409 0.684 . . . . 0.46999999999999997 110.126 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.1 tp -66.21 -41.03 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.824 0.345 . . . . 3.3399999999999999 110.926 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -53.91 -60.18 3.66 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.491 1.517 . . . . 4.0999999999999996 107.635 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -62.36 -46.11 90.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.281 -0.872 . . . . 2.7400000000000002 110.141 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.05 -52.2 45.57 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.878 0.471 . . . . 0.46000000000000002 110.721 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.43 ' CE1' ' CZ ' ' A' ' 116' ' ' TYR . 4.4 m-85 -55.16 -48.52 73.62 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.709 -0.223 . . . . 5.6200000000000001 110.917 171.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -35.16 61.74 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.573 -0.727 . . . . 2.6200000000000001 111.861 -178.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 94.9 t -55.57 -65.04 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.312 0 CA-C-N 119.217 0.917 . . . . 1.3899999999999999 109.821 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.424 ' CZ3' HG23 ' A' ' 258' ' ' ILE . 41.5 m95 -70.66 -33.34 70.85 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.608 -0.886 . . . . 1.03 108.608 -171.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.448 ' HG ' ' H ' ' A' ' 149' ' ' PHE . 23.0 t -68.51 -13.77 62.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 119.104 -0.474 . . . . 1.72 112.27 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.38 -52.49 7.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.911 -1.144 . . . . 1.23 107.911 177.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.9 m -82.47 -37.85 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.802 -0.636 . . . . 2.7400000000000002 112.328 -171.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -87.38 150.5 49.2 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 106.235 -1.765 . . . . 1.9099999999999999 106.235 170.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.66 -0.5 10.7 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.538 1.492 . . . . 1.04 112.459 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.6 mt -61.28 117.05 5.12 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 119.245 0.93 . . . . 3.1499999999999999 108.849 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -94.5 105.43 17.39 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.173 0.589 . . . . 5.5800000000000001 109.518 -172.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.448 ' H ' ' HG ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -64.98 146.75 54.59 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.339 -0.846 . . . . 8.9199999999999999 112.329 -177.357 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.5 t -154.08 96.98 2.01 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.286 0.565 . . . . 1.49 110.704 165.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -79.75 125.97 30.35 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 108.474 -0.936 . . . . 3.0899999999999999 108.474 172.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.85 155.46 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.678 -1.601 . . . . 1.8300000000000001 106.678 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -108.58 -9.31 15.34 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.939 0.791 . . . . 3.3199999999999998 111.919 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 76.8 m -143.04 132.07 22.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.126 1.77 . . . . 2.8599999999999999 106.67 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.82 -156.79 20.79 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 107.962 -2.055 . . . . 2.96 107.962 -172.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 52.4 mtt -105.12 137.86 42.23 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.94 1.296 . . . . 5.7599999999999998 108.159 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.74 147.08 50.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.438 1.095 . . . . 1.3100000000000001 109.015 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.536 ' H ' ' HG1' ' A' ' 115' ' ' THR . 20.6 t70 -75.19 -50.24 16.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.124 -1.065 . . . . 2.0 108.124 175.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.4 154.11 12.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.447 0.642 . . . . 2.1200000000000001 110.833 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.09 132.9 54.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.904 -1.147 . . . . 3.27 107.904 169.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.2 t -78.57 135.65 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.023 -1.473 . . . . 1.22 107.023 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 196' ' ' HIS . 74.1 t -116.49 134.52 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.802 1.183 . . . . 1.8100000000000001 109.29 172.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -95.97 149.44 21.57 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.668 -1.234 . . . . 9.2799999999999994 107.668 167.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -159.04 149.04 19.18 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 120.536 -1.353 . . . . 1.5600000000000001 110.26 170.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -120.25 132.93 55.54 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.604 1.162 . . . . 4.8899999999999997 108.672 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 54.13 -96.8 0.03 OUTLIER Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.293 0.949 . . . . 2.1099999999999999 111.833 -167.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -124.68 140.85 52.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.138 1.375 . . . . 2.4500000000000002 108.852 -169.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.6 p80 . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 121.286 0.565 . . . . 3.4300000000000002 110.363 177.241 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.312 0 CA-C-O 118.757 -0.64 . . . . 3.0 109.309 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.406 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 26.2 t80 -89.66 161.82 15.91 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.932 0.872 . . . . 9.25 109.413 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.406 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 47.1 p-10 -168.85 26.75 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.682 -1.599 . . . . 3.48 110.613 -157.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 91.6 165.64 39.64 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 111.246 -0.742 . . . . 3.0099999999999998 111.246 -170.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.98 111.69 2.27 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 122.544 -0.386 . . . . 6.3899999999999997 110.542 166.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.8 -164.31 13.59 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.61 -1.396 . . . . 2.3900000000000001 109.61 -171.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 59.06 -120.03 20.74 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 110.225 -1.15 . . . . 2.3700000000000001 110.225 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.7 mm -76.57 122.78 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 105.699 -1.963 . . . . 2.3399999999999999 105.699 168.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.57 -44.4 17.34 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.65 -0.5 . . . . 1.98 109.65 174.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -167.08 168.51 13.63 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.69 -0.631 . . . . 0.68000000000000005 109.921 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -145.92 108.35 4.45 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.198 0.999 . . . . 1.3 113.377 -172.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -128.19 156.66 42.57 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.937 2.095 . . . . 0.84999999999999998 107.107 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -145.29 149.15 34.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.024 -1.843 . . . . 3.8300000000000001 106.024 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.75 -85.44 1.71 Allowed Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.506 -1.038 . . . . 0.78000000000000003 110.506 174.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.38 86.54 0.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.638 2.892 . . . . 1.4299999999999999 111.196 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -158.88 164.79 33.87 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 108.165 -1.974 . . . . 1.3700000000000001 108.165 169.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.9 t -79.92 179.85 7.35 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.378 0.589 . . . . 4.0599999999999996 109.964 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 43.8 -102.93 0.04 OUTLIER Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.814 1.674 . . . . 1.4099999999999999 112.574 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.2 tp -60.3 -40.04 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 118.298 -0.858 . . . . 1.55 110.0 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -37.2 134.4 0.89 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.675 1.131 . . . . 1.1399999999999999 112.85 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 99.7 -47.77 1.29 Allowed Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.829 1.681 . . . . 0.88 111.392 -161.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -88.49 138.93 30.99 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.902 0.881 . . . . 1.28 110.084 -156.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -109.65 119.63 40.0 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.669 0.788 . . . . 0.79000000000000004 112.663 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.403 ' HA ' ' O ' ' A' ' 162' ' ' VAL 0.28 0.0 OUTLIER -111.39 113.25 25.57 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-O 117.575 -1.202 . . . . 2.8900000000000001 110.783 -171.912 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -103.03 152.33 21.48 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.42 1.464 . . . . 7.9199999999999999 112.756 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -64.1 95.58 0.13 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.36 -1.291 . . . . 2.6800000000000002 108.767 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -56.89 -40.0 75.42 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 125.395 1.478 . . . . 3.2200000000000002 111.594 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.77 -28.34 68.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.53 1.132 . . . . 3.1400000000000001 110.731 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -69.85 127.1 31.73 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 107.732 -1.21 . . . . 2.2999999999999998 107.732 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -80.59 78.68 7.31 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.904 -1.147 . . . . 3.6800000000000002 107.904 -174.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -77.0 103.7 7.08 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.302 1.041 . . . . 2.75 110.562 -172.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.26 166.54 12.88 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.05 1.405 . . . . 2.5800000000000001 110.72 -174.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.3 t -69.26 -43.44 73.95 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 127.542 2.337 . . . . 1.98 112.371 166.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -82.53 156.88 23.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.374 -0.83 . . . . 4.2800000000000002 109.698 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.4 m -69.11 -32.99 72.78 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.991 1.717 . . . . 4.8700000000000001 110.952 -167.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.81 133.77 52.63 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 111.066 -0.813 . . . . 2.98 111.066 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 90.28 -120.29 5.82 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.069 -2.012 . . . . 2.5499999999999998 108.069 -175.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.45 142.38 50.8 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 108.273 -1.01 . . . . 1.5800000000000001 108.273 162.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -96.81 121.48 38.72 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.363 0.414 . . . . 1.25 110.584 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.79 -53.42 32.0 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 109.143 -0.688 . . . . 2.1600000000000001 109.143 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -47.36 -48.09 25.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.336 0.654 . . . . 2.27 110.637 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.17 -58.21 9.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.321 -0.4 . . . . 1.74 110.941 -174.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.392 80.4 m -56.37 -43.02 78.78 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.102 0.477 . . . . 2.2799999999999998 110.22 176.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.61 -55.99 23.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 117.26 -1.352 . . . . 0.40000000000000002 109.808 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 38.9 t -47.95 -45.39 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 121.157 1.799 . . . . 1.49 110.951 -176.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.815 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 0.4 OUTLIER -56.79 -56.49 20.81 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.78 0.659 . . . . 3.8999999999999999 112.78 170.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -65.76 -44.4 85.98 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 120.406 -1.434 . . . . 3.54 112.737 -176.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.425 HG13 ' CZ ' ' A' ' 138' ' ' PHE . 1.4 mp -49.84 -49.06 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 125.923 1.689 . . . . 1.49 106.96 172.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -53.58 -52.46 41.54 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.684 -0.566 . . . . 0.62 111.684 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.815 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 5.0 m-70 -50.25 -51.0 48.28 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 117.763 0.781 . . . . 1.99 110.642 175.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.0 m -57.34 -47.14 82.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.157 0.983 . . . . 3.1499999999999999 110.951 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.13 -22.6 61.15 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.481 1.112 . . . . 3.3700000000000001 112.392 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 124.54 4.14 7.61 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.557 1.075 . . . . 1.53 112.877 173.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 30.6 mt -80.78 122.34 27.04 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 118.218 1.009 . . . . 4.9299999999999997 110.849 -169.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -65.24 179.68 8.73 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.468 -0.653 . . . . 3.46 111.468 173.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -77.02 121.31 23.34 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.133 0.573 . . . . 1.8600000000000001 110.595 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.8 m -76.09 173.95 10.65 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.829 -0.434 . . . . 1.51 109.829 169.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.3 t -140.03 52.22 1.69 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.679 1.192 . . . . 3.1200000000000001 109.259 -172.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -155.29 140.8 12.54 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 117.739 -1.124 . . . . 1.8 108.436 -173.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -93.85 -3.19 2.96 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.657 2.238 . . . . 1.3300000000000001 114.978 -175.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -83.7 -33.46 25.14 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.243 -1.536 . . . . 2.3700000000000001 109.096 165.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.3 156.67 9.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.259 1.024 . . . . 0.90000000000000002 112.229 171.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 77.7 t -105.39 -19.73 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 114.204 -1.362 . . . . 0.75 110.368 169.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 4.3 tpt -73.47 -9.03 58.26 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.826 1.047 . . . . 2.04 113.826 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.38 167.14 1.34 Allowed Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.906 1.283 . . . . 4.5700000000000003 113.07 176.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -73.61 -26.24 14.08 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.962 1.775 . . . . 1.6200000000000001 112.111 170.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.353 0.2 OUTLIER -78.21 -178.89 5.89 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.224 1.81 . . . . 2.3700000000000001 111.59 -170.039 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -113.72 148.62 36.1 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.184 1.793 . . . . 3.46 108.04 175.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -156.48 140.75 16.57 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.398 -1.334 . . . . 4.0499999999999998 107.398 171.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -66.0 115.8 6.45 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.626 0.77 . . . . 4.5499999999999998 110.19 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.7 m -135.64 99.9 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 124.099 0.959 . . . . 1.8200000000000001 110.015 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.0 137.81 57.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.263 0.554 . . . . 4.5499999999999998 111.639 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.2 pt -81.43 35.74 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 113.509 0.929 . . . . 4.6100000000000003 113.509 -169.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -109.3 -63.1 1.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.033 0.933 . . . . 3.48 109.497 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 61.9 m -63.21 -48.74 77.04 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.228 -0.656 . . . . 2.0600000000000001 109.228 -176.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 55.36 89.38 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.337 1.055 . . . . 5.9299999999999997 110.66 176.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.72 143.68 19.83 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.096 -0.705 . . . . 4.2300000000000004 109.096 170.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.71 164.3 19.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.676 1.59 . . . . 1.0600000000000001 107.802 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.0 m -78.74 151.38 32.12 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 122.119 -0.363 . . . . 1.3100000000000001 110.1 174.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.68 -47.26 77.06 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.001 0.52 . . . . 0.93000000000000005 110.291 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -51.47 -51.57 53.9 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.563 0.745 . . . . 2.5 110.163 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.15 -53.05 62.49 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.11 -0.95 . . . . 2.3399999999999999 109.218 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.1 mt -50.79 -43.44 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.041 1.336 . . . . 1.0 111.259 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -61.43 -50.92 70.86 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.484 -1.385 . . . . 6.5300000000000002 109.36 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -47.25 -47.19 21.6 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.003 0.811 . . . . 1.4299999999999999 112.567 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.424 HG23 ' CZ3' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -70.13 -38.58 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 118.175 0.988 . . . . 2.79 110.413 -174.417 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -61.18 -33.23 73.11 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.68 -0.408 . . . . 3.6299999999999999 110.244 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.9 m -50.82 -23.03 2.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.934 1.087 . . . . 3.3900000000000001 113.934 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 8.8 mt . . . . . 0 C--N 1.345 0.373 0 CA-C-N 120.326 1.421 . . . . 3.6499999999999999 113.028 176.153 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.0 tptt . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 108.862 -0.792 . . . . 6.9900000000000002 108.862 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 69.29 -64.83 0.32 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.984 2.114 . . . . 4.5899999999999999 111.873 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -108.25 119.27 39.0 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.548 -1.279 . . . . 4.4800000000000004 107.548 -176.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.0 mp -134.43 147.4 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 105.405 -2.072 . . . . 3.8999999999999999 105.405 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.65 142.2 17.61 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 105.06 -2.2 . . . . 3.4300000000000002 105.06 -173.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -125.67 165.7 18.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.69 1.196 . . . . 4.9299999999999997 111.148 -174.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -154.85 161.23 41.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.814 -0.809 . . . . 7.3099999999999996 108.814 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.71 155.0 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.339 -1.356 . . . . 1.05 107.339 174.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -80.71 -51.4 8.72 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.643 -0.502 . . . . 3.5299999999999998 109.643 173.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -157.14 170.17 23.11 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.483 0.583 . . . . 3.0499999999999998 111.174 167.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -94.16 126.86 39.65 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.994 1.318 . . . . 4.0499999999999998 109.773 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.733 ' HG1' ' H ' ' A' ' 124' ' ' ASP . 11.2 t -70.29 147.45 95.25 Favored Pre-proline 0 N--CA 1.442 -0.853 0 O-C-N 121.933 -0.479 . . . . 2.8199999999999998 112.29 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -80.34 -16.19 10.93 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 124.678 3.585 . . . . 2.4300000000000002 111.22 168.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.733 ' H ' ' HG1' ' A' ' 122' ' ' THR . 16.1 t70 -50.45 -36.6 34.1 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.858 1.663 . . . . 3.29 112.116 -176.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 13.7 mtm -133.61 -177.96 4.78 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.9 1.68 . . . . 2.6600000000000001 106.949 172.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -78.71 139.74 38.43 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.326 -0.62 . . . . 2.8799999999999999 109.326 171.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -51.39 -42.45 61.4 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.713 -0.617 . . . . 4.5199999999999996 112.179 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -65.19 -5.57 7.21 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.662 0.785 . . . . 3.0800000000000001 112.274 -177.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -94.45 -47.41 6.58 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 126.515 1.926 . . . . 2.21 109.789 166.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.7 t -57.03 -61.72 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 C-N-CA 125.504 1.521 . . . . 1.72 109.454 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -28.06 67.48 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 117.825 -1.55 . . . . 1.7 109.019 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -61.05 -50.99 71.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 118.859 0.754 . . . . 4.1200000000000001 109.952 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.29 -48.11 77.29 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 122.906 0.483 . . . . 0.63 110.729 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.9 -37.49 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.563 0.697 . . . . 2.4700000000000002 110.128 -175.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -55.45 33.66 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.872 1.269 . . . . 4.9500000000000002 107.926 178.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -56.33 -51.84 66.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.383 -0.599 . . . . 3.5800000000000001 109.383 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.37 -49.03 46.27 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.625 0.648 . . . . 0.56000000000000005 112.426 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -61.71 -51.77 67.04 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 121.894 -0.504 . . . . 5.7400000000000002 109.902 173.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -55.82 -37.95 69.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.652 0.781 . . . . 2.4500000000000002 110.777 -172.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.5 t -53.61 -52.21 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.623 1.569 . . . . 1.1799999999999999 108.844 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -74.51 -32.72 62.59 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.997 -0.371 . . . . 0.88 109.997 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.0 m -72.65 -9.2 58.33 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.215 0.45 . . . . 2.5099999999999998 112.215 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -84.87 -52.39 6.05 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 107.565 -1.272 . . . . 1.26 107.565 175.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.7 m -76.42 -33.62 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 112.289 0.478 . . . . 2.71 112.289 -175.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.417 ' HG1' ' H ' ' A' ' 147' ' ' LEU . 6.8 p -100.74 153.88 37.48 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.384 -0.598 . . . . 1.8500000000000001 109.384 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.38 9.31 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.326 2.017 . . . . 0.91000000000000003 112.967 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.417 ' H ' ' HG1' ' A' ' 145' ' ' THR . 8.4 mp -78.85 112.87 16.44 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.407 1.003 . . . . 3.6600000000000001 108.862 -176.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -95.61 73.22 3.17 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.701 -0.624 . . . . 4.2400000000000002 111.676 -163.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -63.82 147.66 51.24 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.488 0.715 . . . . 7.2699999999999996 112.123 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.9 t -149.68 147.5 28.15 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.576 1.55 . . . . 1.5800000000000001 107.883 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -97.93 136.29 38.44 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.262 0.625 . . . . 2.8599999999999999 109.87 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.2 pp -134.84 118.59 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.848 -1.167 . . . . 1.6000000000000001 107.848 172.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -75.83 -32.24 59.72 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 119.723 -0.791 . . . . 3.3300000000000001 110.13 172.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.6 m -113.94 95.68 5.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.681 0.792 . . . . 2.71 109.543 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 151.53 -154.24 25.44 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.665 -1.374 . . . . 1.8600000000000001 109.665 170.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.6 tpt -111.82 136.67 50.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.182 1.393 . . . . 6.5499999999999998 110.52 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -129.36 163.83 24.91 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.849 1.66 . . . . 0.85999999999999999 109.363 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.51 -41.12 56.06 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.509 -0.922 . . . . 1.6799999999999999 108.509 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 33.6 pt -121.97 175.7 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.786 1.234 . . . . 1.6499999999999999 109.508 -176.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.7 tp -148.62 130.24 14.97 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.2 1.4 . . . . 4.2400000000000002 108.879 -173.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.7 t -88.19 109.04 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 108.429 -0.952 . . . . 0.88 108.429 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.7 t -88.26 142.05 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.308 -0.997 . . . . 1.99 108.308 168.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.449 ' CE2' ' HB ' ' A' ' 122' ' ' THR . 0.0 OUTLIER -131.64 125.26 31.71 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 104.565 -2.383 . . . . 7.5 104.565 172.332 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -159.45 161.25 35.46 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.337 -1.727 . . . . 1.77 106.337 -174.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -123.87 152.94 41.79 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.523 -0.917 . . . . 5.1299999999999999 108.523 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 69.2 -142.5 37.66 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.73 2.11 . . . . 1.6299999999999999 113.013 172.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.16 129.83 34.86 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.937 -0.764 . . . . 2.52 108.937 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 . . . . . 0 CA--C 1.532 0.286 0 C-N-CA 122.791 0.436 . . . . 4.8700000000000001 111.315 178.636 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 111.572 0.212 . . . . 3.3399999999999999 111.572 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -125.06 167.1 15.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.52 1.128 . . . . 7.29 108.389 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.4 p30 -140.72 -20.47 0.82 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 115.763 1.764 . . . . 2.9500000000000002 115.763 -150.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.47 132.91 0.27 Allowed Glycine 0 CA--C 1.534 1.24 0 N-CA-C 110.325 -1.11 . . . . 2.3799999999999999 110.325 -162.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.9 tttt 56.31 -152.41 0.38 Allowed 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.389 -1.066 . . . . 6.5700000000000003 110.079 -175.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.8 -107.42 0.01 OUTLIER Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.145 1.355 . . . . 2.5800000000000001 115.343 -162.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 49.68 -114.59 2.42 Favored Glycine 0 C--N 1.34 0.759 0 CA-C-N 117.963 0.882 . . . . 1.48 111.987 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 10.6 mm -78.96 117.34 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 107.272 -1.381 . . . . 3.0699999999999998 107.272 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.53 -60.26 2.42 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.318 -1.364 . . . . 1.77 107.318 170.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -164.82 169.69 16.35 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 121.08 -1.013 . . . . 0.73999999999999999 109.522 -176.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -147.47 124.53 11.4 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 114.307 1.225 . . . . 1.02 114.307 -174.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -151.08 156.6 41.4 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.397 1.879 . . . . 0.56000000000000005 106.454 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -145.52 160.36 41.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.471 -1.677 . . . . 4.6200000000000001 106.471 175.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -90.44 -119.45 2.08 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 118.768 -1.018 . . . . 0.84999999999999998 110.941 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.75 79.35 1.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.678 2.252 . . . . 2.8999999999999999 110.299 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -141.41 163.43 26.79 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.755 -1.738 . . . . 1.5700000000000001 108.755 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.402 ' H ' ' HG ' ' A' ' 189' ' ' SER . 1.7 p -78.94 169.32 18.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.285 1.034 . . . . 3.6000000000000001 112.055 -170.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 53.48 -114.3 3.74 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.358 0.98 . . . . 1.73 111.592 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.406 HG12 ' CE1' ' A' ' 196' ' ' HIS . 3.5 tp -62.2 -35.44 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 118.335 -0.84 . . . . 1.9199999999999999 109.869 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -40.68 141.31 0.94 Allowed Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.42 1.009 . . . . 1.52 113.087 176.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 93.6 -48.2 2.32 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.168 1.366 . . . . 0.81999999999999995 110.883 -160.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.64 171.06 10.75 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.041 0.937 . . . . 1.24 108.824 -167.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -144.9 122.83 12.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 118.725 -0.655 . . . . 0.65000000000000002 112.473 -169.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.475 ' N ' ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -115.37 115.56 26.8 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-O 117.696 -1.145 . . . . 2.8300000000000001 111.076 -171.248 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -92.38 148.51 22.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.752 1.16 . . . . 4.1900000000000004 110.446 174.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.98 98.52 9.29 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 122.497 1.141 . . . . 3.4199999999999999 112.017 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -49.93 -33.19 16.73 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 119.852 -1.78 . . . . 3.0499999999999998 110.389 170.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -36.09 -47.44 0.55 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.981 1.104 . . . . 3.6000000000000001 113.981 172.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -73.78 156.34 37.93 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 123.252 1.501 . . . . 2.3100000000000001 111.435 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -92.86 91.53 7.48 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 105.448 -2.056 . . . . 3.6600000000000001 105.448 167.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -76.81 152.92 35.35 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.172 -1.047 . . . . 1.54 108.172 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 39.1 p -133.7 156.28 48.21 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.533 0.682 . . . . 2.1000000000000001 110.345 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.3 -44.95 23.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.606 1.562 . . . . 1.8999999999999999 110.379 170.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -76.66 178.43 6.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.022 1.329 . . . . 2.8700000000000001 109.224 170.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.32 -60.83 2.86 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.036 1.334 . . . . 3.9900000000000002 109.66 -172.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 57.1 -95.62 0.04 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.367 0.984 . . . . 2.3900000000000001 112.563 168.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -135.41 -72.54 0.07 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.252 -1.539 . . . . 1.76 109.252 175.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.8 m -114.28 122.75 47.7 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.839 -1.541 . . . . 1.55 106.839 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -85.65 117.2 24.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.822 -1.177 . . . . 1.6000000000000001 107.822 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.84 -53.66 14.92 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.271 0.628 . . . . 2.3599999999999999 110.383 -175.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -43.4 -45.36 6.16 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.419 1.088 . . . . 2.5 110.77 177.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.6 tt -67.25 -57.5 6.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.302 -0.408 . . . . 1.75 110.707 -168.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 m -56.54 -46.55 80.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.453 -0.573 . . . . 2.1899999999999999 109.453 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.0 -57.93 5.11 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 124.549 1.155 . . . . 0.65000000000000002 110.69 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 71.0 t -48.27 -41.73 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 119.625 1.102 . . . . 1.1599999999999999 111.168 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.831 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 0.2 OUTLIER -63.91 -54.48 34.08 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.311 -0.868 . . . . 3.4700000000000002 112.404 178.161 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.74 -36.96 65.22 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.234 -0.917 . . . . 3.6200000000000001 111.1 -174.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.7 -42.9 97.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 107.001 -1.481 . . . . 1.8999999999999999 107.001 173.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -47.05 -54.06 9.99 Favored Glycine 0 CA--C 1.536 1.37 0 O-C-N 121.401 -0.812 . . . . 0.52000000000000002 111.571 166.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.831 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 9.0 m-70 -50.79 -45.03 59.0 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 121.572 -0.957 . . . . 2.1899999999999999 111.028 175.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 9.2 t -51.16 -41.17 59.96 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.213 0.605 . . . . 2.6200000000000001 111.972 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.72 -54.15 40.0 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.245 -0.65 . . . . 4.0499999999999998 109.245 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 131.54 73.69 0.11 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 111.565 -0.614 . . . . 1.2 111.565 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.1 mt -124.69 121.48 34.78 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.311 1.044 . . . . 4.3200000000000003 108.858 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -76.64 56.2 3.4 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.76 0.695 . . . . 2.4900000000000002 111.985 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 77.4 m80 57.73 -169.53 0.11 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.656 1.182 . . . . 2.4500000000000002 112.066 -175.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 75.5 m -148.59 -179.82 7.26 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 106.461 -1.681 . . . . 1.4399999999999999 106.461 165.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 36.9 p -136.77 37.82 2.62 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.43 1.492 . . . . 3.0899999999999999 109.244 -168.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -139.88 136.49 17.37 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 106.089 -1.819 . . . . 1.6699999999999999 106.089 -173.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -85.73 -8.06 8.31 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.872 1.715 . . . . 1.1499999999999999 114.287 -172.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -80.83 -42.95 20.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.929 -1.137 . . . . 1.6399999999999999 107.929 168.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -55.19 140.74 37.7 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.203 0.525 . . . . 0.71999999999999997 109.724 174.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 88.2 t -87.04 -23.14 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 108.684 -0.858 . . . . 0.71999999999999997 108.684 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -55.69 -29.5 59.49 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 115.811 1.782 . . . . 2.1099999999999999 115.811 -177.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -50.08 162.48 0.49 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 125.659 1.584 . . . . 4.4000000000000004 113.696 -172.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.93 -16.43 14.35 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.331 1.354 . . . . 1.0 111.907 170.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.377 0.2 OUTLIER -79.3 -179.7 6.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.167 1.387 . . . . 2.1099999999999999 109.609 178.171 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -130.39 148.94 52.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 126.394 1.878 . . . . 3.4700000000000002 106.144 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.66 173.88 13.65 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.768 -1.938 . . . . 3.0 105.768 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -87.75 117.82 26.84 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 119.578 1.081 . . . . 4.9299999999999997 109.055 174.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.5 m -120.32 125.04 73.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 107.669 -1.234 . . . . 1.77 107.669 170.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -81.21 120.21 24.59 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.223 -0.591 . . . . 4.9400000000000004 109.756 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.16 -27.81 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.307 -0.406 . . . . 4.7400000000000002 110.803 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -66.27 -35.01 79.31 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.289 0.495 . . . . 4.0099999999999998 110.313 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 29.6 m -66.55 -49.75 65.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.535 -0.543 . . . . 2.1699999999999999 109.535 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 51.12 83.21 0.05 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.91 0.862 . . . . 6.1100000000000003 110.562 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.48 158.35 31.78 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.64 -0.663 . . . . 5.4000000000000004 109.345 169.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -108.16 157.15 18.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.734 -1.58 . . . . 0.87 106.734 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 29.6 m -77.49 151.52 34.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.005 -0.434 . . . . 1.6599999999999999 110.106 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.41 -45.41 46.18 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.699 0.4 . . . . 0.77000000000000002 110.086 171.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -59.63 -36.11 75.7 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.588 0.708 . . . . 2.4100000000000001 111.605 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -71.77 -51.52 22.27 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.709 1.243 . . . . 1.97 108.887 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 41.0 mt -52.79 -49.06 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 126.831 2.052 . . . . 1.03 112.124 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -55.19 -43.36 74.29 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.498 -1.376 . . . . 8.6699999999999999 110.535 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -55.63 -40.42 78.91 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.045 -1.222 . . . . 0.84999999999999998 110.045 174.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -45.18 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 C-N-CA 123.257 0.623 . . . . 4.6500000000000004 111.267 -176.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -63.31 -27.17 69.14 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 119.343 -0.943 . . . . 2.3700000000000001 110.515 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.29 -15.27 0.91 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.145 1.165 . . . . 2.5600000000000001 114.145 169.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 76.7 mt . . . . . 0 C--N 1.346 0.447 0 CA-C-N 121.055 1.752 . . . . 3.0699999999999998 113.192 164.695 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.9 tptt . . . . . 0 CA--C 1.534 0.329 0 N-CA-C 111.861 0.319 . . . . 7.9500000000000002 111.861 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 74.94 -68.85 0.2 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.902 1.681 . . . . 5.6399999999999997 111.368 172.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -102.56 113.5 26.93 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 126.199 1.8 . . . . 4.3799999999999999 109.128 -174.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 mm -117.76 88.45 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 122.11 0.957 . . . . 2.6899999999999999 109.33 -173.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 p -87.25 146.19 26.07 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.441 0.696 . . . . 1.6399999999999999 109.495 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.438 ' CE2' ' CD1' ' A' ' 138' ' ' PHE . 10.5 m-85 -129.92 166.2 20.51 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.728 0.811 . . . . 6.6900000000000004 110.364 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -153.51 168.91 24.56 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.335 0.654 . . . . 8.4199999999999999 110.458 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.2 mt -119.4 148.53 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.265 -1.383 . . . . 1.8 107.265 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -89.55 -67.71 0.82 Allowed 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.961 -1.126 . . . . 4.9500000000000002 107.961 171.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -138.96 162.0 35.95 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.176 0.806 . . . . 2.1299999999999999 113.176 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -104.3 154.0 20.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.411 1.884 . . . . 3.8500000000000001 108.85 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.546 ' HG1' ' H ' ' A' ' 124' ' ' ASP . 12.7 t -85.48 149.78 52.61 Favored Pre-proline 0 N--CA 1.444 -0.74 0 C-N-CA 124.3 1.04 . . . . 3.0800000000000001 111.68 172.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -86.93 -17.6 3.1 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.155 3.236 . . . . 2.5 111.104 169.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.546 ' H ' ' HG1' ' A' ' 122' ' ' THR . 99.0 m-20 -56.69 -46.84 80.95 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.963 0.905 . . . . 3.8799999999999999 109.83 -177.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 4.2 mmt -101.49 -169.87 1.75 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.477 1.111 . . . . 4.4000000000000004 108.037 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -103.28 145.76 29.47 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 108.397 -0.964 . . . . 2.9900000000000002 108.397 167.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -55.38 -39.98 70.78 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.711 -0.618 . . . . 2.9900000000000002 111.196 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -64.25 -7.68 10.16 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.706 -0.679 . . . . 3.1699999999999999 112.302 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -95.67 -50.16 5.06 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.512 1.125 . . . . 3.25 109.259 162.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -50.58 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 118.894 0.77 . . . . 3.3100000000000001 110.329 -166.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.19 -19.15 58.68 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 118.066 -1.454 . . . . 1.71 109.776 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -73.1 -46.17 52.83 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 119.135 0.88 . . . . 3.6600000000000001 108.736 -175.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.4 -54.24 23.31 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 124.184 0.994 . . . . 0.58999999999999997 109.619 171.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.82 -48.79 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 121.059 -0.256 . . . . 3.5800000000000001 110.472 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -50.26 -57.76 7.12 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.178 1.391 . . . . 4.9199999999999999 108.899 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -64.7 -43.23 94.16 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.191 -0.913 . . . . 3.3900000000000001 109.485 -176.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.01 -52.73 57.47 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.001 0.52 . . . . 0.45000000000000001 110.134 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.438 ' CD1' ' CE2' ' A' ' 116' ' ' TYR . 61.5 m-85 -54.23 -44.84 72.06 Favored 'General case' 0 C--O 1.231 0.111 0 O-C-N 122.182 -0.324 . . . . 5.7300000000000004 111.007 171.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.34 -37.19 67.13 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.547 -0.739 . . . . 2.5 111.852 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 62.7 t -55.55 -63.3 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 119.121 0.873 . . . . 1.2 109.571 177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -70.48 -32.58 70.17 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.964 -0.754 . . . . 0.84999999999999998 108.964 -171.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.3 t -64.62 -14.12 56.58 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.064 -0.97 . . . . 2.2599999999999998 112.998 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -82.67 -48.27 11.09 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.036 -1.098 . . . . 1.1599999999999999 108.036 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.3 m -76.98 -46.37 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 112.282 0.475 . . . . 2.4300000000000002 112.282 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 22.9 p -82.81 152.54 66.3 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 108.18 -1.045 . . . . 1.2 108.18 177.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.26 9.07 3.53 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.334 2.023 . . . . 0.75 112.224 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.2 mt -67.52 108.79 2.97 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.502 1.046 . . . . 2.7599999999999998 110.307 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.1 mpmm? -70.94 91.13 0.84 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.463 0.649 . . . . 4.7199999999999998 109.619 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.94 134.56 57.22 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 127.456 2.303 . . . . 7.9199999999999999 109.687 168.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.3 t -153.46 106.69 2.96 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.372 -0.233 . . . . 1.74 110.372 163.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -80.87 130.25 34.95 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.705 -0.85 . . . . 2.9900000000000002 108.705 173.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.0 pt -128.47 142.2 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.037 -1.468 . . . . 1.8999999999999999 107.037 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -95.59 -15.62 22.67 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 122.497 -0.127 . . . . 3.1200000000000001 110.752 -177.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 52.8 m -136.57 130.09 31.85 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 125.096 1.358 . . . . 2.7799999999999998 107.487 172.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 137.89 -152.87 21.94 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 107.999 -2.04 . . . . 2.0899999999999999 107.999 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 41.2 mtp -123.73 131.57 53.63 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.892 1.677 . . . . 5.2599999999999998 106.746 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -136.72 158.74 43.73 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.769 0.828 . . . . 0.97999999999999998 110.304 -175.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -76.59 -49.11 17.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.706 -0.85 . . . . 1.6299999999999999 108.706 -167.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.14 171.82 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.358 0.599 . . . . 1.6899999999999999 110.772 172.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.59 144.1 31.12 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.917 2.087 . . . . 4.2400000000000002 109.1 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 37.3 t -83.02 106.45 13.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 125.153 1.381 . . . . 1.51 109.054 170.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 69.9 t -84.84 118.3 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.215 -1.031 . . . . 1.9199999999999999 108.215 171.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -80.87 138.79 36.19 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 105.856 -1.905 . . . . 8.9600000000000009 105.856 160.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -147.14 161.59 40.57 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.564 -1.643 . . . . 1.74 106.564 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.6 ptt85 -155.92 121.36 4.87 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.45 -0.574 . . . . 4.3499999999999996 109.45 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.413 ' HA2' ' CD1' ' A' ' 174' ' ' PHE . . . 80.4 -52.42 4.34 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.587 -0.605 . . . . 2.6899999999999999 111.587 175.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -154.03 170.76 20.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.166 0.986 . . . . 2.6099999999999999 108.489 173.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.1 p80 . . . . . 0 CA--C 1.529 0.152 0 C-N-CA 123.84 0.856 . . . . 3.8199999999999998 110.123 166.557 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 114.519 1.303 . . . . 3.46 114.519 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.502 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -159.99 -175.77 5.29 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.637 2.375 . . . . 9.6099999999999994 105.364 -172.122 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.502 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 13.7 p30 177.2 43.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.863 1.265 . . . . 2.3700000000000001 111.296 169.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 53.16 -158.43 4.16 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.49 -0.644 . . . . 1.72 111.49 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -76.73 119.1 20.05 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.94 -0.63 . . . . 6.4199999999999999 109.78 -177.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.91 -160.86 13.71 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.118 -1.193 . . . . 1.8200000000000001 110.118 -168.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.08 -128.52 43.96 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.038 1.304 . . . . 1.6399999999999999 111.515 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -77.65 134.17 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 125.44 1.496 . . . . 3.7999999999999998 107.299 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.14 -55.67 3.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.681 1.992 . . . . 1.5600000000000001 109.14 173.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -163.78 162.44 23.83 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.495 -0.753 . . . . 0.75 111.617 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -154.14 105.01 2.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.356 1.462 . . . . 1.3200000000000001 112.295 -174.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -121.63 158.81 27.81 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.113 2.165 . . . . 1.1299999999999999 109.651 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -154.74 132.0 11.08 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 107.29 -1.374 . . . . 4.0 107.29 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.12 -89.23 0.51 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.286 0.946 . . . . 1.23 112.836 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.08 83.76 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.943 3.096 . . . . 1.8999999999999999 111.041 -169.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -160.05 165.31 34.7 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.532 -1.427 . . . . 1.5700000000000001 109.532 172.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.8 m -78.89 169.99 17.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.468 0.707 . . . . 2.6200000000000001 111.149 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 55.08 -108.06 0.89 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 123.827 0.727 . . . . 1.5800000000000001 111.588 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 8.9 tp -59.82 -40.07 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 118.547 -0.739 . . . . 1.8 109.671 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -42.12 143.23 1.17 Allowed Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.399 0.999 . . . . 1.29 113.111 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 94.26 -59.21 1.97 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.908 1.718 . . . . 1.04 109.213 -155.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.38 148.51 31.99 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.898 -0.778 . . . . 1.4399999999999999 108.898 -155.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -112.24 120.42 41.69 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 118.963 -0.542 . . . . 0.73999999999999999 110.272 -174.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.497 ' N ' ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -107.15 137.89 44.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.024 -1.473 . . . . 3.21 107.024 -175.74 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -127.69 144.29 51.09 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.172 -1.418 . . . . 3.8500000000000001 107.172 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -74.26 67.19 1.37 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.783 -1.191 . . . . 2.9399999999999999 107.783 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -54.5 -45.4 73.25 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.811 -1.181 . . . . 3.6899999999999999 107.811 -174.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -32.54 -44.25 0.1 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.937 1.695 . . . . 3.8399999999999999 112.044 -170.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -63.97 -178.44 0.33 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 129.412 3.085 . . . . 2.5499999999999998 109.399 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -129.06 90.2 2.99 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 120.095 -1.628 . . . . 4.1200000000000001 108.701 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -134.67 119.46 18.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.726 0.81 . . . . 4.6500000000000004 111.32 -173.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 14.9 p -153.62 158.62 41.42 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.822 1.249 . . . . 5.1600000000000001 111.014 -177.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.66 -47.13 63.9 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.255 1.022 . . . . 5.0899999999999999 109.874 172.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -67.78 -29.87 69.17 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 114.884 -1.053 . . . . 4.9699999999999998 110.887 -167.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.0 t -81.64 -44.82 16.65 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.707 -0.849 . . . . 9.2699999999999996 108.707 174.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.09 -35.56 4.32 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 124.579 1.085 . . . . 3.2799999999999998 110.649 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -27.17 -92.85 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 128.782 3.087 . . . . 1.6499999999999999 114.589 -173.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 88.5 m -118.66 123.04 43.97 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 104.525 -2.398 . . . . 1.72 104.525 160.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -69.96 120.19 15.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 118.491 -1.284 . . . . 1.3700000000000001 109.541 172.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 60.8 tp -50.41 -50.75 51.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.827 -0.606 . . . . 2.5699999999999998 111.693 177.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -52.24 -49.88 63.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.974 0.806 . . . . 2.27 110.767 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.5 tt -57.33 -60.92 2.91 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.994 0.917 . . . . 1.45 110.705 -174.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.351 25.4 m -60.71 -35.98 77.67 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.945 -0.391 . . . . 2.6600000000000001 109.945 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.59 -52.2 62.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 117.053 -1.451 . . . . 0.54000000000000004 110.712 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 35.1 t -44.93 -53.22 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 121.579 1.991 . . . . 1.9199999999999999 110.922 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.615 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 4.0 t60 -56.03 -54.05 49.59 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.854 0.862 . . . . 3.79 111.632 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -71.23 -44.68 64.87 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.797 -1.189 . . . . 4.0300000000000002 112.45 -173.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.427 HG13 ' CE1' ' A' ' 138' ' ' PHE . 1.7 mp -49.98 -44.79 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.604 1.562 . . . . 1.76 108.265 166.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -53.19 -51.14 48.68 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.546 -0.721 . . . . 0.56000000000000005 111.82 170.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.615 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 4.5 m-70 -52.03 -42.41 63.05 Favored 'General case' 0 C--N 1.34 0.173 0 O-C-N 121.429 -1.042 . . . . 2.1600000000000001 111.492 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.3 m -58.11 -26.61 62.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.797 0.665 . . . . 3.1899999999999999 112.797 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.4 mt -73.77 -51.96 14.74 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.068 -1.086 . . . . 2.7999999999999998 108.068 171.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 138.48 70.38 0.05 OUTLIER Glycine 0 C--N 1.34 0.755 0 C-N-CA 122.844 0.259 . . . . 1.25 112.548 170.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 15.6 mt -132.74 105.57 7.25 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.178 0.591 . . . . 4.29 109.771 -172.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -76.75 43.3 1.89 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.338 0.97 . . . . 3.0899999999999999 113.046 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 22.0 m80 73.88 155.51 0.16 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.356 1.862 . . . . 1.8600000000000001 111.605 -175.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 58.1 m -120.17 132.0 55.22 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 126.149 1.78 . . . . 1.8300000000000001 106.321 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' SER . . . . . 0.405 ' H ' ' HG ' ' A' ' 230' ' ' SER . 22.6 p -79.64 57.02 2.36 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.398 0.679 . . . . 3.8399999999999999 110.854 -175.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -156.18 137.8 9.73 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 118.006 -0.997 . . . . 2.2000000000000002 109.733 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.92 -20.89 7.26 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.76 2.306 . . . . 1.5600000000000001 114.606 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -27.42 48.91 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 119.258 0.935 . . . . 3.0 109.957 175.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.81 130.65 44.01 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.602 1.161 . . . . 1.0800000000000001 110.105 168.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 85.8 t -70.94 -25.84 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.899 0.856 . . . . 1.03 110.165 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -53.03 -18.12 1.87 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.95 1.3 . . . . 2.2200000000000002 114.278 170.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.401 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 10.3 t80 -56.32 137.89 74.92 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 119.738 1.154 . . . . 7.2000000000000002 110.492 -174.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.401 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 43.4 Cg_endo -63.84 -21.77 69.17 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.88 2.387 . . . . 1.4099999999999999 112.597 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.359 0.2 OUTLIER -92.05 130.74 37.72 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.279 -0.637 . . . . 2.5099999999999998 109.279 -179.558 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -76.71 141.67 40.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.638 -0.875 . . . . 3.2799999999999998 108.638 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.84 131.08 13.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.193 -1.78 . . . . 2.8300000000000001 106.193 170.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -54.73 115.01 1.93 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.066 0.946 . . . . 4.25 110.599 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.4 m -94.18 138.92 19.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 122.957 0.503 . . . . 1.8600000000000001 110.726 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.41 89.64 1.25 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.985 -0.746 . . . . 3.8999999999999999 108.985 173.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 47.1 mt -48.88 -31.25 3.83 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 123.848 0.859 . . . . 3.5600000000000001 110.335 174.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -39.33 -41.54 0.93 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.438 1.495 . . . . 3.9100000000000001 113.589 171.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 8.4 m -81.38 -41.58 21.75 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.796 0.838 . . . . 2.0099999999999998 110.57 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 78.9 t80 46.77 70.63 0.38 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.15 1.38 . . . . 5.71 111.511 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -156.55 167.17 31.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.57 -0.706 . . . . 4.6699999999999999 109.91 175.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -105.9 157.81 17.22 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.727 1.611 . . . . 1.0900000000000001 108.009 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 10.1 m -79.44 154.31 29.03 Favored 'General case' 0 C--O 1.221 -0.404 0 O-C-N 121.295 -0.878 . . . . 1.45 111.418 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.13 -48.63 75.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.975 0.893 . . . . 1.1899999999999999 109.862 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.61 -52.37 18.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.192 1.797 . . . . 4.6200000000000001 108.633 172.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.38 -46.02 88.41 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.978 -1.01 . . . . 2.2200000000000002 110.516 -176.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 45.3 mt -53.12 -42.23 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.725 2.01 . . . . 1.05 110.35 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -64.75 -48.82 73.16 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.007 -1.058 . . . . 6.6699999999999999 111.078 172.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -45.42 -55.5 6.8 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 111.764 -0.535 . . . . 0.83999999999999997 111.764 174.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 1.9 pp -65.81 -40.51 87.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 123.982 0.913 . . . . 3.1600000000000001 111.361 -176.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -62.18 -30.02 70.77 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.741 -1.224 . . . . 2.5600000000000001 110.849 174.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.8 -14.43 2.34 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.101 1.149 . . . . 2.52 114.101 169.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.3 mt . . . . . 0 CA--C 1.537 0.449 0 CA-C-N 121.02 1.736 . . . . 3.1400000000000001 112.716 164.926 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 44.4 mtt . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 106.98 -1.489 . . . . 18.16 106.98 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 146.65 65.63 0.01 OUTLIER Glycine 0 CA--C 1.532 1.139 0 O-C-N 124.094 0.871 . . . . 11.48 111.127 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -70.54 133.91 25.19 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.291 1.994 . . . . 13.289999999999999 109.703 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.6 p -158.06 150.95 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 108.685 -0.857 . . . . 8.4600000000000009 108.685 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -175.98 176.04 1.85 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.98 2.112 . . . . 14.23 106.116 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.27 73.86 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.619 1.967 . . . . 8.2899999999999991 106.081 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.503 ' HZ1' ' C ' ' A' ' 263' ' ' GLY . 0.1 OUTLIER 58.55 -79.05 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.641 1.176 . . . . 6.79 111.342 -164.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 41.6 m80 56.34 -72.33 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.059 1.743 . . . . 4.5199999999999996 110.956 -159.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -104.85 101.3 10.9 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.915 0.886 . . . . 4.6299999999999999 112.315 -169.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 25.8 mm -81.77 91.77 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 108.478 -0.934 . . . . 3.29 108.478 170.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.644 ' HG1' ' H ' ' A' ' 158' ' ' ASP . 25.1 p -79.93 125.21 29.45 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.137 -0.69 . . . . 1.6100000000000001 109.137 171.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -130.75 158.47 40.03 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.383 0.673 . . . . 5.1299999999999999 111.031 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -144.47 145.04 31.66 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.521 -0.918 . . . . 6.0300000000000002 108.521 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.99 147.24 5.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 108.143 -1.058 . . . . 1.46 108.143 174.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -84.71 -44.32 13.49 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.455 -0.572 . . . . 4.4299999999999997 109.455 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -153.25 171.58 18.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.912 -0.773 . . . . 2.25 108.912 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -128.13 129.95 47.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.876 1.27 . . . . 3.1299999999999999 108.15 -163.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.474 ' HG1' ' CG ' ' A' ' 124' ' ' ASP . 6.5 t -63.47 114.18 12.19 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 118.539 0.609 . . . . 2.6699999999999999 109.739 -175.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -68.41 -17.98 43.96 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.488 2.792 . . . . 1.9399999999999999 111.125 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.474 ' CG ' ' HG1' ' A' ' 122' ' ' THR . 0.1 OUTLIER -42.22 -34.25 0.74 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.632 2.773 . . . . 2.27 111.61 174.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.51 -179.64 5.57 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.056 1.342 . . . . 2.77 109.418 175.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -71.32 132.38 44.8 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 109.22 -0.659 . . . . 3.0899999999999999 109.22 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 53.5 ttt-85 -47.79 -40.41 20.82 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.507 0.558 . . . . 2.7999999999999998 112.507 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -50.38 -55.33 16.15 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.812 -0.81 . . . . 2.8399999999999999 108.812 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -55.11 -45.03 75.49 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.937 1.695 . . . . 2.2599999999999998 111.908 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.63 -57.83 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 O-C-N 121.418 -0.802 . . . . 1.8700000000000001 109.694 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.496 ' HB3' ' HZ2' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -68.03 -27.53 66.61 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 117.919 -1.513 . . . . 1.78 109.184 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -59.72 -47.91 83.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.206 0.912 . . . . 3.2000000000000002 110.383 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.82 -52.56 64.95 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.081 0.552 . . . . 0.48999999999999999 110.508 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.05 -37.6 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.289 -0.634 . . . . 2.46 109.289 -175.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -55.34 -60.83 2.85 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.502 1.121 . . . . 4.7400000000000002 108.021 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -58.0 -45.86 86.16 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.246 1.018 . . . . 2.3599999999999999 109.445 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.53 -52.66 36.66 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.968 0.907 . . . . 0.68999999999999995 111.429 175.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.461 ' HB3' ' CD2' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -53.67 -55.48 25.69 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 110.091 -0.337 . . . . 5.71 110.091 170.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.55 -44.61 46.71 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.314 1.046 . . . . 3.4900000000000002 110.497 -171.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.2 t -47.58 -54.06 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.109 0.964 . . . . 1.54 110.098 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.433 ' CZ3' HG23 ' A' ' 258' ' ' ILE . 83.8 m95 -72.08 -41.07 67.78 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.283 -0.636 . . . . 0.82999999999999996 109.283 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.02 -22.76 51.36 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.919 0.888 . . . . 2.0 111.271 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -75.37 -43.63 49.32 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.088 0.955 . . . . 2.0 110.942 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 65.8 t -84.87 -49.39 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.685 1.194 . . . . 3.02 110.825 -173.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 81.6 p -77.24 158.0 80.09 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 107.976 -1.12 . . . . 1.3600000000000001 107.976 174.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.08 -1.03 10.72 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.75 1.633 . . . . 0.83999999999999997 112.601 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.4 mt -62.24 139.76 58.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.021 0.828 . . . . 2.6800000000000002 110.263 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.38 97.13 6.14 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.049 -1.093 . . . . 8.5399999999999991 108.049 177.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.461 ' CD2' ' HB3' ' A' ' 138' ' ' PHE . 0.4 OUTLIER -64.56 153.82 38.03 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.373 0.508 . . . . 8.4499999999999993 112.373 175.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.57 113.77 3.42 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 123.948 0.899 . . . . 1.48 110.103 176.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.496 ' HZ2' ' HB3' ' A' ' 131' ' ' ASP . 0.2 OUTLIER -82.47 139.6 33.86 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.526 -0.916 . . . . 2.8100000000000001 108.526 173.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.1 pp -139.34 114.28 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.309 -0.997 . . . . 1.5800000000000001 108.309 172.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -80.15 -15.74 56.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.452 -0.34 . . . . 2.6600000000000001 110.753 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 72.2 p -124.37 89.2 3.03 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 124.585 1.154 . . . . 3.4500000000000002 110.798 -170.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 145.83 -143.38 11.61 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.41 -1.876 . . . . 2.0499999999999998 108.41 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 33.6 mtt -127.43 131.18 50.28 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.857 2.063 . . . . 5.5999999999999996 107.751 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -109.94 167.22 10.33 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.589 1.556 . . . . 0.88 109.274 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.644 ' H ' ' HG1' ' A' ' 115' ' ' THR . 26.2 t70 -79.94 -50.59 10.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.761 -0.829 . . . . 2.3399999999999999 108.761 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 12.3 pt -106.75 169.08 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.454 0.645 . . . . 1.1699999999999999 109.742 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.64 135.74 35.2 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.929 1.292 . . . . 2.8900000000000001 109.848 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.8 t -100.75 102.56 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.051 0.94 . . . . 1.1599999999999999 109.476 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.3 t -89.17 88.7 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 126.023 1.729 . . . . 2.1600000000000001 111.341 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -81.78 105.43 12.91 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 107.115 -1.439 . . . . 7.0599999999999996 107.115 170.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -123.95 151.76 43.24 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 118.415 0.552 . . . . 1.03 109.737 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.56 99.88 6.53 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.847 1.259 . . . . 4.8300000000000001 109.699 -167.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 54.13 43.29 73.66 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.426 1.012 . . . . 3.7000000000000002 111.439 172.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -157.27 176.39 12.76 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.467 0.707 . . . . 5.5800000000000001 109.895 -170.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 82.01 137.68 0.06 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.522 2.329 . . . . 4.75 110.439 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -72.51 117.74 6.33 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.769 -1.332 . . . . 3.6899999999999999 109.769 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -156.27 -177.14 6.37 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 105.936 -1.876 . . . . 3.04 105.936 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -65.67 0.88 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.276 -1.379 . . . . 5.5199999999999996 107.276 166.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -107.59 69.9 0.76 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.861 1.265 . . . . 6.5 108.043 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -56.59 -75.77 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 119.254 -0.403 . . . . 3.2799999999999998 110.838 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -160.52 166.69 28.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.13 1.772 . . . . 7.7999999999999998 106.34 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.8 p30 -153.76 168.91 24.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.295 -1.372 . . . . 3.6899999999999999 107.295 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -66.79 -148.18 0.09 OUTLIER Glycine 0 CA--C 1.533 1.162 0 CA-C-O 122.867 1.26 . . . . 1.8500000000000001 114.264 -170.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.13 78.78 0.51 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.488 1.515 . . . . 4.5999999999999996 110.065 -171.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 135.7 -159.23 24.12 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 108.711 -1.756 . . . . 2.3399999999999999 108.711 -174.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 64.57 -125.03 30.43 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.892 -1.283 . . . . 2.1499999999999999 109.892 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . 0.276 21.0 mm -77.21 132.32 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 108.67 -0.863 . . . . 2.46 108.67 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.459 HD22 ' H5 ' ' A' ' 269' ' ' NGH . 9.1 mp -85.27 -63.1 1.38 Allowed 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.373 2.269 . . . . 1.5 109.303 168.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.489 ' O ' ' N1 ' ' A' ' 269' ' ' NGH . . . -168.75 152.4 5.48 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 114.385 1.254 . . . . 0.67000000000000004 114.385 -175.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -151.2 138.82 19.65 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.157 0.983 . . . . 1.48 112.772 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . 0.26 . . -163.51 162.21 24.47 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.479 1.911 . . . . 0.81999999999999995 106.087 -157.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -149.28 140.74 23.32 Favored 'General case' 0 C--O 1.227 -0.089 0 N-CA-C 109.282 -0.636 . . . . 4.6500000000000004 109.282 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.94 -87.34 1.77 Allowed Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.189 -1.164 . . . . 0.62 110.189 173.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -69.92 89.38 0.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.72 2.947 . . . . 1.5700000000000001 110.855 -173.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -165.37 172.12 40.85 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 108.047 -2.021 . . . . 1.3899999999999999 108.047 171.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.2 p -84.06 172.81 11.65 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.147 0.979 . . . . 2.8100000000000001 109.782 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.93 -103.54 0.14 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.033 0.825 . . . . 1.52 112.409 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.425 HD13 ' HE2' ' A' ' 196' ' ' HIS . 4.9 tp -59.43 -40.2 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-O 118.371 -0.823 . . . . 1.6499999999999999 109.282 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -36.1 132.13 0.79 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.632 1.11 . . . . 1.3100000000000001 113.0 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.82 -43.28 1.77 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.944 1.735 . . . . 0.89000000000000001 110.915 -164.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.62 159.97 15.62 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.635 0.774 . . . . 1.46 109.482 -162.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -138.75 125.24 20.57 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 117.96 -1.019 . . . . 0.98999999999999999 113.392 -168.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.425 ' HE2' HD13 ' A' ' 191' ' ' ILE . 1.9 m170 -111.83 139.58 47.19 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 119.423 1.01 . . . . 2.98 109.234 -168.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -135.99 148.41 48.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.177 0.899 . . . . 4.1299999999999999 110.741 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -73.33 82.2 1.39 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.411 -1.268 . . . . 2.3799999999999999 110.462 -176.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -61.05 -27.1 68.1 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 121.205 -0.934 . . . . 3.7400000000000002 110.833 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.76 -43.4 12.99 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.263 1.425 . . . . 2.6600000000000001 109.793 172.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -70.89 157.11 38.72 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 123.827 1.775 . . . . 2.0299999999999998 112.581 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -102.4 87.71 3.09 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 112.727 -2.033 . . . . 7.4299999999999997 106.698 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -75.06 154.34 37.97 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 113.762 -1.563 . . . . 1.52 107.595 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.3 p -136.3 137.64 40.89 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.387 0.613 . . . . 2.3199999999999998 109.5 -171.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.9 -47.04 88.24 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.333 -1.479 . . . . 2.29 110.33 173.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -65.61 151.63 46.03 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.588 -0.733 . . . . 2.3700000000000001 110.37 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.7 m -60.27 -38.33 83.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.75 1.22 . . . . 4.79 110.555 -171.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -55.62 120.82 20.43 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-O 118.829 -0.984 . . . . 3.1099999999999999 111.98 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 109.17 -125.71 7.81 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.94 -1.664 . . . . 2.3900000000000001 108.94 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 m -117.07 117.15 28.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.372 -1.714 . . . . 1.1499999999999999 106.372 164.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -77.24 122.11 24.61 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.523 -0.871 . . . . 1.3200000000000001 110.742 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 20.3 tp -56.31 -53.65 54.81 Favored 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 109.6 -0.518 . . . . 2.8500000000000001 109.6 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -48.54 -46.05 38.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.055 0.455 . . . . 2.48 110.135 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.8 tt -57.37 -65.26 0.66 Allowed 'General case' 0 C--O 1.23 0.07 0 C-N-CA 123.85 0.86 . . . . 1.53 110.223 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.29 0.8 OUTLIER -56.49 -40.09 74.34 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.445 0.641 . . . . 2.0 110.214 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.62 -46.75 77.35 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 117.358 -1.306 . . . . 0.51000000000000001 110.36 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 66.4 t -48.79 -45.65 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 120.422 1.464 . . . . 1.26 110.803 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.532 ' CE1' ' O ' ' A' ' 236' ' ' MET . 60.1 t60 -64.15 -50.33 68.61 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.933 0.893 . . . . 3.5699999999999998 112.447 176.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -64.85 -42.92 94.51 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.695 -1.253 . . . . 3.0699999999999998 112.494 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.1 mp -55.51 -43.12 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 107.795 -1.187 . . . . 1.4299999999999999 107.795 172.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.99 -52.0 27.85 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 112.246 -0.341 . . . . 0.77000000000000002 112.246 169.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -49.48 -52.34 29.94 Favored 'General case' 0 C--N 1.341 0.197 0 O-C-N 122.06 -0.67 . . . . 2.52 110.658 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 89.2 p -62.84 -45.85 90.68 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.518 0.562 . . . . 2.46 112.518 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 91.0 mt -56.8 -41.62 78.06 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.647 -0.501 . . . . 3.0 109.647 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 118.43 29.11 1.99 Allowed Glycine 0 C--N 1.337 0.626 0 C-N-CA 124.978 1.275 . . . . 1.2 111.491 171.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.0 143.57 43.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.935 -1.506 . . . . 5.1100000000000003 106.935 -173.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -72.9 143.8 34.06 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.072 -1.211 . . . . 3.1800000000000002 110.072 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -50.92 118.24 3.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.723 0.762 . . . . 1.6799999999999999 110.088 172.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 64.9 m -78.72 173.15 12.76 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.615 -0.513 . . . . 1.3300000000000001 109.615 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.11 30.23 2.47 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.68 0.792 . . . . 3.0 110.742 -170.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -132.06 133.18 23.63 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 106.898 -1.519 . . . . 1.8799999999999999 106.898 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.94 -14.4 44.95 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.449 2.099 . . . . 1.1200000000000001 114.162 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -81.13 -27.79 35.37 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.121 0.968 . . . . 1.6899999999999999 111.279 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.22 152.64 45.17 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.849 -0.797 . . . . 0.68999999999999995 108.849 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 66.8 t -99.11 -25.88 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.296 -0.865 . . . . 0.64000000000000001 109.536 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.532 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 10.8 tpt -65.59 -18.73 65.54 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.157 -0.964 . . . . 3.5499999999999998 113.073 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.471 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.1 157.34 0.66 Allowed Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.719 1.608 . . . . 4.2400000000000002 113.457 -175.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.553 ' O ' ' H1 ' ' A' ' 269' ' ' NGH . 69.2 Cg_endo -74.93 -20.63 16.86 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.712 1.608 . . . . 1.22 111.453 174.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.371 0.2 OUTLIER -77.38 178.03 7.49 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.512 1.125 . . . . 2.0899999999999999 109.1 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -126.66 147.64 49.91 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.418 -1.327 . . . . 3.79 107.418 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -150.54 146.47 26.6 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.047 -1.464 . . . . 3.98 107.047 170.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -72.47 83.41 1.1 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.24 1.016 . . . . 5.25 108.61 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.7 m -76.71 136.75 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 109.413 -0.588 . . . . 1.8300000000000001 109.413 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -87.09 117.97 26.18 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.1 -0.5 . . . . 3.0899999999999999 110.063 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 20.9 mt -60.49 -20.44 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 119.223 -0.417 . . . . 3.3799999999999999 110.222 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -52.35 -36.02 52.57 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.333 0.969 . . . . 3.5099999999999998 111.83 171.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.0 m -81.54 -47.69 12.77 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 122.756 0.423 . . . . 2.5299999999999998 110.31 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 62.1 t80 45.61 73.33 0.17 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.315 1.446 . . . . 5.4500000000000002 111.868 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.89 168.77 23.98 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 121.278 -0.889 . . . . 6.2300000000000004 110.222 177.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.4 ' HG ' ' CZ3' ' A' ' 141' ' ' TRP . 1.3 mm? -108.86 149.03 29.71 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.762 1.625 . . . . 0.83999999999999997 108.066 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.9 m -77.44 158.38 30.04 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 121.17 -0.212 . . . . 1.3799999999999999 111.415 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -58.28 -47.87 82.26 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.728 0.411 . . . . 0.87 110.549 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -55.46 -40.21 71.34 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.039 0.935 . . . . 3.6400000000000001 110.035 176.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.42 -52.1 59.79 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.789 0.835 . . . . 2.0099999999999998 109.815 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.9 mt -56.11 -42.86 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 127.063 2.145 . . . . 0.85999999999999999 112.271 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -61.71 -42.45 98.96 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.177 -1.577 . . . . 9.2599999999999998 110.383 172.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -54.34 -53.14 39.83 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.285 -1.126 . . . . 0.92000000000000004 110.285 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.433 HG23 ' CZ3' ' A' ' 141' ' ' TRP . 1.8 pp -63.96 -43.04 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 O-C-N 122.104 -0.645 . . . . 3.1200000000000001 110.724 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -65.81 -20.14 66.14 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.843 0.747 . . . . 2.77 112.368 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 t -52.11 -33.39 39.55 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.633 0.651 . . . . 2.8700000000000001 110.789 168.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 14.8 mt -71.48 84.52 0.83 Allowed 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 121.594 -0.691 . . . . 3.54 110.196 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -47.12 -33.78 5.41 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.5 1.12 . . . . 7.9500000000000002 111.469 168.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.503 ' C ' ' HZ1' ' A' ' 111' ' ' LYS . . . . . . . . 0 C--O 1.246 0.902 0 N-CA-C 107.411 -2.276 . . . . 9.5 107.411 165.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' NGH . . . . . 0.553 ' H1 ' ' O ' ' A' ' 238' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 116.923 -1.513 . . . . 13.550000000000001 107.358 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -116.69 79.31 0.29 Allowed Glycine 0 CA--C 1.532 1.129 0 CA-C-N 119.901 1.228 . . . . 8.1300000000000008 112.469 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -74.0 165.29 32.41 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.725 2.284 . . . . 10.5 110.176 173.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.4 p -159.86 157.06 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.224 -1.399 . . . . 5.6299999999999999 107.224 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 8.9 m0 -78.78 147.05 33.47 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 112.58 0.585 . . . . 12.109999999999999 112.58 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.7 tpt85 -52.58 -37.86 58.87 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.552 1.141 . . . . 8.8599999999999994 113.574 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.29 -57.59 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.592 0.757 . . . . 6.1100000000000003 110.056 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 2.1 m170 63.16 -63.17 0.12 Allowed 'General case' 0 C--N 1.342 0.244 0 C-N-CA 126.462 1.905 . . . . 4.8600000000000003 113.197 -172.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -79.04 104.11 9.45 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.321 -0.992 . . . . 3.8100000000000001 108.321 -176.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 9.2 mm -113.36 142.57 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.09 -1.448 . . . . 2.4500000000000002 107.09 173.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.51 ' HG1' ' H ' ' A' ' 158' ' ' ASP . 10.6 p -135.61 140.67 44.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.66 -0.867 . . . . 1.5600000000000001 108.66 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -126.73 160.48 30.7 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.645 0.778 . . . . 5.0899999999999999 111.453 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.52 145.8 31.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.252 1.021 . . . . 5.21 108.994 174.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -94.47 159.82 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.105 -1.443 . . . . 1.0900000000000001 107.105 173.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.465 ' ND2' ' H ' ' A' ' 163' ' ' PHE . 1.3 p30 -101.84 -38.95 7.61 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.815 0.846 . . . . 3.6899999999999999 110.385 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -150.78 173.56 14.07 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.077 1.351 . . . . 2.3999999999999999 107.868 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.442 ' HH ' ' ND2' ' A' ' 153' ' ' ASN . 73.7 m-85 -113.5 129.54 56.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.058 0.943 . . . . 3.0800000000000001 109.641 -175.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -41.08 135.48 1.71 Allowed Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.536 1.534 . . . . 3.75 109.64 165.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -84.97 -23.15 2.59 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.44 2.76 . . . . 2.7400000000000002 110.323 167.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.26 -43.95 33.05 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.74 1.616 . . . . 3.1699999999999999 111.085 -174.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 7.8 mtm -127.18 173.38 9.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.431 1.492 . . . . 2.8599999999999999 109.435 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -71.64 152.76 42.59 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.292 0.637 . . . . 3.2999999999999998 110.498 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -44.97 -52.58 8.64 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.915 0.886 . . . . 3.4100000000000001 112.067 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -64.67 -5.28 5.37 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.492 -0.766 . . . . 2.8599999999999999 113.061 -177.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -103.63 -41.74 5.86 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.551 1.54 . . . . 2.4199999999999999 110.56 168.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.5 m -57.62 -52.69 54.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 O-C-N 121.123 -0.986 . . . . 4.1900000000000004 110.021 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.36 -24.74 64.83 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 118.41 -1.316 . . . . 1.6799999999999999 108.449 178.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -63.38 -49.94 71.86 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 120.298 1.408 . . . . 3.3399999999999999 110.402 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.28 -55.12 27.11 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 123.421 0.688 . . . . 0.42999999999999999 109.828 175.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.88 -41.75 92.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 120.495 -0.482 . . . . 3.6000000000000001 110.09 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.6 ttt-85 -57.51 -54.16 49.97 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.906 1.282 . . . . 5.3899999999999997 108.146 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.9 mmmp? -60.27 -46.62 89.17 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.886 0.875 . . . . 2.75 109.291 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.72 -53.43 31.47 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.421 0.689 . . . . 0.46999999999999997 111.238 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -53.84 -50.8 65.4 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.197 0.599 . . . . 5.71 109.969 171.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.57 -38.25 74.52 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 119.166 -0.445 . . . . 2.3599999999999999 111.313 -173.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 98.4 t -51.04 -58.8 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.332 1.053 . . . . 1.6200000000000001 109.127 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.415 ' CZ3' ' HG ' ' A' ' 250' ' ' LEU . 45.7 m95 -72.8 -34.68 67.05 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.299 -0.63 . . . . 1.1499999999999999 109.299 -174.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 t -64.2 -27.24 68.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.129 0.572 . . . . 1.95 111.652 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -70.31 -46.36 64.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 121.573 -0.705 . . . . 1.3 109.56 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.9 t -77.39 -56.46 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.217 0.607 . . . . 3.1499999999999999 110.792 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 72.3 p -80.27 157.07 73.52 Favored Pre-proline 0 CA--C 1.53 0.193 0 N-CA-C 108.564 -0.902 . . . . 1.21 108.564 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.07 3.01 7.01 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.844 1.696 . . . . 1.1000000000000001 112.869 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.8 mt -73.71 100.55 3.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.101 0.864 . . . . 2.6600000000000001 109.928 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -84.61 96.67 9.26 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.096 0.959 . . . . 4.4100000000000001 109.132 -169.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -79.25 154.79 28.92 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.313 1.045 . . . . 6.8300000000000001 112.831 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -155.42 138.98 15.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.681 1.192 . . . . 1.6599999999999999 108.505 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.38 142.1 28.0 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 108.476 -0.935 . . . . 2.8599999999999999 108.476 173.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.2 pt -130.52 115.87 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.397 -1.334 . . . . 1.7 107.397 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.442 ' ND2' ' HH ' ' A' ' 121' ' ' TYR . 6.1 m120 -80.73 -0.31 37.88 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.421 -0.585 . . . . 2.8199999999999998 109.421 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 39.3 m -153.18 113.72 4.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.599 1.16 . . . . 2.79 108.433 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 138.81 -152.42 22.15 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 107.969 -2.053 . . . . 1.8600000000000001 107.969 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -127.89 125.13 39.07 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.453 1.901 . . . . 5.96 107.04 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.69 166.02 11.11 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.429 1.091 . . . . 0.81999999999999995 109.557 -173.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.51 ' H ' ' HG1' ' A' ' 115' ' ' THR . 23.1 t0 -77.97 -41.83 34.85 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.377 -0.971 . . . . 1.8799999999999999 108.377 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.523 ' CD1' ' HG ' ' A' ' 223' ' ' SER . 33.1 pt -124.48 159.93 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.924 0.89 . . . . 1.3300000000000001 111.262 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.6 tt -126.97 128.29 46.16 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.321 1.449 . . . . 2.3700000000000001 109.947 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.8 t -92.93 98.05 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 125.769 1.627 . . . . 0.95999999999999996 108.097 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.9 t -80.14 136.02 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.719 -1.215 . . . . 1.95 107.719 170.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.465 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 7.3 m-85 -122.63 112.99 18.64 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 103.577 -2.749 . . . . 6.9100000000000001 103.577 166.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -147.65 159.76 43.42 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.4 -0.963 . . . . 1.3700000000000001 108.4 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.79 131.39 47.79 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.027 -1.101 . . . . 5.3300000000000001 108.027 -172.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 73.77 -113.18 4.1 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 111.062 -0.815 . . . . 1.71 111.062 -176.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -129.32 83.67 2.16 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.251 1.025 . . . . 2.29 110.527 -168.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -72.9 -40.62 65.39 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.877 0.37 . . . . 3.8399999999999999 111.97 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 175.56 61.64 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 107.695 -2.162 . . . . 2.8700000000000001 107.695 -172.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -155.32 -179.04 7.71 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 104.736 -2.32 . . . . 2.6400000000000001 104.736 175.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.28 -64.99 1.04 Allowed 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 107.951 -1.129 . . . . 4.9199999999999999 107.951 173.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -109.46 -72.41 0.72 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.136 -0.938 . . . . 7.5700000000000003 109.964 -177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 63.44 -68.23 0.09 Allowed 'General case' 0 C--N 1.339 0.11 0 C-N-CA 126.004 1.721 . . . . 2.9900000000000002 114.703 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -123.72 164.93 18.15 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.103 0.961 . . . . 7.3399999999999999 109.683 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -168.98 25.36 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.664 -0.698 . . . . 2.3599999999999999 111.101 -158.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.17 -159.01 41.2 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.25 -1.14 . . . . 1.79 110.25 -171.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.56 104.67 1.32 Allowed 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 122.217 -0.578 . . . . 6.4199999999999999 110.304 175.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 156.44 -179.01 32.63 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 108.678 -1.769 . . . . 2.3399999999999999 108.678 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 45.28 -117.94 2.61 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 126.312 1.911 . . . . 1.9399999999999999 111.123 171.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.3 mm -87.24 132.38 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 108.501 -0.926 . . . . 2.5099999999999998 108.501 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.584 ' HB2' ' H5 ' ' A' ' 269' ' ' NGH . 6.6 mp -82.43 -42.77 18.13 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.708 1.603 . . . . 1.6599999999999999 109.537 170.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.531 ' O ' ' N1 ' ' A' ' 269' ' ' NGH . . . -162.77 158.62 23.08 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.495 -0.753 . . . . 0.82999999999999996 110.423 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -138.44 114.63 10.22 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.647 1.179 . . . . 1.5 113.572 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.21 163.76 27.86 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.919 2.088 . . . . 0.67000000000000004 108.657 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -142.24 153.4 43.93 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.878 -1.527 . . . . 4.29 106.878 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -103.09 -90.35 2.15 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.296 -1.122 . . . . 0.68999999999999995 110.296 172.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.04 82.74 0.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.93 3.086 . . . . 1.5800000000000001 110.965 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -157.96 159.81 30.26 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 108.933 -1.667 . . . . 1.29 108.933 170.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.465 ' H ' ' HG ' ' A' ' 189' ' ' SER . 2.8 p -78.85 171.34 15.32 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.862 0.865 . . . . 2.6899999999999999 110.101 177.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 54.28 -106.53 0.5 Allowed Glycine 0 C--O 1.244 0.721 0 C-N-CA 123.635 0.636 . . . . 1.6100000000000001 111.626 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.4 tp -59.02 -43.22 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 118.501 -0.761 . . . . 1.75 109.14 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -43.3 135.05 4.96 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.492 1.044 . . . . 1.22 112.74 -177.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 107.0 -43.08 1.76 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.485 1.993 . . . . 0.75 110.751 -165.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.87 171.73 10.61 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.502 1.121 . . . . 1.51 110.957 -165.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.31 121.03 8.07 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.66 0.985 . . . . 0.81000000000000005 113.66 -168.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -114.92 113.8 24.63 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 118.923 -0.56 . . . . 3.3900000000000001 112.073 -172.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -100.34 145.67 27.88 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.203 0.91 . . . . 4.1900000000000004 112.412 -177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -73.21 82.66 1.34 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.851 0.834 . . . . 2.79 110.018 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -54.45 -28.96 47.87 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.293 -0.88 . . . . 3.4500000000000002 111.352 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.82 -36.73 65.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.79 -0.448 . . . . 3.1299999999999999 109.79 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.79 146.01 50.02 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 122.374 1.083 . . . . 2.4900000000000002 109.154 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -92.15 92.25 8.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.357 -1.349 . . . . 3.6899999999999999 107.357 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -78.01 131.46 37.38 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.443 -1.317 . . . . 1.51 107.443 -178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 41.0 p -116.87 136.09 53.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.428 0.691 . . . . 1.8799999999999999 109.605 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.1 t -51.13 -49.39 60.89 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.622 1.169 . . . . 2.27 109.717 169.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.39 -179.36 5.69 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.149 0.98 . . . . 2.4199999999999999 111.541 173.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.2 m -56.75 -56.56 19.89 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.791 1.236 . . . . 4.2300000000000004 111.461 -173.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 42.97 -105.9 0.07 OUTLIER Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.017 1.294 . . . . 2.71 114.774 169.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -117.93 -63.3 0.31 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.252 0.93 . . . . 1.8700000000000001 111.348 -172.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.37 164.55 27.18 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.193 -2.151 . . . . 1.6899999999999999 105.193 165.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -116.9 133.24 56.26 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 119.248 0.931 . . . . 1.48 110.967 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 31.4 tp -62.78 -53.58 52.21 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.127 -0.488 . . . . 3.0 109.985 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -50.87 -42.68 59.14 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.205 0.526 . . . . 2.23 109.852 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.02 -63.61 1.24 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.319 0.648 . . . . 1.6200000000000001 109.656 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.315 2.0 m -57.14 -38.43 73.49 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.035 0.445 . . . . 1.9299999999999999 110.651 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.76 -56.65 14.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 118.106 -0.95 . . . . 0.41999999999999998 111.142 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 90.1 t -51.27 -39.42 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 120.538 1.517 . . . . 1.1899999999999999 111.291 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.658 ' CE1' ' CE1' ' A' ' 222' ' ' HIS . 0.5 OUTLIER -64.63 -51.4 62.82 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.128 0.971 . . . . 3.9100000000000001 112.195 174.038 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.46 -45.74 71.64 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.069 -1.019 . . . . 2.6899999999999999 111.965 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.5 mp -54.45 -43.99 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 106.616 -1.624 . . . . 1.46 106.616 170.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.2 -53.38 23.73 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 123.695 0.664 . . . . 0.56999999999999995 113.105 170.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.689 ' CE1' HD23 ' A' ' 226' ' ' LEU . 0.9 OUTLIER -51.25 -42.12 60.82 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 121.848 -0.795 . . . . 2.7599999999999998 110.999 174.163 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.523 ' HG ' ' CD1' ' A' ' 159' ' ' ILE . 8.4 t -51.24 -43.45 61.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 123.602 0.564 . . . . 2.5499999999999998 112.07 -178.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 -60.09 3.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.648 -0.821 . . . . 3.8700000000000001 109.9 174.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 135.98 92.26 0.35 Allowed Glycine 0 C--N 1.338 0.676 0 N-CA-C 111.805 -0.518 . . . . 1.46 111.805 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.689 HD23 ' CE1' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -99.39 177.61 5.13 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.584 0.587 . . . . 7.2000000000000002 112.584 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -120.73 20.7 8.67 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.724 1.154 . . . . 3.0800000000000001 112.74 172.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 30.8 m80 56.14 95.69 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.14 1.776 . . . . 2.2200000000000002 113.08 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.1 m -73.96 171.59 13.17 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.873 0.469 . . . . 1.6000000000000001 110.592 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.7 t -137.25 47.06 2.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.186 0.994 . . . . 3.75 109.101 -169.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -148.9 123.62 4.86 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 107.18 -1.415 . . . . 2.1400000000000001 107.18 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.19 -3.47 13.86 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.191 1.927 . . . . 1.8 114.011 -170.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -82.31 -24.36 34.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.493 1.042 . . . . 1.98 109.943 169.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -82.07 152.6 26.52 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.458 0.703 . . . . 0.81000000000000005 109.632 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 24.0 t -104.52 -21.24 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.246 1.018 . . . . 0.71999999999999997 111.334 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.44 -18.39 17.92 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.479 -0.763 . . . . 3.6899999999999999 112.99 168.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.75 157.31 7.91 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 120.915 -1.116 . . . . 4.4400000000000004 113.353 -176.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.513 ' O ' ' H1 ' ' A' ' 269' ' ' NGH . 72.9 Cg_endo -79.53 -16.98 11.58 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.371 2.047 . . . . 0.98999999999999999 111.791 173.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.355 0.2 OUTLIER -78.49 172.9 12.98 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.963 1.305 . . . . 1.8899999999999999 109.697 -178.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -119.68 142.6 48.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.286 1.435 . . . . 3.4900000000000002 107.265 173.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -156.08 125.73 6.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.422 -1.325 . . . . 4.6500000000000004 107.422 170.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -45.52 142.13 2.42 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.063 1.345 . . . . 3.6099999999999999 112.087 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.0 139.38 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.115 0.966 . . . . 2.5 109.363 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -41.11 96.8 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.111 0.964 . . . . 3.9100000000000001 111.431 171.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 6.1 mt 66.29 18.78 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.623 1.569 . . . . 3.4900000000000002 110.142 -160.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -71.05 -64.09 0.97 Allowed 'General case' 0 C--N 1.343 0.304 0 O-C-N 120.937 -1.102 . . . . 3.6200000000000001 109.865 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 7.4 m -71.94 -39.73 69.22 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.496 -0.775 . . . . 2.0800000000000001 109.558 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 53.05 71.91 0.46 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.336 1.065 . . . . 5.8600000000000003 109.411 176.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -151.36 165.0 35.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.433 -0.951 . . . . 4.25 108.433 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.415 ' HG ' ' CZ3' ' A' ' 141' ' ' TRP . 1.9 mm? -95.42 174.19 7.14 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.419 1.488 . . . . 0.89000000000000001 108.591 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.5 m -91.15 150.73 21.26 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 120.95 -1.094 . . . . 1.5800000000000001 112.217 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.78 -43.37 65.8 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.51 -0.552 . . . . 0.82999999999999996 109.51 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.59 -51.6 68.83 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.954 0.883 . . . . 2.2799999999999998 110.383 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -57.6 -47.28 82.6 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.572 -1.194 . . . . 2.0699999999999998 110.188 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 52.6 mt -52.03 -36.79 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.371 1.868 . . . . 0.81999999999999995 111.329 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 36.7 mtt85 -70.43 -49.06 52.7 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 120.945 -1.097 . . . . 5.9100000000000001 110.177 172.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -45.09 -56.86 5.8 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.708 0.67 . . . . 1.04 111.649 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.87 -46.95 92.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.134 0.974 . . . . 2.9700000000000002 110.434 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -59.69 -26.6 65.72 Favored 'General case' 0 C--N 1.343 0.303 0 O-C-N 120.641 -1.287 . . . . 2.7999999999999998 111.647 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.0 t -49.33 -26.46 3.13 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.652 0.612 . . . . 2.6099999999999999 112.652 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 16.5 mt -65.06 -38.42 90.76 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.441 0.697 . . . . 3.4500000000000002 111.867 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 3.3 t80 59.11 -166.59 0.17 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.222 1.409 . . . . 9.5099999999999998 112.469 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.206 0 CA-C-O 115.82 -2.655 . . . . 9.7300000000000004 111.294 -175.302 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' NGH . . . . . 0.653 ' N1 ' ' CE1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 20.9 ptt? . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 118.927 -0.559 . . . . 14.17 110.897 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.58 72.36 0.46 Allowed Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.206 -1.158 . . . . 11.77 110.206 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.41 148.52 23.69 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.713 2.276 . . . . 11.09 110.065 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.9 p -76.29 -54.48 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 123.375 0.67 . . . . 10.06 110.99 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -169.47 -176.47 2.48 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.06 0.944 . . . . 15.24 109.711 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.4 tpt85 -69.56 70.62 0.3 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.301 1.84 . . . . 15.35 110.322 -176.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.24 -179.88 0.19 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.16 0.984 . . . . 13.02 110.251 -167.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -104.14 19.64 19.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.369 1.468 . . . . 5.8499999999999996 111.084 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -85.45 78.47 9.7 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 109.371 -0.603 . . . . 4.2699999999999996 109.371 -172.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.3 mm -88.03 82.16 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 122.728 1.252 . . . . 2.4399999999999999 108.327 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 p -77.77 126.68 31.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.91 -1.515 . . . . 1.6699999999999999 106.91 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.42 ' CE1' ' CD2' ' A' ' 138' ' ' PHE . 41.7 p90 -128.19 167.14 17.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.855 0.862 . . . . 4.4000000000000004 110.67 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -156.24 177.2 11.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.09 0.471 . . . . 5.4000000000000004 111.076 168.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.29 168.36 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.953 1.301 . . . . 1.4199999999999999 108.199 174.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -95.14 -51.89 4.44 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.736 0.814 . . . . 4.2400000000000002 109.587 169.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.83 153.8 30.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.912 0.485 . . . . 3.9900000000000002 111.638 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -78.31 108.0 11.33 Favored 'General case' 0 CA--C 1.53 0.212 0 N-CA-C 108.369 -0.975 . . . . 3.7599999999999998 108.369 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.9 t -60.17 146.82 82.46 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 118.655 0.662 . . . . 2.7799999999999998 110.575 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.39 -15.97 24.79 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.444 2.763 . . . . 1.9299999999999999 111.356 170.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -47.29 -42.62 21.33 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.829 0.852 . . . . 2.5 111.452 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 5.3 mtm -130.3 175.58 8.82 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.635 1.174 . . . . 2.3700000000000001 108.206 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -75.97 144.8 40.77 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.751 -0.463 . . . . 2.98 109.751 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -45.76 -53.87 8.83 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.486 0.715 . . . . 3.1400000000000001 112.451 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -48.54 -38.94 21.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.402 0.681 . . . . 4.1200000000000001 109.272 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -82.4 -43.09 17.78 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.328 1.851 . . . . 2.04 113.183 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.3 t -50.15 -55.05 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 O-C-N 120.789 -1.194 . . . . 1.8 109.051 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.412 ' OD2' ' NZ ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -71.98 -19.73 61.83 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 119.161 -1.016 . . . . 1.79 109.991 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.426 ' HH ' ' HZ1' ' A' ' 136' ' ' LYS . 27.0 t80 -64.34 -52.62 57.46 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 119.734 1.152 . . . . 3.2400000000000002 109.133 176.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.9 -53.1 44.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 122.998 0.519 . . . . 0.41999999999999998 110.33 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.2 -46.73 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 109.769 -0.456 . . . . 3.5899999999999999 109.769 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -50.77 -55.37 17.05 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 124.365 1.066 . . . . 4.9199999999999999 108.428 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.426 ' HZ1' ' HH ' ' A' ' 132' ' ' TYR . 4.0 mmmt -63.03 -48.89 76.82 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.624 1.169 . . . . 2.5099999999999998 109.292 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -45.89 -55.74 6.32 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.145 0.578 . . . . 0.60999999999999999 111.681 175.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.42 ' CD2' ' CE1' ' A' ' 116' ' ' TYR . 52.8 m-85 -57.54 -48.99 77.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.256 -0.429 . . . . 5.7699999999999996 110.657 173.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.7 -32.87 65.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 113.069 0.766 . . . . 2.75 113.069 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.4 t -63.58 -57.04 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 119.425 1.011 . . . . 1.04 108.518 176.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.546 ' CZ3' HG23 ' A' ' 258' ' ' ILE . 16.9 m95 -68.46 -36.72 79.38 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.039 -0.726 . . . . 1.01 109.039 -172.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.6 t -67.6 -13.09 61.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 118.882 -0.58 . . . . 1.97 112.291 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.17 -54.94 4.47 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 107.946 -1.131 . . . . 1.23 107.946 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.6 m -74.1 -40.88 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 116.105 -0.498 . . . . 2.4100000000000001 111.785 -176.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.1 p -87.06 142.68 34.02 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 107.671 -1.233 . . . . 1.3 107.671 176.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.53 4.95 3.09 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.835 2.356 . . . . 0.75 113.546 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.4 130.43 42.86 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.84 1.256 . . . . 3.5299999999999998 107.818 175.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -97.25 108.34 21.04 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.335 -0.987 . . . . 5.3300000000000001 108.335 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -87.11 142.1 28.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.039 -0.528 . . . . 7.0199999999999996 111.073 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -142.91 117.79 9.95 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.698 0.799 . . . . 1.5900000000000001 110.136 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.412 ' NZ ' ' OD2' ' A' ' 131' ' ' ASP . 20.6 ttpt -78.5 142.75 37.2 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.089 -1.078 . . . . 3.3700000000000001 108.089 172.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.9 pt -134.56 144.04 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 105.519 -2.03 . . . . 1.6200000000000001 105.519 166.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.07 -61.83 1.64 Allowed 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 107.029 -1.471 . . . . 3.4399999999999999 107.029 168.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.4 m -86.67 101.09 12.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.493 0.717 . . . . 2.8900000000000001 110.129 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 153.88 153.4 6.4 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 107.323 -2.311 . . . . 2.3500000000000001 107.323 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.5 ttt -79.37 143.28 35.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.302 -1.37 . . . . 8.2400000000000002 107.302 168.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -127.65 165.44 19.98 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.682 1.193 . . . . 1.45 108.404 -173.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -69.21 -58.21 4.35 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.863 0.839 . . . . 1.9399999999999999 109.359 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.2 pt -105.75 134.49 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.14 -1.059 . . . . 2.1499999999999999 108.14 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . 0.358 0.0 OUTLIER -128.76 132.44 47.91 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.411 -0.806 . . . . 3.6099999999999999 109.424 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.9 t -82.67 106.1 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.677 -0.86 . . . . 1.1000000000000001 108.677 -175.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . 0.417 7.8 t -95.22 94.87 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.411 1.084 . . . . 2.1800000000000002 112.831 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -79.51 115.47 19.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.555 -2.017 . . . . 6.5899999999999999 105.555 167.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -139.57 164.73 29.13 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.294 -1.743 . . . . 1.3100000000000001 106.294 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -132.02 142.6 49.62 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.865 -0.791 . . . . 6.1799999999999997 108.865 -170.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 73.47 -86.1 0.62 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.415 1.007 . . . . 1.97 111.243 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -150.34 145.15 25.95 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 121.581 -0.952 . . . . 2.5 108.661 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -155.32 54.59 0.63 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.648 0.737 . . . . 3.5800000000000001 111.05 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 107.95 -42.73 1.86 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.94 -0.864 . . . . 2.79 110.94 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.41 159.22 31.64 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.685 -1.228 . . . . 2.3399999999999999 107.685 174.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -80.26 -66.75 0.84 Allowed 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.632 -0.877 . . . . 5.0899999999999999 108.632 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -111.5 71.94 0.76 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.25 1.02 . . . . 5.1299999999999999 110.08 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -88.8 -72.53 0.54 Allowed 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 123.596 0.758 . . . . 2.96 111.772 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -118.25 172.35 7.5 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 107.82 -1.178 . . . . 7.3499999999999996 107.82 -172.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -178.56 28.12 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.814 0.301 . . . . 2.71 111.814 -161.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 60.07 -155.16 31.45 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 119.015 -1.564 . . . . 2.0499999999999998 110.261 -160.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -79.52 106.81 11.82 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.322 0.649 . . . . 5.4500000000000002 110.738 -175.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 148.33 -168.65 29.02 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 108.45 -1.86 . . . . 2.77 108.45 -168.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.68 -112.23 2.64 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 125.83 1.681 . . . . 2.6000000000000001 109.911 172.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.586 ' CA ' H143 ' A' ' 269' ' ' NGH 0.571 4.0 mm -109.07 149.27 12.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.565 -0.902 . . . . 2.2599999999999998 108.565 173.812 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.862 ' H ' ' H91' ' A' ' 269' ' ' NGH 0.276 4.4 mp -81.68 -59.02 2.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.74 2.016 . . . . 1.6899999999999999 108.402 170.406 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 1.011 ' H ' ' C13' ' A' ' 269' ' ' NGH . . . -162.87 153.92 17.2 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 122.251 1.024 . . . . 0.64000000000000001 113.291 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -143.88 132.44 22.3 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 114.522 1.304 . . . . 1.1699999999999999 114.522 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -160.49 162.27 33.05 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.655 1.982 . . . . 0.64000000000000001 106.144 -164.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -157.97 156.21 30.8 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 107.631 -1.248 . . . . 4.6200000000000001 107.631 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.33 -88.93 1.75 Allowed Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.186 -0.786 . . . . 0.68999999999999995 111.206 173.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.22 82.82 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.828 3.019 . . . . 1.49 111.547 -171.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -159.03 161.67 32.12 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.051 -1.62 . . . . 1.3 109.051 170.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.9 m -78.51 167.2 21.63 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.077 0.465 . . . . 3.0699999999999998 110.461 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 55.07 -106.32 0.52 Allowed Glycine 0 CA--C 1.529 0.906 0 C-N-CA 123.826 0.727 . . . . 1.6200000000000001 112.059 174.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.8 tp -63.54 -27.58 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.158 0.983 . . . . 1.6899999999999999 110.705 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.19 148.61 19.26 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 110.452 -1.059 . . . . 1.1100000000000001 110.452 172.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 87.92 -45.16 3.29 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.932 1.253 . . . . 0.64000000000000001 110.733 -163.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -84.08 171.74 12.62 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 121.681 -0.894 . . . . 1.25 109.843 -161.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -142.93 120.49 11.75 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 119.236 -0.411 . . . . 0.77000000000000002 112.058 -175.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.453 ' N ' ' CD2' ' A' ' 196' ' ' HIS . 14.5 m80 -109.34 133.83 52.57 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 118.413 -0.803 . . . . 3.2799999999999998 109.591 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -120.75 148.69 43.63 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.301 0.5 . . . . 4.4199999999999999 109.829 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -67.24 89.73 0.2 Allowed 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 124.658 1.224 . . . . 2.7000000000000002 109.533 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -66.64 -26.9 67.28 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.18 -0.95 . . . . 2.9500000000000002 109.499 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.39 -42.41 21.84 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.948 0.899 . . . . 3.3500000000000001 109.404 171.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -73.57 170.37 15.33 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.582 1.182 . . . . 2.6200000000000001 112.272 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -117.62 91.19 3.5 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.779 -1.563 . . . . 4.4900000000000002 106.779 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -75.81 158.33 32.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.634 -0.712 . . . . 1.4299999999999999 109.438 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 75.3 p -138.57 144.43 39.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.608 -0.515 . . . . 1.99 109.608 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 13.7 t -61.23 -43.52 98.74 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 125.913 1.685 . . . . 2.0899999999999999 113.871 169.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.88 174.68 10.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.9 -0.778 . . . . 2.3900000000000001 108.9 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.7 m -43.63 -57.33 3.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.214 1.806 . . . . 4.2199999999999998 109.997 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 51.09 -88.38 0.01 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.375 1.464 . . . . 2.6499999999999999 113.338 167.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -147.07 -69.51 0.01 OUTLIER Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.912 -1.675 . . . . 2.0699999999999998 108.912 168.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.4 m -105.85 97.42 7.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.5 -1.667 . . . . 1.5700000000000001 106.5 175.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.16 109.31 3.49 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.343 -1.354 . . . . 3.1099999999999999 107.343 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 29.2 tp -47.62 -54.54 11.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.327 1.421 . . . . 2.71 111.853 -166.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -40.34 -43.69 1.8 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.956 1.302 . . . . 3.5499999999999998 111.202 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -64.05 1.08 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.281 0.632 . . . . 2.54 111.259 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.291 1.2 m -56.94 -40.84 77.13 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.995 -0.372 . . . . 1.8899999999999999 109.995 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.6 -49.88 64.17 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.58 -0.724 . . . . 0.56999999999999995 111.312 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 61.4 t -54.83 -41.49 57.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 119.567 1.076 . . . . 1.3300000000000001 110.973 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.521 ' CD2' ' O4 ' ' A' ' 269' ' ' NGH 0.449 2.7 t-160 -63.53 -49.47 73.38 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.234 0.614 . . . . 3.2999999999999998 111.535 176.46 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.09 -48.11 72.01 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.897 -1.127 . . . . 3.6499999999999999 111.531 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.36 -39.55 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 107.561 -1.274 . . . . 1.8600000000000001 107.561 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.49 -55.78 6.72 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.552 1.073 . . . . 0.64000000000000001 111.673 165.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -51.89 -47.73 64.42 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.715 -0.873 . . . . 2.0899999999999999 110.698 174.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 67.9 m -54.17 -38.34 65.47 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.293 0.849 . . . . 3.1000000000000001 113.293 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 8.4 mp -56.6 -40.73 75.81 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 119.431 1.014 . . . . 4.2000000000000002 110.266 172.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 117.44 28.89 2.23 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 125.045 1.307 . . . . 1.6599999999999999 111.602 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.95 137.89 36.96 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.074 -0.713 . . . . 4.3600000000000003 109.074 -170.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.77 140.23 21.5 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.655 -0.978 . . . . 2.7599999999999998 110.655 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -47.87 116.23 1.43 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.635 0.774 . . . . 1.8700000000000001 111.307 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 31.7 m -78.56 -177.35 5.28 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.385 0.674 . . . . 1.3999999999999999 109.195 172.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 23.4 m -148.79 39.54 0.87 Allowed 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.328 -0.857 . . . . 3.1200000000000001 109.387 -172.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.13 131.64 15.51 Favored Pre-proline 0 N--CA 1.447 -0.614 0 N-CA-C 106.599 -1.63 . . . . 1.55 106.599 -174.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.52 -9.55 14.8 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.096 1.864 . . . . 1.23 114.367 -172.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -82.07 -26.31 33.78 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.304 0.956 . . . . 1.6599999999999999 109.771 170.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -70.43 148.28 48.51 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.325 -0.62 . . . . 0.76000000000000001 109.325 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 90.2 t -93.92 -23.9 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 123.574 0.749 . . . . 0.93000000000000005 109.383 177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.473 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -49.54 -38.52 31.11 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.859 0.689 . . . . 2.8700000000000001 112.859 175.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.431 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -46.95 149.1 1.65 Allowed Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 126.219 1.808 . . . . 4.4199999999999999 112.802 -165.049 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.418 ' O ' H102 ' A' ' 269' ' ' NGH . 61.4 Cg_endo -71.68 -16.89 29.97 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.541 1.494 . . . . 0.94999999999999996 111.971 176.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.373 0.2 OUTLIER -78.85 -179.54 6.63 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.132 1.373 . . . . 1.97 110.148 176.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -127.39 153.88 45.69 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.594 -1.632 . . . . 3.48 106.594 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -148.56 117.45 6.72 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.615 -1.254 . . . . 2.6699999999999999 107.615 168.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -63.68 122.47 16.46 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.63 -0.878 . . . . 3.5600000000000001 108.63 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.3 m -145.96 154.55 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 O-C-N 123.771 0.669 . . . . 4.25 110.035 169.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -50.56 110.67 0.44 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.58 1.952 . . . . 3.7200000000000002 111.539 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.8 pp -57.55 -19.8 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.091 0.956 . . . . 4.4000000000000004 112.752 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -70.09 -49.7 48.27 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.433 0.693 . . . . 4.2400000000000002 110.899 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 91.7 m -83.88 -30.02 26.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.115 0.566 . . . . 2.48 109.974 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -34.56 116.71 0.33 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.446 1.498 . . . . 9.8300000000000001 111.581 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.27 175.82 10.76 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.714 1.206 . . . . 3.6000000000000001 108.698 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.436 ' HG ' ' CZ3' ' A' ' 141' ' ' TRP . 1.1 mm? -83.3 141.78 31.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.44 -0.948 . . . . 1.1200000000000001 108.44 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.4 m -77.87 155.38 31.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 110.09 -0.337 . . . . 1.48 110.09 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.28 -45.28 62.07 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.005 0.431 . . . . 0.93000000000000005 110.138 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -51.1 -54.11 28.03 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.884 0.874 . . . . 2.1899999999999999 110.191 173.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -59.27 -51.76 68.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.087 -0.961 . . . . 2.1499999999999999 109.92 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.5 mt -49.07 -52.43 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.775 1.63 . . . . 1.23 110.263 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -59.44 -40.51 87.02 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.391 -1.443 . . . . 7.6699999999999999 110.568 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -49.04 -55.05 12.44 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 111.963 -0.455 . . . . 0.91000000000000003 111.963 167.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.546 HG23 ' CZ3' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -60.85 -40.67 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 118.508 1.154 . . . . 3.21 110.282 -173.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -64.74 -17.96 64.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.498 -0.881 . . . . 2.7200000000000002 111.245 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.0 t -63.02 -17.43 62.21 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.473 0.709 . . . . 2.9199999999999999 112.446 171.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 66.7 mt -60.53 74.13 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.657 1.183 . . . . 3.0899999999999999 111.501 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 45.71 67.82 0.68 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.342 1.857 . . . . 9.5999999999999996 111.642 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.419 0 N-CA-C 106.322 -2.711 . . . . 7.3700000000000001 106.322 174.407 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' NGH . . . . . 1.011 ' C13' ' H ' ' A' ' 182' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 90.9 mtp . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 106.03 -1.841 . . . . 13.5 106.03 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 142.09 -168.48 25.69 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 109.225 -1.55 . . . . 8.6600000000000001 109.225 -171.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -70.52 -179.24 3.1 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.391 2.728 . . . . 9.9900000000000002 110.067 173.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.5 p -143.48 149.55 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.355 0.662 . . . . 6.9500000000000002 109.493 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 15.2 p90 -76.48 -65.0 0.98 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.0 1.32 . . . . 12.56 110.06 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 63.64 -56.53 0.2 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.793 2.437 . . . . 8.7899999999999991 112.407 -171.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.09 -51.13 0.12 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.534 1.534 . . . . 9.9700000000000006 110.072 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 57.9 -78.34 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.142 1.377 . . . . 5.2699999999999996 111.283 -170.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -124.63 109.15 12.81 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.102 1.361 . . . . 5.4500000000000002 109.572 -177.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.7 138.18 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.069 0 N-CA-C 106.641 -1.614 . . . . 3.4900000000000002 106.641 170.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.581 ' HG1' ' H ' ' A' ' 158' ' ' ASP . 10.1 p -125.1 139.47 53.75 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.739 -1.208 . . . . 1.55 107.739 177.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -123.04 161.59 24.02 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.696 0.798 . . . . 4.8399999999999999 110.342 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.95 147.82 32.11 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.752 -0.833 . . . . 6.4400000000000004 108.752 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -104.95 149.26 8.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 C-N-CA 123.559 0.744 . . . . 1.05 109.312 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.527 ' H ' HD21 ' A' ' 119' ' ' ASN . 1.4 p30 -104.85 -47.6 3.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.158 1.783 . . . . 3.27 109.648 -172.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -139.18 164.63 29.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.98 -1.119 . . . . 3.2200000000000002 107.98 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -128.16 118.67 23.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.846 -1.539 . . . . 3.2999999999999998 106.846 -174.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.401 ' HG1' ' CG ' ' A' ' 124' ' ' ASP . 8.9 t -66.78 122.98 84.74 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.77 0.828 . . . . 2.8900000000000001 109.384 -173.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -68.84 -17.76 41.73 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.791 2.994 . . . . 2.0099999999999998 111.562 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.401 ' CG ' ' HG1' ' A' ' 122' ' ' THR . 2.4 m-20 -34.3 -42.42 0.13 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.451 2.301 . . . . 2.5699999999999998 112.462 171.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 19.4 mtm -132.69 177.73 7.4 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.261 1.425 . . . . 2.4399999999999999 109.046 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -64.05 142.32 58.45 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 108.824 -0.806 . . . . 3.9500000000000002 108.824 172.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 43.9 ttt-85 -47.68 -51.15 22.78 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.506 -0.746 . . . . 2.8700000000000001 110.491 172.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.33 6.28 3.01 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.453 0.538 . . . . 5.2400000000000002 112.453 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -102.08 -41.92 6.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.15 1.78 . . . . 1.76 109.632 162.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 62.4 t -54.02 -54.79 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 O-C-N 120.508 -1.37 . . . . 1.74 109.719 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -26.43 68.13 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 118.647 -1.221 . . . . 1.76 109.469 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -65.0 -44.71 88.35 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 118.832 0.742 . . . . 3.6600000000000001 111.004 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.91 -52.27 65.76 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.76 0.824 . . . . 0.46000000000000002 110.481 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.51 -37.24 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 109.291 -0.633 . . . . 2.6200000000000001 109.291 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -52.27 -61.37 2.31 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 107.851 -1.166 . . . . 4.2400000000000002 107.851 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -52.34 -53.62 42.18 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.209 1.004 . . . . 2.7200000000000002 110.546 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.21 -49.52 63.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.792 0.837 . . . . 0.68999999999999995 111.834 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.405 ' CD1' ' HB2' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -63.59 -47.23 82.3 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.52 -0.918 . . . . 7.3600000000000003 108.52 176.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.18 -38.95 63.28 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.695 0.398 . . . . 2.6400000000000001 110.599 -171.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 82.3 t -49.79 -58.51 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.34 1.056 . . . . 1.02 109.249 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.406 ' CZ3' ' HG ' ' A' ' 250' ' ' LEU . 17.3 m95 -68.63 -37.23 79.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 119.836 -0.746 . . . . 1.1100000000000001 109.087 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -20.2 65.48 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.374 0.509 . . . . 2.46 112.374 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -78.98 -49.39 12.83 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.527 -0.916 . . . . 1.6899999999999999 108.527 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 26.5 t -75.46 -54.91 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 122.775 0.43 . . . . 3.04 110.877 -174.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.6 p -76.93 157.33 81.74 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 107.758 -1.201 . . . . 1.25 107.758 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.88 15.07 0.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.744 1.629 . . . . 0.91000000000000003 113.594 174.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.04 145.94 55.02 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 122.257 2.299 . . . . 3.7000000000000002 109.641 175.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -110.63 86.93 2.41 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.939 -1.504 . . . . 5.6299999999999999 106.939 160.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.405 ' HB2' ' CD1' ' A' ' 138' ' ' PHE . 3.9 m-85 -71.02 154.43 41.8 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.189 -0.671 . . . . 7.3499999999999996 109.189 163.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.6 t -155.34 144.93 21.23 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.271 1.028 . . . . 1.4399999999999999 108.51 170.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -92.29 138.6 31.39 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 119.493 1.042 . . . . 3.5699999999999998 108.471 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.8 pp -138.29 124.46 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.243 -1.392 . . . . 1.6799999999999999 107.243 167.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -88.03 -7.64 56.73 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 122.384 0.274 . . . . 3.4199999999999999 111.26 172.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 62.2 p -130.11 96.79 4.27 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.024 0.929 . . . . 3.23 109.927 -170.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 140.03 -150.74 21.7 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 106.601 -2.6 . . . . 2.1400000000000001 106.601 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 43.4 ttm -122.54 137.18 54.97 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.452 -1.684 . . . . 4.8799999999999999 106.452 173.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -111.85 170.16 8.33 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.738 1.215 . . . . 0.83999999999999997 109.664 -177.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.581 ' H ' ' HG1' ' A' ' 115' ' ' THR . 11.3 t70 -84.16 -55.7 4.05 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.646 0.778 . . . . 2.0800000000000001 109.361 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.9 pt -101.91 164.26 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.143 -0.688 . . . . 1.23 109.143 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.05 132.31 38.08 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.988 -0.745 . . . . 2.52 108.988 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 10.7 t -78.48 143.03 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.967 -1.123 . . . . 1.55 107.967 168.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 66.6 t -108.24 128.78 63.46 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 C-N-CA 124.546 1.138 . . . . 2.02 108.021 165.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.432 ' N ' HD22 ' A' ' 119' ' ' ASN . 5.7 m-85 -124.31 99.8 6.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 103.903 -2.628 . . . . 6.1699999999999999 103.903 170.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.51 160.13 33.31 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.991 -1.485 . . . . 1.1399999999999999 106.991 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -121.72 128.25 51.6 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.406 -1.331 . . . . 5.1200000000000001 107.406 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 65.79 -161.7 43.04 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-O 121.629 0.572 . . . . 2.23 112.37 -171.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.17 110.06 11.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.269 0.628 . . . . 2.6099999999999999 109.654 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -106.27 -45.42 4.3 Favored 'General case' 0 C--O 1.227 -0.08 0 C-N-CA 125.615 1.566 . . . . 4.7300000000000004 110.14 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -164.64 68.87 0.2 Allowed Glycine 0 C--O 1.243 0.695 0 N-CA-C 104.64 -3.384 . . . . 3.1000000000000001 104.64 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -160.81 -178.43 6.83 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 129.937 3.295 . . . . 2.9300000000000002 106.2 172.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -77.41 -55.68 5.19 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.105 0.962 . . . . 4.75 108.53 165.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.466 ' CG ' ' H ' ' A' ' 173' ' ' ALA . 14.7 p80 -123.41 -72.85 0.66 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.33 1.052 . . . . 6.9800000000000004 110.924 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.466 ' H ' ' CG ' ' A' ' 172' ' ' HIS . . . 56.21 -77.48 0.01 OUTLIER 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.663 1.985 . . . . 3.5 112.791 -169.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -104.63 149.57 25.43 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.467 1.107 . . . . 7.3600000000000003 109.551 -166.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -171.8 10.16 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.323 0.86 . . . . 3.4300000000000002 113.323 -155.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 65.82 -149.96 51.68 Favored Glycine 0 CA--C 1.537 1.428 0 N-CA-C 109.895 -1.282 . . . . 2.6099999999999999 109.895 -162.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -80.3 63.94 4.95 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.66 1.23 . . . . 4.8200000000000003 114.042 -162.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -164.13 -143.77 3.82 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 106.992 -2.443 . . . . 2.23 106.992 160.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.69 -127.31 40.08 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.27 -1.532 . . . . 2.52 109.27 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . 0.267 1.0 OUTLIER -100.39 148.77 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 106.214 -1.773 . . . . 2.9399999999999999 106.214 173.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.22 -46.1 12.21 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.851 0.861 . . . . 3.0099999999999998 109.644 164.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -163.48 165.69 23.48 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.238 -0.914 . . . . 0.65000000000000002 111.246 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.56 141.71 26.09 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.697 0.799 . . . . 1.73 112.398 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -161.79 158.04 25.09 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.97 0.908 . . . . 0.69999999999999996 109.853 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -147.87 139.35 23.72 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.617 1.167 . . . . 4.2800000000000002 108.129 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -85.77 -78.71 1.18 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.365 -1.094 . . . . 0.59999999999999998 110.365 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.78 104.08 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.355 2.703 . . . . 1.55 110.514 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -178.53 172.48 44.85 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 108.242 -1.943 . . . . 1.26 108.242 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 63.9 m -84.05 165.35 18.63 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.025 -0.731 . . . . 2.6000000000000001 109.025 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 53.31 -95.23 0.02 OUTLIER Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.202 0.906 . . . . 2.0600000000000001 112.535 172.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.5 tp -63.35 -16.49 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 125.129 1.372 . . . . 1.8899999999999999 111.504 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -44.37 129.58 7.18 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 110.792 -0.923 . . . . 1.6499999999999999 110.792 166.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 86.07 -31.09 4.13 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.34 1.448 . . . . 1.22 112.891 -175.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -83.34 147.51 27.88 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.484 1.142 . . . . 1.27 109.739 -166.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.78 124.04 38.78 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 118.762 -0.637 . . . . 0.80000000000000004 112.454 -172.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . 0.341 0.0 OUTLIER -112.4 109.06 18.45 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.079 0.551 . . . . 3.1699999999999999 112.19 -165.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -96.2 138.22 34.12 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.661 0.664 . . . . 3.9300000000000002 110.449 -177.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -62.24 92.51 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.171 -0.677 . . . . 3.2799999999999998 109.171 170.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -64.83 -37.54 87.95 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 120.51 -1.369 . . . . 2.6600000000000001 109.576 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -50.46 -27.94 7.42 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.593 0.757 . . . . 2.7400000000000002 110.907 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -66.27 155.15 37.99 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.859 1.264 . . . . 2.8100000000000001 110.179 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -95.78 93.62 7.19 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.583 -1.636 . . . . 5.0999999999999996 106.583 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -78.76 155.75 29.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.695 -0.854 . . . . 1.51 108.695 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.92 136.82 24.46 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.304 0.641 . . . . 4.1699999999999999 111.285 -176.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.2 t -58.03 -45.35 87.08 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.188 0.995 . . . . 1.8999999999999999 111.495 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -74.77 -154.85 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.646 1.179 . . . . 4.7000000000000002 110.761 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.461 ' H ' ' HG ' ' A' ' 207' ' ' SER . 7.4 p -79.16 -68.27 0.67 Allowed 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.938 -1.101 . . . . 3.9700000000000002 110.455 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 38.63 -106.03 0.05 OUTLIER Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.465 1.983 . . . . 2.73 113.495 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.55 -72.28 1.13 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.216 0.912 . . . . 2.2200000000000002 110.839 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 4.3 m -136.45 153.92 50.92 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 106.686 -1.598 . . . . 1.76 106.686 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -107.77 124.75 50.5 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 123.651 0.594 . . . . 1.53 111.968 173.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.17 -53.65 55.86 Favored 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.241 -0.652 . . . . 2.46 109.241 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -49.07 -46.99 45.31 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.667 0.746 . . . . 2.3999999999999999 110.232 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.6 tt -61.5 -61.58 2.43 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.921 0.888 . . . . 1.6799999999999999 110.0 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.279 0.6 OUTLIER -55.99 -37.94 69.79 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.383 -0.198 . . . . 1.8400000000000001 110.904 179.472 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.34 -54.92 29.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 124.591 1.156 . . . . 0.64000000000000001 110.687 175.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.8 t -48.08 -43.45 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 120.12 1.327 . . . . 1.2 110.903 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.461 ' CE1' ' CE1' ' A' ' 222' ' ' HIS . 42.6 t-80 -56.62 -56.54 20.12 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.396 1.078 . . . . 3.25 113.845 171.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -82.1 -43.32 17.98 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.134 -0.979 . . . . 3.6899999999999999 112.679 -170.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.26 -33.95 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.056 -0.72 . . . . 1.95 109.056 164.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.5 -53.68 43.07 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 110.763 -0.935 . . . . 0.76000000000000001 110.763 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.461 ' CE1' ' CE1' ' A' ' 218' ' ' HIS 0.281 62.5 m170 -53.44 -41.19 65.83 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.456 -1.026 . . . . 3.96 111.944 173.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 34.7 t -47.82 -52.97 16.97 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.131 0.972 . . . . 2.6600000000000001 112.346 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.12 -10.85 60.44 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.614 -0.679 . . . . 4.3200000000000003 112.786 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 104.51 43.31 1.73 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 124.289 0.947 . . . . 1.1899999999999999 111.792 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 7.9 mt -77.35 115.37 17.06 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 117.373 0.586 . . . . 4.2800000000000002 111.546 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -66.43 154.96 51.8 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 109.507 -1.437 . . . . 3.1099999999999999 109.507 162.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -68.61 121.54 16.63 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.746 0.773 . . . . 2.7000000000000002 112.716 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.9 m -79.93 118.1 21.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.772 -1.566 . . . . 2.3100000000000001 106.772 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.7 p -76.12 63.29 1.81 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.24 0.927 . . . . 4.3700000000000001 110.502 -175.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -155.78 131.36 5.48 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.85 1.26 . . . . 1.6699999999999999 108.34 -173.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.92 -14.65 9.78 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.776 1.651 . . . . 1.8799999999999999 114.124 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -42.09 59.76 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 119.57 1.077 . . . . 3.2999999999999998 108.971 172.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -57.73 116.41 3.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.744 1.217 . . . . 1.79 110.451 176.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.0 t -62.2 -17.9 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.383 -0.826 . . . . 0.89000000000000001 110.896 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.449 ' HE3' ' CD2' ' A' ' 222' ' ' HIS . 0.0 OUTLIER -51.89 -42.41 62.67 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.331 -0.856 . . . . 3.0600000000000001 113.135 169.029 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -61.03 147.31 86.35 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 109.027 -0.731 . . . . 9.1699999999999999 109.027 -165.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.88 -14.01 32.24 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.375 1.384 . . . . 1.1599999999999999 112.566 -172.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.354 0.2 OUTLIER -76.94 128.01 33.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.751 0.705 . . . . 2.3199999999999998 109.121 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -75.82 129.91 37.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.794 -1.187 . . . . 4.6799999999999997 107.794 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -135.67 139.36 43.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.708 -1.59 . . . . 3.46 106.708 174.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -57.77 120.96 9.34 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.542 -0.91 . . . . 3.5600000000000001 108.542 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.1 m -101.09 130.72 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.854 -0.425 . . . . 2.3799999999999999 109.854 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.66 86.71 0.66 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.491 -0.559 . . . . 4.8300000000000001 109.491 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.6 mt -51.48 -31.3 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.404 0.682 . . . . 3.79 109.449 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -42.05 -49.46 4.72 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.362 1.065 . . . . 3.71 112.404 169.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 35.0 m -84.84 -41.63 15.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.56 0.744 . . . . 1.77 110.24 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 71.1 t80 60.96 75.5 0.41 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.287 1.035 . . . . 5.3099999999999996 109.545 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.06 169.19 25.11 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.135 0.574 . . . . 5.5999999999999996 110.688 -177.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.406 ' HG ' ' CZ3' ' A' ' 141' ' ' TRP . 0.4 OUTLIER -113.76 176.87 4.84 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.505 1.522 . . . . 1.45 107.859 175.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 68.2 m -77.96 145.41 36.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 122.742 0.417 . . . . 1.29 110.7 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.36 -43.19 54.18 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.173 0.589 . . . . 1.54 110.402 171.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -53.43 -55.49 24.69 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.627 0.727 . . . . 2.8700000000000001 110.183 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -59.09 -47.69 84.32 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.078 -0.965 . . . . 2.25 109.02 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 59.3 mt -51.06 -32.31 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.647 1.979 . . . . 1.9399999999999999 112.524 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -73.42 -57.16 4.2 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 121.293 -0.879 . . . . 6.9000000000000004 110.026 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -47.24 -53.85 10.88 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 121.19 0.328 . . . . 1.9199999999999999 112.291 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 2.0 pp -55.88 -32.65 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.946 1.698 . . . . 3.23 111.056 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -78.3 -45.11 23.53 Favored 'General case' 0 C--N 1.339 0.126 0 O-C-N 121.708 -0.62 . . . . 3.2200000000000002 109.811 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 15.1 m -51.99 -31.04 27.72 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.58 0.585 . . . . 4.5 112.58 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.5 mt -51.45 -22.33 2.99 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 114.222 1.193 . . . . 4.5599999999999996 114.222 172.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -47.55 -56.11 7.8 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.588 0.631 . . . . 9.0700000000000003 110.237 167.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 116.7 -2.167 . . . . 7.96 107.793 -171.93 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' NGH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 68.6 mtm . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 106.094 -1.817 . . . . 13.35 106.094 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 119.56 78.39 0.56 Allowed Glycine 0 CA--C 1.532 1.147 0 N-CA-C 110.825 -0.91 . . . . 8.8699999999999992 110.825 -174.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.72 158.78 49.89 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.326 2.018 . . . . 9.7899999999999991 109.919 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.9 p -153.47 152.51 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.368 -1.715 . . . . 6.5099999999999998 106.368 175.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 5.4 t-105 -123.2 167.17 14.07 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 123.832 0.853 . . . . 11.529999999999999 108.959 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.67 -43.02 65.27 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.026 0.931 . . . . 11.869999999999999 111.445 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -159.41 -59.92 0.07 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.499 -0.286 . . . . 7.2400000000000002 110.561 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 15.0 m170 67.02 -54.33 0.45 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.467 1.907 . . . . 4.2800000000000002 112.889 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -107.0 114.52 28.65 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.324 1.45 . . . . 5.0700000000000003 110.139 -176.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.7 mp -141.6 80.44 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.667 1.187 . . . . 3.52 108.396 -173.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.22 141.39 37.19 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.964 -1.124 . . . . 1.73 107.964 174.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -127.31 159.79 33.31 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.145 0.978 . . . . 4.3499999999999996 108.705 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -154.94 173.21 16.86 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.727 0.694 . . . . 5.04 110.419 172.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.78 159.39 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.226 1.01 . . . . 1.0700000000000001 109.834 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -100.29 -42.98 6.43 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.01 0.924 . . . . 3.6200000000000001 109.994 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -149.41 170.46 18.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.751 0.82 . . . . 2.52 109.831 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -117.9 101.76 8.54 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.368 1.467 . . . . 3.7200000000000002 107.959 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.4 t -58.55 125.89 77.69 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.96 0.904 . . . . 2.73 109.173 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.17 -17.26 45.29 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.717 2.945 . . . . 1.95 111.411 -172.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -35.06 -43.75 0.21 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.002 1.721 . . . . 2.2000000000000002 111.827 170.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -130.88 174.59 9.83 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 124.994 1.317 . . . . 2.5 110.037 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -73.13 140.2 46.93 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.65 0.78 . . . . 3.0099999999999998 109.487 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -46.61 -51.41 15.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.035 0.445 . . . . 3.3999999999999999 111.892 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.5 -8.11 8.63 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.742 0.817 . . . . 3.46 112.723 -176.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -100.66 -48.45 4.51 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.695 1.598 . . . . 1.9299999999999999 109.314 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.93 -56.59 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 125.274 1.43 . . . . 1.77 109.374 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -24.53 64.48 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 118.334 -0.841 . . . . 1.8200000000000001 109.349 -177.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -65.84 -50.25 65.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.627 0.648 . . . . 4.6699999999999999 110.071 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -49.67 -54.85 16.23 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.919 0.888 . . . . 0.63 110.091 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -71.38 -30.99 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.028 -0.533 . . . . 2.73 110.233 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -55.04 -54.6 40.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.765 1.269 . . . . 4.5300000000000002 108.157 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -68.82 -39.28 80.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.588 1.555 . . . . 2.3900000000000001 110.282 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -46.44 -57.11 4.97 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 122.576 0.35 . . . . 0.85999999999999999 110.63 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -60.43 -48.55 81.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 119.661 -0.816 . . . . 5.54 111.15 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -45.34 -48.92 13.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.416 0.687 . . . . 4.9100000000000001 111.093 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 94.8 t -58.36 -51.0 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 122.717 0.407 . . . . 1.72 109.941 -173.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -68.68 -33.67 74.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.679 -0.86 . . . . 0.98999999999999999 108.679 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.14 -19.53 61.63 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.251 0.478 . . . . 2.0299999999999998 111.911 174.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -81.27 -42.87 20.01 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.024 0.829 . . . . 2.6499999999999999 108.985 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.7 m -79.87 -54.37 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 112.17 0.433 . . . . 2.1099999999999999 112.17 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 54.4 p -81.83 147.14 57.76 Favored Pre-proline 0 N--CA 1.45 -0.442 0 N-CA-C 108.382 -0.969 . . . . 1.1599999999999999 108.382 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.73 5.01 4.1 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.813 2.342 . . . . 0.90000000000000002 113.008 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.4 125.9 27.93 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.371 1.468 . . . . 3.96 108.589 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -98.17 93.53 6.3 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 109.277 -0.638 . . . . 5.0599999999999996 109.277 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -78.57 149.45 33.01 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.469 -0.332 . . . . 7.2400000000000002 110.797 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.4 t -151.4 137.31 18.12 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.714 -0.476 . . . . 1.6299999999999999 109.714 172.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -90.45 160.09 16.2 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.266 -1.013 . . . . 3.9100000000000001 108.266 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -152.12 152.21 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 104.747 -2.316 . . . . 1.9199999999999999 104.747 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.03 -39.43 21.26 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.262 -0.644 . . . . 3.9500000000000002 109.262 172.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.5 m -75.71 146.23 40.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.283 -0.636 . . . . 4.1799999999999997 109.283 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -78.87 59.29 4.23 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.387 -0.674 . . . . 5.8499999999999996 112.699 -173.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.2 mtt -116.37 72.89 0.83 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.152 0.981 . . . . 7.7599999999999998 109.594 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -141.53 162.68 34.9 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.49 0.716 . . . . 0.94999999999999996 111.702 -173.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -70.97 -46.54 62.17 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.073 -1.084 . . . . 2.0299999999999998 108.073 170.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.9 pt -124.23 146.16 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.017 -0.992 . . . . 2.1099999999999999 108.601 -171.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . 0.308 0.0 OUTLIER -129.93 139.22 51.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.097 -0.705 . . . . 3.54 109.097 176.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.6 t -79.93 112.08 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 118.579 -0.724 . . . . 0.81000000000000005 109.113 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . 0.479 7.4 p -109.0 97.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 N-CA-C 113.47 0.915 . . . . 3.9700000000000002 113.47 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -79.82 130.04 34.98 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.326 1.85 . . . . 6.3300000000000001 107.077 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -141.6 162.11 36.28 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.409 0.549 . . . . 1.0800000000000001 111.029 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -119.01 126.75 52.46 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.897 1.279 . . . . 6.2999999999999998 108.209 -172.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 46.62 -130.35 11.83 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 123.59 0.614 . . . . 1.73 112.208 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.96 138.2 38.72 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.266 0.627 . . . . 2.4700000000000002 109.511 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.73 -31.75 0.12 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 114.124 1.157 . . . . 3.29 114.124 -175.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 178.96 -49.16 0.09 OUTLIER Glycine 0 C--N 1.335 0.509 0 N-CA-C 109.6 -1.4 . . . . 2.5 109.6 -170.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -77.57 158.65 29.73 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.71 -0.848 . . . . 2.8300000000000001 108.71 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.57 -43.09 23.65 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.778 1.231 . . . . 4.6799999999999997 108.719 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -73.7 -60.67 2.14 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.926 0.891 . . . . 4.9000000000000004 109.066 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 49.74 -140.22 0.78 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.076 1.35 . . . . 2.8199999999999998 111.734 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -89.83 156.52 18.43 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 107.366 -1.346 . . . . 9.1199999999999992 107.366 167.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -158.14 11.55 0.18 Allowed 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 126.82 2.048 . . . . 3.1899999999999999 111.105 -157.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 105.29 165.22 23.78 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.351 -1.1 . . . . 2.6499999999999999 110.351 -165.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -58.11 118.0 4.97 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.526 -0.916 . . . . 4.6900000000000004 108.526 166.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.91 -160.81 13.74 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 109.95 -1.26 . . . . 2.0499999999999998 109.95 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.92 -102.94 0.2 Allowed Glycine 0 C--N 1.339 0.715 0 N-CA-C 109.167 -1.573 . . . . 1.8500000000000001 109.167 -171.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.428 HG21 ' H12' ' A' ' 269' ' ' NGH 0.314 12.8 mm -90.73 130.04 40.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.111 -1.07 . . . . 2.6299999999999999 108.111 171.294 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.549 ' HB2' ' H1 ' ' A' ' 269' ' ' NGH . 3.8 mp -82.48 -61.18 1.96 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.806 -0.812 . . . . 1.51 108.806 166.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.961 ' H ' H102 ' A' ' 269' ' ' NGH . . . -158.8 149.65 20.15 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 113.332 0.864 . . . . 0.93999999999999995 113.332 -177.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -131.97 117.05 17.91 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.563 1.945 . . . . 1.1899999999999999 114.678 -170.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -144.19 160.54 40.78 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 128.245 2.618 . . . . 0.59999999999999998 106.388 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.93 149.84 28.65 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.691 -1.596 . . . . 4.9100000000000001 106.691 -177.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -102.15 -86.99 1.97 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-O 119.455 -0.636 . . . . 0.70999999999999996 111.768 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.57 86.83 0.43 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.501 2.801 . . . . 1.5900000000000001 110.543 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -163.71 157.85 30.17 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 108.419 -1.872 . . . . 1.26 108.419 170.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.0 m -80.37 173.87 12.17 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.224 0.535 . . . . 3.2000000000000002 110.45 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 56.53 -112.47 3.41 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.575 0.607 . . . . 1.3200000000000001 111.648 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.1 tp -59.79 -40.05 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 O-C-N 122.131 -0.629 . . . . 1.5600000000000001 109.365 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -39.24 136.06 1.37 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.393 0.997 . . . . 1.1100000000000001 112.288 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.51 -47.58 1.17 Allowed Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.179 1.371 . . . . 0.69999999999999996 111.186 -164.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -84.94 154.12 22.38 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.748 0.774 . . . . 1.3 109.226 -159.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.41 116.71 20.17 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.528 0.936 . . . . 0.71999999999999997 113.528 -166.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -114.86 135.14 54.53 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 118.289 0.495 . . . . 2.8700000000000001 111.629 -163.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -125.36 146.51 49.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.249 -0.649 . . . . 4.0300000000000002 109.249 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -66.52 96.76 0.39 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.073 -0.967 . . . . 2.8199999999999998 109.806 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.44 -42.76 98.66 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 120.558 -1.339 . . . . 3.1800000000000002 111.639 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -53.85 -35.49 61.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.658 1.183 . . . . 2.8599999999999999 110.14 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -67.4 133.94 50.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.721 -1.585 . . . . 2.1099999999999999 106.721 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -93.39 94.25 8.61 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.131 -2.174 . . . . 3.77 105.131 -173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 23.7 m95 -75.79 152.87 37.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.277 -1.749 . . . . 1.3700000000000001 106.277 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 p -128.05 124.5 37.24 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.231 -1.396 . . . . 2.0800000000000001 107.231 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -49.9 75.91 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 120.51 1.504 . . . . 2.5099999999999998 108.028 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.74 177.93 2.33 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.725 0.41 . . . . 2.6299999999999999 110.536 176.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.1 t -48.53 -55.31 11.41 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.726 1.211 . . . . 4.2599999999999998 110.723 -171.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 40.78 -106.64 0.07 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.147 1.356 . . . . 2.9300000000000002 114.611 165.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -121.37 -67.84 0.26 Allowed Glycine 0 CA--C 1.525 0.709 0 C-N-CA 124.293 0.949 . . . . 1.8799999999999999 110.93 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.4 m -131.95 140.69 49.08 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.33 -1.73 . . . . 1.49 106.33 174.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -95.3 129.82 42.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 123.733 0.646 . . . . 1.5600000000000001 111.251 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -47.59 85.18 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.529 -0.759 . . . . 2.3100000000000001 110.137 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -55.51 -38.23 68.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.621 0.768 . . . . 4.0300000000000002 111.475 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.68 -63.4 1.23 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.791 0.836 . . . . 2.5099999999999998 109.706 176.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.303 0.2 OUTLIER -56.4 -38.75 71.95 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.251 -0.432 . . . . 2.21 110.19 -178.148 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.99 -58.5 7.06 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 117.857 -1.068 . . . . 0.71999999999999997 110.641 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.02 -44.01 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 120.275 1.398 . . . . 3.27 111.316 -174.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.657 ' NE2' ' CE1' ' A' ' 222' ' ' HIS 0.48 3.2 t-160 -49.76 -60.9 2.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.555 1.142 . . . . 3.1899999999999999 111.686 169.362 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -58.39 -41.72 85.5 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 120.835 -1.166 . . . . 2.8700000000000001 111.946 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.4 mp -68.68 -39.18 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 109.046 -0.724 . . . . 1.49 109.046 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -52.97 -44.9 62.15 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 111.402 -0.679 . . . . 0.77000000000000002 111.402 167.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.657 ' CE1' ' NE2' ' A' ' 218' ' ' HIS . 3.0 m-70 -53.93 -48.68 69.97 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 117.783 0.791 . . . . 2.04 109.302 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.5 p -61.2 -18.5 58.55 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.59 0.959 . . . . 2.52 113.59 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.6 mt -79.1 -58.98 2.96 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 106.966 -1.494 . . . . 2.7999999999999998 106.966 171.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 149.86 79.66 0.03 OUTLIER Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.615 -0.721 . . . . 1.21 111.859 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 8.7 mt -133.38 102.69 5.63 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.697 -1.223 . . . . 4.0499999999999998 107.697 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -77.81 46.94 2.71 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.14 -0.811 . . . . 3.4199999999999999 112.777 -176.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 63.7 m80 71.38 120.08 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.09 2.156 . . . . 1.9399999999999999 113.0 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 68.4 m -77.55 -179.83 6.08 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.933 -0.395 . . . . 1.28 109.933 173.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.3 t -142.14 29.91 1.63 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.954 0.901 . . . . 3.23 110.005 -171.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.03 143.35 45.23 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.69 1.596 . . . . 2.1600000000000001 107.002 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -86.2 -12.61 5.74 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.158 1.905 . . . . 1.2 114.493 -172.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -81.2 -40.36 23.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.162 -1.051 . . . . 1.6799999999999999 108.162 170.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.401 ' N ' ' HG ' ' A' ' 251' ' ' SER . . . -54.0 145.78 15.93 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.784 0.834 . . . . 0.73999999999999999 110.502 176.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.5 -17.26 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.2 1.0 . . . . 0.75 109.826 -176.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 50.9 mmm -77.5 -12.42 59.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.074 1.139 . . . . 2.71 114.074 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.423 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.9 155.49 1.05 Allowed Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.425 1.09 . . . . 4.3499999999999996 113.275 177.011 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.525 ' O ' ' S1 ' ' A' ' 269' ' ' NGH . 73.4 Cg_endo -73.34 -21.69 19.63 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.774 1.65 . . . . 1.0700000000000001 111.428 175.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.319 0.6 OUTLIER -76.8 173.19 11.97 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.824 1.25 . . . . 2.48 109.362 176.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -116.78 148.75 40.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.285 -1.376 . . . . 3.2599999999999998 107.285 171.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -141.45 122.07 14.24 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.301 -1.74 . . . . 2.6200000000000001 106.301 166.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -61.22 144.4 53.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.054 -0.721 . . . . 3.8799999999999999 109.054 168.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 25.9 m -133.97 159.36 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.023 0.929 . . . . 2.4199999999999999 108.723 167.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.81 -10.66 39.74 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 127.05 2.14 . . . . 4.04 113.107 -174.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . 0.257 24.0 mm 71.78 -23.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 127.081 2.152 . . . . 3.9100000000000001 112.104 -176.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -47.04 -67.04 0.32 Allowed 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 113.81 1.041 . . . . 3.9100000000000001 113.81 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 22.6 m -81.61 -50.15 9.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.528 -0.545 . . . . 1.96 109.528 -173.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 38.5 t80 39.43 82.9 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.435 1.894 . . . . 8.1600000000000001 112.885 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.09 162.18 32.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.829 0.851 . . . . 4.3600000000000003 109.387 -176.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -83.03 146.79 28.54 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.808 -1.182 . . . . 1.1000000000000001 107.808 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' SER . . . . . 0.401 ' HG ' ' N ' ' A' ' 234' ' ' ALA . 5.9 m -76.79 157.28 31.69 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.022 0.529 . . . . 2.04 110.634 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.2 67.21 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 110.045 -0.354 . . . . 1.1599999999999999 110.045 172.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -51.09 -56.78 10.94 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.904 0.859 . . . . 3.0600000000000001 110.262 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -58.53 -42.15 87.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.068 -0.969 . . . . 2.1299999999999999 111.589 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 41.7 mt -57.49 -44.73 85.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.181 1.393 . . . . 1.02 109.604 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -63.15 -45.12 93.36 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.417 -0.802 . . . . 5.1299999999999999 110.622 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -46.09 -62.88 3.2 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.727 -0.549 . . . . 1.01 111.727 173.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 2.8 pp -60.21 -42.44 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 O-C-N 121.803 -0.822 . . . . 3.1200000000000001 111.939 -176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -63.28 -21.53 66.3 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.195 -0.602 . . . . 3.1499999999999999 112.054 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.6 t -53.21 -25.56 14.46 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.99 -0.444 . . . . 2.4900000000000002 111.743 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 56.1 mt -74.27 54.1 0.54 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.212 1.005 . . . . 3.3300000000000001 111.814 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 51.55 44.68 28.93 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.707 1.203 . . . . 6.8499999999999996 111.605 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.207 0 CA-C-O 116.679 -2.179 . . . . 9.4499999999999993 111.6 173.56 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' NGH . . . . . 0.961 H102 ' H ' ' A' ' 182' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 56.3 mtt . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 108.259 -1.015 . . . . 14.359999999999999 108.259 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.85 79.18 0.02 OUTLIER Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.034 -1.626 . . . . 9.0800000000000001 109.034 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.83 168.24 24.38 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.258 1.972 . . . . 11.4 110.133 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.6 p -154.71 167.58 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.079 -1.452 . . . . 6.0999999999999996 107.079 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -114.1 163.61 14.95 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.921 0.888 . . . . 12.18 111.342 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -61.4 -43.5 98.75 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.029 1.331 . . . . 9.6600000000000001 112.377 -171.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.06 -40.21 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.206 0.602 . . . . 6.8399999999999999 112.272 175.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.6 -69.61 0.09 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.766 1.226 . . . . 5.0800000000000001 112.32 -173.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.9 95.15 4.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 119.024 0.829 . . . . 3.77 111.339 -169.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.0 mm -94.03 80.68 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 108.207 -1.035 . . . . 2.6299999999999999 108.207 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.8 p -77.61 129.66 35.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.18 -1.044 . . . . 1.54 108.18 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.401 ' CE2' HD12 ' A' ' 134' ' ' ILE . 39.4 p90 -129.01 163.0 26.31 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.16 0.584 . . . . 5.0 110.59 -178.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.847 HH21 ' HH ' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -148.08 151.8 36.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.618 -0.882 . . . . 7.3200000000000003 108.618 174.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -100.47 144.21 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.142 -1.059 . . . . 1.27 108.142 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -83.99 -58.32 2.83 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.611 -1.255 . . . . 4.4900000000000002 107.611 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -123.8 160.18 27.92 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.782 1.233 . . . . 2.29 109.213 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.847 ' HH ' HH21 ' A' ' 117' ' ' ARG . 71.4 m-85 -111.94 127.32 55.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.237 1.415 . . . . 3.1699999999999999 107.262 -175.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.39 131.03 34.1 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 118.356 0.525 . . . . 3.5099999999999998 110.044 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -87.66 -17.24 2.78 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.848 3.032 . . . . 2.0299999999999998 110.794 171.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -44.55 -48.16 10.24 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 125.442 1.497 . . . . 2.0600000000000001 110.863 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 6.8 ptp -124.33 176.49 6.42 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.097 0.959 . . . . 3.4399999999999999 109.135 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -65.7 134.26 52.82 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.363 -0.236 . . . . 3.0800000000000001 110.363 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -52.58 -47.78 66.65 Favored 'General case' 0 CA--C 1.524 -0.043 0 O-C-N 122.028 -0.42 . . . . 4.4400000000000004 111.651 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -51.01 -25.92 5.4 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.685 -0.674 . . . . 3.2200000000000002 111.529 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -93.02 -35.32 13.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.992 1.317 . . . . 1.98 112.004 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -52.45 -56.58 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 120.469 -1.395 . . . . 1.74 108.875 171.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.83 -25.46 65.57 Favored 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 117.729 -1.588 . . . . 1.74 108.632 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -63.71 -45.43 90.0 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.856 1.207 . . . . 3.1499999999999999 111.216 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.75 -53.01 60.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 122.771 0.428 . . . . 0.56000000000000005 110.187 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.401 HD12 ' CE2' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -70.3 -37.26 70.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.834 -0.432 . . . . 2.8799999999999999 109.834 -176.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -54.07 -59.98 3.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.337 1.455 . . . . 3.7599999999999998 107.848 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -63.16 -43.88 97.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.408 -0.814 . . . . 3.4399999999999999 109.764 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.32 -52.2 47.48 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.372 0.669 . . . . 0.44 111.909 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.04 -46.39 88.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.098 -1.041 . . . . 8.0700000000000003 109.018 174.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.29 -29.03 63.55 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 118.746 -0.645 . . . . 2.5 111.579 -172.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 99.0 t -59.83 -63.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 118.984 0.811 . . . . 1.1299999999999999 109.494 171.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.439 ' CZ3' HG23 ' A' ' 258' ' ' ILE . 46.8 m95 -66.04 -41.15 91.26 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.873 -0.788 . . . . 0.96999999999999997 108.873 -170.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 t -69.08 -4.91 19.03 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 124.312 1.045 . . . . 1.8700000000000001 112.054 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -89.66 -55.98 3.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.05 -0.722 . . . . 1.1000000000000001 109.05 167.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.97 -51.44 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 112.8 0.667 . . . . 2.1600000000000001 112.8 -174.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 42.3 p -79.76 151.96 74.43 Favored Pre-proline 0 N--CA 1.443 -0.812 0 N-CA-C 107.427 -1.323 . . . . 1.8500000000000001 107.427 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.35 12.76 1.48 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.373 2.049 . . . . 0.84999999999999998 112.248 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.61 149.45 50.05 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.221 -0.924 . . . . 3.6600000000000001 109.079 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -120.79 87.46 2.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.661 -1.607 . . . . 5.8499999999999996 106.661 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -72.37 149.07 44.68 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.11 -0.496 . . . . 7.1200000000000001 109.77 172.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.3 t -155.73 129.34 8.43 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 119.172 -0.442 . . . . 1.49 110.01 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.68 149.87 27.1 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.224 -1.028 . . . . 3.1600000000000001 108.224 171.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.0 pt -134.67 119.88 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.627 -1.62 . . . . 1.7 106.627 171.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -76.87 -22.3 53.68 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.505 -0.554 . . . . 3.6499999999999999 109.505 173.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -136.8 113.27 10.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.25 1.42 . . . . 3.0600000000000001 108.858 -176.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 149.5 -144.67 12.33 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 108.739 -1.744 . . . . 2.46 108.739 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 28.2 mtt -135.19 131.87 37.26 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 126.384 1.874 . . . . 4.8799999999999999 107.511 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.77 162.92 14.3 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.552 1.541 . . . . 0.88 110.102 -175.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -86.89 -48.59 8.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.08 0.952 . . . . 1.8799999999999999 109.68 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.2 pt -107.07 166.5 3.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.246 -0.65 . . . . 1.1299999999999999 109.246 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.45 141.11 43.53 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.081 0.552 . . . . 3.0899999999999999 111.269 174.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 73.3 t -90.8 122.77 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.41 -0.959 . . . . 1.0700000000000001 108.41 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.1 t -97.64 115.35 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.745 -0.835 . . . . 2.1099999999999999 108.745 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -107.54 113.37 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.953 -2.239 . . . . 6.4699999999999998 104.953 163.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.13 148.84 50.6 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.77 -1.196 . . . . 1.26 107.77 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.96 105.96 15.99 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.996 0.81 . . . . 6.6500000000000004 109.639 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.19 -134.51 13.6 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.609 -0.997 . . . . 1.8700000000000001 110.609 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.32 137.64 39.99 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 122.043 -0.68 . . . . 2.2999999999999998 109.697 -171.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.2 74.9 1.16 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.385 0.612 . . . . 3.2999999999999998 110.964 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 78.76 -44.21 2.51 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 121.321 -0.862 . . . . 3.27 111.72 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -73.54 158.74 34.28 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.519 -0.919 . . . . 2.8399999999999999 108.519 177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.9 -46.88 61.76 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 125.029 1.332 . . . . 4.7999999999999998 107.815 -170.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 32.3 p-80 -112.9 -71.81 0.74 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.288 -1.324 . . . . 4.7599999999999998 110.709 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 56.35 -77.66 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.454 1.502 . . . . 2.7799999999999998 113.503 -171.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -128.67 165.68 20.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.084 1.354 . . . . 7.2999999999999998 109.036 -168.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -169.08 15.65 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.429 0.9 . . . . 2.6699999999999999 113.429 -153.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 73.12 -160.65 54.07 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 109.812 -1.315 . . . . 1.74 109.812 -164.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -81.5 55.16 2.54 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.297 -0.531 . . . . 6.7999999999999998 112.427 -170.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -142.51 -158.77 7.67 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 107.998 -2.041 . . . . 2.7200000000000002 107.998 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.56 -138.07 41.48 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.172 -1.171 . . . . 2.3500000000000001 110.172 172.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.477 ' CD1' H102 ' A' ' 269' ' ' NGH . 1.3 tp -78.84 151.69 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 109.07 -0.715 . . . . 3.5299999999999998 109.07 173.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.9 tp -84.32 -39.13 19.53 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.523 1.529 . . . . 1.72 111.146 171.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -167.51 164.07 14.81 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.712 0.805 . . . . 0.80000000000000004 109.694 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -145.71 124.66 12.75 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.336 1.235 . . . . 1.3100000000000001 114.336 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -139.52 161.28 37.88 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.065 2.146 . . . . 0.70999999999999996 108.455 -173.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -148.77 141.84 24.9 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.443 -0.947 . . . . 3.8100000000000001 108.443 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -92.08 -83.14 1.48 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.586 -1.006 . . . . 0.65000000000000002 110.586 171.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.2 98.69 0.84 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.104 2.536 . . . . 1.5900000000000001 111.07 -170.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -174.23 173.44 45.99 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.168 -1.973 . . . . 1.21 108.168 172.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 72.1 m -89.53 173.24 8.44 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.977 0.511 . . . . 3.8900000000000001 109.679 169.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 54.66 -101.96 0.12 Allowed Glycine 0 C--O 1.243 0.686 0 C-N-CA 124.069 0.842 . . . . 1.8100000000000001 111.424 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.535 ' CG1' ' HE2' ' A' ' 196' ' ' HIS . 7.1 tp -59.35 -41.14 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-O 117.912 -1.042 . . . . 1.8 109.036 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -33.96 129.48 0.47 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.633 1.111 . . . . 1.22 113.11 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 97.16 -34.94 4.73 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.268 1.413 . . . . 0.92000000000000004 112.125 -167.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -86.47 159.37 19.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.736 1.268 . . . . 1.23 110.72 -165.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -133.66 121.59 22.21 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.385 0.883 . . . . 0.90000000000000002 113.385 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.535 ' HE2' ' CG1' ' A' ' 191' ' ' ILE . 2.2 m170 -109.15 112.25 24.31 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-O 117.473 -1.251 . . . . 2.9100000000000001 111.957 -167.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -106.77 145.0 32.6 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 121.336 1.88 . . . . 4.4699999999999998 111.213 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.36 83.34 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.226 1.011 . . . . 3.0499999999999998 110.227 177.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.81 -24.64 67.84 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 120.376 -1.452 . . . . 2.73 109.901 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.44 -35.42 28.6 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.104 -0.997 . . . . 4.3099999999999996 111.192 169.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -74.22 161.75 29.62 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.668 1.223 . . . . 2.6400000000000001 110.985 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -102.46 95.93 6.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.243 -1.392 . . . . 4.0599999999999996 107.243 176.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -78.27 140.23 38.87 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.549 -0.908 . . . . 1.51 108.549 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.6 p -122.61 105.85 10.47 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 107.599 -1.26 . . . . 1.98 107.599 -172.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.2 t -48.47 -33.24 9.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.384 1.474 . . . . 2.2599999999999998 114.329 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -71.07 178.27 3.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.634 0.73 . . . . 3.0299999999999998 111.455 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.1 m -66.31 -47.4 73.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 121.116 -0.99 . . . . 5.0499999999999998 109.665 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -62.82 132.41 43.62 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.107 -0.951 . . . . 3.2599999999999998 111.241 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 101.46 -119.52 6.53 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.257 -1.137 . . . . 2.6299999999999999 110.257 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.8 m -124.77 106.77 10.31 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.915 -1.143 . . . . 1.4099999999999999 107.915 167.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.93 108.73 2.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.369 -0.604 . . . . 2.0699999999999998 109.369 174.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 37.9 tp -50.78 -43.5 58.52 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.556 0.617 . . . . 2.6899999999999999 111.115 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -44.06 -46.0 8.29 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.952 0.501 . . . . 2.27 111.125 175.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.5 mp -59.51 -63.45 1.3 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.516 0.674 . . . . 3.3900000000000001 110.061 -173.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.349 1.3 m -60.32 -37.14 79.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.729 -0.669 . . . . 1.8700000000000001 109.691 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.85 -53.84 50.12 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 117.955 -1.022 . . . . 0.40000000000000002 110.549 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 62.7 t -50.66 -49.94 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.968 1.258 . . . . 1.1799999999999999 109.538 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.418 ' HB2' ' H73' ' A' ' 269' ' ' NGH . 82.7 t60 -56.82 -45.09 82.5 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.236 -0.915 . . . . 3.7799999999999998 113.313 177.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -83.23 -48.18 10.75 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.085 -1.009 . . . . 3.04 112.448 -170.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.37 -33.77 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.364 -1.347 . . . . 1.6499999999999999 107.364 164.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.15 -61.44 5.79 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.95 -0.86 . . . . 0.77000000000000002 110.95 168.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -47.36 -56.48 6.79 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.495 -1.003 . . . . 2.0800000000000001 110.743 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.0 m -46.36 -40.15 11.48 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 113.226 0.825 . . . . 3.0899999999999999 113.226 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.72 -33.88 76.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 118.924 0.784 . . . . 4.54 110.127 -174.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 130.61 46.18 0.15 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.933 1.73 . . . . 1.3200000000000001 112.603 172.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.8 mt -119.45 147.72 44.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.586 1.193 . . . . 4.46 113.198 -172.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -88.13 166.42 35.18 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.879 1.228 . . . . 2.8900000000000001 110.721 173.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -70.35 121.85 18.46 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.562 0.745 . . . . 2.04 110.536 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 66.5 m -77.01 -179.39 5.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.261 0.625 . . . . 1.6100000000000001 110.903 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 17.6 m -135.53 39.1 2.86 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.038 1.335 . . . . 2.77 110.35 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -135.77 136.33 23.32 Favored Pre-proline 0 N--CA 1.452 -0.325 0 N-CA-C 107.524 -1.287 . . . . 1.99 107.524 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.3 -13.38 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.315 2.01 . . . . 1.1200000000000001 114.325 -175.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -41.69 21.97 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.946 0.898 . . . . 2.9900000000000002 109.068 173.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.29 139.88 34.92 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.333 1.053 . . . . 0.79000000000000004 111.041 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 76.6 t -86.48 -15.18 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.943 0.878 . . . . 0.72999999999999998 110.978 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 3.7 tpt -80.25 -21.71 42.48 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.166 -0.959 . . . . 2.1299999999999999 112.916 -171.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -49.83 165.02 0.32 Allowed Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 128.091 2.556 . . . . 4.4100000000000001 114.59 175.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -78.29 -21.11 10.69 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.536 1.491 . . . . 1.02 112.103 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.365 0.2 OUTLIER -78.64 -178.58 5.97 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.375 1.47 . . . . 1.98 110.686 -176.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -111.05 153.91 24.96 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.491 1.517 . . . . 4.3499999999999996 108.926 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.0 tptt -149.53 133.13 16.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 106.858 -1.534 . . . . 3.7999999999999998 106.858 169.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -70.19 111.69 6.0 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.416 -0.957 . . . . 4.1399999999999997 108.416 170.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 20.6 m -121.65 118.17 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.737 0.815 . . . . 1.97 109.015 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.73 114.0 4.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.557 -0.714 . . . . 3.3599999999999999 110.31 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.1 pp -52.09 -29.72 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 C-N-CA 124.642 1.177 . . . . 4.75 111.231 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -52.8 -40.94 63.69 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.854 0.861 . . . . 4.4000000000000004 110.884 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 35.9 m -73.48 -36.39 65.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 119.108 -0.472 . . . . 2.1000000000000001 110.515 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 44.4 t80 52.47 72.65 0.39 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.007 0.923 . . . . 6.1699999999999999 110.084 172.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.41 167.12 30.55 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.099 -1.001 . . . . 3.5899999999999999 110.965 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.08 -170.46 1.72 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.542 1.937 . . . . 1.48 109.463 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 13.9 m -109.85 149.12 30.32 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.574 1.15 . . . . 1.46 111.295 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.4 -48.84 65.43 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.984 -0.448 . . . . 0.94999999999999996 111.573 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -64.11 -22.88 67.11 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.902 0.334 . . . . 2.9700000000000002 111.902 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -77.78 -47.83 18.02 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.967 -0.458 . . . . 3.4100000000000001 110.805 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 67.8 mt -54.48 -40.65 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.151 1.38 . . . . 0.93000000000000005 110.974 -175.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -56.8 -47.79 79.4 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.311 -1.493 . . . . 7.71 111.214 170.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -57.48 -48.92 77.45 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.625 1.107 . . . . 1.04 110.545 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.439 HG23 ' CZ3' ' A' ' 141' ' ' TRP 0.26 1.6 pp -64.08 -44.03 97.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 O-C-N 121.491 -1.005 . . . . 3.3300000000000001 109.686 -176.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -64.03 -30.23 71.32 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.465 -1.397 . . . . 2.6499999999999999 111.787 176.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.6 t -50.76 -14.82 0.22 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.535 1.309 . . . . 2.52 114.535 169.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 19.2 mt -41.04 -36.91 0.75 Allowed 'General case' 0 C--N 1.345 0.396 0 CA-C-N 120.388 1.449 . . . . 3.3100000000000001 112.713 165.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -156.06 -34.41 0.09 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.399 0.518 . . . . 6.7800000000000002 112.399 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.525 -1.708 . . . . 8.0899999999999999 111.271 -176.404 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' NGH . . . . . 0.477 H102 ' CD1' ' A' ' 180' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 107.449 -1.315 . . . . 18.329999999999998 107.449 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.55 90.47 2.1 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 110.371 -1.091 . . . . 10.949999999999999 110.371 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.49 75.66 3.84 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.265 1.977 . . . . 13.140000000000001 109.716 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.4 p -93.46 111.33 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.986 0.915 . . . . 7.25 109.845 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -163.01 166.73 23.37 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.593 -0.891 . . . . 13.029999999999999 108.593 171.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -151.8 78.0 1.24 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.41 1.884 . . . . 8.9700000000000006 106.045 166.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.7 mttt 52.62 70.27 0.59 Allowed 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 122.494 1.14 . . . . 6.5 111.582 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -73.7 -46.77 44.24 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.172 -0.955 . . . . 3.9100000000000001 108.572 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -126.82 118.41 24.57 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.287 0.635 . . . . 4.7800000000000002 112.452 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.15 92.71 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 107.251 -1.389 . . . . 3.2200000000000002 107.251 172.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.647 ' HG1' ' H ' ' A' ' 158' ' ' ASP . 71.6 p -81.39 136.97 35.73 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.338 -0.986 . . . . 1.5800000000000001 108.338 173.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -142.51 164.87 28.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.336 0.516 . . . . 4.8700000000000001 112.294 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -147.1 142.87 27.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.129 0.971 . . . . 5.5499999999999998 108.435 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.92 164.3 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.555 0.742 . . . . 1.1599999999999999 109.327 172.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.552 ' H ' HD21 ' A' ' 119' ' ' ASN . 0.1 OUTLIER -109.33 -56.33 2.31 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 126.148 1.779 . . . . 3.75 108.441 179.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -139.77 120.98 14.83 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.776 -0.824 . . . . 3.3300000000000001 108.776 -167.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -81.26 113.08 19.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.349 -0.982 . . . . 3.8500000000000001 108.349 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -52.27 128.78 40.98 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 123.025 0.53 . . . . 2.8300000000000001 110.314 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.68 -15.88 11.95 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.69 2.927 . . . . 1.8700000000000001 110.553 173.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -46.2 -39.17 9.36 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.366 1.066 . . . . 2.04 110.479 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 42.4 mtm -124.95 -176.72 3.63 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.316 1.447 . . . . 2.3799999999999999 109.954 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -73.87 144.01 45.61 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.432 -0.581 . . . . 3.0499999999999998 109.432 170.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 64.2 ttt-85 -51.04 -45.55 61.36 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.413 -0.804 . . . . 3.5299999999999998 110.722 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -61.81 -13.0 19.94 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.508 0.723 . . . . 3.4100000000000001 112.028 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -94.52 -45.38 7.44 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.344 1.458 . . . . 1.8999999999999999 109.568 172.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 52.4 t -55.8 -59.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.792 1.237 . . . . 1.75 109.831 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -24.14 65.67 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 117.602 -1.639 . . . . 1.78 108.987 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.529 ' HH ' ' HZ2' ' A' ' 136' ' ' LYS . 23.0 t80 -64.55 -46.61 82.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.798 0.727 . . . . 3.1200000000000001 111.208 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.09 -53.34 58.23 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.465 0.706 . . . . 0.40000000000000002 109.846 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.65 -36.84 72.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 109.516 -0.549 . . . . 2.8799999999999999 109.516 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -57.27 12.45 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 122.173 0.987 . . . . 5.6600000000000001 108.511 178.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.529 ' HZ2' ' HH ' ' A' ' 132' ' ' TYR . 6.2 mmmm -62.03 -43.96 97.72 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.225 -0.657 . . . . 2.3500000000000001 109.225 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -48.39 -53.99 15.64 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.437 0.695 . . . . 0.46000000000000002 112.758 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.458 ' CD1' ' HB2' ' A' ' 149' ' ' PHE . 0.3 OUTLIER -62.25 -47.02 86.23 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 119.304 -0.958 . . . . 8.2100000000000009 109.103 176.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.31 -37.05 71.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 122.511 0.324 . . . . 2.48 110.704 -169.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.0 t -54.63 -52.22 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 109.139 -0.689 . . . . 1.21 109.139 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.445 ' CZ2' ' SD ' ' A' ' 236' ' ' MET . 64.4 m95 -69.69 -35.29 74.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.501 -0.749 . . . . 1.02 109.463 -177.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.6 t -64.2 -16.46 62.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.375 0.67 . . . . 2.4100000000000001 112.16 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -83.38 -51.05 7.73 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.116 -1.068 . . . . 1.2 108.116 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.5 m -74.54 -44.46 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 112.393 0.516 . . . . 2.48 112.393 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 56.4 p -84.84 150.63 56.34 Favored Pre-proline 0 N--CA 1.445 -0.714 0 N-CA-C 108.902 -0.777 . . . . 1.25 108.902 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.52 10.46 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.61 2.207 . . . . 0.89000000000000001 112.636 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 43.8 mt -67.72 133.95 50.19 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.263 1.425 . . . . 3.0 110.309 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.56 82.68 1.69 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.832 -1.173 . . . . 5.9500000000000002 107.832 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.458 ' HB2' ' CD1' ' A' ' 138' ' ' PHE . 77.4 m-85 -67.66 159.17 30.55 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.051 -0.522 . . . . 6.46 111.131 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.3 t -155.79 125.87 6.59 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.83 0.741 . . . . 1.6399999999999999 110.629 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -78.78 137.26 37.65 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 107.256 -1.387 . . . . 2.9300000000000002 107.256 167.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.2 pt -135.08 105.58 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.467 -0.938 . . . . 2.2599999999999998 108.467 170.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -77.41 -15.45 59.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.486 -0.325 . . . . 3.1299999999999999 110.169 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.3 m -127.32 102.02 6.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.308 1.043 . . . . 2.7200000000000002 109.249 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.0 -155.26 26.36 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 108.81 -1.716 . . . . 1.8700000000000001 108.81 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 31.4 mtp -117.71 130.16 56.16 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.129 2.572 . . . . 4.8300000000000001 105.88 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -119.14 161.19 20.73 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.291 1.036 . . . . 0.81999999999999995 109.91 -173.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.647 ' H ' ' HG1' ' A' ' 115' ' ' THR . 9.3 t70 -68.82 -54.61 14.83 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.972 -0.751 . . . . 1.8700000000000001 108.972 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.3 pt -114.3 135.96 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.527 0.731 . . . . 1.4299999999999999 109.271 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.72 131.56 52.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.224 -1.028 . . . . 2.9700000000000002 108.224 172.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.32 124.54 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 106.937 -1.505 . . . . 0.82999999999999996 106.937 169.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.9 t -98.51 137.84 24.85 Favored 'Isoleucine or valine' 0 C--N 1.346 0.422 0 C-N-CA 125.049 1.339 . . . . 1.8 108.92 171.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -130.26 107.56 9.37 Favored 'General case' 0 C--N 1.335 -0.054 0 N-CA-C 106.569 -1.641 . . . . 6.6399999999999997 106.569 171.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -123.26 154.42 38.84 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.51 0.672 . . . . 0.89000000000000001 112.35 -173.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -92.17 70.01 5.28 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.792 0.837 . . . . 7.1600000000000001 109.66 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 95.13 -150.33 19.65 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.66 -0.976 . . . . 2.6000000000000001 110.66 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.55 81.3 3.23 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.96 -0.729 . . . . 3.3300000000000001 112.107 -162.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.11 64.48 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.876 1.27 . . . . 3.4399999999999999 112.561 173.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.73 48.45 66.99 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.551 -1.02 . . . . 2.21 110.551 -175.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -119.1 155.63 31.19 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 104.941 -2.244 . . . . 2.6899999999999999 104.941 160.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -75.75 -58.28 3.38 Favored 'General case' 0 C--O 1.227 -0.113 0 N-CA-C 108.715 -0.846 . . . . 5.0 108.715 171.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -146.22 102.18 3.58 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.991 1.316 . . . . 6.2199999999999998 107.812 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -163.69 -38.5 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 123.355 0.662 . . . . 5.1200000000000001 111.333 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -110.09 166.54 10.87 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 122.933 0.493 . . . . 7.5999999999999996 110.085 166.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -172.92 164.94 5.1 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 127.389 2.276 . . . . 3.8900000000000001 106.539 -170.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -72.39 -143.35 0.47 Allowed Glycine 0 CA--C 1.525 0.68 0 O-C-N 123.969 0.793 . . . . 2.2400000000000002 111.344 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -61.73 108.15 0.95 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.392 0.677 . . . . 6.3300000000000001 110.795 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.24 -145.68 18.11 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.679 -1.368 . . . . 1.9299999999999999 109.679 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 45.44 -126.93 8.02 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 126.136 1.827 . . . . 1.8600000000000001 111.706 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.3 mm -79.99 144.0 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-O 122.218 1.008 . . . . 2.5499999999999998 108.702 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.478 HD22 ' H1 ' ' A' ' 269' ' ' NGH . 6.0 mp -84.23 -62.04 1.66 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.576 1.95 . . . . 1.3799999999999999 109.445 170.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -159.56 158.4 31.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 120.637 -1.29 . . . . 0.53000000000000003 110.151 -172.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -144.06 135.52 25.83 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 114.247 1.202 . . . . 1.5900000000000001 114.247 172.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -149.43 164.04 36.09 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.264 2.226 . . . . 0.55000000000000004 107.8 -169.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -150.05 143.49 25.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.09 -0.707 . . . . 4.1500000000000004 109.09 -173.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -87.11 -130.18 2.94 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.789 -1.006 . . . . 0.69999999999999996 110.665 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.09 105.21 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.54 2.16 . . . . 3.0699999999999998 110.56 -173.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -167.36 168.05 40.26 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 107.56 -2.216 . . . . 1.47 107.56 176.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.5 m -78.16 167.65 21.08 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.42 0.629 . . . . 2.7799999999999998 111.659 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 53.59 -111.78 2.05 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.173 0.892 . . . . 1.3400000000000001 112.165 173.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.5 tp -60.55 -37.26 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 118.239 -0.886 . . . . 1.49 109.61 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -32.58 131.42 0.25 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.176 1.37 . . . . 1.1399999999999999 113.199 173.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.08 -48.89 1.18 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.58 1.562 . . . . 0.75 111.171 -165.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.45 153.13 23.55 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.537 -0.912 . . . . 1.3 108.537 -161.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.39 120.57 30.16 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 118.001 -0.999 . . . . 0.69999999999999996 112.274 -172.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.47 129.51 56.53 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-N 119.213 0.915 . . . . 3.1099999999999999 110.123 -166.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.407 ' CE2' ' HG3' ' A' ' 219' ' ' GLU . 25.2 m-85 -121.63 150.72 41.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 118.736 0.698 . . . . 4.0700000000000003 110.252 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -79.55 77.73 6.12 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 122.082 0.944 . . . . 3.6000000000000001 111.962 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -48.06 -33.43 8.07 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 119.971 -1.706 . . . . 2.75 111.506 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -36.32 -47.8 0.61 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.773 1.229 . . . . 2.6499999999999999 112.004 171.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -73.81 170.18 15.86 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.09 1.356 . . . . 2.2599999999999998 111.0 -175.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -107.41 94.03 4.87 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.885 -1.524 . . . . 3.5800000000000001 106.885 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -82.83 151.46 26.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.587 -0.733 . . . . 1.8500000000000001 109.652 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.99 161.99 29.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.725 0.774 . . . . 2.8100000000000001 110.836 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.39 -41.02 70.18 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.401 2.28 . . . . 2.1800000000000002 111.684 169.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -80.37 157.79 26.22 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.533 -0.758 . . . . 2.77 110.358 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.8 m -70.58 -33.67 71.34 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.175 1.39 . . . . 5.4400000000000004 111.622 -170.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.69 116.3 8.43 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-O 118.402 -1.221 . . . . 2.9900000000000002 110.244 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 109.18 -121.02 6.0 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 107.812 -2.115 . . . . 2.8100000000000001 107.812 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.4 m -124.72 138.66 54.28 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.681 -1.229 . . . . 1.23 107.681 159.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.27 116.44 29.01 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.83 -0.623 . . . . 2.1800000000000002 109.864 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.74 -56.43 10.28 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.268 0.627 . . . . 2.2200000000000002 109.706 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -43.15 -50.87 6.19 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.515 1.526 . . . . 2.3799999999999999 111.892 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.0 tt -62.37 -58.12 8.84 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.61 -0.515 . . . . 1.8200000000000001 109.61 -172.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.291 6.1 m -58.16 -41.47 83.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.948 -0.301 . . . . 1.8899999999999999 110.649 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.79 -49.64 57.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.619 -0.705 . . . . 0.41999999999999998 111.009 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 58.3 t -57.28 -44.76 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 119.533 1.06 . . . . 1.3200000000000001 111.098 -177.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.62 ' CD2' ' CE1' ' A' ' 222' ' ' HIS . 1.0 OUTLIER -57.1 -50.22 73.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.522 1.129 . . . . 3.7200000000000002 111.948 172.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.568 ' HG2' ' HD1' ' A' ' 218' ' ' HIS . 15.0 mm-40 -71.16 -46.93 60.48 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.457 -0.777 . . . . 2.6299999999999999 112.385 -174.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.11 -39.29 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 107.48 -1.304 . . . . 1.46 107.48 170.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.05 -56.92 5.73 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 123.659 0.647 . . . . 0.60999999999999999 112.919 164.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.62 ' CE1' ' CD2' ' A' ' 218' ' ' HIS 0.266 0.3 OUTLIER -49.94 -46.62 52.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.781 0.79 . . . . 2.8199999999999998 110.904 178.258 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.2 t -51.94 -38.05 54.99 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 123.491 0.494 . . . . 3.1099999999999999 112.275 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 mt -70.91 -59.35 2.84 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 107.528 -1.286 . . . . 3.0 107.528 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 139.44 104.11 0.59 Allowed Glycine 0 C--N 1.337 0.611 0 N-CA-C 110.016 -1.234 . . . . 1.7 110.016 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.526 HD23 ' CE1' ' A' ' 222' ' ' HIS . 3.1 pp -130.73 145.42 51.94 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.52 0.728 . . . . 6.7999999999999998 111.847 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -101.06 28.34 16.48 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.65 1.119 . . . . 3.1400000000000001 112.456 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.475 ' H ' ' CD1' ' A' ' 226' ' ' LEU . 32.7 m80 57.39 102.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.393 2.677 . . . . 2.0899999999999999 112.698 -176.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 7.1 m -72.29 170.12 14.79 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.229 -0.656 . . . . 1.1200000000000001 109.229 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.2 m -140.72 44.33 1.83 Allowed 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.472 -0.768 . . . . 3.1699999999999999 110.268 -171.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -143.18 132.08 11.52 Favored Pre-proline 0 N--CA 1.447 -0.614 0 N-CA-C 106.977 -1.49 . . . . 1.75 106.977 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.56 -14.82 27.62 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.972 1.781 . . . . 1.8100000000000001 114.153 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -72.13 -23.61 61.33 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.475 1.034 . . . . 2.0800000000000001 110.269 171.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.31 158.03 31.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.357 0.599 . . . . 1.1699999999999999 110.607 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 45.2 t -110.99 -25.98 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.302 1.441 . . . . 0.79000000000000004 111.074 173.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.445 ' SD ' ' CZ2' ' A' ' 141' ' ' TRP . 52.6 mmm -65.92 -11.86 50.35 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.158 -0.964 . . . . 3.9700000000000002 111.759 173.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.57 159.35 3.45 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.788 1.635 . . . . 4.9199999999999999 113.959 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.25 -17.86 7.59 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.92 2.413 . . . . 1.0600000000000001 111.524 170.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.415 ' O ' ' H71' ' A' ' 269' ' ' NGH 0.3 0.2 OUTLIER -77.21 176.06 9.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.737 1.215 . . . . 3.1000000000000001 108.776 179.063 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -143.19 141.27 31.08 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 104.568 -2.382 . . . . 3.8900000000000001 104.568 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -156.24 145.21 20.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 104.873 -2.269 . . . . 5.29 104.873 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -49.04 109.59 0.27 Allowed 'General case' 0 C--N 1.339 0.118 0 N-CA-C 108.157 -1.053 . . . . 3.9700000000000002 108.157 168.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.91 149.06 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 123.908 0.883 . . . . 1.99 108.891 171.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -60.0 78.5 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.496 2.318 . . . . 5.9699999999999998 111.236 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 39.0 mm -44.95 -35.12 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.864 1.266 . . . . 4.8799999999999999 110.794 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -55.06 -64.76 0.74 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.179 0.807 . . . . 5.0499999999999998 113.179 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 92.7 m -82.22 -51.18 8.19 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.676 -0.861 . . . . 2.5600000000000001 108.676 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 29.2 t80 38.8 72.9 0.12 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.645 1.978 . . . . 8.6400000000000006 113.083 174.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.75 159.29 15.9 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.266 -0.879 . . . . 6.2400000000000002 109.532 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -85.91 143.88 27.97 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.543 -0.91 . . . . 1.1899999999999999 108.543 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.0 m -76.63 156.14 32.93 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 110.572 -0.158 . . . . 1.47 110.572 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.87 80.88 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.783 -0.451 . . . . 0.97999999999999998 109.783 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.15 -57.68 6.27 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 122.261 1.029 . . . . 2.6000000000000001 109.699 174.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -59.11 -39.61 82.81 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.563 -1.199 . . . . 2.2200000000000002 112.266 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 35.5 mt -55.47 -35.14 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 119.114 0.87 . . . . 1.1299999999999999 110.047 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -66.51 -53.31 36.43 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.468 -0.77 . . . . 5.0 110.014 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -50.77 -54.78 20.43 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 123.077 0.37 . . . . 1.3600000000000001 112.532 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.48 -43.35 94.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 121.851 -0.793 . . . . 2.96 110.462 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -67.03 -17.17 64.79 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.66 1.118 . . . . 3.29 112.243 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.1 t -66.12 -11.66 50.5 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.246 -1.359 . . . . 3.48 113.407 167.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . 0.293 0.0 OUTLIER -52.58 87.47 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 120.66 1.573 . . . . 5.4000000000000004 110.162 172.297 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -73.62 -41.54 62.66 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 120.444 -1.41 . . . . 7.0999999999999996 112.167 -166.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.943 0 CA-C-O 117.407 -1.774 . . . . 9.5 109.64 -175.396 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' NGH . . . . . 0.5 ' H5 ' ' O5 ' ' A' ' 269' ' ' NGH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 120.815 0.34 . . . . 12.210000000000001 110.655 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 165.45 -176.45 41.03 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 108.43 -1.868 . . . . 8.5700000000000003 108.43 -171.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.4 152.51 71.15 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.359 2.706 . . . . 11.140000000000001 110.436 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.6 p -166.78 158.11 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 106.488 -1.671 . . . . 6.0800000000000001 106.488 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 22.7 m0 -89.29 161.6 16.29 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 119.478 1.036 . . . . 12.18 110.494 172.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -102.68 -8.55 20.81 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.938 -1.028 . . . . 10.65 112.276 -174.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -100.98 -87.13 0.39 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.048 0.939 . . . . 6.4100000000000001 108.477 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 67.38 -61.14 0.36 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.16 1.784 . . . . 4.6299999999999999 110.283 -168.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -113.25 130.16 56.32 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 125.848 1.659 . . . . 3.9700000000000002 109.72 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.8 mt -138.45 105.51 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 123.54 0.525 . . . . 3.9100000000000001 110.499 173.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 p -101.57 145.82 28.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.474 1.109 . . . . 2.3900000000000001 110.914 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.465 ' HH ' ' HB2' ' A' ' 149' ' ' PHE . 6.8 m-85 -127.1 150.11 49.63 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.305 0.642 . . . . 6.2800000000000002 110.58 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -138.59 142.13 39.18 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.122 0.569 . . . . 5.5999999999999996 109.822 174.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.7 mt -99.8 151.71 4.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.936 -1.135 . . . . 1.24 107.936 174.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -91.92 -56.5 3.06 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.001 -1.111 . . . . 4.0800000000000001 108.001 177.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -144.01 157.86 44.07 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 124.959 1.304 . . . . 2.79 108.78 -171.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -112.75 143.86 43.25 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.659 1.184 . . . . 3.73 108.985 -169.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.31 127.21 86.75 Favored Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 108.528 -0.916 . . . . 3.5699999999999998 108.528 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.26 -18.13 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.13 2.553 . . . . 2.0499999999999998 112.033 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.98 -46.79 64.99 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 118.983 0.811 . . . . 2.23 109.609 174.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 50.8 mtm -105.96 174.26 5.96 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.836 -1.075 . . . . 2.3900000000000001 109.009 179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -80.76 135.11 35.93 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.228 -1.027 . . . . 2.9199999999999999 108.228 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -45.76 -52.24 11.4 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 118.673 0.669 . . . . 3.8399999999999999 111.97 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -51.68 -46.87 63.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.482 -0.487 . . . . 4.0 109.731 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.43 -39.96 92.74 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.465 1.506 . . . . 1.8899999999999999 111.541 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.8 t -56.04 -56.5 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.205 -1.035 . . . . 1.78 108.205 175.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.8 -22.88 61.51 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.026 -1.07 . . . . 1.73 110.312 -176.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -67.9 -49.33 62.56 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.24 1.016 . . . . 3.6200000000000001 109.194 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.44 -54.74 36.69 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 123.71 0.804 . . . . 0.44 109.213 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -68.0 -34.71 68.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 120.212 -0.595 . . . . 3.5099999999999998 110.356 -176.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -56.45 -60.47 3.48 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 108.191 -1.04 . . . . 4.5800000000000001 108.191 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -62.65 -42.9 99.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.592 1.557 . . . . 2.3999999999999999 108.78 -172.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.38 -54.16 18.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.728 0.811 . . . . 0.52000000000000002 110.328 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.47 ' CE1' HG21 ' A' ' 220' ' ' ILE . 4.0 m-85 -58.84 -51.91 68.01 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 118.886 -0.578 . . . . 5.71 110.999 171.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.42 -33.5 21.06 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.745 0.646 . . . . 2.7999999999999998 112.745 -174.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 77.8 t -69.21 -47.32 74.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.583 0.753 . . . . 1.46 110.468 175.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.455 ' CZ3' ' CG2' ' A' ' 258' ' ' ILE . 7.1 m95 -69.78 -32.4 70.86 Favored 'General case' 0 N--CA 1.456 -0.155 0 O-C-N 120.631 -1.293 . . . . 1.0700000000000001 110.638 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.47 -11.08 60.34 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.1 1.36 . . . . 1.8799999999999999 110.778 176.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.63 -45.37 17.38 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 107.809 -1.182 . . . . 1.3999999999999999 107.809 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.0 m -84.07 -45.64 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 112.473 0.546 . . . . 2.4700000000000002 112.473 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 19.9 p -78.86 150.8 75.84 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 107.768 -1.197 . . . . 1.1699999999999999 107.768 178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -72.96 1.91 6.02 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 121.971 1.781 . . . . 1.1899999999999999 112.678 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.1 mt -69.6 142.14 53.59 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.384 1.474 . . . . 3.1299999999999999 109.274 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 103.0 12.62 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.749 -0.834 . . . . 4.9199999999999999 108.749 174.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.465 ' HB2' ' HH ' ' A' ' 116' ' ' TYR . 0.8 OUTLIER -67.96 146.3 53.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.551 0.74 . . . . 8.5399999999999991 110.917 176.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.7 t -152.44 95.15 2.0 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.638 0.653 . . . . 1.3500000000000001 111.964 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.92 133.81 39.13 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 120.583 -1.323 . . . . 4.0700000000000003 108.41 171.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.4 pp -130.56 174.38 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.392 -1.707 . . . . 2.21 106.392 171.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -134.14 21.24 3.76 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 121.613 -0.679 . . . . 3.4700000000000002 109.525 172.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 85.5 m -157.03 117.16 3.51 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.071 -1.455 . . . . 3.0099999999999998 107.071 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 121.34 -144.63 16.72 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 108.209 -1.956 . . . . 2.3999999999999999 108.209 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 33.0 mtt -110.11 139.11 45.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.982 1.313 . . . . 4.96 109.43 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -127.23 159.74 33.39 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.241 1.416 . . . . 1.0800000000000001 109.809 173.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.42 -54.45 6.71 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.054 -1.462 . . . . 2.5299999999999998 107.054 168.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.58 151.58 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 122.397 1.094 . . . . 2.1000000000000001 111.253 -168.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.7 mt -126.08 125.01 41.87 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 112.398 -2.183 . . . . 3.0600000000000001 107.876 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 38.0 t -91.87 105.43 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.934 -1.136 . . . . 0.95999999999999996 107.934 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 62.2 t -110.8 102.88 14.61 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 C-N-CA 123.916 0.887 . . . . 2.1699999999999999 109.237 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -80.61 155.98 26.62 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.955 -1.128 . . . . 8.0500000000000007 107.955 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -158.16 -173.49 4.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.176 0.444 . . . . 1.25 110.199 167.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -129.5 145.89 51.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.296 1.039 . . . . 4.9400000000000004 108.876 170.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.4 -126.24 19.15 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.354 0.978 . . . . 1.97 111.987 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.38 132.92 37.57 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.301 1.04 . . . . 2.6800000000000002 109.677 -173.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' A' ' 168' ' ' HIS 0.255 0.0 OUTLIER -158.66 82.94 0.81 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 123.277 1.513 . . . . 3.8599999999999999 111.193 179.266 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 80.96 -57.11 4.84 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.081 -1.208 . . . . 2.4199999999999999 110.081 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.15 149.4 27.98 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.188 -1.042 . . . . 2.9199999999999999 108.188 167.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.14 -55.96 5.09 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.663 1.585 . . . . 4.5199999999999996 107.712 -169.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 37.8 m170 -68.96 -71.52 0.22 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.856 -1.065 . . . . 5.2999999999999998 109.476 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 53.66 -111.8 0.64 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.173 -0.917 . . . . 2.7799999999999998 111.234 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.407 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 39.5 t80 -92.08 156.03 17.66 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 122.434 1.111 . . . . 9.1899999999999995 110.318 175.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 35.9 p30 -166.02 30.48 0.05 OUTLIER 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.774 -1.557 . . . . 3.52 110.127 -152.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 84.63 172.06 48.72 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.435 -0.666 . . . . 2.98 111.435 -172.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.94 124.99 18.45 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.631 -0.507 . . . . 4.4800000000000004 109.631 167.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 97.08 -154.67 20.55 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.283 -1.127 . . . . 2.4900000000000002 110.283 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 57.61 -122.94 31.11 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 109.451 -1.459 . . . . 2.1499999999999999 109.451 -173.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.6 mm -75.93 128.79 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 105.961 -1.866 . . . . 2.3999999999999999 105.961 168.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.3 mp -81.08 -50.67 9.36 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.008 -0.738 . . . . 1.74 109.008 172.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -161.71 163.61 29.59 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.369 0.268 . . . . 0.55000000000000004 110.328 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -142.82 112.41 6.83 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.321 1.448 . . . . 1.28 113.691 -169.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -146.75 162.0 39.46 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 127.443 2.297 . . . . 0.92000000000000004 107.166 -175.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.86 151.83 16.78 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.801 -0.814 . . . . 7.3399999999999999 108.801 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -102.5 -84.42 1.8 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.61 1.1 . . . . 0.98999999999999999 110.486 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.62 94.46 0.61 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.806 3.004 . . . . 1.5800000000000001 110.625 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -163.91 154.75 25.79 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 108.412 -1.875 . . . . 1.29 108.412 170.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.7 m -78.44 170.28 16.9 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.418 -0.586 . . . . 2.9900000000000002 109.418 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 72.19 -118.81 6.99 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.517 -1.433 . . . . 1.99 109.517 -175.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . 0.266 3.5 tp -84.92 21.71 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 124.304 1.041 . . . . 4.0599999999999996 112.723 -168.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -55.46 143.32 35.23 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 120.891 -1.131 . . . . 2.48 114.231 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 94.04 -32.67 5.73 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.572 1.082 . . . . 1.1200000000000001 111.111 -173.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.28 158.97 18.31 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.666 0.733 . . . . 1.6000000000000001 109.423 -158.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -142.71 127.15 17.79 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.114 0.783 . . . . 0.87 113.114 -157.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -117.8 131.51 56.56 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 117.94 -1.029 . . . . 3.1000000000000001 110.673 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -113.54 152.17 30.6 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.561 0.696 . . . . 8.0099999999999998 111.556 167.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.19 85.08 0.75 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.773 -1.103 . . . . 2.79 108.529 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -60.91 -31.74 71.23 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.4 -1.438 . . . . 2.5299999999999998 111.029 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -47.62 -42.3 23.86 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.304 0.573 . . . . 2.73 110.517 172.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.36 135.34 51.66 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.486 -1.301 . . . . 2.1299999999999999 107.486 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -88.27 94.85 9.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.195 -1.78 . . . . 3.6000000000000001 106.195 -174.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -76.12 138.05 40.5 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.663 -1.606 . . . . 1.49 106.663 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 35.9 p -118.01 124.08 47.27 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.024 -1.843 . . . . 2.1400000000000001 106.024 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.1 t -51.91 -46.5 64.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 121.657 2.026 . . . . 2.4700000000000002 110.452 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.92 132.67 47.19 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.229 -0.896 . . . . 2.9300000000000002 109.768 167.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 11.1 p -39.82 -57.08 1.64 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.693 1.597 . . . . 4.6900000000000004 110.744 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 18.95 -88.9 0.01 OUTLIER Glycine 0 CA--C 1.524 0.622 0 C-N-CA 128.564 2.983 . . . . 2.5600000000000001 115.406 163.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -81.97 -80.22 0.93 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.811 -1.716 . . . . 1.8200000000000001 108.811 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.3 m -150.95 111.2 4.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.048 -1.093 . . . . 1.28 108.048 170.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -61.33 117.81 6.12 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.35 0.66 . . . . 1.52 110.822 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 46.0 tp -53.69 -48.25 69.71 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 119.298 -0.382 . . . . 2.8399999999999999 110.089 178.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -49.68 -42.91 46.75 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.993 0.517 . . . . 2.4199999999999999 111.152 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 9.3 tt -60.34 -59.44 5.41 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.041 0.937 . . . . 1.71 110.32 -176.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.265 0.2 OUTLIER -61.77 -38.71 89.04 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.647 -0.252 . . . . 2.1400000000000001 111.073 177.458 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.42 -56.67 16.36 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 117.954 -1.022 . . . . 0.46000000000000002 109.343 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 93.0 t -47.54 -42.6 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 119.996 1.271 . . . . 1.22 110.986 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.464 ' HB2' ' H73' ' A' ' 269' ' ' NGH . 0.2 OUTLIER -59.92 -51.06 71.29 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.119 0.567 . . . . 3.9700000000000002 111.263 175.365 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -64.53 -54.71 28.01 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 121.043 -1.036 . . . . 4.1500000000000004 110.845 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.47 HG21 ' CE1' ' A' ' 138' ' ' PHE . 1.7 mp -49.34 -46.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 127.041 2.137 . . . . 1.6000000000000001 109.247 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -58.5 -44.84 95.17 Favored Glycine 0 CA--C 1.534 1.261 0 O-C-N 121.482 -0.761 . . . . 0.76000000000000001 111.506 172.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . 0.264 6.7 m-70 -51.94 -49.06 63.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.237 1.518 . . . . 2.0099999999999998 110.855 171.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.3 m -55.42 -44.9 76.7 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.48 1.112 . . . . 3.1200000000000001 111.482 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 93.3 mt -59.28 -52.55 65.17 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.565 -0.531 . . . . 3.3399999999999999 109.565 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 139.37 92.27 0.23 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.679 1.133 . . . . 1.23 111.585 170.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.6 mt -145.96 112.46 5.89 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.242 1.021 . . . . 4.21 111.57 -171.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -79.0 43.38 2.44 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.68 1.133 . . . . 2.6699999999999999 113.664 -174.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 71.6 m80 60.73 175.28 0.1 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.689 1.596 . . . . 1.9299999999999999 113.79 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 69.7 m -139.84 -178.73 5.56 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.903 2.081 . . . . 1.46 108.07 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 27.7 t -143.33 31.74 1.35 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.905 0.882 . . . . 3.3900000000000001 111.128 -173.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -127.92 137.3 30.5 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 106.932 -1.507 . . . . 1.6499999999999999 106.932 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.97 -11.72 14.91 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.39 2.06 . . . . 1.29 114.77 -173.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 25.9 mtmt -81.96 -29.12 32.34 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.916 0.886 . . . . 1.78 109.274 168.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.95 151.87 45.99 Favored 'General case' 0 CA--C 1.519 -0.229 0 O-C-N 121.883 -0.511 . . . . 0.69999999999999996 109.774 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 88.4 t -98.27 -24.29 4.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.508 0.723 . . . . 0.98999999999999999 109.993 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.84 -15.09 58.01 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 114.029 1.122 . . . . 2.46 114.029 177.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -49.65 154.77 1.58 Allowed Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 113.032 0.752 . . . . 4.6100000000000003 113.032 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.27 -23.05 21.32 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.473 1.449 . . . . 1.3200000000000001 111.638 172.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.291 0.6 OUTLIER -79.31 -178.6 6.31 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.497 1.519 . . . . 2.6499999999999999 111.084 -179.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -116.64 155.61 28.49 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.894 1.678 . . . . 3.7000000000000002 107.026 171.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.77 125.65 7.76 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.113 -1.069 . . . . 2.8300000000000001 108.113 165.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -63.37 125.69 24.98 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.066 0.946 . . . . 4.4699999999999998 109.733 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 16.3 m -141.24 148.27 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 108.276 -1.009 . . . . 2.73 108.276 167.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.67 127.96 33.98 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.993 1.317 . . . . 3.6299999999999999 110.239 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.7 pp -58.35 -28.52 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 122.604 0.361 . . . . 4.8099999999999996 111.917 -173.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -76.6 -43.12 39.85 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 123.625 0.77 . . . . 5.4699999999999998 111.942 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 91.1 m -80.55 -27.18 37.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.32 0.648 . . . . 2.9300000000000002 109.628 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -26.13 113.72 0.05 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.869 2.068 . . . . 9.0 112.403 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.35 158.18 44.78 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.129 1.371 . . . . 4.71 109.078 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.406 ' HG ' ' CZ3' ' A' ' 141' ' ' TRP . 1.8 mm? -83.44 146.28 28.51 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.853 -1.166 . . . . 1.1499999999999999 107.853 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.0 m -79.48 152.61 30.14 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 119.705 -0.188 . . . . 1.21 111.304 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.17 -42.46 63.45 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.635 0.374 . . . . 0.82999999999999996 110.857 172.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -50.0 -57.81 6.79 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 122.287 1.041 . . . . 2.7000000000000002 109.681 172.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.93 -41.34 87.11 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.23 -1.35 . . . . 2.3799999999999999 110.495 -176.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 80.0 mt -54.97 -40.12 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.351 1.46 . . . . 1.1699999999999999 111.389 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -67.9 -44.64 76.5 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 120.694 -1.253 . . . . 4.9800000000000004 110.22 174.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -46.65 -55.88 7.79 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.823 -0.911 . . . . 1.05 110.823 174.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.455 ' CG2' ' CZ3' ' A' ' 141' ' ' TRP . 2.0 pp -64.62 -43.93 96.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 O-C-N 121.826 -0.808 . . . . 3.2999999999999998 111.163 -175.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -64.63 -18.41 64.9 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.628 0.649 . . . . 3.4700000000000002 112.057 177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.3 t -51.56 -33.11 30.97 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.738 0.699 . . . . 3.1299999999999999 111.312 169.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 16.2 mt -50.66 -61.77 2.0 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.218 0.917 . . . . 3.48 112.802 172.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -159.05 142.76 15.04 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.061 -1.829 . . . . 7.3499999999999996 106.061 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.3 0 CA-C-O 116.459 -2.301 . . . . 9.1099999999999994 108.182 167.059 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' NGH . . . . . 0.464 ' H73' ' HB2' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 107.52 -1.289 . . . . 22.539999999999999 107.52 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -168.41 87.3 0.09 OUTLIER Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.253 -1.139 . . . . 13.41 110.253 -175.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.7 147.21 62.77 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.157 1.905 . . . . 15.0 109.787 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.8 p -163.01 166.49 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 106.743 -1.577 . . . . 8.6500000000000004 106.743 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 44.6 t-105 -150.18 171.4 16.97 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.655 0.782 . . . . 13.300000000000001 108.958 175.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -61.66 -28.25 69.25 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.706 0.802 . . . . 8.6999999999999993 113.021 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -126.76 -63.61 1.06 Allowed 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.361 0.665 . . . . 6.54 109.91 172.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 61.56 -63.07 0.09 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.908 1.283 . . . . 5.0 111.172 -159.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -77.8 99.68 6.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.41 0.55 . . . . 4.3399999999999999 111.22 -170.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.8 mm -117.08 108.02 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.726 -0.842 . . . . 2.7000000000000002 108.726 174.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 40.3 p -120.03 125.05 47.39 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 117.792 -1.099 . . . . 1.53 109.3 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.57 159.23 24.75 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.626 1.17 . . . . 4.0199999999999996 112.24 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -133.91 149.43 51.29 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.071 0.948 . . . . 6.3099999999999996 109.362 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.8 mt -107.03 137.68 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.466 1.506 . . . . 1.6299999999999999 107.271 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -98.22 -45.26 6.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.989 0.359 . . . . 3.0800000000000001 110.423 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -143.32 161.99 36.87 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.794 -0.817 . . . . 2.2200000000000002 108.794 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -127.41 134.15 49.92 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.47 -1.678 . . . . 4.3200000000000003 106.47 -165.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.525 ' HG1' ' CG ' ' A' ' 124' ' ' ASP . 7.7 t -70.39 115.53 35.78 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 118.797 0.726 . . . . 3.0 109.754 -173.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.99 -17.05 51.06 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 124.006 3.137 . . . . 1.9199999999999999 111.719 -173.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.525 ' CG ' ' HG1' ' A' ' 122' ' ' THR . 0.4 OUTLIER -33.15 -41.14 0.07 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.416 2.686 . . . . 2.1200000000000001 112.074 170.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -133.94 -179.88 5.82 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.1 0.96 . . . . 2.8199999999999998 109.581 171.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -66.09 131.83 47.09 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.451 -0.944 . . . . 3.2599999999999998 108.451 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -44.4 -45.06 8.77 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.063 0.394 . . . . 3.73 112.063 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -46.86 -47.61 21.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.553 0.692 . . . . 3.5699999999999998 109.437 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.34 -39.05 78.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.434 -0.803 . . . . 2.0600000000000001 111.709 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 80.7 t -58.08 -54.28 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 O-C-N 121.6 -0.687 . . . . 1.8100000000000001 109.264 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.14 -25.76 67.12 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 118.02 -1.472 . . . . 1.6899999999999999 109.294 177.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -66.13 -44.91 82.88 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 120.271 1.396 . . . . 3.1099999999999999 110.207 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.75 -52.87 61.16 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.77 0.828 . . . . 0.40000000000000002 110.048 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.67 -34.65 66.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 120.488 -0.485 . . . . 3.0899999999999999 109.742 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.87 -57.01 14.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.604 1.192 . . . . 5.0 108.154 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 mmmm -58.27 -49.01 78.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.997 -1.001 . . . . 2.4399999999999999 108.765 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -44.69 -54.66 5.99 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.106 0.963 . . . . 0.56000000000000005 112.52 175.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -62.38 -46.21 89.66 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 118.989 -1.084 . . . . 8.1600000000000001 110.774 177.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.36 -42.31 73.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 123.316 0.385 . . . . 3.8900000000000001 110.131 -173.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.4 t -54.01 -52.06 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 120.812 0.339 . . . . 2.0699999999999998 110.088 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.489 ' CZ3' ' HG ' ' A' ' 250' ' ' LEU . 67.3 m95 -71.9 -44.3 63.94 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.906 -0.775 . . . . 0.89000000000000001 108.906 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.4 t -57.29 -26.78 61.4 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.985 0.514 . . . . 2.1200000000000001 111.198 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -39.44 89.7 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 122.743 0.417 . . . . 2.1499999999999999 110.881 175.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 81.1 t -82.88 -55.44 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.932 1.293 . . . . 3.3900000000000001 109.61 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 43.6 p -84.92 150.55 55.91 Favored Pre-proline 0 N--CA 1.447 -0.577 0 C-N-CA 123.166 0.586 . . . . 1.8200000000000001 109.93 -172.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.96 8.13 1.79 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 121.509 1.472 . . . . 0.94999999999999996 112.949 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.69 111.95 12.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.326 1.05 . . . . 3.73 108.471 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.62 86.16 3.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.418 -1.327 . . . . 4.7599999999999998 107.418 175.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -67.57 128.96 38.38 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.082 -0.963 . . . . 7.0099999999999998 109.423 170.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.97 134.65 38.82 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 123.964 0.906 . . . . 1.9199999999999999 110.162 172.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -92.84 127.22 38.27 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 107.605 -1.257 . . . . 3.1499999999999999 107.605 173.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.7 pt -130.81 101.19 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.924 -1.139 . . . . 2.3799999999999999 107.924 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -91.75 27.04 2.17 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.673 -0.642 . . . . 3.3599999999999999 111.1 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.94 78.86 1.41 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.89 1.276 . . . . 3.4700000000000002 110.096 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 150.32 -132.29 3.9 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 108.697 -1.761 . . . . 2.0499999999999998 108.697 171.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.1 mtt -128.55 144.86 51.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.851 1.66 . . . . 5.7599999999999998 107.678 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.52 172.66 10.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.85 1.66 . . . . 0.81999999999999995 109.534 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.73 -57.38 3.7 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.089 0.956 . . . . 1.9199999999999999 108.982 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.3 pt -105.17 152.6 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.154 -0.93 . . . . 1.47 108.877 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 tt -131.11 130.34 43.02 Favored 'General case' 0 CA--C 1.523 -0.075 0 N-CA-C 113.31 0.856 . . . . 2.8999999999999999 113.31 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.23 102.68 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.827 -0.805 . . . . 1.01 108.827 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.2 t -93.57 131.29 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.814 2.046 . . . . 1.8899999999999999 108.813 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -129.12 112.92 14.47 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 105.641 -1.985 . . . . 6.4400000000000004 105.641 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -133.97 161.65 34.22 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 123.658 0.783 . . . . 1.0800000000000001 110.978 -165.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.4 121.06 32.76 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.446 1.098 . . . . 7.5700000000000003 110.629 -170.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 65.09 -70.49 0.08 OUTLIER Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.543 -1.143 . . . . 1.8400000000000001 112.216 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.28 163.98 13.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.148 1.474 . . . . 2.8199999999999998 110.62 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -154.23 -45.69 0.09 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.511 0.724 . . . . 3.9500000000000002 109.887 164.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -174.67 22.51 0.06 OUTLIER Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.524 -0.598 . . . . 2.7999999999999998 113.391 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.7 p30 -158.35 175.5 13.64 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.454 1.501 . . . . 4.0700000000000003 107.02 167.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.88 -47.39 62.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.099 1.36 . . . . 5.8099999999999996 108.554 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -54.24 -49.17 70.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.18 -0.918 . . . . 4.5700000000000003 111.39 -170.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 20.06 -109.9 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.698 1.999 . . . . 3.1000000000000001 114.219 171.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 2.8 t80 -121.96 161.41 22.93 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.858 1.208 . . . . 8.9399999999999995 107.771 165.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.43 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 40.7 p-10 -164.32 24.46 0.07 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 113.519 -1.673 . . . . 2.73 110.002 -148.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 86.08 171.34 47.85 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 122.157 0.865 . . . . 1.8799999999999999 111.79 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -72.21 100.86 2.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.658 -0.771 . . . . 5.6399999999999997 109.34 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 131.13 -161.84 23.56 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.64 -1.784 . . . . 1.6200000000000001 108.64 -167.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.68 -121.94 24.97 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.547 -1.421 . . . . 1.45 109.547 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.548 HD13 ' H12' ' A' ' 269' ' ' NGH 0.396 1.8 tp -78.47 140.06 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.361 -1.348 . . . . 3.1699999999999999 107.361 175.439 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.41 -55.67 4.36 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.769 -0.826 . . . . 2.04 108.769 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -169.99 179.87 3.44 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.948 0.899 . . . . 0.94999999999999996 110.09 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.54 143.41 51.18 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 125.955 1.702 . . . . 2.4399999999999999 111.896 -176.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -161.71 159.17 26.97 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.207 -1.405 . . . . 0.88 107.207 164.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.5 143.82 15.06 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.75 -1.574 . . . . 5.7599999999999998 106.75 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.08 -86.6 1.71 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.025 -1.23 . . . . 0.66000000000000003 110.025 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.64 99.38 0.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.254 2.636 . . . . 1.51 110.915 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -175.39 165.11 35.85 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.064 -1.615 . . . . 1.2 109.064 172.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.68 168.7 16.04 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.164 0.586 . . . . 3.3700000000000001 109.868 172.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 55.48 -105.79 0.47 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.01 0.814 . . . . 1.6399999999999999 111.827 173.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.7 tp -64.2 -23.28 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.44 0.696 . . . . 1.8700000000000001 111.002 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -49.4 143.34 9.74 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.854 -0.898 . . . . 1.1200000000000001 110.854 170.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 84.2 -36.07 2.93 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.253 0.93 . . . . 0.72999999999999998 112.358 -169.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -76.73 178.4 6.81 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.068 1.434 . . . . 1.27 110.681 -166.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -153.02 133.81 13.89 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.266 -2.494 . . . . 1.1200000000000001 104.266 -165.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.457 ' CD2' ' C ' ' A' ' 196' ' ' HIS 0.315 14.3 t-80 -155.07 85.16 1.08 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 117.199 -1.8 . . . . 6.9400000000000004 112.489 -133.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -103.67 147.16 27.57 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.244 1.018 . . . . 3.98 112.16 -158.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.87 81.03 0.46 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.022 1.329 . . . . 2.79 109.58 173.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -53.72 -50.04 66.78 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.068 -1.645 . . . . 3.0299999999999998 111.329 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -51.0 -26.15 5.66 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.293 0.637 . . . . 3.3999999999999999 111.674 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -68.43 153.06 44.49 Favored 'General case' 0 C--O 1.243 0.754 0 O-C-N 120.607 -1.308 . . . . 2.2400000000000002 109.445 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -97.33 90.14 4.99 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.627 -1.99 . . . . 4.0199999999999996 105.627 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -77.57 161.79 27.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.12 -1.067 . . . . 1.77 108.12 -177.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 56.7 p -132.75 141.88 48.75 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 122.088 0.946 . . . . 2.1400000000000001 111.19 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.7 t -60.66 -40.32 91.63 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.607 1.563 . . . . 2.29 111.789 163.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -79.55 -177.08 5.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.607 1.163 . . . . 3.0899999999999999 111.496 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 41.6 t -72.89 -50.95 20.65 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.831 0.852 . . . . 5.1299999999999999 110.77 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -55.07 112.71 3.06 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.853 0.74 . . . . 3.1600000000000001 112.724 -167.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 108.4 -121.28 6.23 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 107.634 -2.186 . . . . 3.1200000000000001 107.634 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.7 m -119.35 130.56 55.42 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.666 -1.605 . . . . 1.79 106.666 168.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -89.48 118.9 29.47 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 109.211 -0.663 . . . . 1.3500000000000001 109.211 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.98 -53.96 23.12 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 122.988 0.515 . . . . 2.3599999999999999 109.808 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -54.98 -45.01 74.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.18 0.592 . . . . 3.3300000000000001 110.67 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.7 tt -62.29 -58.83 6.26 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.745 -0.597 . . . . 1.5800000000000001 109.854 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.511 ' CG2' ' H2 ' ' A' ' 269' ' ' NGH 0.315 2.2 m -59.2 -33.13 70.6 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.522 -0.471 . . . . 1.8300000000000001 110.922 178.612 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.0 -45.77 86.31 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.281 -0.887 . . . . 0.56000000000000005 110.898 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 89.0 t -55.05 -48.47 75.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 120.044 1.293 . . . . 1.1899999999999999 110.263 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.716 ' CD2' ' O4 ' ' A' ' 269' ' ' NGH . 0.3 OUTLIER -52.32 -53.06 49.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.478 1.511 . . . . 3.6299999999999999 111.532 172.09 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -68.44 -53.14 25.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 119.159 0.89 . . . . 3.7200000000000002 113.362 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.5 mp -56.01 -41.61 68.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 108.604 -0.887 . . . . 1.4199999999999999 108.604 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.77 -48.44 78.01 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 111.289 -0.724 . . . . 0.68999999999999995 111.289 173.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.406 ' CD2' ' O4 ' ' A' ' 269' ' ' NGH . 2.0 m170 -57.65 -45.72 85.12 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.295 -1.121 . . . . 3.77 111.209 175.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.7 t -54.98 -56.71 16.71 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.479 1.112 . . . . 2.6600000000000001 110.94 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.6 pp -62.39 -34.69 77.22 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.323 -0.551 . . . . 3.79 111.779 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 146.35 107.79 0.53 Allowed Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.18 -1.168 . . . . 2.6699999999999999 110.18 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.423 ' H ' HD21 ' A' ' 226' ' ' LEU . 0.9 OUTLIER -75.69 160.89 29.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 122.984 0.514 . . . . 8.8000000000000007 111.923 176.587 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.22 42.69 0.84 Allowed Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.572 -1.411 . . . . 3.9399999999999999 109.572 167.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -0.88 93.22 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.189 2.596 . . . . 2.2999999999999998 116.139 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.8 m -74.89 171.03 14.76 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.351 0.66 . . . . 1.75 110.495 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 9.5 p -124.66 5.62 8.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.321 1.849 . . . . 4.2000000000000002 111.216 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -96.75 128.0 37.42 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 125.134 1.374 . . . . 1.96 108.532 -172.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -62.55 -14.21 38.22 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.992 2.462 . . . . 1.95 113.614 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -80.11 -34.16 38.09 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.952 0.901 . . . . 2.5800000000000001 110.279 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.68 136.41 39.11 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.68 -0.859 . . . . 0.79000000000000004 108.68 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 45.8 t -85.55 -21.24 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 122.414 0.285 . . . . 0.64000000000000001 110.345 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -21.79 59.77 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 113.945 1.091 . . . . 2.1400000000000001 113.945 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.681 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -49.48 173.15 0.08 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.56 2.344 . . . . 4.5700000000000003 114.533 -173.087 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.431 ' O ' ' H5 ' ' A' ' 269' ' ' NGH . 89.6 Cg_endo -90.24 -22.1 0.82 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.759 1.639 . . . . 1.51 111.685 166.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.293 0.7 OUTLIER -86.94 100.73 12.8 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.78 1.232 . . . . 3.04 110.696 -170.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . 0.329 31.5 t80 -73.63 133.24 43.42 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.036 0.834 . . . . 3.6299999999999999 108.992 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.56 145.99 21.92 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.82 -1.548 . . . . 3.0800000000000001 106.82 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -53.37 127.36 24.54 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.981 0.912 . . . . 3.9100000000000001 111.726 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 31.7 m -98.86 146.55 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.708 0.633 . . . . 2.27 112.708 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -74.54 77.92 1.96 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.878 0.847 . . . . 5.21 111.002 175.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 17.8 mm -54.2 -22.46 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.875 -0.602 . . . . 4.9900000000000002 111.498 168.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -43.57 -48.69 7.57 Favored 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 123.192 0.597 . . . . 4.2300000000000004 112.115 167.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.5 m -84.71 -41.78 15.9 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.134 0.574 . . . . 2.29 110.387 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 60.0 t80 58.5 76.24 0.35 Allowed 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.614 0.766 . . . . 5.2699999999999996 109.778 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.84 174.82 14.41 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 121.58 -0.7 . . . . 4.6299999999999999 109.715 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.489 ' HG ' ' CZ3' ' A' ' 141' ' ' TRP . 0.7 OUTLIER -116.98 163.1 16.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.028 1.331 . . . . 0.84999999999999998 108.459 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 63.5 m -81.09 147.39 30.13 Favored 'General case' 0 C--O 1.225 -0.213 0 O-C-N 122.154 -0.341 . . . . 1.6399999999999999 111.816 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.86 -40.24 60.24 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 122.986 0.514 . . . . 1.24 110.833 169.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -51.44 -58.46 6.2 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.095 0.95 . . . . 2.6099999999999999 109.781 171.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -58.02 -45.07 87.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.96 1.304 . . . . 2.0899999999999999 110.482 -173.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 63.3 mt -46.76 -38.79 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.319 1.448 . . . . 1.73 111.222 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -68.3 -46.55 70.01 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.896 0.771 . . . . 5.6100000000000003 111.205 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -57.14 -55.36 30.73 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 118.788 0.722 . . . . 1.47 111.504 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 2.2 pp -61.15 -39.66 83.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 122.938 0.495 . . . . 3.6699999999999999 111.426 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -70.0 -22.54 63.11 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.042 0.837 . . . . 4.0 112.282 172.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.9 t -64.73 -10.75 29.7 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.303 -1.332 . . . . 3.0099999999999998 113.66 176.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . 0.36 0.0 OUTLIER -44.03 91.65 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.682 1.593 . . . . 5.0800000000000001 114.125 -176.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -105.5 54.94 0.69 Allowed 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.917 -1.115 . . . . 8.2200000000000006 111.655 -170.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.112 0 N-CA-C 107.583 -2.207 . . . . 10.300000000000001 107.583 175.362 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' NGH . . . . . 0.716 ' O4 ' ' CD2' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 107.705 -1.22 . . . . 12.34 107.705 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -70.12 164.65 51.86 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 118.763 0.71 . . . . 10.289999999999999 111.398 174.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -70.35 144.55 51.22 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.447 2.765 . . . . 13.42 109.507 173.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.9 124.66 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 109.131 -0.692 . . . . 7.71 109.131 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -162.53 124.75 2.73 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.89 1.276 . . . . 13.0 107.744 165.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -76.39 -35.21 58.75 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 110.133 -0.321 . . . . 8.0700000000000003 110.133 169.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.14 -72.91 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.559 0.743 . . . . 6.21 110.355 -176.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 65.52 -71.39 0.08 Allowed 'General case' 0 C--N 1.341 0.225 0 C-N-CA 125.916 1.686 . . . . 4.3700000000000001 110.189 -173.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -103.96 122.46 45.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.846 0.859 . . . . 6.6600000000000001 110.065 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.464 ' HB ' ' CD1' ' A' ' 149' ' ' PHE . 1.5 mm -106.69 88.72 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.016 -1.105 . . . . 2.48 108.016 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 p -78.21 131.86 37.33 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.846 -1.159 . . . . 1.6200000000000001 108.897 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -125.73 164.46 20.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.144 0.978 . . . . 4.6299999999999999 110.614 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.21 149.61 28.15 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.636 -0.875 . . . . 7.1500000000000004 108.636 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.5 mt -89.28 150.5 3.7 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 N-CA-C 108.311 -0.996 . . . . 1.25 108.311 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.493 ' H ' HD21 ' A' ' 119' ' ' ASN . 0.8 OUTLIER -81.45 -55.31 4.78 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.604 -0.887 . . . . 3.3300000000000001 108.604 175.686 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -151.25 176.27 11.38 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.782 0.833 . . . . 2.3300000000000001 109.31 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -106.41 146.93 29.89 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.294 1.038 . . . . 3.3199999999999998 109.859 -174.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.2 t -93.25 141.19 23.68 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 124.413 1.085 . . . . 2.52 108.353 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.79 -22.12 9.19 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.044 2.496 . . . . 1.95 111.308 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -29.85 -51.57 0.13 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.976 2.11 . . . . 2.21 113.013 172.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 11.3 mtm -131.29 170.51 14.52 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.934 1.294 . . . . 2.2400000000000002 108.195 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -69.91 149.5 47.74 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.086 0.554 . . . . 4.0999999999999996 109.578 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 29.0 ttt-85 -49.04 -44.95 42.09 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.265 0.626 . . . . 3.7200000000000002 111.496 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.55 3.47 3.05 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.737 1.014 . . . . 2.9900000000000002 113.737 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -112.12 -42.05 3.82 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 125.696 1.598 . . . . 1.96 109.635 164.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.8 t -51.74 -57.58 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.113 0.965 . . . . 1.79 109.538 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.402 ' OD2' ' NZ ' ' A' ' 151' ' ' LYS . 0.1 OUTLIER -73.23 -21.68 60.58 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 118.986 -1.086 . . . . 1.6799999999999999 109.414 -179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -65.57 -47.5 75.59 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.191 0.905 . . . . 3.1600000000000001 109.844 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.15 -52.65 63.58 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.533 1.133 . . . . 0.52000000000000002 109.191 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.39 -40.97 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 120.853 -0.339 . . . . 2.48 111.191 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -49.74 -58.82 4.58 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.518 -1.289 . . . . 5.2199999999999998 107.518 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -59.12 -49.81 76.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.334 1.454 . . . . 3.3300000000000001 110.5 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.72 -49.95 45.91 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.529 0.732 . . . . 0.81000000000000005 111.329 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.486 ' CD1' ' CD1' ' A' ' 149' ' ' PHE . 31.2 m-85 -58.55 -54.04 51.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.309 0.576 . . . . 5.9800000000000004 109.91 173.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -39.88 67.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.486 -0.779 . . . . 2.3900000000000001 111.156 -172.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 68.5 t -48.71 -64.24 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.772 1.229 . . . . 1.5600000000000001 109.852 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -68.55 -35.28 77.2 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.693 -0.854 . . . . 1.3999999999999999 108.693 -174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.1 -16.78 63.86 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 123.708 0.63 . . . . 2.1600000000000001 112.199 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -82.42 -47.88 11.75 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 108.384 -0.969 . . . . 1.6100000000000001 108.384 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.8 m -74.39 -43.88 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 112.635 0.606 . . . . 2.3599999999999999 112.635 -177.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 51.4 p -89.34 158.01 46.77 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 109.424 -0.584 . . . . 1.48 109.424 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.87 -0.95 9.18 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.431 2.088 . . . . 0.89000000000000001 113.334 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.3 mt -59.91 141.31 55.71 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.259 1.424 . . . . 3.27 109.466 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -118.75 90.54 3.35 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.201 -1.037 . . . . 5.0599999999999996 108.201 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.486 ' CD1' ' CD1' ' A' ' 138' ' ' PHE . 30.9 m-85 -70.03 143.73 52.44 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.03 -0.532 . . . . 7.2199999999999998 109.969 173.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -151.88 130.74 12.48 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.553 0.615 . . . . 1.3600000000000001 110.619 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.402 ' NZ ' ' OD2' ' A' ' 131' ' ' ASP . 4.0 ttmt -86.54 138.67 31.53 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.064 -0.717 . . . . 3.1099999999999999 109.064 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.8 pp -140.72 98.53 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 118.224 0.466 . . . . 2.04 110.515 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -80.2 26.73 0.35 Allowed 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.291 -1.506 . . . . 3.1400000000000001 110.708 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 45.5 p -154.07 78.08 1.1 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.157 0.983 . . . . 3.8999999999999999 108.565 -171.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 145.87 -122.84 1.74 Allowed Glycine 0 C--N 1.335 0.513 0 N-CA-C 108.189 -1.965 . . . . 2.3300000000000001 108.189 174.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -149.71 135.07 18.25 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.573 -1.269 . . . . 6.5899999999999999 107.573 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -112.43 163.01 14.95 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.36 1.464 . . . . 0.80000000000000004 110.141 -175.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -79.16 -44.72 21.37 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.991 0.9 . . . . 2.02 108.856 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.513 HD11 ' HG ' ' A' ' 223' ' ' SER . 5.7 pt -112.91 166.44 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.832 0.825 . . . . 1.3799999999999999 112.04 177.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.76 136.57 35.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.68 1.592 . . . . 2.9900000000000002 109.272 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.2 t -79.49 138.76 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 107.375 -1.342 . . . . 1.25 107.375 166.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 73.7 t -108.25 139.42 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 106.923 -1.51 . . . . 1.8999999999999999 106.923 164.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.91 137.9 51.9 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.656 -1.979 . . . . 7.8099999999999996 105.656 172.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -158.41 157.7 32.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.55 0.614 . . . . 1.4199999999999999 109.478 165.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -104.15 119.39 38.84 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.983 -1.118 . . . . 5.6200000000000001 107.983 168.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 71.77 -170.99 48.27 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.74 -0.544 . . . . 2.0699999999999998 111.74 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.66 78.35 3.31 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 122.011 -0.699 . . . . 3.71 110.92 -164.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -62.88 -44.57 95.75 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.247 1.019 . . . . 3.7000000000000002 113.36 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 144.39 93.13 0.16 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 107.009 -2.436 . . . . 3.3300000000000001 107.009 -165.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -150.64 -179.43 7.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.333 1.053 . . . . 2.98 108.811 -173.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.77 -40.66 40.09 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.001 1.32 . . . . 8.0899999999999999 108.057 168.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -96.34 -149.21 0.31 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.767 0.827 . . . . 8.0899999999999999 108.973 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -142.22 151.1 41.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.93 -1.137 . . . . 5.0700000000000003 107.93 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -105.03 171.55 7.26 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 124.814 1.246 . . . . 7.2599999999999998 108.302 164.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -161.72 162.27 29.65 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.314 1.446 . . . . 3.3300000000000001 108.684 -172.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -65.82 -156.04 0.31 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.146 0.879 . . . . 2.0899999999999999 112.726 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -56.15 106.91 0.31 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.592 0.757 . . . . 4.9500000000000002 111.5 -171.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.59 -146.9 18.6 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.183 -1.567 . . . . 2.0600000000000001 109.183 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.53 -126.32 24.21 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 125.342 1.448 . . . . 1.78 110.913 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.2 mm -76.99 130.66 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 122.488 1.137 . . . . 2.29 108.023 173.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.1 mp -84.37 -46.27 11.9 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.725 2.01 . . . . 1.8300000000000001 110.11 170.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -168.37 172.55 8.31 Favored 'General case' 0 C--N 1.338 0.107 0 O-C-N 121.042 -1.036 . . . . 0.90000000000000002 111.402 -176.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -158.33 139.59 13.33 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.092 0.957 . . . . 1.3799999999999999 111.469 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -162.59 174.38 12.69 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.763 -1.199 . . . . 0.77000000000000002 107.763 -174.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.59 151.43 18.69 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.26 -1.015 . . . . 7.8399999999999999 108.26 -173.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -102.31 -79.34 1.38 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.201 -1.56 . . . . 0.93000000000000005 109.201 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.24 177.6 6.41 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.986 2.457 . . . . 2.27 110.51 176.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 97.2 132.11 7.29 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 109.796 -1.322 . . . . 2.4700000000000002 109.796 -175.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.3 p -77.92 150.78 34.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.538 0.735 . . . . 3.0299999999999998 109.472 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.46 -132.2 10.61 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 108.04 -2.024 . . . . 1.8500000000000001 108.04 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . 0.254 10.7 tp -62.94 -43.21 98.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 117.955 -1.022 . . . . 3.9900000000000002 110.662 -171.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 31.15 130.36 0.0 OUTLIER Glycine 0 CA--C 1.544 1.879 0 C-N-CA 130.299 3.809 . . . . 1.98 119.063 164.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 84.83 -21.73 10.74 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.093 -1.828 . . . . 1.0 111.845 -175.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -84.7 148.85 26.17 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 124.638 1.175 . . . . 1.6100000000000001 110.437 -169.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.42 124.56 36.57 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.5 0.556 . . . . 0.68999999999999995 112.5 -162.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -114.25 108.34 16.81 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 117.208 -1.377 . . . . 2.96 110.199 -168.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.11 147.12 23.77 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 121.761 2.073 . . . . 3.7599999999999998 110.119 172.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -70.16 99.45 1.5 Allowed 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 123.585 0.553 . . . . 2.7400000000000002 109.891 176.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -14.59 61.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.217 -0.897 . . . . 3.0800000000000001 110.896 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -57.66 -32.05 66.93 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 121.045 1.748 . . . . 2.6200000000000001 109.498 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.61 170.12 15.86 Favored 'General case' 0 C--O 1.246 0.891 0 C-N-CA 125.044 1.337 . . . . 2.77 110.292 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -117.13 100.9 8.03 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.01 -1.107 . . . . 5.7300000000000004 108.01 169.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 35.4 m95 -78.33 146.23 34.84 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.637 -1.165 . . . . 1.77 109.305 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.3 p -120.47 138.58 53.74 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.732 0.813 . . . . 2.23 109.667 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -50.09 -49.48 51.44 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.745 1.218 . . . . 2.1499999999999999 110.059 169.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -82.26 -178.47 7.05 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.034 1.334 . . . . 2.73 111.654 175.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.658 ' HG ' ' HH ' ' A' ' 242' ' ' TYR . 1.1 m -54.08 -58.12 8.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.343 1.457 . . . . 4.1699999999999999 110.943 -172.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 43.02 -100.49 0.02 OUTLIER Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.312 1.434 . . . . 2.5899999999999999 114.409 169.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -116.71 -70.67 0.44 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.536 -1.026 . . . . 1.73 110.536 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.72 177.65 7.47 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.702 -1.962 . . . . 1.8100000000000001 105.702 169.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -132.92 130.97 40.33 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.924 0.784 . . . . 1.6299999999999999 111.658 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -62.4 -48.97 77.37 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 108.358 -0.979 . . . . 2.6499999999999999 108.358 -174.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -50.63 -50.37 54.53 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.665 -0.495 . . . . 2.3300000000000001 109.665 177.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 7.0 tt -58.65 -58.98 6.19 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.637 1.175 . . . . 1.9099999999999999 109.366 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.317 6.7 m -58.86 -37.52 76.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.574 0.702 . . . . 1.6799999999999999 110.784 176.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.39 -43.76 96.34 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 121.367 -0.833 . . . . 0.90000000000000002 110.877 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 44.1 t -52.84 -44.81 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.948 1.249 . . . . 2.1499999999999999 109.93 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.553 ' HD1' ' C3 ' ' A' ' 269' ' ' NGH . 6.4 t-160 -52.24 -58.55 6.28 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.956 1.303 . . . . 3.2799999999999998 112.667 169.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -69.17 -33.89 74.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.93 1.085 . . . . 3.1299999999999999 113.93 -174.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.404 HG13 ' CE1' ' A' ' 138' ' ' PHE . 0.4 OUTLIER -71.55 -37.85 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 107.282 -1.377 . . . . 1.8500000000000001 107.282 175.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -52.01 -48.44 52.04 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 110.673 -0.971 . . . . 0.81000000000000005 110.673 167.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.503 ' CE1' ' CD2' ' A' ' 218' ' ' HIS . 18.1 m170 -58.79 -44.75 90.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.908 -0.76 . . . . 4.6100000000000003 111.265 174.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.513 ' HG ' HD11 ' A' ' 159' ' ' ILE . 47.6 t -54.0 -55.43 27.33 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.021 0.528 . . . . 2.3900000000000001 111.823 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.2 pp -60.88 -33.72 73.52 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 118.697 -0.668 . . . . 4.3600000000000003 112.415 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 114.57 102.99 2.48 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.105 -1.198 . . . . 1.5 110.105 172.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -108.3 167.17 10.21 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.088 1.144 . . . . 7.3899999999999997 114.088 -175.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -113.2 11.94 24.19 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.411 1.005 . . . . 3.3799999999999999 113.348 167.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 4.5 m80 64.53 98.87 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.904 1.682 . . . . 2.4100000000000001 114.535 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.6 m -75.08 161.9 29.01 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.038 0.447 . . . . 1.6599999999999999 110.44 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.1 p -122.11 11.46 10.2 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.406 1.482 . . . . 3.4100000000000001 111.541 -165.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -119.25 138.57 26.48 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 125.463 1.505 . . . . 1.75 108.664 -169.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -80.81 -12.59 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.946 1.764 . . . . 1.46 114.992 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -75.23 -24.06 57.66 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 120.247 1.385 . . . . 1.77 110.128 172.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -71.77 167.85 19.05 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.941 1.296 . . . . 0.94999999999999996 111.878 176.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.07 -26.14 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 125.668 1.587 . . . . 0.95999999999999996 111.93 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -26.81 68.97 Favored 'General case' 0 C--O 1.245 0.818 0 O-C-N 120.54 -1.35 . . . . 3.02 112.235 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -48.22 177.1 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 130.249 3.419 . . . . 4.7699999999999996 114.094 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.407 ' O ' ' O5 ' ' A' ' 269' ' ' NGH . 86.5 Cg_endo -90.09 -18.4 1.41 Allowed 'Trans proline' 0 CA--C 1.537 0.634 0 CA-C-N 122.319 1.864 . . . . 1.54 112.13 174.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.36 0.2 OUTLIER -81.22 -176.77 6.15 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.086 1.354 . . . . 2.25 110.764 -172.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -113.95 150.07 34.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.341 1.456 . . . . 3.5600000000000001 108.059 171.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.97 137.28 13.89 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.103 -1.073 . . . . 3.5499999999999998 108.103 169.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.658 ' HH ' ' HG ' ' A' ' 207' ' ' SER . 68.9 t80 -65.17 121.25 14.32 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.72 0.808 . . . . 3.9100000000000001 110.562 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.33 135.81 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.165 0.986 . . . . 1.8400000000000001 108.792 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.82 117.38 21.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.844 -0.799 . . . . 5.1299999999999999 108.844 176.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.1 pp -53.03 -33.62 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 C-N-CA 122.922 0.489 . . . . 4.5 110.348 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -52.53 -36.06 54.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.092 0.957 . . . . 4.5800000000000001 112.045 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 25.1 m -74.01 -48.29 31.19 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 119.17 -0.443 . . . . 2.8500000000000001 109.959 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 53.35 87.65 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.271 1.028 . . . . 5.7699999999999996 110.445 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.02 163.21 37.96 Favored 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 121.466 -0.771 . . . . 4.5499999999999998 110.773 175.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.27 154.48 30.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.601 1.56 . . . . 0.84999999999999998 107.836 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.2 m -79.18 152.66 30.56 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 118.012 0.369 . . . . 1.72 111.1 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -58.77 -41.78 87.42 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.762 -0.586 . . . . 1.0800000000000001 111.417 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -51.53 -51.5 54.78 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.903 0.858 . . . . 2.3300000000000001 108.941 171.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.59 -47.07 85.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.8 -1.091 . . . . 2.25 111.442 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 69.2 mt -44.61 -37.6 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.676 1.19 . . . . 1.3400000000000001 111.26 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -65.29 -63.2 1.16 Allowed 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.529 -0.732 . . . . 5.2800000000000002 110.989 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -55.83 -46.66 82.72 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.723 -0.551 . . . . 0.98999999999999999 111.723 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 2.0 pp -70.0 -28.75 37.53 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 C-N-CA 124.76 1.224 . . . . 3.5899999999999999 110.503 -173.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -84.62 -24.19 29.21 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.645 1.111 . . . . 3.3700000000000001 112.024 171.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 46.1 m -58.32 -33.1 69.13 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.85 0.75 . . . . 3.1099999999999999 111.699 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 30.5 mt 40.38 53.26 2.94 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.336 1.854 . . . . 4.6900000000000004 112.498 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -128.19 -173.86 3.06 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.108 1.363 . . . . 10.25 109.045 -172.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.551 1 CA-C-O 80.41 -22.328 . . . . 11.869999999999999 111.742 162.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' NGH . . . . . 0.553 ' C3 ' ' HD1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 108.656 -0.868 . . . . 19.34 108.656 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 179.74 63.81 0.07 OUTLIER Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.832 -0.907 . . . . 13.98 110.832 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.76 130.34 16.79 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.37 2.046 . . . . 16.16 109.613 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.6 p -155.88 154.68 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.413 -1.328 . . . . 10.01 107.413 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -147.92 -52.59 0.19 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.236 1.014 . . . . 14.539999999999999 109.612 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 54.3 33.69 18.9 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.464 0.706 . . . . 8.8699999999999992 111.579 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.5 -84.81 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.224 1.41 . . . . 7.0800000000000001 110.974 -174.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 66.08 -71.3 0.09 Allowed 'General case' 0 C--O 1.231 0.118 0 C-N-CA 127.01 2.124 . . . . 5.0899999999999999 110.48 -177.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -116.5 118.19 31.99 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.443 1.497 . . . . 3.96 107.546 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 24.0 mm -115.36 154.06 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.509 -1.293 . . . . 3.3999999999999999 107.509 160.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.92 133.31 13.63 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 104.509 -2.404 . . . . 3.2999999999999998 104.509 -171.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -128.79 169.18 14.85 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 123.806 0.842 . . . . 5.4199999999999999 111.383 -174.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -153.55 155.59 36.45 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.487 -0.931 . . . . 5.3600000000000003 108.487 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -95.32 162.12 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.719 -1.586 . . . . 1.51 106.719 172.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -86.08 -48.86 8.25 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.032 -1.099 . . . . 4.1600000000000001 108.032 172.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -157.25 167.47 30.25 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.359 1.064 . . . . 2.6899999999999999 109.189 -170.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.592 ' HH ' HD22 ' A' ' 153' ' ' ASN . 51.1 m-85 -112.24 173.03 6.56 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.454 1.502 . . . . 2.9199999999999999 108.927 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.7 t -129.58 135.22 27.2 Favored Pre-proline 0 N--CA 1.445 -0.683 0 N-CA-C 105.83 -1.915 . . . . 2.6699999999999999 105.83 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.48 -19.06 17.23 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.251 2.634 . . . . 2.5299999999999998 112.085 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -37.58 -41.84 0.5 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.406 2.682 . . . . 2.5699999999999998 112.604 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.5 ptp -136.39 173.56 11.58 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.991 0.917 . . . . 3.48 108.88 173.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -70.02 142.0 52.81 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.915 -0.402 . . . . 3.1699999999999999 109.915 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -52.77 -47.7 67.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.118 -0.467 . . . . 3.5800000000000001 111.885 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -45.23 -49.6 12.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.045 -0.724 . . . . 3.8900000000000001 109.045 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.74 -40.71 92.41 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.19 0.996 . . . . 2.0099999999999998 113.364 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.4 t -53.67 -54.63 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.318 -0.993 . . . . 1.74 108.318 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -37.22 83.73 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 119.121 -1.032 . . . . 1.72 108.837 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -55.6 -45.35 77.45 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 119.598 1.09 . . . . 3.5800000000000001 111.753 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.18 -52.16 59.72 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 120.894 0.378 . . . . 0.48999999999999999 110.415 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -72.88 -31.82 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.917 -0.583 . . . . 2.52 110.549 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -57.24 13.1 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.769 -1.567 . . . . 3.8199999999999998 106.769 177.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -66.96 -44.53 80.31 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.427 -1.261 . . . . 2.1899999999999999 109.11 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.24 -53.82 25.49 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 112.483 0.549 . . . . 0.45000000000000001 112.483 173.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.72 -48.37 81.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 119.019 -1.073 . . . . 7.9400000000000004 108.127 177.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.47 -29.7 62.02 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.638 -0.696 . . . . 2.8599999999999999 112.082 -173.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 99.4 t -60.75 -66.8 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 119.02 0.827 . . . . 1.26 109.33 174.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -69.49 -43.09 73.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.465 -0.939 . . . . 1.04 108.465 -169.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.1 t -58.3 -19.01 31.3 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.777 1.231 . . . . 1.8100000000000001 111.865 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -79.29 -44.42 21.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 118.206 0.457 . . . . 1.76 109.929 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.0 m -76.36 -39.92 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 111.907 0.336 . . . . 2.3700000000000001 111.907 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.6 p -83.46 152.69 64.47 Favored Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 107.876 -1.157 . . . . 1.5700000000000001 107.876 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.33 11.39 1.55 Allowed 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.117 2.545 . . . . 1.6899999999999999 113.857 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.86 127.56 56.22 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.238 1.415 . . . . 3.79 110.251 -173.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.29 117.58 33.0 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.034 0.533 . . . . 4.4199999999999999 110.096 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -81.01 160.51 24.55 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.329 1.052 . . . . 7.46 110.772 168.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.8 t -156.7 144.86 19.55 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.466 1.506 . . . . 2.0299999999999998 107.384 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -89.91 149.37 22.64 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 120.491 1.496 . . . . 2.9100000000000001 108.899 173.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.9 pt -127.01 147.78 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 105.742 -1.948 . . . . 1.8500000000000001 105.742 164.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.592 HD22 ' HH ' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -102.44 -5.41 24.11 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.898 0.479 . . . . 3.4700000000000002 110.515 172.471 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 99.4 m -155.4 117.53 4.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.405 -1.332 . . . . 3.1899999999999999 107.405 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 140.76 177.4 16.11 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 107.711 -2.156 . . . . 1.8899999999999999 107.711 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.3 mmt -87.83 141.33 28.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.164 -1.05 . . . . 7.1900000000000004 108.164 164.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -123.42 168.89 11.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.19 -1.411 . . . . 0.90000000000000002 107.19 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -76.46 -45.21 32.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.833 -0.803 . . . . 1.6499999999999999 108.833 -175.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.2 pt -113.94 176.69 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 124.617 1.167 . . . . 1.21 109.91 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.11 135.38 30.87 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.178 1.391 . . . . 2.8599999999999999 109.072 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 36.5 t -93.32 108.68 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.227 -1.398 . . . . 0.85999999999999999 107.227 168.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.07 107.24 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.747 1.219 . . . . 3.7400000000000002 109.964 -175.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -88.4 171.68 9.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.284 -1.006 . . . . 7.21 108.284 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -155.62 -169.59 3.16 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.279 -1.378 . . . . 1.7 107.279 167.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 35.0 mtm180 -139.51 125.81 20.17 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.719 -0.845 . . . . 6.5999999999999996 108.719 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.61 -67.88 3.07 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 125.366 1.46 . . . . 2.6299999999999999 110.599 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -155.95 159.7 39.46 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.553 0.741 . . . . 2.4900000000000002 109.075 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -162.68 -173.78 3.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 106.872 -1.529 . . . . 3.3599999999999999 106.872 168.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.3 110.15 3.07 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 109.33 -1.508 . . . . 3.6299999999999999 109.33 169.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -144.36 168.44 20.09 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.269 1.028 . . . . 4.2199999999999998 109.726 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.4 -38.3 30.53 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.146 1.378 . . . . 9.5299999999999994 109.398 171.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -103.73 -104.08 0.29 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.829 1.652 . . . . 8.0600000000000005 108.588 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -172.37 167.35 5.71 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.398 1.479 . . . . 4.4199999999999999 108.086 -176.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -105.41 172.49 6.76 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.797 1.239 . . . . 7.54 108.11 163.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -162.98 153.8 16.83 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.122 0.969 . . . . 3.8399999999999999 109.175 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -70.84 -149.61 0.59 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.59 0.614 . . . . 1.75 113.203 -174.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -54.31 109.41 0.48 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.708 1.203 . . . . 4.5599999999999996 110.083 -176.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 99.49 -144.38 17.02 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.723 -1.351 . . . . 1.8799999999999999 109.723 -171.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 48.26 -132.32 19.8 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.418 -1.473 . . . . 1.6100000000000001 109.418 -170.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.512 ' HA ' ' O3 ' ' A' ' 269' ' ' NGH . 1.8 tp -77.72 148.51 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 118.038 0.919 . . . . 3.9500000000000002 108.855 175.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . 0.5 5.4 mp -84.75 -44.98 12.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.297 1.439 . . . . 1.8300000000000001 110.577 173.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -165.63 168.28 16.45 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 122.189 -0.319 . . . . 0.87 111.011 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -146.99 120.64 9.16 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 124.277 1.031 . . . . 1.29 113.782 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -139.07 160.96 38.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 120.656 -1.278 . . . . 0.75 107.62 -176.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -141.65 149.6 40.85 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.351 -1.352 . . . . 4.4500000000000002 107.351 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -100.84 -87.63 1.98 Allowed Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.622 -0.991 . . . . 0.81999999999999995 110.622 173.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.17 84.71 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.523 2.815 . . . . 1.53 111.53 -169.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -159.24 165.21 34.24 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.234 -1.546 . . . . 1.3700000000000001 109.234 170.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.0 p -79.39 172.79 13.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.752 0.821 . . . . 3.2799999999999998 109.536 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.21 -105.7 0.27 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 123.865 0.745 . . . . 1.6499999999999999 111.838 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.4 tp -59.65 -40.58 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 118.717 -0.659 . . . . 1.6299999999999999 110.006 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -41.49 135.46 2.97 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 118.976 0.807 . . . . 1.1399999999999999 112.429 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 98.87 -36.98 3.69 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.873 1.702 . . . . 0.65000000000000002 111.646 -166.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -84.02 160.42 21.0 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.946 0.873 . . . . 1.24 110.34 -163.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -134.05 130.71 37.91 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.605 0.762 . . . . 0.68000000000000005 111.871 -169.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -119.96 99.52 6.67 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 117.925 -1.036 . . . . 2.7000000000000002 110.793 -161.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -84.73 139.11 32.22 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 121.165 1.802 . . . . 4.2199999999999998 111.468 176.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.87 61.88 0.42 Allowed 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 123.687 0.617 . . . . 3.3700000000000001 110.329 171.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.21 -6.37 13.42 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 120.607 -1.308 . . . . 5.2300000000000004 111.997 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -27.15 -65.02 0.08 Allowed 'General case' 0 C--N 1.341 0.205 0 C-N-CA 127.851 2.46 . . . . 5.2000000000000002 110.055 158.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . 0.256 2.2 pt-20 -78.72 175.5 10.38 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.308 -0.86 . . . . 3.5800000000000001 110.562 -169.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -98.42 103.11 15.03 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 106.223 -1.769 . . . . 4.7999999999999998 106.223 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -78.3 134.52 37.5 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.918 -1.512 . . . . 1.96 106.918 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.1 p -132.35 75.8 1.66 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.412 -1.329 . . . . 3.2000000000000002 107.412 -171.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.04 -49.31 70.63 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 123.864 0.866 . . . . 4.1200000000000001 108.817 -174.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -55.48 -32.76 63.1 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.906 0.706 . . . . 4.54 112.906 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.8 t -81.47 -42.43 20.32 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.216 0.606 . . . . 7.6500000000000004 110.495 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 106.02 16.57 14.83 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.92 1.247 . . . . 4.3899999999999997 112.952 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.71 -84.62 0.18 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.475 -1.05 . . . . 2.1699999999999999 110.475 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 61.9 m -107.79 119.85 40.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.007 -2.59 . . . . 1.5700000000000001 104.007 157.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -94.84 115.26 27.26 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 124.333 1.021 . . . . 1.4399999999999999 108.293 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.67 -48.66 49.37 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.453 0.701 . . . . 2.25 110.409 -177.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -47.92 -49.77 29.07 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.205 0.602 . . . . 2.3700000000000001 110.955 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.1 tt -56.7 -60.24 3.84 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.144 0.978 . . . . 1.5800000000000001 109.676 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.502 HG21 ' H2 ' ' A' ' 269' ' ' NGH 0.266 93.4 m -57.52 -41.98 81.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.572 -0.74 . . . . 2.02 110.692 177.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.08 -39.62 86.71 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 118.268 -0.872 . . . . 0.54000000000000004 112.1 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.8 t -56.07 -57.65 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 119.842 1.201 . . . . 1.1599999999999999 108.658 175.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -43.84 -53.57 5.92 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.729 0.812 . . . . 3.9900000000000002 112.492 172.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -69.07 -34.66 75.5 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.264 -0.898 . . . . 2.52 113.207 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 4.4 mm -60.6 -47.12 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 106.955 -1.498 . . . . 3.9100000000000001 106.955 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.58 -51.18 33.74 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 111.667 -0.573 . . . . 0.81000000000000005 111.667 173.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.402 ' CE1' ' CD2' ' A' ' 228' ' ' HIS . 4.3 m-70 -54.36 -49.16 70.45 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 121.483 -1.01 . . . . 1.9099999999999999 111.42 176.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 14.5 t -51.57 -48.04 63.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 123.401 0.438 . . . . 2.4500000000000002 111.341 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.22 -36.65 84.37 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.163 -0.615 . . . . 2.77 110.185 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 116.05 55.68 0.34 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 109.934 -1.266 . . . . 1.3100000000000001 109.934 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -103.32 125.3 49.88 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.075 0.55 . . . . 4.9900000000000002 110.475 173.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.61 139.81 47.09 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.461 -1.056 . . . . 2.6600000000000001 110.461 171.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.402 ' CD2' ' CE1' ' A' ' 222' ' ' HIS . 17.7 m80 -43.69 114.17 0.61 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.537 1.535 . . . . 1.98 111.647 173.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 55.8 m -73.93 165.97 24.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.431 0.56 . . . . 1.25 109.78 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 12.4 m -128.33 39.99 3.74 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.437 1.495 . . . . 3.1699999999999999 110.12 -167.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -141.4 142.35 26.27 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 106.863 -1.532 . . . . 1.75 106.863 -174.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -88.98 -14.19 2.87 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.176 1.917 . . . . 1.1599999999999999 114.793 -174.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -82.1 -32.05 30.41 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.065 0.946 . . . . 2.1200000000000001 109.093 172.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.73 152.62 6.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.516 0.727 . . . . 0.92000000000000004 111.014 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 57.7 t -110.5 -20.38 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.254 -1.339 . . . . 0.93999999999999995 110.261 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -31.61 71.59 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.462 1.028 . . . . 2.77 111.181 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -48.07 159.3 0.49 Allowed Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 127.178 2.191 . . . . 4.6500000000000004 114.013 -174.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.503 ' HB2' ' H91' ' A' ' 269' ' ' NGH . 18.6 Cg_endo -71.81 -23.09 22.83 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.415 1.41 . . . . 1.6000000000000001 111.884 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.355 0.2 OUTLIER -78.24 173.29 12.43 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.076 1.35 . . . . 2.3700000000000001 110.219 -171.221 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.459 ' HA ' ' H4 ' ' A' ' 269' ' ' NGH . 44.4 t80 -112.17 140.76 46.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.414 -1.328 . . . . 3.7000000000000002 107.414 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.6 125.59 12.82 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.461 -2.051 . . . . 2.9100000000000001 105.461 172.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -53.22 130.86 35.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.166 0.986 . . . . 4.3799999999999999 110.529 -176.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.53 137.22 52.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 C-N-CA 123.599 0.76 . . . . 2.3799999999999999 110.365 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.85 -42.43 97.58 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.539 1.135 . . . . 3.4199999999999999 111.7 171.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 6.7 mt 69.32 8.57 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 126.118 1.767 . . . . 3.3999999999999999 110.851 -159.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -64.22 -53.96 41.02 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 120.597 -1.315 . . . . 4.2000000000000002 111.253 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 12.1 m -81.82 -41.37 21.18 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.964 0.906 . . . . 2.3700000000000001 109.872 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 57.3 t80 57.43 72.81 0.49 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 122.09 0.948 . . . . 5.5599999999999996 109.953 176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.21 162.04 37.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.955 -0.757 . . . . 3.2999999999999998 108.955 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -95.95 158.21 15.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.637 1.575 . . . . 0.88 108.281 -178.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 2.9 m -76.13 158.71 31.45 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 122.059 -0.401 . . . . 1.4099999999999999 110.695 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.73 -43.74 85.52 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.568 -0.16 . . . . 1.3400000000000001 110.568 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -53.25 -55.92 20.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.564 0.697 . . . . 2.6499999999999999 109.492 173.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.36 -42.32 81.81 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.396 -0.82 . . . . 2.25 110.919 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.467 ' HA ' ' CG2' ' A' ' 258' ' ' ILE . 38.9 mt -55.96 -22.33 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 126.871 2.068 . . . . 1.5600000000000001 111.498 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 -77.14 -55.47 5.41 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.817 -1.177 . . . . 6.2000000000000002 110.273 168.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -50.7 -55.48 17.35 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.534 -1.027 . . . . 0.88 110.534 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.467 ' CG2' ' HA ' ' A' ' 255' ' ' ILE . 0.0 OUTLIER -41.85 -56.26 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 C-N-CA 125.347 1.459 . . . . 3.7400000000000002 111.527 175.597 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -72.98 -21.61 60.82 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.997 0.817 . . . . 2.4700000000000002 110.791 -173.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.9 t -67.15 -25.49 66.19 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 118.695 -0.669 . . . . 2.7400000000000002 111.553 168.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 41.67 46.51 3.22 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.934 2.094 . . . . 5.6299999999999999 112.518 -174.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -135.71 137.18 41.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.869 0.468 . . . . 12.609999999999999 112.238 -167.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 C-N-CA 126.263 1.887 . . . . 13.609999999999999 110.037 175.53 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' NGH . . . . . 0.758 ' C1 ' H101 ' A' ' 269' ' ' NGH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 77.9 mtp . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 107.089 -1.448 . . . . 12.529999999999999 107.089 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 151.25 82.52 0.04 OUTLIER Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.471 -1.052 . . . . 8.7799999999999994 110.471 -176.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.65 168.64 23.93 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.464 2.109 . . . . 10.34 110.189 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.6 p -154.91 154.05 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.243 -1.021 . . . . 5.8399999999999999 108.243 -177.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -85.11 157.92 20.56 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.605 0.717 . . . . 12.32 111.555 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -60.12 -47.44 85.92 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.68 1.192 . . . . 8.8300000000000001 111.476 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -158.27 -64.73 0.09 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.462 0.705 . . . . 7.6200000000000001 109.191 -173.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.11 -66.96 0.09 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.218 1.807 . . . . 4.8399999999999999 112.25 -175.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -79.85 107.85 12.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.159 1.384 . . . . 3.5600000000000001 107.841 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.66 136.89 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 106.564 -1.643 . . . . 3.2200000000000002 106.564 168.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.3 t -142.9 142.95 31.86 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 120.702 0.287 . . . . 3.1899999999999999 110.713 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -130.17 163.84 25.78 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.507 1.123 . . . . 5.4900000000000002 111.488 -170.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -145.22 142.28 29.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.934 -0.765 . . . . 4.9100000000000001 108.934 173.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -83.33 152.91 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 108.499 -0.926 . . . . 1.3200000000000001 108.499 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -88.22 -45.41 10.11 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.391 -0.596 . . . . 4.25 109.391 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -155.35 170.22 22.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.222 -1.029 . . . . 2.3999999999999999 108.222 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.07 127.28 53.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.141 0.976 . . . . 2.9700000000000002 108.916 -165.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.3 t -64.4 124.01 84.49 Favored Pre-proline 0 N--CA 1.442 -0.86 0 C-N-CA 123.941 0.897 . . . . 3.5899999999999999 109.419 -176.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -69.89 -19.07 35.96 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.499 2.8 . . . . 2.2799999999999998 110.138 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -36.59 -40.34 0.25 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.715 2.006 . . . . 2.7799999999999998 111.808 169.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 16.2 mtm -135.76 177.29 7.95 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.255 1.422 . . . . 2.73 109.506 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -76.53 141.98 41.02 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.548 -0.72 . . . . 3.5899999999999999 109.262 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 54.6 ttt-85 -41.54 -48.93 4.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.707 0.685 . . . . 2.7999999999999998 112.285 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -49.39 -47.06 47.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.707 -0.479 . . . . 3.3700000000000001 109.707 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -69.46 -40.71 76.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.408 1.483 . . . . 1.8500000000000001 111.101 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 56.8 t -54.06 -53.82 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 120.811 -1.181 . . . . 1.8300000000000001 109.555 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -25.69 65.29 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 118.77 -1.172 . . . . 1.98 110.01 178.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -63.12 -47.83 81.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.891 0.769 . . . . 3.1000000000000001 109.798 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.91 -53.46 56.57 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.352 0.661 . . . . 0.45000000000000001 110.498 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.82 -41.35 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 109.284 -0.636 . . . . 3.0099999999999998 109.284 -178.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -50.41 -58.59 5.37 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.371 -0.974 . . . . 4.2199999999999998 108.371 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -60.3 -52.0 67.14 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.522 1.129 . . . . 2.3399999999999999 109.249 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -46.48 -49.17 18.77 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 123.944 0.898 . . . . 0.65000000000000002 112.289 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.435 ' HB3' ' CD2' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -66.02 -45.99 79.53 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.996 -0.742 . . . . 6.2300000000000004 108.996 178.086 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.03 -42.25 37.61 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.759 0.824 . . . . 3.8300000000000001 110.829 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.0 t -48.46 -61.51 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.059 0.944 . . . . 1.1599999999999999 110.134 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -73.09 -32.5 65.02 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.423 -0.798 . . . . 1.27 109.736 -175.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 t -61.03 -17.87 54.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.932 0.493 . . . . 2.0699999999999998 111.332 175.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.02 -45.98 15.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.839 -0.8 . . . . 2.3199999999999998 108.839 -177.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.6 m -78.85 -46.28 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.412 0.685 . . . . 2.1800000000000002 111.971 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 43.2 p -82.79 159.14 64.05 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.407 -0.59 . . . . 1.3500000000000001 109.407 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.92 -1.8 11.84 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.764 1.643 . . . . 0.81000000000000005 112.581 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.9 mp -65.34 127.37 31.47 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.59 -0.893 . . . . 3.5099999999999998 108.59 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.44 96.19 6.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.921 -1.14 . . . . 5.1699999999999999 107.921 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.435 ' CD2' ' HB3' ' A' ' 138' ' ' PHE . 1.4 p90 -69.12 155.48 40.31 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.347 -0.388 . . . . 8.2100000000000009 111.534 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.9 t -158.85 140.19 13.19 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.016 0.826 . . . . 2.1099999999999999 111.079 163.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.01 149.83 22.37 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.025 -1.102 . . . . 2.8999999999999999 108.025 171.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.9 pp -129.75 156.9 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 106.018 -1.845 . . . . 2.6200000000000001 106.018 173.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -111.7 -16.62 13.18 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.242 0.339 . . . . 3.6299999999999999 110.577 172.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.9 m -107.19 78.04 1.19 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.603 0.761 . . . . 3.1099999999999999 109.753 -174.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 15.06 63.59 0.01 OUTLIER Glycine 0 CA--C 1.537 1.447 0 C-N-CA 128.144 2.783 . . . . 4.2000000000000002 118.286 171.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 31.7 mtt -147.8 75.69 1.36 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.092 1.357 . . . . 8.9800000000000004 107.786 166.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -124.06 155.08 38.98 Favored 'General case' 0 N--CA 1.461 0.08 0 C-N-CA 123.614 0.766 . . . . 1.1100000000000001 109.598 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.23 -49.46 7.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.042 0.937 . . . . 2.1899999999999999 108.691 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.9 pt -110.25 161.52 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.464 0.705 . . . . 1.1899999999999999 110.511 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.14 140.02 52.91 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.434 0.693 . . . . 3.1499999999999999 110.324 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.87 100.13 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.702 0.801 . . . . 1.1799999999999999 109.215 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.33 93.19 4.23 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 C-N-CA 125.007 1.323 . . . . 1.95 111.05 -171.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -80.94 116.22 20.8 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.536 -1.653 . . . . 6.7599999999999998 106.536 172.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -140.3 155.49 46.81 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 119.135 0.879 . . . . 1.03 109.431 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -124.38 128.51 49.18 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.821 0.849 . . . . 4.96 109.207 -164.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 48.63 -126.75 17.37 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.561 1.077 . . . . 1.8400000000000001 111.948 -164.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.15 137.82 38.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.103 0.561 . . . . 2.2599999999999998 109.722 -175.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.9 -36.01 0.32 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.839 0.681 . . . . 3.5800000000000001 112.839 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -170.39 -50.39 0.04 OUTLIER Glycine 0 CA--C 1.521 0.437 0 N-CA-C 108.674 -1.77 . . . . 2.52 108.674 -178.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.5 157.28 30.49 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 106.732 -1.581 . . . . 2.48 106.732 172.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -77.19 -56.03 4.92 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.334 -0.987 . . . . 6.4500000000000002 108.334 -172.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -69.27 -61.92 1.59 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.082 -0.963 . . . . 5.1200000000000001 110.177 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 41.14 -122.36 0.49 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.353 1.461 . . . . 3.02 111.089 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.41 ' CZ ' ' HB3' ' A' ' 200' ' ' ASP . 48.5 t80 -90.8 151.18 21.29 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.864 0.84 . . . . 9.2599999999999998 109.379 173.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -152.18 4.5 0.39 Allowed 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 126.421 1.888 . . . . 2.9500000000000002 111.779 -162.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.5 -173.02 24.55 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 122.067 0.815 . . . . 2.1400000000000001 112.301 -162.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 68.83 0.36 Allowed 'General case' 0 C--N 1.341 0.222 0 C-N-CA 127.32 2.248 . . . . 5.5899999999999999 110.471 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.35 -157.88 27.87 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 109.329 -1.508 . . . . 1.98 109.329 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 51.14 -125.28 24.22 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 127.097 2.284 . . . . 1.76 110.263 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 4.5 mm -78.82 138.66 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.26 -1.385 . . . . 2.6200000000000001 107.26 174.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.625 ' CB ' ' H1 ' ' A' ' 269' ' ' NGH 0.412 2.6 mp -84.46 -53.82 5.17 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.965 1.306 . . . . 1.6200000000000001 109.527 165.452 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.06 162.26 28.66 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 122.104 -0.373 . . . . 0.66000000000000003 110.132 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -144.37 121.31 11.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.995 1.318 . . . . 1.1399999999999999 114.495 -173.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -143.27 166.64 24.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 127.492 2.317 . . . . 0.91000000000000003 109.271 -171.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -151.78 143.25 23.48 Favored 'General case' 0 C--O 1.227 -0.09 0 N-CA-C 108.739 -0.838 . . . . 4.9500000000000002 108.739 175.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -91.06 -88.62 1.39 Allowed Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.347 -1.101 . . . . 0.60999999999999999 110.347 174.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.69 94.45 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.023 2.482 . . . . 1.4299999999999999 111.028 -174.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -170.2 161.66 34.8 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.069 -1.613 . . . . 1.4099999999999999 109.069 171.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 14.4 m -79.27 168.51 19.45 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.076 0.55 . . . . 2.7999999999999998 110.642 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 54.84 -106.04 0.46 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.813 0.721 . . . . 2.04 111.596 173.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.0 tp -59.69 -40.48 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 118.831 -0.604 . . . . 1.8200000000000001 109.465 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -44.79 141.4 3.78 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.123 -0.986 . . . . 1.3600000000000001 112.489 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 95.23 -37.97 3.26 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.504 1.526 . . . . 0.80000000000000004 111.25 -162.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -86.9 164.06 16.8 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.903 0.851 . . . . 1.1699999999999999 110.33 -166.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -139.6 121.06 15.08 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.85999999999999999 111.91 -172.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -110.54 132.13 54.45 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 118.203 -0.903 . . . . 2.98 109.328 -169.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -123.44 146.5 47.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.885 1.221 . . . . 3.96 110.541 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -66.02 90.51 0.14 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.803 -0.814 . . . . 2.7400000000000002 108.803 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -57.31 -47.37 81.69 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 119.757 -1.839 . . . . 3.1299999999999999 110.61 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 174' ' ' PHE . 1.9 t70 -51.4 -27.55 10.36 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.552 0.741 . . . . 2.8700000000000001 111.285 -178.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -67.17 136.89 55.77 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.074 -1.454 . . . . 2.7599999999999998 107.074 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.61 88.96 6.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.095 -1.076 . . . . 4.2800000000000002 108.095 -172.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 32.8 m95 -79.23 134.49 36.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.513 -1.292 . . . . 1.54 107.513 -174.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.6 p -122.55 137.67 54.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.646 -0.872 . . . . 2.0299999999999998 108.646 -176.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.5 t -50.47 -41.73 53.52 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 124.146 0.978 . . . . 1.9299999999999999 111.654 172.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -86.36 -154.39 0.22 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.323 0.649 . . . . 3.52 111.706 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.4 m -66.37 -62.29 1.55 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.579 0.752 . . . . 3.7999999999999998 110.474 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 39.97 -116.24 0.69 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.25 1.405 . . . . 2.75 113.787 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.03 -54.75 0.66 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.714 1.15 . . . . 2.1600000000000001 110.281 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.58 179.34 6.62 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.869 -1.53 . . . . 1.9199999999999999 106.869 172.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -136.89 127.63 27.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 122.942 0.497 . . . . 2.0099999999999998 111.36 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 25.2 tp -59.14 -51.54 69.59 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 123.838 0.711 . . . . 3.0899999999999999 110.314 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -50.41 -45.48 55.68 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.352 0.596 . . . . 2.2599999999999998 109.654 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.7 tt -63.55 -59.1 5.07 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.588 -0.695 . . . . 1.6200000000000001 110.299 -174.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.256 1.8 m -57.33 -38.94 74.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.351 -0.386 . . . . 1.9299999999999999 110.541 178.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.32 -60.39 3.36 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 117.093 -1.432 . . . . 0.64000000000000001 109.856 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 85.2 t -45.48 -50.64 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 121.234 1.834 . . . . 1.1599999999999999 110.672 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.418 ' CD2' ' O4 ' ' A' ' 269' ' ' NGH . 26.1 t60 -57.43 -58.29 8.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.727 0.811 . . . . 3.4500000000000002 112.523 175.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.26 -42.41 79.65 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.644 -1.285 . . . . 2.96 111.911 -173.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -53.16 -41.1 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 123.972 0.909 . . . . 1.79 109.907 167.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.72 -51.45 38.82 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 123.845 0.736 . . . . 0.62 111.262 170.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . 0.3 20.9 m-70 -53.91 -51.52 63.48 Favored 'General case' 0 C--O 1.226 -0.177 0 O-C-N 121.638 -0.919 . . . . 2.1299999999999999 109.902 172.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.5 m -52.87 -51.04 62.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.529 0.566 . . . . 2.6899999999999999 112.529 -177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.49 -28.94 70.0 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 119.137 -0.458 . . . . 3.9399999999999999 111.595 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 114.9 82.65 1.06 Allowed Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.474 -1.05 . . . . 1.3799999999999999 110.474 172.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 10.7 mt -134.55 142.95 47.13 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 117.622 0.711 . . . . 4.2000000000000002 110.401 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -77.5 164.3 52.16 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.127 -1.189 . . . . 2.9399999999999999 110.127 169.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -71.77 116.9 12.69 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.833 0.853 . . . . 2.1600000000000001 110.158 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.5 m -76.7 175.16 9.63 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.036 0.534 . . . . 1.72 110.896 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 30.4 m -136.84 40.97 2.53 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.637 1.175 . . . . 3.0299999999999998 110.762 -170.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -140.73 141.77 26.03 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.725 -1.583 . . . . 2.2799999999999998 106.725 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -85.51 -12.48 6.53 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.151 1.901 . . . . 1.3200000000000001 114.955 -174.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -80.66 -30.28 36.55 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.365 0.984 . . . . 1.75 109.552 173.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -59.27 153.82 17.8 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.963 0.905 . . . . 1.0700000000000001 110.258 170.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 50.0 t -105.49 -18.77 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.389 -1.278 . . . . 0.71999999999999997 109.873 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 7.5 tpt -76.69 -17.74 58.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.182 -0.949 . . . . 2.52 113.506 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.4 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -49.56 157.78 0.91 Allowed Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.542 1.537 . . . . 4.1399999999999997 113.32 174.086 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.62 ' O ' ' H5 ' ' A' ' 269' ' ' NGH . 68.5 Cg_endo -74.92 -19.21 18.26 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.874 1.716 . . . . 0.87 111.587 177.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.371 0.2 OUTLIER -77.32 177.0 8.29 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.293 1.437 . . . . 2.0899999999999999 109.834 -179.132 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -120.92 142.47 49.69 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.113 -1.44 . . . . 3.4100000000000001 107.113 174.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -148.44 123.37 10.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 104.899 -2.26 . . . . 3.46 104.899 172.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -52.44 115.83 1.96 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.417 0.553 . . . . 3.9300000000000002 109.552 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.4 m -108.99 126.25 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.764 -1.198 . . . . 1.77 107.764 171.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.43 108.36 3.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.966 -0.753 . . . . 3.8799999999999999 108.966 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.4 pp -50.57 -32.1 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.054 0 C-N-CA 125.361 1.464 . . . . 4.5700000000000003 111.182 178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -50.97 -38.97 54.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.343 0.657 . . . . 3.96 111.721 175.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.9 m -68.22 -46.71 69.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.201 0.6 . . . . 2.5 109.935 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 9.1 t80 52.61 82.89 0.07 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.036 1.334 . . . . 6.29 110.975 176.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.41 167.59 27.0 Favored 'General case' 0 CA--C 1.521 -0.15 0 O-C-N 120.525 -1.359 . . . . 4.6399999999999997 111.712 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -111.01 156.09 21.78 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.898 1.679 . . . . 0.98999999999999999 107.554 173.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.5 m -78.33 154.24 31.0 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.228 -0.286 . . . . 1.26 110.228 175.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -53.31 -45.61 69.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.622 0.369 . . . . 1.02 110.033 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -51.92 -57.18 10.18 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 122.071 0.939 . . . . 2.5299999999999998 110.057 174.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -58.26 -40.43 81.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.631 -1.168 . . . . 2.2999999999999998 111.379 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 45.8 mt -57.69 -47.31 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.656 0.782 . . . . 0.89000000000000001 110.051 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 32.5 mtt180 -59.92 -43.52 94.86 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 120.683 -1.26 . . . . 5.6600000000000001 110.144 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -48.26 -46.29 27.97 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.024 -0.831 . . . . 1.0 111.024 170.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.73 -47.88 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 O-C-N 121.776 -0.838 . . . . 4.5499999999999998 110.905 -176.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -63.03 -27.28 69.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.362 -0.935 . . . . 3.9700000000000002 110.582 -175.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 11.9 m -51.41 -19.66 1.46 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.987 1.106 . . . . 3.5499999999999998 113.987 171.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 18.5 mt -34.68 -56.76 0.54 Allowed 'General case' 0 C--N 1.349 0.568 0 CA-C-N 120.601 1.546 . . . . 3.2200000000000002 113.439 164.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -171.66 82.29 0.07 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.331 0.514 . . . . 6.5 110.656 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.407 0 N-CA-C 106.274 -2.73 . . . . 8.1999999999999993 106.274 178.36 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' NGH . . . . . 0.625 ' H1 ' ' CB ' ' A' ' 181' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 59.8 mtt . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 106.689 -1.597 . . . . 14.49 106.689 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.48 -157.24 37.64 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 111.216 -0.754 . . . . 8.0199999999999996 111.216 -174.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.93 122.57 9.7 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.958 2.438 . . . . 10.789999999999999 109.913 -173.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.64 152.95 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.052 -1.092 . . . . 5.7300000000000004 108.052 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -83.92 167.39 17.02 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.754 0.822 . . . . 11.58 110.978 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -82.68 -35.5 26.76 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.429 0.692 . . . . 9.0299999999999994 112.053 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.44 -62.13 0.14 Allowed 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.672 -0.643 . . . . 5.9400000000000004 110.021 -177.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 27.6 m170 61.0 -69.48 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.921 1.289 . . . . 5.0499999999999998 111.353 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -79.91 91.29 5.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 119.046 0.839 . . . . 3.48 110.545 -176.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.0 mp -91.8 88.2 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 107.278 -1.378 . . . . 3.6499999999999999 107.278 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.549 ' HG1' ' H ' ' A' ' 158' ' ' ASP . 31.2 p -81.39 120.09 24.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.262 -1.384 . . . . 1.6399999999999999 107.262 177.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -128.69 171.7 11.94 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 119.219 0.918 . . . . 4.6500000000000004 110.688 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -157.37 176.65 12.39 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.636 -0.665 . . . . 4.8499999999999996 109.829 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.8 mm -109.4 162.96 6.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.184 1.393 . . . . 2.71 108.332 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -102.57 -62.87 1.22 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.342 0.657 . . . . 4.3899999999999997 109.975 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -144.02 159.72 42.11 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.961 1.305 . . . . 2.02 107.595 176.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -111.67 127.31 55.73 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.218 -1.401 . . . . 3.7400000000000002 107.218 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.76 130.53 94.83 Favored Pre-proline 0 N--CA 1.444 -0.732 0 C-N-CA 124.05 0.94 . . . . 5.5 109.842 -177.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -70.04 -27.06 25.61 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.771 2.314 . . . . 2.8500000000000001 109.995 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.8 -28.71 69.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.527 1.131 . . . . 4.7599999999999998 111.368 171.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 35.9 mmt -102.23 179.88 4.18 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.116 0.871 . . . . 5.6200000000000001 109.457 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -105.23 113.72 27.48 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 108.11 -1.07 . . . . 3.48 108.11 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.48 -59.98 2.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.534 1.061 . . . . 3.3300000000000001 112.931 -176.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -49.26 -43.6 43.03 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 108.851 -0.796 . . . . 2.7799999999999998 108.851 -174.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -66.61 -42.96 86.04 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.9 1.28 . . . . 1.6699999999999999 112.571 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.2 t -58.48 -54.2 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 O-C-N 120.842 -1.161 . . . . 2.0299999999999998 108.798 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.428 ' OD2' ' NZ ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -62.92 -45.78 90.89 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.281 -1.007 . . . . 2.1400000000000001 108.281 178.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -53.3 -44.67 68.53 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.018 0.927 . . . . 4.6200000000000001 110.963 -176.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.25 -49.22 69.99 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 122.697 0.399 . . . . 0.67000000000000004 110.608 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.07 -31.17 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 120.874 0.369 . . . . 2.6800000000000002 110.315 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -62.23 -53.6 52.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.724 1.609 . . . . 4.0199999999999996 107.009 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -70.0 -44.8 68.62 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.886 1.674 . . . . 2.1499999999999999 109.863 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -47.34 -52.25 17.04 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.836 0.35 . . . . 0.60999999999999999 111.09 170.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.479 ' HB3' ' CD2' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -57.66 -56.46 21.64 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.951 -0.759 . . . . 5.79 108.951 177.692 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.78 -49.43 38.65 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.926 1.29 . . . . 4.46 110.98 -173.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 54.0 t -51.14 -50.66 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.425 1.09 . . . . 1.49 109.773 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 16.7 m95 -73.77 -32.33 63.74 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.693 -0.63 . . . . 1.5600000000000001 110.369 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.32 -7.29 41.5 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.206 1.402 . . . . 1.9099999999999999 111.283 175.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.61 -51.02 5.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.373 -0.973 . . . . 1.73 108.373 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.8 m -68.99 -41.4 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 111.969 0.359 . . . . 2.3100000000000001 111.969 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.454 ' HG1' ' H ' ' A' ' 147' ' ' LEU . 30.2 p -87.2 160.27 49.13 Favored Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 108.9 -0.778 . . . . 2.0299999999999998 108.9 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -73.51 2.86 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 121.889 1.726 . . . . 0.93999999999999995 112.325 170.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.454 ' H ' ' HG1' ' A' ' 145' ' ' THR . 35.0 mt -68.54 154.92 40.95 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.254 -0.904 . . . . 3.1200000000000001 110.817 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 99.23 5.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.836 1.654 . . . . 6.3300000000000001 109.611 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.479 ' CD2' ' HB3' ' A' ' 138' ' ' PHE . 1.7 p90 -63.51 152.5 38.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.741 -0.663 . . . . 8.7300000000000004 112.007 170.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.6 t -155.11 117.68 4.28 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.698 -0.668 . . . . 1.6499999999999999 111.06 173.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.428 ' NZ ' ' OD2' ' A' ' 131' ' ' ASP . 6.0 ttmt -81.59 131.02 35.26 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 119.514 1.052 . . . . 3.2999999999999998 109.563 175.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.24 88.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 122.001 0.905 . . . . 2.1400000000000001 109.411 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -87.13 33.27 0.67 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.599 0.76 . . . . 3.1499999999999999 110.424 176.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.1 p -149.62 77.97 1.35 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.094 1.358 . . . . 3.2200000000000002 108.982 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 147.71 -120.39 1.22 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.571 -1.411 . . . . 2.04 109.571 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 27.5 mtp -139.53 136.03 34.07 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 127.147 2.179 . . . . 4.8300000000000001 106.352 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.83 165.86 18.54 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.696 1.198 . . . . 0.71999999999999997 109.598 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.549 ' H ' ' HG1' ' A' ' 115' ' ' THR . 31.6 t0 -73.59 -53.0 11.52 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.159 0.984 . . . . 2.2400000000000002 108.4 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.2 pt -119.69 147.76 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.669 -0.696 . . . . 1.23 111.224 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.4 tt -122.95 133.13 54.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.014 1.326 . . . . 3.1099999999999999 109.142 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.7 t -81.19 101.02 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.571 1.148 . . . . 1.03 108.535 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.8 t -78.9 111.75 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.784 -0.821 . . . . 1.8400000000000001 108.784 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -99.0 118.32 35.51 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.203 -1.777 . . . . 6.2300000000000004 106.203 166.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -143.78 161.42 38.66 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.972 -1.121 . . . . 1.1100000000000001 107.972 -176.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -122.99 142.39 50.89 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.335 -1.358 . . . . 4.79 107.335 172.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.434 ' HA2' ' CD1' ' A' ' 174' ' ' PHE . . . 83.98 174.73 50.54 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.982 -0.447 . . . . 2.0 111.982 170.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.14 77.75 3.68 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.915 -0.756 . . . . 3.3399999999999999 109.9 -170.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -73.15 68.77 1.01 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.696 0.798 . . . . 3.6699999999999999 112.269 -175.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 80.77 -36.65 2.29 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 121.442 -0.787 . . . . 3.3399999999999999 111.618 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -71.25 139.73 50.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.452 -1.684 . . . . 2.8999999999999999 106.452 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -76.14 -66.72 0.76 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.832 -1.544 . . . . 5.6299999999999999 106.832 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -98.17 101.73 13.28 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.025 -1.102 . . . . 7.1299999999999999 108.025 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -156.42 -73.65 0.1 Allowed 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 122.657 0.383 . . . . 3.3399999999999999 110.145 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.512 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -83.95 170.72 13.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.677 -1.231 . . . . 9.3100000000000005 107.677 178.147 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.512 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 9.2 p30 175.39 33.14 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.906 1.282 . . . . 2.3500000000000001 112.879 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 53.15 -156.84 4.94 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 120.984 -1.073 . . . . 1.73 111.543 -172.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -76.3 62.14 1.75 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.833 0.853 . . . . 5.0599999999999996 112.567 -175.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -162.17 -154.8 7.69 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 107.839 -2.104 . . . . 2.1899999999999999 107.839 168.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 35.81 -113.6 0.15 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 127.966 2.698 . . . . 1.6499999999999999 112.219 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.1 mm -79.58 139.47 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 118.126 0.963 . . . . 2.5499999999999998 109.001 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.582 ' HB2' ' H5 ' ' A' ' 269' ' ' NGH . 1.5 mp -80.52 -59.9 2.52 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.983 -1.117 . . . . 1.51 107.983 170.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -163.51 159.77 22.41 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.761 -0.459 . . . . 1.0600000000000001 109.761 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -146.55 117.15 7.54 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.264 1.426 . . . . 1.3799999999999999 113.666 -166.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -136.37 159.47 41.67 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.004 1.722 . . . . 0.93999999999999995 109.208 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -148.65 144.03 26.9 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.953 -1.499 . . . . 3.7999999999999998 106.953 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -93.01 -89.99 1.55 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.166 0.888 . . . . 0.88 110.916 173.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.28 97.91 0.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.799 2.333 . . . . 1.5600000000000001 110.962 -175.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -169.01 161.68 35.38 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 108.24 -1.944 . . . . 1.49 108.24 171.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.4 t -80.96 178.38 8.45 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.509 0.654 . . . . 3.9500000000000002 110.466 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 46.24 -109.8 0.41 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.643 1.116 . . . . 1.51 111.314 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.7 tp -59.87 -42.25 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 118.169 -0.92 . . . . 1.76 109.826 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -38.6 128.97 1.85 Allowed Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.805 1.193 . . . . 1.29 112.664 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 108.86 -50.83 0.75 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.366 1.936 . . . . 0.84999999999999998 109.686 -162.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.24 148.02 28.62 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.398 1.079 . . . . 2.6099999999999999 110.481 -166.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -117.95 121.43 40.67 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.498 1.119 . . . . 0.67000000000000004 111.248 -170.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -111.54 122.7 48.53 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 118.512 0.597 . . . . 2.9700000000000002 111.381 -168.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -111.06 136.16 50.5 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.973 -1.121 . . . . 3.8599999999999999 107.973 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -67.0 93.55 0.28 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.476 -1.675 . . . . 2.8500000000000001 106.476 172.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -39.12 82.86 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.688 1.131 . . . . 3.4100000000000001 109.193 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -34.66 -48.87 0.39 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 127.092 2.157 . . . . 2.9700000000000002 110.543 -167.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -61.13 179.7 0.18 Allowed 'General case' 0 C--O 1.24 0.597 0 C-N-CA 126.167 1.787 . . . . 4.6699999999999999 112.283 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -115.52 87.14 2.6 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 105.538 -2.023 . . . . 3.7999999999999998 105.538 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -75.67 163.32 27.43 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.93 -1.032 . . . . 1.3899999999999999 108.276 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.8 p -129.22 144.15 51.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.38 -0.971 . . . . 2.0699999999999998 108.38 174.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . 0.258 6.3 t -61.31 -40.47 94.29 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 126.113 1.765 . . . . 2.3300000000000001 112.414 165.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -96.37 -172.44 2.53 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.406 1.082 . . . . 3.4500000000000002 108.365 177.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.405 ' H ' ' HG ' ' A' ' 207' ' ' SER . 5.3 m -47.53 -65.7 0.52 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.785 2.034 . . . . 4.3200000000000003 110.594 -173.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 45.77 -104.49 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 125.896 1.712 . . . . 2.8900000000000001 114.364 165.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -112.38 -81.48 1.12 Allowed Glycine 0 C--N 1.335 0.495 0 N-CA-C 109.677 -1.369 . . . . 2.3599999999999999 109.677 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.3 m -115.79 123.3 47.88 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.654 -1.98 . . . . 1.6599999999999999 105.654 167.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.79 111.97 10.53 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.839 -0.8 . . . . 2.73 108.839 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.01 -54.41 24.78 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.057 0.844 . . . . 2.3900000000000001 110.585 -175.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -44.77 -43.86 8.88 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.77 1.228 . . . . 3.1699999999999999 111.352 177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.93 -64.74 0.84 Allowed 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.929 -0.482 . . . . 1.53 109.942 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.324 3.4 m -53.89 -43.37 69.59 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.377 0.608 . . . . 1.8 110.701 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.45 -42.73 54.61 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.918 -0.583 . . . . 0.47999999999999998 111.793 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 83.9 t -62.65 -42.78 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 119.699 1.136 . . . . 1.1899999999999999 111.339 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.493 ' CD2' ' O4 ' ' A' ' 269' ' ' NGH . 5.8 t60 -55.33 -47.33 75.83 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.977 0.911 . . . . 3.6600000000000001 109.456 174.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -76.13 -32.75 59.29 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 114.257 1.206 . . . . 3.4900000000000002 114.257 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 4.7 mm -58.0 -50.85 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 106.886 -1.524 . . . . 3.5899999999999999 106.886 171.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.76 -45.46 48.68 Favored Glycine 0 CA--C 1.537 1.436 0 N-CA-C 111.931 -0.468 . . . . 0.98999999999999999 111.931 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -55.08 -50.56 68.87 Favored 'General case' 0 C--O 1.226 -0.18 0 O-C-N 121.569 -0.959 . . . . 2.04 110.335 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 1.5 t -52.21 -49.63 63.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.482 0.713 . . . . 2.9199999999999999 111.377 176.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 10.2 mt -60.1 -45.65 92.24 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.374 0.534 . . . . 3.0 109.721 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 134.48 38.99 0.19 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 123.812 0.72 . . . . 1.3100000000000001 112.608 168.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.06 116.73 24.45 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.132 0.966 . . . . 4.3700000000000001 110.156 174.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.42 52.51 4.36 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.301 -0.722 . . . . 2.8500000000000001 113.151 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 72.5 m80 66.28 161.85 0.15 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.28 1.432 . . . . 1.9099999999999999 113.022 -175.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 74.1 m -131.73 -178.51 4.91 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.872 1.669 . . . . 1.3600000000000001 109.431 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 7.4 p -146.79 16.03 1.24 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.991 1.316 . . . . 3.3100000000000001 111.006 -165.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -115.79 138.52 24.01 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 106.878 -1.527 . . . . 2.5099999999999998 106.878 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.92 -17.49 10.78 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.923 1.749 . . . . 2.0099999999999998 114.182 -172.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.6 mtmt -83.65 -28.35 28.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.94 0.791 . . . . 1.9099999999999999 109.852 173.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.21 147.69 39.05 Favored 'General case' 0 C--O 1.225 -0.19 0 O-C-N 121.902 -0.499 . . . . 0.76000000000000001 110.792 173.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 71.2 t -92.97 -23.5 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.724 1.21 . . . . 0.65000000000000002 109.72 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 16.9 tpp -70.05 -14.68 62.79 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.471 1.108 . . . . 2.7000000000000002 113.411 177.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.406 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -51.33 147.02 10.83 Favored Pre-proline 0 CA--C 1.539 0.545 0 O-C-N 121.378 -0.826 . . . . 4.2000000000000002 112.944 177.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.92 -16.2 29.33 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.317 2.011 . . . . 1.3 111.631 174.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.522 ' O ' ' H2 ' ' A' ' 269' ' ' NGH 0.301 0.1 OUTLIER -76.35 169.13 18.8 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.2 -1.037 . . . . 2.8199999999999998 108.2 171.783 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -128.01 146.98 50.49 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 104.808 -2.293 . . . . 3.2599999999999998 104.808 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.23 144.18 20.78 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.476 -1.305 . . . . 2.8199999999999998 107.476 171.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -62.9 144.35 56.79 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.977 0.911 . . . . 3.52 111.051 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.85 154.35 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.555 0.742 . . . . 2.1099999999999999 110.672 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.18 -16.23 59.45 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.993 1.717 . . . . 3.5 114.334 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . 0.25 14.0 mm 72.21 -41.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 128.019 2.527 . . . . 4.2800000000000002 111.085 -176.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -78.99 -51.81 9.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.878 0.871 . . . . 3.4199999999999999 111.197 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 47.5 m -78.46 -18.07 55.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.482 1.113 . . . . 2.8399999999999999 110.652 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -39.3 110.82 0.15 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.531 1.532 . . . . 9.2799999999999994 112.11 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.02 163.88 31.59 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.448 1.099 . . . . 3.98 109.906 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -81.08 137.42 36.0 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.831 -1.174 . . . . 1.1000000000000001 107.831 -175.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.7 m -77.41 160.66 28.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.651 0.262 . . . . 1.4299999999999999 110.816 -175.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.76 -48.35 78.04 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 110.059 -0.348 . . . . 0.93000000000000005 110.059 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -48.31 -51.88 24.04 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.765 0.793 . . . . 2.6000000000000001 109.96 172.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.97 -47.52 80.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.079 -1.419 . . . . 2.2000000000000002 109.09 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.5 mt -59.86 -47.46 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.816 1.646 . . . . 1.01 111.226 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -60.08 -44.27 94.89 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.346 -1.471 . . . . 5.2400000000000002 109.858 175.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -49.62 -42.59 36.02 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.937 -0.865 . . . . 0.83999999999999997 110.937 170.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.58 -47.04 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 117.826 0.813 . . . . 4.6100000000000003 110.561 -177.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -68.16 -15.95 63.79 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 119.701 -0.8 . . . . 2.6299999999999999 110.849 -178.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.14 -17.69 3.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.755 0.822 . . . . 2.79 112.873 165.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 56.7 mt -56.19 74.1 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 120.076 1.307 . . . . 2.9199999999999999 111.753 161.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -170.16 110.33 0.4 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.954 2.902 . . . . 7.1500000000000004 107.312 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.781 0 N-CA-C 108.248 -1.941 . . . . 8.8000000000000007 108.248 -167.057 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' NGH . . . . . 0.582 ' H5 ' ' HB2' ' A' ' 181' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 108.009 -1.108 . . . . 14.4 108.009 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 138.33 -166.23 25.29 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.566 -1.414 . . . . 10.300000000000001 109.566 -175.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.02 161.98 43.58 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.113 2.542 . . . . 13.48 110.81 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.8 p -158.94 153.27 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 108.122 -1.066 . . . . 7.0700000000000003 108.122 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -178.05 173.82 1.45 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.298 2.239 . . . . 14.289999999999999 105.558 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 -176.4 82.74 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.406 1.883 . . . . 9.1199999999999992 106.26 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.1 mptt 65.86 -80.12 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.898 1.279 . . . . 6.9000000000000004 111.297 -172.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 60.34 -80.27 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.586 1.555 . . . . 4.4199999999999999 109.407 -165.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -114.81 111.84 21.85 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.461 1.105 . . . . 4.5599999999999996 111.499 -168.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.415 HG22 ' CE1' ' A' ' 116' ' ' TYR . 18.0 mm -128.52 103.87 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.926 0.87 . . . . 3.4500000000000002 112.157 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -86.91 140.98 29.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.25 2.22 . . . . 2.27 109.49 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.438 ' CD2' ' CE2' ' A' ' 138' ' ' PHE . 10.3 m-85 -124.47 167.78 13.96 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.579 1.151 . . . . 7.1100000000000003 110.84 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -149.52 149.55 30.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.802 1.241 . . . . 8.3200000000000003 109.608 176.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.4 mt -102.68 155.69 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.656 -1.239 . . . . 1.1399999999999999 107.656 173.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -97.57 -44.56 6.75 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.11 0.564 . . . . 3.3900000000000001 110.156 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -149.03 164.85 33.42 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.865 0.466 . . . . 2.25 110.149 174.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -111.15 127.97 55.75 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.149 1.38 . . . . 2.8399999999999999 107.574 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.1 t -60.46 136.84 92.2 Favored Pre-proline 0 N--CA 1.442 -0.829 0 C-N-CA 122.931 0.492 . . . . 2.54 109.742 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.22 -18.64 14.08 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.16 2.573 . . . . 1.9399999999999999 111.009 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -40.41 -46.58 2.42 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.622 1.569 . . . . 2.0 111.452 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -128.24 176.33 7.76 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.544 1.538 . . . . 2.7799999999999998 109.253 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -73.86 143.42 45.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.285 0.634 . . . . 3.04 110.452 174.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.3 ttt-85 -47.19 -45.0 22.71 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.475 0.71 . . . . 3.7799999999999998 111.512 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.63 -10.04 11.01 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.023 0.929 . . . . 4.2000000000000002 112.997 -177.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -100.03 -45.11 5.78 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.387 1.475 . . . . 2.1699999999999999 110.434 168.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 73.9 t -53.41 -54.94 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 123.991 0.916 . . . . 1.79 109.511 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.439 ' HB3' ' HZ3' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -71.75 -25.53 62.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 117.447 -1.701 . . . . 1.9399999999999999 109.81 178.429 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -59.11 -48.17 82.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.422 1.01 . . . . 3.6499999999999999 109.042 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.27 -52.7 51.25 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 116.21 -0.45 . . . . 0.46000000000000002 111.486 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -36.57 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.663 0.744 . . . . 2.6099999999999999 110.131 -173.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.7 ttm-85 -55.57 -54.87 38.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.479 1.112 . . . . 4.9000000000000004 108.276 173.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -66.34 -41.11 90.06 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.431 0.692 . . . . 2.0800000000000001 109.658 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -47.12 -54.46 10.47 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 118.551 0.614 . . . . 0.54000000000000004 110.686 169.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.438 ' CE2' ' CD2' ' A' ' 116' ' ' TYR . 34.5 m-85 -59.81 -42.67 93.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.476 -0.49 . . . . 5.5499999999999998 111.588 176.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -50.28 -39.85 46.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.393 0.677 . . . . 4.5 110.515 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.6 t -61.0 -56.24 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.131 -0.692 . . . . 1.6100000000000001 109.131 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 26.8 m95 -75.24 -35.21 61.44 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 122.054 -0.404 . . . . 1.1000000000000001 110.585 -173.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 89.0 p -70.7 -15.53 62.71 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.359 0.503 . . . . 2.8799999999999999 112.359 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.13 -48.39 11.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.549 -1.278 . . . . 1.5700000000000001 107.549 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 26.7 m -75.64 -40.42 40.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 113.191 0.811 . . . . 2.3900000000000001 113.191 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 31.7 p -100.06 140.71 21.71 Favored Pre-proline 0 N--CA 1.447 -0.624 0 N-CA-C 108.466 -0.939 . . . . 1.49 108.466 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.33 12.03 0.89 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.241 2.627 . . . . 1.1899999999999999 113.637 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.2 mt -70.09 115.52 9.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.58 1.152 . . . . 3.1200000000000001 108.845 -175.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -82.53 89.79 6.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 122.445 1.117 . . . . 5.7000000000000002 108.282 -172.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.18 146.1 48.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.738 -2.028 . . . . 7.8899999999999997 109.299 170.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.6 t -151.19 147.31 26.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.881 -1.526 . . . . 1.6899999999999999 106.881 165.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.439 ' HZ3' ' HB3' ' A' ' 131' ' ' ASP . 2.5 tmmt? -125.64 129.75 50.24 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 107.363 -1.347 . . . . 3.0099999999999998 107.363 175.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.6 pp -133.75 170.69 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 105.952 -1.87 . . . . 2.4500000000000002 105.952 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -142.63 27.37 1.69 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.798 0.726 . . . . 4.3899999999999997 109.094 169.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 58.2 p -150.72 78.46 1.31 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.401 1.08 . . . . 3.48 108.531 -172.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.15 -128.08 2.76 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 108.028 -2.029 . . . . 2.0299999999999998 108.028 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.0 mtt -126.43 148.81 49.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.407 1.083 . . . . 4.9100000000000001 109.552 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -141.42 160.65 39.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.137 1.375 . . . . 0.93999999999999995 109.299 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -80.86 -58.91 2.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.636 1.974 . . . . 1.98 107.786 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -91.02 179.04 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 122.035 0.921 . . . . 1.8899999999999999 111.243 176.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 tt -138.75 127.61 23.66 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.495 2.318 . . . . 2.6600000000000001 109.094 167.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 20.6 t -86.26 105.73 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.702 -1.221 . . . . 0.76000000000000001 107.702 170.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.3 t -81.56 140.31 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 107.43 -1.322 . . . . 1.8899999999999999 107.43 170.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.29 90.32 2.41 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.568 -2.012 . . . . 6.0599999999999996 105.568 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.42 158.83 39.76 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.068 0.547 . . . . 1.0 109.988 -165.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 14.0 ptt-85 -124.0 115.57 21.43 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.837 0.855 . . . . 5.7800000000000002 109.935 -162.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 60.48 -97.65 0.12 Allowed Glycine 0 CA--C 1.535 1.328 0 C-N-CA 123.335 0.493 . . . . 1.6000000000000001 112.292 -175.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.39 135.8 35.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.785 0.834 . . . . 3.1899999999999999 109.06 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -153.2 -52.95 0.11 Allowed 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 111.621 0.23 . . . . 5.0599999999999996 111.621 176.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 143.21 78.38 0.04 OUTLIER Glycine 0 C--N 1.334 0.445 0 N-CA-C 107.278 -2.329 . . . . 2.8999999999999999 107.278 -173.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -158.69 169.06 25.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.218 -1.03 . . . . 2.5699999999999998 108.218 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -81.8 -40.94 21.82 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.858 1.263 . . . . 5.7300000000000004 109.372 174.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -85.51 -22.8 28.02 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.418 0.687 . . . . 5.6600000000000001 110.714 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 60.78 -171.06 0.14 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.984 1.314 . . . . 3.9199999999999999 111.113 -173.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -109.24 -179.28 3.79 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 106.917 -1.512 . . . . 7.4900000000000002 106.917 159.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -143.74 -168.16 2.77 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.539 1.936 . . . . 3.9900000000000002 106.149 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -90.34 -141.64 9.18 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.952 -0.859 . . . . 2.02 110.952 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.449 ' NZ ' ' OD1' ' A' ' 200' ' ' ASP . 0.1 OUTLIER -58.63 114.85 2.69 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.935 -0.765 . . . . 8.6500000000000004 108.935 169.578 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.92 -155.94 16.21 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.083 -1.207 . . . . 2.1499999999999999 110.083 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.28 -119.44 11.95 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 109.946 -1.262 . . . . 2.02 109.946 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.428 HG12 ' H12' ' A' ' 269' ' ' NGH 0.339 2.2 mt -90.58 137.27 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 107.129 -1.434 . . . . 3.46 107.129 -179.364 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.478 HD21 ' H1 ' ' A' ' 269' ' ' NGH . 2.9 mm? -85.68 -56.85 3.3 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.12 1.368 . . . . 3.1099999999999999 109.856 166.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -156.07 162.17 40.31 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 121.129 -0.982 . . . . 0.91000000000000003 112.322 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.424 ' HA ' ' HN1' ' A' ' 269' ' ' NGH . 26.9 p-80 -145.15 116.07 7.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.36 1.464 . . . . 1.23 114.265 176.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.77 159.04 40.9 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.951 2.1 . . . . 0.93999999999999995 108.308 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -144.42 148.21 34.33 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.965 -1.494 . . . . 4.5599999999999996 106.965 172.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -98.81 -82.34 1.66 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.851 -0.9 . . . . 1.1299999999999999 110.851 170.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.97 92.71 0.71 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.396 2.73 . . . . 2.46 110.551 -172.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -175.39 157.38 23.94 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 108.661 -1.776 . . . . 2.3199999999999998 108.661 171.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.3 m -77.54 157.62 30.27 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.11 -0.7 . . . . 3.7000000000000002 109.11 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.89 -110.69 3.11 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.931 -0.868 . . . . 2.5600000000000001 110.931 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.434 HG12 ' CE1' ' A' ' 196' ' ' HIS . 5.1 tp -63.03 -42.28 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 O-C-N 121.468 -1.019 . . . . 2.4900000000000002 109.632 -170.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -30.75 129.56 0.16 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 126.252 1.882 . . . . 2.1200000000000001 113.814 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 103.78 -52.75 0.75 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.465 1.983 . . . . 0.92000000000000004 109.757 -164.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -84.09 160.61 20.89 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.054 0.942 . . . . 1.98 111.314 -167.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -138.91 124.52 19.53 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 118.136 -0.935 . . . . 0.73999999999999999 111.56 -172.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.434 ' CE1' HG12 ' A' ' 191' ' ' ILE . 1.0 OUTLIER -112.38 127.21 55.95 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-O 117.721 -1.133 . . . . 2.7599999999999998 109.244 -173.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -114.2 151.44 32.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.202 1.365 . . . . 4.1799999999999997 110.947 174.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -73.83 101.34 3.71 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.417 -0.811 . . . . 3.4300000000000002 109.964 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.36 -29.67 70.93 Favored 'General case' 0 C--O 1.24 0.596 0 O-C-N 121.485 -0.76 . . . . 2.5 111.147 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.449 ' OD1' ' NZ ' ' A' ' 177' ' ' LYS . 12.3 t70 -59.44 -31.9 69.72 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.393 0.997 . . . . 3.1099999999999999 109.344 -179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -68.03 150.51 48.35 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 122.107 0.956 . . . . 2.8300000000000001 108.884 -176.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -102.3 93.03 4.98 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 105.695 -1.965 . . . . 4.9000000000000004 105.695 174.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -77.85 138.79 39.13 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 108.536 -0.912 . . . . 1.5 108.536 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.714 ' HG1' ' HD1' ' A' ' 206' ' ' HIS . 0.1 OUTLIER -158.7 108.79 2.02 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 120.975 1.716 . . . . 3.3399999999999999 111.023 -178.127 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.33 -51.38 54.88 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 118.4 0.545 . . . . 4.3799999999999999 111.0 162.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.714 ' HD1' ' HG1' ' A' ' 204' ' ' THR . 3.8 p-80 -65.54 -38.3 89.22 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.7 -0.682 . . . . 4.9199999999999999 111.875 -161.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 21.3 t -80.52 -43.25 21.05 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.345 0.658 . . . . 7.4199999999999999 109.773 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 114.6 -31.69 6.24 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.314 -0.715 . . . . 3.7000000000000002 112.131 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -21.91 -85.0 0.01 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 128.164 2.792 . . . . 1.8799999999999999 114.545 -171.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 26.1 m -122.49 123.37 41.1 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 104.563 -2.384 . . . . 1.29 104.563 156.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -84.97 125.33 32.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.101 0.864 . . . . 1.3600000000000001 109.236 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 43.6 tp -53.94 -51.83 62.54 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 118.044 0.384 . . . . 2.71 110.397 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -50.23 -46.76 55.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.108 0.563 . . . . 3.29 110.488 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.12 -63.39 1.2 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.373 1.069 . . . . 1.5800000000000001 110.866 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.37 0.9 OUTLIER -59.13 -39.86 83.65 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.918 0.39 . . . . 1.99 110.453 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.41 62.31 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 116.822 -1.561 . . . . 0.52000000000000002 109.409 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 8.4 t -44.45 -55.25 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 121.117 1.78 . . . . 2.2200000000000002 111.473 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.443 ' HD1' ' HG2' ' A' ' 219' ' ' GLU . 0.4 OUTLIER -51.71 -46.77 64.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.302 0.641 . . . . 3.52 111.802 178.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.443 ' HG2' ' HD1' ' A' ' 218' ' ' HIS . 9.0 mm-40 -79.51 -47.23 15.93 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.283 -0.885 . . . . 2.77 112.58 -173.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.3 mp -56.53 -41.61 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.035 1.734 . . . . 1.95 107.871 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.36 -47.33 83.54 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.284 -0.726 . . . . 0.96999999999999997 111.284 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.429 ' CE1' ' CD2' ' A' ' 228' ' ' HIS . 7.1 m-70 -52.59 -52.31 55.81 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.433 -1.04 . . . . 2.2799999999999998 110.389 174.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.0 m -51.06 -47.64 61.73 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.923 0.783 . . . . 2.9900000000000002 112.476 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -18.87 15.18 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.204 1.002 . . . . 4.1399999999999997 112.276 176.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 120.4 6.7 9.54 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 125.659 1.599 . . . . 1.8300000000000001 111.243 173.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 49.7 mt -88.89 109.36 20.15 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 117.842 0.821 . . . . 5.8099999999999996 110.498 -159.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -60.63 158.47 28.07 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.503 1.049 . . . . 3.4700000000000002 112.49 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.429 ' CD2' ' CE1' ' A' ' 222' ' ' HIS . 27.1 m80 -62.77 121.64 13.93 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.54 0.736 . . . . 1.8 111.5 -177.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.416 ' HG ' ' HB3' ' A' ' 236' ' ' MET . 64.8 m -77.94 178.39 7.5 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.442 0.639 . . . . 1.5800000000000001 110.678 171.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 p -125.22 6.49 7.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.905 2.082 . . . . 4.1600000000000001 111.927 -164.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -118.38 136.68 24.11 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.264 1.426 . . . . 2.5299999999999998 108.045 -171.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.63 -13.49 14.7 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.679 2.253 . . . . 2.0600000000000001 114.439 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -80.5 -37.7 31.2 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.605 1.162 . . . . 1.8400000000000001 108.892 173.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.02 149.0 24.33 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.424 0.69 . . . . 0.95999999999999996 110.891 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.7 t -93.34 -17.82 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.234 -0.894 . . . . 0.83999999999999997 110.504 177.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.416 ' HB3' ' HG ' ' A' ' 229' ' ' SER . 0.5 OUTLIER -73.73 -20.94 60.37 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 113.139 0.792 . . . . 2.3399999999999999 113.139 -174.419 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -52.92 167.97 0.37 Allowed Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.932 1.693 . . . . 4.1699999999999999 113.644 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -83.98 -14.44 7.39 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 121.942 1.761 . . . . 1.6599999999999999 112.332 173.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.4 ' O ' ' H71' ' A' ' 269' ' ' NGH 0.294 0.0 OUTLIER -79.35 176.74 9.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.913 1.285 . . . . 2.5800000000000001 109.781 178.921 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.475 ' HA ' ' H71' ' A' ' 269' ' ' NGH . 90.1 t80 -121.39 140.94 51.48 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.04 1.736 . . . . 3.6000000000000001 106.503 176.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -151.31 132.51 14.46 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 105.095 -2.187 . . . . 3.4399999999999999 105.095 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -61.21 123.1 16.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.149 0.432 . . . . 3.8700000000000001 110.428 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.2 m -100.85 134.05 42.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 122.818 0.447 . . . . 2.3500000000000001 109.997 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -81.96 90.56 6.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 122.224 1.012 . . . . 3.3900000000000001 109.807 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 92.9 mt -54.06 -24.77 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.191 0.996 . . . . 3.9199999999999999 110.757 178.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -46.74 -45.41 19.65 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.4 0.546 . . . . 3.7999999999999998 111.868 170.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 25.6 m -84.04 -42.32 16.28 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.404 0.682 . . . . 2.0099999999999998 109.895 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 69.8 t80 58.28 68.59 0.81 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.792 0.806 . . . . 5.21 110.223 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -160.49 165.22 31.33 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.009 -0.737 . . . . 4.4199999999999999 109.009 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.17 -175.15 2.68 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.087 1.355 . . . . 2.4700000000000002 110.145 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 39.1 m -81.93 141.68 33.11 Favored 'General case' 0 C--O 1.222 -0.377 0 O-C-N 120.872 -1.143 . . . . 1.4299999999999999 112.029 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.46 -39.61 57.79 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.231 0.539 . . . . 1.0600000000000001 111.026 169.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -66.74 -21.7 66.06 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.929 0.714 . . . . 3.75 112.929 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.36 -51.81 7.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.903 0.881 . . . . 3.3700000000000001 109.57 169.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 56.1 mt -47.58 -43.61 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.13 1.772 . . . . 1.29 111.77 -175.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -52.91 -53.53 47.96 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.823 0.344 . . . . 5.4500000000000002 111.32 172.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.03 -54.37 30.89 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.089 -1.605 . . . . 1.96 109.089 -171.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 2.8 pp -55.37 -35.9 38.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 123.667 0.787 . . . . 3.3700000000000001 112.348 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -73.04 -49.13 30.51 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 118.443 -0.789 . . . . 3.54 111.359 172.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 24.3 m -51.01 -37.15 43.39 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.736 1.153 . . . . 4.9400000000000004 112.321 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 10.9 mt -62.39 -35.05 77.96 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.277 1.031 . . . . 6.2699999999999996 111.489 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -71.43 -51.62 22.93 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.053 -0.404 . . . . 11.42 110.274 169.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.094 -1.948 . . . . 7.4800000000000004 109.4 -175.881 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' NGH . . . . . 0.478 ' H1 ' HD21 ' A' ' 181' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 52.9 mtt . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 108.145 -1.057 . . . . 13.35 108.145 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.04 153.01 39.25 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 111.262 -0.735 . . . . 12.27 111.262 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.49 171.04 17.91 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.058 2.505 . . . . 15.18 109.269 172.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.4 p -153.28 143.58 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 107.419 -1.326 . . . . 8.7300000000000004 107.419 172.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -87.71 -64.91 1.08 Allowed 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.298 -1.001 . . . . 14.98 108.298 173.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 38.44 42.6 0.56 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.398 1.479 . . . . 10.24 111.216 -172.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? 52.08 -83.0 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.117 1.367 . . . . 6.7599999999999998 112.064 -158.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 56.27 -66.5 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.426 1.49 . . . . 4.6699999999999999 110.645 -154.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -120.25 114.34 21.76 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.127 0.971 . . . . 5.04 112.377 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.9 mm -95.03 88.28 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 122.403 1.097 . . . . 3.3900000000000001 109.024 168.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.97 123.87 29.85 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.26 -1.385 . . . . 2.6000000000000001 107.26 176.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -127.08 163.28 24.13 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.531 1.059 . . . . 4.9100000000000001 112.458 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -142.2 144.11 33.24 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.487 1.115 . . . . 6.5300000000000002 109.233 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -92.99 151.79 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 109.5 -0.556 . . . . 1.21 109.5 176.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -86.46 -50.58 6.77 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.813 -0.81 . . . . 4.1100000000000003 108.813 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -133.02 176.69 8.28 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 123.84 0.712 . . . . 3.29 111.777 174.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -138.94 160.93 38.57 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.431 1.893 . . . . 3.2999999999999998 107.136 -177.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 90.6 m 46.99 56.26 17.09 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 123.505 0.722 . . . . 9.0500000000000007 111.858 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.12 -39.96 1.46 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.121 1.881 . . . . 6.8600000000000003 109.326 171.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.99 3.88 0.72 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.543 0.737 . . . . 2.0800000000000001 112.75 -175.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 7.3 mtm -150.24 168.4 24.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.937 1.244 . . . . 2.23 110.843 -169.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -69.85 140.56 53.24 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.691 -0.485 . . . . 3.3399999999999999 109.691 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -56.9 -40.0 75.46 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.267 -0.896 . . . . 2.75 112.138 -174.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.4 -3.06 5.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.892 -0.575 . . . . 3.48 112.289 -178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -96.69 -50.36 4.73 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.866 1.266 . . . . 2.6800000000000002 110.357 161.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.1 m -58.43 -49.42 82.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 O-C-N 121.105 -0.997 . . . . 4.1699999999999999 110.439 -169.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -71.79 -24.46 61.74 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 118.745 -1.182 . . . . 2.25 109.172 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -66.31 -48.93 68.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.659 1.118 . . . . 4.2599999999999998 109.682 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.68 -49.5 76.3 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 123.774 0.829 . . . . 0.63 110.143 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.9 tp -70.88 -38.06 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.951 0.405 . . . . 2.9900000000000002 110.469 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -54.87 41.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.725 -1.213 . . . . 4.3899999999999997 107.725 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -59.24 -51.5 69.72 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.043 -0.981 . . . . 2.54 110.115 176.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -46.08 -50.36 15.37 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 118.686 0.676 . . . . 0.71999999999999997 112.307 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.31 -51.6 62.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 118.839 -1.144 . . . . 8.2699999999999996 109.196 175.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.16 -27.23 65.46 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.641 0.776 . . . . 2.7599999999999998 112.0 -170.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 53.2 t -62.66 -54.76 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.561 1.144 . . . . 1.3100000000000001 109.293 171.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.424 ' CZ3' ' HG ' ' A' ' 250' ' ' LEU . 59.3 m95 -73.6 -33.84 64.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 121.593 -0.692 . . . . 0.87 109.325 -174.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 74.0 m -65.62 -17.35 64.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 118.736 0.698 . . . . 1.97 112.571 173.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -75.71 -46.62 30.1 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.033 0.833 . . . . 1.1499999999999999 109.068 174.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 57.3 t -74.38 -54.3 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.598 0.759 . . . . 3.2799999999999998 110.455 -176.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.409 ' HG1' ' H ' ' A' ' 147' ' ' LEU . 24.4 p -90.08 158.61 43.95 Favored Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 124.945 1.298 . . . . 1.6699999999999999 109.823 -174.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -74.31 2.64 6.01 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.088 1.859 . . . . 0.91000000000000003 112.848 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.409 ' H ' ' HG1' ' A' ' 145' ' ' THR . 45.9 mt -63.62 114.99 4.3 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.367 0.985 . . . . 3.27 110.396 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.5 76.06 2.53 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.348 -1.353 . . . . 5.5599999999999996 107.348 -170.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -63.48 161.2 14.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.479 -0.782 . . . . 6.5599999999999996 112.364 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.8 t -152.09 138.94 18.93 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.833 -1.543 . . . . 1.6200000000000001 106.833 168.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -77.82 147.48 35.19 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.71 -1.959 . . . . 3.75 105.71 156.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.2 pt -132.51 120.83 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 105.556 -2.016 . . . . 1.9299999999999999 105.556 156.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -75.12 -18.11 60.3 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.599 -0.688 . . . . 3.5899999999999999 110.879 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.83 111.97 8.5 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 125.549 1.54 . . . . 3.1400000000000001 109.299 -161.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 137.63 -137.15 8.68 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 108.415 -1.874 . . . . 1.9399999999999999 108.415 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.6 mmt -131.42 135.83 47.49 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.601 1.56 . . . . 7.75 107.223 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -124.98 165.98 17.16 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.867 1.267 . . . . 1.03 110.154 -172.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -76.86 -57.42 3.86 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 122.036 0.922 . . . . 2.1499999999999999 109.104 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.0 pt -109.26 155.41 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.699 -1.593 . . . . 1.23 106.699 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . 0.36 0.0 OUTLIER -139.64 140.74 37.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 121.251 -0.906 . . . . 3.3700000000000001 109.815 175.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 33.2 t -83.82 99.39 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 106.985 -1.487 . . . . 1.3 106.985 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.3 p -102.41 124.76 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 107.173 -1.417 . . . . 3.9300000000000002 107.173 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -86.36 150.08 24.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.118 -1.438 . . . . 9.0800000000000001 107.118 167.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.73 156.55 31.84 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.783 -1.562 . . . . 1.1000000000000001 106.783 161.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -119.44 140.78 49.87 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.625 -1.62 . . . . 6.2699999999999996 106.625 164.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 22.25 53.71 0.02 OUTLIER Glycine 0 CA--C 1.531 1.079 0 C-N-CA 128.137 2.779 . . . . 3.46 115.937 -173.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -156.63 138.67 14.49 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.212 -1.033 . . . . 4.79 108.212 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 159.2 -54.96 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 127.315 2.246 . . . . 6.5099999999999998 108.415 -176.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 164.79 -57.19 0.26 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.694 -0.562 . . . . 4.7199999999999998 111.694 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -79.79 155.99 27.64 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.208 -0.664 . . . . 5.1200000000000001 109.208 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -61.78 -38.84 89.53 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.428 -1.693 . . . . 6.9299999999999997 106.428 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -71.15 39.04 0.06 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 122.396 1.093 . . . . 6.46 111.923 171.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.54 -26.94 31.98 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 119.47 -2.019 . . . . 3.1299999999999999 109.649 163.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.412 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -166.98 -171.98 1.94 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.249 -1.389 . . . . 9.7799999999999994 107.249 176.045 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.412 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 4.0 p30 -171.57 44.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 O-C-N 124.629 1.205 . . . . 2.6099999999999999 109.854 171.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 52.64 -156.54 4.53 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.652 -0.979 . . . . 1.8500000000000001 110.652 -167.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -64.78 140.67 58.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.82 -0.811 . . . . 6.5199999999999996 111.462 170.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 93.05 -164.33 27.3 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 125.462 1.506 . . . . 1.5700000000000001 110.344 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.11 -118.15 9.6 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.834 1.683 . . . . 1.53 111.729 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.551 ' HA ' ' H12' ' A' ' 269' ' ' NGH . 1.2 mp -75.27 123.26 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 106.0 -1.852 . . . . 2.7599999999999998 106.0 175.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.6 HD21 ' H5 ' ' A' ' 269' ' ' NGH 0.669 7.3 mp -76.91 -63.95 1.24 Allowed 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.266 -1.383 . . . . 1.8899999999999999 107.266 168.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 1.022 ' H ' H102 ' A' ' 269' ' ' NGH . . . -159.16 155.98 28.17 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 113.757 1.021 . . . . 0.80000000000000004 113.757 -168.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . 0.351 0.0 OUTLIER -103.32 142.44 34.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.544 1.938 . . . . 2.8999999999999999 110.351 176.005 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -164.43 165.79 21.16 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.628 -1.99 . . . . 0.87 105.628 154.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -151.44 152.36 32.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 104.719 -2.326 . . . . 4.3600000000000003 104.719 173.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -91.88 -78.97 1.4 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 109.964 -1.255 . . . . 0.77000000000000002 109.964 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -69.85 176.71 6.47 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.385 2.057 . . . . 2.1200000000000001 110.089 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 90.12 144.03 11.19 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.86 -1.296 . . . . 2.1000000000000001 109.86 -172.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.3 p -82.55 -178.73 7.18 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.518 1.127 . . . . 2.9700000000000002 110.479 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 61.36 -115.37 7.81 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.802 -0.919 . . . . 1.4399999999999999 110.802 173.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.9 tp -60.21 -40.55 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.419 -0.586 . . . . 1.6799999999999999 109.419 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -39.35 136.41 1.37 Allowed Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.469 1.033 . . . . 1.1499999999999999 112.295 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 96.6 -42.17 2.26 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.452 1.025 . . . . 0.78000000000000003 112.448 -165.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -74.57 171.64 13.47 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.953 1.376 . . . . 1.3999999999999999 111.749 -159.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -132.55 112.81 12.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.994 -1.484 . . . . 2.02 106.994 -163.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -132.48 101.94 5.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.644 -0.502 . . . . 7.54 109.644 -156.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -104.96 133.53 49.6 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.438 1.017 . . . . 3.6499999999999999 109.695 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -57.0 105.67 0.24 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.549 -0.908 . . . . 2.75 108.549 171.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -59.39 -33.54 71.33 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.9 0.88 . . . . 3.1299999999999999 110.925 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.5 -27.15 67.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.51 0.671 . . . . 3.4199999999999999 109.462 -176.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -68.58 133.62 48.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.705 -1.591 . . . . 3.04 106.705 171.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -98.44 96.01 7.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.957 -1.868 . . . . 9.1699999999999999 105.957 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 43.8 m95 -75.13 159.98 31.0 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.999 -1.111 . . . . 1.6399999999999999 107.999 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 12.8 p -139.76 139.6 36.51 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.097 0.475 . . . . 2.3700000000000001 111.454 -173.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.2 t -64.3 -49.34 72.19 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.938 -1.101 . . . . 1.96 111.293 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -81.41 -167.38 1.45 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.938 0.895 . . . . 4.1799999999999997 109.697 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 20.8 t -56.82 -56.32 23.04 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.869 -0.419 . . . . 4.5800000000000001 109.869 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 50.43 -94.85 0.01 OUTLIER Glycine 0 C--N 1.34 0.764 0 C-N-CA 124.869 1.224 . . . . 2.71 113.056 171.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -140.01 -75.26 0.05 OUTLIER Glycine 0 CA--C 1.523 0.572 0 N-CA-C 108.926 -1.67 . . . . 1.9299999999999999 108.926 170.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 11.5 m -108.25 119.29 39.05 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.447 -1.686 . . . . 1.8899999999999999 106.447 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -78.5 125.91 30.03 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 120.103 -0.639 . . . . 1.5600000000000001 109.641 -178.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.34 -52.67 62.72 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 109.115 -0.698 . . . . 2.1299999999999999 109.115 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -52.93 -42.12 65.12 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.955 0.502 . . . . 3.5600000000000001 110.277 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -60.56 3.6 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.284 -0.885 . . . . 2.1099999999999999 111.184 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.343 2.0 m -54.97 -38.91 68.41 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 110.259 -0.274 . . . . 1.78 110.259 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.36 -53.21 60.81 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 118.704 -0.665 . . . . 0.53000000000000003 110.236 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 97.6 t -53.48 -47.38 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 119.542 1.065 . . . . 1.2 109.864 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.429 ' CD2' ' O4 ' ' A' ' 269' ' ' NGH 0.455 5.7 t60 -51.52 -51.44 55.17 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.363 1.065 . . . . 2.9500000000000002 113.819 170.637 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.99 -48.6 12.02 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.053 1.297 . . . . 2.9399999999999999 113.809 -173.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.3 -39.92 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 106.66 -1.607 . . . . 1.51 106.66 167.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -47.88 -57.86 7.4 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.451 1.024 . . . . 0.77000000000000002 113.634 166.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.427 ' CE1' ' CE1' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -50.36 -48.99 55.4 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.449 1.125 . . . . 2.3199999999999998 110.041 176.118 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 69.4 p -61.75 -19.92 62.97 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 113.55 0.944 . . . . 2.3900000000000001 113.55 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.4 mt -66.01 -67.93 0.41 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.713 -1.588 . . . . 3.0899999999999999 106.713 175.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 156.62 66.15 0.01 OUTLIER Glycine 0 C--O 1.228 -0.259 0 N-CA-C 108.721 -1.752 . . . . 1.1699999999999999 108.721 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.69 136.64 53.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.732 1.613 . . . . 6.2699999999999996 107.035 -174.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -109.83 41.81 2.13 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.239 0.923 . . . . 2.9900000000000002 111.902 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.427 ' CE1' ' CE1' ' A' ' 222' ' ' HIS . 70.1 m80 68.81 110.66 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.874 2.069 . . . . 1.6599999999999999 113.407 178.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 34.9 m -74.8 160.51 30.6 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.611 -0.885 . . . . 1.6299999999999999 108.611 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 66.7 m -133.24 47.84 2.45 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.883 1.273 . . . . 3.3599999999999999 108.957 -170.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -143.59 141.14 18.35 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.782 1.633 . . . . 1.8200000000000001 106.607 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -91.39 -8.92 3.07 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.197 1.931 . . . . 1.0700000000000001 114.533 -173.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.455 ' CB ' ' HG ' ' A' ' 251' ' ' SER . 14.9 mtmt -82.17 -37.61 25.87 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.134 -0.979 . . . . 1.72 108.372 170.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -53.18 152.07 4.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.585 1.154 . . . . 0.98999999999999999 111.534 172.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 84.0 t -106.68 -25.9 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.352 1.061 . . . . 0.95999999999999996 111.289 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 4.5 mtt -60.91 -27.39 68.14 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.161 -0.962 . . . . 4.3799999999999999 113.43 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.417 ' O ' ' ND1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.34 160.15 0.46 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 127.975 2.51 . . . . 4.6200000000000001 114.455 -171.28 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.517 ' O ' ' H1 ' ' A' ' 269' ' ' NGH . 59.7 Cg_endo -75.54 -21.23 15.08 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.669 1.579 . . . . 1.1000000000000001 111.818 175.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.368 0.2 OUTLIER -78.03 178.13 7.75 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.126 0.97 . . . . 1.9399999999999999 108.976 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -126.25 149.74 48.89 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.915 -1.513 . . . . 3.75 106.915 174.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -153.5 120.28 5.65 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 104.677 -2.342 . . . . 3.9700000000000002 104.677 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -60.76 122.47 14.87 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.256 -0.646 . . . . 3.5699999999999998 109.256 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.9 m -125.22 142.37 42.29 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.051 0 CA-C-O 121.056 0.455 . . . . 2.0099999999999998 110.961 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.09 91.48 0.16 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.384 1.474 . . . . 3.0299999999999998 108.172 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 2.2 pp -51.7 -29.0 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 123.971 0.909 . . . . 4.1500000000000004 111.419 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -50.29 -40.15 47.59 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.853 1.261 . . . . 4.4400000000000004 111.461 174.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 85.7 m -67.7 -45.89 73.82 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.516 0.727 . . . . 1.96 109.982 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 50.38 81.78 0.06 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.249 1.02 . . . . 6.3300000000000001 110.88 177.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.55 158.36 38.32 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.748 -0.834 . . . . 3.9700000000000002 108.748 167.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.424 ' HG ' ' CZ3' ' A' ' 141' ' ' TRP . 1.3 mm? -105.76 160.63 15.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.531 1.532 . . . . 0.89000000000000001 107.379 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' SER . . . . . 0.455 ' HG ' ' CB ' ' A' ' 233' ' ' LYS . 26.3 m -78.21 152.71 32.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.895 -0.503 . . . . 1.6299999999999999 110.77 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -54.83 -45.99 74.55 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.882 0.473 . . . . 0.73999999999999999 110.323 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -50.33 -54.48 21.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.698 0.761 . . . . 2.4399999999999999 109.924 172.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.77 -47.11 86.99 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.899 -1.046 . . . . 2.1800000000000002 110.35 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.9 mt -50.93 -49.22 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 125.576 1.551 . . . . 0.96999999999999997 110.055 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -58.15 -48.87 78.91 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.827 -1.171 . . . . 5.7800000000000002 110.492 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -56.91 -34.77 66.03 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.514 0.578 . . . . 1.3100000000000001 112.824 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.83 -49.34 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.622 -1.251 . . . . 4.71 107.622 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -63.59 -23.18 67.28 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.138 -0.977 . . . . 3.79 111.772 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.4 m -47.61 -18.77 0.15 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.291 1.219 . . . . 2.6000000000000001 114.291 168.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 24.5 mt -37.77 -48.51 1.1 Allowed 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.428 1.013 . . . . 3.1800000000000002 113.319 169.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -170.63 85.86 0.11 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.272 -0.64 . . . . 8.8699999999999992 109.272 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 N-CA-C 105.963 -2.855 . . . . 8.4299999999999997 105.963 179.042 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' NGH . . . . . 1.022 H102 ' H ' ' A' ' 182' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 3.3 ptt? . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 111.63 0.233 . . . . 13.109999999999999 111.63 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 173.77 177.4 42.94 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 107.966 -2.054 . . . . 12.369999999999999 107.966 -173.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -71.49 174.11 11.42 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.147 2.565 . . . . 12.99 110.29 177.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.2 p -147.93 167.1 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.554 -1.647 . . . . 8.4499999999999993 106.554 174.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 39.1 p90 -120.81 156.55 31.67 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.929 0.892 . . . . 10.35 110.809 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -89.68 71.51 7.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.583 -1.266 . . . . 10.5 107.583 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 73.38 -41.33 0.49 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.223 1.409 . . . . 8.2699999999999996 113.141 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.6 m170 69.72 -61.54 0.44 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 127.704 2.401 . . . . 5.2599999999999998 111.155 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -79.56 108.51 13.15 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.98 1.312 . . . . 5.4100000000000001 108.199 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.4 mm -132.19 136.49 56.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.606 -1.627 . . . . 4.2000000000000002 106.606 171.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.827 ' HG1' ' H ' ' A' ' 158' ' ' ASP . 10.4 p -110.58 141.22 44.08 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.194 0.998 . . . . 1.97 109.116 177.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.457 ' HH ' HD22 ' A' ' 224' ' ' LEU . 5.5 m-85 -126.77 152.15 47.27 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.127 0.971 . . . . 8.0800000000000001 108.768 -172.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -146.94 143.02 28.17 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.357 -0.608 . . . . 5.4000000000000004 109.357 178.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.4 mt -88.36 156.98 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.947 -1.131 . . . . 1.24 107.947 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.15 -46.0 6.01 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.532 0.605 . . . . 3.8799999999999999 109.976 -178.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -136.43 -179.8 5.9 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.491 0.716 . . . . 3.8500000000000001 109.162 173.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -120.98 110.62 16.49 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 105.749 -1.945 . . . . 3.0099999999999998 105.749 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.659 ' HG1' ' H ' ' A' ' 124' ' ' ASP . 0.9 OUTLIER -66.95 141.48 96.72 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-N 119.038 0.836 . . . . 2.8599999999999999 110.282 -173.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -68.36 -14.71 40.82 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.865 3.044 . . . . 1.8899999999999999 111.377 174.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.659 ' H ' ' HG1' ' A' ' 122' ' ' THR . 43.6 m-20 -41.84 -41.32 2.35 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.695 0.798 . . . . 2.4500000000000002 110.72 173.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -134.6 -177.39 4.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.587 1.155 . . . . 2.5499999999999998 109.94 175.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -84.86 156.45 21.29 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.31 0.644 . . . . 3.1099999999999999 109.821 170.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 57.6 ttt-85 -52.47 -50.06 63.41 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.876 0.695 . . . . 3.6699999999999999 112.876 -176.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.22 -2.22 15.25 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.598 -0.715 . . . . 4.9400000000000004 111.84 -176.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -98.71 -45.03 6.18 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.529 1.059 . . . . 1.72 109.95 164.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.43 -47.45 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.546 -0.721 . . . . 3.0600000000000001 109.367 -172.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.25 -26.44 61.11 Favored 'General case' 0 C--O 1.213 -0.846 0 C-N-CA 118.488 -1.285 . . . . 1.8600000000000001 108.709 177.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -61.85 -50.68 71.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 119.918 1.235 . . . . 3.77 109.453 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.22 -53.33 55.0 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.031 0.932 . . . . 0.93999999999999995 109.743 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -69.39 -40.35 79.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.442 0.639 . . . . 2.3500000000000001 111.075 -175.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -58.06 -52.71 64.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.41 1.484 . . . . 5.96 107.783 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -62.94 -51.47 66.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.1 0.96 . . . . 2.54 110.661 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -48.17 -46.03 34.22 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 123.782 0.833 . . . . 1.0800000000000001 110.869 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.403 ' CZ ' HD23 ' A' ' 224' ' ' LEU . 0.7 OUTLIER -66.27 -53.83 32.12 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.324 -0.853 . . . . 6.0199999999999996 110.139 176.068 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -47.38 -40.24 17.1 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.392 1.077 . . . . 3.8799999999999999 111.934 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 84.5 t -48.93 -48.75 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 125.195 1.398 . . . . 1.3400000000000001 109.449 175.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.512 ' CZ3' ' HG ' ' A' ' 250' ' ' LEU . 59.3 m95 -80.23 -38.35 31.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.381 0.672 . . . . 0.97999999999999998 111.497 178.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.5 m -61.99 -24.92 67.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.983 0.811 . . . . 3.7999999999999998 111.577 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -73.34 -45.16 56.79 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.885 -0.413 . . . . 1.28 109.885 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 93.4 t -77.62 -49.84 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.227 1.011 . . . . 3.2000000000000002 110.165 -171.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 81.2 p -79.43 153.94 76.48 Favored Pre-proline 0 N--CA 1.447 -0.618 0 N-CA-C 109.145 -0.687 . . . . 1.48 109.145 175.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.58 4.28 6.51 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.265 1.977 . . . . 0.84999999999999998 112.55 173.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.6 mt -71.53 125.62 27.54 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.643 1.111 . . . . 2.8100000000000001 109.658 -170.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -89.68 76.81 7.23 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.14 -1.43 . . . . 5.04 107.14 -169.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -61.48 156.13 20.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 118.143 -1.423 . . . . 7.7400000000000002 112.76 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.8 t -154.01 92.97 1.59 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.875 -0.787 . . . . 2.46 108.875 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -79.08 128.12 32.87 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.831 -0.803 . . . . 7.5300000000000002 108.831 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.8 pp -133.89 148.71 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 105.901 -1.888 . . . . 1.9199999999999999 105.901 174.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -115.8 6.07 14.27 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 118.079 0.4 . . . . 3.7999999999999998 111.79 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.9 p -136.4 119.55 16.59 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.828 0.851 . . . . 3.1400000000000001 108.817 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 121.6 -149.09 17.26 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 107.213 -2.355 . . . . 2.1400000000000001 107.213 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -114.77 138.0 51.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.233 1.413 . . . . 5.8499999999999996 107.298 172.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.08 164.27 12.79 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.691 1.196 . . . . 1.02 109.558 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.827 ' H ' ' HG1' ' A' ' 115' ' ' THR . 8.5 t70 -77.13 -46.66 22.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.829 -1.175 . . . . 2.73 107.829 178.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.426 HG12 ' CD2' ' A' ' 116' ' ' TYR . 0.7 OUTLIER -107.95 172.62 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 121.486 0.66 . . . . 2.2799999999999998 111.554 173.453 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.58 133.67 36.61 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.008 2.123 . . . . 2.5499999999999998 110.22 170.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.9 t -93.45 107.06 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.589 -1.263 . . . . 1.0900000000000001 107.589 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 70.6 t -117.2 81.48 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.682 1.193 . . . . 2.21 109.378 -174.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -77.31 149.03 35.36 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.605 -1.628 . . . . 6.1200000000000001 106.605 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.07 -170.4 3.27 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.266 -1.013 . . . . 1.3799999999999999 108.266 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.06 141.35 47.15 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.587 0.63 . . . . 7.6699999999999999 110.127 -178.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 33.25 -111.23 0.06 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.907 2.194 . . . . 2.3300000000000001 113.72 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.84 112.67 14.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.815 -1.18 . . . . 2.8599999999999999 107.815 174.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -134.05 -54.4 0.86 Allowed 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 124.411 1.084 . . . . 5.5700000000000003 110.876 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 156.4 74.05 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 106.182 -2.767 . . . . 3.6699999999999999 106.182 -166.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -157.77 164.88 36.6 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.532 -0.914 . . . . 2.71 108.532 170.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -83.11 -36.41 24.85 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 124.455 1.097 . . . . 5.4699999999999998 109.405 171.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -83.24 -28.22 29.37 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.617 0.767 . . . . 7.6299999999999999 111.332 -174.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 66.16 168.61 0.22 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.112 2.165 . . . . 4.0499999999999998 113.001 -173.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -96.96 174.15 6.92 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.899 0.88 . . . . 7.6299999999999999 109.832 168.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -137.63 166.57 23.6 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.698 1.999 . . . . 3.6200000000000001 107.872 176.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -70.92 -156.96 2.18 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.384 0.516 . . . . 2.8399999999999999 112.891 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -51.91 111.01 0.54 Allowed 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.571 -0.958 . . . . 4.2599999999999998 111.541 177.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.4 -151.79 17.47 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.474 -1.45 . . . . 2.79 109.474 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.33 -126.32 23.34 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 124.937 1.256 . . . . 2.6400000000000001 110.372 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.436 ' CD1' ' H12' ' A' ' 269' ' ' NGH . 23.1 mm -78.21 124.75 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 107.532 -1.284 . . . . 2.27 107.532 172.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.8 mp -83.48 -31.71 26.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.318 -0.855 . . . . 2.23 110.653 167.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.431 ' O ' H101 ' A' ' 269' ' ' NGH . . . -171.15 153.28 3.66 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 114.929 1.455 . . . . 0.92000000000000004 114.929 -177.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -136.3 125.95 25.42 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 126.543 1.937 . . . . 1.3200000000000001 113.626 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -157.32 162.03 39.11 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 128.168 2.587 . . . . 0.68999999999999995 104.935 -172.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -149.0 155.33 40.64 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.284 -2.117 . . . . 4.9199999999999999 105.284 171.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -101.41 -74.65 1.08 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.374 -1.09 . . . . 0.79000000000000004 110.374 172.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -68.52 174.12 8.83 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.067 1.845 . . . . 1.6599999999999999 110.204 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 83.12 164.47 36.05 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.198 -1.161 . . . . 2.8999999999999999 110.198 -170.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.8 p -82.9 179.94 7.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.157 0.983 . . . . 3.3100000000000001 111.302 -175.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.27 -114.17 6.54 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.363 0.506 . . . . 1.9299999999999999 111.915 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . 0.255 2.7 tp -60.57 -40.78 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 117.386 -1.293 . . . . 2.04 109.195 -174.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -20.77 115.73 0.01 OUTLIER Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.332 1.92 . . . . 1.5600000000000001 113.56 169.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 109.99 -49.44 0.85 Allowed Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.993 2.235 . . . . 0.89000000000000001 110.64 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -83.87 164.81 19.23 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.349 1.46 . . . . 2.1000000000000001 111.216 -168.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.11 131.99 18.07 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.945 1.091 . . . . 0.78000000000000003 113.945 -172.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -116.55 120.4 38.59 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-O 118.257 -0.878 . . . . 3.3399999999999999 110.352 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.0 150.57 22.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.975 0.807 . . . . 3.8399999999999999 111.877 169.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -76.25 93.17 3.37 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.047 0.939 . . . . 2.5499999999999998 112.064 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -77.76 -8.43 57.97 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 118.061 -0.971 . . . . 3.2599999999999998 111.632 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -57.36 -47.13 82.42 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 107.751 -1.203 . . . . 3.48 107.751 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . 0.268 9.5 pt-20 -73.49 175.57 6.89 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.922 1.344 . . . . 3.21 111.52 173.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -133.08 85.13 2.19 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.458 -1.682 . . . . 6.6100000000000003 106.458 -171.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.15 163.51 27.77 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.105 -1.407 . . . . 2.9900000000000002 108.286 169.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.2 p -145.82 166.35 26.19 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.406 -0.961 . . . . 3.25 108.406 173.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.7 t -49.8 -39.26 37.73 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 121.214 -0.929 . . . . 2.96 111.013 165.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.69 138.98 40.42 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.313 0.645 . . . . 3.4700000000000002 110.628 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.2 m -63.6 -16.95 62.27 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.485 1.514 . . . . 4.5099999999999998 112.603 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.96 -66.07 2.98 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.157 0.885 . . . . 2.73 115.131 -167.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -80.27 -89.59 0.51 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.409 -0.676 . . . . 2.0499999999999998 111.409 -166.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 18.4 m -131.89 170.71 14.5 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 103.179 -2.897 . . . . 1.8999999999999999 103.179 158.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -130.58 133.52 46.26 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 118.14 0.427 . . . . 2.1299999999999999 111.009 171.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -63.69 -45.87 88.08 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.216 -0.661 . . . . 2.73 109.216 -175.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.21 -47.33 54.81 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 109.499 -0.556 . . . . 2.7000000000000002 109.499 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.77 -60.45 3.43 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.038 0.935 . . . . 3.7000000000000002 110.289 -178.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 8.5 m -56.22 -41.9 76.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.961 -0.563 . . . . 2.5899999999999999 110.549 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.68 -51.63 68.76 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 117.921 -1.038 . . . . 0.56999999999999995 110.549 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 70.9 t -45.89 -46.64 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 119.669 1.122 . . . . 1.3200000000000001 110.22 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.635 ' CG ' ' H2 ' ' A' ' 269' ' ' NGH 0.494 0.3 OUTLIER -64.76 -47.28 78.76 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.627 -0.671 . . . . 3.8700000000000001 112.443 178.059 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . 0.403 ' HG2' ' HD1' ' A' ' 218' ' ' HIS 0.285 19.5 mm-40 -70.42 -48.59 55.33 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 120.727 -1.233 . . . . 2.9300000000000002 113.376 -176.268 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -51.66 -42.01 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 107.862 -1.162 . . . . 2.1000000000000001 107.862 171.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -54.86 -55.07 29.58 Favored Glycine 0 CA--C 1.539 1.588 0 N-CA-C 111.595 -0.602 . . . . 0.53000000000000003 111.595 172.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.623 ' CD2' ' CE1' ' A' ' 218' ' ' HIS . 18.4 m-70 -50.22 -58.19 6.16 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 117.878 0.839 . . . . 2.0499999999999998 110.514 177.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.9 t -47.94 -49.67 29.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.963 2.105 . . . . 2.6200000000000001 110.737 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.457 HD22 ' HH ' ' A' ' 116' ' ' TYR . 0.3 OUTLIER -65.32 -37.12 86.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 122.962 0.505 . . . . 4.5800000000000001 110.061 -178.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 143.93 70.45 0.02 OUTLIER Glycine 0 C--N 1.338 0.67 0 N-CA-C 112.001 -0.44 . . . . 1.1699999999999999 112.001 160.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 11.1 mt -133.94 155.61 49.62 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.182 0.593 . . . . 4.0199999999999996 110.312 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -132.19 48.91 0.94 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.823 1.201 . . . . 3.0 110.122 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 70.04 165.17 0.27 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.778 1.631 . . . . 5.0300000000000002 112.514 -176.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.3 m -132.71 141.28 48.49 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.089 -1.819 . . . . 1.8300000000000001 106.089 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 31.5 t -80.34 47.55 0.93 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.004 0.522 . . . . 2.9100000000000001 111.718 -170.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -154.27 135.56 8.86 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-O 118.472 -0.775 . . . . 2.0099999999999998 109.775 -171.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.89 -16.77 7.37 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.82 2.347 . . . . 1.99 114.403 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -76.44 -36.6 57.85 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.458 -1.401 . . . . 2.7200000000000002 109.033 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.98 124.66 17.47 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.325 0.583 . . . . 1.3200000000000001 109.586 167.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 69.2 t -64.59 -25.22 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.926 -0.768 . . . . 0.96999999999999997 108.926 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 1.2 mmt -49.0 -23.96 1.34 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.099 1.518 . . . . 2.6800000000000002 115.099 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -53.91 139.47 52.69 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 119.366 0.985 . . . . 7.8899999999999997 110.59 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.641 ' O ' ' H91' ' A' ' 269' ' ' NGH . 20.1 Cg_endo -64.88 -23.45 62.13 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.274 1.982 . . . . 1.4399999999999999 112.021 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.361 0.2 OUTLIER -94.52 154.43 17.41 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.606 -0.886 . . . . 3.4700000000000002 108.606 178.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -72.86 150.03 43.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.617 -0.883 . . . . 3.54 108.617 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -141.75 139.82 32.93 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.33 -0.989 . . . . 4.0300000000000002 108.33 173.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -76.26 77.7 3.05 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.765 0.826 . . . . 4.9500000000000002 109.509 -176.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 25.5 m -83.79 103.59 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 116.016 -0.538 . . . . 1.8500000000000001 109.957 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.26 115.54 3.59 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.872 0.368 . . . . 3.5299999999999998 110.323 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 8.8 mt -57.45 -24.42 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.268 0.627 . . . . 3.5800000000000001 109.75 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -41.95 -43.54 3.15 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 124.121 0.968 . . . . 3.8199999999999998 112.621 168.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 14.0 m -82.65 -47.74 11.72 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.204 0.602 . . . . 3.29 110.053 -177.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 59.7 t80 52.82 69.4 0.7 Allowed 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.256 1.022 . . . . 5.3099999999999996 110.873 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -157.94 170.12 23.04 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.447 -0.783 . . . . 4.4400000000000004 110.142 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.512 ' HG ' ' CZ3' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -109.89 152.4 25.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.972 1.709 . . . . 1.03 107.47 -179.05 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.0 151.35 33.63 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 121.423 -0.798 . . . . 1.72 111.195 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -47.69 -47.2 29.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.669 0.788 . . . . 1.0600000000000001 110.786 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -57.49 -45.7 84.58 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.444 0.64 . . . . 2.4500000000000002 110.8 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -58.26 -50.61 72.97 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.993 -1.003 . . . . 2.3599999999999999 108.866 177.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.5 mt -55.29 -33.16 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.078 1.751 . . . . 1.3300000000000001 112.525 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -70.94 -50.79 30.79 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.726 -1.234 . . . . 6.8099999999999996 109.809 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -46.87 -52.52 11.54 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.366 -0.694 . . . . 1.02 111.366 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 1.9 pp -63.08 -45.48 98.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.655 0.782 . . . . 2.8999999999999999 109.711 -176.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -61.47 -30.24 70.47 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 120.815 -1.178 . . . . 2.9199999999999999 110.947 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.88 -17.56 0.59 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.573 0.953 . . . . 2.2799999999999998 113.573 172.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 36.4 mt -42.0 -42.67 2.91 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 120.026 1.284 . . . . 3.1800000000000002 113.196 164.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -75.56 -69.05 0.51 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.593 -0.891 . . . . 8.2200000000000006 108.593 170.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 N-CA-C 105.718 -2.953 . . . . 8.4100000000000001 105.718 -178.417 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' NGH . . . . . 0.641 ' H91' ' O ' ' A' ' 238' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 61.8 mtt . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 117.147 -1.406 . . . . 17.510000000000002 107.468 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -117.0 71.21 0.28 Allowed Glycine 0 CA--C 1.53 0.997 0 CA-C-N 119.67 1.123 . . . . 12.9 111.721 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.32 142.72 41.81 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.807 1.671 . . . . 15.49 108.866 174.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.4 p -155.26 153.11 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 105.957 -1.868 . . . . 9.4100000000000001 105.957 174.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.22 177.82 3.65 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.456 -0.942 . . . . 13.49 108.456 171.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -64.57 -39.21 93.33 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.039 -1.038 . . . . 14.76 109.859 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.442 ' HZ2' HD12 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -104.53 -135.17 0.34 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.246 2.219 . . . . 12.0 106.919 177.526 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -139.35 -88.41 0.21 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.087 0.955 . . . . 8.2400000000000002 108.637 173.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -146.12 145.51 30.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.591 1.556 . . . . 4.9199999999999999 107.761 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.86 96.83 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.32 -0.993 . . . . 3.9500000000000002 108.32 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -104.41 140.4 37.97 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.683 1.593 . . . . 1.6200000000000001 108.963 -174.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -122.79 160.81 25.21 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.115 0.966 . . . . 6.3399999999999999 111.821 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -146.46 144.66 29.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.336 1.054 . . . . 9.1199999999999992 110.012 177.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.4 mt -106.0 156.3 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.204 1.402 . . . . 1.49 107.509 175.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.443 HD22 ' HG ' ' A' ' 160' ' ' LEU . 45.7 m-80 -107.04 -44.15 4.46 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.917 0.887 . . . . 4.04 110.54 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -152.2 172.96 15.57 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.499 1.119 . . . . 2.1800000000000002 107.98 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -127.56 139.57 52.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.136 1.374 . . . . 3.1099999999999999 107.86 -170.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.8 t -66.3 141.7 97.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.277 -0.638 . . . . 2.6200000000000001 109.277 172.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -77.77 -16.31 14.69 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.74 2.96 . . . . 2.21 111.088 173.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -44.19 -44.37 7.75 Favored 'General case' 0 C--N 1.345 0.374 0 C-N-CA 124.875 1.27 . . . . 2.5800000000000001 111.357 -178.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 22.0 mtm -126.28 168.86 13.53 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.919 1.687 . . . . 2.2799999999999998 107.756 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -65.7 143.27 57.65 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 108.979 -0.748 . . . . 3.2000000000000002 108.979 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -47.34 -48.21 25.51 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.01 0.823 . . . . 4.8600000000000003 110.99 174.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -58.44 -18.81 31.4 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.54 -0.743 . . . . 3.1400000000000001 112.205 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -93.59 -42.2 9.33 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.128 1.771 . . . . 2.0600000000000001 110.458 173.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.5 t -53.22 -55.47 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 O-C-N 120.603 -1.31 . . . . 1.78 109.48 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -24.88 65.01 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 117.897 -1.521 . . . . 1.8600000000000001 109.482 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -62.93 -48.89 76.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.399 0.999 . . . . 3.3599999999999999 109.889 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -58.97 -48.8 80.25 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 122.403 0.281 . . . . 0.53000000000000003 110.677 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -37.24 70.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 121.227 0.537 . . . . 2.6899999999999999 109.933 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -55.42 31.48 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.277 1.031 . . . . 3.75 108.496 176.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -61.58 -46.64 89.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.397 1.079 . . . . 2.6400000000000001 109.394 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -48.43 -55.77 9.98 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.364 0.666 . . . . 0.64000000000000001 110.701 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -55.99 -51.78 66.51 Favored 'General case' 0 N--CA 1.457 -0.104 0 O-C-N 121.806 -0.559 . . . . 5.5899999999999999 110.394 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.9 -35.27 57.92 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.757 0.651 . . . . 2.6800000000000002 112.757 -175.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 91.4 t -56.89 -51.76 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 123.949 0.9 . . . . 1.3400000000000001 109.862 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -77.35 -28.08 52.88 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.794 -0.566 . . . . 1.21 109.793 -175.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.34 -31.83 72.51 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.952 0.901 . . . . 1.6200000000000001 109.744 175.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -66.05 -49.27 68.27 Favored 'General case' 0 C--N 1.341 0.23 0 O-C-N 121.644 -0.66 . . . . 1.27 109.682 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 64.7 t -70.77 -54.4 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 123.07 0.548 . . . . 3.0899999999999999 110.408 -176.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.482 ' CG2' HG13 ' A' ' 258' ' ' ILE . 81.5 p -82.5 137.19 45.04 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 109.603 -0.517 . . . . 1.9199999999999999 109.603 -174.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -68.05 19.79 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.555 2.836 . . . . 1.74 113.88 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.442 HD12 ' HZ2' ' A' ' 111' ' ' LYS . 2.9 mp -81.06 166.08 21.07 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.774 1.63 . . . . 4.29 108.774 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -124.63 86.13 2.51 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.714 -0.847 . . . . 4.54 108.714 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -74.4 142.32 45.02 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.594 1.158 . . . . 7.1699999999999999 113.256 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 t -151.9 101.57 2.76 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.017 1.117 . . . . 1.4299999999999999 114.017 -176.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.39 126.1 30.76 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 120.157 -1.589 . . . . 4.1399999999999997 109.963 172.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.6 pp -125.6 149.35 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.885 -1.524 . . . . 2.1800000000000002 106.885 174.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -101.73 -15.63 16.91 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.825 0.345 . . . . 2.7599999999999998 110.557 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 55.1 m -144.4 132.41 21.55 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.405 -2.072 . . . . 3.21 105.405 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 141.5 -155.27 25.17 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 106.882 -2.487 . . . . 2.1600000000000001 106.882 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.6 mtt -119.99 140.3 51.17 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.533 -2.025 . . . . 5.7599999999999998 105.533 174.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -144.26 153.5 42.1 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.026 -1.102 . . . . 0.98999999999999999 108.026 -176.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.29 -56.69 4.34 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.427 -1.323 . . . . 1.8500000000000001 107.427 -167.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.1 pt -86.16 -174.66 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 114.82 -1.082 . . . . 1.6200000000000001 110.541 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.443 ' HG ' HD22 ' A' ' 119' ' ' ASN . 1.1 tp -145.39 134.65 22.92 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.862 2.065 . . . . 3.4100000000000001 107.689 173.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.7 t -97.04 98.33 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.182 -1.044 . . . . 0.81999999999999995 108.182 172.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 72.7 t -80.25 129.34 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.804 -1.184 . . . . 2.02 107.804 173.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -111.07 126.55 54.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 104.618 -2.364 . . . . 6.3799999999999999 104.618 156.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -144.2 157.94 44.01 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 109.424 -0.584 . . . . 1.3700000000000001 109.424 175.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.26 91.31 2.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.851 1.261 . . . . 4.8399999999999999 109.347 -173.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 115.28 -55.31 0.54 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.759 1.171 . . . . 1.95 111.093 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -152.78 165.73 34.46 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.998 0.919 . . . . 3.02 108.787 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.95 -37.57 0.08 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.642 0.608 . . . . 4.1699999999999999 112.642 173.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -172.73 -50.53 0.05 OUTLIER Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.433 -1.067 . . . . 2.8900000000000001 110.433 -173.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.86 155.38 31.02 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.305 -0.998 . . . . 2.8300000000000001 108.305 171.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.61 -58.87 3.02 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 125.186 1.394 . . . . 6.1399999999999997 107.97 -173.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -101.53 118.21 36.48 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.004 -1.48 . . . . 5.2999999999999998 107.004 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -157.73 -55.03 0.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.201 0.6 . . . . 3.1499999999999999 111.049 -169.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -112.09 174.84 5.69 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.58 1.552 . . . . 7.4800000000000004 107.646 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -179.38 31.99 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.878 0.871 . . . . 2.3100000000000001 111.536 -174.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 55.01 -155.12 9.11 Favored Glycine 0 CA--C 1.532 1.148 0 O-C-N 120.714 -1.241 . . . . 1.8200000000000001 111.604 -170.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -69.37 98.36 1.07 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.271 1.028 . . . . 4.8099999999999996 110.772 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 152.15 -175.21 30.94 Favored Glycine 0 C--O 1.24 0.512 0 N-CA-C 111.308 -0.717 . . . . 1.97 111.308 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 45.53 -118.6 3.09 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 126.834 2.159 . . . . 1.53 111.131 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.9 mm -80.58 129.61 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.723 -1.214 . . . . 2.0899999999999999 107.723 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.679 ' HB2' ' H1 ' ' A' ' 269' ' ' NGH . 3.8 mm? -81.42 -44.88 16.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.209 1.404 . . . . 3.2400000000000002 109.025 165.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.914 ' O ' H102 ' A' ' 269' ' ' NGH . . . -164.26 149.76 10.5 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 113.062 0.764 . . . . 0.67000000000000004 113.062 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -131.68 115.0 15.47 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.758 1.623 . . . . 1.29 112.469 -174.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -147.43 160.19 42.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.55 2.74 . . . . 0.59999999999999998 105.476 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -150.45 160.05 44.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.855 -1.535 . . . . 5.0899999999999999 106.855 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -81.65 -69.07 1.41 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.173 0.892 . . . . 1.55 111.968 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -58.73 132.79 49.98 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.42 2.08 . . . . 3.6600000000000001 109.215 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -75.69 44.7 1.78 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.639 1.114 . . . . 3.8300000000000001 112.876 -171.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.3 m -77.38 78.93 3.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.636 -1.246 . . . . 6.0999999999999996 107.636 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.53 -101.26 0.75 Allowed Glycine 0 C--O 1.244 0.778 0 N-CA-C 110.317 -1.113 . . . . 3.1200000000000001 110.317 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 2.7 tp -64.41 -39.34 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 121.67 -0.9 . . . . 2.5099999999999998 109.465 -174.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -45.19 159.01 0.2 Allowed Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.468 1.032 . . . . 2.4900000000000002 115.459 176.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 85.68 -52.89 4.65 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 109.715 -1.354 . . . . 1.45 109.715 -159.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.01 162.67 27.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.138 1.375 . . . . 1.95 108.418 -172.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -135.14 121.62 20.54 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.528 0.603 . . . . 0.69999999999999996 112.614 -174.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -113.92 113.39 24.78 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-O 118.729 -0.653 . . . . 2.8599999999999999 111.073 -171.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -96.28 144.65 26.26 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.371 0.668 . . . . 4.0300000000000002 110.572 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -68.67 97.44 0.8 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.454 -0.794 . . . . 2.6899999999999999 111.158 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -70.57 -30.15 66.78 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 120.978 -1.077 . . . . 2.6899999999999999 109.834 173.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -46.89 -42.01 16.82 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.261 1.424 . . . . 2.6400000000000001 109.301 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -74.81 172.13 12.73 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 122.347 1.07 . . . . 2.4399999999999999 113.07 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -113.64 96.11 5.69 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.712 -1.218 . . . . 5.1399999999999997 107.712 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -75.03 151.04 38.76 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.931 -1.137 . . . . 1.52 107.931 172.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 82.4 p -129.92 134.19 47.33 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.407 0.683 . . . . 1.99 109.78 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.6 t -51.57 -43.87 62.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 123.961 0.904 . . . . 1.8700000000000001 111.314 172.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.25 -157.88 0.34 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.645 1.178 . . . . 2.4199999999999999 111.63 -178.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.5 m -60.66 -66.59 0.5 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.336 1.055 . . . . 3.9700000000000002 110.801 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 42.66 -103.81 0.04 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.106 1.336 . . . . 2.8599999999999999 114.825 174.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -125.98 -71.93 0.19 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.309 0.957 . . . . 1.75 110.984 -173.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.3 m -119.21 168.14 11.17 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 105.556 -2.016 . . . . 1.75 105.556 167.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -123.56 128.99 50.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.156 0.182 . . . . 1.3899999999999999 111.113 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.33 -48.14 81.12 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 118.699 -0.667 . . . . 3.1200000000000001 109.495 -177.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -50.52 -43.9 56.06 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.89 0.768 . . . . 2.1899999999999999 110.426 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 7.4 tt -63.24 -60.35 3.52 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.765 0.826 . . . . 1.53 109.698 -175.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.451 ' CG2' ' H2 ' ' A' ' 269' ' ' NGH 0.338 20.1 m -61.27 -38.01 85.2 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 120.454 -0.498 . . . . 1.6799999999999999 111.128 179.235 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.09 -60.69 2.83 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 118.199 -0.905 . . . . 0.40999999999999998 109.48 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -51.87 -45.3 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 119.12 0.873 . . . . 2.7200000000000002 111.061 -173.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.556 ' CD2' ' O4 ' ' A' ' 269' ' ' NGH . 13.0 t60 -52.1 -61.79 2.04 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.236 1.015 . . . . 3.6200000000000001 112.762 168.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -57.41 -38.43 74.31 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.443 -1.411 . . . . 2.8599999999999999 112.184 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.97 -36.16 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 108.247 -1.02 . . . . 1.72 108.247 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -55.81 -44.07 87.03 Favored Glycine 0 CA--C 1.538 1.486 0 O-C-N 121.808 -0.558 . . . . 0.64000000000000001 111.747 166.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -55.35 -50.04 70.68 Favored 'General case' 0 C--N 1.344 0.343 0 O-C-N 122.106 -0.643 . . . . 2.1200000000000001 109.272 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.2 t -44.09 -56.32 4.12 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.204 1.002 . . . . 2.5699999999999998 112.4 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.16 -55.49 28.24 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 119.101 0.864 . . . . 4.4500000000000002 108.879 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 155.38 37.07 0.02 OUTLIER Glycine 0 C--N 1.337 0.6 0 C-N-CA 120.906 -0.664 . . . . 1.1299999999999999 114.607 174.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 4.3 mt -84.64 113.11 21.04 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.65 1.225 . . . . 4.4800000000000004 110.695 175.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -74.56 60.62 2.43 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.928 0.775 . . . . 2.2999999999999998 111.552 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 78.3 m80 60.17 -170.65 0.14 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.099 1.359 . . . . 2.9300000000000002 112.353 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 58.1 m -148.06 -178.38 6.26 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.813 1.645 . . . . 1.3200000000000001 108.865 167.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.9 t -139.19 38.72 2.11 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.884 0.874 . . . . 2.7200000000000002 110.193 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -140.55 143.13 31.51 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.436 -1.69 . . . . 1.6699999999999999 106.436 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -87.6 -13.58 4.05 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.848 1.698 . . . . 1.1499999999999999 114.62 -173.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 18.2 mtmt -80.32 -36.83 33.69 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.948 -1.13 . . . . 1.5700000000000001 107.948 170.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.33 137.27 42.13 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.408 0.623 . . . . 0.71999999999999997 110.682 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.49 HG11 ' H72' ' A' ' 269' ' ' NGH . 58.0 t -86.73 -17.04 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 114.751 -1.113 . . . . 0.84999999999999998 109.886 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.517 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 7.9 tpt -76.15 -18.27 59.2 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 114.06 1.133 . . . . 2.27 114.06 -172.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.487 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.86 161.05 0.43 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 126.217 1.807 . . . . 4.29 114.389 176.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.32 -14.39 13.19 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.846 1.698 . . . . 0.94999999999999996 112.37 172.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.547 ' O ' ' H4 ' ' A' ' 269' ' ' NGH 0.385 0.2 OUTLIER -78.39 168.1 20.32 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.539 -0.911 . . . . 2.0499999999999998 108.539 176.605 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -112.48 133.96 54.27 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.315 -1.735 . . . . 3.7799999999999998 106.315 172.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -134.92 148.35 50.03 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.997 -1.112 . . . . 4.0 107.997 172.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -71.38 79.56 0.75 Allowed 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.778 1.231 . . . . 5.1900000000000004 109.174 178.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.8 m -76.63 112.76 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.831 -0.803 . . . . 2.0800000000000001 108.831 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -64.77 118.22 8.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.965 -0.561 . . . . 3.0099999999999998 110.501 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 33.0 mm -58.98 -21.79 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.877 0.871 . . . . 4.0899999999999999 111.197 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -55.49 -33.29 63.57 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.373 0.988 . . . . 3.6000000000000001 111.595 172.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.6 m -80.33 -50.75 9.75 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.751 -0.463 . . . . 2.54 109.751 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 54.2 t80 46.48 73.99 0.16 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.412 1.485 . . . . 5.46 112.142 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.76 167.91 25.87 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.558 -0.714 . . . . 3.4500000000000002 109.781 175.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.429 ' CD2' ' N ' ' A' ' 250' ' ' LEU . 0.3 OUTLIER -102.43 141.12 35.78 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 105.693 -1.966 . . . . 1.0700000000000001 105.693 178.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.28 170.99 14.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.789 -0.449 . . . . 2.21 109.789 -172.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.92 -42.59 85.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.154 -0.618 . . . . 0.94999999999999996 110.078 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.09 -45.81 89.9 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 110.3 -0.259 . . . . 2.6400000000000001 110.3 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -56.22 -51.51 67.82 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.259 -1.015 . . . . 2.9700000000000002 108.259 175.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 57.0 mt -59.3 -31.2 45.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 126.805 2.042 . . . . 0.88 112.663 -175.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -70.33 -58.53 3.65 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.039 -1.038 . . . . 6.4199999999999999 110.04 172.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -56.93 -44.2 92.63 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 111.758 -0.537 . . . . 1.1599999999999999 111.758 -175.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.482 HG13 ' CG2' ' A' ' 145' ' ' THR . 10.2 tp -59.42 -34.77 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.08 0.952 . . . . 4.9500000000000002 111.816 -176.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -86.41 -26.08 24.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.852 -0.53 . . . . 2.9700000000000002 110.623 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.7 t -53.32 -18.22 2.35 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 117.851 -1.071 . . . . 2.6000000000000001 113.064 171.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -29.37 -56.81 0.15 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.654 1.582 . . . . 3.8100000000000001 113.472 166.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 136.54 -59.82 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 129.041 2.936 . . . . 6.7699999999999996 107.389 -177.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 N-CA-C 105.421 -3.072 . . . . 9.0199999999999996 105.421 -160.846 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' NGH . . . . . 0.914 H102 ' O ' ' A' ' 182' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 49.4 mtt . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 117.406 -1.283 . . . . 19.190000000000001 107.813 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -161.44 174.86 38.05 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.483 -1.447 . . . . 17.539999999999999 109.483 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.21 173.95 12.86 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.563 2.842 . . . . 17.469999999999999 110.106 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.1 p -153.36 143.29 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.987 -1.116 . . . . 10.02 107.987 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -97.41 145.48 26.13 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.217 1.007 . . . . 14.949999999999999 109.296 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -52.26 36.28 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 109.476 -0.565 . . . . 9.3000000000000007 109.476 175.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -76.54 -65.96 0.87 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.338 -0.847 . . . . 6.8499999999999996 110.526 -162.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.0 m80 64.28 -62.23 0.18 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.894 2.078 . . . . 5.54 113.872 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -86.6 101.73 13.5 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.018 1.327 . . . . 4.3399999999999999 110.06 -172.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.7 mm -124.15 109.57 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.539 -0.912 . . . . 2.7200000000000002 108.539 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.536 ' HG1' ' H ' ' A' ' 158' ' ' ASP . 2.5 p -101.92 146.69 27.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.459 1.104 . . . . 1.6000000000000001 109.858 -178.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.43 ' CZ ' ' CE1' ' A' ' 138' ' ' PHE . 1.9 m-85 -130.11 159.78 35.75 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 119.194 -0.432 . . . . 6.5 111.045 -176.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -143.08 146.3 33.67 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.769 0.827 . . . . 6.1399999999999997 109.045 175.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.34 157.54 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.458 -0.942 . . . . 1.46 108.458 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.457 ' H ' HD21 ' A' ' 119' ' ' ASN . 0.1 OUTLIER -91.61 -57.66 2.69 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.502 0.721 . . . . 3.5800000000000001 109.746 171.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -149.79 171.68 16.35 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 110.168 -0.308 . . . . 2.0899999999999999 110.168 175.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -105.68 118.08 35.66 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.974 1.31 . . . . 3.8900000000000001 107.792 -175.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.6 t -71.07 135.7 84.95 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.636 -0.876 . . . . 3.0 108.636 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.03 -19.72 22.7 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.777 2.318 . . . . 2.2999999999999998 112.548 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.64 -43.49 3.85 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.097 1.759 . . . . 2.5899999999999999 112.37 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -128.44 -179.89 5.28 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.371 1.468 . . . . 2.7200000000000002 108.237 175.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -85.26 145.47 27.53 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.358 0.599 . . . . 2.8999999999999999 110.24 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.9 ttt-85 -49.87 -47.58 51.77 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.635 0.774 . . . . 3.75 111.859 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -62.29 -4.88 2.0 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.012 0.925 . . . . 3.0099999999999998 112.909 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -101.42 -46.35 5.03 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.104 1.762 . . . . 2.1400000000000001 110.029 169.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 66.1 t -54.3 -56.37 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 124.569 1.147 . . . . 1.73 109.518 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -26.96 65.83 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 118.182 -1.407 . . . . 1.8 109.678 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -60.09 -50.12 74.95 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 119.613 1.097 . . . . 3.02 110.01 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.65 -54.42 37.94 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 123.409 0.684 . . . . 0.46999999999999997 110.126 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.1 tp -66.21 -41.03 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.824 0.345 . . . . 3.3399999999999999 110.926 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -53.91 -60.18 3.66 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.491 1.517 . . . . 4.0999999999999996 107.635 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -62.36 -46.11 90.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.281 -0.872 . . . . 2.7400000000000002 110.141 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.05 -52.2 45.57 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.878 0.471 . . . . 0.46000000000000002 110.721 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.43 ' CE1' ' CZ ' ' A' ' 116' ' ' TYR . 4.4 m-85 -55.16 -48.52 73.62 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.709 -0.223 . . . . 5.6200000000000001 110.917 171.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -35.16 61.74 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.573 -0.727 . . . . 2.6200000000000001 111.861 -178.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 94.9 t -55.57 -65.04 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.312 0 CA-C-N 119.217 0.917 . . . . 1.3899999999999999 109.821 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.424 ' CZ3' HG23 ' A' ' 258' ' ' ILE . 41.5 m95 -70.66 -33.34 70.85 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.608 -0.886 . . . . 1.03 108.608 -171.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.448 ' HG ' ' H ' ' A' ' 149' ' ' PHE . 23.0 t -68.51 -13.77 62.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 119.104 -0.474 . . . . 1.72 112.27 178.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.38 -52.49 7.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.911 -1.144 . . . . 1.23 107.911 177.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.9 m -82.47 -37.85 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.802 -0.636 . . . . 2.7400000000000002 112.328 -171.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.3 p -87.38 150.5 49.2 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 106.235 -1.765 . . . . 1.9099999999999999 106.235 170.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.66 -0.5 10.7 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.538 1.492 . . . . 1.04 112.459 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.6 mt -61.28 117.05 5.12 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 119.245 0.93 . . . . 3.1499999999999999 108.849 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -94.5 105.43 17.39 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.173 0.589 . . . . 5.5800000000000001 109.518 -172.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.448 ' H ' ' HG ' ' A' ' 142' ' ' SER . 0.0 OUTLIER -64.98 146.75 54.59 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.339 -0.846 . . . . 8.9199999999999999 112.329 -177.357 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.5 t -154.08 96.98 2.01 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.286 0.565 . . . . 1.49 110.704 165.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -79.75 125.97 30.35 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 108.474 -0.936 . . . . 3.0899999999999999 108.474 172.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.85 155.46 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.678 -1.601 . . . . 1.8300000000000001 106.678 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -108.58 -9.31 15.34 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.939 0.791 . . . . 3.3199999999999998 111.919 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 76.8 m -143.04 132.07 22.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.126 1.77 . . . . 2.8599999999999999 106.67 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.82 -156.79 20.79 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 107.962 -2.055 . . . . 2.96 107.962 -172.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 52.4 mtt -105.12 137.86 42.23 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.94 1.296 . . . . 5.7599999999999998 108.159 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.74 147.08 50.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.438 1.095 . . . . 1.3100000000000001 109.015 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.536 ' H ' ' HG1' ' A' ' 115' ' ' THR . 20.6 t70 -75.19 -50.24 16.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.124 -1.065 . . . . 2.0 108.124 175.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.4 154.11 12.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.447 0.642 . . . . 2.1200000000000001 110.833 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.09 132.9 54.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.904 -1.147 . . . . 3.27 107.904 169.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.2 t -78.57 135.65 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.023 -1.473 . . . . 1.22 107.023 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 196' ' ' HIS . 74.1 t -116.49 134.52 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.802 1.183 . . . . 1.8100000000000001 109.29 172.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -95.97 149.44 21.57 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.668 -1.234 . . . . 9.2799999999999994 107.668 167.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -159.04 149.04 19.18 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 120.536 -1.353 . . . . 1.5600000000000001 110.26 170.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -120.25 132.93 55.54 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.604 1.162 . . . . 4.8899999999999997 108.672 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 54.13 -96.8 0.03 OUTLIER Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.293 0.949 . . . . 2.1099999999999999 111.833 -167.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -124.68 140.85 52.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.138 1.375 . . . . 2.4500000000000002 108.852 -169.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -145.4 50.7 1.21 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.286 0.565 . . . . 3.4300000000000002 110.363 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.92 56.87 10.85 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 108.395 -1.882 . . . . 2.6499999999999999 108.395 -169.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -150.89 150.08 30.44 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.07 -1.826 . . . . 2.8300000000000001 106.07 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -80.24 -47.96 13.81 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.749 -0.834 . . . . 4.25 108.749 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -134.46 87.42 2.35 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.273 1.029 . . . . 6.5 108.996 -173.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -107.05 -102.79 0.35 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.731 0.812 . . . . 3.0 109.309 174.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.406 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 26.2 t80 -89.66 161.82 15.91 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.932 0.872 . . . . 9.25 109.413 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.406 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 47.1 p-10 -168.85 26.75 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.682 -1.599 . . . . 3.48 110.613 -157.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 91.6 165.64 39.64 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 111.246 -0.742 . . . . 3.0099999999999998 111.246 -170.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.98 111.69 2.27 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 122.544 -0.386 . . . . 6.3899999999999997 110.542 166.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.8 -164.31 13.59 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.61 -1.396 . . . . 2.3900000000000001 109.61 -171.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 59.06 -120.03 20.74 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 110.225 -1.15 . . . . 2.3700000000000001 110.225 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.437 HD11 H102 ' A' ' 269' ' ' NGH . 6.7 mm -76.57 122.78 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 105.699 -1.963 . . . . 2.3399999999999999 105.699 168.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.57 -44.4 17.34 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.65 -0.5 . . . . 1.98 109.65 174.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -167.08 168.51 13.63 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.69 -0.631 . . . . 0.68000000000000005 109.921 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -145.92 108.35 4.45 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.198 0.999 . . . . 1.3 113.377 -172.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -128.19 156.66 42.57 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.937 2.095 . . . . 0.84999999999999998 107.107 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -145.29 149.15 34.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.024 -1.843 . . . . 3.8300000000000001 106.024 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.75 -85.44 1.71 Allowed Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.506 -1.038 . . . . 0.78000000000000003 110.506 174.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.38 86.54 0.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.638 2.892 . . . . 1.4299999999999999 111.196 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -158.88 164.79 33.87 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 108.165 -1.974 . . . . 1.3700000000000001 108.165 169.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.9 t -79.92 179.85 7.35 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.378 0.589 . . . . 4.0599999999999996 109.964 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 43.8 -102.93 0.04 OUTLIER Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.814 1.674 . . . . 1.4099999999999999 112.574 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.2 tp -60.3 -40.04 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 118.298 -0.858 . . . . 1.55 110.0 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -37.2 134.4 0.89 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.675 1.131 . . . . 1.1399999999999999 112.85 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 99.7 -47.77 1.29 Allowed Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.829 1.681 . . . . 0.88 111.392 -161.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -88.49 138.93 30.99 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.902 0.881 . . . . 1.28 110.084 -156.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -109.65 119.63 40.0 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.669 0.788 . . . . 0.79000000000000004 112.663 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.403 ' HA ' ' O ' ' A' ' 162' ' ' VAL 0.28 0.0 OUTLIER -111.39 113.25 25.57 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-O 117.575 -1.202 . . . . 2.8900000000000001 110.783 -171.912 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -103.03 152.33 21.48 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.42 1.464 . . . . 7.9199999999999999 112.756 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -64.1 95.58 0.13 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.36 -1.291 . . . . 2.6800000000000002 108.767 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -56.89 -40.0 75.42 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 125.395 1.478 . . . . 3.2200000000000002 111.594 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -66.77 -28.34 68.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.53 1.132 . . . . 3.1400000000000001 110.731 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -69.85 127.1 31.73 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 107.732 -1.21 . . . . 2.2999999999999998 107.732 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -80.59 78.68 7.31 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.904 -1.147 . . . . 3.6800000000000002 107.904 -174.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -77.0 103.7 7.08 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.302 1.041 . . . . 2.75 110.562 -172.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.26 166.54 12.88 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.05 1.405 . . . . 2.5800000000000001 110.72 -174.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.3 t -69.26 -43.44 73.95 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 127.542 2.337 . . . . 1.98 112.371 166.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -82.53 156.88 23.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.374 -0.83 . . . . 4.2800000000000002 109.698 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.4 m -69.11 -32.99 72.78 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.991 1.717 . . . . 4.8700000000000001 110.952 -167.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.81 133.77 52.63 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 111.066 -0.813 . . . . 2.98 111.066 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 90.28 -120.29 5.82 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.069 -2.012 . . . . 2.5499999999999998 108.069 -175.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.45 142.38 50.8 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 108.273 -1.01 . . . . 1.5800000000000001 108.273 162.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -96.81 121.48 38.72 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.363 0.414 . . . . 1.25 110.584 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.79 -53.42 32.0 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 109.143 -0.688 . . . . 2.1600000000000001 109.143 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -47.36 -48.09 25.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.336 0.654 . . . . 2.27 110.637 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.5 tt -60.17 -58.21 9.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.321 -0.4 . . . . 1.74 110.941 -174.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.392 80.4 m -56.37 -43.02 78.78 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.102 0.477 . . . . 2.2799999999999998 110.22 176.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.61 -55.99 23.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 117.26 -1.352 . . . . 0.40000000000000002 109.808 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 38.9 t -47.95 -45.39 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 121.157 1.799 . . . . 1.49 110.951 -176.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.429 ' ND1' ' H4 ' ' A' ' 269' ' ' NGH . 0.4 OUTLIER -56.79 -56.49 20.81 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.78 0.659 . . . . 3.8999999999999999 112.78 170.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -65.76 -44.4 85.98 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 120.406 -1.434 . . . . 3.54 112.737 -176.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.425 HG13 ' CZ ' ' A' ' 138' ' ' PHE . 1.4 mp -49.84 -49.06 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 125.923 1.689 . . . . 1.49 106.96 172.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -53.58 -52.46 41.54 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.684 -0.566 . . . . 0.62 111.684 175.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -50.25 -51.0 48.28 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 117.763 0.781 . . . . 1.99 110.642 175.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.0 m -57.34 -47.14 82.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.157 0.983 . . . . 3.1499999999999999 110.951 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 82.1 mt -59.13 -22.6 61.15 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.481 1.112 . . . . 3.3700000000000001 112.392 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 124.54 4.14 7.61 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.557 1.075 . . . . 1.53 112.877 173.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 30.6 mt -80.78 122.34 27.04 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 118.218 1.009 . . . . 4.9299999999999997 110.849 -169.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -65.24 179.68 8.73 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.468 -0.653 . . . . 3.46 111.468 173.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -77.02 121.31 23.34 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.133 0.573 . . . . 1.8600000000000001 110.595 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.8 m -76.09 173.95 10.65 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.829 -0.434 . . . . 1.51 109.829 169.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.3 t -140.03 52.22 1.69 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.679 1.192 . . . . 3.1200000000000001 109.259 -172.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -155.29 140.8 12.54 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 117.739 -1.124 . . . . 1.8 108.436 -173.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -93.85 -3.19 2.96 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.657 2.238 . . . . 1.3300000000000001 114.978 -175.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -83.7 -33.46 25.14 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.243 -1.536 . . . . 2.3700000000000001 109.096 165.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.3 156.67 9.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.259 1.024 . . . . 0.90000000000000002 112.229 171.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 77.7 t -105.39 -19.73 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 114.204 -1.362 . . . . 0.75 110.368 169.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 4.3 tpt -73.47 -9.03 58.26 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.826 1.047 . . . . 2.04 113.826 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.38 167.14 1.34 Allowed Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.906 1.283 . . . . 4.5700000000000003 113.07 176.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.44 ' HB2' ' H91' ' A' ' 269' ' ' NGH . 27.1 Cg_endo -73.61 -26.24 14.08 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.962 1.775 . . . . 1.6200000000000001 112.111 170.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.353 0.2 OUTLIER -78.21 -178.89 5.89 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.224 1.81 . . . . 2.3700000000000001 111.59 -170.039 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -113.72 148.62 36.1 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.184 1.793 . . . . 3.46 108.04 175.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -156.48 140.75 16.57 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.398 -1.334 . . . . 4.0499999999999998 107.398 171.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -66.0 115.8 6.45 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.626 0.77 . . . . 4.5499999999999998 110.19 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.7 m -135.64 99.9 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 124.099 0.959 . . . . 1.8200000000000001 110.015 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.0 137.81 57.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.263 0.554 . . . . 4.5499999999999998 111.639 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.2 pt -81.43 35.74 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 113.509 0.929 . . . . 4.6100000000000003 113.509 -169.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -109.3 -63.1 1.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.033 0.933 . . . . 3.48 109.497 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 61.9 m -63.21 -48.74 77.04 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.228 -0.656 . . . . 2.0600000000000001 109.228 -176.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 55.36 89.38 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.337 1.055 . . . . 5.9299999999999997 110.66 176.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.72 143.68 19.83 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.096 -0.705 . . . . 4.2300000000000004 109.096 170.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.71 164.3 19.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.676 1.59 . . . . 1.0600000000000001 107.802 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.0 m -78.74 151.38 32.12 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 122.119 -0.363 . . . . 1.3100000000000001 110.1 174.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.68 -47.26 77.06 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.001 0.52 . . . . 0.93000000000000005 110.291 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -51.47 -51.57 53.9 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.563 0.745 . . . . 2.5 110.163 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.15 -53.05 62.49 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.11 -0.95 . . . . 2.3399999999999999 109.218 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.1 mt -50.79 -43.44 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.041 1.336 . . . . 1.0 111.259 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -61.43 -50.92 70.86 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.484 -1.385 . . . . 6.5300000000000002 109.36 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -47.25 -47.19 21.6 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.003 0.811 . . . . 1.4299999999999999 112.567 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.424 HG23 ' CZ3' ' A' ' 141' ' ' TRP . 0.5 OUTLIER -70.13 -38.58 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 118.175 0.988 . . . . 2.79 110.413 -174.417 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -61.18 -33.23 73.11 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.68 -0.408 . . . . 3.6299999999999999 110.244 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.9 m -50.82 -23.03 2.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.934 1.087 . . . . 3.3900000000000001 113.934 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 8.8 mt -55.88 -38.93 70.83 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 120.326 1.421 . . . . 3.6499999999999999 113.028 176.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 22.0 t80 44.8 -127.04 1.08 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 122.88 0.472 . . . . 8.3399999999999999 111.989 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.215 0 N-CA-C 108.192 -1.963 . . . . 8.8100000000000005 108.192 -178.339 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' NGH . . . . . 0.44 ' H91' ' HB2' ' A' ' 238' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 65.3 mtm . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 108.271 -1.011 . . . . 19.579999999999998 108.271 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 119.09 157.2 10.29 Favored Glycine 0 CA--C 1.532 1.136 0 N-CA-C 110.332 -1.107 . . . . 11.08 110.332 -175.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.03 164.33 33.51 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.754 2.969 . . . . 10.289999999999999 110.245 176.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.1 p -161.78 162.71 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 107.633 -1.247 . . . . 7.6399999999999997 107.633 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -85.83 169.74 13.06 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.211 0.604 . . . . 11.6 111.305 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.84 -39.07 52.54 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.715 0.806 . . . . 11.789999999999999 111.619 174.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -170.74 -56.98 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.862 -0.792 . . . . 6.9900000000000002 108.862 -172.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 69.29 -64.83 0.32 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.984 2.114 . . . . 4.5899999999999999 111.873 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -108.25 119.27 39.0 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.548 -1.279 . . . . 4.4800000000000004 107.548 -176.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.0 mp -134.43 147.4 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 105.405 -2.072 . . . . 3.8999999999999999 105.405 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.65 142.2 17.61 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 105.06 -2.2 . . . . 3.4300000000000002 105.06 -173.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -125.67 165.7 18.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.69 1.196 . . . . 4.9299999999999997 111.148 -174.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -154.85 161.23 41.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.814 -0.809 . . . . 7.3099999999999996 108.814 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.71 155.0 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.339 -1.356 . . . . 1.05 107.339 174.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -80.71 -51.4 8.72 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.643 -0.502 . . . . 3.5299999999999998 109.643 173.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -157.14 170.17 23.11 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.483 0.583 . . . . 3.0499999999999998 111.174 167.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -94.16 126.86 39.65 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.994 1.318 . . . . 4.0499999999999998 109.773 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.733 ' HG1' ' H ' ' A' ' 124' ' ' ASP . 11.2 t -70.29 147.45 95.25 Favored Pre-proline 0 N--CA 1.442 -0.853 0 O-C-N 121.933 -0.479 . . . . 2.8199999999999998 112.29 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -80.34 -16.19 10.93 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 124.678 3.585 . . . . 2.4300000000000002 111.22 168.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.733 ' H ' ' HG1' ' A' ' 122' ' ' THR . 16.1 t70 -50.45 -36.6 34.1 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.858 1.663 . . . . 3.29 112.116 -176.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 13.7 mtm -133.61 -177.96 4.78 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.9 1.68 . . . . 2.6600000000000001 106.949 172.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -78.71 139.74 38.43 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.326 -0.62 . . . . 2.8799999999999999 109.326 171.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -51.39 -42.45 61.4 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.713 -0.617 . . . . 4.5199999999999996 112.179 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -65.19 -5.57 7.21 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.662 0.785 . . . . 3.0800000000000001 112.274 -177.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -94.45 -47.41 6.58 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 126.515 1.926 . . . . 2.21 109.789 166.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.7 t -57.03 -61.72 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 C-N-CA 125.504 1.521 . . . . 1.72 109.454 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -28.06 67.48 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 117.825 -1.55 . . . . 1.7 109.019 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -61.05 -50.99 71.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 118.859 0.754 . . . . 4.1200000000000001 109.952 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.29 -48.11 77.29 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 122.906 0.483 . . . . 0.63 110.729 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.9 -37.49 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.563 0.697 . . . . 2.4700000000000002 110.128 -175.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -55.45 33.66 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.872 1.269 . . . . 4.9500000000000002 107.926 178.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -56.33 -51.84 66.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.383 -0.599 . . . . 3.5800000000000001 109.383 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.37 -49.03 46.27 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.625 0.648 . . . . 0.56000000000000005 112.426 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -61.71 -51.77 67.04 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 121.894 -0.504 . . . . 5.7400000000000002 109.902 173.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -55.82 -37.95 69.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.652 0.781 . . . . 2.4500000000000002 110.777 -172.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 42.5 t -53.61 -52.21 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.623 1.569 . . . . 1.1799999999999999 108.844 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -74.51 -32.72 62.59 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.997 -0.371 . . . . 0.88 109.997 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.0 m -72.65 -9.2 58.33 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.215 0.45 . . . . 2.5099999999999998 112.215 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -84.87 -52.39 6.05 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 107.565 -1.272 . . . . 1.26 107.565 175.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.7 m -76.42 -33.62 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 112.289 0.478 . . . . 2.71 112.289 -175.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.417 ' HG1' ' H ' ' A' ' 147' ' ' LEU . 6.8 p -100.74 153.88 37.48 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.384 -0.598 . . . . 1.8500000000000001 109.384 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.38 9.31 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.326 2.017 . . . . 0.91000000000000003 112.967 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.417 ' H ' ' HG1' ' A' ' 145' ' ' THR . 8.4 mp -78.85 112.87 16.44 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.407 1.003 . . . . 3.6600000000000001 108.862 -176.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -95.61 73.22 3.17 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.701 -0.624 . . . . 4.2400000000000002 111.676 -163.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -63.82 147.66 51.24 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.488 0.715 . . . . 7.2699999999999996 112.123 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.9 t -149.68 147.5 28.15 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.576 1.55 . . . . 1.5800000000000001 107.883 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -97.93 136.29 38.44 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.262 0.625 . . . . 2.8599999999999999 109.87 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.2 pp -134.84 118.59 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.848 -1.167 . . . . 1.6000000000000001 107.848 172.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -75.83 -32.24 59.72 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 119.723 -0.791 . . . . 3.3300000000000001 110.13 172.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.6 m -113.94 95.68 5.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.681 0.792 . . . . 2.71 109.543 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 151.53 -154.24 25.44 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.665 -1.374 . . . . 1.8600000000000001 109.665 170.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.6 tpt -111.82 136.67 50.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.182 1.393 . . . . 6.5499999999999998 110.52 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -129.36 163.83 24.91 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.849 1.66 . . . . 0.85999999999999999 109.363 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.51 -41.12 56.06 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.509 -0.922 . . . . 1.6799999999999999 108.509 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 33.6 pt -121.97 175.7 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.786 1.234 . . . . 1.6499999999999999 109.508 -176.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.7 tp -148.62 130.24 14.97 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.2 1.4 . . . . 4.2400000000000002 108.879 -173.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.7 t -88.19 109.04 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 108.429 -0.952 . . . . 0.88 108.429 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.7 t -88.26 142.05 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.308 -0.997 . . . . 1.99 108.308 168.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.449 ' CE2' ' HB ' ' A' ' 122' ' ' THR . 0.0 OUTLIER -131.64 125.26 31.71 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 104.565 -2.383 . . . . 7.5 104.565 172.332 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -159.45 161.25 35.46 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.337 -1.727 . . . . 1.77 106.337 -174.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -123.87 152.94 41.79 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.523 -0.917 . . . . 5.1299999999999999 108.523 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 69.2 -142.5 37.66 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.73 2.11 . . . . 1.6299999999999999 113.013 172.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.16 129.83 34.86 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.937 -0.764 . . . . 2.52 108.937 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -141.52 34.44 1.64 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.791 0.436 . . . . 4.8700000000000001 111.315 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 62.63 74.03 0.46 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.113 -1.195 . . . . 2.5 110.113 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -151.43 166.69 30.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.777 -1.194 . . . . 2.75 107.777 -173.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.42 -50.01 15.24 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.328 -0.99 . . . . 5.6900000000000004 108.328 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -102.02 -34.93 9.14 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.681 -0.69 . . . . 5.7800000000000002 109.865 -177.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 58.44 -151.39 0.42 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.328 0.651 . . . . 3.3399999999999999 111.572 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -125.06 167.1 15.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.52 1.128 . . . . 7.29 108.389 178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.4 p30 -140.72 -20.47 0.82 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 115.763 1.764 . . . . 2.9500000000000002 115.763 -150.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.47 132.91 0.27 Allowed Glycine 0 CA--C 1.534 1.24 0 N-CA-C 110.325 -1.11 . . . . 2.3799999999999999 110.325 -162.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.9 tttt 56.31 -152.41 0.38 Allowed 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.389 -1.066 . . . . 6.5700000000000003 110.079 -175.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.8 -107.42 0.01 OUTLIER Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.145 1.355 . . . . 2.5800000000000001 115.343 -162.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 49.68 -114.59 2.42 Favored Glycine 0 C--N 1.34 0.759 0 CA-C-N 117.963 0.882 . . . . 1.48 111.987 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 10.6 mm -78.96 117.34 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 107.272 -1.381 . . . . 3.0699999999999998 107.272 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.428 HD22 ' H5 ' ' A' ' 269' ' ' NGH . 7.7 mp -76.53 -60.26 2.42 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.318 -1.364 . . . . 1.77 107.318 170.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -164.82 169.69 16.35 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 121.08 -1.013 . . . . 0.73999999999999999 109.522 -176.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -147.47 124.53 11.4 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 114.307 1.225 . . . . 1.02 114.307 -174.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -151.08 156.6 41.4 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.397 1.879 . . . . 0.56000000000000005 106.454 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -145.52 160.36 41.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.471 -1.677 . . . . 4.6200000000000001 106.471 175.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -90.44 -119.45 2.08 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 118.768 -1.018 . . . . 0.84999999999999998 110.941 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.75 79.35 1.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.678 2.252 . . . . 2.8999999999999999 110.299 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -141.41 163.43 26.79 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.755 -1.738 . . . . 1.5700000000000001 108.755 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.402 ' H ' ' HG ' ' A' ' 189' ' ' SER . 1.7 p -78.94 169.32 18.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.285 1.034 . . . . 3.6000000000000001 112.055 -170.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 53.48 -114.3 3.74 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.358 0.98 . . . . 1.73 111.592 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.406 HG12 ' CE1' ' A' ' 196' ' ' HIS . 3.5 tp -62.2 -35.44 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 118.335 -0.84 . . . . 1.9199999999999999 109.869 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -40.68 141.31 0.94 Allowed Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.42 1.009 . . . . 1.52 113.087 176.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 93.6 -48.2 2.32 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.168 1.366 . . . . 0.81999999999999995 110.883 -160.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.64 171.06 10.75 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.041 0.937 . . . . 1.24 108.824 -167.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -144.9 122.83 12.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 118.725 -0.655 . . . . 0.65000000000000002 112.473 -169.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.475 ' N ' ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -115.37 115.56 26.8 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-O 117.696 -1.145 . . . . 2.8300000000000001 111.076 -171.248 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -92.38 148.51 22.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.752 1.16 . . . . 4.1900000000000004 110.446 174.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.98 98.52 9.29 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 122.497 1.141 . . . . 3.4199999999999999 112.017 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -49.93 -33.19 16.73 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 119.852 -1.78 . . . . 3.0499999999999998 110.389 170.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -36.09 -47.44 0.55 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.981 1.104 . . . . 3.6000000000000001 113.981 172.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -73.78 156.34 37.93 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 123.252 1.501 . . . . 2.3100000000000001 111.435 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -92.86 91.53 7.48 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 105.448 -2.056 . . . . 3.6600000000000001 105.448 167.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -76.81 152.92 35.35 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.172 -1.047 . . . . 1.54 108.172 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 39.1 p -133.7 156.28 48.21 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.533 0.682 . . . . 2.1000000000000001 110.345 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.3 -44.95 23.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.606 1.562 . . . . 1.8999999999999999 110.379 170.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -76.66 178.43 6.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.022 1.329 . . . . 2.8700000000000001 109.224 170.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.32 -60.83 2.86 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.036 1.334 . . . . 3.9900000000000002 109.66 -172.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 57.1 -95.62 0.04 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.367 0.984 . . . . 2.3900000000000001 112.563 168.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -135.41 -72.54 0.07 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.252 -1.539 . . . . 1.76 109.252 175.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.8 m -114.28 122.75 47.7 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.839 -1.541 . . . . 1.55 106.839 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -85.65 117.2 24.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.822 -1.177 . . . . 1.6000000000000001 107.822 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.84 -53.66 14.92 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.271 0.628 . . . . 2.3599999999999999 110.383 -175.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -43.4 -45.36 6.16 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.419 1.088 . . . . 2.5 110.77 177.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.6 tt -67.25 -57.5 6.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.302 -0.408 . . . . 1.75 110.707 -168.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 m -56.54 -46.55 80.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.453 -0.573 . . . . 2.1899999999999999 109.453 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.0 -57.93 5.11 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 124.549 1.155 . . . . 0.65000000000000002 110.69 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 71.0 t -48.27 -41.73 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 119.625 1.102 . . . . 1.1599999999999999 111.168 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.441 ' NE2' ' CD2' ' A' ' 222' ' ' HIS . 0.2 OUTLIER -63.91 -54.48 34.08 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.311 -0.868 . . . . 3.4700000000000002 112.404 178.161 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.74 -36.96 65.22 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.234 -0.917 . . . . 3.6200000000000001 111.1 -174.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.7 -42.9 97.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 107.001 -1.481 . . . . 1.8999999999999999 107.001 173.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -47.05 -54.06 9.99 Favored Glycine 0 CA--C 1.536 1.37 0 O-C-N 121.401 -0.812 . . . . 0.52000000000000002 111.571 166.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.441 ' CD2' ' NE2' ' A' ' 218' ' ' HIS . 9.0 m-70 -50.79 -45.03 59.0 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 121.572 -0.957 . . . . 2.1899999999999999 111.028 175.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 9.2 t -51.16 -41.17 59.96 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.213 0.605 . . . . 2.6200000000000001 111.972 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.72 -54.15 40.0 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.245 -0.65 . . . . 4.0499999999999998 109.245 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 131.54 73.69 0.11 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 111.565 -0.614 . . . . 1.2 111.565 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 1.1 mt -124.69 121.48 34.78 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.311 1.044 . . . . 4.3200000000000003 108.858 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -76.64 56.2 3.4 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.76 0.695 . . . . 2.4900000000000002 111.985 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 77.4 m80 57.73 -169.53 0.11 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.656 1.182 . . . . 2.4500000000000002 112.066 -175.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 75.5 m -148.59 -179.82 7.26 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 106.461 -1.681 . . . . 1.4399999999999999 106.461 165.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 36.9 p -136.77 37.82 2.62 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.43 1.492 . . . . 3.0899999999999999 109.244 -168.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -139.88 136.49 17.37 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 106.089 -1.819 . . . . 1.6699999999999999 106.089 -173.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -85.73 -8.06 8.31 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.872 1.715 . . . . 1.1499999999999999 114.287 -172.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -80.83 -42.95 20.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.929 -1.137 . . . . 1.6399999999999999 107.929 168.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -55.19 140.74 37.7 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.203 0.525 . . . . 0.71999999999999997 109.724 174.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 88.2 t -87.04 -23.14 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 108.684 -0.858 . . . . 0.71999999999999997 108.684 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -55.69 -29.5 59.49 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 115.811 1.782 . . . . 2.1099999999999999 115.811 -177.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -50.08 162.48 0.49 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 125.659 1.584 . . . . 4.4000000000000004 113.696 -172.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.93 -16.43 14.35 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.331 1.354 . . . . 1.0 111.907 170.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.377 0.2 OUTLIER -79.3 -179.7 6.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.167 1.387 . . . . 2.1099999999999999 109.609 178.171 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -130.39 148.94 52.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 126.394 1.878 . . . . 3.4700000000000002 106.144 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.66 173.88 13.65 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.768 -1.938 . . . . 3.0 105.768 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -87.75 117.82 26.84 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 119.578 1.081 . . . . 4.9299999999999997 109.055 174.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.5 m -120.32 125.04 73.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 107.669 -1.234 . . . . 1.77 107.669 170.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -81.21 120.21 24.59 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.223 -0.591 . . . . 4.9400000000000004 109.756 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.16 -27.81 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.307 -0.406 . . . . 4.7400000000000002 110.803 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -66.27 -35.01 79.31 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.289 0.495 . . . . 4.0099999999999998 110.313 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 29.6 m -66.55 -49.75 65.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.535 -0.543 . . . . 2.1699999999999999 109.535 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 51.12 83.21 0.05 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.91 0.862 . . . . 6.1100000000000003 110.562 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.48 158.35 31.78 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.64 -0.663 . . . . 5.4000000000000004 109.345 169.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -108.16 157.15 18.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.734 -1.58 . . . . 0.87 106.734 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 29.6 m -77.49 151.52 34.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.005 -0.434 . . . . 1.6599999999999999 110.106 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.41 -45.41 46.18 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.699 0.4 . . . . 0.77000000000000002 110.086 171.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -59.63 -36.11 75.7 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.588 0.708 . . . . 2.4100000000000001 111.605 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -71.77 -51.52 22.27 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.709 1.243 . . . . 1.97 108.887 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 41.0 mt -52.79 -49.06 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 126.831 2.052 . . . . 1.03 112.124 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -55.19 -43.36 74.29 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.498 -1.376 . . . . 8.6699999999999999 110.535 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -55.63 -40.42 78.91 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.045 -1.222 . . . . 0.84999999999999998 110.045 174.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -45.18 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 C-N-CA 123.257 0.623 . . . . 4.6500000000000004 111.267 -176.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -63.31 -27.17 69.14 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 119.343 -0.943 . . . . 2.3700000000000001 110.515 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.29 -15.27 0.91 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.145 1.165 . . . . 2.5600000000000001 114.145 169.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 76.7 mt -46.91 -26.88 1.08 Allowed 'General case' 0 C--N 1.346 0.447 0 CA-C-N 121.055 1.752 . . . . 3.0699999999999998 113.192 164.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -131.1 96.09 3.95 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.57 0.623 . . . . 7.2300000000000004 110.238 175.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 116.246 -2.419 . . . . 8.5199999999999996 111.785 173.596 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' NGH . . . . . 0.576 ' O5 ' ' H1 ' ' A' ' 269' ' ' NGH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 3.2 ptt? . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.171 -0.307 . . . . 16.77 110.171 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 112.74 -93.98 0.7 Allowed Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.461 -1.456 . . . . 9.7100000000000009 109.461 -172.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.68 125.9 14.54 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.332 2.021 . . . . 12.91 109.815 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.5 t -148.19 156.96 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 127.049 2.14 . . . . 6.7000000000000002 105.809 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 13.1 m-90 -68.45 168.42 12.77 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 119.116 0.871 . . . . 12.01 111.365 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -100.13 -42.76 6.57 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.746 0.818 . . . . 9.5500000000000007 111.071 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.9 tptt -97.86 -53.49 3.39 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.861 0.319 . . . . 7.9500000000000002 111.861 -162.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 74.94 -68.85 0.2 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.902 1.681 . . . . 5.6399999999999997 111.368 172.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -102.56 113.5 26.93 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 126.199 1.8 . . . . 4.3799999999999999 109.128 -174.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.4 mm -117.76 88.45 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 122.11 0.957 . . . . 2.6899999999999999 109.33 -173.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 p -87.25 146.19 26.07 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.441 0.696 . . . . 1.6399999999999999 109.495 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.438 ' CE2' ' CD1' ' A' ' 138' ' ' PHE . 10.5 m-85 -129.92 166.2 20.51 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.728 0.811 . . . . 6.6900000000000004 110.364 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -153.51 168.91 24.56 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.335 0.654 . . . . 8.4199999999999999 110.458 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.2 mt -119.4 148.53 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.265 -1.383 . . . . 1.8 107.265 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -89.55 -67.71 0.82 Allowed 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.961 -1.126 . . . . 4.9500000000000002 107.961 171.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -138.96 162.0 35.95 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.176 0.806 . . . . 2.1299999999999999 113.176 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -104.3 154.0 20.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.411 1.884 . . . . 3.8500000000000001 108.85 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.546 ' HG1' ' H ' ' A' ' 124' ' ' ASP . 12.7 t -85.48 149.78 52.61 Favored Pre-proline 0 N--CA 1.444 -0.74 0 C-N-CA 124.3 1.04 . . . . 3.0800000000000001 111.68 172.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -86.93 -17.6 3.1 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.155 3.236 . . . . 2.5 111.104 169.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.546 ' H ' ' HG1' ' A' ' 122' ' ' THR . 99.0 m-20 -56.69 -46.84 80.95 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.963 0.905 . . . . 3.8799999999999999 109.83 -177.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 4.2 mmt -101.49 -169.87 1.75 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.477 1.111 . . . . 4.4000000000000004 108.037 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -103.28 145.76 29.47 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 108.397 -0.964 . . . . 2.9900000000000002 108.397 167.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -55.38 -39.98 70.78 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.711 -0.618 . . . . 2.9900000000000002 111.196 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -64.25 -7.68 10.16 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.706 -0.679 . . . . 3.1699999999999999 112.302 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -95.67 -50.16 5.06 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.512 1.125 . . . . 3.25 109.259 162.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -50.58 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 118.894 0.77 . . . . 3.3100000000000001 110.329 -166.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.19 -19.15 58.68 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 118.066 -1.454 . . . . 1.71 109.776 178.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -73.1 -46.17 52.83 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 119.135 0.88 . . . . 3.6600000000000001 108.736 -175.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.4 -54.24 23.31 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 124.184 0.994 . . . . 0.58999999999999997 109.619 171.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.82 -48.79 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 121.059 -0.256 . . . . 3.5800000000000001 110.472 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -50.26 -57.76 7.12 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.178 1.391 . . . . 4.9199999999999999 108.899 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -64.7 -43.23 94.16 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.191 -0.913 . . . . 3.3900000000000001 109.485 -176.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.01 -52.73 57.47 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.001 0.52 . . . . 0.45000000000000001 110.134 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.438 ' CD1' ' CE2' ' A' ' 116' ' ' TYR . 61.5 m-85 -54.23 -44.84 72.06 Favored 'General case' 0 C--O 1.231 0.111 0 O-C-N 122.182 -0.324 . . . . 5.7300000000000004 111.007 171.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.34 -37.19 67.13 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.547 -0.739 . . . . 2.5 111.852 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 62.7 t -55.55 -63.3 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 119.121 0.873 . . . . 1.2 109.571 177.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 58.7 m95 -70.48 -32.58 70.17 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.964 -0.754 . . . . 0.84999999999999998 108.964 -171.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.3 t -64.62 -14.12 56.58 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.064 -0.97 . . . . 2.2599999999999998 112.998 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -82.67 -48.27 11.09 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.036 -1.098 . . . . 1.1599999999999999 108.036 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.3 m -76.98 -46.37 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 112.282 0.475 . . . . 2.4300000000000002 112.282 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 22.9 p -82.81 152.54 66.3 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 108.18 -1.045 . . . . 1.2 108.18 177.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.26 9.07 3.53 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.334 2.023 . . . . 0.75 112.224 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.2 mt -67.52 108.79 2.97 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.502 1.046 . . . . 2.7599999999999998 110.307 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.1 mpmm? -70.94 91.13 0.84 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.463 0.649 . . . . 4.7199999999999998 109.619 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.94 134.56 57.22 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 127.456 2.303 . . . . 7.9199999999999999 109.687 168.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.3 t -153.46 106.69 2.96 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.372 -0.233 . . . . 1.74 110.372 163.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -80.87 130.25 34.95 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.705 -0.85 . . . . 2.9900000000000002 108.705 173.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.0 pt -128.47 142.2 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.037 -1.468 . . . . 1.8999999999999999 107.037 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -95.59 -15.62 22.67 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 122.497 -0.127 . . . . 3.1200000000000001 110.752 -177.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 52.8 m -136.57 130.09 31.85 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 125.096 1.358 . . . . 2.7799999999999998 107.487 172.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 137.89 -152.87 21.94 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 107.999 -2.04 . . . . 2.0899999999999999 107.999 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 41.2 mtp -123.73 131.57 53.63 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.892 1.677 . . . . 5.2599999999999998 106.746 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -136.72 158.74 43.73 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.769 0.828 . . . . 0.97999999999999998 110.304 -175.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -76.59 -49.11 17.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.706 -0.85 . . . . 1.6299999999999999 108.706 -167.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.14 171.82 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.358 0.599 . . . . 1.6899999999999999 110.772 172.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.59 144.1 31.12 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.917 2.087 . . . . 4.2400000000000002 109.1 178.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 37.3 t -83.02 106.45 13.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 125.153 1.381 . . . . 1.51 109.054 170.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 69.9 t -84.84 118.3 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.215 -1.031 . . . . 1.9199999999999999 108.215 171.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -80.87 138.79 36.19 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 105.856 -1.905 . . . . 8.9600000000000009 105.856 160.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -147.14 161.59 40.57 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.564 -1.643 . . . . 1.74 106.564 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.6 ptt85 -155.92 121.36 4.87 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.45 -0.574 . . . . 4.3499999999999996 109.45 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.413 ' HA2' ' CD1' ' A' ' 174' ' ' PHE . . . 80.4 -52.42 4.34 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.587 -0.605 . . . . 2.6899999999999999 111.587 175.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -154.03 170.76 20.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.166 0.986 . . . . 2.6099999999999999 108.489 173.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -159.76 -42.17 0.05 Allowed 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.84 0.856 . . . . 3.8199999999999998 110.123 166.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 140.37 77.06 0.05 OUTLIER Glycine 0 CA--C 1.524 0.631 0 N-CA-C 107.349 -2.301 . . . . 2.7000000000000002 107.349 -172.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -156.59 -177.91 6.95 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 106.371 -1.715 . . . . 2.4700000000000002 106.371 -177.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -79.18 -50.27 11.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.952 -1.129 . . . . 5.8399999999999999 107.952 165.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.47 -60.99 1.44 Allowed 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 122.831 0.452 . . . . 6.3300000000000001 110.002 -174.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 68.48 -51.91 0.56 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.098 1.759 . . . . 3.46 114.519 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.502 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -159.99 -175.77 5.29 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.637 2.375 . . . . 9.6099999999999994 105.364 -172.122 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.502 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 13.7 p30 177.2 43.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.863 1.265 . . . . 2.3700000000000001 111.296 169.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 53.16 -158.43 4.16 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.49 -0.644 . . . . 1.72 111.49 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -76.73 119.1 20.05 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.94 -0.63 . . . . 6.4199999999999999 109.78 -177.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.91 -160.86 13.71 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.118 -1.193 . . . . 1.8200000000000001 110.118 -168.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.08 -128.52 43.96 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.038 1.304 . . . . 1.6399999999999999 111.515 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.47 ' CD1' H102 ' A' ' 269' ' ' NGH . 0.5 OUTLIER -77.65 134.17 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 125.44 1.496 . . . . 3.7999999999999998 107.299 178.762 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.465 ' CD2' ' H5 ' ' A' ' 269' ' ' NGH . 0.2 OUTLIER -85.14 -55.67 3.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.681 1.992 . . . . 1.5600000000000001 109.14 173.448 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -163.78 162.44 23.83 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.495 -0.753 . . . . 0.75 111.617 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -154.14 105.01 2.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.356 1.462 . . . . 1.3200000000000001 112.295 -174.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -121.63 158.81 27.81 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.113 2.165 . . . . 1.1299999999999999 109.651 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -154.74 132.0 11.08 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 107.29 -1.374 . . . . 4.0 107.29 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.12 -89.23 0.51 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.286 0.946 . . . . 1.23 112.836 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.08 83.76 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.943 3.096 . . . . 1.8999999999999999 111.041 -169.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -160.05 165.31 34.7 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.532 -1.427 . . . . 1.5700000000000001 109.532 172.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.8 m -78.89 169.99 17.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.468 0.707 . . . . 2.6200000000000001 111.149 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 55.08 -108.06 0.89 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 123.827 0.727 . . . . 1.5800000000000001 111.588 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 8.9 tp -59.82 -40.07 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 118.547 -0.739 . . . . 1.8 109.671 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -42.12 143.23 1.17 Allowed Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.399 0.999 . . . . 1.29 113.111 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 94.26 -59.21 1.97 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.908 1.718 . . . . 1.04 109.213 -155.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.38 148.51 31.99 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.898 -0.778 . . . . 1.4399999999999999 108.898 -155.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -112.24 120.42 41.69 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 118.963 -0.542 . . . . 0.73999999999999999 110.272 -174.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.497 ' N ' ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -107.15 137.89 44.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.024 -1.473 . . . . 3.21 107.024 -175.74 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -127.69 144.29 51.09 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.172 -1.418 . . . . 3.8500000000000001 107.172 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -74.26 67.19 1.37 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.783 -1.191 . . . . 2.9399999999999999 107.783 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -54.5 -45.4 73.25 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.811 -1.181 . . . . 3.6899999999999999 107.811 -174.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -32.54 -44.25 0.1 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.937 1.695 . . . . 3.8399999999999999 112.044 -170.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -63.97 -178.44 0.33 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 129.412 3.085 . . . . 2.5499999999999998 109.399 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -129.06 90.2 2.99 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 120.095 -1.628 . . . . 4.1200000000000001 108.701 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -134.67 119.46 18.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.726 0.81 . . . . 4.6500000000000004 111.32 -173.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 14.9 p -153.62 158.62 41.42 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.822 1.249 . . . . 5.1600000000000001 111.014 -177.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.66 -47.13 63.9 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.255 1.022 . . . . 5.0899999999999999 109.874 172.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -67.78 -29.87 69.17 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 114.884 -1.053 . . . . 4.9699999999999998 110.887 -167.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.0 t -81.64 -44.82 16.65 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.707 -0.849 . . . . 9.2699999999999996 108.707 174.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.09 -35.56 4.32 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 124.579 1.085 . . . . 3.2799999999999998 110.649 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -27.17 -92.85 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 128.782 3.087 . . . . 1.6499999999999999 114.589 -173.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 88.5 m -118.66 123.04 43.97 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 104.525 -2.398 . . . . 1.72 104.525 160.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -69.96 120.19 15.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 118.491 -1.284 . . . . 1.3700000000000001 109.541 172.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 60.8 tp -50.41 -50.75 51.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.827 -0.606 . . . . 2.5699999999999998 111.693 177.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -52.24 -49.88 63.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.974 0.806 . . . . 2.27 110.767 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.5 tt -57.33 -60.92 2.91 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.994 0.917 . . . . 1.45 110.705 -174.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.351 25.4 m -60.71 -35.98 77.67 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.945 -0.391 . . . . 2.6600000000000001 109.945 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.59 -52.2 62.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 117.053 -1.451 . . . . 0.54000000000000004 110.712 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 35.1 t -44.93 -53.22 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 121.579 1.991 . . . . 1.9199999999999999 110.922 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.493 ' NE2' ' CE1' ' A' ' 222' ' ' HIS . 4.0 t60 -56.03 -54.05 49.59 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.854 0.862 . . . . 3.79 111.632 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -71.23 -44.68 64.87 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.797 -1.189 . . . . 4.0300000000000002 112.45 -173.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.427 HG13 ' CE1' ' A' ' 138' ' ' PHE . 1.7 mp -49.98 -44.79 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.604 1.562 . . . . 1.76 108.265 166.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -53.19 -51.14 48.68 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.546 -0.721 . . . . 0.56000000000000005 111.82 170.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.493 ' CE1' ' NE2' ' A' ' 218' ' ' HIS . 4.5 m-70 -52.03 -42.41 63.05 Favored 'General case' 0 C--N 1.34 0.173 0 O-C-N 121.429 -1.042 . . . . 2.1600000000000001 111.492 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.3 m -58.11 -26.61 62.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.797 0.665 . . . . 3.1899999999999999 112.797 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.4 mt -73.77 -51.96 14.74 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.068 -1.086 . . . . 2.7999999999999998 108.068 171.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 138.48 70.38 0.05 OUTLIER Glycine 0 C--N 1.34 0.755 0 C-N-CA 122.844 0.259 . . . . 1.25 112.548 170.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 15.6 mt -132.74 105.57 7.25 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.178 0.591 . . . . 4.29 109.771 -172.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -76.75 43.3 1.89 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.338 0.97 . . . . 3.0899999999999999 113.046 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 22.0 m80 73.88 155.51 0.16 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.356 1.862 . . . . 1.8600000000000001 111.605 -175.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 58.1 m -120.17 132.0 55.22 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 126.149 1.78 . . . . 1.8300000000000001 106.321 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' SER . . . . . 0.405 ' H ' ' HG ' ' A' ' 230' ' ' SER . 22.6 p -79.64 57.02 2.36 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.398 0.679 . . . . 3.8399999999999999 110.854 -175.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -156.18 137.8 9.73 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 118.006 -0.997 . . . . 2.2000000000000002 109.733 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.92 -20.89 7.26 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.76 2.306 . . . . 1.5600000000000001 114.606 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -27.42 48.91 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 119.258 0.935 . . . . 3.0 109.957 175.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -65.81 130.65 44.01 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.602 1.161 . . . . 1.0800000000000001 110.105 168.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 85.8 t -70.94 -25.84 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.899 0.856 . . . . 1.03 110.165 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -53.03 -18.12 1.87 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.95 1.3 . . . . 2.2200000000000002 114.278 170.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.401 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 10.3 t80 -56.32 137.89 74.92 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 119.738 1.154 . . . . 7.2000000000000002 110.492 -174.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.401 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 43.4 Cg_endo -63.84 -21.77 69.17 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.88 2.387 . . . . 1.4099999999999999 112.597 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.359 0.2 OUTLIER -92.05 130.74 37.72 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.279 -0.637 . . . . 2.5099999999999998 109.279 -179.558 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -76.71 141.67 40.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.638 -0.875 . . . . 3.2799999999999998 108.638 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.84 131.08 13.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.193 -1.78 . . . . 2.8300000000000001 106.193 170.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -54.73 115.01 1.93 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.066 0.946 . . . . 4.25 110.599 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.4 m -94.18 138.92 19.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 122.957 0.503 . . . . 1.8600000000000001 110.726 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.41 89.64 1.25 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.985 -0.746 . . . . 3.8999999999999999 108.985 173.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 47.1 mt -48.88 -31.25 3.83 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 123.848 0.859 . . . . 3.5600000000000001 110.335 174.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -39.33 -41.54 0.93 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.438 1.495 . . . . 3.9100000000000001 113.589 171.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 8.4 m -81.38 -41.58 21.75 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.796 0.838 . . . . 2.0099999999999998 110.57 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 78.9 t80 46.77 70.63 0.38 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.15 1.38 . . . . 5.71 111.511 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -156.55 167.17 31.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.57 -0.706 . . . . 4.6699999999999999 109.91 175.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -105.9 157.81 17.22 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.727 1.611 . . . . 1.0900000000000001 108.009 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 10.1 m -79.44 154.31 29.03 Favored 'General case' 0 C--O 1.221 -0.404 0 O-C-N 121.295 -0.878 . . . . 1.45 111.418 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.13 -48.63 75.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.975 0.893 . . . . 1.1899999999999999 109.862 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.61 -52.37 18.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.192 1.797 . . . . 4.6200000000000001 108.633 172.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.38 -46.02 88.41 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.978 -1.01 . . . . 2.2200000000000002 110.516 -176.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 45.3 mt -53.12 -42.23 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.725 2.01 . . . . 1.05 110.35 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -64.75 -48.82 73.16 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.007 -1.058 . . . . 6.6699999999999999 111.078 172.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -45.42 -55.5 6.8 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 111.764 -0.535 . . . . 0.83999999999999997 111.764 174.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 1.9 pp -65.81 -40.51 87.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 123.982 0.913 . . . . 3.1600000000000001 111.361 -176.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -62.18 -30.02 70.77 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.741 -1.224 . . . . 2.5600000000000001 110.849 174.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.8 -14.43 2.34 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.101 1.149 . . . . 2.52 114.101 169.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.3 mt -47.27 -26.78 1.31 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 121.02 1.736 . . . . 3.1400000000000001 112.716 164.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -69.67 -43.89 71.61 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.951 0.796 . . . . 7.1100000000000003 111.93 172.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 117.232 -1.871 . . . . 8.3599999999999994 108.674 -174.475 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' NGH . . . . . 0.484 ' H2 ' ' CE1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.536 ' HG2' HD11 ' A' ' 114' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.409 0 CA-C-O 120.604 0.24 . . . . 5.81 111.342 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 41.6 m80 56.34 -72.33 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.059 1.743 . . . . 3.52 110.956 -159.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -104.85 101.3 10.9 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.915 0.886 . . . . 3.61 112.315 -169.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.536 HD11 ' HG2' ' A' ' 111' ' ' LYS . 25.8 mm -81.77 91.77 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 108.478 -0.934 . . . . 2.41 108.478 170.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.1 p -79.93 125.21 29.45 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.137 -0.69 . . . . 1.25 109.137 171.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -130.75 158.47 40.03 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.383 0.673 . . . . 4.33 111.031 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -144.47 145.04 31.66 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.521 -0.918 . . . . 5.2 108.521 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.99 147.24 5.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 108.143 -1.058 . . . . 1.15 108.143 174.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -84.71 -44.32 13.49 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.455 -0.572 . . . . 3.56 109.455 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -153.25 171.58 18.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.912 -0.773 . . . . 2.25 108.912 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -128.13 129.95 47.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.876 1.27 . . . . 2.19 108.15 -163.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.5 t -63.47 114.18 12.19 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 118.539 0.609 . . . . 2.38 109.739 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -68.41 -17.98 43.96 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.488 2.792 . . . . 1.58 111.125 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.22 -34.25 0.74 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.632 2.773 . . . . 2.27 111.61 174.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.51 -179.64 5.57 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.056 1.342 . . . . 1.98 109.418 175.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -71.32 132.38 44.8 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 109.22 -0.659 . . . . 3.09 109.22 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 53.5 ttt-85 -47.79 -40.41 20.82 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.507 0.558 . . . . 2.15 112.507 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -50.38 -55.33 16.15 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.812 -0.81 . . . . 2.84 108.812 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -55.11 -45.03 75.49 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.937 1.695 . . . . 2.26 111.908 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.63 -57.83 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 O-C-N 121.418 -0.802 . . . . 1.27 109.694 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -27.53 66.61 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 117.919 -1.513 . . . . 1.78 109.184 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -59.72 -47.91 83.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.206 0.912 . . . . 1.99 110.383 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.82 -52.56 64.95 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.081 0.552 . . . . 0.43 110.508 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.431 HD11 HD11 ' A' ' 220' ' ' ILE . 0.1 OUTLIER -70.05 -37.6 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.289 -0.634 . . . . 1.5 109.289 -175.281 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -55.34 -60.83 2.85 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.502 1.121 . . . . 4.0 108.021 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.656 ' O ' HG23 ' A' ' 140' ' ' VAL . 8.3 mmmm -58.0 -45.86 86.16 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.246 1.018 . . . . 1.49 109.445 -176.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.53 -52.66 36.66 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.968 0.907 . . . . 0.63 111.429 175.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.508 ' HB3' ' CD2' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -53.67 -55.48 25.69 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 110.091 -0.337 . . . . 4.56 110.091 170.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.55 -44.61 46.71 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.314 1.046 . . . . 3.49 110.497 -171.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 136' ' ' LYS . 45.2 t -47.58 -54.06 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.109 0.964 . . . . 0.71 110.098 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.848 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 83.8 m95 -72.08 -41.07 67.78 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.283 -0.636 . . . . 0.66 109.283 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.02 -22.76 51.36 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.919 0.888 . . . . 1.1 111.271 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -75.37 -43.63 49.32 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.088 0.955 . . . . 1.57 110.942 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.633 HG21 HD23 ' A' ' 250' ' ' LEU . 65.8 t -84.87 -49.39 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.685 1.194 . . . . 1.9 110.825 -173.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.501 HG22 HD13 ' A' ' 258' ' ' ILE . 81.6 p -77.24 158.0 80.09 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 107.976 -1.12 . . . . 0.6 107.976 174.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.08 -1.03 10.72 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.75 1.633 . . . . 0.84 112.601 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.948 HD13 HD22 ' A' ' 224' ' ' LEU . 10.4 mt -62.24 139.76 58.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.021 0.828 . . . . 1.86 110.263 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.38 97.13 6.14 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.049 -1.093 . . . . 7.34 108.049 177.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.508 ' CD2' ' HB3' ' A' ' 138' ' ' PHE . 0.4 OUTLIER -64.56 153.82 38.03 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.373 0.508 . . . . 6.9 112.373 175.823 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.57 113.77 3.42 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 123.948 0.899 . . . . 1.11 110.103 176.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.47 139.6 33.86 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.526 -0.916 . . . . 1.99 108.526 173.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.1 pp -139.34 114.28 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.309 -0.997 . . . . 1.36 108.309 172.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -80.15 -15.74 56.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.452 -0.34 . . . . 2.66 110.753 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 72.2 p -124.37 89.2 3.03 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 124.585 1.154 . . . . 2.57 110.798 -170.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 145.83 -143.38 11.61 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.41 -1.876 . . . . 1.53 108.41 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 33.6 mtt -127.43 131.18 50.28 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.857 2.063 . . . . 4.96 107.751 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -109.94 167.22 10.33 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.589 1.556 . . . . 0.78 109.274 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -79.94 -50.59 10.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.761 -0.829 . . . . 2.34 108.761 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 12.3 pt -106.75 169.08 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.454 0.645 . . . . 0.97 109.742 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.64 135.74 35.2 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.929 1.292 . . . . 2.22 109.848 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.8 t -100.75 102.56 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.051 0.94 . . . . 0.99 109.476 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.3 t -89.17 88.7 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 126.023 1.729 . . . . 1.58 111.341 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -81.78 105.43 12.91 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 107.115 -1.439 . . . . 5.65 107.115 170.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -123.95 151.76 43.24 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 118.415 0.552 . . . . 0.84 109.737 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.56 99.88 6.53 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.847 1.259 . . . . 4.07 109.699 -167.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 54.13 43.29 73.66 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.426 1.012 . . . . 3.7 111.439 172.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -157.27 176.39 12.76 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.467 0.707 . . . . 4.57 109.895 -170.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.287 0 C-N-CA 127.522 2.329 . . . . 3.98 110.439 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.237 0 CA-C-O 119.254 -0.403 . . . . 2.66 110.838 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -160.52 166.69 28.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.13 1.772 . . . . 6.47 106.34 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.8 p30 -153.76 168.91 24.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.295 -1.372 . . . . 3.69 107.295 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -66.79 -148.18 0.09 OUTLIER Glycine 0 CA--C 1.533 1.162 0 CA-C-O 122.867 1.26 . . . . 1.61 114.264 -170.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.13 78.78 0.51 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.488 1.515 . . . . 3.91 110.065 -171.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 135.7 -159.23 24.12 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 108.711 -1.756 . . . . 2.12 108.711 -174.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 64.57 -125.03 30.43 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.892 -1.283 . . . . 1.98 109.892 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . 0.276 21.0 mm -77.21 132.32 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 108.67 -0.863 . . . . 1.65 108.67 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 9.1 mp -85.27 -63.1 1.38 Allowed 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.373 2.269 . . . . 1.19 109.303 168.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -168.75 152.4 5.48 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 114.385 1.254 . . . . 0.67 114.385 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -151.2 138.82 19.65 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.157 0.983 . . . . 1.27 112.772 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . 0.26 . . -163.51 162.21 24.47 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.479 1.911 . . . . 0.72 106.087 -157.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -149.28 140.74 23.32 Favored 'General case' 0 C--O 1.227 -0.089 0 N-CA-C 109.282 -0.636 . . . . 3.24 109.282 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.94 -87.34 1.77 Allowed Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.189 -1.164 . . . . 0.62 110.189 173.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -69.92 89.38 0.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.72 2.947 . . . . 1.49 110.855 -173.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -165.37 172.12 40.85 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 108.047 -2.021 . . . . 1.27 108.047 171.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.2 p -84.06 172.81 11.65 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.147 0.979 . . . . 2.27 109.782 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.93 -103.54 0.14 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.033 0.825 . . . . 1.4 112.409 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.9 tp -59.43 -40.2 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-O 118.371 -0.823 . . . . 1.5 109.282 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -36.1 132.13 0.79 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.632 1.11 . . . . 1.17 113.0 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.82 -43.28 1.77 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.944 1.735 . . . . 0.88 110.915 -164.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.62 159.97 15.62 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.635 0.774 . . . . 1.46 109.482 -162.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -138.75 125.24 20.57 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 117.96 -1.019 . . . . 0.9 113.392 -168.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -111.83 139.58 47.19 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 119.423 1.01 . . . . 2.27 109.234 -168.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -135.99 148.41 48.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.177 0.899 . . . . 2.98 110.741 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -73.33 82.2 1.39 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.411 -1.268 . . . . 2.38 110.462 -176.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -61.05 -27.1 68.1 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 121.205 -0.934 . . . . 3.74 110.833 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.76 -43.4 12.99 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.263 1.425 . . . . 2.66 109.793 172.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -70.89 157.11 38.72 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 123.827 1.775 . . . . 2.01 112.581 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -102.4 87.71 3.09 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 112.727 -2.033 . . . . 5.65 106.698 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -75.06 154.34 37.97 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 113.762 -1.563 . . . . 1.17 107.595 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.3 p -136.3 137.64 40.89 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.387 0.613 . . . . 1.63 109.5 -171.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.9 -47.04 88.24 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.333 -1.479 . . . . 1.93 110.33 173.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -65.61 151.63 46.03 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.588 -0.733 . . . . 2.04 110.37 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.7 m -60.27 -38.33 83.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.75 1.22 . . . . 4.44 110.555 -171.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -55.62 120.82 20.43 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-O 118.829 -0.984 . . . . 3.11 111.98 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 109.17 -125.71 7.81 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.94 -1.664 . . . . 1.08 108.94 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 m -117.07 117.15 28.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.372 -1.714 . . . . 0.96 106.372 164.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -77.24 122.11 24.61 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.523 -0.871 . . . . 1.32 110.742 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 20.3 tp -56.31 -53.65 54.81 Favored 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 109.6 -0.518 . . . . 1.95 109.6 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.552 ' O ' HG23 ' A' ' 217' ' ' VAL . 21.6 t80 -48.54 -46.05 38.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.055 0.455 . . . . 1.56 110.135 -178.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.44 ' C ' HD23 ' A' ' 214' ' ' LEU . 6.8 tt -57.37 -65.26 0.66 Allowed 'General case' 0 C--O 1.23 0.07 0 C-N-CA 123.85 0.86 . . . . 1.19 110.223 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.29 0.8 OUTLIER -56.49 -40.09 74.34 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.445 0.641 . . . . 0.83 110.214 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.62 -46.75 77.35 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 117.358 -1.306 . . . . 0.43 110.36 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 213' ' ' PHE . 66.4 t -48.79 -45.65 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 120.422 1.464 . . . . 0.83 110.803 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.532 ' CE1' ' O ' ' A' ' 236' ' ' MET . 60.1 t60 -64.15 -50.33 68.61 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.933 0.893 . . . . 2.39 112.447 176.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -64.85 -42.92 94.51 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.695 -1.253 . . . . 3.07 112.494 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.447 HG21 ' HA ' ' A' ' 138' ' ' PHE . 1.1 mp -55.51 -43.12 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 107.795 -1.187 . . . . 1.1 107.795 172.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.99 -52.0 27.85 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 112.246 -0.341 . . . . 0.68 112.246 169.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.505 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 20.0 m-70 -49.48 -52.34 29.94 Favored 'General case' 0 C--N 1.341 0.197 0 O-C-N 122.06 -0.67 . . . . 1.71 110.658 173.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 89.2 p -62.84 -45.85 90.68 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.518 0.562 . . . . 1.83 112.518 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.948 HD22 HD13 ' A' ' 147' ' ' LEU . 91.0 mt -56.8 -41.62 78.06 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.647 -0.501 . . . . 2.39 109.647 176.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 118.43 29.11 1.99 Allowed Glycine 0 C--N 1.337 0.626 0 C-N-CA 124.978 1.275 . . . . 1.2 111.491 171.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.593 HD22 HG22 ' A' ' 258' ' ' ILE . 12.1 mt -75.0 143.57 43.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.935 -1.506 . . . . 4.3 106.935 -173.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -72.9 143.8 34.06 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.072 -1.211 . . . . 3.18 110.072 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.412 ' CE1' ' HE1' ' A' ' 222' ' ' HIS . 12.1 m80 -50.92 118.24 3.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.723 0.762 . . . . 1.46 110.088 172.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 64.9 m -78.72 173.15 12.76 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.615 -0.513 . . . . 0.95 109.615 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.11 30.23 2.47 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.68 0.792 . . . . 2.31 110.742 -170.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -132.06 133.18 23.63 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 106.898 -1.519 . . . . 1.88 106.898 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.94 -14.4 44.95 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.449 2.099 . . . . 1.02 114.162 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -81.13 -27.79 35.37 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.121 0.968 . . . . 1.4 111.279 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.22 152.64 45.17 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.849 -0.797 . . . . 0.69 108.849 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 66.8 t -99.11 -25.88 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.296 -0.865 . . . . 0.53 109.536 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.532 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 10.8 tpt -65.59 -18.73 65.54 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.157 -0.964 . . . . 2.96 113.073 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.471 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.1 157.34 0.66 Allowed Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.719 1.608 . . . . 3.04 113.457 -175.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.93 -20.63 16.86 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.712 1.608 . . . . 1.11 111.453 174.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.371 0.2 OUTLIER -77.38 178.03 7.49 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.512 1.125 . . . . 1.37 109.1 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -126.66 147.64 49.91 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.418 -1.327 . . . . 2.44 107.418 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -150.54 146.47 26.6 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.047 -1.464 . . . . 3.34 107.047 170.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -72.47 83.41 1.1 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.24 1.016 . . . . 3.9 108.61 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.7 m -76.71 136.75 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 109.413 -0.588 . . . . 1.59 109.413 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -87.09 117.97 26.18 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.1 -0.5 . . . . 3.09 110.063 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 20.9 mt -60.49 -20.44 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 119.223 -0.417 . . . . 2.5 110.222 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -52.35 -36.02 52.57 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.333 0.969 . . . . 3.51 111.83 171.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.0 m -81.54 -47.69 12.77 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 122.756 0.423 . . . . 2.46 110.31 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.547 ' CE1' HG22 ' A' ' 140' ' ' VAL . 62.1 t80 45.61 73.33 0.17 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.315 1.446 . . . . 4.36 111.868 177.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.89 168.77 23.98 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 121.278 -0.889 . . . . 4.76 110.222 177.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.633 HD23 HG21 ' A' ' 144' ' ' VAL . 1.3 mm? -108.86 149.03 29.71 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.762 1.625 . . . . 0.82 108.066 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.9 m -77.44 158.38 30.04 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 121.17 -0.212 . . . . 0.58 111.415 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -58.28 -47.87 82.26 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.728 0.411 . . . . 0.83 110.549 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -55.46 -40.21 71.34 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.039 0.935 . . . . 3.64 110.035 176.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.42 -52.1 59.79 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.789 0.835 . . . . 2.01 109.815 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.424 ' HA ' HG13 ' A' ' 258' ' ' ILE . 48.9 mt -56.11 -42.86 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 127.063 2.145 . . . . 0.74 112.271 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -61.71 -42.45 98.96 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.177 -1.577 . . . . 7.91 110.383 172.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -54.34 -53.14 39.83 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.285 -1.126 . . . . 0.9 110.285 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.848 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 1.8 pp -63.96 -43.04 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 O-C-N 122.104 -0.645 . . . . 2.25 110.724 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -65.81 -20.14 66.14 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.843 0.747 . . . . 2.06 112.368 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 t -52.11 -33.39 39.55 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.633 0.651 . . . . 2.02 110.789 168.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.485 ' CD1' HD23 ' A' ' 226' ' ' LEU . 14.8 mt . . . . . 0 N--CA 1.452 -0.372 0 O-C-N 121.594 -0.691 . . . . 3.54 110.196 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.231 0 N-CA-C 110.056 -0.35 . . . . 5.51 110.056 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 2.1 m170 63.16 -63.17 0.12 Allowed 'General case' 0 C--N 1.342 0.244 0 C-N-CA 126.462 1.905 . . . . 4.1 113.197 -172.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -79.04 104.11 9.45 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.321 -0.992 . . . . 2.75 108.321 -176.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.415 HG21 ' CE1' ' A' ' 149' ' ' PHE . 9.2 mm -113.36 142.57 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.09 -1.448 . . . . 1.78 107.09 173.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.6 p -135.61 140.67 44.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.66 -0.867 . . . . 1.16 108.66 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -126.73 160.48 30.7 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.645 0.778 . . . . 4.21 111.453 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.52 145.8 31.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.252 1.021 . . . . 4.26 108.994 174.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -94.47 159.82 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.105 -1.443 . . . . 0.83 107.105 173.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -101.84 -38.95 7.61 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.815 0.846 . . . . 2.99 110.385 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -150.78 173.56 14.07 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.077 1.351 . . . . 2.4 107.868 175.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -113.5 129.54 56.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.058 0.943 . . . . 1.98 109.641 -175.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -41.08 135.48 1.71 Allowed Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.536 1.534 . . . . 3.12 109.64 165.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -84.97 -23.15 2.59 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.44 2.76 . . . . 2.35 110.323 167.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.26 -43.95 33.05 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.74 1.616 . . . . 3.17 111.085 -174.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 7.8 mtm -127.18 173.38 9.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.431 1.492 . . . . 2.64 109.435 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.423 ' O ' HG13 ' A' ' 130' ' ' VAL . 69.5 m-80 -71.64 152.76 42.59 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.292 0.637 . . . . 3.3 110.498 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -44.97 -52.58 8.64 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.915 0.886 . . . . 2.63 112.067 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -64.67 -5.28 5.37 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.492 -0.766 . . . . 2.86 113.061 -177.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -103.63 -41.74 5.86 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.551 1.54 . . . . 2.42 110.56 168.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 126' ' ' ASN . 1.5 m -57.62 -52.69 54.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 O-C-N 121.123 -0.986 . . . . 2.65 110.021 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.36 -24.74 64.83 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 118.41 -1.316 . . . . 1.68 108.449 178.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -63.38 -49.94 71.86 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 120.298 1.408 . . . . 2.11 110.402 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.28 -55.12 27.11 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 123.421 0.688 . . . . 0.39 109.828 175.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.88 -41.75 92.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 120.495 -0.482 . . . . 2.47 110.09 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.6 ttt-85 -57.51 -54.16 49.97 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.906 1.282 . . . . 4.01 108.146 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.634 ' O ' HG23 ' A' ' 140' ' ' VAL . 4.9 mmmp? -60.27 -46.62 89.17 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.886 0.875 . . . . 1.72 109.291 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.72 -53.43 31.47 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.421 0.689 . . . . 0.47 111.238 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.456 ' HA ' HG21 ' A' ' 220' ' ' ILE . 32.0 m-85 -53.84 -50.8 65.4 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.197 0.599 . . . . 4.57 109.969 171.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.57 -38.25 74.52 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 119.166 -0.445 . . . . 2.04 111.313 -173.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.738 HG22 ' CE1' ' A' ' 248' ' ' PHE . 98.4 t -51.04 -58.8 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.332 1.053 . . . . 0.71 109.127 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.701 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 45.7 m95 -72.8 -34.68 67.05 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.299 -0.63 . . . . 0.88 109.299 -174.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 t -64.2 -27.24 68.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.129 0.572 . . . . 1.18 111.652 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -70.31 -46.36 64.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 121.573 -0.705 . . . . 1.26 109.56 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.9 t -77.39 -56.46 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.217 0.607 . . . . 2.01 110.792 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 72.3 p -80.27 157.07 73.52 Favored Pre-proline 0 CA--C 1.53 0.193 0 N-CA-C 108.564 -0.902 . . . . 0.72 108.564 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.07 3.01 7.01 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.844 1.696 . . . . 1.03 112.869 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.8 mt -73.71 100.55 3.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.101 0.864 . . . . 1.86 109.928 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -84.61 96.67 9.26 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.096 0.959 . . . . 3.59 109.132 -169.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.415 ' CE1' HG21 ' A' ' 114' ' ' ILE . 41.8 m-85 -79.25 154.79 28.92 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.313 1.045 . . . . 5.58 112.831 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -155.42 138.98 15.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.681 1.192 . . . . 1.02 108.505 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.38 142.1 28.0 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 108.476 -0.935 . . . . 2.11 108.476 173.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.2 pt -130.52 115.87 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.397 -1.334 . . . . 1.26 107.397 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -80.73 -0.31 37.88 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.421 -0.585 . . . . 2.82 109.421 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 39.3 m -153.18 113.72 4.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.599 1.16 . . . . 2.29 108.433 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 138.81 -152.42 22.15 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 107.969 -2.053 . . . . 1.39 107.969 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -127.89 125.13 39.07 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.453 1.901 . . . . 5.28 107.04 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.69 166.02 11.11 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.429 1.091 . . . . 0.72 109.557 -173.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -77.97 -41.83 34.85 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.377 -0.971 . . . . 1.88 108.377 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 33.1 pt -124.48 159.93 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.924 0.89 . . . . 1.03 111.262 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.6 tt -126.97 128.29 46.16 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.321 1.449 . . . . 1.94 109.947 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.8 t -92.93 98.05 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 125.769 1.627 . . . . 0.83 108.097 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.9 t -80.14 136.02 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.719 -1.215 . . . . 1.41 107.719 170.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.403 ' CE1' ' HB2' ' A' ' 197' ' ' PHE . 7.3 m-85 -122.63 112.99 18.64 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 103.577 -2.749 . . . . 5.62 103.577 166.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 168' ' ' HIS . . . -147.65 159.76 43.42 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.4 -0.963 . . . . 0.98 108.4 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.79 131.39 47.79 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.027 -1.101 . . . . 4.29 108.027 -172.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 73.77 -113.18 4.1 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 111.062 -0.815 . . . . 1.71 111.062 -176.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -129.32 83.67 2.16 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.251 1.025 . . . . 2.29 110.527 -168.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.418 ' HB3' ' HB1' ' A' ' 164' ' ' ALA . 7.7 p80 . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 120.877 0.37 . . . . 3.21 111.97 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.103 0 N-CA-C 114.703 1.372 . . . . 2.37 114.703 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -123.72 164.93 18.15 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.103 0.961 . . . . 6.07 109.683 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -168.98 25.36 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.664 -0.698 . . . . 2.36 111.101 -158.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.17 -159.01 41.2 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.25 -1.14 . . . . 1.36 110.25 -171.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.56 104.67 1.32 Allowed 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 122.217 -0.578 . . . . 5.26 110.304 175.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 156.44 -179.01 32.63 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 108.678 -1.769 . . . . 1.91 108.678 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 45.28 -117.94 2.61 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 126.312 1.911 . . . . 1.71 111.123 171.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.3 mm -87.24 132.38 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 108.501 -0.926 . . . . 1.94 108.501 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.43 -42.77 18.13 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.708 1.603 . . . . 1.31 109.537 170.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.77 158.62 23.08 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.495 -0.753 . . . . 0.71 110.423 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -138.44 114.63 10.22 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.647 1.179 . . . . 1.34 113.572 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 222' ' ' HIS . . . -132.21 163.76 27.86 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.919 2.088 . . . . 0.64 108.657 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -142.24 153.4 43.93 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.878 -1.527 . . . . 3.14 106.878 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -103.09 -90.35 2.15 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.296 -1.122 . . . . 0.69 110.296 172.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.04 82.74 0.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.93 3.086 . . . . 1.58 110.965 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -157.96 159.81 30.26 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 108.933 -1.667 . . . . 1.05 108.933 170.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.8 p -78.85 171.34 15.32 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.862 0.865 . . . . 2.11 110.101 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 54.28 -106.53 0.5 Allowed Glycine 0 C--O 1.244 0.721 0 C-N-CA 123.635 0.636 . . . . 1.48 111.626 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.4 tp -59.02 -43.22 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 118.501 -0.761 . . . . 1.56 109.14 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -43.3 135.05 4.96 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.492 1.044 . . . . 1.1 112.74 -177.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 107.0 -43.08 1.76 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.485 1.993 . . . . 0.66 110.751 -165.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.87 171.73 10.61 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.502 1.121 . . . . 1.51 110.957 -165.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.31 121.03 8.07 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.66 0.985 . . . . 0.74 113.66 -168.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -114.92 113.8 24.63 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 118.923 -0.56 . . . . 2.63 112.073 -172.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.403 ' HB2' ' CE1' ' A' ' 163' ' ' PHE . 56.5 m-85 -100.34 145.67 27.88 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.203 0.91 . . . . 2.89 112.412 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -73.21 82.66 1.34 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.851 0.834 . . . . 2.79 110.018 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -54.45 -28.96 47.87 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.293 -0.88 . . . . 3.45 111.352 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.82 -36.73 65.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.79 -0.448 . . . . 3.13 109.79 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.79 146.01 50.02 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 122.374 1.083 . . . . 1.89 109.154 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -92.15 92.25 8.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.357 -1.349 . . . . 2.77 107.357 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -78.01 131.46 37.38 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.443 -1.317 . . . . 1.12 107.443 -178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 41.0 p -116.87 136.09 53.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.428 0.691 . . . . 1.67 109.605 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.1 t -51.13 -49.39 60.89 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.622 1.169 . . . . 1.68 109.717 169.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.39 -179.36 5.69 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.149 0.98 . . . . 2.04 111.541 173.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.2 m -56.75 -56.56 19.89 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.791 1.236 . . . . 3.57 111.461 -173.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 42.97 -105.9 0.07 OUTLIER Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.017 1.294 . . . . 2.48 114.774 169.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -117.93 -63.3 0.31 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.252 0.93 . . . . 1.35 111.348 -172.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.37 164.55 27.18 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.193 -2.151 . . . . 1.01 105.193 165.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -116.9 133.24 56.26 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 119.248 0.931 . . . . 1.48 110.967 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 31.4 tp -62.78 -53.58 52.21 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.127 -0.488 . . . . 2.08 109.985 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.435 ' O ' HG23 ' A' ' 217' ' ' VAL . 28.2 t80 -50.87 -42.68 59.14 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.205 0.526 . . . . 1.38 109.852 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.02 -63.61 1.24 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.319 0.648 . . . . 1.33 109.656 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.315 2.0 m -57.14 -38.43 73.49 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.035 0.445 . . . . 0.77 110.651 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.76 -56.65 14.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 118.106 -0.95 . . . . 0.34 111.142 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 213' ' ' PHE . 90.1 t -51.27 -39.42 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 120.538 1.517 . . . . 0.71 111.291 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.917 ' NE2' ' CE1' ' A' ' 222' ' ' HIS . 0.5 OUTLIER -64.63 -51.4 62.82 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.128 0.971 . . . . 2.65 112.195 174.038 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.46 -45.74 71.64 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.069 -1.019 . . . . 2.69 111.965 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.456 HG21 ' HA ' ' A' ' 138' ' ' PHE . 1.5 mp -54.45 -43.99 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 106.616 -1.624 . . . . 1.16 106.616 170.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.2 -53.38 23.73 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 123.695 0.664 . . . . 0.45 113.105 170.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.917 ' CE1' ' NE2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -51.25 -42.12 60.82 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 121.848 -0.795 . . . . 1.58 110.999 174.163 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.4 t -51.24 -43.45 61.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 123.602 0.564 . . . . 1.96 112.07 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.517 ' HB3' HD13 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -66.31 -60.09 3.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.648 -0.821 . . . . 2.7 109.9 174.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 135.98 92.26 0.35 Allowed Glycine 0 C--N 1.338 0.676 0 N-CA-C 111.805 -0.518 . . . . 1.23 111.805 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.76 HD21 ' CE1' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -99.39 177.61 5.13 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.584 0.587 . . . . 5.74 112.584 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -120.73 20.7 8.67 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.724 1.154 . . . . 3.08 112.74 172.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 30.8 m80 56.14 95.69 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.14 1.776 . . . . 2.22 113.08 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.1 m -73.96 171.59 13.17 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.873 0.469 . . . . 1.18 110.592 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.7 t -137.25 47.06 2.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.186 0.994 . . . . 3.36 109.101 -169.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -148.9 123.62 4.86 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 107.18 -1.415 . . . . 2.14 107.18 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.19 -3.47 13.86 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.191 1.927 . . . . 1.59 114.011 -170.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -82.31 -24.36 34.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.493 1.042 . . . . 1.47 109.943 169.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -82.07 152.6 26.52 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.458 0.703 . . . . 0.77 109.632 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 24.0 t -104.52 -21.24 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.246 1.018 . . . . 0.72 111.334 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.44 -18.39 17.92 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.479 -0.763 . . . . 2.92 112.99 168.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.75 157.31 7.91 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 120.915 -1.116 . . . . 3.21 113.353 -176.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.53 -16.98 11.58 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.371 2.047 . . . . 0.9 111.791 173.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.355 0.2 OUTLIER -78.49 172.9 12.98 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.963 1.305 . . . . 1.16 109.697 -178.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -119.68 142.6 48.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.286 1.435 . . . . 2.21 107.265 173.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -156.08 125.73 6.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.422 -1.325 . . . . 3.55 107.422 170.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -45.52 142.13 2.42 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.063 1.345 . . . . 2.35 112.087 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.0 139.38 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.115 0.966 . . . . 2.2 109.363 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -41.11 96.8 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.111 0.964 . . . . 3.91 111.431 171.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 6.1 mt 66.29 18.78 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.623 1.569 . . . . 2.53 110.142 -160.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -71.05 -64.09 0.97 Allowed 'General case' 0 C--N 1.343 0.304 0 O-C-N 120.937 -1.102 . . . . 3.26 109.865 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 7.4 m -71.94 -39.73 69.22 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.496 -0.775 . . . . 1.85 109.558 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.738 ' CE1' HG22 ' A' ' 140' ' ' VAL . 1.0 OUTLIER 53.05 71.91 0.46 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.336 1.065 . . . . 4.71 109.411 176.676 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -151.36 165.0 35.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.433 -0.951 . . . . 3.34 108.433 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.602 HD12 ' CH2' ' A' ' 141' ' ' TRP . 1.9 mm? -95.42 174.19 7.14 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.419 1.488 . . . . 0.89 108.591 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.5 m -91.15 150.73 21.26 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 120.95 -1.094 . . . . 0.83 112.217 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.78 -43.37 65.8 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.51 -0.552 . . . . 0.78 109.51 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.59 -51.6 68.83 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.954 0.883 . . . . 2.28 110.383 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -57.6 -47.28 82.6 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.572 -1.194 . . . . 2.07 110.188 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 52.6 mt -52.03 -36.79 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.371 1.868 . . . . 0.73 111.329 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 36.7 mtt85 -70.43 -49.06 52.7 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 120.945 -1.097 . . . . 4.89 110.177 172.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -45.09 -56.86 5.8 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.708 0.67 . . . . 0.93 111.649 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.701 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 2.3 pp -63.87 -46.95 92.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.134 0.974 . . . . 2.13 110.434 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.51 ' N ' HD12 ' A' ' 258' ' ' ILE . 1.6 mm-40 -59.69 -26.6 65.72 Favored 'General case' 0 C--N 1.343 0.303 0 O-C-N 120.641 -1.287 . . . . 2.18 111.647 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.0 t -49.33 -26.46 3.13 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.652 0.612 . . . . 1.92 112.652 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.517 HD13 ' HB3' ' A' ' 224' ' ' LEU . 16.5 mt . . . . . 0 CA--C 1.528 0.099 0 C-N-CA 123.441 0.697 . . . . 2.59 111.867 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.554 0 CA-C-O 121.601 0.715 . . . . 12.04 110.251 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -104.14 19.64 19.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.369 1.468 . . . . 4.86 111.084 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -85.45 78.47 9.7 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 109.371 -0.603 . . . . 3.1 109.371 -172.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.528 HG21 ' CE2' ' A' ' 149' ' ' PHE . 20.3 mm -88.03 82.16 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 122.728 1.252 . . . . 1.72 108.327 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 p -77.77 126.68 31.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.91 -1.515 . . . . 1.34 106.91 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.42 ' CE1' ' CD2' ' A' ' 138' ' ' PHE . 41.7 p90 -128.19 167.14 17.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.855 0.862 . . . . 4.12 110.67 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -156.24 177.2 11.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.09 0.471 . . . . 4.67 111.076 168.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.29 168.36 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.953 1.301 . . . . 1.13 108.199 174.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -95.14 -51.89 4.44 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.736 0.814 . . . . 4.24 109.587 169.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.83 153.8 30.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.912 0.485 . . . . 2.6 111.638 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -78.31 108.0 11.33 Favored 'General case' 0 CA--C 1.53 0.212 0 N-CA-C 108.369 -0.975 . . . . 2.71 108.369 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.9 t -60.17 146.82 82.46 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 118.655 0.662 . . . . 2.17 110.575 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.39 -15.97 24.79 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.444 2.763 . . . . 1.56 111.356 170.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -47.29 -42.62 21.33 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.829 0.852 . . . . 2.5 111.452 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 5.3 mtm -130.3 175.58 8.82 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.635 1.174 . . . . 2.13 108.206 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -75.97 144.8 40.77 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.751 -0.463 . . . . 2.98 109.751 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -45.76 -53.87 8.83 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.486 0.715 . . . . 2.51 112.451 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -48.54 -38.94 21.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.402 0.681 . . . . 4.12 109.272 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -82.4 -43.09 17.78 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.328 1.851 . . . . 2.04 113.183 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.3 t -50.15 -55.05 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 O-C-N 120.789 -1.194 . . . . 1.23 109.051 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.412 ' OD2' ' NZ ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -71.98 -19.73 61.83 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 119.161 -1.016 . . . . 1.79 109.991 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -64.34 -52.62 57.46 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 119.734 1.152 . . . . 2.07 109.133 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.9 -53.1 44.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 122.998 0.519 . . . . 0.36 110.33 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.2 -46.73 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 109.769 -0.456 . . . . 2.31 109.769 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -50.77 -55.37 17.05 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 124.365 1.066 . . . . 4.27 108.428 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -63.03 -48.89 76.82 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.624 1.169 . . . . 1.51 109.292 -177.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.573 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -45.89 -55.74 6.32 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.145 0.578 . . . . 0.61 111.681 175.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.42 ' CD2' ' CE1' ' A' ' 116' ' ' TYR . 52.8 m-85 -57.54 -48.99 77.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.256 -0.429 . . . . 4.63 110.657 173.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.7 -32.87 65.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 113.069 0.766 . . . . 2.11 113.069 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.55 ' CG1' HD21 ' A' ' 250' ' ' LEU . 85.4 t -63.58 -57.04 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 119.425 1.011 . . . . 0.74 108.518 176.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.79 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 16.9 m95 -68.46 -36.72 79.38 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.039 -0.726 . . . . 0.83 109.039 -172.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.6 t -67.6 -13.09 61.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 118.882 -0.58 . . . . 1.25 112.291 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.17 -54.94 4.47 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 107.946 -1.131 . . . . 1.19 107.946 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.512 HG11 HD23 ' A' ' 250' ' ' LEU . 17.6 m -74.1 -40.88 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 116.105 -0.498 . . . . 1.54 111.785 -176.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.95 HG22 HD13 ' A' ' 258' ' ' ILE . 3.1 p -87.06 142.68 34.02 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 107.671 -1.233 . . . . 0.75 107.671 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.53 4.95 3.09 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.835 2.356 . . . . 0.66 113.546 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.4 130.43 42.86 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.84 1.256 . . . . 2.22 107.818 175.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -97.25 108.34 21.04 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.335 -0.987 . . . . 4.31 108.335 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.528 ' CE2' HG21 ' A' ' 114' ' ' ILE . 52.1 m-85 -87.11 142.1 28.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.039 -0.528 . . . . 5.69 111.073 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -142.91 117.79 9.95 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.698 0.799 . . . . 0.97 110.136 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.412 ' NZ ' ' OD2' ' A' ' 131' ' ' ASP . 20.6 ttpt -78.5 142.75 37.2 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.089 -1.078 . . . . 2.42 108.089 172.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.9 pt -134.56 144.04 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 105.519 -2.03 . . . . 1.27 105.519 166.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.07 -61.83 1.64 Allowed 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 107.029 -1.471 . . . . 3.44 107.029 168.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.4 m -86.67 101.09 12.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.493 0.717 . . . . 2.34 110.129 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 153.88 153.4 6.4 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 107.323 -2.311 . . . . 2.35 107.323 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.5 ttt -79.37 143.28 35.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.302 -1.37 . . . . 7.36 107.302 168.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -127.65 165.44 19.98 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.682 1.193 . . . . 1.25 108.404 -173.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -69.21 -58.21 4.35 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.863 0.839 . . . . 1.94 109.359 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.2 pt -105.75 134.49 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.14 -1.059 . . . . 1.68 108.14 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . 0.358 0.0 OUTLIER -128.76 132.44 47.91 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.411 -0.806 . . . . 2.8 109.424 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.9 t -82.67 106.1 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.677 -0.86 . . . . 1.05 108.677 -175.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.66 ' HB ' ' HD2' ' A' ' 196' ' ' HIS 0.417 7.8 t -95.22 94.87 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.411 1.084 . . . . 1.63 112.831 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -79.51 115.47 19.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.555 -2.017 . . . . 5.4 105.555 167.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -139.57 164.73 29.13 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.294 -1.743 . . . . 0.95 106.294 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -132.02 142.6 49.62 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.865 -0.791 . . . . 5.12 108.865 -170.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 73.47 -86.1 0.62 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.415 1.007 . . . . 1.97 111.243 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -150.34 145.15 25.95 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 121.581 -0.952 . . . . 2.22 108.661 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.4 p80 . . . . . 0 CA--C 1.533 0.303 0 CA-C-O 121.648 0.737 . . . . 2.92 111.05 -178.952 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.093 0 N-CA-C 111.772 0.286 . . . . 2.34 111.772 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -118.25 172.35 7.5 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 107.82 -1.178 . . . . 6.08 107.82 -172.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -178.56 28.12 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.814 0.301 . . . . 2.71 111.814 -161.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 60.07 -155.16 31.45 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 119.015 -1.564 . . . . 1.61 110.261 -160.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -79.52 106.81 11.82 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.322 0.649 . . . . 4.57 110.738 -175.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 148.33 -168.65 29.02 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 108.45 -1.86 . . . . 2.27 108.45 -168.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.68 -112.23 2.64 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 125.83 1.681 . . . . 2.18 109.911 172.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . 0.571 4.0 mm -109.07 149.27 12.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.565 -0.902 . . . . 1.55 108.565 173.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.463 HD23 HG21 ' A' ' 210' ' ' THR 0.276 4.4 mp -81.68 -59.02 2.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.74 2.016 . . . . 1.27 108.402 170.406 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.87 153.92 17.2 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 122.251 1.024 . . . . 0.63 113.291 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -143.88 132.44 22.3 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 114.522 1.304 . . . . 1.09 114.522 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -160.49 162.27 33.05 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.655 1.982 . . . . 0.52 106.144 -164.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -157.97 156.21 30.8 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 107.631 -1.248 . . . . 3.4 107.631 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.33 -88.93 1.75 Allowed Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.186 -0.786 . . . . 0.56 111.206 173.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.22 82.82 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.828 3.019 . . . . 1.38 111.547 -171.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -159.03 161.67 32.12 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.051 -1.62 . . . . 1.03 109.051 170.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.9 m -78.51 167.2 21.63 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.077 0.465 . . . . 2.12 110.461 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 55.07 -106.32 0.52 Allowed Glycine 0 CA--C 1.529 0.906 0 C-N-CA 123.826 0.727 . . . . 1.43 112.059 174.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.8 tp -63.54 -27.58 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.158 0.983 . . . . 1.51 110.705 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.19 148.61 19.26 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 110.452 -1.059 . . . . 0.93 110.452 172.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 87.92 -45.16 3.29 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.932 1.253 . . . . 0.55 110.733 -163.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -84.08 171.74 12.62 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 121.681 -0.894 . . . . 1.25 109.843 -161.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -142.93 120.49 11.75 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 119.236 -0.411 . . . . 0.69 112.058 -175.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.66 ' HD2' ' HB ' ' A' ' 162' ' ' VAL . 14.5 m80 -109.34 133.83 52.57 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 118.413 -0.803 . . . . 2.46 109.591 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -120.75 148.69 43.63 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.301 0.5 . . . . 3.09 109.829 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -67.24 89.73 0.2 Allowed 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 124.658 1.224 . . . . 2.7 109.533 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -66.64 -26.9 67.28 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.18 -0.95 . . . . 2.95 109.499 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.39 -42.41 21.84 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.948 0.899 . . . . 3.35 109.404 171.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -73.57 170.37 15.33 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.582 1.182 . . . . 1.69 112.272 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -117.62 91.19 3.5 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.779 -1.563 . . . . 3.1 106.779 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -75.81 158.33 32.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.634 -0.712 . . . . 1.07 109.438 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 75.3 p -138.57 144.43 39.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.608 -0.515 . . . . 1.58 109.608 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 13.7 t -61.23 -43.52 98.74 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 125.913 1.685 . . . . 1.8 113.871 169.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.88 174.68 10.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.9 -0.778 . . . . 2.08 108.9 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.7 m -43.63 -57.33 3.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.214 1.806 . . . . 3.83 109.997 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 51.09 -88.38 0.01 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.375 1.464 . . . . 2.18 113.338 167.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -147.07 -69.51 0.01 OUTLIER Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.912 -1.675 . . . . 1.77 108.912 168.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.463 HG21 HD23 ' A' ' 181' ' ' LEU . 2.4 m -105.85 97.42 7.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.5 -1.667 . . . . 0.98 106.5 175.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -68.16 109.31 3.49 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.343 -1.354 . . . . 3.11 107.343 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 29.2 tp -47.62 -54.54 11.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.327 1.421 . . . . 1.76 111.853 -166.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.602 ' O ' HG23 ' A' ' 217' ' ' VAL . 1.8 t80 -40.34 -43.69 1.8 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.956 1.302 . . . . 2.21 111.202 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -64.05 1.08 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.281 0.632 . . . . 2.01 111.259 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.291 1.2 m -56.94 -40.84 77.13 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.995 -0.372 . . . . 0.87 109.995 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.6 -49.88 64.17 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.58 -0.724 . . . . 0.43 111.312 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 213' ' ' PHE . 61.4 t -54.83 -41.49 57.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 119.567 1.076 . . . . 0.82 110.973 178.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.504 ' HE2' ' HE2' ' A' ' 222' ' ' HIS 0.449 2.7 t-160 -63.53 -49.47 73.38 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.234 0.614 . . . . 2.2 111.535 176.46 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.09 -48.11 72.01 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.897 -1.127 . . . . 3.65 111.531 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.36 -39.55 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 107.561 -1.274 . . . . 1.33 107.561 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.49 -55.78 6.72 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.552 1.073 . . . . 0.53 111.673 165.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.504 ' HE2' ' HE2' ' A' ' 218' ' ' HIS . 1.9 m-70 -51.89 -47.73 64.42 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.715 -0.873 . . . . 1.37 110.698 174.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 67.9 m -54.17 -38.34 65.47 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.293 0.849 . . . . 2.05 113.293 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.423 ' CD2' HG21 ' A' ' 145' ' ' THR . 8.4 mp -56.6 -40.73 75.81 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 119.431 1.014 . . . . 2.85 110.266 172.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 117.44 28.89 2.23 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 125.045 1.307 . . . . 1.66 111.602 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 1.04 HD11 HG22 ' A' ' 258' ' ' ILE . 0.5 OUTLIER -79.95 137.89 36.96 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.074 -0.713 . . . . 3.36 109.074 -170.174 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.77 140.23 21.5 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.655 -0.978 . . . . 2.76 110.655 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -47.87 116.23 1.43 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.635 0.774 . . . . 1.66 111.307 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 31.7 m -78.56 -177.35 5.28 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.385 0.674 . . . . 1.01 109.195 172.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 23.4 m -148.79 39.54 0.87 Allowed 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.328 -0.857 . . . . 2.31 109.387 -172.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.13 131.64 15.51 Favored Pre-proline 0 N--CA 1.447 -0.614 0 N-CA-C 106.599 -1.63 . . . . 1.55 106.599 -174.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.52 -9.55 14.8 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.096 1.864 . . . . 1.14 114.367 -172.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -82.07 -26.31 33.78 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.304 0.956 . . . . 1.2 109.771 170.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -70.43 148.28 48.51 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.325 -0.62 . . . . 0.76 109.325 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 90.2 t -93.92 -23.9 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 123.574 0.749 . . . . 0.78 109.383 177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.545 ' HG2' HD13 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -49.54 -38.52 31.11 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.859 0.689 . . . . 2.87 112.859 175.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.431 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -46.95 149.1 1.65 Allowed Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 126.219 1.808 . . . . 3.23 112.802 -165.049 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.428 ' HA ' ' HE1' ' A' ' 218' ' ' HIS . 61.4 Cg_endo -71.68 -16.89 29.97 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.541 1.494 . . . . 0.94 111.971 176.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.373 0.2 OUTLIER -78.85 -179.54 6.63 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.132 1.373 . . . . 1.38 110.148 176.72 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -127.39 153.88 45.69 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.594 -1.632 . . . . 2.24 106.594 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -148.56 117.45 6.72 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.615 -1.254 . . . . 2.19 107.615 168.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -63.68 122.47 16.46 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.63 -0.878 . . . . 2.41 108.63 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.3 m -145.96 154.55 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 O-C-N 123.771 0.669 . . . . 3.58 110.035 169.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -50.56 110.67 0.44 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.58 1.952 . . . . 3.72 111.539 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.8 pp -57.55 -19.8 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.091 0.956 . . . . 3.1 112.752 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -70.09 -49.7 48.27 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.433 0.693 . . . . 4.24 110.899 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 91.7 m -83.88 -30.02 26.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.115 0.566 . . . . 2.44 109.974 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.555 ' HE2' HG21 ' A' ' 217' ' ' VAL . 63.7 t80 -34.56 116.71 0.33 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.446 1.498 . . . . 8.33 111.581 174.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.27 175.82 10.76 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.714 1.206 . . . . 2.8 108.698 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.584 HD12 ' CH2' ' A' ' 141' ' ' TRP . 1.1 mm? -83.3 141.78 31.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.44 -0.948 . . . . 0.95 108.44 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.4 m -77.87 155.38 31.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 110.09 -0.337 . . . . 0.7 110.09 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.28 -45.28 62.07 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.005 0.431 . . . . 0.89 110.138 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -51.1 -54.11 28.03 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.884 0.874 . . . . 2.19 110.191 173.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.591 ' O ' HG23 ' A' ' 258' ' ' ILE . 4.1 t0 -59.27 -51.76 68.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.087 -0.961 . . . . 2.15 109.92 -176.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.5 mt -49.07 -52.43 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.775 1.63 . . . . 1.02 110.263 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -59.44 -40.51 87.02 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.391 -1.443 . . . . 6.78 110.568 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -49.04 -55.05 12.44 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 111.963 -0.455 . . . . 0.91 111.963 167.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 1.04 HG22 HD11 ' A' ' 226' ' ' LEU . 0.3 OUTLIER -60.85 -40.67 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 118.508 1.154 . . . . 2.54 110.282 -173.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -64.74 -17.96 64.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.498 -0.881 . . . . 2.64 111.245 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.0 t -63.02 -17.43 62.21 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.473 0.709 . . . . 2.18 112.446 171.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 66.7 mt . . . . . 0 CA--C 1.536 0.438 0 C-N-CA 124.657 1.183 . . . . 2.33 111.501 172.88 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.411 ' HB2' HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 110.072 -0.344 . . . . 8.58 110.072 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 57.9 -78.34 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.142 1.377 . . . . 4.35 111.283 -170.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -124.63 109.15 12.81 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.102 1.361 . . . . 3.89 109.572 -177.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.411 HD13 ' HB2' ' A' ' 111' ' ' LYS . 0.4 OUTLIER -104.7 138.18 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.069 0 N-CA-C 106.641 -1.614 . . . . 2.56 106.641 170.29 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.1 p -125.1 139.47 53.75 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.739 -1.208 . . . . 1.19 107.739 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -123.04 161.59 24.02 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.696 0.798 . . . . 4.4 110.342 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.95 147.82 32.11 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.752 -0.833 . . . . 5.67 108.752 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -104.95 149.26 8.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 C-N-CA 123.559 0.744 . . . . 0.83 109.312 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.47 HD22 ' H ' ' A' ' 119' ' ' ASN . 1.4 p30 -104.85 -47.6 3.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.158 1.783 . . . . 2.96 109.648 -172.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -139.18 164.63 29.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.98 -1.119 . . . . 3.2 107.98 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -128.16 118.67 23.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.846 -1.539 . . . . 2.23 106.846 -174.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.9 t -66.78 122.98 84.74 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.77 0.828 . . . . 2.53 109.384 -173.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -68.84 -17.76 41.73 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.791 2.994 . . . . 1.68 111.562 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -34.3 -42.42 0.13 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.451 2.301 . . . . 2.57 112.462 171.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 19.4 mtm -132.69 177.73 7.4 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.261 1.425 . . . . 2.07 109.046 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -64.05 142.32 58.45 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 108.824 -0.806 . . . . 3.01 108.824 172.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 43.9 ttt-85 -47.68 -51.15 22.78 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.506 -0.746 . . . . 2.15 110.491 172.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.33 6.28 3.01 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.453 0.538 . . . . 5.24 112.453 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -102.08 -41.92 6.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.15 1.78 . . . . 1.76 109.632 162.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 62.4 t -54.02 -54.79 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 O-C-N 120.508 -1.37 . . . . 1.21 109.719 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -26.43 68.13 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 118.647 -1.221 . . . . 1.76 109.469 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -65.0 -44.71 88.35 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 118.832 0.742 . . . . 2.41 111.004 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.91 -52.27 65.76 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.76 0.824 . . . . 0.4 110.481 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.416 HD13 ' O ' ' A' ' 134' ' ' ILE . 0.2 OUTLIER -68.51 -37.24 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 109.291 -0.633 . . . . 1.81 109.291 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -52.27 -61.37 2.31 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 107.851 -1.166 . . . . 3.71 107.851 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.422 ' O ' HG23 ' A' ' 140' ' ' VAL . 52.9 mmtt -52.34 -53.62 42.18 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.209 1.004 . . . . 1.51 110.546 178.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.21 -49.52 63.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.792 0.837 . . . . 0.69 111.834 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -63.59 -47.23 82.3 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.52 -0.918 . . . . 5.75 108.52 176.094 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.18 -38.95 63.28 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.695 0.398 . . . . 2.64 110.599 -171.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.561 ' CG1' HD21 ' A' ' 250' ' ' LEU . 82.3 t -49.79 -58.51 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.34 1.056 . . . . 0.71 109.249 175.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.872 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 17.3 m95 -68.63 -37.23 79.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 119.836 -0.746 . . . . 0.83 109.087 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -20.2 65.48 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.374 0.509 . . . . 1.44 112.374 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -78.98 -49.39 12.83 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.527 -0.916 . . . . 1.48 108.527 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.634 HG12 HD11 ' A' ' 258' ' ' ILE . 26.5 t -75.46 -54.91 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 122.775 0.43 . . . . 1.89 110.877 -174.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.6 p -76.93 157.33 81.74 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 107.758 -1.201 . . . . 0.62 107.758 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.88 15.07 0.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.744 1.629 . . . . 0.78 113.594 174.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.04 145.94 55.02 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 122.257 2.299 . . . . 2.85 109.641 175.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -110.63 86.93 2.41 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.939 -1.504 . . . . 4.34 106.939 160.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.452 ' HB2' ' CD1' ' A' ' 138' ' ' PHE . 3.9 m-85 -71.02 154.43 41.8 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.189 -0.671 . . . . 6.08 109.189 163.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.6 t -155.34 144.93 21.23 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.271 1.028 . . . . 0.92 108.51 170.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -92.29 138.6 31.39 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 119.493 1.042 . . . . 2.61 108.471 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.8 pp -138.29 124.46 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.243 -1.392 . . . . 1.35 107.243 167.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -88.03 -7.64 56.73 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 122.384 0.274 . . . . 3.42 111.26 172.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 62.2 p -130.11 96.79 4.27 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.024 0.929 . . . . 2.39 109.927 -170.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 140.03 -150.74 21.7 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 106.601 -2.6 . . . . 1.64 106.601 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 43.4 ttm -122.54 137.18 54.97 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.452 -1.684 . . . . 4.12 106.452 173.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -111.85 170.16 8.33 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.738 1.215 . . . . 0.83 109.664 -177.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -84.16 -55.7 4.05 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.646 0.778 . . . . 2.08 109.361 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.9 pt -101.91 164.26 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.143 -0.688 . . . . 1.01 109.143 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.05 132.31 38.08 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.988 -0.745 . . . . 2.0 108.988 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 10.7 t -78.48 143.03 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.967 -1.123 . . . . 1.55 107.967 168.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 66.6 t -108.24 128.78 63.46 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 C-N-CA 124.546 1.138 . . . . 1.46 108.021 165.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.435 ' N ' HD21 ' A' ' 119' ' ' ASN . 5.7 m-85 -124.31 99.8 6.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 103.903 -2.628 . . . . 5.03 103.903 170.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.51 160.13 33.31 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.991 -1.485 . . . . 0.97 106.991 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -121.72 128.25 51.6 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.406 -1.331 . . . . 4.18 107.406 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 65.79 -161.7 43.04 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-O 121.629 0.572 . . . . 2.23 112.37 -171.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.17 110.06 11.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.269 0.628 . . . . 2.24 109.654 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 . . . . . 0 C--O 1.227 -0.08 0 C-N-CA 125.615 1.566 . . . . 3.36 110.14 -177.849 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.202 0 N-CA-C 112.791 0.663 . . . . 2.71 112.791 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -104.63 149.57 25.43 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.467 1.107 . . . . 6.05 109.551 -166.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -171.8 10.16 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.323 0.86 . . . . 3.43 113.323 -155.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 65.82 -149.96 51.68 Favored Glycine 0 CA--C 1.537 1.428 0 N-CA-C 109.895 -1.282 . . . . 2.17 109.895 -162.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -80.3 63.94 4.95 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.66 1.23 . . . . 4.22 114.042 -162.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -164.13 -143.77 3.82 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 106.992 -2.443 . . . . 1.85 106.992 160.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.69 -127.31 40.08 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.27 -1.532 . . . . 2.02 109.27 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . 0.267 1.0 OUTLIER -100.39 148.77 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 106.214 -1.773 . . . . 1.56 106.214 173.316 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.22 -46.1 12.21 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.851 0.861 . . . . 2.2 109.644 164.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -163.48 165.69 23.48 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.238 -0.914 . . . . 0.65 111.246 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.56 141.71 26.09 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.697 0.799 . . . . 1.04 112.398 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -161.79 158.04 25.09 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.97 0.908 . . . . 0.56 109.853 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -147.87 139.35 23.72 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.617 1.167 . . . . 2.92 108.129 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -85.77 -78.71 1.18 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.365 -1.094 . . . . 0.5 110.365 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.78 104.08 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.355 2.703 . . . . 1.32 110.514 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -178.53 172.48 44.85 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 108.242 -1.943 . . . . 1.02 108.242 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 63.9 m -84.05 165.35 18.63 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.025 -0.731 . . . . 2.15 109.025 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 53.31 -95.23 0.02 OUTLIER Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.202 0.906 . . . . 1.8 112.535 172.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.5 tp -63.35 -16.49 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 125.129 1.372 . . . . 1.72 111.504 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -44.37 129.58 7.18 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 110.792 -0.923 . . . . 1.3 110.792 166.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 86.07 -31.09 4.13 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.34 1.448 . . . . 0.98 112.891 -175.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -83.34 147.51 27.88 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.484 1.142 . . . . 1.27 109.739 -166.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.78 124.04 38.78 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 118.762 -0.637 . . . . 0.71 112.454 -172.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . 0.341 0.0 OUTLIER -112.4 109.06 18.45 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.079 0.551 . . . . 2.41 112.19 -165.356 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -96.2 138.22 34.12 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.661 0.664 . . . . 2.71 110.449 -177.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -62.24 92.51 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.171 -0.677 . . . . 3.28 109.171 170.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -64.83 -37.54 87.95 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 120.51 -1.369 . . . . 2.66 109.576 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -50.46 -27.94 7.42 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.593 0.757 . . . . 2.74 110.907 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -66.27 155.15 37.99 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.859 1.264 . . . . 2.81 110.179 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -95.78 93.62 7.19 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.583 -1.636 . . . . 3.94 106.583 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -78.76 155.75 29.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.695 -0.854 . . . . 1.18 108.695 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.92 136.82 24.46 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.304 0.641 . . . . 2.79 111.285 -176.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.2 t -58.03 -45.35 87.08 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.188 0.995 . . . . 1.62 111.495 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -74.77 -154.85 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.646 1.179 . . . . 3.23 110.761 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.4 p -79.16 -68.27 0.67 Allowed 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.938 -1.101 . . . . 3.81 110.455 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 38.63 -106.03 0.05 OUTLIER Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.465 1.983 . . . . 2.51 113.495 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.55 -72.28 1.13 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.216 0.912 . . . . 1.58 110.839 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 4.3 m -136.45 153.92 50.92 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 106.686 -1.598 . . . . 0.87 106.686 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -107.77 124.75 50.5 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 123.651 0.594 . . . . 1.53 111.968 173.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.17 -53.65 55.86 Favored 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.241 -0.652 . . . . 1.74 109.241 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -49.07 -46.99 45.31 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.667 0.746 . . . . 1.52 110.232 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.6 tt -61.5 -61.58 2.43 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.921 0.888 . . . . 1.33 110.0 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.279 0.6 OUTLIER -55.99 -37.94 69.79 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.383 -0.198 . . . . 0.76 110.904 179.472 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.34 -54.92 29.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 124.591 1.156 . . . . 0.64 110.687 175.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.8 t -48.08 -43.45 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 120.12 1.327 . . . . 0.84 110.903 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.487 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 42.6 t-80 -56.62 -56.54 20.12 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.396 1.078 . . . . 2.11 113.845 171.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -82.1 -43.32 17.98 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.134 -0.979 . . . . 3.69 112.679 -170.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.413 ' CD1' HD11 ' A' ' 134' ' ' ILE . 1.0 OUTLIER -56.26 -33.95 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.056 -0.72 . . . . 1.46 109.056 164.185 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.5 -53.68 43.07 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 110.763 -0.935 . . . . 0.6 110.763 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.487 ' NE2' ' NE2' ' A' ' 218' ' ' HIS 0.281 62.5 m170 -53.44 -41.19 65.83 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.456 -1.026 . . . . 2.31 111.944 173.685 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 34.7 t -47.82 -52.97 16.97 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.131 0.972 . . . . 1.73 112.346 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.12 -10.85 60.44 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.614 -0.679 . . . . 3.16 112.786 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 104.51 43.31 1.73 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 124.289 0.947 . . . . 1.19 111.792 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.964 HD21 HG22 ' A' ' 258' ' ' ILE . 7.9 mt -77.35 115.37 17.06 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 117.373 0.586 . . . . 3.31 111.546 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -66.43 154.96 51.8 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 109.507 -1.437 . . . . 3.11 109.507 162.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -68.61 121.54 16.63 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.746 0.773 . . . . 2.38 112.716 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.9 m -79.93 118.1 21.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.772 -1.566 . . . . 2.31 106.772 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.7 p -76.12 63.29 1.81 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.24 0.927 . . . . 3.67 110.502 -175.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -155.78 131.36 5.48 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.85 1.26 . . . . 1.67 108.34 -173.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.92 -14.65 9.78 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.776 1.651 . . . . 1.69 114.124 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -42.09 59.76 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 119.57 1.077 . . . . 2.0 108.971 172.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -57.73 116.41 3.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.744 1.217 . . . . 1.79 110.451 176.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.0 t -62.2 -17.9 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.383 -0.826 . . . . 0.82 110.896 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.452 ' SD ' ' HB3' ' A' ' 226' ' ' LEU . 0.0 OUTLIER -51.89 -42.41 62.67 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.331 -0.856 . . . . 3.06 113.135 169.029 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.414 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 14.6 t80 -61.03 147.31 86.35 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 109.027 -0.731 . . . . 7.5 109.027 -165.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.414 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 58.8 Cg_endo -70.88 -14.01 32.24 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.375 1.384 . . . . 1.16 112.566 -172.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.354 0.2 OUTLIER -76.94 128.01 33.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.751 0.705 . . . . 1.88 109.121 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -75.82 129.91 37.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.794 -1.187 . . . . 3.25 107.794 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -135.67 139.36 43.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.708 -1.59 . . . . 2.64 106.708 174.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -57.77 120.96 9.34 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.542 -0.91 . . . . 2.41 108.542 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.1 m -101.09 130.72 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.854 -0.425 . . . . 2.0 109.854 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.66 86.71 0.66 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.491 -0.559 . . . . 4.83 109.491 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.6 mt -51.48 -31.3 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.404 0.682 . . . . 2.81 109.449 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -42.05 -49.46 4.72 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.362 1.065 . . . . 3.71 112.404 169.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 35.0 m -84.84 -41.63 15.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.56 0.744 . . . . 1.65 110.24 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 71.1 t80 60.96 75.5 0.41 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.287 1.035 . . . . 4.29 109.545 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.06 169.19 25.11 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.135 0.574 . . . . 4.61 110.688 -177.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.561 HD21 ' CG1' ' A' ' 140' ' ' VAL . 0.4 OUTLIER -113.76 176.87 4.84 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.505 1.522 . . . . 1.25 107.859 175.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 68.2 m -77.96 145.41 36.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 122.742 0.417 . . . . 0.83 110.7 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.36 -43.19 54.18 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.173 0.589 . . . . 1.36 110.402 171.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -53.43 -55.49 24.69 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.627 0.727 . . . . 2.87 110.183 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.595 ' O ' HG23 ' A' ' 258' ' ' ILE . 1.9 t0 -59.09 -47.69 84.32 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.078 -0.965 . . . . 2.25 109.02 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 59.3 mt -51.06 -32.31 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.647 1.979 . . . . 1.82 112.524 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -73.42 -57.16 4.2 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 121.293 -0.879 . . . . 6.25 110.026 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -47.24 -53.85 10.88 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 121.19 0.328 . . . . 1.73 112.291 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.964 HG22 HD21 ' A' ' 226' ' ' LEU . 2.0 pp -55.88 -32.65 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.946 1.698 . . . . 2.4 111.056 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -78.3 -45.11 23.53 Favored 'General case' 0 C--N 1.339 0.126 0 O-C-N 121.708 -0.62 . . . . 3.22 109.811 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 15.1 m -51.99 -31.04 27.72 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.58 0.585 . . . . 4.22 112.58 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 N--CA 1.465 0.324 0 N-CA-C 114.222 1.193 . . . . 3.7 114.222 172.78 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.3 tttt . . . . . 0 CA--C 1.532 0.283 0 CA-C-O 119.499 -0.286 . . . . 6.49 110.561 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 15.0 m170 67.02 -54.33 0.45 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.467 1.907 . . . . 3.31 112.889 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -107.0 114.52 28.65 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.324 1.45 . . . . 3.93 110.139 -176.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.7 mp -141.6 80.44 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.667 1.187 . . . . 2.33 108.396 -173.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.22 141.39 37.19 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.964 -1.124 . . . . 1.2 107.964 174.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -127.31 159.79 33.31 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.145 0.978 . . . . 4.09 108.705 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -154.94 173.21 16.86 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.727 0.694 . . . . 4.38 110.419 172.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.78 159.39 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.226 1.01 . . . . 0.85 109.834 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -100.29 -42.98 6.43 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.01 0.924 . . . . 2.95 109.994 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -149.41 170.46 18.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.751 0.82 . . . . 2.49 109.831 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -117.9 101.76 8.54 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.368 1.467 . . . . 2.25 107.959 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.4 t -58.55 125.89 77.69 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.96 0.904 . . . . 2.3 109.173 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.17 -17.26 45.29 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.717 2.945 . . . . 1.57 111.411 -172.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -35.06 -43.75 0.21 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.002 1.721 . . . . 2.2 111.827 170.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -130.88 174.59 9.83 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 124.994 1.317 . . . . 1.9 110.037 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -73.13 140.2 46.93 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.65 0.78 . . . . 3.01 109.487 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -46.61 -51.41 15.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.035 0.445 . . . . 2.66 111.892 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.5 -8.11 8.63 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.742 0.817 . . . . 3.46 112.723 -176.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -100.66 -48.45 4.51 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.695 1.598 . . . . 1.93 109.314 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.93 -56.59 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 125.274 1.43 . . . . 1.22 109.374 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -24.53 64.48 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 118.334 -0.841 . . . . 1.82 109.349 -177.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -65.84 -50.25 65.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.627 0.648 . . . . 3.16 110.071 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -49.67 -54.85 16.23 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.919 0.888 . . . . 0.6 110.091 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.476 HD11 HD11 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -71.38 -30.99 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.028 -0.533 . . . . 1.88 110.233 -179.082 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -55.04 -54.6 40.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.765 1.269 . . . . 3.53 108.157 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 140' ' ' VAL . 12.3 mmmm -68.82 -39.28 80.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.588 1.555 . . . . 1.42 110.282 -174.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -46.44 -57.11 4.97 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 122.576 0.35 . . . . 0.8 110.63 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.427 ' CZ ' HG13 ' A' ' 220' ' ' ILE . 11.9 m-85 -60.43 -48.55 81.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 119.661 -0.816 . . . . 4.41 111.15 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -45.34 -48.92 13.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.416 0.687 . . . . 3.47 111.093 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 136' ' ' LYS . 94.8 t -58.36 -51.0 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 122.717 0.407 . . . . 1.05 109.941 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.702 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 92.8 m95 -68.68 -33.67 74.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.679 -0.86 . . . . 0.82 108.679 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.14 -19.53 61.63 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.251 0.478 . . . . 1.19 111.911 174.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -81.27 -42.87 20.01 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.024 0.829 . . . . 2.45 108.985 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.7 m -79.87 -54.37 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 112.17 0.433 . . . . 1.28 112.17 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.439 ' CG2' HD13 ' A' ' 258' ' ' ILE . 54.4 p -81.83 147.14 57.76 Favored Pre-proline 0 N--CA 1.45 -0.442 0 N-CA-C 108.382 -0.969 . . . . 0.73 108.382 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.73 5.01 4.1 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.813 2.342 . . . . 0.81 113.008 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.4 125.9 27.93 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.371 1.468 . . . . 2.7 108.589 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -98.17 93.53 6.3 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 109.277 -0.638 . . . . 4.12 109.277 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -78.57 149.45 33.01 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.469 -0.332 . . . . 5.85 110.797 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.4 t -151.4 137.31 18.12 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.714 -0.476 . . . . 1.01 109.714 172.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -90.45 160.09 16.2 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.266 -1.013 . . . . 3.07 108.266 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.413 HD11 ' HB2' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -152.12 152.21 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 104.747 -2.316 . . . . 1.92 104.747 -177.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.03 -39.43 21.26 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.262 -0.644 . . . . 3.95 109.262 172.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.5 m -75.71 146.23 40.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.283 -0.636 . . . . 3.84 109.283 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -78.87 59.29 4.23 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.387 -0.674 . . . . 4.39 112.699 -173.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.2 mtt -116.37 72.89 0.83 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.152 0.981 . . . . 6.37 109.594 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.413 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -141.53 162.68 34.9 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.49 0.716 . . . . 0.73 111.702 -173.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -70.97 -46.54 62.17 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.073 -1.084 . . . . 2.03 108.073 170.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.9 pt -124.23 146.16 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.017 -0.992 . . . . 1.51 108.601 -171.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 160' ' ' LEU 0.308 0.0 OUTLIER -129.93 139.22 51.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.097 -0.705 . . . . 2.69 109.097 176.867 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.6 t -79.93 112.08 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 118.579 -0.724 . . . . 0.72 109.113 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . 0.479 7.4 p -109.0 97.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 N-CA-C 113.47 0.915 . . . . 2.4 113.47 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -79.82 130.04 34.98 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.326 1.85 . . . . 5.14 107.077 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -141.6 162.11 36.28 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.409 0.549 . . . . 0.87 111.029 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -119.01 126.75 52.46 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.897 1.279 . . . . 5.5 108.209 -172.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 46.62 -130.35 11.83 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 123.59 0.614 . . . . 1.73 112.208 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.96 138.2 38.72 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.266 0.627 . . . . 2.16 109.511 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 114.124 1.157 . . . . 2.43 114.124 -175.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 118.824 -0.608 . . . . 2.27 111.734 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -89.83 156.52 18.43 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 107.366 -1.346 . . . . 7.6 107.366 167.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -158.14 11.55 0.18 Allowed 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 126.82 2.048 . . . . 3.19 111.105 -157.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 105.29 165.22 23.78 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.351 -1.1 . . . . 1.99 110.351 -165.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -58.11 118.0 4.97 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.526 -0.916 . . . . 4.06 108.526 166.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.91 -160.81 13.74 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 109.95 -1.26 . . . . 1.78 109.95 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.92 -102.94 0.2 Allowed Glycine 0 C--N 1.339 0.715 0 N-CA-C 109.167 -1.573 . . . . 1.66 109.167 -171.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . 0.314 12.8 mm -90.73 130.04 40.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.111 -1.07 . . . . 1.9 108.111 171.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.8 mp -82.48 -61.18 1.96 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.806 -0.812 . . . . 1.11 108.806 166.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -158.8 149.65 20.15 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 113.332 0.864 . . . . 0.94 113.332 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -131.97 117.05 17.91 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.563 1.945 . . . . 1.0 114.678 -170.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -144.19 160.54 40.78 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 128.245 2.618 . . . . 0.56 106.388 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.93 149.84 28.65 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.691 -1.596 . . . . 3.68 106.691 -177.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -102.15 -86.99 1.97 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-O 119.455 -0.636 . . . . 0.6 111.768 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.57 86.83 0.43 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.501 2.801 . . . . 1.39 110.543 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -163.71 157.85 30.17 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 108.419 -1.872 . . . . 1.04 108.419 170.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.0 m -80.37 173.87 12.17 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.224 0.535 . . . . 2.63 110.45 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 56.53 -112.47 3.41 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.575 0.607 . . . . 1.24 111.648 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.1 tp -59.79 -40.05 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 O-C-N 122.131 -0.629 . . . . 1.43 109.365 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -39.24 136.06 1.37 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.393 0.997 . . . . 0.94 112.288 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.51 -47.58 1.17 Allowed Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.179 1.371 . . . . 0.58 111.186 -164.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -84.94 154.12 22.38 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.748 0.774 . . . . 1.3 109.226 -159.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.41 116.71 20.17 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.528 0.936 . . . . 0.61 113.528 -166.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -114.86 135.14 54.53 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 118.289 0.495 . . . . 2.19 111.629 -163.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -125.36 146.51 49.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.249 -0.649 . . . . 2.76 109.249 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -66.52 96.76 0.39 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.073 -0.967 . . . . 2.82 109.806 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.44 -42.76 98.66 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 120.558 -1.339 . . . . 3.18 111.639 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -53.85 -35.49 61.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.658 1.183 . . . . 2.86 110.14 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -67.4 133.94 50.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.721 -1.585 . . . . 2.11 106.721 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -93.39 94.25 8.61 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.131 -2.174 . . . . 2.79 105.131 -173.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 23.7 m95 -75.79 152.87 37.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.277 -1.749 . . . . 1.14 106.277 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 p -128.05 124.5 37.24 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.231 -1.396 . . . . 1.75 107.231 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -49.9 75.91 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 120.51 1.504 . . . . 2.14 108.028 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.74 177.93 2.33 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.725 0.41 . . . . 2.04 110.536 176.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.1 t -48.53 -55.31 11.41 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.726 1.211 . . . . 3.67 110.723 -171.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 40.78 -106.64 0.07 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.147 1.356 . . . . 2.3 114.611 165.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -121.37 -67.84 0.26 Allowed Glycine 0 CA--C 1.525 0.709 0 C-N-CA 124.293 0.949 . . . . 1.09 110.93 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.4 m -131.95 140.69 49.08 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.33 -1.73 . . . . 0.85 106.33 174.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -95.3 129.82 42.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 123.733 0.646 . . . . 1.56 111.251 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -47.59 85.18 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.529 -0.759 . . . . 1.59 110.137 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -55.51 -38.23 68.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.621 0.768 . . . . 2.69 111.475 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.68 -63.4 1.23 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.791 0.836 . . . . 1.95 109.706 176.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.303 0.2 OUTLIER -56.4 -38.75 71.95 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.19 -178.148 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.99 -58.5 7.06 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 117.857 -1.068 . . . . 0.63 110.641 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.588 ' CG1' HG11 ' A' ' 235' ' ' VAL . 0.3 OUTLIER -58.02 -44.01 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 120.275 1.398 . . . . 2.12 111.316 -174.845 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.751 ' NE2' ' NE2' ' A' ' 222' ' ' HIS 0.48 3.2 t-160 -49.76 -60.9 2.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.555 1.142 . . . . 2.14 111.686 169.362 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -58.39 -41.72 85.5 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 120.835 -1.166 . . . . 2.87 111.946 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.476 HD11 HD11 ' A' ' 134' ' ' ILE . 1.4 mp -68.68 -39.18 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 109.046 -0.724 . . . . 1.07 109.046 -173.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -52.97 -44.9 62.15 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 111.402 -0.679 . . . . 0.63 111.402 167.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.751 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 3.0 m-70 -53.93 -48.68 69.97 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 117.783 0.791 . . . . 1.26 109.302 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.5 p -61.2 -18.5 58.55 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.59 0.959 . . . . 1.69 113.59 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.6 mt -79.1 -58.98 2.96 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 106.966 -1.494 . . . . 2.19 106.966 171.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 149.86 79.66 0.03 OUTLIER Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.615 -0.721 . . . . 1.21 111.859 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.789 HD11 HG22 ' A' ' 258' ' ' ILE . 8.7 mt -133.38 102.69 5.63 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.697 -1.223 . . . . 3.19 107.697 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -77.81 46.94 2.71 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.14 -0.811 . . . . 3.42 112.777 -176.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 63.7 m80 71.38 120.08 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.09 2.156 . . . . 1.82 113.0 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 68.4 m -77.55 -179.83 6.08 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.933 -0.395 . . . . 1.26 109.933 173.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.3 t -142.14 29.91 1.63 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.954 0.901 . . . . 2.59 110.005 -171.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.03 143.35 45.23 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.69 1.596 . . . . 2.16 107.002 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -86.2 -12.61 5.74 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.158 1.905 . . . . 1.03 114.493 -172.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -81.2 -40.36 23.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.162 -1.051 . . . . 1.38 108.162 170.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.0 145.78 15.93 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.784 0.834 . . . . 0.74 110.502 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.588 HG11 ' CG1' ' A' ' 217' ' ' VAL . 60.3 t -97.5 -17.26 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.2 1.0 . . . . 0.75 109.826 -176.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.476 ' HG3' HD13 ' A' ' 226' ' ' LEU . 50.9 mmm -77.5 -12.42 59.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.074 1.139 . . . . 2.41 114.074 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.423 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.9 155.49 1.05 Allowed Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.425 1.09 . . . . 3.15 113.275 177.011 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.34 -21.69 19.63 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.774 1.65 . . . . 1.01 111.428 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.319 0.6 OUTLIER -76.8 173.19 11.97 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.824 1.25 . . . . 1.35 109.362 176.553 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -116.78 148.75 40.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.285 -1.376 . . . . 2.0 107.285 171.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -141.45 122.07 14.24 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.301 -1.74 . . . . 2.12 106.301 166.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -61.22 144.4 53.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.054 -0.721 . . . . 2.67 109.054 168.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 25.9 m -133.97 159.36 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.023 0.929 . . . . 2.07 108.723 167.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.81 -10.66 39.74 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 127.05 2.14 . . . . 4.04 113.107 -174.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . 0.257 24.0 mm 71.78 -23.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 127.081 2.152 . . . . 2.98 112.104 -176.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -47.04 -67.04 0.32 Allowed 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 113.81 1.041 . . . . 3.69 113.81 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 22.6 m -81.61 -50.15 9.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.528 -0.545 . . . . 1.9 109.528 -173.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 38.5 t80 39.43 82.9 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.435 1.894 . . . . 6.68 112.885 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.09 162.18 32.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.829 0.851 . . . . 3.44 109.387 -176.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.498 ' H ' HD22 ' A' ' 250' ' ' LEU . 1.2 mm? -83.03 146.79 28.54 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.808 -1.182 . . . . 0.99 107.808 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.9 m -76.79 157.28 31.69 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.022 0.529 . . . . 0.95 110.634 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.2 67.21 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 110.045 -0.354 . . . . 1.07 110.045 172.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -51.09 -56.78 10.94 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.904 0.859 . . . . 3.06 110.262 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -58.53 -42.15 87.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.068 -0.969 . . . . 2.13 111.589 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 41.7 mt -57.49 -44.73 85.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.181 1.393 . . . . 0.83 109.604 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -63.15 -45.12 93.36 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.417 -0.802 . . . . 4.55 110.622 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -46.09 -62.88 3.2 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.727 -0.549 . . . . 0.85 111.727 173.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.789 HG22 HD11 ' A' ' 226' ' ' LEU . 2.8 pp -60.21 -42.44 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 O-C-N 121.803 -0.822 . . . . 2.2 111.939 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -63.28 -21.53 66.3 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.195 -0.602 . . . . 2.31 112.054 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.6 t -53.21 -25.56 14.46 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.99 -0.444 . . . . 2.29 111.743 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 56.1 mt . . . . . 0 CA--C 1.531 0.222 0 C-N-CA 124.212 1.005 . . . . 2.87 111.814 176.237 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 112.272 0.471 . . . . 5.99 112.272 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.6 -69.61 0.09 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.766 1.226 . . . . 4.75 112.32 -173.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.9 95.15 4.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 119.024 0.829 . . . . 2.78 111.339 -169.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.0 mm -94.03 80.68 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 108.207 -1.035 . . . . 1.91 108.207 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.8 p -77.61 129.66 35.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.18 -1.044 . . . . 1.18 108.18 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.404 ' CE2' HD12 ' A' ' 134' ' ' ILE . 39.4 p90 -129.01 163.0 26.31 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.16 0.584 . . . . 4.52 110.59 -178.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.08 151.8 36.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.618 -0.882 . . . . 6.6 108.618 174.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -100.47 144.21 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.142 -1.059 . . . . 0.94 108.142 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -83.99 -58.32 2.83 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.611 -1.255 . . . . 3.86 107.611 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -123.8 160.18 27.92 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.782 1.233 . . . . 2.24 109.213 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -111.94 127.32 55.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.237 1.415 . . . . 2.12 107.262 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.39 131.03 34.1 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 118.356 0.525 . . . . 2.53 110.044 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -87.66 -17.24 2.78 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.848 3.032 . . . . 1.65 110.794 171.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -44.55 -48.16 10.24 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 125.442 1.497 . . . . 2.06 110.863 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 6.8 ptp -124.33 176.49 6.42 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.097 0.959 . . . . 2.34 109.135 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -65.7 134.26 52.82 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.363 -0.236 . . . . 2.99 110.363 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -52.58 -47.78 66.65 Favored 'General case' 0 CA--C 1.524 -0.043 0 O-C-N 122.028 -0.42 . . . . 3.57 111.651 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -51.01 -25.92 5.4 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.685 -0.674 . . . . 3.22 111.529 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -93.02 -35.32 13.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.992 1.317 . . . . 1.98 112.004 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -52.45 -56.58 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 120.469 -1.395 . . . . 1.2 108.875 171.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.83 -25.46 65.57 Favored 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 117.729 -1.588 . . . . 1.74 108.632 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -63.71 -45.43 90.0 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.856 1.207 . . . . 1.96 111.216 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.75 -53.01 60.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 122.771 0.428 . . . . 0.5 110.187 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.404 HD12 ' CE2' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -70.3 -37.26 70.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.834 -0.432 . . . . 2.05 109.834 -176.117 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -54.07 -59.98 3.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.337 1.455 . . . . 3.12 107.848 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -63.16 -43.88 97.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.408 -0.814 . . . . 2.4 109.764 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.32 -52.2 47.48 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.372 0.669 . . . . 0.43 111.909 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.04 -46.39 88.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.098 -1.041 . . . . 6.47 109.018 174.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -29.03 63.55 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 118.746 -0.645 . . . . 2.02 111.579 -172.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.404 ' CG1' HD21 ' A' ' 250' ' ' LEU . 99.0 t -59.83 -63.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 118.984 0.811 . . . . 0.81 109.494 171.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.764 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 46.8 m95 -66.04 -41.15 91.26 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.873 -0.788 . . . . 0.71 108.873 -170.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 t -69.08 -4.91 19.03 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 124.312 1.045 . . . . 1.07 112.054 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -89.66 -55.98 3.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.05 -0.722 . . . . 1.1 109.05 167.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.97 -51.44 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 112.8 0.667 . . . . 1.41 112.8 -174.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.511 HG22 HD13 ' A' ' 258' ' ' ILE . 42.3 p -79.76 151.96 74.43 Favored Pre-proline 0 N--CA 1.443 -0.812 0 N-CA-C 107.427 -1.323 . . . . 0.75 107.427 174.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.35 12.76 1.48 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.373 2.049 . . . . 0.74 112.248 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.61 149.45 50.05 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.221 -0.924 . . . . 2.38 109.079 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -120.79 87.46 2.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.661 -1.607 . . . . 4.62 106.661 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -72.37 149.07 44.68 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.11 -0.496 . . . . 5.85 109.77 172.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.3 t -155.73 129.34 8.43 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 119.172 -0.442 . . . . 1.04 110.01 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.68 149.87 27.1 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.224 -1.028 . . . . 2.14 108.224 171.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.0 pt -134.67 119.88 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.627 -1.62 . . . . 1.27 106.627 171.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -76.87 -22.3 53.68 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.505 -0.554 . . . . 3.65 109.505 173.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -136.8 113.27 10.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.25 1.42 . . . . 2.44 108.858 -176.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 149.5 -144.67 12.33 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 108.739 -1.744 . . . . 1.91 108.739 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 28.2 mtt -135.19 131.87 37.26 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 126.384 1.874 . . . . 4.21 107.511 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.77 162.92 14.3 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.552 1.541 . . . . 0.72 110.102 -175.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -86.89 -48.59 8.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.08 0.952 . . . . 1.88 109.68 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.2 pt -107.07 166.5 3.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.246 -0.65 . . . . 0.89 109.246 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.45 141.11 43.53 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.081 0.552 . . . . 2.28 111.269 174.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 73.3 t -90.8 122.77 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.41 -0.959 . . . . 0.87 108.41 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.1 t -97.64 115.35 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.745 -0.835 . . . . 1.56 108.745 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -107.54 113.37 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.953 -2.239 . . . . 5.28 104.953 163.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.613 ' HB3' ' HE2' ' A' ' 174' ' ' PHE . . . -128.13 148.84 50.6 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.77 -1.196 . . . . 0.71 107.77 177.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.96 105.96 15.99 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.996 0.81 . . . . 5.47 109.639 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.19 -134.51 13.6 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.609 -0.997 . . . . 1.87 110.609 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.32 137.64 39.99 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 122.043 -0.68 . . . . 2.02 109.697 -171.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.25 0 CA-C-O 121.385 0.612 . . . . 2.47 110.964 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 113.503 0.927 . . . . 2.21 113.503 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.613 ' HE2' ' HB3' ' A' ' 164' ' ' ALA . 9.5 m-85 -128.67 165.68 20.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.084 1.354 . . . . 6.05 109.036 -168.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -169.08 15.65 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.429 0.9 . . . . 2.67 113.429 -153.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 73.12 -160.65 54.07 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 109.812 -1.315 . . . . 1.27 109.812 -164.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -81.5 55.16 2.54 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.297 -0.531 . . . . 5.9 112.427 -170.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -142.51 -158.77 7.67 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 107.998 -2.041 . . . . 2.28 107.998 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.56 -138.07 41.48 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.172 -1.171 . . . . 1.93 110.172 172.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.3 tp -78.84 151.69 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 109.07 -0.715 . . . . 2.23 109.07 173.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.9 tp -84.32 -39.13 19.53 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.523 1.529 . . . . 1.22 111.146 171.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -167.51 164.07 14.81 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.712 0.805 . . . . 0.8 109.694 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -145.71 124.66 12.75 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.336 1.235 . . . . 1.06 114.336 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -139.52 161.28 37.88 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.065 2.146 . . . . 0.65 108.455 -173.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -148.77 141.84 24.9 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.443 -0.947 . . . . 2.71 108.443 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -92.08 -83.14 1.48 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.586 -1.006 . . . . 0.56 110.586 171.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.2 98.69 0.84 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.104 2.536 . . . . 1.3 111.07 -170.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -174.23 173.44 45.99 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.168 -1.973 . . . . 1.21 108.168 172.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 72.1 m -89.53 173.24 8.44 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.977 0.511 . . . . 2.73 109.679 169.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 54.66 -101.96 0.12 Allowed Glycine 0 C--O 1.243 0.686 0 C-N-CA 124.069 0.842 . . . . 1.61 111.424 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.1 tp -59.35 -41.14 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-O 117.912 -1.042 . . . . 1.59 109.036 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -33.96 129.48 0.47 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.633 1.111 . . . . 1.06 113.11 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 97.16 -34.94 4.73 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.268 1.413 . . . . 0.77 112.125 -167.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -86.47 159.37 19.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.736 1.268 . . . . 1.23 110.72 -165.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -133.66 121.59 22.21 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.385 0.883 . . . . 0.83 113.385 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -109.15 112.25 24.31 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-O 117.473 -1.251 . . . . 2.22 111.957 -167.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -106.77 145.0 32.6 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 121.336 1.88 . . . . 3.17 111.213 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.36 83.34 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.226 1.011 . . . . 3.05 110.227 177.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.81 -24.64 67.84 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 120.376 -1.452 . . . . 2.73 109.901 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.44 -35.42 28.6 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.104 -0.997 . . . . 4.31 111.192 169.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -74.22 161.75 29.62 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.668 1.223 . . . . 1.66 110.985 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -102.46 95.93 6.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.243 -1.392 . . . . 3.04 107.243 176.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -78.27 140.23 38.87 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.549 -0.908 . . . . 1.11 108.549 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.6 p -122.61 105.85 10.47 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 107.599 -1.26 . . . . 1.85 107.599 -172.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.2 t -48.47 -33.24 9.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.384 1.474 . . . . 2.23 114.329 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -71.07 178.27 3.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.634 0.73 . . . . 2.31 111.455 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.1 m -66.31 -47.4 73.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 121.116 -0.99 . . . . 4.7 109.665 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -62.82 132.41 43.62 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.107 -0.951 . . . . 3.26 111.241 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 101.46 -119.52 6.53 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.257 -1.137 . . . . 1.46 110.257 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.8 m -124.77 106.77 10.31 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.915 -1.143 . . . . 1.01 107.915 167.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -65.93 108.73 2.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.369 -0.604 . . . . 2.07 109.369 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 37.9 tp -50.78 -43.5 58.52 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.556 0.617 . . . . 1.61 111.115 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.586 ' CD1' HG22 ' A' ' 245' ' ' ILE . 45.9 t80 -44.06 -46.0 8.29 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.952 0.501 . . . . 1.46 111.125 175.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.407 HD12 ' HD1' ' A' ' 213' ' ' PHE . 3.5 mp -59.51 -63.45 1.3 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.516 0.674 . . . . 2.63 110.061 -173.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.349 1.3 m -60.32 -37.14 79.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.729 -0.669 . . . . 0.75 109.691 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.85 -53.84 50.12 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 117.955 -1.022 . . . . 0.33 110.549 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 213' ' ' PHE . 62.7 t -50.66 -49.94 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.968 1.258 . . . . 0.7 109.538 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.588 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 82.7 t60 -56.82 -45.09 82.5 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.236 -0.915 . . . . 2.53 113.313 177.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -83.23 -48.18 10.75 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.085 -1.009 . . . . 3.04 112.448 -170.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.37 -33.77 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.364 -1.347 . . . . 1.29 107.364 164.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.76 ' HA2' HD23 ' A' ' 224' ' ' LEU . . . -50.15 -61.44 5.79 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.95 -0.86 . . . . 0.63 110.95 168.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.588 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 17.5 m-70 -47.36 -56.48 6.79 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.495 -1.003 . . . . 1.3 110.743 174.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.0 m -46.36 -40.15 11.48 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 113.226 0.825 . . . . 2.16 113.226 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.76 HD23 ' HA2' ' A' ' 221' ' ' GLY . 0.5 OUTLIER -63.72 -33.88 76.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 118.924 0.784 . . . . 3.46 110.127 -174.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 130.61 46.18 0.15 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.933 1.73 . . . . 1.31 112.603 172.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.902 HD11 HG22 ' A' ' 258' ' ' ILE . 4.8 mt -119.45 147.72 44.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.586 1.193 . . . . 3.43 113.198 -172.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -88.13 166.42 35.18 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.879 1.228 . . . . 2.89 110.721 173.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -70.35 121.85 18.46 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.562 0.745 . . . . 1.65 110.536 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 66.5 m -77.01 -179.39 5.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.261 0.625 . . . . 1.1 110.903 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 17.6 m -135.53 39.1 2.86 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.038 1.335 . . . . 2.22 110.35 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -135.77 136.33 23.32 Favored Pre-proline 0 N--CA 1.452 -0.325 0 N-CA-C 107.524 -1.287 . . . . 1.99 107.524 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.3 -13.38 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.315 2.01 . . . . 1.01 114.325 -175.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -41.69 21.97 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.946 0.898 . . . . 1.92 109.068 173.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.29 139.88 34.92 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.333 1.053 . . . . 0.79 111.041 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 76.6 t -86.48 -15.18 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.943 0.878 . . . . 0.63 110.978 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.454 ' SD ' HD13 ' A' ' 226' ' ' LEU . 3.7 tpt -80.25 -21.71 42.48 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.166 -0.959 . . . . 1.69 112.916 -171.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -49.83 165.02 0.32 Allowed Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 128.091 2.556 . . . . 3.1 114.59 175.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -78.29 -21.11 10.69 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.536 1.491 . . . . 0.96 112.103 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.365 0.2 OUTLIER -78.64 -178.58 5.97 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.375 1.47 . . . . 1.28 110.686 -176.894 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -111.05 153.91 24.96 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.491 1.517 . . . . 3.05 108.926 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.0 tptt -149.53 133.13 16.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 106.858 -1.534 . . . . 2.32 106.858 169.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -70.19 111.69 6.0 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.416 -0.957 . . . . 2.87 108.416 170.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 20.6 m -121.65 118.17 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.737 0.815 . . . . 1.72 109.015 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.73 114.0 4.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.557 -0.714 . . . . 3.36 110.31 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.586 HG22 ' CD1' ' A' ' 213' ' ' PHE . 1.1 pp -52.09 -29.72 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 C-N-CA 124.642 1.177 . . . . 3.56 111.231 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -52.8 -40.94 63.69 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.854 0.861 . . . . 3.78 110.884 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 35.9 m -73.48 -36.39 65.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 119.108 -0.472 . . . . 1.82 110.515 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 44.4 t80 52.47 72.65 0.39 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.007 0.923 . . . . 5.08 110.084 172.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.41 167.12 30.55 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.099 -1.001 . . . . 2.55 110.965 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.467 HD22 ' N ' ' A' ' 250' ' ' LEU . 0.9 OUTLIER -114.08 -170.46 1.72 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.542 1.937 . . . . 1.48 109.463 179.487 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 13.9 m -109.85 149.12 30.32 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.574 1.15 . . . . 0.7 111.295 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.4 -48.84 65.43 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.984 -0.448 . . . . 0.88 111.573 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -64.11 -22.88 67.11 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.902 0.334 . . . . 2.97 111.902 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -77.78 -47.83 18.02 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.967 -0.458 . . . . 3.41 110.805 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.418 ' HA ' HG13 ' A' ' 258' ' ' ILE . 67.8 mt -54.48 -40.65 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.151 1.38 . . . . 0.88 110.974 -175.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -56.8 -47.79 79.4 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.311 -1.493 . . . . 6.85 111.214 170.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -57.48 -48.92 77.45 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.625 1.107 . . . . 0.97 110.545 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.902 HG22 HD11 ' A' ' 226' ' ' LEU 0.26 1.6 pp -64.08 -44.03 97.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 O-C-N 121.491 -1.005 . . . . 2.43 109.686 -176.737 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -64.03 -30.23 71.32 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.465 -1.397 . . . . 2.25 111.787 176.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.6 t -50.76 -14.82 0.22 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.535 1.309 . . . . 1.81 114.535 169.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.7 HD11 ' CD1' ' A' ' 224' ' ' LEU . 19.2 mt . . . . . 0 C--N 1.345 0.396 0 CA-C-N 120.388 1.449 . . . . 2.52 112.713 165.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.7 mttt . . . . . 0 C--O 1.225 -0.217 0 CA-C-O 122.494 1.14 . . . . 5.8 111.582 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -73.7 -46.77 44.24 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.172 -0.955 . . . . 3.2 108.572 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -126.82 118.41 24.57 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.287 0.635 . . . . 3.7 112.452 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 114' ' ' ILE . 1.6 mp -97.15 92.71 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 107.251 -1.389 . . . . 2.21 107.251 172.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.6 p -81.39 136.97 35.73 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.338 -0.986 . . . . 1.27 108.338 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.43 ' HA ' ' HB1' ' A' ' 157' ' ' ALA . 43.4 p90 -142.51 164.87 28.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.336 0.516 . . . . 4.13 112.294 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -147.1 142.87 27.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.129 0.971 . . . . 4.75 108.435 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.92 164.3 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.555 0.742 . . . . 0.92 109.327 172.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.606 HD22 ' H ' ' A' ' 119' ' ' ASN . 0.1 OUTLIER -109.33 -56.33 2.31 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 126.148 1.779 . . . . 3.32 108.441 179.068 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -139.77 120.98 14.83 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.776 -0.824 . . . . 3.17 108.776 -167.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -81.26 113.08 19.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.349 -0.982 . . . . 2.35 108.349 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -52.27 128.78 40.98 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 123.025 0.53 . . . . 2.32 110.314 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.68 -15.88 11.95 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.69 2.927 . . . . 1.53 110.553 173.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -46.2 -39.17 9.36 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.366 1.066 . . . . 2.04 110.479 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 42.4 mtm -124.95 -176.72 3.63 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.316 1.447 . . . . 1.95 109.954 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -73.87 144.01 45.61 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.432 -0.581 . . . . 3.05 109.432 170.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 64.2 ttt-85 -51.04 -45.55 61.36 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.413 -0.804 . . . . 2.7 110.722 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -61.81 -13.0 19.94 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.508 0.723 . . . . 3.41 112.028 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -94.52 -45.38 7.44 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.344 1.458 . . . . 1.9 109.568 172.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 52.4 t -55.8 -59.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.792 1.237 . . . . 1.18 109.831 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -24.14 65.67 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 117.602 -1.639 . . . . 1.78 108.987 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -64.55 -46.61 82.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.798 0.727 . . . . 1.91 111.208 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.09 -53.34 58.23 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.465 0.706 . . . . 0.37 109.846 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.4 ' O ' HD13 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -69.65 -36.84 72.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 109.516 -0.549 . . . . 2.04 109.516 -178.094 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -57.27 12.45 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 122.173 0.987 . . . . 4.74 108.511 178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -62.03 -43.96 97.72 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.225 -0.657 . . . . 1.57 109.225 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.466 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -48.39 -53.99 15.64 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.437 0.695 . . . . 0.45 112.758 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 149' ' ' PHE . 0.3 OUTLIER -62.25 -47.02 86.23 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 119.304 -0.958 . . . . 6.56 109.103 176.306 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.31 -37.05 71.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 122.511 0.324 . . . . 1.93 110.704 -169.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.0 t -54.63 -52.22 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 109.139 -0.689 . . . . 0.79 109.139 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.87 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 64.4 m95 -69.69 -35.29 74.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.501 -0.749 . . . . 0.89 109.463 -177.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.6 t -64.2 -16.46 62.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.375 0.67 . . . . 1.48 112.16 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -83.38 -51.05 7.73 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.116 -1.068 . . . . 1.2 108.116 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.464 HG11 HD23 ' A' ' 250' ' ' LEU . 30.5 m -74.54 -44.46 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 112.393 0.516 . . . . 1.6 112.393 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.462 ' CG2' HD13 ' A' ' 258' ' ' ILE . 56.4 p -84.84 150.63 56.34 Favored Pre-proline 0 N--CA 1.445 -0.714 0 N-CA-C 108.902 -0.777 . . . . 0.74 108.902 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.52 10.46 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.61 2.207 . . . . 0.84 112.636 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 43.8 mt -67.72 133.95 50.19 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.263 1.425 . . . . 1.92 110.309 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.56 82.68 1.69 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.832 -1.173 . . . . 4.67 107.832 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.528 ' HB2' ' CD1' ' A' ' 138' ' ' PHE . 77.4 m-85 -67.66 159.17 30.55 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.051 -0.522 . . . . 5.24 111.131 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.3 t -155.79 125.87 6.59 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.83 0.741 . . . . 0.98 110.629 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -78.78 137.26 37.65 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 107.256 -1.387 . . . . 2.19 107.256 167.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.2 pt -135.08 105.58 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.467 -0.938 . . . . 1.67 108.467 170.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -77.41 -15.45 59.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.486 -0.325 . . . . 3.13 110.169 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.3 m -127.32 102.02 6.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.308 1.043 . . . . 2.06 109.249 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.0 -155.26 26.36 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 108.81 -1.716 . . . . 1.41 108.81 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 31.4 mtp -117.71 130.16 56.16 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.129 2.572 . . . . 4.14 105.88 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.43 ' HB1' ' HA ' ' A' ' 116' ' ' TYR . . . -119.14 161.19 20.73 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.291 1.036 . . . . 0.75 109.91 -173.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -68.82 -54.61 14.83 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.972 -0.751 . . . . 1.87 108.972 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.3 pt -114.3 135.96 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.527 0.731 . . . . 1.16 109.271 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.72 131.56 52.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.224 -1.028 . . . . 2.19 108.224 172.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.32 124.54 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 106.937 -1.505 . . . . 0.83 106.937 169.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.9 t -98.51 137.84 24.85 Favored 'Isoleucine or valine' 0 C--N 1.346 0.422 0 C-N-CA 125.049 1.339 . . . . 1.22 108.92 171.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -130.26 107.56 9.37 Favored 'General case' 0 C--N 1.335 -0.054 0 N-CA-C 106.569 -1.641 . . . . 5.34 106.569 171.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -123.26 154.42 38.84 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.51 0.672 . . . . 0.77 112.35 -173.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -92.17 70.01 5.28 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.792 0.837 . . . . 6.2 109.66 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 95.13 -150.33 19.65 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.66 -0.976 . . . . 2.6 110.66 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.55 81.3 3.23 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.96 -0.729 . . . . 2.89 112.107 -162.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.541 0.623 0 C-N-CA 124.876 1.27 . . . . 2.59 112.561 173.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.146 0 CA-C-O 119.658 -0.21 . . . . 3.92 111.333 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -110.09 166.54 10.87 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 122.933 0.493 . . . . 6.46 110.085 166.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -172.92 164.94 5.1 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 127.389 2.276 . . . . 3.89 106.539 -170.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -72.39 -143.35 0.47 Allowed Glycine 0 CA--C 1.525 0.68 0 O-C-N 123.969 0.793 . . . . 1.76 111.344 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -61.73 108.15 0.95 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.392 0.677 . . . . 5.17 110.795 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.24 -145.68 18.11 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.679 -1.368 . . . . 1.71 109.679 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 45.44 -126.93 8.02 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 126.136 1.827 . . . . 1.58 111.706 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.3 mm -79.99 144.0 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-O 122.218 1.008 . . . . 1.99 108.702 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.0 mp -84.23 -62.04 1.66 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.576 1.95 . . . . 1.04 109.445 170.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -159.56 158.4 31.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 120.637 -1.29 . . . . 0.53 110.151 -172.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -144.06 135.52 25.83 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 114.247 1.202 . . . . 1.22 114.247 172.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' A' ' 222' ' ' HIS . . . -149.43 164.04 36.09 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.264 2.226 . . . . 0.54 107.8 -169.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -150.05 143.49 25.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.09 -0.707 . . . . 3.03 109.09 -173.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -87.11 -130.18 2.94 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.789 -1.006 . . . . 0.63 110.665 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.09 105.21 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.54 2.16 . . . . 2.51 110.56 -173.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -167.36 168.05 40.26 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 107.56 -2.216 . . . . 1.1 107.56 176.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.5 m -78.16 167.65 21.08 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.42 0.629 . . . . 2.04 111.659 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 53.59 -111.78 2.05 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.173 0.892 . . . . 1.22 112.165 173.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.5 tp -60.55 -37.26 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 118.239 -0.886 . . . . 1.34 109.61 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -32.58 131.42 0.25 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.176 1.37 . . . . 0.96 113.199 173.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.08 -48.89 1.18 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.58 1.562 . . . . 0.64 111.171 -165.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.45 153.13 23.55 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.537 -0.912 . . . . 1.3 108.537 -161.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.39 120.57 30.16 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 118.001 -0.999 . . . . 0.61 112.274 -172.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.47 129.51 56.53 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-N 119.213 0.915 . . . . 2.36 110.123 -166.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.419 ' CE2' ' HG3' ' A' ' 219' ' ' GLU . 25.2 m-85 -121.63 150.72 41.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 118.736 0.698 . . . . 2.84 110.252 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -79.55 77.73 6.12 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 122.082 0.944 . . . . 3.6 111.962 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -48.06 -33.43 8.07 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 119.971 -1.706 . . . . 2.75 111.506 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -36.32 -47.8 0.61 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.773 1.229 . . . . 2.65 112.004 171.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -73.81 170.18 15.86 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.09 1.356 . . . . 1.77 111.0 -175.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -107.41 94.03 4.87 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.885 -1.524 . . . . 2.63 106.885 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -82.83 151.46 26.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.587 -0.733 . . . . 1.4 109.652 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.99 161.99 29.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.725 0.774 . . . . 2.23 110.836 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.39 -41.02 70.18 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.401 2.28 . . . . 1.7 111.684 169.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -80.37 157.79 26.22 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.533 -0.758 . . . . 2.32 110.358 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.8 m -70.58 -33.67 71.34 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.175 1.39 . . . . 4.78 111.622 -170.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.69 116.3 8.43 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-O 118.402 -1.221 . . . . 2.59 110.244 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 109.18 -121.02 6.0 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 107.812 -2.115 . . . . 1.31 107.812 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.4 m -124.72 138.66 54.28 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.681 -1.229 . . . . 0.77 107.681 159.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.27 116.44 29.01 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.83 -0.623 . . . . 2.18 109.864 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.74 -56.43 10.28 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.268 0.627 . . . . 1.44 109.706 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.583 ' O ' HG23 ' A' ' 217' ' ' VAL . 43.3 t80 -43.15 -50.87 6.19 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.515 1.526 . . . . 1.54 111.892 176.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.412 ' C ' HD23 ' A' ' 214' ' ' LEU . 6.0 tt -62.37 -58.12 8.84 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.61 -0.515 . . . . 1.45 109.61 -172.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.291 6.1 m -58.16 -41.47 83.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.948 -0.301 . . . . 0.77 110.649 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.79 -49.64 57.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.619 -0.705 . . . . 0.42 111.009 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 213' ' ' PHE . 58.3 t -57.28 -44.76 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 119.533 1.06 . . . . 0.81 111.098 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.754 ' NE2' ' CE1' ' A' ' 222' ' ' HIS . 1.0 OUTLIER -57.1 -50.22 73.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.522 1.129 . . . . 2.52 111.948 172.631 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.419 ' HG3' ' CE2' ' A' ' 197' ' ' PHE . 15.0 mm-40 -71.16 -46.93 60.48 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.457 -0.777 . . . . 2.63 112.385 -174.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.11 -39.29 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 107.48 -1.304 . . . . 1.09 107.48 170.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.05 -56.92 5.73 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 123.659 0.647 . . . . 0.46 112.919 164.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.754 ' CE1' ' NE2' ' A' ' 218' ' ' HIS 0.266 0.3 OUTLIER -49.94 -46.62 52.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.781 0.79 . . . . 1.68 110.904 178.258 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.2 t -51.94 -38.05 54.99 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 123.491 0.494 . . . . 2.31 112.275 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 mt -70.91 -59.35 2.84 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 107.528 -1.286 . . . . 2.16 107.528 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 139.44 104.11 0.59 Allowed Glycine 0 C--N 1.337 0.611 0 N-CA-C 110.016 -1.234 . . . . 1.7 110.016 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.807 HD12 ' H ' ' A' ' 228' ' ' HIS . 3.1 pp -130.73 145.42 51.94 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.52 0.728 . . . . 5.38 111.847 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -101.06 28.34 16.48 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.65 1.119 . . . . 3.14 112.456 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.807 ' H ' HD12 ' A' ' 226' ' ' LEU . 32.7 m80 57.39 102.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.393 2.677 . . . . 2.09 112.698 -176.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 7.1 m -72.29 170.12 14.79 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.229 -0.656 . . . . 1.1 109.229 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.2 m -140.72 44.33 1.83 Allowed 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.472 -0.768 . . . . 2.32 110.268 -171.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -143.18 132.08 11.52 Favored Pre-proline 0 N--CA 1.447 -0.614 0 N-CA-C 106.977 -1.49 . . . . 1.75 106.977 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.56 -14.82 27.62 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.972 1.781 . . . . 1.63 114.153 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -72.13 -23.61 61.33 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.475 1.034 . . . . 1.5 110.269 171.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.53 ' HB1' ' OD1' ' A' ' 254' ' ' ASP . . . -76.31 158.03 31.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.357 0.599 . . . . 1.17 110.607 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.421 HG11 ' CG1' ' A' ' 217' ' ' VAL . 45.2 t -110.99 -25.98 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.302 1.441 . . . . 0.79 111.074 173.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.546 ' HE3' HD23 ' A' ' 226' ' ' LEU . 52.6 mmm -65.92 -11.86 50.35 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.158 -0.964 . . . . 2.96 111.759 173.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.57 159.35 3.45 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.788 1.635 . . . . 3.61 113.959 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.25 -17.86 7.59 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.92 2.413 . . . . 0.97 111.524 170.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.3 0.2 OUTLIER -77.21 176.06 9.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.737 1.215 . . . . 1.81 108.776 179.063 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.406 ' CE2' HD13 ' A' ' 214' ' ' LEU . 51.2 t80 -143.19 141.27 31.08 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 104.568 -2.382 . . . . 2.51 104.568 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -156.24 145.21 20.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 104.873 -2.269 . . . . 4.32 104.873 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -49.04 109.59 0.27 Allowed 'General case' 0 C--N 1.339 0.118 0 N-CA-C 108.157 -1.053 . . . . 2.62 108.157 168.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.91 149.06 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 123.908 0.883 . . . . 1.75 108.891 171.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -60.0 78.5 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.496 2.318 . . . . 5.97 111.236 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 39.0 mm -44.95 -35.12 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.864 1.266 . . . . 3.81 110.794 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -55.06 -64.76 0.74 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.179 0.807 . . . . 4.59 113.179 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 92.7 m -82.22 -51.18 8.19 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.676 -0.861 . . . . 2.42 108.676 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 217' ' ' VAL . 29.2 t80 38.8 72.9 0.12 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.645 1.978 . . . . 7.25 113.083 174.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.75 159.29 15.9 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.266 -0.879 . . . . 4.93 109.532 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.691 HD12 ' CH2' ' A' ' 141' ' ' TRP . 1.6 mm? -85.91 143.88 27.97 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.543 -0.91 . . . . 1.02 108.543 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.0 m -76.63 156.14 32.93 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 110.572 -0.158 . . . . 0.74 110.572 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.87 80.88 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.783 -0.451 . . . . 0.91 109.783 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.15 -57.68 6.27 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 122.261 1.029 . . . . 2.6 109.699 174.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.53 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 12.1 m-20 -59.11 -39.61 82.81 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.563 -1.199 . . . . 2.22 112.266 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 35.5 mt -55.47 -35.14 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 119.114 0.87 . . . . 1.01 110.047 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -66.51 -53.31 36.43 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.468 -0.77 . . . . 4.42 110.014 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -50.77 -54.78 20.43 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 123.077 0.37 . . . . 1.29 112.532 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.87 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 2.6 pp -60.48 -43.35 94.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 121.851 -0.793 . . . . 2.24 110.462 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.411 ' HG2' HD12 ' A' ' 258' ' ' ILE . 2.2 mt-30 -67.03 -17.17 64.79 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.66 1.118 . . . . 2.56 112.243 174.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.1 t -66.12 -11.66 50.5 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.246 -1.359 . . . . 2.61 113.407 167.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.626 HD13 ' O ' ' A' ' 261' ' ' LEU 0.293 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.084 0 CA-C-N 120.66 1.573 . . . . 3.83 110.162 172.297 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.0 mptt . . . . . 0 CA--C 1.534 0.35 0 N-CA-C 108.477 -0.935 . . . . 5.56 108.477 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 67.38 -61.14 0.36 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.16 1.784 . . . . 3.75 110.283 -168.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -113.25 130.16 56.32 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 125.848 1.659 . . . . 2.87 109.72 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.8 mt -138.45 105.51 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 123.54 0.525 . . . . 2.58 110.499 173.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 p -101.57 145.82 28.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.474 1.109 . . . . 1.19 110.914 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.411 ' CZ ' ' CE1' ' A' ' 138' ' ' PHE . 6.8 m-85 -127.1 150.11 49.63 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.305 0.642 . . . . 5.84 110.58 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -138.59 142.13 39.18 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.122 0.569 . . . . 4.8 109.822 174.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.405 HD11 ' HE2' ' A' ' 151' ' ' LYS . 2.7 mt -99.8 151.71 4.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.936 -1.135 . . . . 1.01 107.936 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -91.92 -56.5 3.06 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.001 -1.111 . . . . 4.02 108.001 177.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -144.01 157.86 44.07 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 124.959 1.304 . . . . 2.79 108.78 -171.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -112.75 143.86 43.25 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.659 1.184 . . . . 2.24 108.985 -169.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.537 HG22 ' H ' ' A' ' 125' ' ' MET . 0.8 OUTLIER -75.31 127.21 86.75 Favored Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 108.528 -0.916 . . . . 2.51 108.528 179.511 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.26 -18.13 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.13 2.553 . . . . 1.67 112.033 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.98 -46.79 64.99 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 118.983 0.811 . . . . 2.23 109.609 174.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.537 ' H ' HG22 ' A' ' 122' ' ' THR . 50.8 mtm -105.96 174.26 5.96 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.836 -1.075 . . . . 2.06 109.009 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -80.76 135.11 35.93 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.228 -1.027 . . . . 2.92 108.228 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -45.76 -52.24 11.4 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 118.673 0.669 . . . . 3.02 111.97 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -51.68 -46.87 63.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.482 -0.487 . . . . 3.87 109.731 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.43 -39.96 92.74 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.465 1.506 . . . . 1.89 111.541 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.8 t -56.04 -56.5 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.205 -1.035 . . . . 1.26 108.205 175.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.8 -22.88 61.51 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.026 -1.07 . . . . 1.73 110.312 -176.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -67.9 -49.33 62.56 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.24 1.016 . . . . 2.18 109.194 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.44 -54.74 36.69 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 123.71 0.804 . . . . 0.44 109.213 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -68.0 -34.71 68.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 120.212 -0.595 . . . . 2.33 110.356 -176.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -56.45 -60.47 3.48 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 108.191 -1.04 . . . . 4.0 108.191 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -62.65 -42.9 99.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.592 1.557 . . . . 1.45 108.78 -172.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.38 -54.16 18.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.728 0.811 . . . . 0.52 110.328 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.556 ' CE1' HG23 ' A' ' 220' ' ' ILE . 4.0 m-85 -58.84 -51.91 68.01 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 118.886 -0.578 . . . . 4.51 110.999 171.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.42 -33.5 21.06 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.745 0.646 . . . . 2.16 112.745 -174.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.762 HG12 HD21 ' A' ' 250' ' ' LEU . 77.8 t -69.21 -47.32 74.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.583 0.753 . . . . 1.11 110.468 175.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.969 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 7.1 m95 -69.78 -32.4 70.86 Favored 'General case' 0 N--CA 1.456 -0.155 0 O-C-N 120.631 -1.293 . . . . 0.84 110.638 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.47 -11.08 60.34 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.1 1.36 . . . . 1.22 110.778 176.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.63 -45.37 17.38 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 107.809 -1.182 . . . . 1.4 107.809 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.0 m -84.07 -45.64 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 112.473 0.546 . . . . 1.5 112.473 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.775 HG22 HD13 ' A' ' 258' ' ' ILE . 19.9 p -78.86 150.8 75.84 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 107.768 -1.197 . . . . 0.74 107.768 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -72.96 1.91 6.02 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 121.971 1.781 . . . . 1.09 112.678 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.1 mt -69.6 142.14 53.59 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.384 1.474 . . . . 2.05 109.274 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 103.0 12.62 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.749 -0.834 . . . . 3.81 108.749 174.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.547 ' CD2' ' HB3' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -67.96 146.3 53.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.551 0.74 . . . . 6.98 110.917 176.315 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.7 t -152.44 95.15 2.0 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.638 0.653 . . . . 0.88 111.964 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.405 ' HE2' HD11 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -76.92 133.81 39.13 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 120.583 -1.323 . . . . 3.0 108.41 171.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.4 pp -130.56 174.38 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.392 -1.707 . . . . 1.77 106.392 171.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -134.14 21.24 3.76 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 121.613 -0.679 . . . . 3.47 109.525 172.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 85.5 m -157.03 117.16 3.51 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.071 -1.455 . . . . 2.21 107.071 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 121.34 -144.63 16.72 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 108.209 -1.956 . . . . 1.95 108.209 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 33.0 mtt -110.11 139.11 45.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.982 1.313 . . . . 4.18 109.43 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -127.23 159.74 33.39 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.241 1.416 . . . . 0.99 109.809 173.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.42 -54.45 6.71 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.054 -1.462 . . . . 2.53 107.054 168.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.58 151.58 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 122.397 1.094 . . . . 1.69 111.253 -168.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.7 mt -126.08 125.01 41.87 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 112.398 -2.183 . . . . 2.25 107.876 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 38.0 t -91.87 105.43 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.934 -1.136 . . . . 0.96 107.934 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 62.2 t -110.8 102.88 14.61 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 C-N-CA 123.916 0.887 . . . . 1.79 109.237 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -80.61 155.98 26.62 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.955 -1.128 . . . . 6.57 107.955 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -158.16 -173.49 4.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.176 0.444 . . . . 1.08 110.199 167.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -129.5 145.89 51.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.296 1.039 . . . . 4.28 108.876 170.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.4 -126.24 19.15 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.354 0.978 . . . . 1.97 111.987 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.38 132.92 37.57 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.301 1.04 . . . . 2.34 109.677 -173.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' A' ' 168' ' ' HIS 0.255 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.571 0 CA-C-O 123.277 1.513 . . . . 3.41 111.193 179.266 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.401 0 CA-C-O 118.173 -0.917 . . . . 2.22 111.234 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.407 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 39.5 t80 -92.08 156.03 17.66 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 122.434 1.111 . . . . 7.68 110.318 175.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 35.9 p30 -166.02 30.48 0.05 OUTLIER 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.774 -1.557 . . . . 3.52 110.127 -152.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 84.63 172.06 48.72 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.435 -0.666 . . . . 2.34 111.435 -172.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.94 124.99 18.45 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.631 -0.507 . . . . 3.74 109.631 167.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 97.08 -154.67 20.55 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.283 -1.127 . . . . 2.07 110.283 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 57.61 -122.94 31.11 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 109.451 -1.459 . . . . 1.8 109.451 -173.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.6 mm -75.93 128.79 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 105.961 -1.866 . . . . 1.77 105.961 168.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.3 mp -81.08 -50.67 9.36 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.008 -0.738 . . . . 1.28 109.008 172.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -161.71 163.61 29.59 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.369 0.268 . . . . 0.55 110.328 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -142.82 112.41 6.83 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.321 1.448 . . . . 1.25 113.691 -169.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -146.75 162.0 39.46 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 127.443 2.297 . . . . 0.78 107.166 -175.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.86 151.83 16.78 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.801 -0.814 . . . . 5.77 108.801 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -102.5 -84.42 1.8 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.61 1.1 . . . . 0.82 110.486 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.62 94.46 0.61 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.806 3.004 . . . . 1.3 110.625 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -163.91 154.75 25.79 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 108.412 -1.875 . . . . 0.94 108.412 170.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.7 m -78.44 170.28 16.9 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.418 -0.586 . . . . 2.44 109.418 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 72.19 -118.81 6.99 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.517 -1.433 . . . . 1.99 109.517 -175.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . 0.266 3.5 tp -84.92 21.71 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 124.304 1.041 . . . . 3.44 112.723 -168.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -55.46 143.32 35.23 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 120.891 -1.131 . . . . 1.89 114.231 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 94.04 -32.67 5.73 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.572 1.082 . . . . 0.9 111.111 -173.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.28 158.97 18.31 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.666 0.733 . . . . 1.6 109.423 -158.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -142.71 127.15 17.79 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.114 0.783 . . . . 0.82 113.114 -157.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -117.8 131.51 56.56 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 117.94 -1.029 . . . . 2.38 110.673 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -113.54 152.17 30.6 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.561 0.696 . . . . 6.33 111.556 167.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.19 85.08 0.75 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.773 -1.103 . . . . 2.79 108.529 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -60.91 -31.74 71.23 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.4 -1.438 . . . . 2.53 111.029 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -47.62 -42.3 23.86 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.304 0.573 . . . . 2.73 110.517 172.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.36 135.34 51.66 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.486 -1.301 . . . . 2.13 107.486 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -88.27 94.85 9.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.195 -1.78 . . . . 2.64 106.195 -174.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -76.12 138.05 40.5 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.663 -1.606 . . . . 1.15 106.663 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 35.9 p -118.01 124.08 47.27 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.024 -1.843 . . . . 1.77 106.024 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.1 t -51.91 -46.5 64.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 121.657 2.026 . . . . 1.89 110.452 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.92 132.67 47.19 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.229 -0.896 . . . . 2.83 109.768 167.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 11.1 p -39.82 -57.08 1.64 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.693 1.597 . . . . 3.68 110.744 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 18.95 -88.9 0.01 OUTLIER Glycine 0 CA--C 1.524 0.622 0 C-N-CA 128.564 2.983 . . . . 2.45 115.406 163.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -81.97 -80.22 0.93 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.811 -1.716 . . . . 1.03 108.811 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.3 m -150.95 111.2 4.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.048 -1.093 . . . . 1.01 108.048 170.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -61.33 117.81 6.12 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.35 0.66 . . . . 1.52 110.822 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 46.0 tp -53.69 -48.25 69.71 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 119.298 -0.382 . . . . 1.85 110.089 178.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.444 ' O ' HG23 ' A' ' 217' ' ' VAL . 31.4 t80 -49.68 -42.91 46.75 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.993 0.517 . . . . 1.45 111.152 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.44 ' C ' HD23 ' A' ' 214' ' ' LEU . 9.3 tt -60.34 -59.44 5.41 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.041 0.937 . . . . 1.33 110.32 -176.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.265 0.2 OUTLIER -61.77 -38.71 89.04 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.647 -0.252 . . . . 0.92 111.073 177.458 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.42 -56.67 16.36 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 117.954 -1.022 . . . . 0.44 109.343 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 213' ' ' PHE . 93.0 t -47.54 -42.6 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 119.996 1.271 . . . . 0.74 110.986 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.777 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 0.2 OUTLIER -59.92 -51.06 71.29 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.119 0.567 . . . . 2.84 111.263 175.365 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -64.53 -54.71 28.01 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 121.043 -1.036 . . . . 4.15 110.845 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.556 HG23 ' CE1' ' A' ' 138' ' ' PHE . 1.7 mp -49.34 -46.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 127.041 2.137 . . . . 1.27 109.247 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -58.5 -44.84 95.17 Favored Glycine 0 CA--C 1.534 1.261 0 O-C-N 121.482 -0.761 . . . . 0.6 111.506 172.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.777 ' NE2' ' NE2' ' A' ' 218' ' ' HIS 0.264 6.7 m-70 -51.94 -49.06 63.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.237 1.518 . . . . 1.29 110.855 171.733 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.3 m -55.42 -44.9 76.7 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.48 1.112 . . . . 2.22 111.482 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 93.3 mt -59.28 -52.55 65.17 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.565 -0.531 . . . . 2.72 109.565 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.473 ' O ' HD21 ' A' ' 261' ' ' LEU . . . 139.37 92.27 0.23 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.679 1.133 . . . . 1.23 111.585 170.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 1.077 HD11 HG22 ' A' ' 258' ' ' ILE . 2.6 mt -145.96 112.46 5.89 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.242 1.021 . . . . 3.22 111.57 -171.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -79.0 43.38 2.44 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.68 1.133 . . . . 2.67 113.664 -174.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 71.6 m80 60.73 175.28 0.1 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.689 1.596 . . . . 1.93 113.79 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 69.7 m -139.84 -178.73 5.56 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.903 2.081 . . . . 1.09 108.07 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 27.7 t -143.33 31.74 1.35 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.905 0.882 . . . . 2.95 111.128 -173.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -127.92 137.3 30.5 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 106.932 -1.507 . . . . 1.65 106.932 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.97 -11.72 14.91 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.39 2.06 . . . . 1.17 114.77 -173.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 233' ' ' LYS . 25.9 mtmt -81.96 -29.12 32.34 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.916 0.886 . . . . 1.29 109.274 168.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.95 151.87 45.99 Favored 'General case' 0 CA--C 1.519 -0.229 0 O-C-N 121.883 -0.511 . . . . 0.7 109.774 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 88.4 t -98.27 -24.29 4.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.508 0.723 . . . . 0.79 109.993 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.565 ' SD ' HD13 ' A' ' 226' ' ' LEU . 0.6 OUTLIER -63.84 -15.09 58.01 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 114.029 1.122 . . . . 1.79 114.029 177.768 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -49.65 154.77 1.58 Allowed Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 113.032 0.752 . . . . 3.31 113.032 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.27 -23.05 21.32 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.473 1.449 . . . . 1.15 111.638 172.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.291 0.6 OUTLIER -79.31 -178.6 6.31 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.497 1.519 . . . . 1.47 111.084 -179.542 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -116.64 155.61 28.49 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.894 1.678 . . . . 2.36 107.026 171.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.77 125.65 7.76 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.113 -1.069 . . . . 2.26 108.113 165.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -63.37 125.69 24.98 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.066 0.946 . . . . 3.05 109.733 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 16.3 m -141.24 148.27 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 108.276 -1.009 . . . . 2.28 108.276 167.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.67 127.96 33.98 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.993 1.317 . . . . 3.63 110.239 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.7 pp -58.35 -28.52 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 122.604 0.361 . . . . 3.48 111.917 -173.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -76.6 -43.12 39.85 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 123.625 0.77 . . . . 5.47 111.942 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 91.1 m -80.55 -27.18 37.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.32 0.648 . . . . 2.56 109.628 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -26.13 113.72 0.05 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.869 2.068 . . . . 7.72 112.403 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.35 158.18 44.78 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.129 1.371 . . . . 3.79 109.078 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.762 HD21 HG12 ' A' ' 140' ' ' VAL . 1.8 mm? -83.44 146.28 28.51 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.853 -1.166 . . . . 0.96 107.853 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.0 m -79.48 152.61 30.14 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 119.705 -0.188 . . . . 0.72 111.304 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.17 -42.46 63.45 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.635 0.374 . . . . 0.79 110.857 172.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -50.0 -57.81 6.79 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 122.287 1.041 . . . . 2.7 109.681 172.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.93 -41.34 87.11 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.23 -1.35 . . . . 2.38 110.495 -176.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 80.0 mt -54.97 -40.12 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.351 1.46 . . . . 1.01 111.389 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -67.9 -44.64 76.5 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 120.694 -1.253 . . . . 4.37 110.22 174.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -46.65 -55.88 7.79 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.823 -0.911 . . . . 0.93 110.823 174.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 1.077 HG22 HD11 ' A' ' 226' ' ' LEU . 2.0 pp -64.62 -43.93 96.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 O-C-N 121.826 -0.808 . . . . 2.26 111.163 -175.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.603 ' N ' HD12 ' A' ' 258' ' ' ILE . 2.4 mt-30 -64.63 -18.41 64.9 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.628 0.649 . . . . 2.58 112.057 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.3 t -51.56 -33.11 30.97 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.738 0.699 . . . . 2.38 111.312 169.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 261' ' ' LEU . 16.2 mt . . . . . 0 C--N 1.346 0.438 0 CA-C-N 119.218 0.917 . . . . 2.71 112.802 172.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.5 mptt . . . . . 0 CA--C 1.528 0.12 0 N-CA-C 109.91 -0.404 . . . . 5.65 109.91 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 61.56 -63.07 0.09 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.908 1.283 . . . . 4.07 111.172 -159.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -77.8 99.68 6.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.41 0.55 . . . . 3.24 111.22 -170.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.8 mm -117.08 108.02 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.726 -0.842 . . . . 1.9 108.726 174.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.509 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 40.3 p -120.03 125.05 47.39 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 117.792 -1.099 . . . . 1.21 109.3 -176.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.57 159.23 24.75 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.626 1.17 . . . . 3.86 112.24 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -133.91 149.43 51.29 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.071 0.948 . . . . 5.55 109.362 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.8 mt -107.03 137.68 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.466 1.506 . . . . 1.16 107.271 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -98.22 -45.26 6.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.989 0.359 . . . . 2.72 110.423 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -143.32 161.99 36.87 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.794 -0.817 . . . . 2.22 108.794 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -127.41 134.15 49.92 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.47 -1.678 . . . . 2.82 106.47 -165.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.7 t -70.39 115.53 35.78 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 118.797 0.726 . . . . 2.6 109.754 -173.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.99 -17.05 51.06 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 124.006 3.137 . . . . 1.61 111.719 -173.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -33.15 -41.14 0.07 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.416 2.686 . . . . 2.12 112.074 170.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -133.94 -179.88 5.82 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.1 0.96 . . . . 2.25 109.581 171.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -66.09 131.83 47.09 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.451 -0.944 . . . . 3.26 108.451 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -44.4 -45.06 8.77 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.063 0.394 . . . . 2.98 112.063 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -46.86 -47.61 21.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.553 0.692 . . . . 3.57 109.437 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.34 -39.05 78.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.434 -0.803 . . . . 2.06 111.709 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 80.7 t -58.08 -54.28 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 O-C-N 121.6 -0.687 . . . . 1.26 109.264 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.14 -25.76 67.12 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 118.02 -1.472 . . . . 1.69 109.294 177.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -66.13 -44.91 82.88 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 120.271 1.396 . . . . 1.9 110.207 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.75 -52.87 61.16 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.77 0.828 . . . . 0.39 110.048 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.67 -34.65 66.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 120.488 -0.485 . . . . 1.84 109.742 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.87 -57.01 14.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.604 1.192 . . . . 4.08 108.154 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.518 ' O ' HG23 ' A' ' 140' ' ' VAL . 6.8 mmmm -58.27 -49.01 78.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.997 -1.001 . . . . 1.66 108.765 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -44.69 -54.66 5.99 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.106 0.963 . . . . 0.52 112.52 175.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.425 ' HA ' HG21 ' A' ' 220' ' ' ILE . 2.1 p90 -62.38 -46.21 89.66 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 118.989 -1.084 . . . . 6.58 110.774 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.36 -42.31 73.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 123.316 0.385 . . . . 3.89 110.131 -173.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.629 HG12 HD21 ' A' ' 250' ' ' LEU . 1.4 t -54.01 -52.06 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 120.812 0.339 . . . . 1.34 110.088 -176.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.515 ' CZ3' ' HG ' ' A' ' 250' ' ' LEU . 67.3 m95 -71.9 -44.3 63.94 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.906 -0.775 . . . . 0.69 108.906 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.4 t -57.29 -26.78 61.4 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.985 0.514 . . . . 1.22 111.198 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -39.44 89.7 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 122.743 0.417 . . . . 1.67 110.881 175.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 81.1 t -82.88 -55.44 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.932 1.293 . . . . 2.27 109.61 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 43.6 p -84.92 150.55 55.91 Favored Pre-proline 0 N--CA 1.447 -0.577 0 C-N-CA 123.166 0.586 . . . . 0.79 109.93 -172.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.96 8.13 1.79 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 121.509 1.472 . . . . 0.85 112.949 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.69 111.95 12.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.326 1.05 . . . . 2.43 108.471 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.62 86.16 3.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.418 -1.327 . . . . 3.76 107.418 175.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -67.57 128.96 38.38 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.082 -0.963 . . . . 5.7 109.423 170.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.97 134.65 38.82 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 123.964 0.906 . . . . 0.85 110.162 172.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -92.84 127.22 38.27 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 107.605 -1.257 . . . . 2.11 107.605 173.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.7 pt -130.81 101.19 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.924 -1.139 . . . . 1.73 107.924 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -91.75 27.04 2.17 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.673 -0.642 . . . . 3.36 111.1 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.94 78.86 1.41 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.89 1.276 . . . . 2.5 110.096 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 150.32 -132.29 3.9 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 108.697 -1.761 . . . . 1.49 108.697 171.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.1 mtt -128.55 144.86 51.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.851 1.66 . . . . 5.09 107.678 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.509 ' HB1' ' O ' ' A' ' 115' ' ' THR . . . -126.52 172.66 10.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.85 1.66 . . . . 0.74 109.534 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.73 -57.38 3.7 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.089 0.956 . . . . 1.92 108.982 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.3 pt -105.17 152.6 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.154 -0.93 . . . . 1.17 108.877 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 tt -131.11 130.34 43.02 Favored 'General case' 0 CA--C 1.523 -0.075 0 N-CA-C 113.31 0.856 . . . . 2.17 113.31 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.23 102.68 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.827 -0.805 . . . . 0.83 108.827 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.2 t -93.57 131.29 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.814 2.046 . . . . 1.37 108.813 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -129.12 112.92 14.47 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 105.641 -1.985 . . . . 4.96 105.641 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -133.97 161.65 34.22 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 123.658 0.783 . . . . 0.94 110.978 -165.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.4 121.06 32.76 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.446 1.098 . . . . 6.38 110.629 -170.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 65.09 -70.49 0.08 OUTLIER Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.543 -1.143 . . . . 1.84 112.216 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.28 163.98 13.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.148 1.474 . . . . 2.42 110.62 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 4.0 p80 . . . . . 0 CA--C 1.531 0.231 0 C-N-CA 123.511 0.724 . . . . 3.1 109.887 164.162 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 114.219 1.192 . . . . 2.48 114.219 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 2.8 t80 -121.96 161.41 22.93 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.858 1.208 . . . . 7.46 107.771 165.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.43 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 40.7 p-10 -164.32 24.46 0.07 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 113.519 -1.673 . . . . 2.73 110.002 -148.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 86.08 171.34 47.85 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 122.157 0.865 . . . . 1.44 111.79 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -72.21 100.86 2.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.658 -0.771 . . . . 4.72 109.34 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 131.13 -161.84 23.56 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.64 -1.784 . . . . 1.36 108.64 -167.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.68 -121.94 24.97 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.547 -1.421 . . . . 1.27 109.547 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 180' ' ' ILE 0.396 1.8 tp -78.47 140.06 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.361 -1.348 . . . . 1.7 107.361 175.439 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.41 -55.67 4.36 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.769 -0.826 . . . . 1.65 108.769 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -169.99 179.87 3.44 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.948 0.899 . . . . 0.85 110.09 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.54 143.41 51.18 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 125.955 1.702 . . . . 2.18 111.896 -176.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -161.71 159.17 26.97 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.207 -1.405 . . . . 0.77 107.207 164.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.5 143.82 15.06 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.75 -1.574 . . . . 4.17 106.75 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.08 -86.6 1.71 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.025 -1.23 . . . . 0.56 110.025 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.64 99.38 0.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.254 2.636 . . . . 1.27 110.915 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -175.39 165.11 35.85 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.064 -1.615 . . . . 0.96 109.064 172.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.68 168.7 16.04 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.164 0.586 . . . . 2.72 109.868 172.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 55.48 -105.79 0.47 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.01 0.814 . . . . 1.45 111.827 173.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.7 tp -64.2 -23.28 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.44 0.696 . . . . 1.66 111.002 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -49.4 143.34 9.74 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.854 -0.898 . . . . 0.96 110.854 170.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 84.2 -36.07 2.93 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.253 0.93 . . . . 0.61 112.358 -169.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -76.73 178.4 6.81 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.068 1.434 . . . . 1.27 110.681 -166.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -153.02 133.81 13.89 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.266 -2.494 . . . . 0.88 104.266 -165.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.457 ' CD2' ' C ' ' A' ' 196' ' ' HIS 0.315 14.3 t-80 -155.07 85.16 1.08 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 117.199 -1.8 . . . . 5.07 112.489 -133.892 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -103.67 147.16 27.57 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.244 1.018 . . . . 2.74 112.16 -158.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.87 81.03 0.46 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.022 1.329 . . . . 2.79 109.58 173.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -53.72 -50.04 66.78 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.068 -1.645 . . . . 3.03 111.329 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -51.0 -26.15 5.66 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.293 0.637 . . . . 3.4 111.674 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -68.43 153.06 44.49 Favored 'General case' 0 C--O 1.243 0.754 0 O-C-N 120.607 -1.308 . . . . 1.91 109.445 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -97.33 90.14 4.99 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.627 -1.99 . . . . 3.01 105.627 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -77.57 161.79 27.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.12 -1.067 . . . . 1.38 108.12 -177.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 56.7 p -132.75 141.88 48.75 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 122.088 0.946 . . . . 2.09 111.19 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.7 t -60.66 -40.32 91.63 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.607 1.563 . . . . 1.92 111.789 163.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -79.55 -177.08 5.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.607 1.163 . . . . 2.74 111.496 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 41.6 t -72.89 -50.95 20.65 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.831 0.852 . . . . 4.74 110.77 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -55.07 112.71 3.06 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.853 0.74 . . . . 2.67 112.724 -167.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 108.4 -121.28 6.23 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 107.634 -2.186 . . . . 1.78 107.634 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.7 m -119.35 130.56 55.42 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.666 -1.605 . . . . 1.24 106.666 168.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -89.48 118.9 29.47 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 109.211 -0.663 . . . . 1.26 109.211 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.98 -53.96 23.12 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 122.988 0.515 . . . . 1.54 109.808 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -54.98 -45.01 74.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.18 0.592 . . . . 2.03 110.67 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.7 tt -62.29 -58.83 6.26 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.745 -0.597 . . . . 1.29 109.854 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.315 2.2 m -59.2 -33.13 70.6 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.522 -0.471 . . . . 0.72 110.922 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.0 -45.77 86.31 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.281 -0.887 . . . . 0.56 110.898 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 89.0 t -55.05 -48.47 75.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 120.044 1.293 . . . . 0.71 110.263 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.681 ' CE1' ' O ' ' A' ' 237' ' ' PHE . 0.3 OUTLIER -52.32 -53.06 49.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.478 1.511 . . . . 2.84 111.532 172.09 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -68.44 -53.14 25.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 119.159 0.89 . . . . 3.72 113.362 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.425 HG21 ' HA ' ' A' ' 138' ' ' PHE . 1.5 mp -56.01 -41.61 68.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 108.604 -0.887 . . . . 1.11 108.604 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.77 -48.44 78.01 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 111.289 -0.724 . . . . 0.62 111.289 173.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -57.65 -45.72 85.12 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.295 -1.121 . . . . 2.14 111.209 175.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.7 t -54.98 -56.71 16.71 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.479 1.112 . . . . 1.77 110.94 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.6 pp -62.39 -34.69 77.22 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.323 -0.551 . . . . 2.75 111.779 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 146.35 107.79 0.53 Allowed Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.18 -1.168 . . . . 2.67 110.18 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 226' ' ' LEU . 0.9 OUTLIER -75.69 160.89 29.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 122.984 0.514 . . . . 7.11 111.923 176.587 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.22 42.69 0.84 Allowed Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.572 -1.411 . . . . 3.76 109.572 167.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -0.88 93.22 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.189 2.596 . . . . 2.22 116.139 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.8 m -74.89 171.03 14.76 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.351 0.66 . . . . 1.53 110.495 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 9.5 p -124.66 5.62 8.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.321 1.849 . . . . 3.0 111.216 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -96.75 128.0 37.42 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 125.134 1.374 . . . . 1.96 108.532 -172.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -62.55 -14.21 38.22 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.992 2.462 . . . . 1.75 113.614 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -80.11 -34.16 38.09 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.952 0.901 . . . . 2.22 110.279 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.68 136.41 39.11 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.68 -0.859 . . . . 0.76 108.68 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 45.8 t -85.55 -21.24 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 122.414 0.285 . . . . 0.59 110.345 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -21.79 59.77 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 113.945 1.091 . . . . 1.91 113.945 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.681 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -49.48 173.15 0.08 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.56 2.344 . . . . 3.32 114.533 -173.087 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -90.24 -22.1 0.82 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.759 1.639 . . . . 1.36 111.685 166.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.293 0.7 OUTLIER -86.94 100.73 12.8 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.78 1.232 . . . . 2.5 110.696 -170.264 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . 0.329 31.5 t80 -73.63 133.24 43.42 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.036 0.834 . . . . 2.3 108.992 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.56 145.99 21.92 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.82 -1.548 . . . . 2.78 106.82 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -53.37 127.36 24.54 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.981 0.912 . . . . 3.43 111.726 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 31.7 m -98.86 146.55 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.708 0.633 . . . . 1.88 112.708 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -74.54 77.92 1.96 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.878 0.847 . . . . 5.21 111.002 175.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 17.8 mm -54.2 -22.46 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.875 -0.602 . . . . 4.12 111.498 168.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -43.57 -48.69 7.57 Favored 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 123.192 0.597 . . . . 4.23 112.115 167.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.5 m -84.71 -41.78 15.9 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.134 0.574 . . . . 2.17 110.387 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 60.0 t80 58.5 76.24 0.35 Allowed 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.614 0.766 . . . . 4.34 109.778 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.84 174.82 14.41 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 121.58 -0.7 . . . . 3.7 109.715 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.629 HD21 HG12 ' A' ' 140' ' ' VAL . 0.7 OUTLIER -116.98 163.1 16.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.028 1.331 . . . . 0.77 108.459 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 63.5 m -81.09 147.39 30.13 Favored 'General case' 0 C--O 1.225 -0.213 0 O-C-N 122.154 -0.341 . . . . 0.74 111.816 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.86 -40.24 60.24 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 122.986 0.514 . . . . 1.12 110.833 169.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -51.44 -58.46 6.2 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.095 0.95 . . . . 2.61 109.781 171.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -58.02 -45.07 87.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.96 1.304 . . . . 2.09 110.482 -173.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 63.3 mt -46.76 -38.79 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.319 1.448 . . . . 1.39 111.222 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -68.3 -46.55 70.01 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.896 0.771 . . . . 4.9 111.205 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -57.14 -55.36 30.73 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 118.788 0.722 . . . . 1.46 111.504 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.457 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 2.2 pp -61.15 -39.66 83.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 122.938 0.495 . . . . 2.81 111.426 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -70.0 -22.54 63.11 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.042 0.837 . . . . 4.0 112.282 172.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.9 t -64.73 -10.75 29.7 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.303 -1.332 . . . . 2.38 113.66 176.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.62 ' O ' HD22 ' A' ' 261' ' ' LEU 0.36 0.0 OUTLIER . . . . . 0 CA--C 1.551 0.983 0 C-N-CA 125.682 1.593 . . . . 3.49 114.125 -176.621 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 110.355 -0.239 . . . . 5.37 110.355 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 65.52 -71.39 0.08 Allowed 'General case' 0 C--N 1.341 0.225 0 C-N-CA 125.916 1.686 . . . . 3.34 110.189 -173.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -103.96 122.46 45.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.846 0.859 . . . . 5.11 110.065 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.446 ' HB ' ' CD1' ' A' ' 149' ' ' PHE . 1.5 mm -106.69 88.72 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.016 -1.105 . . . . 1.86 108.016 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 p -78.21 131.86 37.33 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.846 -1.159 . . . . 1.29 108.897 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.401 ' CE2' ' HB2' ' A' ' 151' ' ' LYS . 51.3 p90 -125.73 164.46 20.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.144 0.978 . . . . 4.18 110.614 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.21 149.61 28.15 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.636 -0.875 . . . . 6.4 108.636 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.5 mt -89.28 150.5 3.7 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 N-CA-C 108.311 -0.996 . . . . 0.95 108.311 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -81.45 -55.31 4.78 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.604 -0.887 . . . . 2.87 108.604 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -151.25 176.27 11.38 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.782 0.833 . . . . 2.02 109.31 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -106.41 146.93 29.89 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.294 1.038 . . . . 2.23 109.859 -174.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.2 t -93.25 141.19 23.68 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 124.413 1.085 . . . . 2.17 108.353 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.79 -22.12 9.19 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.044 2.496 . . . . 1.57 111.308 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -29.85 -51.57 0.13 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.976 2.11 . . . . 2.21 113.013 172.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 11.3 mtm -131.29 170.51 14.52 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.934 1.294 . . . . 1.97 108.195 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -69.91 149.5 47.74 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.086 0.554 . . . . 3.08 109.578 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 29.0 ttt-85 -49.04 -44.95 42.09 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.265 0.626 . . . . 2.85 111.496 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.55 3.47 3.05 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.737 1.014 . . . . 2.99 113.737 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -112.12 -42.05 3.82 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 125.696 1.598 . . . . 1.96 109.635 164.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.8 t -51.74 -57.58 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.113 0.965 . . . . 1.25 109.538 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -21.68 60.58 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 118.986 -1.086 . . . . 1.68 109.414 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -65.57 -47.5 75.59 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.191 0.905 . . . . 1.94 109.844 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.15 -52.65 63.58 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.533 1.133 . . . . 0.49 109.191 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.695 HD11 HD11 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -69.39 -40.97 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 120.853 -0.339 . . . . 1.45 111.191 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -49.74 -58.82 4.58 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.518 -1.289 . . . . 4.24 107.518 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.624 ' O ' HG23 ' A' ' 140' ' ' VAL . 34.8 mmtm -59.12 -49.81 76.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.334 1.454 . . . . 2.63 110.5 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.72 -49.95 45.91 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.529 0.732 . . . . 0.81 111.329 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.687 ' CE2' HD12 ' A' ' 134' ' ' ILE . 31.2 m-85 -58.55 -54.04 51.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.309 0.576 . . . . 4.83 109.91 173.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -39.88 67.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.486 -0.779 . . . . 2.11 111.156 -172.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 136' ' ' LYS . 68.5 t -48.71 -64.24 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.772 1.229 . . . . 0.95 109.852 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.768 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 72.2 m95 -68.55 -35.28 77.2 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.693 -0.854 . . . . 1.16 108.693 -174.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.1 -16.78 63.86 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 123.708 0.63 . . . . 1.19 112.199 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -82.42 -47.88 11.75 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 108.384 -0.969 . . . . 1.37 108.384 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.8 m -74.39 -43.88 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 112.635 0.606 . . . . 1.62 112.635 -177.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 51.4 p -89.34 158.01 46.77 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 109.424 -0.584 . . . . 0.8 109.424 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.87 -0.95 9.18 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.431 2.088 . . . . 0.76 113.334 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.3 mt -59.91 141.31 55.71 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.259 1.424 . . . . 2.18 109.466 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -118.75 90.54 3.35 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.201 -1.037 . . . . 4.02 108.201 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.486 ' CD1' ' CD1' ' A' ' 138' ' ' PHE . 30.9 m-85 -70.03 143.73 52.44 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.03 -0.532 . . . . 5.91 109.969 173.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -151.88 130.74 12.48 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.553 0.615 . . . . 0.99 110.619 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.401 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 4.0 ttmt -86.54 138.67 31.53 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.064 -0.717 . . . . 2.36 109.064 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.481 ' O ' HD12 ' A' ' 152' ' ' ILE . 1.8 pp -140.72 98.53 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 118.224 0.466 . . . . 2.04 110.515 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -80.2 26.73 0.35 Allowed 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.291 -1.506 . . . . 3.14 110.708 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 45.5 p -154.07 78.08 1.1 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.157 0.983 . . . . 3.4 108.565 -171.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 145.87 -122.84 1.74 Allowed Glycine 0 C--N 1.335 0.513 0 N-CA-C 108.189 -1.965 . . . . 1.91 108.189 174.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -149.71 135.07 18.25 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.573 -1.269 . . . . 5.92 107.573 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -112.43 163.01 14.95 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.36 1.464 . . . . 0.73 110.141 -175.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -79.16 -44.72 21.37 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.991 0.9 . . . . 2.02 108.856 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.7 pt -112.91 166.44 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.832 0.825 . . . . 0.96 112.04 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.76 136.57 35.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.68 1.592 . . . . 2.22 109.272 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.2 t -79.49 138.76 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 107.375 -1.342 . . . . 1.25 107.375 166.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 73.7 t -108.25 139.42 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 106.923 -1.51 . . . . 1.31 106.923 164.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.91 137.9 51.9 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.656 -1.979 . . . . 6.26 105.656 172.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -158.41 157.7 32.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.55 0.614 . . . . 1.14 109.478 165.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -104.15 119.39 38.84 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.983 -1.118 . . . . 4.71 107.983 168.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 71.77 -170.99 48.27 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.74 -0.544 . . . . 2.07 111.74 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.66 78.35 3.31 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 122.011 -0.699 . . . . 3.27 110.92 -164.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.5 p80 . . . . . 0 N--CA 1.454 -0.239 0 C-N-CA 124.247 1.019 . . . . 3.7 113.36 -175.258 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 107.93 -1.137 . . . . 4.1 107.93 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -105.03 171.55 7.26 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 124.814 1.246 . . . . 6.03 108.302 164.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -161.72 162.27 29.65 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.314 1.446 . . . . 3.33 108.684 -172.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -65.82 -156.04 0.31 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.146 0.879 . . . . 1.34 112.726 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -56.15 106.91 0.31 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.592 0.757 . . . . 4.31 111.5 -171.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.59 -146.9 18.6 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.183 -1.567 . . . . 1.78 109.183 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.53 -126.32 24.21 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 125.342 1.448 . . . . 1.6 110.913 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.2 mm -76.99 130.66 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 122.488 1.137 . . . . 1.42 108.023 173.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.1 mp -84.37 -46.27 11.9 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.725 2.01 . . . . 1.39 110.11 170.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.508 ' HB1' ' HG3' ' A' ' 219' ' ' GLU . . . -168.37 172.55 8.31 Favored 'General case' 0 C--N 1.338 0.107 0 O-C-N 121.042 -1.036 . . . . 0.9 111.402 -176.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -158.33 139.59 13.33 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.092 0.957 . . . . 1.04 111.469 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -162.59 174.38 12.69 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.763 -1.199 . . . . 0.77 107.763 -174.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.59 151.43 18.69 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.26 -1.015 . . . . 6.36 108.26 -173.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -102.31 -79.34 1.38 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.201 -1.56 . . . . 0.7 109.201 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.24 177.6 6.41 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.986 2.457 . . . . 2.27 110.51 176.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 97.2 132.11 7.29 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 109.796 -1.322 . . . . 1.56 109.796 -175.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.3 p -77.92 150.78 34.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.538 0.735 . . . . 2.36 109.472 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.46 -132.2 10.61 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 108.04 -2.024 . . . . 1.85 108.04 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . 0.254 10.7 tp -62.94 -43.21 98.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 117.955 -1.022 . . . . 3.56 110.662 -171.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 31.15 130.36 0.0 OUTLIER Glycine 0 CA--C 1.544 1.879 0 C-N-CA 130.299 3.809 . . . . 1.69 119.063 164.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 84.83 -21.73 10.74 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.093 -1.828 . . . . 0.69 111.845 -175.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -84.7 148.85 26.17 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 124.638 1.175 . . . . 1.61 110.437 -169.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.42 124.56 36.57 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.5 0.556 . . . . 0.61 112.5 -162.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -114.25 108.34 16.81 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 117.208 -1.377 . . . . 2.11 110.199 -168.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.11 147.12 23.77 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 121.761 2.073 . . . . 2.58 110.119 172.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -70.16 99.45 1.5 Allowed 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 123.585 0.553 . . . . 2.74 109.891 176.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -14.59 61.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.217 -0.897 . . . . 3.08 110.896 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -57.66 -32.05 66.93 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 121.045 1.748 . . . . 2.62 109.498 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.61 170.12 15.86 Favored 'General case' 0 C--O 1.246 0.891 0 C-N-CA 125.044 1.337 . . . . 2.31 110.292 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -117.13 100.9 8.03 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.01 -1.107 . . . . 4.3 108.01 169.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.41 ' CH2' HG21 ' A' ' 215' ' ' THR . 35.4 m95 -78.33 146.23 34.84 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.637 -1.165 . . . . 1.43 109.305 174.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.3 p -120.47 138.58 53.74 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.732 0.813 . . . . 1.84 109.667 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -50.09 -49.48 51.44 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.745 1.218 . . . . 1.73 110.059 169.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -82.26 -178.47 7.05 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.034 1.334 . . . . 2.25 111.654 175.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.1 m -54.08 -58.12 8.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.343 1.457 . . . . 3.81 110.943 -172.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 43.02 -100.49 0.02 OUTLIER Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.312 1.434 . . . . 2.45 114.409 169.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -116.71 -70.67 0.44 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.536 -1.026 . . . . 1.14 110.536 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.72 177.65 7.47 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.702 -1.962 . . . . 1.39 105.702 169.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -132.92 130.97 40.33 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.924 0.784 . . . . 1.63 111.658 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -62.4 -48.97 77.37 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 108.358 -0.979 . . . . 1.8 108.358 -174.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.723 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.5 t80 -50.63 -50.37 54.53 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.665 -0.495 . . . . 1.5 109.665 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.419 ' C ' HD23 ' A' ' 214' ' ' LEU . 7.0 tt -58.65 -58.98 6.19 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.637 1.175 . . . . 1.54 109.366 -173.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.41 HG21 ' CH2' ' A' ' 203' ' ' TRP 0.317 6.7 m -58.86 -37.52 76.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.574 0.702 . . . . 0.77 110.784 176.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.39 -43.76 96.34 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 121.367 -0.833 . . . . 0.78 110.877 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 213' ' ' PHE . 44.1 t -52.84 -44.81 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.948 1.249 . . . . 1.08 109.93 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.546 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 6.4 t-160 -52.24 -58.55 6.28 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.956 1.303 . . . . 2.32 112.667 169.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.508 ' HG3' ' HB1' ' A' ' 182' ' ' ALA . 14.8 mm-40 -69.17 -33.89 74.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.93 1.085 . . . . 3.13 113.93 -174.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.695 HD11 HD11 ' A' ' 134' ' ' ILE . 0.4 OUTLIER -71.55 -37.85 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 107.282 -1.377 . . . . 1.48 107.282 175.832 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -52.01 -48.44 52.04 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 110.673 -0.971 . . . . 0.69 110.673 167.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.546 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 18.1 m170 -58.79 -44.75 90.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.908 -0.76 . . . . 2.87 111.265 174.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.6 t -54.0 -55.43 27.33 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.021 0.528 . . . . 1.76 111.823 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.2 pp -60.88 -33.72 73.52 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 118.697 -0.668 . . . . 3.18 112.415 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 114.57 102.99 2.48 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.105 -1.198 . . . . 1.5 110.105 172.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.48 HD11 ' CE1' ' A' ' 228' ' ' HIS . 1.8 pt? -108.3 167.17 10.21 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.088 1.144 . . . . 5.65 114.088 -175.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -113.2 11.94 24.19 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.411 1.005 . . . . 3.38 113.348 167.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.48 ' CE1' HD11 ' A' ' 226' ' ' LEU . 4.5 m80 64.53 98.87 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.904 1.682 . . . . 2.11 114.535 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.6 m -75.08 161.9 29.01 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.038 0.447 . . . . 1.3 110.44 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.1 p -122.11 11.46 10.2 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.406 1.482 . . . . 2.79 111.541 -165.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -119.25 138.57 26.48 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 125.463 1.505 . . . . 1.75 108.664 -169.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -80.81 -12.59 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.946 1.764 . . . . 1.29 114.992 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -75.23 -24.06 57.66 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 120.247 1.385 . . . . 1.45 110.128 172.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.539 ' HB1' ' CG ' ' A' ' 254' ' ' ASP . . . -71.77 167.85 19.05 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.941 1.296 . . . . 0.95 111.878 176.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.07 -26.14 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 125.668 1.587 . . . . 0.85 111.93 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.768 ' SD ' HG22 ' A' ' 258' ' ' ILE . 0.0 OUTLIER -62.9 -26.81 68.97 Favored 'General case' 0 C--O 1.245 0.818 0 O-C-N 120.54 -1.35 . . . . 2.74 112.235 176.209 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -48.22 177.1 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 130.249 3.419 . . . . 3.42 114.094 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -90.09 -18.4 1.41 Allowed 'Trans proline' 0 CA--C 1.537 0.634 0 CA-C-N 122.319 1.864 . . . . 1.46 112.13 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.36 0.2 OUTLIER -81.22 -176.77 6.15 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.086 1.354 . . . . 1.48 110.764 -172.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -113.95 150.07 34.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.341 1.456 . . . . 2.31 108.059 171.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.97 137.28 13.89 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.103 -1.073 . . . . 2.92 108.103 169.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -65.17 121.25 14.32 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.72 0.808 . . . . 2.62 110.562 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.33 135.81 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.165 0.986 . . . . 1.65 108.792 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.82 117.38 21.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.844 -0.799 . . . . 5.13 108.844 176.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.568 HG22 ' CD1' ' A' ' 213' ' ' PHE . 1.1 pp -53.03 -33.62 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 C-N-CA 122.922 0.489 . . . . 3.33 110.348 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -52.53 -36.06 54.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.092 0.957 . . . . 4.58 112.045 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 25.1 m -74.01 -48.29 31.19 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 119.17 -0.443 . . . . 2.55 109.959 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.459 ' CD1' HG22 ' A' ' 140' ' ' VAL . 0.5 OUTLIER 53.35 87.65 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.271 1.028 . . . . 4.71 110.445 -178.323 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.02 163.21 37.96 Favored 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 121.466 -0.771 . . . . 3.77 110.773 175.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.525 HD12 ' CH2' ' A' ' 141' ' ' TRP . 1.5 mm? -116.27 154.48 30.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.601 1.56 . . . . 0.84 107.836 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.2 m -79.18 152.66 30.56 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 118.012 0.369 . . . . 0.88 111.1 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -58.77 -41.78 87.42 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.762 -0.586 . . . . 1.03 111.417 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -51.53 -51.5 54.78 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.903 0.858 . . . . 2.33 108.941 171.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.539 ' CG ' ' HB1' ' A' ' 234' ' ' ALA . 1.0 OUTLIER -58.59 -47.07 85.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.8 -1.091 . . . . 2.25 111.442 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 69.2 mt -44.61 -37.6 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.676 1.19 . . . . 1.1 111.26 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -65.29 -63.2 1.16 Allowed 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.529 -0.732 . . . . 4.59 110.989 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -55.83 -46.66 82.72 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.723 -0.551 . . . . 0.99 111.723 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.768 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 2.0 pp -70.0 -28.75 37.53 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 C-N-CA 124.76 1.224 . . . . 2.85 110.503 -173.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -84.62 -24.19 29.21 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.645 1.111 . . . . 2.61 112.024 171.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 46.1 m -58.32 -33.1 69.13 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.85 0.75 . . . . 2.51 111.699 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 30.5 mt . . . . . 0 N--CA 1.449 -0.525 0 C-N-CA 126.336 1.854 . . . . 3.51 112.498 177.703 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.558 0 CA-C-O 119.484 -0.293 . . . . 5.98 110.974 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 66.08 -71.3 0.09 Allowed 'General case' 0 C--O 1.231 0.118 0 C-N-CA 127.01 2.124 . . . . 4.26 110.48 -177.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -116.5 118.19 31.99 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.443 1.497 . . . . 2.85 107.546 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.51 HG21 ' CE1' ' A' ' 149' ' ' PHE . 24.0 mm -115.36 154.06 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.509 -1.293 . . . . 2.71 107.509 160.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.92 133.31 13.63 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 104.509 -2.404 . . . . 2.26 104.509 -171.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -128.79 169.18 14.85 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 123.806 0.842 . . . . 4.43 111.383 -174.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -153.55 155.59 36.45 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.487 -0.931 . . . . 4.7 108.487 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -95.32 162.12 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.719 -1.586 . . . . 1.19 106.719 172.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -86.08 -48.86 8.25 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.032 -1.099 . . . . 3.4 108.032 172.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -157.25 167.47 30.25 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.359 1.064 . . . . 2.69 109.189 -170.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -112.24 173.03 6.56 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.454 1.502 . . . . 1.85 108.927 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.7 t -129.58 135.22 27.2 Favored Pre-proline 0 N--CA 1.445 -0.683 0 N-CA-C 105.83 -1.915 . . . . 2.53 105.83 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.48 -19.06 17.23 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.251 2.634 . . . . 2.1 112.085 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -37.58 -41.84 0.5 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.406 2.682 . . . . 2.57 112.604 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.5 ptp -136.39 173.56 11.58 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.991 0.917 . . . . 2.13 108.88 173.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -70.02 142.0 52.81 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.915 -0.402 . . . . 3.17 109.915 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -52.77 -47.7 67.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.118 -0.467 . . . . 2.81 111.885 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -45.23 -49.6 12.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.045 -0.724 . . . . 3.89 109.045 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.74 -40.71 92.41 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.19 0.996 . . . . 2.01 113.364 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.4 t -53.67 -54.63 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.318 -0.993 . . . . 1.19 108.318 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -37.22 83.73 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 119.121 -1.032 . . . . 1.72 108.837 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -55.6 -45.35 77.45 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 119.598 1.09 . . . . 2.12 111.753 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.18 -52.16 59.72 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 120.894 0.378 . . . . 0.42 110.415 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -72.88 -31.82 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.917 -0.583 . . . . 1.6 110.549 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -57.24 13.1 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.769 -1.567 . . . . 3.15 106.769 177.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.534 ' O ' HG23 ' A' ' 140' ' ' VAL . 11.3 mmmm -66.96 -44.53 80.31 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.427 -1.261 . . . . 1.39 109.11 -176.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.24 -53.82 25.49 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 112.483 0.549 . . . . 0.43 112.483 173.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.486 ' HA ' HG21 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -59.72 -48.37 81.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 119.019 -1.073 . . . . 6.32 108.127 177.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.47 -29.7 62.02 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.638 -0.696 . . . . 2.22 112.082 -173.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 136' ' ' LYS . 99.4 t -60.75 -66.8 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 119.02 0.827 . . . . 0.72 109.33 174.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -69.49 -43.09 73.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.465 -0.939 . . . . 0.88 108.465 -169.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.1 t -58.3 -19.01 31.3 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.777 1.231 . . . . 1.47 111.865 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -79.29 -44.42 21.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 118.206 0.457 . . . . 1.76 109.929 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.0 m -76.36 -39.92 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 111.907 0.336 . . . . 1.51 111.907 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.569 HG23 HG12 ' A' ' 258' ' ' ILE . 1.6 p -83.46 152.69 64.47 Favored Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 107.876 -1.157 . . . . 1.2 107.876 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.33 11.39 1.55 Allowed 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.117 2.545 . . . . 1.48 113.857 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.86 127.56 56.22 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.238 1.415 . . . . 2.68 110.251 -173.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.29 117.58 33.0 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.034 0.533 . . . . 3.22 110.096 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.51 ' CE1' HG21 ' A' ' 114' ' ' ILE . 3.2 m-85 -81.01 160.51 24.55 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.329 1.052 . . . . 6.12 110.772 168.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.8 t -156.7 144.86 19.55 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.466 1.506 . . . . 1.16 107.384 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -89.91 149.37 22.64 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 120.491 1.496 . . . . 2.02 108.899 173.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.9 pt -127.01 147.78 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 105.742 -1.948 . . . . 1.4 105.742 164.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -102.44 -5.41 24.11 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.898 0.479 . . . . 3.47 110.515 172.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 99.4 m -155.4 117.53 4.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.405 -1.332 . . . . 2.75 107.405 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 140.76 177.4 16.11 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 107.711 -2.156 . . . . 1.56 107.711 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.3 mmt -87.83 141.33 28.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.164 -1.05 . . . . 5.76 108.164 164.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -123.42 168.89 11.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.19 -1.411 . . . . 0.76 107.19 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -76.46 -45.21 32.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.833 -0.803 . . . . 1.65 108.833 -175.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.2 pt -113.94 176.69 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 124.617 1.167 . . . . 0.93 109.91 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.11 135.38 30.87 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.178 1.391 . . . . 2.21 109.072 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 36.5 t -93.32 108.68 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.227 -1.398 . . . . 0.77 107.227 168.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.07 107.24 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.747 1.219 . . . . 2.44 109.964 -175.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -88.4 171.68 9.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.284 -1.006 . . . . 5.82 108.284 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.575 ' HB3' ' CE2' ' A' ' 174' ' ' PHE . . . -155.62 -169.59 3.16 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.279 -1.378 . . . . 1.18 107.279 167.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 35.0 mtm180 -139.51 125.81 20.17 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.719 -0.845 . . . . 5.58 108.719 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.61 -67.88 3.07 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 125.366 1.46 . . . . 2.63 110.599 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -155.95 159.7 39.46 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.553 0.741 . . . . 2.17 109.075 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 106.872 -1.529 . . . . 3.25 106.872 168.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 108.086 -1.079 . . . . 3.57 108.086 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.575 ' CE2' ' HB3' ' A' ' 164' ' ' ALA . 8.8 m-85 -105.41 172.49 6.76 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.797 1.239 . . . . 6.34 108.11 163.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -162.98 153.8 16.83 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.122 0.969 . . . . 3.84 109.175 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -70.84 -149.61 0.59 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.59 0.614 . . . . 1.39 113.203 -174.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -54.31 109.41 0.48 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.708 1.203 . . . . 3.93 110.083 -176.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 99.49 -144.38 17.02 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.723 -1.351 . . . . 1.63 109.723 -171.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 48.26 -132.32 19.8 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.418 -1.473 . . . . 1.45 109.418 -170.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 tp -77.72 148.51 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 118.038 0.919 . . . . 2.5 108.855 175.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . 0.5 5.4 mp -84.75 -44.98 12.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.297 1.439 . . . . 1.52 110.577 173.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -165.63 168.28 16.45 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 122.189 -0.319 . . . . 0.78 111.011 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -146.99 120.64 9.16 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 124.277 1.031 . . . . 1.13 113.782 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.509 ' HB3' ' HB2' ' A' ' 222' ' ' HIS . . . -139.07 160.96 38.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 120.656 -1.278 . . . . 0.55 107.62 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -141.65 149.6 40.85 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.351 -1.352 . . . . 3.07 107.351 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -100.84 -87.63 1.98 Allowed Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.622 -0.991 . . . . 0.66 110.622 173.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.17 84.71 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.523 2.815 . . . . 1.52 111.53 -169.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -159.24 165.21 34.24 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.234 -1.546 . . . . 1.09 109.234 170.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.0 p -79.39 172.79 13.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.752 0.821 . . . . 2.35 109.536 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.21 -105.7 0.27 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 123.865 0.745 . . . . 1.52 111.838 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.4 tp -59.65 -40.58 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 118.717 -0.659 . . . . 1.42 110.006 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -41.49 135.46 2.97 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 118.976 0.807 . . . . 0.96 112.429 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 98.87 -36.98 3.69 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.873 1.702 . . . . 0.58 111.646 -166.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -84.02 160.42 21.0 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.946 0.873 . . . . 1.24 110.34 -163.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -134.05 130.71 37.91 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.605 0.762 . . . . 0.59 111.871 -169.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -119.96 99.52 6.67 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 117.925 -1.036 . . . . 2.0 110.793 -161.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -84.73 139.11 32.22 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 121.165 1.802 . . . . 2.93 111.468 176.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.87 61.88 0.42 Allowed 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 123.687 0.617 . . . . 3.37 110.329 171.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.21 -6.37 13.42 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 120.607 -1.308 . . . . 5.23 111.997 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -27.15 -65.02 0.08 Allowed 'General case' 0 C--N 1.341 0.205 0 C-N-CA 127.851 2.46 . . . . 5.2 110.055 158.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . 0.256 2.2 pt-20 -78.72 175.5 10.38 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.308 -0.86 . . . . 1.97 110.562 -169.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -98.42 103.11 15.03 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 106.223 -1.769 . . . . 3.43 106.223 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.45 ' HH2' HG21 ' A' ' 215' ' ' THR . 28.3 m95 -78.3 134.52 37.5 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.918 -1.512 . . . . 1.49 106.918 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.1 p -132.35 75.8 1.66 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.412 -1.329 . . . . 3.2 107.412 -171.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.04 -49.31 70.63 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 123.864 0.866 . . . . 3.22 108.817 -174.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -55.48 -32.76 63.1 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.906 0.706 . . . . 4.54 112.906 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.8 t -81.47 -42.43 20.32 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.216 0.606 . . . . 6.63 110.495 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 106.02 16.57 14.83 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.92 1.247 . . . . 3.52 112.952 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.71 -84.62 0.18 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.475 -1.05 . . . . 1.81 110.475 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 61.9 m -107.79 119.85 40.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.007 -2.59 . . . . 1.32 104.007 157.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -94.84 115.26 27.26 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 124.333 1.021 . . . . 1.44 108.293 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.67 -48.66 49.37 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.453 0.701 . . . . 1.51 110.409 -177.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -47.92 -49.77 29.07 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.205 0.602 . . . . 1.54 110.955 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.1 tt -56.7 -60.24 3.84 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.144 0.978 . . . . 1.2 109.676 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.45 HG21 ' HH2' ' A' ' 203' ' ' TRP 0.266 93.4 m -57.52 -41.98 81.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.572 -0.74 . . . . 0.9 110.692 177.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.08 -39.62 86.71 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 118.268 -0.872 . . . . 0.54 112.1 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.8 t -56.07 -57.65 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 119.842 1.201 . . . . 0.7 108.658 175.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.61 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 0.4 OUTLIER -43.84 -53.57 5.92 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.729 0.812 . . . . 2.81 112.492 172.133 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -69.07 -34.66 75.5 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.264 -0.898 . . . . 2.52 113.207 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.486 HG21 ' HA ' ' A' ' 138' ' ' PHE . 4.4 mm -60.6 -47.12 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 106.955 -1.498 . . . . 2.53 106.955 173.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.58 -51.18 33.74 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 111.667 -0.573 . . . . 0.7 111.667 173.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.61 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 4.3 m-70 -54.36 -49.16 70.45 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 121.483 -1.01 . . . . 1.15 111.42 176.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 14.5 t -51.57 -48.04 63.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 123.401 0.438 . . . . 1.74 111.341 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.22 -36.65 84.37 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.163 -0.615 . . . . 2.0 110.185 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 116.05 55.68 0.34 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 109.934 -1.266 . . . . 1.27 109.934 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.642 HD11 ' HA ' ' A' ' 258' ' ' ILE . 1.9 mm? -103.32 125.3 49.88 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.075 0.55 . . . . 4.06 110.475 173.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.61 139.81 47.09 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.461 -1.056 . . . . 2.66 110.461 171.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.416 ' CD2' ' HE1' ' A' ' 222' ' ' HIS . 17.7 m80 -43.69 114.17 0.61 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.537 1.535 . . . . 1.9 111.647 173.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 55.8 m -73.93 165.97 24.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.431 0.56 . . . . 1.25 109.78 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 12.4 m -128.33 39.99 3.74 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.437 1.495 . . . . 2.73 110.12 -167.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -141.4 142.35 26.27 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 106.863 -1.532 . . . . 1.75 106.863 -174.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -88.98 -14.19 2.87 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.176 1.917 . . . . 1.05 114.793 -174.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -82.1 -32.05 30.41 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.065 0.946 . . . . 1.83 109.093 172.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.73 152.62 6.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.516 0.727 . . . . 0.92 111.014 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 57.7 t -110.5 -20.38 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.254 -1.339 . . . . 0.84 110.261 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -31.61 71.59 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.462 1.028 . . . . 2.45 111.181 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -48.07 159.3 0.49 Allowed Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 127.178 2.191 . . . . 3.35 114.013 -174.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -71.81 -23.09 22.83 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.415 1.41 . . . . 1.53 111.884 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.355 0.2 OUTLIER -78.24 173.29 12.43 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.076 1.35 . . . . 1.5 110.219 -171.221 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -112.17 140.76 46.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.414 -1.328 . . . . 2.39 107.414 172.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.6 125.59 12.82 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.461 -2.051 . . . . 2.31 105.461 172.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -53.22 130.86 35.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.166 0.986 . . . . 3.06 110.529 -176.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.53 137.22 52.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 C-N-CA 123.599 0.76 . . . . 2.07 110.365 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.85 -42.43 97.58 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.539 1.135 . . . . 3.42 111.7 171.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 6.7 mt 69.32 8.57 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 126.118 1.767 . . . . 2.58 110.851 -159.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -64.22 -53.96 41.02 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 120.597 -1.315 . . . . 3.81 111.253 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 12.1 m -81.82 -41.37 21.18 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.964 0.906 . . . . 2.27 109.872 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.469 ' CE1' HG22 ' A' ' 140' ' ' VAL . 57.3 t80 57.43 72.81 0.49 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 122.09 0.948 . . . . 4.46 109.953 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.21 162.04 37.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.955 -0.757 . . . . 2.53 108.955 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.528 HD22 ' N ' ' A' ' 250' ' ' LEU . 1.7 mm? -95.95 158.21 15.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.637 1.575 . . . . 0.84 108.281 -178.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 2.9 m -76.13 158.71 31.45 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 122.059 -0.401 . . . . 0.78 110.695 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.73 -43.74 85.52 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.568 -0.16 . . . . 1.26 110.568 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -53.25 -55.92 20.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.564 0.697 . . . . 2.65 109.492 173.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.36 -42.32 81.81 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.396 -0.82 . . . . 2.25 110.919 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.539 ' HA ' ' CG2' ' A' ' 258' ' ' ILE . 38.9 mt -55.96 -22.33 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 126.871 2.068 . . . . 1.43 111.498 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 -77.14 -55.47 5.41 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.817 -1.177 . . . . 5.5 110.273 168.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -50.7 -55.48 17.35 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.534 -1.027 . . . . 0.81 110.534 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.642 ' HA ' HD11 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -41.85 -56.26 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 C-N-CA 125.347 1.459 . . . . 3.01 111.527 175.597 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -72.98 -21.61 60.82 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.997 0.817 . . . . 2.27 110.791 -173.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.9 t -67.15 -25.49 66.19 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 118.695 -0.669 . . . . 1.95 111.553 168.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.54 ' CD2' HG22 ' A' ' 145' ' ' THR . 0.4 OUTLIER . . . . . 0 CA--C 1.539 0.522 0 C-N-CA 126.934 2.094 . . . . 4.14 112.518 -174.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 109.191 -0.67 . . . . 6.35 109.191 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.11 -66.96 0.09 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.218 1.807 . . . . 4.18 112.25 -175.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -79.85 107.85 12.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.159 1.384 . . . . 2.52 107.841 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.66 136.89 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 106.564 -1.643 . . . . 2.12 106.564 168.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.3 t -142.9 142.95 31.86 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 120.702 0.287 . . . . 3.12 110.713 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.553 ' CE2' HD12 ' A' ' 134' ' ' ILE . 17.8 p90 -130.17 163.84 25.78 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.507 1.123 . . . . 4.48 111.488 -170.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -145.22 142.28 29.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.934 -0.765 . . . . 4.28 108.934 173.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -83.33 152.91 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 108.499 -0.926 . . . . 1.02 108.499 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -88.22 -45.41 10.11 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.391 -0.596 . . . . 3.26 109.391 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -155.35 170.22 22.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.222 -1.029 . . . . 2.4 108.222 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.07 127.28 53.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.141 0.976 . . . . 1.93 108.916 -165.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.3 t -64.4 124.01 84.49 Favored Pre-proline 0 N--CA 1.442 -0.86 0 C-N-CA 123.941 0.897 . . . . 2.68 109.419 -176.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -69.89 -19.07 35.96 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.499 2.8 . . . . 1.95 110.138 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -36.59 -40.34 0.25 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.715 2.006 . . . . 2.78 111.808 169.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 16.2 mtm -135.76 177.29 7.95 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.255 1.422 . . . . 2.49 109.506 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -76.53 141.98 41.02 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.548 -0.72 . . . . 3.48 109.262 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 54.6 ttt-85 -41.54 -48.93 4.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.707 0.685 . . . . 2.15 112.285 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -49.39 -47.06 47.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.707 -0.479 . . . . 3.37 109.707 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -69.46 -40.71 76.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.408 1.483 . . . . 1.85 111.101 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 56.8 t -54.06 -53.82 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 120.811 -1.181 . . . . 1.17 109.555 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -25.69 65.29 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 118.77 -1.172 . . . . 1.98 110.01 178.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -63.12 -47.83 81.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.891 0.769 . . . . 1.91 109.798 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.91 -53.46 56.57 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.352 0.661 . . . . 0.38 110.498 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.587 HD11 HD11 ' A' ' 220' ' ' ILE . 0.1 OUTLIER -68.82 -41.35 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 109.284 -0.636 . . . . 2.27 109.284 -178.313 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -50.41 -58.59 5.37 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.371 -0.974 . . . . 3.34 108.371 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -60.3 -52.0 67.14 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.522 1.129 . . . . 1.44 109.249 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -46.48 -49.17 18.77 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 123.944 0.898 . . . . 0.62 112.289 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.46 ' HB3' ' CD2' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -66.02 -45.99 79.53 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.996 -0.742 . . . . 4.82 108.996 178.086 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -49.03 -42.25 37.61 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.759 0.824 . . . . 3.83 110.829 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.609 HG22 ' CD2' ' A' ' 248' ' ' PHE . 48.0 t -48.46 -61.51 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.059 0.944 . . . . 0.69 110.134 177.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -73.09 -32.5 65.02 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.423 -0.798 . . . . 0.98 109.736 -175.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 t -61.03 -17.87 54.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.932 0.493 . . . . 1.14 111.332 175.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -81.02 -45.98 15.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.839 -0.8 . . . . 2.06 108.839 -177.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.6 m -78.85 -46.28 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.412 0.685 . . . . 1.37 111.971 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.49 HG21 HD12 ' A' ' 258' ' ' ILE . 43.2 p -82.79 159.14 64.05 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.407 -0.59 . . . . 0.71 109.407 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.92 -1.8 11.84 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.764 1.643 . . . . 0.7 112.581 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.9 mp -65.34 127.37 31.47 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.59 -0.893 . . . . 2.23 108.59 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.44 96.19 6.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.921 -1.14 . . . . 4.11 107.921 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.46 ' CD2' ' HB3' ' A' ' 138' ' ' PHE . 1.4 p90 -69.12 155.48 40.31 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.347 -0.388 . . . . 6.66 111.534 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.9 t -158.85 140.19 13.19 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.016 0.826 . . . . 1.12 111.079 163.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.01 149.83 22.37 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.025 -1.102 . . . . 2.01 108.025 171.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.53 HD13 ' H ' ' A' ' 156' ' ' MET . 2.9 pp -129.75 156.9 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 106.018 -1.845 . . . . 2.2 106.018 173.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -111.7 -16.62 13.18 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.242 0.339 . . . . 3.63 110.577 172.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.9 m -107.19 78.04 1.19 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.603 0.761 . . . . 2.64 109.753 -174.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 15.06 63.59 0.01 OUTLIER Glycine 0 CA--C 1.537 1.447 0 C-N-CA 128.144 2.783 . . . . 2.64 118.286 171.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.53 ' H ' HD13 ' A' ' 152' ' ' ILE . 31.7 mtt -147.8 75.69 1.36 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.092 1.357 . . . . 7.74 107.786 166.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -124.06 155.08 38.98 Favored 'General case' 0 N--CA 1.461 0.08 0 C-N-CA 123.614 0.766 . . . . 0.96 109.598 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.23 -49.46 7.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.042 0.937 . . . . 2.19 108.691 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.9 pt -110.25 161.52 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.464 0.705 . . . . 0.97 110.511 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.14 140.02 52.91 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.434 0.693 . . . . 2.49 110.324 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.87 100.13 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.702 0.801 . . . . 0.98 109.215 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.33 93.19 4.23 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 C-N-CA 125.007 1.323 . . . . 1.36 111.05 -171.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -80.94 116.22 20.8 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.536 -1.653 . . . . 5.5 106.536 172.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -140.3 155.49 46.81 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 119.135 0.879 . . . . 0.82 109.431 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -124.38 128.51 49.18 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.821 0.849 . . . . 4.06 109.207 -164.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 48.63 -126.75 17.37 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.561 1.077 . . . . 1.84 111.948 -164.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.15 137.82 38.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.103 0.561 . . . . 1.99 109.722 -175.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.24 0 N-CA-C 112.839 0.681 . . . . 2.63 112.839 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.354 0 CA-C-O 118.516 -0.754 . . . . 2.51 111.089 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 200' ' ' ASP . 48.5 t80 -90.8 151.18 21.29 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.864 0.84 . . . . 7.78 109.379 173.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -152.18 4.5 0.39 Allowed 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 126.421 1.888 . . . . 2.95 111.779 -162.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.5 -173.02 24.55 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 122.067 0.815 . . . . 1.76 112.301 -162.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 68.83 0.36 Allowed 'General case' 0 C--N 1.341 0.222 0 C-N-CA 127.32 2.248 . . . . 4.53 110.471 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.35 -157.88 27.87 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 109.329 -1.508 . . . . 1.74 109.329 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 51.14 -125.28 24.22 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 127.097 2.284 . . . . 1.54 110.263 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 4.5 mm -78.82 138.66 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.26 -1.385 . . . . 1.9 107.26 174.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 181' ' ' LEU 0.412 2.6 mp -84.46 -53.82 5.17 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.965 1.306 . . . . 1.32 109.527 165.452 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.06 162.26 28.66 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 122.104 -0.373 . . . . 0.66 110.132 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -144.37 121.31 11.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.995 1.318 . . . . 1.02 114.495 -173.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -143.27 166.64 24.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 127.492 2.317 . . . . 0.91 109.271 -171.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -151.78 143.25 23.48 Favored 'General case' 0 C--O 1.227 -0.09 0 N-CA-C 108.739 -0.838 . . . . 3.7 108.739 175.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -91.06 -88.62 1.39 Allowed Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.347 -1.101 . . . . 0.59 110.347 174.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.69 94.45 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.023 2.482 . . . . 1.31 111.028 -174.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -170.2 161.66 34.8 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.069 -1.613 . . . . 1.25 109.069 171.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 14.4 m -79.27 168.51 19.45 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.076 0.55 . . . . 2.64 110.642 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 54.84 -106.04 0.46 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.813 0.721 . . . . 1.87 111.596 173.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.0 tp -59.69 -40.48 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 118.831 -0.604 . . . . 1.63 109.465 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -44.79 141.4 3.78 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.123 -0.986 . . . . 1.17 112.489 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 95.23 -37.97 3.26 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.504 1.526 . . . . 0.76 111.25 -162.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -86.9 164.06 16.8 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.903 0.851 . . . . 1.17 110.33 -166.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -139.6 121.06 15.08 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.78 111.91 -172.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -110.54 132.13 54.45 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 118.203 -0.903 . . . . 2.32 109.328 -169.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -123.44 146.5 47.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.885 1.221 . . . . 2.8 110.541 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -66.02 90.51 0.14 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.803 -0.814 . . . . 2.74 108.803 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -57.31 -47.37 81.69 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 119.757 -1.839 . . . . 3.13 110.61 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 174' ' ' PHE . 1.9 t70 -51.4 -27.55 10.36 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.552 0.741 . . . . 2.87 111.285 -178.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -67.17 136.89 55.77 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.074 -1.454 . . . . 2.47 107.074 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.61 88.96 6.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.095 -1.076 . . . . 3.16 108.095 -172.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 32.8 m95 -79.23 134.49 36.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.513 -1.292 . . . . 1.19 107.513 -174.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.6 p -122.55 137.67 54.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.646 -0.872 . . . . 1.75 108.646 -176.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.5 t -50.47 -41.73 53.52 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 124.146 0.978 . . . . 1.76 111.654 172.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -86.36 -154.39 0.22 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.323 0.649 . . . . 2.85 111.706 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.4 m -66.37 -62.29 1.55 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.579 0.752 . . . . 3.69 110.474 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 39.97 -116.24 0.69 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.25 1.405 . . . . 2.53 113.787 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.03 -54.75 0.66 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.714 1.15 . . . . 1.56 110.281 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.58 179.34 6.62 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.869 -1.53 . . . . 1.1 106.869 172.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -136.89 127.63 27.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 122.942 0.497 . . . . 1.63 111.36 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 25.2 tp -59.14 -51.54 69.59 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 123.838 0.711 . . . . 2.27 110.314 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.52 ' CD1' HG22 ' A' ' 245' ' ' ILE . 6.8 t80 -50.41 -45.48 55.68 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.352 0.596 . . . . 1.45 109.654 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.7 tt -63.55 -59.1 5.07 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.588 -0.695 . . . . 1.35 110.299 -174.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.256 1.8 m -57.33 -38.94 74.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.351 -0.386 . . . . 0.95 110.541 178.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.32 -60.39 3.36 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 117.093 -1.432 . . . . 0.56 109.856 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 85.2 t -45.48 -50.64 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 121.234 1.834 . . . . 0.69 110.672 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.641 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 26.1 t60 -57.43 -58.29 8.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.727 0.811 . . . . 2.3 112.523 175.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.26 -42.41 79.65 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.644 -1.285 . . . . 2.96 111.911 -173.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.587 HD11 HD11 ' A' ' 134' ' ' ILE . 1.0 OUTLIER -53.16 -41.1 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 123.972 0.909 . . . . 1.35 109.907 167.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.72 -51.45 38.82 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 123.845 0.736 . . . . 0.52 111.262 170.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.641 ' NE2' ' NE2' ' A' ' 218' ' ' HIS 0.3 20.9 m-70 -53.91 -51.52 63.48 Favored 'General case' 0 C--O 1.226 -0.177 0 O-C-N 121.638 -0.919 . . . . 1.36 109.902 172.782 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.5 m -52.87 -51.04 62.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.529 0.566 . . . . 1.95 112.529 -177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.49 -28.94 70.0 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 119.137 -0.458 . . . . 2.91 111.595 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 114.9 82.65 1.06 Allowed Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.474 -1.05 . . . . 1.38 110.474 172.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.544 HD13 ' SD ' ' A' ' 236' ' ' MET . 10.7 mt -134.55 142.95 47.13 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 117.622 0.711 . . . . 3.25 110.401 178.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -77.5 164.3 52.16 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.127 -1.189 . . . . 2.94 110.127 169.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -71.77 116.9 12.69 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.833 0.853 . . . . 1.86 110.158 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.5 m -76.7 175.16 9.63 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.036 0.534 . . . . 1.11 110.896 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 30.4 m -136.84 40.97 2.53 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.637 1.175 . . . . 2.23 110.762 -170.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -140.73 141.77 26.03 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.725 -1.583 . . . . 2.28 106.725 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -85.51 -12.48 6.53 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.151 1.901 . . . . 1.21 114.955 -174.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -80.66 -30.28 36.55 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.365 0.984 . . . . 1.33 109.552 173.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.443 ' HB1' ' CG ' ' A' ' 254' ' ' ASP . . . -59.27 153.82 17.8 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.963 0.905 . . . . 1.07 110.258 170.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 50.0 t -105.49 -18.77 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.389 -1.278 . . . . 0.66 109.873 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.544 ' SD ' HD13 ' A' ' 226' ' ' LEU . 7.5 tpt -76.69 -17.74 58.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.182 -0.949 . . . . 1.9 113.506 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.4 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -49.56 157.78 0.91 Allowed Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.542 1.537 . . . . 2.96 113.32 174.086 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.92 -19.21 18.26 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.874 1.716 . . . . 0.86 111.587 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.371 0.2 OUTLIER -77.32 177.0 8.29 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.293 1.437 . . . . 1.19 109.834 -179.132 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -120.92 142.47 49.69 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.113 -1.44 . . . . 2.12 107.113 174.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -148.44 123.37 10.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 104.899 -2.26 . . . . 3.05 104.899 172.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -52.44 115.83 1.96 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.417 0.553 . . . . 2.86 109.552 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.4 m -108.99 126.25 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.764 -1.198 . . . . 1.57 107.764 171.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.43 108.36 3.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.966 -0.753 . . . . 3.88 108.966 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.52 HG22 ' CD1' ' A' ' 213' ' ' PHE . 1.4 pp -50.57 -32.1 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.054 0 C-N-CA 125.361 1.464 . . . . 3.36 111.182 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -50.97 -38.97 54.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.343 0.657 . . . . 3.96 111.721 175.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.9 m -68.22 -46.71 69.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.201 0.6 . . . . 2.5 109.935 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.609 ' CD2' HG22 ' A' ' 140' ' ' VAL . 9.1 t80 52.61 82.89 0.07 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.036 1.334 . . . . 5.09 110.975 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.41 167.59 27.0 Favored 'General case' 0 CA--C 1.521 -0.15 0 O-C-N 120.525 -1.359 . . . . 3.43 111.712 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.507 ' N ' HD22 ' A' ' 250' ' ' LEU . 1.3 mm? -111.01 156.09 21.78 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.898 1.679 . . . . 0.87 107.554 173.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.5 m -78.33 154.24 31.0 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.228 -0.286 . . . . 0.82 110.228 175.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -53.31 -45.61 69.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.622 0.369 . . . . 0.96 110.033 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -51.92 -57.18 10.18 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 122.071 0.939 . . . . 2.53 110.057 174.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.443 ' CG ' ' HB1' ' A' ' 234' ' ' ALA . 3.4 m-20 -58.26 -40.43 81.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.631 -1.168 . . . . 2.3 111.379 -177.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 45.8 mt -57.69 -47.31 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.656 0.782 . . . . 0.83 110.051 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 32.5 mtt180 -59.92 -43.52 94.86 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 120.683 -1.26 . . . . 5.01 110.144 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -48.26 -46.29 27.97 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.024 -0.831 . . . . 0.89 111.024 170.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.49 HD12 HG21 ' A' ' 145' ' ' THR . 0.1 OUTLIER -67.73 -47.88 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 O-C-N 121.776 -0.838 . . . . 3.19 110.905 -176.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -63.03 -27.28 69.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.362 -0.935 . . . . 2.91 110.582 -175.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 11.9 m -51.41 -19.66 1.46 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.987 1.106 . . . . 2.45 113.987 171.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 18.5 mt . . . . . 0 C--N 1.349 0.568 0 CA-C-N 120.601 1.546 . . . . 2.55 113.439 164.836 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 110.021 -0.363 . . . . 5.01 110.021 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 27.6 m170 61.0 -69.48 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.921 1.289 . . . . 4.25 111.353 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -79.91 91.29 5.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 119.046 0.839 . . . . 2.52 110.545 -176.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.425 HD12 ' N ' ' A' ' 114' ' ' ILE . 2.0 mp -91.8 88.2 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 107.278 -1.378 . . . . 2.57 107.278 173.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.2 p -81.39 120.09 24.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.262 -1.384 . . . . 1.4 107.262 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -128.69 171.7 11.94 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 119.219 0.918 . . . . 4.38 110.688 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -157.37 176.65 12.39 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.636 -0.665 . . . . 4.22 109.829 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.8 mm -109.4 162.96 6.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.184 1.393 . . . . 1.76 108.332 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -102.57 -62.87 1.22 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.342 0.657 . . . . 3.0 109.975 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -144.02 159.72 42.11 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.961 1.305 . . . . 2.02 107.595 176.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -111.67 127.31 55.73 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.218 -1.401 . . . . 2.26 107.218 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.76 130.53 94.83 Favored Pre-proline 0 N--CA 1.444 -0.732 0 C-N-CA 124.05 0.94 . . . . 4.09 109.842 -177.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -70.04 -27.06 25.61 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.771 2.314 . . . . 2.59 109.995 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.8 -28.71 69.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.527 1.131 . . . . 3.61 111.368 171.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 35.9 mmt -102.23 179.88 4.18 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.116 0.871 . . . . 4.02 109.457 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -105.23 113.72 27.48 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 108.11 -1.07 . . . . 3.48 108.11 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.48 -59.98 2.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.534 1.061 . . . . 2.38 112.931 -176.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -49.26 -43.6 43.03 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 108.851 -0.796 . . . . 2.78 108.851 -174.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -66.61 -42.96 86.04 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.9 1.28 . . . . 1.67 112.571 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.2 t -58.48 -54.2 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 O-C-N 120.842 -1.161 . . . . 1.55 108.798 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.428 ' OD2' ' NZ ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -62.92 -45.78 90.89 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.281 -1.007 . . . . 2.14 108.281 178.535 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -53.3 -44.67 68.53 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.018 0.927 . . . . 3.05 110.963 -176.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.25 -49.22 69.99 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 122.697 0.399 . . . . 0.58 110.608 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.503 ' CD1' HD11 ' A' ' 220' ' ' ILE . 0.3 OUTLIER -71.07 -31.17 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 120.874 0.369 . . . . 1.84 110.315 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -62.23 -53.6 52.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.724 1.609 . . . . 3.38 107.009 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -70.0 -44.8 68.62 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.886 1.674 . . . . 1.31 109.863 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.473 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -47.34 -52.25 17.04 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.836 0.35 . . . . 0.57 111.09 170.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.548 ' HB3' ' CD2' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -57.66 -56.46 21.64 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.951 -0.759 . . . . 4.44 108.951 177.692 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.78 -49.43 38.65 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.926 1.29 . . . . 3.11 110.98 -173.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.66 HG12 HD21 ' A' ' 250' ' ' LEU . 54.0 t -51.14 -50.66 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.425 1.09 . . . . 1.11 109.773 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.438 ' HB3' HD11 ' A' ' 224' ' ' LEU . 16.7 m95 -73.77 -32.33 63.74 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.693 -0.63 . . . . 1.18 110.369 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.32 -7.29 41.5 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.206 1.402 . . . . 1.1 111.283 175.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.61 -51.02 5.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.373 -0.973 . . . . 1.55 108.373 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.8 m -68.99 -41.4 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 111.969 0.359 . . . . 1.45 111.969 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.2 p -87.2 160.27 49.13 Favored Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 108.9 -0.778 . . . . 1.01 108.9 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -73.51 2.86 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 121.889 1.726 . . . . 0.94 112.325 170.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.404 HD12 HD13 ' A' ' 224' ' ' LEU . 35.0 mt -68.54 154.92 40.95 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.254 -0.904 . . . . 2.06 110.817 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 99.23 5.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.836 1.654 . . . . 5.19 109.611 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.548 ' CD2' ' HB3' ' A' ' 138' ' ' PHE . 1.7 p90 -63.51 152.5 38.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.741 -0.663 . . . . 7.15 112.007 170.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.6 t -155.11 117.68 4.28 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.698 -0.668 . . . . 0.85 111.06 173.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.428 ' NZ ' ' OD2' ' A' ' 131' ' ' ASP . 6.0 ttmt -81.59 131.02 35.26 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 119.514 1.052 . . . . 2.52 109.563 175.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.24 88.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 122.001 0.905 . . . . 1.97 109.411 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -87.13 33.27 0.67 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.599 0.76 . . . . 2.94 110.424 176.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.1 p -149.62 77.97 1.35 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.094 1.358 . . . . 2.32 108.982 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 147.71 -120.39 1.22 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.571 -1.411 . . . . 1.53 109.571 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 27.5 mtp -139.53 136.03 34.07 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 127.147 2.179 . . . . 4.13 106.352 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.83 165.86 18.54 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.696 1.198 . . . . 0.64 109.598 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -73.59 -53.0 11.52 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.159 0.984 . . . . 2.24 108.4 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.2 pt -119.69 147.76 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.669 -0.696 . . . . 1.11 111.224 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.4 tt -122.95 133.13 54.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.014 1.326 . . . . 2.54 109.142 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.43 HG13 ' CE1' ' A' ' 197' ' ' PHE . 4.7 t -81.19 101.02 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.571 1.148 . . . . 1.0 108.535 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.8 t -78.9 111.75 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.784 -0.821 . . . . 1.25 108.784 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -99.0 118.32 35.51 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.203 -1.777 . . . . 5.06 106.203 166.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -143.78 161.42 38.66 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.972 -1.121 . . . . 0.92 107.972 -176.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -122.99 142.39 50.89 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.335 -1.358 . . . . 3.93 107.335 172.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.497 ' HA2' ' CD1' ' A' ' 174' ' ' PHE . . . 83.98 174.73 50.54 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.982 -0.447 . . . . 2.0 111.982 170.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.14 77.75 3.68 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.915 -0.756 . . . . 3.34 109.9 -170.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 123.696 0.798 . . . . 2.64 112.269 -175.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.255 0 N-CA-C 110.145 -0.317 . . . . 2.68 110.145 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.512 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -83.95 170.72 13.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.677 -1.231 . . . . 7.65 107.677 178.147 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.512 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 9.2 p30 175.39 33.14 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.906 1.282 . . . . 2.35 112.879 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 53.15 -156.84 4.94 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 120.984 -1.073 . . . . 1.39 111.543 -172.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -76.3 62.14 1.75 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.833 0.853 . . . . 4.25 112.567 -175.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -162.17 -154.8 7.69 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 107.839 -2.104 . . . . 1.68 107.839 168.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 35.81 -113.6 0.15 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 127.966 2.698 . . . . 1.36 112.219 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.1 mm -79.58 139.47 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 118.126 0.963 . . . . 1.84 109.001 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.5 mp -80.52 -59.9 2.52 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.983 -1.117 . . . . 1.16 107.983 170.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -163.51 159.77 22.41 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.761 -0.459 . . . . 0.86 109.761 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -146.55 117.15 7.54 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.264 1.426 . . . . 1.17 113.666 -166.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -136.37 159.47 41.67 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.004 1.722 . . . . 0.73 109.208 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -148.65 144.03 26.9 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.953 -1.499 . . . . 2.76 106.953 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -93.01 -89.99 1.55 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.166 0.888 . . . . 0.8 110.916 173.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.28 97.91 0.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.799 2.333 . . . . 1.3 110.962 -175.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -169.01 161.68 35.38 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 108.24 -1.944 . . . . 1.16 108.24 171.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.4 t -80.96 178.38 8.45 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.509 0.654 . . . . 3.35 110.466 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 46.24 -109.8 0.41 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.643 1.116 . . . . 1.42 111.314 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.7 tp -59.87 -42.25 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 118.169 -0.92 . . . . 1.62 109.826 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -38.6 128.97 1.85 Allowed Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.805 1.193 . . . . 1.09 112.664 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 108.86 -50.83 0.75 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.366 1.936 . . . . 0.72 109.686 -162.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.24 148.02 28.62 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.398 1.079 . . . . 2.61 110.481 -166.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -117.95 121.43 40.67 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.498 1.119 . . . . 0.6 111.248 -170.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -111.54 122.7 48.53 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 118.512 0.597 . . . . 2.24 111.381 -168.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.43 ' CE1' HG13 ' A' ' 161' ' ' VAL . 5.4 m-85 -111.06 136.16 50.5 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.973 -1.121 . . . . 2.64 107.973 -178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -67.0 93.55 0.28 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.476 -1.675 . . . . 2.85 106.476 172.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -39.12 82.86 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.688 1.131 . . . . 3.41 109.193 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -34.66 -48.87 0.39 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 127.092 2.157 . . . . 2.97 110.543 -167.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -61.13 179.7 0.18 Allowed 'General case' 0 C--O 1.24 0.597 0 C-N-CA 126.167 1.787 . . . . 4.67 112.283 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -115.52 87.14 2.6 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 105.538 -2.023 . . . . 2.9 105.538 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -75.67 163.32 27.43 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.93 -1.032 . . . . 1.13 108.276 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.8 p -129.22 144.15 51.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.38 -0.971 . . . . 1.77 108.38 174.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . 0.258 6.3 t -61.31 -40.47 94.29 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 126.113 1.765 . . . . 2.21 112.414 165.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -96.37 -172.44 2.53 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.406 1.082 . . . . 2.47 108.365 177.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.3 m -47.53 -65.7 0.52 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.785 2.034 . . . . 3.88 110.594 -173.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 45.77 -104.49 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 125.896 1.712 . . . . 2.17 114.364 165.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -112.38 -81.48 1.12 Allowed Glycine 0 C--N 1.335 0.495 0 N-CA-C 109.677 -1.369 . . . . 1.56 109.677 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.3 m -115.79 123.3 47.88 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.654 -1.98 . . . . 0.91 105.654 167.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -74.79 111.97 10.53 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.839 -0.8 . . . . 2.73 108.839 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.01 -54.41 24.78 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.057 0.844 . . . . 1.74 110.585 -175.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.56 ' O ' HG23 ' A' ' 217' ' ' VAL . 1.8 t80 -44.77 -43.86 8.88 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.77 1.228 . . . . 1.89 111.352 177.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.93 -64.74 0.84 Allowed 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.929 -0.482 . . . . 1.25 109.942 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.324 3.4 m -53.89 -43.37 69.59 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.377 0.608 . . . . 0.89 110.701 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.45 -42.73 54.61 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.918 -0.583 . . . . 0.47 111.793 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.588 HG21 ' CE2' ' A' ' 248' ' ' PHE . 83.9 t -62.65 -42.78 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 119.699 1.136 . . . . 0.69 111.339 -177.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.506 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 5.8 t60 -55.33 -47.33 75.83 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.977 0.911 . . . . 2.59 109.456 174.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -76.13 -32.75 59.29 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 114.257 1.206 . . . . 3.49 114.257 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.503 HD11 ' CD1' ' A' ' 134' ' ' ILE . 4.7 mm -58.0 -50.85 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 106.886 -1.524 . . . . 2.38 106.886 171.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.76 -45.46 48.68 Favored Glycine 0 CA--C 1.537 1.436 0 N-CA-C 111.931 -0.468 . . . . 0.83 111.931 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.506 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 3.8 m-70 -55.08 -50.56 68.87 Favored 'General case' 0 C--O 1.226 -0.18 0 O-C-N 121.569 -0.959 . . . . 1.27 110.335 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 1.5 t -52.21 -49.63 63.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.482 0.713 . . . . 2.05 111.377 176.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 141' ' ' TRP . 10.2 mt -60.1 -45.65 92.24 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.374 0.534 . . . . 2.18 109.721 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 134.48 38.99 0.19 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 123.812 0.72 . . . . 1.31 112.608 168.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.06 116.73 24.45 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.132 0.966 . . . . 3.48 110.156 174.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.42 52.51 4.36 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.301 -0.722 . . . . 2.85 113.151 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 72.5 m80 66.28 161.85 0.15 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.28 1.432 . . . . 1.91 113.022 -175.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 74.1 m -131.73 -178.51 4.91 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.872 1.669 . . . . 1.12 109.431 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 7.4 p -146.79 16.03 1.24 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.991 1.316 . . . . 2.64 111.006 -165.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -115.79 138.52 24.01 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 106.878 -1.527 . . . . 2.51 106.878 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.92 -17.49 10.78 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.923 1.749 . . . . 1.76 114.182 -172.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.405 ' HE3' ' HB2' ' A' ' 233' ' ' LYS . 14.6 mtmt -83.65 -28.35 28.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.94 0.791 . . . . 1.69 109.852 173.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.21 147.69 39.05 Favored 'General case' 0 C--O 1.225 -0.19 0 O-C-N 121.902 -0.499 . . . . 0.76 110.792 173.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 71.2 t -92.97 -23.5 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.724 1.21 . . . . 0.62 109.72 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 16.9 tpp -70.05 -14.68 62.79 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.471 1.108 . . . . 2.7 113.411 177.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.406 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -51.33 147.02 10.83 Favored Pre-proline 0 CA--C 1.539 0.545 0 O-C-N 121.378 -0.826 . . . . 3.02 112.944 177.509 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.92 -16.2 29.33 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.317 2.011 . . . . 1.3 111.631 174.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.301 0.1 OUTLIER -76.35 169.13 18.8 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.2 -1.037 . . . . 1.62 108.2 171.783 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -128.01 146.98 50.49 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 104.808 -2.293 . . . . 2.0 104.808 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.23 144.18 20.78 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.476 -1.305 . . . . 2.4 107.476 171.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -62.9 144.35 56.79 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.977 0.911 . . . . 2.26 111.051 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.486 HG21 ' CD1' ' A' ' 248' ' ' PHE . 17.4 m -131.85 154.35 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.555 0.742 . . . . 1.91 110.672 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.18 -16.23 59.45 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.993 1.717 . . . . 3.5 114.334 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . 0.25 14.0 mm 72.21 -41.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 128.019 2.527 . . . . 3.33 111.085 -176.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -78.99 -51.81 9.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.878 0.871 . . . . 3.42 111.197 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 47.5 m -78.46 -18.07 55.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.482 1.113 . . . . 2.66 110.652 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.588 ' CE2' HG21 ' A' ' 217' ' ' VAL . 87.7 t80 -39.3 110.82 0.15 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.531 1.532 . . . . 7.89 112.11 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.02 163.88 31.59 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.448 1.099 . . . . 3.36 109.906 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.66 HD21 HG12 ' A' ' 140' ' ' VAL . 1.2 mm? -81.08 137.42 36.0 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.831 -1.174 . . . . 1.1 107.831 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.7 m -77.41 160.66 28.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.651 0.262 . . . . 0.71 110.816 -175.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.76 -48.35 78.04 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 110.059 -0.348 . . . . 0.88 110.059 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -48.31 -51.88 24.04 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.765 0.793 . . . . 2.6 109.96 172.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.97 -47.52 80.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.079 -1.419 . . . . 2.2 109.09 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.5 mt -59.86 -47.46 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.816 1.646 . . . . 0.93 111.226 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -60.08 -44.27 94.89 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.346 -1.471 . . . . 4.63 109.858 175.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -49.62 -42.59 36.02 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.937 -0.865 . . . . 0.8 110.937 170.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 258' ' ' ILE . 0.2 OUTLIER -68.58 -47.04 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 117.826 0.813 . . . . 3.45 110.561 -177.247 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -68.16 -15.95 63.79 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 119.701 -0.8 . . . . 2.63 110.849 -178.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.14 -17.69 3.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.755 0.822 . . . . 2.04 112.873 165.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 56.7 mt . . . . . 0 CA--C 1.54 0.569 0 CA-C-N 120.076 1.307 . . . . 2.54 111.753 161.877 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.487 ' HG3' HD11 ' A' ' 114' ' ' ILE . 3.1 mptt . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 120.483 0.183 . . . . 6.18 111.297 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 60.34 -80.27 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.586 1.555 . . . . 3.46 109.407 -165.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.44 ' O ' HD13 ' A' ' 114' ' ' ILE . 59.9 m-85 -114.81 111.84 21.85 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.461 1.105 . . . . 3.14 111.499 -168.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.546 HG22 ' CE1' ' A' ' 116' ' ' TYR . 18.0 mm -128.52 103.87 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.926 0.87 . . . . 2.69 112.157 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -86.91 140.98 29.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.25 2.22 . . . . 1.22 109.49 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.546 ' CE1' HG22 ' A' ' 114' ' ' ILE . 10.3 m-85 -124.47 167.78 13.96 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.579 1.151 . . . . 6.25 110.84 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -149.52 149.55 30.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.802 1.241 . . . . 7.53 109.608 176.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.4 mt -102.68 155.69 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.656 -1.239 . . . . 0.92 107.656 173.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -97.57 -44.56 6.75 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.11 0.564 . . . . 2.94 110.156 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -149.03 164.85 33.42 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.865 0.466 . . . . 2.25 110.149 174.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -111.15 127.97 55.75 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.149 1.38 . . . . 1.8 107.574 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.1 t -60.46 136.84 92.2 Favored Pre-proline 0 N--CA 1.442 -0.829 0 C-N-CA 122.931 0.492 . . . . 2.24 109.742 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.22 -18.64 14.08 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.16 2.573 . . . . 1.58 111.009 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -40.41 -46.58 2.42 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.622 1.569 . . . . 2.0 111.452 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -128.24 176.33 7.76 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.544 1.538 . . . . 2.63 109.253 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -73.86 143.42 45.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.285 0.634 . . . . 3.04 110.452 174.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.3 ttt-85 -47.19 -45.0 22.71 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.475 0.71 . . . . 2.84 111.512 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.63 -10.04 11.01 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.023 0.929 . . . . 4.2 112.997 -177.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -100.03 -45.11 5.78 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.387 1.475 . . . . 2.17 110.434 168.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 73.9 t -53.41 -54.94 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 123.991 0.916 . . . . 1.25 109.511 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.407 ' HB3' ' NZ ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -71.75 -25.53 62.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 117.447 -1.701 . . . . 1.94 109.81 178.429 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -59.11 -48.17 82.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.422 1.01 . . . . 2.21 109.042 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.27 -52.7 51.25 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 116.21 -0.45 . . . . 0.41 111.486 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -36.57 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.663 0.744 . . . . 1.67 110.131 -173.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.7 ttm-85 -55.57 -54.87 38.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.479 1.112 . . . . 3.94 108.276 173.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.573 ' O ' HG23 ' A' ' 140' ' ' VAL . 12.4 mmmm -66.34 -41.11 90.06 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.431 0.692 . . . . 1.27 109.658 -176.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -47.12 -54.46 10.47 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 118.551 0.614 . . . . 0.48 110.686 169.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.757 ' CD1' HG23 ' A' ' 220' ' ' ILE . 34.5 m-85 -59.81 -42.67 93.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.476 -0.49 . . . . 4.42 111.588 176.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -50.28 -39.85 46.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.393 0.677 . . . . 2.98 110.515 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 136' ' ' LYS . 44.6 t -61.0 -56.24 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.131 -0.692 . . . . 0.77 109.131 -176.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.4 ' CH2' ' HG ' ' A' ' 250' ' ' LEU . 26.8 m95 -75.24 -35.21 61.44 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 122.054 -0.404 . . . . 0.84 110.585 -173.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 89.0 p -70.7 -15.53 62.71 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.359 0.503 . . . . 2.28 112.359 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.13 -48.39 11.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.549 -1.278 . . . . 1.57 107.549 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 26.7 m -75.64 -40.42 40.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 113.191 0.811 . . . . 1.6 113.191 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 31.7 p -100.06 140.71 21.71 Favored Pre-proline 0 N--CA 1.447 -0.624 0 N-CA-C 108.466 -0.939 . . . . 0.87 108.466 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.33 12.03 0.89 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.241 2.627 . . . . 0.99 113.637 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.2 mt -70.09 115.52 9.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.58 1.152 . . . . 2.02 108.845 -175.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -82.53 89.79 6.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 122.445 1.117 . . . . 4.6 108.282 -172.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.18 146.1 48.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.738 -2.028 . . . . 6.38 109.299 170.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.6 t -151.19 147.31 26.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.881 -1.526 . . . . 1.08 106.881 165.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.407 ' NZ ' ' HB3' ' A' ' 131' ' ' ASP . 2.5 tmmt? -125.64 129.75 50.24 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 107.363 -1.347 . . . . 1.96 107.363 175.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.6 pp -133.75 170.69 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 105.952 -1.87 . . . . 1.5 105.952 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -142.63 27.37 1.69 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.798 0.726 . . . . 4.39 109.094 169.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 58.2 p -150.72 78.46 1.31 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.401 1.08 . . . . 2.66 108.531 -172.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.15 -128.08 2.76 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 108.028 -2.029 . . . . 1.54 108.028 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.0 mtt -126.43 148.81 49.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.407 1.083 . . . . 4.13 109.552 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -141.42 160.65 39.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.137 1.375 . . . . 0.69 109.299 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -80.86 -58.91 2.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.636 1.974 . . . . 1.98 107.786 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -91.02 179.04 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 122.035 0.921 . . . . 1.37 111.243 176.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 tt -138.75 127.61 23.66 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.495 2.318 . . . . 2.24 109.094 167.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 20.6 t -86.26 105.73 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.702 -1.221 . . . . 0.75 107.702 170.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.3 t -81.56 140.31 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 107.43 -1.322 . . . . 1.32 107.43 170.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.29 90.32 2.41 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.568 -2.012 . . . . 4.94 105.568 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.42 158.83 39.76 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.068 0.547 . . . . 0.78 109.988 -165.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 14.0 ptt-85 -124.0 115.57 21.43 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.837 0.855 . . . . 4.65 109.935 -162.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 60.48 -97.65 0.12 Allowed Glycine 0 CA--C 1.535 1.328 0 C-N-CA 123.335 0.493 . . . . 1.6 112.292 -175.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.39 135.8 35.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.785 0.834 . . . . 2.83 109.06 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 . . . . . 0 C--O 1.226 -0.148 0 N-CA-C 111.621 0.23 . . . . 3.64 111.621 176.254 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 121.342 0.591 . . . . 3.1 111.113 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -109.24 -179.28 3.79 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 106.917 -1.512 . . . . 6.2 106.917 159.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -143.74 -168.16 2.77 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.539 1.936 . . . . 3.99 106.149 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -90.34 -141.64 9.18 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.952 -0.859 . . . . 1.7 110.952 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.63 114.85 2.69 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.935 -0.765 . . . . 7.49 108.935 169.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.92 -155.94 16.21 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.083 -1.207 . . . . 1.96 110.083 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.28 -119.44 11.95 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 109.946 -1.262 . . . . 1.88 109.946 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . 0.339 2.2 mt -90.58 137.27 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 107.129 -1.434 . . . . 2.0 107.129 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -85.68 -56.85 3.3 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.12 1.368 . . . . 2.18 109.856 166.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -156.07 162.17 40.31 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 121.129 -0.982 . . . . 0.86 112.322 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -145.15 116.07 7.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.36 1.464 . . . . 0.93 114.265 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.77 159.04 40.9 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.951 2.1 . . . . 0.84 108.308 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -144.42 148.21 34.33 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.965 -1.494 . . . . 3.47 106.965 172.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -98.81 -82.34 1.66 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.851 -0.9 . . . . 1.13 110.851 170.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.97 92.71 0.71 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.396 2.73 . . . . 2.34 110.551 -172.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -175.39 157.38 23.94 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 108.661 -1.776 . . . . 2.04 108.661 171.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.3 m -77.54 157.62 30.27 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.11 -0.7 . . . . 2.96 109.11 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.89 -110.69 3.11 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.931 -0.868 . . . . 2.39 110.931 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.452 HG12 ' CE1' ' A' ' 196' ' ' HIS . 5.1 tp -63.03 -42.28 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 O-C-N 121.468 -1.019 . . . . 2.25 109.632 -170.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -30.75 129.56 0.16 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 126.252 1.882 . . . . 1.74 113.814 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 103.78 -52.75 0.75 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.465 1.983 . . . . 0.85 109.757 -164.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -84.09 160.61 20.89 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.054 0.942 . . . . 1.98 111.314 -167.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -138.91 124.52 19.53 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 118.136 -0.935 . . . . 0.65 111.56 -172.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.452 ' CE1' HG12 ' A' ' 191' ' ' ILE . 1.0 OUTLIER -112.38 127.21 55.95 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-O 117.721 -1.133 . . . . 2.07 109.244 -173.909 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -114.2 151.44 32.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.202 1.365 . . . . 2.87 110.947 174.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -73.83 101.34 3.71 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.417 -0.811 . . . . 3.43 109.964 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.36 -29.67 70.93 Favored 'General case' 0 C--O 1.24 0.596 0 O-C-N 121.485 -0.76 . . . . 2.5 111.147 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -59.44 -31.9 69.72 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.393 0.997 . . . . 3.11 109.344 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -68.03 150.51 48.35 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 122.107 0.956 . . . . 2.83 108.884 -176.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -102.3 93.03 4.98 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 105.695 -1.965 . . . . 3.45 105.695 174.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -77.85 138.79 39.13 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 108.536 -0.912 . . . . 1.16 108.536 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.7 108.79 2.02 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 120.975 1.716 . . . . 2.64 111.023 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.33 -51.38 54.88 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 118.4 0.545 . . . . 3.72 111.0 162.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -65.54 -38.3 89.22 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.7 -0.682 . . . . 4.92 111.875 -161.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 21.3 t -80.52 -43.25 21.05 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.345 0.658 . . . . 7.42 109.773 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 114.6 -31.69 6.24 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.314 -0.715 . . . . 3.52 112.131 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -21.91 -85.0 0.01 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 128.164 2.792 . . . . 1.16 114.545 -171.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 26.1 m -122.49 123.37 41.1 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 104.563 -2.384 . . . . 0.87 104.563 156.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -84.97 125.33 32.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.101 0.864 . . . . 1.36 109.236 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 43.6 tp -53.94 -51.83 62.54 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 118.044 0.384 . . . . 1.76 110.397 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.599 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.3 t80 -50.23 -46.76 55.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.108 0.563 . . . . 1.96 110.488 -178.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.503 ' C ' HD23 ' A' ' 214' ' ' LEU . 6.8 tt -56.12 -63.39 1.2 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.373 1.069 . . . . 1.21 110.866 -177.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.37 0.9 OUTLIER -59.13 -39.86 83.65 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.918 0.39 . . . . 0.97 110.453 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.41 62.31 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 116.822 -1.561 . . . . 0.48 109.409 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 213' ' ' PHE . 8.4 t -44.45 -55.25 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 121.117 1.78 . . . . 1.1 111.473 177.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.642 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 0.4 OUTLIER -51.71 -46.77 64.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.302 0.641 . . . . 2.38 111.802 178.82 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -79.51 -47.23 15.93 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.283 -0.885 . . . . 2.77 112.58 -173.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.757 HG23 ' CD1' ' A' ' 138' ' ' PHE . 1.3 mp -56.53 -41.61 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.035 1.734 . . . . 1.52 107.871 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.36 -47.33 83.54 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.284 -0.726 . . . . 0.91 111.284 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.642 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 7.1 m-70 -52.59 -52.31 55.81 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.433 -1.04 . . . . 1.52 110.389 174.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.0 m -51.06 -47.64 61.73 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.923 0.783 . . . . 2.12 112.476 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -18.87 15.18 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.204 1.002 . . . . 3.34 112.276 176.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 120.4 6.7 9.54 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 125.659 1.599 . . . . 1.62 111.243 173.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 258' ' ' ILE . 49.7 mt -88.89 109.36 20.15 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 117.842 0.821 . . . . 4.8 110.498 -159.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -60.63 158.47 28.07 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.503 1.049 . . . . 3.47 112.49 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.429 ' CD2' ' CE1' ' A' ' 222' ' ' HIS . 27.1 m80 -62.77 121.64 13.93 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.54 0.736 . . . . 1.77 111.5 -177.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 64.8 m -77.94 178.39 7.5 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.442 0.639 . . . . 1.58 110.678 171.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 p -125.22 6.49 7.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.905 2.082 . . . . 3.49 111.927 -164.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -118.38 136.68 24.11 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.264 1.426 . . . . 2.53 108.045 -171.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.63 -13.49 14.7 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.679 2.253 . . . . 1.86 114.439 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -80.5 -37.7 31.2 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.605 1.162 . . . . 1.61 108.892 173.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.02 149.0 24.33 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.424 0.69 . . . . 0.96 110.891 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.7 t -93.34 -17.82 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.234 -0.894 . . . . 0.84 110.504 177.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.73 -20.94 60.37 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 113.139 0.792 . . . . 2.14 113.139 -174.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -52.92 167.97 0.37 Allowed Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.932 1.693 . . . . 3.02 113.644 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -83.98 -14.44 7.39 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 121.942 1.761 . . . . 1.55 112.332 173.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.294 0.0 OUTLIER -79.35 176.74 9.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.913 1.285 . . . . 2.12 109.781 178.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.431 ' CE1' HD22 ' A' ' 214' ' ' LEU . 90.1 t80 -121.39 140.94 51.48 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.04 1.736 . . . . 2.28 106.503 176.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -151.31 132.51 14.46 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 105.095 -2.187 . . . . 2.46 105.095 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -61.21 123.1 16.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.149 0.432 . . . . 2.63 110.428 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.2 m -100.85 134.05 42.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 122.818 0.447 . . . . 1.99 109.997 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -81.96 90.56 6.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 122.224 1.012 . . . . 3.38 109.807 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 92.9 mt -54.06 -24.77 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.191 0.996 . . . . 2.95 110.757 178.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -46.74 -45.41 19.65 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.4 0.546 . . . . 3.47 111.868 170.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 25.6 m -84.04 -42.32 16.28 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.404 0.682 . . . . 1.92 109.895 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 69.8 t80 58.28 68.59 0.81 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.792 0.806 . . . . 4.24 110.223 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -160.49 165.22 31.33 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.009 -0.737 . . . . 3.48 109.009 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.4 ' HG ' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -109.17 -175.15 2.68 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.087 1.355 . . . . 1.77 110.145 -179.676 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 39.1 m -81.93 141.68 33.11 Favored 'General case' 0 C--O 1.222 -0.377 0 O-C-N 120.872 -1.143 . . . . 0.98 112.029 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.46 -39.61 57.79 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.231 0.539 . . . . 0.94 111.026 169.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -66.74 -21.7 66.06 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.929 0.714 . . . . 3.75 112.929 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.36 -51.81 7.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.903 0.881 . . . . 3.37 109.57 169.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 56.1 mt -47.58 -43.61 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.13 1.772 . . . . 1.13 111.77 -175.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -52.91 -53.53 47.96 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.823 0.344 . . . . 4.76 111.32 172.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.03 -54.37 30.89 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.089 -1.605 . . . . 1.63 109.089 -171.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.45 ' HA ' HD22 ' A' ' 226' ' ' LEU . 2.8 pp -55.37 -35.9 38.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 123.667 0.787 . . . . 2.46 112.348 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -73.04 -49.13 30.51 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 118.443 -0.789 . . . . 3.54 111.359 172.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 24.3 m -51.01 -37.15 43.39 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.736 1.153 . . . . 4.15 112.321 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 CA--C 1.534 0.353 0 C-N-CA 124.277 1.031 . . . . 5.19 111.489 176.64 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.551 ' CG ' HD11 ' A' ' 114' ' ' ILE . 1.1 mptp? . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 112.064 0.394 . . . . 5.84 112.064 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 56.27 -66.5 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.426 1.49 . . . . 3.82 110.645 -154.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -120.25 114.34 21.76 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.127 0.971 . . . . 3.61 112.377 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.551 HD11 ' CG ' ' A' ' 111' ' ' LYS . 45.9 mm -95.03 88.28 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 122.403 1.097 . . . . 2.68 109.024 168.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.97 123.87 29.85 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.26 -1.385 . . . . 1.72 107.26 176.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -127.08 163.28 24.13 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.531 1.059 . . . . 4.43 112.458 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -142.2 144.11 33.24 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.487 1.115 . . . . 5.82 109.233 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -92.99 151.79 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 109.5 -0.556 . . . . 1.08 109.5 176.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -86.46 -50.58 6.77 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.813 -0.81 . . . . 3.48 108.813 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -133.02 176.69 8.28 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 123.84 0.712 . . . . 3.29 111.777 174.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -138.94 160.93 38.57 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.431 1.893 . . . . 2.52 107.136 -177.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 90.6 m 46.99 56.26 17.09 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 123.505 0.722 . . . . 8.07 111.858 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.12 -39.96 1.46 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.121 1.881 . . . . 5.27 109.326 171.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.99 3.88 0.72 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.543 0.737 . . . . 2.08 112.75 -175.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 7.3 mtm -150.24 168.4 24.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.937 1.244 . . . . 1.66 110.843 -169.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -69.85 140.56 53.24 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.691 -0.485 . . . . 3.34 109.691 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -56.9 -40.0 75.46 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.267 -0.896 . . . . 2.08 112.138 -174.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.4 -3.06 5.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.892 -0.575 . . . . 3.48 112.289 -178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -96.69 -50.36 4.73 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.866 1.266 . . . . 2.68 110.357 161.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.1 m -58.43 -49.42 82.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 O-C-N 121.105 -0.997 . . . . 2.72 110.439 -169.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -71.79 -24.46 61.74 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 118.745 -1.182 . . . . 2.25 109.172 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -66.31 -48.93 68.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.659 1.118 . . . . 2.81 109.682 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.68 -49.5 76.3 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 123.774 0.829 . . . . 0.58 110.143 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.9 tp -70.88 -38.06 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.951 0.405 . . . . 1.69 110.469 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -54.87 41.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.725 -1.213 . . . . 3.45 107.725 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -59.24 -51.5 69.72 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.043 -0.981 . . . . 1.43 110.115 176.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -46.08 -50.36 15.37 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 118.686 0.676 . . . . 0.67 112.307 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.31 -51.6 62.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 118.839 -1.144 . . . . 6.69 109.196 175.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.16 -27.23 65.46 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.641 0.776 . . . . 2.08 112.0 -170.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.602 HG22 ' CD1' ' A' ' 248' ' ' PHE . 53.2 t -62.66 -54.76 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.561 1.144 . . . . 0.66 109.293 171.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.432 ' CZ3' ' HG ' ' A' ' 250' ' ' LEU . 59.3 m95 -73.6 -33.84 64.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 121.593 -0.692 . . . . 0.71 109.325 -174.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 74.0 m -65.62 -17.35 64.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 118.736 0.698 . . . . 1.24 112.571 173.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -75.71 -46.62 30.1 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.033 0.833 . . . . 1.15 109.068 174.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 57.3 t -74.38 -54.3 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.598 0.759 . . . . 2.16 110.455 -176.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.475 HG21 HD12 ' A' ' 258' ' ' ILE . 24.4 p -90.08 158.61 43.95 Favored Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 124.945 1.298 . . . . 0.6 109.823 -174.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -74.31 2.64 6.01 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.088 1.859 . . . . 0.8 112.848 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.9 mt -63.62 114.99 4.3 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.367 0.985 . . . . 2.18 110.396 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.5 76.06 2.53 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.348 -1.353 . . . . 4.26 107.348 -170.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -63.48 161.2 14.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.479 -0.782 . . . . 5.31 112.364 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.8 t -152.09 138.94 18.93 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.833 -1.543 . . . . 0.88 106.833 168.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -77.82 147.48 35.19 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.71 -1.959 . . . . 2.77 105.71 156.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.2 pt -132.51 120.83 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 105.556 -2.016 . . . . 1.31 105.556 156.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -75.12 -18.11 60.3 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.599 -0.688 . . . . 3.59 110.879 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.83 111.97 8.5 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 125.549 1.54 . . . . 2.28 109.299 -161.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 137.63 -137.15 8.68 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 108.415 -1.874 . . . . 1.44 108.415 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.6 mmt -131.42 135.83 47.49 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.601 1.56 . . . . 6.28 107.223 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -124.98 165.98 17.16 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.867 1.267 . . . . 0.94 110.154 -172.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -76.86 -57.42 3.86 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 122.036 0.922 . . . . 2.15 109.104 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.0 pt -109.26 155.41 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.699 -1.593 . . . . 0.95 106.699 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.45 HD22 ' C ' ' A' ' 160' ' ' LEU 0.36 0.0 OUTLIER -139.64 140.74 37.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 121.251 -0.906 . . . . 2.5 109.815 175.902 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 33.2 t -83.82 99.39 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 106.985 -1.487 . . . . 1.3 106.985 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.3 p -102.41 124.76 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 107.173 -1.417 . . . . 2.46 107.173 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -86.36 150.08 24.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.118 -1.438 . . . . 7.47 107.118 167.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.73 156.55 31.84 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.783 -1.562 . . . . 1.1 106.783 161.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -119.44 140.78 49.87 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.625 -1.62 . . . . 5.31 106.625 164.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 22.25 53.71 0.02 OUTLIER Glycine 0 CA--C 1.531 1.079 0 C-N-CA 128.137 2.779 . . . . 3.46 115.937 -173.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -156.63 138.67 14.49 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.212 -1.033 . . . . 4.16 108.212 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.398 0 C-N-CA 127.315 2.246 . . . . 5.43 108.415 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.375 0 N-CA-C 109.649 -0.5 . . . . 2.91 109.649 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.412 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -166.98 -171.98 1.94 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.249 -1.389 . . . . 8.08 107.249 176.045 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.412 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 4.0 p30 -171.57 44.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 O-C-N 124.629 1.205 . . . . 2.61 109.854 171.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 52.64 -156.54 4.53 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.652 -0.979 . . . . 1.54 110.652 -167.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -64.78 140.67 58.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.82 -0.811 . . . . 5.77 111.462 170.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 93.05 -164.33 27.3 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 125.462 1.506 . . . . 1.34 110.344 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.11 -118.15 9.6 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.834 1.683 . . . . 1.28 111.729 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.27 123.26 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 106.0 -1.852 . . . . 1.89 106.0 175.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.442 HD23 HG21 ' A' ' 210' ' ' THR 0.669 7.3 mp -76.91 -63.95 1.24 Allowed 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.266 -1.383 . . . . 1.55 107.266 168.988 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -159.16 155.98 28.17 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 113.757 1.021 . . . . 0.8 113.757 -168.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . 0.351 0.7 OUTLIER -103.32 142.44 34.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.544 1.938 . . . . 1.65 110.351 176.005 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -164.43 165.79 21.16 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.628 -1.99 . . . . 0.54 105.628 154.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -151.44 152.36 32.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 104.719 -2.326 . . . . 3.18 104.719 173.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -91.88 -78.97 1.4 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 109.964 -1.255 . . . . 0.73 109.964 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -69.85 176.71 6.47 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.385 2.057 . . . . 2.12 110.089 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 90.12 144.03 11.19 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.86 -1.296 . . . . 1.1 109.86 -172.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.3 p -82.55 -178.73 7.18 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.518 1.127 . . . . 2.11 110.479 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 61.36 -115.37 7.81 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.802 -0.919 . . . . 1.32 110.802 173.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.9 tp -60.21 -40.55 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.419 -0.586 . . . . 1.53 109.419 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -39.35 136.41 1.37 Allowed Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.469 1.033 . . . . 1.01 112.295 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 96.6 -42.17 2.26 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.452 1.025 . . . . 0.74 112.448 -165.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -74.57 171.64 13.47 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.953 1.376 . . . . 1.4 111.749 -159.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -132.55 112.81 12.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.994 -1.484 . . . . 1.65 106.994 -163.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -132.48 101.94 5.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.644 -0.502 . . . . 5.67 109.644 -156.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -104.96 133.53 49.6 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.438 1.017 . . . . 2.5 109.695 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -57.0 105.67 0.24 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.549 -0.908 . . . . 2.75 108.549 171.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -59.39 -33.54 71.33 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.9 0.88 . . . . 2.89 110.925 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.5 -27.15 67.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.51 0.671 . . . . 3.42 109.462 -176.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -68.58 133.62 48.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.705 -1.591 . . . . 2.17 106.705 171.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -98.44 96.01 7.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.957 -1.868 . . . . 7.39 105.957 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 43.8 m95 -75.13 159.98 31.0 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.999 -1.111 . . . . 1.33 107.999 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 211' ' ' ASN . 12.8 p -139.76 139.6 36.51 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.097 0.475 . . . . 2.2 111.454 -173.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.2 t -64.3 -49.34 72.19 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.938 -1.101 . . . . 1.64 111.293 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -81.41 -167.38 1.45 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.938 0.895 . . . . 3.02 109.697 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 20.8 t -56.82 -56.32 23.04 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.869 -0.419 . . . . 4.1 109.869 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 50.43 -94.85 0.01 OUTLIER Glycine 0 C--N 1.34 0.764 0 C-N-CA 124.869 1.224 . . . . 2.27 113.056 171.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -140.01 -75.26 0.05 OUTLIER Glycine 0 CA--C 1.523 0.572 0 N-CA-C 108.926 -1.67 . . . . 1.26 108.926 170.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.442 HG21 HD23 ' A' ' 181' ' ' LEU . 11.5 m -108.25 119.29 39.05 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.447 -1.686 . . . . 1.1 106.447 176.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 204' ' ' THR . 5.3 t-20 -78.5 125.91 30.03 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 120.103 -0.639 . . . . 1.56 109.641 -178.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.34 -52.67 62.72 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 109.115 -0.698 . . . . 1.38 109.115 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -52.93 -42.12 65.12 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.955 0.502 . . . . 2.26 110.277 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.461 HD11 HG22 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -60.9 -60.56 3.6 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.284 -0.885 . . . . 1.63 111.184 179.027 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.343 2.0 m -54.97 -38.91 68.41 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 110.259 -0.274 . . . . 0.7 110.259 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.36 -53.21 60.81 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 118.704 -0.665 . . . . 0.46 110.236 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 97.6 t -53.48 -47.38 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 119.542 1.065 . . . . 0.74 109.864 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.442 ' HE1' ' HA ' ' A' ' 238' ' ' PRO 0.455 5.7 t60 -51.52 -51.44 55.17 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.363 1.065 . . . . 1.9 113.819 170.637 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.99 -48.6 12.02 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.053 1.297 . . . . 2.94 113.809 -173.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.3 -39.92 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 106.66 -1.607 . . . . 1.19 106.66 167.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -47.88 -57.86 7.4 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.451 1.024 . . . . 0.6 113.634 166.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.468 ' NE2' ' NE2' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -50.36 -48.99 55.4 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.449 1.125 . . . . 1.69 110.041 176.118 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 69.4 p -61.75 -19.92 62.97 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 113.55 0.944 . . . . 1.66 113.55 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 258' ' ' ILE . 9.4 mt -66.01 -67.93 0.41 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.713 -1.588 . . . . 2.26 106.713 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 156.62 66.15 0.01 OUTLIER Glycine 0 C--O 1.228 -0.259 0 N-CA-C 108.721 -1.752 . . . . 1.17 108.721 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.69 136.64 53.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.732 1.613 . . . . 4.77 107.035 -174.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -109.83 41.81 2.13 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.239 0.923 . . . . 2.99 111.902 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.468 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 70.1 m80 68.81 110.66 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.874 2.069 . . . . 1.62 113.407 178.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 34.9 m -74.8 160.51 30.6 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.611 -0.885 . . . . 1.26 108.611 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 66.7 m -133.24 47.84 2.45 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.883 1.273 . . . . 2.86 108.957 -170.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -143.59 141.14 18.35 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.782 1.633 . . . . 1.82 106.607 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -91.39 -8.92 3.07 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.197 1.931 . . . . 0.96 114.533 -173.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -82.17 -37.61 25.87 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.134 -0.979 . . . . 1.42 108.372 170.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -53.18 152.07 4.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.585 1.154 . . . . 0.99 111.534 172.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 84.0 t -106.68 -25.9 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.352 1.061 . . . . 0.95 111.289 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 4.5 mtt -60.91 -27.39 68.14 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.161 -0.962 . . . . 3.22 113.43 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.417 ' O ' ' ND1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.34 160.15 0.46 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 127.975 2.51 . . . . 3.41 114.455 -171.28 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.442 ' HA ' ' HE1' ' A' ' 218' ' ' HIS . 59.7 Cg_endo -75.54 -21.23 15.08 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.669 1.579 . . . . 1.01 111.818 175.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.368 0.2 OUTLIER -78.03 178.13 7.75 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.126 0.97 . . . . 1.28 108.976 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -126.25 149.74 48.89 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.915 -1.513 . . . . 2.46 106.915 174.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -153.5 120.28 5.65 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 104.677 -2.342 . . . . 3.29 104.677 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -60.76 122.47 14.87 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.256 -0.646 . . . . 2.36 109.256 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.461 HG22 HD11 ' A' ' 214' ' ' LEU . 15.9 m -125.22 142.37 42.29 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.051 0 CA-C-O 121.056 0.455 . . . . 1.76 110.961 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.09 91.48 0.16 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.384 1.474 . . . . 3.03 108.172 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 2.2 pp -51.7 -29.0 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 123.971 0.909 . . . . 2.96 111.419 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -50.29 -40.15 47.59 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.853 1.261 . . . . 3.62 111.461 174.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 85.7 m -67.7 -45.89 73.82 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.516 0.727 . . . . 1.7 109.982 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.602 ' CD1' HG22 ' A' ' 140' ' ' VAL . 0.5 OUTLIER 50.38 81.78 0.06 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.249 1.02 . . . . 5.13 110.88 177.117 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.55 158.36 38.32 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.748 -0.834 . . . . 2.98 108.748 167.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 250' ' ' LEU . 1.3 mm? -105.76 160.63 15.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.531 1.532 . . . . 0.79 107.379 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 26.3 m -78.21 152.71 32.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.895 -0.503 . . . . 0.64 110.77 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -54.83 -45.99 74.55 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.882 0.473 . . . . 0.69 110.323 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -50.33 -54.48 21.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.698 0.761 . . . . 2.44 109.924 172.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.77 -47.11 86.99 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.899 -1.046 . . . . 2.18 110.35 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.9 mt -50.93 -49.22 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 125.576 1.551 . . . . 0.97 110.055 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -58.15 -48.87 78.91 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.827 -1.171 . . . . 5.04 110.492 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -56.91 -34.77 66.03 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.514 0.578 . . . . 1.31 112.824 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 224' ' ' LEU . 0.2 OUTLIER -68.83 -49.34 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.622 -1.251 . . . . 3.51 107.622 -178.807 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -63.59 -23.18 67.28 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.138 -0.977 . . . . 2.75 111.772 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.4 m -47.61 -18.77 0.15 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.291 1.219 . . . . 2.35 114.291 168.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 C--N 1.343 0.324 0 CA-C-N 119.428 1.013 . . . . 2.51 113.319 169.299 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.539 0.546 0 N-CA-C 113.141 0.793 . . . . 7.37 113.141 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.6 m170 69.72 -61.54 0.44 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 127.704 2.401 . . . . 4.41 111.155 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -79.56 108.51 13.15 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.98 1.312 . . . . 3.93 108.199 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.4 mm -132.19 136.49 56.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.606 -1.627 . . . . 3.53 106.606 171.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.4 p -110.58 141.22 44.08 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.194 0.998 . . . . 1.75 109.116 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.456 ' CD2' HG12 ' A' ' 159' ' ' ILE . 5.5 m-85 -126.77 152.15 47.27 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.127 0.971 . . . . 7.54 108.768 -172.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -146.94 143.02 28.17 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.357 -0.608 . . . . 4.67 109.357 178.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 118' ' ' ILE . 2.4 mt -88.36 156.98 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.947 -1.131 . . . . 0.92 107.947 175.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.15 -46.0 6.01 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.532 0.605 . . . . 2.78 109.976 -178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -136.43 -179.8 5.9 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.491 0.716 . . . . 3.85 109.162 173.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -120.98 110.62 16.49 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 105.749 -1.945 . . . . 1.97 105.749 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.95 141.48 96.72 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-N 119.038 0.836 . . . . 2.27 110.282 -173.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -68.36 -14.71 40.82 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.865 3.044 . . . . 1.52 111.377 174.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -41.84 -41.32 2.35 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.695 0.798 . . . . 2.45 110.72 173.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -134.6 -177.39 4.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.587 1.155 . . . . 1.83 109.94 175.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -84.86 156.45 21.29 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.31 0.644 . . . . 3.11 109.821 170.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 57.6 ttt-85 -52.47 -50.06 63.41 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.876 0.695 . . . . 2.93 112.876 -176.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.22 -2.22 15.25 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.598 -0.715 . . . . 4.94 111.84 -176.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -98.71 -45.03 6.18 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.529 1.059 . . . . 1.72 109.95 164.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.43 -47.45 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.546 -0.721 . . . . 2.1 109.367 -172.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.25 -26.44 61.11 Favored 'General case' 0 C--O 1.213 -0.846 0 C-N-CA 118.488 -1.285 . . . . 1.86 108.709 177.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -61.85 -50.68 71.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 119.918 1.235 . . . . 2.35 109.453 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.22 -53.33 55.0 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.031 0.932 . . . . 0.85 109.743 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -69.39 -40.35 79.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.442 0.639 . . . . 1.46 111.075 -175.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -58.06 -52.71 64.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.41 1.484 . . . . 5.0 107.783 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.632 ' O ' HG23 ' A' ' 140' ' ' VAL . 9.7 mmtp -62.94 -51.47 66.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.1 0.96 . . . . 1.43 110.661 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -48.17 -46.03 34.22 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 123.782 0.833 . . . . 1.06 110.869 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 149' ' ' PHE . 0.7 OUTLIER -66.27 -53.83 32.12 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.324 -0.853 . . . . 4.58 110.139 176.068 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -47.38 -40.24 17.1 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.392 1.077 . . . . 2.64 111.934 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.639 HG12 HD21 ' A' ' 250' ' ' LEU . 84.5 t -48.93 -48.75 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 125.195 1.398 . . . . 0.95 109.449 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.896 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 59.3 m95 -80.23 -38.35 31.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.381 0.672 . . . . 0.8 111.497 178.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.5 m -61.99 -24.92 67.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.983 0.811 . . . . 2.54 111.577 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -73.34 -45.16 56.79 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.885 -0.413 . . . . 1.25 109.885 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.418 HG21 HD23 ' A' ' 250' ' ' LEU . 93.4 t -77.62 -49.84 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.227 1.011 . . . . 1.88 110.165 -171.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.445 ' CB ' HD12 ' A' ' 147' ' ' LEU . 81.2 p -79.43 153.94 76.48 Favored Pre-proline 0 N--CA 1.447 -0.618 0 N-CA-C 109.145 -0.687 . . . . 0.82 109.145 175.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.58 4.28 6.51 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.265 1.977 . . . . 0.75 112.55 173.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.75 HD11 HD13 ' A' ' 261' ' ' LEU . 4.6 mt -71.53 125.62 27.54 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.643 1.111 . . . . 1.79 109.658 -170.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -89.68 76.81 7.23 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.14 -1.43 . . . . 3.76 107.14 -169.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 138' ' ' PHE . 1.4 p90 -61.48 156.13 20.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 118.143 -1.423 . . . . 6.24 112.76 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.8 t -154.01 92.97 1.59 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.875 -0.787 . . . . 2.14 108.875 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -79.08 128.12 32.87 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.831 -0.803 . . . . 6.13 108.831 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.8 pp -133.89 148.71 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 105.901 -1.888 . . . . 1.22 105.901 174.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -115.8 6.07 14.27 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 118.079 0.4 . . . . 3.8 111.79 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.9 p -136.4 119.55 16.59 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.828 0.851 . . . . 2.32 108.817 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 121.6 -149.09 17.26 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 107.213 -2.355 . . . . 1.64 107.213 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -114.77 138.0 51.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.233 1.413 . . . . 5.14 107.298 172.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.08 164.27 12.79 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.691 1.196 . . . . 1.0 109.558 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -77.13 -46.66 22.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.829 -1.175 . . . . 2.73 107.829 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.456 HG12 ' CD2' ' A' ' 116' ' ' TYR . 0.7 OUTLIER -107.95 172.62 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 121.486 0.66 . . . . 1.8 111.554 173.453 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.58 133.67 36.61 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.008 2.123 . . . . 2.0 110.22 170.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.9 t -93.45 107.06 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.589 -1.263 . . . . 0.96 107.589 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 70.6 t -117.2 81.48 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.682 1.193 . . . . 1.81 109.378 -174.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -77.31 149.03 35.36 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.605 -1.628 . . . . 4.8 106.605 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.07 -170.4 3.27 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.266 -1.013 . . . . 1.24 108.266 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.06 141.35 47.15 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.587 0.63 . . . . 6.79 110.127 -178.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 33.25 -111.23 0.06 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.907 2.194 . . . . 1.98 113.72 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.84 112.67 14.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.815 -1.18 . . . . 2.55 107.815 174.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 . . . . . 0 C--O 1.227 -0.098 0 C-N-CA 124.411 1.084 . . . . 4.08 110.876 -177.035 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 113.001 0.741 . . . . 3.22 113.001 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -96.96 174.15 6.92 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.899 0.88 . . . . 6.37 109.832 168.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -137.63 166.57 23.6 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.698 1.999 . . . . 3.62 107.872 176.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -70.92 -156.96 2.18 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.384 0.516 . . . . 2.03 112.891 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -51.91 111.01 0.54 Allowed 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.571 -0.958 . . . . 3.57 111.541 177.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.4 -151.79 17.47 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.474 -1.45 . . . . 2.45 109.474 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.33 -126.32 23.34 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 124.937 1.256 . . . . 2.37 110.372 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.1 mm -78.21 124.75 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 107.532 -1.284 . . . . 1.76 107.532 172.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.8 mp -83.48 -31.71 26.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.318 -0.855 . . . . 1.73 110.653 167.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.409 ' HB1' ' CD ' ' A' ' 219' ' ' GLU . . . -171.15 153.28 3.66 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 114.929 1.455 . . . . 0.86 114.929 -177.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -136.3 125.95 25.42 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 126.543 1.937 . . . . 0.88 113.626 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -157.32 162.03 39.11 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 128.168 2.587 . . . . 0.58 104.935 -172.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -149.0 155.33 40.64 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.284 -2.117 . . . . 3.48 105.284 171.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -101.41 -74.65 1.08 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.374 -1.09 . . . . 0.67 110.374 172.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -68.52 174.12 8.83 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.067 1.845 . . . . 1.66 110.204 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 83.12 164.47 36.05 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.198 -1.161 . . . . 1.88 110.198 -170.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.8 p -82.9 179.94 7.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.157 0.983 . . . . 2.75 111.302 -175.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.27 -114.17 6.54 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.363 0.506 . . . . 1.76 111.915 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 191' ' ' ILE 0.255 2.7 tp -60.57 -40.78 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 117.386 -1.293 . . . . 1.78 109.195 -174.6 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -20.77 115.73 0.01 OUTLIER Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.332 1.92 . . . . 1.29 113.56 169.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 109.99 -49.44 0.85 Allowed Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.993 2.235 . . . . 0.76 110.64 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -83.87 164.81 19.23 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.349 1.46 . . . . 2.1 111.216 -168.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.11 131.99 18.07 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.945 1.091 . . . . 0.7 113.945 -172.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -116.55 120.4 38.59 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-O 118.257 -0.878 . . . . 2.53 110.352 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.0 150.57 22.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.975 0.807 . . . . 2.72 111.877 169.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -76.25 93.17 3.37 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.047 0.939 . . . . 2.55 112.064 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -77.76 -8.43 57.97 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 118.061 -0.971 . . . . 2.31 111.632 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -57.36 -47.13 82.42 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 107.751 -1.203 . . . . 3.48 107.751 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . 0.268 9.5 pt-20 -73.49 175.57 6.89 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.922 1.344 . . . . 2.43 111.52 173.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -133.08 85.13 2.19 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.458 -1.682 . . . . 5.33 106.458 -171.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.463 ' CE2' HD23 ' A' ' 212' ' ' LEU . 0.0 OUTLIER -74.15 163.51 27.77 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.105 -1.407 . . . . 2.29 108.286 169.418 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.2 p -145.82 166.35 26.19 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.406 -0.961 . . . . 2.66 108.406 173.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.7 t -49.8 -39.26 37.73 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 121.214 -0.929 . . . . 2.03 111.013 165.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.69 138.98 40.42 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.313 0.645 . . . . 2.88 110.628 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.2 m -63.6 -16.95 62.27 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.485 1.514 . . . . 4.07 112.603 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.96 -66.07 2.98 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.157 0.885 . . . . 2.4 115.131 -167.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -80.27 -89.59 0.51 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.409 -0.676 . . . . 1.3 111.409 -166.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 18.4 m -131.89 170.71 14.5 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 103.179 -2.897 . . . . 1.48 103.179 158.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -130.58 133.52 46.26 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 118.14 0.427 . . . . 1.59 111.009 171.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.463 HD23 ' CE2' ' A' ' 203' ' ' TRP . 3.4 tm? -63.69 -45.87 88.08 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.216 -0.661 . . . . 1.73 109.216 -175.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.21 -47.33 54.81 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 109.499 -0.556 . . . . 1.78 109.499 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.77 -60.45 3.43 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.038 0.935 . . . . 2.91 110.289 -178.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 8.5 m -56.22 -41.9 76.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.961 -0.563 . . . . 1.26 110.549 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.68 -51.63 68.76 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 117.921 -1.038 . . . . 0.46 110.549 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 70.9 t -45.89 -46.64 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 119.669 1.122 . . . . 0.83 110.22 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 1.092 ' NE2' ' NE2' ' A' ' 222' ' ' HIS 0.494 0.3 OUTLIER -64.76 -47.28 78.76 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.627 -0.671 . . . . 2.64 112.443 178.059 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 219' ' ' GLU . . . . . 0.409 ' CD ' ' HB1' ' A' ' 182' ' ' ALA 0.285 19.5 mm-40 -70.42 -48.59 55.33 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 120.727 -1.233 . . . . 2.93 113.376 -176.268 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.437 HG21 ' HA ' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -51.66 -42.01 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 107.862 -1.162 . . . . 1.64 107.862 171.885 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -54.86 -55.07 29.58 Favored Glycine 0 CA--C 1.539 1.588 0 N-CA-C 111.595 -0.602 . . . . 0.5 111.595 172.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 1.092 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 18.4 m-70 -50.22 -58.19 6.16 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 117.878 0.839 . . . . 1.27 110.514 177.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.9 t -47.94 -49.67 29.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.963 2.105 . . . . 1.6 110.737 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.67 HD12 HD13 ' A' ' 147' ' ' LEU . 0.3 OUTLIER -65.32 -37.12 86.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 122.962 0.505 . . . . 3.59 110.061 -178.526 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 143.93 70.45 0.02 OUTLIER Glycine 0 C--N 1.338 0.67 0 N-CA-C 112.001 -0.44 . . . . 1.17 112.001 160.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.892 HD11 HG22 ' A' ' 258' ' ' ILE . 11.1 mt -133.94 155.61 49.62 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.182 0.593 . . . . 3.07 110.312 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -132.19 48.91 0.94 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.823 1.201 . . . . 3.0 110.122 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.638 ' HD2' ' O ' ' A' ' 236' ' ' MET . 59.6 m80 70.04 165.17 0.27 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.778 1.631 . . . . 3.2 112.514 -176.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.3 m -132.71 141.28 48.49 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.089 -1.819 . . . . 1.09 106.089 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 31.5 t -80.34 47.55 0.93 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.004 0.522 . . . . 2.28 111.718 -170.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -154.27 135.56 8.86 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-O 118.472 -0.775 . . . . 2.01 109.775 -171.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.89 -16.77 7.37 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.82 2.347 . . . . 1.89 114.403 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -76.44 -36.6 57.85 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.458 -1.401 . . . . 2.34 109.033 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.98 124.66 17.47 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.325 0.583 . . . . 1.32 109.586 167.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 69.2 t -64.59 -25.22 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.926 -0.768 . . . . 0.94 108.926 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.638 ' O ' ' HD2' ' A' ' 228' ' ' HIS . 1.2 mmt -49.0 -23.96 1.34 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.099 1.518 . . . . 2.47 115.099 171.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -53.91 139.47 52.69 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 119.366 0.985 . . . . 6.27 110.59 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.88 -23.45 62.13 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.274 1.982 . . . . 1.44 112.021 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.361 0.2 OUTLIER -94.52 154.43 17.41 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.606 -0.886 . . . . 2.91 108.606 178.592 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -72.86 150.03 43.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.617 -0.883 . . . . 2.21 108.617 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -141.75 139.82 32.93 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.33 -0.989 . . . . 3.5 108.33 173.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -76.26 77.7 3.05 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.765 0.826 . . . . 3.6 109.509 -176.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 25.5 m -83.79 103.59 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 116.016 -0.538 . . . . 1.63 109.957 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.26 115.54 3.59 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.872 0.368 . . . . 3.53 110.323 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 8.8 mt -57.45 -24.42 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.268 0.627 . . . . 2.71 109.75 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -41.95 -43.54 3.15 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 124.121 0.968 . . . . 3.78 112.621 168.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 14.0 m -82.65 -47.74 11.72 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.204 0.602 . . . . 2.4 110.053 -177.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.437 ' CE1' HG22 ' A' ' 140' ' ' VAL . 59.7 t80 52.82 69.4 0.7 Allowed 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.256 1.022 . . . . 4.41 110.873 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -157.94 170.12 23.04 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.447 -0.783 . . . . 3.48 110.142 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.639 HD21 HG12 ' A' ' 140' ' ' VAL . 0.8 OUTLIER -109.89 152.4 25.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.972 1.709 . . . . 0.93 107.47 -179.05 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.0 151.35 33.63 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 121.423 -0.798 . . . . 1.06 111.195 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -47.69 -47.2 29.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.669 0.788 . . . . 1.03 110.786 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -57.49 -45.7 84.58 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.444 0.64 . . . . 2.45 110.8 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 258' ' ' ILE . 4.6 t0 -58.26 -50.61 72.97 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.993 -1.003 . . . . 2.36 108.866 177.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.5 mt -55.29 -33.16 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.078 1.751 . . . . 1.18 112.525 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -70.94 -50.79 30.79 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.726 -1.234 . . . . 5.95 109.809 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -46.87 -52.52 11.54 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.366 -0.694 . . . . 0.93 111.366 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.896 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 1.9 pp -63.08 -45.48 98.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.655 0.782 . . . . 2.26 109.711 -176.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -61.47 -30.24 70.47 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 120.815 -1.178 . . . . 2.1 110.947 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.88 -17.56 0.59 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.573 0.953 . . . . 1.79 113.573 172.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' LEU . . . . . 0.75 HD13 HD11 ' A' ' 147' ' ' LEU . 36.4 mt . . . . . 0 C--N 1.346 0.43 0 CA-C-N 120.026 1.284 . . . . 2.42 113.196 164.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 106.919 -1.511 . . . . 10.51 106.919 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -139.35 -88.41 0.21 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.087 0.955 . . . . 7.79 108.637 173.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -146.12 145.51 30.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.591 1.556 . . . . 3.49 107.761 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 114' ' ' ILE . 0.9 OUTLIER -128.86 96.83 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.32 -0.993 . . . . 2.81 108.32 176.406 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -104.41 140.4 37.97 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.683 1.593 . . . . 1.26 108.963 -174.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -122.79 160.81 25.21 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.115 0.966 . . . . 5.58 111.821 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.407 ' HG3' HD12 ' A' ' 160' ' ' LEU . 15.9 ptt180 -146.46 144.66 29.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.336 1.054 . . . . 8.23 110.012 177.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.476 HD11 ' HD2' ' A' ' 151' ' ' LYS . 5.4 mt -106.0 156.3 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.204 1.402 . . . . 0.94 107.509 175.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.414 HD21 ' HG ' ' A' ' 160' ' ' LEU . 45.7 m-80 -107.04 -44.15 4.46 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.917 0.887 . . . . 3.93 110.54 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -152.2 172.96 15.57 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.499 1.119 . . . . 2.18 107.98 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -127.56 139.57 52.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.136 1.374 . . . . 2.12 107.86 -170.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.8 t -66.3 141.7 97.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.277 -0.638 . . . . 2.45 109.277 172.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -77.77 -16.31 14.69 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.74 2.96 . . . . 1.84 111.088 173.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -44.19 -44.37 7.75 Favored 'General case' 0 C--N 1.345 0.374 0 C-N-CA 124.875 1.27 . . . . 2.58 111.357 -178.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 22.0 mtm -126.28 168.86 13.53 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.919 1.687 . . . . 2.01 107.756 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -65.7 143.27 57.65 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 108.979 -0.748 . . . . 3.2 108.979 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -47.34 -48.21 25.51 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.01 0.823 . . . . 3.93 110.99 174.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -58.44 -18.81 31.4 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.54 -0.743 . . . . 3.14 112.205 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -93.59 -42.2 9.33 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.128 1.771 . . . . 2.06 110.458 173.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.5 t -53.22 -55.47 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 O-C-N 120.603 -1.31 . . . . 1.24 109.48 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -24.88 65.01 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 117.897 -1.521 . . . . 1.86 109.482 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -62.93 -48.89 76.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.399 0.999 . . . . 2.16 109.889 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.478 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -58.97 -48.8 80.25 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 122.403 0.281 . . . . 0.43 110.677 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 220' ' ' ILE . 0.2 OUTLIER -70.27 -37.24 70.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 121.227 0.537 . . . . 1.85 109.933 -179.211 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -55.42 31.48 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.277 1.031 . . . . 2.92 108.496 176.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.598 ' O ' HG23 ' A' ' 140' ' ' VAL . 19.0 mmmt -61.58 -46.64 89.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.397 1.079 . . . . 1.66 109.394 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -48.43 -55.77 9.98 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.364 0.666 . . . . 0.64 110.701 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -55.99 -51.78 66.51 Favored 'General case' 0 N--CA 1.457 -0.104 0 O-C-N 121.806 -0.559 . . . . 4.45 110.394 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.9 -35.27 57.92 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.757 0.651 . . . . 2.14 112.757 -175.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.704 HG12 HD21 ' A' ' 250' ' ' LEU . 91.4 t -56.89 -51.76 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 123.949 0.9 . . . . 0.81 109.862 175.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.453 ' NE1' HG22 ' A' ' 217' ' ' VAL . 95.0 m95 -77.35 -28.08 52.88 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.794 -0.566 . . . . 1.0 109.793 -175.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.34 -31.83 72.51 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.952 0.901 . . . . 1.5 109.744 175.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -66.05 -49.27 68.27 Favored 'General case' 0 C--N 1.341 0.23 0 O-C-N 121.644 -0.66 . . . . 1.27 109.682 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.633 HG21 HD23 ' A' ' 250' ' ' LEU . 64.7 t -70.77 -54.4 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 123.07 0.548 . . . . 1.97 110.408 -176.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.619 ' CG2' HG13 ' A' ' 258' ' ' ILE . 81.5 p -82.5 137.19 45.04 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 109.603 -0.517 . . . . 0.85 109.603 -174.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -68.05 19.79 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.555 2.836 . . . . 1.5 113.88 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.444 HD13 ' HB ' ' A' ' 145' ' ' THR . 2.9 mp -81.06 166.08 21.07 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.774 1.63 . . . . 3.12 108.774 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -124.63 86.13 2.51 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.714 -0.847 . . . . 3.78 108.714 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -74.4 142.32 45.02 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.594 1.158 . . . . 5.86 113.256 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 t -151.9 101.57 2.76 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.017 1.117 . . . . 0.9 114.017 -176.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.476 ' HD2' HD11 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -80.39 126.1 30.76 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 120.157 -1.589 . . . . 2.9 109.963 172.071 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.401 HD11 ' HB2' ' A' ' 157' ' ' ALA . 2.6 pp -125.6 149.35 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.885 -1.524 . . . . 1.3 106.885 174.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -101.73 -15.63 16.91 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.825 0.345 . . . . 2.76 110.557 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 55.1 m -144.4 132.41 21.55 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.405 -2.072 . . . . 2.99 105.405 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 141.5 -155.27 25.17 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 106.882 -2.487 . . . . 1.6 106.882 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.6 mtt -119.99 140.3 51.17 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.533 -2.025 . . . . 4.8 105.533 174.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.401 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -144.26 153.5 42.1 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.026 -1.102 . . . . 0.8 108.026 -176.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.29 -56.69 4.34 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.427 -1.323 . . . . 1.85 107.427 -167.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.1 pt -86.16 -174.66 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 114.82 -1.082 . . . . 1.62 110.541 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.414 ' HG ' HD21 ' A' ' 119' ' ' ASN . 1.1 tp -145.39 134.65 22.92 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.862 2.065 . . . . 2.67 107.689 173.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.7 t -97.04 98.33 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.182 -1.044 . . . . 0.76 108.182 172.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 72.7 t -80.25 129.34 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.804 -1.184 . . . . 1.5 107.804 173.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -111.07 126.55 54.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 104.618 -2.364 . . . . 5.12 104.618 156.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.722 ' HB3' ' CZ ' ' A' ' 174' ' ' PHE . . . -144.2 157.94 44.01 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 109.424 -0.584 . . . . 0.88 109.424 175.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.26 91.31 2.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.851 1.261 . . . . 4.14 109.347 -173.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 115.28 -55.31 0.54 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.759 1.171 . . . . 1.95 111.093 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -152.78 165.73 34.46 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.998 0.919 . . . . 3.02 108.787 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.239 0 N-CA-C 112.642 0.608 . . . . 3.28 112.642 173.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.166 0.031 . . . . 2.47 111.049 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.722 ' CZ ' ' HB3' ' A' ' 164' ' ' ALA . 35.9 m-85 -112.09 174.84 5.69 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.58 1.552 . . . . 6.15 107.646 176.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -179.38 31.99 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.878 0.871 . . . . 2.31 111.536 -174.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 55.01 -155.12 9.11 Favored Glycine 0 CA--C 1.532 1.148 0 O-C-N 120.714 -1.241 . . . . 1.36 111.604 -170.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -69.37 98.36 1.07 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.271 1.028 . . . . 4.11 110.772 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 152.15 -175.21 30.94 Favored Glycine 0 C--O 1.24 0.512 0 N-CA-C 111.308 -0.717 . . . . 1.54 111.308 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 45.53 -118.6 3.09 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 126.834 2.159 . . . . 1.35 111.131 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.9 mm -80.58 129.61 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.723 -1.214 . . . . 1.51 107.723 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.42 -44.88 16.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.209 1.404 . . . . 2.31 109.025 165.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -164.26 149.76 10.5 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 113.062 0.764 . . . . 0.67 113.062 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.457 ' CD2' ' HD1' ' A' ' 196' ' ' HIS . 24.6 p-80 -131.68 115.0 15.47 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.758 1.623 . . . . 1.01 112.469 -174.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -147.43 160.19 42.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.55 2.74 . . . . 0.6 105.476 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -150.45 160.05 44.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.855 -1.535 . . . . 3.56 106.855 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -81.65 -69.07 1.41 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.173 0.892 . . . . 1.23 111.968 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -58.73 132.79 49.98 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.42 2.08 . . . . 2.85 109.215 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -75.69 44.7 1.78 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.639 1.114 . . . . 2.19 112.876 -171.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.3 m -77.38 78.93 3.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.636 -1.246 . . . . 5.33 107.636 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.53 -101.26 0.75 Allowed Glycine 0 C--O 1.244 0.778 0 N-CA-C 110.317 -1.113 . . . . 3.02 110.317 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 2.7 tp -64.41 -39.34 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 121.67 -0.9 . . . . 2.36 109.465 -174.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -45.19 159.01 0.2 Allowed Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.468 1.032 . . . . 2.09 115.459 176.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 85.68 -52.89 4.65 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 109.715 -1.354 . . . . 1.32 109.715 -159.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.01 162.67 27.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.138 1.375 . . . . 1.95 108.418 -172.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -135.14 121.62 20.54 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.528 0.603 . . . . 0.63 112.614 -174.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.457 ' HD1' ' CD2' ' A' ' 183' ' ' HIS . 2.9 m170 -113.92 113.39 24.78 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-O 118.729 -0.653 . . . . 2.16 111.073 -171.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -96.28 144.65 26.26 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.371 0.668 . . . . 2.81 110.572 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -68.67 97.44 0.8 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.454 -0.794 . . . . 2.69 111.158 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -70.57 -30.15 66.78 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 120.978 -1.077 . . . . 2.69 109.834 173.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -46.89 -42.01 16.82 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.261 1.424 . . . . 2.64 109.301 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -74.81 172.13 12.73 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 122.347 1.07 . . . . 1.72 113.07 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -113.64 96.11 5.69 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.712 -1.218 . . . . 3.62 107.712 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.479 ' CH2' HG21 ' A' ' 215' ' ' THR . 18.9 m95 -75.03 151.04 38.76 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.931 -1.137 . . . . 1.2 107.931 172.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 82.4 p -129.92 134.19 47.33 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.407 0.683 . . . . 1.72 109.78 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.6 t -51.57 -43.87 62.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 123.961 0.904 . . . . 1.69 111.314 172.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.25 -157.88 0.34 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.645 1.178 . . . . 2.14 111.63 -178.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.5 m -60.66 -66.59 0.5 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.336 1.055 . . . . 3.77 110.801 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 42.66 -103.81 0.04 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.106 1.336 . . . . 2.47 114.825 174.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -125.98 -71.93 0.19 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.309 0.957 . . . . 1.07 110.984 -173.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.3 m -119.21 168.14 11.17 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 105.556 -2.016 . . . . 1.22 105.556 167.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -123.56 128.99 50.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.156 0.182 . . . . 1.39 111.113 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.478 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.1 tm? -62.33 -48.14 81.12 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 118.699 -0.667 . . . . 2.11 109.495 -177.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -50.52 -43.9 56.06 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.89 0.768 . . . . 1.34 110.426 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 7.4 tt -63.24 -60.35 3.52 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.765 0.826 . . . . 1.24 109.698 -175.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.479 HG21 ' CH2' ' A' ' 203' ' ' TRP 0.338 20.1 m -61.27 -38.01 85.2 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 120.454 -0.498 . . . . 0.66 111.128 179.235 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.09 -60.69 2.83 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 118.199 -0.905 . . . . 0.36 109.48 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.751 ' CG1' HG11 ' A' ' 235' ' ' VAL . 0.3 OUTLIER -51.87 -45.3 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 119.12 0.873 . . . . 1.65 111.061 -173.599 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 236' ' ' MET . 13.0 t60 -52.1 -61.79 2.04 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.236 1.015 . . . . 2.53 112.762 168.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -57.41 -38.43 74.31 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.443 -1.411 . . . . 2.86 112.184 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 134' ' ' ILE . 1.5 mp -67.97 -36.16 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 108.247 -1.02 . . . . 1.23 108.247 -177.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -55.81 -44.07 87.03 Favored Glycine 0 CA--C 1.538 1.486 0 O-C-N 121.808 -0.558 . . . . 0.55 111.747 166.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.451 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 3.2 m-70 -55.35 -50.04 70.68 Favored 'General case' 0 C--N 1.344 0.343 0 O-C-N 122.106 -0.643 . . . . 1.36 109.272 175.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.2 t -44.09 -56.32 4.12 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.204 1.002 . . . . 1.9 112.4 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 224' ' ' LEU . 0.2 OUTLIER -62.16 -55.49 28.24 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 119.101 0.864 . . . . 3.24 108.879 -178.369 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 155.38 37.07 0.02 OUTLIER Glycine 0 C--N 1.337 0.6 0 C-N-CA 120.906 -0.664 . . . . 1.13 114.607 174.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.551 HD13 ' SD ' ' A' ' 236' ' ' MET . 4.3 mt -84.64 113.11 21.04 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.65 1.225 . . . . 3.47 110.695 175.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -74.56 60.62 2.43 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.928 0.775 . . . . 2.3 111.552 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 78.3 m80 60.17 -170.65 0.14 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.099 1.359 . . . . 2.93 112.353 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 58.1 m -148.06 -178.38 6.26 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.813 1.645 . . . . 0.96 108.865 167.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.9 t -139.19 38.72 2.11 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.884 0.874 . . . . 2.06 110.193 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -140.55 143.13 31.51 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.436 -1.69 . . . . 1.67 106.436 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -87.6 -13.58 4.05 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.848 1.698 . . . . 1.02 114.62 -173.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 18.2 mtmt -80.32 -36.83 33.69 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.948 -1.13 . . . . 1.17 107.948 170.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.33 137.27 42.13 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.408 0.623 . . . . 0.72 110.682 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.751 HG11 ' CG1' ' A' ' 217' ' ' VAL . 58.0 t -86.73 -17.04 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 114.751 -1.113 . . . . 0.59 109.886 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.551 ' SD ' HD13 ' A' ' 226' ' ' LEU . 7.9 tpt -76.15 -18.27 59.2 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 114.06 1.133 . . . . 1.71 114.06 -172.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.487 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.86 161.05 0.43 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 126.217 1.807 . . . . 3.01 114.389 176.711 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.32 -14.39 13.19 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.846 1.698 . . . . 0.95 112.37 172.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.385 0.2 OUTLIER -78.39 168.1 20.32 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.539 -0.911 . . . . 1.14 108.539 176.605 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -112.48 133.96 54.27 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.315 -1.735 . . . . 2.37 106.315 172.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -134.92 148.35 50.03 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.997 -1.112 . . . . 3.41 107.997 172.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -71.38 79.56 0.75 Allowed 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.778 1.231 . . . . 3.91 109.174 178.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.8 m -76.63 112.76 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.831 -0.803 . . . . 1.77 108.831 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -64.77 118.22 8.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.965 -0.561 . . . . 3.01 110.501 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 33.0 mm -58.98 -21.79 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.877 0.871 . . . . 3.19 111.197 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -55.49 -33.29 63.57 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.373 0.988 . . . . 3.6 111.595 172.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.6 m -80.33 -50.75 9.75 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.751 -0.463 . . . . 2.54 109.751 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.505 ' CZ ' HG22 ' A' ' 140' ' ' VAL . 54.2 t80 46.48 73.99 0.16 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.412 1.485 . . . . 4.41 112.142 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.76 167.91 25.87 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.558 -0.714 . . . . 2.69 109.781 175.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.704 HD21 HG12 ' A' ' 140' ' ' VAL . 0.3 OUTLIER -102.43 141.12 35.78 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 105.693 -1.966 . . . . 1.07 105.693 178.83 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.28 170.99 14.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.789 -0.449 . . . . 1.09 109.789 -172.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.92 -42.59 85.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.154 -0.618 . . . . 0.85 110.078 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.09 -45.81 89.9 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 110.3 -0.259 . . . . 2.64 110.3 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -56.22 -51.51 67.82 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.259 -1.015 . . . . 2.97 108.259 175.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.408 ' HA ' HG22 ' A' ' 258' ' ' ILE . 57.0 mt -59.3 -31.2 45.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 126.805 2.042 . . . . 0.88 112.663 -175.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -70.33 -58.53 3.65 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.039 -1.038 . . . . 5.58 110.04 172.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.522 ' C ' HD21 ' A' ' 226' ' ' LEU . . . -56.93 -44.2 92.63 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 111.758 -0.537 . . . . 1.1 111.758 -175.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.619 HG13 ' CG2' ' A' ' 145' ' ' THR . 10.2 tp -59.42 -34.77 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.08 0.952 . . . . 3.8 111.816 -176.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -86.41 -26.08 24.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.852 -0.53 . . . . 2.46 110.623 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.7 t -53.32 -18.22 2.35 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 117.851 -1.071 . . . . 1.85 113.064 171.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.4 mm? . . . . . 0 N--CA 1.451 -0.403 0 C-N-CA 125.654 1.582 . . . . 2.85 113.472 166.445 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 tptt . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 110.526 -0.175 . . . . 6.03 110.526 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.0 m80 64.28 -62.23 0.18 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.894 2.078 . . . . 4.58 113.872 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -86.6 101.73 13.5 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.018 1.327 . . . . 3.27 110.06 -172.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.413 HG22 ' CE1' ' A' ' 116' ' ' TYR . 4.7 mm -124.15 109.57 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.539 -0.912 . . . . 1.85 108.539 -178.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.5 p -101.92 146.69 27.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.459 1.104 . . . . 1.24 109.858 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.43 ' CZ ' ' CE1' ' A' ' 138' ' ' PHE . 1.9 m-85 -130.11 159.78 35.75 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 119.194 -0.432 . . . . 5.76 111.045 -176.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -143.08 146.3 33.67 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.769 0.827 . . . . 5.28 109.045 175.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.34 157.54 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.458 -0.942 . . . . 1.16 108.458 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.565 HD22 ' H ' ' A' ' 119' ' ' ASN . 0.1 OUTLIER -91.61 -57.66 2.69 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.502 0.721 . . . . 3.1 109.746 171.913 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -149.79 171.68 16.35 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 110.168 -0.308 . . . . 1.86 110.168 175.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -105.68 118.08 35.66 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.974 1.31 . . . . 2.75 107.792 -175.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.6 t -71.07 135.7 84.95 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.636 -0.876 . . . . 2.6 108.636 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.03 -19.72 22.7 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.777 2.318 . . . . 1.92 112.548 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.64 -43.49 3.85 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.097 1.759 . . . . 2.59 112.37 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -128.44 -179.89 5.28 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.371 1.468 . . . . 2.72 108.237 175.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -85.26 145.47 27.53 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.358 0.599 . . . . 2.9 110.24 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.9 ttt-85 -49.87 -47.58 51.77 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.635 0.774 . . . . 2.87 111.859 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -62.29 -4.88 2.0 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.012 0.925 . . . . 3.01 112.909 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -101.42 -46.35 5.03 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.104 1.762 . . . . 2.14 110.029 169.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 66.1 t -54.3 -56.37 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 124.569 1.147 . . . . 1.17 109.518 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -26.96 65.83 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 118.182 -1.407 . . . . 1.8 109.678 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -60.09 -50.12 74.95 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 119.613 1.097 . . . . 1.86 110.01 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.65 -54.42 37.94 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 123.409 0.684 . . . . 0.43 110.126 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.1 tp -66.21 -41.03 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.824 0.345 . . . . 2.13 110.926 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -53.91 -60.18 3.66 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.491 1.517 . . . . 3.56 107.635 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -62.36 -46.11 90.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.281 -0.872 . . . . 1.4 110.141 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.05 -52.2 45.57 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.878 0.471 . . . . 0.46 110.721 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.438 ' CZ ' HG13 ' A' ' 220' ' ' ILE . 4.4 m-85 -55.16 -48.52 73.62 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.709 -0.223 . . . . 4.47 110.917 171.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -35.16 61.74 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.573 -0.727 . . . . 1.91 111.861 -178.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.423 HG12 HD21 ' A' ' 250' ' ' LEU . 94.9 t -55.57 -65.04 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.312 0 CA-C-N 119.217 0.917 . . . . 0.9 109.821 177.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.868 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 41.5 m95 -70.66 -33.34 70.85 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.608 -0.886 . . . . 0.88 108.608 -171.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 t -68.51 -13.77 62.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 119.104 -0.474 . . . . 1.13 112.27 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.38 -52.49 7.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.911 -1.144 . . . . 1.05 107.911 177.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.447 HG11 HD23 ' A' ' 250' ' ' LEU . 4.9 m -82.47 -37.85 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.802 -0.636 . . . . 1.8 112.328 -171.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' THR . . . . . 1.044 HG22 HD13 ' A' ' 258' ' ' ILE . 1.3 p -87.38 150.5 49.2 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 106.235 -1.765 . . . . 1.13 106.235 170.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.66 -0.5 10.7 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.538 1.492 . . . . 1.04 112.459 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.492 HD13 ' HB3' ' A' ' 224' ' ' LEU . 5.6 mt -61.28 117.05 5.12 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 119.245 0.93 . . . . 2.08 108.849 177.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -94.5 105.43 17.39 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.173 0.589 . . . . 4.6 109.518 -172.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -64.98 146.75 54.59 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.339 -0.846 . . . . 7.31 112.329 -177.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.5 t -154.08 96.98 2.01 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.286 0.565 . . . . 0.87 110.704 165.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -79.75 125.97 30.35 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 108.474 -0.936 . . . . 2.07 108.474 172.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.85 155.46 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.678 -1.601 . . . . 1.57 106.678 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -108.58 -9.31 15.34 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.939 0.791 . . . . 3.32 111.919 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 76.8 m -143.04 132.07 22.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.126 1.77 . . . . 2.05 106.67 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.82 -156.79 20.79 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 107.962 -2.055 . . . . 2.38 107.962 -172.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 52.4 mtt -105.12 137.86 42.23 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.94 1.296 . . . . 4.92 108.159 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.74 147.08 50.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.438 1.095 . . . . 1.13 109.015 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -75.19 -50.24 16.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.124 -1.065 . . . . 2.0 108.124 175.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.4 154.11 12.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.447 0.642 . . . . 1.59 110.833 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.09 132.9 54.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.904 -1.147 . . . . 2.52 107.904 169.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.2 t -78.57 135.65 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.023 -1.473 . . . . 1.14 107.023 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 74.1 t -116.49 134.52 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.802 1.183 . . . . 1.33 109.29 172.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -95.97 149.44 21.57 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.668 -1.234 . . . . 7.66 107.668 167.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -159.04 149.04 19.18 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 120.536 -1.353 . . . . 1.28 110.26 170.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -120.25 132.93 55.54 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.604 1.162 . . . . 3.93 108.672 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 54.13 -96.8 0.03 OUTLIER Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.293 0.949 . . . . 2.11 111.833 -167.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -124.68 140.85 52.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.138 1.375 . . . . 2.13 108.852 -169.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.6 p80 . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 121.286 0.565 . . . . 2.59 110.363 177.241 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.312 0 CA-C-O 118.757 -0.64 . . . . 2.45 109.309 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' A' ' 200' ' ' ASP . 26.2 t80 -89.66 161.82 15.91 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.932 0.872 . . . . 7.73 109.413 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.406 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 47.1 p-10 -168.85 26.75 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.682 -1.599 . . . . 3.48 110.613 -157.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 91.6 165.64 39.64 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 111.246 -0.742 . . . . 2.3 111.246 -170.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.432 ' HA ' ' CG ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -62.98 111.69 2.27 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 122.544 -0.386 . . . . 5.38 110.542 166.3 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.8 -164.31 13.59 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.61 -1.396 . . . . 2.08 109.61 -171.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 59.06 -120.03 20.74 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 110.225 -1.15 . . . . 1.98 110.225 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.7 mm -76.57 122.78 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 105.699 -1.963 . . . . 1.72 105.699 168.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.57 -44.4 17.34 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.65 -0.5 . . . . 1.61 109.65 174.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -167.08 168.51 13.63 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.69 -0.631 . . . . 0.58 109.921 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -145.92 108.35 4.45 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.198 0.999 . . . . 1.06 113.377 -172.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -128.19 156.66 42.57 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.937 2.095 . . . . 0.64 107.107 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -145.29 149.15 34.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.024 -1.843 . . . . 2.75 106.024 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.75 -85.44 1.71 Allowed Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.506 -1.038 . . . . 0.69 110.506 174.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.38 86.54 0.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.638 2.892 . . . . 1.24 111.196 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -158.88 164.79 33.87 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 108.165 -1.974 . . . . 1.03 108.165 169.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.9 t -79.92 179.85 7.35 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.378 0.589 . . . . 3.3 109.964 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 43.8 -102.93 0.04 OUTLIER Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.814 1.674 . . . . 1.3 112.574 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.2 tp -60.3 -40.04 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 118.298 -0.858 . . . . 1.42 110.0 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -37.2 134.4 0.89 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.675 1.131 . . . . 1.0 112.85 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 99.7 -47.77 1.29 Allowed Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.829 1.681 . . . . 0.75 111.392 -161.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -88.49 138.93 30.99 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.902 0.881 . . . . 1.28 110.084 -156.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -109.65 119.63 40.0 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.669 0.788 . . . . 0.72 112.663 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . 0.28 0.0 OUTLIER -111.39 113.25 25.57 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-O 117.575 -1.202 . . . . 2.15 110.783 -171.912 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -103.03 152.33 21.48 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.42 1.464 . . . . 6.23 112.756 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -64.1 95.58 0.13 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.36 -1.291 . . . . 2.68 108.767 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -56.89 -40.0 75.42 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 125.395 1.478 . . . . 2.3 111.594 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.408 ' HB3' ' CE1' ' A' ' 174' ' ' PHE . 8.2 t70 -66.77 -28.34 68.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.53 1.132 . . . . 3.14 110.731 -178.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.432 ' CG ' ' HA ' ' A' ' 177' ' ' LYS . 5.4 mt-10 -69.85 127.1 31.73 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 107.732 -1.21 . . . . 2.3 107.732 174.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -80.59 78.68 7.31 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.904 -1.147 . . . . 2.7 107.904 -174.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -77.0 103.7 7.08 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.302 1.041 . . . . 2.24 110.562 -172.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.26 166.54 12.88 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.05 1.405 . . . . 2.53 110.72 -174.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.3 t -69.26 -43.44 73.95 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 127.542 2.337 . . . . 1.86 112.371 166.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -82.53 156.88 23.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.374 -0.83 . . . . 2.81 109.698 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.4 m -69.11 -32.99 72.78 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.991 1.717 . . . . 4.53 110.952 -167.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.81 133.77 52.63 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 111.066 -0.813 . . . . 2.98 111.066 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 90.28 -120.29 5.82 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.069 -2.012 . . . . 1.14 108.069 -175.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.45 142.38 50.8 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 108.273 -1.01 . . . . 1.23 108.273 162.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -96.81 121.48 38.72 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.363 0.414 . . . . 1.25 110.584 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.79 -53.42 32.0 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 109.143 -0.688 . . . . 1.45 109.143 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.667 ' O ' HG23 ' A' ' 217' ' ' VAL . 35.9 t80 -47.36 -48.09 25.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.336 0.654 . . . . 1.46 110.637 179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.416 HD22 ' CD1' ' A' ' 240' ' ' TYR . 6.5 tt -60.17 -58.21 9.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.321 -0.4 . . . . 1.36 110.941 -174.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.392 80.4 m -56.37 -43.02 78.78 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.102 0.477 . . . . 1.08 110.22 176.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.61 -55.99 23.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 117.26 -1.352 . . . . 0.4 109.808 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 213' ' ' PHE . 38.9 t -47.95 -45.39 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 121.157 1.799 . . . . 0.86 110.951 -176.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.815 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 0.4 OUTLIER -56.79 -56.49 20.81 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.78 0.659 . . . . 2.75 112.78 170.913 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -65.76 -44.4 85.98 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 120.406 -1.434 . . . . 3.54 112.737 -176.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.438 HG13 ' CZ ' ' A' ' 138' ' ' PHE . 1.4 mp -49.84 -49.06 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 125.923 1.689 . . . . 1.24 106.96 172.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.505 ' HA2' HD12 ' A' ' 226' ' ' LEU . . . -53.58 -52.46 41.54 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.684 -0.566 . . . . 0.61 111.684 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.815 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 5.0 m-70 -50.25 -51.0 48.28 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 117.763 0.781 . . . . 1.22 110.642 175.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.0 m -57.34 -47.14 82.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.157 0.983 . . . . 2.25 110.951 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.492 ' HB3' HD13 ' A' ' 147' ' ' LEU . 82.1 mt -59.13 -22.6 61.15 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.481 1.112 . . . . 2.71 112.392 174.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 124.54 4.14 7.61 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.557 1.075 . . . . 1.53 112.877 173.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.505 HD12 ' HA2' ' A' ' 221' ' ' GLY . 30.6 mt -80.78 122.34 27.04 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 118.218 1.009 . . . . 3.92 110.849 -169.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -65.24 179.68 8.73 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.468 -0.653 . . . . 3.46 111.468 173.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -77.02 121.31 23.34 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.133 0.573 . . . . 1.58 110.595 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.8 m -76.09 173.95 10.65 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.829 -0.434 . . . . 1.29 109.829 169.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.3 t -140.03 52.22 1.69 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.679 1.192 . . . . 2.55 109.259 -172.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -155.29 140.8 12.54 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 117.739 -1.124 . . . . 1.8 108.436 -173.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -93.85 -3.19 2.96 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.657 2.238 . . . . 1.16 114.978 -175.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -83.7 -33.46 25.14 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.243 -1.536 . . . . 2.01 109.096 165.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.44 ' HB1' ' CG ' ' A' ' 254' ' ' ASP . . . -58.3 156.67 9.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.259 1.024 . . . . 0.9 112.229 171.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 77.7 t -105.39 -19.73 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 114.204 -1.362 . . . . 0.67 110.368 169.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 4.3 tpt -73.47 -9.03 58.26 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.826 1.047 . . . . 1.83 113.826 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.38 167.14 1.34 Allowed Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.906 1.283 . . . . 3.32 113.07 176.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -73.61 -26.24 14.08 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.962 1.775 . . . . 1.62 112.111 170.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.353 0.2 OUTLIER -78.21 -178.89 5.89 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.224 1.81 . . . . 1.52 111.59 -170.039 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.416 ' CD1' HD22 ' A' ' 214' ' ' LEU . 73.9 t80 -113.72 148.62 36.1 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.184 1.793 . . . . 2.1 108.04 175.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -156.48 140.75 16.57 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.398 -1.334 . . . . 3.45 107.398 171.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -66.0 115.8 6.45 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.626 0.77 . . . . 3.34 110.19 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.7 m -135.64 99.9 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 124.099 0.959 . . . . 1.82 110.015 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.0 137.81 57.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.263 0.554 . . . . 4.55 111.639 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.576 HG22 ' CD1' ' A' ' 213' ' ' PHE . 1.2 pt -81.43 35.74 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 113.509 0.929 . . . . 3.53 113.509 -169.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -109.3 -63.1 1.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.033 0.933 . . . . 3.48 109.497 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 61.9 m -63.21 -48.74 77.04 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.228 -0.656 . . . . 1.84 109.228 -176.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 55.36 89.38 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.337 1.055 . . . . 4.82 110.66 176.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.72 143.68 19.83 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.096 -0.705 . . . . 3.11 109.096 170.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.479 HD12 ' CH2' ' A' ' 141' ' ' TRP . 1.5 mm? -83.71 164.3 19.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.676 1.59 . . . . 0.89 107.802 174.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.0 m -78.74 151.38 32.12 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 122.119 -0.363 . . . . 0.7 110.1 174.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.68 -47.26 77.06 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.001 0.52 . . . . 0.85 110.291 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -51.47 -51.57 53.9 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.563 0.745 . . . . 2.5 110.163 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -57.15 -53.05 62.49 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.11 -0.95 . . . . 2.34 109.218 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.1 mt -50.79 -43.44 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.041 1.336 . . . . 0.9 111.259 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -61.43 -50.92 70.86 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.484 -1.385 . . . . 5.73 109.36 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -47.25 -47.19 21.6 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.003 0.811 . . . . 1.34 112.567 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 1.044 HD13 HG22 ' A' ' 145' ' ' THR . 0.5 OUTLIER -70.13 -38.58 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 118.175 0.988 . . . . 2.2 110.413 -174.417 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -61.18 -33.23 73.11 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.68 -0.408 . . . . 2.69 110.244 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.9 m -50.82 -23.03 2.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.934 1.087 . . . . 2.62 113.934 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 8.8 mt . . . . . 0 C--N 1.345 0.373 0 CA-C-N 120.326 1.421 . . . . 2.96 113.028 176.153 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.0 tptt . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 108.862 -0.792 . . . . 6.16 108.862 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 69.29 -64.83 0.32 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.984 2.114 . . . . 3.65 111.873 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -108.25 119.27 39.0 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.548 -1.279 . . . . 3.41 107.548 -176.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.0 mp -134.43 147.4 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 105.405 -2.072 . . . . 2.6 105.405 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.65 142.2 17.61 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 105.06 -2.2 . . . . 2.27 105.06 -173.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -125.67 165.7 18.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.69 1.196 . . . . 4.32 111.148 -174.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -154.85 161.23 41.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.814 -0.809 . . . . 6.5 108.814 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.71 155.0 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.339 -1.356 . . . . 0.79 107.339 174.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -80.71 -51.4 8.72 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.643 -0.502 . . . . 2.83 109.643 173.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -157.14 170.17 23.11 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.483 0.583 . . . . 3.05 111.174 167.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -94.16 126.86 39.65 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.994 1.318 . . . . 2.77 109.773 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.4 ' HB ' ' CE2' ' A' ' 163' ' ' PHE . 11.2 t -70.29 147.45 95.25 Favored Pre-proline 0 N--CA 1.442 -0.853 0 O-C-N 121.933 -0.479 . . . . 2.57 112.29 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -80.34 -16.19 10.93 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 124.678 3.585 . . . . 2.05 111.22 168.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -50.45 -36.6 34.1 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.858 1.663 . . . . 2.16 112.116 -176.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 13.7 mtm -133.61 -177.96 4.78 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.9 1.68 . . . . 1.91 106.949 172.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -78.71 139.74 38.43 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.326 -0.62 . . . . 2.88 109.326 171.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -51.39 -42.45 61.4 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.713 -0.617 . . . . 4.0 112.179 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -65.19 -5.57 7.21 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.662 0.785 . . . . 3.08 112.274 -177.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -94.45 -47.41 6.58 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 126.515 1.926 . . . . 2.21 109.789 166.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.7 t -57.03 -61.72 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 C-N-CA 125.504 1.521 . . . . 1.15 109.454 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -28.06 67.48 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 117.825 -1.55 . . . . 1.7 109.019 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -61.05 -50.99 71.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 118.859 0.754 . . . . 2.91 109.952 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.29 -48.11 77.29 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 122.906 0.483 . . . . 0.56 110.729 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.9 -37.49 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.563 0.697 . . . . 1.55 110.128 -175.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -55.45 33.66 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.872 1.269 . . . . 4.0 107.926 178.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.585 ' O ' HG23 ' A' ' 140' ' ' VAL . 39.6 mmtm -56.33 -51.84 66.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.383 -0.599 . . . . 2.87 109.383 176.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.37 -49.03 46.27 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.625 0.648 . . . . 0.56 112.426 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -61.71 -51.77 67.04 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 121.894 -0.504 . . . . 4.59 109.902 173.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -55.82 -37.95 69.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.652 0.781 . . . . 2.0 110.777 -172.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 136' ' ' LYS . 42.5 t -53.61 -52.21 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.623 1.569 . . . . 0.76 108.844 177.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.404 ' CZ3' HG13 ' A' ' 258' ' ' ILE . 57.2 m95 -74.51 -32.72 62.59 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.997 -0.371 . . . . 0.71 109.997 -177.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.0 m -72.65 -9.2 58.33 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.215 0.45 . . . . 1.81 112.215 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -84.87 -52.39 6.05 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 107.565 -1.272 . . . . 1.16 107.565 175.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.415 HG11 HD23 ' A' ' 250' ' ' LEU . 5.7 m -76.42 -33.62 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 112.289 0.478 . . . . 1.78 112.289 -175.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.449 HG21 HD12 ' A' ' 258' ' ' ILE . 6.8 p -100.74 153.88 37.48 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.384 -0.598 . . . . 0.72 109.384 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.38 9.31 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.326 2.017 . . . . 0.81 112.967 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.4 mp -78.85 112.87 16.44 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.407 1.003 . . . . 2.44 108.862 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -95.61 73.22 3.17 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.701 -0.624 . . . . 3.42 111.676 -163.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -63.82 147.66 51.24 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.488 0.715 . . . . 5.92 112.123 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.9 t -149.68 147.5 28.15 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.576 1.55 . . . . 1.2 107.883 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -97.93 136.29 38.44 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.262 0.625 . . . . 2.04 109.87 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.2 pp -134.84 118.59 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.848 -1.167 . . . . 1.21 107.848 172.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -75.83 -32.24 59.72 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 119.723 -0.791 . . . . 3.33 110.13 172.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.6 m -113.94 95.68 5.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.681 0.792 . . . . 2.22 109.543 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 151.53 -154.24 25.44 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.665 -1.374 . . . . 1.4 109.665 170.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.6 tpt -111.82 136.67 50.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.182 1.393 . . . . 5.45 110.52 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -129.36 163.83 24.91 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.849 1.66 . . . . 0.8 109.363 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.51 -41.12 56.06 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.509 -0.922 . . . . 1.68 108.509 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 33.6 pt -121.97 175.7 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.786 1.234 . . . . 1.19 109.508 -176.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.7 tp -148.62 130.24 14.97 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.2 1.4 . . . . 2.88 108.879 -173.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.7 t -88.19 109.04 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 108.429 -0.952 . . . . 0.88 108.429 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.7 t -88.26 142.05 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.308 -0.997 . . . . 1.45 108.308 168.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.4 ' CE2' ' HB ' ' A' ' 122' ' ' THR . 0.0 OUTLIER -131.64 125.26 31.71 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 104.565 -2.383 . . . . 6.05 104.565 172.332 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.45 ' HB3' ' HE2' ' A' ' 174' ' ' PHE . . . -159.45 161.25 35.46 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.337 -1.727 . . . . 1.31 106.337 -174.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -123.87 152.94 41.79 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.523 -0.917 . . . . 4.13 108.523 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 69.2 -142.5 37.66 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.73 2.11 . . . . 1.63 113.013 172.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.16 129.83 34.86 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.937 -0.764 . . . . 2.25 108.937 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 . . . . . 0 CA--C 1.532 0.286 0 C-N-CA 122.791 0.436 . . . . 3.41 111.315 178.636 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 111.572 0.212 . . . . 2.58 111.572 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.45 ' HE2' ' HB3' ' A' ' 164' ' ' ALA . 31.6 m-85 -125.06 167.1 15.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.52 1.128 . . . . 6.01 108.389 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.4 p30 -140.72 -20.47 0.82 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 115.763 1.764 . . . . 2.95 115.763 -150.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.47 132.91 0.27 Allowed Glycine 0 CA--C 1.534 1.24 0 N-CA-C 110.325 -1.11 . . . . 2.38 110.325 -162.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.9 tttt 56.31 -152.41 0.38 Allowed 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.389 -1.066 . . . . 5.99 110.079 -175.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.8 -107.42 0.01 OUTLIER Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.145 1.355 . . . . 1.56 115.343 -162.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 49.68 -114.59 2.42 Favored Glycine 0 C--N 1.34 0.759 0 CA-C-N 117.963 0.882 . . . . 1.28 111.987 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 10.6 mm -78.96 117.34 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 107.272 -1.381 . . . . 2.31 107.272 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.53 -60.26 2.42 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.318 -1.364 . . . . 1.41 107.318 170.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -164.82 169.69 16.35 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 121.08 -1.013 . . . . 0.74 109.522 -176.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -147.47 124.53 11.4 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 114.307 1.225 . . . . 0.96 114.307 -174.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -151.08 156.6 41.4 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.397 1.879 . . . . 0.55 106.454 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -145.52 160.36 41.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.471 -1.677 . . . . 3.22 106.471 175.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -90.44 -119.45 2.08 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 118.768 -1.018 . . . . 0.66 110.941 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.75 79.35 1.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.678 2.252 . . . . 2.35 110.299 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -141.41 163.43 26.79 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.755 -1.738 . . . . 1.23 108.755 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 p -78.94 169.32 18.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.285 1.034 . . . . 3.34 112.055 -170.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 53.48 -114.3 3.74 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.358 0.98 . . . . 1.61 111.592 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.439 HG12 ' CE1' ' A' ' 196' ' ' HIS . 3.5 tp -62.2 -35.44 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 118.335 -0.84 . . . . 1.69 109.869 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -40.68 141.31 0.94 Allowed Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.42 1.009 . . . . 1.28 113.087 176.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 93.6 -48.2 2.32 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.168 1.366 . . . . 0.73 110.883 -160.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.64 171.06 10.75 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.041 0.937 . . . . 1.24 108.824 -167.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -144.9 122.83 12.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 118.725 -0.655 . . . . 0.57 112.473 -169.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.475 ' N ' ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -115.37 115.56 26.8 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-O 117.696 -1.145 . . . . 2.09 111.076 -171.248 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -92.38 148.51 22.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.752 1.16 . . . . 2.89 110.446 174.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.98 98.52 9.29 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 122.497 1.141 . . . . 3.42 112.017 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -49.93 -33.19 16.73 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 119.852 -1.78 . . . . 2.9 110.389 170.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -36.09 -47.44 0.55 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.981 1.104 . . . . 3.6 113.981 172.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -73.78 156.34 37.93 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 123.252 1.501 . . . . 2.31 111.435 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -92.86 91.53 7.48 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 105.448 -2.056 . . . . 2.67 105.448 167.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -76.81 152.92 35.35 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.172 -1.047 . . . . 1.2 108.172 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 39.1 p -133.7 156.28 48.21 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.533 0.682 . . . . 1.85 110.345 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.3 -44.95 23.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.606 1.562 . . . . 1.69 110.379 170.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -76.66 178.43 6.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.022 1.329 . . . . 2.15 109.224 170.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.32 -60.83 2.86 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.036 1.334 . . . . 3.57 109.66 -172.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 57.1 -95.62 0.04 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.367 0.984 . . . . 2.34 112.563 168.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -135.41 -72.54 0.07 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.252 -1.539 . . . . 1.2 109.252 175.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.8 m -114.28 122.75 47.7 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.839 -1.541 . . . . 0.94 106.839 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -85.65 117.2 24.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.822 -1.177 . . . . 1.6 107.822 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.84 -53.66 14.92 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.271 0.628 . . . . 1.7 110.383 -175.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.475 ' CD1' HG22 ' A' ' 245' ' ' ILE . 30.3 t80 -43.4 -45.36 6.16 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.419 1.088 . . . . 1.71 110.77 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.6 tt -67.25 -57.5 6.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.302 -0.408 . . . . 1.41 110.707 -168.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 m -56.54 -46.55 80.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.453 -0.573 . . . . 1.16 109.453 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.0 -57.93 5.11 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 124.549 1.155 . . . . 0.57 110.69 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 71.0 t -48.27 -41.73 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 119.625 1.102 . . . . 0.7 111.168 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.831 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 0.2 OUTLIER -63.91 -54.48 34.08 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.311 -0.868 . . . . 2.33 112.404 178.161 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.74 -36.96 65.22 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.234 -0.917 . . . . 3.62 111.1 -174.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.7 -42.9 97.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 107.001 -1.481 . . . . 1.52 107.001 173.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -47.05 -54.06 9.99 Favored Glycine 0 CA--C 1.536 1.37 0 O-C-N 121.401 -0.812 . . . . 0.45 111.571 166.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.831 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 9.0 m-70 -50.79 -45.03 59.0 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 121.572 -0.957 . . . . 1.43 111.028 175.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 9.2 t -51.16 -41.17 59.96 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.213 0.605 . . . . 1.67 111.972 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.72 -54.15 40.0 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.245 -0.65 . . . . 2.63 109.245 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 131.54 73.69 0.11 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 111.565 -0.614 . . . . 1.2 111.565 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.648 HD13 ' SD ' ' A' ' 236' ' ' MET . 1.1 mt -124.69 121.48 34.78 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.311 1.044 . . . . 3.44 108.858 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -76.64 56.2 3.4 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.76 0.695 . . . . 2.49 111.985 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 77.4 m80 57.73 -169.53 0.11 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.656 1.182 . . . . 2.45 112.066 -175.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 75.5 m -148.59 -179.82 7.26 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 106.461 -1.681 . . . . 0.95 106.461 165.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 36.9 p -136.77 37.82 2.62 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.43 1.492 . . . . 2.44 109.244 -168.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -139.88 136.49 17.37 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 106.089 -1.819 . . . . 1.67 106.089 -173.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -85.73 -8.06 8.31 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.872 1.715 . . . . 1.04 114.287 -172.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -80.83 -42.95 20.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.929 -1.137 . . . . 1.18 107.929 168.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -55.19 140.74 37.7 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.203 0.525 . . . . 0.72 109.724 174.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 88.2 t -87.04 -23.14 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 108.684 -0.858 . . . . 0.72 108.684 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.648 ' SD ' HD13 ' A' ' 226' ' ' LEU . 0.6 OUTLIER -55.69 -29.5 59.49 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 115.811 1.782 . . . . 1.7 115.811 -177.126 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -50.08 162.48 0.49 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 125.659 1.584 . . . . 3.11 113.696 -172.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.93 -16.43 14.35 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.331 1.354 . . . . 0.95 111.907 170.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.377 0.2 OUTLIER -79.3 -179.7 6.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.167 1.387 . . . . 1.24 109.609 178.171 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -130.39 148.94 52.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 126.394 1.878 . . . . 2.09 106.144 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.66 173.88 13.65 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.768 -1.938 . . . . 2.46 105.768 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -87.75 117.82 26.84 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 119.578 1.081 . . . . 3.67 109.055 174.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.5 m -120.32 125.04 73.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 107.669 -1.234 . . . . 1.53 107.669 170.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -81.21 120.21 24.59 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.223 -0.591 . . . . 4.94 109.756 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.475 HG22 ' CD1' ' A' ' 213' ' ' PHE . 1.1 pp -59.16 -27.81 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.307 -0.406 . . . . 3.53 110.803 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -66.27 -35.01 79.31 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.289 0.495 . . . . 4.01 110.313 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 29.6 m -66.55 -49.75 65.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.535 -0.543 . . . . 1.89 109.535 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.474 ' CD1' HG22 ' A' ' 140' ' ' VAL . 0.4 OUTLIER 51.12 83.21 0.05 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.91 0.862 . . . . 5.06 110.562 179.533 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.48 158.35 31.78 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.64 -0.663 . . . . 4.06 109.345 169.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.554 ' N ' HD22 ' A' ' 250' ' ' LEU . 1.3 mm? -108.16 157.15 18.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.734 -1.58 . . . . 0.75 106.734 177.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 29.6 m -77.49 151.52 34.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.005 -0.434 . . . . 0.65 110.106 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.41 -45.41 46.18 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.699 0.4 . . . . 0.72 110.086 171.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -59.63 -36.11 75.7 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.588 0.708 . . . . 2.41 111.605 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -71.77 -51.52 22.27 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.709 1.243 . . . . 1.97 108.887 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 41.0 mt -52.79 -49.06 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 126.831 2.052 . . . . 0.94 112.124 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -55.19 -43.36 74.29 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.498 -1.376 . . . . 7.85 110.535 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -55.63 -40.42 78.91 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.045 -1.222 . . . . 0.79 110.045 174.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 258' ' ' ILE . 0.2 OUTLIER -66.91 -45.18 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 C-N-CA 123.257 0.623 . . . . 3.24 111.267 -176.8 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -63.31 -27.17 69.14 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 119.343 -0.943 . . . . 2.35 110.515 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.29 -15.27 0.91 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.145 1.165 . . . . 1.89 114.145 169.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 76.7 mt . . . . . 0 C--N 1.346 0.447 0 CA-C-N 121.055 1.752 . . . . 2.37 113.192 164.695 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.9 tptt . . . . . 0 CA--C 1.534 0.329 0 N-CA-C 111.861 0.319 . . . . 6.93 111.861 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 74.94 -68.85 0.2 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.902 1.681 . . . . 5.34 111.368 172.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -102.56 113.5 26.93 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 126.199 1.8 . . . . 3.03 109.128 -174.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.436 HG22 ' CE1' ' A' ' 116' ' ' TYR . 1.4 mm -117.76 88.45 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 122.11 0.957 . . . . 2.08 109.33 -173.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 p -87.25 146.19 26.07 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.441 0.696 . . . . 1.31 109.495 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.438 ' CE2' ' CD1' ' A' ' 138' ' ' PHE . 10.5 m-85 -129.92 166.2 20.51 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.728 0.811 . . . . 6.69 110.364 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.564 ' HG3' HD23 ' A' ' 160' ' ' LEU . 9.5 ptt180 -153.51 168.91 24.56 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.335 0.654 . . . . 7.6 110.458 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.2 mt -119.4 148.53 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.265 -1.383 . . . . 1.12 107.265 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.597 ' ND2' HD11 ' A' ' 160' ' ' LEU . 29.9 m-20 -89.55 -67.71 0.82 Allowed 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.961 -1.126 . . . . 4.25 107.961 171.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -138.96 162.0 35.95 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.176 0.806 . . . . 1.97 113.176 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -104.3 154.0 20.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.411 1.884 . . . . 2.35 108.85 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.7 t -85.48 149.78 52.61 Favored Pre-proline 0 N--CA 1.444 -0.74 0 C-N-CA 124.3 1.04 . . . . 2.7 111.68 172.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -86.93 -17.6 3.1 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.155 3.236 . . . . 2.18 111.104 169.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -56.69 -46.84 80.95 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.963 0.905 . . . . 3.88 109.83 -177.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 4.2 mmt -101.49 -169.87 1.75 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.477 1.111 . . . . 3.38 108.037 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -103.28 145.76 29.47 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 108.397 -0.964 . . . . 2.93 108.397 167.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -55.38 -39.98 70.78 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.711 -0.618 . . . . 2.33 111.196 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -64.25 -7.68 10.16 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.706 -0.679 . . . . 3.17 112.302 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -95.67 -50.16 5.06 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.512 1.125 . . . . 3.25 109.259 162.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -50.58 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 118.894 0.77 . . . . 2.35 110.329 -166.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.492 ' HB3' ' NZ ' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -76.19 -19.15 58.68 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 118.066 -1.454 . . . . 1.71 109.776 178.558 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -73.1 -46.17 52.83 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 119.135 0.88 . . . . 2.22 108.736 -175.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.4 -54.24 23.31 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 124.184 0.994 . . . . 0.52 109.619 171.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.82 -48.79 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 121.059 -0.256 . . . . 2.33 110.472 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -50.26 -57.76 7.12 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.178 1.391 . . . . 4.34 108.899 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -64.7 -43.23 94.16 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.191 -0.913 . . . . 2.36 109.485 -176.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.01 -52.73 57.47 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.001 0.52 . . . . 0.45 110.134 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.471 ' CE1' HG13 ' A' ' 220' ' ' ILE . 61.5 m-85 -54.23 -44.84 72.06 Favored 'General case' 0 C--O 1.231 0.111 0 O-C-N 122.182 -0.324 . . . . 4.58 111.007 171.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.34 -37.19 67.13 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.547 -0.739 . . . . 2.0 111.852 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.435 HG12 HD21 ' A' ' 250' ' ' LEU . 62.7 t -55.55 -63.3 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 119.121 0.873 . . . . 0.84 109.571 177.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.906 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 58.7 m95 -70.48 -32.58 70.17 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.964 -0.754 . . . . 0.68 108.964 -171.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.3 t -64.62 -14.12 56.58 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.064 -0.97 . . . . 1.27 112.998 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -82.67 -48.27 11.09 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.036 -1.098 . . . . 1.04 108.036 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.3 m -76.98 -46.37 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 112.282 0.475 . . . . 1.5 112.282 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.712 HG22 HD13 ' A' ' 258' ' ' ILE . 22.9 p -82.81 152.54 66.3 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 108.18 -1.045 . . . . 0.61 108.18 177.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.26 9.07 3.53 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.334 2.023 . . . . 0.7 112.224 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.406 ' HB3' HG13 ' A' ' 114' ' ' ILE . 29.2 mt -67.52 108.79 2.97 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.502 1.046 . . . . 1.75 110.307 -178.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.1 mpmm? -70.94 91.13 0.84 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.463 0.649 . . . . 3.64 109.619 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.94 134.56 57.22 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 127.456 2.303 . . . . 6.42 109.687 168.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.3 t -153.46 106.69 2.96 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.372 -0.233 . . . . 0.77 110.372 163.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.492 ' NZ ' ' HB3' ' A' ' 131' ' ' ASP . 1.8 tmmt? -80.87 130.25 34.95 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.705 -0.85 . . . . 1.96 108.705 173.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.0 pt -128.47 142.2 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.037 -1.468 . . . . 1.35 107.037 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -95.59 -15.62 22.67 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 122.497 -0.127 . . . . 3.12 110.752 -177.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 52.8 m -136.57 130.09 31.85 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 125.096 1.358 . . . . 2.39 107.487 172.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 137.89 -152.87 21.94 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 107.999 -2.04 . . . . 1.6 107.999 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 41.2 mtp -123.73 131.57 53.63 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.892 1.677 . . . . 4.5 106.746 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -136.72 158.74 43.73 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.769 0.828 . . . . 0.89 110.304 -175.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -76.59 -49.11 17.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.706 -0.85 . . . . 1.63 108.706 -167.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.14 171.82 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.358 0.599 . . . . 1.25 110.772 172.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.597 HD11 ' ND2' ' A' ' 119' ' ' ASN . 1.0 OUTLIER -144.59 144.1 31.12 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.917 2.087 . . . . 3.22 109.1 178.752 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.505 ' N ' HD22 ' A' ' 160' ' ' LEU . 37.3 t -83.02 106.45 13.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 125.153 1.381 . . . . 1.24 109.054 170.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 69.9 t -84.84 118.3 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.215 -1.031 . . . . 1.39 108.215 171.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -80.87 138.79 36.19 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 105.856 -1.905 . . . . 7.49 105.856 160.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -147.14 161.59 40.57 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.564 -1.643 . . . . 1.22 106.564 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.6 ptt85 -155.92 121.36 4.87 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.45 -0.574 . . . . 3.65 109.45 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.465 ' HA2' ' CD1' ' A' ' 174' ' ' PHE . . . 80.4 -52.42 4.34 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.587 -0.605 . . . . 2.69 111.587 175.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -154.03 170.76 20.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.166 0.986 . . . . 2.23 108.489 173.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.1 p80 . . . . . 0 CA--C 1.529 0.152 0 C-N-CA 123.84 0.856 . . . . 2.9 110.123 166.557 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 114.519 1.303 . . . . 3.46 114.519 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.502 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -159.99 -175.77 5.29 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.637 2.375 . . . . 7.93 105.364 -172.122 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.502 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 13.7 p30 177.2 43.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.863 1.265 . . . . 2.37 111.296 169.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 53.16 -158.43 4.16 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.49 -0.644 . . . . 1.45 111.49 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -76.73 119.1 20.05 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.94 -0.63 . . . . 5.21 109.78 -177.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.91 -160.86 13.71 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.118 -1.193 . . . . 1.61 110.118 -168.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.08 -128.52 43.96 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.038 1.304 . . . . 1.47 111.515 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -77.65 134.17 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 125.44 1.496 . . . . 3.05 107.299 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.14 -55.67 3.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.681 1.992 . . . . 1.21 109.14 173.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -163.78 162.44 23.83 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.495 -0.753 . . . . 0.67 111.617 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -154.14 105.01 2.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.356 1.462 . . . . 0.96 112.295 -174.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -121.63 158.81 27.81 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.113 2.165 . . . . 0.81 109.651 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -154.74 132.0 11.08 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 107.29 -1.374 . . . . 2.99 107.29 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.12 -89.23 0.51 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.286 0.946 . . . . 1.01 112.836 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.08 83.76 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.943 3.096 . . . . 1.56 111.041 -169.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -160.05 165.31 34.7 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.532 -1.427 . . . . 1.14 109.532 172.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.8 m -78.89 169.99 17.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.468 0.707 . . . . 1.99 111.149 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 55.08 -108.06 0.89 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 123.827 0.727 . . . . 1.45 111.588 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 8.9 tp -59.82 -40.07 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 118.547 -0.739 . . . . 1.63 109.671 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -42.12 143.23 1.17 Allowed Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.399 0.999 . . . . 1.12 113.111 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 94.26 -59.21 1.97 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.908 1.718 . . . . 0.82 109.213 -155.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.38 148.51 31.99 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.898 -0.778 . . . . 1.44 108.898 -155.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -112.24 120.42 41.69 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 118.963 -0.542 . . . . 0.62 110.272 -174.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.497 ' N ' ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -107.15 137.89 44.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.024 -1.473 . . . . 2.42 107.024 -175.74 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -127.69 144.29 51.09 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.172 -1.418 . . . . 2.68 107.172 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -74.26 67.19 1.37 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.783 -1.191 . . . . 2.94 107.783 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -54.5 -45.4 73.25 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.811 -1.181 . . . . 2.62 107.811 -174.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -32.54 -44.25 0.1 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.937 1.695 . . . . 3.84 112.044 -170.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -63.97 -178.44 0.33 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 129.412 3.085 . . . . 2.21 109.399 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -129.06 90.2 2.99 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 120.095 -1.628 . . . . 3.02 108.701 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.445 ' HB2' ' HB ' ' A' ' 210' ' ' THR . 5.7 p-90 -134.67 119.46 18.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.726 0.81 . . . . 3.31 111.32 -173.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 14.9 p -153.62 158.62 41.42 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.822 1.249 . . . . 3.86 111.014 -177.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.66 -47.13 63.9 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.255 1.022 . . . . 4.64 109.874 172.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -67.78 -29.87 69.17 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 114.884 -1.053 . . . . 4.97 110.887 -167.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.0 t -81.64 -44.82 16.65 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.707 -0.849 . . . . 8.67 108.707 174.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.09 -35.56 4.32 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 124.579 1.085 . . . . 3.28 110.649 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -27.17 -92.85 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 128.782 3.087 . . . . 1.08 114.589 -173.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 203' ' ' TRP . 88.5 m -118.66 123.04 43.97 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 104.525 -2.398 . . . . 1.72 104.525 160.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -69.96 120.19 15.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 118.491 -1.284 . . . . 1.37 109.541 172.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 60.8 tp -50.41 -50.75 51.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.827 -0.606 . . . . 1.73 111.693 177.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.537 ' O ' HG23 ' A' ' 217' ' ' VAL . 18.0 t80 -52.24 -49.88 63.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.974 0.806 . . . . 1.38 110.767 176.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.5 tt -57.33 -60.92 2.91 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.994 0.917 . . . . 1.2 110.705 -174.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.351 25.4 m -60.71 -35.98 77.67 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.945 -0.391 . . . . 1.53 109.945 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.59 -52.2 62.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 117.053 -1.451 . . . . 0.48 110.712 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 213' ' ' PHE . 35.1 t -44.93 -53.22 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 121.579 1.991 . . . . 0.89 110.922 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.613 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 4.0 t60 -56.03 -54.05 49.59 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.854 0.862 . . . . 2.68 111.632 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -71.23 -44.68 64.87 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.797 -1.189 . . . . 4.03 112.45 -173.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.471 HG13 ' CE1' ' A' ' 138' ' ' PHE . 1.7 mp -49.98 -44.79 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.604 1.562 . . . . 1.46 108.265 166.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -53.19 -51.14 48.68 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.546 -0.721 . . . . 0.46 111.82 170.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.613 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 4.5 m-70 -52.03 -42.41 63.05 Favored 'General case' 0 C--N 1.34 0.173 0 O-C-N 121.429 -1.042 . . . . 1.44 111.492 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.3 m -58.11 -26.61 62.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.797 0.665 . . . . 2.24 112.797 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.4 mt -73.77 -51.96 14.74 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.068 -1.086 . . . . 2.14 108.068 171.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 138.48 70.38 0.05 OUTLIER Glycine 0 C--N 1.34 0.755 0 C-N-CA 122.844 0.259 . . . . 1.25 112.548 170.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.637 ' CD1' HG22 ' A' ' 258' ' ' ILE . 15.6 mt -132.74 105.57 7.25 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.178 0.591 . . . . 3.28 109.771 -172.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -76.75 43.3 1.89 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.338 0.97 . . . . 3.09 113.046 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 22.0 m80 73.88 155.51 0.16 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.356 1.862 . . . . 1.71 111.605 -175.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 58.1 m -120.17 132.0 55.22 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 126.149 1.78 . . . . 1.83 106.321 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 22.6 p -79.64 57.02 2.36 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.398 0.679 . . . . 3.2 110.854 -175.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -156.18 137.8 9.73 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 118.006 -0.997 . . . . 2.2 109.733 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.92 -20.89 7.26 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.76 2.306 . . . . 1.45 114.606 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -27.42 48.91 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 119.258 0.935 . . . . 2.12 109.957 175.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.419 ' HB1' ' CG ' ' A' ' 254' ' ' ASP . . . -65.81 130.65 44.01 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.602 1.161 . . . . 1.08 110.105 168.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 85.8 t -70.94 -25.84 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.899 0.856 . . . . 0.93 110.165 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -53.03 -18.12 1.87 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.95 1.3 . . . . 1.74 114.278 170.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.415 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 10.3 t80 -56.32 137.89 74.92 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 119.738 1.154 . . . . 5.72 110.492 -174.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.415 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 43.4 Cg_endo -63.84 -21.77 69.17 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.88 2.387 . . . . 1.38 112.597 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.359 0.2 OUTLIER -92.05 130.74 37.72 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.279 -0.637 . . . . 2.21 109.279 -179.558 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -76.71 141.67 40.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.638 -0.875 . . . . 2.07 108.638 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.84 131.08 13.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.193 -1.78 . . . . 2.46 106.193 170.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -54.73 115.01 1.93 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.066 0.946 . . . . 3.08 110.599 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.4 m -94.18 138.92 19.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 122.957 0.503 . . . . 1.55 110.726 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.41 89.64 1.25 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.985 -0.746 . . . . 3.9 108.985 173.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 47.1 mt -48.88 -31.25 3.83 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 123.848 0.859 . . . . 2.68 110.335 174.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -39.33 -41.54 0.93 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.438 1.495 . . . . 3.51 113.589 171.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 8.4 m -81.38 -41.58 21.75 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.796 0.838 . . . . 1.9 110.57 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 78.9 t80 46.77 70.63 0.38 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.15 1.38 . . . . 4.68 111.511 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -156.55 167.17 31.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.57 -0.706 . . . . 3.75 109.91 175.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.51 HD12 ' CH2' ' A' ' 141' ' ' TRP . 2.0 mm? -105.9 157.81 17.22 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.727 1.611 . . . . 1.09 108.009 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 10.1 m -79.44 154.31 29.03 Favored 'General case' 0 C--O 1.221 -0.404 0 O-C-N 121.295 -0.878 . . . . 1.03 111.418 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.13 -48.63 75.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.975 0.893 . . . . 1.14 109.862 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.61 -52.37 18.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.192 1.797 . . . . 4.62 108.633 172.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.419 ' CG ' ' HB1' ' A' ' 234' ' ' ALA . 0.7 OUTLIER -63.38 -46.02 88.41 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.978 -1.01 . . . . 2.22 110.516 -176.278 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.4 ' HA ' HG13 ' A' ' 258' ' ' ILE . 45.3 mt -53.12 -42.23 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.725 2.01 . . . . 0.97 110.35 176.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -64.75 -48.82 73.16 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.007 -1.058 . . . . 5.89 111.078 172.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -45.42 -55.5 6.8 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 111.764 -0.535 . . . . 0.82 111.764 174.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.906 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 1.9 pp -65.81 -40.51 87.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 123.982 0.913 . . . . 2.18 111.361 -176.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.569 ' N ' HD12 ' A' ' 258' ' ' ILE . 3.9 mt-30 -62.18 -30.02 70.77 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.741 -1.224 . . . . 2.56 110.849 174.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.8 -14.43 2.34 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.101 1.149 . . . . 1.87 114.101 169.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.3 mt . . . . . 0 CA--C 1.537 0.449 0 CA-C-N 121.02 1.736 . . . . 2.38 112.716 164.926 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 44.4 mtt . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 106.98 -1.489 . . . . 17.38 106.98 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 146.65 65.63 0.01 OUTLIER Glycine 0 CA--C 1.532 1.139 0 O-C-N 124.094 0.871 . . . . 10.98 111.127 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -70.54 133.91 25.19 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.291 1.994 . . . . 11.81 109.703 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.6 p -158.06 150.95 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 108.685 -0.857 . . . . 7.58 108.685 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -175.98 176.04 1.85 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.98 2.112 . . . . 12.72 106.116 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.27 73.86 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.619 1.967 . . . . 7.52 106.081 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.536 ' HG2' HD11 ' A' ' 114' ' ' ILE . 0.1 OUTLIER 58.55 -79.05 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.641 1.176 . . . . 5.81 111.342 -164.684 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 41.6 m80 56.34 -72.33 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.059 1.743 . . . . 3.52 110.956 -159.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -104.85 101.3 10.9 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.915 0.886 . . . . 3.61 112.315 -169.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.536 HD11 ' HG2' ' A' ' 111' ' ' LYS . 25.8 mm -81.77 91.77 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 108.478 -0.934 . . . . 2.41 108.478 170.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.1 p -79.93 125.21 29.45 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.137 -0.69 . . . . 1.25 109.137 171.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -130.75 158.47 40.03 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.383 0.673 . . . . 4.33 111.031 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -144.47 145.04 31.66 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.521 -0.918 . . . . 5.2 108.521 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.99 147.24 5.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 108.143 -1.058 . . . . 1.15 108.143 174.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -84.71 -44.32 13.49 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.455 -0.572 . . . . 3.56 109.455 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -153.25 171.58 18.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.912 -0.773 . . . . 2.25 108.912 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -128.13 129.95 47.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.876 1.27 . . . . 2.19 108.15 -163.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.5 t -63.47 114.18 12.19 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 118.539 0.609 . . . . 2.38 109.739 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -68.41 -17.98 43.96 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.488 2.792 . . . . 1.58 111.125 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.22 -34.25 0.74 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.632 2.773 . . . . 2.27 111.61 174.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.51 -179.64 5.57 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.056 1.342 . . . . 1.98 109.418 175.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -71.32 132.38 44.8 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 109.22 -0.659 . . . . 3.09 109.22 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 53.5 ttt-85 -47.79 -40.41 20.82 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.507 0.558 . . . . 2.15 112.507 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -50.38 -55.33 16.15 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.812 -0.81 . . . . 2.84 108.812 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -55.11 -45.03 75.49 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.937 1.695 . . . . 2.26 111.908 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.63 -57.83 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 O-C-N 121.418 -0.802 . . . . 1.27 109.694 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -27.53 66.61 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 117.919 -1.513 . . . . 1.78 109.184 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -59.72 -47.91 83.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.206 0.912 . . . . 1.99 110.383 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.82 -52.56 64.95 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.081 0.552 . . . . 0.43 110.508 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.431 HD11 HD11 ' A' ' 220' ' ' ILE . 0.1 OUTLIER -70.05 -37.6 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.289 -0.634 . . . . 1.5 109.289 -175.281 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -55.34 -60.83 2.85 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.502 1.121 . . . . 4.0 108.021 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.656 ' O ' HG23 ' A' ' 140' ' ' VAL . 8.3 mmmm -58.0 -45.86 86.16 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.246 1.018 . . . . 1.49 109.445 -176.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.53 -52.66 36.66 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.968 0.907 . . . . 0.63 111.429 175.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.508 ' HB3' ' CD2' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -53.67 -55.48 25.69 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 110.091 -0.337 . . . . 4.56 110.091 170.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.55 -44.61 46.71 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.314 1.046 . . . . 3.49 110.497 -171.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 136' ' ' LYS . 45.2 t -47.58 -54.06 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.109 0.964 . . . . 0.71 110.098 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.848 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 83.8 m95 -72.08 -41.07 67.78 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.283 -0.636 . . . . 0.66 109.283 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.02 -22.76 51.36 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.919 0.888 . . . . 1.1 111.271 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -75.37 -43.63 49.32 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.088 0.955 . . . . 1.57 110.942 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.633 HG21 HD23 ' A' ' 250' ' ' LEU . 65.8 t -84.87 -49.39 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.685 1.194 . . . . 1.9 110.825 -173.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.501 HG22 HD13 ' A' ' 258' ' ' ILE . 81.6 p -77.24 158.0 80.09 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 107.976 -1.12 . . . . 0.6 107.976 174.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.08 -1.03 10.72 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.75 1.633 . . . . 0.84 112.601 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.948 HD13 HD22 ' A' ' 224' ' ' LEU . 10.4 mt -62.24 139.76 58.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.021 0.828 . . . . 1.86 110.263 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.38 97.13 6.14 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.049 -1.093 . . . . 7.34 108.049 177.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.508 ' CD2' ' HB3' ' A' ' 138' ' ' PHE . 0.4 OUTLIER -64.56 153.82 38.03 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.373 0.508 . . . . 6.9 112.373 175.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.57 113.77 3.42 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 123.948 0.899 . . . . 1.11 110.103 176.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.47 139.6 33.86 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.526 -0.916 . . . . 1.99 108.526 173.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.1 pp -139.34 114.28 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.309 -0.997 . . . . 1.36 108.309 172.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -80.15 -15.74 56.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.452 -0.34 . . . . 2.66 110.753 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 72.2 p -124.37 89.2 3.03 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 124.585 1.154 . . . . 2.57 110.798 -170.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 145.83 -143.38 11.61 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.41 -1.876 . . . . 1.53 108.41 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 33.6 mtt -127.43 131.18 50.28 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.857 2.063 . . . . 4.96 107.751 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -109.94 167.22 10.33 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.589 1.556 . . . . 0.78 109.274 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -79.94 -50.59 10.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.761 -0.829 . . . . 2.34 108.761 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 12.3 pt -106.75 169.08 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.454 0.645 . . . . 0.97 109.742 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.64 135.74 35.2 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.929 1.292 . . . . 2.22 109.848 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.8 t -100.75 102.56 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.051 0.94 . . . . 0.99 109.476 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.3 t -89.17 88.7 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 126.023 1.729 . . . . 1.58 111.341 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -81.78 105.43 12.91 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 107.115 -1.439 . . . . 5.65 107.115 170.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -123.95 151.76 43.24 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 118.415 0.552 . . . . 0.84 109.737 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.56 99.88 6.53 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.847 1.259 . . . . 4.07 109.699 -167.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 54.13 43.29 73.66 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.426 1.012 . . . . 3.7 111.439 172.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -157.27 176.39 12.76 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.467 0.707 . . . . 4.57 109.895 -170.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 82.01 137.68 0.06 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.522 2.329 . . . . 3.98 110.439 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -72.51 117.74 6.33 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.769 -1.332 . . . . 2.65 109.769 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -156.27 -177.14 6.37 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 105.936 -1.876 . . . . 2.93 105.936 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -65.67 0.88 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.276 -1.379 . . . . 5.52 107.276 166.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -107.59 69.9 0.76 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.861 1.265 . . . . 5.29 108.043 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -56.59 -75.77 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 119.254 -0.403 . . . . 2.66 110.838 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -160.52 166.69 28.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.13 1.772 . . . . 6.47 106.34 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.8 p30 -153.76 168.91 24.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.295 -1.372 . . . . 3.69 107.295 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -66.79 -148.18 0.09 OUTLIER Glycine 0 CA--C 1.533 1.162 0 CA-C-O 122.867 1.26 . . . . 1.61 114.264 -170.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.13 78.78 0.51 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.488 1.515 . . . . 3.91 110.065 -171.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 135.7 -159.23 24.12 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 108.711 -1.756 . . . . 2.12 108.711 -174.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 64.57 -125.03 30.43 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.892 -1.283 . . . . 1.98 109.892 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . 0.276 21.0 mm -77.21 132.32 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 108.67 -0.863 . . . . 1.65 108.67 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.557 HD22 ' H5 ' ' A' ' 269' ' ' NGH . 9.1 mp -85.27 -63.1 1.38 Allowed 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.373 2.269 . . . . 1.19 109.303 168.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.489 ' O ' ' N1 ' ' A' ' 269' ' ' NGH . . . -168.75 152.4 5.48 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 114.385 1.254 . . . . 0.67 114.385 -175.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -151.2 138.82 19.65 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.157 0.983 . . . . 1.27 112.772 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . 0.26 . . -163.51 162.21 24.47 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.479 1.911 . . . . 0.72 106.087 -157.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -149.28 140.74 23.32 Favored 'General case' 0 C--O 1.227 -0.089 0 N-CA-C 109.282 -0.636 . . . . 3.24 109.282 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.94 -87.34 1.77 Allowed Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.189 -1.164 . . . . 0.62 110.189 173.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -69.92 89.38 0.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.72 2.947 . . . . 1.49 110.855 -173.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -165.37 172.12 40.85 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 108.047 -2.021 . . . . 1.27 108.047 171.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.2 p -84.06 172.81 11.65 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.147 0.979 . . . . 2.27 109.782 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.93 -103.54 0.14 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.033 0.825 . . . . 1.4 112.409 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.9 tp -59.43 -40.2 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-O 118.371 -0.823 . . . . 1.5 109.282 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -36.1 132.13 0.79 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.632 1.11 . . . . 1.17 113.0 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.82 -43.28 1.77 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.944 1.735 . . . . 0.88 110.915 -164.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.62 159.97 15.62 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.635 0.774 . . . . 1.46 109.482 -162.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -138.75 125.24 20.57 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 117.96 -1.019 . . . . 0.9 113.392 -168.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -111.83 139.58 47.19 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 119.423 1.01 . . . . 2.27 109.234 -168.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -135.99 148.41 48.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.177 0.899 . . . . 2.98 110.741 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -73.33 82.2 1.39 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.411 -1.268 . . . . 2.38 110.462 -176.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -61.05 -27.1 68.1 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 121.205 -0.934 . . . . 3.74 110.833 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.76 -43.4 12.99 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.263 1.425 . . . . 2.66 109.793 172.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -70.89 157.11 38.72 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 123.827 1.775 . . . . 2.01 112.581 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -102.4 87.71 3.09 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 112.727 -2.033 . . . . 5.65 106.698 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -75.06 154.34 37.97 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 113.762 -1.563 . . . . 1.17 107.595 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.3 p -136.3 137.64 40.89 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.387 0.613 . . . . 1.63 109.5 -171.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.9 -47.04 88.24 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.333 -1.479 . . . . 1.93 110.33 173.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -65.61 151.63 46.03 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.588 -0.733 . . . . 2.04 110.37 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.7 m -60.27 -38.33 83.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.75 1.22 . . . . 4.44 110.555 -171.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -55.62 120.82 20.43 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-O 118.829 -0.984 . . . . 3.11 111.98 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 109.17 -125.71 7.81 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.94 -1.664 . . . . 1.08 108.94 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 m -117.07 117.15 28.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.372 -1.714 . . . . 0.96 106.372 164.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -77.24 122.11 24.61 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.523 -0.871 . . . . 1.32 110.742 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 20.3 tp -56.31 -53.65 54.81 Favored 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 109.6 -0.518 . . . . 1.95 109.6 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.552 ' O ' HG23 ' A' ' 217' ' ' VAL . 21.6 t80 -48.54 -46.05 38.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.055 0.455 . . . . 1.56 110.135 -178.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.44 ' C ' HD23 ' A' ' 214' ' ' LEU . 6.8 tt -57.37 -65.26 0.66 Allowed 'General case' 0 C--O 1.23 0.07 0 C-N-CA 123.85 0.86 . . . . 1.19 110.223 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.29 0.8 OUTLIER -56.49 -40.09 74.34 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.445 0.641 . . . . 0.83 110.214 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.62 -46.75 77.35 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 117.358 -1.306 . . . . 0.43 110.36 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 213' ' ' PHE . 66.4 t -48.79 -45.65 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 120.422 1.464 . . . . 0.83 110.803 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.532 ' CE1' ' O ' ' A' ' 236' ' ' MET . 60.1 t60 -64.15 -50.33 68.61 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.933 0.893 . . . . 2.39 112.447 176.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -64.85 -42.92 94.51 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.695 -1.253 . . . . 3.07 112.494 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.447 HG21 ' HA ' ' A' ' 138' ' ' PHE . 1.1 mp -55.51 -43.12 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 107.795 -1.187 . . . . 1.1 107.795 172.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.99 -52.0 27.85 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 112.246 -0.341 . . . . 0.68 112.246 169.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.412 ' HE1' ' CE1' ' A' ' 228' ' ' HIS . 20.0 m-70 -49.48 -52.34 29.94 Favored 'General case' 0 C--N 1.341 0.197 0 O-C-N 122.06 -0.67 . . . . 1.71 110.658 173.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 89.2 p -62.84 -45.85 90.68 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.518 0.562 . . . . 1.83 112.518 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.948 HD22 HD13 ' A' ' 147' ' ' LEU . 91.0 mt -56.8 -41.62 78.06 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.647 -0.501 . . . . 2.39 109.647 176.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 118.43 29.11 1.99 Allowed Glycine 0 C--N 1.337 0.626 0 C-N-CA 124.978 1.275 . . . . 1.2 111.491 171.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.593 HD22 HG22 ' A' ' 258' ' ' ILE . 12.1 mt -75.0 143.57 43.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.935 -1.506 . . . . 4.3 106.935 -173.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -72.9 143.8 34.06 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.072 -1.211 . . . . 3.18 110.072 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.412 ' CE1' ' HE1' ' A' ' 222' ' ' HIS . 12.1 m80 -50.92 118.24 3.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.723 0.762 . . . . 1.46 110.088 172.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 64.9 m -78.72 173.15 12.76 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.615 -0.513 . . . . 0.95 109.615 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.11 30.23 2.47 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.68 0.792 . . . . 2.31 110.742 -170.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -132.06 133.18 23.63 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 106.898 -1.519 . . . . 1.88 106.898 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.94 -14.4 44.95 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.449 2.099 . . . . 1.02 114.162 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -81.13 -27.79 35.37 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.121 0.968 . . . . 1.4 111.279 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.22 152.64 45.17 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.849 -0.797 . . . . 0.69 108.849 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 66.8 t -99.11 -25.88 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.296 -0.865 . . . . 0.53 109.536 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.532 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 10.8 tpt -65.59 -18.73 65.54 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.157 -0.964 . . . . 2.96 113.073 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.471 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.1 157.34 0.66 Allowed Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.719 1.608 . . . . 3.04 113.457 -175.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.54 ' O ' ' H1 ' ' A' ' 269' ' ' NGH . 69.2 Cg_endo -74.93 -20.63 16.86 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.712 1.608 . . . . 1.11 111.453 174.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.371 0.2 OUTLIER -77.38 178.03 7.49 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.512 1.125 . . . . 1.37 109.1 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -126.66 147.64 49.91 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.418 -1.327 . . . . 2.44 107.418 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -150.54 146.47 26.6 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.047 -1.464 . . . . 3.34 107.047 170.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -72.47 83.41 1.1 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.24 1.016 . . . . 3.9 108.61 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.7 m -76.71 136.75 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 109.413 -0.588 . . . . 1.59 109.413 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -87.09 117.97 26.18 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.1 -0.5 . . . . 3.09 110.063 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 20.9 mt -60.49 -20.44 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 119.223 -0.417 . . . . 2.5 110.222 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -52.35 -36.02 52.57 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.333 0.969 . . . . 3.51 111.83 171.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.0 m -81.54 -47.69 12.77 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 122.756 0.423 . . . . 2.46 110.31 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.547 ' CE1' HG22 ' A' ' 140' ' ' VAL . 62.1 t80 45.61 73.33 0.17 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.315 1.446 . . . . 4.36 111.868 177.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.89 168.77 23.98 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 121.278 -0.889 . . . . 4.76 110.222 177.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.633 HD23 HG21 ' A' ' 144' ' ' VAL . 1.3 mm? -108.86 149.03 29.71 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.762 1.625 . . . . 0.82 108.066 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.9 m -77.44 158.38 30.04 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 121.17 -0.212 . . . . 0.58 111.415 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -58.28 -47.87 82.26 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.728 0.411 . . . . 0.83 110.549 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -55.46 -40.21 71.34 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.039 0.935 . . . . 3.64 110.035 176.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.42 -52.1 59.79 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.789 0.835 . . . . 2.01 109.815 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.424 ' HA ' HG13 ' A' ' 258' ' ' ILE . 48.9 mt -56.11 -42.86 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 127.063 2.145 . . . . 0.74 112.271 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -61.71 -42.45 98.96 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.177 -1.577 . . . . 7.91 110.383 172.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -54.34 -53.14 39.83 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.285 -1.126 . . . . 0.9 110.285 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.848 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 1.8 pp -63.96 -43.04 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 O-C-N 122.104 -0.645 . . . . 2.25 110.724 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -65.81 -20.14 66.14 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.843 0.747 . . . . 2.06 112.368 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 t -52.11 -33.39 39.55 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.633 0.651 . . . . 2.02 110.789 168.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.485 ' CD1' HD23 ' A' ' 226' ' ' LEU . 14.8 mt -71.48 84.52 0.83 Allowed 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 121.594 -0.691 . . . . 3.54 110.196 175.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -47.12 -33.78 5.41 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.5 1.12 . . . . 7.62 111.469 168.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.902 0 N-CA-C 107.411 -2.276 . . . . 9.5 107.411 165.67 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 269' ' ' NGH . . . . . 0.557 ' H5 ' HD22 ' A' ' 181' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 116.923 -1.513 . . . . 12.86 107.358 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -116.69 79.31 0.29 Allowed Glycine 0 CA--C 1.532 1.129 0 CA-C-N 119.901 1.228 . . . . 8.05 112.469 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -74.0 165.29 32.41 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.725 2.284 . . . . 9.29 110.176 173.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.4 p -159.86 157.06 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.224 -1.399 . . . . 5.38 107.224 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 8.9 m0 -78.78 147.05 33.47 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 112.58 0.585 . . . . 10.76 112.58 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.7 tpt85 -52.58 -37.86 58.87 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.552 1.141 . . . . 7.85 113.574 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.29 -57.59 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.592 0.757 . . . . 5.51 110.056 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 2.1 m170 63.16 -63.17 0.12 Allowed 'General case' 0 C--N 1.342 0.244 0 C-N-CA 126.462 1.905 . . . . 4.1 113.197 -172.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -79.04 104.11 9.45 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.321 -0.992 . . . . 2.75 108.321 -176.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.415 HG21 ' CE1' ' A' ' 149' ' ' PHE . 9.2 mm -113.36 142.57 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.09 -1.448 . . . . 1.78 107.09 173.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.6 p -135.61 140.67 44.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.66 -0.867 . . . . 1.16 108.66 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -126.73 160.48 30.7 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.645 0.778 . . . . 4.21 111.453 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.52 145.8 31.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.252 1.021 . . . . 4.26 108.994 174.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -94.47 159.82 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.105 -1.443 . . . . 0.83 107.105 173.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -101.84 -38.95 7.61 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.815 0.846 . . . . 2.99 110.385 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -150.78 173.56 14.07 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.077 1.351 . . . . 2.4 107.868 175.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -113.5 129.54 56.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.058 0.943 . . . . 1.98 109.641 -175.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -41.08 135.48 1.71 Allowed Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.536 1.534 . . . . 3.12 109.64 165.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -84.97 -23.15 2.59 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.44 2.76 . . . . 2.35 110.323 167.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.26 -43.95 33.05 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.74 1.616 . . . . 3.17 111.085 -174.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 7.8 mtm -127.18 173.38 9.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.431 1.492 . . . . 2.64 109.435 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.423 ' O ' HG13 ' A' ' 130' ' ' VAL . 69.5 m-80 -71.64 152.76 42.59 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.292 0.637 . . . . 3.3 110.498 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -44.97 -52.58 8.64 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.915 0.886 . . . . 2.63 112.067 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -64.67 -5.28 5.37 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.492 -0.766 . . . . 2.86 113.061 -177.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -103.63 -41.74 5.86 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.551 1.54 . . . . 2.42 110.56 168.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 126' ' ' ASN . 1.5 m -57.62 -52.69 54.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 O-C-N 121.123 -0.986 . . . . 2.65 110.021 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.36 -24.74 64.83 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 118.41 -1.316 . . . . 1.68 108.449 178.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -63.38 -49.94 71.86 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 120.298 1.408 . . . . 2.11 110.402 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.28 -55.12 27.11 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 123.421 0.688 . . . . 0.39 109.828 175.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.88 -41.75 92.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 120.495 -0.482 . . . . 2.47 110.09 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.6 ttt-85 -57.51 -54.16 49.97 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.906 1.282 . . . . 4.01 108.146 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.634 ' O ' HG23 ' A' ' 140' ' ' VAL . 4.9 mmmp? -60.27 -46.62 89.17 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.886 0.875 . . . . 1.72 109.291 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.72 -53.43 31.47 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.421 0.689 . . . . 0.47 111.238 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.456 ' HA ' HG21 ' A' ' 220' ' ' ILE . 32.0 m-85 -53.84 -50.8 65.4 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.197 0.599 . . . . 4.57 109.969 171.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.57 -38.25 74.52 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 119.166 -0.445 . . . . 2.04 111.313 -173.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.738 HG22 ' CE1' ' A' ' 248' ' ' PHE . 98.4 t -51.04 -58.8 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.332 1.053 . . . . 0.71 109.127 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.701 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 45.7 m95 -72.8 -34.68 67.05 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.299 -0.63 . . . . 0.88 109.299 -174.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 t -64.2 -27.24 68.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.129 0.572 . . . . 1.18 111.652 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -70.31 -46.36 64.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 121.573 -0.705 . . . . 1.26 109.56 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.9 t -77.39 -56.46 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.217 0.607 . . . . 2.01 110.792 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 72.3 p -80.27 157.07 73.52 Favored Pre-proline 0 CA--C 1.53 0.193 0 N-CA-C 108.564 -0.902 . . . . 0.72 108.564 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.07 3.01 7.01 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.844 1.696 . . . . 1.03 112.869 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.8 mt -73.71 100.55 3.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.101 0.864 . . . . 1.86 109.928 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -84.61 96.67 9.26 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.096 0.959 . . . . 3.59 109.132 -169.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.415 ' CE1' HG21 ' A' ' 114' ' ' ILE . 41.8 m-85 -79.25 154.79 28.92 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.313 1.045 . . . . 5.58 112.831 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -155.42 138.98 15.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.681 1.192 . . . . 1.02 108.505 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.38 142.1 28.0 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 108.476 -0.935 . . . . 2.11 108.476 173.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.2 pt -130.52 115.87 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.397 -1.334 . . . . 1.26 107.397 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -80.73 -0.31 37.88 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.421 -0.585 . . . . 2.82 109.421 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 39.3 m -153.18 113.72 4.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.599 1.16 . . . . 2.29 108.433 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 138.81 -152.42 22.15 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 107.969 -2.053 . . . . 1.39 107.969 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -127.89 125.13 39.07 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.453 1.901 . . . . 5.28 107.04 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.69 166.02 11.11 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.429 1.091 . . . . 0.72 109.557 -173.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -77.97 -41.83 34.85 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.377 -0.971 . . . . 1.88 108.377 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 33.1 pt -124.48 159.93 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.924 0.89 . . . . 1.03 111.262 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.6 tt -126.97 128.29 46.16 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.321 1.449 . . . . 1.94 109.947 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.8 t -92.93 98.05 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 125.769 1.627 . . . . 0.83 108.097 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.9 t -80.14 136.02 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.719 -1.215 . . . . 1.41 107.719 170.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.403 ' CE1' ' HB2' ' A' ' 197' ' ' PHE . 7.3 m-85 -122.63 112.99 18.64 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 103.577 -2.749 . . . . 5.62 103.577 166.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 168' ' ' HIS . . . -147.65 159.76 43.42 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.4 -0.963 . . . . 0.98 108.4 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.79 131.39 47.79 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.027 -1.101 . . . . 4.29 108.027 -172.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 73.77 -113.18 4.1 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 111.062 -0.815 . . . . 1.71 111.062 -176.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -129.32 83.67 2.16 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.251 1.025 . . . . 2.29 110.527 -168.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.418 ' HB3' ' HB1' ' A' ' 164' ' ' ALA . 7.7 p80 -72.9 -40.62 65.39 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.877 0.37 . . . . 3.21 111.97 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 175.56 61.64 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 107.695 -2.162 . . . . 2.87 107.695 -172.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -155.32 -179.04 7.71 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 104.736 -2.32 . . . . 2.64 104.736 175.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.28 -64.99 1.04 Allowed 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 107.951 -1.129 . . . . 4.92 107.951 173.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -109.46 -72.41 0.72 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.136 -0.938 . . . . 7.57 109.964 -177.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.415 ' HB1' ' CE1' ' A' ' 183' ' ' HIS . . . 63.44 -68.23 0.09 Allowed 'General case' 0 C--N 1.339 0.11 0 C-N-CA 126.004 1.721 . . . . 2.37 114.703 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -123.72 164.93 18.15 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.103 0.961 . . . . 6.07 109.683 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -168.98 25.36 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.664 -0.698 . . . . 2.36 111.101 -158.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.17 -159.01 41.2 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.25 -1.14 . . . . 1.36 110.25 -171.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.56 104.67 1.32 Allowed 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 122.217 -0.578 . . . . 5.26 110.304 175.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 156.44 -179.01 32.63 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 108.678 -1.769 . . . . 1.91 108.678 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 45.28 -117.94 2.61 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 126.312 1.911 . . . . 1.71 111.123 171.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.3 mm -87.24 132.38 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 108.501 -0.926 . . . . 1.94 108.501 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.639 ' HB2' ' H5 ' ' A' ' 269' ' ' NGH . 6.6 mp -82.43 -42.77 18.13 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.708 1.603 . . . . 1.31 109.537 170.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.531 ' O ' ' N1 ' ' A' ' 269' ' ' NGH . . . -162.77 158.62 23.08 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.495 -0.753 . . . . 0.71 110.423 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.415 ' CE1' ' HB1' ' A' ' 173' ' ' ALA . 28.6 p-80 -138.44 114.63 10.22 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.647 1.179 . . . . 1.34 113.572 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 222' ' ' HIS . . . -132.21 163.76 27.86 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.919 2.088 . . . . 0.64 108.657 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -142.24 153.4 43.93 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.878 -1.527 . . . . 3.14 106.878 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -103.09 -90.35 2.15 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.296 -1.122 . . . . 0.69 110.296 172.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.04 82.74 0.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.93 3.086 . . . . 1.58 110.965 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -157.96 159.81 30.26 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 108.933 -1.667 . . . . 1.05 108.933 170.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.8 p -78.85 171.34 15.32 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.862 0.865 . . . . 2.11 110.101 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 54.28 -106.53 0.5 Allowed Glycine 0 C--O 1.244 0.721 0 C-N-CA 123.635 0.636 . . . . 1.48 111.626 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.4 tp -59.02 -43.22 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 118.501 -0.761 . . . . 1.56 109.14 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -43.3 135.05 4.96 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.492 1.044 . . . . 1.1 112.74 -177.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 107.0 -43.08 1.76 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.485 1.993 . . . . 0.66 110.751 -165.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.87 171.73 10.61 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.502 1.121 . . . . 1.51 110.957 -165.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.31 121.03 8.07 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.66 0.985 . . . . 0.74 113.66 -168.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -114.92 113.8 24.63 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 118.923 -0.56 . . . . 2.63 112.073 -172.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.403 ' HB2' ' CE1' ' A' ' 163' ' ' PHE . 56.5 m-85 -100.34 145.67 27.88 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.203 0.91 . . . . 2.89 112.412 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -73.21 82.66 1.34 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.851 0.834 . . . . 2.79 110.018 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -54.45 -28.96 47.87 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.293 -0.88 . . . . 3.45 111.352 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.82 -36.73 65.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.79 -0.448 . . . . 3.13 109.79 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.79 146.01 50.02 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 122.374 1.083 . . . . 1.89 109.154 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -92.15 92.25 8.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.357 -1.349 . . . . 2.77 107.357 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -78.01 131.46 37.38 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.443 -1.317 . . . . 1.12 107.443 -178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 41.0 p -116.87 136.09 53.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.428 0.691 . . . . 1.67 109.605 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.1 t -51.13 -49.39 60.89 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.622 1.169 . . . . 1.68 109.717 169.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.39 -179.36 5.69 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.149 0.98 . . . . 2.04 111.541 173.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.2 m -56.75 -56.56 19.89 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.791 1.236 . . . . 3.57 111.461 -173.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 42.97 -105.9 0.07 OUTLIER Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.017 1.294 . . . . 2.48 114.774 169.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -117.93 -63.3 0.31 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.252 0.93 . . . . 1.35 111.348 -172.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.37 164.55 27.18 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.193 -2.151 . . . . 1.01 105.193 165.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -116.9 133.24 56.26 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 119.248 0.931 . . . . 1.48 110.967 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 31.4 tp -62.78 -53.58 52.21 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.127 -0.488 . . . . 2.08 109.985 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.435 ' O ' HG23 ' A' ' 217' ' ' VAL . 28.2 t80 -50.87 -42.68 59.14 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.205 0.526 . . . . 1.38 109.852 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.425 HD23 ' H71' ' A' ' 269' ' ' NGH . 4.7 tt -60.02 -63.61 1.24 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.319 0.648 . . . . 1.33 109.656 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.437 HG23 ' H4 ' ' A' ' 269' ' ' NGH 0.315 2.0 m -57.14 -38.43 73.49 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.035 0.445 . . . . 0.77 110.651 179.155 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.76 -56.65 14.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 118.106 -0.95 . . . . 0.34 111.142 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 213' ' ' PHE . 90.1 t -51.27 -39.42 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 120.538 1.517 . . . . 0.71 111.291 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.658 ' CE1' ' CE1' ' A' ' 222' ' ' HIS . 0.5 OUTLIER -64.63 -51.4 62.82 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.128 0.971 . . . . 2.65 112.195 174.038 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.46 -45.74 71.64 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.069 -1.019 . . . . 2.69 111.965 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.456 HG21 ' HA ' ' A' ' 138' ' ' PHE . 1.5 mp -54.45 -43.99 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 106.616 -1.624 . . . . 1.16 106.616 170.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.2 -53.38 23.73 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 123.695 0.664 . . . . 0.45 113.105 170.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.76 ' CE1' HD21 ' A' ' 226' ' ' LEU . 0.9 OUTLIER -51.25 -42.12 60.82 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 121.848 -0.795 . . . . 1.58 110.999 174.163 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.4 t -51.24 -43.45 61.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 123.602 0.564 . . . . 1.96 112.07 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.517 ' HB3' HD13 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -66.31 -60.09 3.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.648 -0.821 . . . . 2.7 109.9 174.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 135.98 92.26 0.35 Allowed Glycine 0 C--N 1.338 0.676 0 N-CA-C 111.805 -0.518 . . . . 1.23 111.805 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.76 HD21 ' CE1' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -99.39 177.61 5.13 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.584 0.587 . . . . 5.74 112.584 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -120.73 20.7 8.67 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.724 1.154 . . . . 3.08 112.74 172.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 30.8 m80 56.14 95.69 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.14 1.776 . . . . 2.22 113.08 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.1 m -73.96 171.59 13.17 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.873 0.469 . . . . 1.18 110.592 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.7 t -137.25 47.06 2.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.186 0.994 . . . . 3.36 109.101 -169.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -148.9 123.62 4.86 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 107.18 -1.415 . . . . 2.14 107.18 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.19 -3.47 13.86 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.191 1.927 . . . . 1.59 114.011 -170.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -82.31 -24.36 34.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.493 1.042 . . . . 1.47 109.943 169.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -82.07 152.6 26.52 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.458 0.703 . . . . 0.77 109.632 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 24.0 t -104.52 -21.24 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.246 1.018 . . . . 0.72 111.334 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.44 -18.39 17.92 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.479 -0.763 . . . . 2.92 112.99 168.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.75 157.31 7.91 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 120.915 -1.116 . . . . 3.21 113.353 -176.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.502 ' O ' ' H1 ' ' A' ' 269' ' ' NGH . 72.9 Cg_endo -79.53 -16.98 11.58 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.371 2.047 . . . . 0.9 111.791 173.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.355 0.2 OUTLIER -78.49 172.9 12.98 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.963 1.305 . . . . 1.16 109.697 -178.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -119.68 142.6 48.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.286 1.435 . . . . 2.21 107.265 173.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -156.08 125.73 6.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.422 -1.325 . . . . 3.55 107.422 170.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -45.52 142.13 2.42 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.063 1.345 . . . . 2.35 112.087 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.0 139.38 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.115 0.966 . . . . 2.2 109.363 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -41.11 96.8 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.111 0.964 . . . . 3.91 111.431 171.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 6.1 mt 66.29 18.78 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.623 1.569 . . . . 2.53 110.142 -160.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -71.05 -64.09 0.97 Allowed 'General case' 0 C--N 1.343 0.304 0 O-C-N 120.937 -1.102 . . . . 3.26 109.865 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 7.4 m -71.94 -39.73 69.22 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.496 -0.775 . . . . 1.85 109.558 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.738 ' CE1' HG22 ' A' ' 140' ' ' VAL . 1.0 OUTLIER 53.05 71.91 0.46 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.336 1.065 . . . . 4.71 109.411 176.676 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -151.36 165.0 35.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.433 -0.951 . . . . 3.34 108.433 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.602 HD12 ' CH2' ' A' ' 141' ' ' TRP . 1.9 mm? -95.42 174.19 7.14 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.419 1.488 . . . . 0.89 108.591 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.5 m -91.15 150.73 21.26 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 120.95 -1.094 . . . . 0.83 112.217 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.78 -43.37 65.8 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.51 -0.552 . . . . 0.78 109.51 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.59 -51.6 68.83 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.954 0.883 . . . . 2.28 110.383 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -57.6 -47.28 82.6 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.572 -1.194 . . . . 2.07 110.188 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 52.6 mt -52.03 -36.79 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.371 1.868 . . . . 0.73 111.329 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 36.7 mtt85 -70.43 -49.06 52.7 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 120.945 -1.097 . . . . 4.89 110.177 172.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -45.09 -56.86 5.8 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.708 0.67 . . . . 0.93 111.649 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.701 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 2.3 pp -63.87 -46.95 92.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.134 0.974 . . . . 2.13 110.434 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.51 ' N ' HD12 ' A' ' 258' ' ' ILE . 1.6 mm-40 -59.69 -26.6 65.72 Favored 'General case' 0 C--N 1.343 0.303 0 O-C-N 120.641 -1.287 . . . . 2.18 111.647 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.0 t -49.33 -26.46 3.13 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.652 0.612 . . . . 1.92 112.652 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.517 HD13 ' HB3' ' A' ' 224' ' ' LEU . 16.5 mt -65.06 -38.42 90.76 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.441 0.697 . . . . 2.59 111.867 175.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 3.3 t80 59.11 -166.59 0.17 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.222 1.409 . . . . 9.51 112.469 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.206 0 CA-C-O 115.82 -2.655 . . . . 9.73 111.294 -175.302 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 269' ' ' NGH . . . . . 0.653 ' N1 ' ' CE1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 20.9 ptt? . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 118.927 -0.559 . . . . 13.54 110.897 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.58 72.36 0.46 Allowed Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.206 -1.158 . . . . 10.96 110.206 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.41 148.52 23.69 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.713 2.276 . . . . 10.14 110.065 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.9 p -76.29 -54.48 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 123.375 0.67 . . . . 9.02 110.99 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -169.47 -176.47 2.48 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.06 0.944 . . . . 13.62 109.711 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.4 tpt85 -69.56 70.62 0.3 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.301 1.84 . . . . 14.45 110.322 -176.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.24 -179.88 0.19 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.16 0.984 . . . . 12.04 110.251 -167.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -104.14 19.64 19.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.369 1.468 . . . . 4.86 111.084 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -85.45 78.47 9.7 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 109.371 -0.603 . . . . 3.1 109.371 -172.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.528 HG21 ' CE2' ' A' ' 149' ' ' PHE . 20.3 mm -88.03 82.16 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 122.728 1.252 . . . . 1.72 108.327 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 p -77.77 126.68 31.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.91 -1.515 . . . . 1.34 106.91 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.42 ' CE1' ' CD2' ' A' ' 138' ' ' PHE . 41.7 p90 -128.19 167.14 17.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.855 0.862 . . . . 4.12 110.67 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -156.24 177.2 11.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.09 0.471 . . . . 4.67 111.076 168.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.29 168.36 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.953 1.301 . . . . 1.13 108.199 174.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -95.14 -51.89 4.44 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.736 0.814 . . . . 4.24 109.587 169.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.83 153.8 30.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.912 0.485 . . . . 2.6 111.638 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -78.31 108.0 11.33 Favored 'General case' 0 CA--C 1.53 0.212 0 N-CA-C 108.369 -0.975 . . . . 2.71 108.369 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.9 t -60.17 146.82 82.46 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 118.655 0.662 . . . . 2.17 110.575 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.39 -15.97 24.79 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.444 2.763 . . . . 1.56 111.356 170.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -47.29 -42.62 21.33 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.829 0.852 . . . . 2.5 111.452 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 5.3 mtm -130.3 175.58 8.82 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.635 1.174 . . . . 2.13 108.206 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -75.97 144.8 40.77 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.751 -0.463 . . . . 2.98 109.751 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -45.76 -53.87 8.83 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.486 0.715 . . . . 2.51 112.451 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -48.54 -38.94 21.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.402 0.681 . . . . 4.12 109.272 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -82.4 -43.09 17.78 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.328 1.851 . . . . 2.04 113.183 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.3 t -50.15 -55.05 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 O-C-N 120.789 -1.194 . . . . 1.23 109.051 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.412 ' OD2' ' NZ ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -71.98 -19.73 61.83 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 119.161 -1.016 . . . . 1.79 109.991 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -64.34 -52.62 57.46 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 119.734 1.152 . . . . 2.07 109.133 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.9 -53.1 44.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 122.998 0.519 . . . . 0.36 110.33 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.2 -46.73 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 109.769 -0.456 . . . . 2.31 109.769 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -50.77 -55.37 17.05 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 124.365 1.066 . . . . 4.27 108.428 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -63.03 -48.89 76.82 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.624 1.169 . . . . 1.51 109.292 -177.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.573 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -45.89 -55.74 6.32 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.145 0.578 . . . . 0.61 111.681 175.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.42 ' CD2' ' CE1' ' A' ' 116' ' ' TYR . 52.8 m-85 -57.54 -48.99 77.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.256 -0.429 . . . . 4.63 110.657 173.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.7 -32.87 65.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 113.069 0.766 . . . . 2.11 113.069 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.55 ' CG1' HD21 ' A' ' 250' ' ' LEU . 85.4 t -63.58 -57.04 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 119.425 1.011 . . . . 0.74 108.518 176.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.79 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 16.9 m95 -68.46 -36.72 79.38 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.039 -0.726 . . . . 0.83 109.039 -172.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.6 t -67.6 -13.09 61.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 118.882 -0.58 . . . . 1.25 112.291 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.17 -54.94 4.47 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 107.946 -1.131 . . . . 1.19 107.946 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.512 HG11 HD23 ' A' ' 250' ' ' LEU . 17.6 m -74.1 -40.88 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 116.105 -0.498 . . . . 1.54 111.785 -176.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.95 HG22 HD13 ' A' ' 258' ' ' ILE . 3.1 p -87.06 142.68 34.02 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 107.671 -1.233 . . . . 0.75 107.671 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.53 4.95 3.09 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.835 2.356 . . . . 0.66 113.546 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.4 130.43 42.86 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.84 1.256 . . . . 2.22 107.818 175.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -97.25 108.34 21.04 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.335 -0.987 . . . . 4.31 108.335 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.528 ' CE2' HG21 ' A' ' 114' ' ' ILE . 52.1 m-85 -87.11 142.1 28.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.039 -0.528 . . . . 5.69 111.073 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -142.91 117.79 9.95 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.698 0.799 . . . . 0.97 110.136 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.412 ' NZ ' ' OD2' ' A' ' 131' ' ' ASP . 20.6 ttpt -78.5 142.75 37.2 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.089 -1.078 . . . . 2.42 108.089 172.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.9 pt -134.56 144.04 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 105.519 -2.03 . . . . 1.27 105.519 166.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.07 -61.83 1.64 Allowed 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 107.029 -1.471 . . . . 3.44 107.029 168.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.4 m -86.67 101.09 12.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.493 0.717 . . . . 2.34 110.129 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 153.88 153.4 6.4 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 107.323 -2.311 . . . . 2.35 107.323 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.5 ttt -79.37 143.28 35.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.302 -1.37 . . . . 7.36 107.302 168.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -127.65 165.44 19.98 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.682 1.193 . . . . 1.25 108.404 -173.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -69.21 -58.21 4.35 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.863 0.839 . . . . 1.94 109.359 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.2 pt -105.75 134.49 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.14 -1.059 . . . . 1.68 108.14 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . 0.358 0.0 OUTLIER -128.76 132.44 47.91 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.411 -0.806 . . . . 2.8 109.424 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.9 t -82.67 106.1 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.677 -0.86 . . . . 1.05 108.677 -175.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . 0.417 7.8 t -95.22 94.87 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.411 1.084 . . . . 1.63 112.831 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -79.51 115.47 19.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.555 -2.017 . . . . 5.4 105.555 167.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -139.57 164.73 29.13 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.294 -1.743 . . . . 0.95 106.294 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -132.02 142.6 49.62 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.865 -0.791 . . . . 5.12 108.865 -170.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 73.47 -86.1 0.62 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.415 1.007 . . . . 1.97 111.243 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -150.34 145.15 25.95 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 121.581 -0.952 . . . . 2.22 108.661 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -155.32 54.59 0.63 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.648 0.737 . . . . 2.92 111.05 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 107.95 -42.73 1.86 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.94 -0.864 . . . . 2.79 110.94 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.571 ' HB2' ' HB2' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -75.41 159.22 31.64 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.685 -1.228 . . . . 2.34 107.685 174.807 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -80.26 -66.75 0.84 Allowed 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.632 -0.877 . . . . 5.09 108.632 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -111.5 71.94 0.76 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.25 1.02 . . . . 4.26 110.08 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.571 ' HB2' ' HB2' ' A' ' 170' ' ' ASP . . . -88.8 -72.53 0.54 Allowed 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 123.596 0.758 . . . . 2.34 111.772 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -118.25 172.35 7.5 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 107.82 -1.178 . . . . 6.08 107.82 -172.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -178.56 28.12 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.814 0.301 . . . . 2.71 111.814 -161.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 60.07 -155.16 31.45 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 119.015 -1.564 . . . . 1.61 110.261 -160.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -79.52 106.81 11.82 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.322 0.649 . . . . 4.57 110.738 -175.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 148.33 -168.65 29.02 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 108.45 -1.86 . . . . 2.27 108.45 -168.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.68 -112.23 2.64 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 125.83 1.681 . . . . 2.18 109.911 172.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.757 HG23 ' C14' ' A' ' 269' ' ' NGH 0.571 4.0 mm -109.07 149.27 12.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.565 -0.902 . . . . 1.55 108.565 173.812 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.886 ' H ' ' H91' ' A' ' 269' ' ' NGH 0.276 4.4 mp -81.68 -59.02 2.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.74 2.016 . . . . 1.27 108.402 170.406 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 1.02 ' H ' ' C13' ' A' ' 269' ' ' NGH . . . -162.87 153.92 17.2 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 122.251 1.024 . . . . 0.63 113.291 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -143.88 132.44 22.3 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 114.522 1.304 . . . . 1.09 114.522 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -160.49 162.27 33.05 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.655 1.982 . . . . 0.52 106.144 -164.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -157.97 156.21 30.8 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 107.631 -1.248 . . . . 3.4 107.631 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.33 -88.93 1.75 Allowed Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.186 -0.786 . . . . 0.56 111.206 173.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.22 82.82 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.828 3.019 . . . . 1.38 111.547 -171.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -159.03 161.67 32.12 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.051 -1.62 . . . . 1.03 109.051 170.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.9 m -78.51 167.2 21.63 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.077 0.465 . . . . 2.12 110.461 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 55.07 -106.32 0.52 Allowed Glycine 0 CA--C 1.529 0.906 0 C-N-CA 123.826 0.727 . . . . 1.43 112.059 174.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.8 tp -63.54 -27.58 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.158 0.983 . . . . 1.51 110.705 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.19 148.61 19.26 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 110.452 -1.059 . . . . 0.93 110.452 172.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 87.92 -45.16 3.29 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.932 1.253 . . . . 0.55 110.733 -163.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -84.08 171.74 12.62 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 121.681 -0.894 . . . . 1.25 109.843 -161.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -142.93 120.49 11.75 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 119.236 -0.411 . . . . 0.69 112.058 -175.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -109.34 133.83 52.57 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 118.413 -0.803 . . . . 2.46 109.591 -173.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -120.75 148.69 43.63 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.301 0.5 . . . . 3.09 109.829 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -67.24 89.73 0.2 Allowed 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 124.658 1.224 . . . . 2.7 109.533 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -66.64 -26.9 67.28 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.18 -0.95 . . . . 2.95 109.499 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.39 -42.41 21.84 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.948 0.899 . . . . 3.35 109.404 171.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -73.57 170.37 15.33 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.582 1.182 . . . . 1.69 112.272 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -117.62 91.19 3.5 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.779 -1.563 . . . . 3.1 106.779 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -75.81 158.33 32.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.634 -0.712 . . . . 1.07 109.438 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 75.3 p -138.57 144.43 39.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.608 -0.515 . . . . 1.58 109.608 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 13.7 t -61.23 -43.52 98.74 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 125.913 1.685 . . . . 1.8 113.871 169.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.88 174.68 10.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.9 -0.778 . . . . 2.08 108.9 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.7 m -43.63 -57.33 3.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.214 1.806 . . . . 3.83 109.997 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 51.09 -88.38 0.01 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.375 1.464 . . . . 2.18 113.338 167.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -147.07 -69.51 0.01 OUTLIER Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.912 -1.675 . . . . 1.77 108.912 168.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.463 HG21 HD23 ' A' ' 181' ' ' LEU . 2.4 m -105.85 97.42 7.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.5 -1.667 . . . . 0.98 106.5 175.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -68.16 109.31 3.49 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.343 -1.354 . . . . 3.11 107.343 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 29.2 tp -47.62 -54.54 11.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.327 1.421 . . . . 1.76 111.853 -166.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.602 ' O ' HG23 ' A' ' 217' ' ' VAL . 1.8 t80 -40.34 -43.69 1.8 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.956 1.302 . . . . 2.21 111.202 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.603 HD23 ' H71' ' A' ' 269' ' ' NGH . 0.2 OUTLIER -61.23 -64.05 1.08 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.281 0.632 . . . . 2.01 111.259 -176.094 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.291 1.2 m -56.94 -40.84 77.13 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.995 -0.372 . . . . 0.87 109.995 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.6 -49.88 64.17 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.58 -0.724 . . . . 0.43 111.312 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 213' ' ' PHE . 61.4 t -54.83 -41.49 57.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 119.567 1.076 . . . . 0.82 110.973 178.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.521 ' CD2' ' O4 ' ' A' ' 269' ' ' NGH 0.449 2.7 t-160 -63.53 -49.47 73.38 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.234 0.614 . . . . 2.2 111.535 176.46 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.09 -48.11 72.01 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.897 -1.127 . . . . 3.65 111.531 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.36 -39.55 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 107.561 -1.274 . . . . 1.33 107.561 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.49 -55.78 6.72 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.552 1.073 . . . . 0.53 111.673 165.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -51.89 -47.73 64.42 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.715 -0.873 . . . . 1.37 110.698 174.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 67.9 m -54.17 -38.34 65.47 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.293 0.849 . . . . 2.05 113.293 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.423 ' CD2' HG21 ' A' ' 145' ' ' THR . 8.4 mp -56.6 -40.73 75.81 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 119.431 1.014 . . . . 2.85 110.266 172.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 117.44 28.89 2.23 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 125.045 1.307 . . . . 1.66 111.602 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 1.04 HD11 HG22 ' A' ' 258' ' ' ILE . 0.5 OUTLIER -79.95 137.89 36.96 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.074 -0.713 . . . . 3.36 109.074 -170.174 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.77 140.23 21.5 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.655 -0.978 . . . . 2.76 110.655 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -47.87 116.23 1.43 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.635 0.774 . . . . 1.66 111.307 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 31.7 m -78.56 -177.35 5.28 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.385 0.674 . . . . 1.01 109.195 172.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 23.4 m -148.79 39.54 0.87 Allowed 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.328 -0.857 . . . . 2.31 109.387 -172.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.13 131.64 15.51 Favored Pre-proline 0 N--CA 1.447 -0.614 0 N-CA-C 106.599 -1.63 . . . . 1.55 106.599 -174.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.52 -9.55 14.8 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.096 1.864 . . . . 1.14 114.367 -172.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -82.07 -26.31 33.78 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.304 0.956 . . . . 1.2 109.771 170.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -70.43 148.28 48.51 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.325 -0.62 . . . . 0.76 109.325 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 90.2 t -93.92 -23.9 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 123.574 0.749 . . . . 0.78 109.383 177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.545 ' HG2' HD13 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -49.54 -38.52 31.11 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.859 0.689 . . . . 2.87 112.859 175.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.431 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -46.95 149.1 1.65 Allowed Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 126.219 1.808 . . . . 3.23 112.802 -165.049 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.428 ' HA ' ' HE1' ' A' ' 218' ' ' HIS . 61.4 Cg_endo -71.68 -16.89 29.97 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.541 1.494 . . . . 0.94 111.971 176.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.373 0.2 OUTLIER -78.85 -179.54 6.63 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.132 1.373 . . . . 1.38 110.148 176.72 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -127.39 153.88 45.69 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.594 -1.632 . . . . 2.24 106.594 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -148.56 117.45 6.72 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.615 -1.254 . . . . 2.19 107.615 168.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -63.68 122.47 16.46 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.63 -0.878 . . . . 2.41 108.63 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.3 m -145.96 154.55 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 O-C-N 123.771 0.669 . . . . 3.58 110.035 169.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -50.56 110.67 0.44 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.58 1.952 . . . . 3.72 111.539 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.8 pp -57.55 -19.8 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.091 0.956 . . . . 3.1 112.752 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -70.09 -49.7 48.27 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.433 0.693 . . . . 4.24 110.899 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 91.7 m -83.88 -30.02 26.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.115 0.566 . . . . 2.44 109.974 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.555 ' HE2' HG21 ' A' ' 217' ' ' VAL . 63.7 t80 -34.56 116.71 0.33 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.446 1.498 . . . . 8.33 111.581 174.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.27 175.82 10.76 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.714 1.206 . . . . 2.8 108.698 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.584 HD12 ' CH2' ' A' ' 141' ' ' TRP . 1.1 mm? -83.3 141.78 31.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.44 -0.948 . . . . 0.95 108.44 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.4 m -77.87 155.38 31.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 110.09 -0.337 . . . . 0.7 110.09 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.28 -45.28 62.07 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.005 0.431 . . . . 0.89 110.138 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -51.1 -54.11 28.03 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.884 0.874 . . . . 2.19 110.191 173.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.591 ' O ' HG23 ' A' ' 258' ' ' ILE . 4.1 t0 -59.27 -51.76 68.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.087 -0.961 . . . . 2.15 109.92 -176.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.5 mt -49.07 -52.43 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.775 1.63 . . . . 1.02 110.263 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -59.44 -40.51 87.02 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.391 -1.443 . . . . 6.78 110.568 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -49.04 -55.05 12.44 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 111.963 -0.455 . . . . 0.91 111.963 167.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 1.04 HG22 HD11 ' A' ' 226' ' ' LEU . 0.3 OUTLIER -60.85 -40.67 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 118.508 1.154 . . . . 2.54 110.282 -173.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -64.74 -17.96 64.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.498 -0.881 . . . . 2.64 111.245 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.0 t -63.02 -17.43 62.21 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.473 0.709 . . . . 2.18 112.446 171.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 66.7 mt -60.53 74.13 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.657 1.183 . . . . 2.33 111.501 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 45.71 67.82 0.68 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.342 1.857 . . . . 9.54 111.642 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.419 0 N-CA-C 106.322 -2.711 . . . . 7.37 106.322 174.407 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 269' ' ' NGH . . . . . 1.02 ' C13' ' H ' ' A' ' 182' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 90.9 mtp . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 106.03 -1.841 . . . . 12.84 106.03 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 142.09 -168.48 25.69 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 109.225 -1.55 . . . . 8.31 109.225 -171.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -70.52 -179.24 3.1 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.391 2.728 . . . . 8.81 110.067 173.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.5 p -143.48 149.55 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.355 0.662 . . . . 5.92 109.493 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 15.2 p90 -76.48 -65.0 0.98 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.0 1.32 . . . . 11.1 110.06 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 63.64 -56.53 0.2 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.793 2.437 . . . . 8.09 112.407 -171.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.411 ' HB2' HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -151.09 -51.13 0.12 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.534 1.534 . . . . 8.58 110.072 177.226 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 57.9 -78.34 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.142 1.377 . . . . 4.35 111.283 -170.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -124.63 109.15 12.81 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.102 1.361 . . . . 3.89 109.572 -177.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.411 HD13 ' HB2' ' A' ' 111' ' ' LYS . 0.4 OUTLIER -104.7 138.18 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.069 0 N-CA-C 106.641 -1.614 . . . . 2.56 106.641 170.29 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.1 p -125.1 139.47 53.75 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.739 -1.208 . . . . 1.19 107.739 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -123.04 161.59 24.02 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.696 0.798 . . . . 4.4 110.342 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.95 147.82 32.11 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.752 -0.833 . . . . 5.67 108.752 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -104.95 149.26 8.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 C-N-CA 123.559 0.744 . . . . 0.83 109.312 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.47 HD22 ' H ' ' A' ' 119' ' ' ASN . 1.4 p30 -104.85 -47.6 3.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.158 1.783 . . . . 2.96 109.648 -172.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -139.18 164.63 29.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.98 -1.119 . . . . 3.2 107.98 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -128.16 118.67 23.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.846 -1.539 . . . . 2.23 106.846 -174.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.9 t -66.78 122.98 84.74 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.77 0.828 . . . . 2.53 109.384 -173.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -68.84 -17.76 41.73 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.791 2.994 . . . . 1.68 111.562 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -34.3 -42.42 0.13 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.451 2.301 . . . . 2.57 112.462 171.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 19.4 mtm -132.69 177.73 7.4 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.261 1.425 . . . . 2.07 109.046 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -64.05 142.32 58.45 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 108.824 -0.806 . . . . 3.01 108.824 172.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 43.9 ttt-85 -47.68 -51.15 22.78 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.506 -0.746 . . . . 2.15 110.491 172.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.33 6.28 3.01 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.453 0.538 . . . . 5.24 112.453 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -102.08 -41.92 6.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.15 1.78 . . . . 1.76 109.632 162.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 62.4 t -54.02 -54.79 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 O-C-N 120.508 -1.37 . . . . 1.21 109.719 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -26.43 68.13 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 118.647 -1.221 . . . . 1.76 109.469 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -65.0 -44.71 88.35 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 118.832 0.742 . . . . 2.41 111.004 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.91 -52.27 65.76 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.76 0.824 . . . . 0.4 110.481 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.416 HD13 ' O ' ' A' ' 134' ' ' ILE . 0.2 OUTLIER -68.51 -37.24 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 109.291 -0.633 . . . . 1.81 109.291 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -52.27 -61.37 2.31 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 107.851 -1.166 . . . . 3.71 107.851 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.422 ' O ' HG23 ' A' ' 140' ' ' VAL . 52.9 mmtt -52.34 -53.62 42.18 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.209 1.004 . . . . 1.51 110.546 178.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.21 -49.52 63.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.792 0.837 . . . . 0.69 111.834 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -63.59 -47.23 82.3 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.52 -0.918 . . . . 5.75 108.52 176.094 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.18 -38.95 63.28 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.695 0.398 . . . . 2.64 110.599 -171.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.561 ' CG1' HD21 ' A' ' 250' ' ' LEU . 82.3 t -49.79 -58.51 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.34 1.056 . . . . 0.71 109.249 175.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.872 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 17.3 m95 -68.63 -37.23 79.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 119.836 -0.746 . . . . 0.83 109.087 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -20.2 65.48 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.374 0.509 . . . . 1.44 112.374 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -78.98 -49.39 12.83 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.527 -0.916 . . . . 1.48 108.527 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.634 HG12 HD11 ' A' ' 258' ' ' ILE . 26.5 t -75.46 -54.91 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 122.775 0.43 . . . . 1.89 110.877 -174.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.6 p -76.93 157.33 81.74 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 107.758 -1.201 . . . . 0.62 107.758 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.88 15.07 0.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.744 1.629 . . . . 0.78 113.594 174.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.04 145.94 55.02 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 122.257 2.299 . . . . 2.85 109.641 175.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -110.63 86.93 2.41 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.939 -1.504 . . . . 4.34 106.939 160.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.452 ' HB2' ' CD1' ' A' ' 138' ' ' PHE . 3.9 m-85 -71.02 154.43 41.8 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.189 -0.671 . . . . 6.08 109.189 163.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.6 t -155.34 144.93 21.23 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.271 1.028 . . . . 0.92 108.51 170.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -92.29 138.6 31.39 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 119.493 1.042 . . . . 2.61 108.471 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.8 pp -138.29 124.46 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.243 -1.392 . . . . 1.35 107.243 167.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -88.03 -7.64 56.73 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 122.384 0.274 . . . . 3.42 111.26 172.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 62.2 p -130.11 96.79 4.27 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.024 0.929 . . . . 2.39 109.927 -170.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 140.03 -150.74 21.7 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 106.601 -2.6 . . . . 1.64 106.601 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 43.4 ttm -122.54 137.18 54.97 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.452 -1.684 . . . . 4.12 106.452 173.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -111.85 170.16 8.33 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.738 1.215 . . . . 0.83 109.664 -177.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -84.16 -55.7 4.05 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.646 0.778 . . . . 2.08 109.361 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.9 pt -101.91 164.26 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.143 -0.688 . . . . 1.01 109.143 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.05 132.31 38.08 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.988 -0.745 . . . . 2.0 108.988 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 10.7 t -78.48 143.03 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.967 -1.123 . . . . 1.55 107.967 168.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 66.6 t -108.24 128.78 63.46 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 C-N-CA 124.546 1.138 . . . . 1.46 108.021 165.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.435 ' N ' HD21 ' A' ' 119' ' ' ASN . 5.7 m-85 -124.31 99.8 6.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 103.903 -2.628 . . . . 5.03 103.903 170.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.51 160.13 33.31 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.991 -1.485 . . . . 0.97 106.991 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -121.72 128.25 51.6 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.406 -1.331 . . . . 4.18 107.406 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 65.79 -161.7 43.04 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-O 121.629 0.572 . . . . 2.23 112.37 -171.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.17 110.06 11.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.269 0.628 . . . . 2.24 109.654 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -106.27 -45.42 4.3 Favored 'General case' 0 C--O 1.227 -0.08 0 C-N-CA 125.615 1.566 . . . . 3.36 110.14 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -164.64 68.87 0.2 Allowed Glycine 0 C--O 1.243 0.695 0 N-CA-C 104.64 -3.384 . . . . 3.1 104.64 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -160.81 -178.43 6.83 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 129.937 3.295 . . . . 2.64 106.2 172.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -77.41 -55.68 5.19 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.105 0.962 . . . . 4.69 108.53 165.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -123.41 -72.85 0.66 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.33 1.052 . . . . 5.95 110.924 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 56.21 -77.48 0.01 OUTLIER 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.663 1.985 . . . . 2.71 112.791 -169.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -104.63 149.57 25.43 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.467 1.107 . . . . 6.05 109.551 -166.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -171.8 10.16 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.323 0.86 . . . . 3.43 113.323 -155.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 65.82 -149.96 51.68 Favored Glycine 0 CA--C 1.537 1.428 0 N-CA-C 109.895 -1.282 . . . . 2.17 109.895 -162.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -80.3 63.94 4.95 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.66 1.23 . . . . 4.22 114.042 -162.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -164.13 -143.77 3.82 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 106.992 -2.443 . . . . 1.85 106.992 160.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.69 -127.31 40.08 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.27 -1.532 . . . . 2.02 109.27 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . 0.267 1.0 OUTLIER -100.39 148.77 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 106.214 -1.773 . . . . 1.56 106.214 173.316 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.22 -46.1 12.21 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.851 0.861 . . . . 2.2 109.644 164.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -163.48 165.69 23.48 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.238 -0.914 . . . . 0.65 111.246 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.56 141.71 26.09 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.697 0.799 . . . . 1.04 112.398 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -161.79 158.04 25.09 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.97 0.908 . . . . 0.56 109.853 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -147.87 139.35 23.72 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.617 1.167 . . . . 2.92 108.129 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -85.77 -78.71 1.18 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.365 -1.094 . . . . 0.5 110.365 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.78 104.08 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.355 2.703 . . . . 1.32 110.514 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -178.53 172.48 44.85 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 108.242 -1.943 . . . . 1.02 108.242 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 63.9 m -84.05 165.35 18.63 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.025 -0.731 . . . . 2.15 109.025 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 53.31 -95.23 0.02 OUTLIER Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.202 0.906 . . . . 1.8 112.535 172.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.5 tp -63.35 -16.49 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 125.129 1.372 . . . . 1.72 111.504 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -44.37 129.58 7.18 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 110.792 -0.923 . . . . 1.3 110.792 166.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 86.07 -31.09 4.13 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.34 1.448 . . . . 0.98 112.891 -175.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -83.34 147.51 27.88 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.484 1.142 . . . . 1.27 109.739 -166.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.78 124.04 38.78 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 118.762 -0.637 . . . . 0.71 112.454 -172.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . 0.341 0.0 OUTLIER -112.4 109.06 18.45 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.079 0.551 . . . . 2.41 112.19 -165.356 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -96.2 138.22 34.12 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.661 0.664 . . . . 2.71 110.449 -177.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -62.24 92.51 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.171 -0.677 . . . . 3.28 109.171 170.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -64.83 -37.54 87.95 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 120.51 -1.369 . . . . 2.66 109.576 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -50.46 -27.94 7.42 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.593 0.757 . . . . 2.74 110.907 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -66.27 155.15 37.99 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.859 1.264 . . . . 2.81 110.179 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -95.78 93.62 7.19 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.583 -1.636 . . . . 3.94 106.583 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -78.76 155.75 29.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.695 -0.854 . . . . 1.18 108.695 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.92 136.82 24.46 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.304 0.641 . . . . 2.79 111.285 -176.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.2 t -58.03 -45.35 87.08 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.188 0.995 . . . . 1.62 111.495 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -74.77 -154.85 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.646 1.179 . . . . 3.23 110.761 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.4 p -79.16 -68.27 0.67 Allowed 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.938 -1.101 . . . . 3.81 110.455 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 38.63 -106.03 0.05 OUTLIER Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.465 1.983 . . . . 2.51 113.495 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.55 -72.28 1.13 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.216 0.912 . . . . 1.58 110.839 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 4.3 m -136.45 153.92 50.92 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 106.686 -1.598 . . . . 0.87 106.686 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -107.77 124.75 50.5 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 123.651 0.594 . . . . 1.53 111.968 173.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.17 -53.65 55.86 Favored 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.241 -0.652 . . . . 1.74 109.241 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -49.07 -46.99 45.31 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.667 0.746 . . . . 1.52 110.232 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.6 tt -61.5 -61.58 2.43 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.921 0.888 . . . . 1.33 110.0 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.279 0.6 OUTLIER -55.99 -37.94 69.79 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.383 -0.198 . . . . 0.76 110.904 179.472 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.34 -54.92 29.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 124.591 1.156 . . . . 0.64 110.687 175.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.8 t -48.08 -43.45 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 120.12 1.327 . . . . 0.84 110.903 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.837 ' HB2' ' H72' ' A' ' 269' ' ' NGH . 42.6 t-80 -56.62 -56.54 20.12 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.396 1.078 . . . . 2.11 113.845 171.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -82.1 -43.32 17.98 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.134 -0.979 . . . . 3.69 112.679 -170.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.413 ' CD1' HD11 ' A' ' 134' ' ' ILE . 1.0 OUTLIER -56.26 -33.95 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.056 -0.72 . . . . 1.46 109.056 164.185 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.5 -53.68 43.07 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 110.763 -0.935 . . . . 0.6 110.763 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.461 ' CE1' ' CE1' ' A' ' 218' ' ' HIS 0.281 62.5 m170 -53.44 -41.19 65.83 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.456 -1.026 . . . . 2.31 111.944 173.685 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 34.7 t -47.82 -52.97 16.97 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.131 0.972 . . . . 1.73 112.346 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.12 -10.85 60.44 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.614 -0.679 . . . . 3.16 112.786 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 104.51 43.31 1.73 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 124.289 0.947 . . . . 1.19 111.792 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.964 HD21 HG22 ' A' ' 258' ' ' ILE . 7.9 mt -77.35 115.37 17.06 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 117.373 0.586 . . . . 3.31 111.546 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -66.43 154.96 51.8 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 109.507 -1.437 . . . . 3.11 109.507 162.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -68.61 121.54 16.63 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.746 0.773 . . . . 2.38 112.716 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.9 m -79.93 118.1 21.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.772 -1.566 . . . . 2.31 106.772 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.7 p -76.12 63.29 1.81 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.24 0.927 . . . . 3.67 110.502 -175.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -155.78 131.36 5.48 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.85 1.26 . . . . 1.67 108.34 -173.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.92 -14.65 9.78 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.776 1.651 . . . . 1.69 114.124 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -42.09 59.76 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 119.57 1.077 . . . . 2.0 108.971 172.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -57.73 116.41 3.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.744 1.217 . . . . 1.79 110.451 176.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.0 t -62.2 -17.9 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.383 -0.826 . . . . 0.82 110.896 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.452 ' SD ' ' HB3' ' A' ' 226' ' ' LEU . 0.0 OUTLIER -51.89 -42.41 62.67 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.331 -0.856 . . . . 3.06 113.135 169.029 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.414 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 14.6 t80 -61.03 147.31 86.35 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 109.027 -0.731 . . . . 7.5 109.027 -165.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.414 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 58.8 Cg_endo -70.88 -14.01 32.24 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.375 1.384 . . . . 1.16 112.566 -172.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.354 0.2 OUTLIER -76.94 128.01 33.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.751 0.705 . . . . 1.88 109.121 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -75.82 129.91 37.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.794 -1.187 . . . . 3.25 107.794 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -135.67 139.36 43.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.708 -1.59 . . . . 2.64 106.708 174.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -57.77 120.96 9.34 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.542 -0.91 . . . . 2.41 108.542 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.1 m -101.09 130.72 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.854 -0.425 . . . . 2.0 109.854 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.66 86.71 0.66 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.491 -0.559 . . . . 4.83 109.491 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.6 mt -51.48 -31.3 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.404 0.682 . . . . 2.81 109.449 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -42.05 -49.46 4.72 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.362 1.065 . . . . 3.71 112.404 169.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 35.0 m -84.84 -41.63 15.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.56 0.744 . . . . 1.65 110.24 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 71.1 t80 60.96 75.5 0.41 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.287 1.035 . . . . 4.29 109.545 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.06 169.19 25.11 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.135 0.574 . . . . 4.61 110.688 -177.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.561 HD21 ' CG1' ' A' ' 140' ' ' VAL . 0.4 OUTLIER -113.76 176.87 4.84 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.505 1.522 . . . . 1.25 107.859 175.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 68.2 m -77.96 145.41 36.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 122.742 0.417 . . . . 0.83 110.7 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.36 -43.19 54.18 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.173 0.589 . . . . 1.36 110.402 171.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -53.43 -55.49 24.69 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.627 0.727 . . . . 2.87 110.183 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.595 ' O ' HG23 ' A' ' 258' ' ' ILE . 1.9 t0 -59.09 -47.69 84.32 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.078 -0.965 . . . . 2.25 109.02 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 59.3 mt -51.06 -32.31 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.647 1.979 . . . . 1.82 112.524 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -73.42 -57.16 4.2 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 121.293 -0.879 . . . . 6.25 110.026 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -47.24 -53.85 10.88 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 121.19 0.328 . . . . 1.73 112.291 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.964 HG22 HD21 ' A' ' 226' ' ' LEU . 2.0 pp -55.88 -32.65 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.946 1.698 . . . . 2.4 111.056 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -78.3 -45.11 23.53 Favored 'General case' 0 C--N 1.339 0.126 0 O-C-N 121.708 -0.62 . . . . 3.22 109.811 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 15.1 m -51.99 -31.04 27.72 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.58 0.585 . . . . 4.22 112.58 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.5 mt -51.45 -22.33 2.99 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 114.222 1.193 . . . . 3.7 114.222 172.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -47.55 -56.11 7.8 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.588 0.631 . . . . 9.07 110.237 167.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 116.7 -2.167 . . . . 7.96 107.793 -171.93 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 269' ' ' NGH . . . . . 0.837 ' H72' ' HB2' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 68.6 mtm . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 106.094 -1.817 . . . . 12.52 106.094 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 119.56 78.39 0.56 Allowed Glycine 0 CA--C 1.532 1.147 0 N-CA-C 110.825 -0.91 . . . . 8.28 110.825 -174.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.72 158.78 49.89 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.326 2.018 . . . . 8.74 109.919 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.9 p -153.47 152.51 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.368 -1.715 . . . . 5.66 106.368 175.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 5.4 t-105 -123.2 167.17 14.07 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 123.832 0.853 . . . . 10.18 108.959 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.67 -43.02 65.27 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.026 0.931 . . . . 10.56 111.445 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -159.41 -59.92 0.07 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.499 -0.286 . . . . 6.49 110.561 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 15.0 m170 67.02 -54.33 0.45 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.467 1.907 . . . . 3.31 112.889 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -107.0 114.52 28.65 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.324 1.45 . . . . 3.93 110.139 -176.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.7 mp -141.6 80.44 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.667 1.187 . . . . 2.33 108.396 -173.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.22 141.39 37.19 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.964 -1.124 . . . . 1.2 107.964 174.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -127.31 159.79 33.31 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.145 0.978 . . . . 4.09 108.705 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -154.94 173.21 16.86 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.727 0.694 . . . . 4.38 110.419 172.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.78 159.39 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.226 1.01 . . . . 0.85 109.834 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -100.29 -42.98 6.43 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.01 0.924 . . . . 2.95 109.994 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -149.41 170.46 18.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.751 0.82 . . . . 2.49 109.831 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -117.9 101.76 8.54 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.368 1.467 . . . . 2.25 107.959 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.4 t -58.55 125.89 77.69 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.96 0.904 . . . . 2.3 109.173 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.17 -17.26 45.29 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.717 2.945 . . . . 1.57 111.411 -172.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -35.06 -43.75 0.21 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.002 1.721 . . . . 2.2 111.827 170.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -130.88 174.59 9.83 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 124.994 1.317 . . . . 1.9 110.037 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -73.13 140.2 46.93 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.65 0.78 . . . . 3.01 109.487 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -46.61 -51.41 15.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.035 0.445 . . . . 2.66 111.892 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.5 -8.11 8.63 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.742 0.817 . . . . 3.46 112.723 -176.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -100.66 -48.45 4.51 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.695 1.598 . . . . 1.93 109.314 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.93 -56.59 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 125.274 1.43 . . . . 1.22 109.374 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -24.53 64.48 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 118.334 -0.841 . . . . 1.82 109.349 -177.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -65.84 -50.25 65.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.627 0.648 . . . . 3.16 110.071 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -49.67 -54.85 16.23 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.919 0.888 . . . . 0.6 110.091 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.476 HD11 HD11 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -71.38 -30.99 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.028 -0.533 . . . . 1.88 110.233 -179.082 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -55.04 -54.6 40.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.765 1.269 . . . . 3.53 108.157 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 140' ' ' VAL . 12.3 mmmm -68.82 -39.28 80.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.588 1.555 . . . . 1.42 110.282 -174.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -46.44 -57.11 4.97 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 122.576 0.35 . . . . 0.8 110.63 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.427 ' CZ ' HG13 ' A' ' 220' ' ' ILE . 11.9 m-85 -60.43 -48.55 81.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 119.661 -0.816 . . . . 4.41 111.15 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -45.34 -48.92 13.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.416 0.687 . . . . 3.47 111.093 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 136' ' ' LYS . 94.8 t -58.36 -51.0 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 122.717 0.407 . . . . 1.05 109.941 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.702 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 92.8 m95 -68.68 -33.67 74.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.679 -0.86 . . . . 0.82 108.679 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.14 -19.53 61.63 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.251 0.478 . . . . 1.19 111.911 174.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -81.27 -42.87 20.01 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.024 0.829 . . . . 2.45 108.985 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.7 m -79.87 -54.37 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 112.17 0.433 . . . . 1.28 112.17 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.439 ' CG2' HD13 ' A' ' 258' ' ' ILE . 54.4 p -81.83 147.14 57.76 Favored Pre-proline 0 N--CA 1.45 -0.442 0 N-CA-C 108.382 -0.969 . . . . 0.73 108.382 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.73 5.01 4.1 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.813 2.342 . . . . 0.81 113.008 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.4 125.9 27.93 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.371 1.468 . . . . 2.7 108.589 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -98.17 93.53 6.3 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 109.277 -0.638 . . . . 4.12 109.277 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -78.57 149.45 33.01 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.469 -0.332 . . . . 5.85 110.797 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.4 t -151.4 137.31 18.12 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.714 -0.476 . . . . 1.01 109.714 172.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -90.45 160.09 16.2 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.266 -1.013 . . . . 3.07 108.266 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.413 HD11 ' HB2' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -152.12 152.21 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 104.747 -2.316 . . . . 1.92 104.747 -177.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.03 -39.43 21.26 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.262 -0.644 . . . . 3.95 109.262 172.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.5 m -75.71 146.23 40.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.283 -0.636 . . . . 3.84 109.283 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -78.87 59.29 4.23 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.387 -0.674 . . . . 4.39 112.699 -173.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.2 mtt -116.37 72.89 0.83 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.152 0.981 . . . . 6.37 109.594 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.413 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -141.53 162.68 34.9 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.49 0.716 . . . . 0.73 111.702 -173.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -70.97 -46.54 62.17 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.073 -1.084 . . . . 2.03 108.073 170.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.9 pt -124.23 146.16 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.017 -0.992 . . . . 1.51 108.601 -171.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 160' ' ' LEU 0.308 0.0 OUTLIER -129.93 139.22 51.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.097 -0.705 . . . . 2.69 109.097 176.867 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.6 t -79.93 112.08 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 118.579 -0.724 . . . . 0.72 109.113 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . 0.479 7.4 p -109.0 97.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 N-CA-C 113.47 0.915 . . . . 2.4 113.47 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -79.82 130.04 34.98 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.326 1.85 . . . . 5.14 107.077 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -141.6 162.11 36.28 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.409 0.549 . . . . 0.87 111.029 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -119.01 126.75 52.46 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.897 1.279 . . . . 5.5 108.209 -172.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 46.62 -130.35 11.83 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 123.59 0.614 . . . . 1.73 112.208 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.96 138.2 38.72 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.266 0.627 . . . . 2.16 109.511 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.73 -31.75 0.12 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 114.124 1.157 . . . . 2.43 114.124 -175.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 178.96 -49.16 0.09 OUTLIER Glycine 0 C--N 1.335 0.509 0 N-CA-C 109.6 -1.4 . . . . 2.31 109.6 -170.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -77.57 158.65 29.73 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.71 -0.848 . . . . 2.69 108.71 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.57 -43.09 23.65 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.778 1.231 . . . . 4.68 108.719 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -73.7 -60.67 2.14 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.926 0.891 . . . . 4.12 109.066 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 49.74 -140.22 0.78 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.076 1.35 . . . . 2.27 111.734 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -89.83 156.52 18.43 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 107.366 -1.346 . . . . 7.6 107.366 167.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -158.14 11.55 0.18 Allowed 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 126.82 2.048 . . . . 3.19 111.105 -157.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 105.29 165.22 23.78 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.351 -1.1 . . . . 1.99 110.351 -165.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -58.11 118.0 4.97 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.526 -0.916 . . . . 4.06 108.526 166.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.91 -160.81 13.74 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 109.95 -1.26 . . . . 1.78 109.95 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.92 -102.94 0.2 Allowed Glycine 0 C--N 1.339 0.715 0 N-CA-C 109.167 -1.573 . . . . 1.66 109.167 -171.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.505 HG23 ' H12' ' A' ' 269' ' ' NGH 0.314 12.8 mm -90.73 130.04 40.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.111 -1.07 . . . . 1.9 108.111 171.294 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.582 ' HB2' ' H1 ' ' A' ' 269' ' ' NGH . 3.8 mp -82.48 -61.18 1.96 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.806 -0.812 . . . . 1.11 108.806 166.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.995 ' H ' H102 ' A' ' 269' ' ' NGH . . . -158.8 149.65 20.15 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 113.332 0.864 . . . . 0.94 113.332 -177.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -131.97 117.05 17.91 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.563 1.945 . . . . 1.0 114.678 -170.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -144.19 160.54 40.78 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 128.245 2.618 . . . . 0.56 106.388 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.93 149.84 28.65 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.691 -1.596 . . . . 3.68 106.691 -177.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -102.15 -86.99 1.97 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-O 119.455 -0.636 . . . . 0.6 111.768 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.57 86.83 0.43 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.501 2.801 . . . . 1.39 110.543 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -163.71 157.85 30.17 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 108.419 -1.872 . . . . 1.04 108.419 170.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.0 m -80.37 173.87 12.17 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.224 0.535 . . . . 2.63 110.45 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 56.53 -112.47 3.41 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.575 0.607 . . . . 1.24 111.648 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.1 tp -59.79 -40.05 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 O-C-N 122.131 -0.629 . . . . 1.43 109.365 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -39.24 136.06 1.37 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.393 0.997 . . . . 0.94 112.288 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.51 -47.58 1.17 Allowed Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.179 1.371 . . . . 0.58 111.186 -164.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -84.94 154.12 22.38 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.748 0.774 . . . . 1.3 109.226 -159.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.41 116.71 20.17 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.528 0.936 . . . . 0.61 113.528 -166.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -114.86 135.14 54.53 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 118.289 0.495 . . . . 2.19 111.629 -163.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -125.36 146.51 49.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.249 -0.649 . . . . 2.76 109.249 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -66.52 96.76 0.39 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.073 -0.967 . . . . 2.82 109.806 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.44 -42.76 98.66 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 120.558 -1.339 . . . . 3.18 111.639 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -53.85 -35.49 61.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.658 1.183 . . . . 2.86 110.14 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -67.4 133.94 50.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.721 -1.585 . . . . 2.11 106.721 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -93.39 94.25 8.61 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.131 -2.174 . . . . 2.79 105.131 -173.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 23.7 m95 -75.79 152.87 37.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.277 -1.749 . . . . 1.14 106.277 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 p -128.05 124.5 37.24 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.231 -1.396 . . . . 1.75 107.231 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -49.9 75.91 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 120.51 1.504 . . . . 2.14 108.028 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.74 177.93 2.33 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.725 0.41 . . . . 2.04 110.536 176.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.1 t -48.53 -55.31 11.41 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.726 1.211 . . . . 3.67 110.723 -171.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 40.78 -106.64 0.07 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.147 1.356 . . . . 2.3 114.611 165.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -121.37 -67.84 0.26 Allowed Glycine 0 CA--C 1.525 0.709 0 C-N-CA 124.293 0.949 . . . . 1.09 110.93 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.4 m -131.95 140.69 49.08 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.33 -1.73 . . . . 0.85 106.33 174.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -95.3 129.82 42.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 123.733 0.646 . . . . 1.56 111.251 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -47.59 85.18 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.529 -0.759 . . . . 1.59 110.137 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -55.51 -38.23 68.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.621 0.768 . . . . 2.69 111.475 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.68 -63.4 1.23 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.791 0.836 . . . . 1.95 109.706 176.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.303 0.2 OUTLIER -56.4 -38.75 71.95 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.19 -178.148 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.99 -58.5 7.06 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 117.857 -1.068 . . . . 0.63 110.641 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.588 ' CG1' HG11 ' A' ' 235' ' ' VAL . 0.3 OUTLIER -58.02 -44.01 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 120.275 1.398 . . . . 2.12 111.316 -174.845 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.657 ' NE2' ' CE1' ' A' ' 222' ' ' HIS 0.48 3.2 t-160 -49.76 -60.9 2.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.555 1.142 . . . . 2.14 111.686 169.362 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -58.39 -41.72 85.5 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 120.835 -1.166 . . . . 2.87 111.946 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.476 HD11 HD11 ' A' ' 134' ' ' ILE . 1.4 mp -68.68 -39.18 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 109.046 -0.724 . . . . 1.07 109.046 -173.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -52.97 -44.9 62.15 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 111.402 -0.679 . . . . 0.63 111.402 167.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.657 ' CE1' ' NE2' ' A' ' 218' ' ' HIS . 3.0 m-70 -53.93 -48.68 69.97 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 117.783 0.791 . . . . 1.26 109.302 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.5 p -61.2 -18.5 58.55 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.59 0.959 . . . . 1.69 113.59 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.6 mt -79.1 -58.98 2.96 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 106.966 -1.494 . . . . 2.19 106.966 171.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 149.86 79.66 0.03 OUTLIER Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.615 -0.721 . . . . 1.21 111.859 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.789 HD11 HG22 ' A' ' 258' ' ' ILE . 8.7 mt -133.38 102.69 5.63 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.697 -1.223 . . . . 3.19 107.697 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -77.81 46.94 2.71 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.14 -0.811 . . . . 3.42 112.777 -176.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 63.7 m80 71.38 120.08 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.09 2.156 . . . . 1.82 113.0 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 68.4 m -77.55 -179.83 6.08 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.933 -0.395 . . . . 1.26 109.933 173.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.3 t -142.14 29.91 1.63 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.954 0.901 . . . . 2.59 110.005 -171.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.03 143.35 45.23 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.69 1.596 . . . . 2.16 107.002 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -86.2 -12.61 5.74 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.158 1.905 . . . . 1.03 114.493 -172.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -81.2 -40.36 23.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.162 -1.051 . . . . 1.38 108.162 170.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.0 145.78 15.93 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.784 0.834 . . . . 0.74 110.502 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.588 HG11 ' CG1' ' A' ' 217' ' ' VAL . 60.3 t -97.5 -17.26 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.2 1.0 . . . . 0.75 109.826 -176.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.476 ' HG3' HD13 ' A' ' 226' ' ' LEU . 50.9 mmm -77.5 -12.42 59.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.074 1.139 . . . . 2.41 114.074 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.423 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.9 155.49 1.05 Allowed Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.425 1.09 . . . . 3.15 113.275 177.011 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.525 ' O ' ' S1 ' ' A' ' 269' ' ' NGH . 73.4 Cg_endo -73.34 -21.69 19.63 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.774 1.65 . . . . 1.01 111.428 175.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.319 0.6 OUTLIER -76.8 173.19 11.97 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.824 1.25 . . . . 1.35 109.362 176.553 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -116.78 148.75 40.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.285 -1.376 . . . . 2.0 107.285 171.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -141.45 122.07 14.24 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.301 -1.74 . . . . 2.12 106.301 166.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -61.22 144.4 53.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.054 -0.721 . . . . 2.67 109.054 168.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 25.9 m -133.97 159.36 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.023 0.929 . . . . 2.07 108.723 167.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.81 -10.66 39.74 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 127.05 2.14 . . . . 4.04 113.107 -174.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . 0.257 24.0 mm 71.78 -23.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 127.081 2.152 . . . . 2.98 112.104 -176.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -47.04 -67.04 0.32 Allowed 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 113.81 1.041 . . . . 3.69 113.81 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 22.6 m -81.61 -50.15 9.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.528 -0.545 . . . . 1.9 109.528 -173.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 38.5 t80 39.43 82.9 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.435 1.894 . . . . 6.68 112.885 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.09 162.18 32.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.829 0.851 . . . . 3.44 109.387 -176.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.498 ' H ' HD22 ' A' ' 250' ' ' LEU . 1.2 mm? -83.03 146.79 28.54 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.808 -1.182 . . . . 0.99 107.808 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.9 m -76.79 157.28 31.69 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.022 0.529 . . . . 0.95 110.634 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.2 67.21 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 110.045 -0.354 . . . . 1.07 110.045 172.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -51.09 -56.78 10.94 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.904 0.859 . . . . 3.06 110.262 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -58.53 -42.15 87.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.068 -0.969 . . . . 2.13 111.589 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 41.7 mt -57.49 -44.73 85.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.181 1.393 . . . . 0.83 109.604 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -63.15 -45.12 93.36 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.417 -0.802 . . . . 4.55 110.622 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -46.09 -62.88 3.2 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.727 -0.549 . . . . 0.85 111.727 173.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.789 HG22 HD11 ' A' ' 226' ' ' LEU . 2.8 pp -60.21 -42.44 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 O-C-N 121.803 -0.822 . . . . 2.2 111.939 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -63.28 -21.53 66.3 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.195 -0.602 . . . . 2.31 112.054 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.6 t -53.21 -25.56 14.46 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.99 -0.444 . . . . 2.29 111.743 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 56.1 mt -74.27 54.1 0.54 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.212 1.005 . . . . 2.87 111.814 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 51.55 44.68 28.93 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.707 1.203 . . . . 6.43 111.605 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.207 0 CA-C-O 116.679 -2.179 . . . . 9.45 111.6 173.56 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 269' ' ' NGH . . . . . 0.995 H102 ' H ' ' A' ' 182' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 56.3 mtt . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 108.259 -1.015 . . . . 13.47 108.259 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.85 79.18 0.02 OUTLIER Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.034 -1.626 . . . . 8.76 109.034 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.83 168.24 24.38 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.258 1.972 . . . . 10.14 110.133 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.6 p -154.71 167.58 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.079 -1.452 . . . . 5.8 107.079 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -114.1 163.61 14.95 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.921 0.888 . . . . 10.87 111.342 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -61.4 -43.5 98.75 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.029 1.331 . . . . 8.86 112.377 -171.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.06 -40.21 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.206 0.602 . . . . 5.99 112.272 175.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 4.0 m170 64.6 -69.61 0.09 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.766 1.226 . . . . 4.75 112.32 -173.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.9 95.15 4.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 119.024 0.829 . . . . 2.78 111.339 -169.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.0 mm -94.03 80.68 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 108.207 -1.035 . . . . 1.91 108.207 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.8 p -77.61 129.66 35.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.18 -1.044 . . . . 1.18 108.18 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.404 ' CE2' HD12 ' A' ' 134' ' ' ILE . 39.4 p90 -129.01 163.0 26.31 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.16 0.584 . . . . 4.52 110.59 -178.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.08 151.8 36.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.618 -0.882 . . . . 6.6 108.618 174.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -100.47 144.21 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.142 -1.059 . . . . 0.94 108.142 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -83.99 -58.32 2.83 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.611 -1.255 . . . . 3.86 107.611 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -123.8 160.18 27.92 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.782 1.233 . . . . 2.24 109.213 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -111.94 127.32 55.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.237 1.415 . . . . 2.12 107.262 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.39 131.03 34.1 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 118.356 0.525 . . . . 2.53 110.044 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -87.66 -17.24 2.78 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.848 3.032 . . . . 1.65 110.794 171.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -44.55 -48.16 10.24 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 125.442 1.497 . . . . 2.06 110.863 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 6.8 ptp -124.33 176.49 6.42 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.097 0.959 . . . . 2.34 109.135 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -65.7 134.26 52.82 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.363 -0.236 . . . . 2.99 110.363 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -52.58 -47.78 66.65 Favored 'General case' 0 CA--C 1.524 -0.043 0 O-C-N 122.028 -0.42 . . . . 3.57 111.651 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -51.01 -25.92 5.4 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.685 -0.674 . . . . 3.22 111.529 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -93.02 -35.32 13.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.992 1.317 . . . . 1.98 112.004 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -52.45 -56.58 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 120.469 -1.395 . . . . 1.2 108.875 171.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.83 -25.46 65.57 Favored 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 117.729 -1.588 . . . . 1.74 108.632 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -63.71 -45.43 90.0 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.856 1.207 . . . . 1.96 111.216 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.75 -53.01 60.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 122.771 0.428 . . . . 0.5 110.187 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.404 HD12 ' CE2' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -70.3 -37.26 70.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.834 -0.432 . . . . 2.05 109.834 -176.117 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -54.07 -59.98 3.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.337 1.455 . . . . 3.12 107.848 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -63.16 -43.88 97.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.408 -0.814 . . . . 2.4 109.764 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.32 -52.2 47.48 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.372 0.669 . . . . 0.43 111.909 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.04 -46.39 88.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.098 -1.041 . . . . 6.47 109.018 174.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -29.03 63.55 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 118.746 -0.645 . . . . 2.02 111.579 -172.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.404 ' CG1' HD21 ' A' ' 250' ' ' LEU . 99.0 t -59.83 -63.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 118.984 0.811 . . . . 0.81 109.494 171.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.764 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 46.8 m95 -66.04 -41.15 91.26 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.873 -0.788 . . . . 0.71 108.873 -170.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 t -69.08 -4.91 19.03 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 124.312 1.045 . . . . 1.07 112.054 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -89.66 -55.98 3.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.05 -0.722 . . . . 1.1 109.05 167.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.97 -51.44 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 112.8 0.667 . . . . 1.41 112.8 -174.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.511 HG22 HD13 ' A' ' 258' ' ' ILE . 42.3 p -79.76 151.96 74.43 Favored Pre-proline 0 N--CA 1.443 -0.812 0 N-CA-C 107.427 -1.323 . . . . 0.75 107.427 174.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.35 12.76 1.48 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.373 2.049 . . . . 0.74 112.248 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.61 149.45 50.05 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.221 -0.924 . . . . 2.38 109.079 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -120.79 87.46 2.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.661 -1.607 . . . . 4.62 106.661 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -72.37 149.07 44.68 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.11 -0.496 . . . . 5.85 109.77 172.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.3 t -155.73 129.34 8.43 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 119.172 -0.442 . . . . 1.04 110.01 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.68 149.87 27.1 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.224 -1.028 . . . . 2.14 108.224 171.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.0 pt -134.67 119.88 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.627 -1.62 . . . . 1.27 106.627 171.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -76.87 -22.3 53.68 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.505 -0.554 . . . . 3.65 109.505 173.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -136.8 113.27 10.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.25 1.42 . . . . 2.44 108.858 -176.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 149.5 -144.67 12.33 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 108.739 -1.744 . . . . 1.91 108.739 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 28.2 mtt -135.19 131.87 37.26 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 126.384 1.874 . . . . 4.21 107.511 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.77 162.92 14.3 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.552 1.541 . . . . 0.72 110.102 -175.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -86.89 -48.59 8.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.08 0.952 . . . . 1.88 109.68 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.2 pt -107.07 166.5 3.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.246 -0.65 . . . . 0.89 109.246 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.45 141.11 43.53 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.081 0.552 . . . . 2.28 111.269 174.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 73.3 t -90.8 122.77 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.41 -0.959 . . . . 0.87 108.41 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.1 t -97.64 115.35 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.745 -0.835 . . . . 1.56 108.745 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -107.54 113.37 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.953 -2.239 . . . . 5.28 104.953 163.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.613 ' HB3' ' HE2' ' A' ' 174' ' ' PHE . . . -128.13 148.84 50.6 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.77 -1.196 . . . . 0.71 107.77 177.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.96 105.96 15.99 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.996 0.81 . . . . 5.47 109.639 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.19 -134.51 13.6 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.609 -0.997 . . . . 1.87 110.609 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.32 137.64 39.99 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 122.043 -0.68 . . . . 2.02 109.697 -171.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.2 74.9 1.16 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.385 0.612 . . . . 2.47 110.964 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 78.76 -44.21 2.51 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 121.321 -0.862 . . . . 3.27 111.72 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 173' ' ' ALA . 75.3 m-20 -73.54 158.74 34.28 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.519 -0.919 . . . . 2.84 108.519 177.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.9 -46.88 61.76 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 125.029 1.332 . . . . 4.37 107.815 -170.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 32.3 p-80 -112.9 -71.81 0.74 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.288 -1.324 . . . . 3.99 110.709 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 170' ' ' ASP . . . 56.35 -77.66 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.454 1.502 . . . . 2.21 113.503 -171.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.613 ' HE2' ' HB3' ' A' ' 164' ' ' ALA . 9.5 m-85 -128.67 165.68 20.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.084 1.354 . . . . 6.05 109.036 -168.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -169.08 15.65 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.429 0.9 . . . . 2.67 113.429 -153.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 73.12 -160.65 54.07 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 109.812 -1.315 . . . . 1.27 109.812 -164.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -81.5 55.16 2.54 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.297 -0.531 . . . . 5.9 112.427 -170.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -142.51 -158.77 7.67 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 107.998 -2.041 . . . . 2.28 107.998 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.56 -138.07 41.48 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.172 -1.171 . . . . 1.93 110.172 172.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.499 HD11 H102 ' A' ' 269' ' ' NGH . 1.3 tp -78.84 151.69 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 109.07 -0.715 . . . . 2.23 109.07 173.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.9 tp -84.32 -39.13 19.53 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.523 1.529 . . . . 1.22 111.146 171.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -167.51 164.07 14.81 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.712 0.805 . . . . 0.8 109.694 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -145.71 124.66 12.75 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.336 1.235 . . . . 1.06 114.336 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -139.52 161.28 37.88 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.065 2.146 . . . . 0.65 108.455 -173.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -148.77 141.84 24.9 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.443 -0.947 . . . . 2.71 108.443 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -92.08 -83.14 1.48 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.586 -1.006 . . . . 0.56 110.586 171.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.2 98.69 0.84 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.104 2.536 . . . . 1.3 111.07 -170.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -174.23 173.44 45.99 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.168 -1.973 . . . . 1.21 108.168 172.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 72.1 m -89.53 173.24 8.44 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.977 0.511 . . . . 2.73 109.679 169.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 54.66 -101.96 0.12 Allowed Glycine 0 C--O 1.243 0.686 0 C-N-CA 124.069 0.842 . . . . 1.61 111.424 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.531 ' CG1' ' HE2' ' A' ' 196' ' ' HIS . 7.1 tp -59.35 -41.14 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-O 117.912 -1.042 . . . . 1.59 109.036 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -33.96 129.48 0.47 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.633 1.111 . . . . 1.06 113.11 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 97.16 -34.94 4.73 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.268 1.413 . . . . 0.77 112.125 -167.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -86.47 159.37 19.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.736 1.268 . . . . 1.23 110.72 -165.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -133.66 121.59 22.21 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.385 0.883 . . . . 0.83 113.385 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.531 ' HE2' ' CG1' ' A' ' 191' ' ' ILE . 2.2 m170 -109.15 112.25 24.31 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-O 117.473 -1.251 . . . . 2.22 111.957 -167.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -106.77 145.0 32.6 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 121.336 1.88 . . . . 3.17 111.213 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.36 83.34 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.226 1.011 . . . . 3.05 110.227 177.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.81 -24.64 67.84 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 120.376 -1.452 . . . . 2.73 109.901 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.44 -35.42 28.6 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.104 -0.997 . . . . 4.31 111.192 169.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -74.22 161.75 29.62 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.668 1.223 . . . . 1.66 110.985 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -102.46 95.93 6.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.243 -1.392 . . . . 3.04 107.243 176.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -78.27 140.23 38.87 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.549 -0.908 . . . . 1.11 108.549 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.6 p -122.61 105.85 10.47 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 107.599 -1.26 . . . . 1.85 107.599 -172.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.2 t -48.47 -33.24 9.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.384 1.474 . . . . 2.23 114.329 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -71.07 178.27 3.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.634 0.73 . . . . 2.31 111.455 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.1 m -66.31 -47.4 73.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 121.116 -0.99 . . . . 4.7 109.665 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -62.82 132.41 43.62 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.107 -0.951 . . . . 3.26 111.241 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 101.46 -119.52 6.53 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.257 -1.137 . . . . 1.46 110.257 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.8 m -124.77 106.77 10.31 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.915 -1.143 . . . . 1.01 107.915 167.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -65.93 108.73 2.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.369 -0.604 . . . . 2.07 109.369 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 37.9 tp -50.78 -43.5 58.52 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.556 0.617 . . . . 1.61 111.115 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.586 ' CD1' HG22 ' A' ' 245' ' ' ILE . 45.9 t80 -44.06 -46.0 8.29 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.952 0.501 . . . . 1.46 111.125 175.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.407 HD12 ' HD1' ' A' ' 213' ' ' PHE . 3.5 mp -59.51 -63.45 1.3 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.516 0.674 . . . . 2.63 110.061 -173.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.349 1.3 m -60.32 -37.14 79.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.729 -0.669 . . . . 0.75 109.691 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.85 -53.84 50.12 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 117.955 -1.022 . . . . 0.33 110.549 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 213' ' ' PHE . 62.7 t -50.66 -49.94 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.968 1.258 . . . . 0.7 109.538 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -56.82 -45.09 82.5 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.236 -0.915 . . . . 2.53 113.313 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -83.23 -48.18 10.75 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.085 -1.009 . . . . 3.04 112.448 -170.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.37 -33.77 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.364 -1.347 . . . . 1.29 107.364 164.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.76 ' HA2' HD23 ' A' ' 224' ' ' LEU . . . -50.15 -61.44 5.79 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.95 -0.86 . . . . 0.63 110.95 168.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -47.36 -56.48 6.79 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.495 -1.003 . . . . 1.3 110.743 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.0 m -46.36 -40.15 11.48 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 113.226 0.825 . . . . 2.16 113.226 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.76 HD23 ' HA2' ' A' ' 221' ' ' GLY . 0.5 OUTLIER -63.72 -33.88 76.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 118.924 0.784 . . . . 3.46 110.127 -174.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 130.61 46.18 0.15 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.933 1.73 . . . . 1.31 112.603 172.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.902 HD11 HG22 ' A' ' 258' ' ' ILE . 4.8 mt -119.45 147.72 44.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.586 1.193 . . . . 3.43 113.198 -172.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -88.13 166.42 35.18 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.879 1.228 . . . . 2.89 110.721 173.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -70.35 121.85 18.46 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.562 0.745 . . . . 1.65 110.536 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 66.5 m -77.01 -179.39 5.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.261 0.625 . . . . 1.1 110.903 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 17.6 m -135.53 39.1 2.86 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.038 1.335 . . . . 2.22 110.35 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -135.77 136.33 23.32 Favored Pre-proline 0 N--CA 1.452 -0.325 0 N-CA-C 107.524 -1.287 . . . . 1.99 107.524 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.3 -13.38 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.315 2.01 . . . . 1.01 114.325 -175.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -41.69 21.97 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.946 0.898 . . . . 1.92 109.068 173.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.29 139.88 34.92 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.333 1.053 . . . . 0.79 111.041 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 76.6 t -86.48 -15.18 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.943 0.878 . . . . 0.63 110.978 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.454 ' SD ' HD13 ' A' ' 226' ' ' LEU . 3.7 tpt -80.25 -21.71 42.48 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.166 -0.959 . . . . 1.69 112.916 -171.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -49.83 165.02 0.32 Allowed Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 128.091 2.556 . . . . 3.1 114.59 175.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -78.29 -21.11 10.69 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.536 1.491 . . . . 0.96 112.103 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.365 0.2 OUTLIER -78.64 -178.58 5.97 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.375 1.47 . . . . 1.28 110.686 -176.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -111.05 153.91 24.96 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.491 1.517 . . . . 3.05 108.926 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.0 tptt -149.53 133.13 16.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 106.858 -1.534 . . . . 2.32 106.858 169.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -70.19 111.69 6.0 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.416 -0.957 . . . . 2.87 108.416 170.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 20.6 m -121.65 118.17 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.737 0.815 . . . . 1.72 109.015 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.73 114.0 4.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.557 -0.714 . . . . 3.36 110.31 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.586 HG22 ' CD1' ' A' ' 213' ' ' PHE . 1.1 pp -52.09 -29.72 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 C-N-CA 124.642 1.177 . . . . 3.56 111.231 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -52.8 -40.94 63.69 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.854 0.861 . . . . 3.78 110.884 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 35.9 m -73.48 -36.39 65.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 119.108 -0.472 . . . . 1.82 110.515 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 44.4 t80 52.47 72.65 0.39 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.007 0.923 . . . . 5.08 110.084 172.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.41 167.12 30.55 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.099 -1.001 . . . . 2.55 110.965 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.467 HD22 ' N ' ' A' ' 250' ' ' LEU . 0.9 OUTLIER -114.08 -170.46 1.72 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.542 1.937 . . . . 1.48 109.463 179.487 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 13.9 m -109.85 149.12 30.32 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.574 1.15 . . . . 0.7 111.295 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.4 -48.84 65.43 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.984 -0.448 . . . . 0.88 111.573 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -64.11 -22.88 67.11 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.902 0.334 . . . . 2.97 111.902 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -77.78 -47.83 18.02 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.967 -0.458 . . . . 3.41 110.805 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.418 ' HA ' HG13 ' A' ' 258' ' ' ILE . 67.8 mt -54.48 -40.65 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.151 1.38 . . . . 0.88 110.974 -175.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -56.8 -47.79 79.4 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.311 -1.493 . . . . 6.85 111.214 170.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -57.48 -48.92 77.45 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.625 1.107 . . . . 0.97 110.545 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.902 HG22 HD11 ' A' ' 226' ' ' LEU 0.26 1.6 pp -64.08 -44.03 97.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 O-C-N 121.491 -1.005 . . . . 2.43 109.686 -176.737 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -64.03 -30.23 71.32 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.465 -1.397 . . . . 2.25 111.787 176.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.6 t -50.76 -14.82 0.22 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.535 1.309 . . . . 1.81 114.535 169.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.7 HD11 ' CD1' ' A' ' 224' ' ' LEU . 19.2 mt -41.04 -36.91 0.75 Allowed 'General case' 0 C--N 1.345 0.396 0 CA-C-N 120.388 1.449 . . . . 2.52 112.713 165.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -156.06 -34.41 0.09 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.399 0.518 . . . . 6.69 112.399 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.525 -1.708 . . . . 8.09 111.271 -176.404 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 269' ' ' NGH . . . . . 0.499 H102 HD11 ' A' ' 180' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 107.449 -1.315 . . . . 17.45 107.449 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.55 90.47 2.1 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 110.371 -1.091 . . . . 10.34 110.371 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.49 75.66 3.84 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.265 1.977 . . . . 11.57 109.716 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.4 p -93.46 111.33 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.986 0.915 . . . . 6.54 109.845 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -163.01 166.73 23.37 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.593 -0.891 . . . . 11.43 108.593 171.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -151.8 78.0 1.24 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.41 1.884 . . . . 8.07 106.045 166.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.7 mttt 52.62 70.27 0.59 Allowed 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 122.494 1.14 . . . . 5.8 111.582 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -73.7 -46.77 44.24 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.172 -0.955 . . . . 3.2 108.572 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -126.82 118.41 24.57 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.287 0.635 . . . . 3.7 112.452 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 114' ' ' ILE . 1.6 mp -97.15 92.71 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 107.251 -1.389 . . . . 2.21 107.251 172.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.6 p -81.39 136.97 35.73 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.338 -0.986 . . . . 1.27 108.338 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.43 ' HA ' ' HB1' ' A' ' 157' ' ' ALA . 43.4 p90 -142.51 164.87 28.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.336 0.516 . . . . 4.13 112.294 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -147.1 142.87 27.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.129 0.971 . . . . 4.75 108.435 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.92 164.3 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.555 0.742 . . . . 0.92 109.327 172.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.606 HD22 ' H ' ' A' ' 119' ' ' ASN . 0.1 OUTLIER -109.33 -56.33 2.31 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 126.148 1.779 . . . . 3.32 108.441 179.068 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -139.77 120.98 14.83 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.776 -0.824 . . . . 3.17 108.776 -167.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -81.26 113.08 19.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.349 -0.982 . . . . 2.35 108.349 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -52.27 128.78 40.98 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 123.025 0.53 . . . . 2.32 110.314 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.68 -15.88 11.95 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.69 2.927 . . . . 1.53 110.553 173.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -46.2 -39.17 9.36 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.366 1.066 . . . . 2.04 110.479 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 42.4 mtm -124.95 -176.72 3.63 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.316 1.447 . . . . 1.95 109.954 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -73.87 144.01 45.61 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.432 -0.581 . . . . 3.05 109.432 170.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 64.2 ttt-85 -51.04 -45.55 61.36 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.413 -0.804 . . . . 2.7 110.722 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -61.81 -13.0 19.94 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.508 0.723 . . . . 3.41 112.028 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -94.52 -45.38 7.44 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.344 1.458 . . . . 1.9 109.568 172.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 52.4 t -55.8 -59.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.792 1.237 . . . . 1.18 109.831 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -24.14 65.67 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 117.602 -1.639 . . . . 1.78 108.987 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -64.55 -46.61 82.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.798 0.727 . . . . 1.91 111.208 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.09 -53.34 58.23 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.465 0.706 . . . . 0.37 109.846 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.4 ' O ' HD13 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -69.65 -36.84 72.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 109.516 -0.549 . . . . 2.04 109.516 -178.094 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -57.27 12.45 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 122.173 0.987 . . . . 4.74 108.511 178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -62.03 -43.96 97.72 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.225 -0.657 . . . . 1.57 109.225 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.466 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -48.39 -53.99 15.64 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.437 0.695 . . . . 0.45 112.758 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 149' ' ' PHE . 0.3 OUTLIER -62.25 -47.02 86.23 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 119.304 -0.958 . . . . 6.56 109.103 176.306 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.31 -37.05 71.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 122.511 0.324 . . . . 1.93 110.704 -169.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.0 t -54.63 -52.22 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 109.139 -0.689 . . . . 0.79 109.139 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.87 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 64.4 m95 -69.69 -35.29 74.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.501 -0.749 . . . . 0.89 109.463 -177.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.6 t -64.2 -16.46 62.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.375 0.67 . . . . 1.48 112.16 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -83.38 -51.05 7.73 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.116 -1.068 . . . . 1.2 108.116 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.464 HG11 HD23 ' A' ' 250' ' ' LEU . 30.5 m -74.54 -44.46 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 112.393 0.516 . . . . 1.6 112.393 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.462 ' CG2' HD13 ' A' ' 258' ' ' ILE . 56.4 p -84.84 150.63 56.34 Favored Pre-proline 0 N--CA 1.445 -0.714 0 N-CA-C 108.902 -0.777 . . . . 0.74 108.902 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.52 10.46 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.61 2.207 . . . . 0.84 112.636 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 43.8 mt -67.72 133.95 50.19 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.263 1.425 . . . . 1.92 110.309 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.56 82.68 1.69 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.832 -1.173 . . . . 4.67 107.832 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.528 ' HB2' ' CD1' ' A' ' 138' ' ' PHE . 77.4 m-85 -67.66 159.17 30.55 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.051 -0.522 . . . . 5.24 111.131 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.3 t -155.79 125.87 6.59 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.83 0.741 . . . . 0.98 110.629 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -78.78 137.26 37.65 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 107.256 -1.387 . . . . 2.19 107.256 167.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.2 pt -135.08 105.58 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.467 -0.938 . . . . 1.67 108.467 170.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -77.41 -15.45 59.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.486 -0.325 . . . . 3.13 110.169 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.3 m -127.32 102.02 6.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.308 1.043 . . . . 2.06 109.249 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.0 -155.26 26.36 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 108.81 -1.716 . . . . 1.41 108.81 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 31.4 mtp -117.71 130.16 56.16 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.129 2.572 . . . . 4.14 105.88 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.43 ' HB1' ' HA ' ' A' ' 116' ' ' TYR . . . -119.14 161.19 20.73 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.291 1.036 . . . . 0.75 109.91 -173.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -68.82 -54.61 14.83 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.972 -0.751 . . . . 1.87 108.972 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.3 pt -114.3 135.96 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.527 0.731 . . . . 1.16 109.271 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.72 131.56 52.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.224 -1.028 . . . . 2.19 108.224 172.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.32 124.54 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 106.937 -1.505 . . . . 0.83 106.937 169.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.9 t -98.51 137.84 24.85 Favored 'Isoleucine or valine' 0 C--N 1.346 0.422 0 C-N-CA 125.049 1.339 . . . . 1.22 108.92 171.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -130.26 107.56 9.37 Favored 'General case' 0 C--N 1.335 -0.054 0 N-CA-C 106.569 -1.641 . . . . 5.34 106.569 171.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -123.26 154.42 38.84 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.51 0.672 . . . . 0.77 112.35 -173.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -92.17 70.01 5.28 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.792 0.837 . . . . 6.2 109.66 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 95.13 -150.33 19.65 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.66 -0.976 . . . . 2.6 110.66 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.55 81.3 3.23 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.96 -0.729 . . . . 2.89 112.107 -162.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.11 64.48 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.876 1.27 . . . . 2.59 112.561 173.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.73 48.45 66.99 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.551 -1.02 . . . . 2.17 110.551 -175.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -119.1 155.63 31.19 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 104.941 -2.244 . . . . 2.4 104.941 160.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -75.75 -58.28 3.38 Favored 'General case' 0 C--O 1.227 -0.113 0 N-CA-C 108.715 -0.846 . . . . 5.0 108.715 171.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -146.22 102.18 3.58 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.991 1.316 . . . . 5.39 107.812 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -163.69 -38.5 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 123.355 0.662 . . . . 3.92 111.333 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -110.09 166.54 10.87 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 122.933 0.493 . . . . 6.46 110.085 166.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -172.92 164.94 5.1 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 127.389 2.276 . . . . 3.89 106.539 -170.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -72.39 -143.35 0.47 Allowed Glycine 0 CA--C 1.525 0.68 0 O-C-N 123.969 0.793 . . . . 1.76 111.344 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -61.73 108.15 0.95 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.392 0.677 . . . . 5.17 110.795 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.24 -145.68 18.11 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.679 -1.368 . . . . 1.71 109.679 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 45.44 -126.93 8.02 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 126.136 1.827 . . . . 1.58 111.706 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.3 mm -79.99 144.0 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-O 122.218 1.008 . . . . 1.99 108.702 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.585 HD22 ' H1 ' ' A' ' 269' ' ' NGH . 6.0 mp -84.23 -62.04 1.66 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.576 1.95 . . . . 1.04 109.445 170.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -159.56 158.4 31.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 120.637 -1.29 . . . . 0.53 110.151 -172.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -144.06 135.52 25.83 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 114.247 1.202 . . . . 1.22 114.247 172.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' A' ' 222' ' ' HIS . . . -149.43 164.04 36.09 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.264 2.226 . . . . 0.54 107.8 -169.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -150.05 143.49 25.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.09 -0.707 . . . . 3.03 109.09 -173.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -87.11 -130.18 2.94 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.789 -1.006 . . . . 0.63 110.665 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.09 105.21 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.54 2.16 . . . . 2.51 110.56 -173.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -167.36 168.05 40.26 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 107.56 -2.216 . . . . 1.1 107.56 176.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.5 m -78.16 167.65 21.08 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.42 0.629 . . . . 2.04 111.659 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 53.59 -111.78 2.05 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.173 0.892 . . . . 1.22 112.165 173.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.5 tp -60.55 -37.26 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 118.239 -0.886 . . . . 1.34 109.61 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -32.58 131.42 0.25 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.176 1.37 . . . . 0.96 113.199 173.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.08 -48.89 1.18 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.58 1.562 . . . . 0.64 111.171 -165.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.45 153.13 23.55 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.537 -0.912 . . . . 1.3 108.537 -161.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.39 120.57 30.16 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 118.001 -0.999 . . . . 0.61 112.274 -172.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.47 129.51 56.53 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-N 119.213 0.915 . . . . 2.36 110.123 -166.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.419 ' CE2' ' HG3' ' A' ' 219' ' ' GLU . 25.2 m-85 -121.63 150.72 41.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 118.736 0.698 . . . . 2.84 110.252 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -79.55 77.73 6.12 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 122.082 0.944 . . . . 3.6 111.962 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -48.06 -33.43 8.07 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 119.971 -1.706 . . . . 2.75 111.506 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -36.32 -47.8 0.61 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.773 1.229 . . . . 2.65 112.004 171.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -73.81 170.18 15.86 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.09 1.356 . . . . 1.77 111.0 -175.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -107.41 94.03 4.87 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.885 -1.524 . . . . 2.63 106.885 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -82.83 151.46 26.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.587 -0.733 . . . . 1.4 109.652 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.99 161.99 29.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.725 0.774 . . . . 2.23 110.836 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.39 -41.02 70.18 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.401 2.28 . . . . 1.7 111.684 169.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -80.37 157.79 26.22 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.533 -0.758 . . . . 2.32 110.358 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.8 m -70.58 -33.67 71.34 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.175 1.39 . . . . 4.78 111.622 -170.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.69 116.3 8.43 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-O 118.402 -1.221 . . . . 2.59 110.244 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 109.18 -121.02 6.0 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 107.812 -2.115 . . . . 1.31 107.812 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.4 m -124.72 138.66 54.28 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.681 -1.229 . . . . 0.77 107.681 159.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.27 116.44 29.01 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.83 -0.623 . . . . 2.18 109.864 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.74 -56.43 10.28 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.268 0.627 . . . . 1.44 109.706 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.583 ' O ' HG23 ' A' ' 217' ' ' VAL . 43.3 t80 -43.15 -50.87 6.19 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.515 1.526 . . . . 1.54 111.892 176.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.412 ' C ' HD23 ' A' ' 214' ' ' LEU . 6.0 tt -62.37 -58.12 8.84 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.61 -0.515 . . . . 1.45 109.61 -172.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.291 6.1 m -58.16 -41.47 83.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.948 -0.301 . . . . 0.77 110.649 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.79 -49.64 57.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.619 -0.705 . . . . 0.42 111.009 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 213' ' ' PHE . 58.3 t -57.28 -44.76 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 119.533 1.06 . . . . 0.81 111.098 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.62 ' CD2' ' CE1' ' A' ' 222' ' ' HIS . 1.0 OUTLIER -57.1 -50.22 73.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.522 1.129 . . . . 2.52 111.948 172.631 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.58 ' HG2' ' HD1' ' A' ' 218' ' ' HIS . 15.0 mm-40 -71.16 -46.93 60.48 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.457 -0.777 . . . . 2.63 112.385 -174.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.11 -39.29 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 107.48 -1.304 . . . . 1.09 107.48 170.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.05 -56.92 5.73 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 123.659 0.647 . . . . 0.46 112.919 164.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.651 ' ND1' HD21 ' A' ' 226' ' ' LEU 0.266 0.3 OUTLIER -49.94 -46.62 52.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.781 0.79 . . . . 1.68 110.904 178.258 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.2 t -51.94 -38.05 54.99 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 123.491 0.494 . . . . 2.31 112.275 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 mt -70.91 -59.35 2.84 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 107.528 -1.286 . . . . 2.16 107.528 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 139.44 104.11 0.59 Allowed Glycine 0 C--N 1.337 0.611 0 N-CA-C 110.016 -1.234 . . . . 1.7 110.016 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.807 HD12 ' H ' ' A' ' 228' ' ' HIS . 3.1 pp -130.73 145.42 51.94 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.52 0.728 . . . . 5.38 111.847 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -101.06 28.34 16.48 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.65 1.119 . . . . 3.14 112.456 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.807 ' H ' HD12 ' A' ' 226' ' ' LEU . 32.7 m80 57.39 102.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.393 2.677 . . . . 2.09 112.698 -176.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 7.1 m -72.29 170.12 14.79 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.229 -0.656 . . . . 1.1 109.229 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.2 m -140.72 44.33 1.83 Allowed 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.472 -0.768 . . . . 2.32 110.268 -171.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -143.18 132.08 11.52 Favored Pre-proline 0 N--CA 1.447 -0.614 0 N-CA-C 106.977 -1.49 . . . . 1.75 106.977 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.56 -14.82 27.62 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.972 1.781 . . . . 1.63 114.153 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -72.13 -23.61 61.33 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.475 1.034 . . . . 1.5 110.269 171.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.53 ' HB1' ' OD1' ' A' ' 254' ' ' ASP . . . -76.31 158.03 31.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.357 0.599 . . . . 1.17 110.607 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.421 HG11 ' CG1' ' A' ' 217' ' ' VAL . 45.2 t -110.99 -25.98 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.302 1.441 . . . . 0.79 111.074 173.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.546 ' HE3' HD23 ' A' ' 226' ' ' LEU . 52.6 mmm -65.92 -11.86 50.35 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.158 -0.964 . . . . 2.96 111.759 173.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.57 159.35 3.45 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.788 1.635 . . . . 3.61 113.959 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.25 -17.86 7.59 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.92 2.413 . . . . 0.97 111.524 170.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.3 0.2 OUTLIER -77.21 176.06 9.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.737 1.215 . . . . 1.81 108.776 179.063 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.406 ' CE2' HD13 ' A' ' 214' ' ' LEU . 51.2 t80 -143.19 141.27 31.08 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 104.568 -2.382 . . . . 2.51 104.568 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -156.24 145.21 20.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 104.873 -2.269 . . . . 4.32 104.873 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -49.04 109.59 0.27 Allowed 'General case' 0 C--N 1.339 0.118 0 N-CA-C 108.157 -1.053 . . . . 2.62 108.157 168.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.91 149.06 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 123.908 0.883 . . . . 1.75 108.891 171.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -60.0 78.5 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.496 2.318 . . . . 5.97 111.236 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 39.0 mm -44.95 -35.12 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.864 1.266 . . . . 3.81 110.794 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -55.06 -64.76 0.74 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.179 0.807 . . . . 4.59 113.179 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 92.7 m -82.22 -51.18 8.19 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.676 -0.861 . . . . 2.42 108.676 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 217' ' ' VAL . 29.2 t80 38.8 72.9 0.12 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.645 1.978 . . . . 7.25 113.083 174.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.75 159.29 15.9 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.266 -0.879 . . . . 4.93 109.532 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.691 HD12 ' CH2' ' A' ' 141' ' ' TRP . 1.6 mm? -85.91 143.88 27.97 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.543 -0.91 . . . . 1.02 108.543 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.0 m -76.63 156.14 32.93 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 110.572 -0.158 . . . . 0.74 110.572 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.87 80.88 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.783 -0.451 . . . . 0.91 109.783 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.15 -57.68 6.27 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 122.261 1.029 . . . . 2.6 109.699 174.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.53 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 12.1 m-20 -59.11 -39.61 82.81 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.563 -1.199 . . . . 2.22 112.266 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 35.5 mt -55.47 -35.14 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 119.114 0.87 . . . . 1.01 110.047 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -66.51 -53.31 36.43 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.468 -0.77 . . . . 4.42 110.014 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -50.77 -54.78 20.43 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 123.077 0.37 . . . . 1.29 112.532 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.87 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 2.6 pp -60.48 -43.35 94.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 121.851 -0.793 . . . . 2.24 110.462 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.411 ' HG2' HD12 ' A' ' 258' ' ' ILE . 2.2 mt-30 -67.03 -17.17 64.79 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.66 1.118 . . . . 2.56 112.243 174.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.1 t -66.12 -11.66 50.5 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.246 -1.359 . . . . 2.61 113.407 167.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.626 HD13 ' O ' ' A' ' 261' ' ' LEU 0.293 0.0 OUTLIER -52.58 87.47 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 120.66 1.573 . . . . 3.83 110.162 172.297 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -73.62 -41.54 62.66 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 120.444 -1.41 . . . . 6.82 112.167 -166.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.943 0 CA-C-O 117.407 -1.774 . . . . 9.5 109.64 -175.396 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 269' ' ' NGH . . . . . 0.585 ' H1 ' HD22 ' A' ' 181' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 120.815 0.34 . . . . 11.37 110.655 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 165.45 -176.45 41.03 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 108.43 -1.868 . . . . 7.72 108.43 -171.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.4 152.51 71.15 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.359 2.706 . . . . 9.83 110.436 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.6 p -166.78 158.11 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 106.488 -1.671 . . . . 5.65 106.488 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 22.7 m0 -89.29 161.6 16.29 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 119.478 1.036 . . . . 10.81 110.494 172.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -102.68 -8.55 20.81 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.938 -1.028 . . . . 9.89 112.276 -174.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -100.98 -87.13 0.39 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.048 0.939 . . . . 5.56 108.477 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 67.38 -61.14 0.36 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.16 1.784 . . . . 3.75 110.283 -168.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -113.25 130.16 56.32 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 125.848 1.659 . . . . 2.87 109.72 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.8 mt -138.45 105.51 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 123.54 0.525 . . . . 2.58 110.499 173.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 p -101.57 145.82 28.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.474 1.109 . . . . 1.19 110.914 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.411 ' CZ ' ' CE1' ' A' ' 138' ' ' PHE . 6.8 m-85 -127.1 150.11 49.63 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.305 0.642 . . . . 5.84 110.58 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -138.59 142.13 39.18 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.122 0.569 . . . . 4.8 109.822 174.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.405 HD11 ' HE2' ' A' ' 151' ' ' LYS . 2.7 mt -99.8 151.71 4.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.936 -1.135 . . . . 1.01 107.936 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -91.92 -56.5 3.06 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.001 -1.111 . . . . 4.02 108.001 177.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -144.01 157.86 44.07 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 124.959 1.304 . . . . 2.79 108.78 -171.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -112.75 143.86 43.25 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.659 1.184 . . . . 2.24 108.985 -169.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.537 HG22 ' H ' ' A' ' 125' ' ' MET . 0.8 OUTLIER -75.31 127.21 86.75 Favored Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 108.528 -0.916 . . . . 2.51 108.528 179.511 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.26 -18.13 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.13 2.553 . . . . 1.67 112.033 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.98 -46.79 64.99 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 118.983 0.811 . . . . 2.23 109.609 174.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.537 ' H ' HG22 ' A' ' 122' ' ' THR . 50.8 mtm -105.96 174.26 5.96 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.836 -1.075 . . . . 2.06 109.009 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -80.76 135.11 35.93 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.228 -1.027 . . . . 2.92 108.228 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -45.76 -52.24 11.4 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 118.673 0.669 . . . . 3.02 111.97 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -51.68 -46.87 63.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.482 -0.487 . . . . 3.87 109.731 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.43 -39.96 92.74 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.465 1.506 . . . . 1.89 111.541 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.8 t -56.04 -56.5 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.205 -1.035 . . . . 1.26 108.205 175.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.8 -22.88 61.51 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.026 -1.07 . . . . 1.73 110.312 -176.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -67.9 -49.33 62.56 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.24 1.016 . . . . 2.18 109.194 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.44 -54.74 36.69 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 123.71 0.804 . . . . 0.44 109.213 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -68.0 -34.71 68.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 120.212 -0.595 . . . . 2.33 110.356 -176.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -56.45 -60.47 3.48 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 108.191 -1.04 . . . . 4.0 108.191 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -62.65 -42.9 99.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.592 1.557 . . . . 1.45 108.78 -172.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.38 -54.16 18.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.728 0.811 . . . . 0.52 110.328 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.556 ' CE1' HG23 ' A' ' 220' ' ' ILE . 4.0 m-85 -58.84 -51.91 68.01 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 118.886 -0.578 . . . . 4.51 110.999 171.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.42 -33.5 21.06 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.745 0.646 . . . . 2.16 112.745 -174.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.762 HG12 HD21 ' A' ' 250' ' ' LEU . 77.8 t -69.21 -47.32 74.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.583 0.753 . . . . 1.11 110.468 175.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.969 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 7.1 m95 -69.78 -32.4 70.86 Favored 'General case' 0 N--CA 1.456 -0.155 0 O-C-N 120.631 -1.293 . . . . 0.84 110.638 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.47 -11.08 60.34 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.1 1.36 . . . . 1.22 110.778 176.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.63 -45.37 17.38 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 107.809 -1.182 . . . . 1.4 107.809 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.0 m -84.07 -45.64 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 112.473 0.546 . . . . 1.5 112.473 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.775 HG22 HD13 ' A' ' 258' ' ' ILE . 19.9 p -78.86 150.8 75.84 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 107.768 -1.197 . . . . 0.74 107.768 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -72.96 1.91 6.02 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 121.971 1.781 . . . . 1.09 112.678 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.1 mt -69.6 142.14 53.59 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.384 1.474 . . . . 2.05 109.274 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 103.0 12.62 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.749 -0.834 . . . . 3.81 108.749 174.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.547 ' CD2' ' HB3' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -67.96 146.3 53.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.551 0.74 . . . . 6.98 110.917 176.315 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.7 t -152.44 95.15 2.0 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.638 0.653 . . . . 0.88 111.964 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.405 ' HE2' HD11 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -76.92 133.81 39.13 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 120.583 -1.323 . . . . 3.0 108.41 171.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.4 pp -130.56 174.38 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.392 -1.707 . . . . 1.77 106.392 171.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -134.14 21.24 3.76 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 121.613 -0.679 . . . . 3.47 109.525 172.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 85.5 m -157.03 117.16 3.51 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.071 -1.455 . . . . 2.21 107.071 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 121.34 -144.63 16.72 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 108.209 -1.956 . . . . 1.95 108.209 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 33.0 mtt -110.11 139.11 45.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.982 1.313 . . . . 4.18 109.43 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -127.23 159.74 33.39 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.241 1.416 . . . . 0.99 109.809 173.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.42 -54.45 6.71 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.054 -1.462 . . . . 2.53 107.054 168.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.58 151.58 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 122.397 1.094 . . . . 1.69 111.253 -168.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.7 mt -126.08 125.01 41.87 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 112.398 -2.183 . . . . 2.25 107.876 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 38.0 t -91.87 105.43 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.934 -1.136 . . . . 0.96 107.934 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 62.2 t -110.8 102.88 14.61 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 C-N-CA 123.916 0.887 . . . . 1.79 109.237 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -80.61 155.98 26.62 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.955 -1.128 . . . . 6.57 107.955 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -158.16 -173.49 4.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.176 0.444 . . . . 1.08 110.199 167.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -129.5 145.89 51.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.296 1.039 . . . . 4.28 108.876 170.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.4 -126.24 19.15 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.354 0.978 . . . . 1.97 111.987 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.38 132.92 37.57 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.301 1.04 . . . . 2.34 109.677 -173.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' A' ' 168' ' ' HIS 0.255 0.0 OUTLIER -158.66 82.94 0.81 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 123.277 1.513 . . . . 3.41 111.193 179.266 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 80.96 -57.11 4.84 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.081 -1.208 . . . . 2.41 110.081 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.15 149.4 27.98 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.188 -1.042 . . . . 2.92 108.188 167.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.14 -55.96 5.09 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.663 1.585 . . . . 4.52 107.712 -169.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 37.8 m170 -68.96 -71.52 0.22 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.856 -1.065 . . . . 5.03 109.476 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 53.66 -111.8 0.64 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.173 -0.917 . . . . 2.22 111.234 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.407 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 39.5 t80 -92.08 156.03 17.66 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 122.434 1.111 . . . . 7.68 110.318 175.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 35.9 p30 -166.02 30.48 0.05 OUTLIER 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.774 -1.557 . . . . 3.52 110.127 -152.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 84.63 172.06 48.72 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.435 -0.666 . . . . 2.34 111.435 -172.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.94 124.99 18.45 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.631 -0.507 . . . . 3.74 109.631 167.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 97.08 -154.67 20.55 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.283 -1.127 . . . . 2.07 110.283 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 57.61 -122.94 31.11 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 109.451 -1.459 . . . . 1.8 109.451 -173.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.6 mm -75.93 128.79 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 105.961 -1.866 . . . . 1.77 105.961 168.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.3 mp -81.08 -50.67 9.36 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.008 -0.738 . . . . 1.28 109.008 172.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -161.71 163.61 29.59 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.369 0.268 . . . . 0.55 110.328 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -142.82 112.41 6.83 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.321 1.448 . . . . 1.25 113.691 -169.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -146.75 162.0 39.46 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 127.443 2.297 . . . . 0.78 107.166 -175.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.86 151.83 16.78 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.801 -0.814 . . . . 5.77 108.801 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -102.5 -84.42 1.8 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.61 1.1 . . . . 0.82 110.486 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.62 94.46 0.61 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.806 3.004 . . . . 1.3 110.625 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -163.91 154.75 25.79 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 108.412 -1.875 . . . . 0.94 108.412 170.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.7 m -78.44 170.28 16.9 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.418 -0.586 . . . . 2.44 109.418 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 72.19 -118.81 6.99 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.517 -1.433 . . . . 1.99 109.517 -175.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . 0.266 3.5 tp -84.92 21.71 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 124.304 1.041 . . . . 3.44 112.723 -168.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -55.46 143.32 35.23 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 120.891 -1.131 . . . . 1.89 114.231 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 94.04 -32.67 5.73 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.572 1.082 . . . . 0.9 111.111 -173.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.28 158.97 18.31 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.666 0.733 . . . . 1.6 109.423 -158.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -142.71 127.15 17.79 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.114 0.783 . . . . 0.82 113.114 -157.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -117.8 131.51 56.56 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 117.94 -1.029 . . . . 2.38 110.673 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -113.54 152.17 30.6 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.561 0.696 . . . . 6.33 111.556 167.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.19 85.08 0.75 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.773 -1.103 . . . . 2.79 108.529 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -60.91 -31.74 71.23 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.4 -1.438 . . . . 2.53 111.029 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -47.62 -42.3 23.86 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.304 0.573 . . . . 2.73 110.517 172.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.36 135.34 51.66 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.486 -1.301 . . . . 2.13 107.486 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -88.27 94.85 9.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.195 -1.78 . . . . 2.64 106.195 -174.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -76.12 138.05 40.5 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.663 -1.606 . . . . 1.15 106.663 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 35.9 p -118.01 124.08 47.27 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.024 -1.843 . . . . 1.77 106.024 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.1 t -51.91 -46.5 64.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 121.657 2.026 . . . . 1.89 110.452 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.92 132.67 47.19 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.229 -0.896 . . . . 2.83 109.768 167.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 11.1 p -39.82 -57.08 1.64 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.693 1.597 . . . . 3.68 110.744 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 18.95 -88.9 0.01 OUTLIER Glycine 0 CA--C 1.524 0.622 0 C-N-CA 128.564 2.983 . . . . 2.45 115.406 163.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -81.97 -80.22 0.93 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.811 -1.716 . . . . 1.03 108.811 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.3 m -150.95 111.2 4.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.048 -1.093 . . . . 1.01 108.048 170.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -61.33 117.81 6.12 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.35 0.66 . . . . 1.52 110.822 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 46.0 tp -53.69 -48.25 69.71 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 119.298 -0.382 . . . . 1.85 110.089 178.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.444 ' O ' HG23 ' A' ' 217' ' ' VAL . 31.4 t80 -49.68 -42.91 46.75 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.993 0.517 . . . . 1.45 111.152 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.44 ' C ' HD23 ' A' ' 214' ' ' LEU . 9.3 tt -60.34 -59.44 5.41 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.041 0.937 . . . . 1.33 110.32 -176.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.265 0.2 OUTLIER -61.77 -38.71 89.04 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.647 -0.252 . . . . 0.92 111.073 177.458 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.42 -56.67 16.36 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 117.954 -1.022 . . . . 0.44 109.343 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 213' ' ' PHE . 93.0 t -47.54 -42.6 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 119.996 1.271 . . . . 0.74 110.986 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.43 ' CG ' ' H4 ' ' A' ' 269' ' ' NGH . 0.2 OUTLIER -59.92 -51.06 71.29 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.119 0.567 . . . . 2.84 111.263 175.365 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -64.53 -54.71 28.01 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 121.043 -1.036 . . . . 4.15 110.845 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.556 HG23 ' CE1' ' A' ' 138' ' ' PHE . 1.7 mp -49.34 -46.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 127.041 2.137 . . . . 1.27 109.247 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -58.5 -44.84 95.17 Favored Glycine 0 CA--C 1.534 1.261 0 O-C-N 121.482 -0.761 . . . . 0.6 111.506 172.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . 0.264 6.7 m-70 -51.94 -49.06 63.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.237 1.518 . . . . 1.29 110.855 171.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.3 m -55.42 -44.9 76.7 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.48 1.112 . . . . 2.22 111.482 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 93.3 mt -59.28 -52.55 65.17 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.565 -0.531 . . . . 2.72 109.565 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.473 ' O ' HD21 ' A' ' 261' ' ' LEU . . . 139.37 92.27 0.23 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.679 1.133 . . . . 1.23 111.585 170.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 1.077 HD11 HG22 ' A' ' 258' ' ' ILE . 2.6 mt -145.96 112.46 5.89 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.242 1.021 . . . . 3.22 111.57 -171.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -79.0 43.38 2.44 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.68 1.133 . . . . 2.67 113.664 -174.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 71.6 m80 60.73 175.28 0.1 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.689 1.596 . . . . 1.93 113.79 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 69.7 m -139.84 -178.73 5.56 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.903 2.081 . . . . 1.09 108.07 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 27.7 t -143.33 31.74 1.35 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.905 0.882 . . . . 2.95 111.128 -173.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -127.92 137.3 30.5 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 106.932 -1.507 . . . . 1.65 106.932 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.97 -11.72 14.91 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.39 2.06 . . . . 1.17 114.77 -173.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 233' ' ' LYS . 25.9 mtmt -81.96 -29.12 32.34 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.916 0.886 . . . . 1.29 109.274 168.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.95 151.87 45.99 Favored 'General case' 0 CA--C 1.519 -0.229 0 O-C-N 121.883 -0.511 . . . . 0.7 109.774 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 88.4 t -98.27 -24.29 4.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.508 0.723 . . . . 0.79 109.993 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.565 ' SD ' HD13 ' A' ' 226' ' ' LEU . 0.6 OUTLIER -63.84 -15.09 58.01 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 114.029 1.122 . . . . 1.79 114.029 177.768 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -49.65 154.77 1.58 Allowed Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 113.032 0.752 . . . . 3.31 113.032 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.27 -23.05 21.32 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.473 1.449 . . . . 1.15 111.638 172.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.291 0.6 OUTLIER -79.31 -178.6 6.31 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.497 1.519 . . . . 1.47 111.084 -179.542 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -116.64 155.61 28.49 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.894 1.678 . . . . 2.36 107.026 171.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.77 125.65 7.76 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.113 -1.069 . . . . 2.26 108.113 165.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -63.37 125.69 24.98 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.066 0.946 . . . . 3.05 109.733 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 16.3 m -141.24 148.27 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 108.276 -1.009 . . . . 2.28 108.276 167.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.67 127.96 33.98 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.993 1.317 . . . . 3.63 110.239 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.7 pp -58.35 -28.52 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 122.604 0.361 . . . . 3.48 111.917 -173.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -76.6 -43.12 39.85 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 123.625 0.77 . . . . 5.47 111.942 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 91.1 m -80.55 -27.18 37.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.32 0.648 . . . . 2.56 109.628 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -26.13 113.72 0.05 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.869 2.068 . . . . 7.72 112.403 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.35 158.18 44.78 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.129 1.371 . . . . 3.79 109.078 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.762 HD21 HG12 ' A' ' 140' ' ' VAL . 1.8 mm? -83.44 146.28 28.51 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.853 -1.166 . . . . 0.96 107.853 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.0 m -79.48 152.61 30.14 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 119.705 -0.188 . . . . 0.72 111.304 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.17 -42.46 63.45 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.635 0.374 . . . . 0.79 110.857 172.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -50.0 -57.81 6.79 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 122.287 1.041 . . . . 2.7 109.681 172.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.93 -41.34 87.11 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.23 -1.35 . . . . 2.38 110.495 -176.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 80.0 mt -54.97 -40.12 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.351 1.46 . . . . 1.01 111.389 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -67.9 -44.64 76.5 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 120.694 -1.253 . . . . 4.37 110.22 174.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -46.65 -55.88 7.79 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.823 -0.911 . . . . 0.93 110.823 174.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 1.077 HG22 HD11 ' A' ' 226' ' ' LEU . 2.0 pp -64.62 -43.93 96.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 O-C-N 121.826 -0.808 . . . . 2.26 111.163 -175.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.603 ' N ' HD12 ' A' ' 258' ' ' ILE . 2.4 mt-30 -64.63 -18.41 64.9 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.628 0.649 . . . . 2.58 112.057 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.3 t -51.56 -33.11 30.97 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.738 0.699 . . . . 2.38 111.312 169.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 261' ' ' LEU . 16.2 mt -50.66 -61.77 2.0 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.218 0.917 . . . . 2.71 112.802 172.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -159.05 142.76 15.04 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.061 -1.829 . . . . 7.35 106.061 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.3 0 CA-C-O 116.459 -2.301 . . . . 9.11 108.182 167.059 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 269' ' ' NGH . . . . . 0.43 ' H4 ' ' CG ' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 107.52 -1.289 . . . . 21.17 107.52 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -168.41 87.3 0.09 OUTLIER Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.253 -1.139 . . . . 13.34 110.253 -175.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.7 147.21 62.77 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.157 1.905 . . . . 13.67 109.787 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.8 p -163.01 166.49 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 106.743 -1.577 . . . . 8.42 106.743 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 44.6 t-105 -150.18 171.4 16.97 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.655 0.782 . . . . 11.84 108.958 175.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -61.66 -28.25 69.25 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.706 0.802 . . . . 7.83 113.021 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -126.76 -63.61 1.06 Allowed 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.361 0.665 . . . . 5.65 109.91 172.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 61.56 -63.07 0.09 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.908 1.283 . . . . 4.07 111.172 -159.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -77.8 99.68 6.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.41 0.55 . . . . 3.24 111.22 -170.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.8 mm -117.08 108.02 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.726 -0.842 . . . . 1.9 108.726 174.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.509 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 40.3 p -120.03 125.05 47.39 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 117.792 -1.099 . . . . 1.21 109.3 -176.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.57 159.23 24.75 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.626 1.17 . . . . 3.86 112.24 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -133.91 149.43 51.29 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.071 0.948 . . . . 5.55 109.362 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.8 mt -107.03 137.68 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.466 1.506 . . . . 1.16 107.271 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -98.22 -45.26 6.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.989 0.359 . . . . 2.72 110.423 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -143.32 161.99 36.87 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.794 -0.817 . . . . 2.22 108.794 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -127.41 134.15 49.92 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.47 -1.678 . . . . 2.82 106.47 -165.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.7 t -70.39 115.53 35.78 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 118.797 0.726 . . . . 2.6 109.754 -173.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.99 -17.05 51.06 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 124.006 3.137 . . . . 1.61 111.719 -173.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -33.15 -41.14 0.07 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.416 2.686 . . . . 2.12 112.074 170.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -133.94 -179.88 5.82 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.1 0.96 . . . . 2.25 109.581 171.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -66.09 131.83 47.09 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.451 -0.944 . . . . 3.26 108.451 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -44.4 -45.06 8.77 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.063 0.394 . . . . 2.98 112.063 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -46.86 -47.61 21.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.553 0.692 . . . . 3.57 109.437 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.34 -39.05 78.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.434 -0.803 . . . . 2.06 111.709 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 80.7 t -58.08 -54.28 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 O-C-N 121.6 -0.687 . . . . 1.26 109.264 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.14 -25.76 67.12 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 118.02 -1.472 . . . . 1.69 109.294 177.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -66.13 -44.91 82.88 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 120.271 1.396 . . . . 1.9 110.207 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.75 -52.87 61.16 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.77 0.828 . . . . 0.39 110.048 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.67 -34.65 66.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 120.488 -0.485 . . . . 1.84 109.742 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.87 -57.01 14.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.604 1.192 . . . . 4.08 108.154 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.518 ' O ' HG23 ' A' ' 140' ' ' VAL . 6.8 mmmm -58.27 -49.01 78.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.997 -1.001 . . . . 1.66 108.765 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -44.69 -54.66 5.99 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.106 0.963 . . . . 0.52 112.52 175.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.425 ' HA ' HG21 ' A' ' 220' ' ' ILE . 2.1 p90 -62.38 -46.21 89.66 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 118.989 -1.084 . . . . 6.58 110.774 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.36 -42.31 73.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 123.316 0.385 . . . . 3.89 110.131 -173.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.629 HG12 HD21 ' A' ' 250' ' ' LEU . 1.4 t -54.01 -52.06 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 120.812 0.339 . . . . 1.34 110.088 -176.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.515 ' CZ3' ' HG ' ' A' ' 250' ' ' LEU . 67.3 m95 -71.9 -44.3 63.94 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.906 -0.775 . . . . 0.69 108.906 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.4 t -57.29 -26.78 61.4 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.985 0.514 . . . . 1.22 111.198 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -39.44 89.7 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 122.743 0.417 . . . . 1.67 110.881 175.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 81.1 t -82.88 -55.44 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.932 1.293 . . . . 2.27 109.61 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 43.6 p -84.92 150.55 55.91 Favored Pre-proline 0 N--CA 1.447 -0.577 0 C-N-CA 123.166 0.586 . . . . 0.79 109.93 -172.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.96 8.13 1.79 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 121.509 1.472 . . . . 0.85 112.949 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.69 111.95 12.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.326 1.05 . . . . 2.43 108.471 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.62 86.16 3.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.418 -1.327 . . . . 3.76 107.418 175.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -67.57 128.96 38.38 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.082 -0.963 . . . . 5.7 109.423 170.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.97 134.65 38.82 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 123.964 0.906 . . . . 0.85 110.162 172.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -92.84 127.22 38.27 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 107.605 -1.257 . . . . 2.11 107.605 173.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.7 pt -130.81 101.19 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.924 -1.139 . . . . 1.73 107.924 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -91.75 27.04 2.17 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.673 -0.642 . . . . 3.36 111.1 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.94 78.86 1.41 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.89 1.276 . . . . 2.5 110.096 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 150.32 -132.29 3.9 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 108.697 -1.761 . . . . 1.49 108.697 171.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.1 mtt -128.55 144.86 51.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.851 1.66 . . . . 5.09 107.678 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.509 ' HB1' ' O ' ' A' ' 115' ' ' THR . . . -126.52 172.66 10.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.85 1.66 . . . . 0.74 109.534 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.73 -57.38 3.7 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.089 0.956 . . . . 1.92 108.982 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.3 pt -105.17 152.6 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.154 -0.93 . . . . 1.17 108.877 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 tt -131.11 130.34 43.02 Favored 'General case' 0 CA--C 1.523 -0.075 0 N-CA-C 113.31 0.856 . . . . 2.17 113.31 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.23 102.68 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.827 -0.805 . . . . 0.83 108.827 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.2 t -93.57 131.29 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.814 2.046 . . . . 1.37 108.813 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -129.12 112.92 14.47 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 105.641 -1.985 . . . . 4.96 105.641 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -133.97 161.65 34.22 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 123.658 0.783 . . . . 0.94 110.978 -165.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.4 121.06 32.76 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.446 1.098 . . . . 6.38 110.629 -170.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 65.09 -70.49 0.08 OUTLIER Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.543 -1.143 . . . . 1.84 112.216 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.28 163.98 13.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.148 1.474 . . . . 2.42 110.62 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -154.23 -45.69 0.09 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.511 0.724 . . . . 3.1 109.887 164.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -174.67 22.51 0.06 OUTLIER Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.524 -0.598 . . . . 2.8 113.391 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.7 p30 -158.35 175.5 13.64 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.454 1.501 . . . . 2.87 107.02 167.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.88 -47.39 62.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.099 1.36 . . . . 5.81 108.554 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -54.24 -49.17 70.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.18 -0.918 . . . . 4.09 111.39 -170.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 20.06 -109.9 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.698 1.999 . . . . 2.48 114.219 171.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 2.8 t80 -121.96 161.41 22.93 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.858 1.208 . . . . 7.46 107.771 165.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.43 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 40.7 p-10 -164.32 24.46 0.07 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 113.519 -1.673 . . . . 2.73 110.002 -148.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 86.08 171.34 47.85 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 122.157 0.865 . . . . 1.44 111.79 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -72.21 100.86 2.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.658 -0.771 . . . . 4.72 109.34 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 131.13 -161.84 23.56 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.64 -1.784 . . . . 1.36 108.64 -167.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.68 -121.94 24.97 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.547 -1.421 . . . . 1.27 109.547 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.69 HD11 ' H12' ' A' ' 269' ' ' NGH 0.396 1.8 tp -78.47 140.06 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.361 -1.348 . . . . 1.7 107.361 175.439 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.41 -55.67 4.36 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.769 -0.826 . . . . 1.65 108.769 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -169.99 179.87 3.44 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.948 0.899 . . . . 0.85 110.09 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.54 143.41 51.18 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 125.955 1.702 . . . . 2.18 111.896 -176.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -161.71 159.17 26.97 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.207 -1.405 . . . . 0.77 107.207 164.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.5 143.82 15.06 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.75 -1.574 . . . . 4.17 106.75 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.08 -86.6 1.71 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.025 -1.23 . . . . 0.56 110.025 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.64 99.38 0.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.254 2.636 . . . . 1.27 110.915 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -175.39 165.11 35.85 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.064 -1.615 . . . . 0.96 109.064 172.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.68 168.7 16.04 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.164 0.586 . . . . 2.72 109.868 172.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 55.48 -105.79 0.47 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.01 0.814 . . . . 1.45 111.827 173.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.7 tp -64.2 -23.28 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.44 0.696 . . . . 1.66 111.002 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -49.4 143.34 9.74 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.854 -0.898 . . . . 0.96 110.854 170.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 84.2 -36.07 2.93 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.253 0.93 . . . . 0.61 112.358 -169.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -76.73 178.4 6.81 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.068 1.434 . . . . 1.27 110.681 -166.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -153.02 133.81 13.89 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.266 -2.494 . . . . 0.88 104.266 -165.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.457 ' CD2' ' C ' ' A' ' 196' ' ' HIS 0.315 14.3 t-80 -155.07 85.16 1.08 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 117.199 -1.8 . . . . 5.07 112.489 -133.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -103.67 147.16 27.57 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.244 1.018 . . . . 2.74 112.16 -158.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.87 81.03 0.46 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.022 1.329 . . . . 2.79 109.58 173.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -53.72 -50.04 66.78 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.068 -1.645 . . . . 3.03 111.329 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -51.0 -26.15 5.66 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.293 0.637 . . . . 3.4 111.674 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -68.43 153.06 44.49 Favored 'General case' 0 C--O 1.243 0.754 0 O-C-N 120.607 -1.308 . . . . 1.91 109.445 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -97.33 90.14 4.99 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.627 -1.99 . . . . 3.01 105.627 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -77.57 161.79 27.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.12 -1.067 . . . . 1.38 108.12 -177.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 56.7 p -132.75 141.88 48.75 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 122.088 0.946 . . . . 2.09 111.19 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.7 t -60.66 -40.32 91.63 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.607 1.563 . . . . 1.92 111.789 163.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -79.55 -177.08 5.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.607 1.163 . . . . 2.74 111.496 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 41.6 t -72.89 -50.95 20.65 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.831 0.852 . . . . 4.74 110.77 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -55.07 112.71 3.06 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.853 0.74 . . . . 2.67 112.724 -167.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 108.4 -121.28 6.23 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 107.634 -2.186 . . . . 1.78 107.634 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.7 m -119.35 130.56 55.42 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.666 -1.605 . . . . 1.24 106.666 168.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -89.48 118.9 29.47 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 109.211 -0.663 . . . . 1.26 109.211 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.98 -53.96 23.12 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 122.988 0.515 . . . . 1.54 109.808 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -54.98 -45.01 74.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.18 0.592 . . . . 2.03 110.67 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.598 ' CD2' ' H71' ' A' ' 269' ' ' NGH . 5.7 tt -62.29 -58.83 6.26 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.745 -0.597 . . . . 1.29 109.854 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.936 HG23 ' H2 ' ' A' ' 269' ' ' NGH 0.315 2.2 m -59.2 -33.13 70.6 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.522 -0.471 . . . . 0.72 110.922 178.612 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.0 -45.77 86.31 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.281 -0.887 . . . . 0.56 110.898 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 89.0 t -55.05 -48.47 75.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 120.044 1.293 . . . . 0.71 110.263 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.999 ' HD1' ' H72' ' A' ' 269' ' ' NGH . 0.3 OUTLIER -52.32 -53.06 49.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.478 1.511 . . . . 2.84 111.532 172.09 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -68.44 -53.14 25.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 119.159 0.89 . . . . 3.72 113.362 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.425 HG21 ' HA ' ' A' ' 138' ' ' PHE . 1.5 mp -56.01 -41.61 68.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 108.604 -0.887 . . . . 1.11 108.604 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.77 -48.44 78.01 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 111.289 -0.724 . . . . 0.62 111.289 173.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.406 ' CD2' ' O4 ' ' A' ' 269' ' ' NGH . 2.0 m170 -57.65 -45.72 85.12 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.295 -1.121 . . . . 2.14 111.209 175.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.7 t -54.98 -56.71 16.71 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.479 1.112 . . . . 1.77 110.94 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.6 pp -62.39 -34.69 77.22 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.323 -0.551 . . . . 2.75 111.779 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 146.35 107.79 0.53 Allowed Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.18 -1.168 . . . . 2.67 110.18 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 226' ' ' LEU . 0.9 OUTLIER -75.69 160.89 29.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 122.984 0.514 . . . . 7.11 111.923 176.587 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.22 42.69 0.84 Allowed Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.572 -1.411 . . . . 3.76 109.572 167.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -0.88 93.22 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.189 2.596 . . . . 2.22 116.139 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.8 m -74.89 171.03 14.76 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.351 0.66 . . . . 1.53 110.495 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 9.5 p -124.66 5.62 8.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.321 1.849 . . . . 3.0 111.216 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -96.75 128.0 37.42 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 125.134 1.374 . . . . 1.96 108.532 -172.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -62.55 -14.21 38.22 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.992 2.462 . . . . 1.75 113.614 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -80.11 -34.16 38.09 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.952 0.901 . . . . 2.22 110.279 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.68 136.41 39.11 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.68 -0.859 . . . . 0.76 108.68 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 45.8 t -85.55 -21.24 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 122.414 0.285 . . . . 0.59 110.345 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -21.79 59.77 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 113.945 1.091 . . . . 1.91 113.945 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.681 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -49.48 173.15 0.08 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.56 2.344 . . . . 3.32 114.533 -173.087 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.425 ' O ' ' H5 ' ' A' ' 269' ' ' NGH . 89.6 Cg_endo -90.24 -22.1 0.82 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.759 1.639 . . . . 1.36 111.685 166.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.293 0.7 OUTLIER -86.94 100.73 12.8 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.78 1.232 . . . . 2.5 110.696 -170.264 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.489 ' HA ' ' H73' ' A' ' 269' ' ' NGH 0.329 31.5 t80 -73.63 133.24 43.42 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.036 0.834 . . . . 2.3 108.992 -179.15 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.56 145.99 21.92 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.82 -1.548 . . . . 2.78 106.82 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -53.37 127.36 24.54 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.981 0.912 . . . . 3.43 111.726 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 31.7 m -98.86 146.55 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.708 0.633 . . . . 1.88 112.708 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -74.54 77.92 1.96 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.878 0.847 . . . . 5.21 111.002 175.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 17.8 mm -54.2 -22.46 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.875 -0.602 . . . . 4.12 111.498 168.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -43.57 -48.69 7.57 Favored 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 123.192 0.597 . . . . 4.23 112.115 167.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.5 m -84.71 -41.78 15.9 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.134 0.574 . . . . 2.17 110.387 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 60.0 t80 58.5 76.24 0.35 Allowed 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.614 0.766 . . . . 4.34 109.778 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.84 174.82 14.41 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 121.58 -0.7 . . . . 3.7 109.715 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.629 HD21 HG12 ' A' ' 140' ' ' VAL . 0.7 OUTLIER -116.98 163.1 16.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.028 1.331 . . . . 0.77 108.459 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 63.5 m -81.09 147.39 30.13 Favored 'General case' 0 C--O 1.225 -0.213 0 O-C-N 122.154 -0.341 . . . . 0.74 111.816 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.86 -40.24 60.24 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 122.986 0.514 . . . . 1.12 110.833 169.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -51.44 -58.46 6.2 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.095 0.95 . . . . 2.61 109.781 171.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -58.02 -45.07 87.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.96 1.304 . . . . 2.09 110.482 -173.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 63.3 mt -46.76 -38.79 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.319 1.448 . . . . 1.39 111.222 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -68.3 -46.55 70.01 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.896 0.771 . . . . 4.9 111.205 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -57.14 -55.36 30.73 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 118.788 0.722 . . . . 1.46 111.504 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.457 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 2.2 pp -61.15 -39.66 83.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 122.938 0.495 . . . . 2.81 111.426 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -70.0 -22.54 63.11 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.042 0.837 . . . . 4.0 112.282 172.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.9 t -64.73 -10.75 29.7 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.303 -1.332 . . . . 2.38 113.66 176.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.62 HD22 ' O ' ' A' ' 261' ' ' LEU 0.36 0.0 OUTLIER -44.03 91.65 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.682 1.593 . . . . 3.49 114.125 -176.621 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -105.5 54.94 0.69 Allowed 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.917 -1.115 . . . . 8.11 111.655 -170.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.112 0 N-CA-C 107.583 -2.207 . . . . 9.79 107.583 175.362 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 269' ' ' NGH . . . . . 0.999 ' H72' ' HD1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 107.705 -1.22 . . . . 11.95 107.705 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -70.12 164.65 51.86 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 118.763 0.71 . . . . 9.24 111.398 174.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -70.35 144.55 51.22 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.447 2.765 . . . . 11.89 109.507 173.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.9 124.66 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 109.131 -0.692 . . . . 7.07 109.131 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -162.53 124.75 2.73 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.89 1.276 . . . . 11.61 107.744 165.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -76.39 -35.21 58.75 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 110.133 -0.321 . . . . 7.32 110.133 169.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.14 -72.91 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.559 0.743 . . . . 5.37 110.355 -176.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 65.52 -71.39 0.08 Allowed 'General case' 0 C--N 1.341 0.225 0 C-N-CA 125.916 1.686 . . . . 3.34 110.189 -173.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -103.96 122.46 45.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.846 0.859 . . . . 5.11 110.065 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.446 ' HB ' ' CD1' ' A' ' 149' ' ' PHE . 1.5 mm -106.69 88.72 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.016 -1.105 . . . . 1.86 108.016 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 p -78.21 131.86 37.33 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.846 -1.159 . . . . 1.29 108.897 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.401 ' CE2' ' HB2' ' A' ' 151' ' ' LYS . 51.3 p90 -125.73 164.46 20.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.144 0.978 . . . . 4.18 110.614 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.21 149.61 28.15 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.636 -0.875 . . . . 6.4 108.636 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.5 mt -89.28 150.5 3.7 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 N-CA-C 108.311 -0.996 . . . . 0.95 108.311 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -81.45 -55.31 4.78 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.604 -0.887 . . . . 2.87 108.604 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -151.25 176.27 11.38 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.782 0.833 . . . . 2.02 109.31 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -106.41 146.93 29.89 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.294 1.038 . . . . 2.23 109.859 -174.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.2 t -93.25 141.19 23.68 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 124.413 1.085 . . . . 2.17 108.353 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.79 -22.12 9.19 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.044 2.496 . . . . 1.57 111.308 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -29.85 -51.57 0.13 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.976 2.11 . . . . 2.21 113.013 172.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 11.3 mtm -131.29 170.51 14.52 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.934 1.294 . . . . 1.97 108.195 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -69.91 149.5 47.74 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.086 0.554 . . . . 3.08 109.578 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 29.0 ttt-85 -49.04 -44.95 42.09 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.265 0.626 . . . . 2.85 111.496 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.55 3.47 3.05 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.737 1.014 . . . . 2.99 113.737 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -112.12 -42.05 3.82 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 125.696 1.598 . . . . 1.96 109.635 164.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.8 t -51.74 -57.58 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.113 0.965 . . . . 1.25 109.538 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -21.68 60.58 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 118.986 -1.086 . . . . 1.68 109.414 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -65.57 -47.5 75.59 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.191 0.905 . . . . 1.94 109.844 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.15 -52.65 63.58 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.533 1.133 . . . . 0.49 109.191 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.695 HD11 HD11 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -69.39 -40.97 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 120.853 -0.339 . . . . 1.45 111.191 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -49.74 -58.82 4.58 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.518 -1.289 . . . . 4.24 107.518 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.624 ' O ' HG23 ' A' ' 140' ' ' VAL . 34.8 mmtm -59.12 -49.81 76.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.334 1.454 . . . . 2.63 110.5 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.72 -49.95 45.91 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.529 0.732 . . . . 0.81 111.329 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.687 ' CE2' HD12 ' A' ' 134' ' ' ILE . 31.2 m-85 -58.55 -54.04 51.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.309 0.576 . . . . 4.83 109.91 173.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -39.88 67.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.486 -0.779 . . . . 2.11 111.156 -172.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 136' ' ' LYS . 68.5 t -48.71 -64.24 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.772 1.229 . . . . 0.95 109.852 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.768 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 72.2 m95 -68.55 -35.28 77.2 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.693 -0.854 . . . . 1.16 108.693 -174.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.1 -16.78 63.86 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 123.708 0.63 . . . . 1.19 112.199 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -82.42 -47.88 11.75 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 108.384 -0.969 . . . . 1.37 108.384 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.8 m -74.39 -43.88 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 112.635 0.606 . . . . 1.62 112.635 -177.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 51.4 p -89.34 158.01 46.77 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 109.424 -0.584 . . . . 0.8 109.424 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.87 -0.95 9.18 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.431 2.088 . . . . 0.76 113.334 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.3 mt -59.91 141.31 55.71 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.259 1.424 . . . . 2.18 109.466 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -118.75 90.54 3.35 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.201 -1.037 . . . . 4.02 108.201 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.486 ' CD1' ' CD1' ' A' ' 138' ' ' PHE . 30.9 m-85 -70.03 143.73 52.44 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.03 -0.532 . . . . 5.91 109.969 173.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -151.88 130.74 12.48 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.553 0.615 . . . . 0.99 110.619 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.401 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 4.0 ttmt -86.54 138.67 31.53 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.064 -0.717 . . . . 2.36 109.064 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.481 ' O ' HD12 ' A' ' 152' ' ' ILE . 1.8 pp -140.72 98.53 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 118.224 0.466 . . . . 2.04 110.515 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -80.2 26.73 0.35 Allowed 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.291 -1.506 . . . . 3.14 110.708 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 45.5 p -154.07 78.08 1.1 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.157 0.983 . . . . 3.4 108.565 -171.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 145.87 -122.84 1.74 Allowed Glycine 0 C--N 1.335 0.513 0 N-CA-C 108.189 -1.965 . . . . 1.91 108.189 174.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -149.71 135.07 18.25 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.573 -1.269 . . . . 5.92 107.573 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -112.43 163.01 14.95 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.36 1.464 . . . . 0.73 110.141 -175.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -79.16 -44.72 21.37 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.991 0.9 . . . . 2.02 108.856 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.7 pt -112.91 166.44 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.832 0.825 . . . . 0.96 112.04 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.76 136.57 35.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.68 1.592 . . . . 2.22 109.272 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.2 t -79.49 138.76 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 107.375 -1.342 . . . . 1.25 107.375 166.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 73.7 t -108.25 139.42 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 106.923 -1.51 . . . . 1.31 106.923 164.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.91 137.9 51.9 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.656 -1.979 . . . . 6.26 105.656 172.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -158.41 157.7 32.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.55 0.614 . . . . 1.14 109.478 165.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -104.15 119.39 38.84 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.983 -1.118 . . . . 4.71 107.983 168.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 71.77 -170.99 48.27 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.74 -0.544 . . . . 2.07 111.74 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.66 78.35 3.31 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 122.011 -0.699 . . . . 3.27 110.92 -164.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -62.88 -44.57 95.75 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.247 1.019 . . . . 3.7 113.36 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 144.39 93.13 0.16 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 107.009 -2.436 . . . . 3.33 107.009 -165.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -150.64 -179.43 7.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.333 1.053 . . . . 2.97 108.811 -173.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.77 -40.66 40.09 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.001 1.32 . . . . 8.09 108.057 168.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -96.34 -149.21 0.31 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.767 0.827 . . . . 6.94 108.973 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -142.22 151.1 41.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.93 -1.137 . . . . 4.1 107.93 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -105.03 171.55 7.26 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 124.814 1.246 . . . . 6.03 108.302 164.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -161.72 162.27 29.65 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.314 1.446 . . . . 3.33 108.684 -172.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -65.82 -156.04 0.31 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.146 0.879 . . . . 1.34 112.726 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -56.15 106.91 0.31 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.592 0.757 . . . . 4.31 111.5 -171.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.59 -146.9 18.6 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.183 -1.567 . . . . 1.78 109.183 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.53 -126.32 24.21 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 125.342 1.448 . . . . 1.6 110.913 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.2 mm -76.99 130.66 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 122.488 1.137 . . . . 1.42 108.023 173.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.1 mp -84.37 -46.27 11.9 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.725 2.01 . . . . 1.39 110.11 170.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.508 ' HB1' ' HG3' ' A' ' 219' ' ' GLU . . . -168.37 172.55 8.31 Favored 'General case' 0 C--N 1.338 0.107 0 O-C-N 121.042 -1.036 . . . . 0.9 111.402 -176.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -158.33 139.59 13.33 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.092 0.957 . . . . 1.04 111.469 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -162.59 174.38 12.69 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.763 -1.199 . . . . 0.77 107.763 -174.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.59 151.43 18.69 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.26 -1.015 . . . . 6.36 108.26 -173.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -102.31 -79.34 1.38 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.201 -1.56 . . . . 0.7 109.201 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.24 177.6 6.41 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.986 2.457 . . . . 2.27 110.51 176.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 97.2 132.11 7.29 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 109.796 -1.322 . . . . 1.56 109.796 -175.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.3 p -77.92 150.78 34.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.538 0.735 . . . . 2.36 109.472 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.46 -132.2 10.61 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 108.04 -2.024 . . . . 1.85 108.04 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . 0.254 10.7 tp -62.94 -43.21 98.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 117.955 -1.022 . . . . 3.56 110.662 -171.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 31.15 130.36 0.0 OUTLIER Glycine 0 CA--C 1.544 1.879 0 C-N-CA 130.299 3.809 . . . . 1.69 119.063 164.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 84.83 -21.73 10.74 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.093 -1.828 . . . . 0.69 111.845 -175.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -84.7 148.85 26.17 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 124.638 1.175 . . . . 1.61 110.437 -169.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.42 124.56 36.57 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.5 0.556 . . . . 0.61 112.5 -162.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -114.25 108.34 16.81 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 117.208 -1.377 . . . . 2.11 110.199 -168.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.11 147.12 23.77 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 121.761 2.073 . . . . 2.58 110.119 172.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -70.16 99.45 1.5 Allowed 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 123.585 0.553 . . . . 2.74 109.891 176.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -14.59 61.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.217 -0.897 . . . . 3.08 110.896 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -57.66 -32.05 66.93 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 121.045 1.748 . . . . 2.62 109.498 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.61 170.12 15.86 Favored 'General case' 0 C--O 1.246 0.891 0 C-N-CA 125.044 1.337 . . . . 2.31 110.292 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -117.13 100.9 8.03 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.01 -1.107 . . . . 4.3 108.01 169.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.41 ' CH2' HG21 ' A' ' 215' ' ' THR . 35.4 m95 -78.33 146.23 34.84 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.637 -1.165 . . . . 1.43 109.305 174.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.3 p -120.47 138.58 53.74 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.732 0.813 . . . . 1.84 109.667 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -50.09 -49.48 51.44 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.745 1.218 . . . . 1.73 110.059 169.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -82.26 -178.47 7.05 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.034 1.334 . . . . 2.25 111.654 175.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.1 m -54.08 -58.12 8.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.343 1.457 . . . . 3.81 110.943 -172.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 43.02 -100.49 0.02 OUTLIER Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.312 1.434 . . . . 2.45 114.409 169.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -116.71 -70.67 0.44 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.536 -1.026 . . . . 1.14 110.536 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.72 177.65 7.47 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.702 -1.962 . . . . 1.39 105.702 169.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -132.92 130.97 40.33 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.924 0.784 . . . . 1.63 111.658 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -62.4 -48.97 77.37 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 108.358 -0.979 . . . . 1.8 108.358 -174.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.723 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.5 t80 -50.63 -50.37 54.53 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.665 -0.495 . . . . 1.5 109.665 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.419 ' C ' HD23 ' A' ' 214' ' ' LEU . 7.0 tt -58.65 -58.98 6.19 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.637 1.175 . . . . 1.54 109.366 -173.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.41 HG21 ' CH2' ' A' ' 203' ' ' TRP 0.317 6.7 m -58.86 -37.52 76.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.574 0.702 . . . . 0.77 110.784 176.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.39 -43.76 96.34 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 121.367 -0.833 . . . . 0.78 110.877 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 213' ' ' PHE . 44.1 t -52.84 -44.81 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.948 1.249 . . . . 1.08 109.93 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.573 ' HD1' ' H72' ' A' ' 269' ' ' NGH . 6.4 t-160 -52.24 -58.55 6.28 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.956 1.303 . . . . 2.32 112.667 169.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.508 ' HG3' ' HB1' ' A' ' 182' ' ' ALA . 14.8 mm-40 -69.17 -33.89 74.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.93 1.085 . . . . 3.13 113.93 -174.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.695 HD11 HD11 ' A' ' 134' ' ' ILE . 0.4 OUTLIER -71.55 -37.85 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 107.282 -1.377 . . . . 1.48 107.282 175.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -52.01 -48.44 52.04 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 110.673 -0.971 . . . . 0.69 110.673 167.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.503 ' CE1' ' CD2' ' A' ' 218' ' ' HIS . 18.1 m170 -58.79 -44.75 90.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.908 -0.76 . . . . 2.87 111.265 174.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.6 t -54.0 -55.43 27.33 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.021 0.528 . . . . 1.76 111.823 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.2 pp -60.88 -33.72 73.52 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 118.697 -0.668 . . . . 3.18 112.415 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 114.57 102.99 2.48 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.105 -1.198 . . . . 1.5 110.105 172.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.48 HD11 ' CE1' ' A' ' 228' ' ' HIS . 1.8 pt? -108.3 167.17 10.21 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.088 1.144 . . . . 5.65 114.088 -175.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -113.2 11.94 24.19 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.411 1.005 . . . . 3.38 113.348 167.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.48 ' CE1' HD11 ' A' ' 226' ' ' LEU . 4.5 m80 64.53 98.87 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.904 1.682 . . . . 2.11 114.535 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.6 m -75.08 161.9 29.01 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.038 0.447 . . . . 1.3 110.44 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.1 p -122.11 11.46 10.2 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.406 1.482 . . . . 2.79 111.541 -165.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -119.25 138.57 26.48 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 125.463 1.505 . . . . 1.75 108.664 -169.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -80.81 -12.59 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.946 1.764 . . . . 1.29 114.992 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -75.23 -24.06 57.66 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 120.247 1.385 . . . . 1.45 110.128 172.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.539 ' HB1' ' CG ' ' A' ' 254' ' ' ASP . . . -71.77 167.85 19.05 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.941 1.296 . . . . 0.95 111.878 176.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.07 -26.14 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 125.668 1.587 . . . . 0.85 111.93 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.768 ' SD ' HG22 ' A' ' 258' ' ' ILE . 0.0 OUTLIER -62.9 -26.81 68.97 Favored 'General case' 0 C--O 1.245 0.818 0 O-C-N 120.54 -1.35 . . . . 2.74 112.235 176.209 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -48.22 177.1 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 130.249 3.419 . . . . 3.42 114.094 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.407 ' O ' ' O5 ' ' A' ' 269' ' ' NGH . 86.5 Cg_endo -90.09 -18.4 1.41 Allowed 'Trans proline' 0 CA--C 1.537 0.634 0 CA-C-N 122.319 1.864 . . . . 1.46 112.13 174.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.36 0.2 OUTLIER -81.22 -176.77 6.15 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.086 1.354 . . . . 1.48 110.764 -172.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.458 ' HA ' ' H73' ' A' ' 269' ' ' NGH . 91.2 t80 -113.95 150.07 34.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.341 1.456 . . . . 2.31 108.059 171.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.97 137.28 13.89 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.103 -1.073 . . . . 2.92 108.103 169.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -65.17 121.25 14.32 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.72 0.808 . . . . 2.62 110.562 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.33 135.81 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.165 0.986 . . . . 1.65 108.792 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.82 117.38 21.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.844 -0.799 . . . . 5.13 108.844 176.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.568 HG22 ' CD1' ' A' ' 213' ' ' PHE . 1.1 pp -53.03 -33.62 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 C-N-CA 122.922 0.489 . . . . 3.33 110.348 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -52.53 -36.06 54.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.092 0.957 . . . . 4.58 112.045 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 25.1 m -74.01 -48.29 31.19 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 119.17 -0.443 . . . . 2.55 109.959 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.459 ' CD1' HG22 ' A' ' 140' ' ' VAL . 0.5 OUTLIER 53.35 87.65 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.271 1.028 . . . . 4.71 110.445 -178.323 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.02 163.21 37.96 Favored 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 121.466 -0.771 . . . . 3.77 110.773 175.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.525 HD12 ' CH2' ' A' ' 141' ' ' TRP . 1.5 mm? -116.27 154.48 30.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.601 1.56 . . . . 0.84 107.836 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.2 m -79.18 152.66 30.56 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 118.012 0.369 . . . . 0.88 111.1 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -58.77 -41.78 87.42 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.762 -0.586 . . . . 1.03 111.417 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -51.53 -51.5 54.78 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.903 0.858 . . . . 2.33 108.941 171.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.539 ' CG ' ' HB1' ' A' ' 234' ' ' ALA . 1.0 OUTLIER -58.59 -47.07 85.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.8 -1.091 . . . . 2.25 111.442 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 69.2 mt -44.61 -37.6 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.676 1.19 . . . . 1.1 111.26 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -65.29 -63.2 1.16 Allowed 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.529 -0.732 . . . . 4.59 110.989 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -55.83 -46.66 82.72 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.723 -0.551 . . . . 0.99 111.723 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.768 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 2.0 pp -70.0 -28.75 37.53 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 C-N-CA 124.76 1.224 . . . . 2.85 110.503 -173.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -84.62 -24.19 29.21 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.645 1.111 . . . . 2.61 112.024 171.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 46.1 m -58.32 -33.1 69.13 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.85 0.75 . . . . 2.51 111.699 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 30.5 mt 40.38 53.26 2.94 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.336 1.854 . . . . 3.51 112.498 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -128.19 -173.86 3.06 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.108 1.363 . . . . 9.08 109.045 -172.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.551 1 CA-C-O 80.41 -22.328 . . . . 11.34 111.742 162.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 269' ' ' NGH . . . . . 0.573 ' H72' ' HD1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 108.656 -0.868 . . . . 18.55 108.656 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 179.74 63.81 0.07 OUTLIER Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.832 -0.907 . . . . 13.45 110.832 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.76 130.34 16.79 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.37 2.046 . . . . 14.57 109.613 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.6 p -155.88 154.68 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.413 -1.328 . . . . 9.31 107.413 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -147.92 -52.59 0.19 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.236 1.014 . . . . 13.05 109.612 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 54.3 33.69 18.9 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.464 0.706 . . . . 8.11 111.579 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.5 -84.81 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.224 1.41 . . . . 5.98 110.974 -174.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 66.08 -71.3 0.09 Allowed 'General case' 0 C--O 1.231 0.118 0 C-N-CA 127.01 2.124 . . . . 4.26 110.48 -177.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -116.5 118.19 31.99 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.443 1.497 . . . . 2.85 107.546 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.51 HG21 ' CE1' ' A' ' 149' ' ' PHE . 24.0 mm -115.36 154.06 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.509 -1.293 . . . . 2.71 107.509 160.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.92 133.31 13.63 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 104.509 -2.404 . . . . 2.26 104.509 -171.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -128.79 169.18 14.85 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 123.806 0.842 . . . . 4.43 111.383 -174.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -153.55 155.59 36.45 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.487 -0.931 . . . . 4.7 108.487 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -95.32 162.12 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.719 -1.586 . . . . 1.19 106.719 172.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -86.08 -48.86 8.25 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.032 -1.099 . . . . 3.4 108.032 172.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -157.25 167.47 30.25 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.359 1.064 . . . . 2.69 109.189 -170.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -112.24 173.03 6.56 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.454 1.502 . . . . 1.85 108.927 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.7 t -129.58 135.22 27.2 Favored Pre-proline 0 N--CA 1.445 -0.683 0 N-CA-C 105.83 -1.915 . . . . 2.53 105.83 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.48 -19.06 17.23 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.251 2.634 . . . . 2.1 112.085 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -37.58 -41.84 0.5 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.406 2.682 . . . . 2.57 112.604 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.5 ptp -136.39 173.56 11.58 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.991 0.917 . . . . 2.13 108.88 173.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -70.02 142.0 52.81 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.915 -0.402 . . . . 3.17 109.915 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -52.77 -47.7 67.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.118 -0.467 . . . . 2.81 111.885 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -45.23 -49.6 12.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.045 -0.724 . . . . 3.89 109.045 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.74 -40.71 92.41 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.19 0.996 . . . . 2.01 113.364 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.4 t -53.67 -54.63 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.318 -0.993 . . . . 1.19 108.318 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -37.22 83.73 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 119.121 -1.032 . . . . 1.72 108.837 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -55.6 -45.35 77.45 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 119.598 1.09 . . . . 2.12 111.753 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.18 -52.16 59.72 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 120.894 0.378 . . . . 0.42 110.415 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -72.88 -31.82 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.917 -0.583 . . . . 1.6 110.549 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -57.24 13.1 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.769 -1.567 . . . . 3.15 106.769 177.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.534 ' O ' HG23 ' A' ' 140' ' ' VAL . 11.3 mmmm -66.96 -44.53 80.31 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.427 -1.261 . . . . 1.39 109.11 -176.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.24 -53.82 25.49 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 112.483 0.549 . . . . 0.43 112.483 173.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.486 ' HA ' HG21 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -59.72 -48.37 81.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 119.019 -1.073 . . . . 6.32 108.127 177.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.47 -29.7 62.02 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.638 -0.696 . . . . 2.22 112.082 -173.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 136' ' ' LYS . 99.4 t -60.75 -66.8 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 119.02 0.827 . . . . 0.72 109.33 174.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -69.49 -43.09 73.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.465 -0.939 . . . . 0.88 108.465 -169.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.1 t -58.3 -19.01 31.3 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.777 1.231 . . . . 1.47 111.865 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -79.29 -44.42 21.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 118.206 0.457 . . . . 1.76 109.929 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.0 m -76.36 -39.92 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 111.907 0.336 . . . . 1.51 111.907 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.569 HG23 HG12 ' A' ' 258' ' ' ILE . 1.6 p -83.46 152.69 64.47 Favored Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 107.876 -1.157 . . . . 1.2 107.876 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.33 11.39 1.55 Allowed 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.117 2.545 . . . . 1.48 113.857 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.86 127.56 56.22 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.238 1.415 . . . . 2.68 110.251 -173.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.29 117.58 33.0 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.034 0.533 . . . . 3.22 110.096 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.51 ' CE1' HG21 ' A' ' 114' ' ' ILE . 3.2 m-85 -81.01 160.51 24.55 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.329 1.052 . . . . 6.12 110.772 168.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.8 t -156.7 144.86 19.55 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.466 1.506 . . . . 1.16 107.384 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -89.91 149.37 22.64 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 120.491 1.496 . . . . 2.02 108.899 173.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.9 pt -127.01 147.78 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 105.742 -1.948 . . . . 1.4 105.742 164.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -102.44 -5.41 24.11 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.898 0.479 . . . . 3.47 110.515 172.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 99.4 m -155.4 117.53 4.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.405 -1.332 . . . . 2.75 107.405 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 140.76 177.4 16.11 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 107.711 -2.156 . . . . 1.56 107.711 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.3 mmt -87.83 141.33 28.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.164 -1.05 . . . . 5.76 108.164 164.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -123.42 168.89 11.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.19 -1.411 . . . . 0.76 107.19 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -76.46 -45.21 32.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.833 -0.803 . . . . 1.65 108.833 -175.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.2 pt -113.94 176.69 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 124.617 1.167 . . . . 0.93 109.91 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.11 135.38 30.87 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.178 1.391 . . . . 2.21 109.072 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 36.5 t -93.32 108.68 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.227 -1.398 . . . . 0.77 107.227 168.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.07 107.24 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.747 1.219 . . . . 2.44 109.964 -175.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -88.4 171.68 9.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.284 -1.006 . . . . 5.82 108.284 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.575 ' HB3' ' CE2' ' A' ' 174' ' ' PHE . . . -155.62 -169.59 3.16 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.279 -1.378 . . . . 1.18 107.279 167.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 35.0 mtm180 -139.51 125.81 20.17 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.719 -0.845 . . . . 5.58 108.719 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.61 -67.88 3.07 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 125.366 1.46 . . . . 2.63 110.599 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -155.95 159.7 39.46 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.553 0.741 . . . . 2.17 109.075 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -162.68 -173.78 3.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 106.872 -1.529 . . . . 3.25 106.872 168.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.3 110.15 3.07 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 109.33 -1.508 . . . . 3.63 109.33 169.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -144.36 168.44 20.09 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.269 1.028 . . . . 4.22 109.726 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.4 -38.3 30.53 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.146 1.378 . . . . 9.53 109.398 171.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -103.73 -104.08 0.29 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.829 1.652 . . . . 7.0 108.588 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -172.37 167.35 5.71 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.398 1.479 . . . . 3.57 108.086 -176.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.575 ' CE2' ' HB3' ' A' ' 164' ' ' ALA . 8.8 m-85 -105.41 172.49 6.76 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.797 1.239 . . . . 6.34 108.11 163.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -162.98 153.8 16.83 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.122 0.969 . . . . 3.84 109.175 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -70.84 -149.61 0.59 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.59 0.614 . . . . 1.39 113.203 -174.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -54.31 109.41 0.48 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.708 1.203 . . . . 3.93 110.083 -176.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 99.49 -144.38 17.02 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.723 -1.351 . . . . 1.63 109.723 -171.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 48.26 -132.32 19.8 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.418 -1.473 . . . . 1.45 109.418 -170.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.667 ' HA ' ' O3 ' ' A' ' 269' ' ' NGH . 1.8 tp -77.72 148.51 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 118.038 0.919 . . . . 2.5 108.855 175.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . 0.5 5.4 mp -84.75 -44.98 12.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.297 1.439 . . . . 1.52 110.577 173.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -165.63 168.28 16.45 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 122.189 -0.319 . . . . 0.78 111.011 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -146.99 120.64 9.16 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 124.277 1.031 . . . . 1.13 113.782 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.509 ' HB3' ' HB2' ' A' ' 222' ' ' HIS . . . -139.07 160.96 38.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 120.656 -1.278 . . . . 0.55 107.62 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -141.65 149.6 40.85 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.351 -1.352 . . . . 3.07 107.351 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -100.84 -87.63 1.98 Allowed Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.622 -0.991 . . . . 0.66 110.622 173.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.17 84.71 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.523 2.815 . . . . 1.52 111.53 -169.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -159.24 165.21 34.24 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.234 -1.546 . . . . 1.09 109.234 170.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.0 p -79.39 172.79 13.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.752 0.821 . . . . 2.35 109.536 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.21 -105.7 0.27 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 123.865 0.745 . . . . 1.52 111.838 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.4 tp -59.65 -40.58 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 118.717 -0.659 . . . . 1.42 110.006 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -41.49 135.46 2.97 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 118.976 0.807 . . . . 0.96 112.429 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 98.87 -36.98 3.69 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.873 1.702 . . . . 0.58 111.646 -166.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -84.02 160.42 21.0 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.946 0.873 . . . . 1.24 110.34 -163.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -134.05 130.71 37.91 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.605 0.762 . . . . 0.59 111.871 -169.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -119.96 99.52 6.67 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 117.925 -1.036 . . . . 2.0 110.793 -161.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -84.73 139.11 32.22 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 121.165 1.802 . . . . 2.93 111.468 176.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.87 61.88 0.42 Allowed 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 123.687 0.617 . . . . 3.37 110.329 171.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.21 -6.37 13.42 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 120.607 -1.308 . . . . 5.23 111.997 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -27.15 -65.02 0.08 Allowed 'General case' 0 C--N 1.341 0.205 0 C-N-CA 127.851 2.46 . . . . 5.2 110.055 158.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . 0.256 2.2 pt-20 -78.72 175.5 10.38 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.308 -0.86 . . . . 1.97 110.562 -169.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -98.42 103.11 15.03 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 106.223 -1.769 . . . . 3.43 106.223 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.45 ' HH2' HG21 ' A' ' 215' ' ' THR . 28.3 m95 -78.3 134.52 37.5 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.918 -1.512 . . . . 1.49 106.918 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.1 p -132.35 75.8 1.66 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.412 -1.329 . . . . 3.2 107.412 -171.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.04 -49.31 70.63 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 123.864 0.866 . . . . 3.22 108.817 -174.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -55.48 -32.76 63.1 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.906 0.706 . . . . 4.54 112.906 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.8 t -81.47 -42.43 20.32 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.216 0.606 . . . . 6.63 110.495 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 106.02 16.57 14.83 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.92 1.247 . . . . 3.52 112.952 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.71 -84.62 0.18 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.475 -1.05 . . . . 1.81 110.475 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 61.9 m -107.79 119.85 40.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.007 -2.59 . . . . 1.32 104.007 157.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -94.84 115.26 27.26 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 124.333 1.021 . . . . 1.44 108.293 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.67 -48.66 49.37 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.453 0.701 . . . . 1.51 110.409 -177.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -47.92 -49.77 29.07 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.205 0.602 . . . . 1.54 110.955 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.1 tt -56.7 -60.24 3.84 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.144 0.978 . . . . 1.2 109.676 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.847 HG23 ' H2 ' ' A' ' 269' ' ' NGH 0.266 93.4 m -57.52 -41.98 81.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.572 -0.74 . . . . 0.9 110.692 177.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.08 -39.62 86.71 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 118.268 -0.872 . . . . 0.54 112.1 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.8 t -56.07 -57.65 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 119.842 1.201 . . . . 0.7 108.658 175.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -43.84 -53.57 5.92 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.729 0.812 . . . . 2.81 112.492 172.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -69.07 -34.66 75.5 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.264 -0.898 . . . . 2.52 113.207 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.486 HG21 ' HA ' ' A' ' 138' ' ' PHE . 4.4 mm -60.6 -47.12 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 106.955 -1.498 . . . . 2.53 106.955 173.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.58 -51.18 33.74 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 111.667 -0.573 . . . . 0.7 111.667 173.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 184' ' ' ALA . 4.3 m-70 -54.36 -49.16 70.45 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 121.483 -1.01 . . . . 1.15 111.42 176.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 14.5 t -51.57 -48.04 63.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 123.401 0.438 . . . . 1.74 111.341 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.22 -36.65 84.37 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.163 -0.615 . . . . 2.0 110.185 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 116.05 55.68 0.34 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 109.934 -1.266 . . . . 1.27 109.934 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.642 HD11 ' HA ' ' A' ' 258' ' ' ILE . 1.9 mm? -103.32 125.3 49.88 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.075 0.55 . . . . 4.06 110.475 173.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.61 139.81 47.09 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.461 -1.056 . . . . 2.66 110.461 171.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.416 ' CD2' ' HE1' ' A' ' 222' ' ' HIS . 17.7 m80 -43.69 114.17 0.61 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.537 1.535 . . . . 1.9 111.647 173.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 55.8 m -73.93 165.97 24.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.431 0.56 . . . . 1.25 109.78 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 12.4 m -128.33 39.99 3.74 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.437 1.495 . . . . 2.73 110.12 -167.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -141.4 142.35 26.27 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 106.863 -1.532 . . . . 1.75 106.863 -174.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -88.98 -14.19 2.87 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.176 1.917 . . . . 1.05 114.793 -174.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -82.1 -32.05 30.41 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.065 0.946 . . . . 1.83 109.093 172.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.73 152.62 6.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.516 0.727 . . . . 0.92 111.014 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 57.7 t -110.5 -20.38 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.254 -1.339 . . . . 0.84 110.261 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -31.61 71.59 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.462 1.028 . . . . 2.45 111.181 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -48.07 159.3 0.49 Allowed Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 127.178 2.191 . . . . 3.35 114.013 -174.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.508 ' HB2' ' H91' ' A' ' 269' ' ' NGH . 18.6 Cg_endo -71.81 -23.09 22.83 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.415 1.41 . . . . 1.53 111.884 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.355 0.2 OUTLIER -78.24 173.29 12.43 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.076 1.35 . . . . 1.5 110.219 -171.221 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.465 ' HA ' ' H4 ' ' A' ' 269' ' ' NGH . 44.4 t80 -112.17 140.76 46.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.414 -1.328 . . . . 2.39 107.414 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.6 125.59 12.82 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.461 -2.051 . . . . 2.31 105.461 172.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -53.22 130.86 35.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.166 0.986 . . . . 3.06 110.529 -176.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.53 137.22 52.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 C-N-CA 123.599 0.76 . . . . 2.07 110.365 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.85 -42.43 97.58 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.539 1.135 . . . . 3.42 111.7 171.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 6.7 mt 69.32 8.57 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 126.118 1.767 . . . . 2.58 110.851 -159.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -64.22 -53.96 41.02 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 120.597 -1.315 . . . . 3.81 111.253 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 12.1 m -81.82 -41.37 21.18 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.964 0.906 . . . . 2.27 109.872 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.469 ' CE1' HG22 ' A' ' 140' ' ' VAL . 57.3 t80 57.43 72.81 0.49 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 122.09 0.948 . . . . 4.46 109.953 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.21 162.04 37.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.955 -0.757 . . . . 2.53 108.955 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.528 HD22 ' N ' ' A' ' 250' ' ' LEU . 1.7 mm? -95.95 158.21 15.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.637 1.575 . . . . 0.84 108.281 -178.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 2.9 m -76.13 158.71 31.45 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 122.059 -0.401 . . . . 0.78 110.695 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.73 -43.74 85.52 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.568 -0.16 . . . . 1.26 110.568 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -53.25 -55.92 20.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.564 0.697 . . . . 2.65 109.492 173.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.36 -42.32 81.81 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.396 -0.82 . . . . 2.25 110.919 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.539 ' HA ' ' CG2' ' A' ' 258' ' ' ILE . 38.9 mt -55.96 -22.33 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 126.871 2.068 . . . . 1.43 111.498 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 -77.14 -55.47 5.41 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.817 -1.177 . . . . 5.5 110.273 168.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -50.7 -55.48 17.35 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.534 -1.027 . . . . 0.81 110.534 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.642 ' HA ' HD11 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -41.85 -56.26 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 C-N-CA 125.347 1.459 . . . . 3.01 111.527 175.597 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -72.98 -21.61 60.82 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.997 0.817 . . . . 2.27 110.791 -173.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.9 t -67.15 -25.49 66.19 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 118.695 -0.669 . . . . 1.95 111.553 168.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.54 ' CD2' HG22 ' A' ' 145' ' ' THR . 0.4 OUTLIER 41.67 46.51 3.22 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.934 2.094 . . . . 4.14 112.518 -174.774 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -135.71 137.18 41.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.869 0.468 . . . . 12.28 112.238 -167.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 C-N-CA 126.263 1.887 . . . . 13.61 110.037 175.53 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 269' ' ' NGH . . . . . 0.847 ' H2 ' HG23 ' A' ' 215' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 77.9 mtp . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 107.089 -1.448 . . . . 11.69 107.089 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 151.25 82.52 0.04 OUTLIER Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.471 -1.052 . . . . 8.24 110.471 -176.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.65 168.64 23.93 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.464 2.109 . . . . 9.23 110.189 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.6 p -154.91 154.05 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.243 -1.021 . . . . 5.58 108.243 -177.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -85.11 157.92 20.56 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.605 0.717 . . . . 10.97 111.555 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -60.12 -47.44 85.92 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.68 1.192 . . . . 7.75 111.476 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -158.27 -64.73 0.09 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.462 0.705 . . . . 6.35 109.191 -173.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.11 -66.96 0.09 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.218 1.807 . . . . 4.18 112.25 -175.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -79.85 107.85 12.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.159 1.384 . . . . 2.52 107.841 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.66 136.89 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 106.564 -1.643 . . . . 2.12 106.564 168.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.3 t -142.9 142.95 31.86 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 120.702 0.287 . . . . 3.12 110.713 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.553 ' CE2' HD12 ' A' ' 134' ' ' ILE . 17.8 p90 -130.17 163.84 25.78 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.507 1.123 . . . . 4.48 111.488 -170.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -145.22 142.28 29.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.934 -0.765 . . . . 4.28 108.934 173.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -83.33 152.91 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 108.499 -0.926 . . . . 1.02 108.499 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -88.22 -45.41 10.11 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.391 -0.596 . . . . 3.26 109.391 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -155.35 170.22 22.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.222 -1.029 . . . . 2.4 108.222 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.07 127.28 53.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.141 0.976 . . . . 1.93 108.916 -165.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.3 t -64.4 124.01 84.49 Favored Pre-proline 0 N--CA 1.442 -0.86 0 C-N-CA 123.941 0.897 . . . . 2.68 109.419 -176.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -69.89 -19.07 35.96 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.499 2.8 . . . . 1.95 110.138 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -36.59 -40.34 0.25 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.715 2.006 . . . . 2.78 111.808 169.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 16.2 mtm -135.76 177.29 7.95 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.255 1.422 . . . . 2.49 109.506 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -76.53 141.98 41.02 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.548 -0.72 . . . . 3.48 109.262 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 54.6 ttt-85 -41.54 -48.93 4.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.707 0.685 . . . . 2.15 112.285 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -49.39 -47.06 47.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.707 -0.479 . . . . 3.37 109.707 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -69.46 -40.71 76.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.408 1.483 . . . . 1.85 111.101 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 56.8 t -54.06 -53.82 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 120.811 -1.181 . . . . 1.17 109.555 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -25.69 65.29 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 118.77 -1.172 . . . . 1.98 110.01 178.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -63.12 -47.83 81.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.891 0.769 . . . . 1.91 109.798 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.91 -53.46 56.57 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.352 0.661 . . . . 0.38 110.498 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.587 HD11 HD11 ' A' ' 220' ' ' ILE . 0.1 OUTLIER -68.82 -41.35 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 109.284 -0.636 . . . . 2.27 109.284 -178.313 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -50.41 -58.59 5.37 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.371 -0.974 . . . . 3.34 108.371 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -60.3 -52.0 67.14 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.522 1.129 . . . . 1.44 109.249 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -46.48 -49.17 18.77 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 123.944 0.898 . . . . 0.62 112.289 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.46 ' HB3' ' CD2' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -66.02 -45.99 79.53 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.996 -0.742 . . . . 4.82 108.996 178.086 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -49.03 -42.25 37.61 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.759 0.824 . . . . 3.83 110.829 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.609 HG22 ' CD2' ' A' ' 248' ' ' PHE . 48.0 t -48.46 -61.51 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.059 0.944 . . . . 0.69 110.134 177.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -73.09 -32.5 65.02 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.423 -0.798 . . . . 0.98 109.736 -175.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 t -61.03 -17.87 54.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.932 0.493 . . . . 1.14 111.332 175.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -81.02 -45.98 15.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.839 -0.8 . . . . 2.06 108.839 -177.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.6 m -78.85 -46.28 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.412 0.685 . . . . 1.37 111.971 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.49 HG21 HD12 ' A' ' 258' ' ' ILE . 43.2 p -82.79 159.14 64.05 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.407 -0.59 . . . . 0.71 109.407 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.92 -1.8 11.84 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.764 1.643 . . . . 0.7 112.581 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.9 mp -65.34 127.37 31.47 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.59 -0.893 . . . . 2.23 108.59 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.44 96.19 6.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.921 -1.14 . . . . 4.11 107.921 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.46 ' CD2' ' HB3' ' A' ' 138' ' ' PHE . 1.4 p90 -69.12 155.48 40.31 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.347 -0.388 . . . . 6.66 111.534 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.9 t -158.85 140.19 13.19 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.016 0.826 . . . . 1.12 111.079 163.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.01 149.83 22.37 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.025 -1.102 . . . . 2.01 108.025 171.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.53 HD13 ' H ' ' A' ' 156' ' ' MET . 2.9 pp -129.75 156.9 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 106.018 -1.845 . . . . 2.2 106.018 173.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -111.7 -16.62 13.18 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.242 0.339 . . . . 3.63 110.577 172.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.9 m -107.19 78.04 1.19 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.603 0.761 . . . . 2.64 109.753 -174.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 15.06 63.59 0.01 OUTLIER Glycine 0 CA--C 1.537 1.447 0 C-N-CA 128.144 2.783 . . . . 2.64 118.286 171.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.53 ' H ' HD13 ' A' ' 152' ' ' ILE . 31.7 mtt -147.8 75.69 1.36 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.092 1.357 . . . . 7.74 107.786 166.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -124.06 155.08 38.98 Favored 'General case' 0 N--CA 1.461 0.08 0 C-N-CA 123.614 0.766 . . . . 0.96 109.598 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.23 -49.46 7.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.042 0.937 . . . . 2.19 108.691 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.9 pt -110.25 161.52 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.464 0.705 . . . . 0.97 110.511 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.14 140.02 52.91 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.434 0.693 . . . . 2.49 110.324 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.87 100.13 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.702 0.801 . . . . 0.98 109.215 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.33 93.19 4.23 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 C-N-CA 125.007 1.323 . . . . 1.36 111.05 -171.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -80.94 116.22 20.8 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.536 -1.653 . . . . 5.5 106.536 172.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -140.3 155.49 46.81 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 119.135 0.879 . . . . 0.82 109.431 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -124.38 128.51 49.18 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.821 0.849 . . . . 4.06 109.207 -164.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 48.63 -126.75 17.37 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.561 1.077 . . . . 1.84 111.948 -164.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.15 137.82 38.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.103 0.561 . . . . 1.99 109.722 -175.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.9 -36.01 0.32 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.839 0.681 . . . . 2.63 112.839 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -170.39 -50.39 0.04 OUTLIER Glycine 0 CA--C 1.521 0.437 0 N-CA-C 108.674 -1.77 . . . . 2.52 108.674 -178.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.5 157.28 30.49 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 106.732 -1.581 . . . . 2.35 106.732 172.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -77.19 -56.03 4.92 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.334 -0.987 . . . . 6.45 108.334 -172.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -69.27 -61.92 1.59 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.082 -0.963 . . . . 4.88 110.177 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 41.14 -122.36 0.49 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.353 1.461 . . . . 2.51 111.089 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 200' ' ' ASP . 48.5 t80 -90.8 151.18 21.29 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.864 0.84 . . . . 7.78 109.379 173.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -152.18 4.5 0.39 Allowed 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 126.421 1.888 . . . . 2.95 111.779 -162.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.5 -173.02 24.55 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 122.067 0.815 . . . . 1.76 112.301 -162.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 68.83 0.36 Allowed 'General case' 0 C--N 1.341 0.222 0 C-N-CA 127.32 2.248 . . . . 4.53 110.471 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.35 -157.88 27.87 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 109.329 -1.508 . . . . 1.74 109.329 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 51.14 -125.28 24.22 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 127.097 2.284 . . . . 1.54 110.263 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 4.5 mm -78.82 138.66 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.26 -1.385 . . . . 1.9 107.26 174.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.727 ' HB2' ' H1 ' ' A' ' 269' ' ' NGH 0.412 2.6 mp -84.46 -53.82 5.17 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.965 1.306 . . . . 1.32 109.527 165.452 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.06 162.26 28.66 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 122.104 -0.373 . . . . 0.66 110.132 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -144.37 121.31 11.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.995 1.318 . . . . 1.02 114.495 -173.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -143.27 166.64 24.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 127.492 2.317 . . . . 0.91 109.271 -171.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -151.78 143.25 23.48 Favored 'General case' 0 C--O 1.227 -0.09 0 N-CA-C 108.739 -0.838 . . . . 3.7 108.739 175.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -91.06 -88.62 1.39 Allowed Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.347 -1.101 . . . . 0.59 110.347 174.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.69 94.45 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.023 2.482 . . . . 1.31 111.028 -174.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -170.2 161.66 34.8 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.069 -1.613 . . . . 1.25 109.069 171.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 14.4 m -79.27 168.51 19.45 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.076 0.55 . . . . 2.64 110.642 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 54.84 -106.04 0.46 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.813 0.721 . . . . 1.87 111.596 173.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.0 tp -59.69 -40.48 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 118.831 -0.604 . . . . 1.63 109.465 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -44.79 141.4 3.78 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.123 -0.986 . . . . 1.17 112.489 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 95.23 -37.97 3.26 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.504 1.526 . . . . 0.76 111.25 -162.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -86.9 164.06 16.8 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.903 0.851 . . . . 1.17 110.33 -166.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -139.6 121.06 15.08 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.78 111.91 -172.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -110.54 132.13 54.45 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 118.203 -0.903 . . . . 2.32 109.328 -169.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -123.44 146.5 47.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.885 1.221 . . . . 2.8 110.541 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -66.02 90.51 0.14 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.803 -0.814 . . . . 2.74 108.803 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -57.31 -47.37 81.69 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 119.757 -1.839 . . . . 3.13 110.61 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 174' ' ' PHE . 1.9 t70 -51.4 -27.55 10.36 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.552 0.741 . . . . 2.87 111.285 -178.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -67.17 136.89 55.77 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.074 -1.454 . . . . 2.47 107.074 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.61 88.96 6.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.095 -1.076 . . . . 3.16 108.095 -172.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 32.8 m95 -79.23 134.49 36.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.513 -1.292 . . . . 1.19 107.513 -174.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.6 p -122.55 137.67 54.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.646 -0.872 . . . . 1.75 108.646 -176.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.5 t -50.47 -41.73 53.52 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 124.146 0.978 . . . . 1.76 111.654 172.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -86.36 -154.39 0.22 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.323 0.649 . . . . 2.85 111.706 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.4 m -66.37 -62.29 1.55 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.579 0.752 . . . . 3.69 110.474 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 39.97 -116.24 0.69 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.25 1.405 . . . . 2.53 113.787 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.03 -54.75 0.66 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.714 1.15 . . . . 1.56 110.281 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.58 179.34 6.62 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.869 -1.53 . . . . 1.1 106.869 172.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -136.89 127.63 27.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 122.942 0.497 . . . . 1.63 111.36 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 25.2 tp -59.14 -51.54 69.59 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 123.838 0.711 . . . . 2.27 110.314 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.52 ' CD1' HG22 ' A' ' 245' ' ' ILE . 6.8 t80 -50.41 -45.48 55.68 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.352 0.596 . . . . 1.45 109.654 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.7 tt -63.55 -59.1 5.07 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.588 -0.695 . . . . 1.35 110.299 -174.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.256 1.8 m -57.33 -38.94 74.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.351 -0.386 . . . . 0.95 110.541 178.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.32 -60.39 3.36 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 117.093 -1.432 . . . . 0.56 109.856 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 85.2 t -45.48 -50.64 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 121.234 1.834 . . . . 0.69 110.672 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.418 ' CD2' ' O4 ' ' A' ' 269' ' ' NGH . 26.1 t60 -57.43 -58.29 8.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.727 0.811 . . . . 2.3 112.523 175.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.26 -42.41 79.65 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.644 -1.285 . . . . 2.96 111.911 -173.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.587 HD11 HD11 ' A' ' 134' ' ' ILE . 1.0 OUTLIER -53.16 -41.1 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 123.972 0.909 . . . . 1.35 109.907 167.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.72 -51.45 38.82 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 123.845 0.736 . . . . 0.52 111.262 170.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . 0.3 20.9 m-70 -53.91 -51.52 63.48 Favored 'General case' 0 C--O 1.226 -0.177 0 O-C-N 121.638 -0.919 . . . . 1.36 109.902 172.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.5 m -52.87 -51.04 62.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.529 0.566 . . . . 1.95 112.529 -177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.49 -28.94 70.0 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 119.137 -0.458 . . . . 2.91 111.595 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 114.9 82.65 1.06 Allowed Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.474 -1.05 . . . . 1.38 110.474 172.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.544 HD13 ' SD ' ' A' ' 236' ' ' MET . 10.7 mt -134.55 142.95 47.13 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 117.622 0.711 . . . . 3.25 110.401 178.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -77.5 164.3 52.16 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.127 -1.189 . . . . 2.94 110.127 169.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -71.77 116.9 12.69 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.833 0.853 . . . . 1.86 110.158 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.5 m -76.7 175.16 9.63 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.036 0.534 . . . . 1.11 110.896 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 30.4 m -136.84 40.97 2.53 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.637 1.175 . . . . 2.23 110.762 -170.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -140.73 141.77 26.03 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.725 -1.583 . . . . 2.28 106.725 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -85.51 -12.48 6.53 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.151 1.901 . . . . 1.21 114.955 -174.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -80.66 -30.28 36.55 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.365 0.984 . . . . 1.33 109.552 173.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.443 ' HB1' ' CG ' ' A' ' 254' ' ' ASP . . . -59.27 153.82 17.8 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.963 0.905 . . . . 1.07 110.258 170.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 50.0 t -105.49 -18.77 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.389 -1.278 . . . . 0.66 109.873 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.544 ' SD ' HD13 ' A' ' 226' ' ' LEU . 7.5 tpt -76.69 -17.74 58.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.182 -0.949 . . . . 1.9 113.506 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.4 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -49.56 157.78 0.91 Allowed Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.542 1.537 . . . . 2.96 113.32 174.086 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.616 ' O ' ' H5 ' ' A' ' 269' ' ' NGH . 68.5 Cg_endo -74.92 -19.21 18.26 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.874 1.716 . . . . 0.86 111.587 177.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.371 0.2 OUTLIER -77.32 177.0 8.29 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.293 1.437 . . . . 1.19 109.834 -179.132 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -120.92 142.47 49.69 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.113 -1.44 . . . . 2.12 107.113 174.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -148.44 123.37 10.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 104.899 -2.26 . . . . 3.05 104.899 172.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -52.44 115.83 1.96 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.417 0.553 . . . . 2.86 109.552 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.4 m -108.99 126.25 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.764 -1.198 . . . . 1.57 107.764 171.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.43 108.36 3.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.966 -0.753 . . . . 3.88 108.966 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.52 HG22 ' CD1' ' A' ' 213' ' ' PHE . 1.4 pp -50.57 -32.1 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.054 0 C-N-CA 125.361 1.464 . . . . 3.36 111.182 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -50.97 -38.97 54.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.343 0.657 . . . . 3.96 111.721 175.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.9 m -68.22 -46.71 69.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.201 0.6 . . . . 2.5 109.935 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.609 ' CD2' HG22 ' A' ' 140' ' ' VAL . 9.1 t80 52.61 82.89 0.07 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.036 1.334 . . . . 5.09 110.975 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.41 167.59 27.0 Favored 'General case' 0 CA--C 1.521 -0.15 0 O-C-N 120.525 -1.359 . . . . 3.43 111.712 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 250' ' ' LEU . 1.3 mm? -111.01 156.09 21.78 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.898 1.679 . . . . 0.87 107.554 173.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.5 m -78.33 154.24 31.0 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.228 -0.286 . . . . 0.82 110.228 175.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -53.31 -45.61 69.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.622 0.369 . . . . 0.96 110.033 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -51.92 -57.18 10.18 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 122.071 0.939 . . . . 2.53 110.057 174.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.443 ' CG ' ' HB1' ' A' ' 234' ' ' ALA . 3.4 m-20 -58.26 -40.43 81.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.631 -1.168 . . . . 2.3 111.379 -177.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 45.8 mt -57.69 -47.31 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.656 0.782 . . . . 0.83 110.051 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 32.5 mtt180 -59.92 -43.52 94.86 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 120.683 -1.26 . . . . 5.01 110.144 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -48.26 -46.29 27.97 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.024 -0.831 . . . . 0.89 111.024 170.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.49 HD12 HG21 ' A' ' 145' ' ' THR . 0.1 OUTLIER -67.73 -47.88 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 O-C-N 121.776 -0.838 . . . . 3.19 110.905 -176.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -63.03 -27.28 69.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.362 -0.935 . . . . 2.91 110.582 -175.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 11.9 m -51.41 -19.66 1.46 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.987 1.106 . . . . 2.45 113.987 171.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 18.5 mt -34.68 -56.76 0.54 Allowed 'General case' 0 C--N 1.349 0.568 0 CA-C-N 120.601 1.546 . . . . 2.55 113.439 164.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -171.66 82.29 0.07 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.331 0.514 . . . . 6.31 110.656 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.407 0 N-CA-C 106.274 -2.73 . . . . 8.2 106.274 178.36 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 269' ' ' NGH . . . . . 0.727 ' H1 ' ' HB2' ' A' ' 181' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 59.8 mtt . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 106.689 -1.597 . . . . 13.55 106.689 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.48 -157.24 37.64 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 111.216 -0.754 . . . . 7.47 111.216 -174.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.93 122.57 9.7 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.958 2.438 . . . . 9.56 109.913 -173.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.64 152.95 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.052 -1.092 . . . . 5.5 108.052 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -83.92 167.39 17.02 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.754 0.822 . . . . 10.21 110.978 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -82.68 -35.5 26.76 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.429 0.692 . . . . 8.32 112.053 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.44 -62.13 0.14 Allowed 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.672 -0.643 . . . . 5.01 110.021 -177.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 27.6 m170 61.0 -69.48 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.921 1.289 . . . . 4.25 111.353 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -79.91 91.29 5.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 119.046 0.839 . . . . 2.52 110.545 -176.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.425 HD12 ' N ' ' A' ' 114' ' ' ILE . 2.0 mp -91.8 88.2 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 107.278 -1.378 . . . . 2.57 107.278 173.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.2 p -81.39 120.09 24.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.262 -1.384 . . . . 1.4 107.262 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -128.69 171.7 11.94 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 119.219 0.918 . . . . 4.38 110.688 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -157.37 176.65 12.39 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.636 -0.665 . . . . 4.22 109.829 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.8 mm -109.4 162.96 6.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.184 1.393 . . . . 1.76 108.332 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -102.57 -62.87 1.22 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.342 0.657 . . . . 3.0 109.975 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -144.02 159.72 42.11 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.961 1.305 . . . . 2.02 107.595 176.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -111.67 127.31 55.73 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.218 -1.401 . . . . 2.26 107.218 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.76 130.53 94.83 Favored Pre-proline 0 N--CA 1.444 -0.732 0 C-N-CA 124.05 0.94 . . . . 4.09 109.842 -177.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -70.04 -27.06 25.61 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.771 2.314 . . . . 2.59 109.995 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.8 -28.71 69.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.527 1.131 . . . . 3.61 111.368 171.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 35.9 mmt -102.23 179.88 4.18 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.116 0.871 . . . . 4.02 109.457 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -105.23 113.72 27.48 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 108.11 -1.07 . . . . 3.48 108.11 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.48 -59.98 2.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.534 1.061 . . . . 2.38 112.931 -176.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -49.26 -43.6 43.03 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 108.851 -0.796 . . . . 2.78 108.851 -174.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -66.61 -42.96 86.04 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.9 1.28 . . . . 1.67 112.571 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.2 t -58.48 -54.2 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 O-C-N 120.842 -1.161 . . . . 1.55 108.798 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.428 ' OD2' ' NZ ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -62.92 -45.78 90.89 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.281 -1.007 . . . . 2.14 108.281 178.535 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -53.3 -44.67 68.53 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.018 0.927 . . . . 3.05 110.963 -176.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.25 -49.22 69.99 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 122.697 0.399 . . . . 0.58 110.608 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.503 ' CD1' HD11 ' A' ' 220' ' ' ILE . 0.3 OUTLIER -71.07 -31.17 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 120.874 0.369 . . . . 1.84 110.315 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -62.23 -53.6 52.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.724 1.609 . . . . 3.38 107.009 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -70.0 -44.8 68.62 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.886 1.674 . . . . 1.31 109.863 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.473 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -47.34 -52.25 17.04 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.836 0.35 . . . . 0.57 111.09 170.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.548 ' HB3' ' CD2' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -57.66 -56.46 21.64 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.951 -0.759 . . . . 4.44 108.951 177.692 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.78 -49.43 38.65 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.926 1.29 . . . . 3.11 110.98 -173.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.66 HG12 HD21 ' A' ' 250' ' ' LEU . 54.0 t -51.14 -50.66 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.425 1.09 . . . . 1.11 109.773 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.438 ' HB3' HD11 ' A' ' 224' ' ' LEU . 16.7 m95 -73.77 -32.33 63.74 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.693 -0.63 . . . . 1.18 110.369 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.32 -7.29 41.5 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.206 1.402 . . . . 1.1 111.283 175.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.61 -51.02 5.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.373 -0.973 . . . . 1.55 108.373 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.8 m -68.99 -41.4 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 111.969 0.359 . . . . 1.45 111.969 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.2 p -87.2 160.27 49.13 Favored Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 108.9 -0.778 . . . . 1.01 108.9 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -73.51 2.86 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 121.889 1.726 . . . . 0.94 112.325 170.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.404 HD12 HD13 ' A' ' 224' ' ' LEU . 35.0 mt -68.54 154.92 40.95 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.254 -0.904 . . . . 2.06 110.817 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 99.23 5.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.836 1.654 . . . . 5.19 109.611 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.548 ' CD2' ' HB3' ' A' ' 138' ' ' PHE . 1.7 p90 -63.51 152.5 38.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.741 -0.663 . . . . 7.15 112.007 170.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.6 t -155.11 117.68 4.28 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.698 -0.668 . . . . 0.85 111.06 173.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.428 ' NZ ' ' OD2' ' A' ' 131' ' ' ASP . 6.0 ttmt -81.59 131.02 35.26 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 119.514 1.052 . . . . 2.52 109.563 175.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.24 88.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 122.001 0.905 . . . . 1.97 109.411 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -87.13 33.27 0.67 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.599 0.76 . . . . 2.94 110.424 176.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.1 p -149.62 77.97 1.35 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.094 1.358 . . . . 2.32 108.982 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 147.71 -120.39 1.22 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.571 -1.411 . . . . 1.53 109.571 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 27.5 mtp -139.53 136.03 34.07 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 127.147 2.179 . . . . 4.13 106.352 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.83 165.86 18.54 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.696 1.198 . . . . 0.64 109.598 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -73.59 -53.0 11.52 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.159 0.984 . . . . 2.24 108.4 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.2 pt -119.69 147.76 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.669 -0.696 . . . . 1.11 111.224 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.4 tt -122.95 133.13 54.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.014 1.326 . . . . 2.54 109.142 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.43 HG13 ' CE1' ' A' ' 197' ' ' PHE . 4.7 t -81.19 101.02 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.571 1.148 . . . . 1.0 108.535 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.8 t -78.9 111.75 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.784 -0.821 . . . . 1.25 108.784 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -99.0 118.32 35.51 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.203 -1.777 . . . . 5.06 106.203 166.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -143.78 161.42 38.66 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.972 -1.121 . . . . 0.92 107.972 -176.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -122.99 142.39 50.89 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.335 -1.358 . . . . 3.93 107.335 172.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.497 ' HA2' ' CD1' ' A' ' 174' ' ' PHE . . . 83.98 174.73 50.54 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.982 -0.447 . . . . 2.0 111.982 170.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.14 77.75 3.68 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.915 -0.756 . . . . 3.34 109.9 -170.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -73.15 68.77 1.01 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.696 0.798 . . . . 2.64 112.269 -175.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 80.77 -36.65 2.29 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 121.442 -0.787 . . . . 3.34 111.618 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -71.25 139.73 50.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.452 -1.684 . . . . 2.9 106.452 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -76.14 -66.72 0.76 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.832 -1.544 . . . . 5.63 106.832 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -98.17 101.73 13.28 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.025 -1.102 . . . . 5.83 108.025 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -156.42 -73.65 0.1 Allowed 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 122.657 0.383 . . . . 2.68 110.145 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.512 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -83.95 170.72 13.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.677 -1.231 . . . . 7.65 107.677 178.147 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.512 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 9.2 p30 175.39 33.14 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.906 1.282 . . . . 2.35 112.879 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 53.15 -156.84 4.94 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 120.984 -1.073 . . . . 1.39 111.543 -172.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -76.3 62.14 1.75 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.833 0.853 . . . . 4.25 112.567 -175.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -162.17 -154.8 7.69 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 107.839 -2.104 . . . . 1.68 107.839 168.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 35.81 -113.6 0.15 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 127.966 2.698 . . . . 1.36 112.219 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.688 HD13 H142 ' A' ' 269' ' ' NGH . 1.1 mm -79.58 139.47 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 118.126 0.963 . . . . 1.84 109.001 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.625 ' HB2' ' H5 ' ' A' ' 269' ' ' NGH . 1.5 mp -80.52 -59.9 2.52 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.983 -1.117 . . . . 1.16 107.983 170.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -163.51 159.77 22.41 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.761 -0.459 . . . . 0.86 109.761 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -146.55 117.15 7.54 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.264 1.426 . . . . 1.17 113.666 -166.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -136.37 159.47 41.67 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.004 1.722 . . . . 0.73 109.208 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -148.65 144.03 26.9 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.953 -1.499 . . . . 2.76 106.953 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -93.01 -89.99 1.55 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.166 0.888 . . . . 0.8 110.916 173.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.28 97.91 0.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.799 2.333 . . . . 1.3 110.962 -175.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -169.01 161.68 35.38 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 108.24 -1.944 . . . . 1.16 108.24 171.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.4 t -80.96 178.38 8.45 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.509 0.654 . . . . 3.35 110.466 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 46.24 -109.8 0.41 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.643 1.116 . . . . 1.42 111.314 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.7 tp -59.87 -42.25 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 118.169 -0.92 . . . . 1.62 109.826 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -38.6 128.97 1.85 Allowed Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.805 1.193 . . . . 1.09 112.664 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 108.86 -50.83 0.75 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.366 1.936 . . . . 0.72 109.686 -162.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.24 148.02 28.62 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.398 1.079 . . . . 2.61 110.481 -166.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -117.95 121.43 40.67 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.498 1.119 . . . . 0.6 111.248 -170.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -111.54 122.7 48.53 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 118.512 0.597 . . . . 2.24 111.381 -168.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.43 ' CE1' HG13 ' A' ' 161' ' ' VAL . 5.4 m-85 -111.06 136.16 50.5 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.973 -1.121 . . . . 2.64 107.973 -178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -67.0 93.55 0.28 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.476 -1.675 . . . . 2.85 106.476 172.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -39.12 82.86 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.688 1.131 . . . . 3.41 109.193 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -34.66 -48.87 0.39 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 127.092 2.157 . . . . 2.97 110.543 -167.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -61.13 179.7 0.18 Allowed 'General case' 0 C--O 1.24 0.597 0 C-N-CA 126.167 1.787 . . . . 4.67 112.283 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -115.52 87.14 2.6 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 105.538 -2.023 . . . . 2.9 105.538 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -75.67 163.32 27.43 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.93 -1.032 . . . . 1.13 108.276 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.8 p -129.22 144.15 51.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.38 -0.971 . . . . 1.77 108.38 174.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . 0.258 6.3 t -61.31 -40.47 94.29 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 126.113 1.765 . . . . 2.21 112.414 165.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -96.37 -172.44 2.53 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.406 1.082 . . . . 2.47 108.365 177.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.3 m -47.53 -65.7 0.52 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.785 2.034 . . . . 3.88 110.594 -173.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 45.77 -104.49 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 125.896 1.712 . . . . 2.17 114.364 165.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -112.38 -81.48 1.12 Allowed Glycine 0 C--N 1.335 0.495 0 N-CA-C 109.677 -1.369 . . . . 1.56 109.677 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.3 m -115.79 123.3 47.88 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.654 -1.98 . . . . 0.91 105.654 167.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -74.79 111.97 10.53 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.839 -0.8 . . . . 2.73 108.839 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.01 -54.41 24.78 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.057 0.844 . . . . 1.74 110.585 -175.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.56 ' O ' HG23 ' A' ' 217' ' ' VAL . 1.8 t80 -44.77 -43.86 8.88 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.77 1.228 . . . . 1.89 111.352 177.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.93 -64.74 0.84 Allowed 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.929 -0.482 . . . . 1.25 109.942 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.829 HG23 ' H4 ' ' A' ' 269' ' ' NGH 0.324 3.4 m -53.89 -43.37 69.59 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.377 0.608 . . . . 0.89 110.701 -178.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.45 -42.73 54.61 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.918 -0.583 . . . . 0.47 111.793 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.588 HG21 ' CE2' ' A' ' 248' ' ' PHE . 83.9 t -62.65 -42.78 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 119.699 1.136 . . . . 0.69 111.339 -177.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.493 ' CD2' ' O4 ' ' A' ' 269' ' ' NGH . 5.8 t60 -55.33 -47.33 75.83 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.977 0.911 . . . . 2.59 109.456 174.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -76.13 -32.75 59.29 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 114.257 1.206 . . . . 3.49 114.257 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.503 HD11 ' CD1' ' A' ' 134' ' ' ILE . 4.7 mm -58.0 -50.85 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 106.886 -1.524 . . . . 2.38 106.886 171.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.76 -45.46 48.68 Favored Glycine 0 CA--C 1.537 1.436 0 N-CA-C 111.931 -0.468 . . . . 0.83 111.931 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -55.08 -50.56 68.87 Favored 'General case' 0 C--O 1.226 -0.18 0 O-C-N 121.569 -0.959 . . . . 1.27 110.335 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 1.5 t -52.21 -49.63 63.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.482 0.713 . . . . 2.05 111.377 176.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 141' ' ' TRP . 10.2 mt -60.1 -45.65 92.24 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.374 0.534 . . . . 2.18 109.721 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 134.48 38.99 0.19 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 123.812 0.72 . . . . 1.31 112.608 168.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.06 116.73 24.45 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.132 0.966 . . . . 3.48 110.156 174.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.42 52.51 4.36 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.301 -0.722 . . . . 2.85 113.151 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 72.5 m80 66.28 161.85 0.15 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.28 1.432 . . . . 1.91 113.022 -175.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 74.1 m -131.73 -178.51 4.91 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.872 1.669 . . . . 1.12 109.431 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 7.4 p -146.79 16.03 1.24 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.991 1.316 . . . . 2.64 111.006 -165.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -115.79 138.52 24.01 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 106.878 -1.527 . . . . 2.51 106.878 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.92 -17.49 10.78 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.923 1.749 . . . . 1.76 114.182 -172.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.405 ' HE3' ' HB2' ' A' ' 233' ' ' LYS . 14.6 mtmt -83.65 -28.35 28.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.94 0.791 . . . . 1.69 109.852 173.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.21 147.69 39.05 Favored 'General case' 0 C--O 1.225 -0.19 0 O-C-N 121.902 -0.499 . . . . 0.76 110.792 173.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 71.2 t -92.97 -23.5 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.724 1.21 . . . . 0.62 109.72 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 16.9 tpp -70.05 -14.68 62.79 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.471 1.108 . . . . 2.7 113.411 177.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.406 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -51.33 147.02 10.83 Favored Pre-proline 0 CA--C 1.539 0.545 0 O-C-N 121.378 -0.826 . . . . 3.02 112.944 177.509 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.92 -16.2 29.33 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.317 2.011 . . . . 1.3 111.631 174.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.509 ' O ' ' H2 ' ' A' ' 269' ' ' NGH 0.301 0.1 OUTLIER -76.35 169.13 18.8 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.2 -1.037 . . . . 1.62 108.2 171.783 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -128.01 146.98 50.49 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 104.808 -2.293 . . . . 2.0 104.808 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.23 144.18 20.78 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.476 -1.305 . . . . 2.4 107.476 171.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -62.9 144.35 56.79 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.977 0.911 . . . . 2.26 111.051 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.486 HG21 ' CD1' ' A' ' 248' ' ' PHE . 17.4 m -131.85 154.35 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.555 0.742 . . . . 1.91 110.672 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.18 -16.23 59.45 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.993 1.717 . . . . 3.5 114.334 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . 0.25 14.0 mm 72.21 -41.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 128.019 2.527 . . . . 3.33 111.085 -176.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -78.99 -51.81 9.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.878 0.871 . . . . 3.42 111.197 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 47.5 m -78.46 -18.07 55.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.482 1.113 . . . . 2.66 110.652 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.588 ' CE2' HG21 ' A' ' 217' ' ' VAL . 87.7 t80 -39.3 110.82 0.15 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.531 1.532 . . . . 7.89 112.11 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.02 163.88 31.59 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.448 1.099 . . . . 3.36 109.906 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.66 HD21 HG12 ' A' ' 140' ' ' VAL . 1.2 mm? -81.08 137.42 36.0 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.831 -1.174 . . . . 1.1 107.831 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.7 m -77.41 160.66 28.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.651 0.262 . . . . 0.71 110.816 -175.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.76 -48.35 78.04 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 110.059 -0.348 . . . . 0.88 110.059 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -48.31 -51.88 24.04 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.765 0.793 . . . . 2.6 109.96 172.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.97 -47.52 80.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.079 -1.419 . . . . 2.2 109.09 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.5 mt -59.86 -47.46 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.816 1.646 . . . . 0.93 111.226 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -60.08 -44.27 94.89 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.346 -1.471 . . . . 4.63 109.858 175.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -49.62 -42.59 36.02 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.937 -0.865 . . . . 0.8 110.937 170.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 258' ' ' ILE . 0.2 OUTLIER -68.58 -47.04 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 117.826 0.813 . . . . 3.45 110.561 -177.247 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -68.16 -15.95 63.79 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 119.701 -0.8 . . . . 2.63 110.849 -178.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.14 -17.69 3.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.755 0.822 . . . . 2.04 112.873 165.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 56.7 mt -56.19 74.1 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 120.076 1.307 . . . . 2.54 111.753 161.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -170.16 110.33 0.4 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.954 2.902 . . . . 6.85 107.312 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.781 0 N-CA-C 108.248 -1.941 . . . . 8.8 108.248 -167.057 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 269' ' ' NGH . . . . . 0.829 ' H4 ' HG23 ' A' ' 215' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 108.009 -1.108 . . . . 13.65 108.009 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 138.33 -166.23 25.29 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.566 -1.414 . . . . 9.58 109.566 -175.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.02 161.98 43.58 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.113 2.542 . . . . 11.98 110.81 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.8 p -158.94 153.27 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 108.122 -1.066 . . . . 6.72 108.122 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -178.05 173.82 1.45 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.298 2.239 . . . . 12.73 105.558 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 -176.4 82.74 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.406 1.883 . . . . 8.2 106.26 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.487 ' HG3' HD11 ' A' ' 114' ' ' ILE . 3.1 mptt 65.86 -80.12 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.898 1.279 . . . . 6.18 111.297 -172.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 60.34 -80.27 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.586 1.555 . . . . 3.46 109.407 -165.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.44 ' O ' HD13 ' A' ' 114' ' ' ILE . 59.9 m-85 -114.81 111.84 21.85 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.461 1.105 . . . . 3.14 111.499 -168.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.546 HG22 ' CE1' ' A' ' 116' ' ' TYR . 18.0 mm -128.52 103.87 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.926 0.87 . . . . 2.69 112.157 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -86.91 140.98 29.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.25 2.22 . . . . 1.22 109.49 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.546 ' CE1' HG22 ' A' ' 114' ' ' ILE . 10.3 m-85 -124.47 167.78 13.96 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.579 1.151 . . . . 6.25 110.84 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -149.52 149.55 30.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.802 1.241 . . . . 7.53 109.608 176.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.4 mt -102.68 155.69 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.656 -1.239 . . . . 0.92 107.656 173.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -97.57 -44.56 6.75 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.11 0.564 . . . . 2.94 110.156 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -149.03 164.85 33.42 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.865 0.466 . . . . 2.25 110.149 174.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -111.15 127.97 55.75 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.149 1.38 . . . . 1.8 107.574 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.1 t -60.46 136.84 92.2 Favored Pre-proline 0 N--CA 1.442 -0.829 0 C-N-CA 122.931 0.492 . . . . 2.24 109.742 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.22 -18.64 14.08 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.16 2.573 . . . . 1.58 111.009 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -40.41 -46.58 2.42 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.622 1.569 . . . . 2.0 111.452 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -128.24 176.33 7.76 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.544 1.538 . . . . 2.63 109.253 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -73.86 143.42 45.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.285 0.634 . . . . 3.04 110.452 174.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.3 ttt-85 -47.19 -45.0 22.71 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.475 0.71 . . . . 2.84 111.512 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.63 -10.04 11.01 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.023 0.929 . . . . 4.2 112.997 -177.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -100.03 -45.11 5.78 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.387 1.475 . . . . 2.17 110.434 168.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 73.9 t -53.41 -54.94 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 123.991 0.916 . . . . 1.25 109.511 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.407 ' HB3' ' NZ ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -71.75 -25.53 62.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 117.447 -1.701 . . . . 1.94 109.81 178.429 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -59.11 -48.17 82.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.422 1.01 . . . . 2.21 109.042 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.27 -52.7 51.25 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 116.21 -0.45 . . . . 0.41 111.486 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -36.57 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.663 0.744 . . . . 1.67 110.131 -173.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.7 ttm-85 -55.57 -54.87 38.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.479 1.112 . . . . 3.94 108.276 173.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.573 ' O ' HG23 ' A' ' 140' ' ' VAL . 12.4 mmmm -66.34 -41.11 90.06 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.431 0.692 . . . . 1.27 109.658 -176.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -47.12 -54.46 10.47 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 118.551 0.614 . . . . 0.48 110.686 169.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.757 ' CD1' HG23 ' A' ' 220' ' ' ILE . 34.5 m-85 -59.81 -42.67 93.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.476 -0.49 . . . . 4.42 111.588 176.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -50.28 -39.85 46.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.393 0.677 . . . . 2.98 110.515 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 136' ' ' LYS . 44.6 t -61.0 -56.24 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.131 -0.692 . . . . 0.77 109.131 -176.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.4 ' CH2' ' HG ' ' A' ' 250' ' ' LEU . 26.8 m95 -75.24 -35.21 61.44 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 122.054 -0.404 . . . . 0.84 110.585 -173.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 89.0 p -70.7 -15.53 62.71 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.359 0.503 . . . . 2.28 112.359 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.13 -48.39 11.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.549 -1.278 . . . . 1.57 107.549 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 26.7 m -75.64 -40.42 40.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 113.191 0.811 . . . . 1.6 113.191 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 31.7 p -100.06 140.71 21.71 Favored Pre-proline 0 N--CA 1.447 -0.624 0 N-CA-C 108.466 -0.939 . . . . 0.87 108.466 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.33 12.03 0.89 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.241 2.627 . . . . 0.99 113.637 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.2 mt -70.09 115.52 9.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.58 1.152 . . . . 2.02 108.845 -175.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -82.53 89.79 6.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 122.445 1.117 . . . . 4.6 108.282 -172.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.18 146.1 48.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.738 -2.028 . . . . 6.38 109.299 170.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.6 t -151.19 147.31 26.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.881 -1.526 . . . . 1.08 106.881 165.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.407 ' NZ ' ' HB3' ' A' ' 131' ' ' ASP . 2.5 tmmt? -125.64 129.75 50.24 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 107.363 -1.347 . . . . 1.96 107.363 175.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.6 pp -133.75 170.69 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 105.952 -1.87 . . . . 1.5 105.952 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -142.63 27.37 1.69 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.798 0.726 . . . . 4.39 109.094 169.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 58.2 p -150.72 78.46 1.31 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.401 1.08 . . . . 2.66 108.531 -172.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.15 -128.08 2.76 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 108.028 -2.029 . . . . 1.54 108.028 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.0 mtt -126.43 148.81 49.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.407 1.083 . . . . 4.13 109.552 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -141.42 160.65 39.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.137 1.375 . . . . 0.69 109.299 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -80.86 -58.91 2.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.636 1.974 . . . . 1.98 107.786 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -91.02 179.04 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 122.035 0.921 . . . . 1.37 111.243 176.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 tt -138.75 127.61 23.66 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.495 2.318 . . . . 2.24 109.094 167.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 20.6 t -86.26 105.73 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.702 -1.221 . . . . 0.75 107.702 170.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.3 t -81.56 140.31 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 107.43 -1.322 . . . . 1.32 107.43 170.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.29 90.32 2.41 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.568 -2.012 . . . . 4.94 105.568 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.42 158.83 39.76 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.068 0.547 . . . . 0.78 109.988 -165.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 14.0 ptt-85 -124.0 115.57 21.43 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.837 0.855 . . . . 4.65 109.935 -162.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 60.48 -97.65 0.12 Allowed Glycine 0 CA--C 1.535 1.328 0 C-N-CA 123.335 0.493 . . . . 1.6 112.292 -175.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.39 135.8 35.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.785 0.834 . . . . 2.83 109.06 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -153.2 -52.95 0.11 Allowed 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 111.621 0.23 . . . . 3.64 111.621 176.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 143.21 78.38 0.04 OUTLIER Glycine 0 C--N 1.334 0.445 0 N-CA-C 107.278 -2.329 . . . . 2.9 107.278 -173.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -158.69 169.06 25.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.218 -1.03 . . . . 2.21 108.218 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -81.8 -40.94 21.82 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.858 1.263 . . . . 5.73 109.372 174.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -85.51 -22.8 28.02 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.418 0.687 . . . . 4.98 110.714 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 60.78 -171.06 0.14 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.984 1.314 . . . . 3.1 111.113 -173.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -109.24 -179.28 3.79 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 106.917 -1.512 . . . . 6.2 106.917 159.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -143.74 -168.16 2.77 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.539 1.936 . . . . 3.99 106.149 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -90.34 -141.64 9.18 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.952 -0.859 . . . . 1.7 110.952 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.63 114.85 2.69 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.935 -0.765 . . . . 7.49 108.935 169.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.92 -155.94 16.21 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.083 -1.207 . . . . 1.96 110.083 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.28 -119.44 11.95 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 109.946 -1.262 . . . . 1.88 109.946 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.415 HG12 ' H12' ' A' ' 269' ' ' NGH 0.339 2.2 mt -90.58 137.27 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 107.129 -1.434 . . . . 2.0 107.129 -179.364 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.423 HD23 ' H1 ' ' A' ' 269' ' ' NGH . 2.9 mm? -85.68 -56.85 3.3 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.12 1.368 . . . . 2.18 109.856 166.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -156.07 162.17 40.31 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 121.129 -0.982 . . . . 0.86 112.322 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.452 ' HA ' ' HN1' ' A' ' 269' ' ' NGH . 26.9 p-80 -145.15 116.07 7.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.36 1.464 . . . . 0.93 114.265 176.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.77 159.04 40.9 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.951 2.1 . . . . 0.84 108.308 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -144.42 148.21 34.33 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.965 -1.494 . . . . 3.47 106.965 172.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -98.81 -82.34 1.66 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.851 -0.9 . . . . 1.13 110.851 170.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.97 92.71 0.71 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.396 2.73 . . . . 2.34 110.551 -172.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -175.39 157.38 23.94 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 108.661 -1.776 . . . . 2.04 108.661 171.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.3 m -77.54 157.62 30.27 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.11 -0.7 . . . . 2.96 109.11 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.89 -110.69 3.11 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.931 -0.868 . . . . 2.39 110.931 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.452 HG12 ' CE1' ' A' ' 196' ' ' HIS . 5.1 tp -63.03 -42.28 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 O-C-N 121.468 -1.019 . . . . 2.25 109.632 -170.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -30.75 129.56 0.16 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 126.252 1.882 . . . . 1.74 113.814 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 103.78 -52.75 0.75 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.465 1.983 . . . . 0.85 109.757 -164.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -84.09 160.61 20.89 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.054 0.942 . . . . 1.98 111.314 -167.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -138.91 124.52 19.53 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 118.136 -0.935 . . . . 0.65 111.56 -172.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.452 ' CE1' HG12 ' A' ' 191' ' ' ILE . 1.0 OUTLIER -112.38 127.21 55.95 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-O 117.721 -1.133 . . . . 2.07 109.244 -173.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -114.2 151.44 32.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.202 1.365 . . . . 2.87 110.947 174.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -73.83 101.34 3.71 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.417 -0.811 . . . . 3.43 109.964 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.36 -29.67 70.93 Favored 'General case' 0 C--O 1.24 0.596 0 O-C-N 121.485 -0.76 . . . . 2.5 111.147 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -59.44 -31.9 69.72 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.393 0.997 . . . . 3.11 109.344 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -68.03 150.51 48.35 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 122.107 0.956 . . . . 2.83 108.884 -176.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -102.3 93.03 4.98 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 105.695 -1.965 . . . . 3.45 105.695 174.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -77.85 138.79 39.13 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 108.536 -0.912 . . . . 1.16 108.536 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.7 108.79 2.02 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 120.975 1.716 . . . . 2.64 111.023 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.33 -51.38 54.88 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 118.4 0.545 . . . . 3.72 111.0 162.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -65.54 -38.3 89.22 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.7 -0.682 . . . . 4.92 111.875 -161.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 21.3 t -80.52 -43.25 21.05 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.345 0.658 . . . . 7.42 109.773 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 114.6 -31.69 6.24 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.314 -0.715 . . . . 3.52 112.131 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -21.91 -85.0 0.01 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 128.164 2.792 . . . . 1.16 114.545 -171.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 26.1 m -122.49 123.37 41.1 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 104.563 -2.384 . . . . 0.87 104.563 156.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -84.97 125.33 32.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.101 0.864 . . . . 1.36 109.236 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 43.6 tp -53.94 -51.83 62.54 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 118.044 0.384 . . . . 1.76 110.397 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.599 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.3 t80 -50.23 -46.76 55.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.108 0.563 . . . . 1.96 110.488 -178.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.503 ' C ' HD23 ' A' ' 214' ' ' LEU . 6.8 tt -56.12 -63.39 1.2 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.373 1.069 . . . . 1.21 110.866 -177.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.417 HG23 ' H2 ' ' A' ' 269' ' ' NGH 0.37 0.9 OUTLIER -59.13 -39.86 83.65 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.918 0.39 . . . . 0.97 110.453 179.31 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.41 62.31 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 116.822 -1.561 . . . . 0.48 109.409 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 213' ' ' PHE . 8.4 t -44.45 -55.25 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 121.117 1.78 . . . . 1.1 111.473 177.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -51.71 -46.77 64.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.302 0.641 . . . . 2.38 111.802 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -79.51 -47.23 15.93 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.283 -0.885 . . . . 2.77 112.58 -173.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.757 HG23 ' CD1' ' A' ' 138' ' ' PHE . 1.3 mp -56.53 -41.61 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.035 1.734 . . . . 1.52 107.871 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.36 -47.33 83.54 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.284 -0.726 . . . . 0.91 111.284 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.429 ' CE1' ' CD2' ' A' ' 228' ' ' HIS . 7.1 m-70 -52.59 -52.31 55.81 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.433 -1.04 . . . . 1.52 110.389 174.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.0 m -51.06 -47.64 61.73 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.923 0.783 . . . . 2.12 112.476 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -18.87 15.18 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.204 1.002 . . . . 3.34 112.276 176.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 120.4 6.7 9.54 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 125.659 1.599 . . . . 1.62 111.243 173.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 258' ' ' ILE . 49.7 mt -88.89 109.36 20.15 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 117.842 0.821 . . . . 4.8 110.498 -159.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -60.63 158.47 28.07 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.503 1.049 . . . . 3.47 112.49 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.429 ' CD2' ' CE1' ' A' ' 222' ' ' HIS . 27.1 m80 -62.77 121.64 13.93 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.54 0.736 . . . . 1.77 111.5 -177.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 64.8 m -77.94 178.39 7.5 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.442 0.639 . . . . 1.58 110.678 171.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 p -125.22 6.49 7.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.905 2.082 . . . . 3.49 111.927 -164.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -118.38 136.68 24.11 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.264 1.426 . . . . 2.53 108.045 -171.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.63 -13.49 14.7 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.679 2.253 . . . . 1.86 114.439 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -80.5 -37.7 31.2 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.605 1.162 . . . . 1.61 108.892 173.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.02 149.0 24.33 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.424 0.69 . . . . 0.96 110.891 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.7 t -93.34 -17.82 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.234 -0.894 . . . . 0.84 110.504 177.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.73 -20.94 60.37 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 113.139 0.792 . . . . 2.14 113.139 -174.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -52.92 167.97 0.37 Allowed Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.932 1.693 . . . . 3.02 113.644 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -83.98 -14.44 7.39 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 121.942 1.761 . . . . 1.55 112.332 173.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.294 0.0 OUTLIER -79.35 176.74 9.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.913 1.285 . . . . 2.12 109.781 178.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.573 ' HA ' ' H73' ' A' ' 269' ' ' NGH . 90.1 t80 -121.39 140.94 51.48 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.04 1.736 . . . . 2.28 106.503 176.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -151.31 132.51 14.46 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 105.095 -2.187 . . . . 2.46 105.095 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -61.21 123.1 16.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.149 0.432 . . . . 2.63 110.428 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.2 m -100.85 134.05 42.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 122.818 0.447 . . . . 1.99 109.997 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -81.96 90.56 6.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 122.224 1.012 . . . . 3.38 109.807 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 92.9 mt -54.06 -24.77 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.191 0.996 . . . . 2.95 110.757 178.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -46.74 -45.41 19.65 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.4 0.546 . . . . 3.47 111.868 170.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 25.6 m -84.04 -42.32 16.28 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.404 0.682 . . . . 1.92 109.895 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 69.8 t80 58.28 68.59 0.81 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.792 0.806 . . . . 4.24 110.223 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -160.49 165.22 31.33 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.009 -0.737 . . . . 3.48 109.009 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.4 ' HG ' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -109.17 -175.15 2.68 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.087 1.355 . . . . 1.77 110.145 -179.676 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 39.1 m -81.93 141.68 33.11 Favored 'General case' 0 C--O 1.222 -0.377 0 O-C-N 120.872 -1.143 . . . . 0.98 112.029 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.46 -39.61 57.79 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.231 0.539 . . . . 0.94 111.026 169.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -66.74 -21.7 66.06 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.929 0.714 . . . . 3.75 112.929 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.36 -51.81 7.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.903 0.881 . . . . 3.37 109.57 169.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 56.1 mt -47.58 -43.61 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.13 1.772 . . . . 1.13 111.77 -175.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -52.91 -53.53 47.96 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.823 0.344 . . . . 4.76 111.32 172.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.03 -54.37 30.89 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.089 -1.605 . . . . 1.63 109.089 -171.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.45 ' HA ' HD22 ' A' ' 226' ' ' LEU . 2.8 pp -55.37 -35.9 38.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 123.667 0.787 . . . . 2.46 112.348 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -73.04 -49.13 30.51 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 118.443 -0.789 . . . . 3.54 111.359 172.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 24.3 m -51.01 -37.15 43.39 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.736 1.153 . . . . 4.15 112.321 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 10.9 mt -62.39 -35.05 77.96 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.277 1.031 . . . . 5.19 111.489 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -71.43 -51.62 22.93 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.053 -0.404 . . . . 11.12 110.274 169.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.094 -1.948 . . . . 7.48 109.4 -175.881 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 269' ' ' NGH . . . . . 0.573 ' H73' ' HA ' ' A' ' 240' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 52.9 mtt . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 108.145 -1.057 . . . . 12.86 108.145 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.04 153.01 39.25 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 111.262 -0.735 . . . . 11.11 111.262 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.49 171.04 17.91 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.058 2.505 . . . . 13.62 109.269 172.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.4 p -153.28 143.58 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 107.419 -1.326 . . . . 8.29 107.419 172.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -87.71 -64.91 1.08 Allowed 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.298 -1.001 . . . . 13.54 108.298 173.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 38.44 42.6 0.56 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.398 1.479 . . . . 9.16 111.216 -172.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.551 ' CG ' HD11 ' A' ' 114' ' ' ILE . 1.1 mptp? 52.08 -83.0 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.117 1.367 . . . . 5.84 112.064 -158.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 56.27 -66.5 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.426 1.49 . . . . 3.82 110.645 -154.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -120.25 114.34 21.76 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.127 0.971 . . . . 3.61 112.377 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.551 HD11 ' CG ' ' A' ' 111' ' ' LYS . 45.9 mm -95.03 88.28 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 122.403 1.097 . . . . 2.68 109.024 168.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.97 123.87 29.85 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.26 -1.385 . . . . 1.72 107.26 176.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -127.08 163.28 24.13 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.531 1.059 . . . . 4.43 112.458 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -142.2 144.11 33.24 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.487 1.115 . . . . 5.82 109.233 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -92.99 151.79 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 109.5 -0.556 . . . . 1.08 109.5 176.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -86.46 -50.58 6.77 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.813 -0.81 . . . . 3.48 108.813 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -133.02 176.69 8.28 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 123.84 0.712 . . . . 3.29 111.777 174.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -138.94 160.93 38.57 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.431 1.893 . . . . 2.52 107.136 -177.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 90.6 m 46.99 56.26 17.09 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 123.505 0.722 . . . . 8.07 111.858 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.12 -39.96 1.46 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.121 1.881 . . . . 5.27 109.326 171.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.99 3.88 0.72 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.543 0.737 . . . . 2.08 112.75 -175.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 7.3 mtm -150.24 168.4 24.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.937 1.244 . . . . 1.66 110.843 -169.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -69.85 140.56 53.24 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.691 -0.485 . . . . 3.34 109.691 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -56.9 -40.0 75.46 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.267 -0.896 . . . . 2.08 112.138 -174.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.4 -3.06 5.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.892 -0.575 . . . . 3.48 112.289 -178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -96.69 -50.36 4.73 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.866 1.266 . . . . 2.68 110.357 161.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.1 m -58.43 -49.42 82.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 O-C-N 121.105 -0.997 . . . . 2.72 110.439 -169.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -71.79 -24.46 61.74 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 118.745 -1.182 . . . . 2.25 109.172 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -66.31 -48.93 68.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.659 1.118 . . . . 2.81 109.682 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.68 -49.5 76.3 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 123.774 0.829 . . . . 0.58 110.143 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.9 tp -70.88 -38.06 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.951 0.405 . . . . 1.69 110.469 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -54.87 41.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.725 -1.213 . . . . 3.45 107.725 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -59.24 -51.5 69.72 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.043 -0.981 . . . . 1.43 110.115 176.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -46.08 -50.36 15.37 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 118.686 0.676 . . . . 0.67 112.307 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.31 -51.6 62.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 118.839 -1.144 . . . . 6.69 109.196 175.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.16 -27.23 65.46 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.641 0.776 . . . . 2.08 112.0 -170.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.602 HG22 ' CD1' ' A' ' 248' ' ' PHE . 53.2 t -62.66 -54.76 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.561 1.144 . . . . 0.66 109.293 171.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.432 ' CZ3' ' HG ' ' A' ' 250' ' ' LEU . 59.3 m95 -73.6 -33.84 64.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 121.593 -0.692 . . . . 0.71 109.325 -174.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 74.0 m -65.62 -17.35 64.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 118.736 0.698 . . . . 1.24 112.571 173.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -75.71 -46.62 30.1 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.033 0.833 . . . . 1.15 109.068 174.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 57.3 t -74.38 -54.3 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.598 0.759 . . . . 2.16 110.455 -176.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.475 HG21 HD12 ' A' ' 258' ' ' ILE . 24.4 p -90.08 158.61 43.95 Favored Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 124.945 1.298 . . . . 0.6 109.823 -174.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -74.31 2.64 6.01 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.088 1.859 . . . . 0.8 112.848 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.9 mt -63.62 114.99 4.3 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.367 0.985 . . . . 2.18 110.396 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.5 76.06 2.53 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.348 -1.353 . . . . 4.26 107.348 -170.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -63.48 161.2 14.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.479 -0.782 . . . . 5.31 112.364 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.8 t -152.09 138.94 18.93 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.833 -1.543 . . . . 0.88 106.833 168.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -77.82 147.48 35.19 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.71 -1.959 . . . . 2.77 105.71 156.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.2 pt -132.51 120.83 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 105.556 -2.016 . . . . 1.31 105.556 156.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -75.12 -18.11 60.3 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.599 -0.688 . . . . 3.59 110.879 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.83 111.97 8.5 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 125.549 1.54 . . . . 2.28 109.299 -161.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 137.63 -137.15 8.68 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 108.415 -1.874 . . . . 1.44 108.415 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.6 mmt -131.42 135.83 47.49 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.601 1.56 . . . . 6.28 107.223 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -124.98 165.98 17.16 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.867 1.267 . . . . 0.94 110.154 -172.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -76.86 -57.42 3.86 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 122.036 0.922 . . . . 2.15 109.104 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.0 pt -109.26 155.41 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.699 -1.593 . . . . 0.95 106.699 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.45 HD22 ' C ' ' A' ' 160' ' ' LEU 0.36 0.0 OUTLIER -139.64 140.74 37.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 121.251 -0.906 . . . . 2.5 109.815 175.902 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 33.2 t -83.82 99.39 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 106.985 -1.487 . . . . 1.3 106.985 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.3 p -102.41 124.76 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 107.173 -1.417 . . . . 2.46 107.173 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -86.36 150.08 24.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.118 -1.438 . . . . 7.47 107.118 167.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.73 156.55 31.84 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.783 -1.562 . . . . 1.1 106.783 161.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -119.44 140.78 49.87 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.625 -1.62 . . . . 5.31 106.625 164.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 22.25 53.71 0.02 OUTLIER Glycine 0 CA--C 1.531 1.079 0 C-N-CA 128.137 2.779 . . . . 3.46 115.937 -173.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -156.63 138.67 14.49 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.212 -1.033 . . . . 4.16 108.212 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 159.2 -54.96 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 127.315 2.246 . . . . 5.43 108.415 -176.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 164.79 -57.19 0.26 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.694 -0.562 . . . . 4.72 111.694 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -79.79 155.99 27.64 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.208 -0.664 . . . . 3.72 109.208 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -61.78 -38.84 89.53 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.428 -1.693 . . . . 6.93 106.428 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -71.15 39.04 0.06 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 122.396 1.093 . . . . 5.04 111.923 171.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.54 -26.94 31.98 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 119.47 -2.019 . . . . 2.91 109.649 163.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.412 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -166.98 -171.98 1.94 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.249 -1.389 . . . . 8.08 107.249 176.045 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.412 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 4.0 p30 -171.57 44.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 O-C-N 124.629 1.205 . . . . 2.61 109.854 171.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 52.64 -156.54 4.53 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.652 -0.979 . . . . 1.54 110.652 -167.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -64.78 140.67 58.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.82 -0.811 . . . . 5.77 111.462 170.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 93.05 -164.33 27.3 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 125.462 1.506 . . . . 1.34 110.344 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.11 -118.15 9.6 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.834 1.683 . . . . 1.28 111.729 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.602 ' HA ' ' H12' ' A' ' 269' ' ' NGH . 1.2 mp -75.27 123.26 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 106.0 -1.852 . . . . 1.89 106.0 175.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.567 ' CD2' ' H5 ' ' A' ' 269' ' ' NGH 0.669 7.3 mp -76.91 -63.95 1.24 Allowed 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.266 -1.383 . . . . 1.55 107.266 168.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.93 ' H ' H102 ' A' ' 269' ' ' NGH . . . -159.16 155.98 28.17 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 113.757 1.021 . . . . 0.8 113.757 -168.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . 0.351 0.0 OUTLIER -103.32 142.44 34.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.544 1.938 . . . . 1.65 110.351 176.005 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -164.43 165.79 21.16 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.628 -1.99 . . . . 0.54 105.628 154.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -151.44 152.36 32.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 104.719 -2.326 . . . . 3.18 104.719 173.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -91.88 -78.97 1.4 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 109.964 -1.255 . . . . 0.73 109.964 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -69.85 176.71 6.47 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.385 2.057 . . . . 2.12 110.089 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 90.12 144.03 11.19 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.86 -1.296 . . . . 1.1 109.86 -172.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.3 p -82.55 -178.73 7.18 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.518 1.127 . . . . 2.11 110.479 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 61.36 -115.37 7.81 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.802 -0.919 . . . . 1.32 110.802 173.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.9 tp -60.21 -40.55 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.419 -0.586 . . . . 1.53 109.419 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -39.35 136.41 1.37 Allowed Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.469 1.033 . . . . 1.01 112.295 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 96.6 -42.17 2.26 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.452 1.025 . . . . 0.74 112.448 -165.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -74.57 171.64 13.47 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.953 1.376 . . . . 1.4 111.749 -159.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -132.55 112.81 12.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.994 -1.484 . . . . 1.65 106.994 -163.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -132.48 101.94 5.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.644 -0.502 . . . . 5.67 109.644 -156.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -104.96 133.53 49.6 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.438 1.017 . . . . 2.5 109.695 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -57.0 105.67 0.24 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.549 -0.908 . . . . 2.75 108.549 171.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -59.39 -33.54 71.33 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.9 0.88 . . . . 2.89 110.925 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.5 -27.15 67.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.51 0.671 . . . . 3.42 109.462 -176.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -68.58 133.62 48.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.705 -1.591 . . . . 2.17 106.705 171.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -98.44 96.01 7.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.957 -1.868 . . . . 7.39 105.957 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 43.8 m95 -75.13 159.98 31.0 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.999 -1.111 . . . . 1.33 107.999 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 211' ' ' ASN . 12.8 p -139.76 139.6 36.51 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.097 0.475 . . . . 2.2 111.454 -173.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.2 t -64.3 -49.34 72.19 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.938 -1.101 . . . . 1.64 111.293 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -81.41 -167.38 1.45 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.938 0.895 . . . . 3.02 109.697 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 20.8 t -56.82 -56.32 23.04 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.869 -0.419 . . . . 4.1 109.869 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 50.43 -94.85 0.01 OUTLIER Glycine 0 C--N 1.34 0.764 0 C-N-CA 124.869 1.224 . . . . 2.27 113.056 171.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -140.01 -75.26 0.05 OUTLIER Glycine 0 CA--C 1.523 0.572 0 N-CA-C 108.926 -1.67 . . . . 1.26 108.926 170.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.442 HG21 HD23 ' A' ' 181' ' ' LEU . 11.5 m -108.25 119.29 39.05 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.447 -1.686 . . . . 1.1 106.447 176.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 204' ' ' THR . 5.3 t-20 -78.5 125.91 30.03 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 120.103 -0.639 . . . . 1.56 109.641 -178.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.34 -52.67 62.72 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 109.115 -0.698 . . . . 1.38 109.115 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -52.93 -42.12 65.12 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.955 0.502 . . . . 2.26 110.277 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.461 HD11 HG22 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -60.9 -60.56 3.6 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.284 -0.885 . . . . 1.63 111.184 179.027 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.343 2.0 m -54.97 -38.91 68.41 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 110.259 -0.274 . . . . 0.7 110.259 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.36 -53.21 60.81 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 118.704 -0.665 . . . . 0.46 110.236 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 97.6 t -53.48 -47.38 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 119.542 1.065 . . . . 0.74 109.864 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.546 ' HB2' ' H72' ' A' ' 269' ' ' NGH 0.455 5.7 t60 -51.52 -51.44 55.17 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.363 1.065 . . . . 1.9 113.819 170.637 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.99 -48.6 12.02 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.053 1.297 . . . . 2.94 113.809 -173.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.3 -39.92 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 106.66 -1.607 . . . . 1.19 106.66 167.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -47.88 -57.86 7.4 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.451 1.024 . . . . 0.6 113.634 166.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.427 ' CE1' ' CE1' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -50.36 -48.99 55.4 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.449 1.125 . . . . 1.69 110.041 176.118 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 69.4 p -61.75 -19.92 62.97 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 113.55 0.944 . . . . 1.66 113.55 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 258' ' ' ILE . 9.4 mt -66.01 -67.93 0.41 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.713 -1.588 . . . . 2.26 106.713 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 156.62 66.15 0.01 OUTLIER Glycine 0 C--O 1.228 -0.259 0 N-CA-C 108.721 -1.752 . . . . 1.17 108.721 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.69 136.64 53.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.732 1.613 . . . . 4.77 107.035 -174.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -109.83 41.81 2.13 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.239 0.923 . . . . 2.99 111.902 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.427 ' CE1' ' CE1' ' A' ' 222' ' ' HIS . 70.1 m80 68.81 110.66 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.874 2.069 . . . . 1.62 113.407 178.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 34.9 m -74.8 160.51 30.6 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.611 -0.885 . . . . 1.26 108.611 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 66.7 m -133.24 47.84 2.45 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.883 1.273 . . . . 2.86 108.957 -170.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -143.59 141.14 18.35 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.782 1.633 . . . . 1.82 106.607 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -91.39 -8.92 3.07 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.197 1.931 . . . . 0.96 114.533 -173.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -82.17 -37.61 25.87 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.134 -0.979 . . . . 1.42 108.372 170.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -53.18 152.07 4.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.585 1.154 . . . . 0.99 111.534 172.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 84.0 t -106.68 -25.9 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.352 1.061 . . . . 0.95 111.289 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 4.5 mtt -60.91 -27.39 68.14 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.161 -0.962 . . . . 3.22 113.43 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.417 ' O ' ' ND1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.34 160.15 0.46 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 127.975 2.51 . . . . 3.41 114.455 -171.28 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.505 ' O ' ' H1 ' ' A' ' 269' ' ' NGH . 59.7 Cg_endo -75.54 -21.23 15.08 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.669 1.579 . . . . 1.01 111.818 175.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.368 0.2 OUTLIER -78.03 178.13 7.75 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.126 0.97 . . . . 1.28 108.976 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -126.25 149.74 48.89 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.915 -1.513 . . . . 2.46 106.915 174.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -153.5 120.28 5.65 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 104.677 -2.342 . . . . 3.29 104.677 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -60.76 122.47 14.87 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.256 -0.646 . . . . 2.36 109.256 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.461 HG22 HD11 ' A' ' 214' ' ' LEU . 15.9 m -125.22 142.37 42.29 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.051 0 CA-C-O 121.056 0.455 . . . . 1.76 110.961 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.09 91.48 0.16 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.384 1.474 . . . . 3.03 108.172 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 2.2 pp -51.7 -29.0 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 123.971 0.909 . . . . 2.96 111.419 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -50.29 -40.15 47.59 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.853 1.261 . . . . 3.62 111.461 174.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 85.7 m -67.7 -45.89 73.82 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.516 0.727 . . . . 1.7 109.982 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.602 ' CD1' HG22 ' A' ' 140' ' ' VAL . 0.5 OUTLIER 50.38 81.78 0.06 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.249 1.02 . . . . 5.13 110.88 177.117 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.55 158.36 38.32 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.748 -0.834 . . . . 2.98 108.748 167.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 250' ' ' LEU . 1.3 mm? -105.76 160.63 15.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.531 1.532 . . . . 0.79 107.379 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 26.3 m -78.21 152.71 32.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.895 -0.503 . . . . 0.64 110.77 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -54.83 -45.99 74.55 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.882 0.473 . . . . 0.69 110.323 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -50.33 -54.48 21.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.698 0.761 . . . . 2.44 109.924 172.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.77 -47.11 86.99 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.899 -1.046 . . . . 2.18 110.35 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.9 mt -50.93 -49.22 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 125.576 1.551 . . . . 0.97 110.055 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -58.15 -48.87 78.91 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.827 -1.171 . . . . 5.04 110.492 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -56.91 -34.77 66.03 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.514 0.578 . . . . 1.31 112.824 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 224' ' ' LEU . 0.2 OUTLIER -68.83 -49.34 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.622 -1.251 . . . . 3.51 107.622 -178.807 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -63.59 -23.18 67.28 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.138 -0.977 . . . . 2.75 111.772 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.4 m -47.61 -18.77 0.15 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.291 1.219 . . . . 2.35 114.291 168.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 24.5 mt -37.77 -48.51 1.1 Allowed 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.428 1.013 . . . . 2.51 113.319 169.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -170.63 85.86 0.11 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.272 -0.64 . . . . 8.08 109.272 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 N-CA-C 105.963 -2.855 . . . . 8.43 105.963 179.042 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 269' ' ' NGH . . . . . 0.93 H102 ' H ' ' A' ' 182' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 3.3 ptt? . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 111.63 0.233 . . . . 12.41 111.63 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 173.77 177.4 42.94 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 107.966 -2.054 . . . . 11.34 107.966 -173.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -71.49 174.11 11.42 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.147 2.565 . . . . 11.82 110.29 177.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.2 p -147.93 167.1 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.554 -1.647 . . . . 7.8 106.554 174.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 39.1 p90 -120.81 156.55 31.67 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.929 0.892 . . . . 9.08 110.809 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -89.68 71.51 7.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.583 -1.266 . . . . 9.7 107.583 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 73.38 -41.33 0.49 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.223 1.409 . . . . 7.37 113.141 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.6 m170 69.72 -61.54 0.44 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 127.704 2.401 . . . . 4.41 111.155 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -79.56 108.51 13.15 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.98 1.312 . . . . 3.93 108.199 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.4 mm -132.19 136.49 56.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.606 -1.627 . . . . 3.53 106.606 171.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.4 p -110.58 141.22 44.08 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.194 0.998 . . . . 1.75 109.116 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.456 ' CD2' HG12 ' A' ' 159' ' ' ILE . 5.5 m-85 -126.77 152.15 47.27 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.127 0.971 . . . . 7.54 108.768 -172.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -146.94 143.02 28.17 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.357 -0.608 . . . . 4.67 109.357 178.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 118' ' ' ILE . 2.4 mt -88.36 156.98 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.947 -1.131 . . . . 0.92 107.947 175.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.15 -46.0 6.01 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.532 0.605 . . . . 2.78 109.976 -178.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -136.43 -179.8 5.9 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.491 0.716 . . . . 3.85 109.162 173.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -120.98 110.62 16.49 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 105.749 -1.945 . . . . 1.97 105.749 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.95 141.48 96.72 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-N 119.038 0.836 . . . . 2.27 110.282 -173.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -68.36 -14.71 40.82 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.865 3.044 . . . . 1.52 111.377 174.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -41.84 -41.32 2.35 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.695 0.798 . . . . 2.45 110.72 173.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -134.6 -177.39 4.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.587 1.155 . . . . 1.83 109.94 175.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -84.86 156.45 21.29 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.31 0.644 . . . . 3.11 109.821 170.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 57.6 ttt-85 -52.47 -50.06 63.41 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.876 0.695 . . . . 2.93 112.876 -176.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.22 -2.22 15.25 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.598 -0.715 . . . . 4.94 111.84 -176.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -98.71 -45.03 6.18 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.529 1.059 . . . . 1.72 109.95 164.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.43 -47.45 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.546 -0.721 . . . . 2.1 109.367 -172.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.25 -26.44 61.11 Favored 'General case' 0 C--O 1.213 -0.846 0 C-N-CA 118.488 -1.285 . . . . 1.86 108.709 177.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -61.85 -50.68 71.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 119.918 1.235 . . . . 2.35 109.453 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.22 -53.33 55.0 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.031 0.932 . . . . 0.85 109.743 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -69.39 -40.35 79.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.442 0.639 . . . . 1.46 111.075 -175.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -58.06 -52.71 64.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.41 1.484 . . . . 5.0 107.783 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.632 ' O ' HG23 ' A' ' 140' ' ' VAL . 9.7 mmtp -62.94 -51.47 66.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.1 0.96 . . . . 1.43 110.661 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -48.17 -46.03 34.22 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 123.782 0.833 . . . . 1.06 110.869 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 149' ' ' PHE . 0.7 OUTLIER -66.27 -53.83 32.12 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.324 -0.853 . . . . 4.58 110.139 176.068 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -47.38 -40.24 17.1 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.392 1.077 . . . . 2.64 111.934 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.639 HG12 HD21 ' A' ' 250' ' ' LEU . 84.5 t -48.93 -48.75 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 125.195 1.398 . . . . 0.95 109.449 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.896 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 59.3 m95 -80.23 -38.35 31.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.381 0.672 . . . . 0.8 111.497 178.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.5 m -61.99 -24.92 67.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.983 0.811 . . . . 2.54 111.577 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -73.34 -45.16 56.79 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.885 -0.413 . . . . 1.25 109.885 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.418 HG21 HD23 ' A' ' 250' ' ' LEU . 93.4 t -77.62 -49.84 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.227 1.011 . . . . 1.88 110.165 -171.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.445 ' CB ' HD12 ' A' ' 147' ' ' LEU . 81.2 p -79.43 153.94 76.48 Favored Pre-proline 0 N--CA 1.447 -0.618 0 N-CA-C 109.145 -0.687 . . . . 0.82 109.145 175.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.58 4.28 6.51 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.265 1.977 . . . . 0.75 112.55 173.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.75 HD11 HD13 ' A' ' 261' ' ' LEU . 4.6 mt -71.53 125.62 27.54 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.643 1.111 . . . . 1.79 109.658 -170.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -89.68 76.81 7.23 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.14 -1.43 . . . . 3.76 107.14 -169.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 138' ' ' PHE . 1.4 p90 -61.48 156.13 20.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 118.143 -1.423 . . . . 6.24 112.76 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.8 t -154.01 92.97 1.59 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.875 -0.787 . . . . 2.14 108.875 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -79.08 128.12 32.87 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.831 -0.803 . . . . 6.13 108.831 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.8 pp -133.89 148.71 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 105.901 -1.888 . . . . 1.22 105.901 174.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -115.8 6.07 14.27 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 118.079 0.4 . . . . 3.8 111.79 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.9 p -136.4 119.55 16.59 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.828 0.851 . . . . 2.32 108.817 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 121.6 -149.09 17.26 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 107.213 -2.355 . . . . 1.64 107.213 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -114.77 138.0 51.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.233 1.413 . . . . 5.14 107.298 172.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.08 164.27 12.79 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.691 1.196 . . . . 1.0 109.558 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -77.13 -46.66 22.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.829 -1.175 . . . . 2.73 107.829 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.456 HG12 ' CD2' ' A' ' 116' ' ' TYR . 0.7 OUTLIER -107.95 172.62 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 121.486 0.66 . . . . 1.8 111.554 173.453 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.58 133.67 36.61 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.008 2.123 . . . . 2.0 110.22 170.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.9 t -93.45 107.06 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.589 -1.263 . . . . 0.96 107.589 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 70.6 t -117.2 81.48 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.682 1.193 . . . . 1.81 109.378 -174.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -77.31 149.03 35.36 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.605 -1.628 . . . . 4.8 106.605 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.07 -170.4 3.27 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.266 -1.013 . . . . 1.24 108.266 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.06 141.35 47.15 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.587 0.63 . . . . 6.79 110.127 -178.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 33.25 -111.23 0.06 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.907 2.194 . . . . 1.98 113.72 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.84 112.67 14.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.815 -1.18 . . . . 2.55 107.815 174.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -134.05 -54.4 0.86 Allowed 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 124.411 1.084 . . . . 4.08 110.876 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 156.4 74.05 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 106.182 -2.767 . . . . 3.67 106.182 -166.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -157.77 164.88 36.6 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.532 -0.914 . . . . 2.05 108.532 170.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -83.11 -36.41 24.85 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 124.455 1.097 . . . . 4.9 109.405 171.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -83.24 -28.22 29.37 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.617 0.767 . . . . 6.61 111.332 -174.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 66.16 168.61 0.22 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.112 2.165 . . . . 3.22 113.001 -173.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -96.96 174.15 6.92 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.899 0.88 . . . . 6.37 109.832 168.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -137.63 166.57 23.6 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.698 1.999 . . . . 3.62 107.872 176.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -70.92 -156.96 2.18 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.384 0.516 . . . . 2.03 112.891 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -51.91 111.01 0.54 Allowed 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.571 -0.958 . . . . 3.57 111.541 177.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.4 -151.79 17.47 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.474 -1.45 . . . . 2.45 109.474 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.33 -126.32 23.34 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 124.937 1.256 . . . . 2.37 110.372 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.443 HD12 ' H12' ' A' ' 269' ' ' NGH . 23.1 mm -78.21 124.75 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 107.532 -1.284 . . . . 1.76 107.532 172.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.8 mp -83.48 -31.71 26.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.318 -0.855 . . . . 1.73 110.653 167.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.412 ' O ' H101 ' A' ' 269' ' ' NGH . . . -171.15 153.28 3.66 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 114.929 1.455 . . . . 0.86 114.929 -177.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -136.3 125.95 25.42 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 126.543 1.937 . . . . 0.88 113.626 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -157.32 162.03 39.11 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 128.168 2.587 . . . . 0.58 104.935 -172.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -149.0 155.33 40.64 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.284 -2.117 . . . . 3.48 105.284 171.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -101.41 -74.65 1.08 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.374 -1.09 . . . . 0.67 110.374 172.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -68.52 174.12 8.83 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.067 1.845 . . . . 1.66 110.204 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 83.12 164.47 36.05 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.198 -1.161 . . . . 1.88 110.198 -170.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.8 p -82.9 179.94 7.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.157 0.983 . . . . 2.75 111.302 -175.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.27 -114.17 6.54 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.363 0.506 . . . . 1.76 111.915 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 191' ' ' ILE 0.255 2.7 tp -60.57 -40.78 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 117.386 -1.293 . . . . 1.78 109.195 -174.6 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -20.77 115.73 0.01 OUTLIER Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.332 1.92 . . . . 1.29 113.56 169.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 109.99 -49.44 0.85 Allowed Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.993 2.235 . . . . 0.76 110.64 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -83.87 164.81 19.23 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.349 1.46 . . . . 2.1 111.216 -168.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.11 131.99 18.07 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.945 1.091 . . . . 0.7 113.945 -172.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -116.55 120.4 38.59 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-O 118.257 -0.878 . . . . 2.53 110.352 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.0 150.57 22.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.975 0.807 . . . . 2.72 111.877 169.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -76.25 93.17 3.37 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.047 0.939 . . . . 2.55 112.064 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -77.76 -8.43 57.97 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 118.061 -0.971 . . . . 2.31 111.632 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -57.36 -47.13 82.42 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 107.751 -1.203 . . . . 3.48 107.751 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . 0.268 9.5 pt-20 -73.49 175.57 6.89 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.922 1.344 . . . . 2.43 111.52 173.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -133.08 85.13 2.19 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.458 -1.682 . . . . 5.33 106.458 -171.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.463 ' CE2' HD23 ' A' ' 212' ' ' LEU . 0.0 OUTLIER -74.15 163.51 27.77 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.105 -1.407 . . . . 2.29 108.286 169.418 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.2 p -145.82 166.35 26.19 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.406 -0.961 . . . . 2.66 108.406 173.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.7 t -49.8 -39.26 37.73 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 121.214 -0.929 . . . . 2.03 111.013 165.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.69 138.98 40.42 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.313 0.645 . . . . 2.88 110.628 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.2 m -63.6 -16.95 62.27 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.485 1.514 . . . . 4.07 112.603 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.96 -66.07 2.98 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.157 0.885 . . . . 2.4 115.131 -167.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -80.27 -89.59 0.51 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.409 -0.676 . . . . 1.3 111.409 -166.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 18.4 m -131.89 170.71 14.5 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 103.179 -2.897 . . . . 1.48 103.179 158.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -130.58 133.52 46.26 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 118.14 0.427 . . . . 1.59 111.009 171.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.463 HD23 ' CE2' ' A' ' 203' ' ' TRP . 3.4 tm? -63.69 -45.87 88.08 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.216 -0.661 . . . . 1.73 109.216 -175.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.21 -47.33 54.81 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 109.499 -0.556 . . . . 1.78 109.499 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.77 -60.45 3.43 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.038 0.935 . . . . 2.91 110.289 -178.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 8.5 m -56.22 -41.9 76.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.961 -0.563 . . . . 1.26 110.549 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.68 -51.63 68.76 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 117.921 -1.038 . . . . 0.46 110.549 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 70.9 t -45.89 -46.64 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 119.669 1.122 . . . . 0.83 110.22 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.623 ' CE1' ' CD2' ' A' ' 222' ' ' HIS 0.494 0.3 OUTLIER -64.76 -47.28 78.76 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.627 -0.671 . . . . 2.64 112.443 178.059 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLU . . . . . 0.409 ' CD ' ' HB1' ' A' ' 182' ' ' ALA 0.285 19.5 mm-40 -70.42 -48.59 55.33 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 120.727 -1.233 . . . . 2.93 113.376 -176.268 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.437 HG21 ' HA ' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -51.66 -42.01 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 107.862 -1.162 . . . . 1.64 107.862 171.885 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -54.86 -55.07 29.58 Favored Glycine 0 CA--C 1.539 1.588 0 N-CA-C 111.595 -0.602 . . . . 0.5 111.595 172.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.623 ' CD2' ' CE1' ' A' ' 218' ' ' HIS . 18.4 m-70 -50.22 -58.19 6.16 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 117.878 0.839 . . . . 1.27 110.514 177.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.9 t -47.94 -49.67 29.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.963 2.105 . . . . 1.6 110.737 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.67 HD12 HD13 ' A' ' 147' ' ' LEU . 0.3 OUTLIER -65.32 -37.12 86.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 122.962 0.505 . . . . 3.59 110.061 -178.526 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 143.93 70.45 0.02 OUTLIER Glycine 0 C--N 1.338 0.67 0 N-CA-C 112.001 -0.44 . . . . 1.17 112.001 160.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.892 HD11 HG22 ' A' ' 258' ' ' ILE . 11.1 mt -133.94 155.61 49.62 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.182 0.593 . . . . 3.07 110.312 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -132.19 48.91 0.94 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.823 1.201 . . . . 3.0 110.122 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 70.04 165.17 0.27 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.778 1.631 . . . . 3.2 112.514 -176.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.3 m -132.71 141.28 48.49 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.089 -1.819 . . . . 1.09 106.089 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 31.5 t -80.34 47.55 0.93 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.004 0.522 . . . . 2.28 111.718 -170.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -154.27 135.56 8.86 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-O 118.472 -0.775 . . . . 2.01 109.775 -171.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.89 -16.77 7.37 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.82 2.347 . . . . 1.89 114.403 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -76.44 -36.6 57.85 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.458 -1.401 . . . . 2.34 109.033 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.98 124.66 17.47 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.325 0.583 . . . . 1.32 109.586 167.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 69.2 t -64.59 -25.22 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.926 -0.768 . . . . 0.94 108.926 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 1.2 mmt -49.0 -23.96 1.34 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.099 1.518 . . . . 2.47 115.099 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -53.91 139.47 52.69 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 119.366 0.985 . . . . 6.27 110.59 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.641 ' O ' ' H91' ' A' ' 269' ' ' NGH . 20.1 Cg_endo -64.88 -23.45 62.13 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.274 1.982 . . . . 1.44 112.021 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.361 0.2 OUTLIER -94.52 154.43 17.41 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.606 -0.886 . . . . 2.91 108.606 178.592 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -72.86 150.03 43.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.617 -0.883 . . . . 2.21 108.617 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -141.75 139.82 32.93 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.33 -0.989 . . . . 3.5 108.33 173.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -76.26 77.7 3.05 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.765 0.826 . . . . 3.6 109.509 -176.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 25.5 m -83.79 103.59 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 116.016 -0.538 . . . . 1.63 109.957 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.26 115.54 3.59 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.872 0.368 . . . . 3.53 110.323 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 8.8 mt -57.45 -24.42 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.268 0.627 . . . . 2.71 109.75 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -41.95 -43.54 3.15 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 124.121 0.968 . . . . 3.78 112.621 168.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 14.0 m -82.65 -47.74 11.72 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.204 0.602 . . . . 2.4 110.053 -177.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.437 ' CE1' HG22 ' A' ' 140' ' ' VAL . 59.7 t80 52.82 69.4 0.7 Allowed 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.256 1.022 . . . . 4.41 110.873 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -157.94 170.12 23.04 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.447 -0.783 . . . . 3.48 110.142 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.639 HD21 HG12 ' A' ' 140' ' ' VAL . 0.8 OUTLIER -109.89 152.4 25.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.972 1.709 . . . . 0.93 107.47 -179.05 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.0 151.35 33.63 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 121.423 -0.798 . . . . 1.06 111.195 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -47.69 -47.2 29.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.669 0.788 . . . . 1.03 110.786 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -57.49 -45.7 84.58 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.444 0.64 . . . . 2.45 110.8 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 258' ' ' ILE . 4.6 t0 -58.26 -50.61 72.97 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.993 -1.003 . . . . 2.36 108.866 177.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.5 mt -55.29 -33.16 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.078 1.751 . . . . 1.18 112.525 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -70.94 -50.79 30.79 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.726 -1.234 . . . . 5.95 109.809 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -46.87 -52.52 11.54 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.366 -0.694 . . . . 0.93 111.366 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.896 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 1.9 pp -63.08 -45.48 98.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.655 0.782 . . . . 2.26 109.711 -176.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -61.47 -30.24 70.47 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 120.815 -1.178 . . . . 2.1 110.947 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.88 -17.56 0.59 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.573 0.953 . . . . 1.79 113.573 172.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.75 HD13 HD11 ' A' ' 147' ' ' LEU . 36.4 mt -42.0 -42.67 2.91 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 120.026 1.284 . . . . 2.42 113.196 164.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -75.56 -69.05 0.51 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.593 -0.891 . . . . 7.58 108.593 170.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 N-CA-C 105.718 -2.953 . . . . 8.41 105.718 -178.417 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 269' ' ' NGH . . . . . 0.641 ' H91' ' O ' ' A' ' 238' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 61.8 mtt . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 117.147 -1.406 . . . . 16.71 107.468 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -117.0 71.21 0.28 Allowed Glycine 0 CA--C 1.53 0.997 0 CA-C-N 119.67 1.123 . . . . 12.89 111.721 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.32 142.72 41.81 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.807 1.671 . . . . 14.19 108.866 174.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.4 p -155.26 153.11 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 105.957 -1.868 . . . . 9.36 105.957 174.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.22 177.82 3.65 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.456 -0.942 . . . . 12.21 108.456 171.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -64.57 -39.21 93.33 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.039 -1.038 . . . . 13.68 109.859 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.53 -135.17 0.34 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.246 2.219 . . . . 10.51 106.919 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -139.35 -88.41 0.21 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.087 0.955 . . . . 7.79 108.637 173.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -146.12 145.51 30.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.591 1.556 . . . . 3.49 107.761 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 114' ' ' ILE . 0.9 OUTLIER -128.86 96.83 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.32 -0.993 . . . . 2.81 108.32 176.406 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -104.41 140.4 37.97 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.683 1.593 . . . . 1.26 108.963 -174.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -122.79 160.81 25.21 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.115 0.966 . . . . 5.58 111.821 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.407 ' HG3' HD12 ' A' ' 160' ' ' LEU . 15.9 ptt180 -146.46 144.66 29.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.336 1.054 . . . . 8.23 110.012 177.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.476 HD11 ' HD2' ' A' ' 151' ' ' LYS . 5.4 mt -106.0 156.3 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.204 1.402 . . . . 0.94 107.509 175.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.414 HD21 ' HG ' ' A' ' 160' ' ' LEU . 45.7 m-80 -107.04 -44.15 4.46 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.917 0.887 . . . . 3.93 110.54 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -152.2 172.96 15.57 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.499 1.119 . . . . 2.18 107.98 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -127.56 139.57 52.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.136 1.374 . . . . 2.12 107.86 -170.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.8 t -66.3 141.7 97.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.277 -0.638 . . . . 2.45 109.277 172.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -77.77 -16.31 14.69 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.74 2.96 . . . . 1.84 111.088 173.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -44.19 -44.37 7.75 Favored 'General case' 0 C--N 1.345 0.374 0 C-N-CA 124.875 1.27 . . . . 2.58 111.357 -178.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 22.0 mtm -126.28 168.86 13.53 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.919 1.687 . . . . 2.01 107.756 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -65.7 143.27 57.65 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 108.979 -0.748 . . . . 3.2 108.979 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -47.34 -48.21 25.51 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.01 0.823 . . . . 3.93 110.99 174.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -58.44 -18.81 31.4 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.54 -0.743 . . . . 3.14 112.205 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -93.59 -42.2 9.33 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.128 1.771 . . . . 2.06 110.458 173.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.5 t -53.22 -55.47 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 O-C-N 120.603 -1.31 . . . . 1.24 109.48 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -24.88 65.01 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 117.897 -1.521 . . . . 1.86 109.482 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -62.93 -48.89 76.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.399 0.999 . . . . 2.16 109.889 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.478 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -58.97 -48.8 80.25 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 122.403 0.281 . . . . 0.43 110.677 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 220' ' ' ILE . 0.2 OUTLIER -70.27 -37.24 70.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 121.227 0.537 . . . . 1.85 109.933 -179.211 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -55.42 31.48 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.277 1.031 . . . . 2.92 108.496 176.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.598 ' O ' HG23 ' A' ' 140' ' ' VAL . 19.0 mmmt -61.58 -46.64 89.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.397 1.079 . . . . 1.66 109.394 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -48.43 -55.77 9.98 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.364 0.666 . . . . 0.64 110.701 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -55.99 -51.78 66.51 Favored 'General case' 0 N--CA 1.457 -0.104 0 O-C-N 121.806 -0.559 . . . . 4.45 110.394 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.9 -35.27 57.92 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.757 0.651 . . . . 2.14 112.757 -175.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.704 HG12 HD21 ' A' ' 250' ' ' LEU . 91.4 t -56.89 -51.76 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 123.949 0.9 . . . . 0.81 109.862 175.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.453 ' NE1' HG22 ' A' ' 217' ' ' VAL . 95.0 m95 -77.35 -28.08 52.88 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.794 -0.566 . . . . 1.0 109.793 -175.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.34 -31.83 72.51 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.952 0.901 . . . . 1.5 109.744 175.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -66.05 -49.27 68.27 Favored 'General case' 0 C--N 1.341 0.23 0 O-C-N 121.644 -0.66 . . . . 1.27 109.682 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.633 HG21 HD23 ' A' ' 250' ' ' LEU . 64.7 t -70.77 -54.4 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 123.07 0.548 . . . . 1.97 110.408 -176.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.619 ' CG2' HG13 ' A' ' 258' ' ' ILE . 81.5 p -82.5 137.19 45.04 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 109.603 -0.517 . . . . 0.85 109.603 -174.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -68.05 19.79 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.555 2.836 . . . . 1.5 113.88 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.444 HD13 ' HB ' ' A' ' 145' ' ' THR . 2.9 mp -81.06 166.08 21.07 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.774 1.63 . . . . 3.12 108.774 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -124.63 86.13 2.51 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.714 -0.847 . . . . 3.78 108.714 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -74.4 142.32 45.02 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.594 1.158 . . . . 5.86 113.256 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 t -151.9 101.57 2.76 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.017 1.117 . . . . 0.9 114.017 -176.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.476 ' HD2' HD11 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -80.39 126.1 30.76 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 120.157 -1.589 . . . . 2.9 109.963 172.071 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.401 HD11 ' HB2' ' A' ' 157' ' ' ALA . 2.6 pp -125.6 149.35 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.885 -1.524 . . . . 1.3 106.885 174.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -101.73 -15.63 16.91 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.825 0.345 . . . . 2.76 110.557 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 55.1 m -144.4 132.41 21.55 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.405 -2.072 . . . . 2.99 105.405 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 141.5 -155.27 25.17 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 106.882 -2.487 . . . . 1.6 106.882 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.6 mtt -119.99 140.3 51.17 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.533 -2.025 . . . . 4.8 105.533 174.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.401 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -144.26 153.5 42.1 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.026 -1.102 . . . . 0.8 108.026 -176.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.29 -56.69 4.34 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.427 -1.323 . . . . 1.85 107.427 -167.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.1 pt -86.16 -174.66 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 114.82 -1.082 . . . . 1.62 110.541 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.414 ' HG ' HD21 ' A' ' 119' ' ' ASN . 1.1 tp -145.39 134.65 22.92 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.862 2.065 . . . . 2.67 107.689 173.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.7 t -97.04 98.33 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.182 -1.044 . . . . 0.76 108.182 172.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 72.7 t -80.25 129.34 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.804 -1.184 . . . . 1.5 107.804 173.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -111.07 126.55 54.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 104.618 -2.364 . . . . 5.12 104.618 156.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.722 ' HB3' ' CZ ' ' A' ' 174' ' ' PHE . . . -144.2 157.94 44.01 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 109.424 -0.584 . . . . 0.88 109.424 175.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.26 91.31 2.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.851 1.261 . . . . 4.14 109.347 -173.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 115.28 -55.31 0.54 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.759 1.171 . . . . 1.95 111.093 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -152.78 165.73 34.46 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.998 0.919 . . . . 3.02 108.787 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.95 -37.57 0.08 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.642 0.608 . . . . 3.28 112.642 173.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -172.73 -50.53 0.05 OUTLIER Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.433 -1.067 . . . . 2.61 110.433 -173.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.86 155.38 31.02 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.305 -0.998 . . . . 2.55 108.305 171.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.61 -58.87 3.02 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 125.186 1.394 . . . . 6.14 107.97 -173.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -101.53 118.21 36.48 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.004 -1.48 . . . . 4.46 107.004 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -157.73 -55.03 0.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.201 0.6 . . . . 2.47 111.049 -169.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.722 ' CZ ' ' HB3' ' A' ' 164' ' ' ALA . 35.9 m-85 -112.09 174.84 5.69 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.58 1.552 . . . . 6.15 107.646 176.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -179.38 31.99 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.878 0.871 . . . . 2.31 111.536 -174.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 55.01 -155.12 9.11 Favored Glycine 0 CA--C 1.532 1.148 0 O-C-N 120.714 -1.241 . . . . 1.36 111.604 -170.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -69.37 98.36 1.07 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.271 1.028 . . . . 4.11 110.772 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 152.15 -175.21 30.94 Favored Glycine 0 C--O 1.24 0.512 0 N-CA-C 111.308 -0.717 . . . . 1.54 111.308 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 45.53 -118.6 3.09 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 126.834 2.159 . . . . 1.35 111.131 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.9 mm -80.58 129.61 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.723 -1.214 . . . . 1.51 107.723 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.697 ' HB2' ' H1 ' ' A' ' 269' ' ' NGH . 3.8 mm? -81.42 -44.88 16.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.209 1.404 . . . . 2.31 109.025 165.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.989 ' O ' H102 ' A' ' 269' ' ' NGH . . . -164.26 149.76 10.5 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 113.062 0.764 . . . . 0.67 113.062 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -131.68 115.0 15.47 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.758 1.623 . . . . 1.01 112.469 -174.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -147.43 160.19 42.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.55 2.74 . . . . 0.6 105.476 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -150.45 160.05 44.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.855 -1.535 . . . . 3.56 106.855 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -81.65 -69.07 1.41 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.173 0.892 . . . . 1.23 111.968 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -58.73 132.79 49.98 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.42 2.08 . . . . 2.85 109.215 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -75.69 44.7 1.78 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.639 1.114 . . . . 2.19 112.876 -171.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.3 m -77.38 78.93 3.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.636 -1.246 . . . . 5.33 107.636 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.53 -101.26 0.75 Allowed Glycine 0 C--O 1.244 0.778 0 N-CA-C 110.317 -1.113 . . . . 3.02 110.317 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 2.7 tp -64.41 -39.34 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 121.67 -0.9 . . . . 2.36 109.465 -174.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -45.19 159.01 0.2 Allowed Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.468 1.032 . . . . 2.09 115.459 176.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 85.68 -52.89 4.65 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 109.715 -1.354 . . . . 1.32 109.715 -159.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.01 162.67 27.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.138 1.375 . . . . 1.95 108.418 -172.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -135.14 121.62 20.54 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.528 0.603 . . . . 0.63 112.614 -174.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -113.92 113.39 24.78 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-O 118.729 -0.653 . . . . 2.16 111.073 -171.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -96.28 144.65 26.26 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.371 0.668 . . . . 2.81 110.572 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -68.67 97.44 0.8 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.454 -0.794 . . . . 2.69 111.158 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -70.57 -30.15 66.78 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 120.978 -1.077 . . . . 2.69 109.834 173.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -46.89 -42.01 16.82 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.261 1.424 . . . . 2.64 109.301 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -74.81 172.13 12.73 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 122.347 1.07 . . . . 1.72 113.07 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -113.64 96.11 5.69 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.712 -1.218 . . . . 3.62 107.712 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.479 ' CH2' HG21 ' A' ' 215' ' ' THR . 18.9 m95 -75.03 151.04 38.76 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.931 -1.137 . . . . 1.2 107.931 172.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 82.4 p -129.92 134.19 47.33 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.407 0.683 . . . . 1.72 109.78 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.6 t -51.57 -43.87 62.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 123.961 0.904 . . . . 1.69 111.314 172.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.25 -157.88 0.34 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.645 1.178 . . . . 2.14 111.63 -178.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.5 m -60.66 -66.59 0.5 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.336 1.055 . . . . 3.77 110.801 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 42.66 -103.81 0.04 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.106 1.336 . . . . 2.47 114.825 174.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -125.98 -71.93 0.19 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.309 0.957 . . . . 1.07 110.984 -173.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.3 m -119.21 168.14 11.17 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 105.556 -2.016 . . . . 1.22 105.556 167.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -123.56 128.99 50.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.156 0.182 . . . . 1.39 111.113 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.478 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.1 tm? -62.33 -48.14 81.12 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 118.699 -0.667 . . . . 2.11 109.495 -177.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -50.52 -43.9 56.06 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.89 0.768 . . . . 1.34 110.426 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 7.4 tt -63.24 -60.35 3.52 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.765 0.826 . . . . 1.24 109.698 -175.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.702 HG23 ' H2 ' ' A' ' 269' ' ' NGH 0.338 20.1 m -61.27 -38.01 85.2 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 120.454 -0.498 . . . . 0.66 111.128 179.235 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.09 -60.69 2.83 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 118.199 -0.905 . . . . 0.36 109.48 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.751 ' CG1' HG11 ' A' ' 235' ' ' VAL . 0.3 OUTLIER -51.87 -45.3 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 119.12 0.873 . . . . 1.65 111.061 -173.599 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.556 ' CD2' ' O4 ' ' A' ' 269' ' ' NGH . 13.0 t60 -52.1 -61.79 2.04 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.236 1.015 . . . . 2.53 112.762 168.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -57.41 -38.43 74.31 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.443 -1.411 . . . . 2.86 112.184 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 134' ' ' ILE . 1.5 mp -67.97 -36.16 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 108.247 -1.02 . . . . 1.23 108.247 -177.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -55.81 -44.07 87.03 Favored Glycine 0 CA--C 1.538 1.486 0 O-C-N 121.808 -0.558 . . . . 0.55 111.747 166.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -55.35 -50.04 70.68 Favored 'General case' 0 C--N 1.344 0.343 0 O-C-N 122.106 -0.643 . . . . 1.36 109.272 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.2 t -44.09 -56.32 4.12 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.204 1.002 . . . . 1.9 112.4 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 224' ' ' LEU . 0.2 OUTLIER -62.16 -55.49 28.24 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 119.101 0.864 . . . . 3.24 108.879 -178.369 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 155.38 37.07 0.02 OUTLIER Glycine 0 C--N 1.337 0.6 0 C-N-CA 120.906 -0.664 . . . . 1.13 114.607 174.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.551 HD13 ' SD ' ' A' ' 236' ' ' MET . 4.3 mt -84.64 113.11 21.04 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.65 1.225 . . . . 3.47 110.695 175.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -74.56 60.62 2.43 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.928 0.775 . . . . 2.3 111.552 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 78.3 m80 60.17 -170.65 0.14 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.099 1.359 . . . . 2.93 112.353 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 58.1 m -148.06 -178.38 6.26 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.813 1.645 . . . . 0.96 108.865 167.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.9 t -139.19 38.72 2.11 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.884 0.874 . . . . 2.06 110.193 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -140.55 143.13 31.51 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.436 -1.69 . . . . 1.67 106.436 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -87.6 -13.58 4.05 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.848 1.698 . . . . 1.02 114.62 -173.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 18.2 mtmt -80.32 -36.83 33.69 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.948 -1.13 . . . . 1.17 107.948 170.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.33 137.27 42.13 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.408 0.623 . . . . 0.72 110.682 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.751 HG11 ' CG1' ' A' ' 217' ' ' VAL . 58.0 t -86.73 -17.04 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 114.751 -1.113 . . . . 0.59 109.886 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.551 ' SD ' HD13 ' A' ' 226' ' ' LEU . 7.9 tpt -76.15 -18.27 59.2 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 114.06 1.133 . . . . 1.71 114.06 -172.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.487 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.86 161.05 0.43 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 126.217 1.807 . . . . 3.01 114.389 176.711 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.32 -14.39 13.19 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.846 1.698 . . . . 0.95 112.37 172.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.542 ' O ' ' H4 ' ' A' ' 269' ' ' NGH 0.385 0.2 OUTLIER -78.39 168.1 20.32 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.539 -0.911 . . . . 1.14 108.539 176.605 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -112.48 133.96 54.27 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.315 -1.735 . . . . 2.37 106.315 172.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -134.92 148.35 50.03 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.997 -1.112 . . . . 3.41 107.997 172.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -71.38 79.56 0.75 Allowed 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.778 1.231 . . . . 3.91 109.174 178.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.8 m -76.63 112.76 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.831 -0.803 . . . . 1.77 108.831 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -64.77 118.22 8.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.965 -0.561 . . . . 3.01 110.501 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 33.0 mm -58.98 -21.79 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.877 0.871 . . . . 3.19 111.197 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -55.49 -33.29 63.57 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.373 0.988 . . . . 3.6 111.595 172.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.6 m -80.33 -50.75 9.75 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.751 -0.463 . . . . 2.54 109.751 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.505 ' CZ ' HG22 ' A' ' 140' ' ' VAL . 54.2 t80 46.48 73.99 0.16 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.412 1.485 . . . . 4.41 112.142 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.76 167.91 25.87 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.558 -0.714 . . . . 2.69 109.781 175.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.704 HD21 HG12 ' A' ' 140' ' ' VAL . 0.3 OUTLIER -102.43 141.12 35.78 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 105.693 -1.966 . . . . 1.07 105.693 178.83 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.28 170.99 14.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.789 -0.449 . . . . 1.09 109.789 -172.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.92 -42.59 85.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.154 -0.618 . . . . 0.85 110.078 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.09 -45.81 89.9 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 110.3 -0.259 . . . . 2.64 110.3 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -56.22 -51.51 67.82 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.259 -1.015 . . . . 2.97 108.259 175.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.408 ' HA ' HG22 ' A' ' 258' ' ' ILE . 57.0 mt -59.3 -31.2 45.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 126.805 2.042 . . . . 0.88 112.663 -175.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -70.33 -58.53 3.65 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.039 -1.038 . . . . 5.58 110.04 172.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.522 ' C ' HD21 ' A' ' 226' ' ' LEU . . . -56.93 -44.2 92.63 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 111.758 -0.537 . . . . 1.1 111.758 -175.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.619 HG13 ' CG2' ' A' ' 145' ' ' THR . 10.2 tp -59.42 -34.77 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.08 0.952 . . . . 3.8 111.816 -176.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -86.41 -26.08 24.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.852 -0.53 . . . . 2.46 110.623 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.7 t -53.32 -18.22 2.35 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 117.851 -1.071 . . . . 1.85 113.064 171.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -29.37 -56.81 0.15 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.654 1.582 . . . . 2.85 113.472 166.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 136.54 -59.82 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 129.041 2.936 . . . . 6.64 107.389 -177.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 N-CA-C 105.421 -3.072 . . . . 9.02 105.421 -160.846 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 269' ' ' NGH . . . . . 0.989 H102 ' O ' ' A' ' 182' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 49.4 mtt . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 117.406 -1.283 . . . . 19.19 107.813 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -161.44 174.86 38.05 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.483 -1.447 . . . . 16.5 109.483 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.21 173.95 12.86 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.563 2.842 . . . . 16.38 110.106 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.1 p -153.36 143.29 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.987 -1.116 . . . . 10.02 107.987 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -97.41 145.48 26.13 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.217 1.007 . . . . 13.47 109.296 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -52.26 36.28 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 109.476 -0.565 . . . . 8.69 109.476 175.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -76.54 -65.96 0.87 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.338 -0.847 . . . . 6.03 110.526 -162.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.0 m80 64.28 -62.23 0.18 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.894 2.078 . . . . 4.58 113.872 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -86.6 101.73 13.5 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.018 1.327 . . . . 3.27 110.06 -172.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.413 HG22 ' CE1' ' A' ' 116' ' ' TYR . 4.7 mm -124.15 109.57 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.539 -0.912 . . . . 1.85 108.539 -178.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.5 p -101.92 146.69 27.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.459 1.104 . . . . 1.24 109.858 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.43 ' CZ ' ' CE1' ' A' ' 138' ' ' PHE . 1.9 m-85 -130.11 159.78 35.75 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 119.194 -0.432 . . . . 5.76 111.045 -176.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -143.08 146.3 33.67 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.769 0.827 . . . . 5.28 109.045 175.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.34 157.54 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.458 -0.942 . . . . 1.16 108.458 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.565 HD22 ' H ' ' A' ' 119' ' ' ASN . 0.1 OUTLIER -91.61 -57.66 2.69 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.502 0.721 . . . . 3.1 109.746 171.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -149.79 171.68 16.35 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 110.168 -0.308 . . . . 1.86 110.168 175.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -105.68 118.08 35.66 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.974 1.31 . . . . 2.75 107.792 -175.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.6 t -71.07 135.7 84.95 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.636 -0.876 . . . . 2.6 108.636 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.03 -19.72 22.7 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.777 2.318 . . . . 1.92 112.548 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.64 -43.49 3.85 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.097 1.759 . . . . 2.59 112.37 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -128.44 -179.89 5.28 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.371 1.468 . . . . 2.72 108.237 175.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -85.26 145.47 27.53 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.358 0.599 . . . . 2.9 110.24 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.9 ttt-85 -49.87 -47.58 51.77 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.635 0.774 . . . . 2.87 111.859 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -62.29 -4.88 2.0 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.012 0.925 . . . . 3.01 112.909 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -101.42 -46.35 5.03 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.104 1.762 . . . . 2.14 110.029 169.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 66.1 t -54.3 -56.37 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 124.569 1.147 . . . . 1.17 109.518 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -26.96 65.83 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 118.182 -1.407 . . . . 1.8 109.678 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -60.09 -50.12 74.95 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 119.613 1.097 . . . . 1.86 110.01 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.65 -54.42 37.94 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 123.409 0.684 . . . . 0.43 110.126 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.1 tp -66.21 -41.03 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.824 0.345 . . . . 2.13 110.926 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -53.91 -60.18 3.66 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.491 1.517 . . . . 3.56 107.635 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -62.36 -46.11 90.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.281 -0.872 . . . . 1.4 110.141 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.05 -52.2 45.57 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.878 0.471 . . . . 0.46 110.721 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.438 ' CZ ' HG13 ' A' ' 220' ' ' ILE . 4.4 m-85 -55.16 -48.52 73.62 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.709 -0.223 . . . . 4.47 110.917 171.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -35.16 61.74 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.573 -0.727 . . . . 1.91 111.861 -178.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.423 HG12 HD21 ' A' ' 250' ' ' LEU . 94.9 t -55.57 -65.04 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.312 0 CA-C-N 119.217 0.917 . . . . 0.9 109.821 177.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.868 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 41.5 m95 -70.66 -33.34 70.85 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.608 -0.886 . . . . 0.88 108.608 -171.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 t -68.51 -13.77 62.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 119.104 -0.474 . . . . 1.13 112.27 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.38 -52.49 7.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.911 -1.144 . . . . 1.05 107.911 177.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.447 HG11 HD23 ' A' ' 250' ' ' LEU . 4.9 m -82.47 -37.85 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.802 -0.636 . . . . 1.8 112.328 -171.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' THR . . . . . 1.044 HG22 HD13 ' A' ' 258' ' ' ILE . 1.3 p -87.38 150.5 49.2 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 106.235 -1.765 . . . . 1.13 106.235 170.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.66 -0.5 10.7 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.538 1.492 . . . . 1.04 112.459 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.492 HD13 ' HB3' ' A' ' 224' ' ' LEU . 5.6 mt -61.28 117.05 5.12 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 119.245 0.93 . . . . 2.08 108.849 177.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -94.5 105.43 17.39 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.173 0.589 . . . . 4.6 109.518 -172.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -64.98 146.75 54.59 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.339 -0.846 . . . . 7.31 112.329 -177.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.5 t -154.08 96.98 2.01 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.286 0.565 . . . . 0.87 110.704 165.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -79.75 125.97 30.35 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 108.474 -0.936 . . . . 2.07 108.474 172.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.85 155.46 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.678 -1.601 . . . . 1.57 106.678 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -108.58 -9.31 15.34 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.939 0.791 . . . . 3.32 111.919 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 76.8 m -143.04 132.07 22.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.126 1.77 . . . . 2.05 106.67 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.82 -156.79 20.79 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 107.962 -2.055 . . . . 2.38 107.962 -172.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 52.4 mtt -105.12 137.86 42.23 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.94 1.296 . . . . 4.92 108.159 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.74 147.08 50.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.438 1.095 . . . . 1.13 109.015 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -75.19 -50.24 16.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.124 -1.065 . . . . 2.0 108.124 175.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.4 154.11 12.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.447 0.642 . . . . 1.59 110.833 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.09 132.9 54.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.904 -1.147 . . . . 2.52 107.904 169.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.2 t -78.57 135.65 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.023 -1.473 . . . . 1.14 107.023 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 74.1 t -116.49 134.52 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.802 1.183 . . . . 1.33 109.29 172.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -95.97 149.44 21.57 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.668 -1.234 . . . . 7.66 107.668 167.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -159.04 149.04 19.18 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 120.536 -1.353 . . . . 1.28 110.26 170.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -120.25 132.93 55.54 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.604 1.162 . . . . 3.93 108.672 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 54.13 -96.8 0.03 OUTLIER Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.293 0.949 . . . . 2.11 111.833 -167.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -124.68 140.85 52.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.138 1.375 . . . . 2.13 108.852 -169.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -145.4 50.7 1.21 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.286 0.565 . . . . 2.59 110.363 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.92 56.87 10.85 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 108.395 -1.882 . . . . 2.26 108.395 -169.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -150.89 150.08 30.44 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.07 -1.826 . . . . 2.06 106.07 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -80.24 -47.96 13.81 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.749 -0.834 . . . . 4.25 108.749 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -134.46 87.42 2.35 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.273 1.029 . . . . 5.14 108.996 -173.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -107.05 -102.79 0.35 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.731 0.812 . . . . 2.45 109.309 174.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' A' ' 200' ' ' ASP . 26.2 t80 -89.66 161.82 15.91 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.932 0.872 . . . . 7.73 109.413 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.406 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 47.1 p-10 -168.85 26.75 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.682 -1.599 . . . . 3.48 110.613 -157.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 91.6 165.64 39.64 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 111.246 -0.742 . . . . 2.3 111.246 -170.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.432 ' HA ' ' CG ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -62.98 111.69 2.27 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 122.544 -0.386 . . . . 5.38 110.542 166.3 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.8 -164.31 13.59 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.61 -1.396 . . . . 2.08 109.61 -171.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 59.06 -120.03 20.74 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 110.225 -1.15 . . . . 1.98 110.225 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.7 mm -76.57 122.78 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 105.699 -1.963 . . . . 1.72 105.699 168.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.424 HD22 ' C1 ' ' A' ' 269' ' ' NGH . 7.1 mp -81.57 -44.4 17.34 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.65 -0.5 . . . . 1.61 109.65 174.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -167.08 168.51 13.63 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.69 -0.631 . . . . 0.58 109.921 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -145.92 108.35 4.45 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.198 0.999 . . . . 1.06 113.377 -172.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -128.19 156.66 42.57 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.937 2.095 . . . . 0.64 107.107 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -145.29 149.15 34.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.024 -1.843 . . . . 2.75 106.024 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.75 -85.44 1.71 Allowed Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.506 -1.038 . . . . 0.69 110.506 174.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.38 86.54 0.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.638 2.892 . . . . 1.24 111.196 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -158.88 164.79 33.87 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 108.165 -1.974 . . . . 1.03 108.165 169.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.9 t -79.92 179.85 7.35 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.378 0.589 . . . . 3.3 109.964 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 43.8 -102.93 0.04 OUTLIER Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.814 1.674 . . . . 1.3 112.574 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.2 tp -60.3 -40.04 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 118.298 -0.858 . . . . 1.42 110.0 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -37.2 134.4 0.89 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.675 1.131 . . . . 1.0 112.85 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 99.7 -47.77 1.29 Allowed Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.829 1.681 . . . . 0.75 111.392 -161.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -88.49 138.93 30.99 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.902 0.881 . . . . 1.28 110.084 -156.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -109.65 119.63 40.0 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.669 0.788 . . . . 0.72 112.663 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . 0.28 0.0 OUTLIER -111.39 113.25 25.57 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-O 117.575 -1.202 . . . . 2.15 110.783 -171.912 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -103.03 152.33 21.48 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.42 1.464 . . . . 6.23 112.756 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -64.1 95.58 0.13 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.36 -1.291 . . . . 2.68 108.767 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -56.89 -40.0 75.42 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 125.395 1.478 . . . . 2.3 111.594 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.408 ' HB3' ' CE1' ' A' ' 174' ' ' PHE . 8.2 t70 -66.77 -28.34 68.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.53 1.132 . . . . 3.14 110.731 -178.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.432 ' CG ' ' HA ' ' A' ' 177' ' ' LYS . 5.4 mt-10 -69.85 127.1 31.73 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 107.732 -1.21 . . . . 2.3 107.732 174.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -80.59 78.68 7.31 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.904 -1.147 . . . . 2.7 107.904 -174.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -77.0 103.7 7.08 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.302 1.041 . . . . 2.24 110.562 -172.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.26 166.54 12.88 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.05 1.405 . . . . 2.53 110.72 -174.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.3 t -69.26 -43.44 73.95 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 127.542 2.337 . . . . 1.86 112.371 166.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -82.53 156.88 23.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.374 -0.83 . . . . 2.81 109.698 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.4 m -69.11 -32.99 72.78 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.991 1.717 . . . . 4.53 110.952 -167.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.81 133.77 52.63 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 111.066 -0.813 . . . . 2.98 111.066 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 90.28 -120.29 5.82 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.069 -2.012 . . . . 1.14 108.069 -175.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.45 142.38 50.8 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 108.273 -1.01 . . . . 1.23 108.273 162.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -96.81 121.48 38.72 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.363 0.414 . . . . 1.25 110.584 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.79 -53.42 32.0 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 109.143 -0.688 . . . . 1.45 109.143 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.667 ' O ' HG23 ' A' ' 217' ' ' VAL . 35.9 t80 -47.36 -48.09 25.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.336 0.654 . . . . 1.46 110.637 179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.416 HD22 ' CD1' ' A' ' 240' ' ' TYR . 6.5 tt -60.17 -58.21 9.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.321 -0.4 . . . . 1.36 110.941 -174.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.392 80.4 m -56.37 -43.02 78.78 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.102 0.477 . . . . 1.08 110.22 176.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.61 -55.99 23.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 117.26 -1.352 . . . . 0.4 109.808 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 213' ' ' PHE . 38.9 t -47.95 -45.39 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 121.157 1.799 . . . . 0.86 110.951 -176.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.424 ' ND1' ' H4 ' ' A' ' 269' ' ' NGH . 0.4 OUTLIER -56.79 -56.49 20.81 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.78 0.659 . . . . 2.75 112.78 170.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -65.76 -44.4 85.98 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 120.406 -1.434 . . . . 3.54 112.737 -176.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.438 HG13 ' CZ ' ' A' ' 138' ' ' PHE . 1.4 mp -49.84 -49.06 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 125.923 1.689 . . . . 1.24 106.96 172.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.505 ' HA2' HD12 ' A' ' 226' ' ' LEU . . . -53.58 -52.46 41.54 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.684 -0.566 . . . . 0.61 111.684 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -50.25 -51.0 48.28 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 117.763 0.781 . . . . 1.22 110.642 175.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.0 m -57.34 -47.14 82.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.157 0.983 . . . . 2.25 110.951 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.492 ' HB3' HD13 ' A' ' 147' ' ' LEU . 82.1 mt -59.13 -22.6 61.15 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.481 1.112 . . . . 2.71 112.392 174.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 124.54 4.14 7.61 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.557 1.075 . . . . 1.53 112.877 173.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.505 HD12 ' HA2' ' A' ' 221' ' ' GLY . 30.6 mt -80.78 122.34 27.04 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 118.218 1.009 . . . . 3.92 110.849 -169.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -65.24 179.68 8.73 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.468 -0.653 . . . . 3.46 111.468 173.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -77.02 121.31 23.34 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.133 0.573 . . . . 1.58 110.595 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.8 m -76.09 173.95 10.65 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.829 -0.434 . . . . 1.29 109.829 169.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.3 t -140.03 52.22 1.69 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.679 1.192 . . . . 2.55 109.259 -172.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -155.29 140.8 12.54 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 117.739 -1.124 . . . . 1.8 108.436 -173.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -93.85 -3.19 2.96 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.657 2.238 . . . . 1.16 114.978 -175.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -83.7 -33.46 25.14 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.243 -1.536 . . . . 2.01 109.096 165.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.44 ' HB1' ' CG ' ' A' ' 254' ' ' ASP . . . -58.3 156.67 9.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.259 1.024 . . . . 0.9 112.229 171.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 77.7 t -105.39 -19.73 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 114.204 -1.362 . . . . 0.67 110.368 169.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 4.3 tpt -73.47 -9.03 58.26 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.826 1.047 . . . . 1.83 113.826 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.38 167.14 1.34 Allowed Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.906 1.283 . . . . 3.32 113.07 176.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.407 ' HB2' ' H91' ' A' ' 269' ' ' NGH . 27.1 Cg_endo -73.61 -26.24 14.08 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.962 1.775 . . . . 1.62 112.111 170.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.353 0.2 OUTLIER -78.21 -178.89 5.89 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.224 1.81 . . . . 1.52 111.59 -170.039 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.416 ' CD1' HD22 ' A' ' 214' ' ' LEU . 73.9 t80 -113.72 148.62 36.1 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.184 1.793 . . . . 2.1 108.04 175.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -156.48 140.75 16.57 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.398 -1.334 . . . . 3.45 107.398 171.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -66.0 115.8 6.45 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.626 0.77 . . . . 3.34 110.19 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.7 m -135.64 99.9 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 124.099 0.959 . . . . 1.82 110.015 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.0 137.81 57.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.263 0.554 . . . . 4.55 111.639 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.576 HG22 ' CD1' ' A' ' 213' ' ' PHE . 1.2 pt -81.43 35.74 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 113.509 0.929 . . . . 3.53 113.509 -169.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -109.3 -63.1 1.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.033 0.933 . . . . 3.48 109.497 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 61.9 m -63.21 -48.74 77.04 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.228 -0.656 . . . . 1.84 109.228 -176.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 55.36 89.38 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.337 1.055 . . . . 4.82 110.66 176.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.72 143.68 19.83 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.096 -0.705 . . . . 3.11 109.096 170.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.479 HD12 ' CH2' ' A' ' 141' ' ' TRP . 1.5 mm? -83.71 164.3 19.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.676 1.59 . . . . 0.89 107.802 174.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.0 m -78.74 151.38 32.12 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 122.119 -0.363 . . . . 0.7 110.1 174.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.68 -47.26 77.06 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.001 0.52 . . . . 0.85 110.291 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -51.47 -51.57 53.9 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.563 0.745 . . . . 2.5 110.163 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -57.15 -53.05 62.49 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.11 -0.95 . . . . 2.34 109.218 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.1 mt -50.79 -43.44 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.041 1.336 . . . . 0.9 111.259 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -61.43 -50.92 70.86 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.484 -1.385 . . . . 5.73 109.36 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -47.25 -47.19 21.6 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.003 0.811 . . . . 1.34 112.567 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 1.044 HD13 HG22 ' A' ' 145' ' ' THR . 0.5 OUTLIER -70.13 -38.58 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 118.175 0.988 . . . . 2.2 110.413 -174.417 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -61.18 -33.23 73.11 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.68 -0.408 . . . . 2.69 110.244 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.9 m -50.82 -23.03 2.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.934 1.087 . . . . 2.62 113.934 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 8.8 mt -55.88 -38.93 70.83 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 120.326 1.421 . . . . 2.96 113.028 176.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 22.0 t80 44.8 -127.04 1.08 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 122.88 0.472 . . . . 7.68 111.989 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.215 0 N-CA-C 108.192 -1.963 . . . . 8.81 108.192 -178.339 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 269' ' ' NGH . . . . . 0.424 ' C1 ' HD22 ' A' ' 181' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 65.3 mtm . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 108.271 -1.011 . . . . 18.57 108.271 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 119.09 157.2 10.29 Favored Glycine 0 CA--C 1.532 1.136 0 N-CA-C 110.332 -1.107 . . . . 10.99 110.332 -175.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.03 164.33 33.51 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.754 2.969 . . . . 9.43 110.245 176.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.1 p -161.78 162.71 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 107.633 -1.247 . . . . 6.77 107.633 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -85.83 169.74 13.06 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.211 0.604 . . . . 10.18 111.305 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.84 -39.07 52.54 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.715 0.806 . . . . 10.69 111.619 174.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -170.74 -56.98 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.862 -0.792 . . . . 6.16 108.862 -172.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 69.29 -64.83 0.32 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.984 2.114 . . . . 3.65 111.873 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -108.25 119.27 39.0 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.548 -1.279 . . . . 3.41 107.548 -176.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.0 mp -134.43 147.4 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 105.405 -2.072 . . . . 2.6 105.405 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.65 142.2 17.61 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 105.06 -2.2 . . . . 2.27 105.06 -173.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -125.67 165.7 18.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.69 1.196 . . . . 4.32 111.148 -174.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -154.85 161.23 41.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.814 -0.809 . . . . 6.5 108.814 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.71 155.0 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.339 -1.356 . . . . 0.79 107.339 174.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -80.71 -51.4 8.72 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.643 -0.502 . . . . 2.83 109.643 173.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -157.14 170.17 23.11 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.483 0.583 . . . . 3.05 111.174 167.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -94.16 126.86 39.65 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.994 1.318 . . . . 2.77 109.773 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.4 ' HB ' ' CE2' ' A' ' 163' ' ' PHE . 11.2 t -70.29 147.45 95.25 Favored Pre-proline 0 N--CA 1.442 -0.853 0 O-C-N 121.933 -0.479 . . . . 2.57 112.29 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -80.34 -16.19 10.93 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 124.678 3.585 . . . . 2.05 111.22 168.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -50.45 -36.6 34.1 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.858 1.663 . . . . 2.16 112.116 -176.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 13.7 mtm -133.61 -177.96 4.78 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.9 1.68 . . . . 1.91 106.949 172.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -78.71 139.74 38.43 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.326 -0.62 . . . . 2.88 109.326 171.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -51.39 -42.45 61.4 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.713 -0.617 . . . . 4.0 112.179 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -65.19 -5.57 7.21 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.662 0.785 . . . . 3.08 112.274 -177.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -94.45 -47.41 6.58 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 126.515 1.926 . . . . 2.21 109.789 166.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.7 t -57.03 -61.72 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 C-N-CA 125.504 1.521 . . . . 1.15 109.454 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -28.06 67.48 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 117.825 -1.55 . . . . 1.7 109.019 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -61.05 -50.99 71.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 118.859 0.754 . . . . 2.91 109.952 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.29 -48.11 77.29 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 122.906 0.483 . . . . 0.56 110.729 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.9 -37.49 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.563 0.697 . . . . 1.55 110.128 -175.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -55.45 33.66 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.872 1.269 . . . . 4.0 107.926 178.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.585 ' O ' HG23 ' A' ' 140' ' ' VAL . 39.6 mmtm -56.33 -51.84 66.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.383 -0.599 . . . . 2.87 109.383 176.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.37 -49.03 46.27 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.625 0.648 . . . . 0.56 112.426 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -61.71 -51.77 67.04 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 121.894 -0.504 . . . . 4.59 109.902 173.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -55.82 -37.95 69.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.652 0.781 . . . . 2.0 110.777 -172.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 136' ' ' LYS . 42.5 t -53.61 -52.21 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.623 1.569 . . . . 0.76 108.844 177.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.404 ' CZ3' HG13 ' A' ' 258' ' ' ILE . 57.2 m95 -74.51 -32.72 62.59 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.997 -0.371 . . . . 0.71 109.997 -177.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.0 m -72.65 -9.2 58.33 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.215 0.45 . . . . 1.81 112.215 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -84.87 -52.39 6.05 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 107.565 -1.272 . . . . 1.16 107.565 175.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.415 HG11 HD23 ' A' ' 250' ' ' LEU . 5.7 m -76.42 -33.62 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 112.289 0.478 . . . . 1.78 112.289 -175.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.449 HG21 HD12 ' A' ' 258' ' ' ILE . 6.8 p -100.74 153.88 37.48 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.384 -0.598 . . . . 0.72 109.384 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.38 9.31 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.326 2.017 . . . . 0.81 112.967 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.4 mp -78.85 112.87 16.44 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.407 1.003 . . . . 2.44 108.862 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -95.61 73.22 3.17 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.701 -0.624 . . . . 3.42 111.676 -163.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -63.82 147.66 51.24 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.488 0.715 . . . . 5.92 112.123 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.9 t -149.68 147.5 28.15 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.576 1.55 . . . . 1.2 107.883 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -97.93 136.29 38.44 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.262 0.625 . . . . 2.04 109.87 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.2 pp -134.84 118.59 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.848 -1.167 . . . . 1.21 107.848 172.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -75.83 -32.24 59.72 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 119.723 -0.791 . . . . 3.33 110.13 172.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.6 m -113.94 95.68 5.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.681 0.792 . . . . 2.22 109.543 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 151.53 -154.24 25.44 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.665 -1.374 . . . . 1.4 109.665 170.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.6 tpt -111.82 136.67 50.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.182 1.393 . . . . 5.45 110.52 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -129.36 163.83 24.91 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.849 1.66 . . . . 0.8 109.363 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.51 -41.12 56.06 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.509 -0.922 . . . . 1.68 108.509 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 33.6 pt -121.97 175.7 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.786 1.234 . . . . 1.19 109.508 -176.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.7 tp -148.62 130.24 14.97 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.2 1.4 . . . . 2.88 108.879 -173.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.7 t -88.19 109.04 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 108.429 -0.952 . . . . 0.88 108.429 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.7 t -88.26 142.05 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.308 -0.997 . . . . 1.45 108.308 168.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.4 ' CE2' ' HB ' ' A' ' 122' ' ' THR . 0.0 OUTLIER -131.64 125.26 31.71 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 104.565 -2.383 . . . . 6.05 104.565 172.332 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.45 ' HB3' ' HE2' ' A' ' 174' ' ' PHE . . . -159.45 161.25 35.46 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.337 -1.727 . . . . 1.31 106.337 -174.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -123.87 152.94 41.79 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.523 -0.917 . . . . 4.13 108.523 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 69.2 -142.5 37.66 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.73 2.11 . . . . 1.63 113.013 172.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.16 129.83 34.86 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.937 -0.764 . . . . 2.25 108.937 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -141.52 34.44 1.64 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.791 0.436 . . . . 3.41 111.315 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 62.63 74.03 0.46 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.113 -1.195 . . . . 2.3 110.113 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -151.43 166.69 30.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.777 -1.194 . . . . 2.13 107.777 -173.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.42 -50.01 15.24 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.328 -0.99 . . . . 5.69 108.328 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -102.02 -34.93 9.14 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.681 -0.69 . . . . 4.84 109.865 -177.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 58.44 -151.39 0.42 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.328 0.651 . . . . 2.58 111.572 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.45 ' HE2' ' HB3' ' A' ' 164' ' ' ALA . 31.6 m-85 -125.06 167.1 15.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.52 1.128 . . . . 6.01 108.389 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.4 p30 -140.72 -20.47 0.82 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 115.763 1.764 . . . . 2.95 115.763 -150.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.47 132.91 0.27 Allowed Glycine 0 CA--C 1.534 1.24 0 N-CA-C 110.325 -1.11 . . . . 2.38 110.325 -162.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.9 tttt 56.31 -152.41 0.38 Allowed 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.389 -1.066 . . . . 5.99 110.079 -175.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.8 -107.42 0.01 OUTLIER Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.145 1.355 . . . . 1.56 115.343 -162.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 49.68 -114.59 2.42 Favored Glycine 0 C--N 1.34 0.759 0 CA-C-N 117.963 0.882 . . . . 1.28 111.987 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 10.6 mm -78.96 117.34 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 107.272 -1.381 . . . . 2.31 107.272 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.631 HD22 ' H5 ' ' A' ' 269' ' ' NGH . 7.7 mp -76.53 -60.26 2.42 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.318 -1.364 . . . . 1.41 107.318 170.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -164.82 169.69 16.35 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 121.08 -1.013 . . . . 0.74 109.522 -176.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -147.47 124.53 11.4 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 114.307 1.225 . . . . 0.96 114.307 -174.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -151.08 156.6 41.4 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.397 1.879 . . . . 0.55 106.454 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -145.52 160.36 41.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.471 -1.677 . . . . 3.22 106.471 175.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -90.44 -119.45 2.08 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 118.768 -1.018 . . . . 0.66 110.941 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.75 79.35 1.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.678 2.252 . . . . 2.35 110.299 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -141.41 163.43 26.79 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.755 -1.738 . . . . 1.23 108.755 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 p -78.94 169.32 18.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.285 1.034 . . . . 3.34 112.055 -170.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 53.48 -114.3 3.74 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.358 0.98 . . . . 1.61 111.592 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.439 HG12 ' CE1' ' A' ' 196' ' ' HIS . 3.5 tp -62.2 -35.44 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 118.335 -0.84 . . . . 1.69 109.869 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -40.68 141.31 0.94 Allowed Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.42 1.009 . . . . 1.28 113.087 176.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 93.6 -48.2 2.32 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.168 1.366 . . . . 0.73 110.883 -160.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.64 171.06 10.75 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.041 0.937 . . . . 1.24 108.824 -167.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -144.9 122.83 12.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 118.725 -0.655 . . . . 0.57 112.473 -169.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.475 ' N ' ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -115.37 115.56 26.8 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-O 117.696 -1.145 . . . . 2.09 111.076 -171.248 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -92.38 148.51 22.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.752 1.16 . . . . 2.89 110.446 174.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.98 98.52 9.29 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 122.497 1.141 . . . . 3.42 112.017 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -49.93 -33.19 16.73 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 119.852 -1.78 . . . . 2.9 110.389 170.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -36.09 -47.44 0.55 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.981 1.104 . . . . 3.6 113.981 172.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -73.78 156.34 37.93 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 123.252 1.501 . . . . 2.31 111.435 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -92.86 91.53 7.48 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 105.448 -2.056 . . . . 2.67 105.448 167.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -76.81 152.92 35.35 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.172 -1.047 . . . . 1.2 108.172 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 39.1 p -133.7 156.28 48.21 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.533 0.682 . . . . 1.85 110.345 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.3 -44.95 23.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.606 1.562 . . . . 1.69 110.379 170.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -76.66 178.43 6.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.022 1.329 . . . . 2.15 109.224 170.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.32 -60.83 2.86 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.036 1.334 . . . . 3.57 109.66 -172.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 57.1 -95.62 0.04 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.367 0.984 . . . . 2.34 112.563 168.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -135.41 -72.54 0.07 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.252 -1.539 . . . . 1.2 109.252 175.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.8 m -114.28 122.75 47.7 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.839 -1.541 . . . . 0.94 106.839 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -85.65 117.2 24.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.822 -1.177 . . . . 1.6 107.822 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.84 -53.66 14.92 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.271 0.628 . . . . 1.7 110.383 -175.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.475 ' CD1' HG22 ' A' ' 245' ' ' ILE . 30.3 t80 -43.4 -45.36 6.16 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.419 1.088 . . . . 1.71 110.77 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.6 tt -67.25 -57.5 6.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.302 -0.408 . . . . 1.41 110.707 -168.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 m -56.54 -46.55 80.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.453 -0.573 . . . . 1.16 109.453 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.0 -57.93 5.11 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 124.549 1.155 . . . . 0.57 110.69 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 71.0 t -48.27 -41.73 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 119.625 1.102 . . . . 0.7 111.168 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.441 ' NE2' ' CD2' ' A' ' 222' ' ' HIS . 0.2 OUTLIER -63.91 -54.48 34.08 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.311 -0.868 . . . . 2.33 112.404 178.161 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.74 -36.96 65.22 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.234 -0.917 . . . . 3.62 111.1 -174.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.7 -42.9 97.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 107.001 -1.481 . . . . 1.52 107.001 173.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -47.05 -54.06 9.99 Favored Glycine 0 CA--C 1.536 1.37 0 O-C-N 121.401 -0.812 . . . . 0.45 111.571 166.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.441 ' CD2' ' NE2' ' A' ' 218' ' ' HIS . 9.0 m-70 -50.79 -45.03 59.0 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 121.572 -0.957 . . . . 1.43 111.028 175.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 9.2 t -51.16 -41.17 59.96 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.213 0.605 . . . . 1.67 111.972 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.72 -54.15 40.0 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.245 -0.65 . . . . 2.63 109.245 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 131.54 73.69 0.11 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 111.565 -0.614 . . . . 1.2 111.565 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.648 HD13 ' SD ' ' A' ' 236' ' ' MET . 1.1 mt -124.69 121.48 34.78 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.311 1.044 . . . . 3.44 108.858 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -76.64 56.2 3.4 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.76 0.695 . . . . 2.49 111.985 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 77.4 m80 57.73 -169.53 0.11 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.656 1.182 . . . . 2.45 112.066 -175.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 75.5 m -148.59 -179.82 7.26 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 106.461 -1.681 . . . . 0.95 106.461 165.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 36.9 p -136.77 37.82 2.62 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.43 1.492 . . . . 2.44 109.244 -168.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -139.88 136.49 17.37 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 106.089 -1.819 . . . . 1.67 106.089 -173.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -85.73 -8.06 8.31 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.872 1.715 . . . . 1.04 114.287 -172.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -80.83 -42.95 20.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.929 -1.137 . . . . 1.18 107.929 168.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -55.19 140.74 37.7 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.203 0.525 . . . . 0.72 109.724 174.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 88.2 t -87.04 -23.14 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 108.684 -0.858 . . . . 0.72 108.684 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.648 ' SD ' HD13 ' A' ' 226' ' ' LEU . 0.6 OUTLIER -55.69 -29.5 59.49 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 115.811 1.782 . . . . 1.7 115.811 -177.126 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -50.08 162.48 0.49 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 125.659 1.584 . . . . 3.11 113.696 -172.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.93 -16.43 14.35 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.331 1.354 . . . . 0.95 111.907 170.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.377 0.2 OUTLIER -79.3 -179.7 6.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.167 1.387 . . . . 1.24 109.609 178.171 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -130.39 148.94 52.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 126.394 1.878 . . . . 2.09 106.144 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.66 173.88 13.65 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.768 -1.938 . . . . 2.46 105.768 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -87.75 117.82 26.84 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 119.578 1.081 . . . . 3.67 109.055 174.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.5 m -120.32 125.04 73.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 107.669 -1.234 . . . . 1.53 107.669 170.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -81.21 120.21 24.59 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.223 -0.591 . . . . 4.94 109.756 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.475 HG22 ' CD1' ' A' ' 213' ' ' PHE . 1.1 pp -59.16 -27.81 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.307 -0.406 . . . . 3.53 110.803 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -66.27 -35.01 79.31 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.289 0.495 . . . . 4.01 110.313 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 29.6 m -66.55 -49.75 65.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.535 -0.543 . . . . 1.89 109.535 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.474 ' CD1' HG22 ' A' ' 140' ' ' VAL . 0.4 OUTLIER 51.12 83.21 0.05 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.91 0.862 . . . . 5.06 110.562 179.533 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.48 158.35 31.78 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.64 -0.663 . . . . 4.06 109.345 169.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.554 ' N ' HD22 ' A' ' 250' ' ' LEU . 1.3 mm? -108.16 157.15 18.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.734 -1.58 . . . . 0.75 106.734 177.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 29.6 m -77.49 151.52 34.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.005 -0.434 . . . . 0.65 110.106 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.41 -45.41 46.18 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.699 0.4 . . . . 0.72 110.086 171.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -59.63 -36.11 75.7 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.588 0.708 . . . . 2.41 111.605 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -71.77 -51.52 22.27 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.709 1.243 . . . . 1.97 108.887 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 41.0 mt -52.79 -49.06 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 126.831 2.052 . . . . 0.94 112.124 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -55.19 -43.36 74.29 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.498 -1.376 . . . . 7.85 110.535 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -55.63 -40.42 78.91 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.045 -1.222 . . . . 0.79 110.045 174.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 258' ' ' ILE . 0.2 OUTLIER -66.91 -45.18 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 C-N-CA 123.257 0.623 . . . . 3.24 111.267 -176.8 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -63.31 -27.17 69.14 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 119.343 -0.943 . . . . 2.35 110.515 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.29 -15.27 0.91 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.145 1.165 . . . . 1.89 114.145 169.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 76.7 mt -46.91 -26.88 1.08 Allowed 'General case' 0 C--N 1.346 0.447 0 CA-C-N 121.055 1.752 . . . . 2.37 113.192 164.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -131.1 96.09 3.95 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.57 0.623 . . . . 6.88 110.238 175.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 116.246 -2.419 . . . . 8.52 111.785 173.596 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 269' ' ' NGH . . . . . 0.631 ' H5 ' HD22 ' A' ' 181' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 3.2 ptt? . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.171 -0.307 . . . . 15.69 110.171 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 112.74 -93.98 0.7 Allowed Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.461 -1.456 . . . . 8.99 109.461 -172.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.68 125.9 14.54 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.332 2.021 . . . . 11.54 109.815 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.5 t -148.19 156.96 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 127.049 2.14 . . . . 6.51 105.809 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 13.1 m-90 -68.45 168.42 12.77 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 119.116 0.871 . . . . 10.66 111.365 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -100.13 -42.76 6.57 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.746 0.818 . . . . 8.67 111.071 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.9 tptt -97.86 -53.49 3.39 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.861 0.319 . . . . 6.93 111.861 -162.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 74.94 -68.85 0.2 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.902 1.681 . . . . 5.34 111.368 172.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -102.56 113.5 26.93 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 126.199 1.8 . . . . 3.03 109.128 -174.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.436 HG22 ' CE1' ' A' ' 116' ' ' TYR . 1.4 mm -117.76 88.45 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 122.11 0.957 . . . . 2.08 109.33 -173.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 p -87.25 146.19 26.07 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.441 0.696 . . . . 1.31 109.495 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.438 ' CE2' ' CD1' ' A' ' 138' ' ' PHE . 10.5 m-85 -129.92 166.2 20.51 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.728 0.811 . . . . 6.69 110.364 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.564 ' HG3' HD23 ' A' ' 160' ' ' LEU . 9.5 ptt180 -153.51 168.91 24.56 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.335 0.654 . . . . 7.6 110.458 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.2 mt -119.4 148.53 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.265 -1.383 . . . . 1.12 107.265 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.597 ' ND2' HD11 ' A' ' 160' ' ' LEU . 29.9 m-20 -89.55 -67.71 0.82 Allowed 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.961 -1.126 . . . . 4.25 107.961 171.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -138.96 162.0 35.95 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.176 0.806 . . . . 1.97 113.176 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -104.3 154.0 20.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.411 1.884 . . . . 2.35 108.85 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.7 t -85.48 149.78 52.61 Favored Pre-proline 0 N--CA 1.444 -0.74 0 C-N-CA 124.3 1.04 . . . . 2.7 111.68 172.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -86.93 -17.6 3.1 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.155 3.236 . . . . 2.18 111.104 169.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -56.69 -46.84 80.95 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.963 0.905 . . . . 3.88 109.83 -177.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 4.2 mmt -101.49 -169.87 1.75 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.477 1.111 . . . . 3.38 108.037 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -103.28 145.76 29.47 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 108.397 -0.964 . . . . 2.93 108.397 167.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -55.38 -39.98 70.78 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.711 -0.618 . . . . 2.33 111.196 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -64.25 -7.68 10.16 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.706 -0.679 . . . . 3.17 112.302 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -95.67 -50.16 5.06 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.512 1.125 . . . . 3.25 109.259 162.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -50.58 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 118.894 0.77 . . . . 2.35 110.329 -166.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.492 ' HB3' ' NZ ' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -76.19 -19.15 58.68 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 118.066 -1.454 . . . . 1.71 109.776 178.558 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -73.1 -46.17 52.83 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 119.135 0.88 . . . . 2.22 108.736 -175.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.4 -54.24 23.31 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 124.184 0.994 . . . . 0.52 109.619 171.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.82 -48.79 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 121.059 -0.256 . . . . 2.33 110.472 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -50.26 -57.76 7.12 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.178 1.391 . . . . 4.34 108.899 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -64.7 -43.23 94.16 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.191 -0.913 . . . . 2.36 109.485 -176.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.01 -52.73 57.47 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.001 0.52 . . . . 0.45 110.134 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.471 ' CE1' HG13 ' A' ' 220' ' ' ILE . 61.5 m-85 -54.23 -44.84 72.06 Favored 'General case' 0 C--O 1.231 0.111 0 O-C-N 122.182 -0.324 . . . . 4.58 111.007 171.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.34 -37.19 67.13 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.547 -0.739 . . . . 2.0 111.852 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.435 HG12 HD21 ' A' ' 250' ' ' LEU . 62.7 t -55.55 -63.3 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 119.121 0.873 . . . . 0.84 109.571 177.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.906 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 58.7 m95 -70.48 -32.58 70.17 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.964 -0.754 . . . . 0.68 108.964 -171.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.3 t -64.62 -14.12 56.58 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.064 -0.97 . . . . 1.27 112.998 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -82.67 -48.27 11.09 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.036 -1.098 . . . . 1.04 108.036 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.3 m -76.98 -46.37 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 112.282 0.475 . . . . 1.5 112.282 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.712 HG22 HD13 ' A' ' 258' ' ' ILE . 22.9 p -82.81 152.54 66.3 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 108.18 -1.045 . . . . 0.61 108.18 177.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.26 9.07 3.53 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.334 2.023 . . . . 0.7 112.224 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.406 ' HB3' HG13 ' A' ' 114' ' ' ILE . 29.2 mt -67.52 108.79 2.97 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.502 1.046 . . . . 1.75 110.307 -178.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.1 mpmm? -70.94 91.13 0.84 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.463 0.649 . . . . 3.64 109.619 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.94 134.56 57.22 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 127.456 2.303 . . . . 6.42 109.687 168.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.3 t -153.46 106.69 2.96 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.372 -0.233 . . . . 0.77 110.372 163.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.492 ' NZ ' ' HB3' ' A' ' 131' ' ' ASP . 1.8 tmmt? -80.87 130.25 34.95 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.705 -0.85 . . . . 1.96 108.705 173.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.0 pt -128.47 142.2 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.037 -1.468 . . . . 1.35 107.037 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -95.59 -15.62 22.67 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 122.497 -0.127 . . . . 3.12 110.752 -177.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 52.8 m -136.57 130.09 31.85 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 125.096 1.358 . . . . 2.39 107.487 172.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 137.89 -152.87 21.94 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 107.999 -2.04 . . . . 1.6 107.999 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 41.2 mtp -123.73 131.57 53.63 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.892 1.677 . . . . 4.5 106.746 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -136.72 158.74 43.73 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.769 0.828 . . . . 0.89 110.304 -175.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -76.59 -49.11 17.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.706 -0.85 . . . . 1.63 108.706 -167.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.14 171.82 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.358 0.599 . . . . 1.25 110.772 172.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.597 HD11 ' ND2' ' A' ' 119' ' ' ASN . 1.0 OUTLIER -144.59 144.1 31.12 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.917 2.087 . . . . 3.22 109.1 178.752 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.505 ' N ' HD22 ' A' ' 160' ' ' LEU . 37.3 t -83.02 106.45 13.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 125.153 1.381 . . . . 1.24 109.054 170.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 69.9 t -84.84 118.3 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.215 -1.031 . . . . 1.39 108.215 171.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -80.87 138.79 36.19 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 105.856 -1.905 . . . . 7.49 105.856 160.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -147.14 161.59 40.57 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.564 -1.643 . . . . 1.22 106.564 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.6 ptt85 -155.92 121.36 4.87 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.45 -0.574 . . . . 3.65 109.45 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.465 ' HA2' ' CD1' ' A' ' 174' ' ' PHE . . . 80.4 -52.42 4.34 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.587 -0.605 . . . . 2.69 111.587 175.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -154.03 170.76 20.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.166 0.986 . . . . 2.23 108.489 173.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -159.76 -42.17 0.05 Allowed 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.84 0.856 . . . . 2.9 110.123 166.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 140.37 77.06 0.05 OUTLIER Glycine 0 CA--C 1.524 0.631 0 N-CA-C 107.349 -2.301 . . . . 2.7 107.349 -172.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -156.59 -177.91 6.95 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 106.371 -1.715 . . . . 2.42 106.371 -177.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -79.18 -50.27 11.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.952 -1.129 . . . . 5.84 107.952 165.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.47 -60.99 1.44 Allowed 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 122.831 0.452 . . . . 6.02 110.002 -174.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 68.48 -51.91 0.56 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.098 1.759 . . . . 3.46 114.519 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.502 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -159.99 -175.77 5.29 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.637 2.375 . . . . 7.93 105.364 -172.122 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.502 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 13.7 p30 177.2 43.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.863 1.265 . . . . 2.37 111.296 169.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 53.16 -158.43 4.16 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.49 -0.644 . . . . 1.45 111.49 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -76.73 119.1 20.05 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.94 -0.63 . . . . 5.21 109.78 -177.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.91 -160.86 13.71 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.118 -1.193 . . . . 1.61 110.118 -168.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.08 -128.52 43.96 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.038 1.304 . . . . 1.47 111.515 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.435 ' CD1' H102 ' A' ' 269' ' ' NGH . 0.5 OUTLIER -77.65 134.17 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 125.44 1.496 . . . . 3.05 107.299 178.762 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.534 HD22 ' H5 ' ' A' ' 269' ' ' NGH . 0.2 OUTLIER -85.14 -55.67 3.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.681 1.992 . . . . 1.21 109.14 173.448 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -163.78 162.44 23.83 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.495 -0.753 . . . . 0.67 111.617 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -154.14 105.01 2.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.356 1.462 . . . . 0.96 112.295 -174.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -121.63 158.81 27.81 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.113 2.165 . . . . 0.81 109.651 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -154.74 132.0 11.08 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 107.29 -1.374 . . . . 2.99 107.29 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.12 -89.23 0.51 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.286 0.946 . . . . 1.01 112.836 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.08 83.76 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.943 3.096 . . . . 1.56 111.041 -169.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -160.05 165.31 34.7 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.532 -1.427 . . . . 1.14 109.532 172.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.8 m -78.89 169.99 17.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.468 0.707 . . . . 1.99 111.149 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 55.08 -108.06 0.89 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 123.827 0.727 . . . . 1.45 111.588 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 8.9 tp -59.82 -40.07 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 118.547 -0.739 . . . . 1.63 109.671 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -42.12 143.23 1.17 Allowed Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.399 0.999 . . . . 1.12 113.111 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 94.26 -59.21 1.97 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.908 1.718 . . . . 0.82 109.213 -155.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.38 148.51 31.99 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.898 -0.778 . . . . 1.44 108.898 -155.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -112.24 120.42 41.69 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 118.963 -0.542 . . . . 0.62 110.272 -174.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.497 ' N ' ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -107.15 137.89 44.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.024 -1.473 . . . . 2.42 107.024 -175.74 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -127.69 144.29 51.09 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.172 -1.418 . . . . 2.68 107.172 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -74.26 67.19 1.37 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.783 -1.191 . . . . 2.94 107.783 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -54.5 -45.4 73.25 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.811 -1.181 . . . . 2.62 107.811 -174.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -32.54 -44.25 0.1 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.937 1.695 . . . . 3.84 112.044 -170.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -63.97 -178.44 0.33 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 129.412 3.085 . . . . 2.21 109.399 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -129.06 90.2 2.99 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 120.095 -1.628 . . . . 3.02 108.701 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.445 ' HB2' ' HB ' ' A' ' 210' ' ' THR . 5.7 p-90 -134.67 119.46 18.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.726 0.81 . . . . 3.31 111.32 -173.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 14.9 p -153.62 158.62 41.42 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.822 1.249 . . . . 3.86 111.014 -177.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.66 -47.13 63.9 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.255 1.022 . . . . 4.64 109.874 172.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -67.78 -29.87 69.17 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 114.884 -1.053 . . . . 4.97 110.887 -167.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.0 t -81.64 -44.82 16.65 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.707 -0.849 . . . . 8.67 108.707 174.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.09 -35.56 4.32 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 124.579 1.085 . . . . 3.28 110.649 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -27.17 -92.85 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 128.782 3.087 . . . . 1.08 114.589 -173.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 203' ' ' TRP . 88.5 m -118.66 123.04 43.97 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 104.525 -2.398 . . . . 1.72 104.525 160.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -69.96 120.19 15.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 118.491 -1.284 . . . . 1.37 109.541 172.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 60.8 tp -50.41 -50.75 51.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.827 -0.606 . . . . 1.73 111.693 177.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.537 ' O ' HG23 ' A' ' 217' ' ' VAL . 18.0 t80 -52.24 -49.88 63.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.974 0.806 . . . . 1.38 110.767 176.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.5 tt -57.33 -60.92 2.91 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.994 0.917 . . . . 1.2 110.705 -174.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.351 25.4 m -60.71 -35.98 77.67 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.945 -0.391 . . . . 1.53 109.945 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.59 -52.2 62.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 117.053 -1.451 . . . . 0.48 110.712 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 213' ' ' PHE . 35.1 t -44.93 -53.22 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 121.579 1.991 . . . . 0.89 110.922 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.493 ' NE2' ' CE1' ' A' ' 222' ' ' HIS . 4.0 t60 -56.03 -54.05 49.59 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.854 0.862 . . . . 2.68 111.632 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -71.23 -44.68 64.87 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.797 -1.189 . . . . 4.03 112.45 -173.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.471 HG13 ' CE1' ' A' ' 138' ' ' PHE . 1.7 mp -49.98 -44.79 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.604 1.562 . . . . 1.46 108.265 166.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -53.19 -51.14 48.68 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.546 -0.721 . . . . 0.46 111.82 170.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.493 ' CE1' ' NE2' ' A' ' 218' ' ' HIS . 4.5 m-70 -52.03 -42.41 63.05 Favored 'General case' 0 C--N 1.34 0.173 0 O-C-N 121.429 -1.042 . . . . 1.44 111.492 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.3 m -58.11 -26.61 62.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.797 0.665 . . . . 2.24 112.797 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.4 mt -73.77 -51.96 14.74 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.068 -1.086 . . . . 2.14 108.068 171.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 138.48 70.38 0.05 OUTLIER Glycine 0 C--N 1.34 0.755 0 C-N-CA 122.844 0.259 . . . . 1.25 112.548 170.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.637 ' CD1' HG22 ' A' ' 258' ' ' ILE . 15.6 mt -132.74 105.57 7.25 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.178 0.591 . . . . 3.28 109.771 -172.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -76.75 43.3 1.89 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.338 0.97 . . . . 3.09 113.046 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 22.0 m80 73.88 155.51 0.16 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.356 1.862 . . . . 1.71 111.605 -175.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 58.1 m -120.17 132.0 55.22 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 126.149 1.78 . . . . 1.83 106.321 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 22.6 p -79.64 57.02 2.36 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.398 0.679 . . . . 3.2 110.854 -175.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -156.18 137.8 9.73 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 118.006 -0.997 . . . . 2.2 109.733 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.92 -20.89 7.26 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.76 2.306 . . . . 1.45 114.606 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -27.42 48.91 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 119.258 0.935 . . . . 2.12 109.957 175.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.419 ' HB1' ' CG ' ' A' ' 254' ' ' ASP . . . -65.81 130.65 44.01 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.602 1.161 . . . . 1.08 110.105 168.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 85.8 t -70.94 -25.84 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.899 0.856 . . . . 0.93 110.165 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -53.03 -18.12 1.87 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.95 1.3 . . . . 1.74 114.278 170.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.415 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 10.3 t80 -56.32 137.89 74.92 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 119.738 1.154 . . . . 5.72 110.492 -174.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.415 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 43.4 Cg_endo -63.84 -21.77 69.17 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.88 2.387 . . . . 1.38 112.597 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.359 0.2 OUTLIER -92.05 130.74 37.72 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.279 -0.637 . . . . 2.21 109.279 -179.558 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -76.71 141.67 40.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.638 -0.875 . . . . 2.07 108.638 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.84 131.08 13.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.193 -1.78 . . . . 2.46 106.193 170.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -54.73 115.01 1.93 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.066 0.946 . . . . 3.08 110.599 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.4 m -94.18 138.92 19.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 122.957 0.503 . . . . 1.55 110.726 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.41 89.64 1.25 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.985 -0.746 . . . . 3.9 108.985 173.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 47.1 mt -48.88 -31.25 3.83 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 123.848 0.859 . . . . 2.68 110.335 174.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -39.33 -41.54 0.93 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.438 1.495 . . . . 3.51 113.589 171.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 8.4 m -81.38 -41.58 21.75 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.796 0.838 . . . . 1.9 110.57 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 78.9 t80 46.77 70.63 0.38 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.15 1.38 . . . . 4.68 111.511 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -156.55 167.17 31.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.57 -0.706 . . . . 3.75 109.91 175.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.51 HD12 ' CH2' ' A' ' 141' ' ' TRP . 2.0 mm? -105.9 157.81 17.22 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.727 1.611 . . . . 1.09 108.009 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 10.1 m -79.44 154.31 29.03 Favored 'General case' 0 C--O 1.221 -0.404 0 O-C-N 121.295 -0.878 . . . . 1.03 111.418 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.13 -48.63 75.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.975 0.893 . . . . 1.14 109.862 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.61 -52.37 18.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.192 1.797 . . . . 4.62 108.633 172.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.419 ' CG ' ' HB1' ' A' ' 234' ' ' ALA . 0.7 OUTLIER -63.38 -46.02 88.41 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.978 -1.01 . . . . 2.22 110.516 -176.278 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.4 ' HA ' HG13 ' A' ' 258' ' ' ILE . 45.3 mt -53.12 -42.23 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.725 2.01 . . . . 0.97 110.35 176.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -64.75 -48.82 73.16 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.007 -1.058 . . . . 5.89 111.078 172.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -45.42 -55.5 6.8 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 111.764 -0.535 . . . . 0.82 111.764 174.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.906 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 1.9 pp -65.81 -40.51 87.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 123.982 0.913 . . . . 2.18 111.361 -176.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.569 ' N ' HD12 ' A' ' 258' ' ' ILE . 3.9 mt-30 -62.18 -30.02 70.77 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.741 -1.224 . . . . 2.56 110.849 174.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.8 -14.43 2.34 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.101 1.149 . . . . 1.87 114.101 169.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.3 mt -47.27 -26.78 1.31 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 121.02 1.736 . . . . 2.38 112.716 164.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -69.67 -43.89 71.61 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.951 0.796 . . . . 6.92 111.93 172.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 117.232 -1.871 . . . . 8.36 108.674 -174.475 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 269' ' ' NGH . . . . . 0.534 ' H5 ' HD22 ' A' ' 181' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.536 ' HG2' HD11 ' A' ' 114' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.536 0.409 0 CA-C-O 120.604 0.24 . . . . 5.81 111.342 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 41.6 m80 56.34 -72.33 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.059 1.743 . . . . 3.52 110.956 -159.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -104.85 101.3 10.9 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.915 0.886 . . . . 3.61 112.315 -169.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.536 HD11 ' HG2' ' A' ' 111' ' ' LYS . 25.8 mm -81.77 91.77 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 108.478 -0.934 . . . . 2.41 108.478 170.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.1 p -79.93 125.21 29.45 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.137 -0.69 . . . . 1.25 109.137 171.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -130.75 158.47 40.03 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.383 0.673 . . . . 4.33 111.031 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -144.47 145.04 31.66 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.521 -0.918 . . . . 5.2 108.521 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.99 147.24 5.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 108.143 -1.058 . . . . 1.15 108.143 174.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -84.71 -44.32 13.49 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.455 -0.572 . . . . 3.56 109.455 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -153.25 171.58 18.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.912 -0.773 . . . . 2.25 108.912 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -128.13 129.95 47.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.876 1.27 . . . . 2.19 108.15 -163.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.5 t -63.47 114.18 12.19 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 118.539 0.609 . . . . 2.38 109.739 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -68.41 -17.98 43.96 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.488 2.792 . . . . 1.58 111.125 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.22 -34.25 0.74 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.632 2.773 . . . . 2.27 111.61 174.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.51 -179.64 5.57 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.056 1.342 . . . . 1.98 109.418 175.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -71.32 132.38 44.8 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 109.22 -0.659 . . . . 3.09 109.22 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 53.5 ttt-85 -47.79 -40.41 20.82 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.507 0.558 . . . . 2.15 112.507 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -50.38 -55.33 16.15 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.812 -0.81 . . . . 2.84 108.812 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -55.11 -45.03 75.49 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.937 1.695 . . . . 2.26 111.908 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.63 -57.83 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 O-C-N 121.418 -0.802 . . . . 1.27 109.694 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -27.53 66.61 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 117.919 -1.513 . . . . 1.78 109.184 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -59.72 -47.91 83.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.206 0.912 . . . . 1.99 110.383 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.82 -52.56 64.95 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.081 0.552 . . . . 0.43 110.508 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.431 HD11 HD11 ' A' ' 220' ' ' ILE . 0.1 OUTLIER -70.05 -37.6 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.289 -0.634 . . . . 1.5 109.289 -175.281 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -55.34 -60.83 2.85 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.502 1.121 . . . . 4.0 108.021 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.656 ' O ' HG23 ' A' ' 140' ' ' VAL . 8.3 mmmm -58.0 -45.86 86.16 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.246 1.018 . . . . 1.49 109.445 -176.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.53 -52.66 36.66 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.968 0.907 . . . . 0.63 111.429 175.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.508 ' HB3' ' CD2' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -53.67 -55.48 25.69 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 110.091 -0.337 . . . . 4.56 110.091 170.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.55 -44.61 46.71 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.314 1.046 . . . . 3.49 110.497 -171.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 136' ' ' LYS . 45.2 t -47.58 -54.06 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.109 0.964 . . . . 0.71 110.098 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.848 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 83.8 m95 -72.08 -41.07 67.78 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.283 -0.636 . . . . 0.66 109.283 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.02 -22.76 51.36 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.919 0.888 . . . . 1.1 111.271 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -75.37 -43.63 49.32 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.088 0.955 . . . . 1.57 110.942 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.633 HG21 HD23 ' A' ' 250' ' ' LEU . 65.8 t -84.87 -49.39 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.685 1.194 . . . . 1.9 110.825 -173.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.501 HG22 HD13 ' A' ' 258' ' ' ILE . 81.6 p -77.24 158.0 80.09 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 107.976 -1.12 . . . . 0.6 107.976 174.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.08 -1.03 10.72 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.75 1.633 . . . . 0.84 112.601 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.948 HD13 HD22 ' A' ' 224' ' ' LEU . 10.4 mt -62.24 139.76 58.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.021 0.828 . . . . 1.86 110.263 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.38 97.13 6.14 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.049 -1.093 . . . . 7.34 108.049 177.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.508 ' CD2' ' HB3' ' A' ' 138' ' ' PHE . 0.4 OUTLIER -64.56 153.82 38.03 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.373 0.508 . . . . 6.9 112.373 175.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.57 113.77 3.42 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 123.948 0.899 . . . . 1.11 110.103 176.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.47 139.6 33.86 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.526 -0.916 . . . . 1.99 108.526 173.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.1 pp -139.34 114.28 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.309 -0.997 . . . . 1.36 108.309 172.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -80.15 -15.74 56.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.452 -0.34 . . . . 2.66 110.753 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 72.2 p -124.37 89.2 3.03 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 124.585 1.154 . . . . 2.57 110.798 -170.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 145.83 -143.38 11.61 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.41 -1.876 . . . . 1.53 108.41 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 33.6 mtt -127.43 131.18 50.28 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.857 2.063 . . . . 4.96 107.751 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -109.94 167.22 10.33 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.589 1.556 . . . . 0.78 109.274 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -79.94 -50.59 10.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.761 -0.829 . . . . 2.34 108.761 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 12.3 pt -106.75 169.08 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.454 0.645 . . . . 0.97 109.742 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.64 135.74 35.2 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.929 1.292 . . . . 2.22 109.848 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.8 t -100.75 102.56 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.051 0.94 . . . . 0.99 109.476 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.3 t -89.17 88.7 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 126.023 1.729 . . . . 1.58 111.341 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -81.78 105.43 12.91 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 107.115 -1.439 . . . . 5.65 107.115 170.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -123.95 151.76 43.24 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 118.415 0.552 . . . . 0.84 109.737 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.56 99.88 6.53 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.847 1.259 . . . . 4.07 109.699 -167.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 54.13 43.29 73.66 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.426 1.012 . . . . 3.7 111.439 172.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -157.27 176.39 12.76 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.467 0.707 . . . . 4.57 109.895 -170.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.287 0 C-N-CA 127.522 2.329 . . . . 3.98 110.439 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.237 0 CA-C-O 119.254 -0.403 . . . . 2.66 110.838 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -160.52 166.69 28.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.13 1.772 . . . . 6.47 106.34 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.8 p30 -153.76 168.91 24.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.295 -1.372 . . . . 3.69 107.295 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -66.79 -148.18 0.09 OUTLIER Glycine 0 CA--C 1.533 1.162 0 CA-C-O 122.867 1.26 . . . . 1.61 114.264 -170.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.13 78.78 0.51 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.488 1.515 . . . . 3.91 110.065 -171.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 135.7 -159.23 24.12 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 108.711 -1.756 . . . . 2.12 108.711 -174.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 64.57 -125.03 30.43 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.892 -1.283 . . . . 1.98 109.892 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . 0.276 21.0 mm -77.21 132.32 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 108.67 -0.863 . . . . 1.65 108.67 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 9.1 mp -85.27 -63.1 1.38 Allowed 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.373 2.269 . . . . 1.19 109.303 168.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -168.75 152.4 5.48 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 114.385 1.254 . . . . 0.67 114.385 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -151.2 138.82 19.65 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.157 0.983 . . . . 1.27 112.772 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . 0.26 . . -163.51 162.21 24.47 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.479 1.911 . . . . 0.72 106.087 -157.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -149.28 140.74 23.32 Favored 'General case' 0 C--O 1.227 -0.089 0 N-CA-C 109.282 -0.636 . . . . 3.24 109.282 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.94 -87.34 1.77 Allowed Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.189 -1.164 . . . . 0.62 110.189 173.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -69.92 89.38 0.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.72 2.947 . . . . 1.49 110.855 -173.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -165.37 172.12 40.85 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 108.047 -2.021 . . . . 1.27 108.047 171.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.2 p -84.06 172.81 11.65 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.147 0.979 . . . . 2.27 109.782 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.93 -103.54 0.14 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.033 0.825 . . . . 1.4 112.409 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.9 tp -59.43 -40.2 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-O 118.371 -0.823 . . . . 1.5 109.282 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -36.1 132.13 0.79 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.632 1.11 . . . . 1.17 113.0 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.82 -43.28 1.77 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.944 1.735 . . . . 0.88 110.915 -164.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.62 159.97 15.62 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.635 0.774 . . . . 1.46 109.482 -162.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -138.75 125.24 20.57 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 117.96 -1.019 . . . . 0.9 113.392 -168.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -111.83 139.58 47.19 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 119.423 1.01 . . . . 2.27 109.234 -168.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -135.99 148.41 48.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.177 0.899 . . . . 2.98 110.741 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -73.33 82.2 1.39 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.411 -1.268 . . . . 2.38 110.462 -176.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -61.05 -27.1 68.1 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 121.205 -0.934 . . . . 3.74 110.833 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.76 -43.4 12.99 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.263 1.425 . . . . 2.66 109.793 172.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -70.89 157.11 38.72 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 123.827 1.775 . . . . 2.01 112.581 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -102.4 87.71 3.09 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 112.727 -2.033 . . . . 5.65 106.698 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -75.06 154.34 37.97 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 113.762 -1.563 . . . . 1.17 107.595 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.3 p -136.3 137.64 40.89 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.387 0.613 . . . . 1.63 109.5 -171.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.9 -47.04 88.24 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.333 -1.479 . . . . 1.93 110.33 173.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -65.61 151.63 46.03 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.588 -0.733 . . . . 2.04 110.37 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.7 m -60.27 -38.33 83.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.75 1.22 . . . . 4.44 110.555 -171.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -55.62 120.82 20.43 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-O 118.829 -0.984 . . . . 3.11 111.98 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 109.17 -125.71 7.81 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.94 -1.664 . . . . 1.08 108.94 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 m -117.07 117.15 28.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.372 -1.714 . . . . 0.96 106.372 164.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -77.24 122.11 24.61 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.523 -0.871 . . . . 1.32 110.742 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 20.3 tp -56.31 -53.65 54.81 Favored 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 109.6 -0.518 . . . . 1.95 109.6 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.552 ' O ' HG23 ' A' ' 217' ' ' VAL . 21.6 t80 -48.54 -46.05 38.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.055 0.455 . . . . 1.56 110.135 -178.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.44 ' C ' HD23 ' A' ' 214' ' ' LEU . 6.8 tt -57.37 -65.26 0.66 Allowed 'General case' 0 C--O 1.23 0.07 0 C-N-CA 123.85 0.86 . . . . 1.19 110.223 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.29 0.8 OUTLIER -56.49 -40.09 74.34 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.445 0.641 . . . . 0.83 110.214 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.62 -46.75 77.35 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 117.358 -1.306 . . . . 0.43 110.36 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 213' ' ' PHE . 66.4 t -48.79 -45.65 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 120.422 1.464 . . . . 0.83 110.803 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.532 ' CE1' ' O ' ' A' ' 236' ' ' MET . 60.1 t60 -64.15 -50.33 68.61 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.933 0.893 . . . . 2.39 112.447 176.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -64.85 -42.92 94.51 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.695 -1.253 . . . . 3.07 112.494 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.447 HG21 ' HA ' ' A' ' 138' ' ' PHE . 1.1 mp -55.51 -43.12 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 107.795 -1.187 . . . . 1.1 107.795 172.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.99 -52.0 27.85 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 112.246 -0.341 . . . . 0.68 112.246 169.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.505 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 20.0 m-70 -49.48 -52.34 29.94 Favored 'General case' 0 C--N 1.341 0.197 0 O-C-N 122.06 -0.67 . . . . 1.71 110.658 173.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 89.2 p -62.84 -45.85 90.68 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.518 0.562 . . . . 1.83 112.518 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.948 HD22 HD13 ' A' ' 147' ' ' LEU . 91.0 mt -56.8 -41.62 78.06 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.647 -0.501 . . . . 2.39 109.647 176.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 118.43 29.11 1.99 Allowed Glycine 0 C--N 1.337 0.626 0 C-N-CA 124.978 1.275 . . . . 1.2 111.491 171.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.593 HD22 HG22 ' A' ' 258' ' ' ILE . 12.1 mt -75.0 143.57 43.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.935 -1.506 . . . . 4.3 106.935 -173.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -72.9 143.8 34.06 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.072 -1.211 . . . . 3.18 110.072 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.412 ' CE1' ' HE1' ' A' ' 222' ' ' HIS . 12.1 m80 -50.92 118.24 3.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.723 0.762 . . . . 1.46 110.088 172.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 64.9 m -78.72 173.15 12.76 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.615 -0.513 . . . . 0.95 109.615 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.11 30.23 2.47 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.68 0.792 . . . . 2.31 110.742 -170.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -132.06 133.18 23.63 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 106.898 -1.519 . . . . 1.88 106.898 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.94 -14.4 44.95 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.449 2.099 . . . . 1.02 114.162 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -81.13 -27.79 35.37 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.121 0.968 . . . . 1.4 111.279 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.22 152.64 45.17 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.849 -0.797 . . . . 0.69 108.849 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 66.8 t -99.11 -25.88 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.296 -0.865 . . . . 0.53 109.536 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.532 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 10.8 tpt -65.59 -18.73 65.54 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.157 -0.964 . . . . 2.96 113.073 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.471 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.1 157.34 0.66 Allowed Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.719 1.608 . . . . 3.04 113.457 -175.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.93 -20.63 16.86 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.712 1.608 . . . . 1.11 111.453 174.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.371 0.2 OUTLIER -77.38 178.03 7.49 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.512 1.125 . . . . 1.37 109.1 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -126.66 147.64 49.91 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.418 -1.327 . . . . 2.44 107.418 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -150.54 146.47 26.6 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.047 -1.464 . . . . 3.34 107.047 170.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -72.47 83.41 1.1 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.24 1.016 . . . . 3.9 108.61 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.7 m -76.71 136.75 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 109.413 -0.588 . . . . 1.59 109.413 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -87.09 117.97 26.18 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.1 -0.5 . . . . 3.09 110.063 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 20.9 mt -60.49 -20.44 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 119.223 -0.417 . . . . 2.5 110.222 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -52.35 -36.02 52.57 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.333 0.969 . . . . 3.51 111.83 171.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.0 m -81.54 -47.69 12.77 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 122.756 0.423 . . . . 2.46 110.31 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.547 ' CE1' HG22 ' A' ' 140' ' ' VAL . 62.1 t80 45.61 73.33 0.17 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.315 1.446 . . . . 4.36 111.868 177.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.89 168.77 23.98 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 121.278 -0.889 . . . . 4.76 110.222 177.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.633 HD23 HG21 ' A' ' 144' ' ' VAL . 1.3 mm? -108.86 149.03 29.71 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.762 1.625 . . . . 0.82 108.066 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.9 m -77.44 158.38 30.04 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 121.17 -0.212 . . . . 0.58 111.415 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -58.28 -47.87 82.26 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.728 0.411 . . . . 0.83 110.549 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -55.46 -40.21 71.34 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.039 0.935 . . . . 3.64 110.035 176.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.42 -52.1 59.79 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.789 0.835 . . . . 2.01 109.815 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.424 ' HA ' HG13 ' A' ' 258' ' ' ILE . 48.9 mt -56.11 -42.86 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 127.063 2.145 . . . . 0.74 112.271 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -61.71 -42.45 98.96 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.177 -1.577 . . . . 7.91 110.383 172.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -54.34 -53.14 39.83 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.285 -1.126 . . . . 0.9 110.285 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.848 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 1.8 pp -63.96 -43.04 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 O-C-N 122.104 -0.645 . . . . 2.25 110.724 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -65.81 -20.14 66.14 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.843 0.747 . . . . 2.06 112.368 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 t -52.11 -33.39 39.55 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.633 0.651 . . . . 2.02 110.789 168.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.485 ' CD1' HD23 ' A' ' 226' ' ' LEU . 14.8 mt . . . . . 0 N--CA 1.452 -0.372 0 O-C-N 121.594 -0.691 . . . . 3.54 110.196 175.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.231 0 N-CA-C 110.056 -0.35 . . . . 5.51 110.056 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 2.1 m170 63.16 -63.17 0.12 Allowed 'General case' 0 C--N 1.342 0.244 0 C-N-CA 126.462 1.905 . . . . 4.1 113.197 -172.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -79.04 104.11 9.45 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.321 -0.992 . . . . 2.75 108.321 -176.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.415 HG21 ' CE1' ' A' ' 149' ' ' PHE . 9.2 mm -113.36 142.57 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.09 -1.448 . . . . 1.78 107.09 173.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.6 p -135.61 140.67 44.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.66 -0.867 . . . . 1.16 108.66 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -126.73 160.48 30.7 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.645 0.778 . . . . 4.21 111.453 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.52 145.8 31.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.252 1.021 . . . . 4.26 108.994 174.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -94.47 159.82 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.105 -1.443 . . . . 0.83 107.105 173.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.563 ' ND2' ' H ' ' A' ' 163' ' ' PHE . 1.3 p30 -101.84 -38.95 7.61 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.815 0.846 . . . . 2.99 110.385 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -150.78 173.56 14.07 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.077 1.351 . . . . 2.4 107.868 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -113.5 129.54 56.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.058 0.943 . . . . 1.98 109.641 -175.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -41.08 135.48 1.71 Allowed Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.536 1.534 . . . . 3.12 109.64 165.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -84.97 -23.15 2.59 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.44 2.76 . . . . 2.35 110.323 167.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.26 -43.95 33.05 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.74 1.616 . . . . 3.17 111.085 -174.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 7.8 mtm -127.18 173.38 9.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.431 1.492 . . . . 2.64 109.435 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.423 ' O ' HG13 ' A' ' 130' ' ' VAL . 69.5 m-80 -71.64 152.76 42.59 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.292 0.637 . . . . 3.3 110.498 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -44.97 -52.58 8.64 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.915 0.886 . . . . 2.63 112.067 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -64.67 -5.28 5.37 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.492 -0.766 . . . . 2.86 113.061 -177.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -103.63 -41.74 5.86 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.551 1.54 . . . . 2.42 110.56 168.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 126' ' ' ASN . 1.5 m -57.62 -52.69 54.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 O-C-N 121.123 -0.986 . . . . 2.65 110.021 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.36 -24.74 64.83 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 118.41 -1.316 . . . . 1.68 108.449 178.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -63.38 -49.94 71.86 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 120.298 1.408 . . . . 2.11 110.402 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.28 -55.12 27.11 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 123.421 0.688 . . . . 0.39 109.828 175.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.88 -41.75 92.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 120.495 -0.482 . . . . 2.47 110.09 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.6 ttt-85 -57.51 -54.16 49.97 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.906 1.282 . . . . 4.01 108.146 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.634 ' O ' HG23 ' A' ' 140' ' ' VAL . 4.9 mmmp? -60.27 -46.62 89.17 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.886 0.875 . . . . 1.72 109.291 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.72 -53.43 31.47 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.421 0.689 . . . . 0.47 111.238 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.456 ' HA ' HG21 ' A' ' 220' ' ' ILE . 32.0 m-85 -53.84 -50.8 65.4 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.197 0.599 . . . . 4.57 109.969 171.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.57 -38.25 74.52 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 119.166 -0.445 . . . . 2.04 111.313 -173.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.738 HG22 ' CE1' ' A' ' 248' ' ' PHE . 98.4 t -51.04 -58.8 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.332 1.053 . . . . 0.71 109.127 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.701 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 45.7 m95 -72.8 -34.68 67.05 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.299 -0.63 . . . . 0.88 109.299 -174.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 t -64.2 -27.24 68.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.129 0.572 . . . . 1.18 111.652 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -70.31 -46.36 64.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 121.573 -0.705 . . . . 1.26 109.56 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.9 t -77.39 -56.46 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.217 0.607 . . . . 2.01 110.792 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 72.3 p -80.27 157.07 73.52 Favored Pre-proline 0 CA--C 1.53 0.193 0 N-CA-C 108.564 -0.902 . . . . 0.72 108.564 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.07 3.01 7.01 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.844 1.696 . . . . 1.03 112.869 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.8 mt -73.71 100.55 3.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.101 0.864 . . . . 1.86 109.928 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -84.61 96.67 9.26 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.096 0.959 . . . . 3.59 109.132 -169.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.415 ' CE1' HG21 ' A' ' 114' ' ' ILE . 41.8 m-85 -79.25 154.79 28.92 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.313 1.045 . . . . 5.58 112.831 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -155.42 138.98 15.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.681 1.192 . . . . 1.02 108.505 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.38 142.1 28.0 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 108.476 -0.935 . . . . 2.11 108.476 173.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.2 pt -130.52 115.87 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.397 -1.334 . . . . 1.26 107.397 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -80.73 -0.31 37.88 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.421 -0.585 . . . . 2.82 109.421 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 39.3 m -153.18 113.72 4.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.599 1.16 . . . . 2.29 108.433 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 138.81 -152.42 22.15 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 107.969 -2.053 . . . . 1.39 107.969 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -127.89 125.13 39.07 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.453 1.901 . . . . 5.28 107.04 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.69 166.02 11.11 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.429 1.091 . . . . 0.72 109.557 -173.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -77.97 -41.83 34.85 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.377 -0.971 . . . . 1.88 108.377 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 33.1 pt -124.48 159.93 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.924 0.89 . . . . 1.03 111.262 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.6 tt -126.97 128.29 46.16 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.321 1.449 . . . . 1.94 109.947 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.8 t -92.93 98.05 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 125.769 1.627 . . . . 0.83 108.097 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.9 t -80.14 136.02 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.719 -1.215 . . . . 1.41 107.719 170.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.563 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 7.3 m-85 -122.63 112.99 18.64 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 103.577 -2.749 . . . . 5.62 103.577 166.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 168' ' ' HIS . . . -147.65 159.76 43.42 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.4 -0.963 . . . . 0.98 108.4 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.79 131.39 47.79 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.027 -1.101 . . . . 4.29 108.027 -172.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 73.77 -113.18 4.1 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 111.062 -0.815 . . . . 1.71 111.062 -176.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -129.32 83.67 2.16 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.251 1.025 . . . . 2.29 110.527 -168.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.418 ' HB3' ' HB1' ' A' ' 164' ' ' ALA . 7.7 p80 . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 120.877 0.37 . . . . 3.21 111.97 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.415 ' HB1' ' CE1' ' A' ' 183' ' ' HIS . . . . . . . . 0 CA--C 1.528 0.103 0 N-CA-C 114.703 1.372 . . . . 2.37 114.703 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -123.72 164.93 18.15 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.103 0.961 . . . . 6.07 109.683 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -168.98 25.36 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.664 -0.698 . . . . 2.36 111.101 -158.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.17 -159.01 41.2 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.25 -1.14 . . . . 1.36 110.25 -171.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.56 104.67 1.32 Allowed 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 122.217 -0.578 . . . . 5.26 110.304 175.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 156.44 -179.01 32.63 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 108.678 -1.769 . . . . 1.91 108.678 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 45.28 -117.94 2.61 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 126.312 1.911 . . . . 1.71 111.123 171.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.3 mm -87.24 132.38 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 108.501 -0.926 . . . . 1.94 108.501 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.43 -42.77 18.13 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.708 1.603 . . . . 1.31 109.537 170.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.77 158.62 23.08 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.495 -0.753 . . . . 0.71 110.423 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.415 ' CE1' ' HB1' ' A' ' 173' ' ' ALA . 28.6 p-80 -138.44 114.63 10.22 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.647 1.179 . . . . 1.34 113.572 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 222' ' ' HIS . . . -132.21 163.76 27.86 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.919 2.088 . . . . 0.64 108.657 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -142.24 153.4 43.93 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.878 -1.527 . . . . 3.14 106.878 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -103.09 -90.35 2.15 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.296 -1.122 . . . . 0.69 110.296 172.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.04 82.74 0.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.93 3.086 . . . . 1.58 110.965 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -157.96 159.81 30.26 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 108.933 -1.667 . . . . 1.05 108.933 170.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.8 p -78.85 171.34 15.32 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.862 0.865 . . . . 2.11 110.101 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 54.28 -106.53 0.5 Allowed Glycine 0 C--O 1.244 0.721 0 C-N-CA 123.635 0.636 . . . . 1.48 111.626 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.4 tp -59.02 -43.22 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 118.501 -0.761 . . . . 1.56 109.14 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -43.3 135.05 4.96 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.492 1.044 . . . . 1.1 112.74 -177.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 107.0 -43.08 1.76 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.485 1.993 . . . . 0.66 110.751 -165.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.87 171.73 10.61 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.502 1.121 . . . . 1.51 110.957 -165.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.31 121.03 8.07 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.66 0.985 . . . . 0.74 113.66 -168.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -114.92 113.8 24.63 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 118.923 -0.56 . . . . 2.63 112.073 -172.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.403 ' HB2' ' CE1' ' A' ' 163' ' ' PHE . 56.5 m-85 -100.34 145.67 27.88 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.203 0.91 . . . . 2.89 112.412 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -73.21 82.66 1.34 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.851 0.834 . . . . 2.79 110.018 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -54.45 -28.96 47.87 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.293 -0.88 . . . . 3.45 111.352 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.82 -36.73 65.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.79 -0.448 . . . . 3.13 109.79 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.79 146.01 50.02 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 122.374 1.083 . . . . 1.89 109.154 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -92.15 92.25 8.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.357 -1.349 . . . . 2.77 107.357 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -78.01 131.46 37.38 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.443 -1.317 . . . . 1.12 107.443 -178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 41.0 p -116.87 136.09 53.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.428 0.691 . . . . 1.67 109.605 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.1 t -51.13 -49.39 60.89 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.622 1.169 . . . . 1.68 109.717 169.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.39 -179.36 5.69 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.149 0.98 . . . . 2.04 111.541 173.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.2 m -56.75 -56.56 19.89 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.791 1.236 . . . . 3.57 111.461 -173.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 42.97 -105.9 0.07 OUTLIER Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.017 1.294 . . . . 2.48 114.774 169.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -117.93 -63.3 0.31 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.252 0.93 . . . . 1.35 111.348 -172.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.37 164.55 27.18 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.193 -2.151 . . . . 1.01 105.193 165.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -116.9 133.24 56.26 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 119.248 0.931 . . . . 1.48 110.967 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 31.4 tp -62.78 -53.58 52.21 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.127 -0.488 . . . . 2.08 109.985 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.435 ' O ' HG23 ' A' ' 217' ' ' VAL . 28.2 t80 -50.87 -42.68 59.14 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.205 0.526 . . . . 1.38 109.852 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.02 -63.61 1.24 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.319 0.648 . . . . 1.33 109.656 -176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.315 2.0 m -57.14 -38.43 73.49 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.035 0.445 . . . . 0.77 110.651 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.76 -56.65 14.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 118.106 -0.95 . . . . 0.34 111.142 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 213' ' ' PHE . 90.1 t -51.27 -39.42 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 120.538 1.517 . . . . 0.71 111.291 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.917 ' NE2' ' CE1' ' A' ' 222' ' ' HIS . 0.5 OUTLIER -64.63 -51.4 62.82 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.128 0.971 . . . . 2.65 112.195 174.038 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.46 -45.74 71.64 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.069 -1.019 . . . . 2.69 111.965 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.456 HG21 ' HA ' ' A' ' 138' ' ' PHE . 1.5 mp -54.45 -43.99 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 106.616 -1.624 . . . . 1.16 106.616 170.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.2 -53.38 23.73 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 123.695 0.664 . . . . 0.45 113.105 170.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.917 ' CE1' ' NE2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -51.25 -42.12 60.82 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 121.848 -0.795 . . . . 1.58 110.999 174.163 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.4 t -51.24 -43.45 61.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 123.602 0.564 . . . . 1.96 112.07 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.517 ' HB3' HD13 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -66.31 -60.09 3.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.648 -0.821 . . . . 2.7 109.9 174.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 135.98 92.26 0.35 Allowed Glycine 0 C--N 1.338 0.676 0 N-CA-C 111.805 -0.518 . . . . 1.23 111.805 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.76 HD21 ' CE1' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -99.39 177.61 5.13 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.584 0.587 . . . . 5.74 112.584 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -120.73 20.7 8.67 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.724 1.154 . . . . 3.08 112.74 172.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 30.8 m80 56.14 95.69 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.14 1.776 . . . . 2.22 113.08 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.1 m -73.96 171.59 13.17 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.873 0.469 . . . . 1.18 110.592 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.7 t -137.25 47.06 2.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.186 0.994 . . . . 3.36 109.101 -169.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -148.9 123.62 4.86 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 107.18 -1.415 . . . . 2.14 107.18 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.19 -3.47 13.86 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.191 1.927 . . . . 1.59 114.011 -170.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -82.31 -24.36 34.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.493 1.042 . . . . 1.47 109.943 169.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -82.07 152.6 26.52 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.458 0.703 . . . . 0.77 109.632 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 24.0 t -104.52 -21.24 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.246 1.018 . . . . 0.72 111.334 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.44 -18.39 17.92 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.479 -0.763 . . . . 2.92 112.99 168.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.75 157.31 7.91 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 120.915 -1.116 . . . . 3.21 113.353 -176.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.53 -16.98 11.58 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.371 2.047 . . . . 0.9 111.791 173.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.355 0.2 OUTLIER -78.49 172.9 12.98 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.963 1.305 . . . . 1.16 109.697 -178.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -119.68 142.6 48.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.286 1.435 . . . . 2.21 107.265 173.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -156.08 125.73 6.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.422 -1.325 . . . . 3.55 107.422 170.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -45.52 142.13 2.42 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.063 1.345 . . . . 2.35 112.087 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.0 139.38 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.115 0.966 . . . . 2.2 109.363 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -41.11 96.8 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.111 0.964 . . . . 3.91 111.431 171.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 6.1 mt 66.29 18.78 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.623 1.569 . . . . 2.53 110.142 -160.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -71.05 -64.09 0.97 Allowed 'General case' 0 C--N 1.343 0.304 0 O-C-N 120.937 -1.102 . . . . 3.26 109.865 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 7.4 m -71.94 -39.73 69.22 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.496 -0.775 . . . . 1.85 109.558 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.738 ' CE1' HG22 ' A' ' 140' ' ' VAL . 1.0 OUTLIER 53.05 71.91 0.46 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.336 1.065 . . . . 4.71 109.411 176.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -151.36 165.0 35.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.433 -0.951 . . . . 3.34 108.433 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.602 HD12 ' CH2' ' A' ' 141' ' ' TRP . 1.9 mm? -95.42 174.19 7.14 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.419 1.488 . . . . 0.89 108.591 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.5 m -91.15 150.73 21.26 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 120.95 -1.094 . . . . 0.83 112.217 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.78 -43.37 65.8 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.51 -0.552 . . . . 0.78 109.51 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.59 -51.6 68.83 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.954 0.883 . . . . 2.28 110.383 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -57.6 -47.28 82.6 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.572 -1.194 . . . . 2.07 110.188 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 52.6 mt -52.03 -36.79 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.371 1.868 . . . . 0.73 111.329 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 36.7 mtt85 -70.43 -49.06 52.7 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 120.945 -1.097 . . . . 4.89 110.177 172.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -45.09 -56.86 5.8 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.708 0.67 . . . . 0.93 111.649 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.701 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 2.3 pp -63.87 -46.95 92.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.134 0.974 . . . . 2.13 110.434 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.51 ' N ' HD12 ' A' ' 258' ' ' ILE . 1.6 mm-40 -59.69 -26.6 65.72 Favored 'General case' 0 C--N 1.343 0.303 0 O-C-N 120.641 -1.287 . . . . 2.18 111.647 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.0 t -49.33 -26.46 3.13 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.652 0.612 . . . . 1.92 112.652 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.517 HD13 ' HB3' ' A' ' 224' ' ' LEU . 16.5 mt . . . . . 0 CA--C 1.528 0.099 0 C-N-CA 123.441 0.697 . . . . 2.59 111.867 175.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.554 0 CA-C-O 121.601 0.715 . . . . 12.04 110.251 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -104.14 19.64 19.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.369 1.468 . . . . 4.86 111.084 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -85.45 78.47 9.7 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 109.371 -0.603 . . . . 3.1 109.371 -172.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.528 HG21 ' CE2' ' A' ' 149' ' ' PHE . 20.3 mm -88.03 82.16 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 122.728 1.252 . . . . 1.72 108.327 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 p -77.77 126.68 31.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.91 -1.515 . . . . 1.34 106.91 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.42 ' CE1' ' CD2' ' A' ' 138' ' ' PHE . 41.7 p90 -128.19 167.14 17.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.855 0.862 . . . . 4.12 110.67 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -156.24 177.2 11.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.09 0.471 . . . . 4.67 111.076 168.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.29 168.36 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.953 1.301 . . . . 1.13 108.199 174.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -95.14 -51.89 4.44 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.736 0.814 . . . . 4.24 109.587 169.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.83 153.8 30.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.912 0.485 . . . . 2.6 111.638 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -78.31 108.0 11.33 Favored 'General case' 0 CA--C 1.53 0.212 0 N-CA-C 108.369 -0.975 . . . . 2.71 108.369 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.9 t -60.17 146.82 82.46 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 118.655 0.662 . . . . 2.17 110.575 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.39 -15.97 24.79 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.444 2.763 . . . . 1.56 111.356 170.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -47.29 -42.62 21.33 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.829 0.852 . . . . 2.5 111.452 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 5.3 mtm -130.3 175.58 8.82 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.635 1.174 . . . . 2.13 108.206 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -75.97 144.8 40.77 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.751 -0.463 . . . . 2.98 109.751 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -45.76 -53.87 8.83 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.486 0.715 . . . . 2.51 112.451 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -48.54 -38.94 21.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.402 0.681 . . . . 4.12 109.272 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -82.4 -43.09 17.78 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.328 1.851 . . . . 2.04 113.183 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.3 t -50.15 -55.05 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 O-C-N 120.789 -1.194 . . . . 1.23 109.051 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.412 ' OD2' ' NZ ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -71.98 -19.73 61.83 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 119.161 -1.016 . . . . 1.79 109.991 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -64.34 -52.62 57.46 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 119.734 1.152 . . . . 2.07 109.133 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.9 -53.1 44.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 122.998 0.519 . . . . 0.36 110.33 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.2 -46.73 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 109.769 -0.456 . . . . 2.31 109.769 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -50.77 -55.37 17.05 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 124.365 1.066 . . . . 4.27 108.428 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -63.03 -48.89 76.82 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.624 1.169 . . . . 1.51 109.292 -177.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.573 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -45.89 -55.74 6.32 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.145 0.578 . . . . 0.61 111.681 175.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.42 ' CD2' ' CE1' ' A' ' 116' ' ' TYR . 52.8 m-85 -57.54 -48.99 77.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.256 -0.429 . . . . 4.63 110.657 173.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.7 -32.87 65.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 113.069 0.766 . . . . 2.11 113.069 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.55 ' CG1' HD21 ' A' ' 250' ' ' LEU . 85.4 t -63.58 -57.04 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 119.425 1.011 . . . . 0.74 108.518 176.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.79 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 16.9 m95 -68.46 -36.72 79.38 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.039 -0.726 . . . . 0.83 109.039 -172.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.6 t -67.6 -13.09 61.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 118.882 -0.58 . . . . 1.25 112.291 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.17 -54.94 4.47 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 107.946 -1.131 . . . . 1.19 107.946 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.512 HG11 HD23 ' A' ' 250' ' ' LEU . 17.6 m -74.1 -40.88 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 116.105 -0.498 . . . . 1.54 111.785 -176.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.95 HG22 HD13 ' A' ' 258' ' ' ILE . 3.1 p -87.06 142.68 34.02 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 107.671 -1.233 . . . . 0.75 107.671 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.53 4.95 3.09 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.835 2.356 . . . . 0.66 113.546 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.4 130.43 42.86 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.84 1.256 . . . . 2.22 107.818 175.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -97.25 108.34 21.04 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.335 -0.987 . . . . 4.31 108.335 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.528 ' CE2' HG21 ' A' ' 114' ' ' ILE . 52.1 m-85 -87.11 142.1 28.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.039 -0.528 . . . . 5.69 111.073 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -142.91 117.79 9.95 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.698 0.799 . . . . 0.97 110.136 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.412 ' NZ ' ' OD2' ' A' ' 131' ' ' ASP . 20.6 ttpt -78.5 142.75 37.2 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.089 -1.078 . . . . 2.42 108.089 172.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.9 pt -134.56 144.04 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 105.519 -2.03 . . . . 1.27 105.519 166.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.07 -61.83 1.64 Allowed 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 107.029 -1.471 . . . . 3.44 107.029 168.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.4 m -86.67 101.09 12.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.493 0.717 . . . . 2.34 110.129 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 153.88 153.4 6.4 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 107.323 -2.311 . . . . 2.35 107.323 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.5 ttt -79.37 143.28 35.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.302 -1.37 . . . . 7.36 107.302 168.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -127.65 165.44 19.98 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.682 1.193 . . . . 1.25 108.404 -173.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -69.21 -58.21 4.35 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.863 0.839 . . . . 1.94 109.359 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.2 pt -105.75 134.49 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.14 -1.059 . . . . 1.68 108.14 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . 0.358 0.0 OUTLIER -128.76 132.44 47.91 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.411 -0.806 . . . . 2.8 109.424 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.9 t -82.67 106.1 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.677 -0.86 . . . . 1.05 108.677 -175.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.66 ' HB ' ' HD2' ' A' ' 196' ' ' HIS 0.417 7.8 t -95.22 94.87 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.411 1.084 . . . . 1.63 112.831 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -79.51 115.47 19.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.555 -2.017 . . . . 5.4 105.555 167.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -139.57 164.73 29.13 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.294 -1.743 . . . . 0.95 106.294 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -132.02 142.6 49.62 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.865 -0.791 . . . . 5.12 108.865 -170.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 73.47 -86.1 0.62 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.415 1.007 . . . . 1.97 111.243 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -150.34 145.15 25.95 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 121.581 -0.952 . . . . 2.22 108.661 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.4 p80 . . . . . 0 CA--C 1.533 0.303 0 CA-C-O 121.648 0.737 . . . . 2.92 111.05 -178.952 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.093 0 N-CA-C 111.772 0.286 . . . . 2.34 111.772 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -118.25 172.35 7.5 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 107.82 -1.178 . . . . 6.08 107.82 -172.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -178.56 28.12 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.814 0.301 . . . . 2.71 111.814 -161.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 60.07 -155.16 31.45 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 119.015 -1.564 . . . . 1.61 110.261 -160.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -79.52 106.81 11.82 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.322 0.649 . . . . 4.57 110.738 -175.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 148.33 -168.65 29.02 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 108.45 -1.86 . . . . 2.27 108.45 -168.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.68 -112.23 2.64 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 125.83 1.681 . . . . 2.18 109.911 172.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . 0.571 4.0 mm -109.07 149.27 12.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.565 -0.902 . . . . 1.55 108.565 173.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.463 HD23 HG21 ' A' ' 210' ' ' THR 0.276 4.4 mp -81.68 -59.02 2.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.74 2.016 . . . . 1.27 108.402 170.406 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.87 153.92 17.2 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 122.251 1.024 . . . . 0.63 113.291 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -143.88 132.44 22.3 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 114.522 1.304 . . . . 1.09 114.522 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -160.49 162.27 33.05 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.655 1.982 . . . . 0.52 106.144 -164.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -157.97 156.21 30.8 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 107.631 -1.248 . . . . 3.4 107.631 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.33 -88.93 1.75 Allowed Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.186 -0.786 . . . . 0.56 111.206 173.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.22 82.82 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.828 3.019 . . . . 1.38 111.547 -171.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -159.03 161.67 32.12 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.051 -1.62 . . . . 1.03 109.051 170.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.9 m -78.51 167.2 21.63 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.077 0.465 . . . . 2.12 110.461 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 55.07 -106.32 0.52 Allowed Glycine 0 CA--C 1.529 0.906 0 C-N-CA 123.826 0.727 . . . . 1.43 112.059 174.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.8 tp -63.54 -27.58 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.158 0.983 . . . . 1.51 110.705 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.19 148.61 19.26 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 110.452 -1.059 . . . . 0.93 110.452 172.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 87.92 -45.16 3.29 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.932 1.253 . . . . 0.55 110.733 -163.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -84.08 171.74 12.62 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 121.681 -0.894 . . . . 1.25 109.843 -161.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -142.93 120.49 11.75 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 119.236 -0.411 . . . . 0.69 112.058 -175.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.66 ' HD2' ' HB ' ' A' ' 162' ' ' VAL . 14.5 m80 -109.34 133.83 52.57 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 118.413 -0.803 . . . . 2.46 109.591 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -120.75 148.69 43.63 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.301 0.5 . . . . 3.09 109.829 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -67.24 89.73 0.2 Allowed 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 124.658 1.224 . . . . 2.7 109.533 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -66.64 -26.9 67.28 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.18 -0.95 . . . . 2.95 109.499 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.39 -42.41 21.84 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.948 0.899 . . . . 3.35 109.404 171.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -73.57 170.37 15.33 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.582 1.182 . . . . 1.69 112.272 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -117.62 91.19 3.5 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.779 -1.563 . . . . 3.1 106.779 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -75.81 158.33 32.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.634 -0.712 . . . . 1.07 109.438 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 75.3 p -138.57 144.43 39.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.608 -0.515 . . . . 1.58 109.608 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 13.7 t -61.23 -43.52 98.74 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 125.913 1.685 . . . . 1.8 113.871 169.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.88 174.68 10.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.9 -0.778 . . . . 2.08 108.9 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.7 m -43.63 -57.33 3.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.214 1.806 . . . . 3.83 109.997 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 51.09 -88.38 0.01 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.375 1.464 . . . . 2.18 113.338 167.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -147.07 -69.51 0.01 OUTLIER Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.912 -1.675 . . . . 1.77 108.912 168.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.463 HG21 HD23 ' A' ' 181' ' ' LEU . 2.4 m -105.85 97.42 7.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.5 -1.667 . . . . 0.98 106.5 175.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.16 109.31 3.49 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.343 -1.354 . . . . 3.11 107.343 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 29.2 tp -47.62 -54.54 11.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.327 1.421 . . . . 1.76 111.853 -166.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.602 ' O ' HG23 ' A' ' 217' ' ' VAL . 1.8 t80 -40.34 -43.69 1.8 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.956 1.302 . . . . 2.21 111.202 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -64.05 1.08 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.281 0.632 . . . . 2.01 111.259 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.291 1.2 m -56.94 -40.84 77.13 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.995 -0.372 . . . . 0.87 109.995 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.6 -49.88 64.17 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.58 -0.724 . . . . 0.43 111.312 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 213' ' ' PHE . 61.4 t -54.83 -41.49 57.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 119.567 1.076 . . . . 0.82 110.973 178.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.504 ' HE2' ' HE2' ' A' ' 222' ' ' HIS 0.449 2.7 t-160 -63.53 -49.47 73.38 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.234 0.614 . . . . 2.2 111.535 176.46 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.09 -48.11 72.01 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.897 -1.127 . . . . 3.65 111.531 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.36 -39.55 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 107.561 -1.274 . . . . 1.33 107.561 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.49 -55.78 6.72 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.552 1.073 . . . . 0.53 111.673 165.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.504 ' HE2' ' HE2' ' A' ' 218' ' ' HIS . 1.9 m-70 -51.89 -47.73 64.42 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.715 -0.873 . . . . 1.37 110.698 174.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 67.9 m -54.17 -38.34 65.47 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.293 0.849 . . . . 2.05 113.293 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.423 ' CD2' HG21 ' A' ' 145' ' ' THR . 8.4 mp -56.6 -40.73 75.81 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 119.431 1.014 . . . . 2.85 110.266 172.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 117.44 28.89 2.23 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 125.045 1.307 . . . . 1.66 111.602 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 1.04 HD11 HG22 ' A' ' 258' ' ' ILE . 0.5 OUTLIER -79.95 137.89 36.96 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.074 -0.713 . . . . 3.36 109.074 -170.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.77 140.23 21.5 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.655 -0.978 . . . . 2.76 110.655 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -47.87 116.23 1.43 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.635 0.774 . . . . 1.66 111.307 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 31.7 m -78.56 -177.35 5.28 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.385 0.674 . . . . 1.01 109.195 172.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 23.4 m -148.79 39.54 0.87 Allowed 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.328 -0.857 . . . . 2.31 109.387 -172.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.13 131.64 15.51 Favored Pre-proline 0 N--CA 1.447 -0.614 0 N-CA-C 106.599 -1.63 . . . . 1.55 106.599 -174.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.52 -9.55 14.8 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.096 1.864 . . . . 1.14 114.367 -172.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -82.07 -26.31 33.78 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.304 0.956 . . . . 1.2 109.771 170.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -70.43 148.28 48.51 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.325 -0.62 . . . . 0.76 109.325 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 90.2 t -93.92 -23.9 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 123.574 0.749 . . . . 0.78 109.383 177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.545 ' HG2' HD13 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -49.54 -38.52 31.11 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.859 0.689 . . . . 2.87 112.859 175.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.431 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -46.95 149.1 1.65 Allowed Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 126.219 1.808 . . . . 3.23 112.802 -165.049 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.428 ' HA ' ' HE1' ' A' ' 218' ' ' HIS . 61.4 Cg_endo -71.68 -16.89 29.97 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.541 1.494 . . . . 0.94 111.971 176.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.373 0.2 OUTLIER -78.85 -179.54 6.63 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.132 1.373 . . . . 1.38 110.148 176.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -127.39 153.88 45.69 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.594 -1.632 . . . . 2.24 106.594 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -148.56 117.45 6.72 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.615 -1.254 . . . . 2.19 107.615 168.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -63.68 122.47 16.46 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.63 -0.878 . . . . 2.41 108.63 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.3 m -145.96 154.55 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 O-C-N 123.771 0.669 . . . . 3.58 110.035 169.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -50.56 110.67 0.44 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.58 1.952 . . . . 3.72 111.539 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.8 pp -57.55 -19.8 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.091 0.956 . . . . 3.1 112.752 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -70.09 -49.7 48.27 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.433 0.693 . . . . 4.24 110.899 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 91.7 m -83.88 -30.02 26.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.115 0.566 . . . . 2.44 109.974 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.555 ' HE2' HG21 ' A' ' 217' ' ' VAL . 63.7 t80 -34.56 116.71 0.33 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.446 1.498 . . . . 8.33 111.581 174.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.27 175.82 10.76 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.714 1.206 . . . . 2.8 108.698 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.584 HD12 ' CH2' ' A' ' 141' ' ' TRP . 1.1 mm? -83.3 141.78 31.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.44 -0.948 . . . . 0.95 108.44 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.4 m -77.87 155.38 31.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 110.09 -0.337 . . . . 0.7 110.09 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.28 -45.28 62.07 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.005 0.431 . . . . 0.89 110.138 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -51.1 -54.11 28.03 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.884 0.874 . . . . 2.19 110.191 173.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.591 ' O ' HG23 ' A' ' 258' ' ' ILE . 4.1 t0 -59.27 -51.76 68.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.087 -0.961 . . . . 2.15 109.92 -176.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.5 mt -49.07 -52.43 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.775 1.63 . . . . 1.02 110.263 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -59.44 -40.51 87.02 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.391 -1.443 . . . . 6.78 110.568 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -49.04 -55.05 12.44 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 111.963 -0.455 . . . . 0.91 111.963 167.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 1.04 HG22 HD11 ' A' ' 226' ' ' LEU . 0.3 OUTLIER -60.85 -40.67 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 118.508 1.154 . . . . 2.54 110.282 -173.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -64.74 -17.96 64.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.498 -0.881 . . . . 2.64 111.245 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.0 t -63.02 -17.43 62.21 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.473 0.709 . . . . 2.18 112.446 171.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 66.7 mt . . . . . 0 CA--C 1.536 0.438 0 C-N-CA 124.657 1.183 . . . . 2.33 111.501 172.88 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.411 ' HB2' HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.203 0 N-CA-C 110.072 -0.344 . . . . 8.58 110.072 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 57.9 -78.34 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.142 1.377 . . . . 4.35 111.283 -170.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -124.63 109.15 12.81 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.102 1.361 . . . . 3.89 109.572 -177.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.411 HD13 ' HB2' ' A' ' 111' ' ' LYS . 0.4 OUTLIER -104.7 138.18 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.069 0 N-CA-C 106.641 -1.614 . . . . 2.56 106.641 170.29 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.1 p -125.1 139.47 53.75 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.739 -1.208 . . . . 1.19 107.739 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -123.04 161.59 24.02 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.696 0.798 . . . . 4.4 110.342 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.95 147.82 32.11 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.752 -0.833 . . . . 5.67 108.752 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -104.95 149.26 8.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 C-N-CA 123.559 0.744 . . . . 0.83 109.312 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.47 HD22 ' H ' ' A' ' 119' ' ' ASN . 1.4 p30 -104.85 -47.6 3.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.158 1.783 . . . . 2.96 109.648 -172.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -139.18 164.63 29.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.98 -1.119 . . . . 3.2 107.98 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -128.16 118.67 23.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.846 -1.539 . . . . 2.23 106.846 -174.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.9 t -66.78 122.98 84.74 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.77 0.828 . . . . 2.53 109.384 -173.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -68.84 -17.76 41.73 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.791 2.994 . . . . 1.68 111.562 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -34.3 -42.42 0.13 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.451 2.301 . . . . 2.57 112.462 171.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 19.4 mtm -132.69 177.73 7.4 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.261 1.425 . . . . 2.07 109.046 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -64.05 142.32 58.45 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 108.824 -0.806 . . . . 3.01 108.824 172.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 43.9 ttt-85 -47.68 -51.15 22.78 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.506 -0.746 . . . . 2.15 110.491 172.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.33 6.28 3.01 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.453 0.538 . . . . 5.24 112.453 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -102.08 -41.92 6.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.15 1.78 . . . . 1.76 109.632 162.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 62.4 t -54.02 -54.79 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 O-C-N 120.508 -1.37 . . . . 1.21 109.719 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -26.43 68.13 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 118.647 -1.221 . . . . 1.76 109.469 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -65.0 -44.71 88.35 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 118.832 0.742 . . . . 2.41 111.004 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.91 -52.27 65.76 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.76 0.824 . . . . 0.4 110.481 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.416 HD13 ' O ' ' A' ' 134' ' ' ILE . 0.2 OUTLIER -68.51 -37.24 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 109.291 -0.633 . . . . 1.81 109.291 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -52.27 -61.37 2.31 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 107.851 -1.166 . . . . 3.71 107.851 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.422 ' O ' HG23 ' A' ' 140' ' ' VAL . 52.9 mmtt -52.34 -53.62 42.18 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.209 1.004 . . . . 1.51 110.546 178.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.21 -49.52 63.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.792 0.837 . . . . 0.69 111.834 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -63.59 -47.23 82.3 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.52 -0.918 . . . . 5.75 108.52 176.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.18 -38.95 63.28 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.695 0.398 . . . . 2.64 110.599 -171.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.561 ' CG1' HD21 ' A' ' 250' ' ' LEU . 82.3 t -49.79 -58.51 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.34 1.056 . . . . 0.71 109.249 175.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.872 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 17.3 m95 -68.63 -37.23 79.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 119.836 -0.746 . . . . 0.83 109.087 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -20.2 65.48 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.374 0.509 . . . . 1.44 112.374 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -78.98 -49.39 12.83 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.527 -0.916 . . . . 1.48 108.527 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.634 HG12 HD11 ' A' ' 258' ' ' ILE . 26.5 t -75.46 -54.91 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 122.775 0.43 . . . . 1.89 110.877 -174.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.6 p -76.93 157.33 81.74 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 107.758 -1.201 . . . . 0.62 107.758 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.88 15.07 0.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.744 1.629 . . . . 0.78 113.594 174.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.04 145.94 55.02 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 122.257 2.299 . . . . 2.85 109.641 175.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -110.63 86.93 2.41 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.939 -1.504 . . . . 4.34 106.939 160.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.452 ' HB2' ' CD1' ' A' ' 138' ' ' PHE . 3.9 m-85 -71.02 154.43 41.8 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.189 -0.671 . . . . 6.08 109.189 163.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.6 t -155.34 144.93 21.23 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.271 1.028 . . . . 0.92 108.51 170.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -92.29 138.6 31.39 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 119.493 1.042 . . . . 2.61 108.471 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.8 pp -138.29 124.46 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.243 -1.392 . . . . 1.35 107.243 167.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -88.03 -7.64 56.73 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 122.384 0.274 . . . . 3.42 111.26 172.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 62.2 p -130.11 96.79 4.27 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.024 0.929 . . . . 2.39 109.927 -170.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 140.03 -150.74 21.7 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 106.601 -2.6 . . . . 1.64 106.601 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 43.4 ttm -122.54 137.18 54.97 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.452 -1.684 . . . . 4.12 106.452 173.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -111.85 170.16 8.33 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.738 1.215 . . . . 0.83 109.664 -177.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -84.16 -55.7 4.05 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.646 0.778 . . . . 2.08 109.361 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.9 pt -101.91 164.26 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.143 -0.688 . . . . 1.01 109.143 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.05 132.31 38.08 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.988 -0.745 . . . . 2.0 108.988 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 10.7 t -78.48 143.03 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.967 -1.123 . . . . 1.55 107.967 168.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 66.6 t -108.24 128.78 63.46 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 C-N-CA 124.546 1.138 . . . . 1.46 108.021 165.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.435 ' N ' HD21 ' A' ' 119' ' ' ASN . 5.7 m-85 -124.31 99.8 6.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 103.903 -2.628 . . . . 5.03 103.903 170.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.51 160.13 33.31 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.991 -1.485 . . . . 0.97 106.991 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -121.72 128.25 51.6 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.406 -1.331 . . . . 4.18 107.406 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 65.79 -161.7 43.04 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-O 121.629 0.572 . . . . 2.23 112.37 -171.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.17 110.06 11.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.269 0.628 . . . . 2.24 109.654 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 . . . . . 0 C--O 1.227 -0.08 0 C-N-CA 125.615 1.566 . . . . 3.36 110.14 -177.849 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.202 0 N-CA-C 112.791 0.663 . . . . 2.71 112.791 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -104.63 149.57 25.43 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.467 1.107 . . . . 6.05 109.551 -166.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -171.8 10.16 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.323 0.86 . . . . 3.43 113.323 -155.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 65.82 -149.96 51.68 Favored Glycine 0 CA--C 1.537 1.428 0 N-CA-C 109.895 -1.282 . . . . 2.17 109.895 -162.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -80.3 63.94 4.95 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.66 1.23 . . . . 4.22 114.042 -162.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -164.13 -143.77 3.82 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 106.992 -2.443 . . . . 1.85 106.992 160.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.69 -127.31 40.08 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.27 -1.532 . . . . 2.02 109.27 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . 0.267 1.0 OUTLIER -100.39 148.77 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 106.214 -1.773 . . . . 1.56 106.214 173.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.22 -46.1 12.21 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.851 0.861 . . . . 2.2 109.644 164.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -163.48 165.69 23.48 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.238 -0.914 . . . . 0.65 111.246 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.56 141.71 26.09 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.697 0.799 . . . . 1.04 112.398 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -161.79 158.04 25.09 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.97 0.908 . . . . 0.56 109.853 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -147.87 139.35 23.72 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.617 1.167 . . . . 2.92 108.129 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -85.77 -78.71 1.18 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.365 -1.094 . . . . 0.5 110.365 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.78 104.08 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.355 2.703 . . . . 1.32 110.514 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -178.53 172.48 44.85 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 108.242 -1.943 . . . . 1.02 108.242 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 63.9 m -84.05 165.35 18.63 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.025 -0.731 . . . . 2.15 109.025 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 53.31 -95.23 0.02 OUTLIER Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.202 0.906 . . . . 1.8 112.535 172.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.5 tp -63.35 -16.49 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 125.129 1.372 . . . . 1.72 111.504 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -44.37 129.58 7.18 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 110.792 -0.923 . . . . 1.3 110.792 166.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 86.07 -31.09 4.13 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.34 1.448 . . . . 0.98 112.891 -175.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -83.34 147.51 27.88 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.484 1.142 . . . . 1.27 109.739 -166.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.78 124.04 38.78 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 118.762 -0.637 . . . . 0.71 112.454 -172.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . 0.341 0.0 OUTLIER -112.4 109.06 18.45 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.079 0.551 . . . . 2.41 112.19 -165.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -96.2 138.22 34.12 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.661 0.664 . . . . 2.71 110.449 -177.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -62.24 92.51 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.171 -0.677 . . . . 3.28 109.171 170.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -64.83 -37.54 87.95 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 120.51 -1.369 . . . . 2.66 109.576 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -50.46 -27.94 7.42 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.593 0.757 . . . . 2.74 110.907 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -66.27 155.15 37.99 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.859 1.264 . . . . 2.81 110.179 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -95.78 93.62 7.19 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.583 -1.636 . . . . 3.94 106.583 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -78.76 155.75 29.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.695 -0.854 . . . . 1.18 108.695 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.92 136.82 24.46 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.304 0.641 . . . . 2.79 111.285 -176.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.2 t -58.03 -45.35 87.08 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.188 0.995 . . . . 1.62 111.495 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -74.77 -154.85 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.646 1.179 . . . . 3.23 110.761 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.4 p -79.16 -68.27 0.67 Allowed 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.938 -1.101 . . . . 3.81 110.455 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 38.63 -106.03 0.05 OUTLIER Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.465 1.983 . . . . 2.51 113.495 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.55 -72.28 1.13 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.216 0.912 . . . . 1.58 110.839 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 4.3 m -136.45 153.92 50.92 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 106.686 -1.598 . . . . 0.87 106.686 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -107.77 124.75 50.5 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 123.651 0.594 . . . . 1.53 111.968 173.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.17 -53.65 55.86 Favored 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.241 -0.652 . . . . 1.74 109.241 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -49.07 -46.99 45.31 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.667 0.746 . . . . 1.52 110.232 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.6 tt -61.5 -61.58 2.43 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.921 0.888 . . . . 1.33 110.0 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.279 0.6 OUTLIER -55.99 -37.94 69.79 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.383 -0.198 . . . . 0.76 110.904 179.472 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.34 -54.92 29.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 124.591 1.156 . . . . 0.64 110.687 175.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.8 t -48.08 -43.45 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 120.12 1.327 . . . . 0.84 110.903 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.487 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 42.6 t-80 -56.62 -56.54 20.12 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.396 1.078 . . . . 2.11 113.845 171.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -82.1 -43.32 17.98 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.134 -0.979 . . . . 3.69 112.679 -170.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.413 ' CD1' HD11 ' A' ' 134' ' ' ILE . 1.0 OUTLIER -56.26 -33.95 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.056 -0.72 . . . . 1.46 109.056 164.185 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.5 -53.68 43.07 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 110.763 -0.935 . . . . 0.6 110.763 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.487 ' NE2' ' NE2' ' A' ' 218' ' ' HIS 0.281 62.5 m170 -53.44 -41.19 65.83 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.456 -1.026 . . . . 2.31 111.944 173.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 34.7 t -47.82 -52.97 16.97 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.131 0.972 . . . . 1.73 112.346 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.12 -10.85 60.44 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.614 -0.679 . . . . 3.16 112.786 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 104.51 43.31 1.73 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 124.289 0.947 . . . . 1.19 111.792 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.964 HD21 HG22 ' A' ' 258' ' ' ILE . 7.9 mt -77.35 115.37 17.06 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 117.373 0.586 . . . . 3.31 111.546 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -66.43 154.96 51.8 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 109.507 -1.437 . . . . 3.11 109.507 162.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -68.61 121.54 16.63 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.746 0.773 . . . . 2.38 112.716 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.9 m -79.93 118.1 21.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.772 -1.566 . . . . 2.31 106.772 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.7 p -76.12 63.29 1.81 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.24 0.927 . . . . 3.67 110.502 -175.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -155.78 131.36 5.48 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.85 1.26 . . . . 1.67 108.34 -173.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.92 -14.65 9.78 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.776 1.651 . . . . 1.69 114.124 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -42.09 59.76 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 119.57 1.077 . . . . 2.0 108.971 172.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -57.73 116.41 3.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.744 1.217 . . . . 1.79 110.451 176.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.0 t -62.2 -17.9 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.383 -0.826 . . . . 0.82 110.896 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.452 ' SD ' ' HB3' ' A' ' 226' ' ' LEU . 0.0 OUTLIER -51.89 -42.41 62.67 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.331 -0.856 . . . . 3.06 113.135 169.029 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.414 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 14.6 t80 -61.03 147.31 86.35 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 109.027 -0.731 . . . . 7.5 109.027 -165.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.414 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 58.8 Cg_endo -70.88 -14.01 32.24 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.375 1.384 . . . . 1.16 112.566 -172.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.354 0.2 OUTLIER -76.94 128.01 33.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.751 0.705 . . . . 1.88 109.121 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -75.82 129.91 37.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.794 -1.187 . . . . 3.25 107.794 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -135.67 139.36 43.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.708 -1.59 . . . . 2.64 106.708 174.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -57.77 120.96 9.34 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.542 -0.91 . . . . 2.41 108.542 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.1 m -101.09 130.72 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.854 -0.425 . . . . 2.0 109.854 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.66 86.71 0.66 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.491 -0.559 . . . . 4.83 109.491 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.6 mt -51.48 -31.3 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.404 0.682 . . . . 2.81 109.449 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -42.05 -49.46 4.72 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.362 1.065 . . . . 3.71 112.404 169.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 35.0 m -84.84 -41.63 15.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.56 0.744 . . . . 1.65 110.24 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 71.1 t80 60.96 75.5 0.41 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.287 1.035 . . . . 4.29 109.545 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.06 169.19 25.11 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.135 0.574 . . . . 4.61 110.688 -177.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.561 HD21 ' CG1' ' A' ' 140' ' ' VAL . 0.4 OUTLIER -113.76 176.87 4.84 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.505 1.522 . . . . 1.25 107.859 175.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 68.2 m -77.96 145.41 36.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 122.742 0.417 . . . . 0.83 110.7 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.36 -43.19 54.18 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.173 0.589 . . . . 1.36 110.402 171.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -53.43 -55.49 24.69 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.627 0.727 . . . . 2.87 110.183 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.595 ' O ' HG23 ' A' ' 258' ' ' ILE . 1.9 t0 -59.09 -47.69 84.32 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.078 -0.965 . . . . 2.25 109.02 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 59.3 mt -51.06 -32.31 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.647 1.979 . . . . 1.82 112.524 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -73.42 -57.16 4.2 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 121.293 -0.879 . . . . 6.25 110.026 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -47.24 -53.85 10.88 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 121.19 0.328 . . . . 1.73 112.291 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.964 HG22 HD21 ' A' ' 226' ' ' LEU . 2.0 pp -55.88 -32.65 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.946 1.698 . . . . 2.4 111.056 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -78.3 -45.11 23.53 Favored 'General case' 0 C--N 1.339 0.126 0 O-C-N 121.708 -0.62 . . . . 3.22 109.811 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 15.1 m -51.99 -31.04 27.72 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.58 0.585 . . . . 4.22 112.58 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 N--CA 1.465 0.324 0 N-CA-C 114.222 1.193 . . . . 3.7 114.222 172.78 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.3 tttt . . . . . 0 CA--C 1.532 0.283 0 CA-C-O 119.499 -0.286 . . . . 6.49 110.561 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 15.0 m170 67.02 -54.33 0.45 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.467 1.907 . . . . 3.31 112.889 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -107.0 114.52 28.65 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.324 1.45 . . . . 3.93 110.139 -176.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.7 mp -141.6 80.44 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.667 1.187 . . . . 2.33 108.396 -173.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.22 141.39 37.19 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.964 -1.124 . . . . 1.2 107.964 174.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -127.31 159.79 33.31 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.145 0.978 . . . . 4.09 108.705 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -154.94 173.21 16.86 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.727 0.694 . . . . 4.38 110.419 172.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.78 159.39 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.226 1.01 . . . . 0.85 109.834 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -100.29 -42.98 6.43 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.01 0.924 . . . . 2.95 109.994 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -149.41 170.46 18.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.751 0.82 . . . . 2.49 109.831 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -117.9 101.76 8.54 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.368 1.467 . . . . 2.25 107.959 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.4 t -58.55 125.89 77.69 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.96 0.904 . . . . 2.3 109.173 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.17 -17.26 45.29 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.717 2.945 . . . . 1.57 111.411 -172.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -35.06 -43.75 0.21 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.002 1.721 . . . . 2.2 111.827 170.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -130.88 174.59 9.83 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 124.994 1.317 . . . . 1.9 110.037 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -73.13 140.2 46.93 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.65 0.78 . . . . 3.01 109.487 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -46.61 -51.41 15.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.035 0.445 . . . . 2.66 111.892 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.5 -8.11 8.63 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.742 0.817 . . . . 3.46 112.723 -176.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -100.66 -48.45 4.51 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.695 1.598 . . . . 1.93 109.314 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.93 -56.59 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 125.274 1.43 . . . . 1.22 109.374 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -24.53 64.48 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 118.334 -0.841 . . . . 1.82 109.349 -177.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -65.84 -50.25 65.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.627 0.648 . . . . 3.16 110.071 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -49.67 -54.85 16.23 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.919 0.888 . . . . 0.6 110.091 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.476 HD11 HD11 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -71.38 -30.99 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.028 -0.533 . . . . 1.88 110.233 -179.082 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -55.04 -54.6 40.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.765 1.269 . . . . 3.53 108.157 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 140' ' ' VAL . 12.3 mmmm -68.82 -39.28 80.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.588 1.555 . . . . 1.42 110.282 -174.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -46.44 -57.11 4.97 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 122.576 0.35 . . . . 0.8 110.63 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.427 ' CZ ' HG13 ' A' ' 220' ' ' ILE . 11.9 m-85 -60.43 -48.55 81.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 119.661 -0.816 . . . . 4.41 111.15 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -45.34 -48.92 13.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.416 0.687 . . . . 3.47 111.093 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 136' ' ' LYS . 94.8 t -58.36 -51.0 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 122.717 0.407 . . . . 1.05 109.941 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.702 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 92.8 m95 -68.68 -33.67 74.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.679 -0.86 . . . . 0.82 108.679 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.14 -19.53 61.63 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.251 0.478 . . . . 1.19 111.911 174.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -81.27 -42.87 20.01 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.024 0.829 . . . . 2.45 108.985 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.7 m -79.87 -54.37 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 112.17 0.433 . . . . 1.28 112.17 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.439 ' CG2' HD13 ' A' ' 258' ' ' ILE . 54.4 p -81.83 147.14 57.76 Favored Pre-proline 0 N--CA 1.45 -0.442 0 N-CA-C 108.382 -0.969 . . . . 0.73 108.382 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.73 5.01 4.1 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.813 2.342 . . . . 0.81 113.008 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.4 125.9 27.93 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.371 1.468 . . . . 2.7 108.589 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -98.17 93.53 6.3 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 109.277 -0.638 . . . . 4.12 109.277 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -78.57 149.45 33.01 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.469 -0.332 . . . . 5.85 110.797 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.4 t -151.4 137.31 18.12 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.714 -0.476 . . . . 1.01 109.714 172.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -90.45 160.09 16.2 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.266 -1.013 . . . . 3.07 108.266 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.413 HD11 ' HB2' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -152.12 152.21 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 104.747 -2.316 . . . . 1.92 104.747 -177.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.03 -39.43 21.26 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.262 -0.644 . . . . 3.95 109.262 172.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.5 m -75.71 146.23 40.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.283 -0.636 . . . . 3.84 109.283 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -78.87 59.29 4.23 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.387 -0.674 . . . . 4.39 112.699 -173.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.2 mtt -116.37 72.89 0.83 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.152 0.981 . . . . 6.37 109.594 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.413 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -141.53 162.68 34.9 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.49 0.716 . . . . 0.73 111.702 -173.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -70.97 -46.54 62.17 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.073 -1.084 . . . . 2.03 108.073 170.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.9 pt -124.23 146.16 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.017 -0.992 . . . . 1.51 108.601 -171.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 160' ' ' LEU 0.308 0.0 OUTLIER -129.93 139.22 51.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.097 -0.705 . . . . 2.69 109.097 176.867 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.6 t -79.93 112.08 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 118.579 -0.724 . . . . 0.72 109.113 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . 0.479 7.4 p -109.0 97.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 N-CA-C 113.47 0.915 . . . . 2.4 113.47 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -79.82 130.04 34.98 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.326 1.85 . . . . 5.14 107.077 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -141.6 162.11 36.28 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.409 0.549 . . . . 0.87 111.029 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -119.01 126.75 52.46 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.897 1.279 . . . . 5.5 108.209 -172.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 46.62 -130.35 11.83 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 123.59 0.614 . . . . 1.73 112.208 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.96 138.2 38.72 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.266 0.627 . . . . 2.16 109.511 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 114.124 1.157 . . . . 2.43 114.124 -175.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 118.824 -0.608 . . . . 2.27 111.734 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -89.83 156.52 18.43 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 107.366 -1.346 . . . . 7.6 107.366 167.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -158.14 11.55 0.18 Allowed 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 126.82 2.048 . . . . 3.19 111.105 -157.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 105.29 165.22 23.78 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.351 -1.1 . . . . 1.99 110.351 -165.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -58.11 118.0 4.97 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.526 -0.916 . . . . 4.06 108.526 166.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.91 -160.81 13.74 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 109.95 -1.26 . . . . 1.78 109.95 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.92 -102.94 0.2 Allowed Glycine 0 C--N 1.339 0.715 0 N-CA-C 109.167 -1.573 . . . . 1.66 109.167 -171.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . 0.314 12.8 mm -90.73 130.04 40.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.111 -1.07 . . . . 1.9 108.111 171.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.8 mp -82.48 -61.18 1.96 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.806 -0.812 . . . . 1.11 108.806 166.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -158.8 149.65 20.15 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 113.332 0.864 . . . . 0.94 113.332 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -131.97 117.05 17.91 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.563 1.945 . . . . 1.0 114.678 -170.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -144.19 160.54 40.78 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 128.245 2.618 . . . . 0.56 106.388 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.93 149.84 28.65 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.691 -1.596 . . . . 3.68 106.691 -177.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -102.15 -86.99 1.97 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-O 119.455 -0.636 . . . . 0.6 111.768 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.57 86.83 0.43 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.501 2.801 . . . . 1.39 110.543 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -163.71 157.85 30.17 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 108.419 -1.872 . . . . 1.04 108.419 170.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.0 m -80.37 173.87 12.17 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.224 0.535 . . . . 2.63 110.45 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 56.53 -112.47 3.41 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.575 0.607 . . . . 1.24 111.648 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.1 tp -59.79 -40.05 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 O-C-N 122.131 -0.629 . . . . 1.43 109.365 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -39.24 136.06 1.37 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.393 0.997 . . . . 0.94 112.288 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.51 -47.58 1.17 Allowed Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.179 1.371 . . . . 0.58 111.186 -164.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -84.94 154.12 22.38 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.748 0.774 . . . . 1.3 109.226 -159.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.41 116.71 20.17 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.528 0.936 . . . . 0.61 113.528 -166.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -114.86 135.14 54.53 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 118.289 0.495 . . . . 2.19 111.629 -163.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -125.36 146.51 49.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.249 -0.649 . . . . 2.76 109.249 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -66.52 96.76 0.39 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.073 -0.967 . . . . 2.82 109.806 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.44 -42.76 98.66 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 120.558 -1.339 . . . . 3.18 111.639 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -53.85 -35.49 61.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.658 1.183 . . . . 2.86 110.14 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -67.4 133.94 50.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.721 -1.585 . . . . 2.11 106.721 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -93.39 94.25 8.61 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.131 -2.174 . . . . 2.79 105.131 -173.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 23.7 m95 -75.79 152.87 37.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.277 -1.749 . . . . 1.14 106.277 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 p -128.05 124.5 37.24 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.231 -1.396 . . . . 1.75 107.231 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -49.9 75.91 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 120.51 1.504 . . . . 2.14 108.028 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.74 177.93 2.33 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.725 0.41 . . . . 2.04 110.536 176.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.1 t -48.53 -55.31 11.41 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.726 1.211 . . . . 3.67 110.723 -171.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 40.78 -106.64 0.07 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.147 1.356 . . . . 2.3 114.611 165.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -121.37 -67.84 0.26 Allowed Glycine 0 CA--C 1.525 0.709 0 C-N-CA 124.293 0.949 . . . . 1.09 110.93 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.4 m -131.95 140.69 49.08 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.33 -1.73 . . . . 0.85 106.33 174.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -95.3 129.82 42.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 123.733 0.646 . . . . 1.56 111.251 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -47.59 85.18 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.529 -0.759 . . . . 1.59 110.137 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -55.51 -38.23 68.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.621 0.768 . . . . 2.69 111.475 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.68 -63.4 1.23 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.791 0.836 . . . . 1.95 109.706 176.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.303 0.2 OUTLIER -56.4 -38.75 71.95 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.19 -178.148 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.99 -58.5 7.06 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 117.857 -1.068 . . . . 0.63 110.641 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.588 ' CG1' HG11 ' A' ' 235' ' ' VAL . 0.3 OUTLIER -58.02 -44.01 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 120.275 1.398 . . . . 2.12 111.316 -174.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.751 ' NE2' ' NE2' ' A' ' 222' ' ' HIS 0.48 3.2 t-160 -49.76 -60.9 2.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.555 1.142 . . . . 2.14 111.686 169.362 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -58.39 -41.72 85.5 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 120.835 -1.166 . . . . 2.87 111.946 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.476 HD11 HD11 ' A' ' 134' ' ' ILE . 1.4 mp -68.68 -39.18 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 109.046 -0.724 . . . . 1.07 109.046 -173.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -52.97 -44.9 62.15 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 111.402 -0.679 . . . . 0.63 111.402 167.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.751 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 3.0 m-70 -53.93 -48.68 69.97 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 117.783 0.791 . . . . 1.26 109.302 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.5 p -61.2 -18.5 58.55 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.59 0.959 . . . . 1.69 113.59 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.6 mt -79.1 -58.98 2.96 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 106.966 -1.494 . . . . 2.19 106.966 171.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 149.86 79.66 0.03 OUTLIER Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.615 -0.721 . . . . 1.21 111.859 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.789 HD11 HG22 ' A' ' 258' ' ' ILE . 8.7 mt -133.38 102.69 5.63 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.697 -1.223 . . . . 3.19 107.697 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -77.81 46.94 2.71 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.14 -0.811 . . . . 3.42 112.777 -176.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 63.7 m80 71.38 120.08 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.09 2.156 . . . . 1.82 113.0 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 68.4 m -77.55 -179.83 6.08 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.933 -0.395 . . . . 1.26 109.933 173.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.3 t -142.14 29.91 1.63 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.954 0.901 . . . . 2.59 110.005 -171.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.03 143.35 45.23 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.69 1.596 . . . . 2.16 107.002 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -86.2 -12.61 5.74 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.158 1.905 . . . . 1.03 114.493 -172.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -81.2 -40.36 23.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.162 -1.051 . . . . 1.38 108.162 170.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.0 145.78 15.93 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.784 0.834 . . . . 0.74 110.502 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.588 HG11 ' CG1' ' A' ' 217' ' ' VAL . 60.3 t -97.5 -17.26 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.2 1.0 . . . . 0.75 109.826 -176.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.476 ' HG3' HD13 ' A' ' 226' ' ' LEU . 50.9 mmm -77.5 -12.42 59.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.074 1.139 . . . . 2.41 114.074 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.423 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.9 155.49 1.05 Allowed Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.425 1.09 . . . . 3.15 113.275 177.011 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.34 -21.69 19.63 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.774 1.65 . . . . 1.01 111.428 175.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.319 0.6 OUTLIER -76.8 173.19 11.97 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.824 1.25 . . . . 1.35 109.362 176.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -116.78 148.75 40.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.285 -1.376 . . . . 2.0 107.285 171.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -141.45 122.07 14.24 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.301 -1.74 . . . . 2.12 106.301 166.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -61.22 144.4 53.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.054 -0.721 . . . . 2.67 109.054 168.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 25.9 m -133.97 159.36 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.023 0.929 . . . . 2.07 108.723 167.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.81 -10.66 39.74 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 127.05 2.14 . . . . 4.04 113.107 -174.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . 0.257 24.0 mm 71.78 -23.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 127.081 2.152 . . . . 2.98 112.104 -176.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -47.04 -67.04 0.32 Allowed 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 113.81 1.041 . . . . 3.69 113.81 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 22.6 m -81.61 -50.15 9.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.528 -0.545 . . . . 1.9 109.528 -173.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 38.5 t80 39.43 82.9 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.435 1.894 . . . . 6.68 112.885 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.09 162.18 32.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.829 0.851 . . . . 3.44 109.387 -176.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.498 ' H ' HD22 ' A' ' 250' ' ' LEU . 1.2 mm? -83.03 146.79 28.54 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.808 -1.182 . . . . 0.99 107.808 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.9 m -76.79 157.28 31.69 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.022 0.529 . . . . 0.95 110.634 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.2 67.21 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 110.045 -0.354 . . . . 1.07 110.045 172.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -51.09 -56.78 10.94 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.904 0.859 . . . . 3.06 110.262 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -58.53 -42.15 87.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.068 -0.969 . . . . 2.13 111.589 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 41.7 mt -57.49 -44.73 85.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.181 1.393 . . . . 0.83 109.604 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -63.15 -45.12 93.36 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.417 -0.802 . . . . 4.55 110.622 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -46.09 -62.88 3.2 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.727 -0.549 . . . . 0.85 111.727 173.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.789 HG22 HD11 ' A' ' 226' ' ' LEU . 2.8 pp -60.21 -42.44 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 O-C-N 121.803 -0.822 . . . . 2.2 111.939 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -63.28 -21.53 66.3 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.195 -0.602 . . . . 2.31 112.054 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.6 t -53.21 -25.56 14.46 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.99 -0.444 . . . . 2.29 111.743 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 56.1 mt . . . . . 0 CA--C 1.531 0.222 0 C-N-CA 124.212 1.005 . . . . 2.87 111.814 176.237 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.305 0 N-CA-C 112.272 0.471 . . . . 5.99 112.272 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.6 -69.61 0.09 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.766 1.226 . . . . 4.75 112.32 -173.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.9 95.15 4.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 119.024 0.829 . . . . 2.78 111.339 -169.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.0 mm -94.03 80.68 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 108.207 -1.035 . . . . 1.91 108.207 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.8 p -77.61 129.66 35.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.18 -1.044 . . . . 1.18 108.18 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.404 ' CE2' HD12 ' A' ' 134' ' ' ILE . 39.4 p90 -129.01 163.0 26.31 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.16 0.584 . . . . 4.52 110.59 -178.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.08 151.8 36.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.618 -0.882 . . . . 6.6 108.618 174.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -100.47 144.21 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.142 -1.059 . . . . 0.94 108.142 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -83.99 -58.32 2.83 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.611 -1.255 . . . . 3.86 107.611 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -123.8 160.18 27.92 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.782 1.233 . . . . 2.24 109.213 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -111.94 127.32 55.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.237 1.415 . . . . 2.12 107.262 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.39 131.03 34.1 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 118.356 0.525 . . . . 2.53 110.044 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -87.66 -17.24 2.78 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.848 3.032 . . . . 1.65 110.794 171.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -44.55 -48.16 10.24 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 125.442 1.497 . . . . 2.06 110.863 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 6.8 ptp -124.33 176.49 6.42 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.097 0.959 . . . . 2.34 109.135 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -65.7 134.26 52.82 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.363 -0.236 . . . . 2.99 110.363 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -52.58 -47.78 66.65 Favored 'General case' 0 CA--C 1.524 -0.043 0 O-C-N 122.028 -0.42 . . . . 3.57 111.651 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -51.01 -25.92 5.4 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.685 -0.674 . . . . 3.22 111.529 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -93.02 -35.32 13.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.992 1.317 . . . . 1.98 112.004 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -52.45 -56.58 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 120.469 -1.395 . . . . 1.2 108.875 171.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.83 -25.46 65.57 Favored 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 117.729 -1.588 . . . . 1.74 108.632 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -63.71 -45.43 90.0 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.856 1.207 . . . . 1.96 111.216 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.75 -53.01 60.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 122.771 0.428 . . . . 0.5 110.187 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.404 HD12 ' CE2' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -70.3 -37.26 70.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.834 -0.432 . . . . 2.05 109.834 -176.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -54.07 -59.98 3.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.337 1.455 . . . . 3.12 107.848 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -63.16 -43.88 97.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.408 -0.814 . . . . 2.4 109.764 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.32 -52.2 47.48 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.372 0.669 . . . . 0.43 111.909 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.04 -46.39 88.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.098 -1.041 . . . . 6.47 109.018 174.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.29 -29.03 63.55 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 118.746 -0.645 . . . . 2.02 111.579 -172.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.404 ' CG1' HD21 ' A' ' 250' ' ' LEU . 99.0 t -59.83 -63.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 118.984 0.811 . . . . 0.81 109.494 171.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.764 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 46.8 m95 -66.04 -41.15 91.26 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.873 -0.788 . . . . 0.71 108.873 -170.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 t -69.08 -4.91 19.03 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 124.312 1.045 . . . . 1.07 112.054 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -89.66 -55.98 3.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.05 -0.722 . . . . 1.1 109.05 167.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.97 -51.44 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 112.8 0.667 . . . . 1.41 112.8 -174.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.511 HG22 HD13 ' A' ' 258' ' ' ILE . 42.3 p -79.76 151.96 74.43 Favored Pre-proline 0 N--CA 1.443 -0.812 0 N-CA-C 107.427 -1.323 . . . . 0.75 107.427 174.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.35 12.76 1.48 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.373 2.049 . . . . 0.74 112.248 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.61 149.45 50.05 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.221 -0.924 . . . . 2.38 109.079 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -120.79 87.46 2.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.661 -1.607 . . . . 4.62 106.661 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -72.37 149.07 44.68 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.11 -0.496 . . . . 5.85 109.77 172.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.3 t -155.73 129.34 8.43 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 119.172 -0.442 . . . . 1.04 110.01 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.68 149.87 27.1 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.224 -1.028 . . . . 2.14 108.224 171.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.0 pt -134.67 119.88 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.627 -1.62 . . . . 1.27 106.627 171.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -76.87 -22.3 53.68 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.505 -0.554 . . . . 3.65 109.505 173.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -136.8 113.27 10.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.25 1.42 . . . . 2.44 108.858 -176.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 149.5 -144.67 12.33 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 108.739 -1.744 . . . . 1.91 108.739 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 28.2 mtt -135.19 131.87 37.26 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 126.384 1.874 . . . . 4.21 107.511 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.77 162.92 14.3 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.552 1.541 . . . . 0.72 110.102 -175.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -86.89 -48.59 8.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.08 0.952 . . . . 1.88 109.68 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.2 pt -107.07 166.5 3.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.246 -0.65 . . . . 0.89 109.246 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.45 141.11 43.53 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.081 0.552 . . . . 2.28 111.269 174.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 73.3 t -90.8 122.77 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.41 -0.959 . . . . 0.87 108.41 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.1 t -97.64 115.35 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.745 -0.835 . . . . 1.56 108.745 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -107.54 113.37 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.953 -2.239 . . . . 5.28 104.953 163.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.613 ' HB3' ' HE2' ' A' ' 174' ' ' PHE . . . -128.13 148.84 50.6 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.77 -1.196 . . . . 0.71 107.77 177.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.96 105.96 15.99 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.996 0.81 . . . . 5.47 109.639 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.19 -134.51 13.6 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.609 -0.997 . . . . 1.87 110.609 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.32 137.64 39.99 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 122.043 -0.68 . . . . 2.02 109.697 -171.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.25 0 CA-C-O 121.385 0.612 . . . . 2.47 110.964 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 113.503 0.927 . . . . 2.21 113.503 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.613 ' HE2' ' HB3' ' A' ' 164' ' ' ALA . 9.5 m-85 -128.67 165.68 20.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.084 1.354 . . . . 6.05 109.036 -168.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -169.08 15.65 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.429 0.9 . . . . 2.67 113.429 -153.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 73.12 -160.65 54.07 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 109.812 -1.315 . . . . 1.27 109.812 -164.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -81.5 55.16 2.54 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.297 -0.531 . . . . 5.9 112.427 -170.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -142.51 -158.77 7.67 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 107.998 -2.041 . . . . 2.28 107.998 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.56 -138.07 41.48 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.172 -1.171 . . . . 1.93 110.172 172.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.3 tp -78.84 151.69 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 109.07 -0.715 . . . . 2.23 109.07 173.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.9 tp -84.32 -39.13 19.53 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.523 1.529 . . . . 1.22 111.146 171.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -167.51 164.07 14.81 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.712 0.805 . . . . 0.8 109.694 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -145.71 124.66 12.75 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.336 1.235 . . . . 1.06 114.336 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -139.52 161.28 37.88 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.065 2.146 . . . . 0.65 108.455 -173.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -148.77 141.84 24.9 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.443 -0.947 . . . . 2.71 108.443 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -92.08 -83.14 1.48 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.586 -1.006 . . . . 0.56 110.586 171.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.2 98.69 0.84 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.104 2.536 . . . . 1.3 111.07 -170.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -174.23 173.44 45.99 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.168 -1.973 . . . . 1.21 108.168 172.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 72.1 m -89.53 173.24 8.44 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.977 0.511 . . . . 2.73 109.679 169.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 54.66 -101.96 0.12 Allowed Glycine 0 C--O 1.243 0.686 0 C-N-CA 124.069 0.842 . . . . 1.61 111.424 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.1 tp -59.35 -41.14 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-O 117.912 -1.042 . . . . 1.59 109.036 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -33.96 129.48 0.47 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.633 1.111 . . . . 1.06 113.11 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 97.16 -34.94 4.73 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.268 1.413 . . . . 0.77 112.125 -167.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -86.47 159.37 19.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.736 1.268 . . . . 1.23 110.72 -165.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -133.66 121.59 22.21 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.385 0.883 . . . . 0.83 113.385 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.2 m170 -109.15 112.25 24.31 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-O 117.473 -1.251 . . . . 2.22 111.957 -167.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -106.77 145.0 32.6 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 121.336 1.88 . . . . 3.17 111.213 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.36 83.34 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.226 1.011 . . . . 3.05 110.227 177.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.81 -24.64 67.84 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 120.376 -1.452 . . . . 2.73 109.901 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.44 -35.42 28.6 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.104 -0.997 . . . . 4.31 111.192 169.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -74.22 161.75 29.62 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.668 1.223 . . . . 1.66 110.985 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -102.46 95.93 6.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.243 -1.392 . . . . 3.04 107.243 176.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -78.27 140.23 38.87 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.549 -0.908 . . . . 1.11 108.549 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.6 p -122.61 105.85 10.47 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 107.599 -1.26 . . . . 1.85 107.599 -172.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.2 t -48.47 -33.24 9.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.384 1.474 . . . . 2.23 114.329 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -71.07 178.27 3.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.634 0.73 . . . . 2.31 111.455 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.1 m -66.31 -47.4 73.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 121.116 -0.99 . . . . 4.7 109.665 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -62.82 132.41 43.62 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.107 -0.951 . . . . 3.26 111.241 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 101.46 -119.52 6.53 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.257 -1.137 . . . . 1.46 110.257 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.8 m -124.77 106.77 10.31 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.915 -1.143 . . . . 1.01 107.915 167.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.93 108.73 2.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.369 -0.604 . . . . 2.07 109.369 174.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 37.9 tp -50.78 -43.5 58.52 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.556 0.617 . . . . 1.61 111.115 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.586 ' CD1' HG22 ' A' ' 245' ' ' ILE . 45.9 t80 -44.06 -46.0 8.29 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.952 0.501 . . . . 1.46 111.125 175.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.407 HD12 ' HD1' ' A' ' 213' ' ' PHE . 3.5 mp -59.51 -63.45 1.3 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.516 0.674 . . . . 2.63 110.061 -173.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.349 1.3 m -60.32 -37.14 79.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.729 -0.669 . . . . 0.75 109.691 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.85 -53.84 50.12 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 117.955 -1.022 . . . . 0.33 110.549 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 213' ' ' PHE . 62.7 t -50.66 -49.94 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.968 1.258 . . . . 0.7 109.538 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.588 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 82.7 t60 -56.82 -45.09 82.5 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.236 -0.915 . . . . 2.53 113.313 177.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -83.23 -48.18 10.75 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.085 -1.009 . . . . 3.04 112.448 -170.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.37 -33.77 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.364 -1.347 . . . . 1.29 107.364 164.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.76 ' HA2' HD23 ' A' ' 224' ' ' LEU . . . -50.15 -61.44 5.79 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.95 -0.86 . . . . 0.63 110.95 168.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.588 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 17.5 m-70 -47.36 -56.48 6.79 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.495 -1.003 . . . . 1.3 110.743 174.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.0 m -46.36 -40.15 11.48 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 113.226 0.825 . . . . 2.16 113.226 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.76 HD23 ' HA2' ' A' ' 221' ' ' GLY . 0.5 OUTLIER -63.72 -33.88 76.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 118.924 0.784 . . . . 3.46 110.127 -174.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 130.61 46.18 0.15 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.933 1.73 . . . . 1.31 112.603 172.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.902 HD11 HG22 ' A' ' 258' ' ' ILE . 4.8 mt -119.45 147.72 44.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.586 1.193 . . . . 3.43 113.198 -172.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -88.13 166.42 35.18 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.879 1.228 . . . . 2.89 110.721 173.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -70.35 121.85 18.46 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.562 0.745 . . . . 1.65 110.536 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 66.5 m -77.01 -179.39 5.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.261 0.625 . . . . 1.1 110.903 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 17.6 m -135.53 39.1 2.86 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.038 1.335 . . . . 2.22 110.35 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -135.77 136.33 23.32 Favored Pre-proline 0 N--CA 1.452 -0.325 0 N-CA-C 107.524 -1.287 . . . . 1.99 107.524 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.3 -13.38 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.315 2.01 . . . . 1.01 114.325 -175.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -41.69 21.97 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.946 0.898 . . . . 1.92 109.068 173.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.29 139.88 34.92 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.333 1.053 . . . . 0.79 111.041 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 76.6 t -86.48 -15.18 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.943 0.878 . . . . 0.63 110.978 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.454 ' SD ' HD13 ' A' ' 226' ' ' LEU . 3.7 tpt -80.25 -21.71 42.48 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.166 -0.959 . . . . 1.69 112.916 -171.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -49.83 165.02 0.32 Allowed Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 128.091 2.556 . . . . 3.1 114.59 175.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -78.29 -21.11 10.69 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.536 1.491 . . . . 0.96 112.103 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.365 0.2 OUTLIER -78.64 -178.58 5.97 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.375 1.47 . . . . 1.28 110.686 -176.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -111.05 153.91 24.96 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.491 1.517 . . . . 3.05 108.926 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.0 tptt -149.53 133.13 16.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 106.858 -1.534 . . . . 2.32 106.858 169.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -70.19 111.69 6.0 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.416 -0.957 . . . . 2.87 108.416 170.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 20.6 m -121.65 118.17 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.737 0.815 . . . . 1.72 109.015 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.73 114.0 4.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.557 -0.714 . . . . 3.36 110.31 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.586 HG22 ' CD1' ' A' ' 213' ' ' PHE . 1.1 pp -52.09 -29.72 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 C-N-CA 124.642 1.177 . . . . 3.56 111.231 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -52.8 -40.94 63.69 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.854 0.861 . . . . 3.78 110.884 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 35.9 m -73.48 -36.39 65.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 119.108 -0.472 . . . . 1.82 110.515 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 44.4 t80 52.47 72.65 0.39 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.007 0.923 . . . . 5.08 110.084 172.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.41 167.12 30.55 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.099 -1.001 . . . . 2.55 110.965 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.467 HD22 ' N ' ' A' ' 250' ' ' LEU . 0.9 OUTLIER -114.08 -170.46 1.72 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.542 1.937 . . . . 1.48 109.463 179.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 13.9 m -109.85 149.12 30.32 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.574 1.15 . . . . 0.7 111.295 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.4 -48.84 65.43 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.984 -0.448 . . . . 0.88 111.573 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -64.11 -22.88 67.11 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.902 0.334 . . . . 2.97 111.902 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -77.78 -47.83 18.02 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.967 -0.458 . . . . 3.41 110.805 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.418 ' HA ' HG13 ' A' ' 258' ' ' ILE . 67.8 mt -54.48 -40.65 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.151 1.38 . . . . 0.88 110.974 -175.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -56.8 -47.79 79.4 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.311 -1.493 . . . . 6.85 111.214 170.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -57.48 -48.92 77.45 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.625 1.107 . . . . 0.97 110.545 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.902 HG22 HD11 ' A' ' 226' ' ' LEU 0.26 1.6 pp -64.08 -44.03 97.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 O-C-N 121.491 -1.005 . . . . 2.43 109.686 -176.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -64.03 -30.23 71.32 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.465 -1.397 . . . . 2.25 111.787 176.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.6 t -50.76 -14.82 0.22 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.535 1.309 . . . . 1.81 114.535 169.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.7 HD11 ' CD1' ' A' ' 224' ' ' LEU . 19.2 mt . . . . . 0 C--N 1.345 0.396 0 CA-C-N 120.388 1.449 . . . . 2.52 112.713 165.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.7 mttt . . . . . 0 C--O 1.225 -0.217 0 CA-C-O 122.494 1.14 . . . . 5.8 111.582 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -73.7 -46.77 44.24 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.172 -0.955 . . . . 3.2 108.572 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -126.82 118.41 24.57 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.287 0.635 . . . . 3.7 112.452 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 114' ' ' ILE . 1.6 mp -97.15 92.71 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 107.251 -1.389 . . . . 2.21 107.251 172.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.6 p -81.39 136.97 35.73 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.338 -0.986 . . . . 1.27 108.338 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.43 ' HA ' ' HB1' ' A' ' 157' ' ' ALA . 43.4 p90 -142.51 164.87 28.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.336 0.516 . . . . 4.13 112.294 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -147.1 142.87 27.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.129 0.971 . . . . 4.75 108.435 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.92 164.3 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.555 0.742 . . . . 0.92 109.327 172.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.606 HD22 ' H ' ' A' ' 119' ' ' ASN . 0.1 OUTLIER -109.33 -56.33 2.31 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 126.148 1.779 . . . . 3.32 108.441 179.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -139.77 120.98 14.83 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.776 -0.824 . . . . 3.17 108.776 -167.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -81.26 113.08 19.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.349 -0.982 . . . . 2.35 108.349 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -52.27 128.78 40.98 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 123.025 0.53 . . . . 2.32 110.314 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.68 -15.88 11.95 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.69 2.927 . . . . 1.53 110.553 173.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -46.2 -39.17 9.36 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.366 1.066 . . . . 2.04 110.479 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 42.4 mtm -124.95 -176.72 3.63 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.316 1.447 . . . . 1.95 109.954 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -73.87 144.01 45.61 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.432 -0.581 . . . . 3.05 109.432 170.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 64.2 ttt-85 -51.04 -45.55 61.36 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.413 -0.804 . . . . 2.7 110.722 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -61.81 -13.0 19.94 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.508 0.723 . . . . 3.41 112.028 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -94.52 -45.38 7.44 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.344 1.458 . . . . 1.9 109.568 172.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 52.4 t -55.8 -59.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.792 1.237 . . . . 1.18 109.831 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -24.14 65.67 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 117.602 -1.639 . . . . 1.78 108.987 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -64.55 -46.61 82.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.798 0.727 . . . . 1.91 111.208 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.09 -53.34 58.23 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.465 0.706 . . . . 0.37 109.846 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.4 ' O ' HD13 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -69.65 -36.84 72.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 109.516 -0.549 . . . . 2.04 109.516 -178.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -57.27 12.45 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 122.173 0.987 . . . . 4.74 108.511 178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -62.03 -43.96 97.72 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.225 -0.657 . . . . 1.57 109.225 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.466 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -48.39 -53.99 15.64 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.437 0.695 . . . . 0.45 112.758 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 149' ' ' PHE . 0.3 OUTLIER -62.25 -47.02 86.23 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 119.304 -0.958 . . . . 6.56 109.103 176.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.31 -37.05 71.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 122.511 0.324 . . . . 1.93 110.704 -169.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.0 t -54.63 -52.22 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 109.139 -0.689 . . . . 0.79 109.139 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.87 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 64.4 m95 -69.69 -35.29 74.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.501 -0.749 . . . . 0.89 109.463 -177.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.6 t -64.2 -16.46 62.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.375 0.67 . . . . 1.48 112.16 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -83.38 -51.05 7.73 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.116 -1.068 . . . . 1.2 108.116 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.464 HG11 HD23 ' A' ' 250' ' ' LEU . 30.5 m -74.54 -44.46 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 112.393 0.516 . . . . 1.6 112.393 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.462 ' CG2' HD13 ' A' ' 258' ' ' ILE . 56.4 p -84.84 150.63 56.34 Favored Pre-proline 0 N--CA 1.445 -0.714 0 N-CA-C 108.902 -0.777 . . . . 0.74 108.902 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.52 10.46 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.61 2.207 . . . . 0.84 112.636 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 43.8 mt -67.72 133.95 50.19 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.263 1.425 . . . . 1.92 110.309 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.56 82.68 1.69 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.832 -1.173 . . . . 4.67 107.832 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.528 ' HB2' ' CD1' ' A' ' 138' ' ' PHE . 77.4 m-85 -67.66 159.17 30.55 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.051 -0.522 . . . . 5.24 111.131 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.3 t -155.79 125.87 6.59 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.83 0.741 . . . . 0.98 110.629 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -78.78 137.26 37.65 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 107.256 -1.387 . . . . 2.19 107.256 167.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.2 pt -135.08 105.58 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.467 -0.938 . . . . 1.67 108.467 170.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -77.41 -15.45 59.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.486 -0.325 . . . . 3.13 110.169 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.3 m -127.32 102.02 6.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.308 1.043 . . . . 2.06 109.249 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.0 -155.26 26.36 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 108.81 -1.716 . . . . 1.41 108.81 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 31.4 mtp -117.71 130.16 56.16 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.129 2.572 . . . . 4.14 105.88 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.43 ' HB1' ' HA ' ' A' ' 116' ' ' TYR . . . -119.14 161.19 20.73 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.291 1.036 . . . . 0.75 109.91 -173.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -68.82 -54.61 14.83 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.972 -0.751 . . . . 1.87 108.972 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.3 pt -114.3 135.96 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.527 0.731 . . . . 1.16 109.271 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.72 131.56 52.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.224 -1.028 . . . . 2.19 108.224 172.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.32 124.54 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 106.937 -1.505 . . . . 0.83 106.937 169.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.9 t -98.51 137.84 24.85 Favored 'Isoleucine or valine' 0 C--N 1.346 0.422 0 C-N-CA 125.049 1.339 . . . . 1.22 108.92 171.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -130.26 107.56 9.37 Favored 'General case' 0 C--N 1.335 -0.054 0 N-CA-C 106.569 -1.641 . . . . 5.34 106.569 171.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -123.26 154.42 38.84 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.51 0.672 . . . . 0.77 112.35 -173.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -92.17 70.01 5.28 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.792 0.837 . . . . 6.2 109.66 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 95.13 -150.33 19.65 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.66 -0.976 . . . . 2.6 110.66 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.55 81.3 3.23 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.96 -0.729 . . . . 2.89 112.107 -162.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.541 0.623 0 C-N-CA 124.876 1.27 . . . . 2.59 112.561 173.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.146 0 CA-C-O 119.658 -0.21 . . . . 3.92 111.333 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -110.09 166.54 10.87 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 122.933 0.493 . . . . 6.46 110.085 166.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -172.92 164.94 5.1 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 127.389 2.276 . . . . 3.89 106.539 -170.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -72.39 -143.35 0.47 Allowed Glycine 0 CA--C 1.525 0.68 0 O-C-N 123.969 0.793 . . . . 1.76 111.344 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -61.73 108.15 0.95 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.392 0.677 . . . . 5.17 110.795 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.24 -145.68 18.11 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.679 -1.368 . . . . 1.71 109.679 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 45.44 -126.93 8.02 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 126.136 1.827 . . . . 1.58 111.706 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.3 mm -79.99 144.0 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-O 122.218 1.008 . . . . 1.99 108.702 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.0 mp -84.23 -62.04 1.66 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.576 1.95 . . . . 1.04 109.445 170.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -159.56 158.4 31.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 120.637 -1.29 . . . . 0.53 110.151 -172.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -144.06 135.52 25.83 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 114.247 1.202 . . . . 1.22 114.247 172.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' A' ' 222' ' ' HIS . . . -149.43 164.04 36.09 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.264 2.226 . . . . 0.54 107.8 -169.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -150.05 143.49 25.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.09 -0.707 . . . . 3.03 109.09 -173.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -87.11 -130.18 2.94 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.789 -1.006 . . . . 0.63 110.665 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.09 105.21 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.54 2.16 . . . . 2.51 110.56 -173.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -167.36 168.05 40.26 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 107.56 -2.216 . . . . 1.1 107.56 176.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.5 m -78.16 167.65 21.08 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.42 0.629 . . . . 2.04 111.659 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 53.59 -111.78 2.05 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.173 0.892 . . . . 1.22 112.165 173.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.5 tp -60.55 -37.26 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 118.239 -0.886 . . . . 1.34 109.61 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -32.58 131.42 0.25 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.176 1.37 . . . . 0.96 113.199 173.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.08 -48.89 1.18 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.58 1.562 . . . . 0.64 111.171 -165.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.45 153.13 23.55 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.537 -0.912 . . . . 1.3 108.537 -161.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.39 120.57 30.16 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 118.001 -0.999 . . . . 0.61 112.274 -172.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.47 129.51 56.53 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-N 119.213 0.915 . . . . 2.36 110.123 -166.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.419 ' CE2' ' HG3' ' A' ' 219' ' ' GLU . 25.2 m-85 -121.63 150.72 41.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 118.736 0.698 . . . . 2.84 110.252 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -79.55 77.73 6.12 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 122.082 0.944 . . . . 3.6 111.962 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -48.06 -33.43 8.07 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 119.971 -1.706 . . . . 2.75 111.506 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -36.32 -47.8 0.61 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.773 1.229 . . . . 2.65 112.004 171.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -73.81 170.18 15.86 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.09 1.356 . . . . 1.77 111.0 -175.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -107.41 94.03 4.87 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.885 -1.524 . . . . 2.63 106.885 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -82.83 151.46 26.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.587 -0.733 . . . . 1.4 109.652 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.99 161.99 29.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.725 0.774 . . . . 2.23 110.836 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.39 -41.02 70.18 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.401 2.28 . . . . 1.7 111.684 169.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -80.37 157.79 26.22 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.533 -0.758 . . . . 2.32 110.358 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.8 m -70.58 -33.67 71.34 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.175 1.39 . . . . 4.78 111.622 -170.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.69 116.3 8.43 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-O 118.402 -1.221 . . . . 2.59 110.244 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 109.18 -121.02 6.0 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 107.812 -2.115 . . . . 1.31 107.812 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.4 m -124.72 138.66 54.28 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.681 -1.229 . . . . 0.77 107.681 159.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.27 116.44 29.01 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.83 -0.623 . . . . 2.18 109.864 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.74 -56.43 10.28 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.268 0.627 . . . . 1.44 109.706 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.583 ' O ' HG23 ' A' ' 217' ' ' VAL . 43.3 t80 -43.15 -50.87 6.19 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.515 1.526 . . . . 1.54 111.892 176.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.412 ' C ' HD23 ' A' ' 214' ' ' LEU . 6.0 tt -62.37 -58.12 8.84 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.61 -0.515 . . . . 1.45 109.61 -172.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.291 6.1 m -58.16 -41.47 83.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.948 -0.301 . . . . 0.77 110.649 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.79 -49.64 57.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.619 -0.705 . . . . 0.42 111.009 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 213' ' ' PHE . 58.3 t -57.28 -44.76 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 119.533 1.06 . . . . 0.81 111.098 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.754 ' NE2' ' CE1' ' A' ' 222' ' ' HIS . 1.0 OUTLIER -57.1 -50.22 73.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.522 1.129 . . . . 2.52 111.948 172.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.419 ' HG3' ' CE2' ' A' ' 197' ' ' PHE . 15.0 mm-40 -71.16 -46.93 60.48 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.457 -0.777 . . . . 2.63 112.385 -174.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.11 -39.29 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 107.48 -1.304 . . . . 1.09 107.48 170.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.05 -56.92 5.73 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 123.659 0.647 . . . . 0.46 112.919 164.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.754 ' CE1' ' NE2' ' A' ' 218' ' ' HIS 0.266 0.3 OUTLIER -49.94 -46.62 52.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.781 0.79 . . . . 1.68 110.904 178.258 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.2 t -51.94 -38.05 54.99 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 123.491 0.494 . . . . 2.31 112.275 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 mt -70.91 -59.35 2.84 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 107.528 -1.286 . . . . 2.16 107.528 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 139.44 104.11 0.59 Allowed Glycine 0 C--N 1.337 0.611 0 N-CA-C 110.016 -1.234 . . . . 1.7 110.016 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.807 HD12 ' H ' ' A' ' 228' ' ' HIS . 3.1 pp -130.73 145.42 51.94 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.52 0.728 . . . . 5.38 111.847 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -101.06 28.34 16.48 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.65 1.119 . . . . 3.14 112.456 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.807 ' H ' HD12 ' A' ' 226' ' ' LEU . 32.7 m80 57.39 102.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.393 2.677 . . . . 2.09 112.698 -176.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 7.1 m -72.29 170.12 14.79 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.229 -0.656 . . . . 1.1 109.229 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.2 m -140.72 44.33 1.83 Allowed 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.472 -0.768 . . . . 2.32 110.268 -171.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -143.18 132.08 11.52 Favored Pre-proline 0 N--CA 1.447 -0.614 0 N-CA-C 106.977 -1.49 . . . . 1.75 106.977 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.56 -14.82 27.62 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.972 1.781 . . . . 1.63 114.153 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -72.13 -23.61 61.33 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.475 1.034 . . . . 1.5 110.269 171.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.53 ' HB1' ' OD1' ' A' ' 254' ' ' ASP . . . -76.31 158.03 31.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.357 0.599 . . . . 1.17 110.607 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.421 HG11 ' CG1' ' A' ' 217' ' ' VAL . 45.2 t -110.99 -25.98 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.302 1.441 . . . . 0.79 111.074 173.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.546 ' HE3' HD23 ' A' ' 226' ' ' LEU . 52.6 mmm -65.92 -11.86 50.35 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.158 -0.964 . . . . 2.96 111.759 173.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.57 159.35 3.45 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.788 1.635 . . . . 3.61 113.959 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.25 -17.86 7.59 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.92 2.413 . . . . 0.97 111.524 170.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.3 0.2 OUTLIER -77.21 176.06 9.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.737 1.215 . . . . 1.81 108.776 179.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.406 ' CE2' HD13 ' A' ' 214' ' ' LEU . 51.2 t80 -143.19 141.27 31.08 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 104.568 -2.382 . . . . 2.51 104.568 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -156.24 145.21 20.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 104.873 -2.269 . . . . 4.32 104.873 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -49.04 109.59 0.27 Allowed 'General case' 0 C--N 1.339 0.118 0 N-CA-C 108.157 -1.053 . . . . 2.62 108.157 168.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.91 149.06 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 123.908 0.883 . . . . 1.75 108.891 171.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -60.0 78.5 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.496 2.318 . . . . 5.97 111.236 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 39.0 mm -44.95 -35.12 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.864 1.266 . . . . 3.81 110.794 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -55.06 -64.76 0.74 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.179 0.807 . . . . 4.59 113.179 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 92.7 m -82.22 -51.18 8.19 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.676 -0.861 . . . . 2.42 108.676 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 217' ' ' VAL . 29.2 t80 38.8 72.9 0.12 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.645 1.978 . . . . 7.25 113.083 174.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.75 159.29 15.9 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.266 -0.879 . . . . 4.93 109.532 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.691 HD12 ' CH2' ' A' ' 141' ' ' TRP . 1.6 mm? -85.91 143.88 27.97 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.543 -0.91 . . . . 1.02 108.543 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.0 m -76.63 156.14 32.93 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 110.572 -0.158 . . . . 0.74 110.572 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.87 80.88 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.783 -0.451 . . . . 0.91 109.783 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.15 -57.68 6.27 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 122.261 1.029 . . . . 2.6 109.699 174.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.53 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 12.1 m-20 -59.11 -39.61 82.81 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.563 -1.199 . . . . 2.22 112.266 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 35.5 mt -55.47 -35.14 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 119.114 0.87 . . . . 1.01 110.047 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -66.51 -53.31 36.43 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.468 -0.77 . . . . 4.42 110.014 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -50.77 -54.78 20.43 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 123.077 0.37 . . . . 1.29 112.532 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.87 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 2.6 pp -60.48 -43.35 94.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 121.851 -0.793 . . . . 2.24 110.462 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.411 ' HG2' HD12 ' A' ' 258' ' ' ILE . 2.2 mt-30 -67.03 -17.17 64.79 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.66 1.118 . . . . 2.56 112.243 174.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.1 t -66.12 -11.66 50.5 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.246 -1.359 . . . . 2.61 113.407 167.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.626 HD13 ' O ' ' A' ' 261' ' ' LEU 0.293 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.084 0 CA-C-N 120.66 1.573 . . . . 3.83 110.162 172.297 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.0 mptt . . . . . 0 CA--C 1.534 0.35 0 N-CA-C 108.477 -0.935 . . . . 5.56 108.477 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 67.38 -61.14 0.36 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.16 1.784 . . . . 3.75 110.283 -168.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -113.25 130.16 56.32 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 125.848 1.659 . . . . 2.87 109.72 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.8 mt -138.45 105.51 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 123.54 0.525 . . . . 2.58 110.499 173.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 p -101.57 145.82 28.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.474 1.109 . . . . 1.19 110.914 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.411 ' CZ ' ' CE1' ' A' ' 138' ' ' PHE . 6.8 m-85 -127.1 150.11 49.63 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.305 0.642 . . . . 5.84 110.58 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -138.59 142.13 39.18 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.122 0.569 . . . . 4.8 109.822 174.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.405 HD11 ' HE2' ' A' ' 151' ' ' LYS . 2.7 mt -99.8 151.71 4.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.936 -1.135 . . . . 1.01 107.936 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -91.92 -56.5 3.06 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.001 -1.111 . . . . 4.02 108.001 177.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -144.01 157.86 44.07 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 124.959 1.304 . . . . 2.79 108.78 -171.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -112.75 143.86 43.25 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.659 1.184 . . . . 2.24 108.985 -169.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.537 HG22 ' H ' ' A' ' 125' ' ' MET . 0.8 OUTLIER -75.31 127.21 86.75 Favored Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 108.528 -0.916 . . . . 2.51 108.528 179.511 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.26 -18.13 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.13 2.553 . . . . 1.67 112.033 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.98 -46.79 64.99 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 118.983 0.811 . . . . 2.23 109.609 174.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.537 ' H ' HG22 ' A' ' 122' ' ' THR . 50.8 mtm -105.96 174.26 5.96 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.836 -1.075 . . . . 2.06 109.009 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -80.76 135.11 35.93 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.228 -1.027 . . . . 2.92 108.228 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -45.76 -52.24 11.4 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 118.673 0.669 . . . . 3.02 111.97 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -51.68 -46.87 63.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.482 -0.487 . . . . 3.87 109.731 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.43 -39.96 92.74 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.465 1.506 . . . . 1.89 111.541 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.8 t -56.04 -56.5 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.205 -1.035 . . . . 1.26 108.205 175.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.8 -22.88 61.51 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.026 -1.07 . . . . 1.73 110.312 -176.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -67.9 -49.33 62.56 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.24 1.016 . . . . 2.18 109.194 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.44 -54.74 36.69 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 123.71 0.804 . . . . 0.44 109.213 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -68.0 -34.71 68.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 120.212 -0.595 . . . . 2.33 110.356 -176.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -56.45 -60.47 3.48 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 108.191 -1.04 . . . . 4.0 108.191 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -62.65 -42.9 99.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.592 1.557 . . . . 1.45 108.78 -172.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.38 -54.16 18.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.728 0.811 . . . . 0.52 110.328 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.556 ' CE1' HG23 ' A' ' 220' ' ' ILE . 4.0 m-85 -58.84 -51.91 68.01 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 118.886 -0.578 . . . . 4.51 110.999 171.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.42 -33.5 21.06 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.745 0.646 . . . . 2.16 112.745 -174.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.762 HG12 HD21 ' A' ' 250' ' ' LEU . 77.8 t -69.21 -47.32 74.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.583 0.753 . . . . 1.11 110.468 175.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.969 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 7.1 m95 -69.78 -32.4 70.86 Favored 'General case' 0 N--CA 1.456 -0.155 0 O-C-N 120.631 -1.293 . . . . 0.84 110.638 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.47 -11.08 60.34 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.1 1.36 . . . . 1.22 110.778 176.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.63 -45.37 17.38 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 107.809 -1.182 . . . . 1.4 107.809 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.0 m -84.07 -45.64 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 112.473 0.546 . . . . 1.5 112.473 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.775 HG22 HD13 ' A' ' 258' ' ' ILE . 19.9 p -78.86 150.8 75.84 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 107.768 -1.197 . . . . 0.74 107.768 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -72.96 1.91 6.02 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 121.971 1.781 . . . . 1.09 112.678 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.1 mt -69.6 142.14 53.59 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.384 1.474 . . . . 2.05 109.274 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 103.0 12.62 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.749 -0.834 . . . . 3.81 108.749 174.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.547 ' CD2' ' HB3' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -67.96 146.3 53.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.551 0.74 . . . . 6.98 110.917 176.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.7 t -152.44 95.15 2.0 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.638 0.653 . . . . 0.88 111.964 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.405 ' HE2' HD11 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -76.92 133.81 39.13 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 120.583 -1.323 . . . . 3.0 108.41 171.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.4 pp -130.56 174.38 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.392 -1.707 . . . . 1.77 106.392 171.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -134.14 21.24 3.76 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 121.613 -0.679 . . . . 3.47 109.525 172.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 85.5 m -157.03 117.16 3.51 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.071 -1.455 . . . . 2.21 107.071 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 121.34 -144.63 16.72 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 108.209 -1.956 . . . . 1.95 108.209 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 33.0 mtt -110.11 139.11 45.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.982 1.313 . . . . 4.18 109.43 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -127.23 159.74 33.39 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.241 1.416 . . . . 0.99 109.809 173.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.42 -54.45 6.71 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.054 -1.462 . . . . 2.53 107.054 168.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.58 151.58 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 122.397 1.094 . . . . 1.69 111.253 -168.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.7 mt -126.08 125.01 41.87 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 112.398 -2.183 . . . . 2.25 107.876 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 38.0 t -91.87 105.43 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.934 -1.136 . . . . 0.96 107.934 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 62.2 t -110.8 102.88 14.61 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 C-N-CA 123.916 0.887 . . . . 1.79 109.237 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -80.61 155.98 26.62 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.955 -1.128 . . . . 6.57 107.955 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -158.16 -173.49 4.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.176 0.444 . . . . 1.08 110.199 167.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -129.5 145.89 51.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.296 1.039 . . . . 4.28 108.876 170.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.4 -126.24 19.15 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.354 0.978 . . . . 1.97 111.987 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.38 132.92 37.57 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.301 1.04 . . . . 2.34 109.677 -173.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' A' ' 168' ' ' HIS 0.255 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.571 0 CA-C-O 123.277 1.513 . . . . 3.41 111.193 179.266 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.401 0 CA-C-O 118.173 -0.917 . . . . 2.22 111.234 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.407 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 39.5 t80 -92.08 156.03 17.66 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 122.434 1.111 . . . . 7.68 110.318 175.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 35.9 p30 -166.02 30.48 0.05 OUTLIER 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.774 -1.557 . . . . 3.52 110.127 -152.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 84.63 172.06 48.72 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.435 -0.666 . . . . 2.34 111.435 -172.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.94 124.99 18.45 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.631 -0.507 . . . . 3.74 109.631 167.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 97.08 -154.67 20.55 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.283 -1.127 . . . . 2.07 110.283 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 57.61 -122.94 31.11 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 109.451 -1.459 . . . . 1.8 109.451 -173.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.6 mm -75.93 128.79 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 105.961 -1.866 . . . . 1.77 105.961 168.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.3 mp -81.08 -50.67 9.36 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.008 -0.738 . . . . 1.28 109.008 172.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -161.71 163.61 29.59 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.369 0.268 . . . . 0.55 110.328 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -142.82 112.41 6.83 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.321 1.448 . . . . 1.25 113.691 -169.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -146.75 162.0 39.46 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 127.443 2.297 . . . . 0.78 107.166 -175.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.86 151.83 16.78 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.801 -0.814 . . . . 5.77 108.801 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -102.5 -84.42 1.8 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.61 1.1 . . . . 0.82 110.486 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.62 94.46 0.61 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.806 3.004 . . . . 1.3 110.625 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -163.91 154.75 25.79 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 108.412 -1.875 . . . . 0.94 108.412 170.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.7 m -78.44 170.28 16.9 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.418 -0.586 . . . . 2.44 109.418 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 72.19 -118.81 6.99 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.517 -1.433 . . . . 1.99 109.517 -175.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . 0.266 3.5 tp -84.92 21.71 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 124.304 1.041 . . . . 3.44 112.723 -168.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -55.46 143.32 35.23 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 120.891 -1.131 . . . . 1.89 114.231 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 94.04 -32.67 5.73 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.572 1.082 . . . . 0.9 111.111 -173.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.28 158.97 18.31 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.666 0.733 . . . . 1.6 109.423 -158.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -142.71 127.15 17.79 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.114 0.783 . . . . 0.82 113.114 -157.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -117.8 131.51 56.56 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 117.94 -1.029 . . . . 2.38 110.673 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -113.54 152.17 30.6 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.561 0.696 . . . . 6.33 111.556 167.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.19 85.08 0.75 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.773 -1.103 . . . . 2.79 108.529 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -60.91 -31.74 71.23 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.4 -1.438 . . . . 2.53 111.029 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -47.62 -42.3 23.86 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.304 0.573 . . . . 2.73 110.517 172.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.36 135.34 51.66 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.486 -1.301 . . . . 2.13 107.486 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -88.27 94.85 9.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.195 -1.78 . . . . 2.64 106.195 -174.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -76.12 138.05 40.5 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.663 -1.606 . . . . 1.15 106.663 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 35.9 p -118.01 124.08 47.27 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.024 -1.843 . . . . 1.77 106.024 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.1 t -51.91 -46.5 64.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 121.657 2.026 . . . . 1.89 110.452 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.92 132.67 47.19 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.229 -0.896 . . . . 2.83 109.768 167.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 11.1 p -39.82 -57.08 1.64 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.693 1.597 . . . . 3.68 110.744 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 18.95 -88.9 0.01 OUTLIER Glycine 0 CA--C 1.524 0.622 0 C-N-CA 128.564 2.983 . . . . 2.45 115.406 163.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -81.97 -80.22 0.93 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.811 -1.716 . . . . 1.03 108.811 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.3 m -150.95 111.2 4.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.048 -1.093 . . . . 1.01 108.048 170.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -61.33 117.81 6.12 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.35 0.66 . . . . 1.52 110.822 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 46.0 tp -53.69 -48.25 69.71 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 119.298 -0.382 . . . . 1.85 110.089 178.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.444 ' O ' HG23 ' A' ' 217' ' ' VAL . 31.4 t80 -49.68 -42.91 46.75 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.993 0.517 . . . . 1.45 111.152 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.44 ' C ' HD23 ' A' ' 214' ' ' LEU . 9.3 tt -60.34 -59.44 5.41 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.041 0.937 . . . . 1.33 110.32 -176.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.265 0.2 OUTLIER -61.77 -38.71 89.04 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.647 -0.252 . . . . 0.92 111.073 177.458 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.42 -56.67 16.36 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 117.954 -1.022 . . . . 0.44 109.343 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 213' ' ' PHE . 93.0 t -47.54 -42.6 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 119.996 1.271 . . . . 0.74 110.986 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.777 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 0.2 OUTLIER -59.92 -51.06 71.29 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.119 0.567 . . . . 2.84 111.263 175.365 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -64.53 -54.71 28.01 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 121.043 -1.036 . . . . 4.15 110.845 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.556 HG23 ' CE1' ' A' ' 138' ' ' PHE . 1.7 mp -49.34 -46.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 127.041 2.137 . . . . 1.27 109.247 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -58.5 -44.84 95.17 Favored Glycine 0 CA--C 1.534 1.261 0 O-C-N 121.482 -0.761 . . . . 0.6 111.506 172.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.777 ' NE2' ' NE2' ' A' ' 218' ' ' HIS 0.264 6.7 m-70 -51.94 -49.06 63.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.237 1.518 . . . . 1.29 110.855 171.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.3 m -55.42 -44.9 76.7 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.48 1.112 . . . . 2.22 111.482 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 93.3 mt -59.28 -52.55 65.17 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.565 -0.531 . . . . 2.72 109.565 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.473 ' O ' HD21 ' A' ' 261' ' ' LEU . . . 139.37 92.27 0.23 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.679 1.133 . . . . 1.23 111.585 170.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 1.077 HD11 HG22 ' A' ' 258' ' ' ILE . 2.6 mt -145.96 112.46 5.89 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.242 1.021 . . . . 3.22 111.57 -171.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -79.0 43.38 2.44 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.68 1.133 . . . . 2.67 113.664 -174.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 71.6 m80 60.73 175.28 0.1 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.689 1.596 . . . . 1.93 113.79 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 69.7 m -139.84 -178.73 5.56 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.903 2.081 . . . . 1.09 108.07 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 27.7 t -143.33 31.74 1.35 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.905 0.882 . . . . 2.95 111.128 -173.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -127.92 137.3 30.5 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 106.932 -1.507 . . . . 1.65 106.932 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.97 -11.72 14.91 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.39 2.06 . . . . 1.17 114.77 -173.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 233' ' ' LYS . 25.9 mtmt -81.96 -29.12 32.34 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.916 0.886 . . . . 1.29 109.274 168.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.95 151.87 45.99 Favored 'General case' 0 CA--C 1.519 -0.229 0 O-C-N 121.883 -0.511 . . . . 0.7 109.774 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 88.4 t -98.27 -24.29 4.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.508 0.723 . . . . 0.79 109.993 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.565 ' SD ' HD13 ' A' ' 226' ' ' LEU . 0.6 OUTLIER -63.84 -15.09 58.01 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 114.029 1.122 . . . . 1.79 114.029 177.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -49.65 154.77 1.58 Allowed Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 113.032 0.752 . . . . 3.31 113.032 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.27 -23.05 21.32 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.473 1.449 . . . . 1.15 111.638 172.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.291 0.6 OUTLIER -79.31 -178.6 6.31 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.497 1.519 . . . . 1.47 111.084 -179.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -116.64 155.61 28.49 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.894 1.678 . . . . 2.36 107.026 171.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.77 125.65 7.76 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.113 -1.069 . . . . 2.26 108.113 165.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -63.37 125.69 24.98 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.066 0.946 . . . . 3.05 109.733 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 16.3 m -141.24 148.27 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 108.276 -1.009 . . . . 2.28 108.276 167.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.67 127.96 33.98 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.993 1.317 . . . . 3.63 110.239 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.7 pp -58.35 -28.52 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 122.604 0.361 . . . . 3.48 111.917 -173.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -76.6 -43.12 39.85 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 123.625 0.77 . . . . 5.47 111.942 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 91.1 m -80.55 -27.18 37.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.32 0.648 . . . . 2.56 109.628 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -26.13 113.72 0.05 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.869 2.068 . . . . 7.72 112.403 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.35 158.18 44.78 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.129 1.371 . . . . 3.79 109.078 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.762 HD21 HG12 ' A' ' 140' ' ' VAL . 1.8 mm? -83.44 146.28 28.51 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.853 -1.166 . . . . 0.96 107.853 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.0 m -79.48 152.61 30.14 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 119.705 -0.188 . . . . 0.72 111.304 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.17 -42.46 63.45 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.635 0.374 . . . . 0.79 110.857 172.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -50.0 -57.81 6.79 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 122.287 1.041 . . . . 2.7 109.681 172.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.93 -41.34 87.11 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.23 -1.35 . . . . 2.38 110.495 -176.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 80.0 mt -54.97 -40.12 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.351 1.46 . . . . 1.01 111.389 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -67.9 -44.64 76.5 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 120.694 -1.253 . . . . 4.37 110.22 174.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -46.65 -55.88 7.79 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.823 -0.911 . . . . 0.93 110.823 174.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 1.077 HG22 HD11 ' A' ' 226' ' ' LEU . 2.0 pp -64.62 -43.93 96.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 O-C-N 121.826 -0.808 . . . . 2.26 111.163 -175.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.603 ' N ' HD12 ' A' ' 258' ' ' ILE . 2.4 mt-30 -64.63 -18.41 64.9 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.628 0.649 . . . . 2.58 112.057 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.3 t -51.56 -33.11 30.97 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.738 0.699 . . . . 2.38 111.312 169.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 261' ' ' LEU . 16.2 mt . . . . . 0 C--N 1.346 0.438 0 CA-C-N 119.218 0.917 . . . . 2.71 112.802 172.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.5 mptt . . . . . 0 CA--C 1.528 0.12 0 N-CA-C 109.91 -0.404 . . . . 5.65 109.91 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 61.56 -63.07 0.09 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.908 1.283 . . . . 4.07 111.172 -159.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -77.8 99.68 6.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.41 0.55 . . . . 3.24 111.22 -170.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.8 mm -117.08 108.02 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.726 -0.842 . . . . 1.9 108.726 174.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.509 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 40.3 p -120.03 125.05 47.39 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 117.792 -1.099 . . . . 1.21 109.3 -176.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.57 159.23 24.75 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.626 1.17 . . . . 3.86 112.24 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -133.91 149.43 51.29 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.071 0.948 . . . . 5.55 109.362 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.8 mt -107.03 137.68 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.466 1.506 . . . . 1.16 107.271 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -98.22 -45.26 6.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.989 0.359 . . . . 2.72 110.423 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -143.32 161.99 36.87 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.794 -0.817 . . . . 2.22 108.794 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -127.41 134.15 49.92 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.47 -1.678 . . . . 2.82 106.47 -165.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.7 t -70.39 115.53 35.78 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 118.797 0.726 . . . . 2.6 109.754 -173.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.99 -17.05 51.06 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 124.006 3.137 . . . . 1.61 111.719 -173.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -33.15 -41.14 0.07 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.416 2.686 . . . . 2.12 112.074 170.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -133.94 -179.88 5.82 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.1 0.96 . . . . 2.25 109.581 171.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -66.09 131.83 47.09 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.451 -0.944 . . . . 3.26 108.451 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -44.4 -45.06 8.77 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.063 0.394 . . . . 2.98 112.063 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -46.86 -47.61 21.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.553 0.692 . . . . 3.57 109.437 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.34 -39.05 78.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.434 -0.803 . . . . 2.06 111.709 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 80.7 t -58.08 -54.28 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 O-C-N 121.6 -0.687 . . . . 1.26 109.264 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.14 -25.76 67.12 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 118.02 -1.472 . . . . 1.69 109.294 177.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -66.13 -44.91 82.88 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 120.271 1.396 . . . . 1.9 110.207 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.75 -52.87 61.16 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.77 0.828 . . . . 0.39 110.048 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.67 -34.65 66.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 120.488 -0.485 . . . . 1.84 109.742 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.87 -57.01 14.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.604 1.192 . . . . 4.08 108.154 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.518 ' O ' HG23 ' A' ' 140' ' ' VAL . 6.8 mmmm -58.27 -49.01 78.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.997 -1.001 . . . . 1.66 108.765 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -44.69 -54.66 5.99 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.106 0.963 . . . . 0.52 112.52 175.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.425 ' HA ' HG21 ' A' ' 220' ' ' ILE . 2.1 p90 -62.38 -46.21 89.66 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 118.989 -1.084 . . . . 6.58 110.774 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.36 -42.31 73.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 123.316 0.385 . . . . 3.89 110.131 -173.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.629 HG12 HD21 ' A' ' 250' ' ' LEU . 1.4 t -54.01 -52.06 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 120.812 0.339 . . . . 1.34 110.088 -176.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.515 ' CZ3' ' HG ' ' A' ' 250' ' ' LEU . 67.3 m95 -71.9 -44.3 63.94 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.906 -0.775 . . . . 0.69 108.906 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.4 t -57.29 -26.78 61.4 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.985 0.514 . . . . 1.22 111.198 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -39.44 89.7 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 122.743 0.417 . . . . 1.67 110.881 175.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 81.1 t -82.88 -55.44 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.932 1.293 . . . . 2.27 109.61 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 43.6 p -84.92 150.55 55.91 Favored Pre-proline 0 N--CA 1.447 -0.577 0 C-N-CA 123.166 0.586 . . . . 0.79 109.93 -172.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.96 8.13 1.79 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 121.509 1.472 . . . . 0.85 112.949 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.69 111.95 12.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.326 1.05 . . . . 2.43 108.471 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.62 86.16 3.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.418 -1.327 . . . . 3.76 107.418 175.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -67.57 128.96 38.38 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.082 -0.963 . . . . 5.7 109.423 170.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.97 134.65 38.82 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 123.964 0.906 . . . . 0.85 110.162 172.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -92.84 127.22 38.27 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 107.605 -1.257 . . . . 2.11 107.605 173.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.7 pt -130.81 101.19 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.924 -1.139 . . . . 1.73 107.924 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -91.75 27.04 2.17 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.673 -0.642 . . . . 3.36 111.1 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.94 78.86 1.41 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.89 1.276 . . . . 2.5 110.096 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 150.32 -132.29 3.9 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 108.697 -1.761 . . . . 1.49 108.697 171.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.1 mtt -128.55 144.86 51.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.851 1.66 . . . . 5.09 107.678 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.509 ' HB1' ' O ' ' A' ' 115' ' ' THR . . . -126.52 172.66 10.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.85 1.66 . . . . 0.74 109.534 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.73 -57.38 3.7 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.089 0.956 . . . . 1.92 108.982 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.3 pt -105.17 152.6 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.154 -0.93 . . . . 1.17 108.877 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 tt -131.11 130.34 43.02 Favored 'General case' 0 CA--C 1.523 -0.075 0 N-CA-C 113.31 0.856 . . . . 2.17 113.31 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.23 102.68 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.827 -0.805 . . . . 0.83 108.827 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.2 t -93.57 131.29 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.814 2.046 . . . . 1.37 108.813 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -129.12 112.92 14.47 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 105.641 -1.985 . . . . 4.96 105.641 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -133.97 161.65 34.22 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 123.658 0.783 . . . . 0.94 110.978 -165.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.4 121.06 32.76 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.446 1.098 . . . . 6.38 110.629 -170.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 65.09 -70.49 0.08 OUTLIER Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.543 -1.143 . . . . 1.84 112.216 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.28 163.98 13.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.148 1.474 . . . . 2.42 110.62 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 4.0 p80 . . . . . 0 CA--C 1.531 0.231 0 C-N-CA 123.511 0.724 . . . . 3.1 109.887 164.162 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 114.219 1.192 . . . . 2.48 114.219 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 2.8 t80 -121.96 161.41 22.93 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.858 1.208 . . . . 7.46 107.771 165.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.43 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 40.7 p-10 -164.32 24.46 0.07 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 113.519 -1.673 . . . . 2.73 110.002 -148.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 86.08 171.34 47.85 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 122.157 0.865 . . . . 1.44 111.79 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -72.21 100.86 2.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.658 -0.771 . . . . 4.72 109.34 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 131.13 -161.84 23.56 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.64 -1.784 . . . . 1.36 108.64 -167.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.68 -121.94 24.97 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.547 -1.421 . . . . 1.27 109.547 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 180' ' ' ILE 0.396 1.8 tp -78.47 140.06 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.361 -1.348 . . . . 1.7 107.361 175.439 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.41 -55.67 4.36 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.769 -0.826 . . . . 1.65 108.769 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -169.99 179.87 3.44 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.948 0.899 . . . . 0.85 110.09 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.54 143.41 51.18 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 125.955 1.702 . . . . 2.18 111.896 -176.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -161.71 159.17 26.97 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.207 -1.405 . . . . 0.77 107.207 164.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.5 143.82 15.06 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.75 -1.574 . . . . 4.17 106.75 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.08 -86.6 1.71 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.025 -1.23 . . . . 0.56 110.025 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.64 99.38 0.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.254 2.636 . . . . 1.27 110.915 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -175.39 165.11 35.85 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.064 -1.615 . . . . 0.96 109.064 172.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.68 168.7 16.04 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.164 0.586 . . . . 2.72 109.868 172.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 55.48 -105.79 0.47 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.01 0.814 . . . . 1.45 111.827 173.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.7 tp -64.2 -23.28 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.44 0.696 . . . . 1.66 111.002 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -49.4 143.34 9.74 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.854 -0.898 . . . . 0.96 110.854 170.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 84.2 -36.07 2.93 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.253 0.93 . . . . 0.61 112.358 -169.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -76.73 178.4 6.81 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.068 1.434 . . . . 1.27 110.681 -166.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -153.02 133.81 13.89 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.266 -2.494 . . . . 0.88 104.266 -165.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.457 ' CD2' ' C ' ' A' ' 196' ' ' HIS 0.315 14.3 t-80 -155.07 85.16 1.08 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 117.199 -1.8 . . . . 5.07 112.489 -133.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -103.67 147.16 27.57 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.244 1.018 . . . . 2.74 112.16 -158.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.87 81.03 0.46 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.022 1.329 . . . . 2.79 109.58 173.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -53.72 -50.04 66.78 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.068 -1.645 . . . . 3.03 111.329 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -51.0 -26.15 5.66 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.293 0.637 . . . . 3.4 111.674 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -68.43 153.06 44.49 Favored 'General case' 0 C--O 1.243 0.754 0 O-C-N 120.607 -1.308 . . . . 1.91 109.445 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -97.33 90.14 4.99 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.627 -1.99 . . . . 3.01 105.627 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -77.57 161.79 27.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.12 -1.067 . . . . 1.38 108.12 -177.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 56.7 p -132.75 141.88 48.75 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 122.088 0.946 . . . . 2.09 111.19 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.7 t -60.66 -40.32 91.63 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.607 1.563 . . . . 1.92 111.789 163.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -79.55 -177.08 5.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.607 1.163 . . . . 2.74 111.496 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 41.6 t -72.89 -50.95 20.65 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.831 0.852 . . . . 4.74 110.77 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -55.07 112.71 3.06 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.853 0.74 . . . . 2.67 112.724 -167.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 108.4 -121.28 6.23 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 107.634 -2.186 . . . . 1.78 107.634 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.7 m -119.35 130.56 55.42 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.666 -1.605 . . . . 1.24 106.666 168.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -89.48 118.9 29.47 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 109.211 -0.663 . . . . 1.26 109.211 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.98 -53.96 23.12 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 122.988 0.515 . . . . 1.54 109.808 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -54.98 -45.01 74.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.18 0.592 . . . . 2.03 110.67 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.7 tt -62.29 -58.83 6.26 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.745 -0.597 . . . . 1.29 109.854 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.315 2.2 m -59.2 -33.13 70.6 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.522 -0.471 . . . . 0.72 110.922 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.0 -45.77 86.31 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.281 -0.887 . . . . 0.56 110.898 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 89.0 t -55.05 -48.47 75.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 120.044 1.293 . . . . 0.71 110.263 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.681 ' CE1' ' O ' ' A' ' 237' ' ' PHE . 0.3 OUTLIER -52.32 -53.06 49.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.478 1.511 . . . . 2.84 111.532 172.09 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -68.44 -53.14 25.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 119.159 0.89 . . . . 3.72 113.362 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.425 HG21 ' HA ' ' A' ' 138' ' ' PHE . 1.5 mp -56.01 -41.61 68.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 108.604 -0.887 . . . . 1.11 108.604 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.77 -48.44 78.01 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 111.289 -0.724 . . . . 0.62 111.289 173.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -57.65 -45.72 85.12 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.295 -1.121 . . . . 2.14 111.209 175.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.7 t -54.98 -56.71 16.71 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.479 1.112 . . . . 1.77 110.94 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.6 pp -62.39 -34.69 77.22 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.323 -0.551 . . . . 2.75 111.779 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 146.35 107.79 0.53 Allowed Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.18 -1.168 . . . . 2.67 110.18 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 226' ' ' LEU . 0.9 OUTLIER -75.69 160.89 29.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 122.984 0.514 . . . . 7.11 111.923 176.587 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.22 42.69 0.84 Allowed Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.572 -1.411 . . . . 3.76 109.572 167.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -0.88 93.22 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.189 2.596 . . . . 2.22 116.139 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.8 m -74.89 171.03 14.76 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.351 0.66 . . . . 1.53 110.495 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 9.5 p -124.66 5.62 8.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.321 1.849 . . . . 3.0 111.216 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -96.75 128.0 37.42 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 125.134 1.374 . . . . 1.96 108.532 -172.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -62.55 -14.21 38.22 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.992 2.462 . . . . 1.75 113.614 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -80.11 -34.16 38.09 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.952 0.901 . . . . 2.22 110.279 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.68 136.41 39.11 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.68 -0.859 . . . . 0.76 108.68 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 45.8 t -85.55 -21.24 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 122.414 0.285 . . . . 0.59 110.345 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -21.79 59.77 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 113.945 1.091 . . . . 1.91 113.945 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.681 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -49.48 173.15 0.08 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.56 2.344 . . . . 3.32 114.533 -173.087 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -90.24 -22.1 0.82 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.759 1.639 . . . . 1.36 111.685 166.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.293 0.7 OUTLIER -86.94 100.73 12.8 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.78 1.232 . . . . 2.5 110.696 -170.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . 0.329 31.5 t80 -73.63 133.24 43.42 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.036 0.834 . . . . 2.3 108.992 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.56 145.99 21.92 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.82 -1.548 . . . . 2.78 106.82 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -53.37 127.36 24.54 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.981 0.912 . . . . 3.43 111.726 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 31.7 m -98.86 146.55 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.708 0.633 . . . . 1.88 112.708 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -74.54 77.92 1.96 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.878 0.847 . . . . 5.21 111.002 175.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 17.8 mm -54.2 -22.46 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.875 -0.602 . . . . 4.12 111.498 168.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -43.57 -48.69 7.57 Favored 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 123.192 0.597 . . . . 4.23 112.115 167.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.5 m -84.71 -41.78 15.9 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.134 0.574 . . . . 2.17 110.387 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 60.0 t80 58.5 76.24 0.35 Allowed 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.614 0.766 . . . . 4.34 109.778 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.84 174.82 14.41 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 121.58 -0.7 . . . . 3.7 109.715 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.629 HD21 HG12 ' A' ' 140' ' ' VAL . 0.7 OUTLIER -116.98 163.1 16.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.028 1.331 . . . . 0.77 108.459 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 63.5 m -81.09 147.39 30.13 Favored 'General case' 0 C--O 1.225 -0.213 0 O-C-N 122.154 -0.341 . . . . 0.74 111.816 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.86 -40.24 60.24 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 122.986 0.514 . . . . 1.12 110.833 169.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -51.44 -58.46 6.2 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.095 0.95 . . . . 2.61 109.781 171.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -58.02 -45.07 87.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.96 1.304 . . . . 2.09 110.482 -173.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 63.3 mt -46.76 -38.79 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.319 1.448 . . . . 1.39 111.222 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -68.3 -46.55 70.01 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.896 0.771 . . . . 4.9 111.205 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -57.14 -55.36 30.73 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 118.788 0.722 . . . . 1.46 111.504 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.457 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 2.2 pp -61.15 -39.66 83.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 122.938 0.495 . . . . 2.81 111.426 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -70.0 -22.54 63.11 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.042 0.837 . . . . 4.0 112.282 172.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.9 t -64.73 -10.75 29.7 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.303 -1.332 . . . . 2.38 113.66 176.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.62 ' O ' HD22 ' A' ' 261' ' ' LEU 0.36 0.0 OUTLIER . . . . . 0 CA--C 1.551 0.983 0 C-N-CA 125.682 1.593 . . . . 3.49 114.125 -176.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 110.355 -0.239 . . . . 5.37 110.355 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 65.52 -71.39 0.08 Allowed 'General case' 0 C--N 1.341 0.225 0 C-N-CA 125.916 1.686 . . . . 3.34 110.189 -173.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -103.96 122.46 45.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.846 0.859 . . . . 5.11 110.065 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.446 ' HB ' ' CD1' ' A' ' 149' ' ' PHE . 1.5 mm -106.69 88.72 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.016 -1.105 . . . . 1.86 108.016 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 p -78.21 131.86 37.33 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.846 -1.159 . . . . 1.29 108.897 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.401 ' CE2' ' HB2' ' A' ' 151' ' ' LYS . 51.3 p90 -125.73 164.46 20.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.144 0.978 . . . . 4.18 110.614 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.21 149.61 28.15 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.636 -0.875 . . . . 6.4 108.636 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.5 mt -89.28 150.5 3.7 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 N-CA-C 108.311 -0.996 . . . . 0.95 108.311 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.551 HD22 ' H ' ' A' ' 119' ' ' ASN . 0.8 OUTLIER -81.45 -55.31 4.78 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.604 -0.887 . . . . 2.87 108.604 175.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -151.25 176.27 11.38 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.782 0.833 . . . . 2.02 109.31 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -106.41 146.93 29.89 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.294 1.038 . . . . 2.23 109.859 -174.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.2 t -93.25 141.19 23.68 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 124.413 1.085 . . . . 2.17 108.353 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.79 -22.12 9.19 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.044 2.496 . . . . 1.57 111.308 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -29.85 -51.57 0.13 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.976 2.11 . . . . 2.21 113.013 172.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 11.3 mtm -131.29 170.51 14.52 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.934 1.294 . . . . 1.97 108.195 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -69.91 149.5 47.74 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.086 0.554 . . . . 3.08 109.578 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 29.0 ttt-85 -49.04 -44.95 42.09 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.265 0.626 . . . . 2.85 111.496 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.55 3.47 3.05 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.737 1.014 . . . . 2.99 113.737 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -112.12 -42.05 3.82 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 125.696 1.598 . . . . 1.96 109.635 164.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.8 t -51.74 -57.58 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.113 0.965 . . . . 1.25 109.538 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -21.68 60.58 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 118.986 -1.086 . . . . 1.68 109.414 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -65.57 -47.5 75.59 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.191 0.905 . . . . 1.94 109.844 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.15 -52.65 63.58 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.533 1.133 . . . . 0.49 109.191 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.695 HD11 HD11 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -69.39 -40.97 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 120.853 -0.339 . . . . 1.45 111.191 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -49.74 -58.82 4.58 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.518 -1.289 . . . . 4.24 107.518 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.624 ' O ' HG23 ' A' ' 140' ' ' VAL . 34.8 mmtm -59.12 -49.81 76.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.334 1.454 . . . . 2.63 110.5 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.72 -49.95 45.91 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.529 0.732 . . . . 0.81 111.329 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.687 ' CE2' HD12 ' A' ' 134' ' ' ILE . 31.2 m-85 -58.55 -54.04 51.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.309 0.576 . . . . 4.83 109.91 173.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -39.88 67.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.486 -0.779 . . . . 2.11 111.156 -172.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 136' ' ' LYS . 68.5 t -48.71 -64.24 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.772 1.229 . . . . 0.95 109.852 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.768 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 72.2 m95 -68.55 -35.28 77.2 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.693 -0.854 . . . . 1.16 108.693 -174.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.1 -16.78 63.86 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 123.708 0.63 . . . . 1.19 112.199 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -82.42 -47.88 11.75 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 108.384 -0.969 . . . . 1.37 108.384 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.8 m -74.39 -43.88 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 112.635 0.606 . . . . 1.62 112.635 -177.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 51.4 p -89.34 158.01 46.77 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 109.424 -0.584 . . . . 0.8 109.424 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.87 -0.95 9.18 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.431 2.088 . . . . 0.76 113.334 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.3 mt -59.91 141.31 55.71 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.259 1.424 . . . . 2.18 109.466 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -118.75 90.54 3.35 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.201 -1.037 . . . . 4.02 108.201 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.486 ' CD1' ' CD1' ' A' ' 138' ' ' PHE . 30.9 m-85 -70.03 143.73 52.44 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.03 -0.532 . . . . 5.91 109.969 173.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -151.88 130.74 12.48 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.553 0.615 . . . . 0.99 110.619 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.401 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 4.0 ttmt -86.54 138.67 31.53 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.064 -0.717 . . . . 2.36 109.064 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.481 ' O ' HD12 ' A' ' 152' ' ' ILE . 1.8 pp -140.72 98.53 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 118.224 0.466 . . . . 2.04 110.515 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -80.2 26.73 0.35 Allowed 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.291 -1.506 . . . . 3.14 110.708 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 45.5 p -154.07 78.08 1.1 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.157 0.983 . . . . 3.4 108.565 -171.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 145.87 -122.84 1.74 Allowed Glycine 0 C--N 1.335 0.513 0 N-CA-C 108.189 -1.965 . . . . 1.91 108.189 174.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -149.71 135.07 18.25 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.573 -1.269 . . . . 5.92 107.573 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -112.43 163.01 14.95 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.36 1.464 . . . . 0.73 110.141 -175.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -79.16 -44.72 21.37 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.991 0.9 . . . . 2.02 108.856 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.7 pt -112.91 166.44 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.832 0.825 . . . . 0.96 112.04 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.76 136.57 35.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.68 1.592 . . . . 2.22 109.272 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.2 t -79.49 138.76 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 107.375 -1.342 . . . . 1.25 107.375 166.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 73.7 t -108.25 139.42 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 106.923 -1.51 . . . . 1.31 106.923 164.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.91 137.9 51.9 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.656 -1.979 . . . . 6.26 105.656 172.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -158.41 157.7 32.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.55 0.614 . . . . 1.14 109.478 165.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -104.15 119.39 38.84 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.983 -1.118 . . . . 4.71 107.983 168.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 71.77 -170.99 48.27 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.74 -0.544 . . . . 2.07 111.74 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.66 78.35 3.31 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 122.011 -0.699 . . . . 3.27 110.92 -164.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.5 p80 . . . . . 0 N--CA 1.454 -0.239 0 C-N-CA 124.247 1.019 . . . . 3.7 113.36 -175.258 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 107.93 -1.137 . . . . 4.1 107.93 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -105.03 171.55 7.26 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 124.814 1.246 . . . . 6.03 108.302 164.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -161.72 162.27 29.65 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.314 1.446 . . . . 3.33 108.684 -172.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -65.82 -156.04 0.31 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.146 0.879 . . . . 1.34 112.726 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -56.15 106.91 0.31 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.592 0.757 . . . . 4.31 111.5 -171.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.59 -146.9 18.6 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.183 -1.567 . . . . 1.78 109.183 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.53 -126.32 24.21 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 125.342 1.448 . . . . 1.6 110.913 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.2 mm -76.99 130.66 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 122.488 1.137 . . . . 1.42 108.023 173.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.1 mp -84.37 -46.27 11.9 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.725 2.01 . . . . 1.39 110.11 170.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.508 ' HB1' ' HG3' ' A' ' 219' ' ' GLU . . . -168.37 172.55 8.31 Favored 'General case' 0 C--N 1.338 0.107 0 O-C-N 121.042 -1.036 . . . . 0.9 111.402 -176.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -158.33 139.59 13.33 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.092 0.957 . . . . 1.04 111.469 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -162.59 174.38 12.69 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.763 -1.199 . . . . 0.77 107.763 -174.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.59 151.43 18.69 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.26 -1.015 . . . . 6.36 108.26 -173.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -102.31 -79.34 1.38 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.201 -1.56 . . . . 0.7 109.201 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.24 177.6 6.41 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.986 2.457 . . . . 2.27 110.51 176.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 97.2 132.11 7.29 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 109.796 -1.322 . . . . 1.56 109.796 -175.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.3 p -77.92 150.78 34.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.538 0.735 . . . . 2.36 109.472 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.46 -132.2 10.61 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 108.04 -2.024 . . . . 1.85 108.04 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . 0.254 10.7 tp -62.94 -43.21 98.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 117.955 -1.022 . . . . 3.56 110.662 -171.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 31.15 130.36 0.0 OUTLIER Glycine 0 CA--C 1.544 1.879 0 C-N-CA 130.299 3.809 . . . . 1.69 119.063 164.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 84.83 -21.73 10.74 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.093 -1.828 . . . . 0.69 111.845 -175.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -84.7 148.85 26.17 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 124.638 1.175 . . . . 1.61 110.437 -169.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.42 124.56 36.57 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.5 0.556 . . . . 0.61 112.5 -162.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -114.25 108.34 16.81 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 117.208 -1.377 . . . . 2.11 110.199 -168.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.11 147.12 23.77 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 121.761 2.073 . . . . 2.58 110.119 172.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -70.16 99.45 1.5 Allowed 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 123.585 0.553 . . . . 2.74 109.891 176.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -14.59 61.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.217 -0.897 . . . . 3.08 110.896 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -57.66 -32.05 66.93 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 121.045 1.748 . . . . 2.62 109.498 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.61 170.12 15.86 Favored 'General case' 0 C--O 1.246 0.891 0 C-N-CA 125.044 1.337 . . . . 2.31 110.292 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -117.13 100.9 8.03 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.01 -1.107 . . . . 4.3 108.01 169.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.41 ' CH2' HG21 ' A' ' 215' ' ' THR . 35.4 m95 -78.33 146.23 34.84 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.637 -1.165 . . . . 1.43 109.305 174.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.3 p -120.47 138.58 53.74 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.732 0.813 . . . . 1.84 109.667 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -50.09 -49.48 51.44 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.745 1.218 . . . . 1.73 110.059 169.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -82.26 -178.47 7.05 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.034 1.334 . . . . 2.25 111.654 175.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.1 m -54.08 -58.12 8.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.343 1.457 . . . . 3.81 110.943 -172.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 43.02 -100.49 0.02 OUTLIER Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.312 1.434 . . . . 2.45 114.409 169.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -116.71 -70.67 0.44 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.536 -1.026 . . . . 1.14 110.536 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.72 177.65 7.47 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.702 -1.962 . . . . 1.39 105.702 169.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -132.92 130.97 40.33 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.924 0.784 . . . . 1.63 111.658 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -62.4 -48.97 77.37 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 108.358 -0.979 . . . . 1.8 108.358 -174.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.723 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.5 t80 -50.63 -50.37 54.53 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.665 -0.495 . . . . 1.5 109.665 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.419 ' C ' HD23 ' A' ' 214' ' ' LEU . 7.0 tt -58.65 -58.98 6.19 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.637 1.175 . . . . 1.54 109.366 -173.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.41 HG21 ' CH2' ' A' ' 203' ' ' TRP 0.317 6.7 m -58.86 -37.52 76.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.574 0.702 . . . . 0.77 110.784 176.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.39 -43.76 96.34 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 121.367 -0.833 . . . . 0.78 110.877 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 213' ' ' PHE . 44.1 t -52.84 -44.81 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.948 1.249 . . . . 1.08 109.93 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.546 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 6.4 t-160 -52.24 -58.55 6.28 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.956 1.303 . . . . 2.32 112.667 169.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.508 ' HG3' ' HB1' ' A' ' 182' ' ' ALA . 14.8 mm-40 -69.17 -33.89 74.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.93 1.085 . . . . 3.13 113.93 -174.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.695 HD11 HD11 ' A' ' 134' ' ' ILE . 0.4 OUTLIER -71.55 -37.85 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 107.282 -1.377 . . . . 1.48 107.282 175.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -52.01 -48.44 52.04 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 110.673 -0.971 . . . . 0.69 110.673 167.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.546 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 18.1 m170 -58.79 -44.75 90.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.908 -0.76 . . . . 2.87 111.265 174.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.6 t -54.0 -55.43 27.33 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.021 0.528 . . . . 1.76 111.823 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.2 pp -60.88 -33.72 73.52 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 118.697 -0.668 . . . . 3.18 112.415 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 114.57 102.99 2.48 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.105 -1.198 . . . . 1.5 110.105 172.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.48 HD11 ' CE1' ' A' ' 228' ' ' HIS . 1.8 pt? -108.3 167.17 10.21 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.088 1.144 . . . . 5.65 114.088 -175.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -113.2 11.94 24.19 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.411 1.005 . . . . 3.38 113.348 167.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.48 ' CE1' HD11 ' A' ' 226' ' ' LEU . 4.5 m80 64.53 98.87 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.904 1.682 . . . . 2.11 114.535 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.6 m -75.08 161.9 29.01 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.038 0.447 . . . . 1.3 110.44 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.1 p -122.11 11.46 10.2 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.406 1.482 . . . . 2.79 111.541 -165.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -119.25 138.57 26.48 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 125.463 1.505 . . . . 1.75 108.664 -169.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -80.81 -12.59 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.946 1.764 . . . . 1.29 114.992 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -75.23 -24.06 57.66 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 120.247 1.385 . . . . 1.45 110.128 172.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.539 ' HB1' ' CG ' ' A' ' 254' ' ' ASP . . . -71.77 167.85 19.05 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.941 1.296 . . . . 0.95 111.878 176.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.07 -26.14 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 125.668 1.587 . . . . 0.85 111.93 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.768 ' SD ' HG22 ' A' ' 258' ' ' ILE . 0.0 OUTLIER -62.9 -26.81 68.97 Favored 'General case' 0 C--O 1.245 0.818 0 O-C-N 120.54 -1.35 . . . . 2.74 112.235 176.209 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -48.22 177.1 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 130.249 3.419 . . . . 3.42 114.094 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -90.09 -18.4 1.41 Allowed 'Trans proline' 0 CA--C 1.537 0.634 0 CA-C-N 122.319 1.864 . . . . 1.46 112.13 174.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.36 0.2 OUTLIER -81.22 -176.77 6.15 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.086 1.354 . . . . 1.48 110.764 -172.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -113.95 150.07 34.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.341 1.456 . . . . 2.31 108.059 171.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.97 137.28 13.89 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.103 -1.073 . . . . 2.92 108.103 169.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -65.17 121.25 14.32 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.72 0.808 . . . . 2.62 110.562 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.33 135.81 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.165 0.986 . . . . 1.65 108.792 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.82 117.38 21.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.844 -0.799 . . . . 5.13 108.844 176.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.568 HG22 ' CD1' ' A' ' 213' ' ' PHE . 1.1 pp -53.03 -33.62 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 C-N-CA 122.922 0.489 . . . . 3.33 110.348 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -52.53 -36.06 54.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.092 0.957 . . . . 4.58 112.045 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 25.1 m -74.01 -48.29 31.19 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 119.17 -0.443 . . . . 2.55 109.959 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.459 ' CD1' HG22 ' A' ' 140' ' ' VAL . 0.5 OUTLIER 53.35 87.65 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.271 1.028 . . . . 4.71 110.445 -178.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.02 163.21 37.96 Favored 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 121.466 -0.771 . . . . 3.77 110.773 175.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.525 HD12 ' CH2' ' A' ' 141' ' ' TRP . 1.5 mm? -116.27 154.48 30.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.601 1.56 . . . . 0.84 107.836 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.2 m -79.18 152.66 30.56 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 118.012 0.369 . . . . 0.88 111.1 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -58.77 -41.78 87.42 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.762 -0.586 . . . . 1.03 111.417 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -51.53 -51.5 54.78 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.903 0.858 . . . . 2.33 108.941 171.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.539 ' CG ' ' HB1' ' A' ' 234' ' ' ALA . 1.0 OUTLIER -58.59 -47.07 85.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.8 -1.091 . . . . 2.25 111.442 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 69.2 mt -44.61 -37.6 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.676 1.19 . . . . 1.1 111.26 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -65.29 -63.2 1.16 Allowed 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.529 -0.732 . . . . 4.59 110.989 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -55.83 -46.66 82.72 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.723 -0.551 . . . . 0.99 111.723 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.768 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 2.0 pp -70.0 -28.75 37.53 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 C-N-CA 124.76 1.224 . . . . 2.85 110.503 -173.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -84.62 -24.19 29.21 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.645 1.111 . . . . 2.61 112.024 171.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 46.1 m -58.32 -33.1 69.13 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.85 0.75 . . . . 2.51 111.699 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 30.5 mt . . . . . 0 N--CA 1.449 -0.525 0 C-N-CA 126.336 1.854 . . . . 3.51 112.498 177.703 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.558 0 CA-C-O 119.484 -0.293 . . . . 5.98 110.974 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 66.08 -71.3 0.09 Allowed 'General case' 0 C--O 1.231 0.118 0 C-N-CA 127.01 2.124 . . . . 4.26 110.48 -177.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -116.5 118.19 31.99 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.443 1.497 . . . . 2.85 107.546 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.51 HG21 ' CE1' ' A' ' 149' ' ' PHE . 24.0 mm -115.36 154.06 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.509 -1.293 . . . . 2.71 107.509 160.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.92 133.31 13.63 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 104.509 -2.404 . . . . 2.26 104.509 -171.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -128.79 169.18 14.85 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 123.806 0.842 . . . . 4.43 111.383 -174.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -153.55 155.59 36.45 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.487 -0.931 . . . . 4.7 108.487 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -95.32 162.12 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.719 -1.586 . . . . 1.19 106.719 172.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -86.08 -48.86 8.25 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.032 -1.099 . . . . 3.4 108.032 172.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -157.25 167.47 30.25 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.359 1.064 . . . . 2.69 109.189 -170.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -112.24 173.03 6.56 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.454 1.502 . . . . 1.85 108.927 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.7 t -129.58 135.22 27.2 Favored Pre-proline 0 N--CA 1.445 -0.683 0 N-CA-C 105.83 -1.915 . . . . 2.53 105.83 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.48 -19.06 17.23 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.251 2.634 . . . . 2.1 112.085 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -37.58 -41.84 0.5 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.406 2.682 . . . . 2.57 112.604 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.5 ptp -136.39 173.56 11.58 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.991 0.917 . . . . 2.13 108.88 173.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -70.02 142.0 52.81 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.915 -0.402 . . . . 3.17 109.915 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -52.77 -47.7 67.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.118 -0.467 . . . . 2.81 111.885 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -45.23 -49.6 12.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.045 -0.724 . . . . 3.89 109.045 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.74 -40.71 92.41 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.19 0.996 . . . . 2.01 113.364 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.4 t -53.67 -54.63 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.318 -0.993 . . . . 1.19 108.318 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -37.22 83.73 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 119.121 -1.032 . . . . 1.72 108.837 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -55.6 -45.35 77.45 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 119.598 1.09 . . . . 2.12 111.753 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.18 -52.16 59.72 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 120.894 0.378 . . . . 0.42 110.415 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -72.88 -31.82 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.917 -0.583 . . . . 1.6 110.549 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -57.24 13.1 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.769 -1.567 . . . . 3.15 106.769 177.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.534 ' O ' HG23 ' A' ' 140' ' ' VAL . 11.3 mmmm -66.96 -44.53 80.31 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.427 -1.261 . . . . 1.39 109.11 -176.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.24 -53.82 25.49 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 112.483 0.549 . . . . 0.43 112.483 173.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.486 ' HA ' HG21 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -59.72 -48.37 81.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 119.019 -1.073 . . . . 6.32 108.127 177.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.47 -29.7 62.02 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.638 -0.696 . . . . 2.22 112.082 -173.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 136' ' ' LYS . 99.4 t -60.75 -66.8 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 119.02 0.827 . . . . 0.72 109.33 174.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -69.49 -43.09 73.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.465 -0.939 . . . . 0.88 108.465 -169.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.1 t -58.3 -19.01 31.3 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.777 1.231 . . . . 1.47 111.865 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -79.29 -44.42 21.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 118.206 0.457 . . . . 1.76 109.929 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.0 m -76.36 -39.92 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 111.907 0.336 . . . . 1.51 111.907 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.569 HG23 HG12 ' A' ' 258' ' ' ILE . 1.6 p -83.46 152.69 64.47 Favored Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 107.876 -1.157 . . . . 1.2 107.876 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.33 11.39 1.55 Allowed 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.117 2.545 . . . . 1.48 113.857 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.86 127.56 56.22 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.238 1.415 . . . . 2.68 110.251 -173.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.29 117.58 33.0 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.034 0.533 . . . . 3.22 110.096 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.51 ' CE1' HG21 ' A' ' 114' ' ' ILE . 3.2 m-85 -81.01 160.51 24.55 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.329 1.052 . . . . 6.12 110.772 168.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.8 t -156.7 144.86 19.55 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.466 1.506 . . . . 1.16 107.384 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -89.91 149.37 22.64 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 120.491 1.496 . . . . 2.02 108.899 173.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.9 pt -127.01 147.78 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 105.742 -1.948 . . . . 1.4 105.742 164.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -102.44 -5.41 24.11 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.898 0.479 . . . . 3.47 110.515 172.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 99.4 m -155.4 117.53 4.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.405 -1.332 . . . . 2.75 107.405 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 140.76 177.4 16.11 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 107.711 -2.156 . . . . 1.56 107.711 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.3 mmt -87.83 141.33 28.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.164 -1.05 . . . . 5.76 108.164 164.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -123.42 168.89 11.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.19 -1.411 . . . . 0.76 107.19 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -76.46 -45.21 32.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.833 -0.803 . . . . 1.65 108.833 -175.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.2 pt -113.94 176.69 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 124.617 1.167 . . . . 0.93 109.91 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.11 135.38 30.87 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.178 1.391 . . . . 2.21 109.072 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 36.5 t -93.32 108.68 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.227 -1.398 . . . . 0.77 107.227 168.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.07 107.24 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.747 1.219 . . . . 2.44 109.964 -175.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -88.4 171.68 9.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.284 -1.006 . . . . 5.82 108.284 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.575 ' HB3' ' CE2' ' A' ' 174' ' ' PHE . . . -155.62 -169.59 3.16 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.279 -1.378 . . . . 1.18 107.279 167.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 35.0 mtm180 -139.51 125.81 20.17 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.719 -0.845 . . . . 5.58 108.719 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.61 -67.88 3.07 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 125.366 1.46 . . . . 2.63 110.599 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -155.95 159.7 39.46 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.553 0.741 . . . . 2.17 109.075 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 106.872 -1.529 . . . . 3.25 106.872 168.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 108.086 -1.079 . . . . 3.57 108.086 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.575 ' CE2' ' HB3' ' A' ' 164' ' ' ALA . 8.8 m-85 -105.41 172.49 6.76 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.797 1.239 . . . . 6.34 108.11 163.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -162.98 153.8 16.83 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.122 0.969 . . . . 3.84 109.175 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -70.84 -149.61 0.59 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.59 0.614 . . . . 1.39 113.203 -174.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -54.31 109.41 0.48 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.708 1.203 . . . . 3.93 110.083 -176.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 99.49 -144.38 17.02 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.723 -1.351 . . . . 1.63 109.723 -171.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 48.26 -132.32 19.8 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.418 -1.473 . . . . 1.45 109.418 -170.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 tp -77.72 148.51 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 118.038 0.919 . . . . 2.5 108.855 175.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . 0.5 5.4 mp -84.75 -44.98 12.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.297 1.439 . . . . 1.52 110.577 173.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -165.63 168.28 16.45 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 122.189 -0.319 . . . . 0.78 111.011 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -146.99 120.64 9.16 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 124.277 1.031 . . . . 1.13 113.782 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.509 ' HB3' ' HB2' ' A' ' 222' ' ' HIS . . . -139.07 160.96 38.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 120.656 -1.278 . . . . 0.55 107.62 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -141.65 149.6 40.85 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.351 -1.352 . . . . 3.07 107.351 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -100.84 -87.63 1.98 Allowed Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.622 -0.991 . . . . 0.66 110.622 173.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.17 84.71 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.523 2.815 . . . . 1.52 111.53 -169.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -159.24 165.21 34.24 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.234 -1.546 . . . . 1.09 109.234 170.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.0 p -79.39 172.79 13.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.752 0.821 . . . . 2.35 109.536 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.21 -105.7 0.27 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 123.865 0.745 . . . . 1.52 111.838 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.4 tp -59.65 -40.58 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 118.717 -0.659 . . . . 1.42 110.006 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -41.49 135.46 2.97 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 118.976 0.807 . . . . 0.96 112.429 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 98.87 -36.98 3.69 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.873 1.702 . . . . 0.58 111.646 -166.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -84.02 160.42 21.0 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.946 0.873 . . . . 1.24 110.34 -163.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -134.05 130.71 37.91 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.605 0.762 . . . . 0.59 111.871 -169.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -119.96 99.52 6.67 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 117.925 -1.036 . . . . 2.0 110.793 -161.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -84.73 139.11 32.22 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 121.165 1.802 . . . . 2.93 111.468 176.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.87 61.88 0.42 Allowed 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 123.687 0.617 . . . . 3.37 110.329 171.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.21 -6.37 13.42 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 120.607 -1.308 . . . . 5.23 111.997 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -27.15 -65.02 0.08 Allowed 'General case' 0 C--N 1.341 0.205 0 C-N-CA 127.851 2.46 . . . . 5.2 110.055 158.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . 0.256 2.2 pt-20 -78.72 175.5 10.38 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.308 -0.86 . . . . 1.97 110.562 -169.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -98.42 103.11 15.03 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 106.223 -1.769 . . . . 3.43 106.223 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.45 ' HH2' HG21 ' A' ' 215' ' ' THR . 28.3 m95 -78.3 134.52 37.5 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.918 -1.512 . . . . 1.49 106.918 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.1 p -132.35 75.8 1.66 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.412 -1.329 . . . . 3.2 107.412 -171.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.04 -49.31 70.63 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 123.864 0.866 . . . . 3.22 108.817 -174.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -55.48 -32.76 63.1 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.906 0.706 . . . . 4.54 112.906 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.8 t -81.47 -42.43 20.32 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.216 0.606 . . . . 6.63 110.495 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 106.02 16.57 14.83 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.92 1.247 . . . . 3.52 112.952 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.71 -84.62 0.18 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.475 -1.05 . . . . 1.81 110.475 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 61.9 m -107.79 119.85 40.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.007 -2.59 . . . . 1.32 104.007 157.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -94.84 115.26 27.26 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 124.333 1.021 . . . . 1.44 108.293 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.67 -48.66 49.37 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.453 0.701 . . . . 1.51 110.409 -177.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -47.92 -49.77 29.07 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.205 0.602 . . . . 1.54 110.955 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.1 tt -56.7 -60.24 3.84 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.144 0.978 . . . . 1.2 109.676 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.45 HG21 ' HH2' ' A' ' 203' ' ' TRP 0.266 93.4 m -57.52 -41.98 81.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.572 -0.74 . . . . 0.9 110.692 177.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.08 -39.62 86.71 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 118.268 -0.872 . . . . 0.54 112.1 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.8 t -56.07 -57.65 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 119.842 1.201 . . . . 0.7 108.658 175.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.61 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 0.4 OUTLIER -43.84 -53.57 5.92 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.729 0.812 . . . . 2.81 112.492 172.133 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -69.07 -34.66 75.5 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.264 -0.898 . . . . 2.52 113.207 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.486 HG21 ' HA ' ' A' ' 138' ' ' PHE . 4.4 mm -60.6 -47.12 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 106.955 -1.498 . . . . 2.53 106.955 173.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.58 -51.18 33.74 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 111.667 -0.573 . . . . 0.7 111.667 173.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.61 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 4.3 m-70 -54.36 -49.16 70.45 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 121.483 -1.01 . . . . 1.15 111.42 176.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 14.5 t -51.57 -48.04 63.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 123.401 0.438 . . . . 1.74 111.341 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.22 -36.65 84.37 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.163 -0.615 . . . . 2.0 110.185 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 116.05 55.68 0.34 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 109.934 -1.266 . . . . 1.27 109.934 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.642 HD11 ' HA ' ' A' ' 258' ' ' ILE . 1.9 mm? -103.32 125.3 49.88 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.075 0.55 . . . . 4.06 110.475 173.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.61 139.81 47.09 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.461 -1.056 . . . . 2.66 110.461 171.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.416 ' CD2' ' HE1' ' A' ' 222' ' ' HIS . 17.7 m80 -43.69 114.17 0.61 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.537 1.535 . . . . 1.9 111.647 173.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 55.8 m -73.93 165.97 24.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.431 0.56 . . . . 1.25 109.78 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 12.4 m -128.33 39.99 3.74 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.437 1.495 . . . . 2.73 110.12 -167.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -141.4 142.35 26.27 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 106.863 -1.532 . . . . 1.75 106.863 -174.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -88.98 -14.19 2.87 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.176 1.917 . . . . 1.05 114.793 -174.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -82.1 -32.05 30.41 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.065 0.946 . . . . 1.83 109.093 172.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.73 152.62 6.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.516 0.727 . . . . 0.92 111.014 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 57.7 t -110.5 -20.38 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.254 -1.339 . . . . 0.84 110.261 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -31.61 71.59 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.462 1.028 . . . . 2.45 111.181 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -48.07 159.3 0.49 Allowed Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 127.178 2.191 . . . . 3.35 114.013 -174.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -71.81 -23.09 22.83 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.415 1.41 . . . . 1.53 111.884 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.355 0.2 OUTLIER -78.24 173.29 12.43 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.076 1.35 . . . . 1.5 110.219 -171.221 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -112.17 140.76 46.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.414 -1.328 . . . . 2.39 107.414 172.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.6 125.59 12.82 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.461 -2.051 . . . . 2.31 105.461 172.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -53.22 130.86 35.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.166 0.986 . . . . 3.06 110.529 -176.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.53 137.22 52.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 C-N-CA 123.599 0.76 . . . . 2.07 110.365 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.85 -42.43 97.58 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.539 1.135 . . . . 3.42 111.7 171.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 6.7 mt 69.32 8.57 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 126.118 1.767 . . . . 2.58 110.851 -159.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -64.22 -53.96 41.02 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 120.597 -1.315 . . . . 3.81 111.253 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 12.1 m -81.82 -41.37 21.18 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.964 0.906 . . . . 2.27 109.872 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.469 ' CE1' HG22 ' A' ' 140' ' ' VAL . 57.3 t80 57.43 72.81 0.49 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 122.09 0.948 . . . . 4.46 109.953 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.21 162.04 37.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.955 -0.757 . . . . 2.53 108.955 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.528 HD22 ' N ' ' A' ' 250' ' ' LEU . 1.7 mm? -95.95 158.21 15.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.637 1.575 . . . . 0.84 108.281 -178.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 2.9 m -76.13 158.71 31.45 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 122.059 -0.401 . . . . 0.78 110.695 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.73 -43.74 85.52 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.568 -0.16 . . . . 1.26 110.568 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -53.25 -55.92 20.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.564 0.697 . . . . 2.65 109.492 173.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.36 -42.32 81.81 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.396 -0.82 . . . . 2.25 110.919 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.539 ' HA ' ' CG2' ' A' ' 258' ' ' ILE . 38.9 mt -55.96 -22.33 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 126.871 2.068 . . . . 1.43 111.498 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 -77.14 -55.47 5.41 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.817 -1.177 . . . . 5.5 110.273 168.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -50.7 -55.48 17.35 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.534 -1.027 . . . . 0.81 110.534 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.642 ' HA ' HD11 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -41.85 -56.26 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 C-N-CA 125.347 1.459 . . . . 3.01 111.527 175.597 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -72.98 -21.61 60.82 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.997 0.817 . . . . 2.27 110.791 -173.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.9 t -67.15 -25.49 66.19 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 118.695 -0.669 . . . . 1.95 111.553 168.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.54 ' CD2' HG22 ' A' ' 145' ' ' THR . 0.4 OUTLIER . . . . . 0 CA--C 1.539 0.522 0 C-N-CA 126.934 2.094 . . . . 4.14 112.518 -174.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 109.191 -0.67 . . . . 6.35 109.191 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.11 -66.96 0.09 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.218 1.807 . . . . 4.18 112.25 -175.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -79.85 107.85 12.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.159 1.384 . . . . 2.52 107.841 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.66 136.89 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 106.564 -1.643 . . . . 2.12 106.564 168.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.3 t -142.9 142.95 31.86 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 120.702 0.287 . . . . 3.12 110.713 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.553 ' CE2' HD12 ' A' ' 134' ' ' ILE . 17.8 p90 -130.17 163.84 25.78 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.507 1.123 . . . . 4.48 111.488 -170.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -145.22 142.28 29.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.934 -0.765 . . . . 4.28 108.934 173.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -83.33 152.91 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 108.499 -0.926 . . . . 1.02 108.499 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -88.22 -45.41 10.11 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.391 -0.596 . . . . 3.26 109.391 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -155.35 170.22 22.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.222 -1.029 . . . . 2.4 108.222 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.07 127.28 53.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.141 0.976 . . . . 1.93 108.916 -165.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.3 t -64.4 124.01 84.49 Favored Pre-proline 0 N--CA 1.442 -0.86 0 C-N-CA 123.941 0.897 . . . . 2.68 109.419 -176.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -69.89 -19.07 35.96 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.499 2.8 . . . . 1.95 110.138 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -36.59 -40.34 0.25 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.715 2.006 . . . . 2.78 111.808 169.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 16.2 mtm -135.76 177.29 7.95 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.255 1.422 . . . . 2.49 109.506 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -76.53 141.98 41.02 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.548 -0.72 . . . . 3.48 109.262 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 54.6 ttt-85 -41.54 -48.93 4.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.707 0.685 . . . . 2.15 112.285 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -49.39 -47.06 47.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.707 -0.479 . . . . 3.37 109.707 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -69.46 -40.71 76.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.408 1.483 . . . . 1.85 111.101 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 56.8 t -54.06 -53.82 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 120.811 -1.181 . . . . 1.17 109.555 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -25.69 65.29 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 118.77 -1.172 . . . . 1.98 110.01 178.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -63.12 -47.83 81.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.891 0.769 . . . . 1.91 109.798 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.91 -53.46 56.57 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.352 0.661 . . . . 0.38 110.498 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.587 HD11 HD11 ' A' ' 220' ' ' ILE . 0.1 OUTLIER -68.82 -41.35 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 109.284 -0.636 . . . . 2.27 109.284 -178.313 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -50.41 -58.59 5.37 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.371 -0.974 . . . . 3.34 108.371 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -60.3 -52.0 67.14 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.522 1.129 . . . . 1.44 109.249 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -46.48 -49.17 18.77 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 123.944 0.898 . . . . 0.62 112.289 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.46 ' HB3' ' CD2' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -66.02 -45.99 79.53 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.996 -0.742 . . . . 4.82 108.996 178.086 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.03 -42.25 37.61 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.759 0.824 . . . . 3.83 110.829 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.609 HG22 ' CD2' ' A' ' 248' ' ' PHE . 48.0 t -48.46 -61.51 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.059 0.944 . . . . 0.69 110.134 177.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -73.09 -32.5 65.02 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.423 -0.798 . . . . 0.98 109.736 -175.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 t -61.03 -17.87 54.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.932 0.493 . . . . 1.14 111.332 175.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.02 -45.98 15.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.839 -0.8 . . . . 2.06 108.839 -177.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.6 m -78.85 -46.28 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.412 0.685 . . . . 1.37 111.971 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.49 HG21 HD12 ' A' ' 258' ' ' ILE . 43.2 p -82.79 159.14 64.05 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.407 -0.59 . . . . 0.71 109.407 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.92 -1.8 11.84 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.764 1.643 . . . . 0.7 112.581 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.9 mp -65.34 127.37 31.47 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.59 -0.893 . . . . 2.23 108.59 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.44 96.19 6.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.921 -1.14 . . . . 4.11 107.921 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.46 ' CD2' ' HB3' ' A' ' 138' ' ' PHE . 1.4 p90 -69.12 155.48 40.31 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.347 -0.388 . . . . 6.66 111.534 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.9 t -158.85 140.19 13.19 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.016 0.826 . . . . 1.12 111.079 163.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.01 149.83 22.37 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.025 -1.102 . . . . 2.01 108.025 171.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.53 HD13 ' H ' ' A' ' 156' ' ' MET . 2.9 pp -129.75 156.9 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 106.018 -1.845 . . . . 2.2 106.018 173.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -111.7 -16.62 13.18 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.242 0.339 . . . . 3.63 110.577 172.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.9 m -107.19 78.04 1.19 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.603 0.761 . . . . 2.64 109.753 -174.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 15.06 63.59 0.01 OUTLIER Glycine 0 CA--C 1.537 1.447 0 C-N-CA 128.144 2.783 . . . . 2.64 118.286 171.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.53 ' H ' HD13 ' A' ' 152' ' ' ILE . 31.7 mtt -147.8 75.69 1.36 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.092 1.357 . . . . 7.74 107.786 166.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -124.06 155.08 38.98 Favored 'General case' 0 N--CA 1.461 0.08 0 C-N-CA 123.614 0.766 . . . . 0.96 109.598 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.23 -49.46 7.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.042 0.937 . . . . 2.19 108.691 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.9 pt -110.25 161.52 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.464 0.705 . . . . 0.97 110.511 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.14 140.02 52.91 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.434 0.693 . . . . 2.49 110.324 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.87 100.13 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.702 0.801 . . . . 0.98 109.215 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.33 93.19 4.23 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 C-N-CA 125.007 1.323 . . . . 1.36 111.05 -171.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -80.94 116.22 20.8 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.536 -1.653 . . . . 5.5 106.536 172.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -140.3 155.49 46.81 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 119.135 0.879 . . . . 0.82 109.431 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -124.38 128.51 49.18 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.821 0.849 . . . . 4.06 109.207 -164.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 48.63 -126.75 17.37 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.561 1.077 . . . . 1.84 111.948 -164.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.15 137.82 38.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.103 0.561 . . . . 1.99 109.722 -175.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.24 0 N-CA-C 112.839 0.681 . . . . 2.63 112.839 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.354 0 CA-C-O 118.516 -0.754 . . . . 2.51 111.089 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 200' ' ' ASP . 48.5 t80 -90.8 151.18 21.29 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.864 0.84 . . . . 7.78 109.379 173.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -152.18 4.5 0.39 Allowed 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 126.421 1.888 . . . . 2.95 111.779 -162.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.5 -173.02 24.55 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 122.067 0.815 . . . . 1.76 112.301 -162.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 68.83 0.36 Allowed 'General case' 0 C--N 1.341 0.222 0 C-N-CA 127.32 2.248 . . . . 4.53 110.471 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.35 -157.88 27.87 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 109.329 -1.508 . . . . 1.74 109.329 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 51.14 -125.28 24.22 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 127.097 2.284 . . . . 1.54 110.263 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 4.5 mm -78.82 138.66 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.26 -1.385 . . . . 1.9 107.26 174.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 181' ' ' LEU 0.412 2.6 mp -84.46 -53.82 5.17 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.965 1.306 . . . . 1.32 109.527 165.452 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.06 162.26 28.66 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 122.104 -0.373 . . . . 0.66 110.132 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -144.37 121.31 11.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.995 1.318 . . . . 1.02 114.495 -173.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -143.27 166.64 24.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 127.492 2.317 . . . . 0.91 109.271 -171.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -151.78 143.25 23.48 Favored 'General case' 0 C--O 1.227 -0.09 0 N-CA-C 108.739 -0.838 . . . . 3.7 108.739 175.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -91.06 -88.62 1.39 Allowed Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.347 -1.101 . . . . 0.59 110.347 174.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.69 94.45 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.023 2.482 . . . . 1.31 111.028 -174.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -170.2 161.66 34.8 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.069 -1.613 . . . . 1.25 109.069 171.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 14.4 m -79.27 168.51 19.45 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.076 0.55 . . . . 2.64 110.642 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 54.84 -106.04 0.46 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.813 0.721 . . . . 1.87 111.596 173.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.0 tp -59.69 -40.48 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 118.831 -0.604 . . . . 1.63 109.465 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -44.79 141.4 3.78 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.123 -0.986 . . . . 1.17 112.489 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 95.23 -37.97 3.26 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.504 1.526 . . . . 0.76 111.25 -162.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -86.9 164.06 16.8 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.903 0.851 . . . . 1.17 110.33 -166.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -139.6 121.06 15.08 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.78 111.91 -172.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -110.54 132.13 54.45 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 118.203 -0.903 . . . . 2.32 109.328 -169.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -123.44 146.5 47.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.885 1.221 . . . . 2.8 110.541 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -66.02 90.51 0.14 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.803 -0.814 . . . . 2.74 108.803 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -57.31 -47.37 81.69 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 119.757 -1.839 . . . . 3.13 110.61 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 174' ' ' PHE . 1.9 t70 -51.4 -27.55 10.36 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.552 0.741 . . . . 2.87 111.285 -178.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -67.17 136.89 55.77 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.074 -1.454 . . . . 2.47 107.074 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.61 88.96 6.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.095 -1.076 . . . . 3.16 108.095 -172.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 32.8 m95 -79.23 134.49 36.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.513 -1.292 . . . . 1.19 107.513 -174.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.6 p -122.55 137.67 54.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.646 -0.872 . . . . 1.75 108.646 -176.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.5 t -50.47 -41.73 53.52 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 124.146 0.978 . . . . 1.76 111.654 172.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -86.36 -154.39 0.22 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.323 0.649 . . . . 2.85 111.706 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.4 m -66.37 -62.29 1.55 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.579 0.752 . . . . 3.69 110.474 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 39.97 -116.24 0.69 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.25 1.405 . . . . 2.53 113.787 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.03 -54.75 0.66 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.714 1.15 . . . . 1.56 110.281 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.58 179.34 6.62 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.869 -1.53 . . . . 1.1 106.869 172.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -136.89 127.63 27.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 122.942 0.497 . . . . 1.63 111.36 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 25.2 tp -59.14 -51.54 69.59 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 123.838 0.711 . . . . 2.27 110.314 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.52 ' CD1' HG22 ' A' ' 245' ' ' ILE . 6.8 t80 -50.41 -45.48 55.68 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.352 0.596 . . . . 1.45 109.654 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.7 tt -63.55 -59.1 5.07 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.588 -0.695 . . . . 1.35 110.299 -174.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.256 1.8 m -57.33 -38.94 74.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.351 -0.386 . . . . 0.95 110.541 178.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.32 -60.39 3.36 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 117.093 -1.432 . . . . 0.56 109.856 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 85.2 t -45.48 -50.64 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 121.234 1.834 . . . . 0.69 110.672 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.641 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 26.1 t60 -57.43 -58.29 8.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.727 0.811 . . . . 2.3 112.523 175.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.26 -42.41 79.65 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.644 -1.285 . . . . 2.96 111.911 -173.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.587 HD11 HD11 ' A' ' 134' ' ' ILE . 1.0 OUTLIER -53.16 -41.1 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 123.972 0.909 . . . . 1.35 109.907 167.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.72 -51.45 38.82 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 123.845 0.736 . . . . 0.52 111.262 170.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.641 ' NE2' ' NE2' ' A' ' 218' ' ' HIS 0.3 20.9 m-70 -53.91 -51.52 63.48 Favored 'General case' 0 C--O 1.226 -0.177 0 O-C-N 121.638 -0.919 . . . . 1.36 109.902 172.782 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.5 m -52.87 -51.04 62.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.529 0.566 . . . . 1.95 112.529 -177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.49 -28.94 70.0 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 119.137 -0.458 . . . . 2.91 111.595 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 114.9 82.65 1.06 Allowed Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.474 -1.05 . . . . 1.38 110.474 172.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.544 HD13 ' SD ' ' A' ' 236' ' ' MET . 10.7 mt -134.55 142.95 47.13 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 117.622 0.711 . . . . 3.25 110.401 178.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -77.5 164.3 52.16 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.127 -1.189 . . . . 2.94 110.127 169.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -71.77 116.9 12.69 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.833 0.853 . . . . 1.86 110.158 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.5 m -76.7 175.16 9.63 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.036 0.534 . . . . 1.11 110.896 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 30.4 m -136.84 40.97 2.53 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.637 1.175 . . . . 2.23 110.762 -170.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -140.73 141.77 26.03 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.725 -1.583 . . . . 2.28 106.725 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -85.51 -12.48 6.53 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.151 1.901 . . . . 1.21 114.955 -174.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -80.66 -30.28 36.55 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.365 0.984 . . . . 1.33 109.552 173.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.443 ' HB1' ' CG ' ' A' ' 254' ' ' ASP . . . -59.27 153.82 17.8 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.963 0.905 . . . . 1.07 110.258 170.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 50.0 t -105.49 -18.77 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.389 -1.278 . . . . 0.66 109.873 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.544 ' SD ' HD13 ' A' ' 226' ' ' LEU . 7.5 tpt -76.69 -17.74 58.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.182 -0.949 . . . . 1.9 113.506 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.4 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -49.56 157.78 0.91 Allowed Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.542 1.537 . . . . 2.96 113.32 174.086 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.92 -19.21 18.26 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.874 1.716 . . . . 0.86 111.587 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.371 0.2 OUTLIER -77.32 177.0 8.29 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.293 1.437 . . . . 1.19 109.834 -179.132 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -120.92 142.47 49.69 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.113 -1.44 . . . . 2.12 107.113 174.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -148.44 123.37 10.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 104.899 -2.26 . . . . 3.05 104.899 172.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -52.44 115.83 1.96 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.417 0.553 . . . . 2.86 109.552 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.4 m -108.99 126.25 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.764 -1.198 . . . . 1.57 107.764 171.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.43 108.36 3.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.966 -0.753 . . . . 3.88 108.966 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.52 HG22 ' CD1' ' A' ' 213' ' ' PHE . 1.4 pp -50.57 -32.1 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.054 0 C-N-CA 125.361 1.464 . . . . 3.36 111.182 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -50.97 -38.97 54.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.343 0.657 . . . . 3.96 111.721 175.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.9 m -68.22 -46.71 69.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.201 0.6 . . . . 2.5 109.935 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.609 ' CD2' HG22 ' A' ' 140' ' ' VAL . 9.1 t80 52.61 82.89 0.07 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.036 1.334 . . . . 5.09 110.975 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.41 167.59 27.0 Favored 'General case' 0 CA--C 1.521 -0.15 0 O-C-N 120.525 -1.359 . . . . 3.43 111.712 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.507 ' N ' HD22 ' A' ' 250' ' ' LEU . 1.3 mm? -111.01 156.09 21.78 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.898 1.679 . . . . 0.87 107.554 173.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.5 m -78.33 154.24 31.0 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.228 -0.286 . . . . 0.82 110.228 175.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -53.31 -45.61 69.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.622 0.369 . . . . 0.96 110.033 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -51.92 -57.18 10.18 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 122.071 0.939 . . . . 2.53 110.057 174.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.443 ' CG ' ' HB1' ' A' ' 234' ' ' ALA . 3.4 m-20 -58.26 -40.43 81.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.631 -1.168 . . . . 2.3 111.379 -177.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 45.8 mt -57.69 -47.31 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.656 0.782 . . . . 0.83 110.051 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 32.5 mtt180 -59.92 -43.52 94.86 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 120.683 -1.26 . . . . 5.01 110.144 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -48.26 -46.29 27.97 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.024 -0.831 . . . . 0.89 111.024 170.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.49 HD12 HG21 ' A' ' 145' ' ' THR . 0.1 OUTLIER -67.73 -47.88 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 O-C-N 121.776 -0.838 . . . . 3.19 110.905 -176.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -63.03 -27.28 69.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.362 -0.935 . . . . 2.91 110.582 -175.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 11.9 m -51.41 -19.66 1.46 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.987 1.106 . . . . 2.45 113.987 171.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 18.5 mt . . . . . 0 C--N 1.349 0.568 0 CA-C-N 120.601 1.546 . . . . 2.55 113.439 164.836 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 110.021 -0.363 . . . . 5.01 110.021 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 27.6 m170 61.0 -69.48 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.921 1.289 . . . . 4.25 111.353 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -79.91 91.29 5.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 119.046 0.839 . . . . 2.52 110.545 -176.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.425 HD12 ' N ' ' A' ' 114' ' ' ILE . 2.0 mp -91.8 88.2 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 107.278 -1.378 . . . . 2.57 107.278 173.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.2 p -81.39 120.09 24.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.262 -1.384 . . . . 1.4 107.262 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -128.69 171.7 11.94 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 119.219 0.918 . . . . 4.38 110.688 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -157.37 176.65 12.39 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.636 -0.665 . . . . 4.22 109.829 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.8 mm -109.4 162.96 6.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.184 1.393 . . . . 1.76 108.332 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -102.57 -62.87 1.22 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.342 0.657 . . . . 3.0 109.975 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -144.02 159.72 42.11 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.961 1.305 . . . . 2.02 107.595 176.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -111.67 127.31 55.73 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.218 -1.401 . . . . 2.26 107.218 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.76 130.53 94.83 Favored Pre-proline 0 N--CA 1.444 -0.732 0 C-N-CA 124.05 0.94 . . . . 4.09 109.842 -177.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -70.04 -27.06 25.61 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.771 2.314 . . . . 2.59 109.995 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.8 -28.71 69.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.527 1.131 . . . . 3.61 111.368 171.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 35.9 mmt -102.23 179.88 4.18 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.116 0.871 . . . . 4.02 109.457 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -105.23 113.72 27.48 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 108.11 -1.07 . . . . 3.48 108.11 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.48 -59.98 2.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.534 1.061 . . . . 2.38 112.931 -176.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -49.26 -43.6 43.03 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 108.851 -0.796 . . . . 2.78 108.851 -174.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -66.61 -42.96 86.04 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.9 1.28 . . . . 1.67 112.571 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.2 t -58.48 -54.2 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 O-C-N 120.842 -1.161 . . . . 1.55 108.798 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.428 ' OD2' ' NZ ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -62.92 -45.78 90.89 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.281 -1.007 . . . . 2.14 108.281 178.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -53.3 -44.67 68.53 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.018 0.927 . . . . 3.05 110.963 -176.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.25 -49.22 69.99 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 122.697 0.399 . . . . 0.58 110.608 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.503 ' CD1' HD11 ' A' ' 220' ' ' ILE . 0.3 OUTLIER -71.07 -31.17 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 120.874 0.369 . . . . 1.84 110.315 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -62.23 -53.6 52.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.724 1.609 . . . . 3.38 107.009 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -70.0 -44.8 68.62 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.886 1.674 . . . . 1.31 109.863 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.473 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -47.34 -52.25 17.04 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.836 0.35 . . . . 0.57 111.09 170.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.548 ' HB3' ' CD2' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -57.66 -56.46 21.64 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.951 -0.759 . . . . 4.44 108.951 177.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.78 -49.43 38.65 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.926 1.29 . . . . 3.11 110.98 -173.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.66 HG12 HD21 ' A' ' 250' ' ' LEU . 54.0 t -51.14 -50.66 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.425 1.09 . . . . 1.11 109.773 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.438 ' HB3' HD11 ' A' ' 224' ' ' LEU . 16.7 m95 -73.77 -32.33 63.74 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.693 -0.63 . . . . 1.18 110.369 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.32 -7.29 41.5 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.206 1.402 . . . . 1.1 111.283 175.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.61 -51.02 5.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.373 -0.973 . . . . 1.55 108.373 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.8 m -68.99 -41.4 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 111.969 0.359 . . . . 1.45 111.969 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.2 p -87.2 160.27 49.13 Favored Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 108.9 -0.778 . . . . 1.01 108.9 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -73.51 2.86 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 121.889 1.726 . . . . 0.94 112.325 170.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.404 HD12 HD13 ' A' ' 224' ' ' LEU . 35.0 mt -68.54 154.92 40.95 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.254 -0.904 . . . . 2.06 110.817 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 99.23 5.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.836 1.654 . . . . 5.19 109.611 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.548 ' CD2' ' HB3' ' A' ' 138' ' ' PHE . 1.7 p90 -63.51 152.5 38.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.741 -0.663 . . . . 7.15 112.007 170.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.6 t -155.11 117.68 4.28 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.698 -0.668 . . . . 0.85 111.06 173.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.428 ' NZ ' ' OD2' ' A' ' 131' ' ' ASP . 6.0 ttmt -81.59 131.02 35.26 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 119.514 1.052 . . . . 2.52 109.563 175.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.24 88.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 122.001 0.905 . . . . 1.97 109.411 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -87.13 33.27 0.67 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.599 0.76 . . . . 2.94 110.424 176.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.1 p -149.62 77.97 1.35 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.094 1.358 . . . . 2.32 108.982 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 147.71 -120.39 1.22 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.571 -1.411 . . . . 1.53 109.571 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 27.5 mtp -139.53 136.03 34.07 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 127.147 2.179 . . . . 4.13 106.352 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.83 165.86 18.54 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.696 1.198 . . . . 0.64 109.598 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -73.59 -53.0 11.52 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.159 0.984 . . . . 2.24 108.4 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.2 pt -119.69 147.76 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.669 -0.696 . . . . 1.11 111.224 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.4 tt -122.95 133.13 54.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.014 1.326 . . . . 2.54 109.142 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.43 HG13 ' CE1' ' A' ' 197' ' ' PHE . 4.7 t -81.19 101.02 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.571 1.148 . . . . 1.0 108.535 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.8 t -78.9 111.75 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.784 -0.821 . . . . 1.25 108.784 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -99.0 118.32 35.51 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.203 -1.777 . . . . 5.06 106.203 166.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -143.78 161.42 38.66 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.972 -1.121 . . . . 0.92 107.972 -176.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -122.99 142.39 50.89 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.335 -1.358 . . . . 3.93 107.335 172.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.497 ' HA2' ' CD1' ' A' ' 174' ' ' PHE . . . 83.98 174.73 50.54 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.982 -0.447 . . . . 2.0 111.982 170.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.14 77.75 3.68 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.915 -0.756 . . . . 3.34 109.9 -170.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.533 0.316 0 C-N-CA 123.696 0.798 . . . . 2.64 112.269 -175.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.255 0 N-CA-C 110.145 -0.317 . . . . 2.68 110.145 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.512 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -83.95 170.72 13.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.677 -1.231 . . . . 7.65 107.677 178.147 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.512 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 9.2 p30 175.39 33.14 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.906 1.282 . . . . 2.35 112.879 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 53.15 -156.84 4.94 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 120.984 -1.073 . . . . 1.39 111.543 -172.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -76.3 62.14 1.75 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.833 0.853 . . . . 4.25 112.567 -175.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -162.17 -154.8 7.69 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 107.839 -2.104 . . . . 1.68 107.839 168.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 35.81 -113.6 0.15 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 127.966 2.698 . . . . 1.36 112.219 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.1 mm -79.58 139.47 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 118.126 0.963 . . . . 1.84 109.001 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.5 mp -80.52 -59.9 2.52 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.983 -1.117 . . . . 1.16 107.983 170.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -163.51 159.77 22.41 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.761 -0.459 . . . . 0.86 109.761 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -146.55 117.15 7.54 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.264 1.426 . . . . 1.17 113.666 -166.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -136.37 159.47 41.67 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.004 1.722 . . . . 0.73 109.208 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -148.65 144.03 26.9 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.953 -1.499 . . . . 2.76 106.953 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -93.01 -89.99 1.55 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.166 0.888 . . . . 0.8 110.916 173.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.28 97.91 0.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.799 2.333 . . . . 1.3 110.962 -175.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -169.01 161.68 35.38 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 108.24 -1.944 . . . . 1.16 108.24 171.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.4 t -80.96 178.38 8.45 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.509 0.654 . . . . 3.35 110.466 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 46.24 -109.8 0.41 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.643 1.116 . . . . 1.42 111.314 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.7 tp -59.87 -42.25 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 118.169 -0.92 . . . . 1.62 109.826 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -38.6 128.97 1.85 Allowed Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.805 1.193 . . . . 1.09 112.664 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 108.86 -50.83 0.75 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.366 1.936 . . . . 0.72 109.686 -162.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.24 148.02 28.62 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.398 1.079 . . . . 2.61 110.481 -166.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -117.95 121.43 40.67 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.498 1.119 . . . . 0.6 111.248 -170.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -111.54 122.7 48.53 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 118.512 0.597 . . . . 2.24 111.381 -168.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.43 ' CE1' HG13 ' A' ' 161' ' ' VAL . 5.4 m-85 -111.06 136.16 50.5 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.973 -1.121 . . . . 2.64 107.973 -178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -67.0 93.55 0.28 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.476 -1.675 . . . . 2.85 106.476 172.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -39.12 82.86 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.688 1.131 . . . . 3.41 109.193 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -34.66 -48.87 0.39 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 127.092 2.157 . . . . 2.97 110.543 -167.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -61.13 179.7 0.18 Allowed 'General case' 0 C--O 1.24 0.597 0 C-N-CA 126.167 1.787 . . . . 4.67 112.283 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -115.52 87.14 2.6 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 105.538 -2.023 . . . . 2.9 105.538 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -75.67 163.32 27.43 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.93 -1.032 . . . . 1.13 108.276 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.8 p -129.22 144.15 51.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.38 -0.971 . . . . 1.77 108.38 174.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . 0.258 6.3 t -61.31 -40.47 94.29 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 126.113 1.765 . . . . 2.21 112.414 165.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -96.37 -172.44 2.53 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.406 1.082 . . . . 2.47 108.365 177.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.3 m -47.53 -65.7 0.52 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.785 2.034 . . . . 3.88 110.594 -173.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 45.77 -104.49 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 125.896 1.712 . . . . 2.17 114.364 165.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -112.38 -81.48 1.12 Allowed Glycine 0 C--N 1.335 0.495 0 N-CA-C 109.677 -1.369 . . . . 1.56 109.677 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.3 m -115.79 123.3 47.88 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.654 -1.98 . . . . 0.91 105.654 167.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.79 111.97 10.53 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.839 -0.8 . . . . 2.73 108.839 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.01 -54.41 24.78 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.057 0.844 . . . . 1.74 110.585 -175.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.56 ' O ' HG23 ' A' ' 217' ' ' VAL . 1.8 t80 -44.77 -43.86 8.88 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.77 1.228 . . . . 1.89 111.352 177.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.93 -64.74 0.84 Allowed 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.929 -0.482 . . . . 1.25 109.942 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.324 3.4 m -53.89 -43.37 69.59 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.377 0.608 . . . . 0.89 110.701 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.45 -42.73 54.61 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.918 -0.583 . . . . 0.47 111.793 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.588 HG21 ' CE2' ' A' ' 248' ' ' PHE . 83.9 t -62.65 -42.78 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 119.699 1.136 . . . . 0.69 111.339 -177.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.506 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 5.8 t60 -55.33 -47.33 75.83 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.977 0.911 . . . . 2.59 109.456 174.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -76.13 -32.75 59.29 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 114.257 1.206 . . . . 3.49 114.257 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.503 HD11 ' CD1' ' A' ' 134' ' ' ILE . 4.7 mm -58.0 -50.85 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 106.886 -1.524 . . . . 2.38 106.886 171.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.76 -45.46 48.68 Favored Glycine 0 CA--C 1.537 1.436 0 N-CA-C 111.931 -0.468 . . . . 0.83 111.931 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.506 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 3.8 m-70 -55.08 -50.56 68.87 Favored 'General case' 0 C--O 1.226 -0.18 0 O-C-N 121.569 -0.959 . . . . 1.27 110.335 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 1.5 t -52.21 -49.63 63.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.482 0.713 . . . . 2.05 111.377 176.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 141' ' ' TRP . 10.2 mt -60.1 -45.65 92.24 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.374 0.534 . . . . 2.18 109.721 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 134.48 38.99 0.19 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 123.812 0.72 . . . . 1.31 112.608 168.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.06 116.73 24.45 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.132 0.966 . . . . 3.48 110.156 174.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.42 52.51 4.36 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.301 -0.722 . . . . 2.85 113.151 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 72.5 m80 66.28 161.85 0.15 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.28 1.432 . . . . 1.91 113.022 -175.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 74.1 m -131.73 -178.51 4.91 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.872 1.669 . . . . 1.12 109.431 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 7.4 p -146.79 16.03 1.24 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.991 1.316 . . . . 2.64 111.006 -165.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -115.79 138.52 24.01 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 106.878 -1.527 . . . . 2.51 106.878 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.92 -17.49 10.78 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.923 1.749 . . . . 1.76 114.182 -172.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.405 ' HE3' ' HB2' ' A' ' 233' ' ' LYS . 14.6 mtmt -83.65 -28.35 28.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.94 0.791 . . . . 1.69 109.852 173.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.21 147.69 39.05 Favored 'General case' 0 C--O 1.225 -0.19 0 O-C-N 121.902 -0.499 . . . . 0.76 110.792 173.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 71.2 t -92.97 -23.5 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.724 1.21 . . . . 0.62 109.72 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 16.9 tpp -70.05 -14.68 62.79 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.471 1.108 . . . . 2.7 113.411 177.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.406 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -51.33 147.02 10.83 Favored Pre-proline 0 CA--C 1.539 0.545 0 O-C-N 121.378 -0.826 . . . . 3.02 112.944 177.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.92 -16.2 29.33 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.317 2.011 . . . . 1.3 111.631 174.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.301 0.1 OUTLIER -76.35 169.13 18.8 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.2 -1.037 . . . . 1.62 108.2 171.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -128.01 146.98 50.49 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 104.808 -2.293 . . . . 2.0 104.808 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.23 144.18 20.78 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.476 -1.305 . . . . 2.4 107.476 171.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -62.9 144.35 56.79 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.977 0.911 . . . . 2.26 111.051 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.486 HG21 ' CD1' ' A' ' 248' ' ' PHE . 17.4 m -131.85 154.35 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.555 0.742 . . . . 1.91 110.672 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.18 -16.23 59.45 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.993 1.717 . . . . 3.5 114.334 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . 0.25 14.0 mm 72.21 -41.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 128.019 2.527 . . . . 3.33 111.085 -176.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -78.99 -51.81 9.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.878 0.871 . . . . 3.42 111.197 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 47.5 m -78.46 -18.07 55.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.482 1.113 . . . . 2.66 110.652 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.588 ' CE2' HG21 ' A' ' 217' ' ' VAL . 87.7 t80 -39.3 110.82 0.15 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.531 1.532 . . . . 7.89 112.11 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.02 163.88 31.59 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.448 1.099 . . . . 3.36 109.906 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.66 HD21 HG12 ' A' ' 140' ' ' VAL . 1.2 mm? -81.08 137.42 36.0 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.831 -1.174 . . . . 1.1 107.831 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.7 m -77.41 160.66 28.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.651 0.262 . . . . 0.71 110.816 -175.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.76 -48.35 78.04 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 110.059 -0.348 . . . . 0.88 110.059 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -48.31 -51.88 24.04 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.765 0.793 . . . . 2.6 109.96 172.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.97 -47.52 80.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.079 -1.419 . . . . 2.2 109.09 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.5 mt -59.86 -47.46 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.816 1.646 . . . . 0.93 111.226 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -60.08 -44.27 94.89 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.346 -1.471 . . . . 4.63 109.858 175.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -49.62 -42.59 36.02 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.937 -0.865 . . . . 0.8 110.937 170.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 258' ' ' ILE . 0.2 OUTLIER -68.58 -47.04 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 117.826 0.813 . . . . 3.45 110.561 -177.247 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -68.16 -15.95 63.79 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 119.701 -0.8 . . . . 2.63 110.849 -178.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.14 -17.69 3.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.755 0.822 . . . . 2.04 112.873 165.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 56.7 mt . . . . . 0 CA--C 1.54 0.569 0 CA-C-N 120.076 1.307 . . . . 2.54 111.753 161.877 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.487 ' HG3' HD11 ' A' ' 114' ' ' ILE . 3.1 mptt . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 120.483 0.183 . . . . 6.18 111.297 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 60.34 -80.27 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.586 1.555 . . . . 3.46 109.407 -165.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.44 ' O ' HD13 ' A' ' 114' ' ' ILE . 59.9 m-85 -114.81 111.84 21.85 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.461 1.105 . . . . 3.14 111.499 -168.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.546 HG22 ' CE1' ' A' ' 116' ' ' TYR . 18.0 mm -128.52 103.87 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.926 0.87 . . . . 2.69 112.157 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -86.91 140.98 29.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.25 2.22 . . . . 1.22 109.49 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.546 ' CE1' HG22 ' A' ' 114' ' ' ILE . 10.3 m-85 -124.47 167.78 13.96 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.579 1.151 . . . . 6.25 110.84 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -149.52 149.55 30.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.802 1.241 . . . . 7.53 109.608 176.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.4 mt -102.68 155.69 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.656 -1.239 . . . . 0.92 107.656 173.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -97.57 -44.56 6.75 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.11 0.564 . . . . 2.94 110.156 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -149.03 164.85 33.42 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.865 0.466 . . . . 2.25 110.149 174.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -111.15 127.97 55.75 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.149 1.38 . . . . 1.8 107.574 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.1 t -60.46 136.84 92.2 Favored Pre-proline 0 N--CA 1.442 -0.829 0 C-N-CA 122.931 0.492 . . . . 2.24 109.742 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.22 -18.64 14.08 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.16 2.573 . . . . 1.58 111.009 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -40.41 -46.58 2.42 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.622 1.569 . . . . 2.0 111.452 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -128.24 176.33 7.76 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.544 1.538 . . . . 2.63 109.253 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -73.86 143.42 45.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.285 0.634 . . . . 3.04 110.452 174.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.3 ttt-85 -47.19 -45.0 22.71 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.475 0.71 . . . . 2.84 111.512 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.63 -10.04 11.01 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.023 0.929 . . . . 4.2 112.997 -177.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -100.03 -45.11 5.78 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.387 1.475 . . . . 2.17 110.434 168.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 73.9 t -53.41 -54.94 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 123.991 0.916 . . . . 1.25 109.511 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.407 ' HB3' ' NZ ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -71.75 -25.53 62.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 117.447 -1.701 . . . . 1.94 109.81 178.429 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -59.11 -48.17 82.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.422 1.01 . . . . 2.21 109.042 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.27 -52.7 51.25 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 116.21 -0.45 . . . . 0.41 111.486 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -36.57 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.663 0.744 . . . . 1.67 110.131 -173.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.7 ttm-85 -55.57 -54.87 38.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.479 1.112 . . . . 3.94 108.276 173.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.573 ' O ' HG23 ' A' ' 140' ' ' VAL . 12.4 mmmm -66.34 -41.11 90.06 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.431 0.692 . . . . 1.27 109.658 -176.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -47.12 -54.46 10.47 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 118.551 0.614 . . . . 0.48 110.686 169.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.757 ' CD1' HG23 ' A' ' 220' ' ' ILE . 34.5 m-85 -59.81 -42.67 93.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.476 -0.49 . . . . 4.42 111.588 176.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -50.28 -39.85 46.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.393 0.677 . . . . 2.98 110.515 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 136' ' ' LYS . 44.6 t -61.0 -56.24 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.131 -0.692 . . . . 0.77 109.131 -176.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.4 ' CH2' ' HG ' ' A' ' 250' ' ' LEU . 26.8 m95 -75.24 -35.21 61.44 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 122.054 -0.404 . . . . 0.84 110.585 -173.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 89.0 p -70.7 -15.53 62.71 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.359 0.503 . . . . 2.28 112.359 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.13 -48.39 11.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.549 -1.278 . . . . 1.57 107.549 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 26.7 m -75.64 -40.42 40.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 113.191 0.811 . . . . 1.6 113.191 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 31.7 p -100.06 140.71 21.71 Favored Pre-proline 0 N--CA 1.447 -0.624 0 N-CA-C 108.466 -0.939 . . . . 0.87 108.466 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.33 12.03 0.89 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.241 2.627 . . . . 0.99 113.637 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.2 mt -70.09 115.52 9.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.58 1.152 . . . . 2.02 108.845 -175.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -82.53 89.79 6.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 122.445 1.117 . . . . 4.6 108.282 -172.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.18 146.1 48.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.738 -2.028 . . . . 6.38 109.299 170.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.6 t -151.19 147.31 26.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.881 -1.526 . . . . 1.08 106.881 165.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.407 ' NZ ' ' HB3' ' A' ' 131' ' ' ASP . 2.5 tmmt? -125.64 129.75 50.24 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 107.363 -1.347 . . . . 1.96 107.363 175.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.6 pp -133.75 170.69 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 105.952 -1.87 . . . . 1.5 105.952 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -142.63 27.37 1.69 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.798 0.726 . . . . 4.39 109.094 169.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 58.2 p -150.72 78.46 1.31 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.401 1.08 . . . . 2.66 108.531 -172.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.15 -128.08 2.76 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 108.028 -2.029 . . . . 1.54 108.028 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.0 mtt -126.43 148.81 49.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.407 1.083 . . . . 4.13 109.552 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -141.42 160.65 39.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.137 1.375 . . . . 0.69 109.299 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -80.86 -58.91 2.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.636 1.974 . . . . 1.98 107.786 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -91.02 179.04 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 122.035 0.921 . . . . 1.37 111.243 176.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 tt -138.75 127.61 23.66 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.495 2.318 . . . . 2.24 109.094 167.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 20.6 t -86.26 105.73 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.702 -1.221 . . . . 0.75 107.702 170.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.3 t -81.56 140.31 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 107.43 -1.322 . . . . 1.32 107.43 170.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.29 90.32 2.41 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.568 -2.012 . . . . 4.94 105.568 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.42 158.83 39.76 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.068 0.547 . . . . 0.78 109.988 -165.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 14.0 ptt-85 -124.0 115.57 21.43 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.837 0.855 . . . . 4.65 109.935 -162.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 60.48 -97.65 0.12 Allowed Glycine 0 CA--C 1.535 1.328 0 C-N-CA 123.335 0.493 . . . . 1.6 112.292 -175.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.39 135.8 35.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.785 0.834 . . . . 2.83 109.06 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 . . . . . 0 C--O 1.226 -0.148 0 N-CA-C 111.621 0.23 . . . . 3.64 111.621 176.254 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 121.342 0.591 . . . . 3.1 111.113 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -109.24 -179.28 3.79 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 106.917 -1.512 . . . . 6.2 106.917 159.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -143.74 -168.16 2.77 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.539 1.936 . . . . 3.99 106.149 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -90.34 -141.64 9.18 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.952 -0.859 . . . . 1.7 110.952 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.63 114.85 2.69 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.935 -0.765 . . . . 7.49 108.935 169.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.92 -155.94 16.21 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.083 -1.207 . . . . 1.96 110.083 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.28 -119.44 11.95 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 109.946 -1.262 . . . . 1.88 109.946 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . 0.339 2.2 mt -90.58 137.27 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 107.129 -1.434 . . . . 2.0 107.129 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -85.68 -56.85 3.3 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.12 1.368 . . . . 2.18 109.856 166.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -156.07 162.17 40.31 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 121.129 -0.982 . . . . 0.86 112.322 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -145.15 116.07 7.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.36 1.464 . . . . 0.93 114.265 176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.77 159.04 40.9 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.951 2.1 . . . . 0.84 108.308 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -144.42 148.21 34.33 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.965 -1.494 . . . . 3.47 106.965 172.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -98.81 -82.34 1.66 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.851 -0.9 . . . . 1.13 110.851 170.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.97 92.71 0.71 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.396 2.73 . . . . 2.34 110.551 -172.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -175.39 157.38 23.94 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 108.661 -1.776 . . . . 2.04 108.661 171.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.3 m -77.54 157.62 30.27 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.11 -0.7 . . . . 2.96 109.11 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.89 -110.69 3.11 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.931 -0.868 . . . . 2.39 110.931 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.452 HG12 ' CE1' ' A' ' 196' ' ' HIS . 5.1 tp -63.03 -42.28 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 O-C-N 121.468 -1.019 . . . . 2.25 109.632 -170.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -30.75 129.56 0.16 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 126.252 1.882 . . . . 1.74 113.814 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 103.78 -52.75 0.75 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.465 1.983 . . . . 0.85 109.757 -164.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -84.09 160.61 20.89 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.054 0.942 . . . . 1.98 111.314 -167.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -138.91 124.52 19.53 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 118.136 -0.935 . . . . 0.65 111.56 -172.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.452 ' CE1' HG12 ' A' ' 191' ' ' ILE . 1.0 OUTLIER -112.38 127.21 55.95 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-O 117.721 -1.133 . . . . 2.07 109.244 -173.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -114.2 151.44 32.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.202 1.365 . . . . 2.87 110.947 174.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -73.83 101.34 3.71 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.417 -0.811 . . . . 3.43 109.964 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.36 -29.67 70.93 Favored 'General case' 0 C--O 1.24 0.596 0 O-C-N 121.485 -0.76 . . . . 2.5 111.147 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -59.44 -31.9 69.72 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.393 0.997 . . . . 3.11 109.344 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -68.03 150.51 48.35 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 122.107 0.956 . . . . 2.83 108.884 -176.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -102.3 93.03 4.98 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 105.695 -1.965 . . . . 3.45 105.695 174.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -77.85 138.79 39.13 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 108.536 -0.912 . . . . 1.16 108.536 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.7 108.79 2.02 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 120.975 1.716 . . . . 2.64 111.023 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.33 -51.38 54.88 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 118.4 0.545 . . . . 3.72 111.0 162.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -65.54 -38.3 89.22 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.7 -0.682 . . . . 4.92 111.875 -161.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 21.3 t -80.52 -43.25 21.05 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.345 0.658 . . . . 7.42 109.773 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 114.6 -31.69 6.24 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.314 -0.715 . . . . 3.52 112.131 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -21.91 -85.0 0.01 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 128.164 2.792 . . . . 1.16 114.545 -171.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 26.1 m -122.49 123.37 41.1 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 104.563 -2.384 . . . . 0.87 104.563 156.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -84.97 125.33 32.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.101 0.864 . . . . 1.36 109.236 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 43.6 tp -53.94 -51.83 62.54 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 118.044 0.384 . . . . 1.76 110.397 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.599 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.3 t80 -50.23 -46.76 55.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.108 0.563 . . . . 1.96 110.488 -178.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.503 ' C ' HD23 ' A' ' 214' ' ' LEU . 6.8 tt -56.12 -63.39 1.2 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.373 1.069 . . . . 1.21 110.866 -177.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.37 0.9 OUTLIER -59.13 -39.86 83.65 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.918 0.39 . . . . 0.97 110.453 179.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.41 62.31 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 116.822 -1.561 . . . . 0.48 109.409 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 213' ' ' PHE . 8.4 t -44.45 -55.25 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 121.117 1.78 . . . . 1.1 111.473 177.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.642 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 0.4 OUTLIER -51.71 -46.77 64.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.302 0.641 . . . . 2.38 111.802 178.82 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -79.51 -47.23 15.93 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.283 -0.885 . . . . 2.77 112.58 -173.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.757 HG23 ' CD1' ' A' ' 138' ' ' PHE . 1.3 mp -56.53 -41.61 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.035 1.734 . . . . 1.52 107.871 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.36 -47.33 83.54 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.284 -0.726 . . . . 0.91 111.284 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.642 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 7.1 m-70 -52.59 -52.31 55.81 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.433 -1.04 . . . . 1.52 110.389 174.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.0 m -51.06 -47.64 61.73 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.923 0.783 . . . . 2.12 112.476 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -18.87 15.18 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.204 1.002 . . . . 3.34 112.276 176.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 120.4 6.7 9.54 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 125.659 1.599 . . . . 1.62 111.243 173.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 258' ' ' ILE . 49.7 mt -88.89 109.36 20.15 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 117.842 0.821 . . . . 4.8 110.498 -159.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -60.63 158.47 28.07 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.503 1.049 . . . . 3.47 112.49 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.429 ' CD2' ' CE1' ' A' ' 222' ' ' HIS . 27.1 m80 -62.77 121.64 13.93 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.54 0.736 . . . . 1.77 111.5 -177.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 64.8 m -77.94 178.39 7.5 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.442 0.639 . . . . 1.58 110.678 171.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 p -125.22 6.49 7.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.905 2.082 . . . . 3.49 111.927 -164.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -118.38 136.68 24.11 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.264 1.426 . . . . 2.53 108.045 -171.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.63 -13.49 14.7 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.679 2.253 . . . . 1.86 114.439 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -80.5 -37.7 31.2 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.605 1.162 . . . . 1.61 108.892 173.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.02 149.0 24.33 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.424 0.69 . . . . 0.96 110.891 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.7 t -93.34 -17.82 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.234 -0.894 . . . . 0.84 110.504 177.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.73 -20.94 60.37 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 113.139 0.792 . . . . 2.14 113.139 -174.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -52.92 167.97 0.37 Allowed Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.932 1.693 . . . . 3.02 113.644 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -83.98 -14.44 7.39 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 121.942 1.761 . . . . 1.55 112.332 173.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.294 0.0 OUTLIER -79.35 176.74 9.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.913 1.285 . . . . 2.12 109.781 178.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.431 ' CE1' HD22 ' A' ' 214' ' ' LEU . 90.1 t80 -121.39 140.94 51.48 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.04 1.736 . . . . 2.28 106.503 176.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -151.31 132.51 14.46 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 105.095 -2.187 . . . . 2.46 105.095 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -61.21 123.1 16.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.149 0.432 . . . . 2.63 110.428 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.2 m -100.85 134.05 42.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 122.818 0.447 . . . . 1.99 109.997 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -81.96 90.56 6.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 122.224 1.012 . . . . 3.38 109.807 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 92.9 mt -54.06 -24.77 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.191 0.996 . . . . 2.95 110.757 178.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -46.74 -45.41 19.65 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.4 0.546 . . . . 3.47 111.868 170.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 25.6 m -84.04 -42.32 16.28 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.404 0.682 . . . . 1.92 109.895 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 69.8 t80 58.28 68.59 0.81 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.792 0.806 . . . . 4.24 110.223 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -160.49 165.22 31.33 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.009 -0.737 . . . . 3.48 109.009 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.4 ' HG ' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -109.17 -175.15 2.68 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.087 1.355 . . . . 1.77 110.145 -179.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 39.1 m -81.93 141.68 33.11 Favored 'General case' 0 C--O 1.222 -0.377 0 O-C-N 120.872 -1.143 . . . . 0.98 112.029 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.46 -39.61 57.79 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.231 0.539 . . . . 0.94 111.026 169.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -66.74 -21.7 66.06 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.929 0.714 . . . . 3.75 112.929 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.36 -51.81 7.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.903 0.881 . . . . 3.37 109.57 169.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 56.1 mt -47.58 -43.61 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.13 1.772 . . . . 1.13 111.77 -175.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -52.91 -53.53 47.96 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.823 0.344 . . . . 4.76 111.32 172.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.03 -54.37 30.89 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.089 -1.605 . . . . 1.63 109.089 -171.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.45 ' HA ' HD22 ' A' ' 226' ' ' LEU . 2.8 pp -55.37 -35.9 38.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 123.667 0.787 . . . . 2.46 112.348 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -73.04 -49.13 30.51 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 118.443 -0.789 . . . . 3.54 111.359 172.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 24.3 m -51.01 -37.15 43.39 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.736 1.153 . . . . 4.15 112.321 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 10.9 mt . . . . . 0 CA--C 1.534 0.353 0 C-N-CA 124.277 1.031 . . . . 5.19 111.489 176.64 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.551 ' CG ' HD11 ' A' ' 114' ' ' ILE . 1.1 mptp? . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 112.064 0.394 . . . . 5.84 112.064 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 56.27 -66.5 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.426 1.49 . . . . 3.82 110.645 -154.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -120.25 114.34 21.76 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.127 0.971 . . . . 3.61 112.377 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.551 HD11 ' CG ' ' A' ' 111' ' ' LYS . 45.9 mm -95.03 88.28 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 122.403 1.097 . . . . 2.68 109.024 168.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.97 123.87 29.85 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.26 -1.385 . . . . 1.72 107.26 176.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -127.08 163.28 24.13 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.531 1.059 . . . . 4.43 112.458 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -142.2 144.11 33.24 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.487 1.115 . . . . 5.82 109.233 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -92.99 151.79 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 109.5 -0.556 . . . . 1.08 109.5 176.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -86.46 -50.58 6.77 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.813 -0.81 . . . . 3.48 108.813 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -133.02 176.69 8.28 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 123.84 0.712 . . . . 3.29 111.777 174.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -138.94 160.93 38.57 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.431 1.893 . . . . 2.52 107.136 -177.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 90.6 m 46.99 56.26 17.09 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 123.505 0.722 . . . . 8.07 111.858 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.12 -39.96 1.46 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.121 1.881 . . . . 5.27 109.326 171.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.99 3.88 0.72 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.543 0.737 . . . . 2.08 112.75 -175.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 7.3 mtm -150.24 168.4 24.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.937 1.244 . . . . 1.66 110.843 -169.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -69.85 140.56 53.24 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.691 -0.485 . . . . 3.34 109.691 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -56.9 -40.0 75.46 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.267 -0.896 . . . . 2.08 112.138 -174.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.4 -3.06 5.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.892 -0.575 . . . . 3.48 112.289 -178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -96.69 -50.36 4.73 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.866 1.266 . . . . 2.68 110.357 161.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.1 m -58.43 -49.42 82.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 O-C-N 121.105 -0.997 . . . . 2.72 110.439 -169.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -71.79 -24.46 61.74 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 118.745 -1.182 . . . . 2.25 109.172 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -66.31 -48.93 68.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.659 1.118 . . . . 2.81 109.682 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.68 -49.5 76.3 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 123.774 0.829 . . . . 0.58 110.143 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.9 tp -70.88 -38.06 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.951 0.405 . . . . 1.69 110.469 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -54.87 41.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.725 -1.213 . . . . 3.45 107.725 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -59.24 -51.5 69.72 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.043 -0.981 . . . . 1.43 110.115 176.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -46.08 -50.36 15.37 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 118.686 0.676 . . . . 0.67 112.307 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.31 -51.6 62.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 118.839 -1.144 . . . . 6.69 109.196 175.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.16 -27.23 65.46 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.641 0.776 . . . . 2.08 112.0 -170.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.602 HG22 ' CD1' ' A' ' 248' ' ' PHE . 53.2 t -62.66 -54.76 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.561 1.144 . . . . 0.66 109.293 171.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.432 ' CZ3' ' HG ' ' A' ' 250' ' ' LEU . 59.3 m95 -73.6 -33.84 64.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 121.593 -0.692 . . . . 0.71 109.325 -174.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 74.0 m -65.62 -17.35 64.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 118.736 0.698 . . . . 1.24 112.571 173.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -75.71 -46.62 30.1 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.033 0.833 . . . . 1.15 109.068 174.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 57.3 t -74.38 -54.3 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.598 0.759 . . . . 2.16 110.455 -176.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.475 HG21 HD12 ' A' ' 258' ' ' ILE . 24.4 p -90.08 158.61 43.95 Favored Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 124.945 1.298 . . . . 0.6 109.823 -174.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -74.31 2.64 6.01 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.088 1.859 . . . . 0.8 112.848 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.9 mt -63.62 114.99 4.3 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.367 0.985 . . . . 2.18 110.396 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.5 76.06 2.53 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.348 -1.353 . . . . 4.26 107.348 -170.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -63.48 161.2 14.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.479 -0.782 . . . . 5.31 112.364 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.8 t -152.09 138.94 18.93 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.833 -1.543 . . . . 0.88 106.833 168.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -77.82 147.48 35.19 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.71 -1.959 . . . . 2.77 105.71 156.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.2 pt -132.51 120.83 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 105.556 -2.016 . . . . 1.31 105.556 156.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -75.12 -18.11 60.3 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.599 -0.688 . . . . 3.59 110.879 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.83 111.97 8.5 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 125.549 1.54 . . . . 2.28 109.299 -161.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 137.63 -137.15 8.68 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 108.415 -1.874 . . . . 1.44 108.415 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.6 mmt -131.42 135.83 47.49 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.601 1.56 . . . . 6.28 107.223 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -124.98 165.98 17.16 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.867 1.267 . . . . 0.94 110.154 -172.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -76.86 -57.42 3.86 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 122.036 0.922 . . . . 2.15 109.104 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.0 pt -109.26 155.41 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.699 -1.593 . . . . 0.95 106.699 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.45 HD22 ' C ' ' A' ' 160' ' ' LEU 0.36 0.0 OUTLIER -139.64 140.74 37.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 121.251 -0.906 . . . . 2.5 109.815 175.902 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 33.2 t -83.82 99.39 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 106.985 -1.487 . . . . 1.3 106.985 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.3 p -102.41 124.76 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 107.173 -1.417 . . . . 2.46 107.173 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -86.36 150.08 24.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.118 -1.438 . . . . 7.47 107.118 167.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.73 156.55 31.84 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.783 -1.562 . . . . 1.1 106.783 161.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -119.44 140.78 49.87 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.625 -1.62 . . . . 5.31 106.625 164.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 22.25 53.71 0.02 OUTLIER Glycine 0 CA--C 1.531 1.079 0 C-N-CA 128.137 2.779 . . . . 3.46 115.937 -173.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -156.63 138.67 14.49 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.212 -1.033 . . . . 4.16 108.212 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.398 0 C-N-CA 127.315 2.246 . . . . 5.43 108.415 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.375 0 N-CA-C 109.649 -0.5 . . . . 2.91 109.649 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.412 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -166.98 -171.98 1.94 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.249 -1.389 . . . . 8.08 107.249 176.045 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.412 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 4.0 p30 -171.57 44.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 O-C-N 124.629 1.205 . . . . 2.61 109.854 171.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 52.64 -156.54 4.53 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.652 -0.979 . . . . 1.54 110.652 -167.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -64.78 140.67 58.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.82 -0.811 . . . . 5.77 111.462 170.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 93.05 -164.33 27.3 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 125.462 1.506 . . . . 1.34 110.344 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.11 -118.15 9.6 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.834 1.683 . . . . 1.28 111.729 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.27 123.26 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 106.0 -1.852 . . . . 1.89 106.0 175.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.442 HD23 HG21 ' A' ' 210' ' ' THR 0.669 7.3 mp -76.91 -63.95 1.24 Allowed 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.266 -1.383 . . . . 1.55 107.266 168.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -159.16 155.98 28.17 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 113.757 1.021 . . . . 0.8 113.757 -168.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . 0.351 0.0 OUTLIER -103.32 142.44 34.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.544 1.938 . . . . 1.65 110.351 176.005 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -164.43 165.79 21.16 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.628 -1.99 . . . . 0.54 105.628 154.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -151.44 152.36 32.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 104.719 -2.326 . . . . 3.18 104.719 173.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -91.88 -78.97 1.4 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 109.964 -1.255 . . . . 0.73 109.964 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -69.85 176.71 6.47 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.385 2.057 . . . . 2.12 110.089 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 90.12 144.03 11.19 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.86 -1.296 . . . . 1.1 109.86 -172.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.3 p -82.55 -178.73 7.18 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.518 1.127 . . . . 2.11 110.479 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 61.36 -115.37 7.81 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.802 -0.919 . . . . 1.32 110.802 173.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.9 tp -60.21 -40.55 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.419 -0.586 . . . . 1.53 109.419 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -39.35 136.41 1.37 Allowed Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.469 1.033 . . . . 1.01 112.295 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 96.6 -42.17 2.26 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.452 1.025 . . . . 0.74 112.448 -165.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -74.57 171.64 13.47 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.953 1.376 . . . . 1.4 111.749 -159.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -132.55 112.81 12.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.994 -1.484 . . . . 1.65 106.994 -163.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -132.48 101.94 5.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.644 -0.502 . . . . 5.67 109.644 -156.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -104.96 133.53 49.6 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.438 1.017 . . . . 2.5 109.695 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -57.0 105.67 0.24 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.549 -0.908 . . . . 2.75 108.549 171.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -59.39 -33.54 71.33 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.9 0.88 . . . . 2.89 110.925 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.5 -27.15 67.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.51 0.671 . . . . 3.42 109.462 -176.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -68.58 133.62 48.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.705 -1.591 . . . . 2.17 106.705 171.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -98.44 96.01 7.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.957 -1.868 . . . . 7.39 105.957 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 43.8 m95 -75.13 159.98 31.0 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.999 -1.111 . . . . 1.33 107.999 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 211' ' ' ASN . 12.8 p -139.76 139.6 36.51 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.097 0.475 . . . . 2.2 111.454 -173.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.2 t -64.3 -49.34 72.19 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.938 -1.101 . . . . 1.64 111.293 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -81.41 -167.38 1.45 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.938 0.895 . . . . 3.02 109.697 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 20.8 t -56.82 -56.32 23.04 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.869 -0.419 . . . . 4.1 109.869 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 50.43 -94.85 0.01 OUTLIER Glycine 0 C--N 1.34 0.764 0 C-N-CA 124.869 1.224 . . . . 2.27 113.056 171.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -140.01 -75.26 0.05 OUTLIER Glycine 0 CA--C 1.523 0.572 0 N-CA-C 108.926 -1.67 . . . . 1.26 108.926 170.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.442 HG21 HD23 ' A' ' 181' ' ' LEU . 11.5 m -108.25 119.29 39.05 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.447 -1.686 . . . . 1.1 106.447 176.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 204' ' ' THR . 5.3 t-20 -78.5 125.91 30.03 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 120.103 -0.639 . . . . 1.56 109.641 -178.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.34 -52.67 62.72 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 109.115 -0.698 . . . . 1.38 109.115 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -52.93 -42.12 65.12 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.955 0.502 . . . . 2.26 110.277 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.461 HD11 HG22 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -60.9 -60.56 3.6 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.284 -0.885 . . . . 1.63 111.184 179.027 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.343 2.0 m -54.97 -38.91 68.41 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 110.259 -0.274 . . . . 0.7 110.259 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.36 -53.21 60.81 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 118.704 -0.665 . . . . 0.46 110.236 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 97.6 t -53.48 -47.38 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 119.542 1.065 . . . . 0.74 109.864 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.442 ' HE1' ' HA ' ' A' ' 238' ' ' PRO 0.455 5.7 t60 -51.52 -51.44 55.17 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.363 1.065 . . . . 1.9 113.819 170.637 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.99 -48.6 12.02 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.053 1.297 . . . . 2.94 113.809 -173.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.3 -39.92 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 106.66 -1.607 . . . . 1.19 106.66 167.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -47.88 -57.86 7.4 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.451 1.024 . . . . 0.6 113.634 166.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.468 ' NE2' ' NE2' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -50.36 -48.99 55.4 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.449 1.125 . . . . 1.69 110.041 176.118 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 69.4 p -61.75 -19.92 62.97 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 113.55 0.944 . . . . 1.66 113.55 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 258' ' ' ILE . 9.4 mt -66.01 -67.93 0.41 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.713 -1.588 . . . . 2.26 106.713 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 156.62 66.15 0.01 OUTLIER Glycine 0 C--O 1.228 -0.259 0 N-CA-C 108.721 -1.752 . . . . 1.17 108.721 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.69 136.64 53.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.732 1.613 . . . . 4.77 107.035 -174.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -109.83 41.81 2.13 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.239 0.923 . . . . 2.99 111.902 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.468 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 70.1 m80 68.81 110.66 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.874 2.069 . . . . 1.62 113.407 178.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 34.9 m -74.8 160.51 30.6 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.611 -0.885 . . . . 1.26 108.611 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 66.7 m -133.24 47.84 2.45 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.883 1.273 . . . . 2.86 108.957 -170.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -143.59 141.14 18.35 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.782 1.633 . . . . 1.82 106.607 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -91.39 -8.92 3.07 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.197 1.931 . . . . 0.96 114.533 -173.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -82.17 -37.61 25.87 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.134 -0.979 . . . . 1.42 108.372 170.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -53.18 152.07 4.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.585 1.154 . . . . 0.99 111.534 172.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 84.0 t -106.68 -25.9 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.352 1.061 . . . . 0.95 111.289 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 4.5 mtt -60.91 -27.39 68.14 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.161 -0.962 . . . . 3.22 113.43 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.417 ' O ' ' ND1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.34 160.15 0.46 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 127.975 2.51 . . . . 3.41 114.455 -171.28 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.442 ' HA ' ' HE1' ' A' ' 218' ' ' HIS . 59.7 Cg_endo -75.54 -21.23 15.08 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.669 1.579 . . . . 1.01 111.818 175.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.368 0.2 OUTLIER -78.03 178.13 7.75 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.126 0.97 . . . . 1.28 108.976 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -126.25 149.74 48.89 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.915 -1.513 . . . . 2.46 106.915 174.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -153.5 120.28 5.65 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 104.677 -2.342 . . . . 3.29 104.677 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -60.76 122.47 14.87 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.256 -0.646 . . . . 2.36 109.256 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.461 HG22 HD11 ' A' ' 214' ' ' LEU . 15.9 m -125.22 142.37 42.29 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.051 0 CA-C-O 121.056 0.455 . . . . 1.76 110.961 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.09 91.48 0.16 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.384 1.474 . . . . 3.03 108.172 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 2.2 pp -51.7 -29.0 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 123.971 0.909 . . . . 2.96 111.419 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -50.29 -40.15 47.59 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.853 1.261 . . . . 3.62 111.461 174.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 85.7 m -67.7 -45.89 73.82 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.516 0.727 . . . . 1.7 109.982 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.602 ' CD1' HG22 ' A' ' 140' ' ' VAL . 0.5 OUTLIER 50.38 81.78 0.06 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.249 1.02 . . . . 5.13 110.88 177.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.55 158.36 38.32 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.748 -0.834 . . . . 2.98 108.748 167.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 250' ' ' LEU . 1.3 mm? -105.76 160.63 15.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.531 1.532 . . . . 0.79 107.379 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 26.3 m -78.21 152.71 32.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.895 -0.503 . . . . 0.64 110.77 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -54.83 -45.99 74.55 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.882 0.473 . . . . 0.69 110.323 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -50.33 -54.48 21.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.698 0.761 . . . . 2.44 109.924 172.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.77 -47.11 86.99 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.899 -1.046 . . . . 2.18 110.35 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.9 mt -50.93 -49.22 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 125.576 1.551 . . . . 0.97 110.055 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -58.15 -48.87 78.91 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.827 -1.171 . . . . 5.04 110.492 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -56.91 -34.77 66.03 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.514 0.578 . . . . 1.31 112.824 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 224' ' ' LEU . 0.2 OUTLIER -68.83 -49.34 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.622 -1.251 . . . . 3.51 107.622 -178.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -63.59 -23.18 67.28 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.138 -0.977 . . . . 2.75 111.772 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.4 m -47.61 -18.77 0.15 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.291 1.219 . . . . 2.35 114.291 168.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 C--N 1.343 0.324 0 CA-C-N 119.428 1.013 . . . . 2.51 113.319 169.299 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.539 0.546 0 N-CA-C 113.141 0.793 . . . . 7.37 113.141 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.6 m170 69.72 -61.54 0.44 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 127.704 2.401 . . . . 4.41 111.155 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -79.56 108.51 13.15 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.98 1.312 . . . . 3.93 108.199 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.4 mm -132.19 136.49 56.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.606 -1.627 . . . . 3.53 106.606 171.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.4 p -110.58 141.22 44.08 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.194 0.998 . . . . 1.75 109.116 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.456 ' CD2' HG12 ' A' ' 159' ' ' ILE . 5.5 m-85 -126.77 152.15 47.27 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.127 0.971 . . . . 7.54 108.768 -172.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -146.94 143.02 28.17 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.357 -0.608 . . . . 4.67 109.357 178.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 118' ' ' ILE . 2.4 mt -88.36 156.98 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.947 -1.131 . . . . 0.92 107.947 175.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.15 -46.0 6.01 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.532 0.605 . . . . 2.78 109.976 -178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -136.43 -179.8 5.9 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.491 0.716 . . . . 3.85 109.162 173.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -120.98 110.62 16.49 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 105.749 -1.945 . . . . 1.97 105.749 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.95 141.48 96.72 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-N 119.038 0.836 . . . . 2.27 110.282 -173.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -68.36 -14.71 40.82 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.865 3.044 . . . . 1.52 111.377 174.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -41.84 -41.32 2.35 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.695 0.798 . . . . 2.45 110.72 173.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -134.6 -177.39 4.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.587 1.155 . . . . 1.83 109.94 175.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -84.86 156.45 21.29 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.31 0.644 . . . . 3.11 109.821 170.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 57.6 ttt-85 -52.47 -50.06 63.41 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.876 0.695 . . . . 2.93 112.876 -176.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.22 -2.22 15.25 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.598 -0.715 . . . . 4.94 111.84 -176.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -98.71 -45.03 6.18 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.529 1.059 . . . . 1.72 109.95 164.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.43 -47.45 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.546 -0.721 . . . . 2.1 109.367 -172.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.25 -26.44 61.11 Favored 'General case' 0 C--O 1.213 -0.846 0 C-N-CA 118.488 -1.285 . . . . 1.86 108.709 177.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -61.85 -50.68 71.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 119.918 1.235 . . . . 2.35 109.453 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.22 -53.33 55.0 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.031 0.932 . . . . 0.85 109.743 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -69.39 -40.35 79.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.442 0.639 . . . . 1.46 111.075 -175.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -58.06 -52.71 64.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.41 1.484 . . . . 5.0 107.783 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.632 ' O ' HG23 ' A' ' 140' ' ' VAL . 9.7 mmtp -62.94 -51.47 66.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.1 0.96 . . . . 1.43 110.661 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -48.17 -46.03 34.22 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 123.782 0.833 . . . . 1.06 110.869 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 149' ' ' PHE . 0.7 OUTLIER -66.27 -53.83 32.12 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.324 -0.853 . . . . 4.58 110.139 176.068 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -47.38 -40.24 17.1 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.392 1.077 . . . . 2.64 111.934 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.639 HG12 HD21 ' A' ' 250' ' ' LEU . 84.5 t -48.93 -48.75 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 125.195 1.398 . . . . 0.95 109.449 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.896 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 59.3 m95 -80.23 -38.35 31.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.381 0.672 . . . . 0.8 111.497 178.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.5 m -61.99 -24.92 67.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.983 0.811 . . . . 2.54 111.577 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -73.34 -45.16 56.79 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.885 -0.413 . . . . 1.25 109.885 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.418 HG21 HD23 ' A' ' 250' ' ' LEU . 93.4 t -77.62 -49.84 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.227 1.011 . . . . 1.88 110.165 -171.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.445 ' CB ' HD12 ' A' ' 147' ' ' LEU . 81.2 p -79.43 153.94 76.48 Favored Pre-proline 0 N--CA 1.447 -0.618 0 N-CA-C 109.145 -0.687 . . . . 0.82 109.145 175.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.58 4.28 6.51 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.265 1.977 . . . . 0.75 112.55 173.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.75 HD11 HD13 ' A' ' 261' ' ' LEU . 4.6 mt -71.53 125.62 27.54 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.643 1.111 . . . . 1.79 109.658 -170.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -89.68 76.81 7.23 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.14 -1.43 . . . . 3.76 107.14 -169.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 138' ' ' PHE . 1.4 p90 -61.48 156.13 20.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 118.143 -1.423 . . . . 6.24 112.76 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.8 t -154.01 92.97 1.59 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.875 -0.787 . . . . 2.14 108.875 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -79.08 128.12 32.87 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.831 -0.803 . . . . 6.13 108.831 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.8 pp -133.89 148.71 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 105.901 -1.888 . . . . 1.22 105.901 174.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -115.8 6.07 14.27 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 118.079 0.4 . . . . 3.8 111.79 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.9 p -136.4 119.55 16.59 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.828 0.851 . . . . 2.32 108.817 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 121.6 -149.09 17.26 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 107.213 -2.355 . . . . 1.64 107.213 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -114.77 138.0 51.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.233 1.413 . . . . 5.14 107.298 172.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.08 164.27 12.79 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.691 1.196 . . . . 1.0 109.558 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -77.13 -46.66 22.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.829 -1.175 . . . . 2.73 107.829 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.456 HG12 ' CD2' ' A' ' 116' ' ' TYR . 0.7 OUTLIER -107.95 172.62 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 121.486 0.66 . . . . 1.8 111.554 173.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.58 133.67 36.61 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.008 2.123 . . . . 2.0 110.22 170.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.9 t -93.45 107.06 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.589 -1.263 . . . . 0.96 107.589 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 70.6 t -117.2 81.48 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.682 1.193 . . . . 1.81 109.378 -174.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -77.31 149.03 35.36 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.605 -1.628 . . . . 4.8 106.605 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.07 -170.4 3.27 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.266 -1.013 . . . . 1.24 108.266 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.06 141.35 47.15 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.587 0.63 . . . . 6.79 110.127 -178.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 33.25 -111.23 0.06 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.907 2.194 . . . . 1.98 113.72 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.84 112.67 14.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.815 -1.18 . . . . 2.55 107.815 174.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 . . . . . 0 C--O 1.227 -0.098 0 C-N-CA 124.411 1.084 . . . . 4.08 110.876 -177.035 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 113.001 0.741 . . . . 3.22 113.001 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -96.96 174.15 6.92 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.899 0.88 . . . . 6.37 109.832 168.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -137.63 166.57 23.6 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.698 1.999 . . . . 3.62 107.872 176.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -70.92 -156.96 2.18 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.384 0.516 . . . . 2.03 112.891 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -51.91 111.01 0.54 Allowed 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.571 -0.958 . . . . 3.57 111.541 177.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.4 -151.79 17.47 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.474 -1.45 . . . . 2.45 109.474 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.33 -126.32 23.34 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 124.937 1.256 . . . . 2.37 110.372 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 23.1 mm -78.21 124.75 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 107.532 -1.284 . . . . 1.76 107.532 172.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.8 mp -83.48 -31.71 26.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.318 -0.855 . . . . 1.73 110.653 167.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.409 ' HB1' ' CD ' ' A' ' 219' ' ' GLU . . . -171.15 153.28 3.66 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 114.929 1.455 . . . . 0.86 114.929 -177.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -136.3 125.95 25.42 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 126.543 1.937 . . . . 0.88 113.626 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -157.32 162.03 39.11 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 128.168 2.587 . . . . 0.58 104.935 -172.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -149.0 155.33 40.64 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.284 -2.117 . . . . 3.48 105.284 171.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -101.41 -74.65 1.08 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.374 -1.09 . . . . 0.67 110.374 172.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -68.52 174.12 8.83 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.067 1.845 . . . . 1.66 110.204 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 83.12 164.47 36.05 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.198 -1.161 . . . . 1.88 110.198 -170.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.8 p -82.9 179.94 7.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.157 0.983 . . . . 2.75 111.302 -175.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.27 -114.17 6.54 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.363 0.506 . . . . 1.76 111.915 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 191' ' ' ILE 0.255 2.7 tp -60.57 -40.78 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 117.386 -1.293 . . . . 1.78 109.195 -174.6 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -20.77 115.73 0.01 OUTLIER Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.332 1.92 . . . . 1.29 113.56 169.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 109.99 -49.44 0.85 Allowed Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.993 2.235 . . . . 0.76 110.64 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -83.87 164.81 19.23 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.349 1.46 . . . . 2.1 111.216 -168.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.11 131.99 18.07 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.945 1.091 . . . . 0.7 113.945 -172.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -116.55 120.4 38.59 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-O 118.257 -0.878 . . . . 2.53 110.352 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.0 150.57 22.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.975 0.807 . . . . 2.72 111.877 169.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -76.25 93.17 3.37 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.047 0.939 . . . . 2.55 112.064 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -77.76 -8.43 57.97 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 118.061 -0.971 . . . . 2.31 111.632 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -57.36 -47.13 82.42 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 107.751 -1.203 . . . . 3.48 107.751 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . 0.268 9.5 pt-20 -73.49 175.57 6.89 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.922 1.344 . . . . 2.43 111.52 173.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -133.08 85.13 2.19 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.458 -1.682 . . . . 5.33 106.458 -171.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.463 ' CE2' HD23 ' A' ' 212' ' ' LEU . 0.0 OUTLIER -74.15 163.51 27.77 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.105 -1.407 . . . . 2.29 108.286 169.418 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.2 p -145.82 166.35 26.19 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.406 -0.961 . . . . 2.66 108.406 173.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.7 t -49.8 -39.26 37.73 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 121.214 -0.929 . . . . 2.03 111.013 165.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.69 138.98 40.42 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.313 0.645 . . . . 2.88 110.628 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.2 m -63.6 -16.95 62.27 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.485 1.514 . . . . 4.07 112.603 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.96 -66.07 2.98 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.157 0.885 . . . . 2.4 115.131 -167.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -80.27 -89.59 0.51 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.409 -0.676 . . . . 1.3 111.409 -166.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 18.4 m -131.89 170.71 14.5 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 103.179 -2.897 . . . . 1.48 103.179 158.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -130.58 133.52 46.26 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 118.14 0.427 . . . . 1.59 111.009 171.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.463 HD23 ' CE2' ' A' ' 203' ' ' TRP . 3.4 tm? -63.69 -45.87 88.08 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.216 -0.661 . . . . 1.73 109.216 -175.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.21 -47.33 54.81 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 109.499 -0.556 . . . . 1.78 109.499 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.77 -60.45 3.43 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.038 0.935 . . . . 2.91 110.289 -178.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 8.5 m -56.22 -41.9 76.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.961 -0.563 . . . . 1.26 110.549 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.68 -51.63 68.76 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 117.921 -1.038 . . . . 0.46 110.549 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 70.9 t -45.89 -46.64 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 119.669 1.122 . . . . 0.83 110.22 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 1.092 ' NE2' ' NE2' ' A' ' 222' ' ' HIS 0.494 0.3 OUTLIER -64.76 -47.28 78.76 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.627 -0.671 . . . . 2.64 112.443 178.059 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . 0.409 ' CD ' ' HB1' ' A' ' 182' ' ' ALA 0.285 19.5 mm-40 -70.42 -48.59 55.33 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 120.727 -1.233 . . . . 2.93 113.376 -176.268 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.437 HG21 ' HA ' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -51.66 -42.01 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 107.862 -1.162 . . . . 1.64 107.862 171.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -54.86 -55.07 29.58 Favored Glycine 0 CA--C 1.539 1.588 0 N-CA-C 111.595 -0.602 . . . . 0.5 111.595 172.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 1.092 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 18.4 m-70 -50.22 -58.19 6.16 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 117.878 0.839 . . . . 1.27 110.514 177.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.9 t -47.94 -49.67 29.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.963 2.105 . . . . 1.6 110.737 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.67 HD12 HD13 ' A' ' 147' ' ' LEU . 0.3 OUTLIER -65.32 -37.12 86.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 122.962 0.505 . . . . 3.59 110.061 -178.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 143.93 70.45 0.02 OUTLIER Glycine 0 C--N 1.338 0.67 0 N-CA-C 112.001 -0.44 . . . . 1.17 112.001 160.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.892 HD11 HG22 ' A' ' 258' ' ' ILE . 11.1 mt -133.94 155.61 49.62 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.182 0.593 . . . . 3.07 110.312 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -132.19 48.91 0.94 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.823 1.201 . . . . 3.0 110.122 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.489 ' CE1' ' HE2' ' A' ' 222' ' ' HIS . 96.5 m-70 70.04 165.17 0.27 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.778 1.631 . . . . 3.2 112.514 -176.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.3 m -132.71 141.28 48.49 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.089 -1.819 . . . . 1.09 106.089 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 31.5 t -80.34 47.55 0.93 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.004 0.522 . . . . 2.28 111.718 -170.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -154.27 135.56 8.86 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-O 118.472 -0.775 . . . . 2.01 109.775 -171.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.89 -16.77 7.37 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.82 2.347 . . . . 1.89 114.403 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -76.44 -36.6 57.85 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.458 -1.401 . . . . 2.34 109.033 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.98 124.66 17.47 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.325 0.583 . . . . 1.32 109.586 167.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 69.2 t -64.59 -25.22 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.926 -0.768 . . . . 0.94 108.926 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 1.2 mmt -49.0 -23.96 1.34 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.099 1.518 . . . . 2.47 115.099 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -53.91 139.47 52.69 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 119.366 0.985 . . . . 6.27 110.59 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.88 -23.45 62.13 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.274 1.982 . . . . 1.44 112.021 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.361 0.2 OUTLIER -94.52 154.43 17.41 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.606 -0.886 . . . . 2.91 108.606 178.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -72.86 150.03 43.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.617 -0.883 . . . . 2.21 108.617 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -141.75 139.82 32.93 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.33 -0.989 . . . . 3.5 108.33 173.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -76.26 77.7 3.05 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.765 0.826 . . . . 3.6 109.509 -176.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 25.5 m -83.79 103.59 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 116.016 -0.538 . . . . 1.63 109.957 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.26 115.54 3.59 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.872 0.368 . . . . 3.53 110.323 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 8.8 mt -57.45 -24.42 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.268 0.627 . . . . 2.71 109.75 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -41.95 -43.54 3.15 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 124.121 0.968 . . . . 3.78 112.621 168.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 14.0 m -82.65 -47.74 11.72 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.204 0.602 . . . . 2.4 110.053 -177.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.437 ' CE1' HG22 ' A' ' 140' ' ' VAL . 59.7 t80 52.82 69.4 0.7 Allowed 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.256 1.022 . . . . 4.41 110.873 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -157.94 170.12 23.04 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.447 -0.783 . . . . 3.48 110.142 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.639 HD21 HG12 ' A' ' 140' ' ' VAL . 0.8 OUTLIER -109.89 152.4 25.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.972 1.709 . . . . 0.93 107.47 -179.05 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.0 151.35 33.63 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 121.423 -0.798 . . . . 1.06 111.195 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -47.69 -47.2 29.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.669 0.788 . . . . 1.03 110.786 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -57.49 -45.7 84.58 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.444 0.64 . . . . 2.45 110.8 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 258' ' ' ILE . 4.6 t0 -58.26 -50.61 72.97 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.993 -1.003 . . . . 2.36 108.866 177.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.5 mt -55.29 -33.16 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.078 1.751 . . . . 1.18 112.525 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -70.94 -50.79 30.79 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.726 -1.234 . . . . 5.95 109.809 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -46.87 -52.52 11.54 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.366 -0.694 . . . . 0.93 111.366 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.896 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 1.9 pp -63.08 -45.48 98.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.655 0.782 . . . . 2.26 109.711 -176.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -61.47 -30.24 70.47 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 120.815 -1.178 . . . . 2.1 110.947 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.88 -17.56 0.59 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.573 0.953 . . . . 1.79 113.573 172.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . 0.75 HD13 HD11 ' A' ' 147' ' ' LEU . 36.4 mt . . . . . 0 C--N 1.346 0.43 0 CA-C-N 120.026 1.284 . . . . 2.42 113.196 164.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 106.919 -1.511 . . . . 10.51 106.919 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -139.35 -88.41 0.21 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.087 0.955 . . . . 7.79 108.637 173.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -146.12 145.51 30.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.591 1.556 . . . . 3.49 107.761 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 114' ' ' ILE . 0.9 OUTLIER -128.86 96.83 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.32 -0.993 . . . . 2.81 108.32 176.406 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -104.41 140.4 37.97 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.683 1.593 . . . . 1.26 108.963 -174.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -122.79 160.81 25.21 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.115 0.966 . . . . 5.58 111.821 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.407 ' HG3' HD12 ' A' ' 160' ' ' LEU . 15.9 ptt180 -146.46 144.66 29.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.336 1.054 . . . . 8.23 110.012 177.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.476 HD11 ' HD2' ' A' ' 151' ' ' LYS . 5.4 mt -106.0 156.3 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.204 1.402 . . . . 0.94 107.509 175.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.414 HD21 ' HG ' ' A' ' 160' ' ' LEU . 45.7 m-80 -107.04 -44.15 4.46 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.917 0.887 . . . . 3.93 110.54 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -152.2 172.96 15.57 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.499 1.119 . . . . 2.18 107.98 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -127.56 139.57 52.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.136 1.374 . . . . 2.12 107.86 -170.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.8 t -66.3 141.7 97.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.277 -0.638 . . . . 2.45 109.277 172.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -77.77 -16.31 14.69 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.74 2.96 . . . . 1.84 111.088 173.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -44.19 -44.37 7.75 Favored 'General case' 0 C--N 1.345 0.374 0 C-N-CA 124.875 1.27 . . . . 2.58 111.357 -178.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 22.0 mtm -126.28 168.86 13.53 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.919 1.687 . . . . 2.01 107.756 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -65.7 143.27 57.65 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 108.979 -0.748 . . . . 3.2 108.979 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -47.34 -48.21 25.51 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.01 0.823 . . . . 3.93 110.99 174.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -58.44 -18.81 31.4 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.54 -0.743 . . . . 3.14 112.205 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -93.59 -42.2 9.33 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.128 1.771 . . . . 2.06 110.458 173.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.5 t -53.22 -55.47 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 O-C-N 120.603 -1.31 . . . . 1.24 109.48 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -24.88 65.01 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 117.897 -1.521 . . . . 1.86 109.482 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -62.93 -48.89 76.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.399 0.999 . . . . 2.16 109.889 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.478 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -58.97 -48.8 80.25 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 122.403 0.281 . . . . 0.43 110.677 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 220' ' ' ILE . 0.2 OUTLIER -70.27 -37.24 70.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 121.227 0.537 . . . . 1.85 109.933 -179.211 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -55.42 31.48 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.277 1.031 . . . . 2.92 108.496 176.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.598 ' O ' HG23 ' A' ' 140' ' ' VAL . 19.0 mmmt -61.58 -46.64 89.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.397 1.079 . . . . 1.66 109.394 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -48.43 -55.77 9.98 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.364 0.666 . . . . 0.64 110.701 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -55.99 -51.78 66.51 Favored 'General case' 0 N--CA 1.457 -0.104 0 O-C-N 121.806 -0.559 . . . . 4.45 110.394 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.9 -35.27 57.92 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.757 0.651 . . . . 2.14 112.757 -175.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.704 HG12 HD21 ' A' ' 250' ' ' LEU . 91.4 t -56.89 -51.76 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 123.949 0.9 . . . . 0.81 109.862 175.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.453 ' NE1' HG22 ' A' ' 217' ' ' VAL . 95.0 m95 -77.35 -28.08 52.88 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.794 -0.566 . . . . 1.0 109.793 -175.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.34 -31.83 72.51 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.952 0.901 . . . . 1.5 109.744 175.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -66.05 -49.27 68.27 Favored 'General case' 0 C--N 1.341 0.23 0 O-C-N 121.644 -0.66 . . . . 1.27 109.682 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.633 HG21 HD23 ' A' ' 250' ' ' LEU . 64.7 t -70.77 -54.4 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 123.07 0.548 . . . . 1.97 110.408 -176.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.619 ' CG2' HG13 ' A' ' 258' ' ' ILE . 81.5 p -82.5 137.19 45.04 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 109.603 -0.517 . . . . 0.85 109.603 -174.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -68.05 19.79 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.555 2.836 . . . . 1.5 113.88 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.444 HD13 ' HB ' ' A' ' 145' ' ' THR . 2.9 mp -81.06 166.08 21.07 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.774 1.63 . . . . 3.12 108.774 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -124.63 86.13 2.51 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.714 -0.847 . . . . 3.78 108.714 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -74.4 142.32 45.02 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.594 1.158 . . . . 5.86 113.256 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 t -151.9 101.57 2.76 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.017 1.117 . . . . 0.9 114.017 -176.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.476 ' HD2' HD11 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -80.39 126.1 30.76 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 120.157 -1.589 . . . . 2.9 109.963 172.071 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.401 HD11 ' HB2' ' A' ' 157' ' ' ALA . 2.6 pp -125.6 149.35 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.885 -1.524 . . . . 1.3 106.885 174.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -101.73 -15.63 16.91 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.825 0.345 . . . . 2.76 110.557 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 55.1 m -144.4 132.41 21.55 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.405 -2.072 . . . . 2.99 105.405 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 141.5 -155.27 25.17 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 106.882 -2.487 . . . . 1.6 106.882 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.6 mtt -119.99 140.3 51.17 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.533 -2.025 . . . . 4.8 105.533 174.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.401 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -144.26 153.5 42.1 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.026 -1.102 . . . . 0.8 108.026 -176.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.29 -56.69 4.34 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.427 -1.323 . . . . 1.85 107.427 -167.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.1 pt -86.16 -174.66 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 114.82 -1.082 . . . . 1.62 110.541 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.414 ' HG ' HD21 ' A' ' 119' ' ' ASN . 1.1 tp -145.39 134.65 22.92 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.862 2.065 . . . . 2.67 107.689 173.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.7 t -97.04 98.33 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.182 -1.044 . . . . 0.76 108.182 172.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 72.7 t -80.25 129.34 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.804 -1.184 . . . . 1.5 107.804 173.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -111.07 126.55 54.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 104.618 -2.364 . . . . 5.12 104.618 156.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.722 ' HB3' ' CZ ' ' A' ' 174' ' ' PHE . . . -144.2 157.94 44.01 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 109.424 -0.584 . . . . 0.88 109.424 175.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.26 91.31 2.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.851 1.261 . . . . 4.14 109.347 -173.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 115.28 -55.31 0.54 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.759 1.171 . . . . 1.95 111.093 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -152.78 165.73 34.46 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.998 0.919 . . . . 3.02 108.787 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.239 0 N-CA-C 112.642 0.608 . . . . 3.28 112.642 173.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.166 0.031 . . . . 2.47 111.049 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.722 ' CZ ' ' HB3' ' A' ' 164' ' ' ALA . 35.9 m-85 -112.09 174.84 5.69 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.58 1.552 . . . . 6.15 107.646 176.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -179.38 31.99 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.878 0.871 . . . . 2.31 111.536 -174.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 55.01 -155.12 9.11 Favored Glycine 0 CA--C 1.532 1.148 0 O-C-N 120.714 -1.241 . . . . 1.36 111.604 -170.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -69.37 98.36 1.07 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.271 1.028 . . . . 4.11 110.772 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 152.15 -175.21 30.94 Favored Glycine 0 C--O 1.24 0.512 0 N-CA-C 111.308 -0.717 . . . . 1.54 111.308 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 45.53 -118.6 3.09 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 126.834 2.159 . . . . 1.35 111.131 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.9 mm -80.58 129.61 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.723 -1.214 . . . . 1.51 107.723 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.42 -44.88 16.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.209 1.404 . . . . 2.31 109.025 165.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -164.26 149.76 10.5 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 113.062 0.764 . . . . 0.67 113.062 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.457 ' CD2' ' HD1' ' A' ' 196' ' ' HIS . 24.6 p-80 -131.68 115.0 15.47 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.758 1.623 . . . . 1.01 112.469 -174.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -147.43 160.19 42.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.55 2.74 . . . . 0.6 105.476 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -150.45 160.05 44.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.855 -1.535 . . . . 3.56 106.855 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -81.65 -69.07 1.41 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.173 0.892 . . . . 1.23 111.968 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -58.73 132.79 49.98 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.42 2.08 . . . . 2.85 109.215 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -75.69 44.7 1.78 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.639 1.114 . . . . 2.19 112.876 -171.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.3 m -77.38 78.93 3.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.636 -1.246 . . . . 5.33 107.636 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.53 -101.26 0.75 Allowed Glycine 0 C--O 1.244 0.778 0 N-CA-C 110.317 -1.113 . . . . 3.02 110.317 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 2.7 tp -64.41 -39.34 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 121.67 -0.9 . . . . 2.36 109.465 -174.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -45.19 159.01 0.2 Allowed Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.468 1.032 . . . . 2.09 115.459 176.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 85.68 -52.89 4.65 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 109.715 -1.354 . . . . 1.32 109.715 -159.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.01 162.67 27.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.138 1.375 . . . . 1.95 108.418 -172.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -135.14 121.62 20.54 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.528 0.603 . . . . 0.63 112.614 -174.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.457 ' HD1' ' CD2' ' A' ' 183' ' ' HIS . 2.9 m170 -113.92 113.39 24.78 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-O 118.729 -0.653 . . . . 2.16 111.073 -171.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -96.28 144.65 26.26 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.371 0.668 . . . . 2.81 110.572 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -68.67 97.44 0.8 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.454 -0.794 . . . . 2.69 111.158 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -70.57 -30.15 66.78 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 120.978 -1.077 . . . . 2.69 109.834 173.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -46.89 -42.01 16.82 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.261 1.424 . . . . 2.64 109.301 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -74.81 172.13 12.73 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 122.347 1.07 . . . . 1.72 113.07 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -113.64 96.11 5.69 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.712 -1.218 . . . . 3.62 107.712 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.479 ' CH2' HG21 ' A' ' 215' ' ' THR . 18.9 m95 -75.03 151.04 38.76 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.931 -1.137 . . . . 1.2 107.931 172.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 82.4 p -129.92 134.19 47.33 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.407 0.683 . . . . 1.72 109.78 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.6 t -51.57 -43.87 62.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 123.961 0.904 . . . . 1.69 111.314 172.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.25 -157.88 0.34 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.645 1.178 . . . . 2.14 111.63 -178.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.5 m -60.66 -66.59 0.5 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.336 1.055 . . . . 3.77 110.801 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 42.66 -103.81 0.04 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.106 1.336 . . . . 2.47 114.825 174.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -125.98 -71.93 0.19 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.309 0.957 . . . . 1.07 110.984 -173.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.3 m -119.21 168.14 11.17 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 105.556 -2.016 . . . . 1.22 105.556 167.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -123.56 128.99 50.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.156 0.182 . . . . 1.39 111.113 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.478 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.1 tm? -62.33 -48.14 81.12 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 118.699 -0.667 . . . . 2.11 109.495 -177.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -50.52 -43.9 56.06 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.89 0.768 . . . . 1.34 110.426 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 7.4 tt -63.24 -60.35 3.52 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.765 0.826 . . . . 1.24 109.698 -175.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.479 HG21 ' CH2' ' A' ' 203' ' ' TRP 0.338 20.1 m -61.27 -38.01 85.2 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 120.454 -0.498 . . . . 0.66 111.128 179.235 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.09 -60.69 2.83 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 118.199 -0.905 . . . . 0.36 109.48 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.751 ' CG1' HG11 ' A' ' 235' ' ' VAL . 0.3 OUTLIER -51.87 -45.3 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 119.12 0.873 . . . . 1.65 111.061 -173.599 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 236' ' ' MET . 13.0 t60 -52.1 -61.79 2.04 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.236 1.015 . . . . 2.53 112.762 168.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -57.41 -38.43 74.31 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.443 -1.411 . . . . 2.86 112.184 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 134' ' ' ILE . 1.5 mp -67.97 -36.16 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 108.247 -1.02 . . . . 1.23 108.247 -177.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -55.81 -44.07 87.03 Favored Glycine 0 CA--C 1.538 1.486 0 O-C-N 121.808 -0.558 . . . . 0.55 111.747 166.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.451 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 3.2 m-70 -55.35 -50.04 70.68 Favored 'General case' 0 C--N 1.344 0.343 0 O-C-N 122.106 -0.643 . . . . 1.36 109.272 175.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.2 t -44.09 -56.32 4.12 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.204 1.002 . . . . 1.9 112.4 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 224' ' ' LEU . 0.2 OUTLIER -62.16 -55.49 28.24 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 119.101 0.864 . . . . 3.24 108.879 -178.369 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 155.38 37.07 0.02 OUTLIER Glycine 0 C--N 1.337 0.6 0 C-N-CA 120.906 -0.664 . . . . 1.13 114.607 174.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.551 HD13 ' SD ' ' A' ' 236' ' ' MET . 4.3 mt -84.64 113.11 21.04 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.65 1.225 . . . . 3.47 110.695 175.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -74.56 60.62 2.43 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.928 0.775 . . . . 2.3 111.552 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 78.3 m80 60.17 -170.65 0.14 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.099 1.359 . . . . 2.93 112.353 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 58.1 m -148.06 -178.38 6.26 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.813 1.645 . . . . 0.96 108.865 167.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.9 t -139.19 38.72 2.11 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.884 0.874 . . . . 2.06 110.193 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -140.55 143.13 31.51 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.436 -1.69 . . . . 1.67 106.436 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -87.6 -13.58 4.05 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.848 1.698 . . . . 1.02 114.62 -173.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 18.2 mtmt -80.32 -36.83 33.69 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.948 -1.13 . . . . 1.17 107.948 170.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.33 137.27 42.13 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.408 0.623 . . . . 0.72 110.682 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.751 HG11 ' CG1' ' A' ' 217' ' ' VAL . 58.0 t -86.73 -17.04 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 114.751 -1.113 . . . . 0.59 109.886 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.551 ' SD ' HD13 ' A' ' 226' ' ' LEU . 7.9 tpt -76.15 -18.27 59.2 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 114.06 1.133 . . . . 1.71 114.06 -172.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.487 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.86 161.05 0.43 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 126.217 1.807 . . . . 3.01 114.389 176.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.32 -14.39 13.19 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.846 1.698 . . . . 0.95 112.37 172.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.385 0.2 OUTLIER -78.39 168.1 20.32 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.539 -0.911 . . . . 1.14 108.539 176.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -112.48 133.96 54.27 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.315 -1.735 . . . . 2.37 106.315 172.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -134.92 148.35 50.03 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.997 -1.112 . . . . 3.41 107.997 172.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -71.38 79.56 0.75 Allowed 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.778 1.231 . . . . 3.91 109.174 178.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.8 m -76.63 112.76 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.831 -0.803 . . . . 1.77 108.831 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -64.77 118.22 8.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.965 -0.561 . . . . 3.01 110.501 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 33.0 mm -58.98 -21.79 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.877 0.871 . . . . 3.19 111.197 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -55.49 -33.29 63.57 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.373 0.988 . . . . 3.6 111.595 172.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.6 m -80.33 -50.75 9.75 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.751 -0.463 . . . . 2.54 109.751 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.505 ' CZ ' HG22 ' A' ' 140' ' ' VAL . 54.2 t80 46.48 73.99 0.16 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.412 1.485 . . . . 4.41 112.142 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.76 167.91 25.87 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.558 -0.714 . . . . 2.69 109.781 175.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.704 HD21 HG12 ' A' ' 140' ' ' VAL . 0.3 OUTLIER -102.43 141.12 35.78 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 105.693 -1.966 . . . . 1.07 105.693 178.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.28 170.99 14.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.789 -0.449 . . . . 1.09 109.789 -172.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.92 -42.59 85.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.154 -0.618 . . . . 0.85 110.078 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.09 -45.81 89.9 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 110.3 -0.259 . . . . 2.64 110.3 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -56.22 -51.51 67.82 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.259 -1.015 . . . . 2.97 108.259 175.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.408 ' HA ' HG22 ' A' ' 258' ' ' ILE . 57.0 mt -59.3 -31.2 45.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 126.805 2.042 . . . . 0.88 112.663 -175.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -70.33 -58.53 3.65 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.039 -1.038 . . . . 5.58 110.04 172.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.522 ' C ' HD21 ' A' ' 226' ' ' LEU . . . -56.93 -44.2 92.63 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 111.758 -0.537 . . . . 1.1 111.758 -175.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.619 HG13 ' CG2' ' A' ' 145' ' ' THR . 10.2 tp -59.42 -34.77 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.08 0.952 . . . . 3.8 111.816 -176.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -86.41 -26.08 24.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.852 -0.53 . . . . 2.46 110.623 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.7 t -53.32 -18.22 2.35 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 117.851 -1.071 . . . . 1.85 113.064 171.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.4 mm? . . . . . 0 N--CA 1.451 -0.403 0 C-N-CA 125.654 1.582 . . . . 2.85 113.472 166.445 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 tptt . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 110.526 -0.175 . . . . 6.03 110.526 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.0 m80 64.28 -62.23 0.18 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.894 2.078 . . . . 4.58 113.872 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -86.6 101.73 13.5 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.018 1.327 . . . . 3.27 110.06 -172.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.413 HG22 ' CE1' ' A' ' 116' ' ' TYR . 4.7 mm -124.15 109.57 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.539 -0.912 . . . . 1.85 108.539 -178.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.5 p -101.92 146.69 27.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.459 1.104 . . . . 1.24 109.858 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.43 ' CZ ' ' CE1' ' A' ' 138' ' ' PHE . 1.9 m-85 -130.11 159.78 35.75 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 119.194 -0.432 . . . . 5.76 111.045 -176.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -143.08 146.3 33.67 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.769 0.827 . . . . 5.28 109.045 175.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.34 157.54 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.458 -0.942 . . . . 1.16 108.458 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.565 HD22 ' H ' ' A' ' 119' ' ' ASN . 0.1 OUTLIER -91.61 -57.66 2.69 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.502 0.721 . . . . 3.1 109.746 171.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -149.79 171.68 16.35 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 110.168 -0.308 . . . . 1.86 110.168 175.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -105.68 118.08 35.66 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.974 1.31 . . . . 2.75 107.792 -175.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.6 t -71.07 135.7 84.95 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.636 -0.876 . . . . 2.6 108.636 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.03 -19.72 22.7 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.777 2.318 . . . . 1.92 112.548 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.64 -43.49 3.85 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.097 1.759 . . . . 2.59 112.37 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -128.44 -179.89 5.28 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.371 1.468 . . . . 2.72 108.237 175.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -85.26 145.47 27.53 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.358 0.599 . . . . 2.9 110.24 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.9 ttt-85 -49.87 -47.58 51.77 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.635 0.774 . . . . 2.87 111.859 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -62.29 -4.88 2.0 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.012 0.925 . . . . 3.01 112.909 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -101.42 -46.35 5.03 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.104 1.762 . . . . 2.14 110.029 169.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 66.1 t -54.3 -56.37 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 124.569 1.147 . . . . 1.17 109.518 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -26.96 65.83 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 118.182 -1.407 . . . . 1.8 109.678 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -60.09 -50.12 74.95 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 119.613 1.097 . . . . 1.86 110.01 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.65 -54.42 37.94 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 123.409 0.684 . . . . 0.43 110.126 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.1 tp -66.21 -41.03 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.824 0.345 . . . . 2.13 110.926 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -53.91 -60.18 3.66 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.491 1.517 . . . . 3.56 107.635 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -62.36 -46.11 90.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.281 -0.872 . . . . 1.4 110.141 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.05 -52.2 45.57 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.878 0.471 . . . . 0.46 110.721 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.438 ' CZ ' HG13 ' A' ' 220' ' ' ILE . 4.4 m-85 -55.16 -48.52 73.62 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.709 -0.223 . . . . 4.47 110.917 171.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -35.16 61.74 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.573 -0.727 . . . . 1.91 111.861 -178.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.423 HG12 HD21 ' A' ' 250' ' ' LEU . 94.9 t -55.57 -65.04 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.312 0 CA-C-N 119.217 0.917 . . . . 0.9 109.821 177.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.868 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 41.5 m95 -70.66 -33.34 70.85 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.608 -0.886 . . . . 0.88 108.608 -171.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 t -68.51 -13.77 62.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 119.104 -0.474 . . . . 1.13 112.27 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.38 -52.49 7.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.911 -1.144 . . . . 1.05 107.911 177.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.447 HG11 HD23 ' A' ' 250' ' ' LEU . 4.9 m -82.47 -37.85 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.802 -0.636 . . . . 1.8 112.328 -171.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 1.044 HG22 HD13 ' A' ' 258' ' ' ILE . 1.3 p -87.38 150.5 49.2 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 106.235 -1.765 . . . . 1.13 106.235 170.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.66 -0.5 10.7 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.538 1.492 . . . . 1.04 112.459 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.492 HD13 ' HB3' ' A' ' 224' ' ' LEU . 5.6 mt -61.28 117.05 5.12 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 119.245 0.93 . . . . 2.08 108.849 177.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -94.5 105.43 17.39 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.173 0.589 . . . . 4.6 109.518 -172.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -64.98 146.75 54.59 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.339 -0.846 . . . . 7.31 112.329 -177.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.5 t -154.08 96.98 2.01 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.286 0.565 . . . . 0.87 110.704 165.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -79.75 125.97 30.35 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 108.474 -0.936 . . . . 2.07 108.474 172.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.85 155.46 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.678 -1.601 . . . . 1.57 106.678 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -108.58 -9.31 15.34 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.939 0.791 . . . . 3.32 111.919 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 76.8 m -143.04 132.07 22.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.126 1.77 . . . . 2.05 106.67 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.82 -156.79 20.79 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 107.962 -2.055 . . . . 2.38 107.962 -172.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 52.4 mtt -105.12 137.86 42.23 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.94 1.296 . . . . 4.92 108.159 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.74 147.08 50.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.438 1.095 . . . . 1.13 109.015 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -75.19 -50.24 16.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.124 -1.065 . . . . 2.0 108.124 175.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.4 154.11 12.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.447 0.642 . . . . 1.59 110.833 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.09 132.9 54.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.904 -1.147 . . . . 2.52 107.904 169.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.2 t -78.57 135.65 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.023 -1.473 . . . . 1.14 107.023 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 74.1 t -116.49 134.52 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.802 1.183 . . . . 1.33 109.29 172.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -95.97 149.44 21.57 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.668 -1.234 . . . . 7.66 107.668 167.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -159.04 149.04 19.18 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 120.536 -1.353 . . . . 1.28 110.26 170.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -120.25 132.93 55.54 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.604 1.162 . . . . 3.93 108.672 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 54.13 -96.8 0.03 OUTLIER Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.293 0.949 . . . . 2.11 111.833 -167.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -124.68 140.85 52.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.138 1.375 . . . . 2.13 108.852 -169.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.6 p80 . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 121.286 0.565 . . . . 2.59 110.363 177.241 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.312 0 CA-C-O 118.757 -0.64 . . . . 2.45 109.309 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' A' ' 200' ' ' ASP . 26.2 t80 -89.66 161.82 15.91 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.932 0.872 . . . . 7.73 109.413 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.406 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 47.1 p-10 -168.85 26.75 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.682 -1.599 . . . . 3.48 110.613 -157.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 91.6 165.64 39.64 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 111.246 -0.742 . . . . 2.3 111.246 -170.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.432 ' HA ' ' CG ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -62.98 111.69 2.27 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 122.544 -0.386 . . . . 5.38 110.542 166.3 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.8 -164.31 13.59 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.61 -1.396 . . . . 2.08 109.61 -171.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 59.06 -120.03 20.74 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 110.225 -1.15 . . . . 1.98 110.225 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.7 mm -76.57 122.78 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 105.699 -1.963 . . . . 1.72 105.699 168.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.57 -44.4 17.34 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.65 -0.5 . . . . 1.61 109.65 174.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -167.08 168.51 13.63 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.69 -0.631 . . . . 0.58 109.921 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -145.92 108.35 4.45 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.198 0.999 . . . . 1.06 113.377 -172.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -128.19 156.66 42.57 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.937 2.095 . . . . 0.64 107.107 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -145.29 149.15 34.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.024 -1.843 . . . . 2.75 106.024 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.75 -85.44 1.71 Allowed Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.506 -1.038 . . . . 0.69 110.506 174.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.38 86.54 0.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.638 2.892 . . . . 1.24 111.196 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -158.88 164.79 33.87 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 108.165 -1.974 . . . . 1.03 108.165 169.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.9 t -79.92 179.85 7.35 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.378 0.589 . . . . 3.3 109.964 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 43.8 -102.93 0.04 OUTLIER Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.814 1.674 . . . . 1.3 112.574 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.2 tp -60.3 -40.04 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 118.298 -0.858 . . . . 1.42 110.0 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -37.2 134.4 0.89 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.675 1.131 . . . . 1.0 112.85 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 99.7 -47.77 1.29 Allowed Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.829 1.681 . . . . 0.75 111.392 -161.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -88.49 138.93 30.99 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.902 0.881 . . . . 1.28 110.084 -156.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -109.65 119.63 40.0 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.669 0.788 . . . . 0.72 112.663 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . . . . . . . . 0.28 0.0 OUTLIER -111.39 113.25 25.57 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-O 117.575 -1.202 . . . . 2.15 110.783 -171.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -103.03 152.33 21.48 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.42 1.464 . . . . 6.23 112.756 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -64.1 95.58 0.13 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.36 -1.291 . . . . 2.68 108.767 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -56.89 -40.0 75.42 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 125.395 1.478 . . . . 2.3 111.594 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.408 ' HB3' ' CE1' ' A' ' 174' ' ' PHE . 8.2 t70 -66.77 -28.34 68.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.53 1.132 . . . . 3.14 110.731 -178.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.432 ' CG ' ' HA ' ' A' ' 177' ' ' LYS . 5.4 mt-10 -69.85 127.1 31.73 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 107.732 -1.21 . . . . 2.3 107.732 174.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -80.59 78.68 7.31 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.904 -1.147 . . . . 2.7 107.904 -174.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -77.0 103.7 7.08 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.302 1.041 . . . . 2.24 110.562 -172.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.26 166.54 12.88 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.05 1.405 . . . . 2.53 110.72 -174.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.3 t -69.26 -43.44 73.95 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 127.542 2.337 . . . . 1.86 112.371 166.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -82.53 156.88 23.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.374 -0.83 . . . . 2.81 109.698 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.4 m -69.11 -32.99 72.78 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.991 1.717 . . . . 4.53 110.952 -167.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.81 133.77 52.63 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 111.066 -0.813 . . . . 2.98 111.066 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 90.28 -120.29 5.82 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.069 -2.012 . . . . 1.14 108.069 -175.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.45 142.38 50.8 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 108.273 -1.01 . . . . 1.23 108.273 162.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -96.81 121.48 38.72 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.363 0.414 . . . . 1.25 110.584 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.79 -53.42 32.0 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 109.143 -0.688 . . . . 1.45 109.143 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.667 ' O ' HG23 ' A' ' 217' ' ' VAL . 35.9 t80 -47.36 -48.09 25.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.336 0.654 . . . . 1.46 110.637 179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.416 HD22 ' CD1' ' A' ' 240' ' ' TYR . 6.5 tt -60.17 -58.21 9.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.321 -0.4 . . . . 1.36 110.941 -174.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.392 80.4 m -56.37 -43.02 78.78 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.102 0.477 . . . . 1.08 110.22 176.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.61 -55.99 23.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 117.26 -1.352 . . . . 0.4 109.808 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 213' ' ' PHE . 38.9 t -47.95 -45.39 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 121.157 1.799 . . . . 0.86 110.951 -176.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.815 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 0.4 OUTLIER -56.79 -56.49 20.81 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.78 0.659 . . . . 2.75 112.78 170.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -65.76 -44.4 85.98 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 120.406 -1.434 . . . . 3.54 112.737 -176.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.438 HG13 ' CZ ' ' A' ' 138' ' ' PHE . 1.4 mp -49.84 -49.06 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 125.923 1.689 . . . . 1.24 106.96 172.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.505 ' HA2' HD12 ' A' ' 226' ' ' LEU . . . -53.58 -52.46 41.54 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.684 -0.566 . . . . 0.61 111.684 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.815 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 5.0 m-70 -50.25 -51.0 48.28 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 117.763 0.781 . . . . 1.22 110.642 175.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.0 m -57.34 -47.14 82.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.157 0.983 . . . . 2.25 110.951 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.492 ' HB3' HD13 ' A' ' 147' ' ' LEU . 82.1 mt -59.13 -22.6 61.15 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.481 1.112 . . . . 2.71 112.392 174.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 124.54 4.14 7.61 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.557 1.075 . . . . 1.53 112.877 173.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.505 HD12 ' HA2' ' A' ' 221' ' ' GLY . 30.6 mt -80.78 122.34 27.04 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 118.218 1.009 . . . . 3.92 110.849 -169.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -65.24 179.68 8.73 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.468 -0.653 . . . . 3.46 111.468 173.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -77.02 121.31 23.34 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.133 0.573 . . . . 1.58 110.595 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.8 m -76.09 173.95 10.65 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.829 -0.434 . . . . 1.29 109.829 169.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.3 t -140.03 52.22 1.69 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.679 1.192 . . . . 2.55 109.259 -172.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -155.29 140.8 12.54 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 117.739 -1.124 . . . . 1.8 108.436 -173.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -93.85 -3.19 2.96 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.657 2.238 . . . . 1.16 114.978 -175.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -83.7 -33.46 25.14 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.243 -1.536 . . . . 2.01 109.096 165.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.44 ' HB1' ' CG ' ' A' ' 254' ' ' ASP . . . -58.3 156.67 9.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.259 1.024 . . . . 0.9 112.229 171.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 77.7 t -105.39 -19.73 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 114.204 -1.362 . . . . 0.67 110.368 169.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 4.3 tpt -73.47 -9.03 58.26 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.826 1.047 . . . . 1.83 113.826 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.38 167.14 1.34 Allowed Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.906 1.283 . . . . 3.32 113.07 176.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -73.61 -26.24 14.08 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.962 1.775 . . . . 1.62 112.111 170.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.353 0.2 OUTLIER -78.21 -178.89 5.89 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.224 1.81 . . . . 1.52 111.59 -170.039 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.416 ' CD1' HD22 ' A' ' 214' ' ' LEU . 73.9 t80 -113.72 148.62 36.1 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.184 1.793 . . . . 2.1 108.04 175.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -156.48 140.75 16.57 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.398 -1.334 . . . . 3.45 107.398 171.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -66.0 115.8 6.45 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.626 0.77 . . . . 3.34 110.19 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.7 m -135.64 99.9 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 124.099 0.959 . . . . 1.82 110.015 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.0 137.81 57.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.263 0.554 . . . . 4.55 111.639 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.576 HG22 ' CD1' ' A' ' 213' ' ' PHE . 1.2 pt -81.43 35.74 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 113.509 0.929 . . . . 3.53 113.509 -169.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -109.3 -63.1 1.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.033 0.933 . . . . 3.48 109.497 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 61.9 m -63.21 -48.74 77.04 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.228 -0.656 . . . . 1.84 109.228 -176.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 55.36 89.38 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.337 1.055 . . . . 4.82 110.66 176.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.72 143.68 19.83 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.096 -0.705 . . . . 3.11 109.096 170.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.479 HD12 ' CH2' ' A' ' 141' ' ' TRP . 1.5 mm? -83.71 164.3 19.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.676 1.59 . . . . 0.89 107.802 174.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.0 m -78.74 151.38 32.12 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 122.119 -0.363 . . . . 0.7 110.1 174.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.68 -47.26 77.06 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.001 0.52 . . . . 0.85 110.291 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -51.47 -51.57 53.9 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.563 0.745 . . . . 2.5 110.163 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -57.15 -53.05 62.49 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.11 -0.95 . . . . 2.34 109.218 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.1 mt -50.79 -43.44 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.041 1.336 . . . . 0.9 111.259 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -61.43 -50.92 70.86 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.484 -1.385 . . . . 5.73 109.36 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -47.25 -47.19 21.6 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.003 0.811 . . . . 1.34 112.567 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 1.044 HD13 HG22 ' A' ' 145' ' ' THR . 0.5 OUTLIER -70.13 -38.58 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 118.175 0.988 . . . . 2.2 110.413 -174.417 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -61.18 -33.23 73.11 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.68 -0.408 . . . . 2.69 110.244 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.9 m -50.82 -23.03 2.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.934 1.087 . . . . 2.62 113.934 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 8.8 mt . . . . . 0 C--N 1.345 0.373 0 CA-C-N 120.326 1.421 . . . . 2.96 113.028 176.153 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.0 tptt . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 108.862 -0.792 . . . . 6.16 108.862 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 69.29 -64.83 0.32 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.984 2.114 . . . . 3.65 111.873 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -108.25 119.27 39.0 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.548 -1.279 . . . . 3.41 107.548 -176.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.0 mp -134.43 147.4 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 105.405 -2.072 . . . . 2.6 105.405 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.65 142.2 17.61 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 105.06 -2.2 . . . . 2.27 105.06 -173.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -125.67 165.7 18.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.69 1.196 . . . . 4.32 111.148 -174.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -154.85 161.23 41.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.814 -0.809 . . . . 6.5 108.814 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.71 155.0 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.339 -1.356 . . . . 0.79 107.339 174.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -80.71 -51.4 8.72 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.643 -0.502 . . . . 2.83 109.643 173.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -157.14 170.17 23.11 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.483 0.583 . . . . 3.05 111.174 167.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -94.16 126.86 39.65 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.994 1.318 . . . . 2.77 109.773 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.4 ' HB ' ' CE2' ' A' ' 163' ' ' PHE . 11.2 t -70.29 147.45 95.25 Favored Pre-proline 0 N--CA 1.442 -0.853 0 O-C-N 121.933 -0.479 . . . . 2.57 112.29 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -80.34 -16.19 10.93 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 124.678 3.585 . . . . 2.05 111.22 168.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -50.45 -36.6 34.1 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.858 1.663 . . . . 2.16 112.116 -176.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 13.7 mtm -133.61 -177.96 4.78 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.9 1.68 . . . . 1.91 106.949 172.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -78.71 139.74 38.43 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.326 -0.62 . . . . 2.88 109.326 171.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -51.39 -42.45 61.4 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.713 -0.617 . . . . 4.0 112.179 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -65.19 -5.57 7.21 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.662 0.785 . . . . 3.08 112.274 -177.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -94.45 -47.41 6.58 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 126.515 1.926 . . . . 2.21 109.789 166.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.7 t -57.03 -61.72 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 C-N-CA 125.504 1.521 . . . . 1.15 109.454 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -28.06 67.48 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 117.825 -1.55 . . . . 1.7 109.019 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -61.05 -50.99 71.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 118.859 0.754 . . . . 2.91 109.952 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.29 -48.11 77.29 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 122.906 0.483 . . . . 0.56 110.729 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.9 -37.49 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.563 0.697 . . . . 1.55 110.128 -175.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -55.45 33.66 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.872 1.269 . . . . 4.0 107.926 178.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.585 ' O ' HG23 ' A' ' 140' ' ' VAL . 39.6 mmtm -56.33 -51.84 66.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.383 -0.599 . . . . 2.87 109.383 176.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.37 -49.03 46.27 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.625 0.648 . . . . 0.56 112.426 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -61.71 -51.77 67.04 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 121.894 -0.504 . . . . 4.59 109.902 173.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -55.82 -37.95 69.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.652 0.781 . . . . 2.0 110.777 -172.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 136' ' ' LYS . 42.5 t -53.61 -52.21 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.623 1.569 . . . . 0.76 108.844 177.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.404 ' CZ3' HG13 ' A' ' 258' ' ' ILE . 57.2 m95 -74.51 -32.72 62.59 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.997 -0.371 . . . . 0.71 109.997 -177.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.0 m -72.65 -9.2 58.33 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.215 0.45 . . . . 1.81 112.215 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -84.87 -52.39 6.05 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 107.565 -1.272 . . . . 1.16 107.565 175.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.415 HG11 HD23 ' A' ' 250' ' ' LEU . 5.7 m -76.42 -33.62 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 112.289 0.478 . . . . 1.78 112.289 -175.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.449 HG21 HD12 ' A' ' 258' ' ' ILE . 6.8 p -100.74 153.88 37.48 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.384 -0.598 . . . . 0.72 109.384 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.38 9.31 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.326 2.017 . . . . 0.81 112.967 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.4 mp -78.85 112.87 16.44 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.407 1.003 . . . . 2.44 108.862 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -95.61 73.22 3.17 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.701 -0.624 . . . . 3.42 111.676 -163.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -63.82 147.66 51.24 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.488 0.715 . . . . 5.92 112.123 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.9 t -149.68 147.5 28.15 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.576 1.55 . . . . 1.2 107.883 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -97.93 136.29 38.44 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.262 0.625 . . . . 2.04 109.87 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.2 pp -134.84 118.59 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.848 -1.167 . . . . 1.21 107.848 172.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -75.83 -32.24 59.72 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 119.723 -0.791 . . . . 3.33 110.13 172.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.6 m -113.94 95.68 5.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.681 0.792 . . . . 2.22 109.543 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 151.53 -154.24 25.44 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.665 -1.374 . . . . 1.4 109.665 170.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.6 tpt -111.82 136.67 50.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.182 1.393 . . . . 5.45 110.52 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -129.36 163.83 24.91 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.849 1.66 . . . . 0.8 109.363 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.51 -41.12 56.06 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.509 -0.922 . . . . 1.68 108.509 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 33.6 pt -121.97 175.7 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.786 1.234 . . . . 1.19 109.508 -176.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.7 tp -148.62 130.24 14.97 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.2 1.4 . . . . 2.88 108.879 -173.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.7 t -88.19 109.04 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 108.429 -0.952 . . . . 0.88 108.429 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.7 t -88.26 142.05 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.308 -0.997 . . . . 1.45 108.308 168.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.4 ' CE2' ' HB ' ' A' ' 122' ' ' THR . 0.0 OUTLIER -131.64 125.26 31.71 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 104.565 -2.383 . . . . 6.05 104.565 172.332 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.45 ' HB3' ' HE2' ' A' ' 174' ' ' PHE . . . -159.45 161.25 35.46 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.337 -1.727 . . . . 1.31 106.337 -174.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -123.87 152.94 41.79 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.523 -0.917 . . . . 4.13 108.523 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 69.2 -142.5 37.66 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.73 2.11 . . . . 1.63 113.013 172.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.16 129.83 34.86 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.937 -0.764 . . . . 2.25 108.937 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 . . . . . 0 CA--C 1.532 0.286 0 C-N-CA 122.791 0.436 . . . . 3.41 111.315 178.636 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 111.572 0.212 . . . . 2.58 111.572 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.45 ' HE2' ' HB3' ' A' ' 164' ' ' ALA . 31.6 m-85 -125.06 167.1 15.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.52 1.128 . . . . 6.01 108.389 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.4 p30 -140.72 -20.47 0.82 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 115.763 1.764 . . . . 2.95 115.763 -150.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.47 132.91 0.27 Allowed Glycine 0 CA--C 1.534 1.24 0 N-CA-C 110.325 -1.11 . . . . 2.38 110.325 -162.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.9 tttt 56.31 -152.41 0.38 Allowed 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.389 -1.066 . . . . 5.99 110.079 -175.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.8 -107.42 0.01 OUTLIER Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.145 1.355 . . . . 1.56 115.343 -162.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 49.68 -114.59 2.42 Favored Glycine 0 C--N 1.34 0.759 0 CA-C-N 117.963 0.882 . . . . 1.28 111.987 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 10.6 mm -78.96 117.34 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 107.272 -1.381 . . . . 2.31 107.272 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.53 -60.26 2.42 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.318 -1.364 . . . . 1.41 107.318 170.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -164.82 169.69 16.35 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 121.08 -1.013 . . . . 0.74 109.522 -176.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -147.47 124.53 11.4 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 114.307 1.225 . . . . 0.96 114.307 -174.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -151.08 156.6 41.4 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.397 1.879 . . . . 0.55 106.454 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -145.52 160.36 41.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.471 -1.677 . . . . 3.22 106.471 175.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -90.44 -119.45 2.08 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 118.768 -1.018 . . . . 0.66 110.941 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.75 79.35 1.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.678 2.252 . . . . 2.35 110.299 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -141.41 163.43 26.79 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.755 -1.738 . . . . 1.23 108.755 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 p -78.94 169.32 18.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.285 1.034 . . . . 3.34 112.055 -170.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 53.48 -114.3 3.74 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.358 0.98 . . . . 1.61 111.592 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.439 HG12 ' CE1' ' A' ' 196' ' ' HIS . 3.5 tp -62.2 -35.44 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 118.335 -0.84 . . . . 1.69 109.869 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -40.68 141.31 0.94 Allowed Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.42 1.009 . . . . 1.28 113.087 176.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 93.6 -48.2 2.32 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.168 1.366 . . . . 0.73 110.883 -160.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.64 171.06 10.75 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.041 0.937 . . . . 1.24 108.824 -167.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -144.9 122.83 12.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 118.725 -0.655 . . . . 0.57 112.473 -169.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.475 ' N ' ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -115.37 115.56 26.8 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-O 117.696 -1.145 . . . . 2.09 111.076 -171.248 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -92.38 148.51 22.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.752 1.16 . . . . 2.89 110.446 174.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.98 98.52 9.29 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 122.497 1.141 . . . . 3.42 112.017 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -49.93 -33.19 16.73 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 119.852 -1.78 . . . . 2.9 110.389 170.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -36.09 -47.44 0.55 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.981 1.104 . . . . 3.6 113.981 172.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -73.78 156.34 37.93 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 123.252 1.501 . . . . 2.31 111.435 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -92.86 91.53 7.48 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 105.448 -2.056 . . . . 2.67 105.448 167.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -76.81 152.92 35.35 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.172 -1.047 . . . . 1.2 108.172 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 39.1 p -133.7 156.28 48.21 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.533 0.682 . . . . 1.85 110.345 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.3 -44.95 23.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.606 1.562 . . . . 1.69 110.379 170.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -76.66 178.43 6.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.022 1.329 . . . . 2.15 109.224 170.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.32 -60.83 2.86 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.036 1.334 . . . . 3.57 109.66 -172.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 57.1 -95.62 0.04 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.367 0.984 . . . . 2.34 112.563 168.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -135.41 -72.54 0.07 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.252 -1.539 . . . . 1.2 109.252 175.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.8 m -114.28 122.75 47.7 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.839 -1.541 . . . . 0.94 106.839 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -85.65 117.2 24.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.822 -1.177 . . . . 1.6 107.822 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.84 -53.66 14.92 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.271 0.628 . . . . 1.7 110.383 -175.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.475 ' CD1' HG22 ' A' ' 245' ' ' ILE . 30.3 t80 -43.4 -45.36 6.16 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.419 1.088 . . . . 1.71 110.77 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.6 tt -67.25 -57.5 6.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.302 -0.408 . . . . 1.41 110.707 -168.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 m -56.54 -46.55 80.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.453 -0.573 . . . . 1.16 109.453 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.0 -57.93 5.11 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 124.549 1.155 . . . . 0.57 110.69 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 71.0 t -48.27 -41.73 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 119.625 1.102 . . . . 0.7 111.168 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.831 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 0.2 OUTLIER -63.91 -54.48 34.08 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.311 -0.868 . . . . 2.33 112.404 178.161 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.74 -36.96 65.22 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.234 -0.917 . . . . 3.62 111.1 -174.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.7 -42.9 97.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 107.001 -1.481 . . . . 1.52 107.001 173.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -47.05 -54.06 9.99 Favored Glycine 0 CA--C 1.536 1.37 0 O-C-N 121.401 -0.812 . . . . 0.45 111.571 166.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.831 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 9.0 m-70 -50.79 -45.03 59.0 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 121.572 -0.957 . . . . 1.43 111.028 175.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 9.2 t -51.16 -41.17 59.96 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.213 0.605 . . . . 1.67 111.972 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.72 -54.15 40.0 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.245 -0.65 . . . . 2.63 109.245 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 131.54 73.69 0.11 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 111.565 -0.614 . . . . 1.2 111.565 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.648 HD13 ' SD ' ' A' ' 236' ' ' MET . 1.1 mt -124.69 121.48 34.78 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.311 1.044 . . . . 3.44 108.858 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -76.64 56.2 3.4 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.76 0.695 . . . . 2.49 111.985 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 77.4 m80 57.73 -169.53 0.11 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.656 1.182 . . . . 2.45 112.066 -175.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 75.5 m -148.59 -179.82 7.26 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 106.461 -1.681 . . . . 0.95 106.461 165.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 36.9 p -136.77 37.82 2.62 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.43 1.492 . . . . 2.44 109.244 -168.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -139.88 136.49 17.37 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 106.089 -1.819 . . . . 1.67 106.089 -173.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -85.73 -8.06 8.31 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.872 1.715 . . . . 1.04 114.287 -172.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -80.83 -42.95 20.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.929 -1.137 . . . . 1.18 107.929 168.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -55.19 140.74 37.7 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.203 0.525 . . . . 0.72 109.724 174.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 88.2 t -87.04 -23.14 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 108.684 -0.858 . . . . 0.72 108.684 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.648 ' SD ' HD13 ' A' ' 226' ' ' LEU . 0.6 OUTLIER -55.69 -29.5 59.49 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 115.811 1.782 . . . . 1.7 115.811 -177.126 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -50.08 162.48 0.49 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 125.659 1.584 . . . . 3.11 113.696 -172.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.93 -16.43 14.35 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.331 1.354 . . . . 0.95 111.907 170.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.377 0.2 OUTLIER -79.3 -179.7 6.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.167 1.387 . . . . 1.24 109.609 178.171 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -130.39 148.94 52.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 126.394 1.878 . . . . 2.09 106.144 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.66 173.88 13.65 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.768 -1.938 . . . . 2.46 105.768 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -87.75 117.82 26.84 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 119.578 1.081 . . . . 3.67 109.055 174.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.5 m -120.32 125.04 73.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 107.669 -1.234 . . . . 1.53 107.669 170.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -81.21 120.21 24.59 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.223 -0.591 . . . . 4.94 109.756 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.475 HG22 ' CD1' ' A' ' 213' ' ' PHE . 1.1 pp -59.16 -27.81 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.307 -0.406 . . . . 3.53 110.803 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -66.27 -35.01 79.31 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.289 0.495 . . . . 4.01 110.313 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 29.6 m -66.55 -49.75 65.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.535 -0.543 . . . . 1.89 109.535 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.474 ' CD1' HG22 ' A' ' 140' ' ' VAL . 0.4 OUTLIER 51.12 83.21 0.05 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.91 0.862 . . . . 5.06 110.562 179.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.48 158.35 31.78 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.64 -0.663 . . . . 4.06 109.345 169.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.554 ' N ' HD22 ' A' ' 250' ' ' LEU . 1.3 mm? -108.16 157.15 18.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.734 -1.58 . . . . 0.75 106.734 177.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 29.6 m -77.49 151.52 34.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.005 -0.434 . . . . 0.65 110.106 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.41 -45.41 46.18 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.699 0.4 . . . . 0.72 110.086 171.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -59.63 -36.11 75.7 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.588 0.708 . . . . 2.41 111.605 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -71.77 -51.52 22.27 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.709 1.243 . . . . 1.97 108.887 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 41.0 mt -52.79 -49.06 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 126.831 2.052 . . . . 0.94 112.124 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -55.19 -43.36 74.29 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.498 -1.376 . . . . 7.85 110.535 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -55.63 -40.42 78.91 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.045 -1.222 . . . . 0.79 110.045 174.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 258' ' ' ILE . 0.2 OUTLIER -66.91 -45.18 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 C-N-CA 123.257 0.623 . . . . 3.24 111.267 -176.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -63.31 -27.17 69.14 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 119.343 -0.943 . . . . 2.35 110.515 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.29 -15.27 0.91 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.145 1.165 . . . . 1.89 114.145 169.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 76.7 mt . . . . . 0 C--N 1.346 0.447 0 CA-C-N 121.055 1.752 . . . . 2.37 113.192 164.695 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.9 tptt . . . . . 0 CA--C 1.534 0.329 0 N-CA-C 111.861 0.319 . . . . 6.93 111.861 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 74.94 -68.85 0.2 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.902 1.681 . . . . 5.34 111.368 172.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -102.56 113.5 26.93 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 126.199 1.8 . . . . 3.03 109.128 -174.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.436 HG22 ' CE1' ' A' ' 116' ' ' TYR . 1.4 mm -117.76 88.45 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 122.11 0.957 . . . . 2.08 109.33 -173.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 p -87.25 146.19 26.07 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.441 0.696 . . . . 1.31 109.495 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.438 ' CE2' ' CD1' ' A' ' 138' ' ' PHE . 10.5 m-85 -129.92 166.2 20.51 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.728 0.811 . . . . 6.69 110.364 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.564 ' HG3' HD23 ' A' ' 160' ' ' LEU . 9.5 ptt180 -153.51 168.91 24.56 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.335 0.654 . . . . 7.6 110.458 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.2 mt -119.4 148.53 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.265 -1.383 . . . . 1.12 107.265 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.597 ' ND2' HD11 ' A' ' 160' ' ' LEU . 29.9 m-20 -89.55 -67.71 0.82 Allowed 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.961 -1.126 . . . . 4.25 107.961 171.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -138.96 162.0 35.95 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.176 0.806 . . . . 1.97 113.176 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -104.3 154.0 20.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.411 1.884 . . . . 2.35 108.85 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.7 t -85.48 149.78 52.61 Favored Pre-proline 0 N--CA 1.444 -0.74 0 C-N-CA 124.3 1.04 . . . . 2.7 111.68 172.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -86.93 -17.6 3.1 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.155 3.236 . . . . 2.18 111.104 169.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -56.69 -46.84 80.95 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.963 0.905 . . . . 3.88 109.83 -177.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 4.2 mmt -101.49 -169.87 1.75 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.477 1.111 . . . . 3.38 108.037 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -103.28 145.76 29.47 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 108.397 -0.964 . . . . 2.93 108.397 167.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -55.38 -39.98 70.78 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.711 -0.618 . . . . 2.33 111.196 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -64.25 -7.68 10.16 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.706 -0.679 . . . . 3.17 112.302 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -95.67 -50.16 5.06 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.512 1.125 . . . . 3.25 109.259 162.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -50.58 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 118.894 0.77 . . . . 2.35 110.329 -166.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.492 ' HB3' ' NZ ' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -76.19 -19.15 58.68 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 118.066 -1.454 . . . . 1.71 109.776 178.558 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -73.1 -46.17 52.83 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 119.135 0.88 . . . . 2.22 108.736 -175.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.4 -54.24 23.31 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 124.184 0.994 . . . . 0.52 109.619 171.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.82 -48.79 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 121.059 -0.256 . . . . 2.33 110.472 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -50.26 -57.76 7.12 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.178 1.391 . . . . 4.34 108.899 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -64.7 -43.23 94.16 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.191 -0.913 . . . . 2.36 109.485 -176.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.01 -52.73 57.47 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.001 0.52 . . . . 0.45 110.134 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.471 ' CE1' HG13 ' A' ' 220' ' ' ILE . 61.5 m-85 -54.23 -44.84 72.06 Favored 'General case' 0 C--O 1.231 0.111 0 O-C-N 122.182 -0.324 . . . . 4.58 111.007 171.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.34 -37.19 67.13 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.547 -0.739 . . . . 2.0 111.852 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.435 HG12 HD21 ' A' ' 250' ' ' LEU . 62.7 t -55.55 -63.3 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 119.121 0.873 . . . . 0.84 109.571 177.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.906 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 58.7 m95 -70.48 -32.58 70.17 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.964 -0.754 . . . . 0.68 108.964 -171.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.3 t -64.62 -14.12 56.58 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.064 -0.97 . . . . 1.27 112.998 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -82.67 -48.27 11.09 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.036 -1.098 . . . . 1.04 108.036 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.3 m -76.98 -46.37 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 112.282 0.475 . . . . 1.5 112.282 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.712 HG22 HD13 ' A' ' 258' ' ' ILE . 22.9 p -82.81 152.54 66.3 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 108.18 -1.045 . . . . 0.61 108.18 177.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.26 9.07 3.53 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.334 2.023 . . . . 0.7 112.224 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.406 ' HB3' HG13 ' A' ' 114' ' ' ILE . 29.2 mt -67.52 108.79 2.97 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.502 1.046 . . . . 1.75 110.307 -178.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.1 mpmm? -70.94 91.13 0.84 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.463 0.649 . . . . 3.64 109.619 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.94 134.56 57.22 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 127.456 2.303 . . . . 6.42 109.687 168.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.3 t -153.46 106.69 2.96 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.372 -0.233 . . . . 0.77 110.372 163.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.492 ' NZ ' ' HB3' ' A' ' 131' ' ' ASP . 1.8 tmmt? -80.87 130.25 34.95 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.705 -0.85 . . . . 1.96 108.705 173.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.0 pt -128.47 142.2 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.037 -1.468 . . . . 1.35 107.037 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -95.59 -15.62 22.67 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 122.497 -0.127 . . . . 3.12 110.752 -177.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 52.8 m -136.57 130.09 31.85 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 125.096 1.358 . . . . 2.39 107.487 172.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 137.89 -152.87 21.94 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 107.999 -2.04 . . . . 1.6 107.999 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 41.2 mtp -123.73 131.57 53.63 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.892 1.677 . . . . 4.5 106.746 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -136.72 158.74 43.73 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.769 0.828 . . . . 0.89 110.304 -175.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -76.59 -49.11 17.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.706 -0.85 . . . . 1.63 108.706 -167.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.14 171.82 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.358 0.599 . . . . 1.25 110.772 172.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.597 HD11 ' ND2' ' A' ' 119' ' ' ASN . 1.0 OUTLIER -144.59 144.1 31.12 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.917 2.087 . . . . 3.22 109.1 178.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.505 ' N ' HD22 ' A' ' 160' ' ' LEU . 37.3 t -83.02 106.45 13.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 125.153 1.381 . . . . 1.24 109.054 170.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 69.9 t -84.84 118.3 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.215 -1.031 . . . . 1.39 108.215 171.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -80.87 138.79 36.19 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 105.856 -1.905 . . . . 7.49 105.856 160.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -147.14 161.59 40.57 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.564 -1.643 . . . . 1.22 106.564 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.6 ptt85 -155.92 121.36 4.87 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.45 -0.574 . . . . 3.65 109.45 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.465 ' HA2' ' CD1' ' A' ' 174' ' ' PHE . . . 80.4 -52.42 4.34 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.587 -0.605 . . . . 2.69 111.587 175.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -154.03 170.76 20.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.166 0.986 . . . . 2.23 108.489 173.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.1 p80 . . . . . 0 CA--C 1.529 0.152 0 C-N-CA 123.84 0.856 . . . . 2.9 110.123 166.557 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 114.519 1.303 . . . . 3.46 114.519 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.502 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -159.99 -175.77 5.29 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.637 2.375 . . . . 7.93 105.364 -172.122 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.502 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 13.7 p30 177.2 43.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.863 1.265 . . . . 2.37 111.296 169.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 53.16 -158.43 4.16 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.49 -0.644 . . . . 1.45 111.49 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -76.73 119.1 20.05 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.94 -0.63 . . . . 5.21 109.78 -177.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.91 -160.86 13.71 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.118 -1.193 . . . . 1.61 110.118 -168.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.08 -128.52 43.96 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.038 1.304 . . . . 1.47 111.515 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -77.65 134.17 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 125.44 1.496 . . . . 3.05 107.299 178.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.14 -55.67 3.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.681 1.992 . . . . 1.21 109.14 173.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -163.78 162.44 23.83 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.495 -0.753 . . . . 0.67 111.617 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -154.14 105.01 2.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.356 1.462 . . . . 0.96 112.295 -174.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -121.63 158.81 27.81 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.113 2.165 . . . . 0.81 109.651 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -154.74 132.0 11.08 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 107.29 -1.374 . . . . 2.99 107.29 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.12 -89.23 0.51 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.286 0.946 . . . . 1.01 112.836 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.08 83.76 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.943 3.096 . . . . 1.56 111.041 -169.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -160.05 165.31 34.7 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.532 -1.427 . . . . 1.14 109.532 172.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.8 m -78.89 169.99 17.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.468 0.707 . . . . 1.99 111.149 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 55.08 -108.06 0.89 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 123.827 0.727 . . . . 1.45 111.588 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 8.9 tp -59.82 -40.07 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 118.547 -0.739 . . . . 1.63 109.671 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -42.12 143.23 1.17 Allowed Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.399 0.999 . . . . 1.12 113.111 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 94.26 -59.21 1.97 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.908 1.718 . . . . 0.82 109.213 -155.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.38 148.51 31.99 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.898 -0.778 . . . . 1.44 108.898 -155.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -112.24 120.42 41.69 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 118.963 -0.542 . . . . 0.62 110.272 -174.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.497 ' N ' ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -107.15 137.89 44.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.024 -1.473 . . . . 2.42 107.024 -175.74 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -127.69 144.29 51.09 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.172 -1.418 . . . . 2.68 107.172 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -74.26 67.19 1.37 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.783 -1.191 . . . . 2.94 107.783 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -54.5 -45.4 73.25 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.811 -1.181 . . . . 2.62 107.811 -174.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -32.54 -44.25 0.1 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.937 1.695 . . . . 3.84 112.044 -170.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -63.97 -178.44 0.33 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 129.412 3.085 . . . . 2.21 109.399 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -129.06 90.2 2.99 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 120.095 -1.628 . . . . 3.02 108.701 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.445 ' HB2' ' HB ' ' A' ' 210' ' ' THR . 5.7 p-90 -134.67 119.46 18.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.726 0.81 . . . . 3.31 111.32 -173.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 14.9 p -153.62 158.62 41.42 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.822 1.249 . . . . 3.86 111.014 -177.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.66 -47.13 63.9 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.255 1.022 . . . . 4.64 109.874 172.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -67.78 -29.87 69.17 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 114.884 -1.053 . . . . 4.97 110.887 -167.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.0 t -81.64 -44.82 16.65 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.707 -0.849 . . . . 8.67 108.707 174.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.09 -35.56 4.32 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 124.579 1.085 . . . . 3.28 110.649 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -27.17 -92.85 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 128.782 3.087 . . . . 1.08 114.589 -173.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 203' ' ' TRP . 88.5 m -118.66 123.04 43.97 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 104.525 -2.398 . . . . 1.72 104.525 160.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -69.96 120.19 15.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 118.491 -1.284 . . . . 1.37 109.541 172.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 60.8 tp -50.41 -50.75 51.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.827 -0.606 . . . . 1.73 111.693 177.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.537 ' O ' HG23 ' A' ' 217' ' ' VAL . 18.0 t80 -52.24 -49.88 63.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.974 0.806 . . . . 1.38 110.767 176.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.5 tt -57.33 -60.92 2.91 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.994 0.917 . . . . 1.2 110.705 -174.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.351 25.4 m -60.71 -35.98 77.67 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.945 -0.391 . . . . 1.53 109.945 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.59 -52.2 62.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 117.053 -1.451 . . . . 0.48 110.712 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 213' ' ' PHE . 35.1 t -44.93 -53.22 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 121.579 1.991 . . . . 0.89 110.922 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.613 ' NE2' ' NE2' ' A' ' 222' ' ' HIS . 4.0 t60 -56.03 -54.05 49.59 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.854 0.862 . . . . 2.68 111.632 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -71.23 -44.68 64.87 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.797 -1.189 . . . . 4.03 112.45 -173.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.471 HG13 ' CE1' ' A' ' 138' ' ' PHE . 1.7 mp -49.98 -44.79 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.604 1.562 . . . . 1.46 108.265 166.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -53.19 -51.14 48.68 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.546 -0.721 . . . . 0.46 111.82 170.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.613 ' NE2' ' NE2' ' A' ' 218' ' ' HIS . 4.5 m-70 -52.03 -42.41 63.05 Favored 'General case' 0 C--N 1.34 0.173 0 O-C-N 121.429 -1.042 . . . . 1.44 111.492 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.3 m -58.11 -26.61 62.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.797 0.665 . . . . 2.24 112.797 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.4 mt -73.77 -51.96 14.74 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.068 -1.086 . . . . 2.14 108.068 171.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 138.48 70.38 0.05 OUTLIER Glycine 0 C--N 1.34 0.755 0 C-N-CA 122.844 0.259 . . . . 1.25 112.548 170.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.637 ' CD1' HG22 ' A' ' 258' ' ' ILE . 15.6 mt -132.74 105.57 7.25 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.178 0.591 . . . . 3.28 109.771 -172.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -76.75 43.3 1.89 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.338 0.97 . . . . 3.09 113.046 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 22.0 m80 73.88 155.51 0.16 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.356 1.862 . . . . 1.71 111.605 -175.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 58.1 m -120.17 132.0 55.22 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 126.149 1.78 . . . . 1.83 106.321 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 22.6 p -79.64 57.02 2.36 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.398 0.679 . . . . 3.2 110.854 -175.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -156.18 137.8 9.73 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 118.006 -0.997 . . . . 2.2 109.733 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.92 -20.89 7.26 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.76 2.306 . . . . 1.45 114.606 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -27.42 48.91 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 119.258 0.935 . . . . 2.12 109.957 175.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.419 ' HB1' ' CG ' ' A' ' 254' ' ' ASP . . . -65.81 130.65 44.01 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.602 1.161 . . . . 1.08 110.105 168.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 85.8 t -70.94 -25.84 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.899 0.856 . . . . 0.93 110.165 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -53.03 -18.12 1.87 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.95 1.3 . . . . 1.74 114.278 170.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.415 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 10.3 t80 -56.32 137.89 74.92 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 119.738 1.154 . . . . 5.72 110.492 -174.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.415 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 43.4 Cg_endo -63.84 -21.77 69.17 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.88 2.387 . . . . 1.38 112.597 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.359 0.2 OUTLIER -92.05 130.74 37.72 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.279 -0.637 . . . . 2.21 109.279 -179.558 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -76.71 141.67 40.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.638 -0.875 . . . . 2.07 108.638 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.84 131.08 13.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.193 -1.78 . . . . 2.46 106.193 170.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -54.73 115.01 1.93 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.066 0.946 . . . . 3.08 110.599 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.4 m -94.18 138.92 19.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 122.957 0.503 . . . . 1.55 110.726 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.41 89.64 1.25 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.985 -0.746 . . . . 3.9 108.985 173.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 47.1 mt -48.88 -31.25 3.83 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 123.848 0.859 . . . . 2.68 110.335 174.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -39.33 -41.54 0.93 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.438 1.495 . . . . 3.51 113.589 171.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 8.4 m -81.38 -41.58 21.75 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.796 0.838 . . . . 1.9 110.57 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 78.9 t80 46.77 70.63 0.38 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.15 1.38 . . . . 4.68 111.511 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -156.55 167.17 31.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.57 -0.706 . . . . 3.75 109.91 175.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.51 HD12 ' CH2' ' A' ' 141' ' ' TRP . 2.0 mm? -105.9 157.81 17.22 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.727 1.611 . . . . 1.09 108.009 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 10.1 m -79.44 154.31 29.03 Favored 'General case' 0 C--O 1.221 -0.404 0 O-C-N 121.295 -0.878 . . . . 1.03 111.418 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.13 -48.63 75.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.975 0.893 . . . . 1.14 109.862 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.61 -52.37 18.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.192 1.797 . . . . 4.62 108.633 172.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.419 ' CG ' ' HB1' ' A' ' 234' ' ' ALA . 0.7 OUTLIER -63.38 -46.02 88.41 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.978 -1.01 . . . . 2.22 110.516 -176.278 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.4 ' HA ' HG13 ' A' ' 258' ' ' ILE . 45.3 mt -53.12 -42.23 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.725 2.01 . . . . 0.97 110.35 176.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -64.75 -48.82 73.16 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.007 -1.058 . . . . 5.89 111.078 172.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -45.42 -55.5 6.8 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 111.764 -0.535 . . . . 0.82 111.764 174.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.906 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 1.9 pp -65.81 -40.51 87.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 123.982 0.913 . . . . 2.18 111.361 -176.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.569 ' N ' HD12 ' A' ' 258' ' ' ILE . 3.9 mt-30 -62.18 -30.02 70.77 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.741 -1.224 . . . . 2.56 110.849 174.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.8 -14.43 2.34 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.101 1.149 . . . . 1.87 114.101 169.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.3 mt . . . . . 0 CA--C 1.537 0.449 0 CA-C-N 121.02 1.736 . . . . 2.38 112.716 164.926 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 44.4 mtt . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 106.98 -1.489 . . . . 17.38 106.98 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 146.65 65.63 0.01 OUTLIER Glycine 0 CA--C 1.532 1.139 0 O-C-N 124.094 0.871 . . . . 10.98 111.127 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -70.54 133.91 25.19 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.291 1.994 . . . . 11.81 109.703 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.6 p -158.06 150.95 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 108.685 -0.857 . . . . 7.58 108.685 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -175.98 176.04 1.85 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.98 2.112 . . . . 12.72 106.116 177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.27 73.86 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.619 1.967 . . . . 7.52 106.081 -178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.536 ' HG2' HD11 ' A' ' 114' ' ' ILE . 0.1 OUTLIER 58.55 -79.05 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.641 1.176 . . . . 5.81 111.342 -164.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 41.6 m80 56.34 -72.33 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.059 1.743 . . . . 3.52 110.956 -159.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -104.85 101.3 10.9 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.915 0.886 . . . . 3.61 112.315 -169.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.536 HD11 ' HG2' ' A' ' 111' ' ' LYS . 25.8 mm -81.77 91.77 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 108.478 -0.934 . . . . 2.41 108.478 170.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 25.1 p -79.93 125.21 29.45 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 109.137 -0.69 . . . . 1.25 109.137 171.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -130.75 158.47 40.03 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.383 0.673 . . . . 4.33 111.031 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -144.47 145.04 31.66 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.521 -0.918 . . . . 5.2 108.521 175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.99 147.24 5.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 108.143 -1.058 . . . . 1.15 108.143 174.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -84.71 -44.32 13.49 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.455 -0.572 . . . . 3.56 109.455 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -153.25 171.58 18.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.912 -0.773 . . . . 2.25 108.912 174.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -128.13 129.95 47.36 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.876 1.27 . . . . 2.19 108.15 -163.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.5 t -63.47 114.18 12.19 Favored Pre-proline 0 CA--C 1.547 0.858 0 CA-C-N 118.539 0.609 . . . . 2.38 109.739 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -68.41 -17.98 43.96 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.488 2.792 . . . . 1.58 111.125 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -42.22 -34.25 0.74 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.632 2.773 . . . . 2.27 111.61 174.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.51 -179.64 5.57 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.056 1.342 . . . . 1.98 109.418 175.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -71.32 132.38 44.8 Favored 'General case' 0 C--O 1.226 -0.17 0 N-CA-C 109.22 -0.659 . . . . 3.09 109.22 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 53.5 ttt-85 -47.79 -40.41 20.82 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.507 0.558 . . . . 2.15 112.507 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -50.38 -55.33 16.15 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.812 -0.81 . . . . 2.84 108.812 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -55.11 -45.03 75.49 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.937 1.695 . . . . 2.26 111.908 174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -54.63 -57.83 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 O-C-N 121.418 -0.802 . . . . 1.27 109.694 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -27.53 66.61 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 117.919 -1.513 . . . . 1.78 109.184 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -59.72 -47.91 83.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 119.206 0.912 . . . . 1.99 110.383 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.82 -52.56 64.95 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 123.081 0.552 . . . . 0.43 110.508 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.431 HD11 HD11 ' A' ' 220' ' ' ILE . 0.1 OUTLIER -70.05 -37.6 72.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 109.289 -0.634 . . . . 1.5 109.289 -175.281 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -55.34 -60.83 2.85 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.502 1.121 . . . . 4.0 108.021 175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.656 ' O ' HG23 ' A' ' 140' ' ' VAL . 8.3 mmmm -58.0 -45.86 86.16 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.246 1.018 . . . . 1.49 109.445 -176.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.53 -52.66 36.66 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.968 0.907 . . . . 0.63 111.429 175.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.508 ' HB3' ' CD2' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -53.67 -55.48 25.69 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 110.091 -0.337 . . . . 4.56 110.091 170.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -49.55 -44.61 46.71 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.314 1.046 . . . . 3.49 110.497 -171.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 136' ' ' LYS . 45.2 t -47.58 -54.06 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.109 0.964 . . . . 0.71 110.098 178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.848 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 83.8 m95 -72.08 -41.07 67.78 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.283 -0.636 . . . . 0.66 109.283 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.02 -22.76 51.36 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.919 0.888 . . . . 1.1 111.271 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -75.37 -43.63 49.32 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.088 0.955 . . . . 1.57 110.942 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.633 HG21 HD23 ' A' ' 250' ' ' LEU . 65.8 t -84.87 -49.39 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 124.685 1.194 . . . . 1.9 110.825 -173.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.501 HG22 HD13 ' A' ' 258' ' ' ILE . 81.6 p -77.24 158.0 80.09 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 107.976 -1.12 . . . . 0.6 107.976 174.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -75.08 -1.03 10.72 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.75 1.633 . . . . 0.84 112.601 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.948 HD13 HD22 ' A' ' 224' ' ' LEU . 10.4 mt -62.24 139.76 58.49 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.021 0.828 . . . . 1.86 110.263 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.38 97.13 6.14 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.049 -1.093 . . . . 7.34 108.049 177.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.508 ' CD2' ' HB3' ' A' ' 138' ' ' PHE . 0.4 OUTLIER -64.56 153.82 38.03 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.373 0.508 . . . . 6.9 112.373 175.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.57 113.77 3.42 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 123.948 0.899 . . . . 1.11 110.103 176.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.47 139.6 33.86 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.526 -0.916 . . . . 1.99 108.526 173.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.1 pp -139.34 114.28 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.309 -0.997 . . . . 1.36 108.309 172.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -80.15 -15.74 56.42 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.452 -0.34 . . . . 2.66 110.753 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 72.2 p -124.37 89.2 3.03 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 124.585 1.154 . . . . 2.57 110.798 -170.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 145.83 -143.38 11.61 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 108.41 -1.876 . . . . 1.53 108.41 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 33.6 mtt -127.43 131.18 50.28 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.857 2.063 . . . . 4.96 107.751 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -109.94 167.22 10.33 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 125.589 1.556 . . . . 0.78 109.274 -175.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -79.94 -50.59 10.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.761 -0.829 . . . . 2.34 108.761 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 12.3 pt -106.75 169.08 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 CA-C-O 121.454 0.645 . . . . 0.97 109.742 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.64 135.74 35.2 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.929 1.292 . . . . 2.22 109.848 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.8 t -100.75 102.56 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 124.051 0.94 . . . . 0.99 109.476 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 11.3 t -89.17 88.7 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 126.023 1.729 . . . . 1.58 111.341 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -81.78 105.43 12.91 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 107.115 -1.439 . . . . 5.65 107.115 170.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -123.95 151.76 43.24 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 118.415 0.552 . . . . 0.84 109.737 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.56 99.88 6.53 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 124.847 1.259 . . . . 4.07 109.699 -167.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 54.13 43.29 73.66 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 124.426 1.012 . . . . 3.7 111.439 172.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -157.27 176.39 12.76 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.467 0.707 . . . . 4.57 109.895 -170.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 82.01 137.68 0.06 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.522 2.329 . . . . 3.98 110.439 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -72.51 117.74 6.33 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 109.769 -1.332 . . . . 2.65 109.769 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -156.27 -177.14 6.37 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 105.936 -1.876 . . . . 2.93 105.936 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.88 -65.67 0.88 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.276 -1.379 . . . . 5.52 107.276 166.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -107.59 69.9 0.76 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.861 1.265 . . . . 5.29 108.043 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -56.59 -75.77 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 119.254 -0.403 . . . . 2.66 110.838 -172.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -160.52 166.69 28.66 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.13 1.772 . . . . 6.47 106.34 172.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.8 p30 -153.76 168.91 24.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.295 -1.372 . . . . 3.69 107.295 -172.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -66.79 -148.18 0.09 OUTLIER Glycine 0 CA--C 1.533 1.162 0 CA-C-O 122.867 1.26 . . . . 1.61 114.264 -170.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.13 78.78 0.51 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.488 1.515 . . . . 3.91 110.065 -171.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 135.7 -159.23 24.12 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 108.711 -1.756 . . . . 2.12 108.711 -174.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 64.57 -125.03 30.43 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.892 -1.283 . . . . 1.98 109.892 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . 0.276 21.0 mm -77.21 132.32 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 108.67 -0.863 . . . . 1.65 108.67 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.557 HD22 ' H5 ' ' A' ' 269' ' ' NGH . 9.1 mp -85.27 -63.1 1.38 Allowed 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.373 2.269 . . . . 1.19 109.303 168.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.489 ' O ' ' N1 ' ' A' ' 269' ' ' NGH . . . -168.75 152.4 5.48 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 114.385 1.254 . . . . 0.67 114.385 -175.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 36.4 p-80 -151.2 138.82 19.65 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.157 0.983 . . . . 1.27 112.772 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . 0.26 . . -163.51 162.21 24.47 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.479 1.911 . . . . 0.72 106.087 -157.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -149.28 140.74 23.32 Favored 'General case' 0 C--O 1.227 -0.089 0 N-CA-C 109.282 -0.636 . . . . 3.24 109.282 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.94 -87.34 1.77 Allowed Glycine 0 CA--C 1.529 0.915 0 N-CA-C 110.189 -1.164 . . . . 0.62 110.189 173.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -69.92 89.38 0.54 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.72 2.947 . . . . 1.49 110.855 -173.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -165.37 172.12 40.85 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 108.047 -2.021 . . . . 1.27 108.047 171.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.2 p -84.06 172.81 11.65 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.147 0.979 . . . . 2.27 109.782 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.93 -103.54 0.14 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.033 0.825 . . . . 1.4 112.409 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 4.9 tp -59.43 -40.2 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-O 118.371 -0.823 . . . . 1.5 109.282 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -36.1 132.13 0.79 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.632 1.11 . . . . 1.17 113.0 175.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.82 -43.28 1.77 Allowed Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.944 1.735 . . . . 0.88 110.915 -164.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.62 159.97 15.62 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.635 0.774 . . . . 1.46 109.482 -162.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -138.75 125.24 20.57 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 117.96 -1.019 . . . . 0.9 113.392 -168.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -111.83 139.58 47.19 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 119.423 1.01 . . . . 2.27 109.234 -168.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -135.99 148.41 48.42 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 119.177 0.899 . . . . 2.98 110.741 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -73.33 82.2 1.39 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 114.411 -1.268 . . . . 2.38 110.462 -176.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -61.05 -27.1 68.1 Favored 'General case' 0 C--O 1.24 0.557 0 O-C-N 121.205 -0.934 . . . . 3.74 110.833 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.76 -43.4 12.99 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.263 1.425 . . . . 2.66 109.793 172.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -70.89 157.11 38.72 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 123.827 1.775 . . . . 2.01 112.581 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -102.4 87.71 3.09 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 112.727 -2.033 . . . . 5.65 106.698 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 48.6 m95 -75.06 154.34 37.97 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 113.762 -1.563 . . . . 1.17 107.595 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.3 p -136.3 137.64 40.89 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.387 0.613 . . . . 1.63 109.5 -171.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -60.9 -47.04 88.24 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 120.333 -1.479 . . . . 1.93 110.33 173.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -65.61 151.63 46.03 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.588 -0.733 . . . . 2.04 110.37 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.7 m -60.27 -38.33 83.22 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.75 1.22 . . . . 4.44 110.555 -171.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -55.62 120.82 20.43 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-O 118.829 -0.984 . . . . 3.11 111.98 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 109.17 -125.71 7.81 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 108.94 -1.664 . . . . 1.08 108.94 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.2 m -117.07 117.15 28.83 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 106.372 -1.714 . . . . 0.96 106.372 164.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -77.24 122.11 24.61 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 119.523 -0.871 . . . . 1.32 110.742 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 20.3 tp -56.31 -53.65 54.81 Favored 'General case' 0 C--O 1.223 -0.313 0 N-CA-C 109.6 -0.518 . . . . 1.95 109.6 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.552 ' O ' HG23 ' A' ' 217' ' ' VAL . 21.6 t80 -48.54 -46.05 38.35 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.055 0.455 . . . . 1.56 110.135 -178.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.44 ' C ' HD23 ' A' ' 214' ' ' LEU . 6.8 tt -57.37 -65.26 0.66 Allowed 'General case' 0 C--O 1.23 0.07 0 C-N-CA 123.85 0.86 . . . . 1.19 110.223 -177.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.29 0.8 OUTLIER -56.49 -40.09 74.34 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.445 0.641 . . . . 0.83 110.214 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.62 -46.75 77.35 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 117.358 -1.306 . . . . 0.43 110.36 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 213' ' ' PHE . 66.4 t -48.79 -45.65 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 CA-C-N 120.422 1.464 . . . . 0.83 110.803 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.532 ' CE1' ' O ' ' A' ' 236' ' ' MET . 60.1 t60 -64.15 -50.33 68.61 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.933 0.893 . . . . 2.39 112.447 176.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -64.85 -42.92 94.51 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 120.695 -1.253 . . . . 3.07 112.494 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.447 HG21 ' HA ' ' A' ' 138' ' ' PHE . 1.1 mp -55.51 -43.12 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 107.795 -1.187 . . . . 1.1 107.795 172.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.99 -52.0 27.85 Favored Glycine 0 CA--C 1.534 1.238 0 N-CA-C 112.246 -0.341 . . . . 0.68 112.246 169.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.412 ' HE1' ' CE1' ' A' ' 228' ' ' HIS . 20.0 m-70 -49.48 -52.34 29.94 Favored 'General case' 0 C--N 1.341 0.197 0 O-C-N 122.06 -0.67 . . . . 1.71 110.658 173.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 89.2 p -62.84 -45.85 90.68 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.518 0.562 . . . . 1.83 112.518 -173.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.948 HD22 HD13 ' A' ' 147' ' ' LEU . 91.0 mt -56.8 -41.62 78.06 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.647 -0.501 . . . . 2.39 109.647 176.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 118.43 29.11 1.99 Allowed Glycine 0 C--N 1.337 0.626 0 C-N-CA 124.978 1.275 . . . . 1.2 111.491 171.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.593 HD22 HG22 ' A' ' 258' ' ' ILE . 12.1 mt -75.0 143.57 43.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.935 -1.506 . . . . 4.3 106.935 -173.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -72.9 143.8 34.06 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.072 -1.211 . . . . 3.18 110.072 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.412 ' CE1' ' HE1' ' A' ' 222' ' ' HIS . 12.1 m80 -50.92 118.24 3.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.723 0.762 . . . . 1.46 110.088 172.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 64.9 m -78.72 173.15 12.76 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 109.615 -0.513 . . . . 0.95 109.615 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.11 30.23 2.47 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.68 0.792 . . . . 2.31 110.742 -170.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -132.06 133.18 23.63 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 106.898 -1.519 . . . . 1.88 106.898 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.94 -14.4 44.95 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.449 2.099 . . . . 1.02 114.162 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -81.13 -27.79 35.37 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.121 0.968 . . . . 1.4 111.279 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.22 152.64 45.17 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.849 -0.797 . . . . 0.69 108.849 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 66.8 t -99.11 -25.88 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.296 -0.865 . . . . 0.53 109.536 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.532 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 10.8 tpt -65.59 -18.73 65.54 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.157 -0.964 . . . . 2.96 113.073 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.471 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.1 157.34 0.66 Allowed Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 125.719 1.608 . . . . 3.04 113.457 -175.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.54 ' O ' ' H1 ' ' A' ' 269' ' ' NGH . 69.2 Cg_endo -74.93 -20.63 16.86 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.712 1.608 . . . . 1.11 111.453 174.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.371 0.2 OUTLIER -77.38 178.03 7.49 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.512 1.125 . . . . 1.37 109.1 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -126.66 147.64 49.91 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.418 -1.327 . . . . 2.44 107.418 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -150.54 146.47 26.6 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.047 -1.464 . . . . 3.34 107.047 170.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -72.47 83.41 1.1 Allowed 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.24 1.016 . . . . 3.9 108.61 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.7 m -76.71 136.75 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 109.413 -0.588 . . . . 1.59 109.413 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -87.09 117.97 26.18 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.1 -0.5 . . . . 3.09 110.063 -176.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 20.9 mt -60.49 -20.44 20.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 119.223 -0.417 . . . . 2.5 110.222 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -52.35 -36.02 52.57 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.333 0.969 . . . . 3.51 111.83 171.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.0 m -81.54 -47.69 12.77 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 122.756 0.423 . . . . 2.46 110.31 -176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.547 ' CE1' HG22 ' A' ' 140' ' ' VAL . 62.1 t80 45.61 73.33 0.17 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.315 1.446 . . . . 4.36 111.868 177.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.89 168.77 23.98 Favored 'General case' 0 N--CA 1.455 -0.195 0 O-C-N 121.278 -0.889 . . . . 4.76 110.222 177.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.633 HD23 HG21 ' A' ' 144' ' ' VAL . 1.3 mm? -108.86 149.03 29.71 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.762 1.625 . . . . 0.82 108.066 -178.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.9 m -77.44 158.38 30.04 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 121.17 -0.212 . . . . 0.58 111.415 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -58.28 -47.87 82.26 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.728 0.411 . . . . 0.83 110.549 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -55.46 -40.21 71.34 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.039 0.935 . . . . 3.64 110.035 176.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.42 -52.1 59.79 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.789 0.835 . . . . 2.01 109.815 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.424 ' HA ' HG13 ' A' ' 258' ' ' ILE . 48.9 mt -56.11 -42.86 74.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 127.063 2.145 . . . . 0.74 112.271 -176.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -61.71 -42.45 98.96 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 120.177 -1.577 . . . . 7.91 110.383 172.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -54.34 -53.14 39.83 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.285 -1.126 . . . . 0.9 110.285 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.848 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 1.8 pp -63.96 -43.04 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 O-C-N 122.104 -0.645 . . . . 2.25 110.724 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -65.81 -20.14 66.14 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 118.843 0.747 . . . . 2.06 112.368 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 t -52.11 -33.39 39.55 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.633 0.651 . . . . 2.02 110.789 168.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.485 ' CD1' HD23 ' A' ' 226' ' ' LEU . 14.8 mt -71.48 84.52 0.83 Allowed 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 121.594 -0.691 . . . . 3.54 110.196 175.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -47.12 -33.78 5.41 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.5 1.12 . . . . 7.62 111.469 168.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.902 0 N-CA-C 107.411 -2.276 . . . . 9.5 107.411 165.67 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' NGH . . . . . 0.557 ' H5 ' HD22 ' A' ' 181' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 116.923 -1.513 . . . . 12.86 107.358 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -116.69 79.31 0.29 Allowed Glycine 0 CA--C 1.532 1.129 0 CA-C-N 119.901 1.228 . . . . 8.05 112.469 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -74.0 165.29 32.41 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.725 2.284 . . . . 9.29 110.176 173.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.4 p -159.86 157.06 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.224 -1.399 . . . . 5.38 107.224 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 8.9 m0 -78.78 147.05 33.47 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 112.58 0.585 . . . . 10.76 112.58 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.7 tpt85 -52.58 -37.86 58.87 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.552 1.141 . . . . 7.85 113.574 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.29 -57.59 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.592 0.757 . . . . 5.51 110.056 -177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 2.1 m170 63.16 -63.17 0.12 Allowed 'General case' 0 C--N 1.342 0.244 0 C-N-CA 126.462 1.905 . . . . 4.1 113.197 -172.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -79.04 104.11 9.45 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.321 -0.992 . . . . 2.75 108.321 -176.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.415 HG21 ' CE1' ' A' ' 149' ' ' PHE . 9.2 mm -113.36 142.57 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.09 -1.448 . . . . 1.78 107.09 173.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.6 p -135.61 140.67 44.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.66 -0.867 . . . . 1.16 108.66 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -126.73 160.48 30.7 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.645 0.778 . . . . 4.21 111.453 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.52 145.8 31.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.252 1.021 . . . . 4.26 108.994 174.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -94.47 159.82 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.105 -1.443 . . . . 0.83 107.105 173.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.563 ' ND2' ' H ' ' A' ' 163' ' ' PHE . 1.3 p30 -101.84 -38.95 7.61 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.815 0.846 . . . . 2.99 110.385 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -150.78 173.56 14.07 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.077 1.351 . . . . 2.4 107.868 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -113.5 129.54 56.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.058 0.943 . . . . 1.98 109.641 -175.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -41.08 135.48 1.71 Allowed Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.536 1.534 . . . . 3.12 109.64 165.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -84.97 -23.15 2.59 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.44 2.76 . . . . 2.35 110.323 167.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.26 -43.95 33.05 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.74 1.616 . . . . 3.17 111.085 -174.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 7.8 mtm -127.18 173.38 9.77 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.431 1.492 . . . . 2.64 109.435 170.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.423 ' O ' HG13 ' A' ' 130' ' ' VAL . 69.5 m-80 -71.64 152.76 42.59 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.292 0.637 . . . . 3.3 110.498 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 66.6 ttt-85 -44.97 -52.58 8.64 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.915 0.886 . . . . 2.63 112.067 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -64.67 -5.28 5.37 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.492 -0.766 . . . . 2.86 113.061 -177.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -103.63 -41.74 5.86 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.551 1.54 . . . . 2.42 110.56 168.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 126' ' ' ASN . 1.5 m -57.62 -52.69 54.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 O-C-N 121.123 -0.986 . . . . 2.65 110.021 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.36 -24.74 64.83 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 118.41 -1.316 . . . . 1.68 108.449 178.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -63.38 -49.94 71.86 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 120.298 1.408 . . . . 2.11 110.402 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.28 -55.12 27.11 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 123.421 0.688 . . . . 0.39 109.828 175.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.88 -41.75 92.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 120.495 -0.482 . . . . 2.47 110.09 -177.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.6 ttt-85 -57.51 -54.16 49.97 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.906 1.282 . . . . 4.01 108.146 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.634 ' O ' HG23 ' A' ' 140' ' ' VAL . 4.9 mmmp? -60.27 -46.62 89.17 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.886 0.875 . . . . 1.72 109.291 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.72 -53.43 31.47 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.421 0.689 . . . . 0.47 111.238 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.456 ' HA ' HG21 ' A' ' 220' ' ' ILE . 32.0 m-85 -53.84 -50.8 65.4 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.197 0.599 . . . . 4.57 109.969 171.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.57 -38.25 74.52 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 119.166 -0.445 . . . . 2.04 111.313 -173.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.738 HG22 ' CE1' ' A' ' 248' ' ' PHE . 98.4 t -51.04 -58.8 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.332 1.053 . . . . 0.71 109.127 177.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.701 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 45.7 m95 -72.8 -34.68 67.05 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.299 -0.63 . . . . 0.88 109.299 -174.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.9 t -64.2 -27.24 68.93 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.129 0.572 . . . . 1.18 111.652 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -70.31 -46.36 64.39 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 121.573 -0.705 . . . . 1.26 109.56 176.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 46.9 t -77.39 -56.46 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.217 0.607 . . . . 2.01 110.792 -173.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 72.3 p -80.27 157.07 73.52 Favored Pre-proline 0 CA--C 1.53 0.193 0 N-CA-C 108.564 -0.902 . . . . 0.72 108.564 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -77.07 3.01 7.01 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 121.844 1.696 . . . . 1.03 112.869 175.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.8 mt -73.71 100.55 3.42 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.101 0.864 . . . . 1.86 109.928 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -84.61 96.67 9.26 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.096 0.959 . . . . 3.59 109.132 -169.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.415 ' CE1' HG21 ' A' ' 114' ' ' ILE . 41.8 m-85 -79.25 154.79 28.92 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.313 1.045 . . . . 5.58 112.831 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -155.42 138.98 15.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.681 1.192 . . . . 1.02 108.505 171.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.38 142.1 28.0 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 108.476 -0.935 . . . . 2.11 108.476 173.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.2 pt -130.52 115.87 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.397 -1.334 . . . . 1.26 107.397 169.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -80.73 -0.31 37.88 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.421 -0.585 . . . . 2.82 109.421 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 39.3 m -153.18 113.72 4.04 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.599 1.16 . . . . 2.29 108.433 -177.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 138.81 -152.42 22.15 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 107.969 -2.053 . . . . 1.39 107.969 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 9.6 ptt? -127.89 125.13 39.07 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.453 1.901 . . . . 5.28 107.04 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -108.69 166.02 11.11 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.429 1.091 . . . . 0.72 109.557 -173.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -77.97 -41.83 34.85 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.377 -0.971 . . . . 1.88 108.377 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 33.1 pt -124.48 159.93 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 123.924 0.89 . . . . 1.03 111.262 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.6 tt -126.97 128.29 46.16 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.321 1.449 . . . . 1.94 109.947 -177.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 54.8 t -92.93 98.05 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 125.769 1.627 . . . . 0.83 108.097 174.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 48.9 t -80.14 136.02 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.719 -1.215 . . . . 1.41 107.719 170.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.563 ' H ' ' ND2' ' A' ' 119' ' ' ASN . 7.3 m-85 -122.63 112.99 18.64 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 103.577 -2.749 . . . . 5.62 103.577 166.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 168' ' ' HIS . . . -147.65 159.76 43.42 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.4 -0.963 . . . . 0.98 108.4 -174.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -128.79 131.39 47.79 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.027 -1.101 . . . . 4.29 108.027 -172.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 73.77 -113.18 4.1 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 111.062 -0.815 . . . . 1.71 111.062 -176.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -129.32 83.67 2.16 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.251 1.025 . . . . 2.29 110.527 -168.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.418 ' HB3' ' HB1' ' A' ' 164' ' ' ALA . 7.7 p80 -72.9 -40.62 65.39 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.877 0.37 . . . . 3.21 111.97 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 175.56 61.64 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 107.695 -2.162 . . . . 2.87 107.695 -172.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -155.32 -179.04 7.71 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 104.736 -2.32 . . . . 2.64 104.736 175.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -78.28 -64.99 1.04 Allowed 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 107.951 -1.129 . . . . 4.92 107.951 173.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -109.46 -72.41 0.72 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.136 -0.938 . . . . 7.57 109.964 -177.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.415 ' HB1' ' CE1' ' A' ' 183' ' ' HIS . . . 63.44 -68.23 0.09 Allowed 'General case' 0 C--N 1.339 0.11 0 C-N-CA 126.004 1.721 . . . . 2.37 114.703 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -123.72 164.93 18.15 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.103 0.961 . . . . 6.07 109.683 -174.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -168.98 25.36 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.664 -0.698 . . . . 2.36 111.101 -158.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.17 -159.01 41.2 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.25 -1.14 . . . . 1.36 110.25 -171.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.56 104.67 1.32 Allowed 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 122.217 -0.578 . . . . 5.26 110.304 175.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 156.44 -179.01 32.63 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 108.678 -1.769 . . . . 1.91 108.678 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 45.28 -117.94 2.61 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 126.312 1.911 . . . . 1.71 111.123 171.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.3 mm -87.24 132.38 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 108.501 -0.926 . . . . 1.94 108.501 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.639 ' HB2' ' H5 ' ' A' ' 269' ' ' NGH . 6.6 mp -82.43 -42.77 18.13 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.708 1.603 . . . . 1.31 109.537 170.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.531 ' O ' ' N1 ' ' A' ' 269' ' ' NGH . . . -162.77 158.62 23.08 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.495 -0.753 . . . . 0.71 110.423 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.415 ' CE1' ' HB1' ' A' ' 173' ' ' ALA . 28.6 p-80 -138.44 114.63 10.22 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.647 1.179 . . . . 1.34 113.572 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.423 ' HB3' ' HB2' ' A' ' 222' ' ' HIS . . . -132.21 163.76 27.86 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.919 2.088 . . . . 0.64 108.657 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -142.24 153.4 43.93 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.878 -1.527 . . . . 3.14 106.878 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -103.09 -90.35 2.15 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 110.296 -1.122 . . . . 0.69 110.296 172.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.04 82.74 0.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.93 3.086 . . . . 1.58 110.965 -175.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -157.96 159.81 30.26 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 108.933 -1.667 . . . . 1.05 108.933 170.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.8 p -78.85 171.34 15.32 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.862 0.865 . . . . 2.11 110.101 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 54.28 -106.53 0.5 Allowed Glycine 0 C--O 1.244 0.721 0 C-N-CA 123.635 0.636 . . . . 1.48 111.626 174.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.4 tp -59.02 -43.22 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 118.501 -0.761 . . . . 1.56 109.14 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -43.3 135.05 4.96 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.492 1.044 . . . . 1.1 112.74 -177.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 107.0 -43.08 1.76 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.485 1.993 . . . . 0.66 110.751 -165.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.87 171.73 10.61 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.502 1.121 . . . . 1.51 110.957 -165.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.31 121.03 8.07 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.66 0.985 . . . . 0.74 113.66 -168.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -114.92 113.8 24.63 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-O 118.923 -0.56 . . . . 2.63 112.073 -172.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.403 ' HB2' ' CE1' ' A' ' 163' ' ' PHE . 56.5 m-85 -100.34 145.67 27.88 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.203 0.91 . . . . 2.89 112.412 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -73.21 82.66 1.34 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.851 0.834 . . . . 2.79 110.018 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -54.45 -28.96 47.87 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.293 -0.88 . . . . 3.45 111.352 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -54.82 -36.73 65.3 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.79 -0.448 . . . . 3.13 109.79 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.79 146.01 50.02 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 122.374 1.083 . . . . 1.89 109.154 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -92.15 92.25 8.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.357 -1.349 . . . . 2.77 107.357 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -78.01 131.46 37.38 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.443 -1.317 . . . . 1.12 107.443 -178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 41.0 p -116.87 136.09 53.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.428 0.691 . . . . 1.67 109.605 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.1 t -51.13 -49.39 60.89 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.622 1.169 . . . . 1.68 109.717 169.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.39 -179.36 5.69 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.149 0.98 . . . . 2.04 111.541 173.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.2 m -56.75 -56.56 19.89 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.791 1.236 . . . . 3.57 111.461 -173.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 42.97 -105.9 0.07 OUTLIER Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.017 1.294 . . . . 2.48 114.774 169.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -117.93 -63.3 0.31 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.252 0.93 . . . . 1.35 111.348 -172.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.37 164.55 27.18 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 105.193 -2.151 . . . . 1.01 105.193 165.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -116.9 133.24 56.26 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 119.248 0.931 . . . . 1.48 110.967 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 31.4 tp -62.78 -53.58 52.21 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.127 -0.488 . . . . 2.08 109.985 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.435 ' O ' HG23 ' A' ' 217' ' ' VAL . 28.2 t80 -50.87 -42.68 59.14 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.205 0.526 . . . . 1.38 109.852 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.425 HD23 ' H71' ' A' ' 269' ' ' NGH . 4.7 tt -60.02 -63.61 1.24 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.319 0.648 . . . . 1.33 109.656 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.437 HG23 ' H4 ' ' A' ' 269' ' ' NGH 0.315 2.0 m -57.14 -38.43 73.49 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.035 0.445 . . . . 0.77 110.651 179.155 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.76 -56.65 14.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 118.106 -0.95 . . . . 0.34 111.142 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 213' ' ' PHE . 90.1 t -51.27 -39.42 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-N 120.538 1.517 . . . . 0.71 111.291 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.658 ' CE1' ' CE1' ' A' ' 222' ' ' HIS . 0.5 OUTLIER -64.63 -51.4 62.82 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.128 0.971 . . . . 2.65 112.195 174.038 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -68.46 -45.74 71.64 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.069 -1.019 . . . . 2.69 111.965 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.456 HG21 ' HA ' ' A' ' 138' ' ' PHE . 1.5 mp -54.45 -43.99 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 106.616 -1.624 . . . . 1.16 106.616 170.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.2 -53.38 23.73 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 123.695 0.664 . . . . 0.45 113.105 170.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.76 ' CE1' HD21 ' A' ' 226' ' ' LEU . 0.9 OUTLIER -51.25 -42.12 60.82 Favored 'General case' 0 CA--C 1.518 -0.264 0 O-C-N 121.848 -0.795 . . . . 1.58 110.999 174.163 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 8.4 t -51.24 -43.45 61.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 123.602 0.564 . . . . 1.96 112.07 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.517 ' HB3' HD13 ' A' ' 261' ' ' LEU . 0.2 OUTLIER -66.31 -60.09 3.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 119.648 -0.821 . . . . 2.7 109.9 174.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 135.98 92.26 0.35 Allowed Glycine 0 C--N 1.338 0.676 0 N-CA-C 111.805 -0.518 . . . . 1.23 111.805 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.76 HD21 ' CE1' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -99.39 177.61 5.13 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.584 0.587 . . . . 5.74 112.584 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -120.73 20.7 8.67 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 124.724 1.154 . . . . 3.08 112.74 172.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 30.8 m80 56.14 95.69 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.14 1.776 . . . . 2.22 113.08 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.1 m -73.96 171.59 13.17 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 122.873 0.469 . . . . 1.18 110.592 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.7 t -137.25 47.06 2.12 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.186 0.994 . . . . 3.36 109.101 -169.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -148.9 123.62 4.86 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 107.18 -1.415 . . . . 2.14 107.18 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.19 -3.47 13.86 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.191 1.927 . . . . 1.59 114.011 -170.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 22.3 mtmt -82.31 -24.36 34.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.493 1.042 . . . . 1.47 109.943 169.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -82.07 152.6 26.52 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 123.458 0.703 . . . . 0.77 109.632 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 24.0 t -104.52 -21.24 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.246 1.018 . . . . 0.72 111.334 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.44 -18.39 17.92 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.479 -0.763 . . . . 2.92 112.99 168.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.75 157.31 7.91 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 120.915 -1.116 . . . . 3.21 113.353 -176.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.502 ' O ' ' H1 ' ' A' ' 269' ' ' NGH . 72.9 Cg_endo -79.53 -16.98 11.58 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.371 2.047 . . . . 0.9 111.791 173.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.355 0.2 OUTLIER -78.49 172.9 12.98 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.963 1.305 . . . . 1.16 109.697 -178.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -119.68 142.6 48.33 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.286 1.435 . . . . 2.21 107.265 173.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -156.08 125.73 6.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.422 -1.325 . . . . 3.55 107.422 170.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -45.52 142.13 2.42 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.063 1.345 . . . . 2.35 112.087 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.0 139.38 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 124.115 0.966 . . . . 2.2 109.363 174.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.5 -41.11 96.8 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.111 0.964 . . . . 3.91 111.431 171.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 6.1 mt 66.29 18.78 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.623 1.569 . . . . 2.53 110.142 -160.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -71.05 -64.09 0.97 Allowed 'General case' 0 C--N 1.343 0.304 0 O-C-N 120.937 -1.102 . . . . 3.26 109.865 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 7.4 m -71.94 -39.73 69.22 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.496 -0.775 . . . . 1.85 109.558 -176.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.738 ' CE1' HG22 ' A' ' 140' ' ' VAL . 1.0 OUTLIER 53.05 71.91 0.46 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 122.336 1.065 . . . . 4.71 109.411 176.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -151.36 165.0 35.42 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.433 -0.951 . . . . 3.34 108.433 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.602 HD12 ' CH2' ' A' ' 141' ' ' TRP . 1.9 mm? -95.42 174.19 7.14 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.419 1.488 . . . . 0.89 108.591 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.5 m -91.15 150.73 21.26 Favored 'General case' 0 C--O 1.222 -0.393 0 O-C-N 120.95 -1.094 . . . . 0.83 112.217 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.78 -43.37 65.8 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 109.51 -0.552 . . . . 0.78 109.51 174.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -57.59 -51.6 68.83 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.954 0.883 . . . . 2.28 110.383 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -57.6 -47.28 82.6 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 114.572 -1.194 . . . . 2.07 110.188 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 52.6 mt -52.03 -36.79 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.371 1.868 . . . . 0.73 111.329 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 36.7 mtt85 -70.43 -49.06 52.7 Favored 'General case' 0 C--O 1.232 0.138 0 O-C-N 120.945 -1.097 . . . . 4.89 110.177 172.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -45.09 -56.86 5.8 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 123.708 0.67 . . . . 0.93 111.649 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.701 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 2.3 pp -63.87 -46.95 92.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.134 0.974 . . . . 2.13 110.434 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.51 ' N ' HD12 ' A' ' 258' ' ' ILE . 1.6 mm-40 -59.69 -26.6 65.72 Favored 'General case' 0 C--N 1.343 0.303 0 O-C-N 120.641 -1.287 . . . . 2.18 111.647 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.0 t -49.33 -26.46 3.13 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.652 0.612 . . . . 1.92 112.652 174.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.517 HD13 ' HB3' ' A' ' 224' ' ' LEU . 16.5 mt -65.06 -38.42 90.76 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.441 0.697 . . . . 2.59 111.867 175.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 3.3 t80 59.11 -166.59 0.17 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.222 1.409 . . . . 9.51 112.469 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.206 0 CA-C-O 115.82 -2.655 . . . . 9.73 111.294 -175.302 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' NGH . . . . . 0.653 ' N1 ' ' CE1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 20.9 ptt? . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 118.927 -0.559 . . . . 13.54 110.897 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -136.58 72.36 0.46 Allowed Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.206 -1.158 . . . . 10.96 110.206 177.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.41 148.52 23.69 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.713 2.276 . . . . 10.14 110.065 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.448 HG11 ' CE1' ' A' ' 112' ' ' HIS . 7.9 p -76.29 -54.48 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 123.375 0.67 . . . . 9.02 110.99 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -169.47 -176.47 2.48 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.06 0.944 . . . . 13.62 109.711 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.4 tpt85 -69.56 70.62 0.3 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.301 1.84 . . . . 14.45 110.322 -176.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.24 -179.88 0.19 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.16 0.984 . . . . 12.04 110.251 -167.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.448 ' CE1' HG11 ' A' ' 108' ' ' VAL . 57.6 m-70 -104.14 19.64 19.75 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.369 1.468 . . . . 4.86 111.084 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -85.45 78.47 9.7 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 109.371 -0.603 . . . . 3.1 109.371 -172.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.528 HG21 ' CE2' ' A' ' 149' ' ' PHE . 20.3 mm -88.03 82.16 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-O 122.728 1.252 . . . . 1.72 108.327 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.9 p -77.77 126.68 31.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.91 -1.515 . . . . 1.34 106.91 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.42 ' CE1' ' CD2' ' A' ' 138' ' ' PHE . 41.7 p90 -128.19 167.14 17.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.855 0.862 . . . . 4.12 110.67 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -156.24 177.2 11.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.09 0.471 . . . . 4.67 111.076 168.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -98.29 168.36 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.953 1.301 . . . . 1.13 108.199 174.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -95.14 -51.89 4.44 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.736 0.814 . . . . 4.24 109.587 169.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.83 153.8 30.33 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.912 0.485 . . . . 2.6 111.638 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -78.31 108.0 11.33 Favored 'General case' 0 CA--C 1.53 0.212 0 N-CA-C 108.369 -0.975 . . . . 2.71 108.369 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.9 t -60.17 146.82 82.46 Favored Pre-proline 0 N--CA 1.441 -0.887 0 CA-C-N 118.655 0.662 . . . . 2.17 110.575 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.39 -15.97 24.79 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.444 2.763 . . . . 1.56 111.356 170.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -47.29 -42.62 21.33 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.829 0.852 . . . . 2.5 111.452 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 5.3 mtm -130.3 175.58 8.82 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.635 1.174 . . . . 2.13 108.206 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -75.97 144.8 40.77 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.751 -0.463 . . . . 2.98 109.751 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -45.76 -53.87 8.83 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.486 0.715 . . . . 2.51 112.451 -177.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -48.54 -38.94 21.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.402 0.681 . . . . 4.12 109.272 -174.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -82.4 -43.09 17.78 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 126.328 1.851 . . . . 2.04 113.183 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.3 t -50.15 -55.05 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 O-C-N 120.789 -1.194 . . . . 1.23 109.051 176.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.412 ' OD2' ' NZ ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -71.98 -19.73 61.83 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 119.161 -1.016 . . . . 1.79 109.991 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -64.34 -52.62 57.46 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 119.734 1.152 . . . . 2.07 109.133 176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -51.9 -53.1 44.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 122.998 0.519 . . . . 0.36 110.33 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -66.2 -46.73 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 109.769 -0.456 . . . . 2.31 109.769 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -50.77 -55.37 17.05 Favored 'General case' 0 C--N 1.339 0.118 0 C-N-CA 124.365 1.066 . . . . 4.27 108.428 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.0 mmmt -63.03 -48.89 76.82 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.624 1.169 . . . . 1.51 109.292 -177.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.573 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -45.89 -55.74 6.32 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.145 0.578 . . . . 0.61 111.681 175.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.42 ' CD2' ' CE1' ' A' ' 116' ' ' TYR . 52.8 m-85 -57.54 -48.99 77.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 116.256 -0.429 . . . . 4.63 110.657 173.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.7 -32.87 65.9 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 113.069 0.766 . . . . 2.11 113.069 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.55 ' CG1' HD21 ' A' ' 250' ' ' LEU . 85.4 t -63.58 -57.04 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 119.425 1.011 . . . . 0.74 108.518 176.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.79 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 16.9 m95 -68.46 -36.72 79.38 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.039 -0.726 . . . . 0.83 109.039 -172.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.6 t -67.6 -13.09 61.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 118.882 -0.58 . . . . 1.25 112.291 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.17 -54.94 4.47 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 107.946 -1.131 . . . . 1.19 107.946 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.512 HG11 HD23 ' A' ' 250' ' ' LEU . 17.6 m -74.1 -40.88 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 116.105 -0.498 . . . . 1.54 111.785 -176.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.95 HG22 HD13 ' A' ' 258' ' ' ILE . 3.1 p -87.06 142.68 34.02 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 107.671 -1.233 . . . . 0.75 107.671 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.53 4.95 3.09 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.835 2.356 . . . . 0.66 113.546 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.4 130.43 42.86 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.84 1.256 . . . . 2.22 107.818 175.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -97.25 108.34 21.04 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.335 -0.987 . . . . 4.31 108.335 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.528 ' CE2' HG21 ' A' ' 114' ' ' ILE . 52.1 m-85 -87.11 142.1 28.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.039 -0.528 . . . . 5.69 111.073 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -142.91 117.79 9.95 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.698 0.799 . . . . 0.97 110.136 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.412 ' NZ ' ' OD2' ' A' ' 131' ' ' ASP . 20.6 ttpt -78.5 142.75 37.2 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 108.089 -1.078 . . . . 2.42 108.089 172.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.9 pt -134.56 144.04 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 N-CA-C 105.519 -2.03 . . . . 1.27 105.519 166.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.07 -61.83 1.64 Allowed 'General case' 0 CA--C 1.522 -0.101 0 N-CA-C 107.029 -1.471 . . . . 3.44 107.029 168.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 12.4 m -86.67 101.09 12.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.493 0.717 . . . . 2.34 110.129 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 153.88 153.4 6.4 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 107.323 -2.311 . . . . 2.35 107.323 173.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.5 ttt -79.37 143.28 35.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.302 -1.37 . . . . 7.36 107.302 168.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -127.65 165.44 19.98 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.682 1.193 . . . . 1.25 108.404 -173.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -69.21 -58.21 4.35 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.863 0.839 . . . . 1.94 109.359 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.2 pt -105.75 134.49 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 108.14 -1.059 . . . . 1.68 108.14 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . 0.358 0.0 OUTLIER -128.76 132.44 47.91 Favored 'General case' 0 C--N 1.332 -0.194 0 O-C-N 121.411 -0.806 . . . . 2.8 109.424 -179.159 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 18.9 t -82.67 106.1 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 108.677 -0.86 . . . . 1.05 108.677 -175.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.66 ' HB ' ' HD2' ' A' ' 196' ' ' HIS 0.417 7.8 t -95.22 94.87 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.411 1.084 . . . . 1.63 112.831 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -79.51 115.47 19.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.555 -2.017 . . . . 5.4 105.555 167.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -139.57 164.73 29.13 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.294 -1.743 . . . . 0.95 106.294 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -132.02 142.6 49.62 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.865 -0.791 . . . . 5.12 108.865 -170.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 73.47 -86.1 0.62 Allowed Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.415 1.007 . . . . 1.97 111.243 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -150.34 145.15 25.95 Favored 'General case' 0 C--N 1.332 -0.163 0 O-C-N 121.581 -0.952 . . . . 2.22 108.661 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -155.32 54.59 0.63 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.648 0.737 . . . . 2.92 111.05 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 107.95 -42.73 1.86 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.94 -0.864 . . . . 2.79 110.94 177.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.571 ' HB2' ' HB2' ' A' ' 173' ' ' ALA . 0.0 OUTLIER -75.41 159.22 31.64 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.685 -1.228 . . . . 2.34 107.685 174.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -80.26 -66.75 0.84 Allowed 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.632 -0.877 . . . . 5.09 108.632 -171.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -111.5 71.94 0.76 Allowed 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.25 1.02 . . . . 4.26 110.08 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.571 ' HB2' ' HB2' ' A' ' 170' ' ' ASP . . . -88.8 -72.53 0.54 Allowed 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 123.596 0.758 . . . . 2.34 111.772 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -118.25 172.35 7.5 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 107.82 -1.178 . . . . 6.08 107.82 -172.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -178.56 28.12 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.814 0.301 . . . . 2.71 111.814 -161.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 60.07 -155.16 31.45 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 119.015 -1.564 . . . . 1.61 110.261 -160.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -79.52 106.81 11.82 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.322 0.649 . . . . 4.57 110.738 -175.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 148.33 -168.65 29.02 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 108.45 -1.86 . . . . 2.27 108.45 -168.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.68 -112.23 2.64 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 125.83 1.681 . . . . 2.18 109.911 172.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.757 HG23 ' C14' ' A' ' 269' ' ' NGH 0.571 4.0 mm -109.07 149.27 12.37 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.565 -0.902 . . . . 1.55 108.565 173.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.886 ' H ' ' H91' ' A' ' 269' ' ' NGH 0.276 4.4 mp -81.68 -59.02 2.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.74 2.016 . . . . 1.27 108.402 170.406 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 1.02 ' H ' ' C13' ' A' ' 269' ' ' NGH . . . -162.87 153.92 17.2 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-O 122.251 1.024 . . . . 0.63 113.291 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -143.88 132.44 22.3 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 114.522 1.304 . . . . 1.09 114.522 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -160.49 162.27 33.05 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.655 1.982 . . . . 0.52 106.144 -164.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -157.97 156.21 30.8 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 107.631 -1.248 . . . . 3.4 107.631 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.33 -88.93 1.75 Allowed Glycine 0 CA--C 1.532 1.137 0 CA-C-O 119.186 -0.786 . . . . 0.56 111.206 173.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -70.22 82.82 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.828 3.019 . . . . 1.38 111.547 -171.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -159.03 161.67 32.12 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.051 -1.62 . . . . 1.03 109.051 170.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 13.9 m -78.51 167.2 21.63 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.077 0.465 . . . . 2.12 110.461 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 55.07 -106.32 0.52 Allowed Glycine 0 CA--C 1.529 0.906 0 C-N-CA 123.826 0.727 . . . . 1.43 112.059 174.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.8 tp -63.54 -27.58 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.158 0.983 . . . . 1.51 110.705 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -54.19 148.61 19.26 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 110.452 -1.059 . . . . 0.93 110.452 172.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 87.92 -45.16 3.29 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.932 1.253 . . . . 0.55 110.733 -163.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -84.08 171.74 12.62 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 121.681 -0.894 . . . . 1.25 109.843 -161.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -142.93 120.49 11.75 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 119.236 -0.411 . . . . 0.69 112.058 -175.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.66 ' HD2' ' HB ' ' A' ' 162' ' ' VAL . 14.5 m80 -109.34 133.83 52.57 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 118.413 -0.803 . . . . 2.46 109.591 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -120.75 148.69 43.63 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.301 0.5 . . . . 3.09 109.829 177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -67.24 89.73 0.2 Allowed 'General case' 0 N--CA 1.44 -0.965 0 O-C-N 124.658 1.224 . . . . 2.7 109.533 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -66.64 -26.9 67.28 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.18 -0.95 . . . . 2.95 109.499 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.39 -42.41 21.84 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.948 0.899 . . . . 3.35 109.404 171.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -73.57 170.37 15.33 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 122.582 1.182 . . . . 1.69 112.272 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -117.62 91.19 3.5 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.779 -1.563 . . . . 3.1 106.779 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -75.81 158.33 32.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.634 -0.712 . . . . 1.07 109.438 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 75.3 p -138.57 144.43 39.85 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.608 -0.515 . . . . 1.58 109.608 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 13.7 t -61.23 -43.52 98.74 Favored 'General case' 0 N--CA 1.433 -1.316 0 C-N-CA 125.913 1.685 . . . . 1.8 113.871 169.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.88 174.68 10.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.9 -0.778 . . . . 2.08 108.9 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.7 m -43.63 -57.33 3.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.214 1.806 . . . . 3.83 109.997 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 51.09 -88.38 0.01 OUTLIER Glycine 0 CA--C 1.526 0.765 0 C-N-CA 125.375 1.464 . . . . 2.18 113.338 167.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -147.07 -69.51 0.01 OUTLIER Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.912 -1.675 . . . . 1.77 108.912 168.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.463 HG21 HD23 ' A' ' 181' ' ' LEU . 2.4 m -105.85 97.42 7.24 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.5 -1.667 . . . . 0.98 106.5 175.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.16 109.31 3.49 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.343 -1.354 . . . . 3.11 107.343 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 29.2 tp -47.62 -54.54 11.61 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 120.327 1.421 . . . . 1.76 111.853 -166.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.602 ' O ' HG23 ' A' ' 217' ' ' VAL . 1.8 t80 -40.34 -43.69 1.8 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.956 1.302 . . . . 2.21 111.202 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.603 HD23 ' H71' ' A' ' 269' ' ' NGH . 0.2 OUTLIER -61.23 -64.05 1.08 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.281 0.632 . . . . 2.01 111.259 -176.094 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.291 1.2 m -56.94 -40.84 77.13 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.995 -0.372 . . . . 0.87 109.995 177.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.6 -49.88 64.17 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 118.58 -0.724 . . . . 0.43 111.312 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 213' ' ' PHE . 61.4 t -54.83 -41.49 57.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 119.567 1.076 . . . . 0.82 110.973 178.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.521 ' CD2' ' O4 ' ' A' ' 269' ' ' NGH 0.449 2.7 t-160 -63.53 -49.47 73.38 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.234 0.614 . . . . 2.2 111.535 176.46 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.09 -48.11 72.01 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.897 -1.127 . . . . 3.65 111.531 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.7 mp -59.36 -39.55 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 107.561 -1.274 . . . . 1.33 107.561 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.49 -55.78 6.72 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.552 1.073 . . . . 0.53 111.673 165.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -51.89 -47.73 64.42 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.715 -0.873 . . . . 1.37 110.698 174.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 67.9 m -54.17 -38.34 65.47 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.293 0.849 . . . . 2.05 113.293 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.423 ' CD2' HG21 ' A' ' 145' ' ' THR . 8.4 mp -56.6 -40.73 75.81 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 119.431 1.014 . . . . 2.85 110.266 172.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 117.44 28.89 2.23 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 125.045 1.307 . . . . 1.66 111.602 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 1.04 HD11 HG22 ' A' ' 258' ' ' ILE . 0.5 OUTLIER -79.95 137.89 36.96 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.074 -0.713 . . . . 3.36 109.074 -170.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.77 140.23 21.5 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.655 -0.978 . . . . 2.76 110.655 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -47.87 116.23 1.43 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.635 0.774 . . . . 1.66 111.307 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 31.7 m -78.56 -177.35 5.28 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.385 0.674 . . . . 1.01 109.195 172.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 23.4 m -148.79 39.54 0.87 Allowed 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.328 -0.857 . . . . 2.31 109.387 -172.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.13 131.64 15.51 Favored Pre-proline 0 N--CA 1.447 -0.614 0 N-CA-C 106.599 -1.63 . . . . 1.55 106.599 -174.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.52 -9.55 14.8 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.096 1.864 . . . . 1.14 114.367 -172.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -82.07 -26.31 33.78 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.304 0.956 . . . . 1.2 109.771 170.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -70.43 148.28 48.51 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.325 -0.62 . . . . 0.76 109.325 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 90.2 t -93.92 -23.9 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 123.574 0.749 . . . . 0.78 109.383 177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.545 ' HG2' HD13 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -49.54 -38.52 31.11 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.859 0.689 . . . . 2.87 112.859 175.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.431 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -46.95 149.1 1.65 Allowed Pre-proline 0 CA--C 1.536 0.411 0 C-N-CA 126.219 1.808 . . . . 3.23 112.802 -165.049 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.428 ' HA ' ' HE1' ' A' ' 218' ' ' HIS . 61.4 Cg_endo -71.68 -16.89 29.97 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.541 1.494 . . . . 0.94 111.971 176.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.373 0.2 OUTLIER -78.85 -179.54 6.63 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.132 1.373 . . . . 1.38 110.148 176.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -127.39 153.88 45.69 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.594 -1.632 . . . . 2.24 106.594 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -148.56 117.45 6.72 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.615 -1.254 . . . . 2.19 107.615 168.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -63.68 122.47 16.46 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 108.63 -0.878 . . . . 2.41 108.63 174.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.3 m -145.96 154.55 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 O-C-N 123.771 0.669 . . . . 3.58 110.035 169.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -50.56 110.67 0.44 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 126.58 1.952 . . . . 3.72 111.539 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.8 pp -57.55 -19.8 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 124.091 0.956 . . . . 3.1 112.752 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -70.09 -49.7 48.27 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.433 0.693 . . . . 4.24 110.899 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 91.7 m -83.88 -30.02 26.74 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.115 0.566 . . . . 2.44 109.974 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.555 ' HE2' HG21 ' A' ' 217' ' ' VAL . 63.7 t80 -34.56 116.71 0.33 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.446 1.498 . . . . 8.33 111.581 174.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.27 175.82 10.76 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.714 1.206 . . . . 2.8 108.698 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.584 HD12 ' CH2' ' A' ' 141' ' ' TRP . 1.1 mm? -83.3 141.78 31.57 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.44 -0.948 . . . . 0.95 108.44 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.4 m -77.87 155.38 31.0 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 110.09 -0.337 . . . . 0.7 110.09 178.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.28 -45.28 62.07 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.005 0.431 . . . . 0.89 110.138 173.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -51.1 -54.11 28.03 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.884 0.874 . . . . 2.19 110.191 173.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.591 ' O ' HG23 ' A' ' 258' ' ' ILE . 4.1 t0 -59.27 -51.76 68.58 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.087 -0.961 . . . . 2.15 109.92 -176.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.5 mt -49.07 -52.43 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.775 1.63 . . . . 1.02 110.263 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -59.44 -40.51 87.02 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.391 -1.443 . . . . 6.78 110.568 178.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -49.04 -55.05 12.44 Favored Glycine 0 CA--C 1.535 1.322 0 N-CA-C 111.963 -0.455 . . . . 0.91 111.963 167.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 1.04 HG22 HD11 ' A' ' 226' ' ' LEU . 0.3 OUTLIER -60.85 -40.67 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 118.508 1.154 . . . . 2.54 110.282 -173.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -64.74 -17.96 64.61 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 119.498 -0.881 . . . . 2.64 111.245 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.0 t -63.02 -17.43 62.21 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.473 0.709 . . . . 2.18 112.446 171.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 66.7 mt -60.53 74.13 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.657 1.183 . . . . 2.33 111.501 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 45.71 67.82 0.68 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.342 1.857 . . . . 9.54 111.642 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.419 0 N-CA-C 106.322 -2.711 . . . . 7.37 106.322 174.407 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' NGH . . . . . 1.02 ' C13' ' H ' ' A' ' 182' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 90.9 mtp . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 106.03 -1.841 . . . . 12.84 106.03 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 142.09 -168.48 25.69 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 109.225 -1.55 . . . . 8.31 109.225 -171.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -70.52 -179.24 3.1 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.391 2.728 . . . . 8.81 110.067 173.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.5 p -143.48 149.55 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.355 0.662 . . . . 5.92 109.493 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 15.2 p90 -76.48 -65.0 0.98 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.0 1.32 . . . . 11.1 110.06 -177.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 63.64 -56.53 0.2 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.793 2.437 . . . . 8.09 112.407 -171.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.411 ' HB2' HD13 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -151.09 -51.13 0.12 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.534 1.534 . . . . 8.58 110.072 177.226 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 57.9 -78.34 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.142 1.377 . . . . 4.35 111.283 -170.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -124.63 109.15 12.81 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.102 1.361 . . . . 3.89 109.572 -177.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.411 HD13 ' HB2' ' A' ' 111' ' ' LYS . 0.4 OUTLIER -104.7 138.18 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.069 0 N-CA-C 106.641 -1.614 . . . . 2.56 106.641 170.29 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.1 p -125.1 139.47 53.75 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.739 -1.208 . . . . 1.19 107.739 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -123.04 161.59 24.02 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.696 0.798 . . . . 4.4 110.342 177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.95 147.82 32.11 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.752 -0.833 . . . . 5.67 108.752 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -104.95 149.26 8.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 C-N-CA 123.559 0.744 . . . . 0.83 109.312 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.47 HD22 ' H ' ' A' ' 119' ' ' ASN . 1.4 p30 -104.85 -47.6 3.99 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.158 1.783 . . . . 2.96 109.648 -172.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -139.18 164.63 29.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.98 -1.119 . . . . 3.2 107.98 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -128.16 118.67 23.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 106.846 -1.539 . . . . 2.23 106.846 -174.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.9 t -66.78 122.98 84.74 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.77 0.828 . . . . 2.53 109.384 -173.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -68.84 -17.76 41.73 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 123.791 2.994 . . . . 1.68 111.562 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -34.3 -42.42 0.13 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.451 2.301 . . . . 2.57 112.462 171.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 19.4 mtm -132.69 177.73 7.4 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.261 1.425 . . . . 2.07 109.046 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -64.05 142.32 58.45 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 108.824 -0.806 . . . . 3.01 108.824 172.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 43.9 ttt-85 -47.68 -51.15 22.78 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.506 -0.746 . . . . 2.15 110.491 172.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.33 6.28 3.01 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.453 0.538 . . . . 5.24 112.453 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -102.08 -41.92 6.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.15 1.78 . . . . 1.76 109.632 162.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 62.4 t -54.02 -54.79 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 O-C-N 120.508 -1.37 . . . . 1.21 109.719 175.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -26.43 68.13 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 118.647 -1.221 . . . . 1.76 109.469 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -65.0 -44.71 88.35 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 118.832 0.742 . . . . 2.41 111.004 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -60.91 -52.27 65.76 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 123.76 0.824 . . . . 0.4 110.481 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.416 HD13 ' O ' ' A' ' 134' ' ' ILE . 0.2 OUTLIER -68.51 -37.24 77.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 109.291 -0.633 . . . . 1.81 109.291 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -52.27 -61.37 2.31 Favored 'General case' 0 C--N 1.342 0.24 0 N-CA-C 107.851 -1.166 . . . . 3.71 107.851 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.422 ' O ' HG23 ' A' ' 140' ' ' VAL . 52.9 mmtt -52.34 -53.62 42.18 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.209 1.004 . . . . 1.51 110.546 178.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -52.21 -49.52 63.77 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.792 0.837 . . . . 0.69 111.834 -177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -63.59 -47.23 82.3 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.52 -0.918 . . . . 5.75 108.52 176.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.18 -38.95 63.28 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.695 0.398 . . . . 2.64 110.599 -171.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.561 ' CG1' HD21 ' A' ' 250' ' ' LEU . 82.3 t -49.79 -58.51 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.34 1.056 . . . . 0.71 109.249 175.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.872 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 17.3 m95 -68.63 -37.23 79.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 119.836 -0.746 . . . . 0.83 109.087 -177.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -20.2 65.48 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 112.374 0.509 . . . . 1.44 112.374 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -78.98 -49.39 12.83 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.527 -0.916 . . . . 1.48 108.527 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.634 HG12 HD11 ' A' ' 258' ' ' ILE . 26.5 t -75.46 -54.91 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 122.775 0.43 . . . . 1.89 110.877 -174.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.6 p -76.93 157.33 81.74 Favored Pre-proline 0 N--CA 1.45 -0.447 0 N-CA-C 107.758 -1.201 . . . . 0.62 107.758 173.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.88 15.07 0.95 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 121.744 1.629 . . . . 0.78 113.594 174.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.04 145.94 55.02 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 122.257 2.299 . . . . 2.85 109.641 175.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -110.63 86.93 2.41 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.939 -1.504 . . . . 4.34 106.939 160.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.452 ' HB2' ' CD1' ' A' ' 138' ' ' PHE . 3.9 m-85 -71.02 154.43 41.8 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.189 -0.671 . . . . 6.08 109.189 163.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.6 t -155.34 144.93 21.23 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.271 1.028 . . . . 0.92 108.51 170.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -92.29 138.6 31.39 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 119.493 1.042 . . . . 2.61 108.471 174.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.8 pp -138.29 124.46 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 107.243 -1.392 . . . . 1.35 107.243 167.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 55.0 m-20 -88.03 -7.64 56.73 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 122.384 0.274 . . . . 3.42 111.26 172.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 62.2 p -130.11 96.79 4.27 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 124.024 0.929 . . . . 2.39 109.927 -170.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 140.03 -150.74 21.7 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 106.601 -2.6 . . . . 1.64 106.601 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 43.4 ttm -122.54 137.18 54.97 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 106.452 -1.684 . . . . 4.12 106.452 173.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -111.85 170.16 8.33 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.738 1.215 . . . . 0.83 109.664 -177.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -84.16 -55.7 4.05 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.646 0.778 . . . . 2.08 109.361 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 16.9 pt -101.91 164.26 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 109.143 -0.688 . . . . 1.01 109.143 176.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.05 132.31 38.08 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.988 -0.745 . . . . 2.0 108.988 178.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 10.7 t -78.48 143.03 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.967 -1.123 . . . . 1.55 107.967 168.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 66.6 t -108.24 128.78 63.46 Favored 'Isoleucine or valine' 0 C--N 1.345 0.379 0 C-N-CA 124.546 1.138 . . . . 1.46 108.021 165.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.435 ' N ' HD21 ' A' ' 119' ' ' ASN . 5.7 m-85 -124.31 99.8 6.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 103.903 -2.628 . . . . 5.03 103.903 170.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.51 160.13 33.31 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.991 -1.485 . . . . 0.97 106.991 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -121.72 128.25 51.6 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.406 -1.331 . . . . 4.18 107.406 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 65.79 -161.7 43.04 Favored Glycine 0 CA--C 1.538 1.522 0 CA-C-O 121.629 0.572 . . . . 2.23 112.37 -171.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.17 110.06 11.54 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.269 0.628 . . . . 2.24 109.654 -172.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -106.27 -45.42 4.3 Favored 'General case' 0 C--O 1.227 -0.08 0 C-N-CA 125.615 1.566 . . . . 3.36 110.14 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -164.64 68.87 0.2 Allowed Glycine 0 C--O 1.243 0.695 0 N-CA-C 104.64 -3.384 . . . . 3.1 104.64 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -160.81 -178.43 6.83 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 129.937 3.295 . . . . 2.64 106.2 172.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -77.41 -55.68 5.19 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.105 0.962 . . . . 4.69 108.53 165.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -123.41 -72.85 0.66 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.33 1.052 . . . . 5.95 110.924 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 56.21 -77.48 0.01 OUTLIER 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.663 1.985 . . . . 2.71 112.791 -169.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -104.63 149.57 25.43 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.467 1.107 . . . . 6.05 109.551 -166.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -171.8 10.16 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.323 0.86 . . . . 3.43 113.323 -155.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 65.82 -149.96 51.68 Favored Glycine 0 CA--C 1.537 1.428 0 N-CA-C 109.895 -1.282 . . . . 2.17 109.895 -162.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -80.3 63.94 4.95 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.66 1.23 . . . . 4.22 114.042 -162.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -164.13 -143.77 3.82 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 106.992 -2.443 . . . . 1.85 106.992 160.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.69 -127.31 40.08 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 109.27 -1.532 . . . . 2.02 109.27 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . 0.267 1.0 OUTLIER -100.39 148.77 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 106.214 -1.773 . . . . 1.56 106.214 173.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.22 -46.1 12.21 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.851 0.861 . . . . 2.2 109.644 164.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -163.48 165.69 23.48 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 121.238 -0.914 . . . . 0.65 111.246 177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -147.56 141.71 26.09 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 123.697 0.799 . . . . 1.04 112.398 -179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -161.79 158.04 25.09 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 123.97 0.908 . . . . 0.56 109.853 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -147.87 139.35 23.72 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 124.617 1.167 . . . . 2.92 108.129 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -85.77 -78.71 1.18 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.365 -1.094 . . . . 0.5 110.365 173.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -66.78 104.08 0.77 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.355 2.703 . . . . 1.32 110.514 -178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -178.53 172.48 44.85 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 108.242 -1.943 . . . . 1.02 108.242 174.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 63.9 m -84.05 165.35 18.63 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.025 -0.731 . . . . 2.15 109.025 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 53.31 -95.23 0.02 OUTLIER Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.202 0.906 . . . . 1.8 112.535 172.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.5 tp -63.35 -16.49 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 125.129 1.372 . . . . 1.72 111.504 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -44.37 129.58 7.18 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 110.792 -0.923 . . . . 1.3 110.792 166.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 86.07 -31.09 4.13 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.34 1.448 . . . . 0.98 112.891 -175.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -83.34 147.51 27.88 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.484 1.142 . . . . 1.27 109.739 -166.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.78 124.04 38.78 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 118.762 -0.637 . . . . 0.71 112.454 -172.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . 0.341 0.0 OUTLIER -112.4 109.06 18.45 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.079 0.551 . . . . 2.41 112.19 -165.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -96.2 138.22 34.12 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 118.661 0.664 . . . . 2.71 110.449 -177.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -62.24 92.51 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.171 -0.677 . . . . 3.28 109.171 170.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -64.83 -37.54 87.95 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 120.51 -1.369 . . . . 2.66 109.576 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -50.46 -27.94 7.42 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.593 0.757 . . . . 2.74 110.907 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -66.27 155.15 37.99 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.859 1.264 . . . . 2.81 110.179 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -95.78 93.62 7.19 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.583 -1.636 . . . . 3.94 106.583 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 77.7 m95 -78.76 155.75 29.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.695 -0.854 . . . . 1.18 108.695 173.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.92 136.82 24.46 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.304 0.641 . . . . 2.79 111.285 -176.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.2 t -58.03 -45.35 87.08 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.188 0.995 . . . . 1.62 111.495 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -74.77 -154.85 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.646 1.179 . . . . 3.23 110.761 175.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.4 p -79.16 -68.27 0.67 Allowed 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.938 -1.101 . . . . 3.81 110.455 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 38.63 -106.03 0.05 OUTLIER Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.465 1.983 . . . . 2.51 113.495 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -95.55 -72.28 1.13 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.216 0.912 . . . . 1.58 110.839 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 4.3 m -136.45 153.92 50.92 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 106.686 -1.598 . . . . 0.87 106.686 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -107.77 124.75 50.5 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 123.651 0.594 . . . . 1.53 111.968 173.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.17 -53.65 55.86 Favored 'General case' 0 C--O 1.223 -0.333 0 N-CA-C 109.241 -0.652 . . . . 1.74 109.241 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -49.07 -46.99 45.31 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.667 0.746 . . . . 1.52 110.232 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.6 tt -61.5 -61.58 2.43 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.921 0.888 . . . . 1.33 110.0 -176.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.279 0.6 OUTLIER -55.99 -37.94 69.79 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 122.383 -0.198 . . . . 0.76 110.904 179.472 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.34 -54.92 29.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 124.591 1.156 . . . . 0.64 110.687 175.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.8 t -48.08 -43.45 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 120.12 1.327 . . . . 0.84 110.903 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.837 ' HB2' ' H72' ' A' ' 269' ' ' NGH . 42.6 t-80 -56.62 -56.54 20.12 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.396 1.078 . . . . 2.11 113.845 171.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -82.1 -43.32 17.98 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.134 -0.979 . . . . 3.69 112.679 -170.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.413 ' CD1' HD11 ' A' ' 134' ' ' ILE . 1.0 OUTLIER -56.26 -33.95 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.056 -0.72 . . . . 1.46 109.056 164.185 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -57.5 -53.68 43.07 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 110.763 -0.935 . . . . 0.6 110.763 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.461 ' CE1' ' CE1' ' A' ' 218' ' ' HIS 0.281 62.5 m170 -53.44 -41.19 65.83 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.456 -1.026 . . . . 2.31 111.944 173.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 34.7 t -47.82 -52.97 16.97 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.131 0.972 . . . . 1.73 112.346 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.12 -10.85 60.44 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.614 -0.679 . . . . 3.16 112.786 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 104.51 43.31 1.73 Allowed Glycine 0 C--N 1.336 0.552 0 C-N-CA 124.289 0.947 . . . . 1.19 111.792 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.964 HD21 HG22 ' A' ' 258' ' ' ILE . 7.9 mt -77.35 115.37 17.06 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 117.373 0.586 . . . . 3.31 111.546 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -66.43 154.96 51.8 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 109.507 -1.437 . . . . 3.11 109.507 162.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -68.61 121.54 16.63 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 117.746 0.773 . . . . 2.38 112.716 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 3.9 m -79.93 118.1 21.38 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.772 -1.566 . . . . 2.31 106.772 172.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.7 p -76.12 63.29 1.81 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.24 0.927 . . . . 3.67 110.502 -175.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -155.78 131.36 5.48 Favored Pre-proline 0 N--CA 1.451 -0.376 0 C-N-CA 124.85 1.26 . . . . 1.67 108.34 -173.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -81.92 -14.65 9.78 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.776 1.651 . . . . 1.69 114.124 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.42 -42.09 59.76 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 119.57 1.077 . . . . 2.0 108.971 172.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -57.73 116.41 3.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.744 1.217 . . . . 1.79 110.451 176.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.0 t -62.2 -17.9 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.383 -0.826 . . . . 0.82 110.896 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.452 ' SD ' ' HB3' ' A' ' 226' ' ' LEU . 0.0 OUTLIER -51.89 -42.41 62.67 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 121.331 -0.856 . . . . 3.06 113.135 169.029 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.414 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 14.6 t80 -61.03 147.31 86.35 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 109.027 -0.731 . . . . 7.5 109.027 -165.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.414 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 58.8 Cg_endo -70.88 -14.01 32.24 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 121.375 1.384 . . . . 1.16 112.566 -172.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.354 0.2 OUTLIER -76.94 128.01 33.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.751 0.705 . . . . 1.88 109.121 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -75.82 129.91 37.75 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.794 -1.187 . . . . 3.25 107.794 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -135.67 139.36 43.65 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.708 -1.59 . . . . 2.64 106.708 174.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -57.77 120.96 9.34 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.542 -0.91 . . . . 2.41 108.542 173.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 19.1 m -101.09 130.72 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.854 -0.425 . . . . 2.0 109.854 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.66 86.71 0.66 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.491 -0.559 . . . . 4.83 109.491 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.6 mt -51.48 -31.3 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.404 0.682 . . . . 2.81 109.449 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -42.05 -49.46 4.72 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 124.362 1.065 . . . . 3.71 112.404 169.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 35.0 m -84.84 -41.63 15.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.56 0.744 . . . . 1.65 110.24 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 71.1 t80 60.96 75.5 0.41 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.287 1.035 . . . . 4.29 109.545 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.06 169.19 25.11 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.135 0.574 . . . . 4.61 110.688 -177.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.561 HD21 ' CG1' ' A' ' 140' ' ' VAL . 0.4 OUTLIER -113.76 176.87 4.84 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.505 1.522 . . . . 1.25 107.859 175.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 68.2 m -77.96 145.41 36.07 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 122.742 0.417 . . . . 0.83 110.7 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.36 -43.19 54.18 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.173 0.589 . . . . 1.36 110.402 171.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -53.43 -55.49 24.69 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.627 0.727 . . . . 2.87 110.183 176.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.595 ' O ' HG23 ' A' ' 258' ' ' ILE . 1.9 t0 -59.09 -47.69 84.32 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.078 -0.965 . . . . 2.25 109.02 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 59.3 mt -51.06 -32.31 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.647 1.979 . . . . 1.82 112.524 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -73.42 -57.16 4.2 Favored 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 121.293 -0.879 . . . . 6.25 110.026 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -47.24 -53.85 10.88 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-O 121.19 0.328 . . . . 1.73 112.291 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.964 HG22 HD21 ' A' ' 226' ' ' LEU . 2.0 pp -55.88 -32.65 33.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.946 1.698 . . . . 2.4 111.056 -178.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -78.3 -45.11 23.53 Favored 'General case' 0 C--N 1.339 0.126 0 O-C-N 121.708 -0.62 . . . . 3.22 109.811 175.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 15.1 m -51.99 -31.04 27.72 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.58 0.585 . . . . 4.22 112.58 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 85.5 mt -51.45 -22.33 2.99 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 114.222 1.193 . . . . 3.7 114.222 172.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -47.55 -56.11 7.8 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.588 0.631 . . . . 9.07 110.237 167.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 116.7 -2.167 . . . . 7.96 107.793 -171.93 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' NGH . . . . . 0.837 ' H72' ' HB2' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 68.6 mtm . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 106.094 -1.817 . . . . 12.52 106.094 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 119.56 78.39 0.56 Allowed Glycine 0 CA--C 1.532 1.147 0 N-CA-C 110.825 -0.91 . . . . 8.28 110.825 -174.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -72.72 158.78 49.89 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.326 2.018 . . . . 8.74 109.919 175.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.9 p -153.47 152.51 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.368 -1.715 . . . . 5.66 106.368 175.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 5.4 t-105 -123.2 167.17 14.07 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 123.832 0.853 . . . . 10.18 108.959 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.67 -43.02 65.27 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.026 0.931 . . . . 10.56 111.445 -178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -159.41 -59.92 0.07 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.499 -0.286 . . . . 6.49 110.561 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 15.0 m170 67.02 -54.33 0.45 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 126.467 1.907 . . . . 3.31 112.889 -176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -107.0 114.52 28.65 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.324 1.45 . . . . 3.93 110.139 -176.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.7 mp -141.6 80.44 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 124.667 1.187 . . . . 2.33 108.396 -173.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.22 141.39 37.19 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.964 -1.124 . . . . 1.2 107.964 174.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -127.31 159.79 33.31 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.145 0.978 . . . . 4.09 108.705 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -154.94 173.21 16.86 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.727 0.694 . . . . 4.38 110.419 172.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.78 159.39 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.226 1.01 . . . . 0.85 109.834 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -100.29 -42.98 6.43 Favored 'General case' 0 C--O 1.226 -0.144 0 C-N-CA 124.01 0.924 . . . . 2.95 109.994 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -149.41 170.46 18.51 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.751 0.82 . . . . 2.49 109.831 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -117.9 101.76 8.54 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.368 1.467 . . . . 2.25 107.959 -175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.4 t -58.55 125.89 77.69 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.96 0.904 . . . . 2.3 109.173 -176.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.17 -17.26 45.29 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.717 2.945 . . . . 1.57 111.411 -172.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -35.06 -43.75 0.21 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.002 1.721 . . . . 2.2 111.827 170.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.9 mpp? -130.88 174.59 9.83 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 124.994 1.317 . . . . 1.9 110.037 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -73.13 140.2 46.93 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.65 0.78 . . . . 3.01 109.487 173.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -46.61 -51.41 15.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.035 0.445 . . . . 2.66 111.892 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.5 -8.11 8.63 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.742 0.817 . . . . 3.46 112.723 -176.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -100.66 -48.45 4.51 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.695 1.598 . . . . 1.93 109.314 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.93 -56.59 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 125.274 1.43 . . . . 1.22 109.374 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -24.53 64.48 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 118.334 -0.841 . . . . 1.82 109.349 -177.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -65.84 -50.25 65.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.627 0.648 . . . . 3.16 110.071 178.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -49.67 -54.85 16.23 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 123.919 0.888 . . . . 0.6 110.091 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.476 HD11 HD11 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -71.38 -30.99 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.028 -0.533 . . . . 1.88 110.233 -179.082 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 -55.04 -54.6 40.94 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.765 1.269 . . . . 3.53 108.157 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 140' ' ' VAL . 12.3 mmmm -68.82 -39.28 80.1 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.588 1.555 . . . . 1.42 110.282 -174.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -46.44 -57.11 4.97 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 122.576 0.35 . . . . 0.8 110.63 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.427 ' CZ ' HG13 ' A' ' 220' ' ' ILE . 11.9 m-85 -60.43 -48.55 81.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 119.661 -0.816 . . . . 4.41 111.15 177.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -45.34 -48.92 13.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.416 0.687 . . . . 3.47 111.093 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 136' ' ' LYS . 94.8 t -58.36 -51.0 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 122.717 0.407 . . . . 1.05 109.941 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.702 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 92.8 m95 -68.68 -33.67 74.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.679 -0.86 . . . . 0.82 108.679 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.14 -19.53 61.63 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.251 0.478 . . . . 1.19 111.911 174.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -81.27 -42.87 20.01 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.024 0.829 . . . . 2.45 108.985 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 1.7 m -79.87 -54.37 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 112.17 0.433 . . . . 1.28 112.17 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.439 ' CG2' HD13 ' A' ' 258' ' ' ILE . 54.4 p -81.83 147.14 57.76 Favored Pre-proline 0 N--CA 1.45 -0.442 0 N-CA-C 108.382 -0.969 . . . . 0.73 108.382 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.73 5.01 4.1 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.813 2.342 . . . . 0.81 113.008 178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.7 mp -68.4 125.9 27.93 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.371 1.468 . . . . 2.7 108.589 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.0 mtmt -98.17 93.53 6.3 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 109.277 -0.638 . . . . 4.12 109.277 -176.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -78.57 149.45 33.01 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.469 -0.332 . . . . 5.85 110.797 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.4 t -151.4 137.31 18.12 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 109.714 -0.476 . . . . 1.01 109.714 172.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -90.45 160.09 16.2 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.266 -1.013 . . . . 3.07 108.266 172.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.413 HD11 ' HB2' ' A' ' 157' ' ' ALA . 0.1 OUTLIER -152.12 152.21 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 104.747 -2.316 . . . . 1.92 104.747 -177.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.03 -39.43 21.26 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.262 -0.644 . . . . 3.95 109.262 172.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.5 m -75.71 146.23 40.29 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.283 -0.636 . . . . 3.84 109.283 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -78.87 59.29 4.23 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.387 -0.674 . . . . 4.39 112.699 -173.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 19.2 mtt -116.37 72.89 0.83 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.152 0.981 . . . . 6.37 109.594 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.413 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -141.53 162.68 34.9 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 123.49 0.716 . . . . 0.73 111.702 -173.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -70.97 -46.54 62.17 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.073 -1.084 . . . . 2.03 108.073 170.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.9 pt -124.23 146.16 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.017 -0.992 . . . . 1.51 108.601 -171.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 160' ' ' LEU 0.308 0.0 OUTLIER -129.93 139.22 51.14 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.097 -0.705 . . . . 2.69 109.097 176.867 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.6 t -79.93 112.08 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 118.579 -0.724 . . . . 0.72 109.113 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . 0.479 7.4 p -109.0 97.77 6.15 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 N-CA-C 113.47 0.915 . . . . 2.4 113.47 -178.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -79.82 130.04 34.98 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.326 1.85 . . . . 5.14 107.077 175.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -141.6 162.11 36.28 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.409 0.549 . . . . 0.87 111.029 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -119.01 126.75 52.46 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.897 1.279 . . . . 5.5 108.209 -172.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 46.62 -130.35 11.83 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 123.59 0.614 . . . . 1.73 112.208 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.96 138.2 38.72 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.266 0.627 . . . . 2.16 109.511 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -153.73 -31.75 0.12 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 114.124 1.157 . . . . 2.43 114.124 -175.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 178.96 -49.16 0.09 OUTLIER Glycine 0 C--N 1.335 0.509 0 N-CA-C 109.6 -1.4 . . . . 2.31 109.6 -170.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -77.57 158.65 29.73 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.71 -0.848 . . . . 2.69 108.71 168.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.57 -43.09 23.65 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.778 1.231 . . . . 4.68 108.719 -178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 30.6 m80 -73.7 -60.67 2.14 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.926 0.891 . . . . 4.12 109.066 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 49.74 -140.22 0.78 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.076 1.35 . . . . 2.27 111.734 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -89.83 156.52 18.43 Favored 'General case' 0 C--N 1.341 0.215 0 N-CA-C 107.366 -1.346 . . . . 7.6 107.366 167.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -158.14 11.55 0.18 Allowed 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 126.82 2.048 . . . . 3.19 111.105 -157.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 105.29 165.22 23.78 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.351 -1.1 . . . . 1.99 110.351 -165.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -58.11 118.0 4.97 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.526 -0.916 . . . . 4.06 108.526 166.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.91 -160.81 13.74 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 109.95 -1.26 . . . . 1.78 109.95 -177.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.92 -102.94 0.2 Allowed Glycine 0 C--N 1.339 0.715 0 N-CA-C 109.167 -1.573 . . . . 1.66 109.167 -171.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.505 HG23 ' H12' ' A' ' 269' ' ' NGH 0.314 12.8 mm -90.73 130.04 40.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.111 -1.07 . . . . 1.9 108.111 171.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.582 ' HB2' ' H1 ' ' A' ' 269' ' ' NGH . 3.8 mp -82.48 -61.18 1.96 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.806 -0.812 . . . . 1.11 108.806 166.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.995 ' H ' H102 ' A' ' 269' ' ' NGH . . . -158.8 149.65 20.15 Favored 'General case' 0 C--O 1.249 1.043 0 N-CA-C 113.332 0.864 . . . . 0.94 113.332 -177.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -131.97 117.05 17.91 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.563 1.945 . . . . 1.0 114.678 -170.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -144.19 160.54 40.78 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 128.245 2.618 . . . . 0.56 106.388 -176.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.93 149.84 28.65 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.691 -1.596 . . . . 3.68 106.691 -177.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -102.15 -86.99 1.97 Allowed Glycine 0 CA--C 1.526 0.734 0 CA-C-O 119.455 -0.636 . . . . 0.6 111.768 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.57 86.83 0.43 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.501 2.801 . . . . 1.39 110.543 -176.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -163.71 157.85 30.17 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 108.419 -1.872 . . . . 1.04 108.419 170.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 66.0 m -80.37 173.87 12.17 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.224 0.535 . . . . 2.63 110.45 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 56.53 -112.47 3.41 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.575 0.607 . . . . 1.24 111.648 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.1 tp -59.79 -40.05 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 O-C-N 122.131 -0.629 . . . . 1.43 109.365 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -39.24 136.06 1.37 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.393 0.997 . . . . 0.94 112.288 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 101.51 -47.58 1.17 Allowed Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.179 1.371 . . . . 0.58 111.186 -164.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -84.94 154.12 22.38 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.748 0.774 . . . . 1.3 109.226 -159.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.41 116.71 20.17 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.528 0.936 . . . . 0.61 113.528 -166.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -114.86 135.14 54.53 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 118.289 0.495 . . . . 2.19 111.629 -163.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -125.36 146.51 49.55 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.249 -0.649 . . . . 2.76 109.249 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -66.52 96.76 0.39 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.073 -0.967 . . . . 2.82 109.806 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.44 -42.76 98.66 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 120.558 -1.339 . . . . 3.18 111.639 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -53.85 -35.49 61.56 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.658 1.183 . . . . 2.86 110.14 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -67.4 133.94 50.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.721 -1.585 . . . . 2.11 106.721 177.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -93.39 94.25 8.61 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.131 -2.174 . . . . 2.79 105.131 -173.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 23.7 m95 -75.79 152.87 37.25 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 106.277 -1.749 . . . . 1.14 106.277 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 p -128.05 124.5 37.24 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.231 -1.396 . . . . 1.75 107.231 -178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -49.9 75.91 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 120.51 1.504 . . . . 2.14 108.028 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.74 177.93 2.33 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.725 0.41 . . . . 2.04 110.536 176.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.1 t -48.53 -55.31 11.41 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.726 1.211 . . . . 3.67 110.723 -171.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 40.78 -106.64 0.07 OUTLIER Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.147 1.356 . . . . 2.3 114.611 165.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -121.37 -67.84 0.26 Allowed Glycine 0 CA--C 1.525 0.709 0 C-N-CA 124.293 0.949 . . . . 1.09 110.93 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 2.4 m -131.95 140.69 49.08 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 106.33 -1.73 . . . . 0.85 106.33 174.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -95.3 129.82 42.29 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 123.733 0.646 . . . . 1.56 111.251 176.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -47.59 85.18 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.529 -0.759 . . . . 1.59 110.137 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -55.51 -38.23 68.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.621 0.768 . . . . 2.69 111.475 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.68 -63.4 1.23 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.791 0.836 . . . . 1.95 109.706 176.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.303 0.2 OUTLIER -56.4 -38.75 71.95 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.19 -178.148 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.99 -58.5 7.06 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 117.857 -1.068 . . . . 0.63 110.641 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.588 ' CG1' HG11 ' A' ' 235' ' ' VAL . 0.3 OUTLIER -58.02 -44.01 86.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.481 0 CA-C-N 120.275 1.398 . . . . 2.12 111.316 -174.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.657 ' NE2' ' CE1' ' A' ' 222' ' ' HIS 0.48 3.2 t-160 -49.76 -60.9 2.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.555 1.142 . . . . 2.14 111.686 169.362 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -58.39 -41.72 85.5 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 120.835 -1.166 . . . . 2.87 111.946 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.476 HD11 HD11 ' A' ' 134' ' ' ILE . 1.4 mp -68.68 -39.18 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 109.046 -0.724 . . . . 1.07 109.046 -173.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -52.97 -44.9 62.15 Favored Glycine 0 CA--C 1.536 1.345 0 N-CA-C 111.402 -0.679 . . . . 0.63 111.402 167.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.657 ' CE1' ' NE2' ' A' ' 218' ' ' HIS . 3.0 m-70 -53.93 -48.68 69.97 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 117.783 0.791 . . . . 1.26 109.302 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.5 p -61.2 -18.5 58.55 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.59 0.959 . . . . 1.69 113.59 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 5.6 mt -79.1 -58.98 2.96 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 106.966 -1.494 . . . . 2.19 106.966 171.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 149.86 79.66 0.03 OUTLIER Glycine 0 C--N 1.337 0.608 0 CA-C-N 115.615 -0.721 . . . . 1.21 111.859 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.789 HD11 HG22 ' A' ' 258' ' ' ILE . 8.7 mt -133.38 102.69 5.63 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.697 -1.223 . . . . 3.19 107.697 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -77.81 46.94 2.71 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.14 -0.811 . . . . 3.42 112.777 -176.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 63.7 m80 71.38 120.08 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.09 2.156 . . . . 1.82 113.0 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 68.4 m -77.55 -179.83 6.08 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.933 -0.395 . . . . 1.26 109.933 173.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.3 t -142.14 29.91 1.63 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.954 0.901 . . . . 2.59 110.005 -171.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.03 143.35 45.23 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.69 1.596 . . . . 2.16 107.002 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -86.2 -12.61 5.74 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.158 1.905 . . . . 1.03 114.493 -172.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -81.2 -40.36 23.98 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.162 -1.051 . . . . 1.38 108.162 170.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.0 145.78 15.93 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.784 0.834 . . . . 0.74 110.502 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.588 HG11 ' CG1' ' A' ' 217' ' ' VAL . 60.3 t -97.5 -17.26 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 124.2 1.0 . . . . 0.75 109.826 -176.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.476 ' HG3' HD13 ' A' ' 226' ' ' LEU . 50.9 mmm -77.5 -12.42 59.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 114.074 1.139 . . . . 2.41 114.074 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.423 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.9 155.49 1.05 Allowed Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 124.425 1.09 . . . . 3.15 113.275 177.011 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.525 ' O ' ' S1 ' ' A' ' 269' ' ' NGH . 73.4 Cg_endo -73.34 -21.69 19.63 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.774 1.65 . . . . 1.01 111.428 175.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.319 0.6 OUTLIER -76.8 173.19 11.97 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.824 1.25 . . . . 1.35 109.362 176.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -116.78 148.75 40.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.285 -1.376 . . . . 2.0 107.285 171.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 13.5 tttp -141.45 122.07 14.24 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.301 -1.74 . . . . 2.12 106.301 166.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -61.22 144.4 53.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.054 -0.721 . . . . 2.67 109.054 168.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 25.9 m -133.97 159.36 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.023 0.929 . . . . 2.07 108.723 167.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.81 -10.66 39.74 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 127.05 2.14 . . . . 4.04 113.107 -174.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . 0.257 24.0 mm 71.78 -23.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 127.081 2.152 . . . . 2.98 112.104 -176.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -47.04 -67.04 0.32 Allowed 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 113.81 1.041 . . . . 3.69 113.81 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 22.6 m -81.61 -50.15 9.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.528 -0.545 . . . . 1.9 109.528 -173.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 38.5 t80 39.43 82.9 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.435 1.894 . . . . 6.68 112.885 175.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.09 162.18 32.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.829 0.851 . . . . 3.44 109.387 -176.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.498 ' H ' HD22 ' A' ' 250' ' ' LEU . 1.2 mm? -83.03 146.79 28.54 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.808 -1.182 . . . . 0.99 107.808 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.9 m -76.79 157.28 31.69 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.022 0.529 . . . . 0.95 110.634 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.64 -47.2 67.21 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 110.045 -0.354 . . . . 1.07 110.045 172.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -51.09 -56.78 10.94 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.904 0.859 . . . . 3.06 110.262 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -58.53 -42.15 87.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.068 -0.969 . . . . 2.13 111.589 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 41.7 mt -57.49 -44.73 85.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 125.181 1.393 . . . . 0.83 109.604 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -63.15 -45.12 93.36 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.417 -0.802 . . . . 4.55 110.622 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -46.09 -62.88 3.2 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 111.727 -0.549 . . . . 0.85 111.727 173.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.789 HG22 HD11 ' A' ' 226' ' ' LEU . 2.8 pp -60.21 -42.44 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 O-C-N 121.803 -0.822 . . . . 2.2 111.939 -176.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -63.28 -21.53 66.3 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.195 -0.602 . . . . 2.31 112.054 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.6 t -53.21 -25.56 14.46 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 121.99 -0.444 . . . . 2.29 111.743 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 56.1 mt -74.27 54.1 0.54 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.212 1.005 . . . . 2.87 111.814 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 51.55 44.68 28.93 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.707 1.203 . . . . 6.43 111.605 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.207 0 CA-C-O 116.679 -2.179 . . . . 9.45 111.6 173.56 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' NGH . . . . . 0.995 H102 ' H ' ' A' ' 182' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 56.3 mtt . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 108.259 -1.015 . . . . 13.47 108.259 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 152.85 79.18 0.02 OUTLIER Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.034 -1.626 . . . . 8.76 109.034 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.83 168.24 24.38 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.258 1.972 . . . . 10.14 110.133 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.6 p -154.71 167.58 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.079 -1.452 . . . . 5.8 107.079 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -114.1 163.61 14.95 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.921 0.888 . . . . 10.87 111.342 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -61.4 -43.5 98.75 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.029 1.331 . . . . 8.86 112.377 -171.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.06 -40.21 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.206 0.602 . . . . 5.99 112.272 175.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.6 -69.61 0.09 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.766 1.226 . . . . 4.75 112.32 -173.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -77.9 95.15 4.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 119.024 0.829 . . . . 2.78 111.339 -169.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.0 mm -94.03 80.68 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 108.207 -1.035 . . . . 1.91 108.207 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.8 p -77.61 129.66 35.89 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.18 -1.044 . . . . 1.18 108.18 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.404 ' CE2' HD12 ' A' ' 134' ' ' ILE . 39.4 p90 -129.01 163.0 26.31 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.16 0.584 . . . . 4.52 110.59 -178.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.08 151.8 36.27 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.618 -0.882 . . . . 6.6 108.618 174.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -100.47 144.21 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 108.142 -1.059 . . . . 0.94 108.142 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -83.99 -58.32 2.83 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.611 -1.255 . . . . 3.86 107.611 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -123.8 160.18 27.92 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.782 1.233 . . . . 2.24 109.213 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -111.94 127.32 55.82 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.237 1.415 . . . . 2.12 107.262 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.39 131.03 34.1 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 118.356 0.525 . . . . 2.53 110.044 176.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -87.66 -17.24 2.78 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.848 3.032 . . . . 1.65 110.794 171.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -44.55 -48.16 10.24 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 125.442 1.497 . . . . 2.06 110.863 178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 6.8 ptp -124.33 176.49 6.42 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.097 0.959 . . . . 2.34 109.135 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -65.7 134.26 52.82 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 110.363 -0.236 . . . . 2.99 110.363 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -52.58 -47.78 66.65 Favored 'General case' 0 CA--C 1.524 -0.043 0 O-C-N 122.028 -0.42 . . . . 3.57 111.651 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -51.01 -25.92 5.4 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 118.685 -0.674 . . . . 3.22 111.529 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -93.02 -35.32 13.32 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.992 1.317 . . . . 1.98 112.004 177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -52.45 -56.58 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 120.469 -1.395 . . . . 1.2 108.875 171.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.83 -25.46 65.57 Favored 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 117.729 -1.588 . . . . 1.74 108.632 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -63.71 -45.43 90.0 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 119.856 1.207 . . . . 1.96 111.216 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.75 -53.01 60.69 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 122.771 0.428 . . . . 0.5 110.187 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.404 HD12 ' CE2' ' A' ' 116' ' ' TYR . 0.2 OUTLIER -70.3 -37.26 70.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 109.834 -0.432 . . . . 2.05 109.834 -176.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -54.07 -59.98 3.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.337 1.455 . . . . 3.12 107.848 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -63.16 -43.88 97.04 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.408 -0.814 . . . . 2.4 109.764 -177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.32 -52.2 47.48 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 123.372 0.669 . . . . 0.43 111.909 175.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.04 -46.39 88.36 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 119.098 -1.041 . . . . 6.47 109.018 174.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.29 -29.03 63.55 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 118.746 -0.645 . . . . 2.02 111.579 -172.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.404 ' CG1' HD21 ' A' ' 250' ' ' LEU . 99.0 t -59.83 -63.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-N 118.984 0.811 . . . . 0.81 109.494 171.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.764 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 46.8 m95 -66.04 -41.15 91.26 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.873 -0.788 . . . . 0.71 108.873 -170.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 t -69.08 -4.91 19.03 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 124.312 1.045 . . . . 1.07 112.054 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -89.66 -55.98 3.43 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.05 -0.722 . . . . 1.1 109.05 167.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.7 m -69.97 -51.44 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 112.8 0.667 . . . . 1.41 112.8 -174.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.511 HG22 HD13 ' A' ' 258' ' ' ILE . 42.3 p -79.76 151.96 74.43 Favored Pre-proline 0 N--CA 1.443 -0.812 0 N-CA-C 107.427 -1.323 . . . . 0.75 107.427 174.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.35 12.76 1.48 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.373 2.049 . . . . 0.74 112.248 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.9 mp -67.61 149.45 50.05 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.221 -0.924 . . . . 2.38 109.079 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -120.79 87.46 2.76 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.661 -1.607 . . . . 4.62 106.661 173.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -72.37 149.07 44.68 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.11 -0.496 . . . . 5.85 109.77 172.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.3 t -155.73 129.34 8.43 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 119.172 -0.442 . . . . 1.04 110.01 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.68 149.87 27.1 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 108.224 -1.028 . . . . 2.14 108.224 171.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.0 pt -134.67 119.88 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.627 -1.62 . . . . 1.27 106.627 171.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -76.87 -22.3 53.68 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.505 -0.554 . . . . 3.65 109.505 173.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.8 m -136.8 113.27 10.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.25 1.42 . . . . 2.44 108.858 -176.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 149.5 -144.67 12.33 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 108.739 -1.744 . . . . 1.91 108.739 174.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 28.2 mtt -135.19 131.87 37.26 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 126.384 1.874 . . . . 4.21 107.511 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.77 162.92 14.3 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.552 1.541 . . . . 0.72 110.102 -175.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -86.89 -48.59 8.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.08 0.952 . . . . 1.88 109.68 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.2 pt -107.07 166.5 3.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.246 -0.65 . . . . 0.89 109.246 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.45 141.11 43.53 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 123.081 0.552 . . . . 2.28 111.269 174.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 73.3 t -90.8 122.77 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 108.41 -0.959 . . . . 0.87 108.41 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 56.1 t -97.64 115.35 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 108.745 -0.835 . . . . 1.56 108.745 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -107.54 113.37 26.64 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.953 -2.239 . . . . 5.28 104.953 163.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.613 ' HB3' ' HE2' ' A' ' 174' ' ' PHE . . . -128.13 148.84 50.6 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 107.77 -1.196 . . . . 0.71 107.77 177.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.96 105.96 15.99 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 123.996 0.81 . . . . 5.47 109.639 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.19 -134.51 13.6 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.609 -0.997 . . . . 1.87 110.609 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.32 137.64 39.99 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 122.043 -0.68 . . . . 2.02 109.697 -171.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.2 74.9 1.16 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.385 0.612 . . . . 2.47 110.964 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 78.76 -44.21 2.51 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 121.321 -0.862 . . . . 3.27 111.72 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 173' ' ' ALA . 75.3 m-20 -73.54 158.74 34.28 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.519 -0.919 . . . . 2.84 108.519 177.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.9 -46.88 61.76 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 125.029 1.332 . . . . 4.37 107.815 -170.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 32.3 p-80 -112.9 -71.81 0.74 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.288 -1.324 . . . . 3.99 110.709 178.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 170' ' ' ASP . . . 56.35 -77.66 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.454 1.502 . . . . 2.21 113.503 -171.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.613 ' HE2' ' HB3' ' A' ' 164' ' ' ALA . 9.5 m-85 -128.67 165.68 20.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.084 1.354 . . . . 6.05 109.036 -168.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -169.08 15.65 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.429 0.9 . . . . 2.67 113.429 -153.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 73.12 -160.65 54.07 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 109.812 -1.315 . . . . 1.27 109.812 -164.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -81.5 55.16 2.54 Favored 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.297 -0.531 . . . . 5.9 112.427 -170.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -142.51 -158.77 7.67 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 107.998 -2.041 . . . . 2.28 107.998 167.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.56 -138.07 41.48 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.172 -1.171 . . . . 1.93 110.172 172.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.499 HD11 H102 ' A' ' 269' ' ' NGH . 1.3 tp -78.84 151.69 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 109.07 -0.715 . . . . 2.23 109.07 173.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.9 tp -84.32 -39.13 19.53 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.523 1.529 . . . . 1.22 111.146 171.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -167.51 164.07 14.81 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.712 0.805 . . . . 0.8 109.694 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 28.7 p-80 -145.71 124.66 12.75 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 114.336 1.235 . . . . 1.06 114.336 175.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -139.52 161.28 37.88 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.065 2.146 . . . . 0.65 108.455 -173.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -148.77 141.84 24.9 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.443 -0.947 . . . . 2.71 108.443 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -92.08 -83.14 1.48 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 110.586 -1.006 . . . . 0.56 110.586 171.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.2 98.69 0.84 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.104 2.536 . . . . 1.3 111.07 -170.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -174.23 173.44 45.99 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.168 -1.973 . . . . 1.21 108.168 172.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 72.1 m -89.53 173.24 8.44 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.977 0.511 . . . . 2.73 109.679 169.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 54.66 -101.96 0.12 Allowed Glycine 0 C--O 1.243 0.686 0 C-N-CA 124.069 0.842 . . . . 1.61 111.424 174.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.531 ' CG1' ' HE2' ' A' ' 196' ' ' HIS . 7.1 tp -59.35 -41.14 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-O 117.912 -1.042 . . . . 1.59 109.036 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -33.96 129.48 0.47 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.633 1.111 . . . . 1.06 113.11 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 97.16 -34.94 4.73 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.268 1.413 . . . . 0.77 112.125 -167.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -86.47 159.37 19.34 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.736 1.268 . . . . 1.23 110.72 -165.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -133.66 121.59 22.21 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 113.385 0.883 . . . . 0.83 113.385 -172.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.531 ' HE2' ' CG1' ' A' ' 191' ' ' ILE . 2.2 m170 -109.15 112.25 24.31 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-O 117.473 -1.251 . . . . 2.22 111.957 -167.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -106.77 145.0 32.6 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 121.336 1.88 . . . . 3.17 111.213 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.36 83.34 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.226 1.011 . . . . 3.05 110.227 177.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.81 -24.64 67.84 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 120.376 -1.452 . . . . 2.73 109.901 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.44 -35.42 28.6 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.104 -0.997 . . . . 4.31 111.192 169.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -74.22 161.75 29.62 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 122.668 1.223 . . . . 1.66 110.985 176.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -102.46 95.93 6.59 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.243 -1.392 . . . . 3.04 107.243 176.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -78.27 140.23 38.87 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.549 -0.908 . . . . 1.11 108.549 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.6 p -122.61 105.85 10.47 Favored 'General case' 0 C--O 1.217 -0.64 0 N-CA-C 107.599 -1.26 . . . . 1.85 107.599 -172.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.2 t -48.47 -33.24 9.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.384 1.474 . . . . 2.23 114.329 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -71.07 178.27 3.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.634 0.73 . . . . 2.31 111.455 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.1 m -66.31 -47.4 73.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 121.116 -0.99 . . . . 4.7 109.665 -175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -62.82 132.41 43.62 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.107 -0.951 . . . . 3.26 111.241 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 101.46 -119.52 6.53 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.257 -1.137 . . . . 1.46 110.257 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 17.8 m -124.77 106.77 10.31 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.915 -1.143 . . . . 1.01 107.915 167.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -65.93 108.73 2.27 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.369 -0.604 . . . . 2.07 109.369 174.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 37.9 tp -50.78 -43.5 58.52 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.556 0.617 . . . . 1.61 111.115 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.586 ' CD1' HG22 ' A' ' 245' ' ' ILE . 45.9 t80 -44.06 -46.0 8.29 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.952 0.501 . . . . 1.46 111.125 175.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.407 HD12 ' HD1' ' A' ' 213' ' ' PHE . 3.5 mp -59.51 -63.45 1.3 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.516 0.674 . . . . 2.63 110.061 -173.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.349 1.3 m -60.32 -37.14 79.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.729 -0.669 . . . . 0.75 109.691 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.85 -53.84 50.12 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 117.955 -1.022 . . . . 0.33 110.549 176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 213' ' ' PHE . 62.7 t -50.66 -49.94 24.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 119.968 1.258 . . . . 0.7 109.538 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -56.82 -45.09 82.5 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.236 -0.915 . . . . 2.53 113.313 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -83.23 -48.18 10.75 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.085 -1.009 . . . . 3.04 112.448 -170.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.7 mp -55.37 -33.77 32.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.364 -1.347 . . . . 1.29 107.364 164.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.76 ' HA2' HD23 ' A' ' 224' ' ' LEU . . . -50.15 -61.44 5.79 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 110.95 -0.86 . . . . 0.63 110.95 168.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -47.36 -56.48 6.79 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.495 -1.003 . . . . 1.3 110.743 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.0 m -46.36 -40.15 11.48 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 113.226 0.825 . . . . 2.16 113.226 178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.76 HD23 ' HA2' ' A' ' 221' ' ' GLY . 0.5 OUTLIER -63.72 -33.88 76.64 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 118.924 0.784 . . . . 3.46 110.127 -174.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 130.61 46.18 0.15 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.933 1.73 . . . . 1.31 112.603 172.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.902 HD11 HG22 ' A' ' 258' ' ' ILE . 4.8 mt -119.45 147.72 44.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.586 1.193 . . . . 3.43 113.198 -172.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -88.13 166.42 35.18 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.879 1.228 . . . . 2.89 110.721 173.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -70.35 121.85 18.46 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.562 0.745 . . . . 1.65 110.536 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 66.5 m -77.01 -179.39 5.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.261 0.625 . . . . 1.1 110.903 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 17.6 m -135.53 39.1 2.86 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 125.038 1.335 . . . . 2.22 110.35 -175.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -135.77 136.33 23.32 Favored Pre-proline 0 N--CA 1.452 -0.325 0 N-CA-C 107.524 -1.287 . . . . 1.99 107.524 -177.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -82.3 -13.38 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.315 2.01 . . . . 1.01 114.325 -175.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -41.69 21.97 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.946 0.898 . . . . 1.92 109.068 173.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.29 139.88 34.92 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.333 1.053 . . . . 0.79 111.041 172.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 76.6 t -86.48 -15.18 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.943 0.878 . . . . 0.63 110.978 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.454 ' SD ' HD13 ' A' ' 226' ' ' LEU . 3.7 tpt -80.25 -21.71 42.48 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.166 -0.959 . . . . 1.69 112.916 -171.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -49.83 165.02 0.32 Allowed Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 128.091 2.556 . . . . 3.1 114.59 175.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -78.29 -21.11 10.69 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.536 1.491 . . . . 0.96 112.103 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.365 0.2 OUTLIER -78.64 -178.58 5.97 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.375 1.47 . . . . 1.28 110.686 -176.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -111.05 153.91 24.96 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.491 1.517 . . . . 3.05 108.926 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.0 tptt -149.53 133.13 16.75 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 106.858 -1.534 . . . . 2.32 106.858 169.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -70.19 111.69 6.0 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.416 -0.957 . . . . 2.87 108.416 170.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 20.6 m -121.65 118.17 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.737 0.815 . . . . 1.72 109.015 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.73 114.0 4.69 Favored 'General case' 0 N--CA 1.453 -0.282 0 O-C-N 121.557 -0.714 . . . . 3.36 110.31 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.586 HG22 ' CD1' ' A' ' 213' ' ' PHE . 1.1 pp -52.09 -29.72 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 C-N-CA 124.642 1.177 . . . . 3.56 111.231 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -52.8 -40.94 63.69 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.854 0.861 . . . . 3.78 110.884 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 35.9 m -73.48 -36.39 65.81 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 119.108 -0.472 . . . . 1.82 110.515 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 44.4 t80 52.47 72.65 0.39 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.007 0.923 . . . . 5.08 110.084 172.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.41 167.12 30.55 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.099 -1.001 . . . . 2.55 110.965 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.467 HD22 ' N ' ' A' ' 250' ' ' LEU . 0.9 OUTLIER -114.08 -170.46 1.72 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.542 1.937 . . . . 1.48 109.463 179.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 13.9 m -109.85 149.12 30.32 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 124.574 1.15 . . . . 0.7 111.295 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.4 -48.84 65.43 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.984 -0.448 . . . . 0.88 111.573 176.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -64.11 -22.88 67.11 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.902 0.334 . . . . 2.97 111.902 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -77.78 -47.83 18.02 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.967 -0.458 . . . . 3.41 110.805 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.418 ' HA ' HG13 ' A' ' 258' ' ' ILE . 67.8 mt -54.48 -40.65 50.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.151 1.38 . . . . 0.88 110.974 -175.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -56.8 -47.79 79.4 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 120.311 -1.493 . . . . 6.85 111.214 170.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -57.48 -48.92 77.45 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.625 1.107 . . . . 0.97 110.545 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.902 HG22 HD11 ' A' ' 226' ' ' LEU 0.26 1.6 pp -64.08 -44.03 97.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.185 0 O-C-N 121.491 -1.005 . . . . 2.43 109.686 -176.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -64.03 -30.23 71.32 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.465 -1.397 . . . . 2.25 111.787 176.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.6 t -50.76 -14.82 0.22 Allowed 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 114.535 1.309 . . . . 1.81 114.535 169.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.7 HD11 ' CD1' ' A' ' 224' ' ' LEU . 19.2 mt -41.04 -36.91 0.75 Allowed 'General case' 0 C--N 1.345 0.396 0 CA-C-N 120.388 1.449 . . . . 2.52 112.713 165.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -156.06 -34.41 0.09 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.399 0.518 . . . . 6.69 112.399 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.525 -1.708 . . . . 8.09 111.271 -176.404 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' NGH . . . . . 0.499 H102 HD11 ' A' ' 180' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 107.449 -1.315 . . . . 17.45 107.449 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.55 90.47 2.1 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 110.371 -1.091 . . . . 10.34 110.371 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.49 75.66 3.84 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.265 1.977 . . . . 11.57 109.716 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.4 p -93.46 111.33 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.986 0.915 . . . . 6.54 109.845 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -163.01 166.73 23.37 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.593 -0.891 . . . . 11.43 108.593 171.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -151.8 78.0 1.24 Allowed 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 126.41 1.884 . . . . 8.07 106.045 166.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.7 mttt 52.62 70.27 0.59 Allowed 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 122.494 1.14 . . . . 5.8 111.582 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -73.7 -46.77 44.24 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 121.172 -0.955 . . . . 3.2 108.572 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -126.82 118.41 24.57 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.287 0.635 . . . . 3.7 112.452 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 114' ' ' ILE . 1.6 mp -97.15 92.71 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 N-CA-C 107.251 -1.389 . . . . 2.21 107.251 172.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.6 p -81.39 136.97 35.73 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.338 -0.986 . . . . 1.27 108.338 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.43 ' HA ' ' HB1' ' A' ' 157' ' ' ALA . 43.4 p90 -142.51 164.87 28.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 118.336 0.516 . . . . 4.13 112.294 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 -147.1 142.87 27.85 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.129 0.971 . . . . 4.75 108.435 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.92 164.3 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.555 0.742 . . . . 0.92 109.327 172.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.606 HD22 ' H ' ' A' ' 119' ' ' ASN . 0.1 OUTLIER -109.33 -56.33 2.31 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 126.148 1.779 . . . . 3.32 108.441 179.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -139.77 120.98 14.83 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.776 -0.824 . . . . 3.17 108.776 -167.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -81.26 113.08 19.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.349 -0.982 . . . . 2.35 108.349 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -52.27 128.78 40.98 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 123.025 0.53 . . . . 2.32 110.314 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.68 -15.88 11.95 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 123.69 2.927 . . . . 1.53 110.553 173.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -46.2 -39.17 9.36 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.366 1.066 . . . . 2.04 110.479 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 42.4 mtm -124.95 -176.72 3.63 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.316 1.447 . . . . 1.95 109.954 177.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -73.87 144.01 45.61 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.432 -0.581 . . . . 3.05 109.432 170.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 64.2 ttt-85 -51.04 -45.55 61.36 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.413 -0.804 . . . . 2.7 110.722 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -61.81 -13.0 19.94 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.508 0.723 . . . . 3.41 112.028 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -94.52 -45.38 7.44 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.344 1.458 . . . . 1.9 109.568 172.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 52.4 t -55.8 -59.74 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 124.792 1.237 . . . . 1.18 109.831 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.36 -24.14 65.67 Favored 'General case' 0 C--O 1.221 -0.399 0 C-N-CA 117.602 -1.639 . . . . 1.78 108.987 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -64.55 -46.61 82.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.798 0.727 . . . . 1.91 111.208 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.09 -53.34 58.23 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 123.465 0.706 . . . . 0.37 109.846 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.4 ' O ' HD13 ' A' ' 134' ' ' ILE . 0.2 OUTLIER -69.65 -36.84 72.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 109.516 -0.549 . . . . 2.04 109.516 -178.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -57.27 12.45 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 122.173 0.987 . . . . 4.74 108.511 178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -62.03 -43.96 97.72 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.225 -0.657 . . . . 1.57 109.225 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.466 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -48.39 -53.99 15.64 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 123.437 0.695 . . . . 0.45 112.758 176.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 149' ' ' PHE . 0.3 OUTLIER -62.25 -47.02 86.23 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 119.304 -0.958 . . . . 6.56 109.103 176.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -57.31 -37.05 71.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 122.511 0.324 . . . . 1.93 110.704 -169.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.0 t -54.63 -52.22 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 109.139 -0.689 . . . . 0.79 109.139 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.87 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 64.4 m95 -69.69 -35.29 74.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.501 -0.749 . . . . 0.89 109.463 -177.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.6 t -64.2 -16.46 62.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.375 0.67 . . . . 1.48 112.16 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -83.38 -51.05 7.73 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.116 -1.068 . . . . 1.2 108.116 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.464 HG11 HD23 ' A' ' 250' ' ' LEU . 30.5 m -74.54 -44.46 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 112.393 0.516 . . . . 1.6 112.393 -177.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.462 ' CG2' HD13 ' A' ' 258' ' ' ILE . 56.4 p -84.84 150.63 56.34 Favored Pre-proline 0 N--CA 1.445 -0.714 0 N-CA-C 108.902 -0.777 . . . . 0.74 108.902 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.52 10.46 1.56 Allowed 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.61 2.207 . . . . 0.84 112.636 174.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 43.8 mt -67.72 133.95 50.19 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.263 1.425 . . . . 1.92 110.309 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.56 82.68 1.69 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.832 -1.173 . . . . 4.67 107.832 178.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.528 ' HB2' ' CD1' ' A' ' 138' ' ' PHE . 77.4 m-85 -67.66 159.17 30.55 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.051 -0.522 . . . . 5.24 111.131 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 13.3 t -155.79 125.87 6.59 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.83 0.741 . . . . 0.98 110.629 177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -78.78 137.26 37.65 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 107.256 -1.387 . . . . 2.19 107.256 167.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.2 pt -135.08 105.58 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.467 -0.938 . . . . 1.67 108.467 170.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -77.41 -15.45 59.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.486 -0.325 . . . . 3.13 110.169 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 26.3 m -127.32 102.02 6.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.308 1.043 . . . . 2.06 109.249 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.0 -155.26 26.36 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 108.81 -1.716 . . . . 1.41 108.81 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 31.4 mtp -117.71 130.16 56.16 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.129 2.572 . . . . 4.14 105.88 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.43 ' HB1' ' HA ' ' A' ' 116' ' ' TYR . . . -119.14 161.19 20.73 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.291 1.036 . . . . 0.75 109.91 -173.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -68.82 -54.61 14.83 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 108.972 -0.751 . . . . 1.87 108.972 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.3 pt -114.3 135.96 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.527 0.731 . . . . 1.16 109.271 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.72 131.56 52.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.224 -1.028 . . . . 2.19 108.224 172.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.32 124.54 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 106.937 -1.505 . . . . 0.83 106.937 169.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 91.9 t -98.51 137.84 24.85 Favored 'Isoleucine or valine' 0 C--N 1.346 0.422 0 C-N-CA 125.049 1.339 . . . . 1.22 108.92 171.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -130.26 107.56 9.37 Favored 'General case' 0 C--N 1.335 -0.054 0 N-CA-C 106.569 -1.641 . . . . 5.34 106.569 171.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -123.26 154.42 38.84 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.51 0.672 . . . . 0.77 112.35 -173.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -92.17 70.01 5.28 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.792 0.837 . . . . 6.2 109.66 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 95.13 -150.33 19.65 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 110.66 -0.976 . . . . 2.6 110.66 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.55 81.3 3.23 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 121.96 -0.729 . . . . 2.89 112.107 -162.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.11 64.48 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.876 1.27 . . . . 2.59 112.561 173.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.73 48.45 66.99 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.551 -1.02 . . . . 2.17 110.551 -175.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -119.1 155.63 31.19 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 104.941 -2.244 . . . . 2.4 104.941 160.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -75.75 -58.28 3.38 Favored 'General case' 0 C--O 1.227 -0.113 0 N-CA-C 108.715 -0.846 . . . . 5.0 108.715 171.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -146.22 102.18 3.58 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.991 1.316 . . . . 5.39 107.812 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -163.69 -38.5 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 123.355 0.662 . . . . 3.92 111.333 -177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -110.09 166.54 10.87 Favored 'General case' 0 CA--C 1.52 -0.202 0 C-N-CA 122.933 0.493 . . . . 6.46 110.085 166.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -172.92 164.94 5.1 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 127.389 2.276 . . . . 3.89 106.539 -170.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -72.39 -143.35 0.47 Allowed Glycine 0 CA--C 1.525 0.68 0 O-C-N 123.969 0.793 . . . . 1.76 111.344 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -61.73 108.15 0.95 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.392 0.677 . . . . 5.17 110.795 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.24 -145.68 18.11 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 109.679 -1.368 . . . . 1.71 109.679 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 45.44 -126.93 8.02 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 126.136 1.827 . . . . 1.58 111.706 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.3 mm -79.99 144.0 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 CA-C-O 122.218 1.008 . . . . 1.99 108.702 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.585 HD22 ' H1 ' ' A' ' 269' ' ' NGH . 6.0 mp -84.23 -62.04 1.66 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.576 1.95 . . . . 1.04 109.445 170.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -159.56 158.4 31.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 120.637 -1.29 . . . . 0.53 110.151 -172.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 24.2 p-80 -144.06 135.52 25.83 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 114.247 1.202 . . . . 1.22 114.247 172.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' A' ' 222' ' ' HIS . . . -149.43 164.04 36.09 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.264 2.226 . . . . 0.54 107.8 -169.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -150.05 143.49 25.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.09 -0.707 . . . . 3.03 109.09 -173.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -87.11 -130.18 2.94 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.789 -1.006 . . . . 0.63 110.665 177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.09 105.21 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.54 2.16 . . . . 2.51 110.56 -173.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -167.36 168.05 40.26 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 107.56 -2.216 . . . . 1.1 107.56 176.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.5 m -78.16 167.65 21.08 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.42 0.629 . . . . 2.04 111.659 -176.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 53.59 -111.78 2.05 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.173 0.892 . . . . 1.22 112.165 173.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.5 tp -60.55 -37.26 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 118.239 -0.886 . . . . 1.34 109.61 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -32.58 131.42 0.25 Allowed Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.176 1.37 . . . . 0.96 113.199 173.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 100.08 -48.89 1.18 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.58 1.562 . . . . 0.64 111.171 -165.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -84.45 153.13 23.55 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 108.537 -0.912 . . . . 1.3 108.537 -161.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -126.39 120.57 30.16 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 118.001 -0.999 . . . . 0.61 112.274 -172.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.47 129.51 56.53 Favored 'General case' 0 C--N 1.348 0.517 0 CA-C-N 119.213 0.915 . . . . 2.36 110.123 -166.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.419 ' CE2' ' HG3' ' A' ' 219' ' ' GLU . 25.2 m-85 -121.63 150.72 41.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 118.736 0.698 . . . . 2.84 110.252 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -79.55 77.73 6.12 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 122.082 0.944 . . . . 3.6 111.962 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -48.06 -33.43 8.07 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 119.971 -1.706 . . . . 2.75 111.506 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -36.32 -47.8 0.61 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.773 1.229 . . . . 2.65 112.004 171.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -73.81 170.18 15.86 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.09 1.356 . . . . 1.77 111.0 -175.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -107.41 94.03 4.87 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 106.885 -1.524 . . . . 2.63 106.885 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -82.83 151.46 26.05 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.587 -0.733 . . . . 1.4 109.652 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.99 161.99 29.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.725 0.774 . . . . 2.23 110.836 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.39 -41.02 70.18 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.401 2.28 . . . . 1.7 111.684 169.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -80.37 157.79 26.22 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.533 -0.758 . . . . 2.32 110.358 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.8 m -70.58 -33.67 71.34 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.175 1.39 . . . . 4.78 111.622 -170.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.69 116.3 8.43 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-O 118.402 -1.221 . . . . 2.59 110.244 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 109.18 -121.02 6.0 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 107.812 -2.115 . . . . 1.31 107.812 -174.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.4 m -124.72 138.66 54.28 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.681 -1.229 . . . . 0.77 107.681 159.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.27 116.44 29.01 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.83 -0.623 . . . . 2.18 109.864 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.74 -56.43 10.28 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.268 0.627 . . . . 1.44 109.706 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.583 ' O ' HG23 ' A' ' 217' ' ' VAL . 43.3 t80 -43.15 -50.87 6.19 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.515 1.526 . . . . 1.54 111.892 176.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.412 ' C ' HD23 ' A' ' 214' ' ' LEU . 6.0 tt -62.37 -58.12 8.84 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.61 -0.515 . . . . 1.45 109.61 -172.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.291 6.1 m -58.16 -41.47 83.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 120.948 -0.301 . . . . 0.77 110.649 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.79 -49.64 57.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 118.619 -0.705 . . . . 0.42 111.009 176.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 213' ' ' PHE . 58.3 t -57.28 -44.76 84.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 119.533 1.06 . . . . 0.81 111.098 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.62 ' CD2' ' CE1' ' A' ' 222' ' ' HIS . 1.0 OUTLIER -57.1 -50.22 73.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.522 1.129 . . . . 2.52 111.948 172.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.58 ' HG2' ' HD1' ' A' ' 218' ' ' HIS . 15.0 mm-40 -71.16 -46.93 60.48 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.457 -0.777 . . . . 2.63 112.385 -174.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.11 -39.29 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 107.48 -1.304 . . . . 1.09 107.48 170.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -45.05 -56.92 5.73 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 123.659 0.647 . . . . 0.46 112.919 164.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.651 ' ND1' HD21 ' A' ' 226' ' ' LEU 0.266 0.3 OUTLIER -49.94 -46.62 52.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.781 0.79 . . . . 1.68 110.904 178.258 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.2 t -51.94 -38.05 54.99 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 123.491 0.494 . . . . 2.31 112.275 176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 mt -70.91 -59.35 2.84 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 107.528 -1.286 . . . . 2.16 107.528 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 139.44 104.11 0.59 Allowed Glycine 0 C--N 1.337 0.611 0 N-CA-C 110.016 -1.234 . . . . 1.7 110.016 178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.807 HD12 ' H ' ' A' ' 228' ' ' HIS . 3.1 pp -130.73 145.42 51.94 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.52 0.728 . . . . 5.38 111.847 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -101.06 28.34 16.48 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.65 1.119 . . . . 3.14 112.456 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.807 ' H ' HD12 ' A' ' 226' ' ' LEU . 32.7 m80 57.39 102.92 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 128.393 2.677 . . . . 2.09 112.698 -176.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 7.1 m -72.29 170.12 14.79 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.229 -0.656 . . . . 1.1 109.229 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 16.2 m -140.72 44.33 1.83 Allowed 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.472 -0.768 . . . . 2.32 110.268 -171.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -143.18 132.08 11.52 Favored Pre-proline 0 N--CA 1.447 -0.614 0 N-CA-C 106.977 -1.49 . . . . 1.75 106.977 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.56 -14.82 27.62 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.972 1.781 . . . . 1.63 114.153 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -72.13 -23.61 61.33 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.475 1.034 . . . . 1.5 110.269 171.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.53 ' HB1' ' OD1' ' A' ' 254' ' ' ASP . . . -76.31 158.03 31.91 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.357 0.599 . . . . 1.17 110.607 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.421 HG11 ' CG1' ' A' ' 217' ' ' VAL . 45.2 t -110.99 -25.98 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.302 1.441 . . . . 0.79 111.074 173.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.546 ' HE3' HD23 ' A' ' 226' ' ' LEU . 52.6 mmm -65.92 -11.86 50.35 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.158 -0.964 . . . . 2.96 111.759 173.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -54.57 159.35 3.45 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 125.788 1.635 . . . . 3.61 113.959 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -82.25 -17.86 7.59 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.92 2.413 . . . . 0.97 111.524 170.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.3 0.2 OUTLIER -77.21 176.06 9.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.737 1.215 . . . . 1.81 108.776 179.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.406 ' CE2' HD13 ' A' ' 214' ' ' LEU . 51.2 t80 -143.19 141.27 31.08 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 104.568 -2.382 . . . . 2.51 104.568 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -156.24 145.21 20.4 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 104.873 -2.269 . . . . 4.32 104.873 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -49.04 109.59 0.27 Allowed 'General case' 0 C--N 1.339 0.118 0 N-CA-C 108.157 -1.053 . . . . 2.62 108.157 168.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.91 149.06 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 123.908 0.883 . . . . 1.75 108.891 171.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -60.0 78.5 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.496 2.318 . . . . 5.97 111.236 177.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 39.0 mm -44.95 -35.12 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 124.864 1.266 . . . . 3.81 110.794 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -55.06 -64.76 0.74 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.179 0.807 . . . . 4.59 113.179 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 92.7 m -82.22 -51.18 8.19 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.676 -0.861 . . . . 2.42 108.676 -177.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 217' ' ' VAL . 29.2 t80 38.8 72.9 0.12 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.645 1.978 . . . . 7.25 113.083 174.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.75 159.29 15.9 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.266 -0.879 . . . . 4.93 109.532 178.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.691 HD12 ' CH2' ' A' ' 141' ' ' TRP . 1.6 mm? -85.91 143.88 27.97 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.543 -0.91 . . . . 1.02 108.543 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.0 m -76.63 156.14 32.93 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 110.572 -0.158 . . . . 0.74 110.572 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.52 -45.87 80.88 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.783 -0.451 . . . . 0.91 109.783 173.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.15 -57.68 6.27 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 122.261 1.029 . . . . 2.6 109.699 174.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.53 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 12.1 m-20 -59.11 -39.61 82.81 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.563 -1.199 . . . . 2.22 112.266 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 35.5 mt -55.47 -35.14 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 119.114 0.87 . . . . 1.01 110.047 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -66.51 -53.31 36.43 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.468 -0.77 . . . . 4.42 110.014 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -50.77 -54.78 20.43 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 123.077 0.37 . . . . 1.29 112.532 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.87 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 2.6 pp -60.48 -43.35 94.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 121.851 -0.793 . . . . 2.24 110.462 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.411 ' HG2' HD12 ' A' ' 258' ' ' ILE . 2.2 mt-30 -67.03 -17.17 64.79 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.66 1.118 . . . . 2.56 112.243 174.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.1 t -66.12 -11.66 50.5 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 117.246 -1.359 . . . . 2.61 113.407 167.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.626 HD13 ' O ' ' A' ' 261' ' ' LEU 0.293 0.0 OUTLIER -52.58 87.47 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.084 0 CA-C-N 120.66 1.573 . . . . 3.83 110.162 172.297 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -73.62 -41.54 62.66 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 120.444 -1.41 . . . . 6.82 112.167 -166.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.943 0 CA-C-O 117.407 -1.774 . . . . 9.5 109.64 -175.396 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' NGH . . . . . 0.585 ' H1 ' HD22 ' A' ' 181' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 N--CA 1.475 0.813 0 CA-C-O 120.815 0.34 . . . . 11.37 110.655 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 165.45 -176.45 41.03 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 108.43 -1.868 . . . . 7.72 108.43 -171.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.4 152.51 71.15 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.359 2.706 . . . . 9.83 110.436 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.6 p -166.78 158.11 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 106.488 -1.671 . . . . 5.65 106.488 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 22.7 m0 -89.29 161.6 16.29 Favored 'General case' 0 C--N 1.34 0.192 0 CA-C-N 119.478 1.036 . . . . 10.81 110.494 172.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -102.68 -8.55 20.81 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.938 -1.028 . . . . 9.89 112.276 -174.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -100.98 -87.13 0.39 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.048 0.939 . . . . 5.56 108.477 171.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 67.38 -61.14 0.36 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.16 1.784 . . . . 3.75 110.283 -168.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -113.25 130.16 56.32 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 125.848 1.659 . . . . 2.87 109.72 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.8 mt -138.45 105.51 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 O-C-N 123.54 0.525 . . . . 2.58 110.499 173.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 p -101.57 145.82 28.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.474 1.109 . . . . 1.19 110.914 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.411 ' CZ ' ' CE1' ' A' ' 138' ' ' PHE . 6.8 m-85 -127.1 150.11 49.63 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.305 0.642 . . . . 5.84 110.58 -177.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -138.59 142.13 39.18 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.122 0.569 . . . . 4.8 109.822 174.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.405 HD11 ' HE2' ' A' ' 151' ' ' LYS . 2.7 mt -99.8 151.71 4.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.936 -1.135 . . . . 1.01 107.936 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -91.92 -56.5 3.06 Favored 'General case' 0 CA--C 1.51 -0.562 0 N-CA-C 108.001 -1.111 . . . . 4.02 108.001 177.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -144.01 157.86 44.07 Favored 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 124.959 1.304 . . . . 2.79 108.78 -171.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -112.75 143.86 43.25 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.659 1.184 . . . . 2.24 108.985 -169.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.537 HG22 ' H ' ' A' ' 125' ' ' MET . 0.8 OUTLIER -75.31 127.21 86.75 Favored Pre-proline 0 N--CA 1.446 -0.632 0 N-CA-C 108.528 -0.916 . . . . 2.51 108.528 179.511 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.26 -18.13 9.98 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.13 2.553 . . . . 1.67 112.033 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.98 -46.79 64.99 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 118.983 0.811 . . . . 2.23 109.609 174.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.537 ' H ' HG22 ' A' ' 122' ' ' THR . 50.8 mtm -105.96 174.26 5.96 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.836 -1.075 . . . . 2.06 109.009 179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -80.76 135.11 35.93 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.228 -1.027 . . . . 2.92 108.228 176.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -45.76 -52.24 11.4 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 118.673 0.669 . . . . 3.02 111.97 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -51.68 -46.87 63.99 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.482 -0.487 . . . . 3.87 109.731 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.43 -39.96 92.74 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.465 1.506 . . . . 1.89 111.541 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.8 t -56.04 -56.5 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 108.205 -1.035 . . . . 1.26 108.205 175.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.8 -22.88 61.51 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 119.026 -1.07 . . . . 1.73 110.312 -176.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -67.9 -49.33 62.56 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.24 1.016 . . . . 2.18 109.194 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.44 -54.74 36.69 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 123.71 0.804 . . . . 0.44 109.213 174.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -68.0 -34.71 68.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 120.212 -0.595 . . . . 2.33 110.356 -176.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -56.45 -60.47 3.48 Favored 'General case' 0 C--N 1.344 0.358 0 N-CA-C 108.191 -1.04 . . . . 4.0 108.191 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -62.65 -42.9 99.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.592 1.557 . . . . 1.45 108.78 -172.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.38 -54.16 18.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.728 0.811 . . . . 0.52 110.328 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.556 ' CE1' HG23 ' A' ' 220' ' ' ILE . 4.0 m-85 -58.84 -51.91 68.01 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 118.886 -0.578 . . . . 4.51 110.999 171.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -50.42 -33.5 21.06 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.745 0.646 . . . . 2.16 112.745 -174.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.762 HG12 HD21 ' A' ' 250' ' ' LEU . 77.8 t -69.21 -47.32 74.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.583 0.753 . . . . 1.11 110.468 175.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.969 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 7.1 m95 -69.78 -32.4 70.86 Favored 'General case' 0 N--CA 1.456 -0.155 0 O-C-N 120.631 -1.293 . . . . 0.84 110.638 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.47 -11.08 60.34 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.1 1.36 . . . . 1.22 110.778 176.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -80.63 -45.37 17.38 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 107.809 -1.182 . . . . 1.4 107.809 177.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.0 m -84.07 -45.64 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 112.473 0.546 . . . . 1.5 112.473 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.775 HG22 HD13 ' A' ' 258' ' ' ILE . 19.9 p -78.86 150.8 75.84 Favored Pre-proline 0 N--CA 1.448 -0.542 0 N-CA-C 107.768 -1.197 . . . . 0.74 107.768 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -72.96 1.91 6.02 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 121.971 1.781 . . . . 1.09 112.678 178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.1 mt -69.6 142.14 53.59 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.384 1.474 . . . . 2.05 109.274 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 103.0 12.62 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 108.749 -0.834 . . . . 3.81 108.749 174.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.547 ' CD2' ' HB3' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -67.96 146.3 53.7 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.551 0.74 . . . . 6.98 110.917 176.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.7 t -152.44 95.15 2.0 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.638 0.653 . . . . 0.88 111.964 171.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.405 ' HE2' HD11 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -76.92 133.81 39.13 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 120.583 -1.323 . . . . 3.0 108.41 171.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.4 pp -130.56 174.38 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 106.392 -1.707 . . . . 1.77 106.392 171.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -134.14 21.24 3.76 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 121.613 -0.679 . . . . 3.47 109.525 172.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 85.5 m -157.03 117.16 3.51 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.071 -1.455 . . . . 2.21 107.071 -176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 121.34 -144.63 16.72 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 108.209 -1.956 . . . . 1.95 108.209 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 33.0 mtt -110.11 139.11 45.6 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.982 1.313 . . . . 4.18 109.43 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -127.23 159.74 33.39 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.241 1.416 . . . . 0.99 109.809 173.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.42 -54.45 6.71 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.054 -1.462 . . . . 2.53 107.054 168.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.58 151.58 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-O 122.397 1.094 . . . . 1.69 111.253 -168.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.7 mt -126.08 125.01 41.87 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 112.398 -2.183 . . . . 2.25 107.876 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 38.0 t -91.87 105.43 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 107.934 -1.136 . . . . 0.96 107.934 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 62.2 t -110.8 102.88 14.61 Favored 'Isoleucine or valine' 0 C--N 1.344 0.341 0 C-N-CA 123.916 0.887 . . . . 1.79 109.237 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -80.61 155.98 26.62 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 107.955 -1.128 . . . . 6.57 107.955 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -158.16 -173.49 4.36 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.176 0.444 . . . . 1.08 110.199 167.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 2.7 ptt-85 -129.5 145.89 51.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.296 1.039 . . . . 4.28 108.876 170.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 49.4 -126.24 19.15 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.354 0.978 . . . . 1.97 111.987 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.38 132.92 37.57 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 124.301 1.04 . . . . 2.34 109.677 -173.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.417 ' O ' ' CG ' ' A' ' 168' ' ' HIS 0.255 0.0 OUTLIER -158.66 82.94 0.81 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 123.277 1.513 . . . . 3.41 111.193 179.266 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 80.96 -57.11 4.84 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.081 -1.208 . . . . 2.41 110.081 -176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.15 149.4 27.98 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.188 -1.042 . . . . 2.92 108.188 167.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -76.14 -55.96 5.09 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.663 1.585 . . . . 4.52 107.712 -169.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 37.8 m170 -68.96 -71.52 0.22 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 114.856 -1.065 . . . . 5.03 109.476 -176.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 53.66 -111.8 0.64 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.173 -0.917 . . . . 2.22 111.234 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.407 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 39.5 t80 -92.08 156.03 17.66 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 122.434 1.111 . . . . 7.68 110.318 175.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.407 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 35.9 p30 -166.02 30.48 0.05 OUTLIER 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 113.774 -1.557 . . . . 3.52 110.127 -152.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 84.63 172.06 48.72 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.435 -0.666 . . . . 2.34 111.435 -172.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.94 124.99 18.45 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.631 -0.507 . . . . 3.74 109.631 167.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 97.08 -154.67 20.55 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.283 -1.127 . . . . 2.07 110.283 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 57.61 -122.94 31.11 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 109.451 -1.459 . . . . 1.8 109.451 -173.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 8.6 mm -75.93 128.79 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 105.961 -1.866 . . . . 1.77 105.961 168.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.3 mp -81.08 -50.67 9.36 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.008 -0.738 . . . . 1.28 109.008 172.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -161.71 163.61 29.59 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.369 0.268 . . . . 0.55 110.328 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -142.82 112.41 6.83 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.321 1.448 . . . . 1.25 113.691 -169.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -146.75 162.0 39.46 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 127.443 2.297 . . . . 0.78 107.166 -175.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.86 151.83 16.78 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.801 -0.814 . . . . 5.77 108.801 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -102.5 -84.42 1.8 Allowed Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.61 1.1 . . . . 0.82 110.486 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.62 94.46 0.61 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 123.806 3.004 . . . . 1.3 110.625 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -163.91 154.75 25.79 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 108.412 -1.875 . . . . 0.94 108.412 170.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.7 m -78.44 170.28 16.9 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.418 -0.586 . . . . 2.44 109.418 174.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 72.19 -118.81 6.99 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.517 -1.433 . . . . 1.99 109.517 -175.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . 0.266 3.5 tp -84.92 21.71 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 124.304 1.041 . . . . 3.44 112.723 -168.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -55.46 143.32 35.23 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 120.891 -1.131 . . . . 1.89 114.231 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 94.04 -32.67 5.73 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.572 1.082 . . . . 0.9 111.111 -173.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -88.28 158.97 18.31 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.666 0.733 . . . . 1.6 109.423 -158.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -142.71 127.15 17.79 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.114 0.783 . . . . 0.82 113.114 -157.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -117.8 131.51 56.56 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 117.94 -1.029 . . . . 2.38 110.673 -175.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -113.54 152.17 30.6 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.561 0.696 . . . . 6.33 111.556 167.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.19 85.08 0.75 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.773 -1.103 . . . . 2.79 108.529 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -60.91 -31.74 71.23 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.4 -1.438 . . . . 2.53 111.029 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -47.62 -42.3 23.86 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.304 0.573 . . . . 2.73 110.517 172.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -68.36 135.34 51.66 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.486 -1.301 . . . . 2.13 107.486 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -88.27 94.85 9.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.195 -1.78 . . . . 2.64 106.195 -174.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -76.12 138.05 40.5 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.663 -1.606 . . . . 1.15 106.663 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 35.9 p -118.01 124.08 47.27 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 106.024 -1.843 . . . . 1.77 106.024 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.1 t -51.91 -46.5 64.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 121.657 2.026 . . . . 1.89 110.452 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.92 132.67 47.19 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.229 -0.896 . . . . 2.83 109.768 167.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 11.1 p -39.82 -57.08 1.64 Allowed 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 125.693 1.597 . . . . 3.68 110.744 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 18.95 -88.9 0.01 OUTLIER Glycine 0 CA--C 1.524 0.622 0 C-N-CA 128.564 2.983 . . . . 2.45 115.406 163.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -81.97 -80.22 0.93 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.811 -1.716 . . . . 1.03 108.811 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.3 m -150.95 111.2 4.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.048 -1.093 . . . . 1.01 108.048 170.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -61.33 117.81 6.12 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.35 0.66 . . . . 1.52 110.822 171.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 46.0 tp -53.69 -48.25 69.71 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 119.298 -0.382 . . . . 1.85 110.089 178.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.444 ' O ' HG23 ' A' ' 217' ' ' VAL . 31.4 t80 -49.68 -42.91 46.75 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.993 0.517 . . . . 1.45 111.152 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.44 ' C ' HD23 ' A' ' 214' ' ' LEU . 9.3 tt -60.34 -59.44 5.41 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.041 0.937 . . . . 1.33 110.32 -176.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.265 0.2 OUTLIER -61.77 -38.71 89.04 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.647 -0.252 . . . . 0.92 111.073 177.458 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.42 -56.67 16.36 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 117.954 -1.022 . . . . 0.44 109.343 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 213' ' ' PHE . 93.0 t -47.54 -42.6 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 119.996 1.271 . . . . 0.74 110.986 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.43 ' CG ' ' H4 ' ' A' ' 269' ' ' NGH . 0.2 OUTLIER -59.92 -51.06 71.29 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.119 0.567 . . . . 2.84 111.263 175.365 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -64.53 -54.71 28.01 Favored 'General case' 0 C--O 1.218 -0.582 0 O-C-N 121.043 -1.036 . . . . 4.15 110.845 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.556 HG23 ' CE1' ' A' ' 138' ' ' PHE . 1.7 mp -49.34 -46.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 127.041 2.137 . . . . 1.27 109.247 179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -58.5 -44.84 95.17 Favored Glycine 0 CA--C 1.534 1.261 0 O-C-N 121.482 -0.761 . . . . 0.6 111.506 172.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . 0.264 6.7 m-70 -51.94 -49.06 63.88 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.237 1.518 . . . . 1.29 110.855 171.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.3 m -55.42 -44.9 76.7 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.48 1.112 . . . . 2.22 111.482 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 93.3 mt -59.28 -52.55 65.17 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.565 -0.531 . . . . 2.72 109.565 172.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.473 ' O ' HD21 ' A' ' 261' ' ' LEU . . . 139.37 92.27 0.23 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.679 1.133 . . . . 1.23 111.585 170.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 1.077 HD11 HG22 ' A' ' 258' ' ' ILE . 2.6 mt -145.96 112.46 5.89 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.242 1.021 . . . . 3.22 111.57 -171.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -79.0 43.38 2.44 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.68 1.133 . . . . 2.67 113.664 -174.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 71.6 m80 60.73 175.28 0.1 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.689 1.596 . . . . 1.93 113.79 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 69.7 m -139.84 -178.73 5.56 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 126.903 2.081 . . . . 1.09 108.07 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 27.7 t -143.33 31.74 1.35 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.905 0.882 . . . . 2.95 111.128 -173.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -127.92 137.3 30.5 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 106.932 -1.507 . . . . 1.65 106.932 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -78.97 -11.72 14.91 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.39 2.06 . . . . 1.17 114.77 -173.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 233' ' ' LYS . 25.9 mtmt -81.96 -29.12 32.34 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.916 0.886 . . . . 1.29 109.274 168.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -68.95 151.87 45.99 Favored 'General case' 0 CA--C 1.519 -0.229 0 O-C-N 121.883 -0.511 . . . . 0.7 109.774 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 88.4 t -98.27 -24.29 4.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 123.508 0.723 . . . . 0.79 109.993 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.565 ' SD ' HD13 ' A' ' 226' ' ' LEU . 0.6 OUTLIER -63.84 -15.09 58.01 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 114.029 1.122 . . . . 1.79 114.029 177.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -49.65 154.77 1.58 Allowed Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 113.032 0.752 . . . . 3.31 113.032 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -72.27 -23.05 21.32 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.473 1.449 . . . . 1.15 111.638 172.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.291 0.6 OUTLIER -79.31 -178.6 6.31 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.497 1.519 . . . . 1.47 111.084 -179.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -116.64 155.61 28.49 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.894 1.678 . . . . 2.36 107.026 171.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.77 125.65 7.76 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.113 -1.069 . . . . 2.26 108.113 165.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -63.37 125.69 24.98 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.066 0.946 . . . . 3.05 109.733 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 16.3 m -141.24 148.27 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 108.276 -1.009 . . . . 2.28 108.276 167.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.67 127.96 33.98 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.993 1.317 . . . . 3.63 110.239 177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 1.7 pp -58.35 -28.52 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 122.604 0.361 . . . . 3.48 111.917 -173.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -76.6 -43.12 39.85 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 123.625 0.77 . . . . 5.47 111.942 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 91.1 m -80.55 -27.18 37.6 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.32 0.648 . . . . 2.56 109.628 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -26.13 113.72 0.05 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.869 2.068 . . . . 7.72 112.403 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.35 158.18 44.78 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.129 1.371 . . . . 3.79 109.078 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.762 HD21 HG12 ' A' ' 140' ' ' VAL . 1.8 mm? -83.44 146.28 28.51 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.853 -1.166 . . . . 0.96 107.853 178.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.0 m -79.48 152.61 30.14 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 119.705 -0.188 . . . . 0.72 111.304 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.17 -42.46 63.45 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.635 0.374 . . . . 0.79 110.857 172.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -50.0 -57.81 6.79 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 122.287 1.041 . . . . 2.7 109.681 172.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.93 -41.34 87.11 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.23 -1.35 . . . . 2.38 110.495 -176.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 80.0 mt -54.97 -40.12 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 125.351 1.46 . . . . 1.01 111.389 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -67.9 -44.64 76.5 Favored 'General case' 0 C--O 1.232 0.17 0 O-C-N 120.694 -1.253 . . . . 4.37 110.22 174.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -46.65 -55.88 7.79 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.823 -0.911 . . . . 0.93 110.823 174.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 1.077 HG22 HD11 ' A' ' 226' ' ' LEU . 2.0 pp -64.62 -43.93 96.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 O-C-N 121.826 -0.808 . . . . 2.26 111.163 -175.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.603 ' N ' HD12 ' A' ' 258' ' ' ILE . 2.4 mt-30 -64.63 -18.41 64.9 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.628 0.649 . . . . 2.58 112.057 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.3 t -51.56 -33.11 30.97 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.738 0.699 . . . . 2.38 111.312 169.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 261' ' ' LEU . 16.2 mt -50.66 -61.77 2.0 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.218 0.917 . . . . 2.71 112.802 172.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -159.05 142.76 15.04 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.061 -1.829 . . . . 7.35 106.061 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.3 0 CA-C-O 116.459 -2.301 . . . . 9.11 108.182 167.059 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' NGH . . . . . 0.43 ' H4 ' ' CG ' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 107.52 -1.289 . . . . 21.17 107.52 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -168.41 87.3 0.09 OUTLIER Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.253 -1.139 . . . . 13.34 110.253 -175.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.7 147.21 62.77 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.157 1.905 . . . . 13.67 109.787 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.8 p -163.01 166.49 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 106.743 -1.577 . . . . 8.42 106.743 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 44.6 t-105 -150.18 171.4 16.97 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.655 0.782 . . . . 11.84 108.958 175.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -61.66 -28.25 69.25 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.706 0.802 . . . . 7.83 113.021 -176.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -126.76 -63.61 1.06 Allowed 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 123.361 0.665 . . . . 5.65 109.91 172.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 61.56 -63.07 0.09 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.908 1.283 . . . . 4.07 111.172 -159.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -77.8 99.68 6.0 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 118.41 0.55 . . . . 3.24 111.22 -170.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.8 mm -117.08 108.02 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.726 -0.842 . . . . 1.9 108.726 174.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.509 ' O ' ' HB1' ' A' ' 157' ' ' ALA . 40.3 p -120.03 125.05 47.39 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 117.792 -1.099 . . . . 1.21 109.3 -176.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -119.57 159.23 24.75 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.626 1.17 . . . . 3.86 112.24 -177.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -133.91 149.43 51.29 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.071 0.948 . . . . 5.55 109.362 174.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.8 mt -107.03 137.68 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.466 1.506 . . . . 1.16 107.271 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -98.22 -45.26 6.26 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.989 0.359 . . . . 2.72 110.423 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -143.32 161.99 36.87 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.794 -0.817 . . . . 2.22 108.794 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -127.41 134.15 49.92 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.47 -1.678 . . . . 2.82 106.47 -165.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.7 t -70.39 115.53 35.78 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 118.797 0.726 . . . . 2.6 109.754 -173.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -66.99 -17.05 51.06 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 124.006 3.137 . . . . 1.61 111.719 -173.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -33.15 -41.14 0.07 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 128.416 2.686 . . . . 2.12 112.074 170.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.3 mpp? -133.94 -179.88 5.82 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.1 0.96 . . . . 2.25 109.581 171.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -66.09 131.83 47.09 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.451 -0.944 . . . . 3.26 108.451 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -44.4 -45.06 8.77 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.063 0.394 . . . . 2.98 112.063 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -46.86 -47.61 21.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.553 0.692 . . . . 3.57 109.437 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -69.34 -39.05 78.37 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.434 -0.803 . . . . 2.06 111.709 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 80.7 t -58.08 -54.28 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 O-C-N 121.6 -0.687 . . . . 1.26 109.264 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.14 -25.76 67.12 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 118.02 -1.472 . . . . 1.69 109.294 177.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -66.13 -44.91 82.88 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 120.271 1.396 . . . . 1.9 110.207 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.75 -52.87 61.16 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 123.77 0.828 . . . . 0.39 110.048 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.67 -34.65 66.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 120.488 -0.485 . . . . 1.84 109.742 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.87 -57.01 14.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 122.604 1.192 . . . . 4.08 108.154 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.518 ' O ' HG23 ' A' ' 140' ' ' VAL . 6.8 mmmm -58.27 -49.01 78.65 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.997 -1.001 . . . . 1.66 108.765 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -44.69 -54.66 5.99 Favored 'General case' 0 C--N 1.342 0.247 0 C-N-CA 124.106 0.963 . . . . 0.52 112.52 175.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.425 ' HA ' HG21 ' A' ' 220' ' ' ILE . 2.1 p90 -62.38 -46.21 89.66 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 118.989 -1.084 . . . . 6.58 110.774 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.36 -42.31 73.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 123.316 0.385 . . . . 3.89 110.131 -173.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.629 HG12 HD21 ' A' ' 250' ' ' LEU . 1.4 t -54.01 -52.06 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 120.812 0.339 . . . . 1.34 110.088 -176.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.515 ' CZ3' ' HG ' ' A' ' 250' ' ' LEU . 67.3 m95 -71.9 -44.3 63.94 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.906 -0.775 . . . . 0.69 108.906 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.4 t -57.29 -26.78 61.4 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.985 0.514 . . . . 1.22 111.198 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -66.18 -39.44 89.7 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 122.743 0.417 . . . . 1.67 110.881 175.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 81.1 t -82.88 -55.44 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.932 1.293 . . . . 2.27 109.61 -177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 43.6 p -84.92 150.55 55.91 Favored Pre-proline 0 N--CA 1.447 -0.577 0 C-N-CA 123.166 0.586 . . . . 0.79 109.93 -172.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.96 8.13 1.79 Allowed 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 121.509 1.472 . . . . 0.85 112.949 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.69 111.95 12.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.326 1.05 . . . . 2.43 108.471 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.62 86.16 3.29 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.418 -1.327 . . . . 3.76 107.418 175.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -67.57 128.96 38.38 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.082 -0.963 . . . . 5.7 109.423 170.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.97 134.65 38.82 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 123.964 0.906 . . . . 0.85 110.162 172.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -92.84 127.22 38.27 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 107.605 -1.257 . . . . 2.11 107.605 173.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.7 pt -130.81 101.19 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.924 -1.139 . . . . 1.73 107.924 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -91.75 27.04 2.17 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.673 -0.642 . . . . 3.36 111.1 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.94 78.86 1.41 Allowed 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.89 1.276 . . . . 2.5 110.096 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 150.32 -132.29 3.9 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 108.697 -1.761 . . . . 1.49 108.697 171.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 53.1 mtt -128.55 144.86 51.23 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.851 1.66 . . . . 5.09 107.678 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.509 ' HB1' ' O ' ' A' ' 115' ' ' THR . . . -126.52 172.66 10.04 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.85 1.66 . . . . 0.74 109.534 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -79.73 -57.38 3.7 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.089 0.956 . . . . 1.92 108.982 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.3 pt -105.17 152.6 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.154 -0.93 . . . . 1.17 108.877 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 tt -131.11 130.34 43.02 Favored 'General case' 0 CA--C 1.523 -0.075 0 N-CA-C 113.31 0.856 . . . . 2.17 113.31 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.23 102.68 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 108.827 -0.805 . . . . 0.83 108.827 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 99.2 t -93.57 131.29 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.814 2.046 . . . . 1.37 108.813 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -129.12 112.92 14.47 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 105.641 -1.985 . . . . 4.96 105.641 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -133.97 161.65 34.22 Favored 'General case' 0 C--N 1.344 0.333 0 C-N-CA 123.658 0.783 . . . . 0.94 110.978 -165.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.4 121.06 32.76 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.446 1.098 . . . . 6.38 110.629 -170.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 65.09 -70.49 0.08 OUTLIER Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.543 -1.143 . . . . 1.84 112.216 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -112.28 163.98 13.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.148 1.474 . . . . 2.42 110.62 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -154.23 -45.69 0.09 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.511 0.724 . . . . 3.1 109.887 164.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -174.67 22.51 0.06 OUTLIER Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.524 -0.598 . . . . 2.8 113.391 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 17.7 p30 -158.35 175.5 13.64 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.454 1.501 . . . . 2.87 107.02 167.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -69.88 -47.39 62.73 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.099 1.36 . . . . 5.81 108.554 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -54.24 -49.17 70.1 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.18 -0.918 . . . . 4.09 111.39 -170.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 20.06 -109.9 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.698 1.999 . . . . 2.48 114.219 171.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 2.8 t80 -121.96 161.41 22.93 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 119.858 1.208 . . . . 7.46 107.771 165.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.43 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 40.7 p-10 -164.32 24.46 0.07 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 113.519 -1.673 . . . . 2.73 110.002 -148.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 86.08 171.34 47.85 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 122.157 0.865 . . . . 1.44 111.79 -172.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -72.21 100.86 2.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.658 -0.771 . . . . 4.72 109.34 176.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 131.13 -161.84 23.56 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 108.64 -1.784 . . . . 1.36 108.64 -167.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.68 -121.94 24.97 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 109.547 -1.421 . . . . 1.27 109.547 -175.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.69 HD11 ' H12' ' A' ' 269' ' ' NGH 0.396 1.8 tp -78.47 140.06 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 N-CA-C 107.361 -1.348 . . . . 1.7 107.361 175.439 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.41 -55.67 4.36 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.769 -0.826 . . . . 1.65 108.769 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -169.99 179.87 3.44 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.948 0.899 . . . . 0.85 110.09 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.54 143.41 51.18 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 125.955 1.702 . . . . 2.18 111.896 -176.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -161.71 159.17 26.97 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.207 -1.405 . . . . 0.77 107.207 164.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.5 143.82 15.06 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.75 -1.574 . . . . 4.17 106.75 -176.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.08 -86.6 1.71 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.025 -1.23 . . . . 0.56 110.025 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.64 99.38 0.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.254 2.636 . . . . 1.27 110.915 -175.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -175.39 165.11 35.85 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.064 -1.615 . . . . 0.96 109.064 172.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.68 168.7 16.04 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.164 0.586 . . . . 2.72 109.868 172.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 55.48 -105.79 0.47 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 124.01 0.814 . . . . 1.45 111.827 173.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.7 tp -64.2 -23.28 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.44 0.696 . . . . 1.66 111.002 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -49.4 143.34 9.74 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.854 -0.898 . . . . 0.96 110.854 170.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 84.2 -36.07 2.93 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.253 0.93 . . . . 0.61 112.358 -169.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -76.73 178.4 6.81 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 119.068 1.434 . . . . 1.27 110.681 -166.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -153.02 133.81 13.89 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.266 -2.494 . . . . 0.88 104.266 -165.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.457 ' CD2' ' C ' ' A' ' 196' ' ' HIS 0.315 14.3 t-80 -155.07 85.16 1.08 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 117.199 -1.8 . . . . 5.07 112.489 -133.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -103.67 147.16 27.57 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.244 1.018 . . . . 2.74 112.16 -158.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.87 81.03 0.46 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.022 1.329 . . . . 2.79 109.58 173.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -53.72 -50.04 66.78 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.068 -1.645 . . . . 3.03 111.329 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -51.0 -26.15 5.66 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.293 0.637 . . . . 3.4 111.674 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -68.43 153.06 44.49 Favored 'General case' 0 C--O 1.243 0.754 0 O-C-N 120.607 -1.308 . . . . 1.91 109.445 176.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -97.33 90.14 4.99 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 105.627 -1.99 . . . . 3.01 105.627 -175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -77.57 161.79 27.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.12 -1.067 . . . . 1.38 108.12 -177.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 56.7 p -132.75 141.88 48.75 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 122.088 0.946 . . . . 2.09 111.19 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.7 t -60.66 -40.32 91.63 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 125.607 1.563 . . . . 1.92 111.789 163.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -79.55 -177.08 5.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.607 1.163 . . . . 2.74 111.496 178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 41.6 t -72.89 -50.95 20.65 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.831 0.852 . . . . 4.74 110.77 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -55.07 112.71 3.06 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 123.853 0.74 . . . . 2.67 112.724 -167.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 108.4 -121.28 6.23 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 107.634 -2.186 . . . . 1.78 107.634 -177.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 16.7 m -119.35 130.56 55.42 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.666 -1.605 . . . . 1.24 106.666 168.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -89.48 118.9 29.47 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 109.211 -0.663 . . . . 1.26 109.211 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.98 -53.96 23.12 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 122.988 0.515 . . . . 1.54 109.808 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -54.98 -45.01 74.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.18 0.592 . . . . 2.03 110.67 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.598 ' CD2' ' H71' ' A' ' 269' ' ' NGH . 5.7 tt -62.29 -58.83 6.26 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 121.745 -0.597 . . . . 1.29 109.854 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.936 HG23 ' H2 ' ' A' ' 269' ' ' NGH 0.315 2.2 m -59.2 -33.13 70.6 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.522 -0.471 . . . . 0.72 110.922 178.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.0 -45.77 86.31 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.281 -0.887 . . . . 0.56 110.898 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 89.0 t -55.05 -48.47 75.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 120.044 1.293 . . . . 0.71 110.263 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.999 ' HD1' ' H72' ' A' ' 269' ' ' NGH . 0.3 OUTLIER -52.32 -53.06 49.22 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.478 1.511 . . . . 2.84 111.532 172.09 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -68.44 -53.14 25.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 119.159 0.89 . . . . 3.72 113.362 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.425 HG21 ' HA ' ' A' ' 138' ' ' PHE . 1.5 mp -56.01 -41.61 68.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 108.604 -0.887 . . . . 1.11 108.604 176.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.77 -48.44 78.01 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 111.289 -0.724 . . . . 0.62 111.289 173.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.406 ' CD2' ' O4 ' ' A' ' 269' ' ' NGH . 2.0 m170 -57.65 -45.72 85.12 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.295 -1.121 . . . . 2.14 111.209 175.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.7 t -54.98 -56.71 16.71 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.479 1.112 . . . . 1.77 110.94 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.6 pp -62.39 -34.69 77.22 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 120.323 -0.551 . . . . 2.75 111.779 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 146.35 107.79 0.53 Allowed Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.18 -1.168 . . . . 2.67 110.18 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 226' ' ' LEU . 0.9 OUTLIER -75.69 160.89 29.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 122.984 0.514 . . . . 7.11 111.923 176.587 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -148.22 42.69 0.84 Allowed Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.572 -1.411 . . . . 3.76 109.572 167.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -0.88 93.22 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 128.189 2.596 . . . . 2.22 116.139 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.8 m -74.89 171.03 14.76 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.351 0.66 . . . . 1.53 110.495 175.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 9.5 p -124.66 5.62 8.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.321 1.849 . . . . 3.0 111.216 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -96.75 128.0 37.42 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 125.134 1.374 . . . . 1.96 108.532 -172.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -62.55 -14.21 38.22 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.992 2.462 . . . . 1.75 113.614 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -80.11 -34.16 38.09 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.952 0.901 . . . . 2.22 110.279 174.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -76.68 136.41 39.11 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.68 -0.859 . . . . 0.76 108.68 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 45.8 t -85.55 -21.24 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 122.414 0.285 . . . . 0.59 110.345 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.08 -21.79 59.77 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 113.945 1.091 . . . . 1.91 113.945 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.681 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -49.48 173.15 0.08 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.56 2.344 . . . . 3.32 114.533 -173.087 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.425 ' O ' ' H5 ' ' A' ' 269' ' ' NGH . 89.6 Cg_endo -90.24 -22.1 0.82 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.759 1.639 . . . . 1.36 111.685 166.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.293 0.7 OUTLIER -86.94 100.73 12.8 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.78 1.232 . . . . 2.5 110.696 -170.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.489 ' HA ' ' H73' ' A' ' 269' ' ' NGH 0.329 31.5 t80 -73.63 133.24 43.42 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.036 0.834 . . . . 2.3 108.992 -179.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -155.56 145.99 21.92 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 106.82 -1.548 . . . . 2.78 106.82 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -53.37 127.36 24.54 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.981 0.912 . . . . 3.43 111.726 -177.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 31.7 m -98.86 146.55 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 112.708 0.633 . . . . 1.88 112.708 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -74.54 77.92 1.96 Allowed 'General case' 0 C--O 1.239 0.5 0 CA-C-O 121.878 0.847 . . . . 5.21 111.002 175.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 17.8 mm -54.2 -22.46 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 CA-C-N 115.875 -0.602 . . . . 4.12 111.498 168.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -43.57 -48.69 7.57 Favored 'General case' 0 C--O 1.227 -0.126 0 C-N-CA 123.192 0.597 . . . . 4.23 112.115 167.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.5 m -84.71 -41.78 15.9 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.134 0.574 . . . . 2.17 110.387 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 60.0 t80 58.5 76.24 0.35 Allowed 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.614 0.766 . . . . 4.34 109.778 178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.84 174.82 14.41 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 121.58 -0.7 . . . . 3.7 109.715 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.629 HD21 HG12 ' A' ' 140' ' ' VAL . 0.7 OUTLIER -116.98 163.1 16.73 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.028 1.331 . . . . 0.77 108.459 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 63.5 m -81.09 147.39 30.13 Favored 'General case' 0 C--O 1.225 -0.213 0 O-C-N 122.154 -0.341 . . . . 0.74 111.816 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.86 -40.24 60.24 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 122.986 0.514 . . . . 1.12 110.833 169.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -51.44 -58.46 6.2 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.095 0.95 . . . . 2.61 109.781 171.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -58.02 -45.07 87.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.96 1.304 . . . . 2.09 110.482 -173.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 63.3 mt -46.76 -38.79 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.319 1.448 . . . . 1.39 111.222 175.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -68.3 -46.55 70.01 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.896 0.771 . . . . 4.9 111.205 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -57.14 -55.36 30.73 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 118.788 0.722 . . . . 1.46 111.504 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.457 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 2.2 pp -61.15 -39.66 83.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 122.938 0.495 . . . . 2.81 111.426 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -70.0 -22.54 63.11 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.042 0.837 . . . . 4.0 112.282 172.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.9 t -64.73 -10.75 29.7 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 117.303 -1.332 . . . . 2.38 113.66 176.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.62 HD22 ' O ' ' A' ' 261' ' ' LEU 0.36 0.0 OUTLIER -44.03 91.65 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.682 1.593 . . . . 3.49 114.125 -176.621 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -105.5 54.94 0.69 Allowed 'General case' 0 CA--C 1.536 0.41 0 O-C-N 120.917 -1.115 . . . . 8.11 111.655 -170.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.112 0 N-CA-C 107.583 -2.207 . . . . 9.79 107.583 175.362 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' NGH . . . . . 0.999 ' H72' ' HD1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 107.705 -1.22 . . . . 11.95 107.705 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -70.12 164.65 51.86 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 118.763 0.71 . . . . 9.24 111.398 174.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -70.35 144.55 51.22 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 123.447 2.765 . . . . 11.89 109.507 173.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.9 124.66 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 109.131 -0.692 . . . . 7.07 109.131 176.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -162.53 124.75 2.73 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.89 1.276 . . . . 11.61 107.744 165.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -76.39 -35.21 58.75 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 110.133 -0.321 . . . . 7.32 110.133 169.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.14 -72.91 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.559 0.743 . . . . 5.37 110.355 -176.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 65.52 -71.39 0.08 Allowed 'General case' 0 C--N 1.341 0.225 0 C-N-CA 125.916 1.686 . . . . 3.34 110.189 -173.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -103.96 122.46 45.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.846 0.859 . . . . 5.11 110.065 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.446 ' HB ' ' CD1' ' A' ' 149' ' ' PHE . 1.5 mm -106.69 88.72 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.016 -1.105 . . . . 1.86 108.016 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 p -78.21 131.86 37.33 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 120.846 -1.159 . . . . 1.29 108.897 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.401 ' CE2' ' HB2' ' A' ' 151' ' ' LYS . 51.3 p90 -125.73 164.46 20.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.144 0.978 . . . . 4.18 110.614 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.21 149.61 28.15 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.636 -0.875 . . . . 6.4 108.636 177.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.5 mt -89.28 150.5 3.7 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 N-CA-C 108.311 -0.996 . . . . 0.95 108.311 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.551 HD22 ' H ' ' A' ' 119' ' ' ASN . 0.8 OUTLIER -81.45 -55.31 4.78 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.604 -0.887 . . . . 2.87 108.604 175.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -151.25 176.27 11.38 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.782 0.833 . . . . 2.02 109.31 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -106.41 146.93 29.89 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 124.294 1.038 . . . . 2.23 109.859 -174.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.2 t -93.25 141.19 23.68 Favored Pre-proline 0 N--CA 1.449 -0.503 0 C-N-CA 124.413 1.085 . . . . 2.17 108.353 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.79 -22.12 9.19 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.044 2.496 . . . . 1.57 111.308 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -29.85 -51.57 0.13 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.976 2.11 . . . . 2.21 113.013 172.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 11.3 mtm -131.29 170.51 14.52 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.934 1.294 . . . . 1.97 108.195 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -69.91 149.5 47.74 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.086 0.554 . . . . 3.08 109.578 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 29.0 ttt-85 -49.04 -44.95 42.09 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.265 0.626 . . . . 2.85 111.496 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -70.55 3.47 3.05 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.737 1.014 . . . . 2.99 113.737 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -112.12 -42.05 3.82 Favored 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 125.696 1.598 . . . . 1.96 109.635 164.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.8 t -51.74 -57.58 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.113 0.965 . . . . 1.25 109.538 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.23 -21.68 60.58 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 118.986 -1.086 . . . . 1.68 109.414 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -65.57 -47.5 75.59 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 119.191 0.905 . . . . 1.94 109.844 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.15 -52.65 63.58 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 124.533 1.133 . . . . 0.49 109.191 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.695 HD11 HD11 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -69.39 -40.97 80.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 120.853 -0.339 . . . . 1.45 111.191 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -49.74 -58.82 4.58 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.518 -1.289 . . . . 4.24 107.518 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.624 ' O ' HG23 ' A' ' 140' ' ' VAL . 34.8 mmtm -59.12 -49.81 76.46 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.334 1.454 . . . . 2.63 110.5 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.72 -49.95 45.91 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.529 0.732 . . . . 0.81 111.329 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.687 ' CE2' HD12 ' A' ' 134' ' ' ILE . 31.2 m-85 -58.55 -54.04 51.59 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.309 0.576 . . . . 4.83 109.91 173.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.23 -39.88 67.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.486 -0.779 . . . . 2.11 111.156 -172.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 136' ' ' LYS . 68.5 t -48.71 -64.24 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.772 1.229 . . . . 0.95 109.852 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.768 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 72.2 m95 -68.55 -35.28 77.2 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.693 -0.854 . . . . 1.16 108.693 -174.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.1 -16.78 63.86 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 123.708 0.63 . . . . 1.19 112.199 178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -82.42 -47.88 11.75 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 108.384 -0.969 . . . . 1.37 108.384 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.8 m -74.39 -43.88 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 N-CA-C 112.635 0.606 . . . . 1.62 112.635 -177.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 51.4 p -89.34 158.01 46.77 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 109.424 -0.584 . . . . 0.8 109.424 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.87 -0.95 9.18 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.431 2.088 . . . . 0.76 113.334 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.3 mt -59.91 141.31 55.71 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.259 1.424 . . . . 2.18 109.466 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -118.75 90.54 3.35 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.201 -1.037 . . . . 4.02 108.201 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.486 ' CD1' ' CD1' ' A' ' 138' ' ' PHE . 30.9 m-85 -70.03 143.73 52.44 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.03 -0.532 . . . . 5.91 109.969 173.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.0 t -151.88 130.74 12.48 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.553 0.615 . . . . 0.99 110.619 177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.401 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 4.0 ttmt -86.54 138.67 31.53 Favored 'General case' 0 C--N 1.34 0.184 0 N-CA-C 109.064 -0.717 . . . . 2.36 109.064 177.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.481 ' O ' HD12 ' A' ' 152' ' ' ILE . 1.8 pp -140.72 98.53 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 118.224 0.466 . . . . 2.04 110.515 178.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -80.2 26.73 0.35 Allowed 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.291 -1.506 . . . . 3.14 110.708 176.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 45.5 p -154.07 78.08 1.1 Allowed 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.157 0.983 . . . . 3.4 108.565 -171.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 145.87 -122.84 1.74 Allowed Glycine 0 C--N 1.335 0.513 0 N-CA-C 108.189 -1.965 . . . . 1.91 108.189 174.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 8.1 ptt? -149.71 135.07 18.25 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.573 -1.269 . . . . 5.92 107.573 -173.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -112.43 163.01 14.95 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 125.36 1.464 . . . . 0.73 110.141 -175.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -79.16 -44.72 21.37 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 121.991 0.9 . . . . 2.02 108.856 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 5.7 pt -112.91 166.44 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.832 0.825 . . . . 0.96 112.04 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.76 136.57 35.87 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.68 1.592 . . . . 2.22 109.272 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.2 t -79.49 138.76 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 107.375 -1.342 . . . . 1.25 107.375 166.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 73.7 t -108.25 139.42 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 106.923 -1.51 . . . . 1.31 106.923 164.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.91 137.9 51.9 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.656 -1.979 . . . . 6.26 105.656 172.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -158.41 157.7 32.79 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.55 0.614 . . . . 1.14 109.478 165.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -104.15 119.39 38.84 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.983 -1.118 . . . . 4.71 107.983 168.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 71.77 -170.99 48.27 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.74 -0.544 . . . . 2.07 111.74 173.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -76.66 78.35 3.31 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 122.011 -0.699 . . . . 3.27 110.92 -164.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -62.88 -44.57 95.75 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.247 1.019 . . . . 3.7 113.36 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 144.39 93.13 0.16 Allowed Glycine 0 CA--C 1.521 0.448 0 N-CA-C 107.009 -2.436 . . . . 3.33 107.009 -165.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -150.64 -179.43 7.24 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.333 1.053 . . . . 2.97 108.811 -173.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.77 -40.66 40.09 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.001 1.32 . . . . 8.09 108.057 168.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -96.34 -149.21 0.31 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.767 0.827 . . . . 6.94 108.973 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -142.22 151.1 41.8 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.93 -1.137 . . . . 4.1 107.93 176.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -105.03 171.55 7.26 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 124.814 1.246 . . . . 6.03 108.302 164.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -161.72 162.27 29.65 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.314 1.446 . . . . 3.33 108.684 -172.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -65.82 -156.04 0.31 Allowed Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.146 0.879 . . . . 1.34 112.726 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -56.15 106.91 0.31 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.592 0.757 . . . . 4.31 111.5 -171.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 113.59 -146.9 18.6 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.183 -1.567 . . . . 1.78 109.183 -176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.53 -126.32 24.21 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 125.342 1.448 . . . . 1.6 110.913 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 11.2 mm -76.99 130.66 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-O 122.488 1.137 . . . . 1.42 108.023 173.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.1 mp -84.37 -46.27 11.9 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 126.725 2.01 . . . . 1.39 110.11 170.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.508 ' HB1' ' HG3' ' A' ' 219' ' ' GLU . . . -168.37 172.55 8.31 Favored 'General case' 0 C--N 1.338 0.107 0 O-C-N 121.042 -1.036 . . . . 0.9 111.402 -176.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 11.6 p-80 -158.33 139.59 13.33 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.092 0.957 . . . . 1.04 111.469 178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -162.59 174.38 12.69 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 107.763 -1.199 . . . . 0.77 107.763 -174.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.59 151.43 18.69 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.26 -1.015 . . . . 6.36 108.26 -173.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -102.31 -79.34 1.38 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 109.201 -1.56 . . . . 0.7 109.201 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -71.24 177.6 6.41 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.986 2.457 . . . . 2.27 110.51 176.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 97.2 132.11 7.29 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 109.796 -1.322 . . . . 1.56 109.796 -175.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 4.3 p -77.92 150.78 34.0 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 123.538 0.735 . . . . 2.36 109.472 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.46 -132.2 10.61 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 108.04 -2.024 . . . . 1.85 108.04 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . 0.254 10.7 tp -62.94 -43.21 98.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 117.955 -1.022 . . . . 3.56 110.662 -171.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 31.15 130.36 0.0 OUTLIER Glycine 0 CA--C 1.544 1.879 0 C-N-CA 130.299 3.809 . . . . 1.69 119.063 164.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 84.83 -21.73 10.74 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.093 -1.828 . . . . 0.69 111.845 -175.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -84.7 148.85 26.17 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 124.638 1.175 . . . . 1.61 110.437 -169.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.42 124.56 36.57 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.5 0.556 . . . . 0.61 112.5 -162.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -114.25 108.34 16.81 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-O 117.208 -1.377 . . . . 2.11 110.199 -168.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.11 147.12 23.77 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 121.761 2.073 . . . . 2.58 110.119 172.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -70.16 99.45 1.5 Allowed 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 123.585 0.553 . . . . 2.74 109.891 176.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -14.59 61.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.217 -0.897 . . . . 3.08 110.896 174.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -57.66 -32.05 66.93 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 121.045 1.748 . . . . 2.62 109.498 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.61 170.12 15.86 Favored 'General case' 0 C--O 1.246 0.891 0 C-N-CA 125.044 1.337 . . . . 2.31 110.292 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -117.13 100.9 8.03 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.01 -1.107 . . . . 4.3 108.01 169.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.41 ' CH2' HG21 ' A' ' 215' ' ' THR . 35.4 m95 -78.33 146.23 34.84 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.637 -1.165 . . . . 1.43 109.305 174.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.3 p -120.47 138.58 53.74 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.732 0.813 . . . . 1.84 109.667 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -50.09 -49.48 51.44 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.745 1.218 . . . . 1.73 110.059 169.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -82.26 -178.47 7.05 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.034 1.334 . . . . 2.25 111.654 175.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.1 m -54.08 -58.12 8.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.343 1.457 . . . . 3.81 110.943 -172.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 43.02 -100.49 0.02 OUTLIER Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.312 1.434 . . . . 2.45 114.409 169.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -116.71 -70.67 0.44 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.536 -1.026 . . . . 1.14 110.536 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.72 177.65 7.47 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 105.702 -1.962 . . . . 1.39 105.702 169.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -132.92 130.97 40.33 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.924 0.784 . . . . 1.63 111.658 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -62.4 -48.97 77.37 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 108.358 -0.979 . . . . 1.8 108.358 -174.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.723 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.5 t80 -50.63 -50.37 54.53 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.665 -0.495 . . . . 1.5 109.665 177.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.419 ' C ' HD23 ' A' ' 214' ' ' LEU . 7.0 tt -58.65 -58.98 6.19 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.637 1.175 . . . . 1.54 109.366 -173.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.41 HG21 ' CH2' ' A' ' 203' ' ' TRP 0.317 6.7 m -58.86 -37.52 76.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.574 0.702 . . . . 0.77 110.784 176.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.39 -43.76 96.34 Favored 'General case' 0 N--CA 1.441 -0.893 0 O-C-N 121.367 -0.833 . . . . 0.78 110.877 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 213' ' ' PHE . 44.1 t -52.84 -44.81 49.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 119.948 1.249 . . . . 1.08 109.93 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.573 ' HD1' ' H72' ' A' ' 269' ' ' NGH . 6.4 t-160 -52.24 -58.55 6.28 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.956 1.303 . . . . 2.32 112.667 169.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.508 ' HG3' ' HB1' ' A' ' 182' ' ' ALA . 14.8 mm-40 -69.17 -33.89 74.1 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.93 1.085 . . . . 3.13 113.93 -174.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.695 HD11 HD11 ' A' ' 134' ' ' ILE . 0.4 OUTLIER -71.55 -37.85 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 107.282 -1.377 . . . . 1.48 107.282 175.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -52.01 -48.44 52.04 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 110.673 -0.971 . . . . 0.69 110.673 167.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.503 ' CE1' ' CD2' ' A' ' 218' ' ' HIS . 18.1 m170 -58.79 -44.75 90.81 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 121.908 -0.76 . . . . 2.87 111.265 174.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.6 t -54.0 -55.43 27.33 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.021 0.528 . . . . 1.76 111.823 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 3.2 pp -60.88 -33.72 73.52 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 118.697 -0.668 . . . . 3.18 112.415 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 114.57 102.99 2.48 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 110.105 -1.198 . . . . 1.5 110.105 172.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.48 HD11 ' CE1' ' A' ' 228' ' ' HIS . 1.8 pt? -108.3 167.17 10.21 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.088 1.144 . . . . 5.65 114.088 -175.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -113.2 11.94 24.19 Favored Glycine 0 CA--C 1.538 1.498 0 C-N-CA 124.411 1.005 . . . . 3.38 113.348 167.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.48 ' CE1' HD11 ' A' ' 226' ' ' LEU . 4.5 m80 64.53 98.87 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.904 1.682 . . . . 2.11 114.535 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 1.6 m -75.08 161.9 29.01 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.038 0.447 . . . . 1.3 110.44 176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.1 p -122.11 11.46 10.2 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.406 1.482 . . . . 2.79 111.541 -165.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -119.25 138.57 26.48 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 125.463 1.505 . . . . 1.75 108.664 -169.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -80.81 -12.59 12.11 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.946 1.764 . . . . 1.29 114.992 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -75.23 -24.06 57.66 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 120.247 1.385 . . . . 1.45 110.128 172.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.539 ' HB1' ' CG ' ' A' ' 254' ' ' ASP . . . -71.77 167.85 19.05 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.941 1.296 . . . . 0.95 111.878 176.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.07 -26.14 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 125.668 1.587 . . . . 0.85 111.93 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.768 ' SD ' HG22 ' A' ' 258' ' ' ILE . 0.0 OUTLIER -62.9 -26.81 68.97 Favored 'General case' 0 C--O 1.245 0.818 0 O-C-N 120.54 -1.35 . . . . 2.74 112.235 176.209 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -48.22 177.1 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 130.249 3.419 . . . . 3.42 114.094 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.407 ' O ' ' O5 ' ' A' ' 269' ' ' NGH . 86.5 Cg_endo -90.09 -18.4 1.41 Allowed 'Trans proline' 0 CA--C 1.537 0.634 0 CA-C-N 122.319 1.864 . . . . 1.46 112.13 174.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.36 0.2 OUTLIER -81.22 -176.77 6.15 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.086 1.354 . . . . 1.48 110.764 -172.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.458 ' HA ' ' H73' ' A' ' 269' ' ' NGH . 91.2 t80 -113.95 150.07 34.31 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.341 1.456 . . . . 2.31 108.059 171.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -155.97 137.28 13.89 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.103 -1.073 . . . . 2.92 108.103 169.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -65.17 121.25 14.32 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.72 0.808 . . . . 2.62 110.562 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 15.5 m -130.33 135.81 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.165 0.986 . . . . 1.65 108.792 173.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.82 117.38 21.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.844 -0.799 . . . . 5.13 108.844 176.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.568 HG22 ' CD1' ' A' ' 213' ' ' PHE . 1.1 pp -53.03 -33.62 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 C-N-CA 122.922 0.489 . . . . 3.33 110.348 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -52.53 -36.06 54.71 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.092 0.957 . . . . 4.58 112.045 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 25.1 m -74.01 -48.29 31.19 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 119.17 -0.443 . . . . 2.55 109.959 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.459 ' CD1' HG22 ' A' ' 140' ' ' VAL . 0.5 OUTLIER 53.35 87.65 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.271 1.028 . . . . 4.71 110.445 -178.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.02 163.21 37.96 Favored 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 121.466 -0.771 . . . . 3.77 110.773 175.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.525 HD12 ' CH2' ' A' ' 141' ' ' TRP . 1.5 mm? -116.27 154.48 30.07 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.601 1.56 . . . . 0.84 107.836 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.2 m -79.18 152.66 30.56 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 118.012 0.369 . . . . 0.88 111.1 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -58.77 -41.78 87.42 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.762 -0.586 . . . . 1.03 111.417 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -51.53 -51.5 54.78 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.903 0.858 . . . . 2.33 108.941 171.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.539 ' CG ' ' HB1' ' A' ' 234' ' ' ALA . 1.0 OUTLIER -58.59 -47.07 85.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.8 -1.091 . . . . 2.25 111.442 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 69.2 mt -44.61 -37.6 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.676 1.19 . . . . 1.1 111.26 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -65.29 -63.2 1.16 Allowed 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.529 -0.732 . . . . 4.59 110.989 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -55.83 -46.66 82.72 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.723 -0.551 . . . . 0.99 111.723 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.768 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 2.0 pp -70.0 -28.75 37.53 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 C-N-CA 124.76 1.224 . . . . 2.85 110.503 -173.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -84.62 -24.19 29.21 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.645 1.111 . . . . 2.61 112.024 171.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 46.1 m -58.32 -33.1 69.13 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.85 0.75 . . . . 2.51 111.699 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 30.5 mt 40.38 53.26 2.94 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 126.336 1.854 . . . . 3.51 112.498 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -128.19 -173.86 3.06 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.108 1.363 . . . . 9.08 109.045 -172.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 2.551 1 CA-C-O 80.41 -22.328 . . . . 11.34 111.742 162.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' NGH . . . . . 0.573 ' H72' ' HD1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 108.656 -0.868 . . . . 18.55 108.656 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 179.74 63.81 0.07 OUTLIER Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.832 -0.907 . . . . 13.45 110.832 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.76 130.34 16.79 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.37 2.046 . . . . 14.57 109.613 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.6 p -155.88 154.68 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 107.413 -1.328 . . . . 9.31 107.413 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 16.7 p90 -147.92 -52.59 0.19 Allowed 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.236 1.014 . . . . 13.05 109.612 -177.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 54.3 33.69 18.9 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.464 0.706 . . . . 8.11 111.579 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.5 -84.81 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.224 1.41 . . . . 5.98 110.974 -174.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 66.08 -71.3 0.09 Allowed 'General case' 0 C--O 1.231 0.118 0 C-N-CA 127.01 2.124 . . . . 4.26 110.48 -177.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -116.5 118.19 31.99 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.443 1.497 . . . . 2.85 107.546 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.51 HG21 ' CE1' ' A' ' 149' ' ' PHE . 24.0 mm -115.36 154.06 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.509 -1.293 . . . . 2.71 107.509 160.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.92 133.31 13.63 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 104.509 -2.404 . . . . 2.26 104.509 -171.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -128.79 169.18 14.85 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 123.806 0.842 . . . . 4.43 111.383 -174.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -153.55 155.59 36.45 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.487 -0.931 . . . . 4.7 108.487 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -95.32 162.12 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.719 -1.586 . . . . 1.19 106.719 172.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -86.08 -48.86 8.25 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 108.032 -1.099 . . . . 3.4 108.032 172.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -157.25 167.47 30.25 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.359 1.064 . . . . 2.69 109.189 -170.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -112.24 173.03 6.56 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.454 1.502 . . . . 1.85 108.927 -177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.7 t -129.58 135.22 27.2 Favored Pre-proline 0 N--CA 1.445 -0.683 0 N-CA-C 105.83 -1.915 . . . . 2.53 105.83 -173.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.48 -19.06 17.23 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.251 2.634 . . . . 2.1 112.085 -174.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -37.58 -41.84 0.5 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.406 2.682 . . . . 2.57 112.604 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 2.5 ptp -136.39 173.56 11.58 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.991 0.917 . . . . 2.13 108.88 173.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -70.02 142.0 52.81 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.915 -0.402 . . . . 3.17 109.915 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -52.77 -47.7 67.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 119.118 -0.467 . . . . 2.81 111.885 -176.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -45.23 -49.6 12.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.045 -0.724 . . . . 3.89 109.045 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.74 -40.71 92.41 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.19 0.996 . . . . 2.01 113.364 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 93.4 t -53.67 -54.63 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.318 -0.993 . . . . 1.19 108.318 175.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -37.22 83.73 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 119.121 -1.032 . . . . 1.72 108.837 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -55.6 -45.35 77.45 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 119.598 1.09 . . . . 2.12 111.753 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.18 -52.16 59.72 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 120.894 0.378 . . . . 0.42 110.415 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -72.88 -31.82 37.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.917 -0.583 . . . . 1.6 110.549 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -57.24 13.1 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.769 -1.567 . . . . 3.15 106.769 177.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.534 ' O ' HG23 ' A' ' 140' ' ' VAL . 11.3 mmmm -66.96 -44.53 80.31 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.427 -1.261 . . . . 1.39 109.11 -176.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -50.24 -53.82 25.49 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 112.483 0.549 . . . . 0.43 112.483 173.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.486 ' HA ' HG21 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -59.72 -48.37 81.93 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 119.019 -1.073 . . . . 6.32 108.127 177.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.47 -29.7 62.02 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.638 -0.696 . . . . 2.22 112.082 -173.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 136' ' ' LYS . 99.4 t -60.75 -66.8 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-N 119.02 0.827 . . . . 0.72 109.33 174.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 53.9 m95 -69.49 -43.09 73.86 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.465 -0.939 . . . . 0.88 108.465 -169.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.1 t -58.3 -19.01 31.3 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.777 1.231 . . . . 1.47 111.865 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -79.29 -44.42 21.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 118.206 0.457 . . . . 1.76 109.929 175.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 6.0 m -76.36 -39.92 34.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 N-CA-C 111.907 0.336 . . . . 1.51 111.907 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.569 HG23 HG12 ' A' ' 258' ' ' ILE . 1.6 p -83.46 152.69 64.47 Favored Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 107.876 -1.157 . . . . 1.2 107.876 -179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.33 11.39 1.55 Allowed 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 123.117 2.545 . . . . 1.48 113.857 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -112.86 127.56 56.22 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.238 1.415 . . . . 2.68 110.251 -173.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.29 117.58 33.0 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.034 0.533 . . . . 3.22 110.096 -177.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.51 ' CE1' HG21 ' A' ' 114' ' ' ILE . 3.2 m-85 -81.01 160.51 24.55 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.329 1.052 . . . . 6.12 110.772 168.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.8 t -156.7 144.86 19.55 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.466 1.506 . . . . 1.16 107.384 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -89.91 149.37 22.64 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 120.491 1.496 . . . . 2.02 108.899 173.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.9 pt -127.01 147.78 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 N-CA-C 105.742 -1.948 . . . . 1.4 105.742 164.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -102.44 -5.41 24.11 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.898 0.479 . . . . 3.47 110.515 172.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 99.4 m -155.4 117.53 4.14 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.405 -1.332 . . . . 2.75 107.405 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 140.76 177.4 16.11 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 107.711 -2.156 . . . . 1.56 107.711 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 15.3 mmt -87.83 141.33 28.68 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.164 -1.05 . . . . 5.76 108.164 164.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -123.42 168.89 11.95 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.19 -1.411 . . . . 0.76 107.19 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -76.46 -45.21 32.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.833 -0.803 . . . . 1.65 108.833 -175.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.2 pt -113.94 176.69 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 124.617 1.167 . . . . 0.93 109.91 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.11 135.38 30.87 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.178 1.391 . . . . 2.21 109.072 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 36.5 t -93.32 108.68 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 107.227 -1.398 . . . . 0.77 107.227 168.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.07 107.24 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 124.747 1.219 . . . . 2.44 109.964 -175.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -88.4 171.68 9.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.284 -1.006 . . . . 5.82 108.284 173.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.575 ' HB3' ' CE2' ' A' ' 174' ' ' PHE . . . -155.62 -169.59 3.16 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.279 -1.378 . . . . 1.18 107.279 167.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 35.0 mtm180 -139.51 125.81 20.17 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.719 -0.845 . . . . 5.58 108.719 172.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.61 -67.88 3.07 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 125.366 1.46 . . . . 2.63 110.599 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -155.95 159.7 39.46 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.553 0.741 . . . . 2.17 109.075 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -162.68 -173.78 3.67 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 106.872 -1.529 . . . . 3.25 106.872 168.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -62.3 110.15 3.07 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 109.33 -1.508 . . . . 3.63 109.33 169.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -144.36 168.44 20.09 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.269 1.028 . . . . 4.22 109.726 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.4 -38.3 30.53 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.146 1.378 . . . . 9.53 109.398 171.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -103.73 -104.08 0.29 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.829 1.652 . . . . 7.0 108.588 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -172.37 167.35 5.71 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 125.398 1.479 . . . . 3.57 108.086 -176.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.575 ' CE2' ' HB3' ' A' ' 164' ' ' ALA . 8.8 m-85 -105.41 172.49 6.76 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 124.797 1.239 . . . . 6.34 108.11 163.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -162.98 153.8 16.83 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.122 0.969 . . . . 3.84 109.175 177.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -70.84 -149.61 0.59 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.59 0.614 . . . . 1.39 113.203 -174.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -54.31 109.41 0.48 Allowed 'General case' 0 C--N 1.341 0.231 0 C-N-CA 124.708 1.203 . . . . 3.93 110.083 -176.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 99.49 -144.38 17.02 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 109.723 -1.351 . . . . 1.63 109.723 -171.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 48.26 -132.32 19.8 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.418 -1.473 . . . . 1.45 109.418 -170.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.667 ' HA ' ' O3 ' ' A' ' 269' ' ' NGH . 1.8 tp -77.72 148.51 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-N 118.038 0.919 . . . . 2.5 108.855 175.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . 0.5 5.4 mp -84.75 -44.98 12.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.297 1.439 . . . . 1.52 110.577 173.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -165.63 168.28 16.45 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 122.189 -0.319 . . . . 0.78 111.011 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -146.99 120.64 9.16 Favored 'General case' 0 C--O 1.216 -0.702 0 C-N-CA 124.277 1.031 . . . . 1.13 113.782 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.509 ' HB3' ' HB2' ' A' ' 222' ' ' HIS . . . -139.07 160.96 38.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 120.656 -1.278 . . . . 0.55 107.62 -176.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -141.65 149.6 40.85 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.351 -1.352 . . . . 3.07 107.351 175.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -100.84 -87.63 1.98 Allowed Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.622 -0.991 . . . . 0.66 110.622 173.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.17 84.71 1.09 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.523 2.815 . . . . 1.52 111.53 -169.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -159.24 165.21 34.24 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.234 -1.546 . . . . 1.09 109.234 170.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 3.0 p -79.39 172.79 13.31 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.752 0.821 . . . . 2.35 109.536 173.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 52.21 -105.7 0.27 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 123.865 0.745 . . . . 1.52 111.838 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.4 tp -59.65 -40.58 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 118.717 -0.659 . . . . 1.42 110.006 -178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -41.49 135.46 2.97 Favored Glycine 0 CA--C 1.535 1.328 0 CA-C-N 118.976 0.807 . . . . 0.96 112.429 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 98.87 -36.98 3.69 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.873 1.702 . . . . 0.58 111.646 -166.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -84.02 160.42 21.0 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 117.946 0.873 . . . . 1.24 110.34 -163.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -134.05 130.71 37.91 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.605 0.762 . . . . 0.59 111.871 -169.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -119.96 99.52 6.67 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 117.925 -1.036 . . . . 2.0 110.793 -161.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -84.73 139.11 32.22 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 121.165 1.802 . . . . 2.93 111.468 176.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.87 61.88 0.42 Allowed 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 123.687 0.617 . . . . 3.37 110.329 171.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -66.21 -6.37 13.42 Favored 'General case' 0 C--O 1.241 0.637 0 O-C-N 120.607 -1.308 . . . . 5.23 111.997 -178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -27.15 -65.02 0.08 Allowed 'General case' 0 C--N 1.341 0.205 0 C-N-CA 127.851 2.46 . . . . 5.2 110.055 158.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . 0.256 2.2 pt-20 -78.72 175.5 10.38 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 115.308 -0.86 . . . . 1.97 110.562 -169.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -98.42 103.11 15.03 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 106.223 -1.769 . . . . 3.43 106.223 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.45 ' HH2' HG21 ' A' ' 215' ' ' THR . 28.3 m95 -78.3 134.52 37.5 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.918 -1.512 . . . . 1.49 106.918 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.1 p -132.35 75.8 1.66 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.412 -1.329 . . . . 3.2 107.412 -171.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.04 -49.31 70.63 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 123.864 0.866 . . . . 3.22 108.817 -174.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -55.48 -32.76 63.1 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.906 0.706 . . . . 4.54 112.906 177.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.8 t -81.47 -42.43 20.32 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.216 0.606 . . . . 6.63 110.495 178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 106.02 16.57 14.83 Favored Glycine 0 CA--C 1.528 0.866 0 C-N-CA 124.92 1.247 . . . . 3.52 112.952 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.71 -84.62 0.18 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.475 -1.05 . . . . 1.81 110.475 -176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 61.9 m -107.79 119.85 40.61 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.007 -2.59 . . . . 1.32 104.007 157.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -94.84 115.26 27.26 Favored 'General case' 0 N--CA 1.443 -0.796 0 O-C-N 124.333 1.021 . . . . 1.44 108.293 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.67 -48.66 49.37 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.453 0.701 . . . . 1.51 110.409 -177.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -47.92 -49.77 29.07 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.205 0.602 . . . . 1.54 110.955 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.1 tt -56.7 -60.24 3.84 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.144 0.978 . . . . 1.2 109.676 -172.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.847 HG23 ' H2 ' ' A' ' 269' ' ' NGH 0.266 93.4 m -57.52 -41.98 81.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.572 -0.74 . . . . 0.9 110.692 177.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.08 -39.62 86.71 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 118.268 -0.872 . . . . 0.54 112.1 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 78.8 t -56.07 -57.65 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 119.842 1.201 . . . . 0.7 108.658 175.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -43.84 -53.57 5.92 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.729 0.812 . . . . 2.81 112.492 172.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -69.07 -34.66 75.5 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.264 -0.898 . . . . 2.52 113.207 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.486 HG21 ' HA ' ' A' ' 138' ' ' PHE . 4.4 mm -60.6 -47.12 94.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 106.955 -1.498 . . . . 2.53 106.955 173.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.58 -51.18 33.74 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 111.667 -0.573 . . . . 0.7 111.667 173.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 184' ' ' ALA . 4.3 m-70 -54.36 -49.16 70.45 Favored 'General case' 0 C--O 1.224 -0.283 0 O-C-N 121.483 -1.01 . . . . 1.15 111.42 176.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 14.5 t -51.57 -48.04 63.27 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 123.401 0.438 . . . . 1.74 111.341 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.22 -36.65 84.37 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.163 -0.615 . . . . 2.0 110.185 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 116.05 55.68 0.34 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 109.934 -1.266 . . . . 1.27 109.934 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.642 HD11 ' HA ' ' A' ' 258' ' ' ILE . 1.9 mm? -103.32 125.3 49.88 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.075 0.55 . . . . 4.06 110.475 173.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -61.61 139.81 47.09 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.461 -1.056 . . . . 2.66 110.461 171.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.416 ' CD2' ' HE1' ' A' ' 222' ' ' HIS . 17.7 m80 -43.69 114.17 0.61 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.537 1.535 . . . . 1.9 111.647 173.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 55.8 m -73.93 165.97 24.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.431 0.56 . . . . 1.25 109.78 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 12.4 m -128.33 39.99 3.74 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.437 1.495 . . . . 2.73 110.12 -167.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -141.4 142.35 26.27 Favored Pre-proline 0 N--CA 1.453 -0.314 0 N-CA-C 106.863 -1.532 . . . . 1.75 106.863 -174.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -88.98 -14.19 2.87 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.176 1.917 . . . . 1.05 114.793 -174.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -82.1 -32.05 30.41 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.065 0.946 . . . . 1.83 109.093 172.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.73 152.62 6.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.516 0.727 . . . . 0.92 111.014 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 57.7 t -110.5 -20.38 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.254 -1.339 . . . . 0.84 110.261 176.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -31.61 71.59 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.462 1.028 . . . . 2.45 111.181 177.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -48.07 159.3 0.49 Allowed Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 127.178 2.191 . . . . 3.35 114.013 -174.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.508 ' HB2' ' H91' ' A' ' 269' ' ' NGH . 18.6 Cg_endo -71.81 -23.09 22.83 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.415 1.41 . . . . 1.53 111.884 179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.355 0.2 OUTLIER -78.24 173.29 12.43 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.076 1.35 . . . . 1.5 110.219 -171.221 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.465 ' HA ' ' H4 ' ' A' ' 269' ' ' NGH . 44.4 t80 -112.17 140.76 46.6 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.414 -1.328 . . . . 2.39 107.414 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.6 125.59 12.82 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 105.461 -2.051 . . . . 2.31 105.461 172.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -53.22 130.86 35.98 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.166 0.986 . . . . 3.06 110.529 -176.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 34.5 m -117.53 137.22 52.16 Favored 'Isoleucine or valine' 0 C--N 1.339 0.128 0 C-N-CA 123.599 0.76 . . . . 2.07 110.365 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.85 -42.43 97.58 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.539 1.135 . . . . 3.42 111.7 171.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 6.7 mt 69.32 8.57 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 126.118 1.767 . . . . 2.58 110.851 -159.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -64.22 -53.96 41.02 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 120.597 -1.315 . . . . 3.81 111.253 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 12.1 m -81.82 -41.37 21.18 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.964 0.906 . . . . 2.27 109.872 -174.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.469 ' CE1' HG22 ' A' ' 140' ' ' VAL . 57.3 t80 57.43 72.81 0.49 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 122.09 0.948 . . . . 4.46 109.953 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.21 162.04 37.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.955 -0.757 . . . . 2.53 108.955 175.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.528 HD22 ' N ' ' A' ' 250' ' ' LEU . 1.7 mm? -95.95 158.21 15.55 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.637 1.575 . . . . 0.84 108.281 -178.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 2.9 m -76.13 158.71 31.45 Favored 'General case' 0 C--O 1.222 -0.375 0 O-C-N 122.059 -0.401 . . . . 0.78 110.695 -176.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.73 -43.74 85.52 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.568 -0.16 . . . . 1.26 110.568 177.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -53.25 -55.92 20.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.564 0.697 . . . . 2.65 109.492 173.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.36 -42.32 81.81 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.396 -0.82 . . . . 2.25 110.919 -177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.539 ' HA ' ' CG2' ' A' ' 258' ' ' ILE . 38.9 mt -55.96 -22.33 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 C-N-CA 126.871 2.068 . . . . 1.43 111.498 177.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 66.8 mtp180 -77.14 -55.47 5.41 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.817 -1.177 . . . . 5.5 110.273 168.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -50.7 -55.48 17.35 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 110.534 -1.027 . . . . 0.81 110.534 -177.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.642 ' HA ' HD11 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -41.85 -56.26 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.231 0 C-N-CA 125.347 1.459 . . . . 3.01 111.527 175.597 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -72.98 -21.61 60.82 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.997 0.817 . . . . 2.27 110.791 -173.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 6.9 t -67.15 -25.49 66.19 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 118.695 -0.669 . . . . 1.95 111.553 168.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.54 ' CD2' HG22 ' A' ' 145' ' ' THR . 0.4 OUTLIER 41.67 46.51 3.22 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.934 2.094 . . . . 4.14 112.518 -174.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -135.71 137.18 41.49 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.869 0.468 . . . . 12.28 112.238 -167.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 C-N-CA 126.263 1.887 . . . . 13.61 110.037 175.53 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' NGH . . . . . 0.847 ' H2 ' HG23 ' A' ' 215' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 77.9 mtp . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 107.089 -1.448 . . . . 11.69 107.089 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 151.25 82.52 0.04 OUTLIER Glycine 0 CA--C 1.532 1.099 0 N-CA-C 110.471 -1.052 . . . . 8.24 110.471 -176.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.65 168.64 23.93 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.464 2.109 . . . . 9.23 110.189 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.6 p -154.91 154.05 7.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.243 -1.021 . . . . 5.58 108.243 -177.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -85.11 157.92 20.56 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.605 0.717 . . . . 10.97 111.555 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.0 mmt180 -60.12 -47.44 85.92 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.68 1.192 . . . . 7.75 111.476 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -158.27 -64.73 0.09 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.462 0.705 . . . . 6.35 109.191 -173.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.11 -66.96 0.09 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.218 1.807 . . . . 4.18 112.25 -175.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -79.85 107.85 12.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.159 1.384 . . . . 2.52 107.841 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.2 mp -121.66 136.89 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 N-CA-C 106.564 -1.643 . . . . 2.12 106.564 168.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.3 t -142.9 142.95 31.86 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 120.702 0.287 . . . . 3.12 110.713 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.553 ' CE2' HD12 ' A' ' 134' ' ' ILE . 17.8 p90 -130.17 163.84 25.78 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.507 1.123 . . . . 4.48 111.488 -170.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -145.22 142.28 29.41 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.934 -0.765 . . . . 4.28 108.934 173.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -83.33 152.91 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 108.499 -0.926 . . . . 1.02 108.499 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -88.22 -45.41 10.11 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.391 -0.596 . . . . 3.26 109.391 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -155.35 170.22 22.39 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.222 -1.029 . . . . 2.4 108.222 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -119.07 127.28 53.25 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.141 0.976 . . . . 1.93 108.916 -165.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.3 t -64.4 124.01 84.49 Favored Pre-proline 0 N--CA 1.442 -0.86 0 C-N-CA 123.941 0.897 . . . . 2.68 109.419 -176.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -69.89 -19.07 35.96 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.499 2.8 . . . . 1.95 110.138 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -36.59 -40.34 0.25 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.715 2.006 . . . . 2.78 111.808 169.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 16.2 mtm -135.76 177.29 7.95 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.255 1.422 . . . . 2.49 109.506 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -76.53 141.98 41.02 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 121.548 -0.72 . . . . 3.48 109.262 175.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 54.6 ttt-85 -41.54 -48.93 4.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.707 0.685 . . . . 2.15 112.285 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -49.39 -47.06 47.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.707 -0.479 . . . . 3.37 109.707 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -69.46 -40.71 76.98 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.408 1.483 . . . . 1.85 111.101 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 56.8 t -54.06 -53.82 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 O-C-N 120.811 -1.181 . . . . 1.17 109.555 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -25.69 65.29 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 118.77 -1.172 . . . . 1.98 110.01 178.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -63.12 -47.83 81.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.891 0.769 . . . . 1.91 109.798 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -55.91 -53.46 56.57 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.352 0.661 . . . . 0.38 110.498 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.587 HD11 HD11 ' A' ' 220' ' ' ILE . 0.1 OUTLIER -68.82 -41.35 82.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 109.284 -0.636 . . . . 2.27 109.284 -178.313 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -50.41 -58.59 5.37 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.371 -0.974 . . . . 3.34 108.371 178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -60.3 -52.0 67.14 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.522 1.129 . . . . 1.44 109.249 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -46.48 -49.17 18.77 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 123.944 0.898 . . . . 0.62 112.289 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.46 ' HB3' ' CD2' ' A' ' 149' ' ' PHE . 0.2 OUTLIER -66.02 -45.99 79.53 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.996 -0.742 . . . . 4.82 108.996 178.086 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.03 -42.25 37.61 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.759 0.824 . . . . 3.83 110.829 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.609 HG22 ' CD2' ' A' ' 248' ' ' PHE . 48.0 t -48.46 -61.51 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.059 0.944 . . . . 0.69 110.134 177.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -73.09 -32.5 65.02 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.423 -0.798 . . . . 0.98 109.736 -175.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 t -61.03 -17.87 54.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.932 0.493 . . . . 1.14 111.332 175.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.02 -45.98 15.73 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 108.839 -0.8 . . . . 2.06 108.839 -177.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.6 m -78.85 -46.28 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.412 0.685 . . . . 1.37 111.971 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.49 HG21 HD12 ' A' ' 258' ' ' ILE . 43.2 p -82.79 159.14 64.05 Favored Pre-proline 0 N--CA 1.45 -0.435 0 N-CA-C 109.407 -0.59 . . . . 0.71 109.407 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.92 -1.8 11.84 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.764 1.643 . . . . 0.7 112.581 173.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.9 mp -65.34 127.37 31.47 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.59 -0.893 . . . . 2.23 108.59 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.44 96.19 6.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 107.921 -1.14 . . . . 4.11 107.921 177.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.46 ' CD2' ' HB3' ' A' ' 138' ' ' PHE . 1.4 p90 -69.12 155.48 40.31 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.347 -0.388 . . . . 6.66 111.534 177.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.9 t -158.85 140.19 13.19 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.016 0.826 . . . . 1.12 111.079 163.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.01 149.83 22.37 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.025 -1.102 . . . . 2.01 108.025 171.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.53 HD13 ' H ' ' A' ' 156' ' ' MET . 2.9 pp -129.75 156.9 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 106.018 -1.845 . . . . 2.2 106.018 173.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -111.7 -16.62 13.18 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.242 0.339 . . . . 3.63 110.577 172.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.9 m -107.19 78.04 1.19 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 123.603 0.761 . . . . 2.64 109.753 -174.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 15.06 63.59 0.01 OUTLIER Glycine 0 CA--C 1.537 1.447 0 C-N-CA 128.144 2.783 . . . . 2.64 118.286 171.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.53 ' H ' HD13 ' A' ' 152' ' ' ILE . 31.7 mtt -147.8 75.69 1.36 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.092 1.357 . . . . 7.74 107.786 166.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -124.06 155.08 38.98 Favored 'General case' 0 N--CA 1.461 0.08 0 C-N-CA 123.614 0.766 . . . . 0.96 109.598 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.23 -49.46 7.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.042 0.937 . . . . 2.19 108.691 176.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 15.9 pt -110.25 161.52 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.464 0.705 . . . . 0.97 110.511 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.14 140.02 52.91 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.434 0.693 . . . . 2.49 110.324 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.87 100.13 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.702 0.801 . . . . 0.98 109.215 178.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.33 93.19 4.23 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 C-N-CA 125.007 1.323 . . . . 1.36 111.05 -171.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -80.94 116.22 20.8 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.536 -1.653 . . . . 5.5 106.536 172.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -140.3 155.49 46.81 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-N 119.135 0.879 . . . . 0.82 109.431 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -124.38 128.51 49.18 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.821 0.849 . . . . 4.06 109.207 -164.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 48.63 -126.75 17.37 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.561 1.077 . . . . 1.84 111.948 -164.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.15 137.82 38.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.103 0.561 . . . . 1.99 109.722 -175.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.9 -36.01 0.32 Allowed 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.839 0.681 . . . . 2.63 112.839 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -170.39 -50.39 0.04 OUTLIER Glycine 0 CA--C 1.521 0.437 0 N-CA-C 108.674 -1.77 . . . . 2.52 108.674 -178.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.5 157.28 30.49 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 106.732 -1.581 . . . . 2.35 106.732 172.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -77.19 -56.03 4.92 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.334 -0.987 . . . . 6.45 108.334 -172.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -69.27 -61.92 1.59 Allowed 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.082 -0.963 . . . . 4.88 110.177 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 41.14 -122.36 0.49 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.353 1.461 . . . . 2.51 111.089 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 200' ' ' ASP . 48.5 t80 -90.8 151.18 21.29 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 121.864 0.84 . . . . 7.78 109.379 173.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -152.18 4.5 0.39 Allowed 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 126.421 1.888 . . . . 2.95 111.779 -162.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 100.5 -173.02 24.55 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 122.067 0.815 . . . . 1.76 112.301 -162.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.36 68.83 0.36 Allowed 'General case' 0 C--N 1.341 0.222 0 C-N-CA 127.32 2.248 . . . . 4.53 110.471 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.35 -157.88 27.87 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 109.329 -1.508 . . . . 1.74 109.329 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 51.14 -125.28 24.22 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 127.097 2.284 . . . . 1.54 110.263 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 4.5 mm -78.82 138.66 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 107.26 -1.385 . . . . 1.9 107.26 174.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.727 ' HB2' ' H1 ' ' A' ' 269' ' ' NGH 0.412 2.6 mp -84.46 -53.82 5.17 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.965 1.306 . . . . 1.32 109.527 165.452 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -162.06 162.26 28.66 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 122.104 -0.373 . . . . 0.66 110.132 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -144.37 121.31 11.34 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.995 1.318 . . . . 1.02 114.495 -173.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -143.27 166.64 24.15 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 127.492 2.317 . . . . 0.91 109.271 -171.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -151.78 143.25 23.48 Favored 'General case' 0 C--O 1.227 -0.09 0 N-CA-C 108.739 -0.838 . . . . 3.7 108.739 175.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -91.06 -88.62 1.39 Allowed Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.347 -1.101 . . . . 0.59 110.347 174.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.69 94.45 0.45 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.023 2.482 . . . . 1.31 111.028 -174.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -170.2 161.66 34.8 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.069 -1.613 . . . . 1.25 109.069 171.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 14.4 m -79.27 168.51 19.45 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.076 0.55 . . . . 2.64 110.642 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 54.84 -106.04 0.46 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 123.813 0.721 . . . . 1.87 111.596 173.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.0 tp -59.69 -40.48 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 118.831 -0.604 . . . . 1.63 109.465 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -44.79 141.4 3.78 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.123 -0.986 . . . . 1.17 112.489 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 95.23 -37.97 3.26 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 125.504 1.526 . . . . 0.76 111.25 -162.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -86.9 164.06 16.8 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 117.903 0.851 . . . . 1.17 110.33 -166.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -139.6 121.06 15.08 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.78 111.91 -172.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -110.54 132.13 54.45 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 118.203 -0.903 . . . . 2.32 109.328 -169.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -123.44 146.5 47.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 119.885 1.221 . . . . 2.8 110.541 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -66.02 90.51 0.14 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.803 -0.814 . . . . 2.74 108.803 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -57.31 -47.37 81.69 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 119.757 -1.839 . . . . 3.13 110.61 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 174' ' ' PHE . 1.9 t70 -51.4 -27.55 10.36 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.552 0.741 . . . . 2.87 111.285 -178.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -67.17 136.89 55.77 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.074 -1.454 . . . . 2.47 107.074 176.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -92.61 88.96 6.5 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.095 -1.076 . . . . 3.16 108.095 -172.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 32.8 m95 -79.23 134.49 36.66 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 107.513 -1.292 . . . . 1.19 107.513 -174.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.6 p -122.55 137.67 54.81 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.646 -0.872 . . . . 1.75 108.646 -176.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.5 t -50.47 -41.73 53.52 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 124.146 0.978 . . . . 1.76 111.654 172.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -86.36 -154.39 0.22 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.323 0.649 . . . . 2.85 111.706 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.4 m -66.37 -62.29 1.55 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.579 0.752 . . . . 3.69 110.474 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 39.97 -116.24 0.69 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.25 1.405 . . . . 2.53 113.787 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.03 -54.75 0.66 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.714 1.15 . . . . 1.56 110.281 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.58 179.34 6.62 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.869 -1.53 . . . . 1.1 106.869 172.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -136.89 127.63 27.19 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 122.942 0.497 . . . . 1.63 111.36 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 25.2 tp -59.14 -51.54 69.59 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 123.838 0.711 . . . . 2.27 110.314 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.52 ' CD1' HG22 ' A' ' 245' ' ' ILE . 6.8 t80 -50.41 -45.48 55.68 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.352 0.596 . . . . 1.45 109.654 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.7 tt -63.55 -59.1 5.07 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.588 -0.695 . . . . 1.35 110.299 -174.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.256 1.8 m -57.33 -38.94 74.86 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.351 -0.386 . . . . 0.95 110.541 178.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.32 -60.39 3.36 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 117.093 -1.432 . . . . 0.56 109.856 173.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 85.2 t -45.48 -50.64 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 121.234 1.834 . . . . 0.69 110.672 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.418 ' CD2' ' O4 ' ' A' ' 269' ' ' NGH . 26.1 t60 -57.43 -58.29 8.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.727 0.811 . . . . 2.3 112.523 175.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.26 -42.41 79.65 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.644 -1.285 . . . . 2.96 111.911 -173.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.587 HD11 HD11 ' A' ' 134' ' ' ILE . 1.0 OUTLIER -53.16 -41.1 41.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 123.972 0.909 . . . . 1.35 109.907 167.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.72 -51.45 38.82 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 123.845 0.736 . . . . 0.52 111.262 170.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . 0.3 20.9 m-70 -53.91 -51.52 63.48 Favored 'General case' 0 C--O 1.226 -0.177 0 O-C-N 121.638 -0.919 . . . . 1.36 109.902 172.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 4.5 m -52.87 -51.04 62.56 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 112.529 0.566 . . . . 1.95 112.529 -177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.49 -28.94 70.0 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 119.137 -0.458 . . . . 2.91 111.595 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 114.9 82.65 1.06 Allowed Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.474 -1.05 . . . . 1.38 110.474 172.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.544 HD13 ' SD ' ' A' ' 236' ' ' MET . 10.7 mt -134.55 142.95 47.13 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 117.622 0.711 . . . . 3.25 110.401 178.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -77.5 164.3 52.16 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 110.127 -1.189 . . . . 2.94 110.127 169.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -71.77 116.9 12.69 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.833 0.853 . . . . 1.86 110.158 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.5 m -76.7 175.16 9.63 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.036 0.534 . . . . 1.11 110.896 177.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 30.4 m -136.84 40.97 2.53 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.637 1.175 . . . . 2.23 110.762 -170.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -140.73 141.77 26.03 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.725 -1.583 . . . . 2.28 106.725 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -85.51 -12.48 6.53 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.151 1.901 . . . . 1.21 114.955 -174.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 23.8 mtmt -80.66 -30.28 36.55 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 119.365 0.984 . . . . 1.33 109.552 173.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.443 ' HB1' ' CG ' ' A' ' 254' ' ' ASP . . . -59.27 153.82 17.8 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.963 0.905 . . . . 1.07 110.258 170.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 50.0 t -105.49 -18.77 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.389 -1.278 . . . . 0.66 109.873 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.544 ' SD ' HD13 ' A' ' 226' ' ' LEU . 7.5 tpt -76.69 -17.74 58.94 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 121.182 -0.949 . . . . 1.9 113.506 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.4 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -49.56 157.78 0.91 Allowed Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.542 1.537 . . . . 2.96 113.32 174.086 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.616 ' O ' ' H5 ' ' A' ' 269' ' ' NGH . 68.5 Cg_endo -74.92 -19.21 18.26 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 121.874 1.716 . . . . 0.86 111.587 177.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.371 0.2 OUTLIER -77.32 177.0 8.29 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.293 1.437 . . . . 1.19 109.834 -179.132 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -120.92 142.47 49.69 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.113 -1.44 . . . . 2.12 107.113 174.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -148.44 123.37 10.02 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 104.899 -2.26 . . . . 3.05 104.899 172.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -52.44 115.83 1.96 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.417 0.553 . . . . 2.86 109.552 174.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 8.4 m -108.99 126.25 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 107.764 -1.198 . . . . 1.57 107.764 171.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -68.43 108.36 3.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.966 -0.753 . . . . 3.88 108.966 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.52 HG22 ' CD1' ' A' ' 213' ' ' PHE . 1.4 pp -50.57 -32.1 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.054 0 C-N-CA 125.361 1.464 . . . . 3.36 111.182 178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 52.3 m-20 -50.97 -38.97 54.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.343 0.657 . . . . 3.96 111.721 175.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.9 m -68.22 -46.71 69.83 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 123.201 0.6 . . . . 2.5 109.935 -178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.609 ' CD2' HG22 ' A' ' 140' ' ' VAL . 9.1 t80 52.61 82.89 0.07 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.036 1.334 . . . . 5.09 110.975 176.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.41 167.59 27.0 Favored 'General case' 0 CA--C 1.521 -0.15 0 O-C-N 120.525 -1.359 . . . . 3.43 111.712 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 250' ' ' LEU . 1.3 mm? -111.01 156.09 21.78 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.898 1.679 . . . . 0.87 107.554 173.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.5 m -78.33 154.24 31.0 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.228 -0.286 . . . . 0.82 110.228 175.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -53.31 -45.61 69.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 122.622 0.369 . . . . 0.96 110.033 175.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -51.92 -57.18 10.18 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 122.071 0.939 . . . . 2.53 110.057 174.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.443 ' CG ' ' HB1' ' A' ' 234' ' ' ALA . 3.4 m-20 -58.26 -40.43 81.8 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 114.631 -1.168 . . . . 2.3 111.379 -177.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 45.8 mt -57.69 -47.31 85.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.656 0.782 . . . . 0.83 110.051 176.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 32.5 mtt180 -59.92 -43.52 94.86 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 120.683 -1.26 . . . . 5.01 110.144 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -48.26 -46.29 27.97 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.024 -0.831 . . . . 0.89 111.024 170.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.49 HD12 HG21 ' A' ' 145' ' ' THR . 0.1 OUTLIER -67.73 -47.88 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 O-C-N 121.776 -0.838 . . . . 3.19 110.905 -176.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -63.03 -27.28 69.3 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.362 -0.935 . . . . 2.91 110.582 -175.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 11.9 m -51.41 -19.66 1.46 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.987 1.106 . . . . 2.45 113.987 171.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 18.5 mt -34.68 -56.76 0.54 Allowed 'General case' 0 C--N 1.349 0.568 0 CA-C-N 120.601 1.546 . . . . 2.55 113.439 164.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -171.66 82.29 0.07 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.331 0.514 . . . . 6.31 110.656 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.407 0 N-CA-C 106.274 -2.73 . . . . 8.2 106.274 178.36 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' NGH . . . . . 0.727 ' H1 ' ' HB2' ' A' ' 181' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 59.8 mtt . . . . . 0 N--CA 1.472 0.655 0 N-CA-C 106.689 -1.597 . . . . 13.55 106.689 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 62.48 -157.24 37.64 Favored Glycine 0 CA--C 1.536 1.4 0 N-CA-C 111.216 -0.754 . . . . 7.47 111.216 -174.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.93 122.57 9.7 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.958 2.438 . . . . 9.56 109.913 -173.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.64 152.95 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 108.052 -1.092 . . . . 5.5 108.052 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -83.92 167.39 17.02 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.754 0.822 . . . . 10.21 110.978 177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -82.68 -35.5 26.76 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.429 0.692 . . . . 8.32 112.053 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.44 -62.13 0.14 Allowed 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.672 -0.643 . . . . 5.01 110.021 -177.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 27.6 m170 61.0 -69.48 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.921 1.289 . . . . 4.25 111.353 -172.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -79.91 91.29 5.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 119.046 0.839 . . . . 2.52 110.545 -176.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.425 HD12 ' N ' ' A' ' 114' ' ' ILE . 2.0 mp -91.8 88.2 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 107.278 -1.378 . . . . 2.57 107.278 173.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 31.2 p -81.39 120.09 24.52 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.262 -1.384 . . . . 1.4 107.262 177.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -128.69 171.7 11.94 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 119.219 0.918 . . . . 4.38 110.688 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -157.37 176.65 12.39 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.636 -0.665 . . . . 4.22 109.829 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 5.8 mm -109.4 162.96 6.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 125.184 1.393 . . . . 1.76 108.332 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -102.57 -62.87 1.22 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.342 0.657 . . . . 3.0 109.975 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -144.02 159.72 42.11 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.961 1.305 . . . . 2.02 107.595 176.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -111.67 127.31 55.73 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.218 -1.401 . . . . 2.26 107.218 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.76 130.53 94.83 Favored Pre-proline 0 N--CA 1.444 -0.732 0 C-N-CA 124.05 0.94 . . . . 4.09 109.842 -177.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -70.04 -27.06 25.61 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.771 2.314 . . . . 2.59 109.995 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.8 -28.71 69.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.527 1.131 . . . . 3.61 111.368 171.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 35.9 mmt -102.23 179.88 4.18 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.116 0.871 . . . . 4.02 109.457 -176.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -105.23 113.72 27.48 Favored 'General case' 0 C--O 1.226 -0.158 0 N-CA-C 108.11 -1.07 . . . . 3.48 108.11 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.48 -59.98 2.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.534 1.061 . . . . 2.38 112.931 -176.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -49.26 -43.6 43.03 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 108.851 -0.796 . . . . 2.78 108.851 -174.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -66.61 -42.96 86.04 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 124.9 1.28 . . . . 1.67 112.571 178.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 48.2 t -58.48 -54.2 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 O-C-N 120.842 -1.161 . . . . 1.55 108.798 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.428 ' OD2' ' NZ ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -62.92 -45.78 90.89 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.281 -1.007 . . . . 2.14 108.281 178.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -53.3 -44.67 68.53 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.018 0.927 . . . . 3.05 110.963 -176.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.25 -49.22 69.99 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 122.697 0.399 . . . . 0.58 110.608 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.503 ' CD1' HD11 ' A' ' 220' ' ' ILE . 0.3 OUTLIER -71.07 -31.17 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 120.874 0.369 . . . . 1.84 110.315 179.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -62.23 -53.6 52.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.724 1.609 . . . . 3.38 107.009 -177.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -70.0 -44.8 68.62 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.886 1.674 . . . . 1.31 109.863 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.473 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -47.34 -52.25 17.04 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 120.836 0.35 . . . . 0.57 111.09 170.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.548 ' HB3' ' CD2' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -57.66 -56.46 21.64 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.951 -0.759 . . . . 4.44 108.951 177.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.78 -49.43 38.65 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.926 1.29 . . . . 3.11 110.98 -173.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.66 HG12 HD21 ' A' ' 250' ' ' LEU . 54.0 t -51.14 -50.66 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.425 1.09 . . . . 1.11 109.773 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.438 ' HB3' HD11 ' A' ' 224' ' ' LEU . 16.7 m95 -73.77 -32.33 63.74 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.693 -0.63 . . . . 1.18 110.369 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.32 -7.29 41.5 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.206 1.402 . . . . 1.1 111.283 175.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.61 -51.02 5.46 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.373 -0.973 . . . . 1.55 108.373 178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.8 m -68.99 -41.4 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 111.969 0.359 . . . . 1.45 111.969 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.2 p -87.2 160.27 49.13 Favored Pre-proline 0 N--CA 1.446 -0.662 0 N-CA-C 108.9 -0.778 . . . . 1.01 108.9 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -73.51 2.86 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 121.889 1.726 . . . . 0.94 112.325 170.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.404 HD12 HD13 ' A' ' 224' ' ' LEU . 35.0 mt -68.54 154.92 40.95 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 121.254 -0.904 . . . . 2.06 110.817 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.32 99.23 5.14 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.836 1.654 . . . . 5.19 109.611 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.548 ' CD2' ' HB3' ' A' ' 138' ' ' PHE . 1.7 p90 -63.51 152.5 38.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.741 -0.663 . . . . 7.15 112.007 170.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.6 t -155.11 117.68 4.28 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 118.698 -0.668 . . . . 0.85 111.06 173.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.428 ' NZ ' ' OD2' ' A' ' 131' ' ' ASP . 6.0 ttmt -81.59 131.02 35.26 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-N 119.514 1.052 . . . . 2.52 109.563 175.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.1 pt -145.24 88.03 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 122.001 0.905 . . . . 1.97 109.411 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -87.13 33.27 0.67 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.599 0.76 . . . . 2.94 110.424 176.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.1 p -149.62 77.97 1.35 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.094 1.358 . . . . 2.32 108.982 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 147.71 -120.39 1.22 Allowed Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.571 -1.411 . . . . 1.53 109.571 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 27.5 mtp -139.53 136.03 34.07 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 127.147 2.179 . . . . 4.13 106.352 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.83 165.86 18.54 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.696 1.198 . . . . 0.64 109.598 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -73.59 -53.0 11.52 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.159 0.984 . . . . 2.24 108.4 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.2 pt -119.69 147.76 23.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.669 -0.696 . . . . 1.11 111.224 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.4 tt -122.95 133.13 54.4 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.014 1.326 . . . . 2.54 109.142 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.43 HG13 ' CE1' ' A' ' 197' ' ' PHE . 4.7 t -81.19 101.02 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.571 1.148 . . . . 1.0 108.535 178.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.8 t -78.9 111.75 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 108.784 -0.821 . . . . 1.25 108.784 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -99.0 118.32 35.51 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 106.203 -1.777 . . . . 5.06 106.203 166.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -143.78 161.42 38.66 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.972 -1.121 . . . . 0.92 107.972 -176.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -122.99 142.39 50.89 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.335 -1.358 . . . . 3.93 107.335 172.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.497 ' HA2' ' CD1' ' A' ' 174' ' ' PHE . . . 83.98 174.73 50.54 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.982 -0.447 . . . . 2.0 111.982 170.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.14 77.75 3.68 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.915 -0.756 . . . . 3.34 109.9 -170.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -73.15 68.77 1.01 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.696 0.798 . . . . 2.64 112.269 -175.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 80.77 -36.65 2.29 Favored Glycine 0 CA--C 1.527 0.812 0 O-C-N 121.442 -0.787 . . . . 3.34 111.618 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -71.25 139.73 50.14 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.452 -1.684 . . . . 2.9 106.452 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -76.14 -66.72 0.76 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.832 -1.544 . . . . 5.63 106.832 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -98.17 101.73 13.28 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.025 -1.102 . . . . 5.83 108.025 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -156.42 -73.65 0.1 Allowed 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 122.657 0.383 . . . . 2.68 110.145 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.512 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -83.95 170.72 13.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.677 -1.231 . . . . 7.65 107.677 178.147 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.512 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 9.2 p30 175.39 33.14 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.906 1.282 . . . . 2.35 112.879 -177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 53.15 -156.84 4.94 Favored Glycine 0 CA--C 1.536 1.362 0 O-C-N 120.984 -1.073 . . . . 1.39 111.543 -172.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -76.3 62.14 1.75 Allowed 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.833 0.853 . . . . 4.25 112.567 -175.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -162.17 -154.8 7.69 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 107.839 -2.104 . . . . 1.68 107.839 168.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 35.81 -113.6 0.15 Allowed Glycine 0 C--N 1.339 0.728 0 C-N-CA 127.966 2.698 . . . . 1.36 112.219 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.688 HD13 H142 ' A' ' 269' ' ' NGH . 1.1 mm -79.58 139.47 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 118.126 0.963 . . . . 1.84 109.001 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.625 ' HB2' ' H5 ' ' A' ' 269' ' ' NGH . 1.5 mp -80.52 -59.9 2.52 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 107.983 -1.117 . . . . 1.16 107.983 170.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -163.51 159.77 22.41 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.761 -0.459 . . . . 0.86 109.761 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -146.55 117.15 7.54 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.264 1.426 . . . . 1.17 113.666 -166.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -136.37 159.47 41.67 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.004 1.722 . . . . 0.73 109.208 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -148.65 144.03 26.9 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.953 -1.499 . . . . 2.76 106.953 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -93.01 -89.99 1.55 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.166 0.888 . . . . 0.8 110.916 173.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.28 97.91 0.62 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.799 2.333 . . . . 1.3 110.962 -175.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -169.01 161.68 35.38 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 108.24 -1.944 . . . . 1.16 108.24 171.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.4 t -80.96 178.38 8.45 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.509 0.654 . . . . 3.35 110.466 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 46.24 -109.8 0.41 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.643 1.116 . . . . 1.42 111.314 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.7 tp -59.87 -42.25 88.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 118.169 -0.92 . . . . 1.62 109.826 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -38.6 128.97 1.85 Allowed Glycine 0 CA--C 1.534 1.223 0 C-N-CA 124.805 1.193 . . . . 1.09 112.664 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 108.86 -50.83 0.75 Allowed Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.366 1.936 . . . . 0.72 109.686 -162.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.24 148.02 28.62 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.398 1.079 . . . . 2.61 110.481 -166.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -117.95 121.43 40.67 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.498 1.119 . . . . 0.6 111.248 -170.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -111.54 122.7 48.53 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-N 118.512 0.597 . . . . 2.24 111.381 -168.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.43 ' CE1' HG13 ' A' ' 161' ' ' VAL . 5.4 m-85 -111.06 136.16 50.5 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.973 -1.121 . . . . 2.64 107.973 -178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -67.0 93.55 0.28 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 106.476 -1.675 . . . . 2.85 106.476 172.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -39.12 82.86 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 119.688 1.131 . . . . 3.41 109.193 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -34.66 -48.87 0.39 Allowed 'General case' 0 C--O 1.238 0.493 0 C-N-CA 127.092 2.157 . . . . 2.97 110.543 -167.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -61.13 179.7 0.18 Allowed 'General case' 0 C--O 1.24 0.597 0 C-N-CA 126.167 1.787 . . . . 4.67 112.283 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -115.52 87.14 2.6 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 105.538 -2.023 . . . . 2.9 105.538 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -75.67 163.32 27.43 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.93 -1.032 . . . . 1.13 108.276 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.8 p -129.22 144.15 51.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.38 -0.971 . . . . 1.77 108.38 174.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . 0.258 6.3 t -61.31 -40.47 94.29 Favored 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 126.113 1.765 . . . . 2.21 112.414 165.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -96.37 -172.44 2.53 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 124.406 1.082 . . . . 2.47 108.365 177.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.3 m -47.53 -65.7 0.52 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.785 2.034 . . . . 3.88 110.594 -173.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 45.77 -104.49 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 125.896 1.712 . . . . 2.17 114.364 165.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -112.38 -81.48 1.12 Allowed Glycine 0 C--N 1.335 0.495 0 N-CA-C 109.677 -1.369 . . . . 1.56 109.677 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 6.3 m -115.79 123.3 47.88 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 105.654 -1.98 . . . . 0.91 105.654 167.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -74.79 111.97 10.53 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.839 -0.8 . . . . 2.73 108.839 178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.01 -54.41 24.78 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.057 0.844 . . . . 1.74 110.585 -175.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.56 ' O ' HG23 ' A' ' 217' ' ' VAL . 1.8 t80 -44.77 -43.86 8.88 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.77 1.228 . . . . 1.89 111.352 177.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.93 -64.74 0.84 Allowed 'General case' 0 CA--C 1.528 0.128 0 O-C-N 121.929 -0.482 . . . . 1.25 109.942 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.829 HG23 ' H4 ' ' A' ' 269' ' ' NGH 0.324 3.4 m -53.89 -43.37 69.59 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.377 0.608 . . . . 0.89 110.701 -178.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -50.45 -42.73 54.61 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.918 -0.583 . . . . 0.47 111.793 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.588 HG21 ' CE2' ' A' ' 248' ' ' PHE . 83.9 t -62.65 -42.78 97.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 119.699 1.136 . . . . 0.69 111.339 -177.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.493 ' CD2' ' O4 ' ' A' ' 269' ' ' NGH . 5.8 t60 -55.33 -47.33 75.83 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.977 0.911 . . . . 2.59 109.456 174.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -76.13 -32.75 59.29 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 114.257 1.206 . . . . 3.49 114.257 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.503 HD11 ' CD1' ' A' ' 134' ' ' ILE . 4.7 mm -58.0 -50.85 76.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 106.886 -1.524 . . . . 2.38 106.886 171.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.76 -45.46 48.68 Favored Glycine 0 CA--C 1.537 1.436 0 N-CA-C 111.931 -0.468 . . . . 0.83 111.931 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -55.08 -50.56 68.87 Favored 'General case' 0 C--O 1.226 -0.18 0 O-C-N 121.569 -0.959 . . . . 1.27 110.335 175.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 1.5 t -52.21 -49.63 63.52 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.482 0.713 . . . . 2.05 111.377 176.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 141' ' ' TRP . 10.2 mt -60.1 -45.65 92.24 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.374 0.534 . . . . 2.18 109.721 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 134.48 38.99 0.19 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 123.812 0.72 . . . . 1.31 112.608 168.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.06 116.73 24.45 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.132 0.966 . . . . 3.48 110.156 174.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -80.42 52.51 4.36 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 119.301 -0.722 . . . . 2.85 113.151 -178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 72.5 m80 66.28 161.85 0.15 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.28 1.432 . . . . 1.91 113.022 -175.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 74.1 m -131.73 -178.51 4.91 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.872 1.669 . . . . 1.12 109.431 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 7.4 p -146.79 16.03 1.24 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.991 1.316 . . . . 2.64 111.006 -165.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -115.79 138.52 24.01 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 106.878 -1.527 . . . . 2.51 106.878 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -79.92 -17.49 10.78 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.923 1.749 . . . . 1.76 114.182 -172.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.405 ' HE3' ' HB2' ' A' ' 233' ' ' LYS . 14.6 mtmt -83.65 -28.35 28.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 118.94 0.791 . . . . 1.69 109.852 173.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.21 147.69 39.05 Favored 'General case' 0 C--O 1.225 -0.19 0 O-C-N 121.902 -0.499 . . . . 0.76 110.792 173.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 71.2 t -92.97 -23.5 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 124.724 1.21 . . . . 0.62 109.72 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 16.9 tpp -70.05 -14.68 62.79 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.471 1.108 . . . . 2.7 113.411 177.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.406 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -51.33 147.02 10.83 Favored Pre-proline 0 CA--C 1.539 0.545 0 O-C-N 121.378 -0.826 . . . . 3.02 112.944 177.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.92 -16.2 29.33 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.317 2.011 . . . . 1.3 111.631 174.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.509 ' O ' ' H2 ' ' A' ' 269' ' ' NGH 0.301 0.1 OUTLIER -76.35 169.13 18.8 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.2 -1.037 . . . . 1.62 108.2 171.783 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -128.01 146.98 50.49 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 104.808 -2.293 . . . . 2.0 104.808 176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.23 144.18 20.78 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.476 -1.305 . . . . 2.4 107.476 171.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -62.9 144.35 56.79 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.977 0.911 . . . . 2.26 111.051 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.486 HG21 ' CD1' ' A' ' 248' ' ' PHE . 17.4 m -131.85 154.35 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.555 0.742 . . . . 1.91 110.672 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -63.18 -16.23 59.45 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.993 1.717 . . . . 3.5 114.334 -177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . 0.25 14.0 mm 72.21 -41.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 128.019 2.527 . . . . 3.33 111.085 -176.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -78.99 -51.81 9.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.878 0.871 . . . . 3.42 111.197 -177.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 47.5 m -78.46 -18.07 55.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.482 1.113 . . . . 2.66 110.652 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.588 ' CE2' HG21 ' A' ' 217' ' ' VAL . 87.7 t80 -39.3 110.82 0.15 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.531 1.532 . . . . 7.89 112.11 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.02 163.88 31.59 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 124.448 1.099 . . . . 3.36 109.906 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.66 HD21 HG12 ' A' ' 140' ' ' VAL . 1.2 mm? -81.08 137.42 36.0 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.831 -1.174 . . . . 1.1 107.831 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.7 m -77.41 160.66 28.58 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.651 0.262 . . . . 0.71 110.816 -175.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.76 -48.35 78.04 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 110.059 -0.348 . . . . 0.88 110.059 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -48.31 -51.88 24.04 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.765 0.793 . . . . 2.6 109.96 172.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.97 -47.52 80.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.079 -1.419 . . . . 2.2 109.09 -176.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.5 mt -59.86 -47.46 91.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.816 1.646 . . . . 0.93 111.226 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -60.08 -44.27 94.89 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 120.346 -1.471 . . . . 4.63 109.858 175.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -49.62 -42.59 36.02 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.937 -0.865 . . . . 0.8 110.937 170.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 258' ' ' ILE . 0.2 OUTLIER -68.58 -47.04 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 117.826 0.813 . . . . 3.45 110.561 -177.247 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -68.16 -15.95 63.79 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 119.701 -0.8 . . . . 2.63 110.849 -178.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.14 -17.69 3.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.755 0.822 . . . . 2.04 112.873 165.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 56.7 mt -56.19 74.1 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 120.076 1.307 . . . . 2.54 111.753 161.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -170.16 110.33 0.4 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 128.954 2.902 . . . . 6.85 107.312 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.781 0 N-CA-C 108.248 -1.941 . . . . 8.8 108.248 -167.057 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' NGH . . . . . 0.829 ' H4 ' HG23 ' A' ' 215' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 108.009 -1.108 . . . . 13.65 108.009 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 138.33 -166.23 25.29 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 109.566 -1.414 . . . . 9.58 109.566 -175.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.02 161.98 43.58 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.113 2.542 . . . . 11.98 110.81 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.8 p -158.94 153.27 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 108.122 -1.066 . . . . 6.72 108.122 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -178.05 173.82 1.45 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.298 2.239 . . . . 12.73 105.558 176.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.8 mmt85 -176.4 82.74 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 126.406 1.883 . . . . 8.2 106.26 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.487 ' HG3' HD11 ' A' ' 114' ' ' ILE . 3.1 mptt 65.86 -80.12 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.898 1.279 . . . . 6.18 111.297 -172.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 60.34 -80.27 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.586 1.555 . . . . 3.46 109.407 -165.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.44 ' O ' HD13 ' A' ' 114' ' ' ILE . 59.9 m-85 -114.81 111.84 21.85 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 124.461 1.105 . . . . 3.14 111.499 -168.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.546 HG22 ' CE1' ' A' ' 116' ' ' TYR . 18.0 mm -128.52 103.87 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.926 0.87 . . . . 2.69 112.157 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 p -86.91 140.98 29.09 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.25 2.22 . . . . 1.22 109.49 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.546 ' CE1' HG22 ' A' ' 114' ' ' ILE . 10.3 m-85 -124.47 167.78 13.96 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 124.579 1.151 . . . . 6.25 110.84 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -149.52 149.55 30.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.802 1.241 . . . . 7.53 109.608 176.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.4 mt -102.68 155.69 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.656 -1.239 . . . . 0.92 107.656 173.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -97.57 -44.56 6.75 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.11 0.564 . . . . 2.94 110.156 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -149.03 164.85 33.42 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.865 0.466 . . . . 2.25 110.149 174.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -111.15 127.97 55.75 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.149 1.38 . . . . 1.8 107.574 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.1 t -60.46 136.84 92.2 Favored Pre-proline 0 N--CA 1.442 -0.829 0 C-N-CA 122.931 0.492 . . . . 2.24 109.742 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.22 -18.64 14.08 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.16 2.573 . . . . 1.58 111.009 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -40.41 -46.58 2.42 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.622 1.569 . . . . 2.0 111.452 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -128.24 176.33 7.76 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 125.544 1.538 . . . . 2.63 109.253 178.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -73.86 143.42 45.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.285 0.634 . . . . 3.04 110.452 174.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 24.3 ttt-85 -47.19 -45.0 22.71 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.475 0.71 . . . . 2.84 111.512 178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.63 -10.04 11.01 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.023 0.929 . . . . 4.2 112.997 -177.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -100.03 -45.11 5.78 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.387 1.475 . . . . 2.17 110.434 168.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 73.9 t -53.41 -54.94 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 123.991 0.916 . . . . 1.25 109.511 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.407 ' HB3' ' NZ ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -71.75 -25.53 62.08 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 117.447 -1.701 . . . . 1.94 109.81 178.429 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -59.11 -48.17 82.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.422 1.01 . . . . 2.21 109.042 -178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.27 -52.7 51.25 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 116.21 -0.45 . . . . 0.41 111.486 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -74.5 -36.57 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.663 0.744 . . . . 1.67 110.131 -173.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 6.7 ttm-85 -55.57 -54.87 38.72 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.479 1.112 . . . . 3.94 108.276 173.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.573 ' O ' HG23 ' A' ' 140' ' ' VAL . 12.4 mmmm -66.34 -41.11 90.06 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.431 0.692 . . . . 1.27 109.658 -176.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -47.12 -54.46 10.47 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 118.551 0.614 . . . . 0.48 110.686 169.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.757 ' CD1' HG23 ' A' ' 220' ' ' ILE . 34.5 m-85 -59.81 -42.67 93.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 120.476 -0.49 . . . . 4.42 111.588 176.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -50.28 -39.85 46.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.393 0.677 . . . . 2.98 110.515 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 136' ' ' LYS . 44.6 t -61.0 -56.24 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.131 -0.692 . . . . 0.77 109.131 -176.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.4 ' CH2' ' HG ' ' A' ' 250' ' ' LEU . 26.8 m95 -75.24 -35.21 61.44 Favored 'General case' 0 CA--C 1.507 -0.674 0 O-C-N 122.054 -0.404 . . . . 0.84 110.585 -173.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 89.0 p -70.7 -15.53 62.71 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 112.359 0.503 . . . . 2.28 112.359 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.13 -48.39 11.39 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.549 -1.278 . . . . 1.57 107.549 178.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 26.7 m -75.64 -40.42 40.51 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 N-CA-C 113.191 0.811 . . . . 1.6 113.191 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 31.7 p -100.06 140.71 21.71 Favored Pre-proline 0 N--CA 1.447 -0.624 0 N-CA-C 108.466 -0.939 . . . . 0.87 108.466 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.33 12.03 0.89 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.241 2.627 . . . . 0.99 113.637 -175.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.2 mt -70.09 115.52 9.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.58 1.152 . . . . 2.02 108.845 -175.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -82.53 89.79 6.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 122.445 1.117 . . . . 4.6 108.282 -172.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.18 146.1 48.8 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 112.738 -2.028 . . . . 6.38 109.299 170.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.6 t -151.19 147.31 26.87 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.881 -1.526 . . . . 1.08 106.881 165.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.407 ' NZ ' ' HB3' ' A' ' 131' ' ' ASP . 2.5 tmmt? -125.64 129.75 50.24 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 107.363 -1.347 . . . . 1.96 107.363 175.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.6 pp -133.75 170.69 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 105.952 -1.87 . . . . 1.5 105.952 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -142.63 27.37 1.69 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.798 0.726 . . . . 4.39 109.094 169.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 58.2 p -150.72 78.46 1.31 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.401 1.08 . . . . 2.66 108.531 -172.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 148.15 -128.08 2.76 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 108.028 -2.029 . . . . 1.54 108.028 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 2.0 mtt -126.43 148.81 49.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.407 1.083 . . . . 4.13 109.552 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -141.42 160.65 39.69 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.137 1.375 . . . . 0.69 109.299 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -80.86 -58.91 2.88 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.636 1.974 . . . . 1.98 107.786 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -91.02 179.04 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 122.035 0.921 . . . . 1.37 111.243 176.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.4 tt -138.75 127.61 23.66 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.495 2.318 . . . . 2.24 109.094 167.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 20.6 t -86.26 105.73 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 107.702 -1.221 . . . . 0.75 107.702 170.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 45.3 t -81.56 140.31 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 107.43 -1.322 . . . . 1.32 107.43 170.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.29 90.32 2.41 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.568 -2.012 . . . . 4.94 105.568 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.42 158.83 39.76 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 123.068 0.547 . . . . 0.78 109.988 -165.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 14.0 ptt-85 -124.0 115.57 21.43 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.837 0.855 . . . . 4.65 109.935 -162.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 60.48 -97.65 0.12 Allowed Glycine 0 CA--C 1.535 1.328 0 C-N-CA 123.335 0.493 . . . . 1.6 112.292 -175.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.39 135.8 35.68 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.785 0.834 . . . . 2.83 109.06 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -153.2 -52.95 0.11 Allowed 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 111.621 0.23 . . . . 3.64 111.621 176.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 143.21 78.38 0.04 OUTLIER Glycine 0 C--N 1.334 0.445 0 N-CA-C 107.278 -2.329 . . . . 2.9 107.278 -173.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -158.69 169.06 25.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.218 -1.03 . . . . 2.21 108.218 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 -81.8 -40.94 21.82 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.858 1.263 . . . . 5.73 109.372 174.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -85.51 -22.8 28.02 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 123.418 0.687 . . . . 4.98 110.714 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 60.78 -171.06 0.14 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.984 1.314 . . . . 3.1 111.113 -173.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -109.24 -179.28 3.79 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 106.917 -1.512 . . . . 6.2 106.917 159.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -143.74 -168.16 2.77 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.539 1.936 . . . . 3.99 106.149 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -90.34 -141.64 9.18 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 110.952 -0.859 . . . . 1.7 110.952 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.63 114.85 2.69 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 108.935 -0.765 . . . . 7.49 108.935 169.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 106.92 -155.94 16.21 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.083 -1.207 . . . . 1.96 110.083 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.28 -119.44 11.95 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 109.946 -1.262 . . . . 1.88 109.946 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.415 HG12 ' H12' ' A' ' 269' ' ' NGH 0.339 2.2 mt -90.58 137.27 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 107.129 -1.434 . . . . 2.0 107.129 -179.364 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.423 HD23 ' H1 ' ' A' ' 269' ' ' NGH . 2.9 mm? -85.68 -56.85 3.3 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.12 1.368 . . . . 2.18 109.856 166.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -156.07 162.17 40.31 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 121.129 -0.982 . . . . 0.86 112.322 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.452 ' HA ' ' HN1' ' A' ' 269' ' ' NGH . 26.9 p-80 -145.15 116.07 7.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.36 1.464 . . . . 0.93 114.265 176.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -132.77 159.04 40.9 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.951 2.1 . . . . 0.84 108.308 177.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -144.42 148.21 34.33 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.965 -1.494 . . . . 3.47 106.965 172.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -98.81 -82.34 1.66 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.851 -0.9 . . . . 1.13 110.851 170.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.97 92.71 0.71 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.396 2.73 . . . . 2.34 110.551 -172.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -175.39 157.38 23.94 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 108.661 -1.776 . . . . 2.04 108.661 171.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 26.3 m -77.54 157.62 30.27 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.11 -0.7 . . . . 2.96 109.11 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 75.89 -110.69 3.11 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.931 -0.868 . . . . 2.39 110.931 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.452 HG12 ' CE1' ' A' ' 196' ' ' HIS . 5.1 tp -63.03 -42.28 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 O-C-N 121.468 -1.019 . . . . 2.25 109.632 -170.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -30.75 129.56 0.16 Allowed Glycine 0 CA--C 1.535 1.324 0 C-N-CA 126.252 1.882 . . . . 1.74 113.814 175.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 103.78 -52.75 0.75 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 126.465 1.983 . . . . 0.85 109.757 -164.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -84.09 160.61 20.89 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.054 0.942 . . . . 1.98 111.314 -167.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -138.91 124.52 19.53 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 118.136 -0.935 . . . . 0.65 111.56 -172.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.452 ' CE1' HG12 ' A' ' 191' ' ' ILE . 1.0 OUTLIER -112.38 127.21 55.95 Favored 'General case' 0 C--N 1.345 0.41 0 CA-C-O 117.721 -1.133 . . . . 2.07 109.244 -173.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -114.2 151.44 32.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.202 1.365 . . . . 2.87 110.947 174.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -73.83 101.34 3.71 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.417 -0.811 . . . . 3.43 109.964 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -63.36 -29.67 70.93 Favored 'General case' 0 C--O 1.24 0.596 0 O-C-N 121.485 -0.76 . . . . 2.5 111.147 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -59.44 -31.9 69.72 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.393 0.997 . . . . 3.11 109.344 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -68.03 150.51 48.35 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 122.107 0.956 . . . . 2.83 108.884 -176.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -102.3 93.03 4.98 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 105.695 -1.965 . . . . 3.45 105.695 174.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 51.4 m95 -77.85 138.79 39.13 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 108.536 -0.912 . . . . 1.16 108.536 -177.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.7 108.79 2.02 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 120.975 1.716 . . . . 2.64 111.023 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.33 -51.38 54.88 Favored 'General case' 0 C--N 1.341 0.224 0 CA-C-N 118.4 0.545 . . . . 3.72 111.0 162.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -65.54 -38.3 89.22 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.7 -0.682 . . . . 4.92 111.875 -161.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 21.3 t -80.52 -43.25 21.05 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.345 0.658 . . . . 7.42 109.773 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 114.6 -31.69 6.24 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.314 -0.715 . . . . 3.52 112.131 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -21.91 -85.0 0.01 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 128.164 2.792 . . . . 1.16 114.545 -171.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 26.1 m -122.49 123.37 41.1 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 104.563 -2.384 . . . . 0.87 104.563 156.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -84.97 125.33 32.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 119.101 0.864 . . . . 1.36 109.236 173.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 43.6 tp -53.94 -51.83 62.54 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 118.044 0.384 . . . . 1.76 110.397 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.599 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.3 t80 -50.23 -46.76 55.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.108 0.563 . . . . 1.96 110.488 -178.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.503 ' C ' HD23 ' A' ' 214' ' ' LEU . 6.8 tt -56.12 -63.39 1.2 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.373 1.069 . . . . 1.21 110.866 -177.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.417 HG23 ' H2 ' ' A' ' 269' ' ' NGH 0.37 0.9 OUTLIER -59.13 -39.86 83.65 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.918 0.39 . . . . 0.97 110.453 179.31 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.41 62.31 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 116.822 -1.561 . . . . 0.48 109.409 177.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 213' ' ' PHE . 8.4 t -44.45 -55.25 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 121.117 1.78 . . . . 1.1 111.473 177.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -51.71 -46.77 64.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.302 0.641 . . . . 2.38 111.802 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -79.51 -47.23 15.93 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.283 -0.885 . . . . 2.77 112.58 -173.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.757 HG23 ' CD1' ' A' ' 138' ' ' PHE . 1.3 mp -56.53 -41.61 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 126.035 1.734 . . . . 1.52 107.871 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -56.36 -47.33 83.54 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 111.284 -0.726 . . . . 0.91 111.284 170.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.429 ' CE1' ' CD2' ' A' ' 228' ' ' HIS . 7.1 m-70 -52.59 -52.31 55.81 Favored 'General case' 0 C--O 1.224 -0.239 0 O-C-N 121.433 -1.04 . . . . 1.52 110.389 174.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.0 m -51.06 -47.64 61.73 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.923 0.783 . . . . 2.12 112.476 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -18.87 15.18 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.204 1.002 . . . . 3.34 112.276 176.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 120.4 6.7 9.54 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 125.659 1.599 . . . . 1.62 111.243 173.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 258' ' ' ILE . 49.7 mt -88.89 109.36 20.15 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 117.842 0.821 . . . . 4.8 110.498 -159.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -60.63 158.47 28.07 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.503 1.049 . . . . 3.47 112.49 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.429 ' CD2' ' CE1' ' A' ' 222' ' ' HIS . 27.1 m80 -62.77 121.64 13.93 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.54 0.736 . . . . 1.77 111.5 -177.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 64.8 m -77.94 178.39 7.5 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.442 0.639 . . . . 1.58 110.678 171.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 p -125.22 6.49 7.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.905 2.082 . . . . 3.49 111.927 -164.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -118.38 136.68 24.11 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.264 1.426 . . . . 2.53 108.045 -171.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.63 -13.49 14.7 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.679 2.253 . . . . 1.86 114.439 -175.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -80.5 -37.7 31.2 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.605 1.162 . . . . 1.61 108.892 173.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -58.02 149.0 24.33 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.424 0.69 . . . . 0.96 110.891 175.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.7 t -93.34 -17.82 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.234 -0.894 . . . . 0.84 110.504 177.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -73.73 -20.94 60.37 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 113.139 0.792 . . . . 2.14 113.139 -174.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -52.92 167.97 0.37 Allowed Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 125.932 1.693 . . . . 3.02 113.644 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -83.98 -14.44 7.39 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 121.942 1.761 . . . . 1.55 112.332 173.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.294 0.0 OUTLIER -79.35 176.74 9.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.913 1.285 . . . . 2.12 109.781 178.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.573 ' HA ' ' H73' ' A' ' 269' ' ' NGH . 90.1 t80 -121.39 140.94 51.48 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.04 1.736 . . . . 2.28 106.503 176.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -151.31 132.51 14.46 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 105.095 -2.187 . . . . 2.46 105.095 174.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -61.21 123.1 16.75 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.149 0.432 . . . . 2.63 110.428 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 18.2 m -100.85 134.05 42.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 C-N-CA 122.818 0.447 . . . . 1.99 109.997 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -81.96 90.56 6.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 122.224 1.012 . . . . 3.38 109.807 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 92.9 mt -54.06 -24.77 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.191 0.996 . . . . 2.95 110.757 178.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -46.74 -45.41 19.65 Favored 'General case' 0 C--N 1.338 0.096 0 CA-C-N 118.4 0.546 . . . . 3.47 111.868 170.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 25.6 m -84.04 -42.32 16.28 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.404 0.682 . . . . 1.92 109.895 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 69.8 t80 58.28 68.59 0.81 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.792 0.806 . . . . 4.24 110.223 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -160.49 165.22 31.33 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.009 -0.737 . . . . 3.48 109.009 174.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.4 ' HG ' ' CH2' ' A' ' 141' ' ' TRP . 0.1 OUTLIER -109.17 -175.15 2.68 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.087 1.355 . . . . 1.77 110.145 -179.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 39.1 m -81.93 141.68 33.11 Favored 'General case' 0 C--O 1.222 -0.377 0 O-C-N 120.872 -1.143 . . . . 0.98 112.029 178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.46 -39.61 57.79 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.231 0.539 . . . . 0.94 111.026 169.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -66.74 -21.7 66.06 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.929 0.714 . . . . 3.75 112.929 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.36 -51.81 7.51 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.903 0.881 . . . . 3.37 109.57 169.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 56.1 mt -47.58 -43.61 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.13 1.772 . . . . 1.13 111.77 -175.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -52.91 -53.53 47.96 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.823 0.344 . . . . 4.76 111.32 172.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -64.03 -54.37 30.89 Favored Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.089 -1.605 . . . . 1.63 109.089 -171.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.45 ' HA ' HD22 ' A' ' 226' ' ' LEU . 2.8 pp -55.37 -35.9 38.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 123.667 0.787 . . . . 2.46 112.348 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -73.04 -49.13 30.51 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 118.443 -0.789 . . . . 3.54 111.359 172.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 24.3 m -51.01 -37.15 43.39 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 119.736 1.153 . . . . 4.15 112.321 174.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 10.9 mt -62.39 -35.05 77.96 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.277 1.031 . . . . 5.19 111.489 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -71.43 -51.62 22.93 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.053 -0.404 . . . . 11.12 110.274 169.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.183 0 CA-C-O 117.094 -1.948 . . . . 7.48 109.4 -175.881 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' NGH . . . . . 0.573 ' H73' ' HA ' ' A' ' 240' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 52.9 mtt . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 108.145 -1.057 . . . . 12.86 108.145 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -61.04 153.01 39.25 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 111.262 -0.735 . . . . 11.11 111.262 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -72.49 171.04 17.91 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.058 2.505 . . . . 13.62 109.269 172.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.4 p -153.28 143.58 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 107.419 -1.326 . . . . 8.29 107.419 172.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 5.9 p90 -87.71 -64.91 1.08 Allowed 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.298 -1.001 . . . . 13.54 108.298 173.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 38.44 42.6 0.56 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.398 1.479 . . . . 9.16 111.216 -172.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.551 ' CG ' HD11 ' A' ' 114' ' ' ILE . 1.1 mptp? 52.08 -83.0 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.117 1.367 . . . . 5.84 112.064 -158.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.1 m-70 56.27 -66.5 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.426 1.49 . . . . 3.82 110.645 -154.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -120.25 114.34 21.76 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.127 0.971 . . . . 3.61 112.377 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.551 HD11 ' CG ' ' A' ' 111' ' ' LYS . 45.9 mm -95.03 88.28 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 122.403 1.097 . . . . 2.68 109.024 168.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.97 123.87 29.85 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.26 -1.385 . . . . 1.72 107.26 176.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -127.08 163.28 24.13 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.531 1.059 . . . . 4.43 112.458 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -142.2 144.11 33.24 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.487 1.115 . . . . 5.82 109.233 -179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -92.99 151.79 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 109.5 -0.556 . . . . 1.08 109.5 176.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -86.46 -50.58 6.77 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 108.813 -0.81 . . . . 3.48 108.813 -178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -133.02 176.69 8.28 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 123.84 0.712 . . . . 3.29 111.777 174.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -138.94 160.93 38.57 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.431 1.893 . . . . 2.52 107.136 -177.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 90.6 m 46.99 56.26 17.09 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 123.505 0.722 . . . . 8.07 111.858 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -74.12 -39.96 1.46 Allowed 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.121 1.881 . . . . 5.27 109.326 171.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.99 3.88 0.72 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.543 0.737 . . . . 2.08 112.75 -175.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 7.3 mtm -150.24 168.4 24.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.937 1.244 . . . . 1.66 110.843 -169.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -69.85 140.56 53.24 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.691 -0.485 . . . . 3.34 109.691 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -56.9 -40.0 75.46 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.267 -0.896 . . . . 2.08 112.138 -174.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -66.4 -3.06 5.28 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.892 -0.575 . . . . 3.48 112.289 -178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -96.69 -50.36 4.73 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 124.866 1.266 . . . . 2.68 110.357 161.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.1 m -58.43 -49.42 82.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 O-C-N 121.105 -0.997 . . . . 2.72 110.439 -169.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -71.79 -24.46 61.74 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 118.745 -1.182 . . . . 2.25 109.172 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -66.31 -48.93 68.73 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 119.659 1.118 . . . . 2.81 109.682 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.68 -49.5 76.3 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 123.774 0.829 . . . . 0.58 110.143 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.9 tp -70.88 -38.06 70.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.951 0.405 . . . . 1.69 110.469 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -54.87 41.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.725 -1.213 . . . . 3.45 107.725 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -59.24 -51.5 69.72 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.043 -0.981 . . . . 1.43 110.115 176.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -46.08 -50.36 15.37 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 118.686 0.676 . . . . 0.67 112.307 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.31 -51.6 62.65 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 118.839 -1.144 . . . . 6.69 109.196 175.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.16 -27.23 65.46 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.641 0.776 . . . . 2.08 112.0 -170.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.602 HG22 ' CD1' ' A' ' 248' ' ' PHE . 53.2 t -62.66 -54.76 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 124.561 1.144 . . . . 0.66 109.293 171.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.432 ' CZ3' ' HG ' ' A' ' 250' ' ' LEU . 59.3 m95 -73.6 -33.84 64.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 121.593 -0.692 . . . . 0.71 109.325 -174.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 74.0 m -65.62 -17.35 64.53 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 118.736 0.698 . . . . 1.24 112.571 173.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -75.71 -46.62 30.1 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.033 0.833 . . . . 1.15 109.068 174.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 57.3 t -74.38 -54.3 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.598 0.759 . . . . 2.16 110.455 -176.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.475 HG21 HD12 ' A' ' 258' ' ' ILE . 24.4 p -90.08 158.61 43.95 Favored Pre-proline 0 N--CA 1.45 -0.46 0 C-N-CA 124.945 1.298 . . . . 0.6 109.823 -174.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -74.31 2.64 6.01 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.088 1.859 . . . . 0.8 112.848 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.9 mt -63.62 114.99 4.3 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.367 0.985 . . . . 2.18 110.396 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.5 76.06 2.53 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.348 -1.353 . . . . 4.26 107.348 -170.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -63.48 161.2 14.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.479 -0.782 . . . . 5.31 112.364 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.8 t -152.09 138.94 18.93 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.833 -1.543 . . . . 0.88 106.833 168.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -77.82 147.48 35.19 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 105.71 -1.959 . . . . 2.77 105.71 156.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.2 pt -132.51 120.83 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 105.556 -2.016 . . . . 1.31 105.556 156.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -75.12 -18.11 60.3 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.599 -0.688 . . . . 3.59 110.879 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.83 111.97 8.5 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 125.549 1.54 . . . . 2.28 109.299 -161.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 137.63 -137.15 8.68 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 108.415 -1.874 . . . . 1.44 108.415 173.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 4.6 mmt -131.42 135.83 47.49 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 125.601 1.56 . . . . 6.28 107.223 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -124.98 165.98 17.16 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.867 1.267 . . . . 0.94 110.154 -172.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -76.86 -57.42 3.86 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 122.036 0.922 . . . . 2.15 109.104 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 19.0 pt -109.26 155.41 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 106.699 -1.593 . . . . 0.95 106.699 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.45 HD22 ' C ' ' A' ' 160' ' ' LEU 0.36 0.0 OUTLIER -139.64 140.74 37.01 Favored 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 121.251 -0.906 . . . . 2.5 109.815 175.902 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 33.2 t -83.82 99.39 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 106.985 -1.487 . . . . 1.3 106.985 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.3 p -102.41 124.76 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 107.173 -1.417 . . . . 2.46 107.173 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -86.36 150.08 24.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.118 -1.438 . . . . 7.47 107.118 167.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.73 156.55 31.84 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.783 -1.562 . . . . 1.1 106.783 161.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -119.44 140.78 49.87 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.625 -1.62 . . . . 5.31 106.625 164.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 22.25 53.71 0.02 OUTLIER Glycine 0 CA--C 1.531 1.079 0 C-N-CA 128.137 2.779 . . . . 3.46 115.937 -173.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -156.63 138.67 14.49 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.212 -1.033 . . . . 4.16 108.212 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 159.2 -54.96 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 127.315 2.246 . . . . 5.43 108.415 -176.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 164.79 -57.19 0.26 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.694 -0.562 . . . . 4.72 111.694 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -79.79 155.99 27.64 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.208 -0.664 . . . . 3.72 109.208 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -61.78 -38.84 89.53 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.428 -1.693 . . . . 6.93 106.428 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -71.15 39.04 0.06 Allowed 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 122.396 1.093 . . . . 5.04 111.923 171.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.54 -26.94 31.98 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 119.47 -2.019 . . . . 2.91 109.649 163.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.412 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -166.98 -171.98 1.94 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.249 -1.389 . . . . 8.08 107.249 176.045 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.412 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 4.0 p30 -171.57 44.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 O-C-N 124.629 1.205 . . . . 2.61 109.854 171.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 52.64 -156.54 4.53 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.652 -0.979 . . . . 1.54 110.652 -167.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -64.78 140.67 58.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.82 -0.811 . . . . 5.77 111.462 170.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 93.05 -164.33 27.3 Favored Glycine 0 N--CA 1.44 -1.042 0 C-N-CA 125.462 1.506 . . . . 1.34 110.344 -176.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.11 -118.15 9.6 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 125.834 1.683 . . . . 1.28 111.729 175.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.602 ' HA ' ' H12' ' A' ' 269' ' ' NGH . 1.2 mp -75.27 123.26 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 106.0 -1.852 . . . . 1.89 106.0 175.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.567 ' CD2' ' H5 ' ' A' ' 269' ' ' NGH 0.669 7.3 mp -76.91 -63.95 1.24 Allowed 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.266 -1.383 . . . . 1.55 107.266 168.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.93 ' H ' H102 ' A' ' 269' ' ' NGH . . . -159.16 155.98 28.17 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 113.757 1.021 . . . . 0.8 113.757 -168.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . 0.351 0.0 OUTLIER -103.32 142.44 34.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.544 1.938 . . . . 1.65 110.351 176.005 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -164.43 165.79 21.16 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 105.628 -1.99 . . . . 0.54 105.628 154.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -151.44 152.36 32.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 104.719 -2.326 . . . . 3.18 104.719 173.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -91.88 -78.97 1.4 Allowed Glycine 0 CA--C 1.523 0.558 0 N-CA-C 109.964 -1.255 . . . . 0.73 109.964 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -69.85 176.71 6.47 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 122.385 2.057 . . . . 2.12 110.089 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 90.12 144.03 11.19 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.86 -1.296 . . . . 1.1 109.86 -172.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.3 p -82.55 -178.73 7.18 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.518 1.127 . . . . 2.11 110.479 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 61.36 -115.37 7.81 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.802 -0.919 . . . . 1.32 110.802 173.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 3.9 tp -60.21 -40.55 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.419 -0.586 . . . . 1.53 109.419 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -39.35 136.41 1.37 Allowed Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.469 1.033 . . . . 1.01 112.295 176.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 96.6 -42.17 2.26 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.452 1.025 . . . . 0.74 112.448 -165.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -74.57 171.64 13.47 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.953 1.376 . . . . 1.4 111.749 -159.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -132.55 112.81 12.4 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.994 -1.484 . . . . 1.65 106.994 -163.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -132.48 101.94 5.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 109.644 -0.502 . . . . 5.67 109.644 -156.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -104.96 133.53 49.6 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.438 1.017 . . . . 2.5 109.695 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -57.0 105.67 0.24 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.549 -0.908 . . . . 2.75 108.549 171.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -59.39 -33.54 71.33 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 123.9 0.88 . . . . 2.89 110.925 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.5 -27.15 67.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.51 0.671 . . . . 3.42 109.462 -176.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -68.58 133.62 48.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 106.705 -1.591 . . . . 2.17 106.705 171.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -98.44 96.01 7.72 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.957 -1.868 . . . . 7.39 105.957 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 43.8 m95 -75.13 159.98 31.0 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.999 -1.111 . . . . 1.33 107.999 -176.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 211' ' ' ASN . 12.8 p -139.76 139.6 36.51 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.097 0.475 . . . . 2.2 111.454 -173.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.2 t -64.3 -49.34 72.19 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.938 -1.101 . . . . 1.64 111.293 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 13.7 p-80 -81.41 -167.38 1.45 Allowed 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.938 0.895 . . . . 3.02 109.697 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 20.8 t -56.82 -56.32 23.04 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.869 -0.419 . . . . 4.1 109.869 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 50.43 -94.85 0.01 OUTLIER Glycine 0 C--N 1.34 0.764 0 C-N-CA 124.869 1.224 . . . . 2.27 113.056 171.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -140.01 -75.26 0.05 OUTLIER Glycine 0 CA--C 1.523 0.572 0 N-CA-C 108.926 -1.67 . . . . 1.26 108.926 170.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.442 HG21 HD23 ' A' ' 181' ' ' LEU . 11.5 m -108.25 119.29 39.05 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.447 -1.686 . . . . 1.1 106.447 176.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 204' ' ' THR . 5.3 t-20 -78.5 125.91 30.03 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 120.103 -0.639 . . . . 1.56 109.641 -178.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.34 -52.67 62.72 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 109.115 -0.698 . . . . 1.38 109.115 -179.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -52.93 -42.12 65.12 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 122.955 0.502 . . . . 2.26 110.277 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.461 HD11 HG22 ' A' ' 243' ' ' VAL . 0.1 OUTLIER -60.9 -60.56 3.6 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.284 -0.885 . . . . 1.63 111.184 179.027 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.343 2.0 m -54.97 -38.91 68.41 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 110.259 -0.274 . . . . 0.7 110.259 177.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -59.36 -53.21 60.81 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 118.704 -0.665 . . . . 0.46 110.236 178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 97.6 t -53.48 -47.38 59.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 119.542 1.065 . . . . 0.74 109.864 177.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.546 ' HB2' ' H72' ' A' ' 269' ' ' NGH 0.455 5.7 t60 -51.52 -51.44 55.17 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 124.363 1.065 . . . . 1.9 113.819 170.637 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.99 -48.6 12.02 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.053 1.297 . . . . 2.94 113.809 -173.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.3 -39.92 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 106.66 -1.607 . . . . 1.19 106.66 167.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -47.88 -57.86 7.4 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 124.451 1.024 . . . . 0.6 113.634 166.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.427 ' CE1' ' CE1' ' A' ' 228' ' ' HIS . 0.0 OUTLIER -50.36 -48.99 55.4 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.449 1.125 . . . . 1.69 110.041 176.118 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 69.4 p -61.75 -19.92 62.97 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 113.55 0.944 . . . . 1.66 113.55 -172.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.522 HD12 HD11 ' A' ' 258' ' ' ILE . 9.4 mt -66.01 -67.93 0.41 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.713 -1.588 . . . . 2.26 106.713 175.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 156.62 66.15 0.01 OUTLIER Glycine 0 C--O 1.228 -0.259 0 N-CA-C 108.721 -1.752 . . . . 1.17 108.721 -176.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.69 136.64 53.21 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.732 1.613 . . . . 4.77 107.035 -174.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -109.83 41.81 2.13 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.239 0.923 . . . . 2.99 111.902 177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.427 ' CE1' ' CE1' ' A' ' 222' ' ' HIS . 70.1 m80 68.81 110.66 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.874 2.069 . . . . 1.62 113.407 178.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 34.9 m -74.8 160.51 30.6 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.611 -0.885 . . . . 1.26 108.611 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 66.7 m -133.24 47.84 2.45 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.883 1.273 . . . . 2.86 108.957 -170.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -143.59 141.14 18.35 Favored Pre-proline 0 N--CA 1.449 -0.515 0 C-N-CA 125.782 1.633 . . . . 1.82 106.607 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -91.39 -8.92 3.07 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.197 1.931 . . . . 0.96 114.533 -173.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -82.17 -37.61 25.87 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.134 -0.979 . . . . 1.42 108.372 170.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -53.18 152.07 4.63 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.585 1.154 . . . . 0.99 111.534 172.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 84.0 t -106.68 -25.9 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 124.352 1.061 . . . . 0.95 111.289 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 4.5 mtt -60.91 -27.39 68.14 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.161 -0.962 . . . . 3.22 113.43 177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.417 ' O ' ' ND1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.34 160.15 0.46 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 127.975 2.51 . . . . 3.41 114.455 -171.28 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.505 ' O ' ' H1 ' ' A' ' 269' ' ' NGH . 59.7 Cg_endo -75.54 -21.23 15.08 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.669 1.579 . . . . 1.01 111.818 175.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.368 0.2 OUTLIER -78.03 178.13 7.75 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.126 0.97 . . . . 1.28 108.976 179.227 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -126.25 149.74 48.89 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.915 -1.513 . . . . 2.46 106.915 174.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -153.5 120.28 5.65 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 104.677 -2.342 . . . . 3.29 104.677 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -60.76 122.47 14.87 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.256 -0.646 . . . . 2.36 109.256 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.461 HG22 HD11 ' A' ' 214' ' ' LEU . 15.9 m -125.22 142.37 42.29 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.051 0 CA-C-O 121.056 0.455 . . . . 1.76 110.961 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.09 91.48 0.16 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.384 1.474 . . . . 3.03 108.172 172.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 2.2 pp -51.7 -29.0 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 123.971 0.909 . . . . 2.96 111.419 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -50.29 -40.15 47.59 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.853 1.261 . . . . 3.62 111.461 174.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 85.7 m -67.7 -45.89 73.82 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.516 0.727 . . . . 1.7 109.982 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.602 ' CD1' HG22 ' A' ' 140' ' ' VAL . 0.5 OUTLIER 50.38 81.78 0.06 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.249 1.02 . . . . 5.13 110.88 177.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.55 158.36 38.32 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.748 -0.834 . . . . 2.98 108.748 167.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 250' ' ' LEU . 1.3 mm? -105.76 160.63 15.08 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.531 1.532 . . . . 0.79 107.379 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 26.3 m -78.21 152.71 32.49 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.895 -0.503 . . . . 0.64 110.77 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -54.83 -45.99 74.55 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 122.882 0.473 . . . . 0.69 110.323 175.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -50.33 -54.48 21.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.698 0.761 . . . . 2.44 109.924 172.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -59.77 -47.11 86.99 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 114.899 -1.046 . . . . 2.18 110.35 -174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.9 mt -50.93 -49.22 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 125.576 1.551 . . . . 0.97 110.055 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -58.15 -48.87 78.91 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 120.827 -1.171 . . . . 5.04 110.492 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -56.91 -34.77 66.03 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.514 0.578 . . . . 1.31 112.824 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 224' ' ' LEU . 0.2 OUTLIER -68.83 -49.34 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.622 -1.251 . . . . 3.51 107.622 -178.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -63.59 -23.18 67.28 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.138 -0.977 . . . . 2.75 111.772 -171.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.4 m -47.61 -18.77 0.15 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.291 1.219 . . . . 2.35 114.291 168.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 24.5 mt -37.77 -48.51 1.1 Allowed 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.428 1.013 . . . . 2.51 113.319 169.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -170.63 85.86 0.11 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.272 -0.64 . . . . 8.08 109.272 178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 N-CA-C 105.963 -2.855 . . . . 8.43 105.963 179.042 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' NGH . . . . . 0.93 H102 ' H ' ' A' ' 182' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 3.3 ptt? . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 111.63 0.233 . . . . 12.41 111.63 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 173.77 177.4 42.94 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 107.966 -2.054 . . . . 11.34 107.966 -173.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -71.49 174.11 11.42 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.147 2.565 . . . . 11.82 110.29 177.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.2 p -147.93 167.1 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.554 -1.647 . . . . 7.8 106.554 174.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 39.1 p90 -120.81 156.55 31.67 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.929 0.892 . . . . 9.08 110.809 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -89.68 71.51 7.79 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.583 -1.266 . . . . 9.7 107.583 -175.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 73.38 -41.33 0.49 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.223 1.409 . . . . 7.37 113.141 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.6 m170 69.72 -61.54 0.44 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 127.704 2.401 . . . . 4.41 111.155 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -79.56 108.51 13.15 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.98 1.312 . . . . 3.93 108.199 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.4 mm -132.19 136.49 56.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 106.606 -1.627 . . . . 3.53 106.606 171.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.4 p -110.58 141.22 44.08 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.194 0.998 . . . . 1.75 109.116 177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.456 ' CD2' HG12 ' A' ' 159' ' ' ILE . 5.5 m-85 -126.77 152.15 47.27 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 124.127 0.971 . . . . 7.54 108.768 -172.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -146.94 143.02 28.17 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.357 -0.608 . . . . 4.67 109.357 178.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 118' ' ' ILE . 2.4 mt -88.36 156.98 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.947 -1.131 . . . . 0.92 107.947 175.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.15 -46.0 6.01 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.532 0.605 . . . . 2.78 109.976 -178.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -136.43 -179.8 5.9 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.491 0.716 . . . . 3.85 109.162 173.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -120.98 110.62 16.49 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 105.749 -1.945 . . . . 1.97 105.749 172.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.95 141.48 96.72 Favored Pre-proline 0 N--CA 1.443 -0.814 0 CA-C-N 119.038 0.836 . . . . 2.27 110.282 -173.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -68.36 -14.71 40.82 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 123.865 3.044 . . . . 1.52 111.377 174.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -41.84 -41.32 2.35 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.695 0.798 . . . . 2.45 110.72 173.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -134.6 -177.39 4.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.587 1.155 . . . . 1.83 109.94 175.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -84.86 156.45 21.29 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.31 0.644 . . . . 3.11 109.821 170.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 57.6 ttt-85 -52.47 -50.06 63.41 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.876 0.695 . . . . 2.93 112.876 -176.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.22 -2.22 15.25 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 118.598 -0.715 . . . . 4.94 111.84 -176.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -98.71 -45.03 6.18 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.529 1.059 . . . . 1.72 109.95 164.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.43 -47.45 90.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 121.546 -0.721 . . . . 2.1 109.367 -172.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.25 -26.44 61.11 Favored 'General case' 0 C--O 1.213 -0.846 0 C-N-CA 118.488 -1.285 . . . . 1.86 108.709 177.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -61.85 -50.68 71.29 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 119.918 1.235 . . . . 2.35 109.453 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.22 -53.33 55.0 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.031 0.932 . . . . 0.85 109.743 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -69.39 -40.35 79.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.442 0.639 . . . . 1.46 111.075 -175.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -58.06 -52.71 64.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.41 1.484 . . . . 5.0 107.783 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.632 ' O ' HG23 ' A' ' 140' ' ' VAL . 9.7 mmtp -62.94 -51.47 66.8 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.1 0.96 . . . . 1.43 110.661 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -48.17 -46.03 34.22 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 123.782 0.833 . . . . 1.06 110.869 177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 149' ' ' PHE . 0.7 OUTLIER -66.27 -53.83 32.12 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.324 -0.853 . . . . 4.58 110.139 176.068 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -47.38 -40.24 17.1 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.392 1.077 . . . . 2.64 111.934 -176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.639 HG12 HD21 ' A' ' 250' ' ' LEU . 84.5 t -48.93 -48.75 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 125.195 1.398 . . . . 0.95 109.449 175.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.896 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 59.3 m95 -80.23 -38.35 31.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 123.381 0.672 . . . . 0.8 111.497 178.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.5 m -61.99 -24.92 67.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.983 0.811 . . . . 2.54 111.577 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -73.34 -45.16 56.79 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.885 -0.413 . . . . 1.25 109.885 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.418 HG21 HD23 ' A' ' 250' ' ' LEU . 93.4 t -77.62 -49.84 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.227 1.011 . . . . 1.88 110.165 -171.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.445 ' CB ' HD12 ' A' ' 147' ' ' LEU . 81.2 p -79.43 153.94 76.48 Favored Pre-proline 0 N--CA 1.447 -0.618 0 N-CA-C 109.145 -0.687 . . . . 0.82 109.145 175.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -78.58 4.28 6.51 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.265 1.977 . . . . 0.75 112.55 173.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.75 HD11 HD13 ' A' ' 261' ' ' LEU . 4.6 mt -71.53 125.62 27.54 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.643 1.111 . . . . 1.79 109.658 -170.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -89.68 76.81 7.23 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.14 -1.43 . . . . 3.76 107.14 -169.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 138' ' ' PHE . 1.4 p90 -61.48 156.13 20.17 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 118.143 -1.423 . . . . 6.24 112.76 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.8 t -154.01 92.97 1.59 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.875 -0.787 . . . . 2.14 108.875 -177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -79.08 128.12 32.87 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 108.831 -0.803 . . . . 6.13 108.831 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.8 pp -133.89 148.71 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 105.901 -1.888 . . . . 1.22 105.901 174.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -115.8 6.07 14.27 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 118.079 0.4 . . . . 3.8 111.79 174.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 19.9 p -136.4 119.55 16.59 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.828 0.851 . . . . 2.32 108.817 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 121.6 -149.09 17.26 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 107.213 -2.355 . . . . 1.64 107.213 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -114.77 138.0 51.26 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.233 1.413 . . . . 5.14 107.298 172.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -110.08 164.27 12.79 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.691 1.196 . . . . 1.0 109.558 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -77.13 -46.66 22.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.829 -1.175 . . . . 2.73 107.829 178.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.456 HG12 ' CD2' ' A' ' 116' ' ' TYR . 0.7 OUTLIER -107.95 172.62 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 121.486 0.66 . . . . 1.8 111.554 173.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.58 133.67 36.61 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.008 2.123 . . . . 2.0 110.22 170.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 48.9 t -93.45 107.06 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.589 -1.263 . . . . 0.96 107.589 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 70.6 t -117.2 81.48 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.682 1.193 . . . . 1.81 109.378 -174.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -77.31 149.03 35.36 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 106.605 -1.628 . . . . 4.8 106.605 175.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.07 -170.4 3.27 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.266 -1.013 . . . . 1.24 108.266 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.06 141.35 47.15 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.587 0.63 . . . . 6.79 110.127 -178.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 33.25 -111.23 0.06 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.907 2.194 . . . . 1.98 113.72 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.84 112.67 14.94 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.815 -1.18 . . . . 2.55 107.815 174.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -134.05 -54.4 0.86 Allowed 'General case' 0 C--O 1.227 -0.098 0 C-N-CA 124.411 1.084 . . . . 4.08 110.876 -177.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 156.4 74.05 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 106.182 -2.767 . . . . 3.67 106.182 -166.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -157.77 164.88 36.6 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.532 -0.914 . . . . 2.05 108.532 170.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -83.11 -36.41 24.85 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 124.455 1.097 . . . . 4.9 109.405 171.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -83.24 -28.22 29.37 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.617 0.767 . . . . 6.61 111.332 -174.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 66.16 168.61 0.22 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.112 2.165 . . . . 3.22 113.001 -173.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -96.96 174.15 6.92 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.899 0.88 . . . . 6.37 109.832 168.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -137.63 166.57 23.6 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 126.698 1.999 . . . . 3.62 107.872 176.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -70.92 -156.96 2.18 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.384 0.516 . . . . 2.03 112.891 -176.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -51.91 111.01 0.54 Allowed 'General case' 0 N--CA 1.462 0.157 0 O-C-N 121.571 -0.958 . . . . 3.57 111.541 177.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.4 -151.79 17.47 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 109.474 -1.45 . . . . 2.45 109.474 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 50.33 -126.32 23.34 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 124.937 1.256 . . . . 2.37 110.372 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.443 HD12 ' H12' ' A' ' 269' ' ' NGH . 23.1 mm -78.21 124.75 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 107.532 -1.284 . . . . 1.76 107.532 172.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.8 mp -83.48 -31.71 26.38 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.318 -0.855 . . . . 1.73 110.653 167.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.412 ' O ' H101 ' A' ' 269' ' ' NGH . . . -171.15 153.28 3.66 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 114.929 1.455 . . . . 0.86 114.929 -177.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -136.3 125.95 25.42 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 126.543 1.937 . . . . 0.88 113.626 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -157.32 162.03 39.11 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 128.168 2.587 . . . . 0.58 104.935 -172.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -149.0 155.33 40.64 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 105.284 -2.117 . . . . 3.48 105.284 171.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -101.41 -74.65 1.08 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.374 -1.09 . . . . 0.67 110.374 172.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -68.52 174.12 8.83 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.067 1.845 . . . . 1.66 110.204 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 83.12 164.47 36.05 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 110.198 -1.161 . . . . 1.88 110.198 -170.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 2.8 p -82.9 179.94 7.62 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.157 0.983 . . . . 2.75 111.302 -175.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.27 -114.17 6.54 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.363 0.506 . . . . 1.76 111.915 171.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 191' ' ' ILE 0.255 2.7 tp -60.57 -40.78 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 117.386 -1.293 . . . . 1.78 109.195 -174.6 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -20.77 115.73 0.01 OUTLIER Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.332 1.92 . . . . 1.29 113.56 169.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 109.99 -49.44 0.85 Allowed Glycine 0 CA--C 1.533 1.178 0 C-N-CA 126.993 2.235 . . . . 0.76 110.64 -167.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -83.87 164.81 19.23 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.349 1.46 . . . . 2.1 111.216 -168.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.11 131.99 18.07 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.945 1.091 . . . . 0.7 113.945 -172.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -116.55 120.4 38.59 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-O 118.257 -0.878 . . . . 2.53 110.352 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.0 150.57 22.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.975 0.807 . . . . 2.72 111.877 169.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -76.25 93.17 3.37 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.047 0.939 . . . . 2.55 112.064 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -77.76 -8.43 57.97 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 118.061 -0.971 . . . . 2.31 111.632 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -57.36 -47.13 82.42 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 107.751 -1.203 . . . . 3.48 107.751 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . 0.268 9.5 pt-20 -73.49 175.57 6.89 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.922 1.344 . . . . 2.43 111.52 173.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -133.08 85.13 2.19 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.458 -1.682 . . . . 5.33 106.458 -171.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.463 ' CE2' HD23 ' A' ' 212' ' ' LEU . 0.0 OUTLIER -74.15 163.51 27.77 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.105 -1.407 . . . . 2.29 108.286 169.418 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.2 p -145.82 166.35 26.19 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.406 -0.961 . . . . 2.66 108.406 173.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.7 t -49.8 -39.26 37.73 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 121.214 -0.929 . . . . 2.03 111.013 165.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.69 138.98 40.42 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.313 0.645 . . . . 2.88 110.628 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 1.2 m -63.6 -16.95 62.27 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.485 1.514 . . . . 4.07 112.603 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.96 -66.07 2.98 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.157 0.885 . . . . 2.4 115.131 -167.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -80.27 -89.59 0.51 Allowed Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.409 -0.676 . . . . 1.3 111.409 -166.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 18.4 m -131.89 170.71 14.5 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 103.179 -2.897 . . . . 1.48 103.179 158.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -130.58 133.52 46.26 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 118.14 0.427 . . . . 1.59 111.009 171.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.463 HD23 ' CE2' ' A' ' 203' ' ' TRP . 3.4 tm? -63.69 -45.87 88.08 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.216 -0.661 . . . . 1.73 109.216 -175.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.21 -47.33 54.81 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 109.499 -0.556 . . . . 1.78 109.499 176.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.77 -60.45 3.43 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 124.038 0.935 . . . . 2.91 110.289 -178.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 8.5 m -56.22 -41.9 76.37 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.961 -0.563 . . . . 1.26 110.549 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.68 -51.63 68.76 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 117.921 -1.038 . . . . 0.46 110.549 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 70.9 t -45.89 -46.64 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 119.669 1.122 . . . . 0.83 110.22 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.623 ' CE1' ' CD2' ' A' ' 222' ' ' HIS 0.494 0.3 OUTLIER -64.76 -47.28 78.76 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.627 -0.671 . . . . 2.64 112.443 178.059 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . 0.409 ' CD ' ' HB1' ' A' ' 182' ' ' ALA 0.285 19.5 mm-40 -70.42 -48.59 55.33 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 120.727 -1.233 . . . . 2.93 113.376 -176.268 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.437 HG21 ' HA ' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -51.66 -42.01 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 107.862 -1.162 . . . . 1.64 107.862 171.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -54.86 -55.07 29.58 Favored Glycine 0 CA--C 1.539 1.588 0 N-CA-C 111.595 -0.602 . . . . 0.5 111.595 172.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.623 ' CD2' ' CE1' ' A' ' 218' ' ' HIS . 18.4 m-70 -50.22 -58.19 6.16 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 117.878 0.839 . . . . 1.27 110.514 177.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 10.9 t -47.94 -49.67 29.56 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.963 2.105 . . . . 1.6 110.737 -177.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.67 HD12 HD13 ' A' ' 147' ' ' LEU . 0.3 OUTLIER -65.32 -37.12 86.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 122.962 0.505 . . . . 3.59 110.061 -178.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 143.93 70.45 0.02 OUTLIER Glycine 0 C--N 1.338 0.67 0 N-CA-C 112.001 -0.44 . . . . 1.17 112.001 160.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.892 HD11 HG22 ' A' ' 258' ' ' ILE . 11.1 mt -133.94 155.61 49.62 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.182 0.593 . . . . 3.07 110.312 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -132.19 48.91 0.94 Allowed Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.823 1.201 . . . . 3.0 110.122 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 70.04 165.17 0.27 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.778 1.631 . . . . 3.2 112.514 -176.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.3 m -132.71 141.28 48.49 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 106.089 -1.819 . . . . 1.09 106.089 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 31.5 t -80.34 47.55 0.93 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.004 0.522 . . . . 2.28 111.718 -170.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -154.27 135.56 8.86 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-O 118.472 -0.775 . . . . 2.01 109.775 -171.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.89 -16.77 7.37 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.82 2.347 . . . . 1.89 114.403 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -76.44 -36.6 57.85 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 120.458 -1.401 . . . . 2.34 109.033 174.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.98 124.66 17.47 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.325 0.583 . . . . 1.32 109.586 167.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 69.2 t -64.59 -25.22 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.926 -0.768 . . . . 0.94 108.926 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 1.2 mmt -49.0 -23.96 1.34 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.099 1.518 . . . . 2.47 115.099 171.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -53.91 139.47 52.69 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 119.366 0.985 . . . . 6.27 110.59 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.641 ' O ' ' H91' ' A' ' 269' ' ' NGH . 20.1 Cg_endo -64.88 -23.45 62.13 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.274 1.982 . . . . 1.44 112.021 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.361 0.2 OUTLIER -94.52 154.43 17.41 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.606 -0.886 . . . . 2.91 108.606 178.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -72.86 150.03 43.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.617 -0.883 . . . . 2.21 108.617 -177.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -141.75 139.82 32.93 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.33 -0.989 . . . . 3.5 108.33 173.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -76.26 77.7 3.05 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.765 0.826 . . . . 3.6 109.509 -176.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 25.5 m -83.79 103.59 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 116.016 -0.538 . . . . 1.63 109.957 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.26 115.54 3.59 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.872 0.368 . . . . 3.53 110.323 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 8.8 mt -57.45 -24.42 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.268 0.627 . . . . 2.71 109.75 177.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -41.95 -43.54 3.15 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 124.121 0.968 . . . . 3.78 112.621 168.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 14.0 m -82.65 -47.74 11.72 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 123.204 0.602 . . . . 2.4 110.053 -177.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.437 ' CE1' HG22 ' A' ' 140' ' ' VAL . 59.7 t80 52.82 69.4 0.7 Allowed 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.256 1.022 . . . . 4.41 110.873 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 6.2 ppt_? -157.94 170.12 23.04 Favored 'General case' 0 N--CA 1.455 -0.213 0 O-C-N 121.447 -0.783 . . . . 3.48 110.142 175.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.639 HD21 HG12 ' A' ' 140' ' ' VAL . 0.8 OUTLIER -109.89 152.4 25.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.972 1.709 . . . . 0.93 107.47 -179.05 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.0 151.35 33.63 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 121.423 -0.798 . . . . 1.06 111.195 178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -47.69 -47.2 29.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.669 0.788 . . . . 1.03 110.786 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -57.49 -45.7 84.58 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.444 0.64 . . . . 2.45 110.8 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.461 ' O ' HG23 ' A' ' 258' ' ' ILE . 4.6 t0 -58.26 -50.61 72.97 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.993 -1.003 . . . . 2.36 108.866 177.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.5 mt -55.29 -33.16 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 126.078 1.751 . . . . 1.18 112.525 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -70.94 -50.79 30.79 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.726 -1.234 . . . . 5.95 109.809 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -46.87 -52.52 11.54 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.366 -0.694 . . . . 0.93 111.366 177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.896 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 1.9 pp -63.08 -45.48 98.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 123.655 0.782 . . . . 2.26 109.711 -176.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -61.47 -30.24 70.47 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 120.815 -1.178 . . . . 2.1 110.947 178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.88 -17.56 0.59 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.573 0.953 . . . . 1.79 113.573 172.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.75 HD13 HD11 ' A' ' 147' ' ' LEU . 36.4 mt -42.0 -42.67 2.91 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 120.026 1.284 . . . . 2.42 113.196 164.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -75.56 -69.05 0.51 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.593 -0.891 . . . . 7.58 108.593 170.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.021 0 N-CA-C 105.718 -2.953 . . . . 8.41 105.718 -178.417 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' NGH . . . . . 0.641 ' H91' ' O ' ' A' ' 238' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 61.8 mtt . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 117.147 -1.406 . . . . 16.71 107.468 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -117.0 71.21 0.28 Allowed Glycine 0 CA--C 1.53 0.997 0 CA-C-N 119.67 1.123 . . . . 12.89 111.721 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.32 142.72 41.81 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.807 1.671 . . . . 14.19 108.866 174.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.4 p -155.26 153.11 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 105.957 -1.868 . . . . 9.36 105.957 174.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.22 177.82 3.65 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.456 -0.942 . . . . 12.21 108.456 171.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 63.8 mmt-85 -64.57 -39.21 93.33 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.039 -1.038 . . . . 13.68 109.859 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.53 -135.17 0.34 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.246 2.219 . . . . 10.51 106.919 177.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -139.35 -88.41 0.21 Allowed 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.087 0.955 . . . . 7.79 108.637 173.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -146.12 145.51 30.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.591 1.556 . . . . 3.49 107.761 -173.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 114' ' ' ILE . 0.9 OUTLIER -128.86 96.83 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 108.32 -0.993 . . . . 2.81 108.32 176.406 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -104.41 140.4 37.97 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.683 1.593 . . . . 1.26 108.963 -174.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -122.79 160.81 25.21 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.115 0.966 . . . . 5.58 111.821 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.407 ' HG3' HD12 ' A' ' 160' ' ' LEU . 15.9 ptt180 -146.46 144.66 29.82 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.336 1.054 . . . . 8.23 110.012 177.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.476 HD11 ' HD2' ' A' ' 151' ' ' LYS . 5.4 mt -106.0 156.3 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.204 1.402 . . . . 0.94 107.509 175.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.414 HD21 ' HG ' ' A' ' 160' ' ' LEU . 45.7 m-80 -107.04 -44.15 4.46 Favored 'General case' 0 C--O 1.227 -0.092 0 C-N-CA 123.917 0.887 . . . . 3.93 110.54 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 13.1 p30 -152.2 172.96 15.57 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.499 1.119 . . . . 2.18 107.98 177.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -127.56 139.57 52.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.136 1.374 . . . . 2.12 107.86 -170.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.8 t -66.3 141.7 97.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.277 -0.638 . . . . 2.45 109.277 172.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -77.77 -16.31 14.69 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.74 2.96 . . . . 1.84 111.088 173.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -44.19 -44.37 7.75 Favored 'General case' 0 C--N 1.345 0.374 0 C-N-CA 124.875 1.27 . . . . 2.58 111.357 -178.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 22.0 mtm -126.28 168.86 13.53 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 125.919 1.687 . . . . 2.01 107.756 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -65.7 143.27 57.65 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 108.979 -0.748 . . . . 3.2 108.979 175.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -47.34 -48.21 25.51 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.01 0.823 . . . . 3.93 110.99 174.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -58.44 -18.81 31.4 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 118.54 -0.743 . . . . 3.14 112.205 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -93.59 -42.2 9.33 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.128 1.771 . . . . 2.06 110.458 173.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.5 t -53.22 -55.47 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 O-C-N 120.603 -1.31 . . . . 1.24 109.48 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.18 -24.88 65.01 Favored 'General case' 0 C--O 1.221 -0.421 0 C-N-CA 117.897 -1.521 . . . . 1.86 109.482 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -62.93 -48.89 76.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 119.399 0.999 . . . . 2.16 109.889 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.478 ' HB3' HD12 ' A' ' 212' ' ' LEU . . . -58.97 -48.8 80.25 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 122.403 0.281 . . . . 0.43 110.677 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 220' ' ' ILE . 0.2 OUTLIER -70.27 -37.24 70.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 121.227 0.537 . . . . 1.85 109.933 -179.211 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -55.42 31.48 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.277 1.031 . . . . 2.92 108.496 176.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.598 ' O ' HG23 ' A' ' 140' ' ' VAL . 19.0 mmmt -61.58 -46.64 89.03 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.397 1.079 . . . . 1.66 109.394 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -48.43 -55.77 9.98 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.364 0.666 . . . . 0.64 110.701 175.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -55.99 -51.78 66.51 Favored 'General case' 0 N--CA 1.457 -0.104 0 O-C-N 121.806 -0.559 . . . . 4.45 110.394 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.9 -35.27 57.92 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 112.757 0.651 . . . . 2.14 112.757 -175.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.704 HG12 HD21 ' A' ' 250' ' ' LEU . 91.4 t -56.89 -51.76 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 123.949 0.9 . . . . 0.81 109.862 175.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.453 ' NE1' HG22 ' A' ' 217' ' ' VAL . 95.0 m95 -77.35 -28.08 52.88 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 121.794 -0.566 . . . . 1.0 109.793 -175.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.34 -31.83 72.51 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.952 0.901 . . . . 1.5 109.744 175.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -66.05 -49.27 68.27 Favored 'General case' 0 C--N 1.341 0.23 0 O-C-N 121.644 -0.66 . . . . 1.27 109.682 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.633 HG21 HD23 ' A' ' 250' ' ' LEU . 64.7 t -70.77 -54.4 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 C-N-CA 123.07 0.548 . . . . 1.97 110.408 -176.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.619 ' CG2' HG13 ' A' ' 258' ' ' ILE . 81.5 p -82.5 137.19 45.04 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 109.603 -0.517 . . . . 0.85 109.603 -174.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -68.05 19.79 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.555 2.836 . . . . 1.5 113.88 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.444 HD13 ' HB ' ' A' ' 145' ' ' THR . 2.9 mp -81.06 166.08 21.07 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.774 1.63 . . . . 3.12 108.774 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -124.63 86.13 2.51 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 108.714 -0.847 . . . . 3.78 108.714 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -74.4 142.32 45.02 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.594 1.158 . . . . 5.86 113.256 -173.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.8 t -151.9 101.57 2.76 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.017 1.117 . . . . 0.9 114.017 -176.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.476 ' HD2' HD11 ' A' ' 118' ' ' ILE . 0.1 OUTLIER -80.39 126.1 30.76 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 120.157 -1.589 . . . . 2.9 109.963 172.071 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.401 HD11 ' HB2' ' A' ' 157' ' ' ALA . 2.6 pp -125.6 149.35 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 106.885 -1.524 . . . . 1.3 106.885 174.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -101.73 -15.63 16.91 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.825 0.345 . . . . 2.76 110.557 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 55.1 m -144.4 132.41 21.55 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 105.405 -2.072 . . . . 2.99 105.405 174.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 141.5 -155.27 25.17 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 106.882 -2.487 . . . . 1.6 106.882 -173.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 5.6 mtt -119.99 140.3 51.17 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.533 -2.025 . . . . 4.8 105.533 174.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.401 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -144.26 153.5 42.1 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 108.026 -1.102 . . . . 0.8 108.026 -176.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.29 -56.69 4.34 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.427 -1.323 . . . . 1.85 107.427 -167.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.1 pt -86.16 -174.66 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 114.82 -1.082 . . . . 1.62 110.541 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.414 ' HG ' HD21 ' A' ' 119' ' ' ASN . 1.1 tp -145.39 134.65 22.92 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.862 2.065 . . . . 2.67 107.689 173.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.7 t -97.04 98.33 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.182 -1.044 . . . . 0.76 108.182 172.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 72.7 t -80.25 129.34 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 107.804 -1.184 . . . . 1.5 107.804 173.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -111.07 126.55 54.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 104.618 -2.364 . . . . 5.12 104.618 156.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.722 ' HB3' ' CZ ' ' A' ' 174' ' ' PHE . . . -144.2 157.94 44.01 Favored 'General case' 0 CA--C 1.522 -0.103 0 N-CA-C 109.424 -0.584 . . . . 0.88 109.424 175.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -132.26 91.31 2.93 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.851 1.261 . . . . 4.14 109.347 -173.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 115.28 -55.31 0.54 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.759 1.171 . . . . 1.95 111.093 176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -152.78 165.73 34.46 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.998 0.919 . . . . 3.02 108.787 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.95 -37.57 0.08 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 112.642 0.608 . . . . 3.28 112.642 173.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -172.73 -50.53 0.05 OUTLIER Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.433 -1.067 . . . . 2.61 110.433 -173.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.86 155.38 31.02 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.305 -0.998 . . . . 2.55 108.305 171.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.61 -58.87 3.02 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 125.186 1.394 . . . . 6.14 107.97 -173.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -101.53 118.21 36.48 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.004 -1.48 . . . . 4.46 107.004 174.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -157.73 -55.03 0.07 Allowed 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 123.201 0.6 . . . . 2.47 111.049 -169.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.722 ' CZ ' ' HB3' ' A' ' 164' ' ' ALA . 35.9 m-85 -112.09 174.84 5.69 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.58 1.552 . . . . 6.15 107.646 176.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -179.38 31.99 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.878 0.871 . . . . 2.31 111.536 -174.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 55.01 -155.12 9.11 Favored Glycine 0 CA--C 1.532 1.148 0 O-C-N 120.714 -1.241 . . . . 1.36 111.604 -170.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.3 tttt -69.37 98.36 1.07 Allowed 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.271 1.028 . . . . 4.11 110.772 -177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 152.15 -175.21 30.94 Favored Glycine 0 C--O 1.24 0.512 0 N-CA-C 111.308 -0.717 . . . . 1.54 111.308 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 45.53 -118.6 3.09 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 126.834 2.159 . . . . 1.35 111.131 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 9.9 mm -80.58 129.61 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.723 -1.214 . . . . 1.51 107.723 179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.697 ' HB2' ' H1 ' ' A' ' 269' ' ' NGH . 3.8 mm? -81.42 -44.88 16.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.209 1.404 . . . . 2.31 109.025 165.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.989 ' O ' H102 ' A' ' 269' ' ' NGH . . . -164.26 149.76 10.5 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 113.062 0.764 . . . . 0.67 113.062 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -131.68 115.0 15.47 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.758 1.623 . . . . 1.01 112.469 -174.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -147.43 160.19 42.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.55 2.74 . . . . 0.6 105.476 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -150.45 160.05 44.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.855 -1.535 . . . . 3.56 106.855 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -81.65 -69.07 1.41 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.173 0.892 . . . . 1.23 111.968 175.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -58.73 132.79 49.98 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.42 2.08 . . . . 2.85 109.215 -176.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -75.69 44.7 1.78 Allowed Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.639 1.114 . . . . 2.19 112.876 -171.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.3 m -77.38 78.93 3.9 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.636 -1.246 . . . . 5.33 107.636 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 68.53 -101.26 0.75 Allowed Glycine 0 C--O 1.244 0.778 0 N-CA-C 110.317 -1.113 . . . . 3.02 110.317 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 2.7 tp -64.41 -39.34 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 O-C-N 121.67 -0.9 . . . . 2.36 109.465 -174.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -45.19 159.01 0.2 Allowed Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.468 1.032 . . . . 2.09 115.459 176.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 85.68 -52.89 4.65 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 109.715 -1.354 . . . . 1.32 109.715 -159.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.01 162.67 27.36 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.138 1.375 . . . . 1.95 108.418 -172.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -135.14 121.62 20.54 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.528 0.603 . . . . 0.63 112.614 -174.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -113.92 113.39 24.78 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-O 118.729 -0.653 . . . . 2.16 111.073 -171.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -96.28 144.65 26.26 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.371 0.668 . . . . 2.81 110.572 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -68.67 97.44 0.8 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.454 -0.794 . . . . 2.69 111.158 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -70.57 -30.15 66.78 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 120.978 -1.077 . . . . 2.69 109.834 173.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -46.89 -42.01 16.82 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.261 1.424 . . . . 2.64 109.301 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -74.81 172.13 12.73 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 122.347 1.07 . . . . 1.72 113.07 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -113.64 96.11 5.69 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.712 -1.218 . . . . 3.62 107.712 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.479 ' CH2' HG21 ' A' ' 215' ' ' THR . 18.9 m95 -75.03 151.04 38.76 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 107.931 -1.137 . . . . 1.2 107.931 172.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 82.4 p -129.92 134.19 47.33 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.407 0.683 . . . . 1.72 109.78 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.6 t -51.57 -43.87 62.57 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 123.961 0.904 . . . . 1.69 111.314 172.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.25 -157.88 0.34 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.645 1.178 . . . . 2.14 111.63 -178.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.5 m -60.66 -66.59 0.5 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.336 1.055 . . . . 3.77 110.801 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 42.66 -103.81 0.04 OUTLIER Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.106 1.336 . . . . 2.47 114.825 174.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -125.98 -71.93 0.19 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 124.309 0.957 . . . . 1.07 110.984 -173.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.3 m -119.21 168.14 11.17 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 105.556 -2.016 . . . . 1.22 105.556 167.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -123.56 128.99 50.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.156 0.182 . . . . 1.39 111.113 170.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.478 HD12 ' HB3' ' A' ' 133' ' ' ALA . 2.1 tm? -62.33 -48.14 81.12 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 118.699 -0.667 . . . . 2.11 109.495 -177.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -50.52 -43.9 56.06 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.89 0.768 . . . . 1.34 110.426 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 7.4 tt -63.24 -60.35 3.52 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.765 0.826 . . . . 1.24 109.698 -175.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.702 HG23 ' H2 ' ' A' ' 269' ' ' NGH 0.338 20.1 m -61.27 -38.01 85.2 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 120.454 -0.498 . . . . 0.66 111.128 179.235 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.09 -60.69 2.83 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 118.199 -0.905 . . . . 0.36 109.48 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.751 ' CG1' HG11 ' A' ' 235' ' ' VAL . 0.3 OUTLIER -51.87 -45.3 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 119.12 0.873 . . . . 1.65 111.061 -173.599 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.556 ' CD2' ' O4 ' ' A' ' 269' ' ' NGH . 13.0 t60 -52.1 -61.79 2.04 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.236 1.015 . . . . 2.53 112.762 168.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -57.41 -38.43 74.31 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.443 -1.411 . . . . 2.86 112.184 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.43 HD11 HD11 ' A' ' 134' ' ' ILE . 1.5 mp -67.97 -36.16 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 108.247 -1.02 . . . . 1.23 108.247 -177.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -55.81 -44.07 87.03 Favored Glycine 0 CA--C 1.538 1.486 0 O-C-N 121.808 -0.558 . . . . 0.55 111.747 166.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -55.35 -50.04 70.68 Favored 'General case' 0 C--N 1.344 0.343 0 O-C-N 122.106 -0.643 . . . . 1.36 109.272 175.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 47.2 t -44.09 -56.32 4.12 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.204 1.002 . . . . 1.9 112.4 -178.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 224' ' ' LEU . 0.2 OUTLIER -62.16 -55.49 28.24 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 119.101 0.864 . . . . 3.24 108.879 -178.369 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 155.38 37.07 0.02 OUTLIER Glycine 0 C--N 1.337 0.6 0 C-N-CA 120.906 -0.664 . . . . 1.13 114.607 174.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.551 HD13 ' SD ' ' A' ' 236' ' ' MET . 4.3 mt -84.64 113.11 21.04 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.65 1.225 . . . . 3.47 110.695 175.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -74.56 60.62 2.43 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 123.928 0.775 . . . . 2.3 111.552 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 78.3 m80 60.17 -170.65 0.14 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.099 1.359 . . . . 2.93 112.353 -177.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 58.1 m -148.06 -178.38 6.26 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.813 1.645 . . . . 0.96 108.865 167.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.9 t -139.19 38.72 2.11 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.884 0.874 . . . . 2.06 110.193 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -140.55 143.13 31.51 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 106.436 -1.69 . . . . 1.67 106.436 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -87.6 -13.58 4.05 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.848 1.698 . . . . 1.02 114.62 -173.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 18.2 mtmt -80.32 -36.83 33.69 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.948 -1.13 . . . . 1.17 107.948 170.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -54.33 137.27 42.13 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.408 0.623 . . . . 0.72 110.682 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.751 HG11 ' CG1' ' A' ' 217' ' ' VAL . 58.0 t -86.73 -17.04 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 114.751 -1.113 . . . . 0.59 109.886 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.551 ' SD ' HD13 ' A' ' 226' ' ' LEU . 7.9 tpt -76.15 -18.27 59.2 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 114.06 1.133 . . . . 1.71 114.06 -172.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.487 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.0 OUTLIER -48.86 161.05 0.43 Allowed Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 126.217 1.807 . . . . 3.01 114.389 176.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -79.32 -14.39 13.19 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.846 1.698 . . . . 0.95 112.37 172.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.542 ' O ' ' H4 ' ' A' ' 269' ' ' NGH 0.385 0.2 OUTLIER -78.39 168.1 20.32 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.539 -0.911 . . . . 1.14 108.539 176.605 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -112.48 133.96 54.27 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.315 -1.735 . . . . 2.37 106.315 172.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 38.7 tptt -134.92 148.35 50.03 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.997 -1.112 . . . . 3.41 107.997 172.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -71.38 79.56 0.75 Allowed 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.778 1.231 . . . . 3.91 109.174 178.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.8 m -76.63 112.76 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.831 -0.803 . . . . 1.77 108.831 177.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -64.77 118.22 8.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.965 -0.561 . . . . 3.01 110.501 -177.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 33.0 mm -58.98 -21.79 20.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 123.877 0.871 . . . . 3.19 111.197 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -55.49 -33.29 63.57 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 119.373 0.988 . . . . 3.6 111.595 172.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.6 m -80.33 -50.75 9.75 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.751 -0.463 . . . . 2.54 109.751 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.505 ' CZ ' HG22 ' A' ' 140' ' ' VAL . 54.2 t80 46.48 73.99 0.16 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.412 1.485 . . . . 4.41 112.142 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.76 167.91 25.87 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.558 -0.714 . . . . 2.69 109.781 175.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.704 HD21 HG12 ' A' ' 140' ' ' VAL . 0.3 OUTLIER -102.43 141.12 35.78 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 105.693 -1.966 . . . . 1.07 105.693 178.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.28 170.99 14.99 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.789 -0.449 . . . . 1.09 109.789 -172.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.92 -42.59 85.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.154 -0.618 . . . . 0.85 110.078 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -59.09 -45.81 89.9 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 110.3 -0.259 . . . . 2.64 110.3 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -56.22 -51.51 67.82 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 108.259 -1.015 . . . . 2.97 108.259 175.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.408 ' HA ' HG22 ' A' ' 258' ' ' ILE . 57.0 mt -59.3 -31.2 45.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 126.805 2.042 . . . . 0.88 112.663 -175.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -70.33 -58.53 3.65 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 121.039 -1.038 . . . . 5.58 110.04 172.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.522 ' C ' HD21 ' A' ' 226' ' ' LEU . . . -56.93 -44.2 92.63 Favored Glycine 0 CA--C 1.535 1.31 0 N-CA-C 111.758 -0.537 . . . . 1.1 111.758 -175.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.619 HG13 ' CG2' ' A' ' 145' ' ' THR . 10.2 tp -59.42 -34.77 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 124.08 0.952 . . . . 3.8 111.816 -176.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -86.41 -26.08 24.93 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.852 -0.53 . . . . 2.46 110.623 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 7.7 t -53.32 -18.22 2.35 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 117.851 -1.071 . . . . 1.85 113.064 171.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -29.37 -56.81 0.15 Allowed 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.654 1.582 . . . . 2.85 113.472 166.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 1.2 m-30 136.54 -59.82 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 129.041 2.936 . . . . 6.64 107.389 -177.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 N-CA-C 105.421 -3.072 . . . . 9.02 105.421 -160.846 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' NGH . . . . . 0.989 H102 ' O ' ' A' ' 182' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 49.4 mtt . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 117.406 -1.283 . . . . 19.19 107.813 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -161.44 174.86 38.05 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.483 -1.447 . . . . 16.5 109.483 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.21 173.95 12.86 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.563 2.842 . . . . 16.38 110.106 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.1 p -153.36 143.29 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.987 -1.116 . . . . 10.02 107.987 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -97.41 145.48 26.13 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.217 1.007 . . . . 13.47 109.296 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.2 -52.26 36.28 Favored 'General case' 0 C--O 1.227 -0.097 0 N-CA-C 109.476 -0.565 . . . . 8.69 109.476 175.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 14.4 tptt -76.54 -65.96 0.87 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.338 -0.847 . . . . 6.03 110.526 -162.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.0 m80 64.28 -62.23 0.18 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.894 2.078 . . . . 4.58 113.872 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -86.6 101.73 13.5 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 125.018 1.327 . . . . 3.27 110.06 -172.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.413 HG22 ' CE1' ' A' ' 116' ' ' TYR . 4.7 mm -124.15 109.57 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 108.539 -0.912 . . . . 1.85 108.539 -178.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.5 p -101.92 146.69 27.49 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.459 1.104 . . . . 1.24 109.858 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.43 ' CZ ' ' CE1' ' A' ' 138' ' ' PHE . 1.9 m-85 -130.11 159.78 35.75 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 119.194 -0.432 . . . . 5.76 111.045 -176.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -143.08 146.3 33.67 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.769 0.827 . . . . 5.28 109.045 175.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.34 157.54 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.458 -0.942 . . . . 1.16 108.458 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.565 HD22 ' H ' ' A' ' 119' ' ' ASN . 0.1 OUTLIER -91.61 -57.66 2.69 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.502 0.721 . . . . 3.1 109.746 171.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -149.79 171.68 16.35 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 110.168 -0.308 . . . . 1.86 110.168 175.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -105.68 118.08 35.66 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.974 1.31 . . . . 2.75 107.792 -175.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.6 t -71.07 135.7 84.95 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.636 -0.876 . . . . 2.6 108.636 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.03 -19.72 22.7 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.777 2.318 . . . . 1.92 112.548 -178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -42.64 -43.49 3.85 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.097 1.759 . . . . 2.59 112.37 179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -128.44 -179.89 5.28 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.371 1.468 . . . . 2.72 108.237 175.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -85.26 145.47 27.53 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.358 0.599 . . . . 2.9 110.24 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.9 ttt-85 -49.87 -47.58 51.77 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.635 0.774 . . . . 2.87 111.859 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -62.29 -4.88 2.0 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.012 0.925 . . . . 3.01 112.909 -177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -101.42 -46.35 5.03 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 126.104 1.762 . . . . 2.14 110.029 169.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 66.1 t -54.3 -56.37 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 124.569 1.147 . . . . 1.17 109.518 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.38 -26.96 65.83 Favored 'General case' 0 C--O 1.221 -0.441 0 C-N-CA 118.182 -1.407 . . . . 1.8 109.678 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -60.09 -50.12 74.95 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 119.613 1.097 . . . . 1.86 110.01 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.65 -54.42 37.94 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 123.409 0.684 . . . . 0.43 110.126 177.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.1 tp -66.21 -41.03 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.824 0.345 . . . . 2.13 110.926 -176.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -53.91 -60.18 3.66 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.491 1.517 . . . . 3.56 107.635 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -62.36 -46.11 90.17 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.281 -0.872 . . . . 1.4 110.141 -177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -51.05 -52.2 45.57 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.878 0.471 . . . . 0.46 110.721 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.438 ' CZ ' HG13 ' A' ' 220' ' ' ILE . 4.4 m-85 -55.16 -48.52 73.62 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.709 -0.223 . . . . 4.47 110.917 171.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.07 -35.16 61.74 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 118.573 -0.727 . . . . 1.91 111.861 -178.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.423 HG12 HD21 ' A' ' 250' ' ' LEU . 94.9 t -55.57 -65.04 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.312 0 CA-C-N 119.217 0.917 . . . . 0.9 109.821 177.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.868 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 41.5 m95 -70.66 -33.34 70.85 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.608 -0.886 . . . . 0.88 108.608 -171.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 t -68.51 -13.77 62.55 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 119.104 -0.474 . . . . 1.13 112.27 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.38 -52.49 7.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.911 -1.144 . . . . 1.05 107.911 177.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.447 HG11 HD23 ' A' ' 250' ' ' LEU . 4.9 m -82.47 -37.85 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.802 -0.636 . . . . 1.8 112.328 -171.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 1.044 HG22 HD13 ' A' ' 258' ' ' ILE . 1.3 p -87.38 150.5 49.2 Favored Pre-proline 0 N--CA 1.443 -0.791 0 N-CA-C 106.235 -1.765 . . . . 1.13 106.235 170.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.66 -0.5 10.7 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 121.538 1.492 . . . . 1.04 112.459 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.492 HD13 ' HB3' ' A' ' 224' ' ' LEU . 5.6 mt -61.28 117.05 5.12 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 119.245 0.93 . . . . 2.08 108.849 177.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 16.0 mttt -94.5 105.43 17.39 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 123.173 0.589 . . . . 4.6 109.518 -172.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -64.98 146.75 54.59 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.339 -0.846 . . . . 7.31 112.329 -177.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.5 t -154.08 96.98 2.01 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.286 0.565 . . . . 0.87 110.704 165.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -79.75 125.97 30.35 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 108.474 -0.936 . . . . 2.07 108.474 172.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.85 155.46 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 106.678 -1.601 . . . . 1.57 106.678 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -108.58 -9.31 15.34 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.939 0.791 . . . . 3.32 111.919 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 76.8 m -143.04 132.07 22.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.126 1.77 . . . . 2.05 106.67 179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 127.82 -156.79 20.79 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 107.962 -2.055 . . . . 2.38 107.962 -172.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 52.4 mtt -105.12 137.86 42.23 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.94 1.296 . . . . 4.92 108.159 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.74 147.08 50.01 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.438 1.095 . . . . 1.13 109.015 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -75.19 -50.24 16.88 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.124 -1.065 . . . . 2.0 108.124 175.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.4 154.11 12.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.447 0.642 . . . . 1.59 110.833 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.09 132.9 54.28 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.904 -1.147 . . . . 2.52 107.904 169.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 81.2 t -78.57 135.65 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 107.023 -1.473 . . . . 1.14 107.023 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 74.1 t -116.49 134.52 59.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 119.802 1.183 . . . . 1.33 109.29 172.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -95.97 149.44 21.57 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 107.668 -1.234 . . . . 7.66 107.668 167.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -159.04 149.04 19.18 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 120.536 -1.353 . . . . 1.28 110.26 170.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -120.25 132.93 55.54 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.604 1.162 . . . . 3.93 108.672 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 54.13 -96.8 0.03 OUTLIER Glycine 0 CA--C 1.523 0.569 0 C-N-CA 124.293 0.949 . . . . 2.11 111.833 -167.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -124.68 140.85 52.55 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.138 1.375 . . . . 2.13 108.852 -169.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -145.4 50.7 1.21 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 121.286 0.565 . . . . 2.59 110.363 177.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 66.92 56.87 10.85 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 108.395 -1.882 . . . . 2.26 108.395 -169.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -150.89 150.08 30.44 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.07 -1.826 . . . . 2.06 106.07 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -80.24 -47.96 13.81 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.749 -0.834 . . . . 4.25 108.749 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -134.46 87.42 2.35 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.273 1.029 . . . . 5.14 108.996 -173.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -107.05 -102.79 0.35 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.731 0.812 . . . . 2.45 109.309 174.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.408 ' CE1' ' HB3' ' A' ' 200' ' ' ASP . 26.2 t80 -89.66 161.82 15.91 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 121.932 0.872 . . . . 7.73 109.413 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.406 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 47.1 p-10 -168.85 26.75 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 113.682 -1.599 . . . . 3.48 110.613 -157.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 91.6 165.64 39.64 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 111.246 -0.742 . . . . 2.3 111.246 -170.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.432 ' HA ' ' CG ' ' A' ' 201' ' ' GLU . 0.0 OUTLIER -62.98 111.69 2.27 Favored 'General case' 0 C--N 1.34 0.195 0 O-C-N 122.544 -0.386 . . . . 5.38 110.542 166.3 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 119.8 -164.31 13.59 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 109.61 -1.396 . . . . 2.08 109.61 -171.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 59.06 -120.03 20.74 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 110.225 -1.15 . . . . 1.98 110.225 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.7 mm -76.57 122.78 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 105.699 -1.963 . . . . 1.72 105.699 168.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.424 HD22 ' C1 ' ' A' ' 269' ' ' NGH . 7.1 mp -81.57 -44.4 17.34 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.65 -0.5 . . . . 1.61 109.65 174.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -167.08 168.51 13.63 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.69 -0.631 . . . . 0.58 109.921 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -145.92 108.35 4.45 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.198 0.999 . . . . 1.06 113.377 -172.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -128.19 156.66 42.57 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.937 2.095 . . . . 0.64 107.107 172.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -145.29 149.15 34.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.024 -1.843 . . . . 2.75 106.024 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -95.75 -85.44 1.71 Allowed Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.506 -1.038 . . . . 0.69 110.506 174.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.38 86.54 0.66 Allowed 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.638 2.892 . . . . 1.24 111.196 -173.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -158.88 164.79 33.87 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 108.165 -1.974 . . . . 1.03 108.165 169.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.9 t -79.92 179.85 7.35 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 117.378 0.589 . . . . 3.3 109.964 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 43.8 -102.93 0.04 OUTLIER Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.814 1.674 . . . . 1.3 112.574 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.2 tp -60.3 -40.04 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 118.298 -0.858 . . . . 1.42 110.0 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -37.2 134.4 0.89 Allowed Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.675 1.131 . . . . 1.0 112.85 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 99.7 -47.77 1.29 Allowed Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.829 1.681 . . . . 0.75 111.392 -161.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -88.49 138.93 30.99 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.902 0.881 . . . . 1.28 110.084 -156.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -109.65 119.63 40.0 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.669 0.788 . . . . 0.72 112.663 -170.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . 0.28 0.0 OUTLIER -111.39 113.25 25.57 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-O 117.575 -1.202 . . . . 2.15 110.783 -171.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -103.03 152.33 21.48 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.42 1.464 . . . . 6.23 112.756 177.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -64.1 95.58 0.13 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 114.36 -1.291 . . . . 2.68 108.767 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -56.89 -40.0 75.42 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 125.395 1.478 . . . . 2.3 111.594 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.408 ' HB3' ' CE1' ' A' ' 174' ' ' PHE . 8.2 t70 -66.77 -28.34 68.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.53 1.132 . . . . 3.14 110.731 -178.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.432 ' CG ' ' HA ' ' A' ' 177' ' ' LYS . 5.4 mt-10 -69.85 127.1 31.73 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 107.732 -1.21 . . . . 2.3 107.732 174.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -80.59 78.68 7.31 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.904 -1.147 . . . . 2.7 107.904 -174.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -77.0 103.7 7.08 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.302 1.041 . . . . 2.24 110.562 -172.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -91.26 166.54 12.88 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 123.05 1.405 . . . . 2.53 110.72 -174.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.3 t -69.26 -43.44 73.95 Favored 'General case' 0 N--CA 1.44 -0.928 0 C-N-CA 127.542 2.337 . . . . 1.86 112.371 166.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -82.53 156.88 23.77 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.374 -0.83 . . . . 2.81 109.698 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.4 m -69.11 -32.99 72.78 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.991 1.717 . . . . 4.53 110.952 -167.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.81 133.77 52.63 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 111.066 -0.813 . . . . 2.98 111.066 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 90.28 -120.29 5.82 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 108.069 -2.012 . . . . 1.14 108.069 -175.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.45 142.38 50.8 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 108.273 -1.01 . . . . 1.23 108.273 162.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -96.81 121.48 38.72 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.363 0.414 . . . . 1.25 110.584 -176.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.79 -53.42 32.0 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 109.143 -0.688 . . . . 1.45 109.143 178.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.667 ' O ' HG23 ' A' ' 217' ' ' VAL . 35.9 t80 -47.36 -48.09 25.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.336 0.654 . . . . 1.46 110.637 179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.416 HD22 ' CD1' ' A' ' 240' ' ' TYR . 6.5 tt -60.17 -58.21 9.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.321 -0.4 . . . . 1.36 110.941 -174.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.392 80.4 m -56.37 -43.02 78.78 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.102 0.477 . . . . 1.08 110.22 176.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.61 -55.99 23.74 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 117.26 -1.352 . . . . 0.4 109.808 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 213' ' ' PHE . 38.9 t -47.95 -45.39 11.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 121.157 1.799 . . . . 0.86 110.951 -176.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.424 ' ND1' ' H4 ' ' A' ' 269' ' ' NGH . 0.4 OUTLIER -56.79 -56.49 20.81 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 112.78 0.659 . . . . 2.75 112.78 170.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -65.76 -44.4 85.98 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 120.406 -1.434 . . . . 3.54 112.737 -176.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.438 HG13 ' CZ ' ' A' ' 138' ' ' PHE . 1.4 mp -49.84 -49.06 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 125.923 1.689 . . . . 1.24 106.96 172.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.505 ' HA2' HD12 ' A' ' 226' ' ' LEU . . . -53.58 -52.46 41.54 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.684 -0.566 . . . . 0.61 111.684 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -50.25 -51.0 48.28 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 117.763 0.781 . . . . 1.22 110.642 175.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 7.0 m -57.34 -47.14 82.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.157 0.983 . . . . 2.25 110.951 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.492 ' HB3' HD13 ' A' ' 147' ' ' LEU . 82.1 mt -59.13 -22.6 61.15 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.481 1.112 . . . . 2.71 112.392 174.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 124.54 4.14 7.61 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 124.557 1.075 . . . . 1.53 112.877 173.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.505 HD12 ' HA2' ' A' ' 221' ' ' GLY . 30.6 mt -80.78 122.34 27.04 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 118.218 1.009 . . . . 3.92 110.849 -169.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -65.24 179.68 8.73 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.468 -0.653 . . . . 3.46 111.468 173.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -77.02 121.31 23.34 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.133 0.573 . . . . 1.58 110.595 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 2.8 m -76.09 173.95 10.65 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.829 -0.434 . . . . 1.29 109.829 169.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.3 t -140.03 52.22 1.69 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.679 1.192 . . . . 2.55 109.259 -172.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -155.29 140.8 12.54 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-O 117.739 -1.124 . . . . 1.8 108.436 -173.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -93.85 -3.19 2.96 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.657 2.238 . . . . 1.16 114.978 -175.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -83.7 -33.46 25.14 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 120.243 -1.536 . . . . 2.01 109.096 165.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.44 ' HB1' ' CG ' ' A' ' 254' ' ' ASP . . . -58.3 156.67 9.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.259 1.024 . . . . 0.9 112.229 171.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 77.7 t -105.39 -19.73 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 114.204 -1.362 . . . . 0.67 110.368 169.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 4.3 tpt -73.47 -9.03 58.26 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.826 1.047 . . . . 1.83 113.826 -176.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.38 167.14 1.34 Allowed Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 124.906 1.283 . . . . 3.32 113.07 176.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.407 ' HB2' ' H91' ' A' ' 269' ' ' NGH . 27.1 Cg_endo -73.61 -26.24 14.08 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.962 1.775 . . . . 1.62 112.111 170.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.353 0.2 OUTLIER -78.21 -178.89 5.89 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.224 1.81 . . . . 1.52 111.59 -170.039 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.416 ' CD1' HD22 ' A' ' 214' ' ' LEU . 73.9 t80 -113.72 148.62 36.1 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 126.184 1.793 . . . . 2.1 108.04 175.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -156.48 140.75 16.57 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.398 -1.334 . . . . 3.45 107.398 171.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -66.0 115.8 6.45 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.626 0.77 . . . . 3.34 110.19 -173.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 17.7 m -135.64 99.9 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 124.099 0.959 . . . . 1.82 110.015 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.0 137.81 57.96 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.263 0.554 . . . . 4.55 111.639 -179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.576 HG22 ' CD1' ' A' ' 213' ' ' PHE . 1.2 pt -81.43 35.74 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 113.509 0.929 . . . . 3.53 113.509 -169.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -109.3 -63.1 1.4 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.033 0.933 . . . . 3.48 109.497 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 61.9 m -63.21 -48.74 77.04 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.228 -0.656 . . . . 1.84 109.228 -176.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 55.36 89.38 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.337 1.055 . . . . 4.82 110.66 176.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.72 143.68 19.83 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.096 -0.705 . . . . 3.11 109.096 170.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.479 HD12 ' CH2' ' A' ' 141' ' ' TRP . 1.5 mm? -83.71 164.3 19.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 125.676 1.59 . . . . 0.89 107.802 174.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 5.0 m -78.74 151.38 32.12 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 122.119 -0.363 . . . . 0.7 110.1 174.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -55.68 -47.26 77.06 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.001 0.52 . . . . 0.85 110.291 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -51.47 -51.57 53.9 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.563 0.745 . . . . 2.5 110.163 175.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 258' ' ' ILE . 0.2 OUTLIER -57.15 -53.05 62.49 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.11 -0.95 . . . . 2.34 109.218 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.1 mt -50.79 -43.44 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 125.041 1.336 . . . . 0.9 111.259 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -61.43 -50.92 70.86 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 120.484 -1.385 . . . . 5.73 109.36 175.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -47.25 -47.19 21.6 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.003 0.811 . . . . 1.34 112.567 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 1.044 HD13 HG22 ' A' ' 145' ' ' THR . 0.5 OUTLIER -70.13 -38.58 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 118.175 0.988 . . . . 2.2 110.413 -174.417 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -61.18 -33.23 73.11 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.68 -0.408 . . . . 2.69 110.244 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.9 m -50.82 -23.03 2.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.934 1.087 . . . . 2.62 113.934 172.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 8.8 mt -55.88 -38.93 70.83 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 120.326 1.421 . . . . 2.96 113.028 176.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 22.0 t80 44.8 -127.04 1.08 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 122.88 0.472 . . . . 7.68 111.989 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.215 0 N-CA-C 108.192 -1.963 . . . . 8.81 108.192 -178.339 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' NGH . . . . . 0.424 ' C1 ' HD22 ' A' ' 181' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 65.3 mtm . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 108.271 -1.011 . . . . 18.57 108.271 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 119.09 157.2 10.29 Favored Glycine 0 CA--C 1.532 1.136 0 N-CA-C 110.332 -1.107 . . . . 10.99 110.332 -175.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.03 164.33 33.51 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 123.754 2.969 . . . . 9.43 110.245 176.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.1 p -161.78 162.71 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 107.633 -1.247 . . . . 6.77 107.633 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -85.83 169.74 13.06 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.211 0.604 . . . . 10.18 111.305 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.84 -39.07 52.54 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.715 0.806 . . . . 10.69 111.619 174.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -170.74 -56.98 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.862 -0.792 . . . . 6.16 108.862 -172.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 69.29 -64.83 0.32 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 126.984 2.114 . . . . 3.65 111.873 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -108.25 119.27 39.0 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.548 -1.279 . . . . 3.41 107.548 -176.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.0 mp -134.43 147.4 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 105.405 -2.072 . . . . 2.6 105.405 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.65 142.2 17.61 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 105.06 -2.2 . . . . 2.27 105.06 -173.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -125.67 165.7 18.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.69 1.196 . . . . 4.32 111.148 -174.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -154.85 161.23 41.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.814 -0.809 . . . . 6.5 108.814 174.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.71 155.0 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.339 -1.356 . . . . 0.79 107.339 174.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -80.71 -51.4 8.72 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.643 -0.502 . . . . 2.83 109.643 173.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -157.14 170.17 23.11 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.483 0.583 . . . . 3.05 111.174 167.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -94.16 126.86 39.65 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.994 1.318 . . . . 2.77 109.773 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.4 ' HB ' ' CE2' ' A' ' 163' ' ' PHE . 11.2 t -70.29 147.45 95.25 Favored Pre-proline 0 N--CA 1.442 -0.853 0 O-C-N 121.933 -0.479 . . . . 2.57 112.29 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -80.34 -16.19 10.93 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 124.678 3.585 . . . . 2.05 111.22 168.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -50.45 -36.6 34.1 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.858 1.663 . . . . 2.16 112.116 -176.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 13.7 mtm -133.61 -177.96 4.78 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.9 1.68 . . . . 1.91 106.949 172.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -78.71 139.74 38.43 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.326 -0.62 . . . . 2.88 109.326 171.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -51.39 -42.45 61.4 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.713 -0.617 . . . . 4.0 112.179 -176.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -65.19 -5.57 7.21 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.662 0.785 . . . . 3.08 112.274 -177.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -94.45 -47.41 6.58 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 126.515 1.926 . . . . 2.21 109.789 166.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.7 t -57.03 -61.72 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 C-N-CA 125.504 1.521 . . . . 1.15 109.454 -174.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -28.06 67.48 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 117.825 -1.55 . . . . 1.7 109.019 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -61.05 -50.99 71.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 118.859 0.754 . . . . 2.91 109.952 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.29 -48.11 77.29 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 122.906 0.483 . . . . 0.56 110.729 178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -71.9 -37.49 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.563 0.697 . . . . 1.55 110.128 -175.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 -55.45 33.66 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.872 1.269 . . . . 4.0 107.926 178.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.585 ' O ' HG23 ' A' ' 140' ' ' VAL . 39.6 mmtm -56.33 -51.84 66.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.383 -0.599 . . . . 2.87 109.383 176.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -49.37 -49.03 46.27 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.625 0.648 . . . . 0.56 112.426 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -61.71 -51.77 67.04 Favored 'General case' 0 CA--C 1.52 -0.208 0 O-C-N 121.894 -0.504 . . . . 4.59 109.902 173.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -55.82 -37.95 69.36 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.652 0.781 . . . . 2.0 110.777 -172.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 136' ' ' LYS . 42.5 t -53.61 -52.21 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.623 1.569 . . . . 0.76 108.844 177.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.404 ' CZ3' HG13 ' A' ' 258' ' ' ILE . 57.2 m95 -74.51 -32.72 62.59 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.997 -0.371 . . . . 0.71 109.997 -177.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.0 m -72.65 -9.2 58.33 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.215 0.45 . . . . 1.81 112.215 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -84.87 -52.39 6.05 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 107.565 -1.272 . . . . 1.16 107.565 175.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.415 HG11 HD23 ' A' ' 250' ' ' LEU . 5.7 m -76.42 -33.62 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 112.289 0.478 . . . . 1.78 112.289 -175.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.449 HG21 HD12 ' A' ' 258' ' ' ILE . 6.8 p -100.74 153.88 37.48 Favored Pre-proline 0 CA--C 1.531 0.219 0 N-CA-C 109.384 -0.598 . . . . 0.72 109.384 176.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -78.38 9.31 3.19 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.326 2.017 . . . . 0.81 112.967 176.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.4 mp -78.85 112.87 16.44 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.407 1.003 . . . . 2.44 108.862 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -95.61 73.22 3.17 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 121.701 -0.624 . . . . 3.42 111.676 -163.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -63.82 147.66 51.24 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.488 0.715 . . . . 5.92 112.123 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.9 t -149.68 147.5 28.15 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.576 1.55 . . . . 1.2 107.883 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -97.93 136.29 38.44 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.262 0.625 . . . . 2.04 109.87 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.2 pp -134.84 118.59 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 107.848 -1.167 . . . . 1.21 107.848 172.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -75.83 -32.24 59.72 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 119.723 -0.791 . . . . 3.33 110.13 172.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.6 m -113.94 95.68 5.44 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.681 0.792 . . . . 2.22 109.543 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 151.53 -154.24 25.44 Favored Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.665 -1.374 . . . . 1.4 109.665 170.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 6.6 tpt -111.82 136.67 50.8 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.182 1.393 . . . . 5.45 110.52 -177.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -129.36 163.83 24.91 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.849 1.66 . . . . 0.8 109.363 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.51 -41.12 56.06 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.509 -0.922 . . . . 1.68 108.509 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 33.6 pt -121.97 175.7 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.786 1.234 . . . . 1.19 109.508 -176.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 33.7 tp -148.62 130.24 14.97 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.2 1.4 . . . . 2.88 108.879 -173.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.7 t -88.19 109.04 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 108.429 -0.952 . . . . 0.88 108.429 169.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.7 t -88.26 142.05 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.308 -0.997 . . . . 1.45 108.308 168.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.4 ' CE2' ' HB ' ' A' ' 122' ' ' THR . 0.0 OUTLIER -131.64 125.26 31.71 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 104.565 -2.383 . . . . 6.05 104.565 172.332 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.45 ' HB3' ' HE2' ' A' ' 174' ' ' PHE . . . -159.45 161.25 35.46 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.337 -1.727 . . . . 1.31 106.337 -174.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 21.6 ptt-85 -123.87 152.94 41.79 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.523 -0.917 . . . . 4.13 108.523 175.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 69.2 -142.5 37.66 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.73 2.11 . . . . 1.63 113.013 172.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.16 129.83 34.86 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.937 -0.764 . . . . 2.25 108.937 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -141.52 34.44 1.64 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.791 0.436 . . . . 3.41 111.315 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 62.63 74.03 0.46 Allowed Glycine 0 CA--C 1.528 0.849 0 N-CA-C 110.113 -1.195 . . . . 2.3 110.113 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -151.43 166.69 30.3 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.777 -1.194 . . . . 2.13 107.777 -173.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.42 -50.01 15.24 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.328 -0.99 . . . . 5.69 108.328 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -102.02 -34.93 9.14 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.681 -0.69 . . . . 4.84 109.865 -177.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 58.44 -151.39 0.42 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.328 0.651 . . . . 2.58 111.572 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.45 ' HE2' ' HB3' ' A' ' 164' ' ' ALA . 31.6 m-85 -125.06 167.1 15.23 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.52 1.128 . . . . 6.01 108.389 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 14.4 p30 -140.72 -20.47 0.82 Allowed 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 115.763 1.764 . . . . 2.95 115.763 -150.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.47 132.91 0.27 Allowed Glycine 0 CA--C 1.534 1.24 0 N-CA-C 110.325 -1.11 . . . . 2.38 110.325 -162.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 34.9 tttt 56.31 -152.41 0.38 Allowed 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.389 -1.066 . . . . 5.99 110.079 -175.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.8 -107.42 0.01 OUTLIER Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.145 1.355 . . . . 1.56 115.343 -162.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 49.68 -114.59 2.42 Favored Glycine 0 C--N 1.34 0.759 0 CA-C-N 117.963 0.882 . . . . 1.28 111.987 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 10.6 mm -78.96 117.34 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 107.272 -1.381 . . . . 2.31 107.272 171.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.631 HD22 ' H5 ' ' A' ' 269' ' ' NGH . 7.7 mp -76.53 -60.26 2.42 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.318 -1.364 . . . . 1.41 107.318 170.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -164.82 169.69 16.35 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 121.08 -1.013 . . . . 0.74 109.522 -176.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -147.47 124.53 11.4 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 114.307 1.225 . . . . 0.96 114.307 -174.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -151.08 156.6 41.4 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.397 1.879 . . . . 0.55 106.454 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -145.52 160.36 41.73 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.471 -1.677 . . . . 3.22 106.471 175.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -90.44 -119.45 2.08 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 118.768 -1.018 . . . . 0.66 110.941 -176.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.75 79.35 1.26 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.678 2.252 . . . . 2.35 110.299 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -141.41 163.43 26.79 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 108.755 -1.738 . . . . 1.23 108.755 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.7 p -78.94 169.32 18.4 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.285 1.034 . . . . 3.34 112.055 -170.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 53.48 -114.3 3.74 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.358 0.98 . . . . 1.61 111.592 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.439 HG12 ' CE1' ' A' ' 196' ' ' HIS . 3.5 tp -62.2 -35.44 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 118.335 -0.84 . . . . 1.69 109.869 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -40.68 141.31 0.94 Allowed Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.42 1.009 . . . . 1.28 113.087 176.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 93.6 -48.2 2.32 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.168 1.366 . . . . 0.73 110.883 -160.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.64 171.06 10.75 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.041 0.937 . . . . 1.24 108.824 -167.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -144.9 122.83 12.0 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 118.725 -0.655 . . . . 0.57 112.473 -169.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.475 ' N ' ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -115.37 115.56 26.8 Favored 'General case' 0 C--N 1.347 0.473 0 CA-C-O 117.696 -1.145 . . . . 2.09 111.076 -171.248 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -92.38 148.51 22.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 119.752 1.16 . . . . 2.89 110.446 174.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.98 98.52 9.29 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 122.497 1.141 . . . . 3.42 112.017 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -49.93 -33.19 16.73 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 119.852 -1.78 . . . . 2.9 110.389 170.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -36.09 -47.44 0.55 Allowed 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.981 1.104 . . . . 3.6 113.981 172.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -73.78 156.34 37.93 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 123.252 1.501 . . . . 2.31 111.435 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -92.86 91.53 7.48 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 105.448 -2.056 . . . . 2.67 105.448 167.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -76.81 152.92 35.35 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 108.172 -1.047 . . . . 1.2 108.172 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 39.1 p -133.7 156.28 48.21 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.533 0.682 . . . . 1.85 110.345 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.3 -44.95 23.95 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.606 1.562 . . . . 1.69 110.379 170.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -76.66 178.43 6.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.022 1.329 . . . . 2.15 109.224 170.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.32 -60.83 2.86 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.036 1.334 . . . . 3.57 109.66 -172.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 57.1 -95.62 0.04 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 124.367 0.984 . . . . 2.34 112.563 168.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -135.41 -72.54 0.07 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.252 -1.539 . . . . 1.2 109.252 175.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.8 m -114.28 122.75 47.7 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 106.839 -1.541 . . . . 0.94 106.839 171.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -85.65 117.2 24.4 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.822 -1.177 . . . . 1.6 107.822 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -47.84 -53.66 14.92 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.271 0.628 . . . . 1.7 110.383 -175.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.475 ' CD1' HG22 ' A' ' 245' ' ' ILE . 30.3 t80 -43.4 -45.36 6.16 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.419 1.088 . . . . 1.71 110.77 177.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 2.6 tt -67.25 -57.5 6.56 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.302 -0.408 . . . . 1.41 110.707 -168.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 7.3 m -56.54 -46.55 80.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.453 -0.573 . . . . 1.16 109.453 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -48.0 -57.93 5.11 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 124.549 1.155 . . . . 0.57 110.69 -178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 71.0 t -48.27 -41.73 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 119.625 1.102 . . . . 0.7 111.168 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.441 ' NE2' ' CD2' ' A' ' 222' ' ' HIS . 0.2 OUTLIER -63.91 -54.48 34.08 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.311 -0.868 . . . . 2.33 112.404 178.161 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -73.74 -36.96 65.22 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.234 -0.917 . . . . 3.62 111.1 -174.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.7 -42.9 97.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 N-CA-C 107.001 -1.481 . . . . 1.52 107.001 173.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -47.05 -54.06 9.99 Favored Glycine 0 CA--C 1.536 1.37 0 O-C-N 121.401 -0.812 . . . . 0.45 111.571 166.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.441 ' CD2' ' NE2' ' A' ' 218' ' ' HIS . 9.0 m-70 -50.79 -45.03 59.0 Favored 'General case' 0 C--N 1.341 0.233 0 O-C-N 121.572 -0.957 . . . . 1.43 111.028 175.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 9.2 t -51.16 -41.17 59.96 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.213 0.605 . . . . 1.67 111.972 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 7.6 mp -63.72 -54.15 40.0 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.245 -0.65 . . . . 2.63 109.245 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 131.54 73.69 0.11 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 111.565 -0.614 . . . . 1.2 111.565 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.648 HD13 ' SD ' ' A' ' 236' ' ' MET . 1.1 mt -124.69 121.48 34.78 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.311 1.044 . . . . 3.44 108.858 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -76.64 56.2 3.4 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.76 0.695 . . . . 2.49 111.985 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 77.4 m80 57.73 -169.53 0.11 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.656 1.182 . . . . 2.45 112.066 -175.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 75.5 m -148.59 -179.82 7.26 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 106.461 -1.681 . . . . 0.95 106.461 165.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 36.9 p -136.77 37.82 2.62 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.43 1.492 . . . . 2.44 109.244 -168.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -139.88 136.49 17.37 Favored Pre-proline 0 N--CA 1.45 -0.468 0 N-CA-C 106.089 -1.819 . . . . 1.67 106.089 -173.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -85.73 -8.06 8.31 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.872 1.715 . . . . 1.04 114.287 -172.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -80.83 -42.95 20.77 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.929 -1.137 . . . . 1.18 107.929 168.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -55.19 140.74 37.7 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.203 0.525 . . . . 0.72 109.724 174.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 88.2 t -87.04 -23.14 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 108.684 -0.858 . . . . 0.72 108.684 179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.648 ' SD ' HD13 ' A' ' 226' ' ' LEU . 0.6 OUTLIER -55.69 -29.5 59.49 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 115.811 1.782 . . . . 1.7 115.811 -177.126 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -50.08 162.48 0.49 Allowed Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 125.659 1.584 . . . . 3.11 113.696 -172.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -77.93 -16.43 14.35 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 121.331 1.354 . . . . 0.95 111.907 170.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.377 0.2 OUTLIER -79.3 -179.7 6.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.167 1.387 . . . . 1.24 109.609 178.171 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -130.39 148.94 52.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 126.394 1.878 . . . . 2.09 106.144 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -150.66 173.88 13.65 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 105.768 -1.938 . . . . 2.46 105.768 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -87.75 117.82 26.84 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 119.578 1.081 . . . . 3.67 109.055 174.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 3.5 m -120.32 125.04 73.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.141 0 N-CA-C 107.669 -1.234 . . . . 1.53 107.669 170.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -81.21 120.21 24.59 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.223 -0.591 . . . . 4.94 109.756 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.475 HG22 ' CD1' ' A' ' 213' ' ' PHE . 1.1 pp -59.16 -27.81 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-N 116.307 -0.406 . . . . 3.53 110.803 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -66.27 -35.01 79.31 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 118.289 0.495 . . . . 4.01 110.313 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 29.6 m -66.55 -49.75 65.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.535 -0.543 . . . . 1.89 109.535 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.474 ' CD1' HG22 ' A' ' 140' ' ' VAL . 0.4 OUTLIER 51.12 83.21 0.05 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.91 0.862 . . . . 5.06 110.562 179.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.48 158.35 31.78 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 121.64 -0.663 . . . . 4.06 109.345 169.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.554 ' N ' HD22 ' A' ' 250' ' ' LEU . 1.3 mm? -108.16 157.15 18.55 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.734 -1.58 . . . . 0.75 106.734 177.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 29.6 m -77.49 151.52 34.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.005 -0.434 . . . . 0.65 110.106 -179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.41 -45.41 46.18 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.699 0.4 . . . . 0.72 110.086 171.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -59.63 -36.11 75.7 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.588 0.708 . . . . 2.41 111.605 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -71.77 -51.52 22.27 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.709 1.243 . . . . 1.97 108.887 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 41.0 mt -52.79 -49.06 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 126.831 2.052 . . . . 0.94 112.124 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -55.19 -43.36 74.29 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 120.498 -1.376 . . . . 7.85 110.535 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -55.63 -40.42 78.91 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.045 -1.222 . . . . 0.79 110.045 174.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 258' ' ' ILE . 0.2 OUTLIER -66.91 -45.18 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 C-N-CA 123.257 0.623 . . . . 3.24 111.267 -176.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -63.31 -27.17 69.14 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 119.343 -0.943 . . . . 2.35 110.515 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.29 -15.27 0.91 Allowed 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.145 1.165 . . . . 1.89 114.145 169.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 76.7 mt -46.91 -26.88 1.08 Allowed 'General case' 0 C--N 1.346 0.447 0 CA-C-N 121.055 1.752 . . . . 2.37 113.192 164.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -131.1 96.09 3.95 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.57 0.623 . . . . 6.88 110.238 175.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 116.246 -2.419 . . . . 8.52 111.785 173.596 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' NGH . . . . . 0.631 ' H5 ' HD22 ' A' ' 181' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 3.2 ptt? . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.171 -0.307 . . . . 15.69 110.171 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 112.74 -93.98 0.7 Allowed Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.461 -1.456 . . . . 8.99 109.461 -172.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.68 125.9 14.54 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.332 2.021 . . . . 11.54 109.815 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 70.5 t -148.19 156.96 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 127.049 2.14 . . . . 6.51 105.809 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 13.1 m-90 -68.45 168.42 12.77 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 119.116 0.871 . . . . 10.66 111.365 176.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -100.13 -42.76 6.57 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.746 0.818 . . . . 8.67 111.071 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.9 tptt -97.86 -53.49 3.39 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.861 0.319 . . . . 6.93 111.861 -162.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 74.94 -68.85 0.2 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.902 1.681 . . . . 5.34 111.368 172.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -102.56 113.5 26.93 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 126.199 1.8 . . . . 3.03 109.128 -174.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.436 HG22 ' CE1' ' A' ' 116' ' ' TYR . 1.4 mm -117.76 88.45 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 122.11 0.957 . . . . 2.08 109.33 -173.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 p -87.25 146.19 26.07 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.441 0.696 . . . . 1.31 109.495 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.438 ' CE2' ' CD1' ' A' ' 138' ' ' PHE . 10.5 m-85 -129.92 166.2 20.51 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.728 0.811 . . . . 6.69 110.364 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.564 ' HG3' HD23 ' A' ' 160' ' ' LEU . 9.5 ptt180 -153.51 168.91 24.56 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 123.335 0.654 . . . . 7.6 110.458 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.2 mt -119.4 148.53 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.265 -1.383 . . . . 1.12 107.265 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.597 ' ND2' HD11 ' A' ' 160' ' ' LEU . 29.9 m-20 -89.55 -67.71 0.82 Allowed 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.961 -1.126 . . . . 4.25 107.961 171.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -138.96 162.0 35.95 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.176 0.806 . . . . 1.97 113.176 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -104.3 154.0 20.34 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.411 1.884 . . . . 2.35 108.85 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.7 t -85.48 149.78 52.61 Favored Pre-proline 0 N--CA 1.444 -0.74 0 C-N-CA 124.3 1.04 . . . . 2.7 111.68 172.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -86.93 -17.6 3.1 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.155 3.236 . . . . 2.18 111.104 169.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -56.69 -46.84 80.95 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 123.963 0.905 . . . . 3.88 109.83 -177.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 4.2 mmt -101.49 -169.87 1.75 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.477 1.111 . . . . 3.38 108.037 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -103.28 145.76 29.47 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 108.397 -0.964 . . . . 2.93 108.397 167.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -55.38 -39.98 70.78 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.711 -0.618 . . . . 2.33 111.196 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -64.25 -7.68 10.16 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.706 -0.679 . . . . 3.17 112.302 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -95.67 -50.16 5.06 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.512 1.125 . . . . 3.25 109.259 162.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -50.58 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 118.894 0.77 . . . . 2.35 110.329 -166.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.492 ' HB3' ' NZ ' ' A' ' 151' ' ' LYS . 0.2 OUTLIER -76.19 -19.15 58.68 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 118.066 -1.454 . . . . 1.71 109.776 178.558 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -73.1 -46.17 52.83 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 119.135 0.88 . . . . 2.22 108.736 -175.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -50.4 -54.24 23.31 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 124.184 0.994 . . . . 0.52 109.619 171.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.82 -48.79 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 121.059 -0.256 . . . . 2.33 110.472 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -50.26 -57.76 7.12 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.178 1.391 . . . . 4.34 108.899 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -64.7 -43.23 94.16 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.191 -0.913 . . . . 2.36 109.485 -176.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -53.01 -52.73 57.47 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.001 0.52 . . . . 0.45 110.134 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.471 ' CE1' HG13 ' A' ' 220' ' ' ILE . 61.5 m-85 -54.23 -44.84 72.06 Favored 'General case' 0 C--O 1.231 0.111 0 O-C-N 122.182 -0.324 . . . . 4.58 111.007 171.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.34 -37.19 67.13 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 118.547 -0.739 . . . . 2.0 111.852 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.435 HG12 HD21 ' A' ' 250' ' ' LEU . 62.7 t -55.55 -63.3 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 119.121 0.873 . . . . 0.84 109.571 177.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.906 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 58.7 m95 -70.48 -32.58 70.17 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.964 -0.754 . . . . 0.68 108.964 -171.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.3 t -64.62 -14.12 56.58 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 118.064 -0.97 . . . . 1.27 112.998 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -82.67 -48.27 11.09 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.036 -1.098 . . . . 1.04 108.036 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 32.3 m -76.98 -46.37 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 112.282 0.475 . . . . 1.5 112.282 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.712 HG22 HD13 ' A' ' 258' ' ' ILE . 22.9 p -82.81 152.54 66.3 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 108.18 -1.045 . . . . 0.61 108.18 177.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -79.26 9.07 3.53 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.334 2.023 . . . . 0.7 112.224 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.406 ' HB3' HG13 ' A' ' 114' ' ' ILE . 29.2 mt -67.52 108.79 2.97 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.502 1.046 . . . . 1.75 110.307 -178.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.1 mpmm? -70.94 91.13 0.84 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.463 0.649 . . . . 3.64 109.619 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.94 134.56 57.22 Favored 'General case' 0 CA--C 1.527 0.093 0 C-N-CA 127.456 2.303 . . . . 6.42 109.687 168.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.3 t -153.46 106.69 2.96 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.372 -0.233 . . . . 0.77 110.372 163.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.492 ' NZ ' ' HB3' ' A' ' 131' ' ' ASP . 1.8 tmmt? -80.87 130.25 34.95 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.705 -0.85 . . . . 1.96 108.705 173.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.0 pt -128.47 142.2 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.037 -1.468 . . . . 1.35 107.037 177.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -95.59 -15.62 22.67 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 122.497 -0.127 . . . . 3.12 110.752 -177.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 52.8 m -136.57 130.09 31.85 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 125.096 1.358 . . . . 2.39 107.487 172.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 137.89 -152.87 21.94 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 107.999 -2.04 . . . . 1.6 107.999 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 41.2 mtp -123.73 131.57 53.63 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 125.892 1.677 . . . . 4.5 106.746 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -136.72 158.74 43.73 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.769 0.828 . . . . 0.89 110.304 -175.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -76.59 -49.11 17.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.706 -0.85 . . . . 1.63 108.706 -167.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.14 171.82 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 121.358 0.599 . . . . 1.25 110.772 172.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.597 HD11 ' ND2' ' A' ' 119' ' ' ASN . 1.0 OUTLIER -144.59 144.1 31.12 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.917 2.087 . . . . 3.22 109.1 178.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.505 ' N ' HD22 ' A' ' 160' ' ' LEU . 37.3 t -83.02 106.45 13.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 125.153 1.381 . . . . 1.24 109.054 170.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 69.9 t -84.84 118.3 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.215 -1.031 . . . . 1.39 108.215 171.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -80.87 138.79 36.19 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 105.856 -1.905 . . . . 7.49 105.856 160.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -147.14 161.59 40.57 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.564 -1.643 . . . . 1.22 106.564 174.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.6 ptt85 -155.92 121.36 4.87 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.45 -0.574 . . . . 3.65 109.45 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.465 ' HA2' ' CD1' ' A' ' 174' ' ' PHE . . . 80.4 -52.42 4.34 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.587 -0.605 . . . . 2.69 111.587 175.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -154.03 170.76 20.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.166 0.986 . . . . 2.23 108.489 173.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -159.76 -42.17 0.05 Allowed 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 123.84 0.856 . . . . 2.9 110.123 166.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 140.37 77.06 0.05 OUTLIER Glycine 0 CA--C 1.524 0.631 0 N-CA-C 107.349 -2.301 . . . . 2.7 107.349 -172.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -156.59 -177.91 6.95 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 106.371 -1.715 . . . . 2.42 106.371 -177.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -79.18 -50.27 11.24 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.952 -1.129 . . . . 5.84 107.952 165.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.47 -60.99 1.44 Allowed 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 122.831 0.452 . . . . 6.02 110.002 -174.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 68.48 -51.91 0.56 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.098 1.759 . . . . 3.46 114.519 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.502 ' CG ' ' N ' ' A' ' 175' ' ' ASP . 0.0 OUTLIER -159.99 -175.77 5.29 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 127.637 2.375 . . . . 7.93 105.364 -172.122 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.502 ' N ' ' CG ' ' A' ' 174' ' ' PHE . 13.7 p30 177.2 43.59 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.863 1.265 . . . . 2.37 111.296 169.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 53.16 -158.43 4.16 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.49 -0.644 . . . . 1.45 111.49 -177.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -76.73 119.1 20.05 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 114.94 -0.63 . . . . 5.21 109.78 -177.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 107.91 -160.86 13.71 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.118 -1.193 . . . . 1.61 110.118 -168.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 55.08 -128.52 43.96 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 125.038 1.304 . . . . 1.47 111.515 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.435 ' CD1' H102 ' A' ' 269' ' ' NGH . 0.5 OUTLIER -77.65 134.17 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 C-N-CA 125.44 1.496 . . . . 3.05 107.299 178.762 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.534 HD22 ' H5 ' ' A' ' 269' ' ' NGH . 0.2 OUTLIER -85.14 -55.67 3.93 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.681 1.992 . . . . 1.21 109.14 173.448 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -163.78 162.44 23.83 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.495 -0.753 . . . . 0.67 111.617 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -154.14 105.01 2.67 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.356 1.462 . . . . 0.96 112.295 -174.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -121.63 158.81 27.81 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.113 2.165 . . . . 0.81 109.651 174.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -154.74 132.0 11.08 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 107.29 -1.374 . . . . 2.99 107.29 176.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -80.12 -89.23 0.51 Allowed Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.286 0.946 . . . . 1.01 112.836 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.08 83.76 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.943 3.096 . . . . 1.56 111.041 -169.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -160.05 165.31 34.7 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.532 -1.427 . . . . 1.14 109.532 172.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.8 m -78.89 169.99 17.37 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.468 0.707 . . . . 1.99 111.149 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 55.08 -108.06 0.89 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 123.827 0.727 . . . . 1.45 111.588 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 8.9 tp -59.82 -40.07 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 118.547 -0.739 . . . . 1.63 109.671 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -42.12 143.23 1.17 Allowed Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.399 0.999 . . . . 1.12 113.111 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 94.26 -59.21 1.97 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.908 1.718 . . . . 0.82 109.213 -155.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -79.38 148.51 31.99 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.898 -0.778 . . . . 1.44 108.898 -155.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -112.24 120.42 41.69 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 118.963 -0.542 . . . . 0.62 110.272 -174.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.497 ' N ' ' CD2' ' A' ' 196' ' ' HIS . 0.0 OUTLIER -107.15 137.89 44.36 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.024 -1.473 . . . . 2.42 107.024 -175.74 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -127.69 144.29 51.09 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.172 -1.418 . . . . 2.68 107.172 175.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -74.26 67.19 1.37 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.783 -1.191 . . . . 2.94 107.783 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -54.5 -45.4 73.25 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.811 -1.181 . . . . 2.62 107.811 -174.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -32.54 -44.25 0.1 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.937 1.695 . . . . 3.84 112.044 -170.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -63.97 -178.44 0.33 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 129.412 3.085 . . . . 2.21 109.399 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -129.06 90.2 2.99 Favored 'General case' 0 CA--C 1.52 -0.206 0 O-C-N 120.095 -1.628 . . . . 3.02 108.701 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.445 ' HB2' ' HB ' ' A' ' 210' ' ' THR . 5.7 p-90 -134.67 119.46 18.33 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.726 0.81 . . . . 3.31 111.32 -173.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 14.9 p -153.62 158.62 41.42 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.822 1.249 . . . . 3.86 111.014 -177.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.66 -47.13 63.9 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 124.255 1.022 . . . . 4.64 109.874 172.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -67.78 -29.87 69.17 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 114.884 -1.053 . . . . 4.97 110.887 -167.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 38.0 t -81.64 -44.82 16.65 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.707 -0.849 . . . . 8.67 108.707 174.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 115.09 -35.56 4.32 Favored Glycine 0 C--N 1.339 0.706 0 C-N-CA 124.579 1.085 . . . . 3.28 110.649 -178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -27.17 -92.85 0.01 OUTLIER Glycine 0 CA--C 1.533 1.158 0 C-N-CA 128.782 3.087 . . . . 1.08 114.589 -173.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 203' ' ' TRP . 88.5 m -118.66 123.04 43.97 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 104.525 -2.398 . . . . 1.72 104.525 160.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -69.96 120.19 15.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 118.491 -1.284 . . . . 1.37 109.541 172.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 60.8 tp -50.41 -50.75 51.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.827 -0.606 . . . . 1.73 111.693 177.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.537 ' O ' HG23 ' A' ' 217' ' ' VAL . 18.0 t80 -52.24 -49.88 63.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 118.974 0.806 . . . . 1.38 110.767 176.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.5 tt -57.33 -60.92 2.91 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.994 0.917 . . . . 1.2 110.705 -174.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.351 25.4 m -60.71 -35.98 77.67 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 109.945 -0.391 . . . . 1.53 109.945 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.59 -52.2 62.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 117.053 -1.451 . . . . 0.48 110.712 173.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 213' ' ' PHE . 35.1 t -44.93 -53.22 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 121.579 1.991 . . . . 0.89 110.922 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.493 ' NE2' ' CE1' ' A' ' 222' ' ' HIS . 4.0 t60 -56.03 -54.05 49.59 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.854 0.862 . . . . 2.68 111.632 176.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -71.23 -44.68 64.87 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 120.797 -1.189 . . . . 4.03 112.45 -173.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.471 HG13 ' CE1' ' A' ' 138' ' ' PHE . 1.7 mp -49.98 -44.79 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.604 1.562 . . . . 1.46 108.265 166.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -53.19 -51.14 48.68 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.546 -0.721 . . . . 0.46 111.82 170.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.493 ' CE1' ' NE2' ' A' ' 218' ' ' HIS . 4.5 m-70 -52.03 -42.41 63.05 Favored 'General case' 0 C--N 1.34 0.173 0 O-C-N 121.429 -1.042 . . . . 1.44 111.492 174.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 6.3 m -58.11 -26.61 62.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 112.797 0.665 . . . . 2.24 112.797 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.4 mt -73.77 -51.96 14.74 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.068 -1.086 . . . . 2.14 108.068 171.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 138.48 70.38 0.05 OUTLIER Glycine 0 C--N 1.34 0.755 0 C-N-CA 122.844 0.259 . . . . 1.25 112.548 170.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.637 ' CD1' HG22 ' A' ' 258' ' ' ILE . 15.6 mt -132.74 105.57 7.25 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.178 0.591 . . . . 3.28 109.771 -172.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -76.75 43.3 1.89 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.338 0.97 . . . . 3.09 113.046 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 22.0 m80 73.88 155.51 0.16 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.356 1.862 . . . . 1.71 111.605 -175.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 58.1 m -120.17 132.0 55.22 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 126.149 1.78 . . . . 1.83 106.321 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 22.6 p -79.64 57.02 2.36 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.398 0.679 . . . . 3.2 110.854 -175.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -156.18 137.8 9.73 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 118.006 -0.997 . . . . 2.2 109.733 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -80.92 -20.89 7.26 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.76 2.306 . . . . 1.45 114.606 -177.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -27.42 48.91 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 119.258 0.935 . . . . 2.12 109.957 175.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.419 ' HB1' ' CG ' ' A' ' 254' ' ' ASP . . . -65.81 130.65 44.01 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.602 1.161 . . . . 1.08 110.105 168.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 85.8 t -70.94 -25.84 26.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.899 0.856 . . . . 0.93 110.165 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -53.03 -18.12 1.87 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.95 1.3 . . . . 1.74 114.278 170.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.415 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 10.3 t80 -56.32 137.89 74.92 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 119.738 1.154 . . . . 5.72 110.492 -174.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.415 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 43.4 Cg_endo -63.84 -21.77 69.17 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.88 2.387 . . . . 1.38 112.597 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.359 0.2 OUTLIER -92.05 130.74 37.72 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.279 -0.637 . . . . 2.21 109.279 -179.558 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -76.71 141.67 40.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.638 -0.875 . . . . 2.07 108.638 176.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.84 131.08 13.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.193 -1.78 . . . . 2.46 106.193 170.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -54.73 115.01 1.93 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.066 0.946 . . . . 3.08 110.599 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 14.4 m -94.18 138.92 19.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 122.957 0.503 . . . . 1.55 110.726 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.41 89.64 1.25 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.985 -0.746 . . . . 3.9 108.985 173.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 47.1 mt -48.88 -31.25 3.83 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 C-N-CA 123.848 0.859 . . . . 2.68 110.335 174.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -39.33 -41.54 0.93 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.438 1.495 . . . . 3.51 113.589 171.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 8.4 m -81.38 -41.58 21.75 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 123.796 0.838 . . . . 1.9 110.57 -177.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 78.9 t80 46.77 70.63 0.38 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.15 1.38 . . . . 4.68 111.511 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -156.55 167.17 31.26 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 121.57 -0.706 . . . . 3.75 109.91 175.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.51 HD12 ' CH2' ' A' ' 141' ' ' TRP . 2.0 mm? -105.9 157.81 17.22 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.727 1.611 . . . . 1.09 108.009 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 10.1 m -79.44 154.31 29.03 Favored 'General case' 0 C--O 1.221 -0.404 0 O-C-N 121.295 -0.878 . . . . 1.03 111.418 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.13 -48.63 75.88 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.975 0.893 . . . . 1.14 109.862 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.61 -52.37 18.14 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.192 1.797 . . . . 4.62 108.633 172.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.419 ' CG ' ' HB1' ' A' ' 234' ' ' ALA . 0.7 OUTLIER -63.38 -46.02 88.41 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.978 -1.01 . . . . 2.22 110.516 -176.278 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.4 ' HA ' HG13 ' A' ' 258' ' ' ILE . 45.3 mt -53.12 -42.23 44.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.725 2.01 . . . . 0.97 110.35 176.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -64.75 -48.82 73.16 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.007 -1.058 . . . . 5.89 111.078 172.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -45.42 -55.5 6.8 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 111.764 -0.535 . . . . 0.82 111.764 174.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.906 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 1.9 pp -65.81 -40.51 87.86 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 C-N-CA 123.982 0.913 . . . . 2.18 111.361 -176.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.569 ' N ' HD12 ' A' ' 258' ' ' ILE . 3.9 mt-30 -62.18 -30.02 70.77 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 120.741 -1.224 . . . . 2.56 110.849 174.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.8 -14.43 2.34 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.101 1.149 . . . . 1.87 114.101 169.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 52.3 mt -47.27 -26.78 1.31 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 121.02 1.736 . . . . 2.38 112.716 164.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -69.67 -43.89 71.61 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 118.951 0.796 . . . . 6.92 111.93 172.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 117.232 -1.871 . . . . 8.36 108.674 -174.475 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' NGH . . . . . 0.534 ' H5 ' HD22 ' A' ' 181' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_